<SEC-DOCUMENT>0000950170-25-042754.txt : 20250320
<SEC-HEADER>0000950170-25-042754.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250320170030
ACCESSION NUMBER:		0000950170-25-042754
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eledon Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		25757334

	BUSINESS ADDRESS:	
		STREET 1:		19800 MACARTHUR BLVD.
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19800 MACARTHUR BLVD.
		STREET 2:		SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Novus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>eldn-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-20T15:30:40.4066+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:eldn="http://www.eledon.com/20241231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_90bfbf48-ef71-4575-8a52-7482cf0e07e9" name="dei:DocumentFiscalPeriodFocus" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048">FY</ix:nonNumeric><ix:nonNumeric id="F_f400e978-1c14-4570-b233-ea68b2a2c832" name="dei:AmendmentFlag" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048">false</ix:nonNumeric><ix:nonNumeric id="F_0b8e0ea0-01c7-495c-8425-f3986990b5f6" name="dei:EntityCentralIndexKey" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048">0001404281</ix:nonNumeric><ix:nonFraction id="F_29380120-6261-4933-adfd-72f6c322e830" name="us-gaap:CommitmentsAndContingencies" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_21dc383f-2aac-43ed-b5d6-870ed73f88bc" name="us-gaap:CommitmentsAndContingencies" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_bbd260aa-271e-433c-b079-94771270927e" name="us-gaap:PreferredStockValue" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_afd1d160-84ed-4383-a341-993295a87c54" name="us-gaap:PreferredStockValue" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_90a1a123-deec-4dcc-8f08-aa722dd895ed" name="us-gaap:PreferredStockValue" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_4e19efd9-6caf-49ac-88e0-63ff7273d146" name="us-gaap:PreferredStockValue" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_1691d7f7-1fe6-4184-b13f-c7d5693df0ef" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonFraction id="F_b5c49917-80ca-456f-a3d2-e4aad4794ea8" name="us-gaap:NumberOfReportableSegments" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" unitRef="U_Segment" decimals="INF" format="ixt:num-dot-decimal">1</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="eldn-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_8011d9d7-7503-40f9-9f2d-d6ad11ebdb59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_81754e8f-b125-4baa-9396-af3d23d394f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_824d879a-0a5b-49ca-807d-ab0c7354476a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_82eefdd4-1476-421e-8c82-01746b54038c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_830b14e6-5177-41fb-b6ce-4f9c69a9e2b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8362f16b-85c6-4b35-869d-da150d474503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_844f75c9-11bb-444d-8d75-a4c62096d783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8633a155-8473-424a-b31b-6ae76ea8dfef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_873fc4f3-2e27-45ab-b247-49134db6a39a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_87cefaba-5105-4ff2-a002-a1c4d73aeb66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c38178a-6212-4724-822a-073a46d7cd51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8ca31066-99f4-48c4-a2bf-5e1ade8e2d92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_923a3e58-9c3e-413a-b35a-231f00431e8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_993efb3c-896c-44af-92dc-051235d5309e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a1c4e3d-58af-4481-a493-f277082ece01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a80f4c6-f976-44ce-8ccc-11733f31a205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d05956d-2390-4ca6-b6a3-2f100db0a54a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3d4e2f7-7728-4ff5-b3c1-f6d4d89e0518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a6d60598-ba1e-477f-8dff-52c79620152c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a6f2684c-3401-4fe8-a32b-794554ab28db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-19</xbrli:startDate><xbrli:endDate>2024-04-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a83408d9-d439-46ef-8f80-2334a97de048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aa45efb2-8f97-4e4f-8227-a73968b58522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aadaadaa-a7c0-44c6-8113-f3d665a31ddc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-13</xbrli:startDate><xbrli:endDate>2024-06-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ab227fe8-0ca1-4386-b398-a0fc655a8391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abc1f2cd-e8e8-41c3-9872-62e589ee5c9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_acb31783-dc63-46da-a53e-d4cc59b2703b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af30e24c-32c0-41f6-be04-5126201680f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b03f2283-1f48-4ad2-8437-e177dcaf160b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-12</xbrli:startDate><xbrli:endDate>2022-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b0f8372f-04b0-40a7-b325-70e0c012674c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b3bf1192-2c65-401c-8714-cbce96407407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4bf66a1-e90d-4ead-835b-58305a0590ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b84bbaad-df1d-4435-bcda-30c2fee202cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-14</xbrli:startDate><xbrli:endDate>2020-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_baf27155-1f9e-4cf5-835b-da4532020138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-30</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bea8a10c-6aaf-4cf5-a1ef-0c858fe3ff2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf411a33-997b-43c5-804f-81fcc2c67a2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c01ec1c7-4246-48a0-911e-d83e8235923b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0260335-e1df-4dc7-9951-e61eec7e4e07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c13fc831-8ebf-4b35-97bb-3fd07acab079"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1814a1c-a776-4ae5-81fb-2c334235981f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c200f68f-c405-4e48-bf2a-38f307006e4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c48e2f04-d819-41f4-9794-6444de71c031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c48f7041-bd5d-4520-badc-9c02123e560c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:GuggenheimSecuritiesLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-20</xbrli:startDate><xbrli:endDate>2024-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c508875a-d414-4f73-bf48-c4925adce371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c53b5cf6-4630-40a4-9931-9f67538e192a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c59b7a41-84c2-4669-8972-016e60680975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c655824d-1655-43e8-bda3-bfbadd4707f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c6c9bd31-68b2-4a71-971a-851b219ff30f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c7360e16-b2f5-4ebe-87d7-85ccacc39a7b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c763de0f-2331-4e42-9eed-6f3c61e5a6f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-08</xbrli:startDate><xbrli:endDate>2024-07-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c88b7102-5db9-49c6-a914-b6a1c69ddd87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ca588c4b-fe6a-413d-9b1b-50b767ebb7e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb145333-a71b-4f8a-9efc-683fbaf92968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd66f0aa-05ca-4940-a515-241bc4f1483a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ce203d5d-8a57-4364-b573-86117fd33f97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cef653d0-53e3-464e-a7ff-1a07fbe50a84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d174fc95-378b-4f2e-a041-e159aefc096b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d212cec7-7f13-4076-ad8f-1298f4fbccfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d28d1435-9f97-49ba-8b24-67f48845ba10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOnePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d2bff3d0-c82e-407b-9765-471560864917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d74c7b95-2405-4e2a-92fa-de35246ee4c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d928ea5e-1b31-4b26-9a65-5053f8c68714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d98efdad-c5fb-4fe9-bf2b-dae2dda62705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da023f2b-8828-431e-a5c6-01ba27160e08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da93e26a-a221-416f-aa1d-44b6fa0cbbfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dd3aadef-8b9e-4abb-a618-63b7b63a02d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df73341b-d5e3-4456-832d-4dec35538295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df992d11-47da-4652-9a72-20ae69c98503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e03375d3-d9dd-4d85-99e4-7301552a0c4f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e092348f-329a-4fe9-9031-99230e36eb27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e2da67cb-75fc-4021-ac60-f7e057d84c73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3be1d1a-7a2e-46c0-af2c-74af00b30e00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">eldn:OticPharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8e45f71-13aa-4500-9629-91aae4aff6f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e9b52517-cc36-438f-9a32-3591a45bba9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e9c43112-a3f3-45ba-bd41-44cbb2d1fbf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ec3b3914-3993-491b-8996-5d595c2548d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed194ea2-3267-4246-aebb-e5dd647171a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_edc2adbf-8141-490c-92ff-6e31ec443f9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef1d6638-1928-4543-b113-5a669804d921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ef59653d-33ae-47a7-ad08-ba5af6c5f5ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0a737c0-ea83-4888-a416-315bbec6d943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2abefcd-f6bf-453b-a559-74741ea3100a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-04</xbrli:startDate><xbrli:endDate>2024-09-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5f8bce9-24d2-424b-9d3f-cb4374e792c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsLlcAndOticPharmaLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7f796ca-5ede-4fab-bd41-35bedc579277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f913f031-70f5-4d82-9777-c7eada81288b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f95c9f8c-c83b-4faa-a94a-8bc7cdd24a68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa324109-4c1e-442a-b30b-a82030888207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa5ed16e-e45b-4b1c-88b4-26d3ddd75f76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fcd27fad-ba34-47a9-a7a2-6c51de3732d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-20</xbrli:startDate><xbrli:endDate>2024-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fda21e42-08d9-4af5-8424-38a2c795691f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fe31b2b8-289c-4f2d-9530-6c3e7c7a5ee4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fe6f7e17-f28c-49da-acb4-0df89a0d0e69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffbc6245-1de4-432c-97ca-016d4dec5720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffcde828-6f01-4bd7-af9e-2cd1f5dee182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00e18809-6dee-4971-b3b0-b854a750129c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_027f47be-a809-4a42-bc04-44816aea7e4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-10</xbrli:startDate><xbrli:endDate>2024-07-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_043095c1-b1ac-48c7-a4f2-27e2c8f8cc98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_087efa66-298a-4ae4-8500-8f2f2044cb36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_099f74fb-7263-4363-8e20-38ff695e2998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09b59681-3f5b-4085-9903-94d6298ba631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-30</xbrli:startDate><xbrli:endDate>2024-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:SeptemberTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c7e74c0-0fff-4859-bb0f-e4991cbcdf79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-11</xbrli:startDate><xbrli:endDate>2022-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0cfe28eb-20ed-4453-b17c-b2da148bbb6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1011d176-24c6-4711-ab33-00f6e6c3a295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1206a149-d99b-42c3-828f-7f43aedc8be0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-06</xbrli:startDate><xbrli:endDate>2024-05-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13bc12ba-1049-47bb-868c-4b5d72553817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_18c0a78a-1e2f-466e-b8fc-e87b9eed2108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1987a0f3-1c0e-49ee-81ad-cc7a111a2cf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a557357-a976-4702-be2e-81994f5f0bdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1bdd8687-8b04-4339-9c36-3704d34477a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1d2b5181-f6f0-4b8c-83a1-6db86dab8d21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d975291-218c-42ec-9222-8136c8da23ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e0927e2-efa8-48c2-8418-566f24cf7f14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-29</xbrli:startDate><xbrli:endDate>2024-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e34edcb-7733-41f4-96c4-4098b67eb851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_223d8e7d-db53-4014-ad03-258351d47431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_263741cf-175e-4ce0-9e5d-54eeafb843a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2708372d-5984-4b8b-8394-2e808b98a215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2dca0082-86a4-43f6-957f-6b699928251b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31bf3867-db9f-4f90-8142-37e4eadc782b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31ca3166-3194-499d-a328-f836589f3df6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31d1acfa-3b45-4abf-9e35-bfef36f23e5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_33505f9b-7127-48ca-9287-5490646f361b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3363cfd2-6725-47cd-bf09-3c58731efbb2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_33a03f84-df70-43cd-9c50-4ba91ddfe366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37560e31-d09e-45ce-aca9-615ecf64f681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3959ebff-dd82-4919-8415-9cfb3aeb832a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_396c0ec5-b10d-49bf-a96a-9db1863a6f32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f46a1a6-a8f6-442b-b1ff-f3c98cff71b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_412645b3-9ae1-4e3c-b5b6-869162daa220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43aca5e8-7607-40e9-b22d-49e309162053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48114a84-98ab-4aa1-b043-13f209b76a80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4adef842-ba46-4a9a-9d41-be6305e99c40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f4b59d8-1b4f-410c-855d-a6241a17fff1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50ee3b39-8b65-4a18-aa5f-b1aa2197b68e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_515ae42a-7ff1-4e13-959f-75425bb4a13f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_53f04ea6-32a3-4a74-9360-047d032d09a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57da919f-7744-4288-b384-8049ba29e1b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58527e40-73be-44c7-ac20-a9366f484716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5a950f73-2372-4ecd-bd27-5625ddd12c79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_601e9cd6-2771-40cc-9def-1378742631ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_62fc708e-94d9-4e0c-835b-84f88b33655c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_63ba02b2-0219-4203-aeec-903a75c59cda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedAndPerformanceBasedVestingRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65c0870e-3c32-4ada-9d89-29c1727f64b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66748007-3bbb-4063-96d0-b1f1e7fe5949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66849e82-39b6-4778-bd00-50de1525fd28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6907689f-f9ed-4e1e-951a-30df656bbdd0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c87749c-011d-4371-ab13-14962a69c063"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6daf1c28-0057-48b3-9e51-5792ff52bc2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f5052df-2ced-4dca-8f26-17b0a53037c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_74107382-fd40-42f9-90be-490979e94f04"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_752ba685-b573-457c-ab6b-760279f576b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7539102a-4a3f-4b85-9f9a-eff15ced7207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75635e8c-9491-4ef8-9631-b061f8135c6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_785be526-652e-459b-b095-3ed96eaf857d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7972f6f5-bbc6-4b58-ae0c-1d51da007c0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EGenesisIncCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79cc014d-d674-4ff4-b42a-bb3cc0e63e25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79dfe68d-c36f-4af9-8f4e-5e28df0b6596"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b2f7f52-abb1-46cd-b411-b13302614ae5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7cdba64b-c16d-4e4d-afdf-1f90b0947296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d93a268-3600-4a83-af6b-4e24c9653c56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f974fdd-1b57-4a34-a7de-915221b5d0fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f980e84-3bfd-4c6a-9f98-ef8ea64fd7f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001404281</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>eldn:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Milestone"><xbrli:measure>eldn:Milestone</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="z-index:-3;min-height:0.75in;position:relative;"></div>
  <p style="border-top:1.5pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Form </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b758d615-6a4b-413c-8810-40b625f09f23" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_844cdbbf-29e2-4ab2-afc5-85d36b0016c5" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_878961e8-ed55-4d4c-9149-51f785a87de7" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_31cb0102-80de-4089-8899-3dae83ca82e2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09823324-2be2-4028-9ee5-1bd5a5ea5848" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_43949aa9-93eb-420c-954d-3eb68d6955a6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the transition period from</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                      </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                    </span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission file number</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0e07de50-88c9-40cf-b984-d20875ed3bd6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-36620</span></ix:nonNumeric></span></p>
  <p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:23pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b1e8a1e-744f-41b6-94bf-ac2c6c4b8ba6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:23pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_5888b583-f17e-4958-ac18-266b30e07baf" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_afca5089-789f-4ca7-81b0-0ae6d620d380" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">20-1000967</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_9fa3aff2-7c5e-4041-8ee4-ae667c9d7425" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">19800 MacArthur Boulevard</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_06c4bd9c-9839-471a-a0d3-9ae614b6dce6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 250</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_6dbf08b8-3b36-4ccc-9ab0-7ac424dd591a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Irvine</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_7973b07b-2578-41eb-82d5-f5476fa8b8a4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_2688aafc-f561-44e6-b4f5-4139b2476182" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92612</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c17c5ad7-7bd2-49b8-9ccc-510f6522c339" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(949) </span></ix:nonNumeric></span><span style="font-size:8.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98b53bc5-a1c1-47bd-aa50-e1c233365fe4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">238-8090</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:33%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:32%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of Class</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Exchange on Which Registered</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_4568df1d-7827-460d-83f0-e2692220a7cc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_3cb7bf37-e9a7-4db2-9472-c2f134d6f73a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ELDN</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_590ea3dc-e24d-4ae9-94ac-69c485b32c26" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">&#160;Capital Market</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="margin-left:38.893%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid #000000;margin-right:38.889%;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9bff12d6-9942-431f-b13a-f2cc225a799c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bac9b3bf-82d3-4bab-8f86-847f91453401" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c65ecd1d-8e59-49ae-8bd5-a95a36a853a9" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d4e1e418-d8b1-4441-94b0-19fb2362dea8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:28%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_02ad8210-d698-4566-aa6f-c08cc89b16e9" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_d3eefb67-b060-406e-b3ef-f5921ca550fc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_52286fa8-20f2-47cd-9868-8091a42cf005" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation of the effectiveness of its internal control over financial reporting under Section 404(b) of Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by registered public accounting firm that prepared or issued its audit report </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ad7b993-5037-4598-901f-9882eda8143f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant  included in the filing reflect the correction of an error to previously issued financial statements </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_aec8e73e-50be-408c-97f2-2e19f2c6c89d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  &#9744;    No  </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_20ed1262-1c3d-40c4-a529-98a99e0fd914" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_837365be-ffd7-4315-87c0-fbf8b66df64c" contextRef="C_37560e31-d09e-45ce-aca9-615ecf64f681" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">64,885,717</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, b</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ased on the last reported sale price of such stock on the Nasdaq Global Market as of such date.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s of March 17, 2025, the registrant had </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7123269-7c5e-4574-89bf-e3c6abf2b6f2" contextRef="C_c48e2f04-d819-41f4-9794-6444de71c031" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,881,775</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, sh</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ares of Common Stock, $0.001 par value per share, outstanding.</span></p>
  <div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fed6b0b2-0d97-4a7b-bd21-3f6a48bc16f6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true" continuedAt="F_fed6b0b2-0d97-4a7b-bd21-3f6a48bc16f6_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_fed6b0b2-0d97-4a7b-bd21-3f6a48bc16f6_1"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December 31, 2024, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">X</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:82.46%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.54%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">   </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12pt;padding-left:12pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1A.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1B.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 1C.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 2.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 3.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 4.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 5.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 6.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reserved</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 7.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 7A.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 8.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9A.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9B.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_or_information"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 9C.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspection</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 10.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 11.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 12.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 13.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 14.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 15.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ITEM 16.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#index_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Index to Financial Statements</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this Annual Report on Form 10-K, Annual Report, unless the context requires otherwise, &#8220;Eledon&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221;, and &#8220;us&#8221; means Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics, Inc.) and all wholly owned subsidiaries.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; as defined by the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. Any statements other than statements of historical or current fact in this Annual Report on Form 10-K are forward looking statements. In some instances, you can identify forward-looking statements by the use of words such as &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;estimates,&#8221; &#8220;intends,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;targets,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; and similar expressions, although not all forward-looking statements include such identifying words. Forward-looking statements include, but are not limited to statements regarding:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our product development plans, expectations for and the timing of commencement, enrollment, completion, data, and release of results of clinical trials for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our estimates regarding expenses, capital requirements and needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our strategies with respect to our preclinical and clinical development programs, including our expectations regarding the production of clinical quantities of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our plans, strategy and timing to obtain and maintain regulatory approvals of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding competitive conditions for our product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations about our future financial performance or condition.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we believe that we have a reasonable basis for each forward looking statement contained in this Annual Report on Form 10-K, actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including the factors listed under &#8220;Risk Factor Summary&#8221; below. These risks and uncertainties, as well as other risks and uncertainties that could cause the Company&#8217;s actual results to differ significantly from the forward-looking statements contained herein, are described in greater detail in Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-looking statements contained in this Annual Report on Form 10-K are based on our current beliefs, assumptions, expectations, estimates and projections, which may be impacted by known or unknown factors. Any forward-looking statements contained in this Annual Report on Form 10-K speak only as of the date hereof and not as of any future date, and the Company expressly disclaims any intent to update any forward-looking statements, whether as a result of new information, future events or otherwise. You are therefore cautioned not to place undue reliance on the forward-looking statements included in this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market data and certain other statistical information used in this Annual Report on Form 10-K are based on independent industry publications, governmental publications, reports by market research firms or other independent sources. Some data are also based on our good faith estimates. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTOR SUMMARY</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following summarizes the principal factors that make an investment in the Company speculative or risky, all of which are more fully described in Part I, Item 1A, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K. This summary should be read in conjunction with the Risk Factors section and should not be relied upon as an exhaustive summary of the material risks facing our business. The occurrence of any of these risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described in our public filings when evaluating our business.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our short operating history and shifts in our business strategy may make it difficult to evaluate the success of our business to date and to assess our future viability.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since our inception and expect that we will continue to incur losses over the next several years and may never achieve or maintain profitability. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require additional funding to be able to complete the development of our lead drug candidate. If we are unable to raise such capital, or if we are unable to do so on acceptable terms, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuances of our common stock, including common stock that may be issuable pursuant to outstanding warrants or other convertible securities as well as shares and warrants issued or issuable in connection with our recent private placement transactions, could result in significant dilution and could cause our stock price to fall.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates are in the early stages of clinical development and may not be successfully developed. If we are unable to successfully develop and commercialize these or any other product candidate, or if we experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could have a material adverse effect on our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse conditions in the financial markets, including bank failures, could adversely affect our liquidity and financial performance.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug development involves a lengthy and expensive process with an uncertain outcome, including failure to demonstrate safety and efficacy to the satisfaction of the U.S. Food and Drug Administration (&#8220;FDA&#8221;) or similar regulatory authorities outside the United States. We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development, formulation and commercialization of our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of non-clinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials, and there is a risk that additional non-clinical and/or clinical safety studies will be required by the FDA or similar regulatory authorities outside the United States or that subsequent studies will not match results seen in prior studies.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delays or difficulties in the enrollment of patients in clinical trials could delay or prevent our receipt of necessary regulatory approvals and increase expenses for the development of our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If serious adverse events or unacceptable side effects are identified during the development of our product candidates, we may need to abandon or limit our development of some of our product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success depends on our ability to retain executives and key employees and to attract, retain and motivate qualified personnel in the future.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, or the approvals may be for a narrow indication, we may not be able to commercialize our product candidates, and our ability to generate revenue may be materially impaired.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislation regulating the pharmaceutical and healthcare industries may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and affect the prices we may obtain.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our internal computer systems, or those of our third-party collaborators, service providers, contractors or consultants, may fail or suffer security breaches, disruptions, or incidents, which could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The compromise of privacy, security, integrity or confidentiality of sensitive information related to our business or failure to comply with confidentiality and data privacy obligations could have a material adverse effect on our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, we may fail to achieve the degree of market acceptance by physicians, patients, third-party payers and others in the medical community necessary for commercial success.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our current product candidates, or a future product candidate receives marketing approval and we, or others, later discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, our ability to market the product could be compromised.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The insurance coverage and reimbursement status of newly-approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our reliance on third parties for the manufacture of our product candidates for non-clinical and clinical trials, and for eventual commercialization, increases the risk that we will not have sufficient quantities of our product candidates or products at an acceptable cost and quality, which could delay, prevent or impair our development or commercialization efforts.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on contract research organizations (&#8220;CROs&#8221;) and other contracted third parties to perform non-clinical and clinical testing and certain other research and development activities. As a result, the outcomes of the activities performed by these organizations will be, to a certain extent, beyond our control.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain intellectual property protection for our technology and products or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize our technology and products may be impaired.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public health crises, including pandemics or epidemics, could adversely affect our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stock price could be volatile, and the market price of our common stock may drop</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unexpectedly.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have previously identified and remediated a material weakness in our internal control over financial reporting. If we fail to maintain effective internal controls, we may conclude that our internal control over financial reporting is not effective, which could adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter and under Delaware law could make an acquisition of the Company more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WEBSITE REFERENCES</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In this Annual Report on Form 10-K, we make references to our website at www.eledon.com. References to our website through this Form 10-K are provided for convenience only and the content on our website does not constitute a part of, and shall not be deemed incorporated by reference into, this Annual Report on Form 10-K.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> I</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">usiness.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon is a clinical stage biotechnology company using our immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). Our lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. We believe the central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is engineered to potentially both improve safety and provide pharmacokinetic, pharmacodynamic, and dosing advantages compared to other anti-CD40 approaches. The CD40L/CD40 pathway is recognized for its prominent role in immune regulation. CD40L is primarily expressed on activated CD4+ T cells, platelets and endothelial cells while the CD40 receptor is constitutively expressed on antigen presenting cells such as macrophages and dendritic cells, as well as B cells. By blocking CD40L and not the CD40 receptor, tegoprubart inhibits both the CD40 and CD11 costimulatory signaling pathways, providing the potential for improved efficacy compared to anti-CD40 receptor approaches. Blocking CD40L also increases polarization of CD4+ lymphocytes to Tregs, a specialized subpopulation of T cells that act to suppress an immune response, thus creating a more tolerogenic environment, which may play a therapeutic role in autoimmune diseases and in the prevention of allograft rejection after solid organ transplantation.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is designed to negate the risk of thrombolytic events seen in the first generation of anti-CD40L antibodies by introducing structural modifications that have been shown in preclinical models to eliminate binding to the Fc&#947; receptors associated with platelet activation without altering the binding of tegoprubart to CD40L. In non-human primate studies, dosing of tegoprubart up to 200 mg/kg per week for 26 weeks, demonstrated no adverse events regarding coagulation, platelet activation or thromboembolism.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1: Mechanism overview of CD40L inflammatory signaling and tegoprubart site of action</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_0.jpg" alt="img117130267_0.jpg" style="width:382px;height:298px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interaction of CD40 with CD40L on immune cells mediates activation of the co-stimulatory immune pathway, controlling &#8220;cross talk&#8221; between the adaptive and innate immune systems. Blocking CD40L shifts polarization away from pro-inflammatory signaling to T-cell anergy, apoptosis, and polarization to a &#8220;T-reg&#8221; environment. (Source: Adapted from Kant et al., Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022, AJKD.)</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business strategy is to optimize the clinical and commercial value of tegoprubart and become a global biopharmaceutical company with a focused immunology franchise. Our strategy is to develop tegoprubart for the prevention of rejection of allograft (i.e., transplanting an organ from one human to another) and xenograft (i.e., transplanting an organ from an animal to a human) organs and cells, and for the treatment of ALS. We selected our indications based on preclinical and clinical data that was generated with either tegoprubart or historical anti-CD40L molecules. In January 2023, we announced plans to prioritize and focus resources on our kidney transplantation programs, discontinue the Company funded islet cell transplantation program and the IgAN program. We also remain committed to further progressing ALS clinical development and are working with key stakeholders on potential next steps to do so. However, we are unable to continue our clinical development of tegoprubart for people with ALS without additional financing.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following chart summarizes the status of our current clinical development programs. Details for each program are outlined below.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_1.jpg" alt="img117130267_1.jpg" style="width:672px;height:260px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisition</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2020, we acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), the company that owned and controlled the intellectual property related to tegoprubart. See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements included in this Annual Report on Form 10-K, for further details of grants and licenses related to this acquisition.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to our acquisition of Anelixis, we focused on developing medicines for patients with disorders of the ear, nose, and throat (&#8220;ENT&#8221;). In June 2020, we announced that our lead program did not achieve statistical significance for the primary efficacy endpoints in the treatment of acute otitis media. As a result of this failure to achieve the primary study endpoint, we suspended the clinical development of our legacy ENT assets while we assessed potential development strategies. Following the June 2020 announcement, we significantly curtailed development expenses as we sought to identify strategic alternatives that would maximize stockholder value. As a result of these activities, we acquired Anelixis and raised additional capital in September 2020, as described above. After acquiring Anelixis, we terminated our ENT activities and returned our product rights to the original license holders in July 2021.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for the Prevention of Allograft Rejection in Kidney Transplantation</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we announced plans to prioritize and focus resources on our kidney transplantation programs. We are first focusing on kidney transplantation as this is the most common type of solid organ transplantation in the U.S. with an estimated 260,000 Americans living with a transplanted kidney. There are an estimated 27,000 kidneys transplanted annually in the U.S. Approximately 100,000 people in the U.S. are on a waiting list where they typically wait an average 3-5 years for a kidney transplant while about 5,000 people in the U.S. in need of a kidney transplant die each year waiting for a suitable kidney. Approximately 11% of U.S. people on the waiting list are waiting for a repeat transplant. There remains a critical shortage of kidneys and other organs available for transplantation.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years. The standard of care immunosuppressive drugs used post-transplant have been shown to reduce the risk of organ rejection, but they are also associated with potentially toxic side effects. Organ transplant recipients require immunosuppression on a lifelong basis, and any disruption in the immunosuppression therapy can trigger transplant rejection. Calcineurin inhibitors (&#8220;CNI&#8221;s) are a critical component of most immunosuppressive regimens to prevent acute and long-term kidney transplant rejection. However, chronic exposure to CNIs (tacrolimus is the drug most commonly used) is associated with nephrotoxicity, hypertension, new onset diabetes due to pancreatic beta cell toxicity, as well as central nervous system (&#8220;CNS&#8221;) side effects, like tremor. Over time, these CNI side effects may significantly damage the transplanted kidneys or result in a requirement for reduced exposures to CNIs which can lead to an increased risk of rejection. Moreover, CNS side effects like tremors may result in patients decreasing their adherence to their medicines. Today, an implanted kidney is expected to fail within 10-15 years on average using currently available immunosuppression options. The fact that American transplant patients are on average in their 50s means that many of them will ultimately need a second or even third transplant procedure during their lifetime or a return to dialysis.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The central role of CD40L signaling in generating pro-inflammatory responses makes it a highly attractive candidate for therapeutic intervention in the protection of transplanted organs and prevention of transplant rejection. Results from prior studies demonstrate that targeting and blocking CD40L has the potential for better efficacy and improved safety, including reduced risk of nephrotoxicity, diabetes, hypertension, and other side effects associated with standard-of-care CNIs such as tacrolimus.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart seeks to address challenges associated with current immunosuppressive transplantation regimens using CNI-based therapies. The ability to prevent acute and chronic transplant rejection without the need for CNIs has the potential to transform the clinical management of preventing graft rejection by mitigating the adverse events associated with CNIs and improving long-term graft survival, thus potentially decreasing the need for repeat kidney transplants and increasing organ availability for other patients on the wait list. By identifying and advancing novel strategies in immunosuppression including targeting the CD40L pathway, we may be able to help organs remain functional for longer and potentially throughout the natural lifespan of each recipient.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In aggregated data from the published studies referenced in Figure 1 below, non-human primates undergoing allograft renal transplantation receiving anti-CD40L monotherapy (e.g., 5c8, AI794, IDEC-131) had longer average survival than both those receiving anti-CD40 monotherapy (e.g., 4D11, cH5D12, Chi220, ASKP1240), tacrolimus monotherapy or untreated controls (Figure 2).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2: Inhibition of CD40L improved survival vs. CD40 inhibition in non-human primate kidney transplantation monotherapy studies</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_2.jpg" alt="img117130267_2.jpg" style="width:672px;height:326px;"/></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Kaplan-Meir estimates of the probability of rejection free survival by treatment group from eleven published studies of allograft kidney transplant in non-human primates. Sources: Perrin, 2022; Song, 2014; Song, 2016; Duan, 2017. Note: In aggregated data from published studies, NHPs receiving anti-CD40L (e.g., 5c8, AI794, IDEC-131) immunomodulation monotherapy post kidney transplantation had longer average survival than those receiving anti-CD40 monotherapy (e.g., 4D11, cH5D12, Chi220, ASKP1240), tacrolimus monotherapy or untreated controls. Tac = tacrolimus. Meta-analysis is not based on head-to-head studies. Differences between any individual programs may vary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have received regulatory approvals in the United States, Canada, the United Kingdom and Australia, for a Phase 1b clinical trial of tegoprubart in up to 36 subjects, replacing tacrolimus as an immunosuppressive regimen component in patients undergoing de novo kidney transplantation. Each participant will receive rabbit antithymocyte globulin induction and a maintenance regimen consisting of tegoprubart, mycophenolate mofetil, and corticosteroids. The primary endpoint of the study is safety. Other endpoints include glomerular filtration rate (&#8220;eGFR&#8221;), characterizing the pharmacokinetic profile of tegoprubart, and the incidence of biopsy proven rejection. The first subject in the Phase 1b study was dosed in July 2022.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Better graft function as assessed by eGFR has been associated with improved long-term patient and graft survival and is an early predictor of future graft failure. Historical studies have reported average eGFRs generally in the low 50 mL/min/1.73m2 range during the first year after kidney transplant using current standard of care immunosuppression. An eGFR of 50 mL/min/1.73m2 or below indicates chronic kidney disease.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We reported interim safety and efficacy results from the Phase 1b clinical trial in March 2023, and provided updated data in November 2023 and June 2024. At the time of the June 2024 update, which reported data as of April 3, 2024, results from the 13 participants in the Phase 1b trial support tegoprubart&#8217;s potential to protect organs from rejection while improving renal function in patients undergoing kidney transplantation. As mentioned above, data from historical studies using standard of care, calcineurin inhibitor-based, immunosuppression therapy typically report aggregate mean estimated eGFRs of approximately 53 mL/min/1.73m&#178; during the first year after kidney transplant. In the ongoing Phase 1b trial, as of April 3, 2024, mean eGFR was above 60 mL/min/1.73m&#178; at each reported time points after day 30, with an overall mean eGFR of 70.5 mL/min/1.73m&#178; for all the reported time points after day 30 post-transplant. Two participants completed 12 months on therapy post-transplant, and both demonstrated mean eGFRs above 90 mL/min/1.73m&#178; at one-year post-transplant. The interim results demonstrated that tegoprubart is generally safe and well tolerated in patients undergoing de novo kidney transplantation. As of April 3, 2024, three subjects have discontinued the study due to hair loss and fatigue, viral infection, and rejection, respectively. There have been no cases of hyperglycemia, new onset diabetes, or tremor, all of which are side effects often associated with standard of care immunosuppression therapy. There have been no cases of graft loss or death.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2022, we received Investigational New Drug (&#8220;IND&#8221;) application clearance from the FDA for our controlled, Phase 2 BESTOW trial of tegoprubart for the prevention of transplant rejection in persons receiving a kidney transplant. The BESTOW study is a multi-center, two-arm, active comparator, head-to-head superiority clinical study, and will enroll approximately 120 participants undergoing kidney transplantation in the U.S. and other countries to evaluate the safety, pharmacokinetics, and efficacy of tegoprubart compared to the calcineurin inhibitor tacrolimus. The study&#8217;s primary objective is to assess graft function as measured by estimated eGFR at 12 months post-transplant in participants treated with tegoprubart compared to tacrolimus. Secondary objectives will include assessment of graft survival, biopsy-proven acute rejection, and the incidence of new onset diabetes mellitus after transplant. The BESTOW study is running in parallel to the ongoing Phase 1b clinical trial of tegoprubart in kidney transplantation. The first subject in the BESTOW study was dosed in August 2023. On September 4, 2024, we announced the completion of enrollment in the BESTOW study.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, we enrolled the first participant in a Phase 2 open-label extension study which is designed to evaluate the long-term safety, pharmacokinetics, and efficacy of tegoprubart in participants who have completed one year of treatment in either the ongoing Phase 1b study or the Phase 2 BESTOW study.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of tegoprubart for the Prevention of Allograft Rejection in Xenotransplantation</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While inhibition of CD40L has shown it may play an important role in immunosuppression in allograft kidney transplantation, this mechanism of action has also demonstrated that it may be a promising option in xenotransplantation (i.e., transplanting an organ from an animal to a human).</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we entered into a non-exclusive collaborative research agreement with eGenesis, Inc., (&#8220;eGenesis&#8221;), under which eGenesis gained access to tegoprubart for preclinical and clinical xenotransplantation studies in support of eGenesis&#8217; kidney, heart and islet cell xenotransplantation programs.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of tegoprubart for the Prevention of Allograft Rejection in Islet Cell Transplantation (&#8220;ICT&#8221;)</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Type 1 diabetes (&#8220;T1D&#8221;) is a T cell mediated autoimmune disease with progressive loss of insulin producing pancreatic beta cells and affects approximately 2 million persons in the United States. Approximately 33% of people with T1D report impaired awareness of hypoglycemia regardless of continuous glucose monitoring or automated insulin usage. Approximately 12% of people with T1D experience recurrent severe hypoglycemic events annually, putting them at higher risk for adverse outcomes. Approximately 5% to 8% of adults with T1D experience diabetic ketoacidosis annually, often as a result of poor glycemic control. ICT is gaining attention as a thera</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">peutic option for T1D because it can restore physiological insulin secretion, minimize the risk of hypoglycemic unawareness, and reduce the risk of death due to severe hypoglycemia. The advances made in this field over the past decade have improved patient outcomes, and the procedure has been evolving from an experimental treatment to a clinical treatment option</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A number of issues are believed to continue to hamper the overall success of ICT and to need to be addressed in order for there to be widespread clinical acceptance. These include the acute loss of transplanted islets with current immunosuppressive treatments, particularly those with CNI-based therapies, due to islet cell toxicity and alloreactive immunologic responses to transplanted islets. Over time, the progressive loss of islet cells and decline in islet cell function can lead to the need for multiple transplants in order for T1D patients to have optimal response to blood glucose levels and possibly achieve insulin independence. Tegoprubart seeks to address the challenges associated with current ICT immunosuppressive regimens using CNI-based therapies, by replacing the CNIs with tegoprubart to prevent rejection and protect the transplanted cells. We believe that tegoprubart may unlock the ICT market by potentially improving islet cell graft survival and reduce the side effects associated with standard of care regimens</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Historical studies in nonhuman primate models of ICT have demonstrated that treatment with anti-CD40L antibodies induces long term islet cell function and graft survival, even as a monotherapy. Tegoprubart has shown pre-clinical, proof-of-concept efficacy in a non-human primate model of T1D, where animals undergoing ICT maintained glucose control and sustained levels of C-peptide with chronic tegoprubart treatment for up to a year. Compared to combination immunosuppressive therapy including CNIs, tegoprubart monotherapy was more effective in preventing long term islet cell rejection, associated with better graft function, and showed an improved safety profile.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2022, the FDA granted orphan designation to tegoprubart for the prevention of allograft rejection in pancreatic islet cell transplantation.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2024, we announced that tegoprubart would be utilized in an investigator-initiated trial, conducted at the University of Chicago Medicine's Transplantation Institute. This pilot study is assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with T1D mellitus undergoing islet cell transplantation. The Company is not funding this trial but is providing tegoprubart for use in the study.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, positive data were reported for the first three islet transplant recipients in the study, potentially demonstrating the first human cases of insulin independence achieved using an anti-CD40L monoclonal antibody therapy without the use of tacrolimus. The first two subjects achieved insulin independence and normal hemoglobin A1C (HbA1c) levels, a measure of average blood glucose, post-transplant. The third subject, decreased insulin use by more than 60% three days following the procedure and continues on insulin independence trajectory typically observed one-to-two months post-transplant. Subjects in the study received islet transplants combined with induction therapy and for chronic maintenance therapy, mycophenolate mofetil plus tegoprubart given every third week by intravenous infusion. The first two subjects achieved insulin independence and presented stable islet graft function at approximately three months and six months post-transplant, respectively. Islet engraftment, measured by graft function standardized to the number of islets infused, was three to five times higher than three comparable subjects who received tacrolimus-based immunosuppression, suggesting treatment with tegoprubart results is less toxic to transplanted islet cells resulting in improved graft survival and function. Treatment was generally well tolerated in all subjects with no unexpected adverse events or hypoglycemic episodes. After initial islet transplant, the first participant reduced insulin requirements by over 60% and normalized blood glucose control. As of October 29, 2024, the first patient had achieved insulin independence within approximately a week after a second islet transplantation procedure.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for ALS</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALS is a progressive, paralytic disorder characterized by degeneration of motor neurons in the brain and spinal cord. In the U.S., the incidence is estimated at approximately 5,000 cases per year with a prevalence of approximately 30,000 cases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overall. Despite 3 approved drugs, in most cases, death from respiratory failure occurs between 3 to 5 years from diagnosis, with 50% of patients living at least 3 years from diagnosis and only 20% of patients living at least 5 years from diagnosis.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While the exact pathogenic mechanism of ALS is still not fully understood, there is strong evidence indicating that neuroinflammation plays an important role in the disease&#8217;s pathogenesis. Neuroinflammation in ALS is characterized by the infiltration of lymphocytes and macrophages into the central nervous system, and the activation of microglia and reactive astrocytes. Reactive astrocytes and microglia as well as infiltrating lymphocytes, dendritic cells, monocytes, macrophages and immune complexes have been identified in cerebrospinal fluid and neural tissues in both animal models of ALS and at autopsy in ALS patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is designed to block CD40L binding to CD40, thereby potentially inhibiting neuroinflammatory pathways leading to disease progression in ALS. In vitro proof-of-concept studies have shown that tegoprubart binds to CD40L in human cells and blocks CD40L binding on antigen presenting cells and activated T cells. The potential for therapeutic benefit of CD40L blockage in treating ALS has been demonstrated in a SOD1 mouse model of ALS, where a murine anti-CD40L antibody, MR1 (as defined below), prolonged survival and delayed the onset of neurological disease progression. These pathophysiological manifestations are believed to be due to reduced immune cell infiltration of macrophages into skeletal muscle and their destroying denervated nerves. The plasticity of the nervous system to repair itself in the absence of this immune cell attack is believed to result in improved neuromuscular junction occupancy and improved muscle function. Blocking CD40L signaling also prevents pro-inflammatory polarization of lymphocytes, reduced neuroinflammation and improved motor neuron survival in rodent ALS models (Figure 3).</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3: Blocking CD40L Improves Survival and Pathophysiology Associated with ALS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img117130267_3.jpg" alt="img117130267_3.jpg" style="width:657px;height:257px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3: Anti-CD40L (&#8220;MR1&#8221;) treatment decreases CD68+ macrophages, improves neuromuscular junction occupancy and improves motor neuron survival.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (A) Quantification of reduction of CD68+ macrophages by anti-CD40L treatment at day 100. (White bar, control IgG); gray bar (anti-CD40L&#8211;treatment); black bar (untreated age-matched non-transgenic mice) (B) Quantification of neuromuscular occupancy in SOD1 mice prior to overt symptoms (day 70) versus after symptom onset (day 85) treated with an IgG control antibody (vehicle) or anti-CD40L antibody. (C) Quantitative comparison of lumbar spinal cord motor neuron counts per mm2 in IgG vehicle control (White bar) versus anti-CD40L treated mice (grey bar) at day 100 (Lincecum, 2010).</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2018, the FDA granted orphan drug designation to tegoprubart for ALS. In 2019, we completed a single ascending dose Phase 1 study of tegoprubart in healthy volunteers and people with ALS. In this study, the doses of tegoprubart studied were well tolerated in healthy adult subjects and adults with ALS. Tegoprubart demonstrated low anti-drug antibody responses that were not dose related, linear dose proportionality across the dose ranges, and a half-life of up to 26 days.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2020, we initiated a Phase 2a, open-label, multi-center study to evaluate the safety and tolerability of multiple doses of tegoprubart in adult subjects with ALS. Fifty-four subjects with ALS were enrolled into the study in the United States and Canada at 13 ALS treatment sites. Ascending doses of tegoprubart were administered as IV infusions to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four sequentially enrolling cohorts. The first two cohorts consisted of nine participants, and the last two cohorts of 18 participants each. All enrolled subjects received six infusions of tegoprubart over a 12-week period. Blood samples for target engagement, and exploratory biomarkers for inflammation and neurodegeneration were taken and analyzed. Participant-focused clinical outcomes were also assessed. In May 2022, we completed the Phase 2a study and released positive topline results. Tegoprubart successfully met the primary endpoints of safety and tolerability. Fifty of the fifty-four subjects completed all six study infusions, and adverse events were typical of an ALS patient population. Tegoprubart was well-tolerated, and no drug-related serious adverse events were observed. No new safety signals emerged. Anti-drug antibodies (&#8220;ADAs&#8221;) were present in less than 5 percent of samples. All ADAs were of low titer and did not impact tegoprubart drug levels. Tegoprubart target engagement was demonstrated in all dose cohorts with increasing target engagement in a dose-dependent manner, plateauing at the 4 and 8 mg / kg dosing levels using CD40L and CXCL13 biomarkers related to T cell and B cell function, respectively. Tegoprubart exposure decreased inflammatory biomarker levels, in a dose dependent manner, in 20 of 32 pro-inflammatory proteins. Pro-inflammatory biomarkers reduced included biomarkers also associated with IgA nephropathy and kidney transplant rejection, such as IgA, IgE, IgM, C3, CXCL9, and CXCL10.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are seeking to further progress ALS clinical development and plan to work with key stakeholders on potential next steps to do so. However, we will be unable to continue our clinical development of tegoprubart for people with ALS without additional financing specific for our ALS program, and we can provide no assurances that we will be able to obtain financing on acceptable terms or at all.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Development of Tegoprubart for IgA Nephropathy</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, the Company announced the deprioritization of its IgAN program and all IgAN clinical development activities were discontinued in 2023. IgAN is the leading cause of chronic glomerulonephritis, a state of inflammation producing damage to the filtering part of the kidney. Disease manifestation and clinical presentation involves renal dysfunction characterized by proteinuria with a slow relentless course. Approximately 30%-40% of persons living with IgAN ultimately reach end stage renal disease (&#8220;ESRD&#8221;). The standard of care for ESRD is dialysis or kidney transplant, which represents a significant economic burden as well as a major impact on a patient&#8217;s quality of life. With an estimated prevalence of approximately 150,000 persons in the United States, IgAN is one of the most common autoimmune glomerulonephropathies. In the United States, oral budesonide Tarpeyo was approved for use in IgAN by the FDA in December 2021 and Kinpeygo received conditional approval by the European Medicines Agency (&#8220;EMA&#8221;) in July 2022.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2022, we received IND clearance from the FDA to evaluate tegoprubart for the treatment of IgAN. The Phase 2 global study was a 96-week open-label, dose ranging trial, and included both a high dose and a low dose cohort. The primary endpoint was change in urinary protein:creatinine ratio at week twenty-four. Secondary endpoints included change in estimated eGFR at week 96 as well as safety and tolerability. The first subject was dosed in May 2022. We reported interim safety data from the Phase 2 high dose cohort in March 2023.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon&#8217;s success depends in part on our ability to obtain and maintain proprietary protection for our product candidates, novel discoveries, product technologies and other know-how, to operate without infringing on the proprietary rights of others and to prevent others from infringing our proprietary rights. We seek to protect our product candidates by, among other methods, filing U.S. and foreign patent applications related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on trademarks, trade secrets, know-how, continuing technological innovation and potential in-licensing opportunities to develop and maintain proprietary protection for our product candidates.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property portfolio includes issued patents and pending patent applications directed toward (i) isolated antibodies and (ii) methods of treatment using the isolated antibodies that block the interaction of CD40L and CD40 to treat CD40L-related diseases or disorders. We own and have exclusive rights to six active patent families, of which three families are exclusively licensed and the rest are wholly-owned by Eledon. The first exclusively-licensed family is directed to methods for treating amyotrophic lateral sclerosis with antibodies and includes two issued United States patents and 14 issued foreign patents (Japan, Hong Kong, Belgium, Germany, Denmark, Spain, Finland, France, Great Britain, Ireland, Italy, the Netherlands, Sweden, and Switzerland). Absent any patent term adjustments or extensions, patents in this family expire in December 2029. The second exclusively-licensed family is directed to tegoprubart, with 13 pending applications, and issued patents including four issued United States patents and 23 issued foreign patents (Australia, Belgium, Switzerland, China, Germany, Denmark, France, Great Britain, Hong Kong, Ireland, Israel, India, Italy, Japan, South Korea, Mexico, the Netherlands, New Zealand, Russia, Sweden, Singapore). Absent any term adjustments or extensions, patents in this family</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expire in February 2036. The third exclusively-licensed family is directed to tegoprubart, with 17 pending applications, including one pending United States patent application, and issued patents, including one issued United States patent and four issued foreign patents (China, Hong Kong, Mexico, Russia). Absent any term adjustments or extensions, patents in this family expire in May 2038. Our Eledon-owned patent families are directed to methods for treating neurodegenerative disorders, kidney disorders, and transplant rejection. We have recently nationalized two of our Eledon-owned patent families in the United States, Europe, Australia, Canada, China, Japan, South Korea, Mexico, and Singapore, and one of our Eledon-owned patent families is at the Patent Cooperation Treaty stage. Absent any term adjustments or extensions, any patents to issue from the pending applications in these patent families would expire in May 2043, and November 2044, respectively.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent to our acquisition of Anelixis, we undertook a strategic review of the legacy ENT assets. We concluded this review and determined that the best path forward was to terminate license agreements associated with these ENT assets and return the rights to the original license holders, which we did in July 2021. There was no financial impact to returning these assets.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patents extend for varying periods according to the date of patent filing or grant and the legal term of patents in various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends on the type of patent, the scope of its coverage and the availability of legal remedies in the country.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon also protects its proprietary information by requiring its employees, consultants, contractors, and other advisors to execute nondisclosure and assignment of invention agreements upon commencement of their respective employment or engagement. In addition, Eledon also requires confidentiality or service agreements from third parties that receive confidential information or materials.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K under the caption &#8220;Grants and Licenses&#8221; for further information about the Company&#8217;s intellectual property.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The biotechnology and pharmaceutical industries are characterized by continuing technological advancement and significant competition. While we believe that our product candidates, technology, knowledge, experience and scientific resources provide us with competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others. Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. Key product features that would affect our ability to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. The availability of reimbursement from the government and other third-party payors will also significantly affect the pricing and competitiveness of our products. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the companies against which we may compete have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical studies, obtaining regulatory approvals and marketing approved products than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and patient registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The competitive conditions faced by the Company are also described in greater detail in Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K under the caption &#8220;We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span></p>
  <p style="text-indent:5%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of tegoprubart or any future product candidates, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely on third parties for raw materials and the manufacturing of drug substance and drug product for non-clinical and clinical activities. As of the date of this Annual Report, we have not experienced any difficulty in obtaining raw materials required with respect to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the manufacturing of tegoprubart. We believe we have enough drug substance and drug product on hand and manufacturing capacity with our third-party manufacturing providers to meet forecasted clinical trial demand.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also rely on third parties to label, store and distribute drug product for our non-clinical and clinical trials.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government authorities in the United States, including federal, state, and local authorities, and in other countries, extensively regulate, among other things, the manufacturing, research and clinical development, marketing, labeling, and packaging, storage, distribution, post-approval monitoring and reporting, advertising and promotion, and export and import of pharmaceutical and biological products, such as those we are developing. Pricing of such products is also subject to regulation in many countries. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Government Regulation</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and its implementing regulations, and biologics under the FDCA and the Public Health Service Act (&#8220;PHSA&#8221;) and its implementing regulations. FDA approval is required before any new unapproved drug or biologic or dosage form, including a new use of a previously approved drug, can be marketed in the U.S. Drugs and biologics are also subject to other federal, state, and local statutes and regulations. If we fail to comply with applicable FDA or other requirements at any time during the product development process, clinical testing, approval process or after approval, we may become subject to administrative or judicial sanctions. These sanctions could include the FDA&#8217;s refusal to approve pending applications, license suspension or revocation, withdrawal of an approval, untitled or warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties or criminal prosecution. Any FDA enforcement action could have a material adverse effect on us.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process required by the FDA before product candidates may be marketed in the United States generally involves the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of extensive preclinical laboratory tests and preclinical animal studies, all performed in accordance with the Good Laboratory Practices (&#8220;GLP&#8221;) regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an IND which must become effective before human clinical trials may begin and must be updated annually;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an independent institutional review board (&#8220;IRB&#8221;) or ethics committee representing each clinical site before each clinical trial may be initiated;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the product candidate for each proposed indication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of manufacturing scale up and stability studies, all performed in accordance with the Good Manufacturing Practices (&#8220;GMP&#8221;) regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation of and submission to the FDA of a biologics license application (&#8220;BLA&#8221;) or a new drug application, or NDA, after completion of all pivotal clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential review of the product application by an FDA advisory committee, where appropriate and if applicable;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of a BLA or NDA to file the application for review;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facilities where the proposed product is produced to assess compliance with current Good Manufacturing Practices (&#8220;cGMP&#8221;) regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential FDA audit of the clinical trial sites that generated the data in support of the BLA or NDA; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of a BLA or NDA prior to any commercial marketing or sale of the product.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preclinical and clinical testing and approval process requires substantial time, effort, and financial resources, and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An IND is a request for authorization from the FDA to administer an investigational new drug product to humans in clinical trials. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human trials. The IND also includes results of animal and in vitro studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product; chemistry, manufacturing, and controls information; and any available human data or literature to support the use of the investigational new drug. An IND must become effective before human clinical trials may begin. An IND will automatically become effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to the proposed clinical trials. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before clinical trials can begin. Accordingly, submission of an IND may or may not result in the FDA allowing clinical trials to commence. The FDA may impose a clinical hold at any time during clinical trials and may impose a partial clinical hold that would limit trials, for example, to certain doses or for a certain length of time.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Trials</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators in accordance with Good Clinical Practices (&#8220;GCPs&#8221;) which include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety, and the efficacy criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. Additionally, approval must also be obtained from each clinical trial site&#8217;s IRB before the trials may be initiated, and the IRB must monitor the trial until completed. There are also requirements governing the reporting of ongoing clinical trials and clinical trial results to public registries.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical investigation of a drug is generally divided into three phases. Although the phases are usually conducted sequentially, they may overlap or be combined.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1. The drug is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to evaluate the safety, dosage tolerance, metabolism and pharmacologic actions of the investigational new drug in humans, the side effects associated with increasing doses, and if possible, to gain early evidence on effectiveness.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 2. The drug is administered to a limited patient population to evaluate dosage tolerance and optimal dosage, identify possible adverse side effects and safety risks, and preliminarily evaluate efficacy.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3. The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites to generate enough data to evaluate dosage, clinical effectiveness and safety, to establish the overall benefit-risk relationship of the investigational new drug product, and to provide an adequate basis for physician labeling.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the FDA may condition approval of a BLA or NDA for a product candidate on the sponsor&#8217;s agreement to conduct additional clinical trials after approval. In other cases, a sponsor may voluntarily conduct additional clinical trials after approval to gain more information about the drug. Such post-approval studies are typically referred to as Phase 4 clinical trials.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sponsors must also report to the FDA, within certain timeframes, serious and unexpected adverse reactions, any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator&#8217;s brochure, or any findings from other studies or animal or in vitro testing that suggest a significant risk in humans exposed to the product candidate. The FDA, the IRB, or the clinical trial sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated check points based on access to certain data from the trial. We may also suspend or terminate a clinical trial based on evolving business objectives or competitive climate.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical trial process can take three to ten years or more to complete, and there can be no assurance that the data collected will support FDA approval or licensure of the product. Results from one trial are not necessarily predictive of results from later trials.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A drug being studied in clinical trials may be made available to individual patients in certain circumstances. Pursuant to the 21st Century Cures Act (&#8220;Cures Act&#8221;) which was signed into law in December 2016, the manufacturer of an investigational drug for a serious disease or condition is required to make available, such as by posting on its website, its policy on evaluating and responding to requests for individual patient access to such investigational drug (compassionate use). This requirement applies on the later of 60 calendar days after the date of enactment of the Cures Act or the first initiation of a Phase 2 or Phase 3 trial of the investigational drug. At this time, Eledon does not have a program for the compassionate use of an investigational product outside of a clinical trial as it is not applicable to our investigational products.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Submission of a BLA or NDA to the FDA</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming successful completion of all required testing (e.g., completion of pivotal clinical trials) in accordance with all applicable regulatory requirements, detailed investigational new drug product information is submitted to the FDA in the form of a BLA or NDA requesting approval to market the product for one or more indications. Under federal law, the submission of most BLAs and NDAs is subject to an application user fee and these fees are typically increased on an annual basis. Applications for orphan drug products are exempted from the BLA and NDA user fees and may be exempted from product and establishment user fees, unless the application includes an indication for other than a rare disease or condition. No application user fees were paid for tegoprubart in calendar 2024.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A BLA or NDA for a new molecular entity must include all relevant data available from pertinent preclinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come from company-sponsored clinical trials intended to test the safety and effectiveness of a use of a product, or from several alternative sources, including investigator-initiated trials that are not sponsored by Eledon. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the investigational new drug product to the satisfaction of the FDA.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a BLA or NDA for a new molecular entity has been submitted, the FDA&#8217;s goal is to review the application within ten months after it accepts the application for filing, or, if the application relates to an unmet medical need in a serious or life-threatening indication, six months after the FDA accepts the application for filing. The review process is often significantly extended by the FDA&#8217;s requests for additional information or clarification.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving a BLA or NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA or NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA is required to refer an application for a novel drug to an advisory committee or explain why such referral was not made. Typically, an advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The FDA&#8217;s Decision on a BLA or NDA</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA evaluates a BLA to determine whether the data demonstrate that the biologic is safe, pure, and potent, or effective, and an NDA to determine whether the drug is safe and effective. After the FDA evaluates the BLA or NDA and conducts inspections of manufacturing facilities where the product will be produced, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete, and the application is not ready for approval. A Complete Response Letter may require additional clinical data or an additional pivotal Phase 3 clinical trial(s), or other significant, expensive and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. Even if such additional information is submitted, the FDA may ultimately decide that the BLA or NDA does not satisfy the criteria for approval and issue a denial. The FDA could also approve the BLA or NDA with a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-market studies or clinical trials. Such post-market testing may include Phase 4 clinical trials and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pediatric Trials and Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Pediatric Research Equity Act of 2003 (&#8220;PREA&#8221;) as amended, BLAs and NDAs must contain data to assess the safety and effectiveness of an investigational new drug product for the claimed indications in all relevant pediatric populations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. A sponsor who is planning to submit a marketing application for a drug product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration must submit an initial Pediatric Study Plan (&#8220;PSP&#8221;) within sixty days of an end-of-phase 2 meeting or as may be agreed between the sponsor and the FDA. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults or full or partial waivers if certain criteria are met. The FDA and the sponsor must reach agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials, and/or other clinical development programs. The requirements for pediatric data do not apply to any drug for an indication for which orphan designation has been granted. In the future we may seek pediatric approval for tegoprubart applications in connection with renal and islet cell transplantations, which may require the submission of a PSP.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pediatric exclusivity is another type of non-patent exclusivity in the United States and, if granted, provides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity, including the five-year and three-year non-patent and orphan exclusivity. This six-month exclusivity may be granted if a BLA or NDA sponsor submits pediatric data that fairly respond to a written request from the FDA for such data. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted. If reports of FDA-requested pediatric trials are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity or patent protection covering the product are extended by six months. This is not a patent term extension, but it effectively extends the regulatory period during which the FDA cannot accept or approve another application relying on the BLA or NDA sponsor&#8217;s data.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Approval Requirements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug manufacturers are subject to periodic unannounced inspections by the FDA and state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely, and expect to continue to rely, on third parties for the production of clinical quantities of our product candidates and expect to rely in the future on third parties for the production of commercial quantities. Future FDA and state inspections may identify compliance issues at our facilities or at the facilities of our contract manufacturers that may disrupt production, distribution, or require substantial resources to correct. In addition, discovery of previously unknown problems with a product or the failure to comply with applicable requirements may result in restrictions on a product, manufacturer or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">holder of an approved BLA or NDA, including withdrawal or recall of the product from the market or other voluntary, FDA-initiated or judicial action that could delay or prohibit further marketing. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#8217;s policies may change, which could delay or prevent regulatory approval of our products under development.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, untitled or warning letters or holds on post-approval clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to approve pending BLAs or NDAs or supplements to approved BLAs or NDAs, or suspension or revocation of licenses or withdrawal of approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan Designation and Exclusivity</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making the drug for this type of disease or condition will be recovered from sales in the United States.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages, and user-fee waivers. In addition, if a product is the first to receive FDA approval for the indication for which it has orphan designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity. The Company received orphan drug designations for tegoprubart for the treatment of ALS and prevention of allograft rejection in pancreatic islet cell transplantation.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Term Restoration</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration, and specifics of the FDA approval of the use of our product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of a BLA or NDA, plus the time between the submission date and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved product is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent and within 60 days of the product&#8217;s approval. The U.S. Patent and Trademark Office, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of the patent term for one of our currently owned or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA or NDA.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Abbreviated New Drug Applications for Generic Drugs</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 1984, with passage of the Hatch-Waxman Amendments, Congress authorized the FDA to approve generic drugs that are the same as drugs previously approved by the FDA under the NDA provisions of the statute. To obtain approval of a generic drug, an applicant must submit an abbreviated new drug application (&#8220;ANDA&#8221;) to the agency. In support of such applications, a generic manufacturer may rely on the preclinical and clinical testing previously conducted for a drug product previously approved under an NDA, known as the reference listed drug (&#8220;RLD&#8221;).</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, in order for an ANDA to be approved, the FDA must find that the generic version is identical to the RLD with respect to the active ingredients, the route of administration, the dosage form, and the strength of the drug. At the same time, the FDA must also determine that the generic drug is &#8220;bioequivalent&#8221; to the innovator drug. Under the statute, a generic drug is bioequivalent to an RLD if &#8220;the rate and extent of absorption of the generic drug do not show a significant difference from the rate and extent of absorption of the listed drug.&#8221;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon approval of an ANDA, the FDA indicates that the generic product is &#8220;therapeutically equivalent&#8221; to the RLD and it assigns a therapeutic equivalence rating to the approved generic drug in its publication &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; also referred to as the &#8220;Orange Book.&#8221; Physicians and pharmacists consider an &#8220;AB&#8221; therapeutic equivalence rating to mean that a generic drug is fully substitutable for the RLD. In addition, by operation of certain state laws and numerous health insurance programs, the FDA&#8217;s designation of an &#8220;AB&#8221; rating often results in substitution of the generic drug without the knowledge or consent of either the prescribing physician or patient.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDCA provides a period of five years of non-patent exclusivity for a new drug containing a new chemical entity. In cases where such exclusivity has been granted, an ANDA may not be filed with the FDA until the expiration of five years unless the submission is accompanied by a Paragraph IV certification, in which case the applicant may submit its application four years following the original product approval. The FDCA also provides for a period of three years of exclusivity if the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence studies, that were conducted by or for the applicant and are essential to the approval of the application. This three-year exclusivity period often protects changes to a previously approved drug product, such as a new dosage form, route of administration, combination or indication.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hatch-Waxman Patent Certification and the 30-Month Stay</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon approval of an NDA or a supplement thereto, NDA sponsors are required to list with the FDA each patent with claims that cover the applicant&#8217;s product or a method of using the product. Each of the patents listed by the NDA sponsor is published in the Orange Book. When an ANDA applicant files its application with the FDA, the applicant is required to certify to the FDA concerning any patents listed for the reference product in the Orange Book, except for patents covering methods of use for which the ANDA applicant is not seeking approval.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, the applicant must certify with respect to each patent that:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the required patent information has not been filed;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent has expired;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent has not expired, but will expire on a particular date and approval is sought after patent expiration; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the listed patent is invalid, unenforceable or will not be infringed by the new product.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A certification that the new product will not infringe the already approved product&#8217;s listed patents or that such patents are invalid or unenforceable is called a Paragraph IV certification. If the applicant does not challenge the listed patents or indicates that it is not seeking approval of a patented method of use, the ANDA application will not be approved until all the listed patents claiming the referenced product have expired.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the ANDA applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the NDA and patent holders once the ANDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph IV certification. The filing of a patent infringement lawsuit within 45 days after the receipt of a Paragraph IV certification</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">automatically prevents the FDA from approving the ANDA until the earlier of 30 months after the receipt of the Paragraph IV notice, expiration of the patent, or a decision in the infringement case that is favorable to the ANDA applicant.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">European Union/Rest of World Government Regulation</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to regulations in the United States, we will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of our products. The cost of establishing a regulatory compliance system for numerous varying jurisdictions can be very significant. Although many of the issues discussed above with respect to the United States apply similarly in the context of the European Union (&#8220;EU&#8221;) and in other jurisdictions, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whether or not we obtain FDA approval for a product candidate, we must obtain the requisite approvals from regulatory authorities in foreign countries prior to the commencement of clinical trials or marketing of the product in those countries. Certain countries outside of the United States have a similar process that requires the submission of a clinical trial application much like the IND prior to the commencement of human clinical trials. In the EU, for example, a clinical trial authorization application (&#8220;CTA&#8221;) must be submitted for each clinical protocol to each country&#8217;s national health authority and an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is accepted in accordance with a country&#8217;s requirements, the clinical trial may proceed.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The requirements and process governing the conduct of clinical trials vary from country to country. In all cases, the clinical trials are conducted in accordance with GCP the applicable regulatory requirements, and the ethical principles that have their origin in the Declaration of Helsinki.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To obtain regulatory approval of an investigational medicinal product under EU regulatory systems, we must submit a marketing authorization application. The content of the BLA or NDA filed in the United States is like that required in the EU, except, among other things, country-specific document requirements.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For other countries outside of the EU, such as countries in Eastern Europe, Latin America or Asia, the requirements governing product licensing, pricing, and reimbursement vary from country to country.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Countries that are part of the EU, as well as countries outside of the European Union, have their own governing bodies, requirements, and processes with respect to the approval of pharmaceutical and biologic products. If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Authorization Procedures in the EU</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicines can be authorized in the EU by using either the centralized authorization procedure or national authorization procedures.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Centralized procedure. The EMA implemented the centralized procedure for the approval of human medicines to facilitate marketing authorizations that are valid throughout the European Economic Area (&#8220;EEA&#8221;). This procedure results in a single marketing authorization issued by the EMA that is valid across the EEA. The centralized procedure is compulsory for human medicines that are: derived from biotechnology processes, such as genetic engineering, contain a new active substance indicated for the treatment of certain diseases, such as HIV/AIDS, cancer, diabetes, neurodegenerative disorders or autoimmune diseases and other immune dysfunctions, and officially designated orphan medicines.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized marketing authorization to the European Commission following a favorable opinion by the EMA, as long as the medicine concerned is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest of public health.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">National authorization procedures. There are also two other possible routes to authorize medicinal products in several EU countries, which are available for investigational medicinal products that fall outside the scope of the centralized procedure:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Decentralized procedure. Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mutual recognition procedure. In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. Following this, further marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned agree to recognize the validity of the original, national marketing authorization.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, a Pediatric Investigation Plan (&#8220;PIP&#8221;) or a request for waiver or deferral, is required for submission prior to submitting a marketing authorization application. A PIP describes, among other things, proposed pediatric trials and their timing relative to clinical trials in adults. A PIP will be submitted to EMA and other EU countries, as required. The PIP will need to be submitted early during product development before marketing authorization applications are submitted. The timing of PIP submission cannot be after initiation of pivotal trials or confirmatory (phase 3) trials. In the future we may seek pediatric approval for tegoprubart applications in connection with renal and islet cell transplantations, which may require the submission of a PIP.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exclusivity of New Chemical Entities and New Fixed Dose Combinations</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, new chemical entities, sometimes referred to as new active substances as well as new fixed dose combinations, qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. This data exclusivity, if granted, prevents regulatory authorities in the EU from referencing the innovator&#8217;s data to assess a generic (abbreviated) application for eight years, after which a generic application can be submitted, and the innovator&#8217;s data may be referenced, but not approved for two years. The overall ten-year period will be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exceptional Circumstances/Conditional Approval</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drugs or drugs with unmet medical needs may be eligible for EU approval under exceptional circumstances or with conditional approval. Approval under exceptional circumstances may be applicable to orphan products and is used when an applicant is unable to provide comprehensive data on the efficacy and safety under normal conditions of use because the indication for which the product is intended is encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence, when the present state of scientific knowledge does not allow comprehensive information to be provided, or when it is medically unethical to collect such information. Conditional marketing authorization may be applicable to orphan medicinal products, medicinal products for seriously debilitating or life-threatening diseases, or medicinal products to be used in emergency situations in response to recognized public threats. Conditional marketing authorization can be granted on the basis of less complete data than is normally required in order to meet unmet medical needs and in the interest of public health, provided the risk-benefit balance is positive, it is likely that the applicant will be able to provide the comprehensive clinical data, and unmet medical needs will be fulfilled. Conditional marketing authorization is subject to certain specific obligations to be reviewed annually.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accelerated Review</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the centralized procedure in the EU, the maximum timeframe for the evaluation of a marketing authorization application is 210 days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the EMA&#8217;s Committee for Medicinal Products for Human Use, or CHMP). Accelerated evaluation might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. In this circumstance, EMA ensures that the opinion of the CHMP is given within 150 days, excluding clock stops.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmaceutical Coverage, Pricing and Reimbursement</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we obtain regulatory approval. In the United States and in other countries, sales of any products for which we receive regulatory approval for commercial sale will depend in part on the availability of coverage and reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the reimbursement rate that the payor will pay for the product. Third-party payors may limit coverage to specific products on an approved list, or formulary, which might not include all of the FDA-approved products for a particular indication. Moreover, a payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain regulatory approvals. Our product candidates may not be considered medically necessary or cost-effective. If third-party payors do not consider a product to be cost-effective compared to other available therapies, they may not cover the product after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow a company to sell its products at a profit.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. government, state legislatures and foreign governments have shown significant interest in implementing cost containment programs to limit the growth of government-paid healthcare costs, including price controls, restrictions on reimbursement and requirements for substitution of generic products for branded prescription drugs. By way of example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively (the &#8220;Affordable Care Act&#8221;), contains provisions that may reduce the profitability of drug products, including, for example, increased rebates for drugs sold to Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries and annual fees based on pharmaceutical companies&#8217; share of sales to federal healthcare programs. Since its enactment, there have been several judicial, administrative, executive and congressional challenges to certain aspects of the Affordable Care Act. In addition, other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. For example, the American Rescue Plan Act of 2021 eliminates the statutory Medicaid drug rebate cap, for single source and innovator multiple source drugs, beginning in January 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, The Inflation Reduction Act of 2022, (the &#8220;IRA&#8221;), includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket cap for Medicare Part D beneficiaries to $2,000 starting in 2025; impose new manufacturer financial liability on certain drugs under Medicare Part D; allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs without generic competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the rebate rule that would limit the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. Further, judicial challenges to the IRA may have an impact on the implementation of the IRA&#8217;s provisions; and the overall effects of the IRA on our business and the healthcare industry in general is not yet known. Adoption of further government controls, measures and tightening of restrictive policies in jurisdictions with existing controls and measures could limit payments for pharmaceuticals.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In European countries, governments influence the price of pharmaceutical products through their pricing and reimbursement rules and control of national healthcare systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed to by the government. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a product candidate to currently available therapies. Other member states allow companies to fix their own prices for medicines but monitor and control company profits. The downward pressure on healthcare costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert commercial pressure on pricing within a country.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketability of any products for which we receive regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide adequate coverage and reimbursement. In addition, the emphasis on cost containment measures in the United States and other countries has increased, and we expect will continue to increase the pressure on pharmaceutical pricing. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Healthcare Laws and Compliance Requirements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we obtain regulatory approval for any of our product candidates, we may be subject to various federal and state laws targeting fraud and abuse in the healthcare industry. These laws may impact, among other things, our proposed sales, marketing and education programs. In addition, we may be subject to patient privacy regulation by both the federal government and the states in which we conduct our business. The laws that may affect our ability to operate include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, to induce, or in return for, the purchase or recommendation of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal civil and criminal false claims laws and civil monetary penalty laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Health Insurance Portability and Accountability Act of 1996, (&#8220;HIPAA&#8221;), which created new federal criminal statutes that prohibit executing a scheme to defraud any healthcare benefit program and making false statements relating to healthcare matters;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal transparency laws, including the provision of the Affordable Care Act referred to as the federal Physician Payment Sunshine Act, that requires drug and biologics manufacturers to disclose payments and other transfers of value provided to physicians and teaching hospitals and ownership interests of physicians and their immediate family members;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;) and its implementing regulations, which imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers, and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Affordable Care Act broadened the reach of the fraud and abuse laws by, among other things, amending the intent requirement of the federal Anti-Kickback Statute and the applicable criminal healthcare fraud statutes contained within 42 U.S.C. &#167; 1320a-7b. Pursuant to the statutory amendment, a person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act or the civil monetary penalties statute. Many states have adopted laws similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare items or services reimbursed by any source, not only the Medicare and Medicaid programs.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) which prohibits improper payments or offers of payments to foreign governments and their officials for the purpose of obtaining or retaining business. Safeguards we implement to discourage improper payments or offers of payments by our employees, consultants, and others may be ineffective, and violations of the FCPA and similar laws may result in severe criminal or civil sanctions, or other liabilities or proceedings against us, any of which would likely harm our reputation, business, financial condition and result of operations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, exclusion from participation in government healthcare programs, such as Medicare and Medicaid and imprisonment, damages, fines and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 20, 2025, Eledon had 31 employees, all of whom are full-time. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Otic Pharma, Ltd. (&#8220;Otic&#8221;) was founded in the State of Israel in 2008. In 2015, Otic established U.S. operations and moved its corporate headquarters to Irvine, California. In 2017, Otic consummated a reverse merger with Tokai Pharmaceuticals, Inc. (&#8220;Tokai&#8221;), a Delaware corporation that was incorporated on March 26, 2004, pursuant to which, among other things, Tokai purchased from Otic and its stockholders all of the common and preferred shares of Otic in exchange for the issuance of a certain number of shares of common stock of Tokai (the &#8220;Reverse Merger&#8221;). Following the Reverse Merger, Tokai changed its name to Novus Therapeutics, Inc. On September 14, 2020, the Company acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a Delaware Corporation, after which Anelixis became a wholly owned subsidiary of the Company. On January 4, 2021, the Company changed its name from Novus Therapeutics, Inc. to Eledon Pharmaceuticals, Inc.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive offices are located at 19800 MacArthur Boulevard, Suite 250, Irvine, California 92612. The Company also has a research and development office in Burlington, Massachusetts. Our telephone number is (949) 238-8090 and our website is www.eledon.com.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are advised to read this Annual Report on Form 10-K in conjunction with other reports and documents that we file from time to time with the Securities and Exchange Commission (&#8220;SEC&#8221;). In particular, please read our definitive proxy statement, which will be filed with the SEC in connection with our 2025 annual meeting of stockholders, our quarterly reports on Form 10-Q and any current reports on Form 8-K that we may file from time to time. You may obtain copies of these reports after the date of this annual report directly from us or from the SEC at its website at www.sec.gov. We make our periodic and current reports available on our internet website, free of charge, as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Ris</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">k Factors.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">An investment in shares of our common stock involves a high degree of risk. You should carefully consider the following risk factors, as well as the other information in this Annual Report on Form 10-K and in our other public filings. The occurrence of any of these risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the risk factors described in our public filings when evaluating our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Operations</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our short operating history and shifts in our business strategy may make it difficult to evaluate the success of our business to date and to assess our future viability.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical stage biopharmaceutical company. Our ongoing operations to date have been limited to organizing and staffing the Company, business planning, raising capital, acquiring and developing technology, identifying potential product candidates and pursuing non-clinical and clinical trials. We have not yet demonstrated our ability to successfully manufacture drug product in large enough quantities and with stability to support additional clinical trials, execute pivotal clinical trials, obtain marketing approvals, manufacture a commercial scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. It can take many years to develop a new medicine from the time it is discovered to when it is available for treating patients. Consequently, any predictions made about our future success or viability based on our short operating history to date may not be as accurate as they could be if we had a longer operating history. In addition, as a result of the acquisition of Anelixis and our decision to discontinue our Company funding of the islet cell transplantation program and the IgAN program, our future business, prospects, financial position and operating results could be significantly different than those in historical periods or previously projected by our management.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as an early-stage business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. To successfully market any of our current or future product candidates, we will need to transition from a company with a clinical development focus to a company capable of supporting commercial activities. We may not be successful in such a transition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since our inception and expect that we will continue to incur losses over the next several years and may never achieve or maintain profitability.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant annual net operating losses in every year since our inception. We have no products approved for commercial sale and have not generated any revenue from product sales to date, and we continue to incur significant research and development and other general and administrative expenses related to our ongoing operations. If tegoprubart or any future product candidates we develop are not successfully developed and approved, we may never generate any revenue from sales of products. The Company has experienced recurring net losses and negative cash flows from operating activities since its inception. The Company&#8217;s net loss for the year ended December 31, 2024 is $36.2 million. As of December 31, 2024, the Company had cash and cash equivalents and short-term investments of $140.2 million, working capital of $132.2 million and an accumulated deficit of $355.6 million. We have not generated any revenues from product sales, have not completed the development of any product candidate and may never have a product candidate approved for commercialization. We expect it will be several years, if ever, before we have a product candidate ready for commercialization. We have financed our operations to date primarily through the sale of preferred and common stock, and the sale of warrants and have devoted substantially all of our financial resources and efforts to research and development, including preclinical studies and our clinical trials. Our net losses may fluctuate significantly from quarter to quarter and year to year and will depend, in part, on the rate at which we incur expenses and our ability to generate revenue. Net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#8217; equity and working capital.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We anticipate that we will continue to incur significant expenses as we:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conduct non-clinical and clinical development of our product candidates or any future product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek to identify and acquire additional product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acquire or in-license other products and technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enter into collaboration arrangements with regards to product discovery or development;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop manufacturing processes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek marketing approvals for any of our product candidates that successfully complete clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a sales, marketing, and distribution infrastructure to commercialize any products for which we may obtain marketing approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, expand, and protect our intellectual property portfolio;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hire additional personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operate as a public company.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To become and remain profitable, we must develop and eventually commercialize a product or products with significant market potential. This will require us to be successful in a range of challenging activities, including completing clinical trials of our product candidates, obtaining marketing approval for these product candidates and manufacturing, marketing and selling those products for which we obtain marketing approval. We may never succeed in these activities, including if we do not have available financial resources to allow us to pursue clinical trials and other clinical development activities, and, even if we are successful, we may never generate revenues that are significant or large enough to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of the Company, could impair our ability to raise capital, maintain our non-clinical and clinical development efforts, and expand our business or continue our operations and may require us to raise additional capital that may dilute the ownership interest of common stockholders. A decline in the value of the Company could also cause stockholders to lose all or part of their investment.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will require additional funding to be able to complete the development of our lead drug candidate. If we are unable to raise capital, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In view of our expectation to incur significant losses for the foreseeable future, we will be required to raise additional capital resources in the future in order to fund our operations. We can also provide no assurance that other funding will be available to us, will be obtained on terms favorable to us or will provide us with sufficient funds to meet our objectives. If we are unable to raise such capital, or if we are unable to do so on acceptable terms, we will be forced to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether. For example, we are currently unable to continue our clinical development of tegoprubart for people with ALS without additional financing, and we can provide no assurances that we will be able to obtain financing on acceptable terms or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our funding needs may fluctuate significantly based on a number of factors, such as:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of formulation development and manufacture of drug product to support non-clinical and clinical development of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we enter into additional collaboration arrangements regarding product discovery or development, or acquire or in-license products or technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish additional collaborations with favorable terms, if at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing, and outcome of regulatory review of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of future commercialization activities, including product sales, marketing, manufacturing and distribution, for any of our product candidates for which we receive marketing approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">revenue, if any, received from commercial sales of our product candidates, should any of our product candidates receive marketing approval; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Identifying potential product candidates and conducting formulation development, non-clinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for several years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Even if we generate positive clinical data or are able to successfully commercialize one or more of our product candidates, additional financing may not be available to us on acceptable terms, or at all.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In addition to the dilution of our current stockholders&#8217; ownership as a result of the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering, we currently have a significant number of securities outstanding that are exercisable for our common stock, which could result in significant additional dilution and downward pressure on our stock price. Future issuances of our common stock, including common stock that may be issuable pursuant to outstanding warrants or other convertible securities, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, there were 59,789,275 shares of our common stock outstanding and warrants to purchase 33,052,744 shares of our common stock outstanding. The issuance of shares of common stock in the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering (each as defined and described in Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), diluted the ownership interests of our existing stockholders. The issuance of shares of common stock pursuant to our &#8220;at-the-market&#8221; equity offering program or upon exercise of pre-funded warrants or common warrants issued in the initial closing of the 2023 Private Placement, the pre-funded warrants issued in the 2024 Private Placement and the pre-funded warrants issued in the 2024 Underwritten Offering would result in significant additional dilution to our current stockholders, which could adversely affect the price of our common stock and the terms on which we could raise additional capital. If we sell additional shares of common stock, convertible securities or other equity securities, investors may be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new investors could gain rights, preferences and privileges senior to the holders of our common stock.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates are in the early stages of clinical development and may not be successfully developed. If we are unable to successfully develop and commercialize these or any other product candidate, or if we experience significant delays in doing so, our business will be materially harmed.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently do not have any products that have gained regulatory approval. We have invested substantially all of our efforts and financial resources in the development of our lead drug candidate tegoprubart, including funding non-clinical studies, clinical trials, drug formulation and the manufacturing of clinical trial materials. Our ability to generate product revenues, which we do not expect will occur for several years, if ever, will depend heavily on the successful development and eventual commercialization of one or more drug candidates. As a result, our business is substantially depending on our ability to successfully complete the development of and obtain approval for one of our potential future additional product candidates.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not yet demonstrated an ability to successfully overcome many of the risks and uncertainties frequently encountered by companies in new and rapidly evolving fields, particularly in the pharmaceutical area. For example, to execute our business plan, we will need to successfully:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain additional financing in order to advance our drug product through clinical development, and to manufacture, obtain regulatory approval for and commercialize our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">execute formulation, manufacturing, clinical, and non-clinical development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacture drug product at commercial scale;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish and confirm commercially acceptable stability (shelf-life) of our drug products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in-license or acquire other product candidates and advance them through clinical development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain required regulatory approvals for the development and commercialization of tegoprubart or other product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, leverage, and expand our intellectual property portfolio;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">build and maintain robust sales, distribution and marketing capabilities, either on our own or in collaboration with strategic partners;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">gain market acceptance for any approved and marketed drug products;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain and maintain adequate product pricing and reimbursement;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">develop and maintain any strategic relationships we elect to enter; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manage our spending as costs and expenses increase due to product manufacturing, non-clinical development, clinical trials, regulatory approvals, post-marketing commitments, and commercialization.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unsuccessful in accomplishing these objectives, we may not be able to successfully develop and commercialize our or other product candidates, and our business will suffer.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public health crises, including pandemics or epidemics could adversely affect our business.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business and operations, including but not limited to ongoing or planned research and development activities may be impacted by public health crises. For example, our business was adversely affected by the COVID-19 pandemic, which also caused significant disruption in the operations of third parties upon whom we rely. Other future public health crises, including any future pandemics or epidemics could have a similar impact on our business. We may experience, as we did with the COVID-19 pandemic, disruptions as a result of future public health crisis, such as a future pandemic or epidemic, that could severely impact our operations and development activities, including, but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in manufacturing of our drug candidates due to increased competition for manufacturing capacity as a result of the pandemic;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitations in employee resources that would otherwise be focused on the conduct of our development activities, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to accept data from clinical trials in affected geographies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in procuring drug substance and/or in manufacturing drug product due to limitations in employee resources or forced furloughs at our contract manufacturing organizations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in initiation of future clinical trials, including delays in receiving authorization from local regulatory authorities to initiate such clinical trials; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays or disturbances in enrollment and trial execution, for example, because clinical trial sites may be unable to operate normally, or patients may elect to forego visits to medical facilities or undertake voluntary medical procedures.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of the foregoing factors, or other effects of any public health crisis, including any future pandemic or epidemic, could materially affect our business, possibly to a significant degree. The severity and duration of any such impacts cannot be predicted.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could adversely affect our business, financial condition and results of operations</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The global economy, including the financial and credit markets, continues to experience extreme volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, elevated interest rates and uncertainty about economic stability. Likewise, the current conflicts in Ukraine and the Middle East have created extreme volatility in the global capital markets and global economic consequences, including disruptions of the global supply chain and energy markets. A severe or prolonged economic downturn or continued volatility in the financial and credit markets could negatively impact our ability to obtain necessary debt or equity financing in a timely manner or on favorable terms, if at all. The severity and duration of any such impacts cannot be predicted. Any such failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies or cause us to delay our clinical development plans, research and development programs or commercialization efforts, out-license intellectual property rights to our product candidates or sell unsecured assets, or a combination of the above. Any of these actions could materially harm our business. For example, we do not currently have sufficient liquidity to fund the continued clinical development of tegoprubart for people with ALS without additional financing, notwithstanding the positive topline results of our Phase 2a study of tegoprubart for adult subjects with ALS.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, inflation has increased throughout the U.S. economy in the past few years. As a result of inflation, we have experienced and may continue to experience cost increases, including costs of clinical trials and research and development of our product candidates, production costs, the price of labor, administration and other costs of doing business. Although we may continue to take measures to mitigate the impact of this inflation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Further, in an inflationary environment, cost increases may outpace our expectations, causing us to use our cash and other liquid assets faster than forecasted. If this happens, we may need to raise more capital to fund our operations than expected, and such capital may not be available in sufficient amounts or on reasonable terms, if at all.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse conditions in the financial markets, including bank failures, could adversely affect our liquidity and financial performance.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently maintain domestic cash deposits, for short term operating requirements, in Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured banks, which exceed the FDIC insurance limits. Our additional cash and cash equivalents are held in accounts managed by third&#8209;party financial institutions and consist primarily of cash invested in money market funds and government bonds. Bank failures, events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, or concerns or rumors about such events, may lead to widespread demands for customer withdrawals and liquidity constraints that may result in market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank failed and was taken into receivership by the FDIC. At that time, we maintained deposits amounting to approximately 78% of our total cash at Silicon Valley Bank. On March 26, 2023, the assets, deposits and loans of Silicon Valley Bank were acquired by First-Citizens Bank &amp; Trust Company. In response to the failure of Silicon Valley Bank, we diversified our cash deposits into money market funds, U.S. treasuries and U.S. government agency securities and, as of the date of this report, our total cash maintained in FDIC insured banking accounts is less than 3% of our total cash and cash equivalents and short-term investments. The failure of a bank, or other adverse conditions in the financial or credit markets impacting financial institutions at which we maintain balances, could adversely impact our liquidity and financial performance. There can be no assurance that our deposits in excess of the FDIC or other comparable insurance limits will be backstopped by the U.S. or any applicable foreign government in the future or that any bank or financial institution with which we do business will be able to obtain needed liquidity from other banks, government institutions or by acquisition in the event of a future failure or liquidity crisis. Additionally, our cash investments outside of FDIC insured bank accounts are subject to general credit, liquidity, market, and interest rate risks. If the carrying value of an investment exceeds the fair value, and the decline in fair value is deemed to be other-than-temporary, we are required to write down the value of the investment, which could materially harm our results of operations and financial condition and could limit our access to liquidity.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Drug development involves a lengthy and expensive process with an uncertain outcome, including failure to demonstrate safety and efficacy to the satisfaction of the FDA or similar regulatory authorities outside the United States. We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the formulation and commercialization of our product candidates.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the early stage of development for our product candidates, the risk of failure is high. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must conduct non-clinical trials and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Formulation and device development, non-clinical and clinical testing are all expensive activities, difficult to design and implement, and can take years to complete. Failure can occur at any time during the development program, including during the clinical trial process. Further, the results of non-clinical studies and early clinical trials of our product candidates, as well as earlier generation formulations may not be predictive of the results of later-stage clinical trials. Interim results of a clinical trial do not necessarily predict final results. Moreover, non-clinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in non-clinical and clinical trials have nonetheless failed to obtain marketing approval of their products. There is a risk that additional non-clinical and/or clinical safety studies will be required by the FDA or similar regulatory authorities outside the United States and/or that subsequent studies will not match results seen in prior studies. It is impossible to predict when or if any of our product candidates will prove effective, safe and well-tolerated in humans or will receive regulatory approval.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience delays in our clinical trials, and we do not know whether planned clinical trials will begin or enroll subjects on time, need to be redesigned or be completed on schedule, if at all. There can be no assurance that the FDA or equivalent foreign regulatory bodies will approve investigational new drug applications and allow us to start clinical trials for any of our product candidates in the future, including for islet cell transplant. Once a clinical trial has commenced, there is also no assurance that the FDA or equivalent foreign regulatory body will not put any of our product candidates on clinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hold. We may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates. Clinical trials may be delayed, suspended or prematurely terminated for a variety of reasons, such as:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in reaching agreement with the FDA or a comparable foreign regulatory authority on a trial design that we want to execute;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in obtaining authorization to commence a trial or inability to comply with conditions imposed by a regulatory authority regarding the scope or design of a clinical trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching, or failure to reach, agreement on acceptable clinical trial contracts or clinical trial protocols with prospective trial sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in completing formulation development and manufacturing as a prerequisite to commencing clinical work;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability, delay, or failure in identifying and maintaining a sufficient number of trial sites, many of which may already be engaged in other clinical programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in recruiting and enrolling suitable subjects to participate in a trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delay or failure in having subjects complete a trial or return for post-treatment follow-up;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical sites and investigators deviating from trial protocol, failing to conduct the trial in accordance with regulatory requirements, or dropping out of a trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of adequate funding to continue the clinical trial, including the incurrence of unforeseen costs due to enrollment delays, requirements to conduct additional clinical trials and increased expenses associated with the services of our contract research organizations (&#8220;CROs&#8221;) and other third parties;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate, or participants may drop out of these clinical trials at a higher rate than we anticipate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may experience delays or difficulties in the enrollment of patients that our product candidates are designed to target;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may have difficulty partnering with experienced CROs and study sites that can identify patients that our product candidates are designed to target and run our clinical trials effectively;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators or IRBs may require that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of our product candidates may be greater than we anticipate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be changes in governmental regulations or administrative actions. For example, the Trump administration recently issued an Executive Order that pauses the FDA&#8217;s rulemaking ability and could affect recently finalized FDA rules that have not yet taken effect. The extent to which such existing or future executive orders impact the healthcare regulatory environment remains uncertain and could materially impact our development and commercialization activities. In addition, our development and commercialization activities could be harmed or delayed by a shutdown of the U.S. government, including the FDA. For example, a prolonged shutdown may significantly delay the FDA's ability to timely review and process any submissions we may file or cause other regulatory delays, which could materially and adversely affect our business. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are not positive or are only modestly positive, or if there are safety concerns, we may:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be delayed in obtaining marketing approval for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not obtain marketing approval at all;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings that would reduce the potential market for our products or inhibit our ability to successfully commercialize our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be subject to additional post-marketing restrictions and/or testing requirements; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">have the product removed from the market after obtaining marketing approval.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product development costs will also increase if we experience delays in testing or marketing approvals. We do not know whether any of our non-clinical studies or clinical trials will need to be restructured or will be completed on schedule, or at all. Significant non-clinical or clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates or may allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented and expenses for the development of our product candidates could increase.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials to demonstrate safety and efficacy. We do not know whether the ongoing or planned clinical trials will enroll subjects in a timely fashion, require redesign of essential trial elements or be completed on its projected schedule. In addition, competitors may have ongoing clinical trials for product candidates that treat related or the same indications as our product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#8217; product candidates. Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patient enrollment is affected by other factors including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the eligibility criteria for the study in question;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the perceived risks and benefits of the product candidate under study;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efforts to facilitate timely enrollment in clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to identify and maintain a sufficient number of trial sites, many of which may already be engaged in other clinical trial programs, including some that may be for the same disease indication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patient referral practices of physicians;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity and availability of clinical trial sites for prospective patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ambiguous or negative interim results of our clinical trials, or results that are inconsistent with earlier results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">feedback from regulatory authorities, IRBs, ethics committees (&#8220;ECs&#8221;), or data safety monitoring boards, or results from earlier stage or concurrent non-clinical and clinical trials, that might require modifications to the protocol;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decisions by regulatory authorities, IRBs, ECs, or the Company, or recommendations by data safety monitoring boards, to suspend or terminate clinical trials at any time for safety issues or for any other reason; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unacceptable risk-benefit profile or unforeseen safety issues or adverse effects.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enrollment delays in our clinical trials may result in increased development costs for our product candidates, which would cause the value of the Company to decline and limit our ability to obtain additional financing.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to conduct clinical trials in some jurisdictions outside of the United States may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently have clinical trial sites in regions outside the United States, including Asia, the European Union and the United Kingdom, and we will continue to conduct future clinical trials in these markets. Our ability to conduct clinical trials at sites located outside the United States is subject to numerous risks unique to conducting business in jurisdictions outside the United States, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in establishing or managing relationships with qualified CROs, physicians and clinical trial sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">different local standards for the conduct of clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in complying with various and complex import laws and regulations when shipping drugs to certain countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential burden of complying with a variety of laws, medical standards and regulatory requirements, including the regulation of pharmaceutical and biotechnology products and treatments; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of consistency in standard of care from country to country;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diminished protection of intellectual property in some countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">instability in economic or political conditions, including inflation, recession and actual or anticipated military conflicts, social upheaval or political uncertainty;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign exchange fluctuations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cultural differences in medical practice and clinical research; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in country or regional regulatory requirements.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ongoing conflict in Ukraine and the resulting imposition of economic and other sanctions by the United States, European Union and many other nations on Russia, individuals in Russia, Russian businesses and the Russian central bank, or any escalation of tensions in the region, could have a broader impact that expands into other countries. The ongoing conflict in the Middle East could have similar impacts. Although the length and impact of any military action and expansion of the conflict into other countries are highly unpredictable, if either conflict spreads or has effects on additional countries, we may experience disruptions or delays in our plans to conduct clinical trial activities in affected regions outside the United States.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If severe adverse events or unacceptable side effects are identified during the development of our product candidates, we may need to abandon or limit our development of some of our product candidates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our product candidates are associated with severe adverse events or unacceptable side effects in non-clinical or clinical trials or have characteristics that are unexpected, we may need to interrupt, delay or abandon their development or limit development to more narrow uses or subpopulations in which the adverse event or undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Any occurrences of clinically significant adverse events or unacceptable side effects with our product candidates may harm our business, financial condition and prospects significantly.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is an early&#8209;product candidate, and the side effect profile in humans has not been fully established. Currently unknown, drug-related side effects may be identified through ongoing and future clinical trials and, as such, these possible drug-related side effects could affect patient recruitment, the ability of enrolled subjects to complete the trial, or result in potential product liability claims.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our future success depends on our ability to retain executives and key employees and to attract, retain and motivate qualified personnel in the future.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are highly dependent on the product development, clinical and business development expertise of the principal members of our management, scientific and clinical team. Although we have entered into employment agreements with our executives and key employees, each of them may terminate their employment with us at any time. We do not maintain &#8220;key person&#8221; insurance for any of our executives or other employees. Our recent decision to discontinue the islet cell transplantation program and IgAN program and uncertainties regarding our financial condition may increase the likelihood that employees depart in the foreseeable future.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recruiting and retaining qualified scientific, clinical, manufacturing, sales and marketing personnel is critical to our success. Due to the small size of the Company and the limited number of employees, each of our executives and key employees serves in a critical role. The loss of the services of our executive officers or other key employees could impede the achievement of our development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of, and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating drug product, non-clinical development, clinical development, regulatory strategy, and commercial strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to provide services to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Regulatory Approval of Our Product Candidates and Other Compliance Matters</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, or the approvals may be for a narrow indication, we may not be able to commercialize our product candidates, and our ability to generate revenue may be materially impaired.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates must be approved by the FDA pursuant to a new drug application in the United States and by other regulatory authorities outside the United States prior to commercialization in the respective regions. The process of obtaining marketing approvals, both in the United States and outside the United States, is expensive and takes several years, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Failure to obtain marketing approval for a product candidate will prevent us from commercializing the product candidate. We have not received approval to market any of our product candidates from regulatory authorities in any country. We have no experience in filing and supporting the applications necessary to gain marketing approvals for our products and may engage third-party consultants to assist in this process. Securing marketing approval requires the submission of extensive non-clinical and clinical data, and other supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#8217;s safety and efficacy. Securing marketing approval also requires the submission of information about the product formulation and manufacturing process to, and inspection of manufacturing facilities by, the regulatory authorities. Our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. Regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional non-clinical, clinical or other data. In addition, varying interpretations of the data obtained from non-clinical and clinical trials could delay, limit or prevent marketing approval of a product candidate. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may also cause delays in or prevent the approval of an application.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any marketing approval we ultimately obtain may be for fewer or more limited indications than requested or subject to restrictions or post-approval commitments that render the approved product not commercially viable or its market potential significantly impaired. In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to market and sell our products in the EU and other international jurisdictions outside of the United States, we or our third-party collaborators must obtain separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and may require additional non-clinical, clinical or health outcome data. In addition, the time required to obtain approval may differ substantially amongst international jurisdictions. The regulatory approval process outside the United States generally includes all the risks associated with obtaining FDA approval. In addition to regulatory approval, in many countries outside the United States, it is required that the product be approved for reimbursement before the product can be approved for sale in that country.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of our product candidates, the commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any product candidate for which we obtain marketing approval will be subject to extensive post-marketing regulatory requirements and could be subject to post-marketing restrictions or withdrawal from the market, and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products, when and if any of them are approved.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates and the activities associated with their development and commercialization, including their testing, manufacture, recordkeeping, labeling, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulations that are specific to those defined by regulatory authorities in the countries where the product is approved. In the United States and other countries that follow the International Conference on Harmonization, these requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, including periodic inspections by the FDA and other regulatory authorities, requirements regarding the distribution of samples to physicians and recordkeeping.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA, or other regulatory authorities, may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of the product. The FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#8217; communications regarding use of their products and if we promote our products beyond their approved indications, we may be subject to enforcement action for off-label promotion. Violations of the FDCA relating to the promotion of prescription drugs may lead to investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, later discovery of previously unknown adverse events or other problems with our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on such products, manufacturers, or manufacturing processes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the labeling or marketing of a product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on product distribution or use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to conduct post-marketing studies or clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warning or untitled letters;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of the products from the market;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to approve pending applications or supplements to approved applications that we submit;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recall of products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, restitution or disgorgement of profits or revenues;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspension or withdrawal of marketing approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal to permit the import or export of our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-compliance with EU requirements regarding safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population, can also result in significant financial penalties. Similarly, failure to comply with the EU&#8217;s requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legislation regulating the pharmaceutical and healthcare industries may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and affect the prices we may obtain.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes intended to contain healthcare costs and modify the regulation of drug and biologic products. These and other regulatory changes could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022, which, among other things, includes policies that are designed to have a direct impact on drug prices and reduce drug spending by the federal government, which took effect in 2023. The Inflation Reduction Act of 2022 requires drug manufacturers to pay rebates to Medicare if they increase prices faster than inflation for certain drugs used by Medicare beneficiaries. The mechanics of the rebate calculation would mimic those of the Medicaid rebate, but the expansion of inflation-based rebates may further complicate pricing strategies. The Inflation Reduction Act of 2022 or other similar legislation could have the effect of reducing the prices we can charge and reimbursement we receive for our products, thereby reducing our profitability.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that additional state and federal healthcare reform measures and regulations will be adopted in the future. Any of these measures and regulations could limit the amounts that federal and state governments will pay for healthcare products and services, result in reduced demand for our product candidates or additional pricing pressures and affect our product development, testing, marketing approvals and post-market activities.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent administrative law cases decided by the U.S. Supreme Court in 2024 may create uncertainty with respect to actions taken by regulatory agencies to interpret, implement and enforce federal legislation. For example, in its June 2024 decision in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper Bright Enterprises v. Raimondo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8221;), the U.S. Supreme Court overturned the longstanding Chevron doctrine, under which courts were required to give deference to regulatory agencies&#8217; reasonable interpretations of ambiguous federal statutes. The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> decision could result in legal challenges to regulations and guidance issued by federal agencies that are currently applicable to or will be applicable to our business, including those issued by the FDA and the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;). Further, the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loper</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> decision may result in increased regulatory uncertainty, inconsistent judicial interpretations and delays in or other impacts to the agency rulemaking process, which could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws, restrictions, and other regulatory measures are also imposed by healthcare laws and regulations in international jurisdictions and in those jurisdictions we face the same issues as in the United States regarding difficulty and cost for us to obtain marketing approval and commercialization of our product candidates and which may affect the prices we may obtain.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some countries, particularly the countries of the EU, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. If reimbursement of our products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be harmed, possibly materially.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business operations and relationships with healthcare providers, physicians, third-party payers, and customers will be subject to applicable anti-kickback, fraud and abuse and other broadly applicable healthcare laws, which could expose us to criminal sanctions, civil penalties, program exclusion, contractual damages, reputational harm and diminished profits and future earnings.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare providers, physicians and third-party payers will play a primary role in the recommendation and prescription of any product candidates for which we receive marketing approval. Our current and future arrangements may expose us to broadly applicable fraud and abuse and other healthcare laws that may constrain the business or financial arrangements and relationships through which we would market, sell and distribute the products for which we receive marketing approval. Even though we will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payers, federal and state healthcare laws are and will be applicable to our business. Such laws include, but are not limited to federal false claims, false statements and civil monetary penalties laws, including the federal civil False Claims Act (&#8220;FCA&#8221;), the federal Anti-Kickback Statute, the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), patient data privacy and security regulation, including, in the United States, HIPAA, as amended by the Health Information Technology for Clinical Health Act of 2009 (&#8220;HITECH&#8221;), the federal transparency requirements under the Physician Payments Sunshine Act, and analogous state, local or foreign law.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceutical and other healthcare companies have been prosecuted under these laws for a variety of promotional and marketing activities, such as: providing free trips, free goods, sham consulting fees and grants and other monetary benefits to prescribers; reporting to pricing services inflated average wholesale prices that were then used by federal programs to set reimbursement rates; engaging in off-label promotion; and submitting inflated best price information to the Medicaid Rebate Program to reduce liability for Medicaid rebates. Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, disgorgement, fines, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, additional oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, that person or entity may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws, restrictions, and other regulatory measures are also imposed by anti-kickback, fraud and abuse, and other healthcare laws and regulations in international jurisdictions, and in those jurisdictions we face the same issues as in the United State regarding exposure to criminal sanctions, civil penalties, program exclusion, contractual damages, reputational harm, and diminished profits and future earnings.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on our information systems and infrastructure to effectively manage our business, including our clinical trials and studies. Our information systems and infrastructure, and those of our current or future third-party collaborators, service providers, contractors and consultants are vulnerable to damage from cybersecurity incidents, including computer viruses, denial-of-service attacks, hacking, phishing and other social engineering attacks, unauthorized access or use resulting from malware, as well as disruptions due to natural disasters, terrorism, war, mistakes or technical errors, including due to software updates and telecommunication and electrical failures. We may also experience cybersecurity incidents stemming from persons inside our organizations (including employees or contractors), or other persons with access to information systems inside our organization. Attacks on information systems are increasing in their frequency, levels of persistence, sophistication and intensity, and they are being conducted by increasingly sophisticated and organized foreign governments, groups and individuals with a wide range of motives and expertise. Further, cybersecurity threats and the techniques used in cyberattacks change, develop and evolve rapidly, including from emerging technologies, such as advanced forms of artificial intelligence and quantum computing. In addition to extracting or accessing sensitive information, such attacks could include the deployment of harmful malware, ransomware, denial-of-service attacks, social engineering and other means to affect service reliability and threaten the security, confidentiality, integrity and availability of information. The prevalent use of mobile devices that access sensitive information also increases the risk of data security incidents which could lead to the loss of confidential information or other intellectual property. Information system disruptions, even if inadvertent, may limit or disable our access or important third parties&#8217; access to our systems. While to our knowledge none of the cybersecurity incidents we have experienced to date have had a material adverse impact on our business, financial condition or operations, if such an event were to occur and cause interruptions in our operations or the operations of third-party collaborators, service providers, contractors or consultants, it could result in a material disruption of our development programs and significant reputational, financial, legal, regulatory, business or operational harm. The costs to us to mitigate, investigate and respond to potential security incidents, breaches, disruptions, network security problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant, and while we have implemented security measures to protect our data security and information systems, our efforts to address these problems may not be successful, and these problems could result in unexpected interruptions, delays, cessation of service and other harm to our business and our competitive position. Moreover, data security incidents and other security breaches can be difficult to detect, and any delay in identifying them may lead to increased harm.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The compromise of privacy, security, integrity or confidentiality of sensitive information related to our business or failure to comply with confidentiality and data privacy obligations could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. For example, the loss of clinical trial data from completed, ongoing or planned clinical trials for our product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any real or perceived security breach affects our information systems (or those of our third-party collaborators, service providers, contractors or consultants), or results in the loss of or accidental, unlawful or unauthorized access to, use of, release of, or other processing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of personally identifiable information or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could be found to have violated applicable U.S. and international privacy, data protection and other laws, which could subject us to litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the U.S. and by international regulatory entities, resulting in exposure to material civil and/or criminal liability. and the further development of our product candidates could be delayed. Such a breach may require notification to governmental agencies, the media or individuals pursuant to various foreign, domestic (federal and state) privacy and security laws, if applicable, including HIPAA, as amended by HITECH, and its implementing rules and regulations, as well as regulations promulgated by the Federal Trade Commission and state breach notification laws. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to cybersecurity incidents.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, processing of, or transfer of sensitive information, including personally identifiable information, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including those that assert that we have breached our privacy, confidentiality, data security or similar obligations, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. To the extent we maintain individually identifiable health information, we could be subject to fines and penalties (including civil and criminal) under HIPAA for any failure by us or our business associates to comply with HIPAA&#8217;s requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">European data collection is governed by restrictive regulations governing the collection, use, processing and cross-border transfer of personal information.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may collect, process, use or transfer personal information from individuals located in the European Economic Area in connection with our business, including in connection with conducting clinical trials in the EEA. Additionally, if any of our product candidates are approved, we may seek to commercialize those products in the EEA. The collection and use of personal health data in the EEA is governed by the provisions of the General Data Protection Regulation ((EU) 2016/679) (the &#8220;GDPR&#8221;), along with other European Union and country-specific laws and regulations. The United Kingdom and Switzerland have also adopted data protection laws and regulations. These legislative acts (together with regulations and guidelines) impose requirements relating to having legal bases for processing personal data relating to identifiable individuals and transferring such data outside of the EEA, including to the United States, providing details to those individuals regarding the processing of their personal data, keeping personal data secure, having data processing agreements with third parties who process personal data, responding to individuals&#8217; requests to exercise their rights in respect of their personal data, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing data protection officers or corporate representatives, conducting data protection impact assessments and record-keeping. The GDPR imposes additional responsibilities and liabilities in relation to personal data that we process, and we may be required to put in place additional mechanisms ensuring compliance with the new data protection rules. Failure to comply with the requirements of the GDPR and related national data protection laws of the member states of the European Economic Area and other states in the European Economic Area may result in substantial fines, other administrative penalties and civil claims being brought against us, which could have a material adverse effect on our business, financial condition and results of operations. European data protection authorities may interpret the GDPR and national laws differently and may impose additional requirements, which adds to the complexity of processing personal data in or from the EEA or United Kingdom. Guidance on implementation and compliance practices are often updated or otherwise revised.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our non-clinical or clinical development or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Commercialization of Our Product Candidates</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if any of our product candidates receives marketing approval, we may fail to achieve the degree of market acceptance by physicians, patients, third-party payers and others in the medical community necessary for commercial success.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates receives marketing approval, we may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payers and others in the medical community. In addition, physicians, patients and third-party payers may prefer other novel products to ours. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the efficacy and safety and potential advantages and disadvantages compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to offer our products for sale at competitive prices;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the convenience and ease of administration compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength of our marketing and distribution support;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of third-party coverage and adequate reimbursement, including patient cost-sharing programs such as copays and deductibles;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to develop or partner with third-party collaborators to develop companion diagnostics;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any restrictions on the use of our products together with other medications.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our current product candidates, or a future product candidate receives marketing approval and we, or others, later discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, the ability to market the product could be compromised.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials are conducted in carefully defined subsets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials may indicate an apparent beneficial effect of a product candidate that is greater than the actual positive effect in a broader patient population or alternatively fail to identify undesirable side effects. If, following approval of a product candidate, we, or others, discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, any of the following events could occur:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may withdraw their approval of the product or seize the product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product may be required to be recalled or changes may be required to the way the product is administered;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional restrictions may be imposed on the marketing of, or the manufacturing processes for, the product;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may require the addition of labeling statements, such as a &#8220;black box&#8221; warning or a contraindication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the creation of a Medication Guide outlining the risks of the previously unidentified side effects for distribution to patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional restrictions may be imposed on the distribution or use of the product via a Risk Evaluation and Mitigation Strategy;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could be sued and held liable for harm caused to patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product may become less competitive; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reputation may suffer.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these events could have a material and adverse effect on our operations and business. The commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently have no marketing and sales force. If we are unable to establish effective marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to effectively market and sell our product candidates, if approved, or generate product revenues.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently do not have a marketing or sales team for the marketing, sales and distribution of any of our product candidates that are able to obtain regulatory approval. In order to commercialize any product candidates, we must build on a territory-by-territory basis marketing, sales, distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform these services, and we may not be successful in doing so. If our product candidates receive regulatory approval, we intend to establish an internal sales and marketing team with technical expertise and supporting distribution capabilities to commercialize our product candidates, which will be expensive and time-consuming, will require significant attention of our executive officers to manage and may nonetheless fail to effectively market and sell our product candidates. Any failure or delay in the development of our internal sales, marketing and distribution capabilities would adversely impact the commercialization of any of our products that we obtain approval to market. With respect to the commercialization of all or certain of our product candidates, we may choose to collaborate, either globally or on a territory-by-territory basis, with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems. If we are unable to enter into such arrangements when needed on acceptable terms or at all, we may not be able to successfully commercialize any of our product candidates that receive regulatory approval, or any such commercialization may experience delays or limitations. If we are not successful in commercializing our product candidates, either on our own or through collaborations with one or more third parties, our future product revenue will suffer, and we may incur significant additional losses.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and commercialization of new drug products is highly competitive. We face competition with respect to our current product candidates and will face competition with respect to any product candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There are several large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of the disease indications for which we are developing our product candidates. Some of these competitive products and therapies are based on scientific approaches that are the same as or similar to our approach, and others are based on entirely different approaches. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specifically, there are a number of companies developing competing anti-CD40 and anti-CD40L therapeutics in clinical trials for transplant, autoimmune or central nervous system indications, including: Novartis, Sanofi, UCB, Amgen (post-acquisition of Horizon Therapeutics), Bristol Myers Squibb, Tonix Pharmaceuticals and Kiniksa Pharmaceuticals. Most of these companies are larger than Eledon and have significantly greater resources to develop their drug candidates.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If approved, we expect that tegoprubart will face competition from numerous FDA-approved therapeutics for the prevention of transplant rejection, including PROGRAF</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, ASTAGRAF XL</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, ENVARSUS XR</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, NULOJIX</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, CELLCEPT</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, MYFORTIC</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:5.695pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and numerous other branded and generic immunosuppressive agents. Multiple companies are working on islet cell and kidney transplant solutions that may ultimately potentially negate the need for immunosuppressive agents in these indications altogether.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that tegoprubart will face competition from FDA-approved therapeutics for the treatment of ALS including RADICAVA&#174;, riluzole, and numerous other branded and generic immunosuppressive agents. Multiple pharmaceutical and biotechnology companies, including but not limited to Biogen, Ionis Pharmaceuticals, Alexion Pharmaceuticals, Orion Pharma, Orphazyme, AZTherapies, Voyager Therapeutics, Apic Bio, Brainstorm Cell Therapeutics, and Cytokinetics, are also working on competing ALS pharmaceutical, gene therapy and cell therapy approaches.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop. In addition, our ability to compete may be affected in many cases by insurers or other third-party payers seeking to encourage the use of generic products.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generic products are currently available, with additional generic products expected to become available over the coming years, potentially creating pricing pressure. If our product candidates achieve marketing approval, we expect that they will be priced at a significant premium over competitive generic products.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the companies against which we are competing or against which we may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, conducting non-clinical studies, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The insurance coverage and reimbursement status of newly approved products is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The availability and extent of reimbursement by governmental and private payers is essential for most patients to be able to afford expensive treatments. Sales of our product candidates will depend substantially, both domestically and internationally, on the extent to which the costs of our product candidates will be paid by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payers. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, the principal decisions about reimbursement for new medicines are typically made by CMS, as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payers tend to follow CMS to a substantial degree. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally novel products such as ours, as there is no body of established practices and precedents for these new products. Reimbursement agencies in Europe may be more conservative than CMS. Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe, Canada, and other countries has and will continue to put pressure on the pricing and usage of our product candidates. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our product candidates. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, increasing efforts by governmental and third-party payers, in the United States and internationally, to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for new products approved and, as a result, they may not cover or provide adequate payment for our product candidates. Increased expense is incurred to cover costs of health outcome focused research used to generate data necessary to justify the value of our products in order to secure reimbursement. We expect to experience pricing pressures in connection with the sale of any of our product candidates, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products into the healthcare market.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, many private payers contract with commercial vendors who sell software that provide guidelines that attempt to limit utilization of, and therefore reimbursement for, certain products deemed to provide limited benefit to existing alternatives. Such organizations may set guidelines that limit reimbursement or utilization of our products.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. If we cannot successfully defend against claims that our product candidates or products caused injuries, we will incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in decreased demand for any product candidates or products that we may develop; injury to our reputation and significant negative media attention; withdrawal of clinical trial participants; significant costs to defend the related litigation; substantial monetary awards to trial participants or patients; loss of revenue; reduced resources of our management to pursue our business strategy; and the inability to commercialize any products that we may develop.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently hold $10.0 million in product liability insurance coverage in the aggregate, with a per incident limit of $10.0 million, which may not be adequate to cover all liabilities that we may incur. We may need to increase our insurance coverage as we expand our clinical trials or if we commence commercialization of our product candidates. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We contract with third parties for the manufacture of our product candidates for non-clinical and clinical trials and expect to continue to do so for commercialization. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidates or products at an acceptable cost and quality, which could delay, prevent or impair our development or commercialization efforts.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have utilized, and intend to continue utilizing, third parties to formulate, manufacture, package, and distribute clinical supplies of our drug candidates. We have no experience in manufacturing and do not have any manufacturing facilities. Currently, we rely on third parties for the manufacturing of drug substance and drug product for non-clinical and clinical activities. Our manufacturing vendors utilize proprietary cell culture media, cell lines, buffers, manufacturing equipment, manufacturing supplies, and storage buffers for the manufacturing of tegoprubart and other product candidates. These materials are custom-made and available from only a limited number of sources. Although we believe that our third-party suppliers maintain a significant supply of these materials and equipment on hand, any sustained disruption in this supply, could adversely affect our operations. We do not have any long-term agreements in place with our current suppliers. If we are required to change manufacturers, we may experience delays associated with finding an alternate manufacturer that is properly qualified to produce supplies of our products and product candidates in accordance with regulatory requirements and our specifications. Any delays or difficulties in obtaining or in manufacturing, packaging or distributing approved product candidates could negatively impact our clinical trials.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to rely on third-party manufacturers or third-party collaborators for the manufacture of commercial supply of any other product candidates for which our collaborators or we obtain marketing approval. Despite drug substance and product risk management, this reliance on third parties presents a risk that we will not have sufficient quantities of our product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or commercialization efforts. For example, these third parties experienced disruptions in their operations in conjunction with the COVID-19 pandemic. Any delay or performance failure on the part of our existing or future manufacturers of drug substance or drug products could delay clinical development or marketing approval. We do not currently have arrangements in place for redundant supply. If suppliers cannot supply us with our requirements, we may be required to identify alternative manufacturers, which would lead us to incur added costs and delays in identifying and qualifying any such replacement.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Formulations and devices used in early studies are not final formulations and devices for commercialization. Additional changes may be required by the FDA or other regulatory authorities on specifications and storage conditions. These may require additional studies and may result in a delay in our clinical trials and commercialization activities.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also expect to rely on other third parties to label, store, and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of our product candidates or commercialization of our products, producing additional losses and depriving us of potential product revenue.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reliance on the third party for regulatory compliance and quality assurance;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible breach of the manufacturing agreement by the third party;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible misappropriation of our proprietary information, including our trade secrets and know-how; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The third parties we rely on for manufacturing and packaging are also subject to regulatory review, and any regulatory compliance problems with these third parties could significantly delay or disrupt our clinical or commercialization activities. Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products. Additionally, macro-economic conditions may adversely affect these third parties, causing them to suffer liquidity or operational problems. If a key third-party vendor becomes insolvent or is forced to lay off workers assisting with our projects, our results and development timing could suffer.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates and any products that we may develop may compete with other product candidates and products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current and anticipated future dependence upon others for the manufacture of our product candidates or products may adversely affect our future profit margins and our ability to commercialize any products that receive marketing approval on a timely and competitive basis.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on CROs and other contracted third parties to perform non-clinical and clinical testing and certain other research and development activities. As a result, the outcomes of the activities performed by these organizations will be, to a certain extent, beyond our control.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The nature of outsourcing a substantial portion of our business will require that we rely on CROs and other contractors to assist us with research and development, clinical testing activities, patient enrollment, data collection, and regulatory submissions to the FDA or other regulatory bodies. As a result, our success will depend partially on the success of these third parties in performing their responsibilities. Although we intend to pre-qualify our CROs and other contractors and we believe that the contractors selected will be fully capable of performing their contractual obligations, we cannot directly control the adequacy and timeliness of the resources and expertise that they apply to these activities. Additionally, macro-economic conditions may affect our development partners and vendors, which could adversely affect their ability to timely perform their tasks. If our contractors do not perform their obligations in an adequate and timely manner, the pace of clinical development, regulatory approval and commercialization of our drug candidates could be significantly delayed, and our prospects could be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain intellectual property protection for our technology and products or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize our technology and products may be impaired.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in large part on our ability to obtain and maintain patent protection in relevant countries with respect to our proprietary technology and products. We seek to protect our proprietary position by filing patent applications in the United States and internationally that are related to our novel technologies and product candidates. This patent portfolio includes issued patents and pending patent applications covering pharmaceutical compositions and methods of use.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. We may choose not to seek patent protection for certain innovations and may choose not to pursue patent protection in certain jurisdictions, and under the laws of certain jurisdictions, patents or other intellectual property rights may be unavailable or limited in scope. It is also possible that we will fail to identify patentable aspects of our discovery and non-clinical development output before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. For example, India and China do not allow patents for methods of treating the human body. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the EU, the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risks described pertaining to our patents and other intellectual property rights also apply to the intellectual property rights that we license, and any failure to obtain, maintain and enforce these rights could have a material adverse effect on our business. In some cases, we may not have control over the prosecution, maintenance or enforcement of the patents that we license, and our licensors may fail to take the steps that we believe are necessary or desirable in order to obtain, maintain and enforce the licensed patents. Any inability on our part to protect adequately our intellectual property may have a material adverse effect on our business, operating results and financial position.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The United States Patent and Trademark Office (&#8220;USPTO&#8221;) and various non-U.S. governmental patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. In certain situations, non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we have acquired rights to tegoprubart and other product candidates through a license agreement with The ALS Therapy Development Institute, and may in the future enter into other license agreements with third parties for other intellectual property rights or assets. These license agreements may impose various diligence, milestone payment, royalty, and other obligations on us. If we fail to comply with our obligations under these agreements, or we are subject to a bankruptcy, we may be required to make certain payments to the licensor, we may lose the exclusivity of our license, or the licensor may have the right to terminate the license, in which event we would not be able to develop or market products covered by the license. Additionally, the milestone and other payments associated with these licenses will make it less profitable for us to develop our drug candidates than if we had developed the licensed technology internally.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, patent prosecution of our licensed technology may be controlled solely by the licensor. If our licensors fail to obtain and maintain patent or other protection for the proprietary intellectual property we license from them, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, and our competitors could market competing products using the intellectual property. In certain cases, we may control the prosecution of patents resulting from licensed technology. In the event we breach any of our obligations related to such prosecution, we may incur significant liability to our licensing partners. If disputes over intellectual property and other rights that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends upon our ability, and the ability of our collaborators, to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology, including interference or derivation proceedings before the USPTO. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are found to infringe a third party&#8217;s intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because competition in our industry is intense, competitors may infringe or otherwise violate our issued patents, patents of our licensors or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly, or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. We may also elect to enter into license agreements in order to settle patent infringement claims or to resolve disputes prior to litigation, and any such license agreements may require us to pay royalties and other fees that could be significant. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may need to license certain intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A third party may hold intellectual property, including patent rights, that are important or necessary to the development of our products. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties on commercially reasonable terms, or our business could be harmed, possibly materially. If we were not able to obtain a license or are not able to obtain a license on commercially reasonable terms, our business could be harmed, possibly materially.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to seeking patents for some of our technology and product candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. Any NDAs or similar agreements entered into by the Company may not be with all relevant parties, or adequately protect the confidentiality of our trade secrets. Moreover, to the extent we enter into such agreements, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate them, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims of misappropriation of trade secrets from former employers of Company personnel.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our employees and certain of our directors were previously employed at or affiliated with research foundations or other biotechnology or pharmaceutical companies. Although we try to ensure that our employees and directors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees or directors have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee&#8217;s or director&#8217;s former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Common Stock</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect our stock price to be volatile, and the market price of our common stock may drop unexpectedly.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price of our common stock could be subject to significant fluctuations. Market prices for securities of early-stage pharmaceutical, biopharmaceutical, and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">uncertainties regarding our financial condition and our ability to raise sufficient capital to fund our ongoing operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain regulatory approvals for our product candidates or other product candidates, and delays or failures to obtain such approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of any of our product candidates, if approved, to achieve commercial success;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issues in manufacturing our approved products, if any, or product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the results of our current and any future clinical trials of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the entry into, or termination of, key agreements, including key commercial partner agreements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation of, material developments in, or conclusion of litigation to enforce or defend any of our intellectual property rights or defend against the intellectual property rights of others;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements by commercial partners or competitors of new commercial products, clinical progress, or the lack thereof, significant contracts, commercial relationships, or capital commitments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the introduction of technological innovations or new therapies that compete with our potential products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the loss of key employees;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in estimates or recommendations by securities analysts, if any, who cover our common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general and industry-specific economic conditions that may affect our research and development expenditures;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the structure of healthcare payment systems; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period-to-period fluctuations in our financial results; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future issuances of shares of common stock.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of our common stock.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have previously identified and remediated a material weakness in our internal control over financial reporting. If we fail to maintain effective internal controls, we may conclude that our internal control over financial reporting is not effective, which could adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have previously identified and remediated a material weakness in our internal control over financial reporting. If we fail to maintain effective internal controls, we may conclude that our internal control over financial reporting is not effective, which could adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner. Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose any changes and material weaknesses identified through such evaluation in those internal controls.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described Part II Item 9A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Controls and Procedures </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of this Annual Report on Form 10-K, a material weakness in our internal control over financial reporting existed previously which was initially disclosed as of June 30, 2024. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. The Company identified and implemented a number of actions that effectively remediated the previously disclosed material weakness and concluded that as of December 31, 2024 its internal control over financial reporting was effective. However, the Company cannot provide assurances that the remediated material weakness will not reoccur, or that a new material weakness will not occur in the future. The existence of any material weakness could require management to devote significant time and incur significant expense to remediate any such material weakness and management may not be able to remediate any such material weakness in a timely manner. If such material weakness is not remediated effectively or in a sufficient amount time, we could be impacted by a material misstatement of our annual or interim financial statements that was not prevented or detected on a timely basis, which could have a negative effect on our results of operations and/or the trading price of our securities.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter documents and under Delaware law could make an acquisition of the Company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our corporate charter and bylaws may discourage, delay or prevent a merger, acquisition or other change in control of the Company that stockholders may consider favorable, including transactions in which our stockholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our Board is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by stockholders to replace or remove the current management by making it more difficult for stockholders to replace members of our Board. Among other things, these provisions:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a classified Board such that not all members of the Board are elected at one time;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allow the authorized number of our directors to be changed only by resolution of our Board;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit the manner in which stockholders can remove directors from our Board;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our Board;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit who may call stockholder meetings;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorize our Board to issue preferred stock without stockholder approval, which could be used to institute a &#8220;poison pill&#8221; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by our Board; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require the approval of the holders of at least 75% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of the Company&#8217;s charter or bylaws.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not expect to pay any cash dividends in the foreseeable future.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to retain our future earnings to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be the sole source of gain, if any, for any stockholders for the foreseeable future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolve</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d Staff Comments.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div><ix:nonNumeric id="F_dbe0f1d7-8006-4430-b22a-85d97b1fdaa2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_dbe0f1d7-8006-4430-b22a-85d97b1fdaa2_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy and Oversight</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#8217;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a7c6e283-dd80-48fa-800e-5f997cdd00ac" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_766dced8-d879-4338-b7d2-f0bb0ce54a5f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_24bf4382-f565-4126-9903-1eeeea8ca8e3" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5f57f5f0-5390-4461-bb07-1ebbab6eea99" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span></ix:nonNumeric></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d10d074d-a44c-4ec9-b8d7-89d4ef754fbd" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">materially affected</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K, including the risk factor titled &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_14ca2c56-ddca-43b0-9b5a-0532c480f0a8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#8221;</span></p><div><ix:nonNumeric id="F_b215318b-5d1d-4274-bc98-57a0d35a5cf6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true" continuedAt="F_b215318b-5d1d-4274-bc98-57a0d35a5cf6_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b29b80ca-2e5c-4e2e-bc9a-7f07e81b4cc6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aeb0a1d4-79bc-4cdc-ae00-06b1c2c35715" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_dbe0f1d7-8006-4430-b22a-85d97b1fdaa2_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b215318b-5d1d-4274-bc98-57a0d35a5cf6_1"><div><ix:nonNumeric id="F_3a65dbb4-0121-42f4-9cf7-26dd225024c3" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_88393aa2-522f-4edd-ba6f-f45254d89e7c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_12286c5f-2a13-469e-8159-a75ff7e95ad7" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b25cf37f-aa12-40c9-92cb-264e561dc8a7" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></ix:nonNumeric></span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_cbee25b9-e38a-4f5a-993d-7feda161c30a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></ix:nonNumeric></div></ix:continuation></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Pr</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operties.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive offices are located in Irvine, California. We lease approximately 5,817 square feet of office space under an operating lease that expires on June 30, 2027. Additionally, we have an operating lease for approximately 6,138 square feet of office space in Burlington, Massachusetts, that expires on November 21, 2027.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Legal</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Proceedings.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither we nor any of our subsidiaries is a party to, and none of their respective property is the subject of, any material legal proceeding, although we are from time-to-time party to legal proceedings that arise in the ordinary course of our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Saf</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ety Disclosures.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> II</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Registrant&#8217;s Common Equity, Related Stoc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">kholder Matters and Issuer Purchases of Equity Securities.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is traded on the Nasdaq Capital Market under the symbol &#8220;ELDN&#8221;.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 17, 2025, there were approximately 48 stockholders of record of our common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid, and do not anticipate declaring or paying in the foreseeable future, any cash dividends on our common stock. Future determination as to the declaration and payment of dividends, if any, will be at the discretion of our Board and will depend on then existing conditions, including our operating results, financial condition, contractual restrictions, capital requirements, business prospects and other factors that our Board may deem relevant.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [R</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eserved.]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Discussion and Analysis of </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is intended to help the reader understand the results of operations and financial condition of the Company. The Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our audited consolidated financial statements and notes thereto for the year ended December 31, 2024. In addition to historical information, this Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. See &#8220;Special Note Regarding Forward-Looking Statements&#8221; in this Annual Report on Form 10-K. Our actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under the Part I, Item 1A. Risk Factors section and elsewhere in this report, as well as, in other reports and documents we file with the Securities and Exchange Commission from time to time. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECENT DEVELOPMENTS</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business strategy is to optimize the clinical and commercial value of tegoprubart and become a global biopharmaceutical company with a focused immunology franchise. Tegoprubart targets the CD40 ligand (also known as CD40L). Blocking CD40L has been shown to inhibit multiple costimulatory receptors including CD40 and CD11, key components of how immune cells communicate with one another. Blocking CD40L also increases polarization of lymphocytes into Tregs, a specialized subpopulation of T cells that act to suppress immune response.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe the central role of CD40L signaling in generating pro-inflammatory responses makes it an attractive candidate for therapeutic intervention in the protection of transplanted organs and the prevention of transplant rejection, as well as modulating immune responses in autoimmune disease, and in neuroinflammation. Blocking the activation of the CD40L pathway has been shown to slow disease progression and pathology in preclinical models of autoimmunity and neurodegeneration, and to prevent acute and long-term allograft transplant rejection in multiple animal species.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continue to focus on the development of tegoprubart for the prevention of rejection of allograft (i.e., transplanting an organ from one human to another) and xenograft (i.e., transplanting an organ from an animal to a human) organs and cells. Our mission is to both extend the functional life of transplanted organ and reduce side effect of current immunosuppressive treatments such as kidney toxicity, high blood pressure, and tremor.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tegoprubart is being evaluated in multiple kidney transplantation studies, including a Phase 1b trial, the Phase 2 BESTOW trial, and a Phase 2 open-label extension study, all designed to assess safety, pharmacokinetics, and efficacy compared to standard-of-care immunosuppression. Interim data suggest improved renal function and reduced immunosuppressive-related adverse events. Additionally, an investigator-initiated islet cell transplantation study has shown potential in achieving insulin independence without the use of calcineurin inhibitors, supporting further exploration in Type 1 diabetes. We also continue to explore xenotransplantation applications, an emerging area of scientific and commercial interest. Our collaboration with eGenesis, Inc. supports preclinical and clinical studies in kidney, heart, and islet cell transplantation.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Update</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2023, we announced our decision to prioritize resources on our kidney transplantation programs, discontinue the Company funded islet cell transplantation program and the IgAN program. We also remain committed to further progressing ALS clinical development and are working with key stakeholders on potential next steps to do so. However, we are unable to continue our clinical development of tegoprubart for people with ALS without additional financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, we entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;) 550,000 shares of our common stock for 9,899.99 shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. For information regarding the terms of our Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, we entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which we agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of 15,151,518 shares (the &#8220;Shares&#8221;) of our common stock, $0.001 par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of 15,151,518 shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of 20,202,024 shares of common stock (or Pre-Funded Warrants); and (iii) in a third closing (the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of 25,252,530 shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $3.00 per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $0.001 per share. The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at 9.99% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed 19.99% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the initial closing occurred, and we received gross proceeds of $35.0 million, or net proceeds of approximately $33.0 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 8,730,168 shares of common stock and Pre-Funded Warrants to purchase 6,421,350 shares of common stock.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $2.1 million, or net proceeds of approximately $2.0 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 909,088 shares of common stock.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $4.0 million, or net proceeds of approximately $3.8 million after deducting underwriting discounts and commissions and offering expenses, in exchange for 1,727,400 shares of common stock.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 16, 2023, Cormorant Global Healthcare Master Fund LP provided us notice of its intention to convert (i) 1,782 shares of Series X Non-Voting Convertible Preferred Stock for 99,000 shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) 7,883.586 shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for 437,977 shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023. For information regarding the terms of our Series X and Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase 501,197 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued 501,197 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 653,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued 653,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 600,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued 600,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase 583,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued 583,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase 240,000 shares of common stock at an exercise price of $0.001 per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued 240,000 shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, we entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which we agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of 13,110,484 shares (the &#8220;2024 Shares&#8221;) of our common stock at a price of $2.37 per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $2.369 per underlying share, which are exercisable to purchase 7,989,516 shares of common stock at an exercise price of $0.001 per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to 4.99% or 9.99% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed 19.99% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $50.0 million, or net proceeds of approximately $48.1 million after deducting offering costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, on May 24, 2024, we filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, we entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of our common stock, having aggregate sales proceeds of up to $75.0 million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, we filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of December 31, 2024, we have not sold any shares under the Sales Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, we entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of 18,356,173 shares of our common stock, at an offering price of $3.65 per share, and pre-funded warrants at a price of $3.649 per pre-funded warrant, which are exercisable to purchase 4,931,507 shares of our common stock at an exercise price of $0.001 per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $85 million, or net proceeds of approximately $79.5 million after deducting underwriting discounts and commissions and offering expenses. The 2024 Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of 4.99% (or, at the holder&#8217;s option upon issuance, 9.99%) of the number of shares of the our common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrants.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, 33,052,744 warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership conversion blockers). The shares of common stock underlying the registered direct and private placement warrants are registered for offer and sale under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to our effective registration statements on Forms S-1.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Preferred Stock Warrants</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, 50,207.419 warrants were exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock which are convertible into 2,789,301 shares of common stock (after rounding for fractional shares and subject to beneficial ownership conversion blockers). For information regarding the terms of our Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock, see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Operations Overview</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operating expenses consist primarily of costs associated with research and development activities and general and administrative activities.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses, which consist primarily of costs associated with our product research and development efforts, are expensed as incurred. Research and development expenses consist primarily of:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personnel costs, including salaries, benefits, stock-based compensation and travel expenses, for employees engaged in research and development functions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred under agreements with contract research organizations, or (&#8220;CROs&#8221;), and sites that conduct our non-clinical studies and clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses associated with manufacturing materials for use in non-clinical studies and clinical trials and developing external manufacturing capabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs of outside consultants engaged in research and development activities, including their fees and travel expenses; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other expenses related to our non-clinical studies and clinical trials and expenses related to our regulatory activities; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payments made under our third-party license agreements.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of personnel costs that include salaries, benefits and travel expenses for our executive, finance, and other administrative functions, and stock-based compensation expense. General and administrative expenses also include professional fees for expenses incurred under agreements with third parties relating to public relations, audit, tax and legal services, including legal expenses to pursue patent protection of our intellectual property; and our information technology, facilities and other related expenses, including rent, maintenance of facilities, insurance and supplies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds represents the initial recognition of warrant liabilities at fair value in excess of proceeds received, as well as subsequent period remeasurements of these warrant liabilities at fair value. These remeasurements reflect changes in market conditions, such as fluctuations in stock price, volatility, interest rates, and other valuation inputs that impact the fair value of the liability.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRITICAL ACCOUNTING POLICIES AND SIGNIFICANT JUDGMENTS AND ESTIMATES</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets, liabilities, and expenses and the disclosure of contingent assets and liabilities as of the date of the financial statements. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued Research and Development Expenses</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts, communicating with our personnel and vendors to identify services that have been performed on our behalf and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in our consolidated financial statements based on facts and circumstances known to us at that time. Examples of estimated accrued research and development expenses include fees paid to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CROs in connection with performing research and development services on our behalf;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other providers in connection with clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors in connection with non-clinical development activities; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors related to product manufacturing, development and distribution of clinical supplies.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We base our expenses related to clinical trials on our estimates of the services received and efforts expended pursuant to contracts with multiple CROs that conduct and manage clinical trials on our behalf. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the clinical expense. Payments under some of these contracts depend on factors such as the successful enrollment of patients and the completion of clinical trial milestones. When determining accruals, we estimate the time period over which services will be performed, enrollment of patients, number of sites activated and level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or prepaid accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reporting expenses that are too high or too low in any particular period. To date, we have not made any material adjustments to our prior estimates of accrued research and development expenses.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSU&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrants are accounted for as either derivative liabilities or as equity instruments depending on the specific terms of the underlying agreement. Warrants that are equity-classified instruments and recorded in additional paid-in capital at issuance are not subject to remeasurement. The Common Warrants and the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholder&#8217;s Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Notes to Financial Statements) issued in the 2023 Private Placement are liability classified and recorded at fair value using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the consolidated statements of operations. We periodically evaluate changes in facts and circumstances that could impact the classification of warrants. As of December 31, 2024, the Subsequent Closing Warrants were settled or expired and only the Common Warrants remain.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We first assess qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, we determine it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of our annual qualitative assessment, we concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is set forth in Note 2. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Notes to Financial Statements included in this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESULTS OF OPERATIONS</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of the Years Ended December 31, 2024 and 2023</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides comparative results of operations for the years ended December 31, 2024 and 2023 (in thousands):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:41.608%;box-sizing:content-box;"/>
    <td style="width:1.52%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.082%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.52%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.082%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.52%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.082%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.04%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.542%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Variance</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Variance</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,964</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,312</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,652</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,613</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,688</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,925</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,577</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(70,577</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(43,000</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(27,577</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-64</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,250</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(76,211</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,111</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(35,753</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(116,537</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,784</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(431</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(431</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-100</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36,184</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(116,537</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80,353</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the period-over-period changes in research and development expenses for the periods presented (in thousands):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.97%;box-sizing:content-box;"/>
    <td style="width:3.061%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.462%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.061%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.482000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.061%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.903%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,512</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,880</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,400</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,292</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,512</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,780</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,786</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">135</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51,964</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,312</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,652</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses increased $21.7 million for the year ended December 31, 2024, compared to the year ended December 31, 2023. The increase was primarily due to the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $15.5 million in Tegoprubart - kidney transplantation programs, primarily with external CROs, related to increased activities in our Phase 1b, Phase 2 BESTOW and Phase 2 open-label extension trials for kidney transplantation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a decrease of $2.9 million in Tegoprubart - other development programs, primarily with external CROs, related to our IgAN program that was completed in 2023; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $4.4 million in manufacturing costs, primarily with contract manufacturing organizations, for the increased production of drug substance and drug product clinical trial supply;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $1.8 million in personnel-related expenses due to an increase in headcount to support ongoing clinical development programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $2.8 million in stock-based compensation expense, primarily due to the recognition of expense for the achievement of performance-based vesting criteria during the year ended December 31, 2024; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $0.1 million in other operating expenses.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the period-over-period changes in general and administrative expenses for the periods presented (in thousands):</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:53.561%;box-sizing:content-box;"/>
    <td style="width:3.041%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11.385%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.041%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.964%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.041%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.964%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional Fees</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,212</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,680</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,532</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,414</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,839</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">575</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,791</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,142</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,115</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total general and administrative expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,613</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,688</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,925</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses increased $5.9 million for the year ended December 31, 2024, compared to the year ended December 31, 2023. The increase was primarily due to the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $1.5 million in professional fees and consulting fees primarily driven by increased audit and legal services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $0.6 million in personnel-related expenses due to increased headcount; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an increase of $3.8 million in stock-based compensation expense, primarily due to the recognition of expense for the achievement of performance-based vesting criteria during the year ended December 31, 2024.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $1.3 million increase in other income, net was primarily due to an increase in interest income, driven by higher balances of our cash and cash equivalents and short-term investments during the year ended December 31, 2024 as compared to the year ended December 31, 2023.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, the fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds increased by $107.1 million to $30.9 million. The change was primarily due to the reversal of $59.1 million in warrant liabilities associated with the Subsequent Closing Warrants, which were settled or expired in 2024, partially offset by increase in the fair value of Common Warrants of $27.8 million. This is compared to $76.2 million in fair value of the Common Warrants and the Subsequent Closing Warrants for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provision for Income Taxes</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $0.4 million provision for income taxes for the year ended December 31, 2024, is the result of a change in the effective state tax rate used to remeasure deferred tax liability related to indefinite-lived assets.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LIQUIDITY AND CAPITAL RESOURCES</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had cash and cash equivalents and short-term investments of $140.2 million, working capital of $132.2 million and an accumulated deficit of $355.6 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any approved products for commercial sale and have never generated revenue from product sales and have incurred significant net losses since our inception and expect to continue to incur net operating losses for the foreseeable future. We do not expect to receive any revenue from any product candidates that we develop unless and until we obtain regulatory approval and commercialize our product candidates or enter into collaborative arrangements with third parties. We currently have no credit facility or committed sources of capital. To date, our operations have been financed primarily by net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proceeds from the sale of preferred and common stock, and the sale of warrants. Additionally, in view of our expectation to incur significant losses for the foreseeable future we will be required to raise additional capital resources in the future in order to fund our operations, although the availability of, and our access to, such resources is not assured.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have based this estimate on assumptions that may prove to be incorrect, and we could utilize our available resources sooner than we currently expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured. Further, from time to time, our operating plans may change, and we may need additional funds to meet operational needs for clinical studies sooner than planned or to fund additional clinical studies. For example, we do not currently have sufficient liquidity to fund the continued clinical development of tegoprubart for people with ALS without additional financing. We will continue to monitor our liquidity position in light of various financing alternatives and may pursue additional financing or other alternatives to allow us to continue our product development. However, there can be no assurance such financing or other alternatives will be available to us on acceptable terms, or at all, which could force us to significantly alter our business strategy, substantially curtail our current operations, or liquidate and cease operations altogether.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Cash Requirements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our primary use of cash is to fund operating expenses, which consist of clinical research and development expenses, manufacturing expenses, legal and compliance expenses, compensation and related expenses, and general overhead costs. Cash used to fund operating expenses is impacted by the timing of when we pay or prepay these expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our expenses to increase in connection with our ongoing activities, particularly as we expand our clinical program with tegoprubart, continue the research and development of, and seek marketing approval for, our product candidates. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will continue to require additional financing in order to advance our drug product through clinical development, to manufacture, obtain regulatory approval for and to commercialize our product candidates, to develop, acquire or in-license other potential product candidates, and to fund operations for the foreseeable future. Therefore, we will seek to raise additional capital through equity offerings, debt financings or other capital sources, including potentially collaborations, licenses and other similar arrangements. The ability to raise substantial additional capital will depend on many factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation, progress, timing, costs and results of our ongoing and future clinical trials of tegoprubart, including as such activities may be adversely impacted by global events or macroeconomic conditions; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of global macroeconomic trends and uncertainties, which continue to experience volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, rising interest rates and uncertainty about economic stability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of indications we decide to pursue for tegoprubart development; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost, timing and outcome of regulatory review of any biologics license application, or BLA, we may submit for tegoprubart;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of manufacturing for tegoprubart, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of tegoprubart;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs associated with being a public company; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost associated with commercializing tegoprubart, if approved for commercial sale.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding. As a result of any of the foregoing factors, adequate additional funding may not be available to us on acceptable terms on a timely basis, or at all. The severity and duration of any such impacts cannot be predicted. Any such failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies or cause us to delay our clinical development plans, research and development programs or commercialization efforts, out-license intellectual property rights to our product candidates or sell unsecured assets, or a combination of the above. Any of these actions could materially harm our business. The issuance of shares of common stock in the 2023 Private Placement, the 2024 Private Placement and the 2024 Underwritten Offering diluted the ownership interests of our existing stockholders, and to the extent that we raise additional capital through the sale of additional equity, including through our &#8220;at the market&#8221; equity offering program, or convertible debt securities in the future, our stockholders&#8217; ownership interests may be further diluted, and the terms of these securities may also include liquidation or other preferences that adversely affect our stockholders&#8217; rights. Debt financing, if available, would result in fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends, that could adversely impact our ability to conduct our business. If we raise funds through collaborations, licenses and other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us. Please see Part I, Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of this Annual Report on Form 10-K for additional risks associated with our substantial capital requirements and the challenges we may face in raising capital.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We lease our office facilities in Irvine, California and Burlington, Massachusetts under non-cancelable operating leases that expire in June 2027 and November 2027, respectively. As of December 31, 2024, we expect to make total lease payments of $1.1 million through November 2027.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into contracts in the normal course of business with third-party contract organizations for preclinical and clinical studies, manufacture and supply of our preclinical and clinical materials and providing other services and products for operating purposes. Contracts for preclinical and clinical studies and other services generally provide for termination following a certain period after notice, and therefore we believe that our non-cancelable obligations under these agreements are not material. We do not have any long-term manufacturing and supply agreements with our third-party contract manufacturers but enter into specific contracts on an as needed basis for individual batch production runs.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary of our net cash flow activity for the years ended December 31, 2024 and 2023 (in thousands):</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.72%;box-sizing:content-box;"/>
    <td style="width:1.72%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.92%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.72%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.92%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(47,271</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(39,527</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(70,314</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(45,287</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133,522</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,017</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net change in cash and cash equivalents</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,937</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(51,797</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, operating activities used $47.3 million of cash, which primarily consisted of our net loss of $36.2 million. Operating activities include adjustments for certain non-cash charges including $30.9 million due to a change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds, accretion of investment discounts of $2.8 million, partially offset by $13.1 million of stock-based compensation, $0.4 million of operating lease amortization, and $0.4 million of deferred tax provision. Net operating assets and liabilities changed by $8.7 million, primarily driven by an increase in accounts payable and accrued expenses of $7.7 million and a decrease in prepaid expenses and other assets of $1.3 million.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2023, operating activities used $39.5 million of cash, which resulted from our net loss of $116.5 million and the changes in operating activities described below. Operating activities include adjustments for certain non-cash charges including $76.2 million due to a change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds, $6.5 million of stock-based compensation, and $0.4 million of operating lease</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amortization, partially offset by accretion of investment discounts of $1.2 million. Net operating assets and liabilities changed by $4.9 million, primarily driven by a decrease in accounts payable and accrued expenses of $2.6 million, a decrease in operating lease liability of $0.4 million and an increase in prepaid expenses and other assets of $2.0 million.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2024 was $70.3 million. We purchased $156.1 million of short-term investments, which was partially offset by the maturing of $85.8 million of our short-term investments during the year.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities for the year ended December 31, 2023 was $45.3 million. We purchased $78.3 million of short-term investments, which was partially offset by the maturing of $33.0 million of our short-term investments during the year.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities for the year ended December 31, 2024 consisted of the following: $79.5 million in net proceeds from the 2024 Underwritten Offering, involving the sale of 18.4 million shares of the common stock and pre-funded warrants to purchase 4.9 million shares of common stock; $48.1 million in net proceeds from the 2024 Private Placement, involving the sale of 13.1 million shares of common stock and pre-funded warrants to purchase 8.0 million shares of common stock; $1.9 million in net proceeds from the Second Closing, involving the sale of 0.9 million shares of common stock; $3.8 million in net proceeds from the Third Closing, involving the sale of 1.7 million shares of common stock; and $0.2 million from exercise of stock options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities for the year ended December 31, 2023 consisted of the 2023 Private Placement, totaling $33.0 million in net proceeds from the sale of 8.7 million shares of common stock and pre-funded warrants to purchase 6.4 million shares of common stock.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A. Quantitative and Qualitati</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ve Disclosures About Market Risk.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Per &#167;229.305 of Regulation S-K, the Company, designated a Smaller Reporting Company as defined in &#167;229.10(f)(1) of Regulation S-K, is not required to provide the disclosure required by this Item.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements_supplementar"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Financial Statement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s and Supplementary Data.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report of Independent Registered Public Accounting Firm, our consolidated financial statements and accompanying notes listed under Part IV, Item 15. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of this Annual Report on Form 10-K are set forth beginning on page F-1 immediately following the signature page hereof and incorporated by reference herein.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Changes in and Disagreements with Accoun</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tants on Accounting and Financial Disclosure.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and Procedures.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the end of the period covered by this Annual Report on Form 10-K, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on this evaluation, management concluded that our disclosure controls and procedures were effective at the reasonable assurance level, as of December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Control Over Financial Reporting</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance to our management and Board regarding the preparation and fair presentation of published financial statements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2024. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO Framework&#8221;) in its 2013</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Internal Control&#8212;Integrated Framework.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Management believes that the COSO Framework is a suitable framework for its evaluation of financial reporting because it is free from bias, permits reasonably consistent qualitative and quantitative measurements of our internal control over financial reporting, is sufficiently complete so that those relevant factors that would alter a conclusion about the effectiveness of our internal control over financial reporting are not omitted and is relevant to an evaluation of internal control over financial reporting.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed Remediation of Prior Years&#8217; Material Weakness</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of preparing our unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2024, our management concluded that the Common Warrants and Subsequent Closing Warrants do not meet the conditions to be classified as equity instruments under ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity,&#8221; and must instead be recorded as liabilities on our consolidated balance sheet at their fair value and remeasured at fair value for each subsequent reporting period. In light of this determination, on August 13, 2024, management and the Audit Committee of our Board together concluded that our previously issued (i) audited consolidated financial statements as of and for the year ended December 31, 2023 included in our Annual Report on Form 10-K filed with the SEC on March 28, 2024 and (ii) unaudited condensed consolidated financial statements as of and for (a) the three months ended March 31, 2024 included in our Quarterly Report on Form 10-Q filed with the SEC on May 15, 2024, (b) the three and nine months ended September 30, 2023 included in our Quarterly Report on Form 10-Q filed with the SEC on November 9, 2023 and (c) the three and six months ended June 30, 2023 included in our Quarterly Report on Form 10-Q filed with the SEC on August 10, 2023 (together, the &#8220;Impacted Reports&#8221;) were each materially misstated.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, our management, including our principal executive officer and principal financial officer, determined that there existed a material weakness identified in our internal control over financial reporting related to our accounting for equity instruments for the periods covered by each of the Impacted Reports. A material weakness is a deficiency, or a combination of deficiencies, in the internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Specifically, our management determined that we did not maintain effective controls to timely identify and account for complex derivative type financial instruments. This material weakness resulted in the material misstatement of each of the Impacted Reports.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As previously disclosed, in August 2024, the Company immediately implemented a plan to address and remediate the material weakness described above and to improve our internal control over financial reporting. As part of the remediation plan, management identified and implemented a number of actions including, but not limited to, the following actions:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engaged with independent technical accounting experts to advise and review complex financial matters, ensuring appropriate technical analysis, documentation, and oversight prior to the preparation of our financial statements.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hiring of internal financial expertise within the corporate accounting department.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implemented an accounting standards compliance framework to ensure timely adoption and assessment of evolving accounting standards.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strengthened financial disclosure and technical guidance resources.</span></div></div>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> During the fourth quarter of the year ended December 31, 2024, we successfully completed the testing necessary to conclude that the material weakness has been remediated. As such, management, including our principal executive officer and principal financial officer have concluded that the plan and actions described above were satisfactorily executed and the related policies, procedures and controls have been implemented, operated effectively and tested satisfactorily for a sufficient period of time to demonstrate that the previously identified material weakness has been remediated as of December 31, 2024. The Company is committed to evaluating and monitoring adherence to the established policies and procedures listed above.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a non-accelerated filer, we are not required to provide an attestation report on our internal control over financial reporting issued by the Company&#8217;s independent registered public accounting firm.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than as described above, there have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) of the Exchange Act) during the quarter ended December 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_or_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Other </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Insider Trading Arrangements</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69325e08-09a3-4d04-aa22-0a650cb33876" contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_90a256f5-23b2-46d3-b08c-dfd26e1346ad" contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_260cc79a-09c7-4d66-9d97-433150b5311d" contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_a435edc9-b801-4dd3-9360-b70a5da939b9" contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Regarding Foreign J</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">urisdictions that Prevent Inspection.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> III</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Executive Off</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">icers and Corporate Governance.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 10 is incorporated herein by reference to information in our proxy statement for our 2025 Annual Meeting of Stockholders (the &#8220;2025 Proxy Statement&#8221;), which we expect to be filed with the SEC within 120 days of the end of our fiscal year ended December 31, 2024, including under headings &#8220;Board of Directors and Corporate Governance&#8212;Election of Directors,&#8221; &#8220;Executive Officers and Executive Compensation&#8212;Executive Officers,&#8221; &#8220;Board of Directors and Corporate Governance&#8212;Director Nomination Process,&#8221; &#8220;Board of Directors and Corporate Governance&#8212; Committees of the Board of Directors&#8221; and &#8220;Board of Directors and Corporate Governance&#8212;Insider Trading Policy.&#8221;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_daa34ba1-0008-444f-829e-feeb2de68ccb" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is available on the Corporate Governance section of our website, which is located at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">http://ir.eledon.com/corporate-governance/governance-overview</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We intend to disclose on our website any amendments to, or waivers from, the code of business conduct and ethics that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K within four business days following the date of the amendment or waiver.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Executiv</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e Compensation.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 11 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Executive Compensation,&#8221; &#8220;Director Compensation,&#8221; and &#8220;Board of Directors and Corporate Governance&#8212;Compensation Committee Interlocks and Insider Participation&#8221;.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security_ownership_certain_benef"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Own</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ers and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 12 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Securities Authorized for Issuance Under Equity Compensation Plans&#8221;.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships_related_tr"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Certain Relationships and Related</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Transactions, and Director Independence.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 13 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Board of Directors and Corporate Governance&#8212;Related Person Transactions,&#8221; &#8220;Board of Directors and Corporate Governance,&#8221; and &#8220;Board of Directors and Corporate Governance&#8212;Committees of the Board of Directors&#8221;.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal Accountant Fees and Services.</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 14 is incorporated herein by reference to information in our 2025 Proxy Statement, including under headings &#8220;Matters to be Voted&#8212;on Proposal No. 2&#8212;Ratification of the Appointment of Independent Registered Public Accounting Firm&#8221;.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> IV</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits, Financi</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">al Statement Schedules.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following documents are filed as part of this Annual Report on Form 10-K:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statements:</span></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Report of Independent Registered Public Accounting Firm, our consolidated financial statements and accompanying notes are set forth beginning on page F-1 immediately following the signature page of this Annual Report on Form 10-K.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statement Schedules:</span></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial statements and notes thereto under Part II, Item 8. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits:</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.663%;box-sizing:content-box;"/>
    <td style="width:1.301%;box-sizing:content-box;"/>
    <td style="width:30.752%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:6.583%;box-sizing:content-box;"/>
    <td style="width:2.361%;box-sizing:content-box;"/>
    <td style="width:10.144%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:7.683%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:17.007%;box-sizing:content-box;"/>
    <td style="width:2.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.664%;box-sizing:content-box;"/>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520246314/d26397dex21.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated September 14, 2020, by and among Novus Therapeutics, Inc., Nautilus Merger Sub 1, Inc., Nautilus Merger Sub 2, LLC and Anelixis Therapeutics, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 15, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312514354857/d793658dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restated Certificate of Incorporation of Novus Therapeutics, Inc., a Delaware corporation, dated September 22, 2014</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 26, 2014</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517170677/d393884dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Certificate of Incorporation of Novus Therapeutics, Inc. (effecting, among other things a reverse stock-split), filed with the Secretary of the State of Delaware on May 9, 2017</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 15, 2017</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517170677/d393884dex32.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Certificate of Incorporation of Novus Therapeutics, Inc. (effecting, among other things a change in the corporation&#8217;s name to &#8220;Novus Therapeutics, Inc.&#8221;), filed with the Secretary of the State of Delaware on May 9, 2017</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 15, 2017</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;3.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520264806/d18987dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Restated Certificate of Incorporation of Novus Therapeutics, Inc., (effecting, among other things a reverse stock-split) effective as of October 5, 2020</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 6, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.663%;box-sizing:content-box;"/>
    <td style="width:1.301%;box-sizing:content-box;"/>
    <td style="width:30.752%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:6.583%;box-sizing:content-box;"/>
    <td style="width:2.361%;box-sizing:content-box;"/>
    <td style="width:10.144%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:7.683%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:17.007%;box-sizing:content-box;"/>
    <td style="width:2.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.664%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000110465921000921/tm211620d1_ex3-1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Restated Certificate of Incorporation of Novus Therapeutics, Inc., (effecting, among other things a change in the corporation&#8217;s name to &#8220;Eledon Pharmaceuticals, Inc.&#8221;) effective as of January 5, 2021</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 5, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517211880/d406180dex34.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of Eledon Pharmaceuticals, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 5, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520041903/d888744dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Designations of Series X Convertible Preferred Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 19, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520246314/d26397dex31.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certificate of Designations of Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> Convertible Preferred Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 15, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001404281/000119312517211880/d406180dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Common Stock Certificate</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-A/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">June 23, 2017</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312519135059/d740901dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Warrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 2, 2019</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312519135059/d740901dex42.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Placement Agent Warrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 2, 2019</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312520008426/d873828dex41.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Common Stock Purchase Warrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 16, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex45_320.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Description of Securities</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex4_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Tranche A Warrant to Purchase Common Stock or Pre-Funded Warrants</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/eldn-ex4_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 30, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000119312524222880/d893946dex12.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Open Market Sales Agreement by and between the Registrant and Guggenheim Securities, LLC dated September 20, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-282260</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 20, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated April 28, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated April 28, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated May 6, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated May 6, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 7, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023049046/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement to be entered into with each of the directors and officers of Eledon</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 21, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex10_7.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fourth Amendment to Lease Agreement, dated March 12, 2024, by and between Newport Gateway Office LLC and Eledon Pharmaceuticals, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.663%;box-sizing:content-box;"/>
    <td style="width:1.301%;box-sizing:content-box;"/>
    <td style="width:30.752%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:6.583%;box-sizing:content-box;"/>
    <td style="width:2.361%;box-sizing:content-box;"/>
    <td style="width:10.144%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:7.683%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:17.007%;box-sizing:content-box;"/>
    <td style="width:2.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.664%;box-sizing:content-box;"/>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex10_8.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease Agreement, dated September 4, 2024, by and between Blanchard Group LLC and Eledon Pharmaceuticals, Inc</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018007314/nvus-ex1011_429.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tokai Pharmaceuticals, Inc. 2007 Stock Incentive Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 2, 2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018019519/nvus-ex102_213.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tokai Pharmaceuticals, Inc. 2014 Stock Incentive Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 7, 2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459018019519/nvus-ex103_212.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Novus Therapeutics, Inc., 2014 Employee Stock Purchase Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 7, 2018</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex108_318.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Employment Agreement, dated September 9, 2020, between Novus Therapeutics, Inc. and David-Alexandre C. Gros, M.D.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_3.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre Gros, M.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex10_14.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre Gros, M.D. Letter Agreement, dated December 16, 2024</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex1010_316.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Executive Employment Agreement, dated March 15, 2021, between Eledon Pharmaceuticals, Inc. and Paul Little</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017023016017/eldn-ex10_4.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Steve Perrin, Ph.D. Letter Agreement, dated April 27, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 1, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459021016828/nvus-ex1011_319.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Novus Therapeutics, Inc., 2020 Long Term Incentive Plan</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 31, 2021</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024082730/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. 2020 Long Term Incentive Plan, as amended</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 10, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459022011698/eldn-ex1012_1073.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Performance Stock Option Agreement, dated February 1, 2022, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 24, 2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amended and Restated License Agreement by and between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc, dated February 18, 2020</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_2.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">First Amendment to Restated License Agreement between ALS Therapy Development Foundation, Inc. and Anelixis Therapeutics, Inc. dated September 5, 2020</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017022016935/eldn-ex10_3.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">License Agreement between Lonza Sales AG and Anelixis Therapeutics, LLC, dated September 11, 2018</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2022</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.663%;box-sizing:content-box;"/>
    <td style="width:1.301%;box-sizing:content-box;"/>
    <td style="width:30.752%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:6.583%;box-sizing:content-box;"/>
    <td style="width:2.361%;box-sizing:content-box;"/>
    <td style="width:10.144%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:7.683%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:17.007%;box-sizing:content-box;"/>
    <td style="width:2.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.664%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex10_22.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Stock Option Agreement, dated May 1, 2023, between Eledon Pharmaceuticals, Inc. and each of David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex10_23.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated December 30, 2023, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex10_25.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated June 13, 2024, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex10_26.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Agreement, dated November 20, 2024, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D., Bryan Smith and Paul Little</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex19_1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. Insider Trading Policy</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000156459020011260/nvus-ex211_11.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subsidiaries of the Registrant</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 17, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex23_1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of Crowe LLP, independent registered public accounting firm</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex23_2.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consent of KMJ Corbin &amp; Company LLP, independent registered public accounting firm</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex31_1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex31_2.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex32_1.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.663%;box-sizing:content-box;"/>
    <td style="width:1.301%;box-sizing:content-box;"/>
    <td style="width:30.752%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:6.583%;box-sizing:content-box;"/>
    <td style="width:2.361%;box-sizing:content-box;"/>
    <td style="width:10.144%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:7.683%;box-sizing:content-box;"/>
    <td style="width:1.281%;box-sizing:content-box;"/>
    <td style="width:17.007%;box-sizing:content-box;"/>
    <td style="width:2.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.664%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eldn-ex32_2.htm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-ex97_1.htm" style="-sec-extract:exhibit;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Incentive Compensation Recoupment Policy</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-36620</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INLINE XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">INLINE XBRL Taxonomy Extension Schema with Embedded Linkbase Documents</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover page formatted as INLINE XBRL and contained in Exhibit 101</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indicates a management contract or compensatory plan</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">#</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">These certifications are not deemed filed by the SEC and are not to be incorporated by reference in any filing we make under the Securities Act of 1933 or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K Summary.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNAT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">URES</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:47%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">and Director (Principal</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Executive Officer and Duly Authorized Officer)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paul Little</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28.2%;box-sizing:content-box;"/>
    <td style="width:1.92%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1.92%;box-sizing:content-box;"/>
    <td style="width:27.96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:15.85pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Executive Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paul Little</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Keith A. Katkin</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chairman of the Board of Directors</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Keith A. Katkin</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jan Hillson, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jan Hillson, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ James Robinson</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">James Robinson</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Allan Kirk, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allan Kirk, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John S. McBride</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John S. McBride</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ June Lee, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">June Lee, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Steven Perrin</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President, Director</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Steven Perrin</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="index_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO CONSOLIDATED FINANC</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IAL STATEMENTS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:94.54%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.46%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_independent_pub_acctg_firm"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (Crowe LLP PCAOB ID#: </span><span><ix:nonNumeric id="F_889967a0-6c36-4c56-9e1e-a197f5ee416a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#kmj_opinion"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (KMJ Corbin &amp; Company LLP PCAOB ID#: </span><span><ix:nonNumeric id="F_14de40d7-1938-4eff-a08a-b92b1e02222d" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">170</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0in;text-indent:18pt;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="margin-left:5.75pt;text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_operat"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0in;text-indent:18pt;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="margin-left:5.75pt;text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#equity"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity for the Years Ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0in;text-indent:18pt;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="margin-left:5.75pt;text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12.25pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_cash_f"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;text-indent:18pt;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="margin-left:5.75pt;text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_consolidated_financia"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0in;text-indent:18pt;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="margin-left:5.75pt;text-indent:-12.25pt;padding-left:12.25pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_independent_pub_acctg_firm"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Board of Directors and Stockholders of<br/>Eledon Pharmaceuticals, Inc.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_b04b43bb-624d-45c1-8ddc-086927084c2f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:AuditorOpinionTextBlock" escape="true" continuedAt="F_b04b43bb-624d-45c1-8ddc-086927084c2f_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Issuer (the "Company") as of December 31, 2024, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statements of the Company as of December 31, 2023, were audited by other auditors whose report dated March 28, 2024, except for the effects of the Restatement disclosed in Note 13, as to which the date is August 19, 2024, expressed an unqualified opinion on those statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provided a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Classification and Valuation of Pre-Funded Warrants</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#8217;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b04b43bb-624d-45c1-8ddc-086927084c2f_1" continuedAt="F_b04b43bb-624d-45c1-8ddc-086927084c2f_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#8217;s conclusions and inputs to its calculation of fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consulting with specialists on the classification and valuation of the pre-funded warrants.</span></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#8217;s valuation.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28520a39-8788-437c-b1ae-b14fe3cfba1a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Crowe LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company's auditor since 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a55db684-b4af-481e-8a94-46db01e3aff1" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Los Angeles, CA</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 20, 2025</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="kmj_opinion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Board of Directors and Stockholders of<br/>Eledon Pharmaceuticals, Inc.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b04b43bb-624d-45c1-8ddc-086927084c2f_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#8220;Company&#8221;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provide a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0edadf2d-2db6-4c77-bc03-a9af2679b09f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KMJ Corbin &amp; Company LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We served as the Company's auditor from 2019 to 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_697e6cf4-d1f6-48f6-8954-be5addea7c38" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Glendora, California</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/>March 28, 2024 (except for previously disclosed adjustments to 2023, as to which the date is August 19, 2024 and Note 10, as to which the date is March 20, 2025)</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TED BALANCE SHEETS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:68.274%;box-sizing:content-box;"/>
    <td style="width:1.64%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.222000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.64%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.222000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ASSETS</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_154c8dd3-0a66-486d-a16d-4b36d0fe275b" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,549</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5deff3b-5937-4607-9f18-44be237718e2" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6047fe1-b87d-4a48-b626-37696c9b0903" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9694d387-e637-4c3f-adf4-1f88065b7752" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b70df460-7d8c-467d-b2f1-3ea6356c1e3e" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,552</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1798751a-6477-4ec0-9404-ed378a894c41" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,027</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7528eba7-5c84-48db-98f9-afbe561ab048" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,730</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc015ba8-b813-4101-ab27-2523a74bb309" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,129</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use asset, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cebd40c-d03a-47d1-b84a-1e4d95ad319d" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">926</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae7392c5-3f39-4008-8d91-61da926d2618" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">In-process research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d9edda3-3b8f-45bd-b465-7a8521f41c26" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:InProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_586eeb6a-9f6c-48d3-90a2-b22ea0d90ee5" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:InProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96a10153-a8bc-46fd-8b5c-7cf1bdbed480" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">363</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2090195b-c2fe-4631-88a0-a8e3891de4ff" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">186</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90763d21-7f0f-42e3-b003-d2023044b8ca" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,405</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73c4a8d9-197e-473c-ba48-646088fa00d0" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,066</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b550d8ef-20af-46db-bc41-ccb94009db3e" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,833</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53a1dc3d-0b79-4bf2-b624-57681090b51b" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">967</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current operating lease liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc5813c1-b058-4d74-b527-0d3b85ca60a9" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94eb5e78-7266-46cc-bade-f7be895ebacd" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">383</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49f57a20-9a67-49da-ac2f-f634d0538019" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,430</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_484c1aef-a08c-4155-9896-34adddc11ac1" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95a10388-d581-442c-a2b3-bf27507a70c0" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,577</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_409f5235-4c87-405f-bd92-0dc3c782bce5" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,895</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a97379dc-a58a-4a3b-814e-02a4374804b5" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,183</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff70dda6-eb14-4f1c-990f-7dd11db399fc" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,752</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c47cf38-43b3-4bbe-81e4-1e3a61123670" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">640</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_604606a3-5880-4855-8a2b-9028f6e5f673" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00c3769a-f868-4e85-a958-681783a1510f" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dae289a3-406d-426e-b658-cf7d9a4758db" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,265</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d38e0f47-a515-4056-9e6a-b2df991f8e78" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,858</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_29380120-6261-4933-adfd-72f6c322e830;"><span style="-sec-ix-hidden:F_21dc383f-2aac-43ed-b5d6-870ed73f88bc;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 6)</span></span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c57e90cc-c0ba-40dc-8d93-bf49743a1b4c" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c76834f9-0a37-4ee0-b0f8-f24d5dab40aa" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35e5b2be-3111-4f86-b24f-421775bdc8ad" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_60ab34e2-69a2-4a74-aef5-c78b42acb1da" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, <br/>&#160;&#160;&#160;2024 and 2023:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a8fcba6-e3e9-4e4d-8b1e-e1cbdee25553" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fc532e85-e5a1-40f9-9700-7b021eaf687d" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_818e278b-2d4f-49b5-9f9e-7676de57a234" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d2b20abf-ce00-4c98-a5b5-6063f97b5e65" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;<br/>&#160;&#160;&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f654b9f-a7e9-4aac-b6c3-98b75de1f063" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f2bb22a9-c874-40f3-9a28-61daecdc0e61" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8b7c5870-4b4d-4f8a-871e-932ec880ab62" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b4bb4e27-124c-40a6-8777-735105ef9e1c" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31,<br/>&#160;&#160;&#160;2024 and 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_bbd260aa-271e-433c-b079-94771270927e;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_afd1d160-84ed-4383-a341-993295a87c54;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12e11e93-9be7-42cb-846b-d7e3c837e7ac" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_07a19863-24bb-412b-9f1d-5846a974c4fc" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba9e49e5-a932-434e-9826-7b5d096f73d0" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b7570845-3032-471d-b73b-a87a383b00b9" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;<br/>&#160;&#160;&#160;shares designated; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d20e2fda-0c66-45d7-acc5-6e588771c0fd" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_af1e18c2-280b-444e-9f38-ab1d6133fadd" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3e662158-9d9b-4abb-b910-ea3113f21606" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ec72e695-e012-44a6-83ed-43eacc651c08" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31,<br/>&#160;&#160;&#160;2024 and 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_90a1a123-deec-4dcc-8f08-aa722dd895ed;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_4e19efd9-6caf-49ac-88e0-63ff7273d146;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44a7f1c4-e07e-423c-acb2-ae1a8b9a4f69" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_da7b5fb1-7497-4dc5-a8b8-51bace5995ea" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c90b6dbf-1b5a-4b93-8ca3-1c8df88eeeb0" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8988b060-fcf6-4dc9-a501-fea4cb919bdb" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized at <br/>&#160;&#160;&#160;&#160;December 31, 2024 and 2023; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12b91b5f-341e-4d8f-b52c-682214a61b22" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9370fb9e-05b2-4089-ac6a-eefdc75bb3f8" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,789,275</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50086be2-219a-410b-90df-8d10215e764f" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_99646a80-00c7-42dd-8771-fb9e1b97ebff" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,213,130</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued<br/>&#160;&#160;&#160;&#160;and outstanding at December 31, 2024 and 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc908b77-b7d6-4e74-aa90-90338143c08a" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_391bfc28-8665-4aae-aa55-eed46efecbb7" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3">24</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7ad639e-4eaf-4395-b8dd-0c2a11b13486" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473,640</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eaf5221a-b3bd-4666-b39d-e0b2575c03f1" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326,586</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e822680e-f6af-4833-bbc0-06ecde34d5e1" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31f1f298-d477-4718-a677-f18186971068" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">355,586</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca68b301-4b9c-4347-a687-90bbd086befa" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">319,402</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10487d98-2bb7-41ca-b0f6-bbf8f4a812c1" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,140</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a05397f8-2bd9-4611-b6a5-955cb7580fde" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,208</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_225d133a-b248-4ea7-b942-76a8f06e53a9" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">177,405</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef0ff4d5-d2aa-41a9-934a-73a60b83df3c" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,066</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_operat"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> OPERATIONS AND COMPREHENSIVE LOSS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:63.52%;box-sizing:content-box;"/>
    <td style="width:1.9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:14.34%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:14.34%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a26a109-1480-4787-85a8-1bd46247ccd4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,964</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ba92aba-9b18-443e-a42a-c2d114a854af" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,312</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3db63db6-4226-497d-8a3d-5d7d34ce1737" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,613</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c774e8fc-4448-4bce-be9c-ebb5bff3a767" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,688</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef1a5aa3-f53c-4ecc-b8da-b56926b64a12" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b20313d-bbf3-459b-92b3-db552ca19ecf" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_663eeb34-eb74-4b4d-a08a-179fb67a5187" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63fefb5f-5ebf-44e9-a09b-ab4a0819087b" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af783ee2-35ce-4d6c-974b-cc7993d52ab0" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d13b46e3-80ee-4a3d-98a9-1d84c2ef0f42" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cfa75de-0cf0-475c-b426-e7e967099a79" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,753</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_315dc9cc-929c-4039-ad45-a230246baead" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edd1cb63-55f5-44ee-9e01-ed5f6a2313b3" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f8f18cb-cd88-4e7c-8d19-1aac10d4948c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba08427f-2436-497a-849e-0e60999e8a29" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84e48dcd-189e-4df7-abd7-158e57838d20" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5882da48-43b7-4369-b784-837ad627eb4d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.75</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33b656b1-9139-4d06-b1fc-0c6f8ad2a105" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_dfa67eee-90e8-4b1d-8b60-aff6c65d9e6e" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">4.73</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6866c3e-d880-4491-95ca-bd4edb79f95b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d30ebfc7-c8b2-455a-8662-e0651775745f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,543,787</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca9827e0-f7ad-4efa-b1d6-f9dbaa28babc" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_be1cc26c-0b2a-4399-b6cc-1539357d5720" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,619,197</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF ST</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OCKHOLDERS&#8217; EQUITY</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands, except share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:21%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.58%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.42%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Non-Voting Convertible<br/>Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series X Non-Voting Convertible Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional <br/>Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Other Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Stockholders'</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36e2d3a2-0a8d-47f4-b8ae-2cd7ee0b89f7" contextRef="C_da93e26a-a221-416f-aa1d-44b6fa0cbbfe" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">117,970</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba1f2766-123c-42f9-82a1-801ee90b8f97" contextRef="C_4f4b59d8-1b4f-410c-855d-a6241a17fff1" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,204</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0625e46-0036-492e-8bb3-b3fccca1d91e" contextRef="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,776,788</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79c5df39-eb9e-4f0b-93e7-dc0c3f40dcda" contextRef="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a4c0bbe-5e0b-4271-aea6-6ed533dcf052" contextRef="C_6907689f-f9ed-4e1e-951a-30df656bbdd0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">287,034</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a99c07a-72e8-4327-b67a-7aecb48cabdf" contextRef="C_cb145333-a71b-4f8a-9efc-683fbaf92968" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">202,865</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4087bb25-175e-4769-9bb2-e2610c8f9bee" contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,183</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with the 2023 Securities Purchase Agreement, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_574b3e0e-9529-49d1-bebf-d7e237596ee4" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,730,168</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_932350e1-556f-4baa-872d-81b9edf6a506" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcccc4b0-9a4a-438f-9e6b-148747ecbcdb" contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,008</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9267dd6-5279-4242-8cf3-dc3f0ff9489c" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1584e4d-555c-4caf-8f6b-2232d5f1c3c0" contextRef="C_ca588c4b-fe6a-413d-9b1b-50b767ebb7e8" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54190f9c-ef18-42d0-83de-54080e313cb3" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">99,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with conversion of X</span><span style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-size:4.69pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e5331f8-98f5-4f41-8654-52071809a427" contextRef="C_263741cf-175e-4ce0-9e5d-54eeafb843a3" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">7,884</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf2a181d-9baf-497a-87e9-46ba4a821eba" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">437,977</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a2ef3ec-a32c-458c-b9bd-876c31e143a5" contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c33bfbc0-42a3-4bc7-afd8-91ee81aca1ce" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with exercise of pre-funded warrants</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d4296a2-1888-4b90-bb98-a88312612a92" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,154,197</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_458903d6-0103-438f-8716-20868df4cb5b" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70e23ca4-d718-40f1-a73a-85f71f9f6f95" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with vesting of restricted stock units</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a923ae29-fb47-4d5b-9159-2bc6fe7ea0d3" contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c8a46e9-6164-4035-96c3-6af0f80a4718" contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_351991a9-bb51-4ed5-8478-e7269bebd64e" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss and comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52181fa8-5604-459a-94f9-0272d44e1f32" contextRef="C_48114a84-98ab-4aa1-b043-13f209b76a80" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80c96a05-3fc9-4669-b249-f58846ac6eb7" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5db84a56-b122-4dc0-9efb-70ed7fa61ec8" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4af9692-0c87-4e80-b91a-f9d9c1461065" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6a25f7d-14f0-4247-b3e5-f5336b5d023a" contextRef="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,213,130</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59d0d670-49e7-4db9-b828-2076f73bb220" contextRef="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d5b72bd-6f29-488c-b5c5-b57de3e4efdb" contextRef="C_e9c43112-a3f3-45ba-bd41-44cbb2d1fbf3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326,586</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41559d21-f34d-448e-b32c-a9d79f65ba8b" contextRef="C_31ca3166-3194-499d-a328-f836589f3df6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">319,402</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec831e9b-aa06-401d-90ae-996405c5a522" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,208</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with the 2024 Securities Purchase Agreement, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_930a00fc-fe7c-49f9-9870-f5907132570d" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,110,484</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4bf39eb-1675-4868-8877-8c9edfd911c6" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73c550aa-5538-41c7-8550-9c1457b40de6" contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,051</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63da2dfe-ce88-46c9-bb8c-9d8ac34cb2f2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8d537fb-ac7b-466d-a9c3-4bf1e2f27da9" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,636,488</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33e35406-7cc9-4736-8c05-56670e152ca6" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fa3f064-3981-4f2c-b3a5-b000fd7327cb" contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,152</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9b7bb35-9d94-4e9a-b664-85f4a6f6dd7c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,155</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock in connection with exercise of pre-funded warrants</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8f2c687-0cc0-444c-b099-9e402d91f7f8" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f39a5c1-b15c-43a4-ac4c-c8035694b64b" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a512bcb-32a7-4d1c-a3cd-b25a23e48fbb" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e16477be-3265-4cfa-b2a1-77cc724b6a4f" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,356,173</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a43ef75-02cb-454a-8f64-f4aaf55eb531" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55354fcc-e867-45e9-9c28-6c56d93f4f92" contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,515</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c5d2594-18c1-4c7e-9d29-f033e2406b71" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,533</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Option Exercise</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3100aabe-8098-4802-b03f-8dc97aee7c5f" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e84eee93-cd36-450a-9fbb-f1a7c03f6e41" contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ff8fee2-d20a-4d33-a101-c4af70474245" contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_804a0b2b-5d56-452f-bdb7-600bd9376d03" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e436c0b-aa16-4f7a-bf9f-5975880ad213" contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aeaa05c2-0485-4dc4-8335-81ad1a8e4a0d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2cc33ed-69c9-436d-971d-3f78b0b34c2d" contextRef="C_fa5ed16e-e45b-4b1c-88b4-26d3ddd75f76" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_303f5e42-b588-437f-9392-a660ee192d43" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76f62d98-f08d-491d-945d-4a4cdf5c2bce" contextRef="C_7cdba64b-c16d-4e4d-afdf-1f90b0947296" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3cd0d9a-fd5b-462d-b587-78caf922d367" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56273f71-1b02-446d-b6e6-18ca25d7ad11" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c31df40-0db6-46b6-9697-95dc157fc63a" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2b9443c-0bfc-418c-acc1-9ed0ff1c6fb8" contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">59,789,275</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18adc8d8-8fdb-4e28-b4f9-0223576e7aa9" contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08817c67-9eaa-4867-a537-d03bfaf833c5" contextRef="C_f913f031-70f5-4d82-9777-c7eada81288b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473,640</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_276270a5-c2c4-4a02-9a52-31e7c184fb87" contextRef="C_c88b7102-5db9-49c6-a914-b6a1c69ddd87" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03d0b6d9-8252-4c0f-a64c-341a48920cab" contextRef="C_fda21e42-08d9-4af5-8424-38a2c795691f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">355,586</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:7pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be04ec56-2a6c-47b4-a53e-ffdbc7842ded" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,140</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_cash_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TATEMENTS OF CASH FLOWS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:71.32%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.860000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.860000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c492b211-7447-4680-b3e4-4ccd78151b1e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f50d237-a33f-4ec3-934b-5c44770d6773" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on lease termination</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcc64686-8dac-4297-b3eb-b4c87e97d853" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:GainLossOnTerminationOfLease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of operating lease right-of-use asset</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2caa125-5c75-4544-99a2-bcc81ac4bfa1" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5d68cef-d6c7-46a7-acaf-d58519b1deea" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion of investment discounts</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f9b39a8-0ccc-410c-9131-efcc07a363ba" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:AccretionOnInvestmentDiscounts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,799</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5874c709-102d-48a1-b08d-a8c71c8c5d12" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:AccretionOnInvestmentDiscounts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,203</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e58b22b3-d8fc-42cd-b990-559500ae0e10" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff52e49d-8da2-4fec-9bbf-140cc831727f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_883482ee-06d5-4d83-8da4-ba922f0a3a2e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d06be886-2802-45b3-8cbe-0a5051b0cd18" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax provision</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df848f4c-2734-4a4f-808a-adfe2d147ebc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13f130c4-f200-463d-848b-110f02003911" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,298</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fc31fa1-94f4-4532-a33c-70c4e2586550" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,954</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable, accrued expenses and other liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41e7624e-77f2-4d5c-8e15-bcde4bb9a14f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:AccountsPayableAccruedExpensesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,751</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79f37428-a5ee-4b14-b594-49b41f9aeff3" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:AccountsPayableAccruedExpensesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_931c0133-d525-4e04-9a61-f2904a4046aa" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">339</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5d5df28-c1f8-4675-9a8a-90ddbf7efd19" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">363</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b28c613b-4c43-4785-b476-b8946e576d0a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,271</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3be732e-64d2-47ca-9e8b-cf7016ff7233" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">39,527</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of available-for-sale short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_582978f0-ae5e-4c70-8f31-6a86a9f37186" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">156,131</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_064d9c5f-60a0-47e9-ab12-4350d6a13915" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,287</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from maturities of available-for-sale short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_612b4d75-6e4d-406b-903b-47abf9f12826" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85,817</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5276ef9f-69c9-49db-ab45-141594fd8341" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17775a76-4e3b-4663-b323-4e63ffd61a9d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">70,314</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceb2213c-e20d-4411-8e5a-9efed337e2ac" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">45,287</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuances of common stock and pre-funded warrants, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60df9323-ec16-4df4-b1fb-0abac6d8ee39" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,307</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f817092-1183-4356-9826-ff20a0a7be36" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88001ec5-729f-4877-92be-3210f4f06655" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_383f72b9-bde4-447c-8477-fda9c231e679" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,522</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba46a8d0-a03a-41e2-af37-8c112fc1c10f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,017</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net change in cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ccf3229-9aa1-45ce-8555-429853daeba3" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,937</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_369e8d65-dac3-46c8-89b8-c9a29ea4073f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">51,797</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8085c339-6233-4b35-b35c-01027f0a297a" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df53ce2c-5528-4afb-9000-6e21b1f8e734" contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,409</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of year</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c915788d-aa58-4aef-8785-c53a2028094a" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,549</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c2251eb-12ec-4c23-91bd-81b9b6d10d9a" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash investing and financing activities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock exchanged for X and X</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;non-voting convertible preferred stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e46b7268-170d-4802-8c58-7c38f8330305" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afcd9c17-75fd-473e-8e44-3f4e4052ff17" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:UnrealizedGainOnAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase in operating right-of-use lease asset and liability due to new lease</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ef989d8-9c99-4f1c-80ac-8a6af8576dbc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">920</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability into common stock due to exercise</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c34996e9-c11b-43a5-9422-8c4a694785e4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See accompanying notes to consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_condensed_consolidated_financia"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONSOLID</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATED FINANCIAL STATEMENTS</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b0773ac5-3198-437e-a803-b5d0e84a6560" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). The Company&#8217;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#8220;Eledon,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;we,&#8221; or the &#8220;Company&#8221; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e57692ae-8ce5-4668-bb15-ccadc815409c" contextRef="C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2020</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Eledon acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_00b664c1-b3fa-402c-916f-58548a4f88c4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_00b664c1-b3fa-402c-916f-58548a4f88c4_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af8df058-23f6-4dd2-b85e-ce86c6d9a59e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17b00d5f-348c-4036-bc3f-77f06078c384" contextRef="C_f5f8bce9-24d2-424b-9d3f-cb4374e792c5" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" unitRef="U_pure" scale="-2" decimals="INF">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27e80b6a-b4f6-4d86-81c2-4f49a1415fb0" contextRef="C_e3be1d1a-7a2e-46c0-af2c-74af00b30e00" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" unitRef="U_pure" scale="-2" decimals="INF">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3bc08921-21d1-4f8a-8c74-07bde34edc19" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ac3104b-81b8-4403-b4dc-d7ca519a18d3" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_00eccfe4-7325-490b-9792-c7f1995214de" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true" continuedAt="F_00eccfe4-7325-490b-9792-c7f1995214de_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18adf21c-a3ca-4520-9b4a-719acaed6c49" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_00b664c1-b3fa-402c-916f-58548a4f88c4_1" continuedAt="F_00b664c1-b3fa-402c-916f-58548a4f88c4_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_00eccfe4-7325-490b-9792-c7f1995214de_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_144e18b1-caaf-4e31-99b6-0b495155d40d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:RisksAndUncertaintiesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages all its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2d22359f-9a0e-4322-8d39-d14a3ff95bb0" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f1e6a98-d2e7-4bdb-ae34-8d984b552151" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58cbad51-7fc5-4b37-99f0-3b73b90a4304" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdc89edb-4cd6-45c2-b3cc-a0125d10cf0d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5226ffae-25fa-449d-a9d9-8374752eb624" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_950c0214-9c61-4f17-81e4-d616a696712b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:InProcessResearchAndDevelopmentPolicy" escape="true" continuedAt="F_950c0214-9c61-4f17-81e4-d616a696712b_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_00b664c1-b3fa-402c-916f-58548a4f88c4_2" continuedAt="F_00b664c1-b3fa-402c-916f-58548a4f88c4_3"><div><ix:continuation id="F_950c0214-9c61-4f17-81e4-d616a696712b_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18c55de5-2252-4c5a-a97b-e2b29a4ef7f1" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_f055d2db-8f31-41d1-8e52-570ca880565b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_f055d2db-8f31-41d1-8e52-570ca880565b_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> include </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ebb8152-bfa3-4385-8742-6df38c0506c8" contextRef="C_223d8e7d-db53-4014-ad03-258351d47431" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,443,755</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed480e45-a60b-472b-ad70-dd15d9d3a849" contextRef="C_c655824d-1655-43e8-bda3-bfbadd4707f7" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,776,270</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6039368-bb8c-4da4-a7a9-dfc5e0f22ede" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true" continuedAt="F_c6039368-bb8c-4da4-a7a9-dfc5e0f22ede_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d8e0af8-5863-4575-8fde-d7835dd1536f" contextRef="C_5a950f73-2372-4ecd-bd27-5625ddd12c79" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c6039368-bb8c-4da4-a7a9-dfc5e0f22ede_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.3%;box-sizing:content-box;"/>
          <td style="width:1.66%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:14.34%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1.66%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:14.040000000000001%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06c43a25-8ae3-491a-bd74-f2cd26fe163d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0e7fe1a-786d-4ed4-aa47-ba91b20cb202" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36f8e6ce-a0f6-4496-9bc5-5d14a8b0899e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a57d5bfe-418f-4ee3-b443-400165a70451" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.75</ix:nonFraction></ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74d8758f-7578-4af1-ae68-9a338db488aa" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fa810fe6-0c8b-42fd-8dc4-eac030b1847d" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">4.73</ix:nonFraction></ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of common shares</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e514815d-8645-47cd-b42b-6b31fc91d2e6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cd67de88-d3ab-4b35-a205-bd8b69b7b630" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,543,787</ix:nonFraction></ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cd50913-3e43-4346-846c-54e38307eb1f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_25c45b5f-28aa-4a7e-9ea5-23dffc2ebab0" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,619,197</ix:nonFraction></ix:nonFraction></span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_00b664c1-b3fa-402c-916f-58548a4f88c4_3" continuedAt="F_00b664c1-b3fa-402c-916f-58548a4f88c4_4"><div><ix:continuation id="F_f055d2db-8f31-41d1-8e52-570ca880565b_1"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><ix:nonNumeric id="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e_1" continuedAt="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e_2">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.76%;box-sizing:content-box;"/>
          <td style="width:1.72%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:17.4%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1.72%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:17.4%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_814545f8-15d3-4fa6-8382-e19bc2a4dddb" contextRef="C_79dfe68d-c36f-4af9-8f4e-5e28df0b6596" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,007,789</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74088672-6995-412c-9b9e-d40c9fad8435" contextRef="C_ce203d5d-8a57-4364-b573-86117fd33f97" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,909,155</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4b9f624-58b6-46fb-b0fc-8d42a4fe627b" contextRef="C_8011d9d7-7503-40f9-9f2d-d6ad11ebdb59" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,567,751</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb00ab6e-d969-45d4-98ab-78116622c913" contextRef="C_cd66f0aa-05ca-4940-a515-241bc4f1483a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,577,332</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df4dc8d6-1c85-4fb6-8cd7-e9f0bc9ed7d6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">24,575,540</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf8cebad-dddf-4eb5-865e-991f22441dee" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">33,486,487</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e_2"></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fcf5d144-1fc8-4a41-be46-76e4789f4c97" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_a371b26a-dc84-4d11-bae5-32fdc960d29c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_a371b26a-dc84-4d11-bae5-32fdc960d29c_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_577725e9-389f-464e-92d2-e810af93f6cc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2f789d96-b7a3-4a0f-b646-a424f8cd9ef8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" continuedAt="F_2f789d96-b7a3-4a0f-b646-a424f8cd9ef8_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></ix:nonNumeric></span><span style=""></span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_00b664c1-b3fa-402c-916f-58548a4f88c4_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a371b26a-dc84-4d11-bae5-32fdc960d29c_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2f789d96-b7a3-4a0f-b646-a424f8cd9ef8_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a3ab8a1-e05f-44d3-8891-f6d16c7da1ef" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4aef25bc-08b3-408e-99ea-148d84c62685" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:StockholdersEquityPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ca8204a5-05ca-4124-8aad-3481f2955106" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1089dda6-986a-4c9e-b2e6-0bf12df3653b" contextRef="C_c508875a-d414-4f73-bf48-c4925adce371" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41b6d511-7ada-455c-97fd-8fdde15a98cb" contextRef="C_c508875a-d414-4f73-bf48-c4925adce371" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5ebd17fd-5c64-4d5e-9757-1544241f9bb8" contextRef="C_c508875a-d414-4f73-bf48-c4925adce371" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af5de421-a188-4a70-91e8-c2d38cb1bec1" contextRef="C_c508875a-d414-4f73-bf48-c4925adce371" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:nonNumeric id="F_f7cf4405-a48b-4e8f-b5c2-ce0b59383727" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock" escape="true" continuedAt="F_f7cf4405-a48b-4e8f-b5c2-ce0b59383727_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Short-Term Investments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The objectives of the Company&#8217;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_f7cf4405-a48b-4e8f-b5c2-ce0b59383727_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such investments may be required prior to maturity to implement management strategies, and therefore has classified all investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_865de5dd-04f0-4d90-a74d-741f989814af" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.294%;box-sizing:content-box;"/>
        <td style="width:1.8%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.577%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.14%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.577%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.577%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.14%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.577%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc3e1d3c-7132-4804-b982-4e903144ba31" contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,603</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a588e54-3a02-4fab-86e3-94225d523ca9" contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1f903de-d18b-4c5f-9e5e-cb6454ae388d" contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15310c3f-2a3e-4219-8c4a-51fdd2992660" contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ffc19de-f1c3-4418-ab28-04944bc1455e" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,603</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4532b33e-1a2f-4e2c-82ba-3b2e7ab48108" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3797753f-0ca3-41d4-b83c-be24c6449fe9" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2feade9-94b7-4d0e-8fdc-ce48a6d0146a" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d956e13b-65d7-436e-898d-2e28eba3764f" contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f132dd67-465b-40dc-9d47-7ce46be1d001" contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5dedc7bf-d47c-4243-b4a8-0155608fb4c3" contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89d63340-aa39-4e1d-a87a-d78453c55de9" contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcdcb925-67a7-4ebe-82eb-0d64d91ded83" contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6b47241-f98e-4e23-ba98-e6a7931f152b" contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e255fe14-9c55-47bf-844c-bc7bfff5d144" contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_494e9c60-3cad-432d-8000-f92a1166f5be" contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b29ce25-c26a-4835-ab0a-a55046222af9" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e810ca27-e907-4e77-a96a-d84892b635e6" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a93336a-2bae-4077-b15f-9e05993701f0" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_097c8244-1142-4947-ad5e-058538abfc90" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the Company's available-for-sale securities have a stated maturity of less than one year.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_25762a20-31cc-4e18-a118-ba939850af26" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_25762a20-31cc-4e18-a118-ba939850af26_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities are recorded at fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.</span></div></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_25762a20-31cc-4e18-a118-ba939850af26_1" continuedAt="F_25762a20-31cc-4e18-a118-ba939850af26_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2350326a-5ff2-4284-934b-2990dacef67a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"/>
        <td style="width:1.78%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ab42da7-b740-4cec-ba54-d2616f886fd6" contextRef="C_396c0ec5-b10d-49bf-a96a-9db1863a6f32" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ee8c71-834a-42e6-86a3-3b897db46aa7" contextRef="C_3f46a1a6-a8f6-442b-b1ff-f3c98cff71b3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0567f32e-5628-404e-9fde-bbd8d1b7c7da" contextRef="C_d212cec7-7f13-4076-ad8f-1298f4fbccfe" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9feba799-93ec-450e-a619-b47aa17be134" contextRef="C_e2da67cb-75fc-4021-ac60-f7e057d84c73" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b6336fe-3a79-4703-b162-e491aa6801ad" contextRef="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2776221-6597-492a-ba88-609201246873" contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,464</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb53d8cb-656e-455c-a554-697b6e20102c" contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,679</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9b29f25-3eb9-4f46-9e58-db1d9cf41040" contextRef="C_2dca0082-86a4-43f6-957f-6b699928251b" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b357317e-8c8f-4140-b5b8-2fc7dbf8914e" contextRef="C_7f980e84-3bfd-4c6a-9f98-ef8ea64fd7f8" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ff62d21-0faf-421c-8c17-d366e341573b" contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab505f81-362a-49dc-b79e-2837e3e85126" contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119,629</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb4198b8-5d4c-40fc-a06a-94310f1b6f47" contextRef="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1183625f-022f-4f26-a2d5-0ecc4f605d4f" contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137,093</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72bda83e-c276-4320-aea7-2b654aa542f4" contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,308</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"/>
        <td style="width:1.78%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.12%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.323%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3480e123-601f-4a1e-b969-51bb3245a199" contextRef="C_ef1d6638-1928-4543-b113-5a669804d921" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89659273-e8fe-4d92-9e7e-fffe8927625c" contextRef="C_8633a155-8473-424a-b31b-6ae76ea8dfef" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28f89ee2-6530-4c40-9341-3e74a40e58c5" contextRef="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58744214-0f28-4992-ba27-b313b386629c" contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2734495-a007-4557-b22b-0afc3c23af94" contextRef="C_785be526-652e-459b-b095-3ed96eaf857d" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_557688a3-7895-499b-81c0-9f4f788a3f00" contextRef="C_6daf1c28-0057-48b3-9e51-5792ff52bc2b" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6650aba-eea3-4699-86fa-ebfe8819ef64" contextRef="C_baf27155-1f9e-4cf5-835b-da4532020138" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c484a62-545f-49fd-a4fa-3c28bfe5536e" contextRef="C_8ca31066-99f4-48c4-a2bf-5e1ade8e2d92" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_838d4099-c5cb-47fb-9786-c0e12eb391be" contextRef="C_65c0870e-3c32-4ada-9d89-29c1727f64b8" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb8514b4-38b4-4b85-9f20-1d0ef95b7932" contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53e06f98-ca9a-47c5-bceb-383bc2577757" contextRef="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,246</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c879fcdf-86d0-440a-b925-947e5effef88" contextRef="C_65c0870e-3c32-4ada-9d89-29c1727f64b8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88be9288-496c-4ea3-bdf5-516eac86bb34" contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,736</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c44c5d17-a677-47ba-9d73-bdac84233f87" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"/>
        <td style="width:6.879%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.758000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.199%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.758000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.46%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.498000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.439%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.498000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59f7c943-61d6-4540-9e1e-628d1f4cfe8e" contextRef="C_f7f796ca-5ede-4fab-bd41-35bedc579277" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5051f75e-7691-4682-ac21-5c9f7e0ee837" contextRef="C_66748007-3bbb-4063-96d0-b1f1e7fe5949" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"/>
        <td style="width:6.879%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.758000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.199%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.758000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.46%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.498000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.439%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.498000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f8f2a8a-aa3b-4b1f-b2a3-c44e4c5ee97f" contextRef="C_9a1c4e3d-58af-4481-a493-f277082ece01" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1042fc1a-efe4-4449-812c-3de97805d09f" contextRef="C_33505f9b-7127-48ca-9287-5490646f361b" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_25762a20-31cc-4e18-a118-ba939850af26_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f8eaf374-4283-4335-867d-e880ff1b2e0e" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.2%;box-sizing:content-box;"/>
        <td style="width:6.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:28.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a067186d-529a-4159-bfa1-3f933475fc97" contextRef="C_33505f9b-7127-48ca-9287-5490646f361b" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a44e069-b471-4a58-87b7-2830a8c99975" contextRef="C_6f5052df-2ced-4dca-8f26-17b0a53037c7" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8a703c6-b87b-4f3b-9840-f3163e7f37ad" contextRef="C_6f5052df-2ced-4dca-8f26-17b0a53037c7" name="eldn:SettlementOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">446</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4f23977-b875-40bf-930a-8a992432e679" contextRef="C_66748007-3bbb-4063-96d0-b1f1e7fe5949" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,865</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_890aa0e1-c6bb-4b75-8b99-c23cae3762ac" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">59.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which expired and or settled as of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cac27d44-06e0-4808-bb95-fa5cabfb0d11" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_05617d63-31ed-4ae5-b8ec-bb4a8ba1bf6b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.709%;box-sizing:content-box;"/>
        <td style="width:2.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.697%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.32%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:17.956%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_051595e1-7429-4ed8-9ab4-c8bcb7688184" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:PrepaidClinicalExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,915</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05981656-4c01-4830-94a0-bcbef7902746" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:PrepaidClinicalExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,128</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aebb2675-5194-4542-97d1-38880009755b" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17ce243a-afa5-445f-8936-f01372f1a8ae" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">624</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c897b715-ddb8-4e6c-8d61-2313c3e0e830" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a36617d0-a0e7-4c95-9f75-5827b981487e" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c565b41-325e-4c36-b650-a674dbd47865" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">729</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81bba03f-f843-4056-ac2e-7a692cf1b531" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c8b395c-acf9-4cb8-b65e-ee2b0dbfc1b8" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,552</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b329d368-e3a0-4d2b-8091-ffd7c76f502e" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,027</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ea07de1-d36c-4523-be0b-c25fe1a50566" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.08%;box-sizing:content-box;"/>
        <td style="width:2.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.119999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:18.119999999999997%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a72ad3fc-9bb4-42e7-adf4-84bc5696b9a8" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:AccruedClinicalCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,642</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0edb6d59-8266-4eae-a730-9a4a34dbd6ff" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:AccruedClinicalCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04efb182-982d-486e-a6ce-71393456e9dc" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:WorkersCompensationLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,601</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0920d3ba-1961-4ff6-a26d-93dd2e0d35e2" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:WorkersCompensationLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,003</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22a47f25-5121-491b-afa7-7664ae5de54e" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_619231ef-1968-45f1-b3c1-20cf42d53932" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0436ff38-b299-4882-86aa-8426f76fcc70" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a02d825d-8acf-4139-88c8-a0d75359856c" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22d81313-71fb-45e0-830e-f3403d0bd194" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,430</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e51edaa-01aa-4813-8a3b-164ea7dfd36f" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,545</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_7a379e00-4e30-4103-80fa-c6080c25d95c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_7a379e00-4e30-4103-80fa-c6080c25d95c_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cb385cc-1c91-4b9f-aa61-9f6133e31346" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3ae2a208-5caa-4820-b98a-7b025afe17c6" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 19, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29436473-cf60-4f49-8d11-8ef81142a06f" contextRef="C_57da919f-7744-4288-b384-8049ba29e1b4" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a670456-5da8-43b7-9a5c-c7a14f90c70e" contextRef="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">5,817</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1f0da4b7-55e6-4261-adc2-f62e2d8f513b" contextRef="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Irvine Lease Agreement&#8221;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_abfeb4d6-fbaf-4599-a071-32a48687926d" contextRef="C_1a557357-a976-4702-be2e-81994f5f0bdc" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">5,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that was set to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f1123c63-7f05-49bb-88f3-cf67823857b0" contextRef="C_b03f2283-1f48-4ad2-8437-e177dcaf160b" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_275e8f28-bc7c-4c6c-ae77-9e268b53ec7c" contextRef="C_57da919f-7744-4288-b384-8049ba29e1b4" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_7a379e00-4e30-4103-80fa-c6080c25d95c_1" continuedAt="F_7a379e00-4e30-4103-80fa-c6080c25d95c_2"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 4, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_73af81a2-bece-41b7-9c48-bb36447f68e0" contextRef="C_c763de0f-2331-4e42-9eed-6f3c61e5a6f3" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e82cfa47-1b7d-46fe-864a-a94976a6ad46" contextRef="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8" name="eldn:AreaOfOfficeSpace" unitRef="U_sqft" decimals="INF" format="ixt:num-dot-decimal">6,138</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Burlington, Massachusetts, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ef98869d-1e9f-4971-acad-f1bbd933e147" contextRef="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8" name="us-gaap:LeaseExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 21, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Burlington Lease Agreement&#8221;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e89b4c1-c877-494b-813c-d198b36fdd1b" contextRef="C_9a80f4c6-f976-44ce-8ccc-11733f31a205" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1e9dc572-3f01-41ab-90f7-688b9f4f3bb0" contextRef="C_9a80f4c6-f976-44ce-8ccc-11733f31a205" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8855c84d-1b91-4958-8a31-bc692e481671" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:LesseeOperatingLeaseRemainingTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and do not include options to extend the leases for additional periods.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d94416b-907d-4e33-adf4-ff04a1fd30b4" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#8217;s judgment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bbc95bed-837f-4c68-9fb6-65a5d1f2a71d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.833%;box-sizing:content-box;"/>
        <td style="width:1.88%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.203000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.88%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.203000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8eae38f1-529b-4066-8516-2c8b0b1a1fb8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fde50c73-6624-4dea-ab16-7e09d3112d67" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">400</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_729896f0-eed6-40fa-a86c-33c5ab953100" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.299999999999999%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.84%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.860000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fd90eda-2e1c-415e-9d14-31de7fa0408a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">378</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7972339e-c083-4a1e-9c51-6b8e109a08e2" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">378</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.433%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.403%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.403%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0d203df1-26b9-4259-8907-3c98ed69443d" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_40e79c76-f18d-48aa-ab7c-8e973502c923" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d7d48d5-192a-410b-924b-64b9ece2d8f1" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4">9.46</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6368990-226a-4a05-b7b6-043f3b5e6a3d" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4">2.49</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_7a379e00-4e30-4103-80fa-c6080c25d95c_2" continuedAt="F_7a379e00-4e30-4103-80fa-c6080c25d95c_3"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ced6984-b015-456a-ad59-e39d0a338047" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.514%;box-sizing:content-box;"/>
        <td style="width:2.941%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:24.544999999999998%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db02a04e-3862-4f04-947f-9814ab3bc8cd" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">391</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df09174d-1107-4365-98c9-fb4cb07eceb6" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">403</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4dc325f-b937-4bcd-9fd5-fa8e3cc3c4c2" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_351a7de3-c262-4d05-9226-a77805ac4e86" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,087</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2517901-9e3b-4463-83ca-d7a6cf65eaad" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01544ed5-96c5-4d55-9e57-b059abd25580" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3">954</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93fa6f4f-bb40-42d8-a70f-d60919cb6cf9" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70222624-cf1c-4a36-83e7-c10e059fec7e" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">640</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Grants and Licenses</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ALS Therapy Development Foundation, Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2015, Anelixis executed a License Agreement (the &#8220;Agreement&#8221;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#8220;ALS TDI&#8221;) for certain patents and &#8220;know-how&#8221; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0a5fa9e-0319-466b-8cfb-f5e64109266f" contextRef="C_abc1f2cd-e8e8-41c3-9872-62e589ee5c9d" name="eldn:FeeDueForMilestonesAchieved" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_96ece248-4dec-4a88-b50e-003230427a80" contextRef="C_62fc708e-94d9-4e0c-835b-84f88b33655c" name="eldn:FeeDueForMilestonesAchieved" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million each. During 2018 and 2017, Anelixis issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cde95983-5391-446b-a8e4-76ba91ca6f4a" contextRef="C_043095c1-b1ac-48c7-a4f2-27e2c8f8cc98" name="us-gaap:StockIssued1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0079c0e3-31d4-482a-acb9-a5b60ccb63a8" contextRef="C_f95c9f8c-c83b-4faa-a94a-8bc7cdd24a68" name="us-gaap:StockIssued1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million wort</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h of its common stock in lieu of making a cash payment. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb0a7a16-0723-4785-8b09-1043605850f4" contextRef="C_33a03f84-df70-43cd-9c50-4ba91ddfe366" name="eldn:NumberOfMilestonesAchieved" unitRef="U_Milestone" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_70a1e74f-7297-4241-af0d-21d60d94d4a4" contextRef="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7" name="eldn:NumberOfMilestonesAchieved" unitRef="U_Milestone" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> milestones achieved during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46241bd3-1a84-4a11-b4bd-6a75f3509774" contextRef="C_1d2b5181-f6f0-4b8c-83a1-6db86dab8d21" name="eldn:RemainingMilestonePaymentsForFirstLicensedProduct" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ef77699-bd0c-429e-b5d2-8e8d540854d3" contextRef="C_ffcde828-6f01-4bd7-af9e-2cd1f5dee182" name="eldn:RegulatoryMilestonePaymentsObligation" unitRef="U_USD" scale="6" decimals="INF">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional milestone payments.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5af7f3c-35d3-4b64-9749-a6428aa43da9" contextRef="C_00e18809-6dee-4971-b3b0-b854a750129c" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million beginning on the earlier of January 1, 2022, the Company&#8217;s first sublicense, or change in control, as defined in the Agreement. The Company has made a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39fd93e3-95c6-48a3-a72b-71a5e5508248" contextRef="C_33a03f84-df70-43cd-9c50-4ba91ddfe366" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_60fecc2d-9fde-439d-a5cc-792b4cc3ac70" contextRef="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2b9e8a9c-f9dc-4b72-ba3b-512d65ca18d1" contextRef="C_a6f2684c-3401-4fe8-a32b-794554ab28db" name="eldn:AnnualLicenseMaintenanceFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million annual license maintenance fee in each year since 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdc78e42-d3fa-458c-b2df-6dc2dfca2058" contextRef="C_8362f16b-85c6-4b35-869d-da150d474503" name="eldn:AggregateNetSalesAchievement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">500.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ba50141-04fa-4c16-a691-670afefe1aea" contextRef="C_2708372d-5984-4b8b-8394-2e808b98a215" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_156d5f21-b2fe-4204-8f0c-1f818a88d5c2" contextRef="C_aa45efb2-8f97-4e4f-8227-a73968b58522" name="eldn:AggregateNetSalesAchievement" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3092b0bd-6af7-4c11-bde9-156341749cf2" contextRef="C_50ee3b39-8b65-4a18-aa5f-b1aa2197b68e" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lonza Sales AG Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2018, Anelixis executed a License Agreement (the &#8220;Lonza Agreement&#8221;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#8220;Lonza&#8221;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_7a379e00-4e30-4103-80fa-c6080c25d95c_3"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">eGenesis, Inc. Collaboration Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#8220;eGenesis Agreement&#8221;), under which eGenesis will gain access to tegoprubart for eGenesis&#8217; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company offset $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fab2746-b0d6-44b8-94e6-7a3a9893879b" contextRef="C_7972f6f5-bbc6-4b58-ae0c-1d51da007c0c" name="eldn:ManufacturingExpensesOffset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_716cfe97-bac4-4f18-bafd-ef80eebc8816" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts associated with such indemnifications have been recorded to date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e4f7fda-41a3-4414-a441-446854c41d44" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:ContingentLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_e3e9b68b-5816-4cf7-9dfd-03f0b27e42c3" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:ContingentLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contingent liabilities requiring accrual at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_84d6029e-af7b-4e7b-b51c-7c8191720521" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_84d6029e-af7b-4e7b-b51c-7c8191720521_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e8882c78-b3c1-4c1b-9579-462a39c34f7c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daa49bce-fe77-44ce-b19e-baa5c4b5892f" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,951</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fee65c4b-b7e3-43ff-b534-b8746e171f5f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,736</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60ea9b9a-1a22-42d8-a27a-32c039aa17d6" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">198</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_883c2a1b-73da-4ca7-9967-09dd866a7673" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3">199</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c49264e-5012-42be-922e-c1008bb55954" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,753</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b9c605-b235-4f5e-9924-47409f760d02" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_84d6029e-af7b-4e7b-b51c-7c8191720521_1" continuedAt="F_84d6029e-af7b-4e7b-b51c-7c8191720521_2"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_898f9f4b-ae22-42b5-8cb8-78e53fba81a4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.88%;box-sizing:content-box;"/>
        <td style="width:3.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.64%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.4%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.68%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e250f017-9355-4b89-ad64-4d1f1622a2e5" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b553f2b4-6aae-4df4-9663-b4d905851e31" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59496318-0906-4ab4-bf3b-e7dfdac5e0eb" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#8217;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_509c9b13-5ba7-40ad-9214-cabc4bac4c87" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.913%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.783000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.422%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33ab3111-1291-4a9f-98f7-68b1f020f180" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,508</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4801a004-a85e-45a5-96bf-1414b3a6dce8" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,473</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30737076-959c-422c-89ca-8936cef7c4a2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:StateIncomeTaxesNetOfFederalTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">908</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_faf3f220-6b79-4c02-82e8-fa9fed21bdeb" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:StateIncomeTaxesNetOfFederalTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,170</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_448a211b-e8f4-4e84-ad98-248705709c06" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxReconciliationTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,358</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6875fed-995a-4ce0-92a9-e8f6ee5081ee" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxReconciliationTaxCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7938f1d-efbf-4e83-9cf5-47003616a3b4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,819</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68525e68-1aaa-4567-8123-207c21f2aabd" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">728</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e50fa2dd-08f2-4927-8131-3daa6de6bccd" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e328ca7a-c545-4f2c-8c8a-e2e0fcb8d62f" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_663a9b9d-5d8b-4dad-b8bc-4952955de176" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,273</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_491fad97-06ad-4e43-a707-882d454e48fa" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,078</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d632007-66e0-4ef0-a863-e0c663a49a2d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:IncomeTaxReconciliationStateTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">490</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1539e6c-b437-4e0d-aa91-e254362fec68" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:IncomeTaxReconciliationStateTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35a370db-b6c1-413d-8eef-716eca9a0d6c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:NOLTrueUp" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_855905f8-00bb-4d09-a316-338392fc0bfe" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="eldn:NOLTrueUp" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f370dca-68a2-4f3c-87d7-a5f4f68378dd" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10562ae1-7994-42c8-8dd3-c23ae1e5ddd6" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">566</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_064b6ab0-038e-4c4f-a426-db0c37c46fc5" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,137</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3722742c-f775-443d-8244-e88eb96ef6ed" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,200</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cb93228-cbcb-4a6b-8c78-fd0d2de63a9c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fa77c16-d23a-4446-98cf-b1951588987a" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_84d6029e-af7b-4e7b-b51c-7c8191720521_2" continuedAt="F_84d6029e-af7b-4e7b-b51c-7c8191720521_3"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1db02667-958a-4acd-b3b2-7fe1f8d85d06" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd630ffd-c020-49ff-b137-42786180e95c" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,740</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2efc52a5-68ab-4dd1-9c3c-8976d6da862e" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b69b5cf0-dea6-439b-b1b4-a41e393b2d3b" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,560</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdef6281-4654-49c3-a40d-250875c09764" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,202</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b90eff8-8850-4500-b3ef-04418b3a4b4d" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">366</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_005d778d-97a3-4175-b90b-0670b48fd9d2" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">475</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02197b3d-e6a7-425e-918d-47f4177f9b0f" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,809</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_740f4b66-a1cd-45cd-98d8-464db1a38da7" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,567</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b581dbde-fc6c-4570-8654-7699186f892f" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,281</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c2fe4e6-141b-4485-bac1-5bf86b3efd77" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,085</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a4fc12b-af85-472c-a9c9-210c07e4c0c5" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,056</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f0b6abb-2538-4df6-932b-2bd11d5546af" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:DeferredTaxAssetsDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,319</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d448236-e2fb-4bbd-91e5-278db94d6fe8" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cc60977-2708-4bcc-af4e-6f8ce800b22d" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de806cd7-e04d-47c5-950e-157727f55aa8" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,037</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9d0ffa8-1d57-4566-a879-4e1a671e046e" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,828</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d6ce4e0-fc0c-4483-abdd-9fbf2e55f76b" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:DeferredTaxAssetsRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">218</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ebe792f-7bcd-4aea-a0b7-cf1b9602a989" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:DeferredTaxAssetsRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fddcbcf-3e81-4121-8079-398eba202602" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,623</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37acb95d-c207-41d8-87a6-9e086554b89d" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,682</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34b184a7-5a15-4c18-8158-2a786df182ae" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,841</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ff95c19-4139-4d0d-b652-b4e129bc04d5" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,769</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75847908-f3a7-489b-b796-3fc1255f8404" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,379</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53254db0-fbdc-424c-a15f-882359281c72" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,811</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd900805-6022-46b3-9aaf-460e139b37c6" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,183</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ff26a82-e271-4e4d-9708-b704672cdf21" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,752</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_455df9c3-1153-4202-a4f9-d3fb9d859935" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:61.448%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.277000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.277000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1d838db-8414-4527-80cc-642de2c7ee13" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,636</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6d6f894-3abc-4c5b-bebc-f0a63d7fd08f" contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,664</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_188f75c9-debb-4ff6-8da0-21f027bbd149" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,596</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c67c031-d69a-4ad8-a1ca-2b11261da141" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bd46f61-1182-48df-8a69-ee1f2709efd0" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2466ab5-5e7d-4b4e-8a5e-8cf5372fb8f5" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b51f58e-6520-42e7-a64b-f5ec99d0bf3b" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,232</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d47c734-c3ce-408d-b8b0-3fbc2dcc8ccf" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,636</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c29ffdb5-4502-48ab-b840-4f9c08a51dd2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The net valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_259e1540-48d2-46bf-8c70-0d747f877b31" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2022 to December 31, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#8217;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19075218-683b-4dd1-adbc-b7eff0e20dc4" contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">88.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_857ed8cc-cdc4-4ffe-b884-388eba7f09fc" contextRef="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">68.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, available to reduce future taxable income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also has state net operating loss carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22fc95b5-828b-4a10-b57c-84824ae09e0c" contextRef="C_b3bf1192-2c65-401c-8714-cbce96407407" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">37.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f42899a-9acb-4a76-bbfb-3bd22c5c28ef" contextRef="C_993efb3c-896c-44af-92dc-051235d5309e" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cb67e64-3021-4f7a-8a80-5d912eb64c3e" contextRef="C_1bdd8687-8b04-4339-9c36-3704d34477a6" name="eldn:NetOperatingLossCarryforwardsExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if not utilized. The federal net operating losses incurred since 2018 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdacc0f3-5a56-4ca1-aca7-fe3b603e3c7f" contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">87.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million do not expire. The state net operating losses begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84e7037a-dd92-47b8-8a75-8817921e6f56" contextRef="C_b4bf66a1-e90d-4ead-835b-58305a0590ab" name="eldn:NetOperatingLossCarryforwardsExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1675e7d-ab8d-4f8d-8893-c57934da7b8c" contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c7914bf-faac-48e8-804f-7138813ad942" contextRef="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. If not utilized, the carryforwards will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b5b799f2-4777-4111-8a20-a213100cc752" contextRef="C_1bdd8687-8b04-4339-9c36-3704d34477a6" name="eldn:TaxCreditCarryforwardExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2036</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1291e88a-75a6-4e87-bef1-4d88f3c14e8d" contextRef="C_4adef842-ba46-4a9a-9d41-be6305e99c40" name="eldn:TaxCreditCarryforwardExpirationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has state research and development credit carryforwards or approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bc22050-4d1a-44b8-9af1-008257833da0" contextRef="C_b3bf1192-2c65-401c-8714-cbce96407407" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a1d20ba-5c42-420d-b1f3-0bf08f3de538" contextRef="C_993efb3c-896c-44af-92dc-051235d5309e" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84085083-9484-4a7a-93b3-7b77aa230d3b" contextRef="C_4adef842-ba46-4a9a-9d41-be6305e99c40" name="eldn:TaxCreditCarryforwardExpirationPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#8217;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20e1efaf-cc30-4ac3-ba25-d377ff410ad9" contextRef="C_f2abefcd-f6bf-453b-a559-74741ea3100a" name="eldn:PercentageOfCumulativeChangeInOwnership" unitRef="U_pure" scale="-2" decimals="INF">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% occurs within a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_28a84bfe-6a5b-4ff8-9180-67eb1f1b4e58" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not completed an IRC Section 382/383 analysis regarding the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_84d6029e-af7b-4e7b-b51c-7c8191720521_3"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#8217;s unrecognized tax benefits will not impact the Company&#8217;s effective tax rate.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#8217;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_787bab87-892c-44fc-a721-52d4e6267ea5" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c4c11b79-3270-4ca1-8813-036a05d548b4" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest and penalties associated with uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85edca3a-976b-4d61-9aff-484a252f7211" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_15c95ee7-0184-4d79-a9db-86562730eeda" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any interest or penalties in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5bfe926-1d03-4379-bed8-885da804be07" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fa3de91-268e-4f6a-8aae-ec665208cf01" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6deffbff-e8a4-4283-b1a0-66f17d7635ed" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4dd1e6a2-7166-48bc-9cea-4c21d07afea5" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">515,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_035c4dd8-9b02-4714-964e-6d05d92b66e7" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_79d0e5e8-497b-42f7-9dc8-b893d889eaee" contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a27122ba-bb3e-4612-9ccb-932f627a6426" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4d690588-823a-48b8-a2a3-e7145594ff77" contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">110,086</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and outstand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ing at December 31, 2024 and 2023, and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2ac5c3c-fa63-400e-b31e-02ca8c95ef31" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a8b42c0e-266d-4c8a-b4cb-a0f7efac839e" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2564a1b1-0145-4b84-9dc0-2864d33a7b0a" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6c2f0516-27bf-47a6-a1e8-2ce1d0cb5ad7" contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c0c7802d-a727-4e72-9a43-3c74442ec5cd" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e272d8ba-9c13-4488-821b-e6c17f5d517b" contextRef="C_6c87749c-011d-4371-ab13-14962a69c063" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,422</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding at December 31, 2024 and 2023.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or X non-voting convertible preferred stock (the &#8220;Preferred Stock&#8221;) is convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb7e22c3-6db4-46f0-b762-a221d17270fc" contextRef="C_fe6f7e17-f28c-49da-acb4-0df89a0d0e69" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_662762ca-396e-4afb-9e9e-62b13e98e2f0" contextRef="C_1e34edcb-7733-41f4-96c4-4098b67eb851" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">55.5556</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0849a1ae-465f-48f6-89e3-cba82394c26a" contextRef="C_830b14e6-5177-41fb-b6ce-4f9c69a9e2b7" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fd25b47c-94df-4544-bdea-c3fbff929968" contextRef="C_cef653d0-53e3-464e-a7ff-1a07fbe50a84" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_312525dd-6c09-40bf-9d79-3c68f7026f4d" contextRef="C_c7360e16-b2f5-4ebe-87d7-85ccacc39a7b" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2caf43a3-2cdd-46ae-a509-8c5daae152bf" contextRef="C_da023f2b-8828-431e-a5c6-01ba27160e08" name="eldn:ConversionOfPreferredStockConversionBlockerPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">9.9</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, the Company entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e80927f-7295-4a8f-ae90-a182b03ef46a" contextRef="C_81754e8f-b125-4baa-9396-af3d23d394f2" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">550,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b713c0e3-2224-4a1c-8241-5c127c623584" contextRef="C_0c7e74c0-0fff-4859-bb0f-e4991cbcdf79" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,899.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Ser</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ies X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c4b5c0e-e484-4a75-bb59-7ba4458fbc1d" contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47c93518-0222-4d26-b6f8-e6769b65de17" contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e19deb7e-8777-48b4-9582-df62d4bd603d" contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_178efd26-d12a-4b64-ab01-d6106ded0134" contextRef="C_ef59653d-33ae-47a7-ad08-ba5af6c5f5ff" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">20,202,024</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of common stock (or Pre-Funded Warrants); and (iii) in a third</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_1" continuedAt="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">closing </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb6176d5-bb3b-490b-b5de-4961c4624f9d" contextRef="C_f0a737c0-ea83-4888-a416-315bbec6d943" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">25,252,530</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a5a7b6b-350b-4d2d-86e4-91301e7b0cee" contextRef="C_601e9cd6-2771-40cc-9def-1378742631ad" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_459d0b7e-0169-46d6-85d5-35c5d5d14bf1" contextRef="C_7f974fdd-1b57-4a34-a7de-915221b5d0fa" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_097a7a9d-e609-4e57-a786-400f9c7b5a7f" contextRef="C_9d05956d-2390-4ca6-b6a3-2f100db0a54a" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_492769d9-36f9-45b8-a675-5a5f2b846cbc" contextRef="C_ed194ea2-3267-4246-aebb-e5dd647171a5" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc936737-1cb6-4e61-8201-c77722262ca5" contextRef="C_8c38178a-6212-4724-822a-073a46d7cd51" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4102c1e2-8f7b-4295-9379-6149e2e8e120" contextRef="C_7539102a-4a3f-4b85-9f9a-eff15ced7207" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the initial closing occurred, and the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e11cef9b-3fee-4a94-954e-91fe527f45da" contextRef="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c41c3f3-9e26-4ff7-b656-473da3b46b38" contextRef="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c" name="eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">33.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ef8461f-755b-4b44-af97-f44e9fec0eb0" contextRef="C_e8e45f71-13aa-4500-9629-91aae4aff6f7" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">8,730,168</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d795e0c-7a71-4984-a7fa-9cd7bd739eef" contextRef="C_bf411a33-997b-43c5-804f-81fcc2c67a2b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,421,350</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcd546cb-9a01-4e14-8027-1086afa57ac5" contextRef="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2ab88ac-95e8-4de6-86d5-4b3b068cf601" contextRef="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9560d7a-9267-4487-a24d-4a5c90815a71" contextRef="C_e9b52517-cc36-438f-9a32-3591a45bba9f" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">909,088</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1292e09-3319-484d-9787-648b302fa831" contextRef="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a1dac2a7-7a5a-4018-9a3d-51389ca043ba" contextRef="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d056d1e-04a8-4c73-b14b-6a2af24ea9cf" contextRef="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3d97f050-e0b4-43db-bc35-1845ce71bf7f" contextRef="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.8</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f369e936-b686-41cf-92b0-abd79ca1a46c" contextRef="C_c200f68f-c405-4e48-bf2a-38f307006e4c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5bbb475f-2ec3-4fc6-8e21-546bfc1a79db" contextRef="C_74107382-fd40-42f9-90be-490979e94f04" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,727,400</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#8220;Subsequent Closing Warrants&#8221;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#8217;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e845a8e-61f1-4816-8b60-56681b0089a2" contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.149%;box-sizing:content-box;"/>
        <td style="width:1.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:20.823999999999998%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.481%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:23.064999999999998%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad7b62e5-5bc2-4b70-b563-0beb5a02a18c" contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">96.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf188f1c-cfa1-4934-af7e-9119e9ae021a" contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">89.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94633025-aa18-4123-b13b-52ec3226436c" contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">94.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b67b9a33-df86-4d1d-90ba-fcd1031d9c03" contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_860afa12-820d-436c-8ff2-b9e0c42d17ac" contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_684e023f-3e1a-4eb3-9265-9bc6d3dc50bc" contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7a2dab66-9820-4944-a4ad-bfa7021a56dc" contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_abc75288-dc74-4f09-b4eb-19f04167ffa4" contextRef="C_87cefaba-5105-4ff2-a002-a1c4d73aeb66" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_2fb89093-a985-4b96-bdfa-bb33421e024a" contextRef="C_515ae42a-7ff1-4e13-959f-75425bb4a13f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c0c36b7-a4a9-4c98-9490-7984bce1988b" contextRef="C_c53b5cf6-4630-40a4-9931-9f67538e192a" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">4.14</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a071e7f1-7029-461e-a41d-4d4771755796" contextRef="C_bea8a10c-6aaf-4cf5-a1ef-0c858fe3ff2c" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.80</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a51577b-4df4-4910-8a6e-a12ee632a463" contextRef="C_df992d11-47da-4652-9a72-20ae69c98503" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b7f359b-5ac8-47be-9d55-a181ec47d881" contextRef="C_58527e40-73be-44c7-ac20-a9366f484716" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">99,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41be5b79-8014-478c-aec2-8f4f0bbf570a" contextRef="C_c59b7a41-84c2-4669-8972-016e60680975" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,883.586</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e25a523-4f13-4ba4-94d2-9f54fb7a7365" contextRef="C_c0260335-e1df-4dc7-9951-e61eec7e4e07" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">437,977</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_2" continuedAt="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_3"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e94255c3-2aba-4ccd-b0f5-8896aa2a7d6f" contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">13,110,484</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;2024 Shares&#8221;) of the Company&#8217;s common stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6508f6ef-44fe-41bb-8c04-550649da8711" contextRef="C_18c0a78a-1e2f-466e-b8fc-e87b9eed2108" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.37</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5edda2ad-4686-4a21-acc9-0db065f37fc2" contextRef="C_752ba685-b573-457c-ab6b-760279f576b4" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">2.369</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per underlying share, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e7ffc2b-7c31-413c-bb27-663b8d5d2ac3" contextRef="C_752ba685-b573-457c-ab6b-760279f576b4" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,989,516</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ac16374-73ba-478f-b32c-fd5ab7bf61af" contextRef="C_752ba685-b573-457c-ab6b-760279f576b4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc063103-85f2-4101-861e-7e39fecb813a" contextRef="C_d98efdad-c5fb-4fe9-bf2b-dae2dda62705" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05d4590b-cff7-4d3a-b95d-20e7b384ddc6" contextRef="C_1011d176-24c6-4711-ab33-00f6e6c3a295" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce5f47f8-b674-4f4d-ae54-9d70b7d0bb49" contextRef="C_1011d176-24c6-4711-ab33-00f6e6c3a295" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_232c180c-5d85-4400-a079-9c9c28d5b36d" contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f39d1117-f11c-42c3-b70e-6c7c9583825e" contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b" name="eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">48.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of the Company&#8217;s common stock, having aggregate sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c94920b-1deb-4cca-9a47-f6ccbf83459c" contextRef="C_c48f7041-bd5d-4520-badc-9c02123e560c" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cac02d53-25fe-4e26-a5e1-1ffb30652f61" contextRef="C_1e0927e2-efa8-48c2-8418-566f24cf7f14" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,356,173</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c201899-6563-49aa-bd21-f19b2ed7a9be" contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.65</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5f8e7a7-20fd-4225-93c4-e60c66917f5c" contextRef="C_7b2f7f52-abb1-46cd-b411-b13302614ae5" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">3.649</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per pre-funded warrant, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41b3e9f8-a9f1-448c-8e1c-d08d8b6664b1" contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,931,507</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fb81863-b87b-4d22-a607-35bde99a34fc" contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4b29d13-5945-403a-b325-b2a19ba62a96" contextRef="C_09b59681-3f5b-4085-9903-94d6298ba631" name="eldn:ProceedsFromIssuanceOffering" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf6c7425-fcac-4d4b-8ac8-87ce838bd7c8" contextRef="C_09b59681-3f5b-4085-9903-94d6298ba631" name="eldn:ProceedsFromIssuanceOfNetOfOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">79.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after deducting underwriting discounts and commissions and offering expenses. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_3" continuedAt="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_4"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_036549ce-ec18-480f-a321-210041910d6a" contextRef="C_1d975291-218c-42ec-9222-8136c8da23ab" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (or, at the holder&#8217;s option upon issuance, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b66da4ed-015c-41a4-bdd2-3acba275ba65" contextRef="C_099f74fb-7263-4363-8e20-38ff695e2998" name="eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a84fc22-66ef-4b13-8d33-d4b5bc165fba" contextRef="C_acb31783-dc63-46da-a53e-d4cc59b2703b" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">501,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5ae940d-7945-4a1a-8d17-8c82d6ab88e3" contextRef="C_acb31783-dc63-46da-a53e-d4cc59b2703b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9c6b09a-79c4-40af-ad4e-a2ac7eddf0f2" contextRef="C_75635e8c-9491-4ef8-9631-b061f8135c6f" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">501,197</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9c35f04-bec6-4e25-903e-f2cdd9d40e52" contextRef="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">653,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acad543b-f8fd-490e-b307-560babd6e81a" contextRef="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4577b8c-ceaa-4284-992e-43e0a64e651c" contextRef="C_e03375d3-d9dd-4d85-99e4-7301552a0c4f" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">653,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ded25f0-0429-416f-b7c3-ccebd2301a32" contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">600,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e45572ad-7fb3-42c4-84da-9f7699ba273b" contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a85850a-db9c-49a5-b4df-b500d1e4c7eb" contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">600,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a37b2424-9c8a-49d9-bba5-ee55a4b91944" contextRef="C_c6c9bd31-68b2-4a71-971a-851b219ff30f" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">583,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a925e7f-529b-4495-b41d-b3254fa33de5" contextRef="C_c6c9bd31-68b2-4a71-971a-851b219ff30f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e561baaf-6e9c-4bf4-bbb0-0cbe9ac6d0be" contextRef="C_79cc014d-d674-4ff4-b42a-bb3cc0e63e25" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">583,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a081e345-44b0-4060-8c63-978518d3aea8" contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb" name="eldn:NumberOfPreFundedWarrantsExercisedForCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">240,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b252a8b3-8ec7-4259-954c-1f4be74179f6" contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32553b2f-8cdd-4f5c-b308-b0aea77b3647" contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">240,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53b9e50c-c64c-490c-9d9b-49059596a317" contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aa1ef5e1-9e7b-4fe9-b764-78fd26ff7267" contextRef="C_fa324109-4c1e-442a-b30b-a82030888207" name="eldn:ScheduleOfWarrantActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.5%;box-sizing:content-box;"/>
        <td style="width:1.44%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.44%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4988d877-691e-421d-bee9-0245ddfe94dc" contextRef="C_fe31b2b8-289c-4f2d-9530-6c3e7c7a5ee4" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,788,032</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1b6c300-3ec2-4019-9f52-2495075aa46a" contextRef="C_a3d4e2f7-7728-4ff5-b3c1-f6d4d89e0518" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,776,270</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cd3c8e2-0559-49ce-aab3-40e7e327dfdb" contextRef="C_873fc4f3-2e27-45ab-b247-49134db6a39a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">21,564,302</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2872f2a-de5f-4d61-9c04-57848d971948" contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dab23e9-ee5b-40f7-9785-939cef757a34" contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,921,023</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_428316b6-b6b8-4ada-9042-e6ba18a6e249" contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,921,023</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_292b4ad7-60f7-4c36-94e4-d252d2ec7d57" contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db5fc122-f899-4b9a-a5ce-f58d8e47c948" contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfecb677-c1e8-4908-b345-a6932ddde932" contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,423,000</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5501ac4d-708b-4cb6-a575-9d33af921c44" contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,581</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c8ed1da-4c9d-4078-97b7-1870f8d629ee" contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc07d464-898e-4e26-ace2-a6843492f6d8" contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,581</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d70e18d-1037-4165-a929-ddafd4e01774" contextRef="C_43aca5e8-7607-40e9-b22d-49e309162053" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,778,451</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b710f85-2a78-4bb1-84eb-c34f8b293ba0" contextRef="C_ec3b3914-3993-491b-8996-5d595c2548d5" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">17,274,293</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c679d456-7089-4671-a5e7-fe141a00d589" contextRef="C_1206a149-d99b-42c3-828f-7f43aedc8be0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67544a77-b799-4b60-aaa7-f51bb55df6bc" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.492%;box-sizing:content-box;"/>
        <td style="width:1.44%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.297%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.837%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.2%;box-sizing:content-box;"/>
        <td style="width:17.836%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b016f18f-86bb-4070-8c63-10daccc1e552" contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,586</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94d3c3e7-f643-49b6-800d-6aaa1bc91fe9" contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.90</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_24e2ce92-975d-4f1a-96aa-2aa00ef4e616" contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8aa5cde-c1db-47ee-b117-569973fc9a89" contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,591</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fff8730f-0bcb-4f6d-972b-84fe4c6eb670" contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.90</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_cf1d216d-e16d-484d-96f3-f83e79a09cc6" contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e396f41e-bfee-44ad-9e38-a7ca357b09d9" contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">247,264</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59dd9aca-36cd-42f5-8f71-fe0da8ef9dab" contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8a92c7d7-04fa-433f-bf65-96c777cefb56" contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cce845c-3ab6-4a52-b93d-fd3b8c74e800" contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">71,800</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbb89847-cde3-4fa5-94e2-214e61213a30" contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_41026326-014f-4e23-ba0e-1ebfd2bc149d" contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7d01e32-4b92-4438-baa1-d7839c8540d2" contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">298,692</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7034e32-a84c-4693-b26d-d02ec24357f7" contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.08</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_01d47d21-08d0-47a9-84f8-49796b2fcbe5" contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20af60b5-06af-4dcc-8c15-bc376ff4965d" contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,151,518</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fe8e5d1-f4d7-48aa-9418-965ffe6e1469" contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.00</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0e515321-dbf0-4713-9a8c-fba272cf713f" contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23b0ef79-23a5-42ee-bb5f-e31dc841b218" contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">509,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06a3645b-0f78-4900-9c94-4728374c9d31" contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0b1cd16d-43c7-413c-9401-3edbfb59fb5f" contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_737f49f8-7e62-4d27-aa2b-76e6394004a8" contextRef="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,844,153</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_644120aa-e0e7-45cd-a2bf-7ae1ca7c9ba7" contextRef="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b246268-b22a-4892-85af-3dd76dfe9a39" contextRef="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,989,516</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdb82f70-bf8f-4619-83fa-e145ba58600a" contextRef="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44f7e7e1-29c3-4715-9625-1c6fcfad8fd3" contextRef="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,931,507</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ac375aa-e173-4523-9392-6f9c75defd71" contextRef="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a270c1e-4a38-4bf4-8c0f-b7acae2f83c8" contextRef="C_1206a149-d99b-42c3-828f-7f43aedc8be0" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,052,744</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock Warrants</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_985eee59-054b-4890-85a6-a0468b114d48" contextRef="C_31d1acfa-3b45-4abf-9e35-bfef36f23e5a" name="eldn:ScheduleOfWarrantActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d8d5c98-9db4-4c11-9bbb-93a0698f9dfb" contextRef="C_d28d1435-9f97-49ba-8b24-67f48845ba10" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_091add36-7b33-4a6a-aa15-e1f0db744772" contextRef="C_d28d1435-9f97-49ba-8b24-67f48845ba10" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,789,301</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.52%;box-sizing:content-box;"/>
        <td style="width:2.44%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:41.04%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5da3efb-6d5c-48ed-9111-4b201fca9680" contextRef="C_0cfe28eb-20ed-4453-b17c-b2da148bbb6b" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59c9edb9-d82f-4d52-8260-2b843e0a7302" contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ef6d3a-7d9e-41d9-857b-306ab4d9b3d8" contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4645ee30-f68d-4422-9dfc-f0ff22b9abe3" contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc" name="eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c049327c-e9da-4864-b005-b0bbbb563aa4" contextRef="C_824d879a-0a5b-49ca-807d-ab0c7354476a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,207.419</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Warrants were issued on September 14, 2020, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6d629de-5265-4848-97d1-9088ede1d0be" contextRef="C_c1814a1c-a776-4ae5-81fb-2c334235981f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_64cf8b12-3ea9-42a8-b8b7-4c8201fbe14e" contextRef="C_c1814a1c-a776-4ae5-81fb-2c334235981f" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_c7dd20ff-b759-4e65-a802-4be23331b886" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_c7dd20ff-b759-4e65-a802-4be23331b886_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Plans</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7a223f2e-089b-4ecf-bd93-509b42718a96" contextRef="C_82eefdd4-1476-421e-8c82-01746b54038c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2906465f-ec94-4df9-bfa4-f6588d4272c6" contextRef="C_b84bbaad-df1d-4435-bcda-30c2fee202cc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b215707-cdbb-46c7-9ec2-8d75e7416e00" contextRef="C_df73341b-d5e3-4456-832d-4dec35538295" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months that vested stock options granted to Board members may be exercised upon termination. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_c7dd20ff-b759-4e65-a802-4be23331b886_1" continuedAt="F_c7dd20ff-b759-4e65-a802-4be23331b886_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#8217;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dee157d6-8243-49c9-9e60-ccbcf8c8b499" contextRef="C_027f47be-a809-4a42-bc04-44816aea7e4b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares so that the new aggregate share limit under the 2020 Plan is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8fc7203-a16a-4f41-9107-d80385ceb962" contextRef="C_027f47be-a809-4a42-bc04-44816aea7e4b" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">17,960,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d194fac2-f416-4c8c-9b2d-fdfca73a96d4" contextRef="C_63ba02b2-0219-4203-aeec-903a75c59cda" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,381,857</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options, with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_380f1ade-5457-4809-881f-3c6f9f054579" contextRef="C_13bc12ba-1049-47bb-868c-4b5d72553817" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,476,372</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the granted stock options subject to the Company&#8217;s customary time-based vesting schedule. The remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_250feb90-7ea7-43fc-96c5-49021f55762f" contextRef="C_63ba02b2-0219-4203-aeec-903a75c59cda" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,905,485</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#8217; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b99f732f-daf1-4ca3-b6b0-e69d1a5272b6" contextRef="C_aadaadaa-a7c0-44c6-8113-f3d665a31ddc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_656fc5f0-7b6e-443b-afcf-19a6826553ae" contextRef="C_fcd27fad-ba34-47a9-a7a2-6c51de3732d8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,763,085</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options were issued.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2014 Stock Incentive Plan (the &#8220;2014 Plan&#8221;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_333b3f7e-421a-4303-803e-b27f05953eea" contextRef="C_ab227fe8-0ca1-4386-b398-a0fc655a8391" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved for issuance under the 2014 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddb592e9-0b58-487e-9bf9-161df93b4f5f" contextRef="C_66849e82-39b6-4778-bd00-50de1525fd28" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,373,242</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eee6dd80-01d7-4de4-9340-77de19a1b24c" contextRef="C_1987a0f3-1c0e-49ee-81ad-cc7a111a2cf3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">24,077</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8cd4a99f-cfb2-426b-bdab-6b39fccbf6d4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.708%;box-sizing:content-box;"/>
        <td style="width:1.06%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.762%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.282%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.06%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.762%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.282%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f756a6e0-138f-4a3f-a94d-86492ae901b9" contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,218,033</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1feaeb40-f933-4b48-9a05-5f41d35e447a" contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.69</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a864bba7-7a44-41b6-95cb-e624c8677ba2" contextRef="C_d2bff3d0-c82e-407b-9765-471560864917" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cd3a210-ea00-44a7-aa48-7ac83b999513" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">11,026,451</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_711b7440-08ad-475e-b0b8-ceee99bb404d" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.10</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7aba8457-2399-44c2-9253-2de3f91eb719" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">862,631</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e16568b-8008-4db5-9749-26ea2ca97018" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.07</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62d4c45c-280d-48e9-ad94-bfc20336c885" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,381,853</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aee7fb2e-f501-48ed-b609-b942e082b4c2" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_dc1b3b4a-0d05-4260-8a32-c7ab27664b2a" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_943df1b0-785f-4e42-b266-caf24a848887" contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">235</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd406300-f935-4b81-8cdf-6e3dacee8ba5" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">622,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2339c15a-0ce7-4974-a4bc-411aad48bf41" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed40850a-930b-40d3-8c92-2b8336b6be67" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3258fdcb-3281-4114-bc55-17f12ec3f433" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.30</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9791cf65-7a97-4cf2-9f29-869019ee0b45" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">316,465</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_828f4fe5-ea89-41e7-ad93-574f271bebae" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.29</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11ab38d6-25d5-4e0f-8ba0-807e263c46d4" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,637,388</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e32cdc1d-cbba-4127-bd89-7991de1678a2" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.02</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ce475f1c-ced8-4bf3-9c98-d790da084d6c" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd2e02e6-c59d-436f-8587-c522b521a0cc" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,628</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91b529a6-b33e-4c8c-9b7d-e73fee35d622" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,637,388</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54408ab6-d6b3-4011-886a-61d083fcce84" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.02</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_a3204eb6-1cff-4141-9885-4df4db99c106" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd174181-ffbc-4c5d-9a8d-a29c50310ea7" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,628</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfc90392-905b-4ae4-96e3-062eea2bc970" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,667,177</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca86967e-55c5-48be-9252-7ad2b0b288b0" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.37</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_179a7bfb-273e-4a12-8efd-4ed96821c15a" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b438599-94f6-4c07-bb89-78eecb185957" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,898</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71c9e5db-22a7-4135-b4bb-9f2959bfada4" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c7dd20ff-b759-4e65-a802-4be23331b886_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_773ba3f7-e30b-4441-a186-75e5ab1bfa87" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.72%;box-sizing:content-box;"/>
        <td style="width:2.54%;box-sizing:content-box;"/>
        <td style="width:26.1%;box-sizing:content-box;"/>
        <td style="width:2.54%;box-sizing:content-box;"/>
        <td style="width:26.1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_652e6395-cfcc-4701-bf11-8c97ddd19e28" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">101.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2102d6a1-dca3-4cd6-b770-11b9d6743e92" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">90.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76f119e4-5c97-4c1e-b9b2-f669f59101a8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38b082f3-5bb0-4096-a0a4-c45e4fbf2962" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cc92c6ef-029c-4c07-b971-11555e849742" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_24f73755-1234-4cd3-b6a4-a42af67ad47c" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18a2fbd8-49b4-401e-b254-36ec23b2fa82" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53a09bc1-ccef-4344-ab98-05e002697c01" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7433610c-012a-483c-945a-a6a78c0bd0eb" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.93</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c31b9c7f-318e-453c-b470-664d44d971e0" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ede7bb7b-5d2e-493a-a200-fd53dca1031d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"/>
        <td style="width:1.26%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.38%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.72%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d3334d6-689b-46bb-a884-b131466cd28b" contextRef="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_509d9280-483f-4dd5-a131-958ffa4b311f" contextRef="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32319448-3885-4beb-936b-920c9be98fd2" contextRef="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3b7bba3-cc13-4d51-8bd9-d139ae08c864" contextRef="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dbc667b-1fcd-4f90-b505-a39f163a7314" contextRef="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dce3385-27e3-409d-8062-c367594d9c8a" contextRef="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5781a6c0-fcf1-4df0-ab0c-0715cc1f5fb3" contextRef="C_3959ebff-dd82-4919-8415-9cfb3aeb832a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">46,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96293874-4932-4ca7-a282-75dddd7f26de" contextRef="C_3959ebff-dd82-4919-8415-9cfb3aeb832a" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.97</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_731b0edf-a420-4a79-9a35-b3280492b8c0" contextRef="C_d174fc95-378b-4f2e-a041-e159aefc096b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c444f35-8636-4df2-87b8-ae8ca8ee6f88" contextRef="C_d174fc95-378b-4f2e-a041-e159aefc096b" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4e5a72e-ec4a-4338-87de-7166b3eef6bf" contextRef="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">46,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bc3bf18-c390-4587-8c9f-be1fcd3ee808" contextRef="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0" name="eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.97</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_88e913ca-d27a-4cea-bb87-e78f9be6cb6b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.47%;box-sizing:content-box;"/>
        <td style="width:2.46%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:19.304%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.46%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:19.304%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86d95724-1e9b-4f10-9307-5744ecf90a10" contextRef="C_d74c7b95-2405-4e2a-92fa-de35246ee4c0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,277</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4384f9a2-820a-4b98-865b-ed8f3d993789" contextRef="C_edc2adbf-8141-490c-92ff-6e31ec443f9f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,491</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14642334-1033-4234-9104-0458515f1481" contextRef="C_dd3aadef-8b9e-4abb-a618-63b7b63a02d8" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,845</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96d48547-7814-4790-987b-f84a04a5b2ca" contextRef="C_d928ea5e-1b31-4b26-9a65-5053f8c68714" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,054</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb879ef3-d26d-487f-88c8-368982819449" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52433577-c3ef-4135-8c5c-75cd8caebb65" contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f2ca0c7-6472-4fab-8a68-f2b5be4128ab" contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over an estimated weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7522680b-bc8f-4e01-a38a-ae0373a97af5" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.4</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_9783de3b-75fc-4212-b881-8a501bc4490b" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Segment Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently operates and manages its business as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dc6a6fe-b68e-4936-9ce1-b68474e230bd" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;CODM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;), is the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1691d7f7-1fe6-4184-b13f-c7d5693df0ef;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32d34539-39ff-4469-9b94-7b02d17f280d" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:FactorsUsedToIdentifyEntitysReportableSegments"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</span></ix:nonNumeric></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b5c49917-80ca-456f-a3d2-e4aad4794ea8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment entity, </span><span><ix:nonNumeric id="F_a2e16cd9-2df9-49fe-ba8e-c93aa0a451e2" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true" continuedAt="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span></ix:nonNumeric></span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71_1" continuedAt="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71_2"></ix:continuation></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71_2"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.026%;box-sizing:content-box;"/>
        <td style="width:1.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.078000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.078000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e25599a-9ab5-49ec-ae23-4426ff4df650" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="eldn:Tegoprubart-KidneyTransplantationPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,452</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35616a99-61c7-49f9-a96f-010ad5307ec0" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="eldn:Tegoprubart-KidneyTransplantationPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,940</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b594d10-d7f4-429e-9612-4591047b9582" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="eldn:Tegoprubart-OtherDevelopmentPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">306</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_129eaded-1c66-4afa-b5ec-c5cd59523d5c" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="eldn:Tegoprubart-OtherDevelopmentPrograms" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,186</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3610ada5-d637-45a7-bdfe-cf0aeb53b2ec" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:ManufacturingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,448</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a09f9553-a4c1-4fab-9168-74b02deb831a" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:ManufacturingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,048</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eacdfb3d-5d71-464b-9028-b6f575845c2c" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="eldn:Personnel-RelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afae4fc8-5a3d-46bd-87be-b63d52a16716" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="eldn:Personnel-RelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,351</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d606a45-688b-488b-8c28-2993ac12678e" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,122</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fcb1f31-208a-4a85-bc95-8349a1b26230" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,545</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_839f39e2-dfd2-44b0-b681-baa253543e2c" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,543</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc134c8b-f67c-46d7-9115-e82f9852e206" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,930</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31188c78-a33e-470d-b526-449b7698f124" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a39848-14bc-474e-a4d6-30991cb7a6c1" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_892338ad-0455-4dd3-8c96-b63edfadf69e" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">70,577</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a3000bf-4d0f-4b1c-b81d-5c90d45af9ae" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">43,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3625d07-2536-4324-8141-29013a810dbe" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_361e9246-a0ac-45ac-82bf-f81e0d967161" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2570a038-3cf1-4805-81fa-24aa3296b83b" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03e42872-32fb-4fe0-8244-7a87d42da45f" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,211</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_225f1487-04e6-459c-ae92-10018fee512f" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e31e035f-c466-4141-b23c-4e644e1dd8b1" contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,184</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8715801-40be-4027-97c6-9430b21079a8" contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116,537</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f11f3f7e-0aca-4a61-aeb8-93e7b76acfe8" contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Subsequent Events</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated events subsequent to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>eldn-ex10_7.htm
<DESCRIPTION>EX-10.7
<TEXT>
<html>
 <head>
  <title>EX-10.7</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.63%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">FOURTH AMENDMENT TO LEASE</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  This Fourth Amendment to Lease (&#x201c;Amendment&#x201d;) dated March 12, 2024, by and</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  between </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">NEWPORT GATEWAY OFFICE LLC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, a Delaware limited liability company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Landlord</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), and</font></p>
  <p style="margin-left:1.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, a Delaware corporation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:1.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:6.7387678778996305%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">II.</font><div style="width:100%;display:inline;" id="ii__recitals"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">RECITALS</font></div></div>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:6.877%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.139%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Landlord (The Irvine Company LLC, a Delaware limited liability company) and Tenant (formerly known as Novus Therapeutics, Inc., a Delaware corporation, as successor in interest to Otic Pharma, Inc., a Delaware corporation) are parties to that certain lease dated September 2, 2015, which lease was amended by a First Amendment to Lease dated April 19, 2018, a Second Amendment to Lease dated May 3, 2021 and a Third Amendment to Lease dated August 12, 2022 (collectively, the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Lease</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;) for space consisting of approximately 5,197 rentable square feet known as Suite No. 550 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Original Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) in the building located at 19900 MacArthur Boulevard, Irvine, California (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Original Building</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;).</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:6.877%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.139%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Landlord and Tenant each desire to modify the Lease to substitute for the Original Premises approximately 5,817 rentable square feet of space known as Suite No. 250 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Suite 250</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) in the Building located at 19800 MacArthur Boulevard, Irvine, CA 92612 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Building</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), extend the Term, adjust the Basic Rent, and make such other modifications as are set forth in &#x201c;III. MODIFICATIONS&#x201d; next below.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;display:flex;margin-top:11.4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:6.7387678778996305%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">III.</font><div style="width:100%;display:inline;" id="iii__modifications_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">MODIFICATIONS.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;" id="a__basic_lease_provisions___the_basic_le"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Basic Lease Provisions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. The Basic Lease Provisions are hereby amended as follows:</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_da_5"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 2 will be deleted in its entirety and the following will be substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="x2__premises___suite_no__250"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;2.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">:	Suite No. 250</font></p>
  <p style="margin-left:27.787%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="address_of_building__19800_macarthur_bou"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Address of Building</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">:	19800 MacArthur Boulevard, Irvine, CA 92612</font></p>
  <p style="margin-left:27.787%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="project_description__newport_gateway"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Project Description</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">:	Newport Gateway</font></p>
  <p style="margin-left:27.787%;font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="xthe_premises_are_more_particularly_desc"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(the Premises are more particularly described in Section 2.1).&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;" id="x__item_4_is_hereby_amended_by_adding_th"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Item 4 is hereby amended by adding the following:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;4.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Estimated Commencement Date for Suite 250</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: April 1, 2024.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;" id="x__item_5_is_hereby_deleted_in_its_entir"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Item 5 is hereby deleted in its entirety and the following substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;text-indent:-9.542%;padding-left:6.68%;font-size:10pt;margin-top:11.4pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.204%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;5.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Lease Term</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: The Term will expire 38 months after the Commencement Date for Suite 250, plus such additional days as may be required to cause this Lease to expire on the final day of the calendar month.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_da_4"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 6 will be deleted in its entirety, and the following substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="x6__basic_rent_"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;6. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Basic Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">:</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:14.593%;border-spacing:0;table-layout:auto;width:83.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.14%;box-sizing:content-box;"></td>
    <td style="width:39.18%;box-sizing:content-box;"></td>
    <td style="width:34.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:23.05pt;white-space:pre-wrap;word-break:break-word;">
    <td style="border-top:1.5pt solid #000000;padding-top:0in;border-right:1.5pt solid #000000;text-indent:36.9pt;border-left:1.5pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;"><p style="margin-left:1.587%;text-indent:-5.722%;padding-left:5.253%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.343%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Months of Term or Period</font></p></td>
    <td style="border-top:1.5pt solid #000000;padding-top:0in;border-right:1.5pt solid #000000;text-indent:1.15pt;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;"><p style="margin-left:0.213%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Monthly Rate Per Square Foot</font></p></td>
    <td style="border-top:1.5pt solid #000000;padding-top:0in;border-right:1.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;font-kerning:none;min-width:fit-content;">Basic Monthly Rent</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.15pt;border-left:0.5pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.213%;text-indent:0;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">1 to 14</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$2.70</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$15,705.90</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.15pt;border-left:0.5pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.213%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">15 to 26</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$2.78</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$16,171.26</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.15pt;border-left:0.5pt solid #000000;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.213%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">27 to 38</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$2.86</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;text-indent:1.05pt;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="margin-left:0.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">$16,636.62</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:14.44%;font-size:10pt;margin-top:11.5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All such Basic Rent will be payable by Tenant in accordance with the terms of the Lease.</font></p>
  <p style="margin-left:14.44%;font-size:10pt;margin-top:5.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.204%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Notwithstanding the above schedule of Basic Rent to the contrary, as long as Tenant is not in Default (as defined in Section 14.1) under this Lease, Tenant will be entitled to an abatement of 2 full calendar months of Basic Rent in the aggregate amount of $31,411.80 (i.e., $15,705.90 per month) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Abated Basic Rent</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) for the first 2 full calendar months of the Term (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Abatement Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;). If Tenant is in Default, at any time during the Term, the unamortized portion of the Abated Basic Rent (amortized on a straight-line basis over the portion of the Term commencing on the Commencement Date for Suite 250 and ending on the last day of the 38</font><font style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">th </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">full calendar month thereafter) will immediately become due and payable. The payment by Tenant of the Abated Basic Rent in the event of a Default will not limit or affect any of Landlord's other rights, pursuant to this Lease or at law or in equity. Only Basic Rent will be abated during the Abatement Period and all other additional Rent and other costs and charges specified in this Lease will remain as due and payable pursuant to the provisions of this Lease.</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_da_2"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 7 will be deleted in its entirety and the following will be substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.185%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;7. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Property Tax Base</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: The Property Taxes per rentable square foot incurred by Landlord and attributable to the twelve-month period ending June 30, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Base Year</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.231%;text-align:justify;" id="project_cost_base__the_project_costs_per"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Project Cost Base</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: The Project Costs per rentable square foot incurred by Landlord and attributable to the Base Year.</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="expense_recovery_period__every_12_month_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Expense Recovery Period</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Every 12-month period during the Term (or portion thereof during the first and last Lease years) ending June 30.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_da_3"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 8 will be deleted in its entirety and the following will be substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="x8__floor_area_of_premises___approximate"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;8.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Floor Area of Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: approximately 5,817 rentable square feet</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Floor Area of Building</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: approximately: 302,296 rentable square feet&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_da_1"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 9 will be deleted in its entirety, and the following substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.231%;text-align:justify;" id="x9__security_deposit____18_300_28__as_mo"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;9.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Security Deposit</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: $18,300.28, as more fully described in Section 4.3 of this Lease.&#x201d;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:11.5pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;" id="x__effective_as_of_the_commencement_date"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effective as of the Commencement Date for Suite 250, Item 11 will be deleted in its entirety, and the following substituted in lieu thereof:</font></div></div>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:11.3pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.222%;text-align:left;" id="x11__parking___up_to_19_parking_passes_i"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;11.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Parking</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">: Up to 19 Parking Passes in accordance with the provisions set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit F </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">to this Lease.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.398%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.788369430620779%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;" id="x__item_12_with_respect_to_tenant_s_addr"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Item 12 with respect to Tenant&#x2019;s Address for Payments and Notices is hereby deleted in its entirety, and the following substituted in lieu thereof:</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:21.067%;font-size:10pt;margin-top:11.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="xtenant"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">TENANT</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">19800 MacArthur Boulevard, Suite 250</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Irvine, CA 92612</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:43.148%;text-align:left;" id="attn___chief_financial_officer"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Attn: Chief Financial Officer </font><font id="with_a_copy_of_notices_to_"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">with a copy of notices to:</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="eledon_pharmaceuticals__inc_"><font id="x9800_macarthur_boulevard__suite_250"></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc.</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">19800 MacArthur Boulevard, Suite 250</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="irvine__ca_92612"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Irvine, CA 92612</font></p>
  <p style="margin-left:21.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="attn___general_counsel_"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Attn: General Counsel&#x201d;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.45pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Commencement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. As used herein, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Commencement Date for Suite 250</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d; will occur on the earlier of (a) the date Suite 250 is deemed ready for occupancy as set forth below, provided that such date will not be prior to March 1, 2024, or (b) the date Tenant commences its business activities within Suite 250. Promptly following request by Landlord, the parties will memorialize on a form provided by Landlord (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Suite 250 Commencement Memorandum</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) the actual Commencement Date for Suite 250. If Tenant fails to execute and return the Suite 250 Commencement Memorandum to Landlord within 10 business days (or provide specific written objections thereto within that period), then Landlord&#x2019;s determination of the Commencement Date for Suite 250 as set forth in the Suite 250 Commencement Memorandum will be conclusive. Suite 250 will be deemed &#x201c;ready for occupancy&#x201d; if and when Landlord, to the extent applicable, (i) has substantially completed all the work required to be completed by Landlord pursuant to the Work Letter attached to this Amendment, but for minor punch list matters, and has obtained the requisite governmental approvals for Tenant&#x2019;s occupancy in connection with such work,</font></div></div>
  <p style="margin-left:14.44%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.194%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(ii) has provided reasonable access to Suite 250 for Tenant so that Suite 250 may be used without unreasonable interference, and (iii) has put into operation all building services required to be provided by Landlord under the Lease and essential for the use of Suite 250 by Tenant.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;" id="c__delay_in_possession___if_landlord__fo"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Delay in Possession</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. If Landlord, for any reason whatsoever, cannot deliver possession of Suite 250 to Tenant on or before the Estimated Commencement Date for Suite 250 set forth in Section III.A.2 above, this Amendment will not be void or voidable, nor will Landlord be liable to Tenant for any resulting loss or damage. However, Tenant will not be liable for Basic Rent for Suite 250 until the Commencement Date for Suite 250 occurs as provided in Section III.B above, except that if Landlord&#x2019;s failure to substantially complete all work required of Landlord pursuant to Section III.B above is attributable to any action or inaction by Tenant (including, without limitation, any Tenant Delay described in the Work Letter attached to this Amendment), then Suite 250 will be deemed to be ready for occupancy, and Landlord will be entitled to full performance by Tenant (including, but not limited to, the payment of Rent), as of the date Landlord would have been able to substantially complete such work and deliver Suite 250 to Tenant but for such Tenant&#x2019;s delay(s).</font></div></div>
  <p style="margin-left:7.773%;text-indent:-7.998%;padding-left:6.667%;font-size:10pt;margin-top:11.45pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.204%;text-align:justify;" id="d_security_deposit___on_or_before_the_co"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">D.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Security Deposit</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. On or before the Commencement Date for Suite 250, Tenant must deliver the sum of $2,946.28 to Landlord, which sum will be added to the Security Deposit presently being held by Landlord in accordance with Section 4.3 of the Lease.</font></p>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;" id="e__operating_expenses___notwithstanding_"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Operating Expenses.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Notwithstanding any contrary provision in the Lease, Landlord agrees that Tenant will not be obligated to pay Landlord for Operating Expenses accruing during the 12-month period commencing as of the Commencement Date for Suite 250.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.35pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">F.</font><div style="width:100%;display:inline;" id="f__floor_plan_of_premises___effective_as"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Floor Plan of Premises.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Effective as of the Commencement Date for Suite 250, </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit A </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">to the Lease will be deleted in its entirety and substituted with the attached </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit A </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">in lieu thereof.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">G.</font><div style="width:100%;display:inline;" id="g__parking___notwithstanding_any_contrar"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Parking</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Notwithstanding any contrary provision in </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit F </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">to the Lease, &#x201c;Parking,&#x201d; (i) effective as of the Commencement Date for Suite 250, </font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant may purchase from Landlord, all or a portion of the parking passes set forth in Item 11 of the Basic Lease Provisions (as reflected in the revised parking allotment set forth in Section III.A.7 of this Amendment) (the &#34;</font><font style="color:#212121;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Parking Passes</font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;). During the period commencing on the Commencement Date for Suite 250 and ending on the Expiration Date (as extended by this Amendment), the charge for the Parking Passes will be $50.00 per Parking Pass for unreserved parking per month. Thereafter, the parking charges will be at Landlord&#x2019;s scheduled parking rates from time to time.</font></div></div>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">H.</font><div style="width:100%;display:inline;" id="h__suite_250_tenant_improvements___landl"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Suite 250 Tenant Improvements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Landlord hereby agrees to complete the Suite 250 Tenant Improvements in accordance with the provisions of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit X</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, Work Letter, attached hereto.</font></div></div>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">I.</font><div style="width:100%;display:inline;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;</font><font style="color:#212121;white-space:pre-wrap;text-decoration:underline solid #212121;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Indemnity</font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Section 10.2 of the Lease is hereby amended by adding the following:</font></div></div>
  <p style="margin-left:14.44%;font-size:10pt;margin-top:11.45pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.185%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;Tenant will in all cases accept any tender of defense of any action or proceeding in which Landlord is named or made a party, within 14 days of the tender and will, notwithstanding any allegations of sole negligence or willful misconduct on the part of Landlord, defend Landlord as provided herein until a final determination of sole negligence or willful misconduct is made, and if such final determination of Landlord&#x2019;s sole negligence or willful misconduct is made, Landlord will reimburse Tenant (but not Tenant&#x2019;s insurer) for the reasonable and actual defense costs so incurred by Tenant. Costs will also include all of Landlord's reasonable attorneys' fees, litigation costs, investigation costs and court costs and all other costs, expenses and liabilities incurred by Landlord or its counsel from the date Landlord first receives notice that any claim or demand is to be made or may be made. Tenant must also tender the action or proceeding to its insurer, and request coverage for its indemnity obligations to Landlord. For purposes of this Section 10.2, &#34;</font><font style="color:#212121;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Landlord</font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34; includes Landlord and Landlord's directors, officers, shareholders, members, agents and employees. Tenant's obligations under this Section 10.2 will survive the termination of this Lease.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">J.</font><div style="width:100%;display:inline;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;</font><font style="color:#212121;white-space:pre-wrap;text-decoration:underline solid #212121;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Insurance</font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Exhibit D attached to the Lease is hereby deleted in its entirety, and</font></div></div>
  <p style="margin-left:14.44%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit D </font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">attached to this Amendment is substituted in lieu thereof.</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">K.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Termination as to Original Premises</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. The Lease with respect to the Original Premises will terminate on the day preceding the Commencement Date for Suite 250 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), provided that such termination will not relieve Tenant of (i) any Rent or other charges owed by Tenant, or other obligations required of Tenant, as are set forth in the Lease through and including the Termination Date, except as otherwise provided in the last sentence of this Section K, (ii) any obligations that are set forth in this Amendment, and (iii) any indemnity or hold harmless obligations set forth in the Lease as to the Original Premises. Tenant will quit and surrender possession of the Original Premises to Landlord on or before the Termination Date. Notwithstanding anything to the contrary contained in Section 15.2 of the Lease, Tenant will not be required to remove from the Premises any Required Removables, wallpapering, or cabling installed by Tenant, or to make any repairs to the Premises caused by the removal of Tenant&#x2019;s personal property. Tenant will be provided a 7 day grace-period after the Commencement Date for Suite 250 to remove from the Original Premises any personal property not moved by Landlord pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit X</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;display:flex;margin-top:11.4pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:6.7387678778996305%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">IV.</font><div style="width:100%;display:inline;" id="iv__general_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">GENERAL.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;" id="a__effect_of_amendments___the_lease_rema"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Effect of Amendments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. The Lease remains in full force and effect except to the extent that it is modified by this Amendment.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.45pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;" id="b__entire_agreement___this_amendment_emb"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. This Amendment embodies the entire understanding between Landlord and Tenant with respect to the modifications set forth in &#x201c;III. MODIFICATIONS&#x201d; above and can be changed only by a writing signed by Landlord and Tenant.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;" id="c__counterparts__digital_signatures___th"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Counterparts; Digital Signatures</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. </font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This Amendment may be executed in one or more counterparts, each of which constitutes an original and all of which are one and the same agreement. The parties expressly agree that one or each of the parties may execute and deliver this Amendment electronically using a certificate-based electronic signature and delivery software service approved and initiated by Landlord that provides an audit trail and method for authenticating signers (the &#x201c;</font><font style="color:#212121;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Approved Service</font><font style="color:#212121;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;). The Approved Service will have the same legal effect as a handwritten signature and will be admissible evidence of the parties' mutual intent to be legally bound by this Amendment. The parties declare that they have received all of the information required to be fully aware of the certificate-based electronic signature software process and each party hereby waives any claim which it may have against the enforceability of this Amendment based on the use of the Approved Service.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.45pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;" id="d__defined_terms___all_words_commencing_"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Defined Terms</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. All words commencing with initial capital letters in this Amendment and defined in the Lease have the same meaning in this Amendment as in the Lease, unless they are otherwise defined in this Amendment.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;" id="e__authority___if_tenant_is_a_corporatio"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Authority</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. If Tenant is a corporation, limited liability company or partnership, or is comprised of any of them, each individual executing this Amendment for the corporation, limited liability company or partnership represents that he or she is duly authorized to execute and deliver this Amendment on behalf of such entity and that this Amendment is binding upon such entity in accordance with its terms.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">F.</font><div style="width:100%;display:inline;" id="f__california_certified_access_specialis"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">California Certified Access Specialist Inspection</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Pursuant to California Civil Code &#167; 1938, Landlord hereby states that the Premises have not undergone inspection by a Certified Access Specialist (CASp) (defined in California Civil Code &#167; 55.52(a)(3)). Pursuant to Section 1938 of the California Civil Code, Landlord hereby provides the following notification to Tenant: &#34;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties will mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction related accessibility standards within the premises.&#34;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.45pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.269%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">G.</font><div style="width:100%;display:inline;" id="g__attorneys__fees___the_provisions_of_t"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Attorneys&#x2019; Fees</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. The provisions of the Lease respecting payment of attorneys&#x2019; fees also apply to this Amendment.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.5pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">H.</font><div style="width:100%;display:inline;" id="h__nondisclosure_of_lease_terms___tenant"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Nondisclosure of Lease Terms</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Tenant acknowledges that the content of this Amendment and any related documents are confidential information. Except to the extent disclosure is required by law, Tenant will keep such confidential information strictly confidential and will not disclose such confidential information to any person or entity other than Tenant&#x2019;s financial, legal and space-planning consultants, provided, however, that Landlord Consents to Tenant&#x2019;s disclosure of the terms to prospective subtenants or assignees under </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">5</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:11.5pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">the Lease or pursuant to legal requirement.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:7.731%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:2.13%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:7.225612069058946%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">I.</font><div style="width:100%;display:inline;" id="i__brokers___article_18_of_the_lease_is_"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Brokers</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Article 18 of the Lease is amended to provide that the parties recognize the following parties as the brokers who negotiated this Amendment, and agree that Landlord will be responsible for payment of brokerage commissions to such brokers pursuant to its separate agreements with such brokers: Irvine Management Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Landlord&#x2019;s Broker</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) is the agent of Landlord exclusively and Savills (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Broker</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) is the agent of Tenant exclusively. By the execution of this Amendment, each of Landlord and Tenant hereby acknowledge and confirm (a) receipt of a copy of a Disclosure Regarding Real Estate Agency Relationship conforming to the requirements of California Civil Code 2079.16, and (b) the agency relationships specified herein, which acknowledgement and confirmation is expressly made for the benefit of Tenant&#x2019;s Broker. If there is no Tenant&#x2019;s Broker so identified herein, then such acknowledgement and confirmation is expressly made for the benefit of Landlord&#x2019;s Broker. By the execution of this Amendment, Landlord and Tenant are executing the confirmation of the agency relationships set forth herein. The warranty and indemnity provisions of Article 18 of the Lease, as amended hereby, are binding and enforceable in connection with the negotiation of this Amendment.</font></div></div>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">[SIGNATURES ON FOLLOWING PAGE]</font></p>
  <p style="margin-left:7.773%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.176%;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:11.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.96in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;display:flex;margin-top:4.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:6.7387678778996305%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">V.</font><div style="width:100%;display:inline;" id="v__execution_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXECUTION.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="landlord_and_tenant_executed_this_amendm"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Landlord and Tenant executed this Amendment on the date as set forth in &#x201c;I. PARTIES AND DATE.&#x201d;</font></p>
  <p style="margin-left:1.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">above.</font></p>
  <p style="font-size:10pt;margin-top:11.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">LANDLORD:									TENANT:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:50%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:5.75pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.067%;text-indent:0;font-size:10pt;margin-top:4.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">NEWPORT GATEWAY OFFICE LLC,</font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">a Delaware limited liability company</font></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:5.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.528%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">By: /s/ Steven M. Case</font></p><p style="margin-left:3.333%;text-indent:0;font-size:10pt;margin-top:5.35pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.944%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Steven M. Case Executive Vice President Office Properties</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">By: /s/ Stacy Nishioka</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">      </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Stacy Nishioka</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Vice President, Operations Office Properties</font></p></td>
    <td style="padding-top:0.01in;text-indent:5.75pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.067%;text-indent:0;font-size:10pt;margin-top:4.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.,</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">a Delaware corporation</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.227%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">By: /s/ David-Alexandre C. Gros, MD</font></p><p style="margin-left:3.333%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.528%;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.333%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.528%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, MD</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.528%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;By: /s/ Paul Little</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">        </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Paul Little</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.83in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">7</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.13in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:4.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:17.147%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img107301401_0.jpg" alt="img107301401_0.jpg" style="width:387px;height:32px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:center;" id="x9800_macarthur_blvd__suite_250"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd, Suite 250</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:8.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img107301401_1.jpg" alt="img107301401_1.jpg" style="width:624px;height:506px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">8</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:34.04%;text-indent:18.844%;font-size:10pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:35.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT D TENANT&#x2019;S INSURANCE</font></p>
  <p style="font-size:10pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:4.314%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.157%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The following requirements for Tenant&#x2019;s insurance must be in effect during the Term, and Tenant must also cause any subtenant to comply with the requirements. Landlord reserves the right to adopt reasonable nondiscriminatory modifications and additions to these requirements.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.132%;font-size:0;margin-top:11.45pt;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant must maintain, at its sole cost and expense, during the entire Term: (i) commercial general liability insurance with respect to the Premises and the operations of Tenant in, on or about the Premises, on a policy form that is at least as broad as Insurance Service Office (ISO) CGL 00 01 (if alcoholic beverages are sold on the Premises, liquor liability must be explicitly covered), which policy(ies) must be written on an &#x201c;occurrence&#x201d; basis and for not less than $2,000,000 combined single limit per occurrence for bodily injury, personal injury, death, and property damage liability; such policy must include, but not be limited to bodily injury, personal injury, blanket contractual liability, products/completed operations, broad form property damage liability and independent contractor&#x2019;s liability coverage; (ii) workers&#x2019; compensation insurance coverage as required by law, together with employers&#x2019; liability insurance coverage of at least</font></div></div>
  <p style="margin-left:1.107%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.167%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">$1,000,000 each employee, each accident and each disease; (iii) with respect to Alterations constructed by Tenant under the Lease, builder&#x2019;s risk insurance, in an amount equal to the replacement cost of the work; and (iv) insurance against fire, vandalism, malicious mischief and such other additional perils as may be included in a standard &#x201c;special form&#x201d; policy, insuring all Alterations, trade fixtures, furnishings, equipment and items of personal property in the Premises, in an amount equal to not less than 90% of their replacement cost (with replacement cost endorsement), which policy must also include business interruption coverage in an amount sufficient to cover 1 year of loss. In no event will the limits of any policy be considered as limiting the liability of Tenant under the Lease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.132%;font-size:0;margin-top:11.35pt;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All policies of insurance required to be carried by Tenant pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit D </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">must be written by insurance companies authorized to do business in the State of California and with a general policyholder rating of not less than &#x201c;A-&#x201d; and financial rating of not less than &#x201c;VIII&#x201d; in the most current Best&#x2019;s Insurance Report. The deductible, self-insured retention or other retained limit under any policy carried by Tenant must not exceed $100,000 unless approved in writing by Landlord, and Tenant will be responsible for payment of such deductible, self-insured retention or retained limit with waiver of subrogation in favor of Landlord. Landlord may, without any obligation to do so, advance or pay any deductible, self-insured retention or retained limit due on any claim that may involve it or its officers, directors or employees. Any insurance required of Tenant may be furnished by Tenant under any blanket policy carried by it or under a separate policy. A certificate of insurance, certifying that the policy has been issued, provides the coverage required by this Exhibit and contains the required provisions, together with endorsements acceptable to Landlord evidencing the waiver of subrogation and additional insured provisions required below, must be delivered to Landlord prior to the date Tenant is given the right of possession of the Premises. Proper evidence of the renewal of any insurance coverage must also be delivered to Landlord not less than 30 days prior to the expiration of the coverage. If a loss covered by any policy under which Landlord is an additional insured, Landlord will be entitled to review a copy of such policy.</font></div></div>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.132%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s commercial general liability insurance must contain a provision that the policy(ies) will be primary to and noncontributory with any insurance or self-insurance carried by Landlord, together with a provision including Landlord and all entities controlling, controlled by, or under common control with Landlord, together with their respective owners, shareholders, partners, members, divisions, officers, directors, employees, representatives and agents, and all of their respective successors and assigns as additional insureds. It must not include any exclusions or limitations applicable to the Additional Insureds that are not applicable to Tenant nor an insured vs. insured exclusion.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.138%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s policies described in Subsections 1 (i), (ii), (iii) and (iv) above must each contain a waiver by the insurer of any right to subrogation against Landlord and all entities controlling, controlled by, or under common control with Landlord, together with their respective owners, shareholders, partners, members, divisions, officers, directors, employees, representatives and agents, and all of their respective successors </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:4%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and assigns. Tenant also waives its right of recovery for any deductible, self-insured retention or retained limit under same policies enumerated above.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.138%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All of Tenant&#x2019;s policies must contain a provision that the insurer will not cancel or change the coverage provided by the policy without first giving Landlord 30 days&#x2019; prior written notice. Tenant must also name Landlord as an additional insured on any excess or umbrella liability insurance policy(ies) carried by Tenant.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:1.065%;text-indent:4.132%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.045080103097993%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">VENDORS&#x2019; AND CONTRACTORS&#x2019; INSURANCE. If Tenant hires any vendor or contractor to complete work on the Premises; Tenant must cause such vendor or contractor to comply with the following insurance requirements:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:4.317%;font-size:0;margin-top:11.45pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7769526518143985%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Commercial general liability insurance with coverage limits of not less than $1,000,000 combined single limit for bodily injury, personal injury, death and property damage liability per occurrence or the current limit carried by vendor or contractor, whichever is greater,</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:4.317%;font-size:0;margin-top:11.45pt;justify-content:flex-start;margin-bottom:0;margin-right:2.269%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7769526518143985%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Worker's compensation coverage as required by law, including employer's liability coverage with a limit of not less than $1,000,000 each employee, each accident and each disease.</font></div></div>
  <p style="margin-left:5.107%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.204%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:4.31%;font-size:0;margin-top:4.25pt;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7769526518143985%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Vendor or Contractor and its insurer(s) providing the insurance coverages described in this Section 6 Parts A, and B above, must waive any and all rights of recovery against Landlord and all entities controlling, controlled by, or under common control with Landlord, together with their respective owners, shareholders, partners, members, divisions, officers, directors, employees, representatives and agents, and all of their respective successors.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:4.31%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:0;margin-right:2.13%;min-width:4%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:4.7769526518143985%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The commercial general liability insurance policy required in Section 6 Part A, must name Landlord and all entities controlling, controlled by, or under common control with Landlord, together with their respective owners, shareholders, partners, members, divisions, officers, directors, employees, representatives and agents, and all of their respective successors as additional insured for both operations and product completed operations coverage. Such coverage will be primary and non-contributory to any insurance or self-insurance carried by Landlord and all entities controlling, controlled by, or under common control with Landlord.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:11.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.611%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">NOTICE TO TENANT: IN ACCORDANCE WITH THE TERMS OF THE LEASE, TENANT MUST PROVIDE EVIDENCE OF THE REQUIRED INSURANCE TO</font></p>
  <p style="margin-left:0.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.694%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S MANAGEMENT AGENT PRIOR TO BEING AFFORDED ACCESS TO THE PREMISES.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:37.373%;text-indent:-0.113%;padding-left:0.027%;font-size:10pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:39%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT X WORK LETTER</font></p>
  <p style="margin-left:1.107%;text-indent:4.135%;font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.167%;text-align:justify;" id="for_purposes_of_this_exhibit_x__the_term"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">For purposes of this </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit X</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, the term &#x201c;Premises&#x201d; means Suite 250. Landlord will cause its contractor to make the following improvements to the Premises: (i) relocate Tenant&#x2019;s existing furniture, fixtures and equipment to the Premises; (ii) provide new electrical furniture feeds and floor core feeds, raise existing pendant fixtures and install TV at locations mutually agreed to by Landlord and Tenant; (iii) provide 1 new glass inset door; (iv) install film on the existing conference room and corner office; and (v) install new cabling to match Tenant&#x2019;s existing cabling (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Suite 250 Tenant Improvements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;). In addition, Landlord agrees to perform as part of the Suite 250 Improvements such other improvements reasonably requested by Tenant to prepare the Premises for occupancy by Tenant, as long as such other improvements neither increase the cost of the Suite 250 Tenant Improvements, nor delay the completion of the Suite 250 Improvements Unless otherwise agreed in writing by Landlord, all materials and finishes utilized in constructing the Suite 250 Tenant Improvements must be Landlord's building standard. If Landlord submits any additional plans, equipment specification sheets, or other matters to Tenant for approval or completion, Tenant must respond in writing, as appropriate, within 3 business days unless a shorter period is provided herein. Tenant will not unreasonably withhold its approval of any matter, and any disapproval will be with reasons specified. Landlord may require that one or more designated subtrades be union contractors.</font></p>
  <p style="margin-left:1.107%;text-indent:4.316%;font-size:10pt;margin-top:8.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.194%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If Tenant requests any changes or additional work (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Changes</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), then provided such Change is reasonably acceptable to Landlord, Landlord will advise Tenant by written change order of any additional cost and/or Tenant Delay (as defined below) such change would cause. Tenant must approve or disapprove such change order in writing within 2 business days following its receipt. Tenant's approval of a change order will not be effective unless accompanied by payment in full of the additional cost of the Tenant Improvement work resulting from the change order. Landlord will have no obligation to interrupt or modify the Tenant Improvement work pending Tenant's approval of a change order.</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:4.316%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.204%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Notwithstanding any provision in the Lease to the contrary, if Tenant fails to comply with any of the time periods specified in this Work Letter, requests any Changes to the work, fails to make timely payment of any sum due hereunder, furnishes inaccurate or erroneous specifications or other information, or otherwise delays in any manner the completion of the Suite 250 Tenant Improvements or the issuance of an occupancy certificate (any of the foregoing being referred to in this Amendment as a &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant Delay</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#34;), then Tenant must bear any resulting additional construction cost or other expenses and the Commencement Date for Suite 250 will be deemed to have occurred for all purposes, including, but not limited to, Tenant's obligation to pay Rent, as of the date Landlord reasonably determines that it would have been able to deliver the Premises to Tenant but for the collective Tenant Delays.</font></p>
  <p style="margin-left:1.107%;text-indent:4.315%;font-size:10pt;margin-top:11.5pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.176%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Provided that Tenant has paid the increase in the Security Deposit and has provided Landlord with adequate evidence that Tenant is carrying the insurance for the Premises required by Exhibit D, Landlord will permit Tenant and its agents to enter the Premises up to 30 days prior to the Commencement Date for Suite 250 in order that Tenant may install its telephones, furniture, equipment, and computers using its own contractors, subject to Landlord's prior written approval (which approval will not be unreasonably withheld, conditioned, or delayed), and in a manner and upon terms and conditions and at times reasonably satisfactory to Landlord's representative. The foregoing license to enter the Premises prior to the Commencement Date for Suite 250 is, however, conditioned upon Tenant's contractors and their subcontractors and employees working in harmony and not interfering with the work being performed by Landlord. If at any time that entry causes disharmony or interferes with the work being performed by Landlord, this license may be withdrawn by Landlord upon 24 hours&#x2019; written notice to Tenant. That license is further conditioned upon the compliance by Tenant's contractors with all reasonable requirements imposed by Landlord on third party contractors, including without limitation the maintenance by Tenant and its contractors and subcontractors of workers' compensation and public liability and property damage insurance in amounts and with companies and on forms reasonably satisfactory to Landlord, with certificates of such insurance being furnished to Landlord prior to proceeding with any such entry. The entry will be deemed to be under all of the provisions of the Lease except as to the covenants to pay Basic Rent,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.93in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:1.107%;font-size:10pt;margin-top:11.5pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.176%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">unless Tenant commences business activities in the Premises. Landlord will not be liable in any way for any injury, loss or damage which may occur to any such work being performed by Tenant, the same being solely at Tenant's risk. In no event will the failure of Tenant's contractors to complete any work in the Premises extend the Commencement Date for Suite 250.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:4.315%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.167%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Tenant hereby designates Paul Little, Telephone No. (949) 238-8090, Email: plittle@eledon.com as its representative, agent and attorney-in-fact for the purpose of receiving notices, approving submittals and issuing requests for Changes, and Landlord will be entitled to rely upon authorizations and directives of such person(s) as if given by Tenant. Tenant may amend the designation of its construction representative(s) at any time upon delivery of written notice to Landlord.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.99in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>eldn-ex10_8.htm
<DESCRIPTION>EX-10.8
<TEXT>
<html>
 <head>
  <title>EX-10.8</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.813%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.417%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LEASE</font></p>
  <p style="margin-left:0.827%;font-size:10pt;margin-top:12.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BLANCHARD WOODS</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78 Blanchard Road, Burlington, Massachusetts</font></p>
  <p style="margin-left:0.813%;font-size:10pt;margin-top:12.55pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Premises: Approximately 6,138 rentable square feet of space on the third (3</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) floor of the Building Tenant: Eledon Pharmaceuticals, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T A B L E O F C O N T E N T S</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BASIC LEASE PROVISIONS								1</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTRODUCTION	1</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BASIC DATA AND DEFINITIONS.							1</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEMISING OF PREMISES, TERM, OPTIONS						2</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEMISE OF PREMISES.									2</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">APPURTENANT RIGHTS AND RESERVATIONS.					2</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TERM.											3</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RENT	</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIXED RENT.										3</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LATE PAYMENT.									4</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">USE OF PREMISES; ALTERATIONS							4</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PERMITTED USE									4</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALTERATIONS.										5</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT AND SUBLETTING								6</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GENERALLY										6</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REIMBURSEMENT, RECAPTURE AND EXCESS RENT.				8</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTAIN TRANSFERS.									10</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDITION OF PREMISES AND RESPONSIBILITY FOR REPAIRS			10</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDITION OF PREMISES								10</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S IMPROVEMENTS								11</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPAIRS TO BE MADE BY LANDLORD						12</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAINTENANCE AND REPAIRS TO BE MADE BY TENANT.				13</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FLOOR LOAD - HEAVY MACHINERY; OCCUPANT DENSITY			13</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERVICES; UTILITY CHARGES								14</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S SERVICES.								14</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UTILITY SERVICES AND CHARGES							15</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELECTRICAL SERVICE AND ELECTRICAL CHARGE.					16</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL RENT FOR TAXES AND OPERATING EXPENSES			17</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S PAYMENT OF ITS SHARE OF REAL ESTATE TAXES			17</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S PAYMENT OF ITS SHARE OF OPERATING EXPENSES.			18</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEMNITY AND INSURANCE								21</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEMNITY										21</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INSURANCE.										22</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S RISK										23</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INJURY CAUSED BY THIRD PARTIES							23</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:32.75pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S ACCESS TO PREMISES</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">							</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S RIGHT OF ACCESS.							24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBITION OF SPACE TO PROSPECTIVE TENANTS					24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KEYS.											24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRE, EMINENT DOMAIN, ETC								24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRE OR OTHER CASUALTY								24</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EMINENT DOMAIN									25</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:11.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEFAULT											26</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S DEFAULT									26</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REMEDIES										27</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTEREST ON LATE PAYMENTS							28</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S DEFAULT.								28</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COSTS OF ENFORCEMENT.								29</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BANKRUPTCY AND INSOLVENCY							29</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:6.729924796850553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MISCELLANEOUS PROVISIONS								30</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXTRA HAZARDOUS USE								30</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONTROLLED SUBSTANCES								30</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER											31</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVENANT OF QUIET ENJOYMENT.							31</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S LIABILITY								31</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICE TO MORTGAGEE AND GROUND LESSOR					32</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT OF RENTS.								32</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MECHANIC&#x2019;S LIENS.									33</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NO BROKERAGE.									33</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INVALIDITY OF PARTICULAR PROVISIONS.						33</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROVISIONS BINDING, ETC								33</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECORDING										34</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.13</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICES											34</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.14</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHEN LEASE BECOMES BINDING							34</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.15</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PARAGRAPH HEADINGS.								34</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.16</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RIGHTS OF MORTGAGEE.								34</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.17</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATUS REPORT.									35</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.18</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S FINANCIAL CONDITION							36</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.19</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL REMEDIES OF LANDLORD; SURVIVAL.				36</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.20</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER OF COUNTERCLAIMS.							36</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.21</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENTS										36</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.22</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HOLDING OVER										36</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NON-SUBROGATION									37</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.24</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ENVIRONMENTAL HAZARDS.								37</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.25</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITY DEPOSIT.									38</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.26</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GOVERNING LAW.									39</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.27</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBSTITUTION OF OTHER PREMISES.						39</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.28</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITY MEASURES									39</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.29</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EASEMENTS										39</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.30</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CHANGES TO PROPERTY								40</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.31</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INCORPORATION OF PRIOR AGREEMENTS						40</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.32</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDMENTS										40</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.33</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVENANTS										40</font></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:32.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:32.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:32.75pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.34</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AUCTIONS.										40</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.1pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.35</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MERGER											41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.36</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AUTHORITY										41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.37</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELATIONSHIP OF PARTIES								41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.38</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RIGHT TO LEASE									41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.39</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONFIDENTIALITY									41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.40</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OFAC CERTIFICATION AND INDEMNITY						41</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.935%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:10%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:10.094382476152022%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.41</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER OF JURY TRIAL.								42</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.04%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:16.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.417%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LEASE</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BLANCHARD WOODS</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease, by and between Landlord and the Tenant (as defined below), relates to the space in the building (the &#x201c;Building&#x201d;) known as 78 Blanchard Road of Blanchard Woods (the &#x201c;Office Park&#x201d;), in Burlington, Middlesex County, Massachusetts, with an address at 78 Blanchard Road Burlington, Massachusetts. The term &#x201c;Lot&#x201d; shall mean the parcel of land on which the Building is located; and the term &#x201c;Property&#x201d; shall mean the Lot and all improvements thereon from time to time, including the Building.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.1pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The parties to this Lease hereby agree with each other as follows:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BASIC LEASE PROVISIONS</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTRODUCTION.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.056%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As further supplemented in the balance of this instrument and its Exhibits, the following sets forth the basic terms of this Lease and, where appropriate, constitutes definitions of certain terms used in this Lease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BASIC DATA AND DEFINITIONS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease Date:  </font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">9/4/2024</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>    Landlord:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BLANCHARD GROUP LLC</font></p>
  <p style="font-size:10pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    Present Mailing Address of Landlord:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    c/o Duffy Properties LLC</font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">465 Waverley Oaks Road, Suite 500</font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waltham, MA 02452</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;text-indent:-99.516%;padding-left:32.52%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.815%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. a Delaware corporation.</font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.204%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Present Mailing Address of Tenant:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19900 MacArthur Blvd., Suite 550, Irvine, CA 92612 Term or original Term:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	                               </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Three (3) years (plus the partial month, if any, immediately</font></p>
  <p style="margin-left:34.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">following the Commencement Date).</font></p>
  <p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Scheduled Commencement Date:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 21, 2024.</font></p>
  <p style="font-size:10pt;margin-top:3.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:1.602%;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:24.305%;box-sizing:content-box;"></td>
    <td style="width:24.785%;box-sizing:content-box;"></td>
    <td style="width:9.262%;box-sizing:content-box;"></td>
    <td style="width:20.664%;box-sizing:content-box;"></td>
    <td style="width:20.984%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:13.15pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:2.5pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.467%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed Rent:</font></p></td>
    <td style="padding-top:0in;text-indent:61.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:11.467%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease Year</font></p></td>
    <td style="padding-top:0in;text-indent:6.6pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.227%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PSF</font></p></td>
    <td style="padding-top:0in;text-indent:7.4pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.373%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Annual Fixed Rent</font></p></td>
    <td style="padding-top:0in;text-indent:7.7pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.427%;text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Monthly Installment</font></p></td>
   </tr>
   <tr style="height:13.75pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;text-indent:61.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:11.467%;text-indent:0;font-size:11pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
    <td style="padding-top:0in;text-indent:6.6pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.227%;text-indent:0;font-size:11pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$32.50</font></p></td>
    <td style="padding-top:0in;text-indent:7.4pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.373%;text-indent:0;font-size:11pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$199,485.00</font></p></td>
    <td style="padding-top:0in;text-indent:7.7pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.427%;text-indent:0;font-size:11pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$16,623.75</font></p></td>
   </tr>
   <tr style="height:13.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;text-indent:61.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:11.467%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
    <td style="padding-top:0in;text-indent:6.6pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.227%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$33.48</font></p></td>
    <td style="padding-top:0in;text-indent:7.4pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.373%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$205,500.24</font></p></td>
    <td style="padding-top:0in;text-indent:7.7pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.427%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$17,125.02</font></p></td>
   </tr>
   <tr style="height:12.8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;text-indent:61.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:11.467%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</font></p></td>
    <td style="padding-top:0in;text-indent:6.6pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.227%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$34.48</font></p></td>
    <td style="padding-top:0in;text-indent:7.4pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.373%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$211,638.24</font></p></td>
    <td style="padding-top:0in;text-indent:7.7pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.427%;text-indent:0;font-size:11pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$17,636.52</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:2.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;text-indent:-53.808%;padding-left:32.52%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.056%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Electrical Charge:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant electric will be separately metered and billed directly to Tenant in accordance with Section 7 below.</font></p>
  <p style="font-size:10pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;text-indent:-54.015%;padding-left:32.52%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.287%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Premises:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The portion of the Building (as defined above) located on the third (3</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rd</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) floor, Suite 304, and shown as outlined on Exhibit A attached hereto.</font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rentable Floor Area of the Premises:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Approximately 6,138 rentable square feet.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:8.15pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rentable Floor Area of the Building:	  Approximately 113,160 rentable square feet.</font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;text-indent:-55.333%;padding-left:32.52%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.722%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Permitted Use:	First-class office space and ancillary office uses substantially associated with Tenant&#x2019;s research and development business, and no other use.</font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Security Deposit Amount:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	                 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$34,250.04.</font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Brokers:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	                                              </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Savills (Tenant) and Colliers (Landlord).</font></p>
  <p style="font-size:10pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;text-indent:-55.082%;padding-left:32.52%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:6.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax Base:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Taxes for Tax Year 2025 (the fiscal year ending June 30, 2025), as provided in Section 8.1.</font></p>
  <p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:1.987%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Base Operating Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	                </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Operating Expenses for Operating Year 2025 (currently the</font></p>
  <p style="margin-left:34.507%;font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.056%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">calendar year ending December 31, 2025), as provided in Section 8.2.</font></p>
  <p style="font-size:10pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEMISING OF PREMISES, TERM, OPTIONS</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEMISE OF PREMISES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord hereby demises and leases to Tenant, and Tenant hereby accepts from Landlord, the Premises, subject to the terms and conditions of this Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purposes of this Lease, it is agreed that the Rentable Floor Area of the Premises shall be as stated in Section 1.2 above, and the Rentable Floor Area of the Building shall be as stated in Section 1.2 above. Landlord shall have the right to adjust the Rentable Floor Area of the Premises or the Building, from time to time, based on a remeasurement of same or on changes to the physical size of the Building or rentable area(s) thereof. In the event such remeasurement reflects that the stated Rentable Floor Area of the Premises set forth herein is different from as stated in Section 1.2 above, the parties hereto shall thereafter adjust the Fixed Rent, and any other charges, expenses or benefits based thereon to reflect the correct measurement.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">APPURTENANT RIGHTS AND RESERVATIONS.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall have, as appurtenant to the Premises, the nonexclusive right to use and to permit its invitees to use in common with others, public or common lobbies, hallways, stairways, passenger elevators and sanitary facilities in the Building necessary for Tenant&#x2019;s use and occupancy of the Premises, and (as provided in the next subsection) the parking facilities serving the Building. Such rights shall always be subject to reasonable rules and regulations from time to time established by Landlord by suitable notice, provided that the same do not materially and adversely conflict with the terms and conditions of this Lease, and shall be subject to the right of Landlord to designate and change from time to time areas and facilities to be so used.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall also have, as appurtenant to the Premises and at no additional cost to Tenant, the nonexclusive right to use, and permit its employees and invitees to use, in common with others, on a first come, first serve basis, the open parking facilities serving the Building (excepting those spaces now or hereafter designated by Landlord as being for the exclusive use of others). Such parking rights shall be subject to the right of Landlord to limit the number of parking spaces available to Tenant, its employees and invitees, where the use of the same exceeds, in Landlord&#x2019;s commercially reasonable judgment, the ratio of approximately three (3) spaces per 1,000 square feet of the Rentable Floor Area of the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excepted and excluded from the Premises are the roof and all perimeter walls of the Premises, except the inner surfaces thereof, but the entry doors to the Premises are not excluded from the Premises and are a part thereof for all purposes; and Tenant agrees that Landlord shall have the right to place in the Premises (but in such manner as to not substantially interfere with Tenant&#x2019;s use of the Premises subject to Landlord&#x2019;s notice and opportunity to cure) utility lines, pipes and the like to serve premises other than the Premises, and to replace and maintain and repair such utility lines, pipes and the like in, over and upon the Premises.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the hours of 8:00 A.M. to 6:00 P.M., Monday through Friday, legal holidays (both federal and state) in all cases excepted (&#x201c;Normal Building Operating Hours&#x201d;), the Building shall be open and access to the Premises shall be freely available, subject to interruption due to causes beyond Landlord&#x2019;s reasonable control. During periods other than Normal Building Operating Hours, Landlord shall provide means of access to the Premises, subject to commercially reasonable security restrictions on such access, such as card access systems as well as causes beyond Landlord&#x2019;s control including, without limitation, inclement weather. Access to the Premises during Normal Building Operating Hours and at other times shall always be subject to reasonable rules and regulations therefor from time to time established by Landlord by suitable notice, provided that the same do not materially and adversely conflict with the terms and conditions of this Lease. Tenant acknowledges that, in all events, Tenant is responsible for providing security to the Premises and its own personnel, and Tenant shall indemnify, defend with counsel of Landlord&#x2019;s selection, and save Landlord harmless from any claim for injury to person or damage to property asserted by any personnel, employee, guest, invitee or agent of Tenant which is suffered or occurs in or about the Premises or in or about the Building by reason of the act of any intruder or any other person in or about the Premises or the Building, provided the same does not arise from the gross negligence or willful misconduct of Landlord or its employees, agents or contractors or from Landlord&#x2019;s breach of this Lease subject to Landlord&#x2019;s receipt of written notice of such breach with an opportunity to cure.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TERM.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the conditions herein stated, Tenant shall hold the Premises for the Term (as defined in Section 1.2) commencing on the Commencement Date (as defined below) and expiring at midnight of the last day of the Term, unless sooner terminated as provided herein.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term &#x201c;Commencement Date&#x201d; shall mean November 21, 2024.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RENT</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIXED RENT.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant agrees to pay to Landlord, without offset or deduction, except as otherwise specifically set forth herein, and without previous demand therefor, annual Fixed Rent during each Lease Year (as defined below) of the Term. The annual Fixed Rent during the original Term shall be as provided in Section 1.2 above.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All such annual Fixed Rent shall be payable in equal monthly installments, in advance, on the first day of each and every calendar month during the Term, commencing on the Commencement Date, to Landlord, or as directed by Landlord, at the Present Mailing Address of Landlord (as set forth in Section 1.2) or at the address from time to time designated by Landlord. Notwithstanding the foregoing, Tenant shall pay the first monthly installment of Fixed Rent on the date that Tenant executes and delivers this Lease.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fixed Rent for any partial month shall be paid by Tenant on a pro rata basis, and if the Commencement Date occurs on a day other than the first day of a calendar month, the first payment which Tenant shall make shall be a payment equal to a proportionate part of such monthly Fixed Rent for the partial month from such date to the first day of the succeeding calendar month, and the monthly Fixed Rent for such succeeding calendar month.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purposes of this Lease, &#x201c;Lease Year&#x201d; shall mean each successive 12-month period included in whole or in part in the Term of this Lease; the first Lease Year beginning on the Commencement Date and ending at midnight on the day before the first anniversary of the Commencement Date (provided that if the Commencement Date is not the first day of a calendar month, the first Lease Year shall end at midnight on the last day of the calendar month which includes the first anniversary of the Commencement Date). If the first Lease Year of the Term shall be greater than one full calendar year, the annual Fixed Rent for such Lease Year shall be increased proportionately to the greater length of such Lease Year.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.1.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the fact that the amounts of Fixed Rent set forth in this Lease were or may have been determined with reference to the floor area of the Premises, said amounts as set forth above are </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stipulated to be the amounts of Fixed Rent due hereunder, whether or not the actual floor area of the Premises are in fact more or less than the floor area figures used to determine said Fixed Rent.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LATE PAYMENT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any Fixed Rent, additional rent or any other payments due hereunder from Tenant are not paid within 5 days of the due date thereof, Tenant shall be charged a late fee of $250.00 for each late payment for each month or portion thereof that said payment remains outstanding. Said late fee shall be payable in addition to and not in exclusion of any other remedies of Landlord on account of such late payments, including without limitation the obligation to pay interest on late payments, as provided in Section 12.3. Notwithstanding the foregoing, however, Landlord shall grant Tenant up to two (2) instances during the initial Lease term where any late fee shall be waived in the case of Base Rent payments arriving late due to being lost in the mail, clerical error or some other unforeseeable event so long as payment is received by Landlord within ten (10) days of the due date thereof.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">USE OF PREMISES; ALTERATIONS</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PERMITTED USE.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant agrees that the Premises shall be used and occupied by Tenant only for the Permitted Use, as provided in Section 1.2 of this Lease, and for no other purpose or purposes.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant further covenants and agrees to conform to the following provisions during the entire Lease Term:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall cause all freight (including furniture, fixtures and equipment used by Tenant in the occupancy of the Premises) to be delivered to or removed from the Building and the Premises in accordance with reasonable rules and regulations established by Landlord therefor and Landlord may require that such deliveries or removals be undertaken during periods other than Normal Building Operating Hours.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not place on the exterior of exterior walls (including both interior and exterior surfaces of windows and doors) or on any part of the Building outside the Premises, any sign, symbol, free-standing sign or advertisement or the like visible to public view outside of the Premises except as provided in the next paragraph.</font></div></div>
  <p style="margin-left:14.267%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, Tenant may, at Tenant&#x2019;s sole expense, locate and affix a sign at the entrance door to the Premises of the type commonly and customarily found in first-class office buildings (but not a free-standing sign) for the purpose of identifying and locating the Premises, which sign and location shall be subject to the prior approval of Landlord. Where Landlord establishes reasonable standards for such signs, Tenant agrees to conform to the same and to submit for Landlord&#x2019;s prior approval, such approval not unreasonably to be withheld, a plan or sketch of the sign to be placed on or about such entry door and location thereof. Without limitation, lettering on windows and window displays are expressly prohibited. Landlord shall also provide Tenant with a listing on the Building&#x2019;s main tenant directory.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not perform any act or any practice which may injure the Premises, or any other part of the Building or the Property, or cause any offensive odors or loud noise, or constitute a nuisance or a menace to any other tenant or tenants or other persons in the Building, or be detrimental to the reputation or appearance of the Building, and Tenant shall permit no waste with respect to the Premises or the Property.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall conduct Tenant&#x2019;s business in the Premises in such a manner that Tenant&#x2019;s invitees shall not collect, line up or linger in the lobby or corridors of the Building, but shall be entirely accommodated within the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall comply and shall cause all employees to comply with all commercially reasonable rules and regulations from time to time established by Landlord by suitable notice, provided the same do not materially and adversely conflict with the terms of this Lease, including without limitation the current rules and regulations, a copy of which are attached hereto as Exhibit B. Landlord shall not, however, be responsible for the noncompliance of any such rules and regulations by any other tenant or occupant provided that Landlord has knowledge of and uses commercially reasonable efforts to request compliance with the same.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall, at Tenant&#x2019;s sole expense, promptly comply with all applicable laws, ordinances, rules, regulations, orders, certificates of occupancy, conditional use or other permits, variances, covenants and restrictions of record, the reasonable recommendations of Landlord&#x2019;s engineers or other consultants, and requirements of any fire insurance underwriters, rating bureaus or government agencies, now in effect or which may hereafter come into </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effect during the Lease Term relating in any manner to the Premises or the occupation and use by Tenant of the Premises (&#x201c;Laws and Restrictions&#x201d;); provided, however, that Tenant shall not be required to make any alterations to the Premises to comply with Laws and Regulations unless such alterations are required because (i) Tenant&#x2019;s use or occupancy of the Premises for any purposes other than general office use or (ii) any Alterations (as defined below) made to the Premises by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALTERATIONS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not make any alterations, improvements, additions, utility installations or repairs (collectively referred to as &#x201c;Alterations&#x201d; or singly as an &#x201c;Alteration&#x201d;) to the Premises, except in accordance with this Section 4.2 and with the prior written consent of Landlord, which Landlord agrees not unreasonably to withhold, condition or delay as to nonstructural Alterations (nonstructural Alterations being those that do not affect the Building&#x2019;s structure, roof, exterior or mechanical, electrical, plumbing, life safety or other Building systems or architectural design, character or use of the Building or Premises); provided, however, that Landlord&#x2019;s consent shall not be required for any cosmetic, nonstructural Alterations that do not cost in excess of $10,000.00 in the aggregate in any rolling twelve (12) month period so long as Tenant gives Landlord at least ten (10) days prior written notice of such cosmetic, nonstructural Alterations which shall include, without limitation, a detailed description of such project. Without limiting any of the terms hereof, Landlord will not approve any Alterations requiring unusual expense to readapt the Premises to normal office use on lease termination or materially increasing the cost of maintenance, insurance or taxes on the Building or of Landlord&#x2019;s services to the Premises, unless Tenant first gives assurances or security acceptable to Landlord that such re-adaptation will be made prior to such termination without expense to Landlord and makes provisions acceptable to Landlord for payment of such increased cost. All Alterations requiring Landlord&#x2019;s consent made by Tenant shall be made in accordance with plans and specifications which have been approved in writing by the Landlord, pursuant to a duly issued permit, if applicable, and in accordance with all Laws and Restrictions, the provisions of this Lease and in a good and first-class workmanlike manner using new materials of same or better quality as base building standard materials, finishes and colors, free of all liens and encumbrances. All Alterations shall be performed by a contractor or contractors selected by Tenant and approved in writing by Landlord which approval shall not be unreasonably withheld, conditioned or delayed. Tenant shall pay to Landlord a fee equal to five percent (5%) of the cost of any such Alterations to compensate Landlord for the overhead and other costs it incurs in reviewing the plans therefor and in monitoring the construction of the Alterations. Subject to Section 4.1.2(f) above, if, as a result of any Alterations made by Tenant, Landlord is obligated to comply with the Americans With Disabilities Act or any other Laws and Restrictions and such compliance requires Landlord to make any improvement or Alteration to any portion of the Building, as a condition to Landlord's consent, Landlord shall have the right to require Tenant to pay to Landlord prior to the construction of any Alteration by Tenant, the entire cost of any improvement or alteration Landlord is obligated to complete by such law or regulation. Tenant agrees to obtain or cause its contractor(s) to obtain, prior to the commencement of any work or Alterations, &#x201c;builder&#x2019;s all risk&#x201d; insurance in an amount and with such coverages approved by Landlord and worker&#x2019;s compensation insurance in the statutorily required amount(s) and evidence of all such insurance shall be furnished to Landlord prior to the performance by such contractor(s) or person(s) of any work in respect of the Premises. Landlord shall have the right to stop any work not being performed in conformance with this Lease, and, at its option, may repair or remove non-conforming work at the expense of Tenant. Tenant hereby indemnifies and holds Landlord harmless from and against any liens, encumbrances and violations of Laws and Restrictions related to such Alterations. The filing of any lien or encumbrance, or the violation of Laws and Restrictions in connection with such Alterations, shall constitute a default hereunder. The repair and indemnity obligations of Tenant hereunder, including Tenant&#x2019;s obligations to repay Landlord the cost of repairing or removing Alterations, shall survive the termination of this Lease. All Alterations performed by Tenant in the Premises shall remain therein (unless Landlord directs Tenant to remove the same on termination or expiration of this Lease, provided that Landlord notified Tenant at the time of giving its consent that Tenant would be required to remove the same) and, at termination or expiration, shall be surrendered as a part thereof, except for Tenant&#x2019;s usual trade furniture and equipment, if movable, installed prior to or during the Lease term at Tenant&#x2019;s cost, which trade furniture and equipment Tenant shall remove in their entirety prior to the termination or expiration of this Lease, provided that if Tenant is then in default hereunder, Landlord may direct that no such trade fixtures, furniture and equipment be removed. Tenant agrees to repair any and all damage to the Premises resulting from such removal (including removal of Tenant&#x2019;s Alterations directed by Landlord) or, if Landlord so elects, to pay Landlord for the cost of any such repairs forthwith after billing therefor.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT AND SUBLETTING</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GENERALLY.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding any other provisions of this Lease, Tenant covenants and agrees that it will not assign this Lease or sublet (which term, without limitation, shall include the granting of any concessions, licenses, occupancy rights, management arrangements and the like) the whole or any part of the Premises without, in each instance, having first received the express, written consent of Landlord, which consent shall not be unreasonably withheld, conditioned or delayed. A change in Tenant&#x2019;s name shall not constitute an assignment or sublease hereunder, provided Tenant notifies Landlord in writing of such name change prior to making such change. Tenant shall not collaterally assign this Lease (or any portion thereof) or permit any assignment of this Lease by mortgage, other encumbrance or operation of law.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without limitation, it shall not be unreasonable for Landlord to withhold such approval from any assignment or subletting where, in Landlord&#x2019;s opinion: (a) the proposed assignee or sublessee does not have a financial standing and credit rating reasonably acceptable to Landlord; (b) the proposed assignee or sublessee does not have a good reputation in the community; (c) the business in which the proposed assignee or sublessee is engaged could detract from the Building, its value or the costs of ownership thereof; (d) Intentionally omitted; (e) the proposed sublessee or assignee is a current tenant (and Landlord has space available to meet the demands of such tenant) or a prospective tenant of the Building or of the Office Park with whom Landlord has been negotiating within the prior nine (9) months; (f) the use of the Premises by any sublessee or assignee (even though a Permitted Use) is not substantially similar to Tenant&#x2019;s use or violates any use restriction granted by Landlord in any other lease or would otherwise cause Landlord to be in violation of its obligations under another lease or agreement to which Landlord is a party (Tenant is advised that the Landlord has granted another fourth (4</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) floor tenant in the Building who is a Wealth Management Firm (herein after defined) exclusive rights restricting the leasing, assignment of any lease, or subletting to another tenant within the Building to operate a Wealth Management Firm, a &#x201c;Wealth Management Firm&#x201d; as used herein shall be defined as a firm that provides as its primary and principal business retail wealth management services to the general public but it shall not include, by way of example and not limitation, lawyers or law firms that provide trustee or wealth management services as part of, for example, its larger trust and estates practice; accountants or accounting firms that provide wealth management services as part of, for example, its general accounting, trust, tax and estate planning services; commercial pension fund managers that do not have as part of its principal use a retail wealth management focus; commercial asset management or hedge fund firms that do not have as part of its principal use a retail wealth management focus; tax preparation firms; and the like; (g) if such assignment or subleasing is not approved of by the holder of any mortgage on the Property (if such approval is required); (h) a proposed assignee&#x2019;s or subtenant&#x2019;s business will impose a commercially unreasonable burden on the Property&#x2019;s parking facilities, elevators, common areas, facilities, or utilities that is greater than the burden imposed by Tenant, in Landlord&#x2019;s reasonable judgment; (i) any guarantor of this Lease refuses to consent to the proposed transfer or to execute a written agreement reaffirming the guaranty, unless such guarantor has been replaced with a guarantor approved by Landlord; (j) Tenant is in default of any of its obligations under the Lease beyond all applicable notice and cure periods at the time of the request or at the time of the proposed assignment or sublease; (k) if requested by Landlord, the assignee or subtenant refuses to sign a commercially reasonable non-disturbance and attornment agreement in favor of Landlord&#x2019;s lender; (l) Landlord has sued or been sued by the proposed assignee or subtenant or has otherwise been involved in a legal dispute with the proposed assignee or subtenant; (m) the assignee or subtenant is involved in a business which is not in keeping with the then current standards of the Property; (n) the assignment or sublease will result in there being more than one subtenant of the Premises (e.g., the assignee or subtenant intends to use the Premises as an executive suite); or (o) the assignee or subtenant is a governmental or quasi- governmental entity or an agency, department or instrumentality of a governmental or quasi-governmental agency. Landlord may condition its consent upon such assignee or sublessee depositing with Landlord such additional security as Landlord may reasonably require to assure the performance and observance of the obligations of such party to Landlord. In no event, however, shall Tenant assign this Lease or sublet the whole or any part of the Premises to a proposed assignee or sublessee which has been judicially declared bankrupt or insolvent according to law, or with respect to which an assignment has been </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">made of property for the benefit of creditors, or with respect to which a receiver, guardian, conservator, trustee in involuntary bankruptcy or similar officer has been appointed to take charge of all or any substantial part of the proposed assignee&#x2019;s or sublessee&#x2019;s property by a court of competent jurisdiction, or with respect to which a petition</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has been filed for reorganization under any provisions of the Bankruptcy Code now or hereafter enacted, or if a proposed assignee or sublessee has filed a petition for such reorganization, or for arrangements under any provisions of the Bankruptcy Code now or hereafter enacted and providing a plan for a debtor to settle, satisfy or extend the time for the payment of debts.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any request by Tenant for such consent shall set forth or be accompanied by, in detail reasonably satisfactory to Landlord, the identification of the proposed assignee or sublessee, its financial condition and the terms on which the proposed assignment or subletting is to be made, including, without limitation, a signed copy of all assignment and sublease documents, and clearly stating the rent or any other consideration to be paid in respect thereto; and such request shall be treated as Tenant&#x2019;s warranty in respect of the information submitted therewith. Tenant&#x2019;s request shall not be deemed complete or submitted until all of the foregoing information has been received by Landlord. Landlord shall respond to such request for consent within forty-five (45) days following Landlord&#x2019;s receipt of all information, documentation and security required by Landlord with respect to such proposed sublease or assignment.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing restrictions shall be binding on any assignee or sublessee to which Landlord has consented, provided, notwithstanding anything else contained in this Lease, Landlord&#x2019;s consent to any further assignment, subleasing or any sub-subleasing by any approved assignee or sublessee may be withheld by Landlord at Landlord&#x2019;s sole and absolute discretion.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent by Landlord to any assignment or subleasing (other than a Permitted Transfer) shall not include consent to the assignment or transferring of any lease renewal, extension or other option, first offer, first refusal or other rights granted hereunder, or any special privileges or extra services granted to tenant by separate agreement (written or oral), or by addendum or amendment of the Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the case of any assignment of this Lease or subletting of the Premises, the Tenant named herein shall be and remain fully and primarily liable for the obligations of Tenant hereunder, notwithstanding such assignment or subletting, including, without limitation, the obligation to pay the Fixed Rent and other amounts provided under this Lease, and the Tenant shall be deemed to have waived all suretyship defenses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.1.7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the foregoing, it shall be a condition of the validity of any such assignment or subletting that the assignee or sublessee agrees directly with Landlord, in a commercially reasonable form satisfactory to Landlord, to be bound by all the obligations of Tenant hereunder, including, without limitation, the obligation to pay Fixed Rent and other amounts provided for under this Lease, the covenant regarding use and the covenant against further assignment and subletting.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REIMBURSEMENT, RECAPTURE AND EXCESS RENT.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall, upon demand, reimburse Landlord for the reasonable fees and expenses (including legal and administrative fees and costs) incurred by Landlord in processing any request to assign this Lease or to sublet all or any portion of the Premises in an amount not to exceed $3,000.00, whether or not Landlord agrees thereto, and if Tenant shall fail promptly so to reimburse Landlord, the same shall be a default in Tenant&#x2019;s monetary obligations under this Lease subject to the applicable grace and cure period set forth in Section 12.1(b).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant requests Landlord&#x2019;s consent to assign this Lease or sublet (or otherwise grant occupancy rights in and to) more than fifty percent (50%) of the Premises, Landlord shall have the option, exercisable by written notice to Tenant given within twenty (20) days after Landlord&#x2019;s receipt of Tenant&#x2019;s completed request, to terminate this Lease as of the date specified in such notice, which shall </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not be less than thirty (30) nor more than one hundred twenty (120) days after the date of such notice, as to the entire Premises in the case of a proposed assignment or subletting of the whole Premises, and as to the portion of the Premises to be sublet in the case of a subletting of a portion. In the event of termination in respect of a portion of the Premises, the portion so eliminated shall be delivered to Landlord on the date specified in good order and condition in the manner provided in Section 4.2 at the end of the Term and thereafter, to the extent necessary in Landlord&#x2019;s judgment, Landlord, at its own cost and expense, may have access to and may make modification to the Premises (or portion thereof) so as to make such portion a self-contained rental unit with access to common areas, elevators and the like. Fixed Rent and the Rentable Floor Area of the Premises shall be adjusted according to the extent of the Premises for which the Lease is terminated.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without limitation of the rights of Landlord hereunder in respect thereto, if there is any assignment of this Lease by Tenant for consideration or a subletting of the whole of the Premises by Tenant at a rent which exceeds the rent payable hereunder by Tenant, or if there is a subletting of a portion of the Premises by Tenant at a rent in excess of the subleased portion&#x2019;s pro rata share of the rent payable hereunder by Tenant, then Tenant shall pay to Landlord, as additional rent, forthwith upon Tenant&#x2019;s receipt of, in the case of an assignment, fifty percent (50%) of the consideration (or the cash equivalent thereof) therefor and in the case of a subletting, fifty percent (50%) of any such excess rent. For the purposes of this subsection, the term &#x201c;rent&#x201d; shall mean all Fixed Rent, additional rent or other payments and/or consideration payable by one party to another for the use and occupancy of all or a portion of the Premises including, without limitation, key money, or bonus money paid by the assignee or subtenant to Tenant in connection with such transaction and any payment in excess of fair market value for services rendered by Tenant to the assignee or subtenant or for assets, fixtures, inventory, equipment or furniture transferred by Tenant to the assignee or subtenant in connection with any such transaction, but shall exclude any separate payments by Tenant for reasonable attorney&#x2019;s fees and broker&#x2019;s commissions in connection with such assignment or subletting. In addition, in no event shall Landlord be entitled to any portion of any consideration paid by an assignee or transferee for the acquisition of the business of Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Premises or any part thereof are sublet by Tenant, following the occurrence of a default which has continued beyond the applicable cure period, Landlord, in addition to any other remedies provided hereunder or at law, may at its option collect directly from such sublessee(s) all rents becoming due to the Tenant under such sublease(s) and apply such rent against any amounts due Landlord by Tenant under this Lease, and Tenant hereby irrevocably authorizes and directs such sublessee(s) to so make all such rent payments, if so directed by Landlord; and it is understood that no such election or collection or payment shall be construed to constitute a novation of this Lease or a release of Tenant hereunder, or to create any lease or occupancy agreement between the Landlord and such subtenant or impose any obligations on Landlord, or otherwise constitute the recognition of such sublease by Landlord for any purpose whatsoever.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.2.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following terms and conditions shall apply to any subletting by Tenant of all or any part of the Premises and shall be deemed included in all subleases under this Lease whether or not expressly incorporated therein:</font></div></div>
  <p style="margin-left:0.92%;text-indent:6.958%;font-size:10pt;margin-top:11.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant hereby absolutely and unconditionally assigns and transfers to Landlord all of Tenant&#x2019;s interest in all rentals and income arising from any sublease entered into by Tenant, and Landlord may collect such rent and income and apply same toward Tenant&#x2019;s obligations under this Lease; provided, however, that until a default occurs in the performance of Tenant&#x2019;s obligations under this Lease that is not cured within any applicable notice and cure period, Tenant may receive, collect and enjoy the rents accruing under such sublease. Landlord shall not, by reason of this or any other assignment of such rents to Landlord nor by reason of the collection of the rents from a subtenant, be deemed to have assumed or recognized any sublease or to be liable to the subtenant for any failure of Tenant to perform and comply with any of Tenant&#x2019;s obligations to such subtenant under such sublease, including, but not limited to, Tenant&#x2019;s obligation to return any security deposit. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a written notice from Landlord stating that a default exists in the performance of</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  Tenant&#x2019;s obligations under this Lease, to pay to Landlord the rents due as they become due under the sublease. Tenant agrees that such subtenant shall have the right to rely upon any such statement and request from Landlord, and that such</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">subtenant shall pay such rents to Landlord without any obligation or right to inquire as to whether such default exists and notwithstanding any notice from or claim from Tenant to the contrary. In the event Tenant shall default in the performance of its obligations under this Lease or Landlord terminates this Lease by reason of a default of Tenant, Landlord at its option and without any obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of Tenant under such sublease from the time of the exercise of said option to the termination of such sublease; provided, however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to Tenant or for any other prior defaults of Tenant under such sublease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTAIN TRANSFERS.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If at any time Tenant&#x2019;s interest in this Lease is held by a corporation, trust, partnership, limited liability company or other entity, the transfer of more than 50% of the voting stock, beneficial interests, partnership interests, membership interests or other ownership interests therein (whether at one time or in the aggregate) shall be deemed an assignment of this Lease, and shall require Landlord&#x2019;s prior written consent. The foregoing provisions shall not be applicable so long as the Tenant is a corporation, the outstanding voting stock of which is listed on a recognized security exchange, or if at least 80% of its voting stock is owned by another corporation, the voting stock of which is so listed.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding anything to the contrary in this Section 5, Tenant may assign this Lease without Landlord&#x2019;s consent and without extending any recapture or termination option to Landlord and without any obligation to share any rent or compensation paid to Tenant for such transfer, to any corporation or other entity which controls, is controlled by or is under common control with Tenant, or to any corporation or other entity which resulting from a merger or consolidation with Tenant, or to any person or entity which acquires all of the assets of Tenant&#x2019;s business, provided that (i) the assignee assumes, in full and in writing, the obligations of Tenant under this Lease, (ii) any and all Tenant defaults are cured prior to such transfer and (iii) the Permitted Use remains unchanged. (a &#x201c;Permitted Transfer&#x201d;). To enable Landlord to determine the ownership of Tenant, Tenant agrees to furnish to Landlord, from time to time promptly after Landlord&#x2019;s request therefor, (a) if the last sentence of subsection 5.3.1 is applicable, proof of listing on a recognized security exchange, or (b) if the last sentence of subsection 5.3.1 is not applicable, an accurate and complete listing of the holders of its stock, beneficial interests, partnership interests, membership interests or other ownership interests therein as of such request and as of the date of this Lease. Landlord shall use reasonable efforts to keep confidential any information received by Landlord pursuant to this Section 5.3, provided, however, that Landlord shall have the right to disclose any such information to existing or prospective mortgagees, or prospective purchasers of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDITION OF PREMISES AND RESPONSIBILITY FOR REPAIRS</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDITION OF PREMISES.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.9pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the following sentence, Tenant accepts the Premises and the Building in their present &#x201c;as is&#x201d; condition, without representation or warranty, express or implied, in fact or in law, by Landlord and without recourse to Landlord as to the nature, condition or usability thereof; and Tenant agrees that, except for the Tenant&#x2019;s Improvements (as hereinafter defined), Landlord has no work to perform in or on the Premises to prepare the Premises for Tenant&#x2019;s use and occupancy, and that any and all work to be done in or on the Premises will be performed by Tenant at Tenant&#x2019;s sole cost and expense in accordance with the terms of this Lease. Notwithstanding the foregoing, Landlord represents that the Building, the Premises, foundation, walls, floors and roof shall be in good condition as of the Commencement Date and the Premises and all base building systems, equipment and fixtures, including, without limitation, all mechanical, lighting, life safety or support and electrical equipment and systems, HVAC and plumbing, shall be in good working order and condition as of the Commencement Date. If it is determined that Landlord has failed to reasonably comply with its obligations hereunder, then it shall be the obligation of Landlord, after prior written notice from Tenant, to rectify any such violation at no cost to Tenant (through Operating Expenses or otherwise).</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S IMPROVEMENTS.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant has provided Landlord with all necessary information regarding Tenant&#x2019;s space planning needs in connection with its use of the Premises. Based upon such information supplied by Tenant, Landlord has prepared a space plan and outline specifications (the &#x201c;Space Plans&#x201d;) for the layout of </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s leasehold improvements to the Premises (&#x201c;Tenant&#x2019;s Improvements&#x201d;). Tenant&#x2019;s Improvements shall not include Tenant&#x2019;s furniture, trade fixtures, equipment and personal property and are limited to normal office fit-up construction, as generally laid out and specified on the Space Plans. Tenant acknowledges that Tenant&#x2019;s Improvements have been designed to the general quality of the design of the Building and in accordance with Landlord&#x2019;s building standards for office build-out for the Building. Landlord has submitted the Space Plans to Tenant and Tenant has approved the Space Plans. The Space Plans are attached hereto as Exhibit C.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based upon the approved Space Plans, the Landlord shall cause, at its sole cost and expense, final plans and specifications, sufficient to permit the construction of Tenant&#x2019;s Improvements, to be prepared (the &#x201c;Plans&#x201d;), which Plans shall be submitted to Tenant for approval, which approval shall not be unreasonably withheld or delayed and shall be deemed given if not disapproved of in writing (with a detailed list of the deficiencies in the Plans) within 5 business days of submittal. Tenant&#x2019;s approval of the Plans shall be consistent with previous approvals, choices and directions given. Tenant understands and agrees that changes to the Space Plans that may be needed or desired by Tenant, and or the specification by Tenant of any components or finishes that are not building-standard or as depicted on the Space Plans, will be incorporated into the Plans only if (a) such changes do not materially modify the scope or character of the Tenant&#x2019;s Improvements or any material component thereof, and (b) such changes will not, individually or in the aggregate, in Landlord&#x2019;s reasonable opinion, result in a likelihood of delay in the substantial completion of Tenant&#x2019;s Improvements. Tenant agrees that any additional cost (taking into consideration any savings achieved in connection with changes to the Plans and with construction of the Tenant Improvements) resulting from such changes, as well as from any changes to the Tenant&#x2019;s Improvements after the approval of the Plans (including design and construction costs, including materials, labor and general conditions costs) shall be the responsibility of Tenant and shall be paid in full by Tenant to Landlord within 15 business days of billing therefor by Landlord; and Tenant agrees that if such changes do result in delay in substantial completion, same shall be deemed a Tenant Delay (as defined below).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the completion and approval of the Plans, Landlord shall, at its sole cost and expense but subject to the terms of subsection 6.2.2 above, proceed, using reasonable efforts, to obtain all necessary permits and approvals for the construction of Tenant&#x2019;s Improvements, to engage a contractor or construction manager to perform or supervise the construction and to proceed to construct Tenant&#x2019;s Improvements in substantial conformance with the Plans. Landlord reserves the right to make changes and substitutions to the Plans in connection with the construction of Tenant&#x2019;s Improvements, provided same do not materially adversely modify the Plans approved by Tenant, and Tenant agrees to not unreasonably withhold or delay its consent to any changes that do materially adversely modify the Plans, in accordance with subsection 6.2.2.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord agrees to use reasonable efforts to substantially complete Tenant&#x2019;s Improvements by the Scheduled Commencement Date subject to delays caused by Tenant, Force Majeure, and/or factors beyond the reasonable control of Landlord but in no event shall Landlord be liable to Tenant for any failure to deliver the Premises on any specified date, nor shall such failure give rise to any default or other remedies under this Lease or at law or equity. Tenant acknowledges that Tenant&#x2019;s Improvement work, in whole or in part, may be conducted during normal business hours and Tenant agrees to provide access to the Premises to complete such work. Tenant shall be responsible to remove any personal property and equipment in the affected areas and to adequately protect any non-movable personal property and equipment from damage that may be caused by the Tenant Improvement work.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s Improvements shall be deemed substantially complete on the date (the &#x201c;Substantial Completion Date&#x201d;) the Landlord notifies Tenant that, with the exception of Punchlist (defined below) items, the Landlord has completed the Tenant Improvements in conformance with the Plans and, if applicable, has obtained a certificate of occupancy or its equivalent permitting occupancy. Notwithstanding the foregoing, if any delay in the substantial completion of the Tenant&#x2019;s Improvements by Landlord is due to Tenant Delays, then the Substantial Completion Date shall be deemed to be the date Tenant&#x2019;s Improvements would have been substantially completed, if not for same, as reasonably determined by Landlord. &#x201c;Tenant Delays&#x201d; shall mean delays caused by: (a) requirements of the Plans requested by Tenant that do not conform to Landlord&#x2019;s building standards </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for office build-out, or which contain long lead-time or non-standard items requested by Tenant; (b) any change in the Plans requested by Tenant; (c) failure to approve the Plans (or changes thereto or modifications thereof) within the time limits provided herein; (d) any request by Tenant for a delay in the commencement or completion of Tenant&#x2019;s Improvements for any reason; or (e) any other act or omission of Tenant or its employees, agents or contractors.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Within seven (7) days after the Substantial Completion Date, Landlord and Tenant shall confer and create a specific list of any defects or incomplete remaining items of work with respect to Tenant&#x2019;s Improvements (a &#x201c;Punchlist&#x201d;). Landlord shall complete the Punchlist within thirty (30) days after such meeting.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease is subject to the Landlord obtaining all permits, licenses and approvals necessary to allow Landlord to construct Tenant&#x2019;s Improvements and obtain a certificate of occupancy with respect thereto; and if Landlord shall be unable to obtain same, and is therefore unable to commence or complete Tenant&#x2019;s Improvements, then this lease may be terminated by Landlord by written notice to Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All components of the Tenant&#x2019;s Improvements shall be part of the Building, except only for such items as Landlord and Tenant agree in writing shall be removed by Tenant on the termination of this Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.2.9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant occupies the Premises prior to the Commencement Date, such occupancy shall be subject to all provisions of this Lease, such occupancy shall not change the termination date, and Tenant shall pay Fixed Rent and all other charges provided for in this Lease during the period of such occupancy. Tenant shall be liable for any damages or delays caused by Tenant&#x2019;s activities at the Premises. Prior to entering the Premises, Tenant shall obtain all insurance it is required to obtain by the Lease and shall provide certificates of said insurance to Landlord. Tenant shall coordinate such entry with Landlord&#x2019;s building manager, and such entry shall be made in compliance with all terms and conditions of this Lease and the rules and regulations in effect from time to time.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REPAIRS TO BE MADE BY LANDLORD.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise provided in this Lease, Landlord agrees to keep in good order, condition and repair, the roof, exterior walls, structural components and common building systems of the Building insofar as they affect or serve the Premises and the appurtenant common areas of the Building, and to maintain and repair the HVAC system and equipment serving the Premises, unless installed by or for Tenant. Without limitation, Landlord shall in no event be responsible to Tenant for the condition of interior glass in and about the Premises or for the doors leading to the Premises, or for any improvements, additions or alterations (including the Tenant&#x2019;s Improvements) installed by or for the Tenant, or for any condition in the Premises or the Building caused by the negligence or willful misconduct of Tenant or any contractor, agent, employee or invitee of Tenant, or anyone claiming by, through or under Tenant. Landlord also agrees to maintain the parking areas, roadways and landscaping on the property surrounding the Building in good order and repair. Landlord shall not be responsible to make any improvements or repairs to the Building or the Premises other than as expressed in this Section unless expressly otherwise provided in this Lease. All costs incurred by Landlord in connection with the foregoing obligations shall be included as part of Operating Expenses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall never be liable for any failure to make repairs which, under the provisions of this Section or elsewhere in this Lease, Landlord has undertaken to make unless: (a) Tenant has given notice to Landlord of the need to make such repairs as a result of a condition in the Building or in the Premises requiring any repair for which Landlord is responsible; and (b) Landlord has failed to commence to make such repairs within a reasonable time after receipt of such notice if any repairs are, in fact, necessary.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAINTENANCE AND REPAIRS TO BE MADE BY TENANT.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.4.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant covenants and agrees that Tenant will keep neat and clean and maintain in good order, condition and repair, the Premises and every part thereof (and any signs permitted hereunder) throughout the Lease Term, excepting only those repairs for which Landlord is responsible under the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terms of this Lease, damage by fire or other casualty or as a consequence of the exercise of the power of eminent domain and reasonable wear and tear and Tenant shall surrender the Premises at the end of the Term in such condition. Without limitation, Tenant shall maintain and use the Premises in accordance with all Laws and Restrictions and shall, at Tenant&#x2019;s own expense obtain and maintain in effect all permits, licenses and the like required by applicable law for Tenant&#x2019;s operation of his business. No such requirement by Tenant to comply with Laws shall be construed as requiring Tenant to make structural or capital improvements to the Premises, except as required because of Tenant&#x2019;s use of the Premises or because of any alterations to the Premises made by Tenant. Tenant shall not permit or commit any waste, and Tenant shall be responsible for the cost of repairs which may be made necessary by reason of damage to any areas in the Building or Office Park, including the Premises, by Tenant, Tenant&#x2019;s contractors or Tenant&#x2019;s agents, employees, invitees, or anyone claiming by, through or under Tenant. Landlord may replace as needed any bulbs, LED fixtures, and ballasts in the Premises during the Lease Term at Tenant&#x2019;s cost and expense, or Landlord may require Tenant to replace the same, at Tenant&#x2019;s cost and expense.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.4.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If repairs are required to be made by Tenant pursuant to the terms hereof, Landlord may demand that Tenant make the same forthwith, and if Tenant fails, refuses or neglects to commence such repairs and complete the same with reasonable dispatch after such demand, Landlord may (but shall not be obligated to) make or cause such repairs to be made and shall not be responsible to Tenant for any loss or damage that may accrue to Tenant&#x2019;s stock or business by reason thereof. If Landlord makes or causes such repairs to be made, Tenant agrees that Tenant will forthwith, on demand, pay to Landlord the cost thereof, and if Tenant shall fail to so reimburse Landlord upon demand, Landlord shall have the remedies provided for the nonpayment of rent or other charges payable hereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FLOOR LOAD - HEAVY MACHINERY; OCCUPANT DENSITY.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.5.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not place a load upon any floor in the Premises exceeding the floor load per square foot of area which such floor was designed to carry and which is allowed by law. Landlord reserves the right to prescribe the weight and position of all business machines and mechanical equipment, including safes, which shall be placed so as to distribute the weight. Business machines and mechanical equipment shall be placed and maintained by Tenant at Tenant&#x2019;s expense in settings sufficient, in Landlord&#x2019;s judgment, to absorb and prevent vibration, noise and annoyance. Tenant shall not move any safe, heavy machinery, heavy equipment, freight, bulky matter or fixtures into or out of the Building without Landlord&#x2019;s prior consent.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.5.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If such safe, machinery, equipment, freight, bulky matter or fixtures requires special handling, Tenant agrees to employ only persons holding a Master Rigger&#x2019;s License to do said work, and that all work in connection therewith shall comply with Laws and Restrictions. Any such moving shall be at the sole risk and hazard of Tenant and Tenant will exonerate, indemnify and save Landlord harmless against and from any liability, loss, injury, claim or suit resulting directly or indirectly from such moving. Tenant shall schedule such moving at such times as Landlord shall require for the convenience of the normal operations of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.5.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall maintain a ratio of not more than one Occupant (as defined below) per square foot of rentable area in the Premises as required by applicable federal, state and local building codes and requirements, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and in conformance with number of allotted non-exclusive parking spaces</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. &#x201c;Occupants&#x201d; means the employees, visitors, contractors and other people that visit the Premises. For purposes of this section, &#x201c;Occupants&#x201d; shall not include people not employed by Tenant that deliver or pick up mail or other packages at the Premises, employees of Landlord or employees of Landlord&#x2019;s agents or contractors. Tenant acknowledges that increased numbers of Occupants causes additional wear and tear on the Premises and the Common Areas, additional use of electricity, water and other utilities, and additional demand for other Building services.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERVICES; UTILITY CHARGES</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S SERVICES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord covenants during the Term:</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To furnish, through Landlord&#x2019;s employees or independent contractors, electricity (for lights, convenience receptacles, and normal office machines and equipment in the Premises, subject to Section 7.2 below, and for the common areas and facilities), heat, air conditioning and ventilation and general cleaning services to a level customarily provided by operators of buildings such as the Building; it is understood, however, that heat, air conditioning and ventilation and certain other services shall only be furnished during Normal Building Operating Hours; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To furnish, through Landlord&#x2019;s employees or independent contractors, additional Building operation services upon reasonable advance request of Tenant at rates from time to time established by Landlord to be paid by Tenant provided the same may be reasonably and conveniently provided by Landlord. Tenant hereby agrees to pay to Landlord the cost of such additional services as additional rent upon demand by Landlord. The current charge for afterhours HVAC service is $85.00 per hour for such use, subject to change from time to time reasonably reflect changes in the cost factors relating thereto.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord may provide for the operation of a food service amenity, mini market, and/or such similar service (the &#x201c;Food Amenity&#x201d;) in the Building and/or the Office Park. The Food Amenity will be available during its hours of operation as established by Landlord and in accordance with any rules and regulations that may be established concerning such use. Charges for food and other services provided at the Food Amenity shall be as determined by Landlord (or the operator of the Food Amenity) from time to time in its sole discretion. It is understood and agreed that all use of the Amenity and its facilities shall be at the sole risk of Tenant and the employees using same, and, to the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#x2019;s insurance requirements hereunder and Section 13.22, Tenant hereby releases Landlord from any liability in connection with such use and indemnifies and holds the Landlord harmless from and against any loss, cost, liability, damage or expense occasioned by or in any way related to or arising from the use of the Food Amenity by Tenant or Tenant&#x2019;s employees or by any other party allowed to use same by Tenant or any of its employees. Landlord reserves the right at any time or from time to time, in its sole discretion, to discontinue the Food Amenity, or alter its size, type, location or serving capacity, or its meals or hours of operation or any other aspect thereof. To the extent the Food Amenity is open and available to the Tenant as provided herein, Tenant shall pay to Landlord, as additional rent and on a so-called net basis, Tenant&#x2019;s share (as computed in Section 8.1.2) of any losses, costs or subsidies incurred or paid by Landlord in operating the Food Amenity within thirty (30) days of invoice therefor; provided Landlord may elect to collect same in monthly estimated payments (as reasonably estimated by Landlord from time to time), due on the same date as monthly Fixed Rent installment payments are due hereunder, with a periodic (not more often than annual) reconciliation.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord may open, operate, from time to time, a fitness center facility (the &#x201c;Fitness Center&#x201d;) in the Building and/or Office Park. If provided, the Fitness Center may be available for use by Tenant and its employees, together with others, during its hours of operation and in accordance with any rules and regulations that may be established concerning such use in Landlord&#x2019;s sole discretion. Charges for use of and services provided at the Fitness Center shall be as determined by Landlord (or the operator of the Fitness Center, as the case may be) from time to time in its sole discretion. It is understood and agreed that all use of the Fitness Center and its facilities shall be at the sole risk of Tenant and the employees using same, and, to the maximum extent this agreement may be made effective according to law (including the limitations set forth in M.G.L. c. 186, &#167;15), but subject to Tenant&#x2019;s insurance requirements hereunder and Section 13.22, Tenant hereby releases Landlord from any liability in connection with such use and indemnifies and holds the Landlord harmless from and against any loss, cost, liability, damage or expense occasioned by or in any way related to or arising from the use of the in connection with such use. Landlord reserves the right at any time or from time to time, in its sole discretion, to discontinue the Fitness Center, limit the access to or use thereof, or alter its size, type, location or serving capacity, or hours of operation or any other aspect thereof. To the extent the Fitness Center is open and available to the Tenant as provided herein, Tenant shall pay to Landlord, as additional rent and on a so-called net basis, Tenant&#x2019;s share (as computed in Section 8.1.2) of any losses, costs or subsidies incurred or paid by Landlord in operating the Fitness Center within thirty (30) days of invoice therefor; provided Landlord may elect to collect same in monthly estimated payments (as reasonably estimated by Landlord from time to time), due on the same date </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as monthly Fixed Rent installment payments are due hereunder, with a periodic (not more often than annual) reconciliation.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UTILITY SERVICES AND CHARGES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Tenant shall obtain directly from the supplier or utility company any services (such as telephone service, or should it be separately metered and provided as provided in Section 7.3 below, electrical service) not provided to the Premises by Landlord, and Tenant shall pay all charges therefor when due. If requested by Landlord, Tenant shall promptly provide Landlord with evidence of such payment. If such utility company shall have a lien on the Premises for nonpayment of such charges and Tenant shall fail at any time to make payment of same, without limitation of Landlord&#x2019;s rights on account of such failure, Tenant shall thereafter, if requested by Landlord, pay to Landlord, when monthly Fixed Rent is next due and thereafter on Landlord&#x2019;s demand, an amount reasonably estimated by Landlord to be sufficient to discharge any such lien in the event of a further failure of Tenant to pay any such charges when due. Landlord shall hold the amounts from time to time deposited under this Section 7.2 as security for payment of such charges and may, without limitation of remedies on account of Tenant&#x2019;s failure to make any subsequent payment of such charges, use such amounts for such payments. Such amount or such portion thereof as shall be unexpended at the expiration of this Lease shall, upon full performance of all Tenant&#x2019;s obligations hereunder, be repaid to Tenant without interest.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not introduce to the Premises personnel, fixtures or equipment which (individually or in the aggregate) materially exceed those used by the average office tenant or overload the capacity of the electrical, heating, ventilating and air conditioning, mechanical, plumbing or other utility systems serving the Premises; such capacities shall be deemed overloaded if such use by Tenant materially exceeds, on a square foot basis, the capacity of such systems; and in no event shall the electrical usage at the Premises exceed, on a square foot basis, the capacity of such systems. If Tenant uses the Premises or installs fixtures or equipment in such a manner as would so overload said systems, as reasonably determined by Landlord, Tenant shall pay, as additional rent, within ten (10) days of billing therefor, the cost of providing and installing any additional equipment, facilities or services that may be required as a result thereof, and for any repairs or damage resulting therefrom.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All costs incurred by Landlord in connection with utility services provided to the Premises shall be included as part of the Operating Expenses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall not be responsible for any interruption of electricity, oil, water, sewer, telephone, data or other utility or Building services supplied to the Premises. Furthermore, Landlord shall not be liable for loss of property or for injury to, or interference with, Tenant&#x2019;s business, including, without limitation, loss of profits, however occurring, through or in connection with or incidental to an interruption of any such services or utilities. Landlord may comply with voluntary controls or guidelines promulgated by any governmental entity relating to the use or conservation of energy, water, gas, light or electricity or the reduction of automobile or other emissions without creating any liability of Landlord to Tenant under this Lease. Notwithstanding the foregoing, if an event or circumstance (other than those addressed in the casualty and condemnation provisions of this Lease) outside of the reasonable control of Tenant or Landlord (&#x201c;Abatement Event&#x201d;) prevents Tenant from using the Premises for a period in excess of seven (7) consecutive business days after Landlord&#x2019;s receipt of written notice of any such Abatement Event, then the Base Rent obligations to Landlord shall be abated entirely or reduced, as the case may be, after expiration or such seven (7) day period, for such time that Tenant continues to be so prevented from using the Premises or a portion thereof, in the proportion that the Rentable Floor Area of that portion of the Premises that Tenant is prevented from using bears to the total Rentable Floor Area of the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELECTRICAL SERVICE AND ELECTRICAL CHARGE.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is understood that the electrical service for the Premises (for lights and convenience outlets) is separately metered from service provided to other rentable spaces and common areas of the Building, and Tenant shall pay to utility supplier directly. In the event the Premises shall not be separately metered, then Tenant shall pay to Landlord, as additional rent hereunder, within thirty (30) days of being billed therefor, the Electrical Charge at a rate of $1.75 per rsf or, if Landlord elects, the Tenant </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shall pay the Electrical Charge at a rate of $1.75 per rsf in monthly installments due on the same date as monthly Fixed Rent installment payments are due hereunder (regardless of any waiver, deferral or abatement of any Fixed Rent). Landlord reserves the right, at any time during the Term, to install a monitor or check meter to measure Tenant&#x2019;s consumption of electricity, in which event Landlord shall calculate the Electrical Charge based on Tenant&#x2019;s actual usage of electricity, rather than as provided in the previous sentence.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord may elect to collect the Electrical Charge in monthly estimated payments (as reasonably estimated by Landlord from time to time), due on the same date as monthly Fixed Rent installment payments are due hereunder.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL RENT FOR TAXES AND OPERATING EXPENSES</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S PAYMENT OF ITS SHARE OF REAL ESTATE TAXES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purposes of this Section, the following terms shall have the following meaning: &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tax Year</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the twelve-month period in use in the Town of Burlington</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.491%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for the purpose of imposing ad valorem taxes upon real property. In the event that such Town changes the period of its tax year, &#x201c;Tax Year&#x201d; shall mean a twelve-month period commencing on the first day of such new tax year, and each twelve-month period commencing on the anniversary of such date during the Term of this Lease.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;text-indent:20.901%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean all taxes and assessments of every kind and nature imposed, assessed or levied by a governmental authority on the Property, including without limitation all real estate taxes, betterments, assessments (ordinary and extraordinary), water rents, sewer, and other charges. If taxes upon rentals or otherwise pertaining to the Property (including without limitation any tax on rentals or income or any value added tax, so called) shall be substituted, in whole or in part, for the present ad valorem real estate taxes, or shall be assessed in addition thereto, then the term &#x201c;Taxes&#x201d; shall include such substituted taxes, to the extent to which the same shall be a substitute for present ad valorem real estate taxes, together with any such additional taxes. The term &#x201c;Taxes&#x201d; shall not include any inheritance, estate taxes, income, capital levy, transfer, capital stock, gift, estate, excess profits or franchise tax, any taxes on income to the extent applicable to Landlord&#x2019;s net income, or any fine, penalty, cost or interest for any tax or assessment, or part thereof, which Landlord or its lender failed to timely pay, unless such late payment was attributable to late payment by Tenant of Tenant&#x2019;s share of Taxes.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that the Taxes imposed with respect to the Property shall be greater during any Tax Year (and in the event the Town shall first send estimated tax bills, until a final bill is sent at which time Tenant&#x2019;s share of real estate taxes shall be recomputed, real estate taxes shall be such taxes as shown on the estimated tax bill) than the Tax Base (as defined in Section 1.2), Tenant shall pay to Landlord, as additional rent, the amount obtained by multiplying the amount by which the Taxes exceed the Tax Base by a fraction, the numerator of which is the Rentable Floor Area of the Premises and the denominator of which is the Rentable Floor Area of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall submit to Tenant a statement setting forth the amount of such additional rent, and within thirty (30) days after the delivery of such statement (whether or not such statement shall be timely), Tenant shall pay to Landlord the payment under subparagraph 8.1.2 above. So long as the Taxes, or any portion thereof, shall be payable in installments, Landlord may submit such statements to Tenant in similar installments. The failure by Landlord to send any statement required by this subparagraph shall not be deemed to be a waiver of Landlord&#x2019;s right to receive such additional rent.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the first day of the Tax Year in such Town of Burlington should be changed after the Commencement Date so as to change the twelve-month period comprising the Tax Year, or if the Tax Year shall be a period of time other than twelve months, in determining the additional rent to be paid by Tenant under this Section with respect to the Taxes payable by Tenant for any such Tax Year, including a partial Tax Year, the Tax Amount shall be pro-rated on a per day basis.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any betterment assessment, so-called &#x201c;rent tax&#x201d; or any other tax levied or imposed by any governmental authority in addition to, in lieu of or as a substitute for real estate taxes, shall nevertheless be deemed to be real estate taxes for the purpose of this Section.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s obligations to pay additional rent under this Section on account of Taxes shall commence on the Commencement Date.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant is obligated to pay any additional rent as aforesaid with respect to any Tax Year or fraction thereof during the Term, then Tenant shall pay, as additional rent, on the first day of each month of the next ensuing Tax Year, estimated monthly tax escalation payments equal to 1/12 of the annualized amount of additional rent payable hereunder for said previous Tax Year (or as otherwise reasonably estimated by Landlord). Estimated monthly tax escalation payments for each ensuing Tax Year shall be made retroactively to the first day of the Tax Year in question.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that Landlord obtains an abatement, reduction or refund of any Taxes for a Tax Year which Tenant was obligated to pay a share of the increase in Taxes, then Tenant shall receive as a credit against its payment obligations under this Section, its proportionate share of the net proceeds of such abatement, reduction or refund (after deduction of all reasonable costs, including legal and appraisal fees, incurred by Landlord in obtaining the same) but only to the extent and not in excess of any payments made by Tenant for such increase as required under this Section. Landlord shall be under no obligation to seek such an abatement, reduction or refund. To the extent same are not credited as aforesaid, any of Landlord&#x2019;s reasonable costs (including legal and appraisal fees) incurred in attempting to obtain an abatement, reduction or refund shall be deemed Operating Expenses hereunder. Tenant shall not contest by any proceedings the assessed valuation of Landlord&#x2019;s Property or any part thereof for purposes of obtaining a reduction of its assessment or of any taxes.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.1.9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall pay prior to delinquency all taxes assessed against and levied upon trade fixtures, furnishings, equipment and all other personal property of Tenant contained in the Premises or related to Tenant&#x2019;s use of the Premises. If any of Tenant&#x2019;s personal property shall be assessed with Landlord&#x2019;s real or personal property, Tenant shall pay to Landlord the taxes attributable to Tenant within thirty (30) days after receipt of a written statement from Landlord setting forth the taxes applicable to Tenant&#x2019;s property.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S PAYMENT OF ITS SHARE OF OPERATING EXPENSES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purposes of this Section, the following terms shall have the following meanings: &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating Year</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the calendar year, or such other twelve-month period</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as Landlord may designate from time to time.</font></p>
  <p style="margin-left:0.92%;text-indent:20.907%;font-size:10pt;margin-top:12.55pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean all expenses incurred by or attributable to Landlord in operating and maintaining the Building and Lot and their appurtenances, including but without limitation: premiums for fire, casualty, liability, rental interruption and such other insurance as Landlord may from time to time maintain with respect to the Lot and Building; security expenses; compensation and all fringe benefits, worker&#x2019;s compensation insurance premiums and payroll taxes paid by Landlord to, for or with respect to all persons engaged in operating, maintaining, or cleaning of the Building, the common areas of the Lot on which the Building is located and the other common areas of the Office Park; steam, water, sewer, electric, gas, telephone and other utility charges not billed directly to tenants by Landlord or the utility; costs of building and cleaning supplies and equipment (including rental); cost of maintenance, cleaning and repairs; cost of snow plowing or removal, or both and care of landscaping and irrigation systems; the cost of operating, replacing, modifying and/or adding improvements or equipment mandated by any law, statute, regulation or directive of any governmental agency and any repairs or removals necessitated thereby but only to the extent that the Building or the Lot was not in material violation of the foregoing as of the Commencement Date; the cost of installing intrabuilding network cabling (&#x201c;INC&#x201d;) and maintaining, repairing, securing and replacing existing INC; payments to independent contractors under service contracts for cleaning, operating, managing, maintaining and repairing the Building and said common areas (which payments may be to affiliates of Landlord); all other expenses paid in connection with the operation, cleaning, maintenance and repair of the Building and said common areas; either reasonable reserves for the replacement of equipment contained in and/or used in connection with the operation of the Building and the Office Park or the amortized portion, properly attributable to the Operating Year in question, of the cost, with interest thereon at a rate reasonably determined by Landlord, of any capital repairs, improvements or replacements made to the Building or the Property, by Landlord; and a management fee based on a percentage of the gross rentals of the Building. Landlord may equitably adjust Tenant&#x2019;s share of Operating Expenses for all or part of any item of expense or cost reimbursable by Tenant that relates to a repair, replacement, or service that benefits only the Premises or only a portion of the Building or that varies with the</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.55pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">occupancy of the Building. Landlord shall have the right but not the obligation, from time to time, to equitably allocate some or all of the Operating Expenses among different tenants of the Building or Office Park ( &#x201c;Cost Pools&#x201d;). The Operating Expenses shall also include the Building&#x2019;s share (as reasonably determined and allocated by Landlord) of: (a) the costs incurred by Landlord in operating, maintaining, repairing, insuring and paying real estate and other taxes upon any common facilities of the Office Park (including, without limitation, the common facilities from time to time serving the Lot or Building in common with other buildings or parcels of land), such as any so-called &#x201c;loop&#x201d; access roads, retention ponds, sewer and other utility lines, amenities and the like; (b) shuttle bus service (if and so long as Landlord shall provide the same); (c) the actual or imputed cost of the space occupied by on-the-grounds building attendant(s) and related personnel and the cost of administrative and or service personnel whose duties are not limited solely to the Building and/or the Lot, as allocated to the Building and/or Property by Landlord; and (d) payments made by Landlord under any easement, license, operating agreement, declaration, restrictive covenant, or instrument pertaining to the payment or sharing of costs among Office Park property owners.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;text-indent:7.076%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.056%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided for in the Lease, the following costs and expenses shall be excluded from Operating Expenses:</font></p>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of capital improvements to the Building or the Office Park which do not service or benefit Tenant;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of repairing structural or latent defects to the Building;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest and principal payments on mortgages and deeds of trust and any other costs incurred in connection with financing and ground lease rental payments and related costs;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Real estate brokers&#x2019; leasing commissions or other leasing costs (including, without limitation, costs for tenant improvements) incurred with leasing activities at the Office Park;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any cost or expenditure for which Landlord is entitled to reimbursement by insurance proceeds or by any third party;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs resulting from Landlord&#x2019;s negligence or willful misconduct;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant improvement costs contemplated in Exhibit A-1;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazardous Substances remediation or removal costs, except if due to the act or omission of Tenant;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(x)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts paid to affiliates of Landlord in excess of fair market rates;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts expended by Landlord in connection with its organizational matters, corporate overhead, executive salaries or other compensation or any other costs related to the operation of the business of the entity which constitutes Landlord or Landlord&#x2019;s affiliated organizations or Landlord&#x2019;s managing agent and not directly in connection with the operation of the Building;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts paid to employees or for equipment or tools to the extent the same are not directly in connection with the operation of the Building;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xiii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts paid to employees or for equipment or tools to the extent the same are not employed or used at the Building but are employed or used at another property;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xiv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADA compliance expenses unless as result of change in applicable law or regulation after Commencement Date and impacts entire Office Park;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest or penalties resulting from Landlord&#x2019;s late payment;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.861%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.267068343026968%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xvi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expenses in connection with services or other benefits which are provided to another tenant or occupant of the Building and which do not benefit Tenant;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xvii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reserves of any kind;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xviii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The cost of any insurance coverage, whether or not required by the holder of any deed of trust on the Building or the Office Park which is related, in whole or in part, to (a) property or casualty insurance coverage in amounts </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">greater than the replacement cost of the property, or (b) lease enhancement insurance or other credit enhancement-related insurance;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and asset management fees in excess of the customary rates charged by comparable properties in the geographical Boston metropolitan area of the Building;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(xx)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Donations to charitable organizations.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If, during any Operating Year (including the Operating Year used for determining the Base Operating Expenses), less than 95% of the rentable area of the Building is occupied, the Operating Expenses that vary with the occupancy of the Building shall be equitably adjusted by Landlord, on an item by item basis, as appropriate, to reflect Operating Expenses based on 95% occupancy.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the Base Operating Expenses, there shall be excluded from the Operating Expenses for said Operating Year any non-recurring costs and expenses and/or capital expenditures.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After the expiration of each Operating Year, Landlord shall furnish Tenant with a statement setting forth the Operating Expenses for such Operating Year. Such statement shall be accompanied by a computation of the amount, if any, of the additional rent payable to Landlord pursuant to this subsection. The failure by Landlord to send any statement required by this subparagraph shall not be deemed to be a waiver of Landlord&#x2019;s right to receive such additional rent.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event the Operating Expenses during any Operating Year shall be greater than the Base Operating Expenses (as defined in Section 1.2), Tenant shall pay to Landlord, as additional rent, the amount obtained by multiplying the amount by which the Operating Expenses exceed the Base Operating Expenses by a fraction, the numerator of which is the Rentable Floor Area of the Premises and the denominator of which is the Rentable Floor Area of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Said additional rent shall, with respect to the Operating Years in which the Commencement Date and end of the Term of this Lease fall, be pro-rated on a per day basis. If Landlord shall change its Operating Year, appropriate adjustment shall be made for any Operating Year less than or greater than twelve-months which may result.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any additional rent payable by Tenant under this Section shall be paid within 7 days after Landlord has furnished Tenant with the statement described above.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s obligations to pay additional rent under this Section on account of Operating Expenses shall commence on the Commencement Date.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If with respect to any Operating Year or fraction thereof during the Term, Tenant is obligated to pay any additional rent as aforesaid, then Tenant shall pay, as additional rent, on the first day of each month of the next ensuing Operating Year, estimated monthly operating escalation payments equal to 1/12th of the amount of additional rent payable hereunder for said previous Operating Year (or as otherwise reasonably estimated by Landlord). Estimated monthly operating escalation payments for each ensuing Operating Year shall be made retroactively to the first day of the Operating Year in question.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.2.10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall permit Tenant, at Tenant&#x2019;s expense and during normal business hours, but only one time with respect to any Operating Year, to review Landlord&#x2019;s invoices and statements relating to the Operating Expenses for the applicable Operating Year for the purpose of verifying the Operating Expenses and Tenant&#x2019;s share thereof; provided that notice of Tenant&#x2019;s desire to so review is given to Landlord not later than sixty (60) days after Tenant receives an annual statement from Landlord, and provided that such review is thereafter commenced and prosecuted by Tenant with due diligence. Any Operating Expenses statement or accounting by Landlord shall be binding and conclusive upon Tenant unless (a) Tenant duly requests such review within such 60-day period, and (b) within 3 months after such review request, Tenant shall notify Landlord in writing that Tenant disputes the correctness of such statement, specifying the particular respects in which the statement is claimed to be incorrect. Tenant shall have no right to conduct a review or to give Landlord notice that it desires to conduct a review at any time Tenant is in default under the Lease. The accountant conducting the review shall be compensated on an hourly basis and shall not be compensated based upon a percentage </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of overcharges it discovers. No subtenant shall have any right to conduct a review, and no assignee shall conduct a review for any period during which such assignee was not in possession of the Premises. Tenant agrees that the results of any Operating Expense review shall be kept strictly confidential by Tenant and shall not be disclosed to any other person or entity. Tenant agrees to pay for the cost for any such review of Landlord&#x2019;s records, unless it is determined that Landlord&#x2019;s statement overstated the Operating Expenses for the applicable Operating Year by more than five percent (5%), then Landlord shall be required to reimburse Tenant for the actual and reasonable expenses incurred by Tenant in reviewing Landlord&#x2019;s records, provided, however, that such expenses shall in no event exceed $1,500.00.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEMNITY AND INSURANCE</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEMNITY.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the maximum extent this agreement may be made effective according to law, Tenant shall indemnify and save harmless Landlord (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents, contractors, attorneys, and mortgagees) from and against all claims of whatever nature arising from: (a) any negligent or willful act, omission of Tenant, or Tenant&#x2019;s contractors, licensees, invitees, agents, servants or employees (&#x201c;Tenant&#x2019;s Agents&#x201d;), or any default or failure to perform an obligation by Tenant hereunder; or (b) any accident, injury, damage or loss whatsoever caused to any person or property during the Term, and thereafter, arising out of the use and occupancy of the Premises by Tenant and Tenant&#x2019;s Agents; or (c) any accident, injury, damage or loss occurring outside of the Premises, where such accident, injury, damage or loss results or is claimed to have resulted from the negligence or willful misconduct of Tenant or Tenant&#x2019;s Agents. Tenant&#x2019;s obligations hereunder shall include any other matters for which Tenant has agreed to indemnify Landlord pursuant to any other provision of this Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the maximum extent this agreement may be made effective according to law, Landlord shall indemnify and save harmless Tenant (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents, contractors and attorneys) from and against all claims of whatever nature arising from any negligent or willful act or omission of Landlord, or Landlord&#x2019;s contractors, licensees, agents, servants or employees (&#x201c;Landlord&#x2019;s Agents&#x201d;) or any default or failure to perform an obligation by Landlord hereunder subject to prior written notice and Landlord&#x2019;s opportunity to cure.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This indemnity and hold harmless agreement shall include indemnity against all costs, expenses and liabilities incurred in or in connection with any such claim or proceeding brought thereon and providing a defense, with counsel reasonably satisfactory to Landlord or Tenant, as the case may be, at the other party&#x2019;s sole expense, within ten (10) days after written demand from Landlord or Tenant, as the case may be, of any claims, action or proceeding arising out of or relating hereto whether or not litigated or reduced to judgment and whether or not well founded.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INSURANCE.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall obtain and keep in force and effect during the Term, at its own cost and expense, commercial general liability, on an occurrence basis, in an amount of not less than One Million Dollars ($1,000,000), and a general aggregate limit of not less than Two Million Dollars ($2,000,000), for injury, death, property damage or other loss arising out of any one occurrence or in the aggregate, protecting Tenant as insured, and naming Landlord, Landlord&#x2019;s Affiliates, Landlord&#x2019;s mortgagees, property managers and managing agents as additional insureds (&#x201c;Additional Insureds&#x201d;), on a primary and non-contributory basis, against any and all claims for bodily injury, personal injury, death, property damage or other loss occurring in, upon, adjacent to or connected with the Premises or any part thereof. The policy shall not contain any intra- insured exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#x201c;insured contract&#x201d; for the performance of Tenant&#x2019;s indemnity obligations under this Lease. The policy shall cover host liquor liability exposure, and should contemplate coverage for pollution liability claims arising out Bodily Injury or Property Damage arising out of heat, smoke or fumes caused by </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a hostile fire. A Waiver of Subrogation shall be provided in favor of Landlord, Landlord&#x2019;s Affiliates and each Additional Insured. Landlord may increase the coverages required of Tenant hereunder to that customarily carried in the area in which the Premises is located on property similar to the Premises at the time of any extension or renewal by Tenant of the Lease term.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant further agrees to maintain: (a) workers&#x2019; compensation insurance with a limit of liability as required by law to be maintained, including a Waiver of Subrogation in favor of Landlord, Landlord&#x2019;s Affiliates and each Additional Insured; (b) employer's liability insurance with a minimum limit of coverage of Two Million Dollars ($2,000,000), including a Waiver of Subrogation in favor of Landlord, Landlord&#x2019;s Affiliates and each Additional Insured; (c) so called &#x201c;Special Form&#x201d; insurance coverage for all of its contents, furniture, furnishings, equipment, improvements, fixtures and personal property located at the Premises providing protection in an amount equal to one hundred percent (100%) of the replacement cost basis of said items (subject to reasonable deductible amounts) without deduction for depreciation of the covered items and in amounts that meet any co-insurance clauses of the policies of insurance; (d) business interruption and extra expense insurance coverage(s) satisfactory to Landlord; (e) automobile liability insurance covering all owned, hired, and non-owned vehicles with a combined single limit of not less than One Million Dollars ($1,000,000); and (f) a minimum umbrella liability limit of Three Million Dollars ($3,000,000) covering any general commercial liability, employer&#x2019;s liability, and auto liability policies, with the Additional Insureds and Waiver of Subrogation provisions mirroring the underlying policies. With respect to automobile liability insurance, Landlord, Landlord&#x2019;s mortgagees, property managers and managing agents shall be afforded additional insured status on a primary and non-contributory basis, and Waiver of Subrogation shall be provided in favor of Landlord and Landlord&#x2019;s Affiliates. If this Lease is terminated as the result of a casualty in accordance with Section 11, the proceeds of said insurance attributable to the replacement of all tenant improvements installed at the Premises by Landlord or at Landlord&#x2019;s cost shall be paid to Landlord.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The insurance required hereunder shall be written in form and substance satisfactory to Landlord by a good and solvent insurance company of recognized standing, admitted to do business in Massachusetts, with a general policyholder&#x2019;s rating of not less than A- and financial rating of not less than Class VIII (as rated in the most current Best&#x2019;s Insurance Reports). Tenant shall procure, maintain and place such insurance and pay all premiums and charges therefor, and upon failure to pay all premiums and charges (and without limiting any other remedies on account thereof), Landlord may, but shall not be obligated to, procure, maintain and place such insurance or make such payments, and in such event, Tenant agrees to pay the amount thereof to Landlord on demand, as additional rent hereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall cause to be included in all such insurance policies a provision to the effect that the same will be non-cancelable except upon thirty (30) days written notice to Landlord, except that only ten (10) days written notice shall be required in connection with a cancellation resulting from a failure to pay insurance premiums. Prior to the Commencement Date, the original insurance policies, or appropriate certificates of same (at Landlord&#x2019;s reasonable election) shall be deposited with the Landlord. Certificates of any renewals, replacements and endorsements shall also be deposited with Landlord, in the case of renewals; same shall be so deposited prior to the expiration of the prior policy.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.2.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall maintain and keep in effect throughout the Term of this Lease (a) insurance against loss or damage to the Building by fire or other casualty as may be included within either fire and extended coverage insurance or &#34;special form&#34; insurance in commercially </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reasonable amounts, or such other coverages, amounts and/or endorsements as Landlord determines in its sole but good faith judgment, (b) commercial general liability insurance in amounts determined by Landlord in its sole but good faith judgment, and (c) such other insurance coverages and policies as Landlord determines in its sole but good faith judgment. Any such coverages may be effected directly and/or through the use of blanket insurance coverage covering more than one location and may contain such commercially reasonable deductibles as Landlord may elect in its reasonable discretion. The costs and expense of obtaining and maintaining all such insurance shall be included as part of Operating Expenses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S RISK.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the maximum extent this Agreement may be made effective according to law but subject to the negligence or willful misconduct of Landlord or Landlord&#x2019;s Agents, Tenant agrees its use and occupancy of the Premises shall be at Tenant&#x2019;s sole risk; and Landlord shall have no responsibility or liability for any loss of or damage to furniture, fixtures, equipment or other personal property of Tenant for any reason whatsoever, excluding the negligence or willful misconduct of Landlord or Landlord&#x2019;s Agents; and, except for the negligence or willful misconduct of Landlord or Landlord&#x2019;s Agents, Landlord shall not be responsible or liable for any loss or damage resulting to Tenant or those claiming by, through or under Tenant, or its or their property, from the breaking, bursting, stopping or leaking of electric cables and wires, water, gas, sewer or steam pipes, sprinklers, and from roof leaks and the like. The provisions of this Section shall be applicable from and after the execution of this Lease, and until the end of the Lease Term, and during such further period as Tenant may use or be in occupancy of any part of the Premises or of the Building.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INJURY CAUSED BY THIRD PARTIES.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the maximum extent this agreement may be made effective according to law but subject to the negligence or willful misconduct of Landlord or Landlord&#x2019;s Agents, Tenant agrees that Landlord shall not be responsible or liable to Tenant, or to those claiming by, through or under Tenant, for any loss or damage that may be occasioned by or through the acts or omissions of any third parties, including without limitation persons occupying adjoining premises or any part of the premises adjacent to or connecting with the Premises or any part of the Building, or otherwise.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S ACCESS TO PREMISES</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S RIGHT OF ACCESS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall have the right to enter the Premises at all reasonable business hours and after normal business hours upon at least twenty four (24) hours advance notice, except in the case of emergencies to persons or property in which case no notice is required, for the purpose of inspecting or making repairs to the same (or to the Building), and Landlord shall also have the right to make access available at all reasonable hours upon advance notice to prospective or existing mortgagees or purchasers of any part of the Building.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBITION OF SPACE TO PROSPECTIVE TENANTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a period of nine (9) months prior to the expiration of the Lease Term, and during any period in which Landlord is considering exercising its recapture rights (as provided in Section 5.2), or after Landlord has exercised same, Landlord may have reasonable access to the Premises at all reasonable hours upon at least twenty four (24) hours advance notice for the purpose of exhibiting the same to prospective tenants, and may post suitable notice on the Premises advertising the same for rent.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KEYS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.528%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall have the right to retain keys and electric codes or card keys to the locks and card key access systems and other security systems on the entry doors to the Premises and all interior doors at the Premises.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRE, EMINENT DOMAIN, ETC.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FIRE OR OTHER CASUALTY.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Premises or the Building are damaged in whole or in part by any fire or other casualty (a &#x201c;casualty&#x201d;), the Tenant shall immediately give notice thereof to the Landlord. Unless this Lease is terminated as provided herein, the Landlord, at its own expense (except for any insurance deductibles, </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">which shall be deemed Operating Expenses), and proceeding with due diligence and all reasonable dispatch, but subject to delays beyond the reasonable control of Landlord, shall repair and reconstruct the same so as to restore the Premises (but not any alterations or additions made by or for Tenant or any trade fixtures, equipment or personal property of Tenant) to substantially the same condition they were in prior to the casualty, subject to zoning and building laws then in effect. Notwithstanding the foregoing, in no event shall Landlord be obligated either to repair or rebuild if the damage or destruction results from an uninsured casualty or if the costs of such repairing or rebuilding exceeds the amount of the insurance proceeds (net of all costs and expenses incurred in obtaining same) received by Landlord on account thereof. Landlord shall not be liable for any inconvenience or annoyance to Tenant or injury to the business of Tenant resulting from delays in repairing such damage. If such damage or destruction occurs as a result of the negligence or the intentional acts of Tenant or Tenant&#x2019;s employees, agents, contractors or invitees, and the proceeds of insurance which are actually received by Landlord are not sufficient to pay for the repair of all of the damage, Tenant shall pay, at Tenant&#x2019;s sole cost and expense, to Landlord upon demand, the difference between the cost of repairing the damage and the insurance proceeds received by Landlord.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Landlord shall, within 45 days after the occurrence of a casualty, provide Tenant with a good faith estimate of the time required to repair the damage to the Premises or the Building, as provided herein; if such estimate is for a period of more than two hundred seventy (270) days from the occurrence of the casualty (or during the last 18 months of the Term, for a period of more than ninety (90) days), the Premises shall be deemed &#x201c;substantially damaged&#x201d;. If the Premises or the Building are substantially damaged, Landlord may elect to terminate this Lease by giving Tenant written notice of such termination within sixty (60) days of the date of such casualty; and if the Premises or the Building are substantially damaged, and if as a result the Premises are rendered untenantable for the Permitted Use, then Tenant may terminate this Lease by giving Landlord written notice of such termination within sixty (60) days of the date of such casualty.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For so long as such damage results in material interference with the operation of Tenant&#x2019;s use of the Premises which material interference causes Tenant to be unable to use the Premises, the Fixed Rent and additional rent payable by Tenant shall abate or be reduced proportionately for the period, commencing on the day following such material interference and continuing until the Premises has been substantially restored. Notwithstanding the foregoing, if such casualty was due to the negligence or willful misconduct of Tenant or Tenant&#x2019;s employees, contractors or agents, such abatement or reduction shall be made only if and to the extent of any proceeds of rental interruption insurance actually received by Landlord and allocated to the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.1.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Premises are damaged by a casualty, and the Lease is not terminated as provided herein, the Tenant, at its own expense, and proceeding with all reasonable dispatch, shall repair and reconstruct all of the improvements, alterations and additions made to the Premises by or for Tenant, including the Tenant&#x2019;s Improvements, and any trade fixtures, equipment or personal property of Tenant which shall have been damaged or destroyed.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EMINENT DOMAIN.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of any condemnation or taking in any manner for public or quasi-public use, which shall be deemed to include a voluntary conveyance in lieu of a taking (a &#x201c;taking&#x201d;) of the whole of the Property, this Lease shall forthwith terminate as of the date when Tenant is required to vacate the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless this Lease is terminated as provided herein, the Landlord, at its own expense, and proceeding with due diligence and all reasonable dispatch, but subject to delays beyond the reasonable control of Landlord, shall restore the remaining portion of the Premises (but not any alterations or improvements made by or for Tenant, including the Tenant&#x2019;s Improvements, or any trade fixtures, equipment or personal property of Tenant) and the necessary portions of the Property as nearly as practicable to the same condition as it was prior to such taking, subject to zoning and building laws then in effect. Notwithstanding the foregoing, Landlord&#x2019;s obligation to restore the remaining portion of the Premises shall be limited to the extent of the condemnation proceeds (net of all costs and expenses incurred in connection with same) received by Landlord on account thereof. Landlord shall not be liable for any </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inconvenience or annoyance to Tenant or injury to the business of Tenant resulting from delays in restoring the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that only a part of the Premises or the Property shall be taken, then, if such taking is a substantial taking (as hereinafter defined), either Landlord or Tenant may by delivery of notice in writing to the other within sixty (60) days following the date on which Landlord&#x2019;s title has been divested by such authority, terminate this Lease, effective as of the date when Tenant is required to vacate any portion of the Premises or appurtenant rights. A &#x201c;substantial taking&#x201d; shall mean a taking which: requires restoration and repair of the remaining portion of the Property that cannot in the ordinary course be reasonably expected to be repaired within 180 days; results in the loss of reasonable access to the Premises; results in the loss of more than 25% of the rentable floor area of the Premises; or results in loss of parking or of facilities in the Building and Landlord reasonably determines it is not practical to relocate such parking or relocate and reconnect such facilities within the remaining Building or Property.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this Lease is not terminated as aforesaid, then this Lease shall continue in full force and effect, provided if as a result of which there is material interference with the operation of Tenant&#x2019;s use of the Premises, then the Fixed Rent and additional rent payable by Tenant shall be justly and equitably abated and reduced according to the nature and extent of the loss of use thereof suffered by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.2.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall have and hereby reserves and excepts, and Tenant hereby grants and assigns to Landlord, all rights to recover for damages to the Building, the Lot, and the leasehold interest hereby created (including any award made for the value of the estate vested by this Lease in Tenant), and to compensation accrued or hereafter to accrue by reason of such taking, and by way of confirming the foregoing, Tenant hereby grants and assigns, and covenants with Landlord to grant and assign, to Landlord all rights to such damages of compensation. Nothing contained herein shall be construed to prevent Tenant from prosecuting in any condemnation proceedings a separate claim for the value of any of Tenant&#x2019;s personal property and for relocation expenses and business losses, provided that such action shall not affect the amount of compensation otherwise recoverable by Landlord from the taking authority.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DEFAULT</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S DEFAULT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following shall be deemed to be defaults hereunder:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s failure to pay Fixed Rent or monthly installments of additional rent on or before the first (1st) day of each month, which failure is not cured within five (5) days thereof; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s failure to pay additional rent (except monthly installments thereof) or any other charges for which provision is made herein on or before the date on which the same become due and payable; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant&#x2019;s failure to perform or observe any other covenants, terms or conditions contained in this Lease, which failure is not cured within thirty (30) days after notice from Landlord thereof or such longer period of time as may be reasonably necessary provided Tenant materially commences to cure such default during such thirty (30) day period and diligently proceeds to cure the same unless such failure creates i) an emergency to persons or property or ii) nuisance to another tenant, and in either case then Landlord shall attempt to cure Tenant&#x2019;s failure and invoice Tenant for any costs and expenses associated therewith; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the estate hereby created shall be taken on execution or by other process of law, or if Tenant shall be judicially declared bankrupt or insolvent according to law, or if any assignment shall be made of the property of Tenant for the benefit of creditors, or if a receiver, guardian, conservator, trustee in involuntary bankruptcy or other-similar officer shall be appointed to take charge of all or any substantial part of Tenant&#x2019;s property by a court of competent jurisdiction, or if a petition shall be filed for the reorganization of Tenant under any provisions of the Bankruptcy Code now or hereafter enacted or if Tenant shall file a petition for such reorganization or for arrangements under any provision of the Bankruptcy Code now or hereafter enacted and providing a plan for a debtor to settle, satisfy or extend the time for payment of debts (references herein to Tenant shall include any guarantor of Tenant&#x2019;s obligations hereunder)(and as to such matters involuntarily taken against Tenant, Tenant </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shall be in the default if Tenant has not within forty five (45) days thereof obtained a release or discharge therefrom); or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The discovery by Landlord that any financial statement, representation or warranty given to Landlord by Tenant, or by any guarantor of Tenant&#x2019;s obligations hereunder, was materially false at the time given. Tenant acknowledges that Landlord has entered into this Lease in material reliance on such information; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant is a corporation or a partnership, the dissolution or liquidation of Tenant; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant&#x2019;s obligations under this Lease are guaranteed: (i) the death of a guarantor, (ii) the termination of a guarantor&#x2019;s liability with respect to this Lease other than in accordance with the terms of such guaranty, (iii) a guarantor&#x2019;s becoming insolvent or the subject of a bankruptcy filing, (iv) a guarantor&#x2019;s refusal to honor the guaranty, or (v) a guarantor&#x2019;s breach of its guaranty obligation on an anticipatory breach basis.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REMEDIES.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event any default shall occur (notwithstanding any license of a former breach of covenant or waiver of the benefit hereof or consent in a former instance), Landlord lawfully may, immediately or at any time thereafter, and without demand or notice: enter into and upon the Premises or any part thereof in the name of the whole and repossess the same as of Landlord&#x2019;s former estate, and expel Tenant and those claiming through or under Tenant and remove its or their effects (forcibly, if necessary) without being guilty of any manner of trespass, and without prejudice to any remedies which might otherwise be used for arrears of rent or preceding breach of covenant; and, with or without making such entry as aforesaid, Landlord shall have the right, by suitable notice to Tenant, forthwith to terminate this Lease.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant covenants and agrees, notwithstanding any entry or re-entry by Landlord, whether by summary proceedings or otherwise, and notwithstanding any such termination, to pay and be liable for, on the days originally fixed herein for the payment thereof, amounts equal to the several installments of rent and other charges reserved as they would, under the terms of this Lease, become due if this Lease had not been terminated or if Landlord had not entered or re-entered, as aforesaid, and whether the Premises be relet or remain vacant, in whole or in part, or for a period less than the remainder of the term, and for the whole thereof. Tenant shall also be liable for the cost of any other amounts due to Landlord as a result of any Tenant&#x2019;s Improvements including the unamortized costs of same and any construction management fees or costs relating thereto and brokerage commissions. In the event the Premises be relet by Landlord, Tenant shall be entitled to a credit in the net amount of rent and other charges received by Landlord in reletting, after deduction of all expenses incurred in reletting the premises (including, without limitation, remodeling and repair costs, brokerage fees, advertising costs, inspection fees, free rent and rental concessions, tenant allowances, and attorneys&#x2019; fees and costs, and the like), and in collecting the rent in connection therewith, in the following manner:</font></div></div>
  <p style="margin-left:7.587%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts received by Landlord after reletting shall first be applied against such Landlord&#x2019;s expenses, until the same are recovered, and until such recovery, Tenant shall pay, as of each day when a payment would fall due under this Lease, the amount which Tenant is obligated to pay under the terms of this Lease (Tenant&#x2019;s liability prior to any such reletting and such recovery not in any way to be diminished as a result of the fact that such reletting might be for a rent higher than the rent provided for in this Lease); when and if such expenses have been completely recovered, the amounts received from reletting by Landlord as have not previously been applied shall be credited against Tenant&#x2019;s obligations as of each day when a payment would fall due under this Lease, and only the net amount thereof shall be payable by Tenant. Further, amounts received by Landlord from such reletting for any period shall be credited only against obligations of Tenant allocable to such period, and shall not be credited against obligations of Tenant hereunder accruing subsequent or prior to such period, nor shall any credit of any kind be due for any period after the date when the term of this Lease is scheduled to expire according to its terms.</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an alternative, at the election of Landlord, Tenant will upon such termination, pay to Landlord, as damages, such a sum as at the time of such termination represents the amount of the excess, if any, of the then value of the total rent and other benefits which would have accrued to Landlord under this Lease for the remainder of the Lease Term if the Lease terms had been fully complied with by Tenant over and above the then cash rental value (in advance) of the</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Premises for the balance of the term. For the purposes of this Section, if Landlord elects to require Tenant to pay damages in accordance with this subsection, the total rent shall be computed by assuming that Tenant&#x2019;s share of additional rent would be, for the balance of the unexpired term, the amount thereof (if any) for the immediately preceding annual period payable by Tenant to Landlord.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to any other damages or indemnity and in lieu of full recovery by Landlord of all sums payable under all the foregoing provisions of this Section, Landlord may, by written notice to Tenant, at any time after termination of this Lease or repossession of the Premises, elect to recover, and Tenant shall thereupon pay, Liquidated Damages. &#x201c;Liquidated Damages&#x201d; shall be equal to (a) the aggregate of the Fixed Rent and additional rent (for the purposes of this Section, if Landlord elects to require Tenant to pay damages in accordance with this subsection, the total rent shall be computed by assuming that Tenant&#x2019;s share of additional rent would be, for the 18 month period after termination or repossession, equal to the amount of additional rent which accrued during the full monthly rental period immediately prior to the termination or repossession and multiplied by 18) in the eighteen (18) months after such termination or repossession (but not more than the Fixed Rent and additional rent due for the then remainder of the Term); plus (b) the amount of rent of any kind and the remaining unamortized cost of any Tenant&#x2019;s Improvements and brokerage commissions accrued and unpaid at the time of termination or repossession. Nothing contained in this Lease shall, however, limit or prejudice the right of Landlord to prove for and obtain in proceedings for bankruptcy or insolvency by reason of the termination of this Lease, an amount equal to the maximum allowed by any statute or rule of law in effect at the time when, and governing the proceedings in which, the damages are to be proved, whether or not the amount be greater, equal to, or less than the amount of the loss or damages referred to above.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.2.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Without limiting any of Landlord&#x2019;s rights and remedies hereunder, and in addition to all other amounts Tenant is otherwise obligated to pay, it is expressly agreed that Landlord shall be entitled to recover from Tenant all costs and expenses, including reasonable attorney&#x2019;s fees incurred by Landlord in enforcing this Lease from and after Tenant&#x2019;s default.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTEREST ON LATE PAYMENTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any payment of Fixed Rent, additional rent or any other payment payable hereunder by Tenant to Landlord shall not be paid when due, the same shall bear interest from the date when the same was payable until the date paid at the lesser of (a) 15% per annum, compounded monthly, or (b) the highest lawful rate of interest which Landlord may charge to Tenant without violating any applicable law. Such interest shall constitute additional rent payable hereunder and be payable upon demand therefor by Landlord.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S DEFAULT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall in no event be in default in the performance of any of Landlord&#x2019;s obligations hereunder unless and until Landlord shall have failed to perform such obligations within thirty (30) days, or such additional time as is reasonably required to correct any such default, after written notice by Tenant to Landlord properly specifying wherein Landlord has failed to perform any such obligation. It is the express understanding and agreement of the parties and a condition of Landlord&#x2019;s agreement to execute this Lease that in no event shall Tenant have the right to terminate this Lease or seek an abatement to or offset from Fixed Rent or Additional Rent as a result of Landlord's default, but Tenant shall be entitled to seek all other remedies, at law or equity, as a result of such default. Unless otherwise provided in this Lease, Tenant and Landlord each hereby waives its right to recover punitive, special or consequential damages arising out any act, omission or default by the other party (or any party for whom such party is responsible). This Lease and the obligations of Tenant and Landlord hereunder shall not be affected or impaired because Landlord or Tenant is unable to fulfill any of its obligations hereunder or is delayed in doing so, if such inability or delay is caused by reason of a Force Majeure Event (as defined below), and the time for Landlord's or Tenant&#x2019;s performance shall be extended for the period of any such delay. Any claim, demand, right or defense by Tenant that arises out of this Lease or the negotiations which preceded this Lease shall be barred unless Tenant commences an action thereon, or interposes a defense by reason thereof, within nine (9) months after the date of the inaction, omission, event or action that gave rise to such claim, demand, right or defense. Tenant shall look solely to the equity of Landlord in the Building for the satisfaction of Tenant&#x2019;s remedies. As used herein, a &#x201c;Force Majeure Event&#x201d; shall be any delay caused by or resulting from acts of God, war, civil commotion, fire, flood or other casualty, labor difficulties, shortages of or inability to obtain labor, materials or equipment, government regulations, unusually severe weather, or other causes beyond such</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">party&#x2019;s reasonable control.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COSTS OF ENFORCEMENT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.509%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord and Tenant shall each pay all reasonable costs and expenses (including without limitation reasonable attorney&#x2019;s fees) incurred by the other party in enforcing the other party&#x2019;s obligations or its rights under this Lease, provided such other party prevails in enforcing such obligations or rights, such costs not to accrue for the purposes hereof until the expiration of any notice and cure period with respect to such default.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BANKRUPTCY AND INSOLVENCY.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the estate created hereby shall be taken in execution, or by other process of law, or if Tenant shall be declared bankrupt or insolvent, according to law, or if any receiver be appointed for the business and property of Tenant, or if any assignment shall be made of Tenant&#x2019;s property for the benefit of creditors (and as to such matters involuntarily taken against Tenant, Tenant has not within sixty (60) days thereof obtained a release or discharge therefrom), then this Lease may be canceled at the option of Landlord. If, as a matter of law, Landlord has no right upon the bankruptcy of Tenant to terminate this Lease then, the rights of Tenant, as debtor, or its trustee, shall be deemed abandoned or rejected unless Tenant, as debtor, or its trustee, (a) within sixty (60) days after the date of the order for relief under Chapter 7 of the Bankruptcy Code or sixty (60) days after the date the petition is filed under Chapter 11 of the Bankruptcy Code assumes in writing the obligations under this Lease, (b) cures or adequately assures the cure of all defaults existing under this Lease on Tenant&#x2019;s part within such sixty (60) days, and (c) furnishes adequate assurance of future performance of the obligations of Tenant under this Lease. Adequate assurance of curing defaults means the posting with Landlord of a sum in cash sufficient to defray the costs of such cure. Adequate assurance of future performance of the Tenant&#x2019;s obligations under this Lease means increasing the security deposit amount by an amount equal to six (6) Monthly Installments of Fixed Rent.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not be permitted to assume and assign this Lease in connection with any bankruptcy or insolvency proceedings without full and complete compliance with the following provisions: (a) Landlord is provided with the following information regarding the party desiring to assume the Lease (&#x201c;Assumptor&#x201d;) which Landlord in its sole and absolute discretion deems sufficient (1) organizational information regarding the Assumptor (2) audited financial statements for the three (3) most recent fiscal years, and (3) such other information as Landlord deems appropriate, (b) Landlord determines that the use of the Demised Premises by the intended Assignee is compatible with the character of the Building, (c) all existing defaults under this Lease are cured at least ten (10) days prior to any hearings in connection with Tenant&#x2019;s request to assume and assign the Lease, (d) the Assumptor at any such hearing provides adequate assurance of its future performance of the Lease as determined by Landlord in its sole and absolute discretion, which adequately assurance shall include at least the following: (1) posting of security deposit equal to six (6) Monthly Installments of Fixed Rent, if such was not already posted by Tenant, (2) paying in advance to Landlord the next six (6) Monthly Installments of Fixed Rent, or posting an irrevocable letter of credit for such amount, (3) establishing with Landlord an escrow in advance for the full cost of all real estate taxes, and insurance, as required under the Lease for the next twelve (12) months of the Lease and thereafter on an annual basis in advance, (4) providing Landlord with an unconditional continuing guarantee of the Lease executed by the owners or officers of the Assumptor as determined by Landlord in its sole and absolute discretion, and (5) the Assumptor executes a written agreement assuming the Lease and such Lease amendments as are necessary, which agreements and amendments are satisfactory to Landlord in its sole and absolute discretion.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MISCELLANEOUS PROVISIONS</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXTRA HAZARDOUS USE.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant covenants and agrees that Tenant will not do or permit anything to be done in or upon the Premises or the Property, or bring in anything or keep anything therein which shall increase the rate of insurance on the Premises or on the Property above the standard rate applicable to premises being occupied for the use to which Tenant has agreed to devote the Premises; and Tenant further agrees that in the event that Tenant shall do any of the foregoing, Tenant will promptly pay to Landlord, on demand, any such increase resulting therefrom which shall be due and payable as additional rent hereunder.</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONTROLLED SUBSTANCES.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.2.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except for Permitted Activities (Drug-Relatives Activities in accordance with all laws, both terms defined below), Tenant shall not engage in any Drug-Related Activities and shall prohibit any use or occupancy of the Premises for Drug-Related Activities. Without limiting the generality of the foregoing, Tenant shall (i) not enter into an assignment or sublease, consent or permit any assignment or sublease which allows Drug-Related Activities to occur in the Premises, other than the Permitted Activities for the Permitted Uses, and (ii) expressly prohibit in any assignment or sublease any Controlled Substances Uses (defined below) and Drug-Related Activities on any portion of the Premises other than Permitted Activities for the Permitted Uses. Tenant shall not knowingly make any payments to the Landlord derived from Drug-Related Activities, other than Permitted Activities for the Permitted Uses. The provisions of this Section 13.2 are intended and shall apply notwithstanding any state or local law permitting the Controlled Substances Uses or Drug-Related Activities.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.2.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Controlled Substance means any drug or chemical whose manufacture, possession, or use is regulated by any Governmental Authority, such as illicitly used drugs or prescription medications that are designated a controlled substance by the US Drug Enforcement Agency.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Controlled Substances Uses means any cultivation, growth, creation, production, manufacture, sale, distribution, storage, handling, possession or other use of a Controlled Substance.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Controlled Substances Laws means The Federal Controlled Substances Act (21 U.S.C. &#167; 801 et seq.) or any other similar or related federal, state or local law, ordinance, code, rule, regulation or order.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Drug-Related Activities means any Controlled Substances Uses, any violation of any Controlled Substances Law or any business, communications, financial transactions or other activities related to Controlled Substances or Controlled Substances Uses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Permitted Activities means the Tenant or an occupant of the Building shall not be precluded from engaging in the sale, creation, production, manufacture, storage, distribution, possession or handling of any Controlled Substances in accordance with all applicable federal laws and state laws for the Permitted Uses.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.3.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure on the part of Landlord or Tenant to complain of any action or nonaction on the part of the other party, no matter how long the same may continue, shall never be a waiver by such party of any of such party&#x2019;s rights hereunder. Further, no waiver at any time of any of the provisions hereof by Landlord or Tenant shall be construed as a waiver of any of the other provisions hereof, and, a waiver at any time of any of the provisions hereof shall not be construed as a waiver at any subsequent time of the same provisions. The consent or approval of Landlord to or of any action by Tenant requiring such consent or approval shall not be construed to waive or render unnecessary Landlord&#x2019;s consent or approval to or of any subsequent similar act by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.3.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No payment by Tenant or acceptance by Landlord of a lesser amount than shall be due from Tenant to Landlord shall be treated otherwise than as a payment on account. The acceptance by Landlord of a check for a lesser amount with an endorsement or statement thereon, or upon any letter accompanying such check that such lesser amount is payment in full, shall be given no effect, and Landlord may accept such check without prejudice to any other rights or remedies which Landlord may have against Tenant. In no event shall Tenant ever be entitled to receive interest upon, or any payments on account of earnings or profits derived from any payments hereunder by Tenant to Landlord.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVENANT OF QUIET ENJOYMENT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant, upon payment of the rent and the observing, keeping and performing all of the covenants, terms and provisions of this Lease on Tenant&#x2019;s part to be observed, kept and performed, shall lawfully, peaceably and quietly have, hold, occupy and enjoy the Premises during the term hereof, without hindrance or ejection by any persons lawfully claiming under Landlord to have title to the Premises superior to that of Tenant, subject, however, to the rights of the holders of mortgages on the Property, and subject to the terms and conditions of this Lease. The foregoing covenant of quiet</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enjoyment is in lieu of any other covenant, expressed or implied.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD&#x2019;S LIABILITY.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.5.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is understood and agreed that the obligations, covenants or liabilities of Landlord contained in this Lease shall be binding upon Landlord and Landlord&#x2019;s successors only with respect to breaches occurring during Landlord&#x2019;s and Landlord&#x2019;s successors&#x2019; respective ownership of Landlord&#x2019;s interest hereunder. Further, Tenant specifically agrees to look solely to Landlord&#x2019;s then equity interest in the Building at the time owned, or in which Landlord holds an interest as ground lessee, for recovery of any judgment from Landlord; it being specifically agreed that Landlord (original or successor and their respective officers, directors, stockholders, partners, managers, members, beneficial owners, trustees, employees, agents, contractors, attorneys, and mortgagees), shall never be personally liable for any such judgment, or for the payment of any monetary obligation to Tenant. The provision contained in the foregoing sentence is not intended to, and shall not limit, any right that Tenant might otherwise have to obtain injunctive relief against Landlord or Landlord&#x2019;s successors in interest, or any action not involving the personal liability of Landlord (original or successor) or not involving any claim in monetary damages from Landlord&#x2019;s assets other than a claim limited to Landlord&#x2019;s equity interest aforesaid in the Building. Notwithstanding any other provision of this Lease to the contrary, in no event shall Landlord ever be liable for any indirect, special or consequential damages suffered by Tenant or Tenant&#x2019;s Agents from any cause whatsoever.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.5.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to any services, including, without limitation, electric current or water to be furnished by Landlord to Tenant, or obligations to be performed by Landlord hereunder, Landlord shall in no event be liable for failure to furnish or perform the same when (and the date for performance of the same shall be postponed so long as Landlord is) prevented from doing so by strike, lockout, breakdown, accident, order or regulation of or by any governmental authority, or failure of supply, or inability by the exercise of reasonable diligence to obtain supplies, parts or employees necessary to furnish such services, or perform such obligations or because of war or other emergency, or for any cause beyond Landlord&#x2019;s reasonable control, or for any cause due to any negligence or willful misconduct of Tenant or Tenant&#x2019;s Agents.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICE TO MORTGAGEE AND GROUND LESSOR.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After receiving notice from any person, firm or other entity that it holds a mortgage which includes the Premises as part of the mortgaged premises, or that it is the ground lessor under a lease with Landlord, as ground lessee, which includes the Premises as part of the demised premises, no notice from Tenant to Landlord shall be effective unless and until a copy of the same is given to such holder or ground lessor, and the curing of any of Landlord&#x2019;s defaults by such holder or ground lessor shall be treated as performance by Landlord. For the purposes of this Lease, the term &#x201c;mortgage&#x201d; includes a mortgage on a leasehold interest of the Landlord (but not one on Tenant&#x2019;s leasehold interest).</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.556%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant acknowledges that, as of the date of this Lease, the mortgage holder is Nationwide Life Insurance Company, One Nationwide Plaza, Columbus, Ohio 43215, Attention: Real Estate Investments 1-05-701.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT OF RENTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.509%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With reference to any assignment by Landlord of Landlord&#x2019;s interest in this Lease, or the rents payable hereunder, conditional in nature or otherwise, which assignment is made to the holder of a mortgage or ground lease on property which includes the Premises, Tenant agrees:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that the execution thereof by Landlord, and the acceptance thereof by the holder of such mortgage, or the ground lessor, shall never be treated as an assumption by such holder or ground lessor of any of the obligations of Landlord hereunder, unless such holder or ground lessor shall, by notice sent to Tenant, specifically otherwise elect; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that, except as aforesaid, such holder or ground lessor shall be treated as having assumed Landlord&#x2019;s obligations hereunder only upon foreclosure of such holder&#x2019;s mortgage and the taking of possession of the Premises, or in the case of a ground lessor, the assumption of Landlord&#x2019;s position hereunder by such ground lessor. In no event shall the acquisition of title to the Building and the land on which the same is located by a purchaser which, simultaneously therewith, leases the entire Building or such land back to the seller thereof, be treated as an </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assumption by operation of law or otherwise of Landlord&#x2019;s obligations hereunder, but Tenant shall look solely to such seller-lessee, and its successors from time to time in title, for performance of Landlord&#x2019;s obligations hereunder. In any such event, this Lease shall be subject and subordinate to the lease to such seller. For all purposes such seller-lessee, and its successors in title, shall be the landlord hereunder unless and until Landlord&#x2019;s position shall have been assumed by such purchaser-lessor.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MECHANIC&#x2019;S LIENS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant agrees to discharge within twenty (20) days (either by payment or by the filing of the necessary bond, or otherwise) any mechanics&#x2019;, materialmen&#x2019;s or other lien or encumbrance against the Premises and/or Landlord&#x2019;s interest therein, which liens may arise out of any payment due for, or purported to be due for, any labor, services, materials, supplies or equipment alleged to have been furnished to or for Tenant in, upon or about the Premises. If Tenant shall fail to so discharge such lien or encumbrance then, in addition to any other right or remedy of Landlord, Landlord may, but shall not be obligated to, discharge same (either by payment or by filing of the necessary bond or otherwise) and any amount paid by Landlord for any of the aforesaid purposes, and all actual and legal and other expenses of Landlord, including actual counsel fees, in or about procuring the discharge of such lien, together with all necessary disbursements in connection therewith, and together with interest thereon at the rate set forth in Section 12.3 from the date of payment, shall be repaid by Tenant to Landlord on demand, and if unpaid may be treated as additional rent.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NO BROKERAGE.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant and Landlord each warrants and represents that such party has not dealt with any broker other than the Brokers, named in Section 1.2 hereof, in connection with the consummation of this Lease, and in the event any claim is made against the other party relative to dealings with brokers other than the Brokers, Tenant or Landlord, as the case may be, shall defend the claim against the other party with counsel of such party&#x2019;s selection and save harmless and indemnify the other party on account of loss, cost or damage which may arise by reason of any such claim. Landlord shall pay a commission to the Brokers, named in Section</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.2 hereof, pursuant to separate agreement.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INVALIDITY OF PARTICULAR PROVISIONS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any term or provision of this Lease or the application thereof to any person or circumstance shall, to any extent, be invalid or unenforceable, the remainder of this Lease, or the application of such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected thereby, and each term and provision of this Lease shall be valid and enforceable to the fullest extent permitted by law.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROVISIONS BINDING, ETC.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as herein otherwise provided, the terms hereof shall be binding upon and shall inure to the benefit of the successors and assigns, respectively, of Landlord and Tenant and, if Tenant shall be an individual, upon and to his heirs, executors, administrators, successors and assigns. If two or more persons or entities are named as Tenant herein, each of such person or entity shall be jointly and severally liable for the obligations of the Tenant hereunder, and Landlord may proceed against any one without first having commenced proceedings against any other of them. The reference contained to successors and assigns of Tenant is not intended to constitute a consent to assignment by Tenant, but has reference only to those instances in which Landlord may later give consent to a particular assignment as required by those provisions of Section 5 hereof.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECORDING.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant agrees not to record the within Lease, but, if required by applicable law in order to protect Tenant&#x2019;s interest in the Premises, each party hereto agrees, on the request of the other, to execute a so-called memorandum of lease or short form lease in recordable form and complying with applicable law and reasonably satisfactory to Landlord&#x2019;s attorneys. In no event shall such document set forth the rent or other charges payable by Tenant under this Lease; and any such document shall expressly state that it is executed pursuant to the provisions contained in this Lease and is not intended to vary the terms and conditions of this Lease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICES.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whenever, by the terms of this Lease, notice shall or may be given either to Landlord or to Tenant, such notice shall</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be in writing and shall be deemed duly given if sent either (i) by registered or certified mail, postage prepaid, return receipt requested, or (ii) by overnight mail service as provided by the U.S. mail or by a nationally recognized private common carrier with provisions for receipt of delivery, or (iii) by hand, and addressed as follows:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If intended for Landlord, addressed to Landlord at the Present Mailing Address of Landlord (as set forth in Section 1.2 of this Lease) (or to such other address or addresses as may from time to time hereafter be designated by Landlord by like notice).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If intended for Tenant: if given prior to the Commencement Date, addressed to Tenant at the Present Mailing Address of Tenant (as set forth in Section 1.2 of this Lease); and if given after the Commencement Date, addressed to Tenant at the Premises (or to such other address or addresses as may from time to time hereafter be designated by Tenant by like notice).</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All such notices shall be effective when delivered in hand, or when delivered if deposited in the United States mail within the continental United States or when sent by overnight mail.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHEN LEASE BECOMES BINDING.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees or agents of Landlord have no authority to make or agree to make a lease or any other agreement or undertaking in connection herewith. The submission of this document for examination and negotiation does not constitute an offer to lease, or a reservation of, or option for, the Premises, and this document shall become effective and binding only upon the execution and delivery hereof by both Landlord and Tenant. All negotiations, considerations, representations and understandings between Landlord and Tenant are incorporated herein and may be modified or altered only by written agreement between Landlord and Tenant, and no act or omission of any employee or agent of Landlord shall alter, change or modify any of the provisions hereof.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.14.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PARAGRAPH HEADINGS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The section and paragraph headings throughout this instrument are for convenience and reference only, and the words contained therein shall in no way be held to explain, modify, amplify or aid in the interpretation, construction or meaning of the provisions of this Lease. This Lease shall be interpreted as if it was prepared by both parties and ambiguities shall not be resolved in favor of Tenant because all or a portion of this Lease was prepared by Landlord. As used in this Lease the words tenant and landlord include the plural as well as the singular. Words used in the neuter gender include the masculine and feminine gender.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.15.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RIGHTS OF MORTGAGEE.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease shall be subordinate to any existing mortgage currently encumbering the Premises and to any and all advances made or to be made thereunder and any extensions, renewals or modifications thereof, unless the holder of such mortgage elects to cause the Lease to be superior to such mortgage. This Lease shall be automatically subordinate to any future mortgages or ground leases from time to time encumbering the Premises, executed or delivered subsequent to the date of this Lease and to any and all advances made or to be made thereunder and any extensions, renewals or modifications thereof (unless the holder or ground lessor elects to cause the Lease to be superior to such mortgage or ground lease), provided such mortgagee or ground lessor enters into an agreement (upon such commercially reasonable terms as are customarily required by institutional lenders) recognizing Tenant under this Lease and providing that in the event of a foreclosure Tenant shall remain undisturbed under this Lease if Tenant is not in default (after applicable notice and grace periods) under any of the terms and conditions of this Lease (a &#x201c;nondisturbance agreement&#x201d;). Tenant agrees to execute such instruments of subordination in confirmation of the foregoing agreement as such holder may request and similar to the attached Exhibit E. After the expiration of any applicable cure periods, Tenant hereby appoints such holder as Tenant&#x2019;s attorney-in-fact to execute such subordination agreement upon default of Tenant in complying with such holder&#x2019;s request. Landlord agrees, upon written request from Tenant, to use reasonable efforts to obtain a nondisturbance agreement from the holder of the existing mortgage on the Premises.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.16.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATUS REPORT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recognizing that Landlord may find it necessary to establish to third parties, such as accountants, banks, mortgagees, purchasers or the like, the then current status of performance hereunder, Tenant, on the request of Landlord made from time to time, will within seven (7) days of such request furnish to Landlord, or the holder of any mortgage encumbering</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Premises, or such other party, as the case may be, a statement in form provided by Landlord, of the status of any matter pertaining to this Lease, including, without limitation:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">That the Lease is unmodified and in full force and effect or, if there has been any modification, that the same is in full force and effect, as modified and stating any such modification;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Whether or not there are any existing setoffs or defenses against the enforcement of any of the terms, agreements, covenants and conditions of this Lease and any modifications thereof on the part of Tenant to be performed or complied with, and if so, specifying the same;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The date to which Fixed Rent and all additional rent and other charges have been paid; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other matters reasonably requested by the Landlord or such other party.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any statement furnished pursuant to this Section may be relied upon by Landlord, any mortgagee or ground lessee, any purchaser, or by any other third party interested in the status of this Lease or the Premises. Tenant hereby irrevocably appoints Landlord as attorney in fact for the Tenant with full power and authority to execute and deliver in the name of Tenant such status report if Tenant fails to deliver the same within such period and such certificate as signed by Landlord shall be fully binding on Tenant, if Tenant fails to deliver a contrary certificate within five (5) days after receipt by Tenant of a copy of the certificate executed by Landlord on behalf of Tenant. At Landlord's option, the failure of Tenant to deliver such statement within such time shall constitute a material default of Tenant hereunder, or it shall be conclusive upon Tenant that (a) this Lease is in full force and effect, without modification except as may be represented by Landlord, (b) there are no uncured defaults in Landlord's performance, (c) not more than one (1) month's Fixed Rent has been paid in advance, (d) all tenant improvements to be constructed by Landlord, if any, have been completed in accordance with Landlord's obligations and (e) Tenant has taken possession of the Premises.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.17.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT&#x2019;S FINANCIAL CONDITION.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant warrants and represents that all information furnished to Landlord or Landlord&#x2019;s representatives in connection with this Lease are true and correct in all material respects and in respect of the financial condition of Tenant, properly reflect the same without material adverse change, as of the date hereof. Upon Landlord&#x2019;s request, which may be made no more often than annually, Tenant shall furnish to Landlord, at Tenant&#x2019;s sole cost and expense, then current financial statements of Tenant, audited (if audited statements have been recently prepared on behalf of Tenant, or otherwise certified as being true and correct by the chief financial officer of Tenant).</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.18.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADDITIONAL REMEDIES OF LANDLORD; SURVIVAL.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.18.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall have the right, but shall not be required to do so, to pay such sums or do any act which requires the expenditure of monies which may be necessary or appropriate by reason of the failure or neglect of Tenant to perform any of the provisions of this Lease, and in the event of the exercise of such right by Landlord, Tenant agrees to pay to Landlord forthwith upon demand all such sums; and if Tenant shall default in such payment, Landlord shall have the same rights and remedies as Landlord has hereunder for the failure of Tenant to pay the Fixed Rent.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.18.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise set forth herein, any obligations of Tenant as set forth herein (including, without limitation, rental and other monetary obligations, repair obligations and obligations to indemnify Landlord), shall survive the expiration or earlier termination of this Lease, and Tenant shall promptly reimburse Landlord for any expense incurred by Landlord in curing Tenant&#x2019;s failure to satisfy any such obligation (notwithstanding the fact that such cure might be effected by Landlord following the expiration or earlier termination of this Lease).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.19.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER OF COUNTERCLAIMS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Landlord commences any summary proceeding for possession of the Premises based on an event of default by Tenant hereunder, Tenant hereby waives the right to interpose any non-compulsory counterclaim of whatever nature or description in any such proceeding; provided, however, that Tenant shall have the right to bring a separate action against Landlord to the extent otherwise allowed under this Lease as long as Tenant does not attempt to have such action joined or otherwise consolidated with Landlord&#x2019;s summary proceeding.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.20.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENTS.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as otherwise specifically provided in this Lease, any consent or approval to be given by Landlord under this Lease may be withheld or denied at Landlord&#x2019;s sole and absolute discretion. Whenever in this Lease the consent or approval of Landlord is required, and it is specifically provided that such consent or approval is not to be unreasonably withheld, delayed or conditioned, but nevertheless Landlord shall refuse or delay or condition such consent or approval, Tenant shall not be entitled to make any claim, and Tenant hereby waives any claim, for money damages (nor shall Tenant claim any money damages by any setoff, counterclaim or defense) based upon any claim or assertion by Tenant that Landlord unreasonably withheld or delayed or conditioned its consent or approval; and Tenant&#x2019;s sole remedy in such circumstances shall be an action or proceeding for specific performance, injunctive relief or declaratory judgment.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.21.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HOLDING OVER.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If for any reason Tenant holds over or occupies the Premises (or any portion thereof, including as a result of Tenant&#x2019;s failure to surrender all or any portion thereof as required hereunder) beyond the Term, Tenant shall have no more rights than a tenant by sufferance (or, at Landlord&#x2019;s sole option, such holding over shall constitute a tenancy from month to month, terminable by either party upon thirty (30) days prior written notice to the other); and, in any case, Tenant shall be liable for the full payment of the monthly installment of rent during such period in an amount equal to two times the rent (including Fixed Rent and all additional rent) payable hereunder during the final year of the Term prior to such holding over, for any month or portion thereof (without reduction for a partial month), that Tenant so holds over or occupies the Premises, with such tenancy otherwise on the same terms and conditions as set forth in the Lease, as far as applicable. In addition, if Tenant holds over beyond any such thirty (30) day written notice, Tenant shall save Landlord, its agents and employees harmless and will exonerate, defend and indemnify Landlord, its agents and employees from and against any and all damages which Landlord may suffer on account of such hold over. Nothing in this Section shall be construed to permit such holding over, or to limit Landlord&#x2019;s other rights and remedies on account thereof.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.22.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NON-SUBROGATION.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord and Tenant mutually agree that, with respect to any hazard which is covered by property insurance then being carried by them, respectively, the one carrying such insurance and suffering such loss releases the other of and from any and all claims with respect to such loss, to the extent of such coverage; and they further mutually agree that their respective insurance companies shall have no right of subrogation against the other on account thereof. Such waiver shall be included in the policy, or such other party shall be named as an additional insured in such policy, and the other party shall reimburse the party paying such premium the amount of such extra premium. Each such policy which shall so name a party hereto as an additional insured shall contain the agreement of the insurer that the policy will not be canceled without at least thirty (30) days notice (or ten (10) days notice in the event of a cancellation for a failure to pay insurance premiums) to both insureds and that the act or omission of on insured shall not invalidate the policy as to the other insured.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ENVIRONMENTAL HAZARDS.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant and Tenant&#x2019;s Agents shall not use, maintain, generate, allow or bring on the Premises or the Property or transport or dispose of, on or from the Premises or the Property (whether into the ground, into any sewer or septic system, into the air, by removal off-site or otherwise) any Hazardous Matter (as hereinafter defined), except that Tenant&#x2019;s use on the Premises of office cleaning supplies, copying fluids, other office and maintenance supplies and other substances normally and customarily used by tenants of space similar to the Premises shall not be deemed a violation of this Section 13.24.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall promptly deliver to Landlord copies of any notices, orders or other communications received from any governmental agency or official affecting the Premises and concerning alleged violations of the Environmental Requirements (hereinafter defined).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall save Landlord (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents, contractors, attorneys, and mortgagees) harmless and indemnified from and against any and all Environmental Damages (hereinafter defined) which may be asserted by Tenant, any other person or entity, or government </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agency or which the indemnified parties may sustain or be put to on account of: (a) the presence or release of any Hazardous Matter upon, in or from the Premises during the Term and during any period when the Tenant, or Tenant&#x2019;s Agents are occupying the Premises or any part thereof, unless proven to have been caused by Landlord or Landlord&#x2019;s employees, agents or contractors; (b) the presence or release of any Hazardous Matter upon, in or from the Property caused by the act, omission or default of Tenant or Tenant&#x2019;s Agents; (c) the activities or other action or inaction of Tenant or Tenant&#x2019;s Agents in violation of Environmental Requirements; and</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) the breach of any of Tenant&#x2019;s obligations under this Section 13.24. Notwithstanding anything to the contrary herein, Tenant&#x2019;s indemnification obligation hereunder shall not apply to claims or damages arising from the presence of Hazardous Matter on, in under or about the Premises, Building or Property prior to Tenant&#x2019;s possession or caused or permitted by third parties including Landlord or Landlord&#x2019;s Agents or which migrate to the Premises or Property from other property.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provisions of this Section shall be in addition to any other obligations and liabilities Tenant may have to Landlord under this Lease or otherwise at law or in equity, and in the case of conflict between this Section 13.23 and any other provision of this Lease, the provision imposing the most stringent requirement on Tenant shall control. The obligations of Tenant under this Section 13.24 shall survive the expiration or termination of this Lease and the transfer of title to the Premises.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.593%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:5.250732000879558%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.23.5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following terms as used herein shall have the meanings set forth below:</font></div></div>
  <p style="margin-left:0.92%;text-indent:20.905%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazardous Matter</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean any substance: (a) which is or becomes defined as Hazardous Substance, Hazardous Waste, Hazardous Material or Oil under The Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. Section 9601 et seq., M.G.L. Chapter 21C, M.G.L. Chapter 21D or M.G.L. Chapter 21E, and the regulations promulgated thereunder, as same may be amended from time to time; or (b) which is toxic, explosive, corrosive, flammable, infectious, radioactive, carcinogenic, mutagenic or otherwise hazardous to health or the environment and which is or becomes regulated and the presence of which requires investigation or remediation pursuant to any applicable law.</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;text-indent:20.901%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Environmental Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean all applicable law, the provisions of any and all approvals, and the terms and conditions of this Lease insofar as same relate to the release, maintenance, use, keeping in place, transportation, disposal or generation of Hazardous Matter, including without limitation those pertaining to reporting, licensing, permitting, health and safety of persons, investigation, containment, remediation, and disposal.</font></p>
  <p style="margin-left:0.92%;text-indent:20.903%;font-size:10pt;margin-top:12.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Environmental Damages</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall mean all liabilities, injuries, losses, claims, damages (whether special, consequential or otherwise), settlements, attorneys&#x2019; and consultants&#x2019; fees, fines and penalties, interest and expenses, and costs of environmental site investigations, reports and cleanup, including without limitation costs incurred in connection with: any investigation or assessment of site conditions or of health of persons using the Building or the Lot; risk assessment and monitoring; any cleanup, remedial, removal or restoration work required by any governmental agency or recommended by Landlord&#x2019;s environmental consultant; any decrease in value of Landlord&#x2019;s Property; any damage caused by loss or restriction of rentable or usable space in Landlord&#x2019;s Property; or any damage caused by adverse impact on marketing or financing of Landlord&#x2019;s Property.</font></p>
  <p style="font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.24.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITY DEPOSIT.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.435%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Simultaneously with the execution and delivery of this Lease, Tenant shall deliver to Landlord a security deposit (the &#x201c;Security Deposit&#x201d;), which Security Deposit shall be in the Security Deposit Amount (as defined in Section 1.2) and shall consist either of cash or of a clean, irrevocable letter of credit reasonably satisfactory in form and content to Landlord and issued by an FDIC insured bank located in Boston reasonably satisfactory to Landlord in favor of the Landlord. During the Term hereof, and any extensions thereof, and for sixty (60) days after the expiration of the Term, or for so long thereafter as Tenant is in possession of the Premises or has unsatisfied obligations hereunder to Landlord, the Security Deposit shall be security for the full and timely performance of Tenant&#x2019;s obligations under this Lease; which cash may be used or letter of credit drawn upon by Landlord and applied from time to time against outstanding obligations of Tenant hereunder that Tenant has not satisfied within any applicable notice and cure periods without notice or demand. Tenant shall have no right to require Landlord to so apply the Security Deposit, nor shall Tenant be entitled to credit the same against rents or other sums payable hereunder; no interest shall accrue thereon. If the Security</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.435%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deposit is in the form of a letter of credit, during the entire Term hereof, including any extension thereof, Tenant shall cause said letter of credit to be renewed, in identical form to that delivered herewith, no later than thirty (30) days prior to the date of expiration of same. Without limiting any other remedies of Landlord, in the event that Tenant fails to renew any letter of credit given hereunder at least thirty (30) days prior to the date of expiration thereof, then Landlord shall have the right to draw down the entire amount of said letter of credit and hold such sums as a cash deposit If and to the extent that Landlord makes such use of the Security Deposit, or any part thereof, the sum so applied by Landlord (from cash or from a drawing on the letter of credit) shall be restored to the Security Deposit, in cash, by Tenant upon notice from Landlord, and failure to pay Landlord the amount to be so restored (within the grace period applicable to Fixed Rent hereunder) shall be a default hereunder giving rise to all of Landlord&#x2019;s rights and remedies applicable to a default in the payment of rent. In the event of a change of circumstance relating to the bank issuing the letter of credit, or Landlord otherwise reasonably believes the financial conditions of the issuing bank has been degraded, Landlord reserves the right to require Tenant to replace the letter of credit from time to time with a substitute similar letter of credit issued by another bank satisfactory to Landlord. No trust relationship is created herein between Landlord and Tenant with respect to said Security Deposit. Tenant acknowledges that the Security Deposit is not an advance payment of any kind or a measure of Landlord's damages in the event of Tenant's default; Landlord shall not be obliged to keep the Security Deposit as a separate fund or pay interest thereon but may commingle the Security Deposit with its own funds. Tenant hereby waives the provisions of any law which is inconsistent with this Section 13.25.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.25.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GOVERNING LAW.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.528%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Lease shall be governed exclusively by the provisions hereof and by the laws of The Commonwealth of Massachusetts as the same may from time to time exist.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.26.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBSTITUTION OF OTHER PREMISES. INTENTIONALLY OMITTED.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.27.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITY MEASURES.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant acknowledges that Landlord shall have no obligation to provide guard service or other security measures for the benefit of the Premises or the Property, and Landlord shall have no liability to Tenant due to its failure to provide such services. Tenant assumes all responsibility for the protection of Tenant, its agents, employees, contractors and invitees and the property of Tenant and of Tenant&#x2019;s agents, employees, contractors and invitees from acts of third parties. Nothing herein contained shall prevent Landlord, at Landlord&#x2019;s sole option, from implementing security measures for the Building or any part thereof, in which event Tenant shall participate in such security measures and the cost thereof shall be included within the definition of Operating Expenses, and to the maximum extent permissible by law, Landlord shall have no liability to Tenant and its agents, employees, contractors and invitees arising out of Landlord&#x2019;s negligent provision of security measures. Landlord shall have the right, but not the obligation, to require all persons entering or leaving the Building to identify themselves to a security guard and to reasonably establish that such person should be permitted access to the Building.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.28.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EASEMENTS.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> Landlord reserves to itself the right, from time to time, to grant such easements, rights and dedications that Landlord deems necessary or desirable, and to cause the recordation of parcel maps and restrictions, so long as such easements, rights, dedications, maps and restrictions do not unreasonably interfere with the use of or access to the Premises by Tenant or parking for the Premises. Tenant shall sign any of the aforementioned documents within ten (10) business days after Landlord&#x2019;s request and Tenant&#x2019;s failure to do so shall constitute a material default by Tenant. The obstruction of Tenant&#x2019;s view, air, or light by any structure erected in the vicinity of the Property, whether by Landlord or third parties, shall in no way affect this Lease or impose any liability upon Landlord.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.29.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CHANGES TO PROPERTY.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall have the right, from time to time, to make changes to the size, shape, location, number and extent of the improvements comprising the Property and to consent to changes in the Office Park (hereinafter referred to collectively as &#x201c;Changes&#x201d;) including, but not limited to, the Building interior and exterior, the common areas and elements thereof, elevators, escalators, restrooms, HVAC, electrical systems, communication systems, fire protection and detection systems, plumbing systems, security systems, parking control systems, driveways, entrances, parking spaces, parking areas and landscaped areas. In connection with the Changes, Landlord may, among other things, erect scaffolding or other necessary structures at the Property, limit or eliminate access to portions of the Property, including</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.454%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">portions of the common areas, or perform work in the Building, which work may create noise, dust or leave debris in the Building. Tenant hereby agrees that such Changes and Landlord&#x2019;s actions in connection with such Changes shall in no way constitute a constructive eviction of Tenant or entitle Tenant to any abatement of rent. Provided that such changes do not materially and adversely interfere with Tenant&#x2019;s use of or access to the Premises, Landlord shall have no responsibility or for any reason be liable to Tenant for any direct or indirect injury to or interference with Tenant&#x2019;s business arising from the Changes, nor shall Tenant be entitled to any compensation or damages from Landlord for any inconvenience or annoyance occasioned by such Changes or Landlord&#x2019;s actions in connection with such Changes.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.30.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INCORPORATION OF PRIOR AGREEMENTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease and the Exhibits hereto contain all agreements of the parties with respect to the Lease of the Premises and any other matter mentioned herein. No prior or contemporaneous agreement or understanding pertaining to any such matter shall be effective. Except as otherwise stated in this Lease, Tenant hereby acknowledges that no real estate broker nor Landlord or any employee or agents of any of said persons has made any oral or written warranties or representations to Tenant concerning the condition or use by Tenant of the Premises or the Property or concerning any other matter addressed by this Lease.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.31.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDMENTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.1pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease may be modified in writing only, signed by the parties in interest at the time of the modification.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.32.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVENANTS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Lease shall be construed as though Landlord&#x2019;s covenants contained herein are independent and not dependent and Tenant hereby waives the benefit of any law to the contrary. All provisions of this Lease to be observed or performed by Tenant are both covenants and conditions.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.33.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AUCTIONS.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not conduct, nor permit to be conducted, either voluntarily or involuntarily, any auction upon the Premises or the Property. The holding of any auction on the Premises or Common Areas in violation of this Section 13.33 shall constitute a default hereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.34.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MERGER.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The voluntary or other surrender of this Lease by Tenant, or a mutual cancellation thereof, or a termination by Landlord, shall not result in the merger of Landlord&#x2019;s and Tenant&#x2019;s estates, and shall, at the option of Landlord, terminate all or any existing subtenancies or may, at the option of Landlord, operate as an assignment to Landlord of any or all of such subtenancies.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.35.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AUTHORITY.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.491%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Tenant is a corporation, limited liability corporation, trust, or general or limited partnership, Tenant, and each individual executing this Lease on behalf of such entity, represents and warrants that such individual is duly authorized to execute and deliver this Lease on behalf of said entity, that said entity is duly authorized to enter into this Lease, and that this Lease is enforceable against said entity in accordance with its terms. If Tenant is a corporation, trust or partnership, Tenant shall deliver to Landlord upon request evidence of such authority satisfactory to Landlord.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.36.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RELATIONSHIP OF PARTIES.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.509%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nothing contained in this Lease shall be deemed or construed by the parties hereto or by any third party to create the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.37.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RIGHT TO LEASE.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.556%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord reserves the absolute right to effect such other tenancies in the Property as Landlord in its sole discretion shall determine, and Tenant is not relying on any representation that any specific tenant or number of tenants will occupy the Property.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.38.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONFIDENTIALITY.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant acknowledges and agrees that the terms of this Lease are confidential. Disclosure of the terms hereof could adversely affect the ability of Landlord to negotiate other leases with respect to the Building and may impair Landlord&#x2019;s relationship with other tenants of the Building. Tenant agrees that it and its partners, officers, directors, employees, brokers, and attorneys, if any, shall not disclose the terms and conditions of this Lease to any other person or entity without the prior written consent of Landlord which may be given or withheld by Landlord, in Landlord&#x2019;s sole discretion, except as required for financial disclosures or securities filings. It is understood and agreed that damages alone would be an inadequate remedy for the breach of this provision by Tenant, and Landlord shall also have the right to seek specific performance of this provision and to seek injunctive relief to prevent its breach or continued breach.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.39.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OFAC CERTIFICATION AND INDEMNITY.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.472%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (the &#34;Executive Order&#34;), and the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Public Law 10756, the &#34;Patriot Act&#34;) prohibit certain property transfers. Tenant hereby represents and warrants to Landlord (which representations and warranties shall be deemed to be continuing and re-made at all times during the Term) that neither Tenant nor, to its actual knowledge, any stockholder, manager, beneficiary, partner, or principal of Tenant is subject to the Executive Order, that none of them is listed on the United States Department of the Treasury Office of Foreign Assets Control (&#x201c;OFAC&#x201d;) list of &#34;Specially Designated Nationals and Blocked Persons&#34; as modified from time to time, and that none of them is otherwise subject to the provisions of the Executive Order or the Patriot Act. The most current list of &#34;Specially Designated Nationals and Blocked Persons&#34; can be found at http://www.treas.gov/offices/eotffc/ofac/sdn/index.html. Tenant shall from time to time, within ten business days after request by Landlord, deliver to Landlord any certification or other evidence requested from time to time by Landlord in its reasonable discretion, confirming Tenant&#x2019;s compliance with these provisions. No assignment or subletting shall be effective unless and until the assignee or subtenant thereunder delivers to Landlord written confirmation of such party&#x2019;s compliance with the provisions of this subsection, in form and content satisfactory to Landlord. If for any reason the representations and warranties set forth in this subsection, or any certificate or other evidence of compliance delivered to Landlord hereunder, is untrue in any material respect when made or delivered, or thereafter becomes untrue in any material respect, then an event of default hereunder shall be deemed to occur immediately, and there shall be no opportunity to cure. Tenant shall indemnify, defend with counsel reasonably acceptable to Landlord, and hold Landlord harmless from and against, any and all liabilities, losses claims, damages, penalties, fines, and costs (including attorneys&#x2019; fees and costs) arising from or related to the breach of any of the foregoing representations, warranties, and duties of Tenant. The provisions of this subsection shall survive the expiration or earlier termination of this Lease for the longest period permitted by law.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.40.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WAIVER OF JURY TRIAL; ATTORNEYS&#x2019; FEES.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD AND TENANT HEREBY WAIVE THEIR RESPECTIVE RIGHT TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, COUNTERCLAIM OR CROSS-COMPLAINT IN ANY ACTION, PROCEEDING AND/OR HEARING BROUGHT BY EITHER LANDLORD AGAINST TENANT OR TENANT AGAINST LANDLORD ON ANY MATTER WHATSOEVER ARISING OUT OF, OR IN ANY WAY CONNECTED WITH, THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT, TENANT&#x2019;S USE OR OCCUPANCY OF THE PREMISES, OR ANY CLAIM OF INJURY OR DAMAGE, OR THE ENFORCEMENT OF ANY REMEDY UNDER ANY LAW, STATUTE, OR REGULATION, EMERGENCY OR OTHERWISE, NOW OR HEREAFTER IN</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EFFECT. In the event of any such commencement of litigation, the prevailing party shall be entitled to recover from the other party such costs and reasonable attorneys&#x2019; fees as may have been incurred, including any and all costs incurred in enforcing, perfecting and executing such judgment. This recovery, if at all, of attorneys&#x2019; fees by Landlord shall not impact or modify any other rights or remedies which Landlord has or may have under this Lease, at law or equity.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.546%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Witness the execution hereof, under seal, in any number of counterparts, each of which counterparts shall be deemed an original for all purposes, as of the day and year first above written.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:11.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TENANT:</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="font-size:10pt;margin-top:12.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:51.611%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: /s/ Paul Little</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name: Paul Little</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title: CFO, Duly Authorized</font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LANDLORD:</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BLANCHARD GROUP LLC</font></p>
  <p style="font-size:10pt;margin-top:12.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;text-indent:-9.437%;padding-left:4.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:51.611%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Robert L. Duffy, Jr.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Name: Robert L. Duffy, Jr.</font></p>
  <p style="margin-left:5.013%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title: Manager, Duly Authorized</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THEPREMISES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.85pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font><img src="img108224922_0.jpg" alt="img108224922_0.jpg" style="width:557px;height:342px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:2.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:3.12%;text-indent:-29.982%;padding-left:22.347%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Any furniture, appliances or wiring shown on this Plan, is shown for illustrative purposes only and not included as part of the Tenant&#x2019;s Improvements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:7.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A-1</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THE TENANT IMPROVEMENTS</font></p>
  <p style="font-size:10pt;margin-top:11.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.435%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord shall, at its sole cost and expense, conduct the following Tenant Improvements using available building standard quantities and materials:</font></p>
  <p style="font-size:10pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:7.587%;text-indent:-3.892%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.435%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New paint and carpet throughout Premises using colors previously selected by Tenant; remove wall between kitchenette and storage to make kitchenette area larger, including matching floor.</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:8.1pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not included in the Tenant Improvements are any and all costs or work associated with:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">telephone/data/voice/network throughout the Premises; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cubicles and/or open areas, including but not limited to costs or work associated with their purchase, installation or setup, and any telephone/data/voice/network and/or A/C power wiring, coring, through floor access modules, or other wiring therefore; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interior blinds; the installation of any interior blinds and/or window treatments which may be visible from the common area or outside the Premises is subject to the Landlord&#x2019;s written consent; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Coring the conference room floor(s) and/or the server room(s), if any; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furniture and appliances.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.426%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except for the items noted above or otherwise set forth in the Lease, the Premises shall be delivered in &#x201c;AS IS&#x201d; condition and Tenant acknowledges that by taking possession of the Premises, the Premises &#x201c;AS IS&#x201d; are suitable for its intended use. Tenant shall be responsible for any delays, costs and expenses caused by Tenant&#x2019;s failure to make decisions affecting the Tenant Improvements in a timely manner. Tenant shall be solely responsible for all costs, expenses and delays resulting from requests by Tenant for work, quantities or materials in excess of the Tenant Improvements noted above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.65pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT RULES AND REGULATIONS</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will endeavor to review the non-binding tenant manual provided prior to move-in at Building and will provide referenced forms including emergency contacts, designated tenant representative, and card access requests and will notify Landlord when changes in information occur.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The entrances, vestibules, passages, corridors, halls, elevators and stairways shall not be encumbered nor obstructed by Tenant, Tenant&#x2019;s agents, servants, employees, licensees or visitors, or be used by them for any purpose other than ingress or egress to and from the Premises. Landlord reserves the right to reasonably restrict and regulate the use of aforementioned public areas of the Building by Tenant, Tenant&#x2019;s agents, employees, servants, licensees and visitors and by persons making deliveries to Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Movement in or out of the Building of furniture or office equipment which requires the use of elevators or stairways or the movement through the main Building entrance shall be restricted to the after business hours designated by Landlord. All such movement shall be under the supervision of Landlord and performed in the manner agreed upon between Tenant and Landlord by pre- arrangement before performance. Such pre-arrangement initiated by Tenant will include the determination by Landlord and subject to Landlord&#x2019;s reasonable discretion, relating to the time, method, and routing of the items&#x2019; movement, as well as reasonable limitations imposed by safety, appearance or other reasonable concerns which may include the prohibition of equipment or any other item from being brought into the Building, as well as the method of the items&#x2019; movement through the Building. Tenant shall assume with its contractors, all risk as to damage caused by any such movement or property being moved or injury to persons or public engaged or not engaged in such movement, including equipment, property, and personnel of Landlord if damaged or injured as a result of Tenant or its contractor&#x2019;s negligent or willful acts in connection with such Tenant arranged moving from the time of entering the property to the completion of work. Landlord shall not be liable for the acts of any person engaged in, or any damage or loss to any of said property or persons resulting from any act in connection with such moving performed by Tenant arrangement, except relating to Landlord&#x2019;s or its agent&#x2019;s or contractor&#x2019;s negligence or misconduct.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All deliveries, inclusive of packages, office supplies, etc., must be made via the freight elevator during Normal Building Operating Hours. Landlord&#x2019;s written approval must be obtained for any delivery made after business hours and Tenant will be responsible for the expense of the security attendant who monitors access to the Building during the period of such delivery.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not permit the parking or standing of delivery vehicles to interfere with the use of any driveway, walk, parking area or other common areas.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No hand trucks or delivery dollies, except those equipped with rubber tires and padded side guards, shall be used in any space, or in public halls of the building, either by Tenant or by jobbers or others in the delivery or receipt of merchandise.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All deliveries to the Tenant must be accepted by Tenant. The Landlord and its agents or employees will not accept, sign for, or hold Tenant mail, packages, or deliveries.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not make, or permit to be made, any unseemly or disturbing noises, odors, or vibrations to emanate from premises or otherwise unreasonably disturb or interfere with the occupancy of the Building whether by the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">use of any equipment, musical instrument, radio, television, talking machine, unmusical noise, whistling, singing, or in any other way.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No additional locks, or security devices will be installed without prior notification and approval by Landlord. New locks or rekeying must be coordinated with Landlord and keyed on building master system. Additional keys may be requested in advance and at an additional charge to Tenant. Upon termination of Lease, Tenant will return 2 keys to each lock, and further will disclose any previously approved and installed security devices including combination locks, punch codes to doors and vaults.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After the initial move-in, for which the distribution of access cards will be provided at no cost to Tenant, Tenant agrees to pay an amount fixed by Landlord from time to time, for each additional access card issued by Landlord to Tenant. Such expense is presently $20.00 per card.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord specifically reserves the right to exclude from the Building during non-business hours, such as before 8:00 a.m. and after 6:00 p.m. on weekdays, on Saturdays and Sundays, and Building recognized Holidays, all persons not permitted entry by utilizing card access, telephone access system, or previous arrangement with the management office.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall be responsible for persons it authorizes to have access to the Building during non- business hours and shall be liable for and shall coordinate which persons should have access cards issued. Tenant shall keep access card records current and properly identified by employee name.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord is under no obligation to permit entrance to Tenant&#x2019;s premises or offices by use of pass keys controlled by Landlord to any person at any time except Landlord&#x2019;s employees, contractors, or service personnel directly supervised by Landlord. It is recommended that Tenant inform Tenant employees of these lockout procedures.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">14.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All service requests of Tenant required of Landlord shall be administered through Building management office. Tenants will not contract independently with employees and agents of Landlord without the coordination of the management office, nor shall Tenant request employees or agents of Landlord to receive or carry messages for or to any Tenant or other person.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">15.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None of the entries, passages, doors, elevators, elevator doors, hallways, or stairways shall be blocked or obstructed, nor shall any rubbish, litter, trash, or material of any nature be placed, emptied, or thrown into these areas, nor shall such areas be used at any time except for ingress and egress by Tenant, Tenant&#x2019;s agents, employees, or invitees.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">16.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No boxes, crates, pallets, or other such materials shall be stored in building hallways or other common areas. When Tenant must dispose of crates, boxes, etc., it will be the responsibility of Tenant to dispose of same prior to, or Normal Building Operating Hours, so as to avoid having such debris visible or being moved in the Common Areas during normal business hours. If such items are desired to be removed as part of evening janitorial service, the expense of such will be borne by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">17.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each Tenant shall cooperate with Landlord&#x2019;s employees in keeping leased premises neat and clean.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">18.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The water and wash closets and other plumbing fixtures shall not be used for any purposes other than those for which they were constructed, and no sweepings, rubbish, rags, or other substances shall be thrown or placed therein. Damages or maintenance expense resulting from any misuse of fixtures or disposal of the above by Tenant, its servants, employees, agents, visitors, or licensees, shall be borne by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">19.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided for in this Lease, Tenant shall not mark, paint, drill into, or in any way deface any part of the Premises or the Building, except for Tenant&#x2019;s interior design components and furnishings in the Premises or the approved signage. Other than for initial move-in, no boring, cutting, or stringing for wires shall be permitted without the prior written consent of Landlord and as Landlord may direct.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">20.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise provided in this Lease, neither Tenant, nor its servants, employees, agents, visitors, or licensees, shall at any time bring or keep upon the Premises any flammable, combustible, or explosive fluid, chemical or substance (including Christmas trees and ornaments) except such items as may be incidentally used, provided Tenant notifies Landlord of the location thereof and makes adequate provision for safe storage. No space heaters or fans shall be operated or located in the Premises, other than UL approved or Landlord installed appliances.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">21.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No bicycles, vehicles, or animals, except for the disabled, shall be brought into or kept in or about the Premises or Building.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">22.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will not locate furnishings or cabinets adjacent to mechanical or electrical panels, HVAC equipment or other mechanical equipment so as to prevent personnel from servicing such units or equipment as routine or emergency access may require. Cost of moving such furnishings for Landlord&#x2019;s access will be borne by Tenant.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">23.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No space in the Premises or Building shall be used for manufacturing, for lodging, sleeping, storage of money in excess of $300, storage of drugs or medicine not typically found of quality or quantity in First Aid supply kits or for legal purposes.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">24.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall not place, install or operate on the demised premises or in any part of Building, any engine, stove, or machinery, or conduct mechanical operations or cook thereon or therein except Tenants microwave, refrigerator, office and communication equipment.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">25.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant must obtain prior written approval, which shall be at Landlord&#x2019;s sole discretion, for installation of window shades, blinds, drapes, or any other window treatment of any kind whatsoever which would be visible from exterior of building other than Landlord supplied. Landlord will approve all internal lighting that may be visible from the exterior of the Building and shall have the right to change any unapproved lighting, without notice to Tenant, at Tenant&#x2019;s expense.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">26.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will coordinate with Landlord all Tenant arranged contractors, and installation technicians, rendering any construction or installation service to Tenant before performance of any such service. This provision shall apply to all work performed in the Building by Tenant arranged contractors including the installation of telephones, telegraph equipment, electrical devices and attachments, and the installation of any nature affecting the floors, walls, woodwork, trim, windows, ceiling, equipment (other than Tenant&#x2019;s office equipment), or any other physical portion of the Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">27.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord may utilize Tenant&#x2019;s electricity while making repairs or providing services in said Premises regardless of whether occurring during business or non-business hours after lease commencement date.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">28.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Smoking is prohibited in common entrances, vestibules, passages, corridors, halls, elevators, stairways, and toilet rooms of the Building. Tenant is responsible for informing all of its vendors, service providers, agents, employees, licensees, and visitors of this policy. Landlord reserves the right to request that any person(s) engaged in the act of smoking (in the common areas recited above), at his or her choice, either cease smoking or leave the common areas of the Building immediately.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">29.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Canvassing, soliciting, and peddling in the Building and Parking Lot is prohibited. Landlord and Tenant shall cooperate to prevent same.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">30.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant shall restrict parking by Tenant, its employees, service providers, agents, and visitors to parking areas designated by Landlord and shall comply with reasonable parking rules and regulations as may be modified, posted, and distributed by Landlord from time to time. The parking spaces shall not be used for overnight parking or dead storage of vehicles or other merchandise or material. All vehicles parked or traveling through the Office Park shall maintain a current registration and be properly insured. All parking shall be within the striped spaces in the parking lot. Landlord reserves the right to promulgate a system of parking stickers or passes as necessary to control parking by tenants and their visitors, and tenants shall reasonably cooperate in the implementation of such system.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">31.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will evacuate the Premises and Building in the event of emergency or catastrophe notification; whether practice drill, false alarm, or actual occurrence.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">32.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will notify Landlord of any incidents, accidents, injuries, or hazards which Tenant is aware of, which occur, or are present in Premises or Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">33.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant will be requested to participate in recycling and other expense reduction programs offered by Building.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">34.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event the Premises is separately metered for any utility, Tenant shall provide the applicable utility provider with all information necessary for the Tenant to assume control of the appropriate account or meter on or before the earlier of the following, regardless of whether or not any base rent is due: (i) the Lease Commencement Date; (ii) the date of any early access to the Premises, regardless of whether said access is for Tenant to (a) conduct its business, (b) conduct or participate in any improvements to the Leased Premises, (c) install or store any fixtures, furniture, or equipment, or (d) prepare the Premises for the Tenant&#x2019;s occupancy or move-in. Tenant shall maintain electrical service to the Premises throughout the Term of the Lease, regardless of whether Tenant is actually occupying the space or not.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">35.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord reserves the right to rescind any of these rules and make such other and further reasonable rules and regulations as in Landlord&#x2019;s judgment shall from time to time be needed for the safety, protection, care and cleanliness of the Building, the operation thereof, the preservation of good order therein, and the protection and comfort of its Tenants, their agents, employees, and invitees, which rules when made and notice thereof given to a Tenant shall be binding upon Tenant in the manner as if originally prescribed; provided, however, that in the event of a material and adverse conflict between the rules and regulations of the building and the Lease, the terms and conditions of the Lease shall control.</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:12.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.509%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Landlord desires to maintain high standards of environmental comfort and convenience for the Tenants of Building. It will be appreciated if any undesirable conditions, lack of courtesy or attention are reported directly to the management.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT C</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">APPROVED SPACE PLANS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:7.85pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font><img src="img108224922_1.jpg" alt="img108224922_1.jpg" style="width:557px;height:342px;"></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:4.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:3.12%;text-indent:-29.982%;padding-left:22.347%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Any furniture, appliances or wiring shown on this Plan, is shown for illustrative purposes only and not included as part of the Tenant&#x2019;s Improvements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT D</font></p>
  <p style="font-size:10pt;margin-top:11.85pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intentionally omitted.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:1.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.867%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT E</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:11.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SAMPLE SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:11.25pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:14.253%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THIS</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBORDINATION,</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NON-DISTURBANCE</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AND</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATTORNMENT</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AGREEMENT  (this  &#x201c;Agreement&#x201d;),  is  made  this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day  of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 20</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> between</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">corporation or limited liability corporation (&#x201c;Tenant&#x201d;), and NATIONWIDE LIFE INSURANCE COMPANY, an Ohio corporation, its successors and assigns (&#x201c;Lender&#x201d;) and Blanchard Group LLC, a Massachusetts limited liability company (&#x201c;Landlord&#x201d;), whose address is One Nationwide Plaza, 1-05-701, Columbus, Ohio, 43215, Attention: Real Estate Investments (Loan Servicing).</font></p>
  <p style="margin-left:7.44%;font-size:10pt;margin-top:12.1pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BACKGROUND</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lender is the owner and holder of: (i) that certain deed of trust, or mortgage or other similar security instrument (the &#x201c;Mortgage&#x201d;) dated August 1, 2018, in the original amount of</font></div></div>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$30,000,000, on the real estate more particularly described in the Mortgage (the &#x201c;Property&#x201d;); and</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii) an assignment of leases and rents (the &#x201c;Assignment&#x201d;). The Mortgage, the Assignment and any other instruments evidencing the loan to Landlord are collectively referred to as the &#x201c;Security Documents&#x201d;.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant is negotiating or has executed a lease (the &#x201c;Lease&#x201d;) with Landlord to lease </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">76, 78, or 80 </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Blanchard Road (the &#x201c;Premises&#x201d;), located in Burlington, Massachusetts, and constituting a portion of the Property.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tenant, Landlord and Lender desire to confirm their understanding with respect to the Security Documents and the Lease.</font></div></div>
  <p style="margin-left:0.92%;text-indent:13.444%;font-size:10pt;margin-top:13.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOW THEREFORE, in consideration of the mutual promises of this Agreement, and intending to be legally bound hereby, the parties hereto agree and covenant as follows:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:11pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subordination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Lease and all rights, options, liens and charges of Tenant thereunder are hereby subordinated and made subject to the Security Documents, and any modification, renewal, substitution, extension or replacement thereof and each advance made thereunder as though the Security Documents, and each such modification, renewal, substitution, extension or replacement were executed and recorded, and the advance made, prior to the execution of the Lease; provided, however, in the event Lender at any time elects to have this Lease constitute a prior and superior lien to its Mortgage, then, and in such event, upon Lender or Landlord notifying Tenant to that effect in writing, the Lease will be </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">deemed prior and superior in lien to the Mortgage, whether the Lease is dated prior to or subsequent to the date of the Mortgage.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Disturbance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Lender hereby acknowledges and agrees that no foreclosure (whether judicial or non-judicial), deed in lieu of foreclosure, or other sale of the Property in connection with the enforcement of the Security Documents or otherwise in satisfaction of the underlying loan shall terminate the Lease or Tenant&#x2019;s rights thereunder to possess and use the Premises, subject to the following: (i) Tenant is in possession of the Premises, and (ii) Tenant is not in default in the payment of rent or in the performance of any of the terms, covenants or conditions of the Lease beyond any applicable notice and cure periods.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attornment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If Lender succeeds to the interest of Landlord, as landlord under the Lease, or if the Property or the Premises are sold pursuant to Lender&#x2019;s rights under the Security Documents to a purchaser (&#x201c;Purchaser&#x201d;), Tenant shall attorn to Lender or to Purchaser and shall recognize Lender, or such Purchaser, thereafter as landlord under the Lease and agrees to be bound under all the terms, covenants and conditions of the Lease. Such attornment shall be effective and self-operative without the execution of any further instruments.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lender&#x2019;s Rights and Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If Lender exercises any of its rights under the Security Documents, or if Lender shall succeed to the interest of Landlord under the Lease, or if any Purchaser acquires the Security Documents, the Property, or the Premises, then Lender or Purchaser shall have the same remedies by entry, action or otherwise in the event of any default by Tenant (beyond any applicable notice and cure period) in the payment of rent or in the performance or observance of any of the terms, covenants and conditions of the Lease on Tenant&#x2019;s part to be paid, performed or observed that Landlord had or would have had if Lender or Purchaser had not succeeded to the interest of the present Landlord. Lender or Purchaser shall be bound to Tenant under all terms, covenants and conditions under the Lease and for any landlord defaults which arise after Lender or Purchaser succeeds to Landlord&#x2019;s interest under the Lease. Tenant acknowledges the Assignment and after written notice (the &#x201c;Rent Notice&#x201d;) is given to Tenant by Lender, Tenant shall thereafter pay to Lender all rent and other amounts due or to become due (the &#x201c;Rent&#x201d;) to Landlord under the Lease and Tenant shall not be liable to Lender for Rent paid to Landlord prior to receipt of the Rent Notice provided no Rent has been paid more than thirty (30) days in advance. Landlord hereby expressly authorizes Tenant to make such payments to Lender upon reliance on the Rent Notice, without any inquiry into the factual basis or any prior notice to or consent from Landlord and hereby releases Tenant from all liability, excepting Tenant fraud, to Landlord in connection with Tenant&#x2019;s compliance with the Rent Notice.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice and Right to Cure</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Tenant agrees, until the Mortgage is released by Lender, to provide Lender (at the address noted above) with a copy of each notice of default given to Landlord under the Lease at the same time such notice of default is given to Landlord. In the event of any default by Landlord under the Lease, Tenant shall not seek to terminate the Lease or to exercise any rights to setoff or abate Rent or any other remedies, until Lender has received such notice and has been given the opportunity, but without undertaking Landlord&#x2019;s other obligations under the Lease, to cure the default within sixty (60) days from receipt of notice. In the event Lender, has begun action to cure the default, but not completed the same during the sixty (60) day period, Tenant agrees that Lender shall have a reasonable period of time thereafter to do so. If the default is such that it cannot practically be cured by Lender without taking possession of the Premises, Tenant agrees that any right it may have to terminate the Lease or to setoff or abate any Rent, shall be suspended for a reasonable period of time so long as Lender is diligently proceeding to acquire possession of the Premises, by foreclosure or is otherwise undertaking to cure the default of Landlord. Notwithstanding the foregoing, Lender shall have no obligation to cure any default under the Lease.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parties Bound</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The provisions of this Agreement shall be binding upon and inure to the benefit of Tenant, Lender and Landlord and their respective successors and/or assigns. Any party may record this Agreement at any time.</font></div></div>
  <p style="font-size:10pt;margin-top:1.1pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Captions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Captions and headings of sections are not parts of this Agreement and shall not be deemed to affect the meaning or construction of any of the provisions of this Agreement.</font></div></div>
  <p style="font-size:10pt;margin-top:1.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Agreement may be executed in several counterparts each of which when executed and delivered is an original, but all of which together shall constitute one instrument.</font></div></div>
  <p style="font-size:10pt;margin-top:1.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Agreement shall be governed by and construed in accordance with the laws of the state where the Property is located.</font></div></div>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:7.44%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.389%;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Lender and Landlord&#x2019;s Signature Pages Follow]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:5.056%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:2.9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TENANT:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:67.6%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> corporation or limited liability company</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.648%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Title: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATE OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  )</font></p>
  <p style="margin-left:0.92%;text-indent:66.688%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:59.093%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) SS: COUNTY OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> )</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">day of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 20</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, before me, the undersigned officer, personally appeared</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,  who  acknowledged  himself/herself  to  be  the</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.481%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a(n) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> corporation or limited liability company, and that he/she, as such </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">being authorized so to do, executed the foregoing instrument for the purposes therein contained, by signing such instrument in such capacity.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, I hereunto set my hand and official seal.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notary Public</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">My Commission Expires:</font></p>
  <p style="font-size:10pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:3.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.813%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:3.407%;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Lender and Landlord&#x2019;s Signature Pages Follow]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LENDER:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NATIONWIDE LIFE INSURANCE</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPANY</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an Ohio corporation</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.648%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Title: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATE OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  )</font></p>
  <p style="margin-left:0.92%;text-indent:66.672%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:59.083%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) SS: COUNTY OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> )</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">day of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 20</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, before me, the undersigned officer, personally appeared</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,  who  acknowledged  himself/herself  to  be  the</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.509%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NATIONWIDE LIFE INSURANCE COMPANY</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an Ohio corporation, and that he/she, as such </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> being authorized so to do, executed the foregoing instrument for the purposes therein contained, by signing such instrument in such capacity.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, I hereunto set my hand and official seal.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notary Public</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">My Commission Expires:</font></p>
  <p style="font-size:10pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.583%;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Landlord&#x2019;s Signature Pages Follow]</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:80%;text-indent:33.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.8</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LANDLORD:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BLANCHARD GROUP LLC,</font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a Massachusetts limited liability company</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:9.648%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Title: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STATE OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  )</font></p>
  <p style="margin-left:0.92%;text-indent:66.688%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:59.093%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) SS: COUNTY OF </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> )</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">day of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, 20</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, before me, the undersigned officer, personally appeared</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, who acknowledged himself to be the </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:3.519%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a Massachusetts limited liability corporation, and that he, as such </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> being authorized so to do, executed the foregoing instrument for the purposes therein contained, by signing such instrument in such capacity.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, I hereunto set my hand and official seal.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notary Public</font></p>
  <p style="margin-left:0.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">My Commission Expires:</font></p>
  <p style="font-size:10pt;margin-top:0.85pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>4
<FILENAME>eldn-ex10_14.htm
<DESCRIPTION>EX-10.14
<TEXT>
<html>
 <head>
  <title>EX-10.14</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.3in;z-index:-3;min-height:1.01in;position:relative;box-sizing:border-box;"><p style="margin-left:73.333%;text-indent:25%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img205580551_0.jpg" alt="img205580551_0.jpg" style="width:259px;height:65px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 16, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dear David-Alexandre:</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and you are parties to the executive employment agreement dated September 9, 2020, as amended on April 27, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  The Company desires to provide certain additional benefits to you as described below.  The Employment Agreement continues in effect, as amended and supplemented by this letter agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Letter Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) pursuant to section 11(c) of the Employment Agreement.  Capitalized terms not otherwise defined herein shall have the meanings attributed to them in the Employment Agreement.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Performance Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Employment Agreement provides for your eligibility to receive</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a pro rata Performance Bonus, if upon the date of your termination of employment for any reason other than a termination by the Company for Cause (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Qualifying Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Market Value is equal to or greater than $600 million, but less than $1 billion.  For purposes of your eligibility to earn a pro rata performance bonus, the cap is hereby adjusted from $1 billion to $1.5 billion.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Employment Agreement provides for your eligibility to receive the Performance Bonus upon the occurrence of, at any time during the Measurement Period, the market value of the Company&#x2019;s Common Stock exceeding $600,000,000 either (1) for a period of 30 consecutive calendar days, (ii) upon a Change of Control of the Company, or (iii) upon a Qualifying Termination.  You will be eligible to earn this 1% Performance Bonus in a pro rata amount based on the Company&#x2019;s market value ranging from $600 million to $1.5 billion.  If the Company achieves a Market Value between $600 million and $1.5 billion either (i) for a period of 30 consecutive calendar days, (ii) upon a Change in Control, or (iii) upon the date of a Qualifying Termination, then the amount of the Performance Bonus will be pro-rated between the $6,000,000 threshold bonus and $15,000,000 maximum bonus using linear interpolation.  By way of example, if the Company achieves a Market Value equal to $1.2B upon a Change in Control (or for 30 consecutive calendar days or upon the date of a Qualifying Termination), then the amount of the Performance Bonus will equal $12,000,000.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.44in;min-height:0.57in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.173%;text-indent:-8.776%;padding-left:8.053%;font-size:10pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250 - Irvine - California - 92612</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.173%;text-indent:-8.776%;padding-left:8.053%;font-size:10pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(949) 238-8090 - </font><font><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.eledon.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> - </font><font><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">info@eledonpharma.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:-3;min-height:1.01in;position:relative;box-sizing:border-box;"><p style="margin-left:73.333%;text-indent:25%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img205580551_0.jpg" alt="img205580551_0.jpg" style="width:259px;height:65px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Tahoma',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as amended and supplemented by this Letter Agreement, the Employment Agreement shall continue in effect and the terms of the Employment Agreement are incorporated into this Letter Agreement. This Letter Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Thank you for your continuing contributions to the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sincerely,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Keith A. Katkin<br>Chairman of the Board</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXECUTIVE ACKNOWLEDGEMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I agree to the terms and conditions set forth above and agree that this letter agreement amends and supplements the Employment Agreement.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ David Alexandre C. Gros	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 16, 2024</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">_______________		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros		Date</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.44in;min-height:0.57in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.173%;text-indent:-8.776%;padding-left:8.053%;font-size:10pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250 - Irvine - California - 92612</font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:0.173%;text-indent:-8.776%;padding-left:8.053%;font-size:10pt;margin-top:0.65pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(949) 238-8090 - </font><font><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.eledon.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> - </font><font><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">info@eledonpharma.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>5
<FILENAME>eldn-ex10_25.htm
<DESCRIPTION>EX-10.25
<TEXT>
<html>
 <head>
  <title>EX-10.25</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:66.667%;text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.25</font></p></div>
  <p style="margin-left:28.32%;font-size:10pt;margin-top:2.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:69.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 13, 2024</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:69.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[NAME]</font></p>
  <p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Re:	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amendment to Stock Option Agreement</font></p>
  <p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dear [NAME],</font></p>
  <p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You and Eledon Pharmaceuticals, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; or the &#x201c;Company&#x201d;) have mutually agreed to enter into this letter agreement (the &#x201c;Agreement&#x201d;) in order to document an amendment to your outstanding stock option agreement, effective as of the date hereof (the &#x201c;Effective Date&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You were granted an option to purchase [&#x25cf;] shares of the common stock of the Company under the Company&#x2019;s 2020 Long Term Incentive Plan (the &#x201c;Plan&#x201d;) on [May 1, 2023] (the &#x201c;Award&#x201d;) pursuant to a Stock Option Agreement (as previously amended, the &#x201c;Award Agreement&#x201d;). Capitalized terms used and not otherwise defined in this Agreement will have the meanings set forth for such terms in the Award Agreement. The Compensation Committee of the Board of Directors of the Company (the &#x201c;Compensation Committee&#x201d;) has approved an amendment to the Award Agreement, and you hereby agree, to amend the Award Agreement as of the Effective Date as set forth below.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.973%;text-indent:6.796%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. 	The Performance-Based Vesting Requirements applicable to the Second Closing Shares shall be deemed to be achieved as of the Effective Date.  The Second Closing Shares shall otherwise remain subject to the terms of the Award Agreement, including, without limitation, the applicable Time-Based Vesting Requirements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as modified above, the provisions of the Award Agreement remain in full force and effect.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:66.667%;text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.25</font></p></div>
  <p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We appreciate your service to the Company. Please sign where indicated below to confirm your agreement to the terms of this Agreement.</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">***</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____________________________________________</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:39.627%;text-indent:2.231%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accepted and Agreed:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:	_____________________________					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	[NAME]</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>6
<FILENAME>eldn-ex10_26.htm
<DESCRIPTION>EX-10.26
<TEXT>
<html>
 <head>
  <title>EX-10.26</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:60%;text-indent:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.26</font></p></div>
  <p style="margin-left:28.32%;font-size:10pt;margin-top:2.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:69.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 20, 2024</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:69.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[NAME]</font></p>
  <p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Re:	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amendment to Stock Option Agreement</font></p>
  <p style="font-size:10pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:69.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dear [NAME],</font></p>
  <p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You and Eledon Pharmaceuticals, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; or the &#x201c;Company&#x201d;) have mutually agreed to enter into this letter agreement (the &#x201c;Agreement&#x201d;) in order to document an amendment to your outstanding stock option agreement, effective as of the date hereof (the &#x201c;Effective Date&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You were granted an option to purchase [&#x25cf;] shares of the common stock of the Company under the Company&#x2019;s 2020 Long Term Incentive Plan (the &#x201c;Plan&#x201d;) on May 1, 2023 (the &#x201c;Award&#x201d;) pursuant to a Stock Option Agreement (as previously amended, the &#x201c;Award Agreement&#x201d;). Capitalized terms used and not otherwise defined in this Agreement will have the meanings set forth for such terms in the Award Agreement. The Compensation Committee of the Board of Directors of the Company (the &#x201c;Compensation Committee&#x201d;) has approved an amendment to the Award Agreement, and you hereby agree, to amend the Award Agreement as of the Effective Date as set forth below.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.973%;text-indent:6.796%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. 	The Performance-Based Vesting Requirements applicable to 100% of the options subject to the Award shall be deemed to be achieved as of the Effective Date.  The options subject to the Award shall otherwise remain subject to the terms of the Award Agreement, including, without limitation, the applicable Time-Based Vesting Requirements.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except as modified above, the provisions of the Award Agreement remain in full force and effect.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="margin-left:60%;text-indent:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.26</font></p></div>
  <p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We appreciate your service to the Company. Please sign where indicated below to confirm your agreement to the terms of this Agreement.</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.73%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.935%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">***</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ELEDON PHARMACEUTICALS, INC.</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____________________________________________</font></p>
  <p style="margin-left:40.973%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:39.627%;text-indent:2.231%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accepted and Agreed:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By:	_____________________________					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	[NAME]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>7
<FILENAME>eldn-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:28.82%;box-sizing:content-box;"></td>
    <td style="width:71.18%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;background-color:#00a3ad;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Document Number:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">OP-0013</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#00a3ad;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Document Revision:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1.1</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#00a3ad;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Document Name:</font><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Insider Trading</font></p></td>
   </tr>
   <tr style="height:11pt;background-color:#00a3ad;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Effective Date:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">January 09, 2021</font></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;border-bottom:0.5pt solid;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Policy Scope</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Policy applies to all employees, temporary workers, and members of the Board of Directors of Eledon Pharmaceuticals, Inc. (together &#x201c;Personnel&#x201d;) along with its affiliates and subsidiaries (together &#34;Company''). This Policy also applies to any individuals such as consultants and contractors whom the Company&#x2019;s Principal Financial and Accounting Officer may designate as Personnel because they have access to material nonpublic information concerning the Company.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Purpose</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The federal securities laws prohibit any Personnel from purchasing or selling Company securities on the basis of material nonpublic information concerning the Company, or from tipping material nonpublic information to others.  These laws impose severe sanctions on individuals who violate them.  In addition, the Securities and Exchange Commission (&#x201c;SEC&#x201d;) has the authority to impose large fines on the Company and on the Company&#x2019;s Directors, executive officers and controlling stockholders if the Company&#x2019;s Personnel engage in insider trading and the Company has failed to take appropriate steps to prevent it (so-called &#x201c;controlling person&#x201d; liability).</font></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This insider trading policy is being adopted in light of these legal requirements, and with the goal of helping:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">prevent inadvertent violations of the insider trading laws;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">avoid embarrassing proxy disclosure of reporting violations by persons subject to Section 16 of the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;); </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">avoid even the appearance of impropriety on the part of those employed by, or associated with, the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">protect the Company from controlling person liability; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">v.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">protect the reputation of the Company, its Directors and its employees.</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As detailed below, this policy applies to family members and certain other persons and entities with whom Personnel have relationships.  However, nothing in this policy is applicable to transactions by the Company itself.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Policy Details</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Types of Material Information</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Information concerning the Company is considered material if there is a substantial likelihood that a reasonable stockholder would consider the information important in making a decision to buy or sell the Company&#x2019;s securities.  Stated another way, there must be a substantial likelihood that a reasonable stockholder would view the information as having significantly altered the &#x201c;total mix&#x201d; of information available about the Company.  Material information can include positive or negative information about the Company.  Information concerning any of the following subjects, or the Company&#x2019;s plans with respect to any of these subjects, would often be considered material:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the Company&#x2019;s revenues or earnings, including the Company&#x2019;s forecasts of the same; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a significant merger or acquisition involving the Company; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a significant change in management or the Board of Directors of the Company (the &#x201c;Board of Directors&#x201d;); </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the Company&#x2019;s decision to commence or terminate the payment of cash dividends;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">v.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the public or private sale of a significant amount of securities of the Company; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">vi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the establishment of a program to repurchase securities of the Company; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">vii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a stock split;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">viii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a default on outstanding debt of the Company or a bankruptcy filing;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ix.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a new product release or a significant development, invention or discovery; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">x.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">information concerning upcoming Food and Drug Administration actions or other significant regulatory developments, including a significant product recall;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">information concerning significant clinical trials or non-clinical studies, including the timing of and findings and data from such trials and studies;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a significant licensing or collaboration agreement or serious discussions regarding such an agreement;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xiii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the loss, delay or gain of a significant contract, sale or order or other important development regarding customers or suppliers; </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xiv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">any litigation or disputes to which the Company may be a party;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a conclusion by the Company or a notification from its independent auditor that any of the Company&#x2019;s previously issued financial statements should no longer be relied upon; or </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">xvi.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a change in or a dispute with the Company&#x2019;s independent auditor.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This list is illustrative only and is not intended to provide a comprehensive list of circumstances that could give rise to material information.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Nonpublic Information</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Information concerning the Company is considered nonpublic if it has not been disseminated in a manner making it available to investors generally.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Information will generally be considered nonpublic unless (i) the information has been disclosed in a press release, in a public filing made with the SEC (such as a Report on Form 10-K, Form 10-Q or Form 8-K), or through a news wire service or daily newspaper of wide circulation, and (ii) a sufficient amount of time has passed so that the information has had an opportunity to be digested by the marketplace.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Procedures</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibitions Relating to Transactions in the Company&#x2019;s Securities</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">i.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Covered Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  This section applies to:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">all Personnel;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">all family members of Personnel who share the same address as, or are financially dependent on, the Personnel and any other person who shares the same address as the Personnel (other than (i) an employee or tenant of the Personnel or (ii) another unrelated person whom the Company&#x2019;s Chief Executive Officer or Principal Financial and Accounting Officer determines should not be covered by this policy); and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">all corporations, partnerships, trusts or other entities controlled by any of the above persons, unless the entity has implemented policies or procedures designed to ensure that such person cannot influence transactions by the entity involving Company securities.</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">ii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibition on Trading While Aware of Material Nonpublic Information.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibited Activities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  Except as provided in this section, no Covered Person or entity covered by </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.i.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> may:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchase, sell or donate any securities of the Company while he or she is aware of any material nonpublic information concerning the Company or recommend to another person that they do so;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">disclose to any other person any material nonpublic information concerning the Company if such person may misuse that information, such as by purchasing or selling Company securities or tipping that information to others;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchase, sell or donate any securities of another company while he or she is aware of any material nonpublic information concerning such other company which he or she learned in the course of his or her service as Personnel of the Company or recommend to another person that they do so; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">disclose to any other person any material nonpublic information concerning another company which he or she learned in the course of his or her service as Personnel of the Company if such person may misuse that information, such as by purchasing or selling securities of such other company or tipping that information to others.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  The prohibitions in </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> and </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iii.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> on purchases, sales and donations of Company securities do not apply to:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">exercises of stock options or other equity awards or the surrender of shares to the Company in payment of the exercise price or in satisfaction of any tax withholding obligations, in each case in a manner permitted by the applicable equity award agreement; provided, however, that the securities so acquired may not be sold (either outright or in connection with a &#x201c;cashless&#x201d; exercise transaction through a broker) while the Personnel is aware of material nonpublic information or during a blackout period (as defined in </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iii.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">); </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">acquisitions or dispositions of Company common stock under the Company&#x2019;s 401(k) or other individual account plan that are made pursuant to standing instructions not entered into or modified while the Personnel is aware of material nonpublic information or during a blackout period;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">other purchases of securities from the Company (including purchases under the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company&#x2019;s Employee Stock Purchase Plan) or sales of securities to the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">bona fide gifts, unless the person making the gift has reason to believe that the recipient intends to sell the securities while the Personnel is aware of material nonpublic information or during a blackout period; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchases or sales made pursuant to a binding contract, written plan or specific instruction (a &#x201c;trading plan&#x201d;) which is adopted and operated in compliance with Rule 10b5-1; provided (i) such trading plan: (1) is in writing; (2) was submitted to the Company for review by the Company prior to its adoption; and (3) was not adopted while the Personnel was aware of material nonpublic information or during a blackout period; and (ii) any trade under such trading plan shall not occur until at least 60 days after the date of such trading plan, and if such trading plan is amended in any material respect or terminated, trades may not occur pursuant to such trading plan or a subsequent trading plan until at least 60 days after such amendment or termination.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Application of Policy After Cessation of Service</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  If a person ceases to be Personnel of the Company at a time when he or she is aware of material nonpublic information concerning the Company, the prohibition on purchases, sales or donations of Company securities in </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> shall continue to apply to such person until that information has become public or is no longer material.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iii.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Blackout Periods.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Regular Blackout Periods</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  Except as provided in </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.b.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, no Personnel or entity covered by </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> may purchase, sell or donate any securities of the Company during the period beginning one week prior to the end of each fiscal quarter and ending upon the completion of the first full trading day after the public announcement of earnings for such quarter (a &#x201c;regular blackout period&#x201d;). </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Corporate Blackout Periods</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  The Company may from time to time notify Personnel of a period in which no securities of the Company may be traded (a &#x201c;Blackout Period&#x201d;). Blackout Periods are often put into effect around the time of significant events or developments involving the Company.  In such event, except as provided in </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.b.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, no such Personnel may purchase, sell or donate any securities of the Company during such Blackout Period or inform anyone else that a Blackout Period is in effect.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibition on Pledges</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  No Personnel or entity covered by </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> may </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchase Company securities on margin, borrow against Company securities held in a margin account, or pledge Company securities as collateral for a loan.  However, an exception may be granted where a person wishes to pledge Company securities as collateral for a loan (other than a margin loan) and clearly demonstrates the financial capacity to repay the loan without resort to the pledged securities.  Any person who wishes to pledge Company securities as collateral for a loan must submit a request for approval to the Company&#x2019;s Principal Financial and Accounting Officer.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibition on Short Sales and Derivative Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  No Personnel or entity covered by this section may engage in any of the following types of transactions:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">short sales of Company securities, including short sales &#x201c;against the box&#x201d;; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchases or sales of puts, calls or other derivative securities based on the Company&#x2019;s securities; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchases of financial instruments (including prepaid variable forward contracts, equity swaps, collars and exchange funds) that are designed to hedge or offset any decrease in the market value of Company securities.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">e.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Partnership Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  Nothing in this policy is intended to limit the ability of a venture capital partnership or other similar entity with which a Director is affiliated to distribute Company securities to its partners, members or other similar persons.  It is the responsibility of each affected Director and the affiliated entity, in consultation with their own counsel (as appropriate), to determine the timing of any distributions, based on all relevant facts and circumstances and applicable securities laws.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">f.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Underwritten Public Offering</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  Nothing in this policy is intended to limit the ability of any Personnel to sell Company securities as a selling stockholder in an underwritten public offering pursuant to an effective registration statement in accordance with applicable securities law.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">iv.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notice and Pre-Clearance of Transactions. </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Pre-Transaction Clearance</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  No Personnel or entity covered by </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> (a &#x201c;Pre-Clearance Person&#x201d;) may purchase or sell or otherwise acquire or dispose of securities of the Company, other than in a transaction permitted under </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.b.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, unless such person pre-clears the transaction with the Principal Financial and Accounting Officer.  A request for pre-clearance shall be made in accordance </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">with the procedures established by the Principal Financial and Accounting Officer.   The Principal Financial and Accounting Officer shall have sole discretion to decide whether to clear any contemplated transaction.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the Company&#x2019;s Chief Executive Officer or Principal Financial and Accounting Officer shall have sole discretion to decide whether to clear transactions by a Director or persons or entities subject to this policy as a result of their relationship with a Director; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the Chief Executive Officer shall have sole discretion to decide whether to clear transactions by the Principal Financial and Accounting Officer or persons or entities subject to this policy as a result of their relationship with the Principal Financial and Accounting Officer; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the Chairman of the Audit Committee of the Board of Directors shall have sole discretion to decide whether to clear transactions by the Company&#x2019;s Chief Executive Officer or persons or entities subject to this policy as a result of their relationship with the Company&#x2019;s Chief Executive Officer.  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">All trades that are pre-cleared must be effected within five (5) business days of receipt of the pre-clearance unless a specific exception has been granted by the Principal Financial and Accounting Officer or (i) the Chief Executive Officer or Principal Financial and Accounting Officer in the case of transactions by a Director or persons or entities subject to this policy as a result of their relationship with a Director, (ii) the Chief Executive Officer in the case of transactions by the Principal Financial and Accounting Officer or persons or entities subject to this policy as a result of their relationship with the Principal Financial and Accounting Officer, or (iii) the Chairman of the Audit Committee of the Board of Directors in the case of transactions by the Chief Executive Officer or persons or entities subject to this policy as a result of their relationship with the Chief Executive Officer.  A pre-cleared trade (or any portion of a pre-cleared trade) that has not been effected during the five (5) business day period must be pre-cleared again prior to execution.  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:16.667%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.999615998463994%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding receipt of pre-clearance, if the Pre-Clearance Person becomes aware of material non-public information or becomes subject to a Blackout Period before the transaction is effected, the transaction may not be completed.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Post-Transaction Notice</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  Each Personnel or entity covered by </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> who is subject to reporting obligations under Section 16 of the Exchange Act shall also </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">notify the Principal Financial and Accounting Officer (or his or her designee) of the occurrence of any purchase, sale or other acquisition or disposition of securities of the Company as soon as possible following the transaction, but in any event within one (1) business day after the transaction.  Such notification may be oral or in writing (including by e-mail) and should include the identity of the covered person, the type of transaction, the date of the transaction, the number of shares involved and the purchase or sale price.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Deemed Time of a Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.  For purposes of this </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iv.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, a purchase, sale or other acquisition or disposition shall be deemed to occur at the time the person becomes irrevocably committed to it (for example, in the case of an open market purchase or sale, this occurs when the trade is executed, not when it settles).</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Regulation BTR</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">If the Company is required to impose a &#x201c;pension fund blackout period&#x201d; under Regulation BTR, each Director and executive officer shall not, directly or indirectly sell, purchase or otherwise transfer during such blackout period any equity securities of the Company acquired in connection with his or her service as a director or officer of the Company, except as permitted by Regulation BTR.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Violations</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Violation of any of the foregoing rules is grounds for disciplinary action by the Company, including termination of employment.  In addition to any disciplinary actions the Company may take, insider trading can also result in administrative, civil or criminal proceedings which can result in significant fines and civil penalties, being barred from service as an officer or director of a public company or being sent to jail.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company Assistance and Education</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Education</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Company shall take reasonable steps designed to ensure that all Personnel of the Company are educated about, and periodically reminded of, the federal securities law restrictions and Company policies regarding insider trading.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Assistance</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Company shall provide reasonable assistance to all Directors and executive officers, as requested by such Directors and executive officers, in connection with the filing of Forms 3, 4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:4.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img36229724_0.jpg" alt="img36229724_0.jpg" style="width:192px;height:48px;"></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19800 MacArthur Blvd., Suite 250</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Irvine, California 92612</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">+1 (949) 238-8090</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">eledon.com</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">and 5 under Section 16 of the Exchange Act.  However, the ultimate responsibility, and liability, for timely filing remains with the Directors and executive officers.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Limitation on Liability</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">None of the Company, the Chief Executive Officer, the Principal Financial and Accounting Officer, the Chairman of the Company&#x2019;s Board of Directors or the Company&#x2019;s other employees will have any liability for any delay in reviewing, or refusal of, a trading plan submitted pursuant to </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.b.5.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, a request for pre-clearance submitted pursuant to </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iv.a.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> or a request to allow a pledge submitted pursuant to </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iii.c.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  Notwithstanding any review of a trading plan pursuant to </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.ii.b.5.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> or pre-clearance of a transaction pursuant to </font><font style="color:#404040;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section 4.A.iv.a.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, none of the Company, the Principal Financial and Accounting Officer or the Company&#x2019;s other employees assumes any liability for the legality or consequences of such trading plan or transaction to the person engaging in or adopting such trading plan or transaction.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Related Policies</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">OP-0003 Code of Conduct</font></p>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:21.116%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:20.216%;box-sizing:content-box;"></td>
      <td style="width:21.176%;box-sizing:content-box;"></td>
      <td style="width:7.698%;box-sizing:content-box;"></td>
      <td style="width:9.578%;box-sizing:content-box;"></td>
     </tr>
     <tr style="height:9pt;background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Page:</font><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9</font></p></td>
     </tr>
     <tr style="background-color:#f2f2f2;white-space:pre-wrap;word-break:break-word;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>eldn-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428, 333-237380, 333-255173 and 333-273900 on Form S-8 and Registration Statement Nos. 333-254890, 333-272052, 333-279711 and 333-282260 on Form S-3 of our report dated March 20, 2025, relating to the consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                                    </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Crowe LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Los Angeles, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 20, 2025</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;">
    <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
     <tr style="visibility:collapse;">
      <td style="width:33.333%;box-sizing:content-box;"></td>
      <td style="width:33.333%;box-sizing:content-box;"></td>
      <td style="width:33.333%;box-sizing:content-box;"></td>
     </tr>
     <tr style="word-break:break-word;white-space:pre-wrap;">
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
      <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     </tr>
    </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>9
<FILENAME>eldn-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html>
 <head>
  <title>EX-23.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1.01in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.2</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428, 333-237380, 333-255173 and 333-273900 on Form S-8 and Registration Statement Nos. 333-254890, 333-272052, 333-279711 and 333-282260 on Form S-3 of our report dated March 28, 2024 (except for previously disclosed adjustments to 2023, as to which the date is August 19, 2024 and Note 10, as to which the date is March 20, 2025), relating to the 2023 consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                                     </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ KMJ Corbin &amp; Company LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Glendora, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 20, 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>eldn-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, David-Alexandre C. Gros, M.D., certify that:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc.; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions): </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:3.74%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:47.26%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>eldn-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATIONS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Paul Little, certify that:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc.; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.508421052631579%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.065%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.065%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions): </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.5108231948175064%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.5108231948175064%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.251%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:3.499%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:47.251%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Little</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;padding-left:0.1in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>eldn-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.75in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="exhibit_321"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 32.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), the undersigned, David-Alexandre C. Gros, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1).</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of <br>1934; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2).</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:45%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David-Alexandre C. Gros, M.D.</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David-Alexandre C. Gros, M.D.</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>eldn-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.75in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="exhibit_322"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 32.2</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), the undersigned, Paul Little, Chief Financial and Accounting Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1).</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of <br>1934; and </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.752626672113803%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2).</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"></td>
    <td style="width:5%;box-sizing:content-box;"></td>
    <td style="width:45%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 20, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Paul Little</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Little</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img36229724_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img36229724_0.jpg
M_]C_X  02D9)1@ ! @$%H 6@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +7"T$# 2(  A$! Q$!_\0
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MOV4>H:-K>D745[IVH6DI91+;W$3,I*2*\,\3;9K>XCEM[B.*>*2->@K^1/\
M8H_;B\:?LF^)GT^ZBO/%?PB\17L4OBOP7]I"SZ?<,8H9/%'A-IV$%GK\%LBI
M<V<C0:?XAMH8;'49;:>#3=5TO^K?X=_$3P9\5_!F@_$#X?Z]9>)/"?B2R6]T
MO5+)CM=<F.>UNH) EQ8ZC8W"26FHZ==QPWMA>PS6EW#%/$Z+_GUXJ>$V=>&>
M9J-7GS#A[&U9+*<ZC3Y85&DY_4L="+E'#8^E"[Y&U3Q5.$J^&;4:U*A_NO\
M1G^E!PA](KAR4\*J.1<=Y/AJ<^*.$*E=U*E!.4:2S?)ZM10GF&1XFJXQ551>
M(RVO5A@LPBI5,)B<;VM%%%?DY_3X4444 %%%% !1110 4444 %%%% !1110
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MY9F&%J*KAL=E^.H4\5@\7AZBTG1Q&'JTZM.2^*$T] HHHKF/0"BBB@ HHHH
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MY+G3%^*7Q&\+>#]2UV.-I%=?#>B:QJ5MK7B6XW0S*MIH&GZC=N89@D+&*3:
M?2%%?S>_%?\ X.OO^"+GPSN;NRT3X\?$3XRWEEN6:+X4? _XC36SSH6#06FK
M_$+2/AYH=_T!6ZL=3N-/<,OEWC8?;X'_ ,1DG_!)#_H6OVP/_#-^!_\ Y\%
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M;F35O!^K75J/''@&[N&CTCQ/80[X_-B<I+_96OV4,TKZ5K5O$TD$NV"]AO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAMO$.BM9Z7XEMK50"?/UK1+C3;Z4-B-8O"SLI625A+_0Q7\?7_!.[7;SP_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?YDO\ P<Q?\%I?V^)/VY?VB_V!OAE\8=:^!/[.7P;OO"OA2ZT7X0WM
MWX1\7_%"37_AYX2\7ZO?_$/X@:?-%XMN]-FN?$U]I*>#M"U/0_"%UHL<$&OZ
M/K]\KZ@W^FU7^.+_ ,'(7_*;7]O?_LH'P^_]4?\ "^@#\0W=Y'9W9G=V9W=V
M+.[L269F))9F))9B22223FFT44 %%%% 'ZD?\$Z_^"QO[>?_  3'\5Z?J'[.
MOQAU:\^&8U*.^\3?L^?$.ZU+Q;\#_%D+3))?I-X-N-0@/A75M12-(KCQ9X#O
MO"WBQDBAAEUF:SC-H_\ J1_\$??^"T/[-W_!7?X17VO_  ^C;X9_'WP!8Z>W
MQH_9Z\0ZO::CXB\*/=K! OBSPAJ<<=DWCCX8ZCJ4CZ?IWBN'3-,OK"^$6F>*
M-#T"_O-+CU+_ !E*^D?V1OVL/C;^Q#^T+\-?VFOV>_%MUX1^)OPRUZVU;3IT
MDN3I'B#2RZQZ[X,\6Z?;W%K_ &WX-\6Z6;C1/$NBRS1K?:9=S"&:VNTMKN
M_P!V>BOB3_@G7^W-\+_^"CG['_P>_:U^%(_L_2OB+H;P^*O"$]Y#>:I\._B-
MH,S:3X[\ ZO)&(W>X\/Z_;W*:;?S6UD=?\.7&B>)[:S@L-;LP?MN@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M35DLKGP[\0X[+S((?&>EOX@,&CZ=XUT/1[4 _I"HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSRM+<ZEX]^$,M[\(/'FIW3.2_P!HU3Q?X%UK4I Y)S=AE9D97;].Z "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH _SP_^#XO_ )*I_P $[?\ LG_[1W_J
M1_""OX0Z_N\_X/B_^2J?\$[?^R?_ +1W_J1_""OX0Z "BBB@ HHHH **** /
M]2K_ (,U?BC/XV_X)1^,O M[=223_!K]K3XJ>$M-LY)9I1:^'?$_@WX8_$BU
ME@#H(;>WNO$7C'Q6!;0R,1<V]U=2JANU+_UG5_#)_P &/OB*XN?@!^WQX2:-
MA:Z)\8?@QXBAE-P[(]QXH\%^,=-N8UM2HCA:*/PA:,UPCL]R)4CD55M(B_\
M<W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !1110!]<?L&_\GA?L_\ _8_6?_I%?5_9!7\;_P"P;_R>%^S_ /\
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MO]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?YX?_!\7_P E4_X)V_\
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M@<!2E9U*U3EISS#,:L?K68UX1J5G"C2PV'PY1117W!^-A1110 4444 %%%%
M!1110 4444 %%%% 'UQ^P;_R>%^S_P#]C]9_^D5]7]D%?QO_ +!O_)X7[/\
M_P!C]9_^D5]7]D%?P1]++_DL^&_^R8C_ .K7,3_;_P#9??\ )HO$#_LX]3_U
MF,@"BBBOY6/],0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#_%%_X+6?\ *6__ (*-_P#9X'QQ
M_P#4XU6OS!K]/O\ @M9_REO_ ."C?_9X'QQ_]3C5:_,&@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS%?P4H[QNKHS(Z,KHZ,5='4@JRL""K*0"K @@@$'-?T%?\$]/^"DD6NIX>^
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M7_NR;_W[BO[_ "@#^4'_ (@V_P#@DA_T,O[8'_AY/ __ ,Y^C_B#;_X)(?\
M0R_M@?\ AY/ _P#\Y^OZOJ* /Y0?^(-O_@DA_P!#+^V!_P"'D\#_ /SGZ/\
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M?K^KZB@#^4'_ (@V_P#@DA_T,O[8'_AY/ __ ,Y^C_B#;_X)(?\ 0R_M@?\
MAY/ _P#\Y^OZOJ* /Y0?^(-O_@DA_P!#+^V!_P"'D\#_ /SGZ/\ B#;_ ."2
M'_0R_M@?^'D\#_\ SGZ_J^HH _E!_P"(-O\ X)(?]#+^V!_X>3P/_P#.?H_X
M@V_^"2'_ $,O[8'_ (>3P/\ _.?K^KZB@#^4'_B#;_X)(?\ 0R_M@?\ AY/
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M#K^[S_@^+_Y*I_P3M_[)_P#M'?\ J1_""OX0Z "BBB@ HHHH **** /[_/\
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MB>,?"O@+PIIBA]2\3^-/$.D>%O#VGH0S!K[6M<O+'3;12J.P:>YC&$8YPIP
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M0Z_N\_X/B_\ DJG_  3M_P"R?_M'?^I'\(*_A#H **** "BBB@ HHHH _O\
M/^#&/_G*+_W9-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@
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M(;=5^T1W/U[\.?\ @^"^/&FR0?\ "W/V!OA'XSB&!<GX<_&CQE\,I&^6\#/
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MK/\ ](KZO[(*_C?_ &#?^3POV?\ _L?K/_TBOJ_L@K^"/I9?\EGPW_V3$?\
MU:YB?[?_ ++[_DT7B!_V<>I_ZS&0!1117\K'^F(4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MBB_\%K/^4M__  4;_P"SP/CC_P"IQJM?F#7Z??\ !:S_ )2W_P#!1O\ [/ ^
M./\ ZG&JU^8- !1110 4444 %%%% ']_G_!C'_SE%_[LF_\ ?N*_O\K^ /\
MX,8_^<HO_=DW_OW%?W^4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?X
MXO\ P<A?\IM?V]_^R@?#[_U1_P +Z_V.J_QQ?^#D+_E-K^WO_P!E ^'W_JC_
M (7T ?B#1110 4444 %%%% !7^OU_P &N/\ R@H_89_[N9_];#_:"K_(%K_7
MZ_X-<?\ E!1^PS_W<S_ZV'^T%0!^_P!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%8?B;Q/X:\%>'=;\7^,O$.A^$O"?AG2[W7/$GB?Q-JUAH/
MAWP_HNF6\EWJ.L:WK6JW%IINE:7I]K%+<WNH7]S;VEI;QR33S1QHS#^/3_@I
MS_P=_?LQ?L\3:]\+/^"?WA?3?VM?BM9->Z==_%W7YM4T3]G#PMJ,.(TFT>:R
M:P\6_&5H+E)XYU\.7'@[P?=VYMM1T+XAZ[!(]NH!_83XH\5>&/!'A[6/%WC3
MQ'H/A#PIX>L9M3U_Q/XHUC3] \/:'IML-UQJ.L:UJUQ::;IEC OS37=[<P6\
M0Y>117\SO[<?_!V7_P $P_V5)=:\*_!?6O$W[:WQ-TQ9K>/3O@C]FT[X30:H
MD<TD5OJOQN\1PKH%_ILNR -K7PRT3XH6D?VM%"23P7D%M_G"_MP?\%1?V[/^
M"BGB1];_ &L/VA?&GQ T2#4)=0T#X9V5TGA7X0^$I'=O)_X1OX9>'$T[PG:W
MEM;^79CQ!>Z?J'BJ^MH(?[7U[4IU,[? - ']3O[87_!W7_P5&_:)_M70?@=<
M_#?]C;P)>_:[:"'X5Z##XR^)TNF760+;5?BA\1+?6$M]0@0@0ZWX \'_  [U
M&)@9(GC<@C^</XS_ +0WQ[_:-\3/XT_: ^-7Q6^-OBQVF*^(OBO\0/%7C_5X
M%GD,DD%I>^*=5U2>RM=Q^2TM&@M8D5(XH4C1%7QZB@ HHHH **** "BBB@ H
MHHH **** /1_A;\8_B[\#?%-MXY^"GQ4^)'P?\;66S['XP^%OCCQ/\/_ !3:
M>7*D\?V;Q!X3U32-6@\N:-)D\J[3;*B2+AU!']#W[(7_  =A_P#!6/\ 9IN=
M,TKXF^//!?[7O@"TDLX;GP_\>/#%M'XRBTR$JMU'H_Q4\"?\(OXL?6+J-<)K
M'CL_$**"4^:^EW(+1M_,U10!_JD?L,_\'=7_  3=_::.C^%?VC;7Q=^Q)\2]
M0:*W<?$1V\>?!BYO957;#I_Q@\+:39SZ9"&$QGU#XA>!? .C6R+"#JTTLVQ/
MZAO!'CKP1\3/"NB>.OAQXQ\*_$#P1XEL8=3\.>,?!'B'2/%?A7Q!IMPH>WU'
M1/$.@WE_I&JV,Z$/#=V%Y/;RJ0R2,#FO\#&ON7]BO_@I/^V[_P $]?%B^*OV
M2OVA/'7PMM[C4H-3\0>!H;Y->^%GC.:%!;L/&7PR\0QZGX*U^:2RWV,>JW6C
M#7M-@E:31=6TR\2&ZB /]Q.BOXTO^"8/_!WY^S1^T))X;^%'_!0;PSI?[*'Q
M8NX['3(OC)H,VJ:O^SEXMU>14A>YU<7?]H>*O@S]LNG41KXBO/%_@[3X%GOM
M;^(&BVX6%?[%]!U_0O%6B:1XF\,:UI/B/PWX@TVRUG0?$&@ZC9ZQHFMZ/J5O
M'=Z=JND:KI\UQ8:EIM_:3175E?6=Q-:W5O+'/!+)$ZL0#6HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^'/VZ/^"CW[''_  3B
M^&C_ !-_:S^,OA_X?6UY;W;^$?!%L_\ ;OQ0^(M]:HQ_LSP#\/M,:7Q!K\C7
M'DV=WK!M[3PMH,UU;3>)]?T.PD-XH!]QU^=W[<G_  5<_8%_X)T:/+=_M5_M
M$^#?!/BA[$7^D?"G199O&?QB\012B/[(^E_#3PO'J?B>&QO7FBC@U_6K+2/#
M$18RWNMVEO%--'_ %_P4S_X.Y?VS/VHKC7_AO^Q%87W[&'P0NEN=.'C&RO++
M5OVEO%]A(\T?VR[\;VPFTCX3+<VXM)X--^&:/XKT2^CN1'\5-7LKE;:'^2WQ
M!XAU_P 6ZYJWB?Q5KFL>)O$NOZA=:MKOB'Q!J=[K.N:UJM],]Q>ZGJVK:C/<
MW^I:A>3N\]U>WEQ-<W$SO+-([L6(!_=)^VY_P>K_ !%UV76_"?\ P3\_9HT?
MP+I#^=:Z?\8_VD;A?$_C&6%VEC&H:3\)?!NJP^%/#FH0J(9[.77O'?C^PD9V
M2]T'$>Q_Y2_VK_\ @JY_P47_ &W9=4B_:8_:]^,WQ!\.ZPTQO?A[:^)G\$?"
MEDGC\AHE^%'@&'PO\.PHM\V_F-X:>X>)I1--*T\[R_GO10 4444 %%%% !11
M10 4444 %%%% 'TO^SE^V9^UE^R'KX\2?LP_M&?&3X%ZF]PES>Q_#?Q_XB\-
MZ-K3Q[2L7B7PW97R>'/%%F2J%]/\1:5JEC(T<;26[&-"O]1/[%7_  >7_MP_
M"!M(\,?MF?"GX=_M;>$+?RK>\\;>'DM/@C\:5C>0I)?75YX:TG4/A9XA^PP%
M'MM)A^&_A&[U&2)X[_Q3%)<F]M_XWZ* /]EG_@G]_P %]O\ @F=_P47DT;PS
M\)OC?;_#7XRZQ);VMO\  /X]Q:?\-/B?>ZC<JYAT_P +"XU74O!?Q$O)3%.Z
M6/P[\7^*=4@@B$VI:?IPEB5_V?K_  "4=XW5T9D=&5T=&*NCJ0596!!5E(!5
M@000"#FOZ.?^"9G_  <X_P#!0C_@G\_A[P!X^\1S?M?_ +..F30V\OPO^-'B
M'4KCQSX;T=2JO:?#/XSSPZSXK\-K;PQPV^F:)XJM?'?@K2;*%K/1O"NE-.UW
M& ?ZWM%?E9_P35_X+)?L-_\ !4WPC_:/[.WQ&_L?XH:7IXOO&G[/?Q(.F^&?
MC-X116>.XO1X=BU+4+'Q=X;C94?_ (2SP/JGB+0K6.[L;;6KG1M8N&TF']4Z
M "BBB@#_ #P_^#XO_DJG_!.W_LG_ .T=_P"I'\(*_A#K^[S_ (/B_P#DJG_!
M.W_LG_[1W_J1_""OX0Z "BBB@ HHHH **** /[_/^#&/_G*+_P!V3?\ OW%?
MW^5_ '_P8Q_\Y1?^[)O_ '[BO[_* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHKSWXJ?%KX7_  ,\ ^(_BI\9OB%X-^%GPV\(6+:EXG\=>/O$6E>%
M?"VAV898UEU'6M9NK.Q@:>9X[:T@:;S[R[EAM+2*:YFBB< ]"KE?&_CKP1\,
M_"NM^.OB/XQ\*_#_ ,$>&K&;4_$?C'QOXATCPIX5\/Z;;J7N-1UOQ#KUY8:1
MI5C @+S7=_>06\2@L\B@9K^)3_@I1_P>4_"OX>W/B#X7_P#!-3X8V_QH\2VD
MEQILG[1GQDT_6M!^$]K,A,4EYX!^&EO<:)XZ\<Q[78V>M>+=1^'EA:ZA:B5?
M#GBW1IXY9_X;_P!LG_@HE^VG^W_XP/C+]K7]H3X@?%R:WO+F\T+PMJ>IC2?A
MQX/>Z)\Q/!?PUT"/2_ WA;=$([>>ZT?0;74+^*" ZG>7TT8EH _TD_VV?^#M
MO_@F'^S#)K'A?X'7WC3]M3XD:=]IMH[3X06J>&_A+;ZG $9+;5OC)XPMH+&^
MT^Y20&#6_AGX6^)^G%U>.1XY(W5?Y0OVMO\ @[W_ ."I'Q[EU/2/@4?A7^QY
MX+N9)H[*/X<>%[3X@?$DZ=*Q(M=8^(7Q/M=>TQ[Q$(C75O!_@3P+=ICS(/)D
M.\?RK44 >]_'?]JC]IC]J'7?^$E_:/\ V@/C)\=-;6X:YM[[XK_$?Q;X[.GR
M,C1!=)M_$>K:A:Z/;Q0NUO;VFEP6=I:VQ%M;0Q0 1CP2BB@ HHHH **** "B
MBB@ HHHH **** /O7]EW_@J-_P %#OV+GTV+]F;]L'XY?##0M(4+8>!;?QE=
M^*/A=$%(*&7X3>-U\2_#.Z:/E8WN_"<[QH\D:,J2R*W].O['G_!ZA^U%X&NM
M/T#]MO\ 9S^'/QY\,JL%M/X]^#=U<_"#XF6JJH^T:KJ?A_4I/%'P\\773E2$
MTK2+/X86JF4R&_VPK!+_ !*T4 ?[*O[#/_!P%_P2W_;ZDTGP_P##']HG1_AG
M\5=6\B*'X*_M!I:?"3XA7%_<@F+2O#\VLZA<>!O'FJ/LF;^S?AWXS\6:A%##
M)<7-K;Q;6/[1U_@#U^X__!/+_@X:_P""EO\ P3M?1O#'@[XO3?''X(:5##8Q
M_ ?]H.?6/'W@S3-+B+".U\#ZZ^J6?CGX=K:)+<-8:?X4\2V?A474HN=5\+ZP
M(DA !_L8T5_.+_P3(_X.;_\ @GW_ ,%!Y/"_PX\<Z[_PR-^TKKGV;3T^%7Q@
MUNR7P3XIUZ50HL/AC\96M])\+>(Y+R=X+/2-#\5VG@/QIK.I3KIVA^%M795N
M9OZ.J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _A*_P""ZW_!
MTQ\>_P!ES]HGXN?L0?L,?#_P_P"!O&?P>U@^#_B/^T9\3=)T_P 9:JOBB32;
M6_NK/X3_  [O/M'A.TM]"DOK6/\ X2KXA6_BRWUNY2^M8O >GVEM::QJ?\-_
M[2O[>/[9W[8FJ7.J?M/_ +3_ ,;/C8+BX6ZCT3QSX_U_4?!VFR)+YZ+H'@2.
M\M_!?ANWCGS/':>'] TRTCG+3)"LK,Y^R_\ @OO_ ,IDO^"A/_9P&L?^F/0:
M_(&@ HHHH ^@_P!G_P#:R_:>_92\1+XK_9J_: ^,'P+UTW"7-S=_"_X@^)O!
MT.J.@C7RM=T[1M1M=,\06<J1117&GZW9ZA8W4*+#<VTL0"5_8[_P2\_X/&/B
MKX2USP]\*?\ @J'X:L_B7X#NY(=.'[3OPP\*V.A_$GPP\TT42:I\1OAIX;@L
M/"GC70[5':2_OOA]HWA;Q-865N\UOX:\;:I,MNW\+]% '^]I\)?BW\,_CQ\-
MO!GQA^#7CGPW\2OA?\0]#M?$?@OQQX1U.#5_#_B#1[O>J75E>6[$"2">.>RO
M[*=8;_2]2MKO3-2MK34+.ZMHO1*_R./^#>W_ (+=>,?^"6W[0-C\,?BOK^J:
MU^P]\;/$EE9_%CPS<27VI1_"7Q'?+%IME\;_  /IT<K_ &.\TW98VWQ&TS3[
M:5_%W@RTS]BOO$7AWPJUK_K;Z3JVE:_I6F:[H6IZ?K6B:UI]EJVC:SI-[;:C
MI6K:5J-M'>:?J>F:A9R36E_I]_:30W5E>VLTMM=6TL<\$DD4BL0#0HHHH **
M** "L?Q#XAT#PEH>K>)_%6N:/X9\-:!I]UJVN^(?$.IV6BZ'HNE6,+7%[J>K
M:MJ4]M8:;I]G CSW5[>7$-M;PHTDTB(I8?@__P %;/\ @X<_8O\ ^"6EMK/P
MY-\O[0W[6<5BDFG?L]> -9@MU\+3WD$DUA>_&/QVEGJND?#BQ9%AN/[!%IKG
MQ O+6\TV^M?!PT2_77;?_-3_ ."D'_!9?]O#_@J%XFO9_P!HCXJW6F?"B+5C
MJ7A/]GCX=&[\*_!?PF(9 ^GL?#D5W<7OC+6K$AI8?%7C_4_%'B*WFGN4TV_T
MW3GATZW /[Y/^"@W_!W+_P $_?V6)M?\"?LN:?JW[;WQ9TQKBQ_M+P-JB>$O
M@#I6I1[HRUW\7;_3M3G\90P,\5W;R?#3POXJ\-ZS"LMK'XTTN<^='_%Y^VO_
M ,'+7_!6/]M"36=$D^/EQ^S9\,-3DG2/X:_LOPWOPMC%A*LUN;/5OB/;ZA?_
M !>UV.[L9?LNL6%WX\B\-:H3*X\.6D4OV9/P*HH T-5U;5==U*]UG7-3U#6=
M7U*XDN]1U75;RYU'4K^[F.Z6YO;Z[DFNKJXE;YI)IY9)'/+,36?110 4444
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MKG&+E#A[BAT5[7!U:GM*D,@XB5%*EALWH4H2]AB8QI8/.*%.6*PD:%:&,R_
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MT HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OGS]I/]I/X=?LO_  ZO/'OCV\\VXE\ZS\*>%+.:)=<\
M8:XL6^+2]+B?=Y5O%NCEU;5I8VL](LV$TPEN);.SN\']JG]J[X<_LH^ _P#A
M*?&,IU;Q%JQFM?!?@:PN8HM;\4ZC"$\YD+K*-.T73A+%+K&MSPR6]E')#;PQ
M7FIWFGZ?=_R6_'?X[_$/]HOXAZK\1_B/JIOM4OB;?3-,MS)%HOAG18I)'LM
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MU<=FF:9A6E7Q>,Q59WG4JU)=$E&G2IP4:5"C"G1HPIT:<(1****[3QPHHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_ !Q?^#D+_E-K^WO_ -E
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MCXU>.=/%W!HUY8D&>3X>: -0\<W3+;6VL0^#M.U2T\1)_FF?M_?\%0/VTO\
M@IC\1/\ A/OVKOB]JGBG3].O)KKP7\*_#_VCPW\'/AO',LL7D^!_A];7<^FV
M-Y]EE-E=^)]6EUKQMK-I'#%X@\3ZL8(F3X"N+BXN[B>[NYYKJZNII;BYN;B5
MYKBXN)G:2:>>:1FDEFFD9I)99&9Y'9G=BQ),- !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5_2S_P $F/\ @YK_ &T?^"=USX9^
M%7QDU'6/VLOV3=/^RZ6/AWXZUR27XF?#;1D/E+)\(OB5J0N]2M[/3(/)6S\
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M/.SLU=3IU:52,*V&Q-&=/$87$4Z6)PU6E7I4ZD?XE/CY^S]\2OV;O'U[\/\
MXEZ,;"^C$EUHNKVK&XT+Q3HOGR0VVN:!?[56YLKCRR)()5AU#3I]UEJ=I9WL
M4L"^)5_:U^T;^S=\-?VGO %QX$^(FGN3"\E[X:\3:>(8_$/A+6&C$8U+1[J6
M.1=DRJD6I:;<+)8:I;*L=U#YL-I<6W\E7[2?[-'Q(_9?^(-YX'\?:>\EG,\]
MQX4\7V=O,OA_QCHT;J$U'2KB0,L=U"LD*:OH\LK7NCW4BQ3^9;S6=Y=_Z.>#
MOC1EWB-@XY9F3H9=Q?A*/-BL%%\F'S2E37OX[*U.3;27O8K!.4JN&;<X.KAU
M[2/_ #_?2Q^B)G_@#FU3B/AY8W/_  JS3%JGEV<3C[;'<.8FO+]UDO$CI4X0
MBY2;IY;FT84\-F,5&E46'QS^KU/GJBBBOW0_BT**** "BBB@ HHHH ^FOV7/
MVJOB7^RKX[C\5>";PWWA_4Y;2'QMX'OIBNA^+M*MY&(AF_=S'3=8M$EF?1M?
MM(C>:=/(\<J7NEW6HZ7??UJ? 7X_?#;]H[P!I_Q!^&NM1W]C.L4&L:/<-%%K
MWA76#$LEQH7B+3TDD:RO[<L3&ZM)9ZA;^7?Z9<WEA/#<R?Q(U[_^SA^TE\2/
MV8?B#;>//AY?HRS)'9>)O#&H/,_A_P 6Z,'+MINKVT,D;"2!F>;3-2@9+W2[
MHF6WD:&:[MKK\$\9?!7 >(>$J9QE$:&7\886C:EB&HTL/G-*E%*&"S*45I5C
M"*IX/'-.=%<M"OSX90]A_;WT2?I@9YX#YG0X4XJJ8W/?"C,\7?%8!2GB,=PC
MB,14;K9QP]3G*SPLZDW7S7)8N-+%MU,9@_99A*M]=_M9HKY\_9L_:3^'7[4'
MPZL_'O@*\\JXB\FS\5^%+R:)M<\'ZXT6^72]4B3;YMO+MDETG5HHUL]7LU,T
M(BN(KRSM/H.O\Z,SRS'Y-C\7E>:82O@<PP-:>'Q>$Q$'3K4*T'K&47HTU:4)
MQ<H5(2C4IRE"49/_ 'YX>XAR/BS(\KXEX:S3!YUD6=8.EC\KS3 556PN,PM9
M7A4IS5FI)J5.K2J1A6H5H5*%>G3K4YTXE%%%<)[(4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\@?M>?MC?#S]DWP
M8;_6Y(M>^(6N65RW@;P!;3[+[6)XR8%U/5I4#G1_#-I<G%WJ4RB2Z:*>STF&
M\O8Y8X><_;2_;:\#_LG^$)+>&33_ !-\7M>LG;P=X$%R&-NLOF11^)_%:6\J
MW.G>&K69)/)3=!>>(;N"33=*>-(=3U/2?Y1_B?\ $_QS\8_&^N?$/XBZ_=^(
M_%7B"Y\^^O[DJD<42#9:Z?I]I&%MM.TNP@"VVGZ=:1Q6MI;HL<48^8M_1W@K
MX'8KCBM1XBXDI5L'PC0J<U&E>='%<05:<E>CAY64Z66QDG'%8V#4ZK4L-@Y*
MK[7$83_/_P"E_P#3-RSP9PF,X!\/<1@\V\4\7A^3%XFU/%Y;P-A\1!\N*Q\+
MRI8GB&=.4:N6Y/54J6&C*GF.;4WAGA<!F>C\8/C'\0_CMXZU7XA_$SQ!<Z_X
MBU1V2/>SQZ=H^FK---::'H-@7>+2]%T\SRK:6,).&DEN;B2XO;BYNIO,***_
MT*PF$PN PN'P6!P]'"8/"TH4,-A<-3A1H4*-.*C3I4J5-1A3A"*2C&*22/\
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M\'"G_!P-XS_X*4^.M;_9E_9NUC6/!O["?@'Q(\:M ]SI>M_M,>)/#]^?L7Q
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MXW+,UR[$0Q.#QN&JWY:M&M3;B[24J=2#M4I583HU80JTYPB4445Q'KA1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4,L)U+PKXNT2:\T36[+S(YA;70O+">SU2TL;ZV^7J* /]RO_ ()__MR?!O\
MX*+_ +*?PM_:M^"-\I\-^/\ 25B\1^%;B^M[W7_AI\0-,CAA\9?#7Q7Y"0^7
MKWA75)#!]H:VM8-=T>?2/%&E1R:'KNEW,_V;7^4)_P &O?\ P5GG_8"_;(L_
MV>/BQXC^Q?LJ_M>>(- \'>)I=2NTATCX8_&2XD31?AQ\4!->7,%AI&CZC<W4
M'@GXBWSO:P#P[?:1XEU2XEA\!V5I+_J]T %%%% !1110 4444 %%%% !117Q
M=_P4)_;=^%W_  3M_9$^,?[6?Q8E6XT7X:^'9&\-^%X[I+74_B#\0M7;^S/
MGP_T9V65UOO%'B*>SLKB\2"X31-(&J>(;V+^S=(O9$ /YVO^#J'_ (+0W/[%
MWP4'["_[./BZ33?VHOVBO"=Q-\0_%?A[4#!K7P/^!>KM<Z9=SVE[;-Y^C_$#
MXIB'4="\-3P21ZMX;\*V^O\ BJV?2-5O/!.K3?Y?M>\_M/\ [2?Q:_; ^/\
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MU*%N6*3F\#E&%G*HLMRFG5G2PT)SJUJF)QU?%8RN4445^<G[^%%%% !1110
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M]@3_ */B_8__ /$E_@O_ /-K1_P\*_8$_P"CXOV/_P#Q)?X+_P#S:U_ACT4
M?[G'_#PK]@3_ */B_8__ /$E_@O_ /-K1_P\*_8$_P"CXOV/_P#Q)?X+_P#S
M:U_ACT4 ?[G'_#PK]@3_ */B_8__ /$E_@O_ /-K7I'A+]J?]F+Q\UFO@7]H
MWX#^-&U".2:P7PE\7OA]XC:^BAD,4LMF-'\0WAN8XI5:.1X=ZI(I1B&!%?X/
M]% '^_Q17^&A^S7_ ,%#?VY?V/=5TW5/V:/VK?CE\(4TMH3!X>\,^/\ 7)/
MMTENRO#;:S\.M6N=2\!>(+&-E4KI^O>&]2L<CFW()K^UK_@DE_P>!'QGXI\*
M_ 7_ (*F:)X7\+2ZY<6FAZ!^UWX!TK^P/#4&J7,L,%FWQT^']J9=-\/:?>SR
M3+>_$7P"FG^'=$=K!=9^'^D:$FM>,-- /[U:*IZ=J.GZOI]CJVDWUGJFE:I9
MVVHZ9J>G7,%[I^HZ?>P)<V=]8WEL\MM=V=W;2QW%M<V\DD$\$B2Q.\;JQN4
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M!CPKI^Q?B>8K=4^V^./@[H=H%UR[G22\UOX4V'DR7F?AYX?TK4 #_-@HHHH
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ML['SO$8FG\.\7_P4*_X*3I&FN? K]G/7Y5NEEN=)\??%/1KGRUA6/]S>>&_
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M75)$\7_"A&,8BCN/A5XGGDT?3;1;B]N?^$!U+P#JVHW(U#6;F"#\):_UW/\
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MFU3Q'XK\4:I:Z+H.BV$<CQ1&ZU+4[RVM(6FEB@1Y0\\L42O(O^R[_P $9/\
M@EK\//\ @E'^QKX0^">D0:3K7QI\80Z=XY_:3^)=E#ON/''Q2O+$?:-+L+^5
M([E_ OP^@N)?"7@*R,5G"VFVUYXFN=-M?$?BOQ'-=@'V_P#LH_LJ? []BCX!
M_#S]FO\ 9V\%V/@;X6_#718-*TC3[>.!M3UF_**^L>+?%>IPV]M)X@\9>*=0
M\[6/$WB"[C%SJFJ7,\Q6&$0V\/T5110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?P\?\'A_P#P2UM?B1\)/#?_  4Z^$GA]1X]^"]KH7PY_:5M=-A;
MSO$WPBU35TTSP'X_GM+:%C=ZM\.O%.M1^'-:OV5[N?P7XEL+B_N8=%\ 6ZQ?
MYQU?[VWQ;^%O@CXX_"SXD?!CXE:-#XB^'GQ8\"^*_AQXXT*? BU?PGXTT.^\
M.Z_IY<J_E-=:7J-U%',JEX)&2:/#HI'^'5^VO^R[XO\ V*?VM/VA/V4_'+37
M'B#X%_%+Q1X$&JS6DEB/$V@:??-/X/\ &=I:S*DL.F^-_"%UH7B[25D56.F:
MW:,5!;  /EZBBB@ HHHH **** "O]#O_ (,AOV@Y-1^%W[<?[*VH7D@3PCX\
M^&OQ]\*V+RJR3#X@:!J7P]\=W$$1^>+[$_PW^'JSL-T<K:E#@(Z.9?\ /$K^
MIG_@S]^-$GPT_P""OFE?#U[G9:?M$?L\?&;X8K9O*%BN-3\+6FB?&^TN$B9@
M)+RTT_X3ZS'$Z*TL5I=WX $4DQH _P!5^BBB@#\,O^"OW[,%YK>G:'^TSX-T
MM[FZ\/6<'A;XI064.Z9M"69CX:\6S1Q@%TTFYN)]"UBZ(FG%C>:"S"+3])N9
M8OY]*_O+U+3M/UC3K_2-6LK34]*U2RNM.U/3;^WBN['4-/OH)+:\LKVUG5X+
MFTN[:62"XMYD>*:&1XY%9&(/\Q_[?O\ P3OUCX"7VK?%GX1V%WK/P3O+D7.I
MZ7&TU[JWPRN;R8K]EO"YDN;[P@T[I%I>MR-+<:=YL6F:X[2I:ZKJO]N_1U\8
M,%/ 8/P]XDQ4<-C,+)T.&L=B)J-'&8>I-RIY/5JR=J>+H3G*&7\S4,10=/!4
M^2M1H0Q/^-_T^OHI9Q2SO-_'CP_RZ>893F5..,\0\EP-&4\7E..H48TZ_%>&
MP]*+=?*\91I0JY][.+K8#&QK9M6]K@\9C*V7?E)1117]AG^3X4444 %%%% !
M1110!O>&/%'B/P5X@TGQ7X2UO4O#GB30;V+4-'UO1[N:QU'3KR'.R:VN8&61
M"59XY$R8YH7D@F22&21&_J/_ &$/^"@'AO\ :9TJR^'_ (\EL_#GQTTK3V:Z
MLP(K/2/B!:V,6;C7/#"[PD.J1P(;O7/#:JKVRB?4M(6?2H[N+2/Y4JU-$UO6
M/#6L:7XA\/:I?:+KNBWUKJ>D:OIEU-9:CINHV4R3VE[97<#I-;W-O,B212QN
MKHZ@@U^8^)WA=D?B7E'U7&QC@\YP<*CR?.J=-2KX.K)-^PKI6>)R^M.WM\-*
M2L_WM"5*LE,_HSZ.7TDN,_H\<5K,LGG4S;A+-:U"/%G"%>O*&"S;#0DHO&8.
M3YH9?GN%I<RP68PA)-?[-C*>)P<I43^\2BORI_8#_P""A^D?'_3]/^%GQ>U'
M3]$^-UE$+?3=0=+?3=+^)]M#$SF\TV&%(;*P\60Q1,^K:! D%O? '4] A6W:
M]TK1OU6K_-'BSA//."LZQ60Y_A)87&X9WA-<TL-C,/)M4L9@J[C%8C"UE%N%
M1)2C)3HUH4J]*K2A_P!$?AAXH<&>+_"&6\;<#9K3S/)\PCR5:4N2GF.4X^$(
M2Q.49Q@XU*DL#F>#<XJM0E*=.I3E2Q6$K8G!8C#8FL4445\V?H(4444 %%%%
M !1110 4444 %5;VRLM3LKO3M1M+74-/U"UN+*_L+VWBN[*]LKN)X+JTN[6=
M)(+FUN8))(;BWFC>*:)WCD1D8J;5%--Q:E%N,HM.,DVFFG=--:IIZIK5,F<(
M5(RA.,9PG&4)PG%2C.$DU*,HM-2C)-J46FFFTU8_FM_X*"?\$X[SX13:E\9/
M@1HU]J7PLE\^^\6^#K07&H7_ ,.657GN-4L=QFN[SP245Y)WE::Y\-,";F27
M2&6?3_QYK^]62..:-XI426*5&CDCD57CDC=2KHZ,"KHZDJRL"K*2""#7\[O_
M  4*_P"";I\#1Z]\=OV?](EF\'>;<ZMX[^&^G6Y=_!T+*)KOQ#X3MH@7E\*Q
MOYUQJNC1J7\,QL;K3U;P[%/#H/\ <'@?X]K,?J?!O'.,2S!^SPV2\08F>F8-
MODI8#-:TG:..?NT\-C9M1QC2I8F2QCC5Q?\ C5],SZ$$LA6;>+7@SE+GD2]O
MF/%_ N7T5S9'%+VF)SOAG"TES3R=?O*V8Y/1BYY0N;$Y?3>4JIA\K_$RBBBO
MZ_/\I@HHHH **** "BBB@"U97MYIMY::CIUW=:?J&GW5O>V%_97$MK>65Y:R
MI/:W=I=0/'/;75M/&DUO<0NDL,J))&ZNH(_I+_X)]_\ !1NT^,,>F_!KXZZK
M8:7\4X8X++PGXON6AT_3_B,B(D,>G:@69+6S\<,P!C2(06GB4OMLH+?55%K?
M_P U5/CDDAD26)WBEB=9(Y(V9)(Y$8,CHZD,CHP#*RD,K $$$5^?^(OAQD/B
M1DLLLS:G[#&4%.IE6<4:<98S+,1)*\J=W'VV&K.,(XO!SG&GB(1BU*E7IT*]
M']T\ _I <;_1^XOI\1\+UWC,IQDJ-'B?A3%5ZE/*>(\!3E*U.LHQJ?5,QPJJ
M59Y9FM*E.O@:TYQE#$X*OC,%BO[U:*_$W_@GM_P4BC\<-X?^!'Q_U5(/&FR#
M2? OQ*U*Z58?&4@*PV/ASQ5-*%6W\5LNR#2];EF,7BF399WWD^(S#/XB_;*O
M\S>->"<^X"SNOD>?X;V5:%ZF$Q5.\\'F.$<I1IXS!5FDJE*=FI0DHUJ%12HU
MZ=.K"4%_T4^#_C%P1XW<&X/C/@C,5B<)5Y</F>68CDIYMD&:*E"IB,IS?"J4
MG0Q5'G3IU82J87&4'#%X*OB,-5IU9%%%%?(GZF%%%% !1110 4444 %%%07-
MS;65M<7EY<06EG:02W-U=7,L<%M;6T$;2SW%Q/*R10P0Q(\DLLC+''&K.[*J
MDAI-M))MMI))7;;T226K;>B2W%*48QE*4E&,4Y2E)I1C%*[E)NR223;;=DM6
M2221PQO+*Z111(TDDDC*D<<:*6=W=B%1$4%F9B%5022 *_GL_P""A'_!2:7Q
M.VK_  /_ &<_$1C\+/%<:9X]^)FD2@2^)EFC:&[\->#[Y1YEOX?56>'5O$-H
MT=QKC[[+2YH]"6>ZU[CO^"@W_!1V]^*4NO?!#X$ZJUG\,%:33/&'CFR>6'4/
MB"T;/'>:3HMPKH;3P/(?W5U.J"Z\4HA3S(O#TLMOK'XW5_;W@?X!K _4^,>.
ML&I8WW,3DO#V)@I1P::4Z./S:C--/&JZGAL#--8-J-;$Q>+Y:.$_QN^F7]."
M><_VKX3>"^;2IY0G6R_B_CS+J\H5<V<92I8K(^&,71DI0REVE1S'.J,N;-8N
M>%RZ<<L=3%9F4445_8)_E"%%%% !1110 4444 %/CCDFD2*)'EEE=8XXXU9Y
M))'8*B(B@L[NQ"JJ@LS$  DU/965YJ5Y::=IUI=:AJ&H75O96%A96\MU>7MY
M=2I!:VEI:P))/<W5S/(D-O;PH\LTKI'&C.P!_I _X)\_\$X['X66^B?&OX[Z
M/#>_%%V@U7P=X+O0D]E\/$*%K74]8@R]O>^-&WK<00R"6#PLZ0O%NUY#-I?P
M'B)XC9#X<9++-,WJ>VQ==3IY5E%&I%8S,\3&-^2FG?V.&I-QEB\9.,J6'A**
M4:M>I0P];]R\!? 'C?Z0/%]/AOA7#_5,KPCHU^)N*<91JRRCAW+IS:=6O*'+
M]:S'$QC4AE>4TJD,1CZT).4\-@J&-QV$Y+_@GO\ \$VD\'MI/QO_ &B= MKG
MQ24MM2\!?#35K>.YM_#'F1QW%MXD\7V,Z-%)XGC+*VE:#<(Z>&Y$%]J"/X@%
MM!H'[=T45_F;QMQOGW'V=UL\S[$^TJRO3PF$I<T<%EV%3;AA,%1E*7LZ<?BG
M-N56O4<JU:<ZDG(_Z*?![P;X(\#^#L'P;P1E_P!7PU-QKYIFN)5.IF_$&9N"
MC6S3-\7"G3]OB)VY*-*,88;!8=0PN#HT:%., HHHKY _50HHHH **** "BBB
M@ HHHH **** "OQ._P""A/\ P4BB\#_\)#\"/@!JRS^-=LVD^.?B3IMRKP>#
MF;?#J'ASPM/%N$_BQ!FWU/6HI/*\,.9;2Q,GB-)9_#_%_P#!0K_@I,D2:U\"
MOV<O$$GVKS+G2O'_ ,4]&N6C%N(V,%YX:\"ZC;N':=G$D&K>*;1U2%%:UT&>
M625]2M?P-)+$LQ)8DDDDDDDY))/))/))Y)K^R? _P#=?ZGQCQW@FJ%X8G)>'
M<53:=:SC.CF&;T9I-4-%/#9=5C^_7+5Q<?8<M"M_DI],OZ<*P7]J^$W@KFZE
MC+5LOXOX_P MKQE#"*2G1Q>1<*XNDVI8RSE2S#/L/.V#:GALJJ/%\^-PCI))
M)I'EE=Y997:2221F>221V+.[NQ+.[L2S,Q+,Q)))-,HHK^UTDE9*R6B2V2['
M^/3;;;;;;=VWJVWNV^K84444 %%%% !1110 445^]O\ P3O_ .";\\$_AK]H
M#]H'26@>!K37OAU\,M0@>.>.>-TN=*\5^-+>4*8C$5COM&\,R(7+FVO=;$?E
M_P!DR?%\=\>9#X>Y'6SK/*Z3:G3R_+Z4H_7,TQBAS0PN%IN_]UU\1)>QPU-^
MTJR5X1G^O>"G@GQMX[<9X7A#@W!-I.EB,]SS$0FLIX;RJ554ZN99E65EHE..
M#P5.3Q>8UX^PPT':K.E]??\ !,/]E^^^ /P3G\7>,-.ET_XC_%]]-\0:OI]W
M"T-[X>\*V4,__")>'[J&0F2VU%HK^^US5H76WN+>XU:#2;^V2ZT4L?TMHHK_
M "SXJXDS'B_B'->),UDI8W-<5+$5(Q;=.A348TL-A*/->7L,)AJ='#4>9N7L
MJ4.>4I7D_P#I8\-/#[(?"O@3ACP_X:ISAD_#&64\!0J55%8C&XB4YXG,,SQ?
M(E!XS-,PKXK,<7[.,:?UC$U%2A"FH0B4445\^?=!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
M^*+_ ,%K/^4M_P#P4;_[/ ^./_J<:K7Y@U^GW_!:S_E+?_P4;_[/ ^./_J<:
MK7Y@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ?M]_P;>_\ *;7]@C_LH'Q!_P#5'_%"O]CJ
MO\I#_@T.^ .K_%C_ (*^>$OBI!9R/H'[,/P7^,'Q/U?4'1_L<6H^-/"UQ\#=
M"TUI ZQ'4+W_ (6EJFI65O*)6>WT+4;N*,/8^=#_ *M] !1110 4444 %%%%
M !1110 4444 %%%% !7^.+_P<A?\IM?V]_\ LH'P^_\ 5'_"^O\ 8ZK_ !Q?
M^#D+_E-K^WO_ -E ^'W_ *H_X7T ?B#1110 4444 %%%% !7^OU_P:X_\H*/
MV&?^[F?_ %L/]H*O\@6O]?K_ (-<?^4%'[#/_=S/_K8?[05 '[_4444 %%%%
M !1110 445P/Q6^)'AGX-_"[XD_%_P :W+67@WX5> ?&/Q(\6WB>7OM/#/@;
MP[J/B?7KE?->*+=!I6EW<J^9)''E!O=%RP /\N3_ (.Z_P!L5_VBO^"H<_P+
MT'6&OO '[&GPYT/X76]K;WANM)?XH^-8+3XA_%/6+5 QCM]2BCU3P7\/]>B5
M0Z7_ ,./)E):#"_RP5ZK\=OC!XK_ &A/C;\7_CSX[F6?QK\:?B=X[^*OBR2.
M2:6'_A(?B!XGU3Q5J\=N]PSS?98;[59X;59&+1VZ1)P% 'E5 !1110 4444
M%?I]_P $<OV"+[_@I'_P4,^ '[,UQ:7DGPZOO$#>/?CCJ-G*]L^D?!/P 8=<
M\=XO8F$UA>>)H$LO 6@W\22FT\3>+M$FDC\A973\P:_TA_\ @RU_8GMO G[-
M?Q^_;P\3Z3L\5?'KQH?@K\,+R[LPLUM\*/A9-;W_ (OU71[X@-)I_C/XFW\F
MB:K;KE%O_A'9.3N!"@']K^C:-I/AW1]*\/Z!IMCHVA:%IMCHVBZ/IEK#8Z;I
M.DZ9:Q66G:;IUE;I';V=C8V<$-K:6L$:0V]O%'%$BHBJ-*BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&XM[>\MY[2[@ANK6ZAEM[F
MVN(DGM[BWG1HIH)X95:.:&:-FCEBD5DD1F1U*D@_XC/_  5?_9#D_83_ ."B
MG[6G[,$%@VG>&/A]\6M;OOAO ?-93\)?'45MX_\ A2!/*/\ 29K?X?>)_#ME
MJ$L;/&NJ6M]!NWPNJ_[=E?YNO_!['^S3#X/_ &J?V2OVKM)LEAM?C?\ !WQ5
M\(_%,EK;%8G\5? [Q)::WINJZI<J,-J6M>%OBS8:-9B5@TNG>!@D*E;*4@ _
MB1HHHH **** "BBB@#].O^",?[3TG['W_!4?]B?XZ37W]G>'](^.'AKP3XZN
MWE6.WM_AS\75N?A-\0+VY1PT4\>E>$?&NKZS##*%'VS3K66.:VN(H;J#_:^K
M_ )1WC=71F1T971T8JZ.I!5E8$%64@%6!!! (.:_W,O^">WQ_D_:I_86_9$_
M:*N[O[=K'Q@_9W^$WC7Q1/E25\::IX-TD^.+5RK.#)8^+X];LI"&.9+=B<$D
M  ^Q**** "BBB@ K^=7_ (.F/VJ9/V9/^"/WQPT32-4_LSQC^T[X@\(?LS>&
MFCE43R:9XWN+SQ%\3(6@$B32V>H?"7P=XZ\/W,BYB@FURS\\,)4AF_HJK_.K
M_P"#W+]I&?6/C?\ L7_LCZ;?[=/\ _#/QM^T#XLL8)4DBO=7^)WB7_A /!9U
M!07,-YX?TSX8>,9;*(>3)]D\83S3K/'/9-$ ?PMT444 %%%% !1110 5ZS\!
M?@IX]_:0^-GPG^ 'PMTMM9^(GQE^(7A/X:^#=/VSF"37O&&M6>B6-Q?R6\-Q
M)::38RWGV_6-0,+PZ9I5M>:A<[;>VE=?)J_LH_X,U/V'(/C+^V?\6/VU/&&C
MQWGA']DGP7!X;^'\M[;N89OC7\9+/6-&@U.P>2-K2[D\'_#73?&BZA"2;C3-
M0\:>$M3B\N86\@ /]"[]BK]E'X=?L.?LJ? S]E#X5P*O@[X*> =)\)PZB;:.
MTNO$^O#S=2\8^-M4MX6:*/6O'/B^_P!<\7ZTL3&%=4UJZ2 ) L:+]1444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?EY_P6)_X)W>&
MO^"G/[!?QC_9MO+33U^),>ES?$'X >(KXPP#PO\ ''P?I^H7/@F:34)@5T[1
M_$[7%]X$\5W>V0P>%/%.M7$,37<%JR?J'10!_@/^(?#^N>$M?USPKXGTG4-
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M62*D7BVQTV2#X1?%/43;QM*[:]H&F3_#+Q'JEXT%G:7'AOX9Z?"9=0U^8O\
MZ%U?,_[97[+O@']M;]E?X\?LJ?$V&-O!_P <OAOX@\#W=^UI%?3^&]8O+<77
MA+QMIEK,R0RZYX#\76>A>-/#_G'R4UO0=/DE#(C*0#_"?HKTOXT?"/QS\ ?B
M]\4/@;\3=*_L3XB_![X@>+_AGXXTD.TL5CXJ\$:]?^'-<@MIVCB^U68U'3KA
MK*\6-8[RT:&ZB'E3(3YI0 4444 %%%% !7]VW_!D]^V-+H7Q._:K_8.\1ZLR
MZ3X]\.Z7^TM\+=.G>.*UM_%W@^72? 'Q6MK0DB2YU;Q/X7U7X<ZBMNN[R]+^
M'6HW*@*DQ/\ "37ZA?\ !%O]J27]CC_@J/\ L7?'*;4I-+\-V'QH\/\ @+X@
M7'G-':K\./BZMQ\+/'5U?Q>;%#=V^C^'?%]]X@@@N28DU'2+&[0)<6L$L8!_
MM;4444 %%%% !1110 4444 ?XPO_  7W_P"4R7_!0G_LX#6/_3'H-?D#7Z_?
M\%]_^4R7_!0G_LX#6/\ TQZ#7Y T %%%% !1110 4444 ?W9?\&<7_!+V/QE
MXX\<?\%/_B[X;:7P_P##:ZUCX3?LM0:G#$;74?B!?Z<]G\5?B?:6TJ+/(O@[
MP]J4/@'PSJ:>=I=SK'BGQTB!=<\'V\UG_HC5^.G_  ;\Z=I^E_\ !&;_ ()]
M6VFV-GIUM+\#(=1DM[&V@M()-0U?Q;XHU;5KYXK=(XWO-4U6]O-3U&Y93/>Z
MA=W5Y<O+<SRR/^Q= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6+RK,</.6'S+*,:H>ZL5E^,IU</.<4J>(IQIXNAS8;$49R****^8/T8****
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MA"BBB@ HHHH **** "GQQR32)%$CRRRNL<<<:L\DDCL%1$106=W8A55069B
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MD*BB@ HHHH **** "BBB@ HHHH **** "BBB@ K_ !Q?^#D+_E-K^WO_ -E
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M@M+2":ZNKJ:*WMK:WB>:XN+B9UCA@@AC5I)9II&6.**-6>1V5$4L0#_N1?\
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M4C151%"@ 34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ!POGN$I2;<*-;B;+\WP.,]G?X547"V&E.*M%27.ES3DV4445_(9_JH%%%%
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MBBB@#^_S_@QC_P"<HO\ W9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO[_*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O\ '%_X.0O^4VO[>_\ V4#X
M??\ JC_A?7^QU7^.+_P<A?\ *;7]O?\ [*!\/O\ U1_POH _$&BBB@ HHHH
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M /&:_B#HH _M\_XC>?VI_P#HQ_\ 9_\ _#A?$7_XS1_Q&\_M3_\ 1C_[/_\
MX<+XB_\ QFOX@Z* /[?/^(WG]J?_ *,?_9__ /#A?$7_ .,T?\1O/[4__1C_
M .S_ /\ APOB+_\ &:_B#HH _M\_XC>?VI_^C'_V?_\ PX7Q%_\ C-'_ !&\
M_M3_ /1C_P"S_P#^'"^(O_QFOX@Z* /[?/\ B-Y_:G_Z,?\ V?\ _P .%\1?
M_C-'_$;S^U/_ -&/_L__ /APOB+_ /&:_B#HH _M\_XC>?VI_P#HQ_\ 9_\
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M@:]U[3+.]A%G<ZEHUOKLFI6$%T1;R7=K"LI"%B/X]:* "BBB@ HHHH ****
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M\/%\5?\ !5#XF>-+F'-K\+OV//B;K5I<[HSY>O\ B7XD?!_P;96_E?:HI_\
M2-"UOQ/+YXM[NVB^R>3,L,US:2C_ %%Z "BBB@ HHHH **** "BBB@ HHHH
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M>O[V*_B_Z7O_ #;W_N[/_?9/]>/V57_-^/\ O%__ ,$0****_B\_UX"BBB@
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MVNY5:U2RO&G&G"!1117A'V@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MBB_\%K/^4M__  4;_P"SP/CC_P"IQJM?F#7Z??\ !:S_ )2W_P#!1O\ [/ ^
M./\ ZG&JU^8- !1110 4444 %%%% ']_G_!C'_SE%_[LF_\ ?N*_O\K^ /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD10I]EN3XD^TV.Y#-]BEM_M,L]QYL\G^T17^.+_P<A?\IM?V]_\ LH'P^_\
M5'_"^@#\0:*** "BBB@ HHHH _JY_P"#-[Q(NA?\%<M>TMM0DLSXR_9$^,WA
MM+=(Y775FM?&/PE\8'3YFCBD2&.-/"CZH))W@B,NFQ1+*9Y88)O]3^O\H3_@
MT._Y3)^"?^R ?';_ -,6F5_J]T %%%% !1110 4444 ?XPO_  7W_P"4R7_!
M0G_LX#6/_3'H-?D#7Z_?\%]_^4R7_!0G_LX#6/\ TQZ#7Y T %%%% !1110
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M\=_M9^-S>WQNO#OPVT"XG3P/X"CNB\%C"V8VUO76B(AU/Q/J$0'VBY*M;Z;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5_CB_P#!R%_RFU_;W_[*!\/O_5'_  OK_8ZK_'%_X.0O
M^4VO[>__ &4#X??^J/\ A?0!^(-%%% !1110 4444 %?Z_7_  :X_P#*"C]A
MG_NYG_UL/]H*O\@6O]?K_@UQ_P"4%'[#/_=S/_K8?[05 '[_ %%%% !1110
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M:?[?_P#XAO\ M%?_ #N:/^'3O_!4W_I&G^W_ /\ B&_[17_SN: /@"BOO_\
MX=._\%3?^D:?[?\ _P"(;_M%?_.YH_X=._\ !4W_ *1I_M__ /B&_P"T5_\
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MFC_AT[_P5-_Z1I_M_P#_ (AO^T5_\[F@#X HK[__ .'3O_!4W_I&G^W_ /\
MB&_[17_SN:/^'3O_  5-_P"D:?[?_P#XAO\ M%?_ #N: /@"BOO_ /X=._\
M!4W_ *1I_M__ /B&_P"T5_\ .YH_X=._\%3?^D:?[?\ _P"(;_M%?_.YH ^
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MWP&T?4;NS#6UWXQ^+/C70/'.I?V-=RQ,IU+P[X=^$T4&KFUE6XL]/\;:?%<
M6^L()/SX_8X_X--/^"JO[1OBK1S\;O _AG]CKX63303:UXV^+'B7PWXE\8_V
M8607,?ACX4> M>UOQ%>Z]&CAH-.\;7OP\TN4++OUZ*2-89?]*C_@GO\ L#?
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M]D.Z\6P%T4-+-X"^,?PRTLP0SM.A$C0>/YYS;);S-/%;2W!E@2S99_\ 3 H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^
M$+_@^+_Y);_P3L_['_\ :/\ _4=^#U?YXE?Z'?\ P?%_\DM_X)V?]C_^T?\
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M43Q"]M=(U/X)_L[ZQ;7%Y"KF;R[S5KS74M+J5$286D]O$SFRE"?Y?%?Z,/\
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M **** /\87_@OO\ \IDO^"A/_9P&L?\ ICT&OR!K]?O^"^__ "F2_P""A/\
MV<!K'_ICT&OR!H **** "BBB@ HHHH _V>?^" __ "AL_P"">W_9 -(_]/NO
M5^O]?D!_P0'_ .4-G_!/;_L@&D?^GW7J_7^@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#_!&^+'_ "5+XE?]C_XR_P#4BU*N KO_ (L?
M\E2^)7_8_P#C+_U(M2K@* "BBB@ HHHH **** /[^**** /] "BBB@ HHHH
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M$'P[PN$RKQ2PE!U,;@H^QPF7\>4:$(J&&QU6<J=#!\0TZ4%2R_-ZKA2Q:5/
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MO!<2*RM';WGA&76[.X<'Y(9W8@@8/^YC0 4444 %%%% !1110 4444 %%%%
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MS!<QAW^SO9KJ?Q;UFSBF@C60W=I?PSR2""%(?[3: "BBB@ HHHH **** /\
M&%_X+[_\IDO^"A/_ &<!K'_ICT&OR!K]?O\ @OO_ ,IDO^"A/_9P&L?^F/0:
M_(&@ HHHH **** "BBB@#_9Y_P"" _\ RAL_X)[?]D TC_T^Z]7Z_P!?D!_P
M0'_Y0V?\$]O^R :1_P"GW7J_7^@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@#_%%_P""UG_*6_\ X*-_]G@?''_U.-5K\P:_3[_@M9_REO\
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MVT,\37GC+Q%>S-;.2;H _O+HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_LX#6/\ TQZ#7Y U^OW_  7W_P"4R7_!0G_LX#6/_3'H-?D#0 4444 %%%%
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MB2OW7Z-__)V<B_[ L\_]5&+/XL_:!_\ *+W&O_8WX-_]:K*C\4:***_TK/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_%%_X+6?\
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MASXTO[CS?/NM9\9ZM+-"FU9[C^4"@ HHHH **** "OZ)?^#8W_@H5;?L(_\
M!3+P)H/CC78]'^!_[6-G:_L]?$R:]DV:7HGB'7]4M[GX0^-KIWE@M[3^POB
M+'P]J6KWLHL=%\'^-/%^HW"$PQR1?SM4Y'>-U=&9'1E='1BKHZD%65@0592
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M^ M7\06-C;:;H'PSB64 _N;HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK\@:_7[_ (+[_P#*9+_@H3_V<!K'_ICT&OR!H **** "BBB@ HHHH _V>?\
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ME]3ELW0S+*JN,P&(BFG*CB*BBU)IK^[*BBBO\A#_ *K0HHHH *_G5_X+6_\
M)4?@G_V(/B#_ -2)*_HJK^=7_@M;_P E1^"?_8@^(/\ U(DK]U^C?_R=G(O^
MP+//_51BS^+/V@?_ "B]QK_V-^#?_6JRH_%&BBBO]*S_ )X@HHHH **** "O
M[V*_@GK^]BOXO^E[_P V]_[NS_WV3_7C]E5_S?C_ +Q?_P#!$"BBBOXO/]>
MHHHH *^9?VS_ /DTW]HC_LD?C;_TRW5?35?,O[9__)IO[1'_ &2/QM_Z9;JO
MH>$?^2KX8_[*')?_ %988^%\4?\ DV?B)_V0O%W_ *S^8'\8-%%%?Z_G_*2%
M%%% !1110 5_21_P1:_Y(/\ %3_LKDG_ *AOABOYMZ_I(_X(M?\ )!_BI_V5
MR3_U#?#%?@GTE/\ DU.:_P#8SR7_ -3Z9_<'[/+_ )2:X<_[)OB__P!4U8_9
M"BBBO\VC_H0"BBB@!KND:L[LJ(BL[N[!51%!+,S$@*J@$LQ(  ))Q7\8'[7G
MQVOOVB_C_P"/?B/)=3SZ#)J4N@>!K:9F*:?X'T.>>UT"&&(JGV<W\9GUV^@
M(75=7U!][F0NW]8_[4_B&\\*?LU?'OQ!I[/'J&F?"+X@RZ?-&_EO;7TGAC4K
M>SNE8 G-I<S17.!AF\K:K(6##^*&O[-^B9P]AIRXJXIK0C/%47A,CP,VDW0I
MU8RQN8-7O:5;EP$5)6:C3J1NXU)(_P C/VHO'>8T:?AEX;86M4HY;C(YMQCG
M-*,I*&-Q&&J4\HR*,[64H8-5,[J2IR<HRJ5\/4Y8SH0DRBBBO[3/\@@HHHH
M**** "BBB@ K]1?V"/\ @GKK?[1E[I_Q/^)L-[H'P1TW4 8+?]_9ZO\ $N>R
MD=;C3=%F4QS67AR&YB%IK7B&(K+.PN=*T*0:A'>ZAHO7_P#!/S_@G5J?QHN]
M&^,?QJTNYTOX/6[QZCX<\-W)DM=2^)LL4I,,DB*4N;#P4'C+7%Z3#<Z_'MM]
M)(L9Y=3B_I7TS3--T73K'2-'T^QTG2=+L[?3],TO3+2"PT[3K"SA2WM+&QLK
M6.*VM+.U@CCAM[:WBCA@A1(XD5%"C^3_ !O\>H9"L7PAP5BH5,[:GA\WSNA*
M,Z>3WO"K@L#-7C/-5K&O75X9<[PAS8Y2>#_T^^AM]".MQM+*_%7Q@RRKA^#4
MZ6.X6X.QM.I0Q'%EG"KALWSFE)0J4>&9:5,)@I*-7/URUJJCDLH+-H-#T/1_
M#6CZ7X>\/:78:)H6B6%KI>D:1I=K#9:=ING64*6]I965I;HD-O;6\*)'%%&B
MHB* !6I117\(SG.I.=2I.52I4E*<YSDY3G.3<I3G*3<I2E)MRDVVVVVVV?[7
M4J5+#TJ5"A2IT:%&G"E1HTH1ITJ5*G%0ITJ5."C"G3IPBH0A!*,8I1BDDD%%
M%%2:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?XHO_  6L_P"4M_\ P4;_ .SP/CC_ .IQJM?F#7Z??\%K/^4M_P#P
M4;_[/ ^./_J<:K7Y@T %%%% !1110 4444 ?W^?\&,?_ #E%_P"[)O\ W[BO
M[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5_CB_\'(7_*;7]O?_ +*!\/O_ %1_POK_ &.J_P <7_@Y"_Y3:_M[
M_P#90/A]_P"J/^%] 'X@T444 %%%% !1110 5_K]?\&N/_*"C]AG_NYG_P!;
M#_:"K_(%K_7Z_P"#7'_E!1^PS_W<S_ZV'^T%0!^_U%%% !1110 4444 %%%%
M '\YO_!T1^P?-^VG_P $MOB/XJ\):1_:/Q:_9$U!_P!I3P2+:W@?4]2\)^%M
M(U"R^,?AB*X<&Y^QW?PXO-5\8#3+$-=:UXC\!^%[&**64Q(?\CFO]^Z^L;+4
M[*\TW4K.UU#3M0M;BQO["^MXKNROK*[B>WNK.\M;A)(+FUN8))(;BWFC>*:)
MWCD1D9E/^+;_ ,%K/^"?=[_P36_X*)?'3]GC3]+OK+X4ZAJP^*7[/M]>-+,F
MI_!+Q_=7NH^$[2"^G)FU*;P3?0:U\-=7U&81R7VO>"]4NQ&L4\3, ?E'1110
M 4444 %%%% 'ZP?\$9_^"GWCC_@E/^VIX*^/>F+J6N_"/Q,L'P]_:)^'MG/*
M5\8?";6-2LY=4O\ 3;$SP6DWC;P-<PQ>+? ]Q</!OU73YO#]S?6NA^(]<$_^
MRM\)OBM\//CI\,O ?QD^$OBO2?'/PS^)OA71?&O@?Q=H<_VC3-?\-Z_8PZAI
ME_;L0DL3/!,J7-G<QPWMA=)/8WUO;WEO/!'_ ()-?UZ?\&S/_!>M?V&/'&F?
ML/\ [6GBV2/]C[XH>)$7X:^.M9FC-G^S=\3/$NJ1+/<ZIJ5U<0KI?P7\:WUW
M+<>,GF,UCX(\1M%XVC33-(U'QW?7(!_J"45#;W%O>6\%W:3PW5K=0Q7%M<V\
MJ3V]Q;SHLL,\$T3-'-#-&RR12QLR2(RNC%2"9J "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** *]W=VEA:W-_?W-O96-E;S7=Y>7<T=M:VE
MI;1M-<7-S<3,D,%O!"CRS32ND<4:,[LJJ2/\EK_@Y-_X+&#_ (*;?M5Q?"_X
M*^)+J[_8U_9GU+5] ^%\EK.\.E_%SX@RDZ?XR^-]S:IM6ZTV_$)\-?#$WS7$
MUEX(MKCQ!;1:)?\ C_Q)I$7[D?\ !TU_P7LM+/3?'O\ P2Y_8Z\822ZM??:_
M"W[9'Q:\-WTL,>F:<1)!J_[.'A?48(U:YO-55EM_C)JFFW@M+;2Q<?"V:2^F
MU7QYI>E?Y]E !1110!_1#_P1]_X.+?VNO^"8VO\ A?X:^.=8\0?M&_L:Q26^
MFZM\#_%6L&[\0?#S1SY<7]I_ KQ7JKRW/A&XTI%$T/@.]N9?AWK$1O+0:7X>
MU?48_%FF?ZJ?[+/[4WP+_;0^!?@/]H[]G'QYI?Q$^%/Q$TM=0T36]/8Q7=A=
MQ$1:KX;\2:5*1?>'?%GAV^$NE^(O#NJ10:CI.HP2P3Q;?+DD_P (NOZ9?^#8
MS_@K'X@_8"_;6\-? #XA^([P_LH_M=^+- ^'_C72+RYDETCX>?%O7)K;P_\
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MQ_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444
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M/;_L@&D?^GW7J_7^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#_!&^+'_)4OB5_V/_C+_P!2+4JX"N_^+'_)4OB5_P!C_P",O_4BU*N
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MZMMO5MO=G^Q<8QC%1BE&,4HQC%)1C%*R22T22T26B6B"BBBD,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _Q1
M?^"UG_*6_P#X*-_]G@?''_U.-5K\P:_3[_@M9_REO_X*-_\ 9X'QQ_\ 4XU6
MOS!H **** "BBB@ HHHH _O\_P"#&/\ YRB_]V3?^_<5_?Y7^9'_ ,&EO_!2
M+]B3_@GQ_P -^_\ #8WQ\\/_  /_ .%N?\,K?\*Y_MWP]XYU[_A)_P#A ?\
MAI#_ (2_[+_PAGA?Q+]D_L7_ (33PQY_]I?8O/\ [6A^Q_:?)NO(_L=_XB1/
M^")7_1^_@#_PWOQQ_P#G74 ?M_17X@?\1(G_  1*_P"C]_ '_AO?CC_\ZZC_
M (B1/^")7_1^_@#_ ,-[\<?_ )UU '[?T5^('_$2)_P1*_Z/W\ ?^&]^./\
M\ZZC_B)$_P"")7_1^_@#_P -[\<?_G74 ?M_17X@?\1(G_!$K_H_?P!_X;WX
MX_\ SKJ/^(D3_@B5_P!'[^ /_#>_''_YUU '[?T5^('_ !$B?\$2O^C]_ '_
M (;WXX__ #KJ/^(D3_@B5_T?OX _\-[\<?\ YUU '[?T5^('_$2)_P $2O\
MH_?P!_X;WXX__.NH_P"(D3_@B5_T?OX _P##>_''_P"==0!^W]%?B!_Q$B?\
M$2O^C]_ '_AO?CC_ /.NH_XB1/\ @B5_T?OX _\ #>_''_YUU '[?T5^('_$
M2)_P1*_Z/W\ ?^&]^./_ ,ZZC_B)$_X(E?\ 1^_@#_PWOQQ_^==0!^W]%?B!
M_P 1(G_!$K_H_?P!_P"&]^./_P ZZC_B)$_X(E?]'[^ /_#>_''_ .==0!^W
M]%?B!_Q$B?\ !$K_ */W\ ?^&]^./_SKJ/\ B)$_X(E?]'[^ /\ PWOQQ_\
MG74 ?M_17X@?\1(G_!$K_H_?P!_X;WXX_P#SKJ/^(D3_ ((E?]'[^ /_  WO
MQQ_^==0!^W]%?B!_Q$B?\$2O^C]_ '_AO?CC_P#.NH_XB1/^")7_ $?OX _\
M-[\<?_G74 ?M_17X@?\ $2)_P1*_Z/W\ ?\ AO?CC_\ .NH_XB1/^")7_1^_
M@#_PWOQQ_P#G74 ?M_17X@?\1(G_  1*_P"C]_ '_AO?CC_\ZZC_ (B1/^")
M7_1^_@#_ ,-[\<?_ )UU '[?T5^;WP<_X+"?\$MOC[?6&D_"S]O?]E[7-=U5
MHH]+\-:Q\6/#/@?Q5J<TT<<B6^G>%O'EYX9\17UULD7?:VNF2W,;+*DD2/!,
ML?Z-V]Q;WEO!=VD\-U:W4,5Q;7-O*D]O<6\Z++#/!-$S1S0S1LLD4L;,DB,K
MHQ4@D FHHHH **** "BBB@ HHHH *_QQ?^#D+_E-K^WO_P!E ^'W_JC_ (7U
M_L=5_CB_\'(7_*;7]O?_ +*!\/O_ %1_POH _$&BBB@ HHHH **** "O]?K_
M (-<?^4%'[#/_=S/_K8?[05?Y M?Z_7_  :X_P#*"C]AG_NYG_UL/]H*@#]_
MJ*** "BBB@ HHHH **** "OY=?\ @ZD_X)?2?MR?L+R_M#?"WPU_:?[1W[&-
MOKOQ!TB#2M-6YU[Q]\$;JWBG^+7@./[/LO+^\T&ST^S^)?A:V;^T9TN?"_B'
MP]H.F_VEXYGFK^HJFNB2(T<BJZ.K(Z.H9'1@5965@0RL"0RD$$$@C!H _P
MFBOZ-_\ @Y,_X)&W'_!-/]LJ]^(/PI\--8_LA?M1:EKGCCX/G3;1QHWPS\7B
M6*\^('P2N)(XTM]/A\/ZA>_V_P##ZU9(HI_A[J^FZ19SZKJ7@_Q-=0_SD4 %
M%%% !1110 4444 ?V@?\&]'_  <M7?[)%IX-_8A_;\\1:IKO[,<,EOH7P<^/
MFH2:CK7B']GFT\MHK#P1XQM;:TU#5O$_P;6806V@7UKYNM?"V)CIT5OJW@/^
MS[+P-_I/>&_$GAWQEX?T/Q;X0U_1?%7A7Q-I.GZ_X;\3>&]4L=<\/^(="U:U
MBOM*UK0]:TR>ZTW5M)U.QG@O-/U&PN;BSO;6:*XMII89$<_X$-?T&_\ !''_
M (.&?VJO^"5FJZ;\-=<_M#]H3]CV\U#?K/P*\2:Z]MJO@,7MSYFH>(?@IXIO
M(+]_".H!Y)K^\\'W44_@?Q+<M=>?9:%K>HMXKLP#_7KHKX._8(_X*6?L<?\
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M9X9[>>%TEAFB=XY8W5T9E8$@%BBBB@ HHHH **** "O\<7_@Y"_Y3:_M[_\
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M8^'=!L0MO#<3A;C4]1MHY'C@E:.-GD\M@I!\^K^V+_@S[_X)9ZC\7?COK?\
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M)[5M/^_/"'_!\C$52#Q[_P $VI%=8YVDU3PA^U4KK)+YH-K"F@ZS^S]&8(Q
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M^KZ)K>D:A%!>Z=J6G7L$UM=VES#'+#+&RLHQ0!RM%%% !1110 4444 %%%%
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MCDBMW^T&%[BX_%_]H_\ X.7_ /@LG^TC#J&EWG[6>K?!7PS?K.H\._LX>&M
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M%'] 4 %%%% !1110 4444 %%%% !1110!_C"_P#!??\ Y3)?\%"?^S@-8_\
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M04444 %%%% !7][%?P3U_>Q7\7_2]_YM[_W=G_OLG^O'[*K_ )OQ_P!XO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"%]?['5?XXO_!R%_RFU_;W_P"R@?#[_P!4?\+Z /Q!HHHH **** "BBB@
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M %%%% !1110 4444 %?SJ_\ !:W_ )*C\$_^Q!\0?^I$E?T55_.K_P %K?\
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M$OBU\.M0FF_X1GXB>#+FX,D=QI>KV\3V^IZ>EU=7?A?Q)9ZUX3UATUG1+^)
M#X8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"2**6XEB@@BDFGFD2*&&)&
MDEEED8)'%%&@9Y))'8(B("S,0J@D@5_NI?L0?!:?]F_]C+]DW]GZ\@6WU'X)
M_LV_!'X6:PHBMH7FUSP)\-O#?AK7+RY6SCBMGOK_ %?3KV^U">*-1=7UQ<7+
M;GE9C_EB?\&U7_!,_7_^"@/_  40^'OC/Q-X8NK[]FW]D[7O#?QK^,^MW5DL
MWA_5-?T*_DU7X3_"VX:Y1[._NO'?C#1HKO5]%E21;SP#X;\:&0QN+83?Z[M
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M_#6A6K/@;VM]+TRUB9L#<4)QS0!W5%%% !1110 4444 %%%% !1110 4444
M%%%% 'YE?\%-/^"3'[(7_!57X3GP!^T7X,6S\<Z!8WD?PK^._A&WL=/^+'PL
MU"YWRXT37)K:5=9\*WET5EU_P'X@2^\,:UA;P6EAX@L](U[2_P#+>_X*N_\
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MPWG6S#+*4;*./WGB<%"*CCO>JX=+&\U+&?ZJ_0T^F_/A[^RO"?QGS:53A_\
M<Y?PCQUF%64ZF1)*%'"9%Q'B)\TIY(DE2R_.*TG/)KPPV/G+*%#$Y3_2[156
MRO;+4[*TU'3KNUU#3]0M;>]L+^RN(KNRO;*[B2>UN[2Z@>2"YM;F"2.:WN(9
M'BFB=)(W9&#&U7\.M.+<9)QE%M2BTTTT[--/5-/1IZIG^S,)PJ1C.$HSA.,9
MPG"2E&<)).,HR3:E&2:<9)M---.P4444B@HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*_VN?^'*7_!(_P#Z1R_L@?\ AC_!/_RKH_X<I?\ !(__ *1R_L@?^&/\$_\
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M?^'*7_!(_P#Z1R_L@?\ AC_!/_RKH_X<I?\ !(__ *1R_L@?^&/\$_\ RKH
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MO@EXXEU&3Y7U?5[OX;W&@:+XRU)HB8#-X^T/Q9%Y?EGR/-M;.6W /\8BBO\
M0O\ VEO^#(KX?ZA)J.K?L?\ [;'BSPN!O?3/ O[1G@+2O&4,KNNY8KCXG?#B
M;P9/I]O%("J$?"O6IVA=?,E:6%I+G\(_CS_P:;?\%E/@P;RX\*_"/X6_M%Z1
M9,S2ZK\#/C%X7DD:V"%A<6_AWXMCX3>+K]MVR%K/2O#^H7_FONCMI+9)+A #
M^:RBOM?XO_\ !-K_ (*#? )KMOC+^Q+^U/\ #NQLOM!FUWQ'\"OB3;>%I$M(
MFGNIK/Q;'X=F\,ZA;VT"/-/<V&K7-O%$C/)(JJ2/BZXM[BTN)[2[@FM;JUFE
MM[FVN(GAN+>XA=HYH)X9%62*:&16CEBD57C=61U# @ $-%%% !1110 445U_
M@SX>^/OB/J@T/X>>!_&'CS6FQC1_!GAK6O%&J'='/,N-/T.ROKLYBMKB48AY
MCMYW'RQ2%0#D**_5CX,_\$-O^"NWQZ>U'P^_X)]?M)6T%\UN+/4OB7X(?X'Z
M+=1W1C$%S;Z[\;+KX>Z-+8N)%<Z@E^UBD>Z5[A8HW=?V:_9Z_P"#,W_@I5\2
M7L[_ ./'Q-_9U_9LT255-YI]QXFUGXN_$"T=B?ECT#P)I<?@6Z5%4F1A\4H"
M&>-8DE!E:( _D-K>\,>%O$_C;7]*\*>#/#FO>+O%.NW2V.B>&O#&D:AK^OZQ
M>NK.EGI6C:5;W>HZA=,B.ZV]I;32LJ,P0A21_IL_LP_\&97_  3K^%DEAJO[
M2?Q7^.G[5>LVWE?;-$34;3X%_#34=JGSO-T#P+<ZI\1[;S7(*?9?C!'Y48*'
MS'/FC^E/]F3]A;]CC]C+2&T?]EC]F?X,_ Q+BQCTW4M7\ ^!=$TKQ=X@LX7$
MD47BKQRUK-XS\6LCJK+-XFU[5IP43][A$P ?YA7[#?\ P:K_ /!4K]KF?1?$
M/Q-\!:7^QK\*-1\JXN?%O[0+36?C^6P=-TG]A_!#29)?'O\ :B%H2EEX^C^'
M&GSQ/(\.LL\)B;^U_P#X)Z_\&N?_  31_8>ET'QMX^\(77[8_P <=':TO4^(
M'Q]TZPO? NC:O!''YEWX,^!]M)=^ ]-A6\BCU'2Y_'!^)'BC0;V..;2/%=LZ
M[C_2)10!'##%;Q10011P001I###"BQQ0Q1J$CBBC0*D<<:*$1$4*B@*H  %2
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\B_MU?L6_!O\
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MPAX&\$:%J7B;Q7XEUBZW&#3M%T+2+:[U'4+ID225H[:WD,<$4L\FR&*21?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH YGQ3X*\&^.=.;2/&WA+PSXQTEUF1M+\4Z#I7B'3F2XC\J=6LM6M+NV*S
MQ$Q3*8B)(SL<,O%?)7BW_@F?_P $X_'TLEQXW_8#_8K\6W<LFH3-?>(OV6_@
MAK&H+<:LRR:G=Q:A?>!Y[V"\OI8XYKJ\@GCNIIXXIGE,L:.OVW10!^46N_\
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MB=EP9I"W:44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>;^//@W\(?BI UM\3_A5\-_B/;/&(7M_'G@;PQXO@:(0W5N(FB\0Z7J
M,;1BWOKV (5*B&\NH@-EQ*K^D44 ?GYXL_X).?\ !+SQPUS+XG_X)U_L2:C>
M7DEM+=:K'^R_\&-.UNX:TB2"W$VNZ7X-LM8>.*"** 0M?&(P110LC11HJ^)Z
MK_P0:_X(ZZQ?SZC=_P#!/+]G"&XN?*\R/2O"5QH=@ODPQP)Y&E:)J6GZ9:Y2
M)6E^S6</GS&2YF\RXFEE?];Z* /R _X<#_\ !&W_ *1[? #_ ,%&N_\ R^KJ
M-!_X(;?\$@O#D3PZ?_P3K_98N$DN!<LVO?#'2/%4HD540*D_B<:Q/';XC4FT
MCD2T9B[M"7DD9OU7HH ^-_!W_!.K_@GU\.YC<?#_ /84_8W\"W!DEE,_@[]F
M+X)^&)C+- +::4RZ)X(L7,DML!;RN6W20 1,3&-M?6FC:'HOAS3X-(\/:/I>
MA:5;;_LVF:-I]II>GV_F.7D\BRL88+:+>[,[^7$NYR6;))-:E% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P'^V[^PIX,_
M:K\.3:_HZ6/A?XU:'IQA\,^+BK16>MP6^^6'PQXP2!'>[TJ9V>.QU18IM2\/
MSR_:+475B;W2;_[\HKV^'N(LXX5S?"9YD6-JX#,<%/GI5J3]V<&U[3#XBF_<
MKX:O%<E>A54J=6#:E'9KX_CS@+A/Q,X6S7@SC7)\-G>09O1=+$X3$1]^C52?
ML,=@<1&U;!9C@ZC5;!XW#RAB,-5BITYK5/\ A7\>^ /&7PO\6ZSX%\?^'M1\
M+>*_#]T;35-&U2'RKB!RHDAFB=2\%W97<#QW5AJ%G+/8W]G+#=V=Q/;31RMQ
M]?V _MF?L4^!/VM?"<9N'M_"_P 4?#MG.G@WQW%;!V"$2S+X<\31Q+YVI>&;
MJZ<RA5W7VBW4DNH:42)]2T_5/Y/?BA\+_''P;\<:[\._B)H5UX>\5>'KHV][
M97 W13Q-\]KJ.G729@U#2M0@*W6GZA:L]O=V[K)&V=RK_I1X3^+>3^)F6<J]
MEE_$N!HQEFV3.;>EU!X_+W-\]? 5)M)J\JV#J3C0Q+:E0KXG_GG^D]]%OBOZ
M.W$?/+ZQGOA[G.*J0X7XM5**?-RRK+)<^A1BJ6"SS#THS<6HT\+FV'I5,;EZ
M@Z>-P67\!1117ZZ?RN%%%% !1110 4444 ??_P"Q!^W;XP_93\0+X>UE;OQ5
M\%]?U&.;Q)X5\PR7WA^XF*17'B;P<9I4AMM36,*VH:5*T>GZ_#"D$[V=ZMKJ
MEI_5;X&\=>$?B7X3T/QSX%UZP\2^%?$=C%J&D:QILOF6]S!)D,DB,$FM;RVE
M#VU]87<4%[87D4UG>V\%U#+$G\*=?;?[%_[:OC;]DKQ?(%2[\4?"KQ%=1OXS
M\"?:0A,H1(%\2>&7G;[/IWB6SA2..3<8[+7;*)--U1HVATS4M)_FKQL\"\/Q
MG3Q'$W"U&CA>+*5-U,5A(\E'#\0PA%+EJ2;C3H9I&$>6ABI6IXFT:&+E%>SQ
M-#_0[Z'GTT<?X1XC >'/B5B\5F?AAB:T:&69I/VN*Q_ =2M-MU*$(QJ8C&<-
MSJ3Y\9EM-3K9=>>,RN$VJ^ QG]?M%>?_  O^*'@?XR^!]"^(GP[UVU\0^%O$
M-J+BRO;<[9H)E^6ZTW4K5L3Z=JNG3AK;4-/N52XM;A&1UQM9O0*_S[Q.&Q&"
MQ%?"8NA6PN*PM:IA\3AL13G2KT*]*;A5HUJ4U&=.I3G&4)PE%2C)--)H_P!U
MLNS' 9O@,%FN58W"YCEN8X6ACLOS# UZ6*P>-P>*I1K8;%87$T93I5\/7I3A
M4I5:<Y0J0E&49--,****P.P**** "BBB@ HHHH **** "BBB@ K^=7_@M;_R
M5'X)_P#8@^(/_4B2OZ*J_G5_X+6_\E1^"?\ V(/B#_U(DK]U^C?_ ,G9R+_L
M"SS_ -5&+/XL_:!_\HO<:_\ 8WX-_P#6JRH_%&BBBO\ 2L_YX@HHHH ****
M"O[V*_@GK^]BOXO^E[_S;W_N[/\ WV3_ %X_95?\WX_[Q?\ _!$"BBBOXO/]
M> HHHH *^9?VS_\ DTW]HC_LD?C;_P!,MU7TU7S+^V?_ ,FF_M$?]DC\;?\
MIENJ^AX1_P"2KX8_[*')?_5EACX7Q1_Y-GXB?]D+Q=_ZS^8'\8-%%%?Z_G_*
M2%%%% !1110 5_21_P $6O\ D@_Q4_[*Y)_ZAOABOYMZ_I(_X(M?\D'^*G_9
M7)/_ %#?#%?@GTE/^34YK_V,\E_]3Z9_<'[/+_E)KAS_ +)OB_\ ]4U8_9"B
MBBO\VC_H0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO3Q6"QN$KQ4Z5?#UZ4I0G"47T=XR4H349QE%%%%%<AZ@4444 %%%% !1110
M4444 %?SJ_\ !:W_ )*C\$_^Q!\0?^I$E?T55_.K_P %K?\ DJ/P3_[$'Q!_
MZD25^Z_1O_Y.SD7_ &!9Y_ZJ,6?Q9^T#_P"47N-?^QOP;_ZU65'XHT445_I6
M?\\04444 %%%% !7][%?P3U_>Q7\7_2]_P";>_\ =V?^^R?Z\?LJO^;\?]XO
M_P#@B!1117\7G^O 4444 %?,O[9__)IO[1'_ &2/QM_Z9;JOIJOF7]L__DTW
M]HC_ +)'XV_],MU7T/"/_)5\,?\ 90Y+_P"K+#'POBC_ ,FS\1/^R%XN_P#6
M?S _C!HHHK_7\_Y20HHHH **** "OZ2/^"+7_)!_BI_V5R3_ -0WPQ7\V]?T
MD?\ !%K_ )(/\5/^RN2?^H;X8K\$^DI_R:G-?^QGDO\ ZGTS^X/V>7_*37#G
M_9-\7_\ JFK'[(4445_FT?\ 0@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>!?M&?LW?#3]IWP!<>!/B+IK,86FO/#7B6P$47B#P
MEK+Q>4NIZ-=NCC;( D>H:;<++I^J0(D5W TD-K-;^^T5VY=F6/RC'87,\KQ=
M? 9A@JT<1A,7AJDJ5>A5AM.$XZZIN,HN\9PE*$XRA*47X_$'#^2<59+F?#G$
MF5X+.LBSC"5,#F>5YC0AB,'C,+57O4JU*::=FHU*=2/+4HU84ZU&<*M.$X_Q
M6?M)_LT?$C]E_P"(-YX'\?:>\EG,\]QX4\7V=O,OA_QCHT;J$U'2KB0,L=U"
MLD*:OH\LK7NCW4BQ3^9;S6=Y=_/5?VY_'CX#_#O]HOX>:K\-_B1I0OM+O@;G
M3-3MA'%K7AG6HHY$LO$'A^]>.0V>I69D=?F22UO;62XT[4;>[TZ[NK67^2_]
MJW]E'XA?LH_$"3PKXLC;5O#.JM<77@?QU:6LD&D>*M+A=0_R%YQINNZ>)88]
M:T.6XEFL99(IX)KW3+O3]1O/]%O!KQKP'B%A:>39S*A@.,,+1;J4%:GA\ZI4
MH)U,;EZ=HQKI)U,7@$W*DE*OAU/#*I'#?X$?2W^A[G?@1F5?B[A.GC,\\*,R
MQ:C0QLKXC'\(8K%56J&3Y[*-YU,'.;C1RO.Y1C3Q$I4\#CG2S"5">8?+E%%%
M?OI_#P4444 %%%% !1110!] ?LW_ +27Q'_9@^(5KX]^'U\KQRK'9>)_"]_)
M,= \7:*LA=]-U:WB92LL)9YM+U.'%[I5VQE@9X);NUNOZU?V;/VD_AU^U!\.
MK/Q[X"O/*N(O)L_%?A2\FB;7/!^N-%OETO5(DV^;;R[9)=)U:*-;/5[-3-"(
MKB*\L[3^*JO9O@/\>?B)^SI\0M*^(WPWU9K'4[)E@U32[@RR:)XFT9Y$>\T'
MQ!8I)&+W3KL(""&CNK&Y2#4-.N+34+6VN8OPSQA\&,M\1L%/,LN5#+N+\)1Y
M<+CW'DH9G2IQ?)E^9\JNX_8PV,Y95L([1:JX=.D?V?\ 1/\ I=<0^ &;T^'L
M^>,S_P *\UQ?/F>2QG[3&<.XC$3BJV>\.*HTHU%K4S#*'.EA<S2E.,L/CN7%
M/^W*BOE_]E?]J[X<?M7>!/\ A*?!LS:5XATG[/:^-/ VHW$,FM^%M2F1C&7,
M>P:CHFH&*:31==@BC@OXHY89X;'5+34--LOJ"O\ ./-LIS+(LRQ>49O@Z^7Y
ME@*TJ&+PF(CRU:51)-;-QG"<'&I2JTY2I5J4X5:4YTYQD_\ H"X7XHX>XUX?
MRKBGA7-L'GG#^=86&-RS-,!4]KA\30FW%[J-2E6HU(SH8G#5X4L3A,33JX;$
MTJ6(I5*<2BBBO./?"BBB@ HHHH **** "OYU?^"UO_)4?@G_ -B#X@_]2)*_
MHJK^=7_@M;_R5'X)_P#8@^(/_4B2OW7Z-_\ R=G(O^P+//\ U48L_BS]H'_R
MB]QK_P!C?@W_ -:K*C\4:***_P!*S_GB"BBB@ HHHH *_O8K^">O[V*_B_Z7
MO_-O?^[L_P#?9/\ 7C]E5_S?C_O%_P#\$0****_B\_UX"BBB@ KYE_;/_P"3
M3?VB/^R1^-O_ $RW5?35?,O[9_\ R:;^T1_V2/QM_P"F6ZKZ'A'_ )*OAC_L
MH<E_]66&/A?%'_DV?B)_V0O%W_K/Y@?Q@T445_K^?\I(4444 %%%% !7])'_
M  1:_P"2#_%3_LKDG_J&^&*_FWK^DC_@BU_R0?XJ?]E<D_\ 4-\,5^"?24_Y
M-3FO_8SR7_U/IG]P?L\O^4FN'/\ LF^+_P#U35C]D****_S:/^A **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%?-_P"V%^T9I7[(7[*_[0?[46M^&=0\::5\ OA'XX^*U[X1
MTJ_MM*U#Q+%X,T&\UD:):ZI=P75MILFI/:I:'4);2\6R25KG['=F(6\O\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOIM]!,DUC?"WNXR6A"G_ !5* /[_ #_B.<_ZQ=?^;L__ )(]'_$<Y_UBZ_\
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MCC4&^)'P8O+"U<&73(OAUXR.K:)X;COH/]#O-5\$IX6\2BV$0L]<M);:TF@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0OB#X,\#^"(=,:1-2F\7^+/$>FZ#X:BT]X989DOI-:U"R2T:*:&1;@QE)8V
M< '^]O1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^8'_!:W_E$?\
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M'%9+C:]*K7Q,82J5,IGF.$2<JU*5/^OFBBBO\QS_ *-0HHHH *_G5_X+6_\
M)4?@G_V(/B#_ -2)*_HJK^=7_@M;_P E1^"?_8@^(/\ U(DK]U^C?_R=G(O^
MP+//_51BS^+/V@?_ "B]QK_V-^#?_6JRH_%&BBBO]*S_ )X@HHHH **** "O
M[V*_@GK^]BOXO^E[_P V]_[NS_WV3_7C]E5_S?C_ +Q?_P#!$"BBBOXO/]>
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M(_P^L_(>3S(8[;P9'%E(XY8Y8$$5?T944 ?YU_[9/_!E'\6O#%KK'BC]A/\
M:E\/_%*VMXY+FP^$W[0FC)X"\82PP1%OL&E_%'PE'J?@[Q!K%Y( EHFM^#/A
MQH\3-B[UF) 9J_CP_:J_8U_:D_8@^)4WPB_:O^"'CKX(>/4AEN['3/%^G1?V
M9XBTZ";[-+K/@WQ7I-QJ?A'QQH*70:U.O^#M=US1?M22VPOS/%)&O^Z_7S3^
MU?\ L>_LU_MP_"#7/@5^U+\)/"OQ=^'&N*\BZ9XAM'CU7P]JODR06_B3P7XG
ML)+3Q)X*\5644LL=EXD\+:II6L0037%I]K:RNKJWG /\)VOZ@_\ @A!_P<7_
M !=_X)M>)_#'[._[26K>(OBU^PKK6K6M@^GW+W>O>-_V<%O))8Y_$_PM+R/>
M:CX)2XGBOO%7PO9I[5H+>YUCP'!I?B*?5;#Q;X+_ ,%U/^"#_P 5?^"1WQ&T
M_P ;^$=3UCXK_L;?%#Q!?Z=\,/BG>6D0\0^!];<W=_:?"KXMBPA@T^'Q9#H\
M#W.@^*;&TTW0O'UC8:E?:;INC:EINL>'M*_GVH _WS/ ?COP9\4?!7A3XC_#
MGQ1H?C;P%XZ\/Z3XK\'>+_#.HVVK^'_$OAO7;*'4=(UK1]3LY);:]T_4+*XA
MN;:XAD9'CD!X.0.LK_.Q_P"#0G_@KMJ?@[Q])_P2S^/'BMIO GCYM=\5_LE:
MQKNH!8O"7Q!C6Z\0>,_@U;7%U\D&B_$"T75/&'A"R-S;06GCG3]<TC3[:_U?
MXAV<,'^B=0 4444 ?/\ ^UE_R:Q^TO\ ]F__ !E_]5UXCK_"'K_=X_:R_P"3
M6/VE_P#LW_XR_P#JNO$=?X0] ']7O_!FW_REP\1_]F@?&7_U-OA!7^IW7^6)
M_P &;?\ REP\1_\ 9H'QE_\ 4V^$%?ZG= !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M _\ ]0G2Z /T_HHHH **** "BBB@ KP_]I+]G'X-?M<? [XC_LY?M ^"M/\
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M *A.J5_BC4 ?W>?\&.G_ "53_@HE_P!D_P#V<?\ U(_B_7^AY7^>'_P8Z?\
M)5/^"B7_ &3_ /9Q_P#4C^+]?Z'E !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%,DCCFC>*5$EBE1HY(Y%5XY(W4JZ.C JZ.I*LK JRD@@@T^BA-IW3LUJFMT^
MXFDTTTFFK-/5-/=-=4S^=O\ X*%_\$WO^$&CUWX[?L_:1--X/$EUJWCWX<:?
M#YC^#XFS-=^(O"5K"GF2>%(V\V?5M%0/)X90M>:>&\.)-;^'_P 2Z_O8K\$?
M^"A?_!-IPWB'X]?L\:*OE[;C6?'_ ,+-)M2'5P6GU'Q-X'L[=2&5@7N]6\+0
M1J4*W%YH2N'&DQ_VMX'^/BK?4^#>.\;:M[F&R7B/%5/XS;C"CEV;U9;5=5##
M9E5E:JN6EC)*K;$5O\??IE_0>>$_M7Q9\%<H;PG[[,.+^ ,MH7>$24ZV+S[A
M;#4]985V=7,,@P]-RPS<\3E4'A7+ X7\%:***_LH_P D@HHHH **** "M#2=
M3N]$U73-9L'"7VD:A9:G9N2X"7=A<QW5NY,;QR +-$A)21'P/E=6PPSZ])^#
MG@BX^)7Q9^&OP_MH6GD\9>.?"WAQT4 A;;5=9L[2\FDW?*L-M:23W$[M\J0Q
M2.WRJ:YL;7P^%P>+Q.+<8X7#X:O7Q+E;E6'HTIU*SE>RY53C)N[M;<]')\%C
MLRS;*\NRR,YYEC\QP6"R^-._M)8[%8FE0PD:?*G+GEB*E-1LF^9JRN?W'T44
M5_C0?];X4444 %?SJ_\ !:W_ )*C\$_^Q!\0?^I$E?T55_.K_P %K?\ DJ/P
M3_[$'Q!_ZD25^Z_1O_Y.SD7_ &!9Y_ZJ,6?Q9^T#_P"47N-?^QOP;_ZU65'X
MHT445_I6?\\04444 %%%% !7][%?P3U_>Q7\7_2]_P";>_\ =V?^^R?Z\?LJ
MO^;\?]XO_P#@B!1117\7G^O 4444 %?,O[9__)IO[1'_ &2/QM_Z9;JOIJOF
M7]L__DTW]HC_ +)'XV_],MU7T/"/_)5\,?\ 90Y+_P"K+#'POBC_ ,FS\1/^
MR%XN_P#6?S _C!HHHK_7\_Y20HHHH **** "OZ2/^"+7_)!_BI_V5R3_ -0W
MPQ7\V]?TD?\ !%K_ )(/\5/^RN2?^H;X8K\$^DI_R:G-?^QGDO\ ZGTS^X/V
M>7_*37#G_9-\7_\ JFK'[(4445_FT?\ 0@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?D!_P7X_Y0V?\ !0G_ +(!J_\ Z?=!
MK_&&K_9Y_P""_'_*&S_@H3_V0#5__3[H-?XPU ']OG_!D-_R=/\ MP?]F_\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_
M'_P?.?\ .+K_ +O9_P#?1Z_O\K^ /_@^<_YQ=?\ =[/_ +Z/0!_ '7^US_P1
M2_Y1'_\ !.7_ +- ^!__ *A.EU_BC5_M<_\ !%+_ )1'_P#!.7_LT#X'_P#J
M$Z70!^G]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRYLMS#"4:BC4EDF28B,<P6865'&9GA\'A<*\32I9C]7[2BBBOX%/]PPHHHH
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M_P#M9?\ )K'[2_\ V;_\9?\ U77B.O\ "'K_ '>/VLO^36/VE_\ LW_XR_\
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M;S_L.N?M"?%6XT6U<,'5=-\/IXICT/2H5<>8EOIFG6ENDA:18@[,QS_V7O\
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MSQV]A$5$<>E>,_A!%X.T>#4%C186U7Q+X'\837"&2:]BNKZ0W@_KE_X)Z?\
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M=K:PWB)=PVMK9PVT5THN8XEF^>O*?^&L/VIO^CE?C_\ ^'D^(O\ \T=?UO\
MPO\ ^#)']LK6K"VN/C%^V+^S;\.[Z:%I9M.\ >&OB5\5S:.VYH;>6[US2_A+
M#),J^6MVUN)K>&8RI:SWT,<=Q/\ 15__ ,&-&M1Z6\VE_P#!372[S6A';E-/
MO_V/KO3=+:5I(A=(^L6_[3FJW:1PQ&=[>4:'(US)'%%)#:+,\T !_(E\-_\
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MA/\ R?U^W#_V=_\ M+?^KG\:U]__ /!M[_RFU_8(_P"R@?$'_P!4?\4* /\
M8ZHHHH **** "BBB@ HHHH **** /X,/^"_G_!S)^V!^R!^VOX__ &*/V)K/
MX>_#^S^!]CX0M/B/\6O%W@^R\?\ BKQ3XW\6>#] \=2Z7X6TKQ&9/"F@^&?#
MFD^)M.T2];4/#NLZOJOB&UU2YM=1LM+BM([OYV_X(\?\'5W[<?Q4_;6^ 7[,
MW[;*_#/XL_#/]HOXF>$O@S8^.?#W@+3OA]\0/ ?CCXB:Y%X8\!:M#_PAWV#P
MGK7ANY\6:SHNC>);#4O#4%W:Z3.-<L]=M9-+O;/6OYW_ /@OR[O_ ,%D_P#@
MH0SLSD?'[5D!9BQ"1Z!H$<:@DD[4151%Z*BJJ@  5\??\$]O^3^OV'O^SO\
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M@O2;W('V?7O';64/@SP_)\PR-<U[3P/7@T >K_$3_@K?_P %1?BK<M<>./\
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MBDHQ2222222"BBBD4%%%% !7\ZO_  6M_P"2H_!/_L0?$'_J1)7]%5?SJ_\
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MDCJBLP_QE?\ @NQ_P4(MO^"E'_!2+XU?'7PKJ=UJ/P:\)M8?!;X &X,RQO\
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M^*[7P;!X4\0(XFAU'PGK7B#1IHC'J3.GV7_P2>_X)E_%[_@JI^UQX0_9T^'
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MCP_\1?",<DTDTDO_  AWQ T;Q-X5:9IIO.?1VE$LBN';Z\H **** "O\P_\
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M\??$'4K&#RAX@^(WCF\23Q%XPUJ9S+*DFJ7KV.F+,UAH-AI.DQ6VGP?8M%%
M!7SG^U-^R5^SI^VK\(=?^!?[3_PG\)_%WX:^((Y&?1_$VGI+>Z'JAMI[6V\2
M^$-=@,.M^#O%FFQ7,XTOQ/X:U#3-;L!--'!>K#//%+]&44 ?+/[&W[&/[.W[
M WP$\+?LW?LP> ;7P!\,?"\U[J1M_M,^J:_XF\2ZL86UOQCXR\17K/J7B7Q5
MK36]M'>:I?R'R+"RTW1-+@T_0=(TG2['ZFHHH *_RA/^#O'_ )3)^-O^R ?
MG_TQ:G7^KW7^4)_P=X_\ID_&W_9 /@3_ .F+4Z /YP?A/_R5+X:_]C_X-_\
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MX\:Z3JU]K5JMK>^'/ NL^'=8LO%4/^B!^Q7_ ,$R/V%?^">WAV+0OV3OV<_
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MWO+>>TNX(;JUNH9;>YMKB))[>XMYT:*:">&56CFAFC9HY8I%9)$9D=2I(/\
M,;_P5"_X-:OV#_VY-*\3_$']GG0=%_8R_:8O%NM4M/%/PVT-8/@UXVUG;),+
M/XB_"#3IK'0=-75KII/MWC'X=P>&_$<-]>2Z_KEGXX>V&BW?]/%% '^&=^W)
M^P3^U#_P3J^.6M_ #]JCX<WG@CQAI_F7GA_7+21M6\!_$;PR9=EEXS^''BZ*
M&&P\3^&[]&C+/&EKK&B7C2Z%XJT?P_XEL=2T6R\1^!7QU^+G[,_Q<\!_'?X$
M>/->^&GQ9^&FO6WB/P9XS\.7*V^HZ5J-NKQ2QR12I-9:GI.IV4USI6O:#JMM
M>Z)X@T2]U#1-;T^_TF_O+.;_ &B/^"GG_!,W]GO_ (*F_LS>(_V?_CAI-O8:
M];6^IZQ\&OBY8Z=#=^,?@O\ $66Q:WTWQ9H#F:SFU#1[B:.TMO&G@V:_M-+\
M9Z%$=/NI[#4[;1=<T;_&Y_;&_9'^,_["_P"TC\4OV7/C[H']@_$CX5^()=(O
MWMA<OH?B32+B-+[PYXT\*7UU;6DNJ>$_%VB7%EKV@:@UO!-+87L<5Y;6>H07
M=G;@'^NE_P $3O\ @K3\/_\ @K;^R5I_Q4MH-'\(_'[X;W%AX*_:0^%>G7AD
M3POXT>T>;3/%OAVUNI7U,_#OXC65M<ZSX2NKOS_L%]:>)/!LNIZOJ7@_4M2N
M?V+K_'#_ .#?'_@H1K7_  3T_P""EOP3\6:AK4UE\%OCCK6E_L__ ![TN:[D
MAT=_!?Q"UBPT[1/&=[$2]M'=?#+QFV@^,UU#[-+?KH%AXFT&RFMH?$=^S_['
ME !1110 5_)/_P ''W_!P5#_ ,$]_#NH?L<?LCZ[INI?MI>.O#JR^,_&L#6^
MHV?[,/@[7[&*;3-6FM9$FL[SXO>*=+NUU'P5H=ZLMOX7TB2U\;^(;.6"_P#"
MFF^(/UU_X+/?\%.?"'_!*G]B+QW\?KG^Q]9^,'B.0_#O]G7P#JCM+'XP^+6N
M6=S)IUYJ5A;SVUW/X/\  ^G6][XS\92QW%BD^EZ3'X>M]2L]<\1Z&MQ_C2?$
M[XF^/_C/\1/&OQ:^*OBW6O'GQ)^(WB;6/&/CCQEXBNVO=:\2>)=>O9=0U;5M
M0N"%4S75U/(XBA2*VMX]EM:PP6T44* ',ZYKFM>)M:U?Q)XDU?5/$'B+Q!JF
MH:YK^OZYJ%WJVM:YK6K7<U_JFKZOJE_-<7VI:IJ5]<3WNH:A>SSW=Y=S37-S
M-)-([M^FG_!+S_@D/^UU_P %7OBK+X)_9_\ #,.A_#GPO?6,?Q7^/GC.WU"T
M^%_PTL;EHI6M;G4+:WEF\2^-KRQ=KC0/ 6A>;K.J'9=ZA+H7AU-0\1:=W'_!
M&3_@D5\6_P#@KG^TY#\,?#MUJ7@?X$_#Q=,\2?M$_&>"QBNH_ _A.]GN5TWP
M[X>CO,6.H_$;QW-87VE^$-,G%Q#:16NL>*M2L[S1O#6HVL_^OI^RS^RS\"_V
M+_@7X#_9Q_9Q\!Z7\._A3\.]+73]$T33U,MW?W<I$NJ^)/$FJR@WWB+Q9XBO
MC+JGB+Q%JDL^HZMJ,\L\\NWRXXP#\LO^"9G_  ;V?\$]_P#@FE8>'O%7ASX?
M6OQ[_:.TM8;J\_:-^-&DZ;KOB?3]83:[77PS\)RB[\*_"BUMIC.FF77ARVN/
M&J6,[6.M^.?$"J):_=&BB@ HHHH *S=9T;1_$6DZEH'B#2M-UW0M9L;K3-8T
M76;&UU/2=6TV^A>WO=.U+3KV*>SOK&\MY)(+JTNH9;>XA=XI8W1F4Z5% '\;
M'_!7_P#X-,_@!^TAI7BGXY?\$YM/\,_LV_'^*UO-8O\ X%QXTC]GSXKWL*^<
M=/\ #EE&&MO@EXJOHE:VTU]!@3X97EZEC:ZGX<\*?;M8\:0_YNGQ<^$7Q-^
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M :Q_Z8]!KY _X)[?\G]?L/?]G?\ [-/_ *N?P50!_N<T444 %%%% !7\ ?\
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M5?[03:W\/?V=]*F-I<2>')[6SMCXV^,.H:=<[UNM)^&>FZKISZ?#);7=M?\
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M-MY8!_JGT444 %%%% 'Y@?\ !:W_ )1'_P#!1K_LT#XX?^H3JE?XHU?[7/\
MP6M_Y1'_ /!1K_LT#XX?^H3JE?XHU ']WG_!CI_R53_@HE_V3_\ 9Q_]2/XO
MU_H>5_GA_P#!CI_R53_@HE_V3_\ 9Q_]2/XOU_H>4 %%%% ',^-?&7A;X<^#
M?%OQ"\<:W8^&?!7@3PSKWC+QAXDU.1HM-\/^%O"^E7>M^(-;U&55=H['2M)L
M;N_NY%1V2WMY&"L0 ?\ &!_X+%?\%.?B+_P52_;/\=_'KQ!=ZMIGPFT"ZO\
MP1^SI\.+RXD6S\ _"33-0F_LB2;3UEDM8O&7C1E7Q7X]OXVGEN-=OQI,%W)H
M.@>'[2Q_T2/^#L3]JG5?V;_^"1?C_P '>&[UK'Q+^U9\2O _[.,5U;3M%?V?
MA/5K?7?B)\0I8D1U\RQUGP?\.]2\#:MYB20_8O&;1%5FG@D3_)CH ^K_ -B?
M]BSX_P#_  4!_:+\"_LP_LV^$_\ A*/B+XWN))IKJ]FDL?"_@KPKI[PMXB\?
M>.=:6"Y70O!_AFUGCN-3OA;W5[=W$UCHFA:?J_B/5]'T;4/]8[_@D[_P0<_8
MO_X)7>$-!UKPQX5TOXR?M2/I_P#Q6/[3OCW0[*Y\6K?WEHL&J:7\+=+N&OK/
MX5>#_GN;:"RT"5_$NK6$YA\7>*?$?EVRVOYK?\&?O[!_AKX#?\$^]1_;'UW1
M+5_B]^V1XJUZ?3M=F3=J.B? SX9^(=2\&>$?#%NDOF'3UUWQKH_C;QMJDUFT
M"^(--U'P4-0AE/AS39$_KDH **** "BBB@ K\H/^"C'_  19_8"_X*;^'-57
MX^_![2]"^+<VGO:^'OVB_AE;:?X.^-7AVY1,64MWXDMK*6S\<Z79Y=(_#7Q$
MTWQ5H,$5Q=2:=9:;J4D6I0?J_10!_C8_\%>O^"&_[5O_  20\;07GCN./XL_
MLV>+-8_LKX:_M(>$=(N['PYJ>H3175U;>$/'NARW&H3_  \^(!LK*ZNXM#O=
M1U/1];L[:ZN_"WB+7!I^LP:3^,>F:GJ6B:EI^LZ-J%]I&L:1?6FIZ5JNF7=Q
M8:EIFI6%Q'=6.H:??6LD5U97UE=117-I=VTL5Q;7$4<T,B2(K#_>0^.WP)^$
M?[3/PC\>? CX[^ ]!^)?PF^)>@W/ASQGX,\1VS7&G:KIUPR2Q2Q2Q/#>Z9JV
MF7L-MJN@Z]I5S9:WX?UNRL-;T2_L-5L+.\A_RHOV[_\ @VO_ &]/@G_P4$US
M]EK]D[X%?%C]HGX/>.+BT\7?!+XR6?AV>W\$:3\/O$5[>16^B_&/XGW45A\.
M_!'BSP)>6E]H'B&;7];T0^(8+'3/%6DZ1:0>*M,T:$ _T,O^"#_[>/B+_@HI
M_P $R_@'\>OB!?+J7Q?T2'7/@_\ &C456W0ZO\1?AE>KH\_B:>.WD9(K[QMX
M7E\+^.-3@$%E%;ZGXDO(+.SBL([1Y/V%K\N/^"./_!.>V_X);?L&_"_]E>[\
M3:?XU\?6NH>(?B'\7O%^C6]Q:Z%KGQ0\<7,-UKB>'HKQ(KV3P_X<TRST/P=H
MFH7UO97^M:;X<MM<OM-TFZU*;2[+]1Z "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *_G5_X+6_\E1^"?\ V(/B#_U(DK^BJOYU?^"UO_)4?@G_ -B#X@_]2)*_
M=?HW_P#)V<B_[ L\_P#51BS^+/V@?_*+W&O_ &-^#?\ UJLJ/Q1HHHK_ $K/
M^>(**** "BBB@ K^]BOX)Z_O8K^+_I>_\V]_[NS_ -]D_P!>/V57_-^/^\7_
M /P1 HHHK^+S_7@**** "OF7]L__ )--_:(_[)'XV_\ 3+=5]-5\R_MG_P#)
MIO[1'_9(_&W_ *9;JOH>$?\ DJ^&/^RAR7_U988^%\4?^39^(G_9"\7?^L_F
M!_&#1117^OY_RDA1110 4444 %?TD?\ !%K_ )(/\5/^RN2?^H;X8K^;>OZ2
M/^"+7_)!_BI_V5R3_P!0WPQ7X)])3_DU.:_]C/)?_4^F?W!^SR_Y2:X<_P"R
M;XO_ /5-6/V0HHHK_-H_Z$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA>']5M5S?^#O .G:-'/;7NH:!XE\3^-=%F\I@#]@O^#G3_@X2\'ZAX-\=_\
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M=QJ.C7'&F>/?%'CQH\I=#'^8]_P2@_9;M/VTO^"C_P"QQ^S3J]BNI^%_B/\
M&[PO)X]TYHUE&H?#'P3]I^(?Q1L@KY0-=?#SPGXF@2219(HG=99(9HT:)_\
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MXO\ P<A?\IM?V]_^R@?#[_U1_P +Z_$&OV^_X.0O^4VO[>__ &4#X??^J/\
MA?7X@T ?W.?\&5G[$EEXQ^,7[27[?/B_1OM-E\'-'L/@'\&[ZXC+VT?C_P ?
MV']O_%+6;%U93#K'ACP!'X7\/ N)(I=)^*FJ+L$J1R)_HN5^!/\ P;(_LYVW
M[.O_  1K_9866QCM/$OQSM_%_P"T9XMFCA$/]I7/Q1\174G@R^<%5DDD7X3Z
M/\.[!II&D,GV$-$PMO(C3]]J "BBB@ HHHH **** "O\H3_@[Q_Y3)^-O^R
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M<")#:VEO#!$BHB@=!10 4444 %%%% !1110 4444 ?A)_P '(W[(&F_M?_\
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MG_LX#6/_ $QZ#7R!_P $]O\ D_K]A[_L[_\ 9I_]7/X*H _W.:*** "BBB@
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M"NH0ZA)X3\4:3K$]AJ5O97^@_P!JKX:N+.!M% /[9T44 %?SX_\ !;O_ ((
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_G5_P""UO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/H?_ ,O:U-'_ .#?#_@L[KEZMA9?\$_/C9!.T<DHDUB3P3X>L@L8!8-J6O\
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MG2Z_Q1J_VN?^"*7_ "B/_P""<O\ V:!\#_\ U"=+H _3^BBB@ HHHH ****
M"OG_ /:R_P"36/VE_P#LW_XR_P#JNO$=?0%?/_[67_)K'[2__9O_ ,9?_5=>
M(Z /\(>OZ_?^#*G_ )2F_'S_ +, ^*?_ *T5^RK7\@5?U^_\&5/_ "E-^/G_
M &8!\4__ %HK]E6@#_3[HHHH *_A _X/?OCK/I_PO_80_9FL=09K;Q9X]^+'
MQU\3Z6DF$AG^'OA[P_X \"ZA<1=6:YC^)WQ%M[.0#Y!:WRG'F#/]W]?YC_\
MP>L^-I=6_P""D7[.?@*.[CN-/\&?L7^%=<>".Y:0V.N>-/C3\:HM1@GMLF.V
MN)='\+>&KLL )KBVN+5I,QQP&@#^.>O]>#_@UQ_9OM_V>/\ @C;^SIJ-QI2Z
M7XJ_:%U;Q]^T7XN/V=(9;]_&_B.?0? >H22 "2Y6[^$?@_X>3PRR\K'((H\P
MI&S?Y#]?[HG[ W@*T^%?["_[&/PSL8O)M?A_^RG^SUX-B0P2V[G_ (1OX2^$
MM(>2:&=Y+A+B:2T>:Y^T22W+3R2-<2R3M([ 'UI1110 4444 %%%% !1110
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M35DFO(?AO\7-+MQ#>^+/A[<7LUQ/I=U;747B3P!JU[<ZYX;EO=/O/$WA'Q:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y ?\ !?C_ )0V
M?\%"?^R :O\ ^GW0:_QAJ_V>?^"_'_*&S_@H3_V0#5__ $^Z#7^,-0!_;Y_P
M9#?\G3_MP?\ 9O\ \//_ %8LU?Z/E?YP?_!D-_R=/^W!_P!F_P#P\_\ 5BS5
M_H^4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S_P#M9?\ )K'[2_\
MV;_\9?\ U77B.O\ "'K_ '>/VLO^36/VE_\ LW_XR_\ JNO$=?X0] ']7O\
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MVG:I967BZP)B F^$G@.V2#Q1\2HY?-+6WB"(Z!\/)S9ZE9?\)XFL69TN4 _
MVNN\$> /'GQ-\0VOA'X;^"?%WQ!\5WZN]CX8\$>&]9\5^(;Q(RBR-:Z+H-E?
MZE<*C21J[0VSA2Z D%ES_JJ?L:?\&FG_  2M_9EM-+UCXO\ A3QA^V3\1[:.
M":[UWXVZS/I?P^@U**0/)+H/PC\$SZ-H!TN=$1'TGX@ZI\2B"9R+XI(D</\
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M_G05_J=T4 ?Y8G_$&W_P5P_Z&/\ 9 _\/+XV_P#G04?\0;?_  5P_P"AC_9
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M -K+_DUC]I?_ +-_^,O_ *KKQ'7T!7S_ /M9?\FL?M+_ /9O_P 9?_5=>(Z
M/\(>OZ_?^#*G_E*;\?/^S /BG_ZT5^RK7\@5?U^_\&5/_*4WX^?]F ?%/_UH
MK]E6@#_3[HHHH *_RS/^#RJTN[;_ (*V>$9KBVN((;_]CCX.W=A+-#)%'>VB
M?$'XT6#W-H[JJW-NE]97EFTT)>-;NTN;<L)H)43_ %,Z_P U7_@]L^'EQIO[
M<?[(?Q7:-A:>-/V4;WX>0S%W*/<?#'XO>.?$EU&L941HT4?Q<M&9T=GD$R+(
MJ+'&7 /XL:_WJO@GJ5CK/P9^$>L:9<+=Z;JOPQ\!:EI]TBR(ES8WWA72;JTN
M%25(Y56:"6.15D1)%# .BL"!_@JU_N#_ /!+;XGV_P 9O^";/[!GQ,ANUO9_
M%7[(O[/USK$RW"76SQ-8_##PUI/BRTDN(PJRS:?XFL-6L)W,<4GG6T@E@@E#
MPH ?>-%%% !1110 4444 %%%% !1110 4444 %%%% !117\Y/_!P-_P76\,?
M\$G_ (3Z=\,/A%'H?C/]MKXR>'[J_P#AQX:U5!?Z!\)_!LLUYI4GQC\>:<I"
MZA&NIVEYIO@+PI<20P^*->L-1O=0:30?#FJV.I 'Z'_\%%O^"L_[$G_!+OP)
M!XK_ &H_BC'9>+-;LYKKP'\%/!$%MXI^,_Q$\AVC=_#?@Y;ZQCT_1XY$DBN/
M%_C#5/"_@NVN8QIT_B)-5N;*PNOX#/\ @H#_ ,'?/[>_[1]UKO@S]D#1]!_8
MN^$MRUU96NNZ.MCX]^/^MZ;*KV[RZGX^UVP;PUX-:[B$=Y:P?#_PCI?B3P]=
M230P?$#6%CANA_+I\;/C?\7/VC_BCXP^-7QV^(?BCXI_%7Q]JCZQXM\<>,-2
MEU36]7O61(84:5]L-GI]A:10:?I&D:?#::3HNEVUII6DV-EIUI;6L76?LS_L
ML?M#?MC_ !9T+X'?LQ_"7QA\8_BAXAS+:>&?"&G&Y^P:='-!;W>O^(]6N7MM
M$\)^%].ENK9=5\4>)M2TGP_I?GP_;]2M_.BW@'"_%+XP?%GXY>+]0^(/QJ^)
M_P 0OB[X\U5F;4_&GQ-\9^(O'?BJ_+223$7?B#Q1J.J:K<+YLLCA)+ID5G<J
MHW&O.J_T$_V!?^#+/0X++0?'?_!1[]H#4+_4Y/LM_=? ']G"6&QTNRVD7 TO
MQ?\ &CQ)IMU>ZMYZ,MEK>E>"?!FA?8I(;@Z%\0M12>WOX/ZT/V6?^"2/_!-G
M]BZ'37_9T_8W^"/@OQ!I2H+/Q_J_A6'X@_%.-D*,S#XI_$:7Q9\08UEEC2XD
MMX/$<-GYZ1R);)Y400 _QZ?@7_P3I_;V_::@LK[X!?L;?M*_%?1=0:!;;Q3X
M0^#7CS4?!?\ I/E^1)<^-SHD?A&QAE65)%GO=:MX/))G,@A1Y%_5KX7_ /!J
MQ_P6M^)$5M=:E^S/X6^%6GW;,(;WXH?'#X0Z=*J)(T3RW.A^$_%WC#Q19*'1
M]L=[H5O<2QA9X89+>6"67_71HH _S)? ?_!E-_P48UE+>?XA?M'_ +'/@>&=
MH6DM=#\0_&+QQJ]I"PE\\7-L_P (O"NDM=1,L/E0VFNW5O,DKLU["T0CE^KO
M"W_!CAX_NXT/C7_@H_X/\/RFS1Y$\+?LO:UXPC34"R>9;))JWQU\#-)9HID*
M7S113R,B*VG1"1FC_P!"RB@#^$[0?^#'?X.V\UFWBC_@H5\2]8MTMPM_%H/[
M/WA;PW-<W?D;3-9SZC\4/%26-O\ :?WHMIK?4)!!_H_VLR?Z37IFB?\ !D9^
MQU!=R/XC_;._:7U6Q-NZQ6^B>&/A;X?NTNS)$4FDO+_1?$L,MNL*SH]LMA%(
M\DD4HNXUA>&?^V6B@#_**_X.&O\ @AA^SU_P1[\'?LN>(_@A\7?C+\3KKX[>
M)?BKHGB*#XJR>"'M]'M_ 6E^!K_39=%_X1'PIX;D$UY)XIO$O?MSW:%+>V\A
M(6\TR?R^5_H=_P#!\7_R2W_@G9_V/_[1_P#ZCOP>K_/$H _V>?\ @@/_ ,H;
M/^">W_9 -(_]/NO5^O\ 7Y ?\$!_^4-G_!/;_L@&D?\ I]UZOU_H **** /S
M _X+6_\ *(__ (*-?]F@?'#_ -0G5*_Q1J_VN?\ @M;_ ,HC_P#@HU_V:!\<
M/_4)U2O\4:@#^[S_ (,=/^2J?\%$O^R?_LX_^I'\7Z_T/*_SP_\ @QT_Y*I_
MP42_[)_^SC_ZD?Q?K_0\H **** "BBB@#@_B;\+?AI\:? ^O_#/XP?#[P7\4
MOAUXJLVT_P 2^!?B#X9T;QAX2UZR9@_V?5O#^OV=_I=]&DBK+$+BUD,,R)-$
M4E1'7^6?]L__ (,]?^"<G[0%UK?BK]FKQ3\2OV,?&VIM=7,&D^%IQ\5?@O'?
MW2^9)<2?#GQMJ5MXKL83=@RPZ7X6^*7AK0=/@GGL].T6WM$L8++^M2B@#_*X
M_:6_X,^/^"JWP<DU'4/@M+\#_P!JWPY!OEL(OA_\0+?X>^.Y;2)<R/J7A7XO
MP^#?#UM> *[QZ?H7CWQ/+.@1());N06@_!7]H#_@GE^W9^RM]NF_:)_9#_:(
M^$6EZ=YIN?$_C'X3^,;#P4R0>;YTUGXZCTJ?P=J-O&(97:YT_7+JW$:&3S-F
M&/\ N8T4 ?X ]%?[A?Q^_P""7_\ P3L_:C2^?X]?L5?LV_$/5M2;==^+;_X4
M>$])^(#$C#"#XC>'-.T?QY:+)\IF2S\10),T<+2J[0Q%/PJ_:,_X,Z_^"5_Q
M8CO;[X*:M\?/V6]<D\Y]/M/!OQ /Q+\#02RLS+_:'A[XNV?BSQ;>V\)($4%A
M\1=%8*H5YGZ@ _RY?#?B?Q)X,UW3?%'@_P 0ZYX4\3:-<?:]'\1>&]6O]"UW
M2;L(\0N=-U?2[BUU"QN/+DDC\ZUN(I-CNF[:S _NS^R!_P ',7_!7?\ 9$DT
M[38_VC+C]I#P+8R*TG@3]JFPN?B]'<QA1&(A\1+C4M(^,UI'%"-EK:6GQ)CT
MNW(1CILJIL;])_VK/^#,']O;X6Q:EK?[*WQK^"_[5>B6GFM:>&-:-U\ _BIJ
M&5WP0V.D^*M1\2_"^3:5D@GN=4^+NA9D-M+%:-%/<"P_EP_:6_9"_:@_8Y\;
MM\.OVH_@/\3O@9XM9KG[!8?$+PKJ6BV6OP6AB6XO_">OO$_A[QAI,3S1(VL^
M%M5UC2C(X1;POE0 ?Z3/_!.?_@[G_87_ &JKS1/AS^UIHEY^Q+\6]2DM-/M-
M?\3ZPWB[]GWQ'J,PCA!A^)EOINFW_P /I+B<3W,L/Q&T#2O"ND6GV>&3XAZG
M>2%*_K"TG5M*U_2M,UW0M3T_6M$UK3[+5M&UG2;VVU'2M6TK4;:.\T_4],U"
MSDFM+_3[^TFANK*]M9I;:ZMI8YX))(I%8_X"]?T3_P#!$C_@X+_:%_X);>./
M#GPM^)&K>)OC1^PYK>M11>,?A'?WSZKXA^%EK?RN+[QE\";O5;R.+P_?V5Q.
MVL:O\/WNK7P;XT9;^)T\/>(]33Q?8@'^NC17G?PD^+/PY^._PQ\!_&7X1>+M
M'\>?#+XF>%](\9>"/%^@W(NM*U[P]KEI'>6%[;OA9(9/+D\F\LKJ."^TZ]BN
M-/U"WMKVVN+>/T2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYU?^"UO_)4?
M@G_V(/B#_P!2)*_HJK^?3_@MGH-S#XI^ /BC;(UIJ&@>.]!+!28H;G2-1\.:
M@JNX&$DN8M<8Q*[ R+:RF,'RI2/W+Z.52%/Q:X>C.2BZN%SRG33^U/\ L7'5
M.5>?)3F_.Q_&7T_J%:M]%OCR=*$IQPV8\&5Z[BK^SH_ZX9+0YW_=56O2BWTY
MKO1-GX94445_I<?\[@4444 %%%% !7][%?PD^#] F\5^+?"_A:V61[CQ+XBT
M30+=(B%E:;6=3MM.B6-C',!(SW*A"890&(/EO]T_W;5_%?TO*L'5X HJ2=2G
M3XHJSCU4*LN'H4Y/RE*C42_PL_U__968>M'#>.6+E!K#UZ_AOAZ52SY95L+3
MX[JUX)[7IPQF'DU>Z52-[75RBBBOXS/]<0HHHH *^9?VS_\ DTW]HC_LD?C;
M_P!,MU7TU7@7[5>@W7B;]F;X_:'8))+?7_P?^(:V,$2>9+<WL'A;4[JTM$3*
MY:[N(([8$$E?-W!6("GWN%JD*/$_#E:K)0ITL^RBI4F]%"$,PP\IR?E&*;?D
MCXKQ)H5L5X=<?8;#TY5:^(X*XIH4*4%>=2M6R+'TZ=.*ZRG.48Q75M'\4E%%
M%?[!'_*(%%%% !1110 5_21_P1:_Y(/\5/\ LKDG_J&^&*_FWK^G#_@C?X>F
MTO\ 9A\5:W<1E#XG^+_B*ZLWW.5ETS3/#/A#28WVLBJKKJ=KJ\;,C.K*D8+!
ME9%_ /I,5:=/PKQ\)R2E7S?)J5):>]46*==Q7FJ5&I+2[M%]+M?W/^SLPU:O
M]);)JM*#E#!<*<6XG$22;5.C/+X8.,W9-)/$8NA3N[*\TKW:3_6BBBBO\WC_
M *"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M\@/^"_'_ "AL_P""A/\ V0#5_P#T^Z#7^,-7^SS_ ,%^/^4-G_!0G_L@&K_^
MGW0:_P 8:@#^WS_@R&_Y.G_;@_[-_P#AY_ZL6:O]'RO\X/\ X,AO^3I_VX/^
MS?\ X>?^K%FK_1\H **** "BBB@ HHHH **** "BBB@ HHHH **** /G_P#:
MR_Y-8_:7_P"S?_C+_P"JZ\1U_A#U_N\?M9?\FL?M+_\ 9O\ \9?_ %77B.O\
M(>@#^KW_ (,V_P#E+AXC_P"S0/C+_P"IM\(*_P!3NO\ +$_X,V_^4N'B/_LT
M#XR_^IM\(*_U.Z "BBB@ HHHH **** "BBB@ K_"&_:P_P"3IOVE?^R__&3_
M -6+XCK_ '>:_P (;]K#_DZ;]I7_ ++_ /&3_P!6+XCH _7_ /X-<?\ E.O^
MPS_W<S_ZQY^T%7^OU7^0+_P:X_\ *=?]AG_NYG_UCS]H*O\ 7ZH **** /XI
M/^#R3_@HQKOP6_9^^%'_  3Z^&/B";2/%'[3\-Y\1?CC/IUP]MJ=O\"O!VM1
M6/AGPI)(JK+'IOQ0^(-CJ#ZA-9W$<EQI'PQUGPYJ23:-XFO;:Y_S8J_H)_X.
MA_C3J7QD_P""TW[5-K/?R7FA?!ZS^%?P6\)0/,9ETS3?"?PS\,ZOXCL(<_+%
M&WQ&\3>.-0,*!0DM_+OW2F1W_"'P'X-UGXC>.?!GP]\.1QS>(?'?BSP[X-T&
M&:18HI=9\3ZQ9Z)I<<LKD+'&]]?0*\C$*BDL2 ": /[)?^#7W_@@;X-_:[2U
M_P""A?[9WA"W\3_L\^%O%%WIG[/OP9\06,5YX;^.'B[PM?7%CXB\=>/]/NXW
MMM9^%?@O7[5] TSPI(EQ8>/O&6FZ]9^*(U\*>%[O0_''^E!:6EI86MM86%M;
MV5C96\-I9V=I#';6MI:6T:PV]M;6\*I#!;P0HD4,,2)'%&BHBJJ@#Q_]G+X%
M^"OV8?@%\&?V=?AQ;?9O WP2^&?@SX8^&0T4<-Q<Z7X-T&QT.'4K\1DK)JFK
MM9OJFK7!9Y+O4[R[NII))9GD;VB@ HHHH **** "BBB@ JCJFIV&BZ;J.L:K
M=PV&EZ38W>IZE?7#;+>RL+"WDNKR[G?G9#;V\4DTK8.U$8]JO5^-W_!?C]L+
M3?V*O^"47[6?Q&_M==+\;_$7P#J'[/GPGCBN(+?5+SXB?&ZRO?!5K=:&+B2-
M)]2\'>%[SQ3\1WB7S9%TSP7J-PEO<&#R) #_ !S_ (F^,9OB)\2/B#\0+@2"
MX\=>-_%GC&<2Q00RB;Q/KU_K<HEAMB;:*0/?,'BMR8(VRD1,86OZ!O\ @U _
MY3:_LX_]B!^T1_ZH[QQ7\X5?T>_\&H'_ "FU_9Q_[$#]HC_U1WCB@#_6[HHH
MH **** /\<7_ (.0O^4VO[>__90/A]_ZH_X7U\ ?\$]O^3^OV'O^SO\ ]FG_
M -7/X*K[_P#^#D+_ )3:_M[_ /90/A]_ZH_X7U\ ?\$]O^3^OV'O^SO_ -FG
M_P!7/X*H _W.:*** "BBB@ HHHH **** "O\H3_@[Q_Y3)^-O^R ? G_ -,6
MIU_J]U_E"?\ !WC_ ,ID_&W_ &0#X$_^F+4Z /Y@J_W^*_P!Z_W^* "BBB@
MHHHH **** "BBB@#^8'_ (.\O^4-OC3_ +. ^!/_ *?-5K_*%K_5Z_X.\O\
ME#;XT_[. ^!/_I\U6O\ *%H _P!/O_@RI_Y19?'S_L__ .*?_K.O[*M?U^U_
M(%_P94_\HLOCY_V?_P#%/_UG7]E6OZ_: "BBB@ HHHH **** "BBB@#_  AO
MVL/^3IOVE?\ LO\ \9/_ %8OB.OU_P#^#7'_ )3K_L,_]W,_^L>?M!5^0'[6
M'_)TW[2O_9?_ (R?^K%\1U^O_P#P:X_\IU_V&?\ NYG_ -8\_:"H _U^J***
M "OXA/\ @\G_ ."D&N_"7X/?"?\ X)S_  OU^;2/$/[0VFO\6OC]<Z=>/:ZD
MGP7\/:]/I'@3P6YAD$ATGXC^/-%\0:CKF# \EC\-8M'E-WI7B+5+4_V]U_CZ
M_P#!S9\9-7^,?_!:;]L![ZZN)=(^%^H?#OX-^%+*=W9=)TCP)\,_"D.KVML'
M"[+>^\<7_B_7PB*$$NM3%3(&\UP#\$:_MR_X->/^"!G@;]J'3M/_ ."BO[:?
M@J'Q9\$=(\175K^S5\'=?BD;P[\5/%'@_6Y+'6OB?XZL,I%KWP]\*>)-+O/#
MN@^$+SSM(\9^)M,UP^*;.Z\,:*ND>*?XQOA?\/M=^+7Q+^'?PK\+1K+XF^)G
MCKPE\/O#D3J[I)KOC/7]/\.:1&RQAI&5]0U*W5EC4N02%!8@5_NS_ ?X,>!O
MV<_@I\)O@'\,],CT?X??!KX=^$/AIX/T]$57BT#P9H5CH.G2W3J,W&H7<%BM
MYJ=[*TES?ZA/=7MU+-<W$LK@'J5O;V]G;P6EI!#:VMK#%;VUM;Q)!;V]O BQ
M0P00Q*L<,,,:K'%%&JI&BJB*%  FHHH **** "BBB@ HHHH R=?UW2/"^A:U
MXFU^^ATO0?#NDZCKNMZG<;_L^G:1I%G-J&I7T_EJ\GDVEG;S7$NQ'?9&VU6;
M /\ @>>+-=_X2CQ3XE\2_9?L/_"1>(-9UW[%Y_VG['_:VHW-_P#9?M/DV_VC
M[/\ :/*\_P B#S=GF>3%NV+_ +%W_!PM^U[9?L:?\$E?VL/&L.HQV7C7XL^"
M[C]FSX90_:#;7MWXP^.=K>^#M0N=)F'*:IX4\ 3^./'UKC#8\(R;3OVU_C94
M ?T^_P#!H=_RF3\$_P#9 /CM_P"F+3*_U>Z_RA/^#0[_ )3)^"?^R ?';_TQ
M:97^KW0 4444 ?Y:W_!X]^SY<?##_@J5X:^-=IIC0Z%^TU^SUX!\2W.KK&ZP
MZAXZ^&%QJ?PK\06!=ALDNM*\&>'OAI/-Y;'9;:M9!@K<M_)M;W%Q:7$%W:3S
M6MU:S17%M<V\KPW%O<0NLD,\$T;+)%-#(JR12QLKQNJNC!@"/]1S_@\,_8SG
M^/O_  3C\*_M+^&-&_M#QK^QC\3+;Q/JMQ!;I<7T?P:^++:9X%^(4-LBE;IH
M[3Q?!\*O$VHRQ>?#8Z'X<UB_N[=;:":^LO\ +=H _P!S3_@GS^TUIG[97[$/
M[+/[3^FWUO?R_&7X)^!?%?B-K4Q&*P\>?V-!IGQ'T)O()A6X\.>/M.\2^'[M
M(SLCNM,F10 N!]B5_#1_P9A_\%!;#QA\&?C'_P $X?'.M*OBWX1:MJOQV^!=
MM>3X?4OA?XSU.RMOB;X8TJ-G$:KX,^(E]:>+F@1&NKT_%#5KE0UMI%PT/]R]
M !1110 4444 %%%% !1110 445XK^T?\>_A]^RS\ _C%^T=\5=0;3?AW\$OA
MSXL^)7BR>$PF]N-*\*:/=:J^E:1#/+"E[KVMS6\.C>'],603ZKK=_8:;;![B
MZB1@#VJBOYE_^"=?_!U!_P $_/V]OC'X=_9[U_P]\2OV7/BWX[U:WT'X:P?%
MT^&M0^'WQ \0ZA(D&D>$-(\?^&M5N(M'\9:S<;K;2-)\7:'X=TO6M0DT_0M!
MU_5_$NK:=H=Q_310 5_'M_P>@_ .Y^('_!.;X+?'72K#[7J'[/?[2>BV^N7.
MP_\ $L\ _%WPIK_A?5KOS0K%?.\>Z1\,-/\ *8)'+]L\QI1)!#%-_837PQ_P
M4S_9-M?VYOV!?VKOV5)8+>?5?B[\'_$6F^"C=B,VMI\3_#OV?QI\)M3NA*T:
M&WTCXF^&_">JS@RP-Y5FVRXMWVS1@'^'=7^LA_P:7?M,6_QY_P""0?P\^'MW
M?+=>*?V5_B=\2_@;K232)]ODT6\UH?%GP1>O K[ETVW\,_$JU\)Z7<B***?_
M (1&\@S-=6=Y,_\ D^ZGIFHZ+J6H:/J]C=:9JVDWUWIFJ:;?026U[I^HV%Q)
M:WMC>6TRI+;W5I<Q2P7$$JK)%-&\;J&4@?UC_P#!H1^WU9?LS?M^>(_V5O'>
MO?V9\-/VV/#>G^%?#XO;HQ:9I_Q]\!R:CJ_PS<F8M!;2>,-$U/QIX$BC@2*Y
MUKQ-K7@FRDED%K;Q  _U(Z*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#_#\_X*H^$G\"_P#!37_@H9X2,=U'#HG[;/[45MIYOI;>:\GT>3XU^-;G
M1+RYEM4BMWFOM(GLKR0QPP -.0;>W8-"GM/_  0M\?1_#;_@L#_P3M\123R6
MRZC^U!\._ (DB=HV:3XK7TOPNB@++!<$QW4OC%+69#&JR13/&T]LK&YB^DO^
M#F[X,W'P9_X+3_M@1+9-:Z'\4+[X<?&;PY,T;Q#4;?X@_#'PE>^)KU Y965/
MB%:^,[ R1R.DCV+OB&1GMH/Q.^$_Q%UOX/\ Q3^&GQ:\-"-O$?PN^('@WXB^
M'UF9DB;6_!/B+3?$NE"5T!=8S?Z9 '9065<E02 * /\ >YHKA?A=\1/#/Q?^
M&?P[^+/@J]74?!OQ1\"^$?B)X2U!&C=+_P ,^-M T_Q+H-ZKQ/)$ZW6E:G:3
MJT;O&PD!1V4@GNJ "BBB@ HHHH **** "BBJ]W=VEA:W-_?W-O96-E;S7=Y>
M7<T=M:VEI;1M-<7-S<3,D,%O!"CRS32ND<4:,[LJJ2 #_&-_X+[_ /*9+_@H
M3_V<!K'_ *8]!KY _P"">W_)_7[#W_9W_P"S3_ZN?P57H_\ P5=_:&\!?M7?
M\%(/VS?VA?A;-<7?PX^)OQX\9ZOX'U*Y4)+K?A>PNDT'1O$2PX5[>W\1V.DP
MZ[:6LP%Q:6NHPVUS_I$4E><?\$]O^3^OV'O^SO\ ]FG_ -7/X*H _P!SFBBB
M@ HHHH *_@#_ .#YS_G%U_W>S_[Z/7]_E?P!_P#!\Y_SBZ_[O9_]]'H _@#K
M_:Y_X(I?\HC_ /@G+_V:!\#_ /U"=+K_ !1J_P!KG_@BE_RB/_X)R_\ 9H'P
M/_\ 4)TN@#]/Z*** "BBB@ HHHH *^?_ -K+_DUC]I?_ +-_^,O_ *KKQ'7T
M!7S_ /M9?\FL?M+_ /9O_P 9?_5=>(Z /\(>OZ_?^#*G_E*;\?/^S /BG_ZT
M5^RK7\@5?U^_\&5/_*4WX^?]F ?%/_UHK]E6@#_3[HHHH *_BP_X/7OV>;SQ
MK^QC^RK^TIIEBUY-\!OCSX@^'VO200L\NF>$_CQX1BN9=8NY@ D6FP^+?A+X
M/T1M[%SJ/B/3EB0K).Z?VGU^>W_!5O\ 8_C_ &\?^"=_[5_[+=O9PWGB?XB_
M"G5[OX;K,T421_%KP//:^/OA2SW4BDV=K-\0/#/AVSU.XC*R?V1=:A#DI,Z,
M ?XB%?ZLG_!H?^U!8_'#_@D[HGP;N]16?Q?^R5\6OB#\+M0LIYY)M1;P=XUU
MB?XO^"-9F+@A--ED\<>)O".D)YA,47@BXMUCC@@@W_Y4M]8WNF7MYINI6=UI
M^HZ?=7%C?V%];RVE[8WMI*\%U9WEK.D<]M=6T\<D-Q;S1I+#*CQR(KJRC^GW
M_@T^_P""A%A^QS_P4:@^!OC[6FTKX0?MOZ3HOP;OI;B[^S:3I/QJTK4[B^^!
M6O7Z,2LS:GJVK>)?A=9(J*8K_P")]I?3SPV5A<E@#_5QHHHH **** "BBB@
MHHHH **** "BBOY3=6_X.[O^"<_@[]KWXC_LT?$+P7\9/#OP^\ _$SQ)\+T_
M:9T.RT#QM\-]3U#PMKTWAW4?%DWAW0]2_P"$VB\!SWUG?3Z;K6@:3XJU2^TU
M+/4(M!^SWA-N ?U945S?@WQCX4^(?A'PQX^\"^(M'\7>"?&OA_1_%?A'Q5X>
MO[?5=!\2>&O$&GV^JZ'KNC:G:22VNH:7JNFW=M?6%Y;R/#<VT\4L;LC@UTE
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M _\ RAL_X)[?]D TC_T^Z]7Z_P!?D!_P0'_Y0V?\$]O^R :1_P"GW7J_7^@
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M0=#LXD:*]O?B;KDOG"ZF:V_OLK_'9_X-K/B7J7PO_P""UG[$.H6,\D=IXO\
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M%*6)R?,,/C84Y2<8UX4IKVV&J22;C2Q5!U,/5<5S*G5DXV=F?%>(_ V5^)?
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M?]G?_LT_^KG\%5]__P#!R%_RFU_;W_[*!\/O_5'_  OKX _X)[?\G]?L/?\
M9W_[-/\ ZN?P50!_N<T444 %%%% !1110 4444 %?Y0G_!WC_P ID_&W_9 /
M@3_Z8M3K_5[K_*$_X.\?^4R?C;_L@'P)_P#3%J= '\P5?[_%?X ]?[_% !11
M10 4444 %%%% !1110!_,#_P=Y?\H;?&G_9P'P)_]/FJU_E"U_J]?\'>7_*&
MWQI_V<!\"?\ T^:K7^4+0!_I]_\ !E3_ ,HLOCY_V?\ _%/_ -9U_95K^OVO
MY O^#*G_ )19?'S_ +/_ /BG_P"LZ_LJU_7[0 4444 %%%% !1110 4444 ?
MX0W[6'_)TW[2O_9?_C)_ZL7Q'7Z__P#!KC_RG7_89_[N9_\ 6//V@J_(#]K#
M_DZ;]I7_ ++_ /&3_P!6+XCK]?\ _@UQ_P"4Z_[#/_=S/_K'G[05 '^OU111
M0 5_BL_\%P]'O=#_ ."O7_!16ROUC6>?]JSXJZQ&(I!(ILO$.O2Z_IK%@ !(
MVG:G:M-'UBE+Q$DH2?\ :FK_ "A/^#N+]FK5_@G_ ,%=?&OQ6_L^XA\(_M5_
M"OX8?%K0+];9TTPZYX6\,V7P<\9:/!=DM'-JEMJ'P[LO$VK6P836T7C'3)Y(
MDAOK5I #\3_^"<>NZ+X7_P""AG[!WB7Q);6MYX=\._MF_LO:[KUI?2Q0V5UH
MND_&_P #7^J6UY-,DD,5K/8V\\5Q++')%'$SM(C("I_W*Z_P#[2[NK"ZMKZQ
MN;BRO;*XAN[.\M)I+:ZM+JVD6:WN;:XA9)H+B"9$EAFB=)(I$5T964$?[:?_
M  2>_;[\%_\ !2?]A7X'_M.>&]6TVY\7ZOX9T_PK\;_#UBT$<W@CXY^%]-L+
M/XD>&[NPB"/I]K/J\@\2^%UFAMVU#P7X@\-:Q'!%!J,2* ?H[1110 4444 %
M%%% !117\,'_  <>_P#!R)X8^'_AOX@_\$_?^"??CY=;^*^L+?>#OVB/VC?!
MNH:??>&_AQH5U;7-AXE^%/PM\0V4]T-3^)U\LDFD>-O&&F&.S^&UM]MT#0=0
MNOB)-J%U\.@#\1_^#J/_ (*OZ3^WC^U]I7[-?P4\3V^N_LS_ +']YKN@6NN:
M-=FXT3XG?'/51;V7Q$\9VES!+]DU?P_X0AL+;X?>#+TPS1^?9>.-?T34;S0_
M&=JY_E>K[A_X)R_L+_%'_@HY^V#\'OV3_A7:W4=YX]UZ*Z\;^*X[5[C3_AO\
M+M$DBO?'_P 0M9DV&W@M?#VAB8:9!=R0)KOB>\T#PM:2MJNO:?#-\B^-]%M?
M#7C/Q=X=L9+B6RT#Q/K^BV<MV\<EU+:Z5JMW8V\ER\,4$+W#PP(TSQ00QM(6
M*11J0B@']*W_  :'?\ID_!/_ &0#X[?^F+3*_P!7NO\ *$_X-#O^4R?@G_L@
M'QV_],6F5_J]T %%%% ' _%7X8^"/C7\,?B'\'?B5H=KXF^'GQ4\$^*/AYXX
M\/7JAK76_"?C'1;WP_K^F39#;5O-+U"Z@$BC?$SK+&0Z*1_B.?\ !1']B/XC
M_P#!.[]L7XV?LE_$R.XN=0^&?BB5/"OBA[26VLO'_P .-:C76/A_X\TLO&D$
MMOXC\,7=A<7\-H\\6CZ_'K/AVXF.H:->QQ_[D-?R[_\ !S;_ ,$9;S_@H[^S
MCI_[0_P!\,KJ/[8?[,>@ZO<:#HNF6L U7XW?"%I6UCQ+\+2Z1"\U'Q5X>N%O
M?%GPKM3-,LVL7GBCPG:V9O/'4-_IH!_F>?L0?M@_%;]@G]J?X-_M8?!B\6+Q
MM\(O%4&LC2;F>6#2?&'AJ]@FTGQCX$U\PJ\AT'QIX7O]6\.:F\<;7-G#J']H
MZ>8=2L[.XA_VH?V*/VQ?@O\ M[?LS?"S]J?X"ZZNL> ?B=H,5^;"XD@_M[P;
MXFM#]D\5> ?%MI"\@T_Q5X/UN.[T;5[<,]M</;Q:II5Q?:+J&FZA=_X6]Q;W
M%I<3VEW!-:W5K-+;W-M<1/#<6]Q"[1S03PR*LD4T,BM'+%(JO&ZLCJ&! _;_
M /X(B_\ !;#XP_\ !(GXWSR-;ZI\1_V3_BEK&F_\+Y^"L5S"+LM"D=A#\3OA
MI)>S0V>C_$SP[IX$1MY[BTT3QYHMM'X6\336<EOX9\3^$@#_ &,Z*^??V7_V
MJ/@#^V;\&/"G[0'[-'Q,\._%;X5>,(7.F^(O#]P_F6.HVZ1-J/ASQ'I%TEOJ
M_A?Q5HSSQ0ZUX9U^RT_6=+EDC%W9QI-"\GT%0 4444 %%%% !1110 5_ M_P
M>+?\%4])71?#/_!*_P"#?B+[5J]UJ'AKXI_M:W^EW>(-,T^Q6WU_X3?!R^$>
M];F\U*^ET[XK^*+200/I<.D_#-H)KHZOJ]K8?N;_ ,%W?^"\7PC_ ."4_P *
M-6^&_P .=5\._$+]NKQ[X=67X7_"V13JVD_#G3M4D^SQ_%7XOQVEQ#_96@V%
MN+J\\)^%9[B'6_'^LV]K:VUM;>&(]?\ $>C_ .2K\1/B%XX^+7CSQE\4/B9X
MIUKQQ\0_B%XFUKQEXV\8>([V74==\3>*/$>H7&JZWK>K7TQ,ES?:CJ%U/=7$
MAPN^0A%1 J@ R?#-KXAOO$GAZR\(QZI+XKO-<TFU\,1:&UPFM2>(;B_MX=%C
MTA[1DNDU1]2>V73VMG6X6[,)A99 I'^^!X8@UFU\->'K;Q'<QWGB&WT/28->
MO(2K17>LPV%O'JES$R0VZF.>^6>5"L$"E7!$,8PB_P"4]_P:P?\ !,S6OVUO
MV_O#7[17C30)I/V=OV*=:T'XJ>(M2O+:5=-\5_&>TEEU#X-> ].N)(GMKVZT
MOQ'80?$?Q);@7$-OH/A2VTG5%M3XOT>6?_5]H **** /\GK_ (.I?^";]_\
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M&)08M0T/6[..6671?%'AS48[K0_%'AZ^\O4M!UVPO]*U"&*ZM94 ![I1110
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M37H8EF*7^DS?"OX\Z+#:7!B^184US5]%OE:Y_<_:+*!5_P!(:"O\MNO]D?\
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MZU#4=0NKB^O[^^N);N]OKV[E>>ZO+RZG>2>YNKF>22:XN)I'EFE=Y)'9V9B
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MG_!7S]@__@IGX1TS5_V;/C1H;_$*73VO/$?P!\=7>G>$_CIX/EMX!/J,>H^
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MU>"4CBBC0,\DDCL$1$4L[$*H)(% '^YK1110 4444 %%%% !1110 5_E"?\
M!WC_ ,ID_&W_ &0#X$_^F+4Z_P!7NO\ *&_X.\T=?^"R/C-F5E$G[/WP)>,L
MI =!HFK1ED) #*'1T++D!T9<Y4@ '\P%?[_%?X!*(\CJB*SN[*B(BEG=V("J
MJ@$LS$@*H!))  S7^_M0 4444 %%%% !1110 4444 ?S _\ !WE_RAM\:?\
M9P'P)_\ 3YJM?Y0M?ZO7_!WE_P H;?&G_9P'P)_]/FJU_E"T ?Z??_!E3_RB
MR^/G_9__ ,4__6=?V5:_K]K^03_@RJ1U_P""6/QZ+*RB3]OWXJ.A92 Z#]G?
M]E="R$C#*'1T+#(WHRYRI _K[H **** "BBB@ HHHH **** /\(;]K#_ ).F
M_:5_[+_\9/\ U8OB.OU__P"#7'_E.O\ L,_]W,_^L>?M!5^0'[6'_)TW[2O_
M &7_ .,G_JQ?$=?L#_P:X([?\%UOV'"JLPC7]IEW*J2$0_L??M (&<@852[H
M@8X&]U7.6 (!_K\4444 %?SJ_P#!RO\ \$J]6_X*6?L,-KWPET+^V?VH?V5;
MS7_BE\&]-MHM^I^.O#6H:?9P_%?X1V!"2NVH>,M&T31M?\,VL47GZGXY\$>%
M-"^TV-CK.H72?T544 ?X!MQ;W%I<3VEW!-:W5K-+;W-M<1/#<6]Q"[1S03PR
M*LD4T,BM'+%(JO&ZLCJ&! _8#_@CM_P63_: _P""0WQNU'QCX"LH_B3\#?B/
M)I-E\<O@-K.J3Z9I'C&PTN9_L'B7POJR17:^$?B1X?M;F^M]#\1_V?J5A<V=
M[=:5K^D:I9/:FP_L1_X. /\ @V&?]J7Q)XR_;7_X)W:/X?T'X_:W)?>(_C5^
MSDTMCX<\.?&[6IWEN]2\?_#?5;N>TT+PM\6-4G9IO%/A_6)-,\+?$2ZFG\2C
M6= \;+JH^('^<W\0_AQ\0/A'XT\0_#CXI^"/%GPX^('A/4)=*\3^"O''A_5?
M"WBKP_J4.#)9:QH.M6MEJ>GW"JRN([FVC9XW25-T;HQ /]IC_@GS_P %<OV$
M?^"F7A#3];_9E^-&BW?CEM-6_P#$OP(\;W&G^$OCGX+=(S)>PZWX!N-0N;C5
M;&PVLLWBGP9>>*?!DK K:^(YW61$_2VO\!G1]9U?P]JEAKF@:KJ6AZUI5U#?
M:7K&CWUUIFJ:;>V[AX+RPU"RE@N[.Z@<!X;BWFCEC<!D=2,U^RGP$_X.'_\
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M VD+<ZE;?#+X=O?PQ7;>%]%U"]U'6Y;72Y_&OB7Q;=Z)H=QI@!YO_P $&O\
M@B[X&_X)(_LY3MXH.C^,?VO/C3I^BZK\?_B-9JMW8Z"EK"MUI?P;^'MY)&DD
M?@/P=>3W,VH:LL<%]X^\4R7'B/5A%I5CX.\/^%?\BGXL?\E2^)7_ &/_ (R_
M]2+4J_WN:_PT/^"B7PAUSX"?MZ?ME?!WQ#IS:9J'P_\ VF?C5H,,'V,6$%SH
ML7Q!UZX\-ZM86@5%BTG7?#MQI6MZ-Y:K%)I6H6<L0$;J* /VT_X-#O\ E,GX
M)_[(!\=O_3%IE?ZO=?Y0G_!H=_RF3\$_]D ^.W_IBTRO]7N@ HHHH **** /
MX2O^#C__ (-M]9^+&L^./^"@G_!/7P/;W?CZ[M[_ ,4_M'_LS^$],6&^^(%]
M"KW>K_%GX.:+IMMLO_B!?IYU]X\\ VL27GCJ\2?Q+X72]\<WNI:/XL_SPKBW
MN+2XGM+N":UNK6:6WN;:XB>&XM[B%VCF@GAD59(IH9%:.6*15>-U9'4,"!_O
MY5_,'_P64_X-E?V:/^"D-YXB^._P"OM!_9>_;"U%;F^U;Q38Z1)_PJ+XSZH[
M";S?BYX5T6 W.E^)KN42+-\4/"%G)XAG:[N+OQ=H/CZ:#2XM/ /\X+_@GW_P
M4Y_;(_X)D_%"3XF_LH?%&X\,Q:O)9+X[^&GB.WD\2_"7XG:=8S++%IOCOP1/
M=6UO>2)'YUK9>)-$N]!\;:%:WE_%X;\4:,;Z[>7_ $*?^">7_!W3^P3^TW9:
M-X,_:[L[[]BCXPS+#:7&I^(Y[[QA\ _$-Z(FW7.D_$C3--34O!:W#037,UC\
M1M T;1M(2:UL(?''B&Z9IC_GB_MR_P#!-']M;_@G-XY;P1^UE\#?%'P^ANKR
M>U\,>/[6)/$?PJ\=11-*8[KP;\1=%-WX:U62>VC6]DT2:\LO%.E6\T2:_H&D
M79>V3X1H _WO/AM\4_AC\9?"6G^/OA!\1_ ?Q6\"ZMG^RO&OPV\7^'O'/A+4
M]J1R-_9_B/POJ.J:/>[8YH9#]FO),)+&Y^5U)[RO\%CX3_''XU_ ;Q"/%WP-
M^,'Q2^#'BM6MW7Q/\)_B!XL^'7B$/:-*UJPUKPAJ^CZD&MFGG:W87.86FE,9
M4R/G]2_A]_P<-?\ !:+X90VL'AS_ (* _&+4DLVB:)OB#IWP\^+4SF$S%!=7
M/Q5\%>,[B^4^>_FI>RW"3[81,L@M[?R@#_9<HK_'YU#_ (.@/^"Z.IV5Q87/
M[=-Y'!=1F*633_V=OV2])O54D'-OJ6E? :SU&SDR!B:TNH)0,@. 2#\D_%[_
M (+3?\%8?CG:76G?$7_@H#^T]<Z5?,3?Z/X1^)FL_##1+^-E=6MK_1OA@_@[
M2[VQ._<=/NK2:Q,B0R_9_-@A>, _V!OVI/V\OV-?V)_#L_B?]JK]I/X2_!.R
MBM6O+;2O%_BNR7QEK4*Q3SA/"_P_TPZCX[\6W4D5M</#8^%_#FKWLXAD$-O(
M5(K^)W_@J'_P>07VMZ;XF^$'_!+GP-J'AU+R.\TBY_:M^+^A6HUR&%PT)U/X
M0?"2^-Y9Z=</A9]-\4?%-+V>."2:&Y^%]A?BVU&V_@OU75M5UW4KW6=<U/4-
M9U?4KB2[U'5=5O+G4=2O[N8[I;F]OKN2:ZNKB5OFDFGEDD<\LQ-9] '7>/?'
M_CGXI^,_$GQ%^)?C#Q-\0/'WC+5KK7O%GC3QEK>I>)/%'B36KU]]WJFMZ[J]
MS=ZEJ=].V/,N;NYEE(55W!551]@_\$Z_^"=?[1W_  4V_:.\-_LY_LY^&_M>
MH7?DZOX_\?ZO#=1^!/A)X$CNHK?5?'/CG5;>*3[)I]IY@M]+TNW$FL>)M8DM
M-"T*TN]0NT1?U6_X)8?\&R_[=O\ P4&U;PUX_P#BOX9US]D;]EN[DLM1O?B?
M\4?#MU8>/_&^AR@SF/X1_"O4VT[7]9_M*V^SM8>,O%,?ASP*UE?+J^C:IXLE
MLY-#N/\ 3:_8+_X)[?LM?\$V_@=IGP&_99^'MKX2\/JUO?\ B_Q9J)@U/XA?
M$_Q/% 8)?%WQ&\5BVMKKQ#K4BO*EG (K31- LY/[)\,Z1HVCQ0V$8!-_P3[_
M &$/@?\ \$W_ -EGX=_LJ_ 339(_#'@ZWEU+Q+XJU&"UC\4?$SX@ZO%;'Q;\
M1_&-Q:HJ77B#Q%<VMO&D2E[70]!L-$\+:2(-#T'2[6W^TZ** "BBB@ K^;7_
M (. O^""O@S_ (*J?#9?C+\%X]#\#?MR?"SPW/9>"O$-V;;3/#_QM\+6/G7M
MO\)_B-J)119WD,[W+?#SQK<N8O#>HWUSI.N;O#6J/?:!_2510!_@G?%[X0?%
M#X!?$OQG\'/C1X%\2?#7XH?#W7+SPYXR\$^+-.FTO7-"U>Q?9+!<6\HV36\R
M%+K3]1LY+C3=5T^>UU+3+N\T^[MKF7K/V<?VF?CW^R)\6_#7QV_9J^*GBSX.
M_%CPE)(VC>,/"-[';W1M;@QF]T?6-.O(;S1?$OAO5%BCAUKPOXDTW5O#FMVZ
MBUU;2[VWS$?]@3_@JQ_P1/\ V.?^"LO@F*'XPZ#-\/OCMX;TF;3OAQ^TEX!L
M+"+XA^&8@+B:RT+Q-;SB&R^(W@&*_G>[E\'^(9HY;/S]1D\):]X1U/5;[5)?
M\RS_ (*8?\$%_P#@H'_P3$U/6->^)OPVF^*O[/\ ;74PTC]I+X/6NH>)_ATU
M@!YL+^.K!+?_ (27X5:DL+Q17<'C?3-/T&XU+[39^&/$_BF"U>_< _JO_P""
M;O\ P>7_  N\76F@_#7_ (*9?#*X^%GB>*WMK!_VD/@MHVJ^)OAUK$T4:Q-J
M7CSX40'4O&O@VXF2$S7NH> 9O'UAJ&JW;"S\(>$=(B"0_P!B?[.7[8O[*G[7
MGAJ+Q;^S%^T-\(?CGHSV,6HW7_"N/'6@>(]6T:WF\D"/Q-X<L[UO$?A2^C:Y
MMX[K3/$VE:3J5G--%!=VD,SJA_PF:V- \0Z_X4UG3O$?A;7-8\->(=(N%N])
MUW0-3O=&UG3+M595N=.U33I[:^LKA5=E6:VGBD"LP#8)! /]^"BO\5?X4_\
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M>T&YCBOKCX>?$(:=;V]G;>./#]E++=0V6EV?BO2/%FBZ79Z-'_0)_P %O?\
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MI3?CY_V8!\4__6BOV5:_D"K^O_\ X,J$<_\ !4OX_.%8HO[ 7Q11G"G8KO\
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MGT>/6[C4M"TO2M$US7M)3P[J%U-;Z]&44 ?T_4444 %%%% !7P-^V[_P2_\
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M^SA;Z<MM9[W>9;?QC\5/"6M,LL*-/"@TGSO+PLL<4Y\FBB@#P[P;_P &[O\
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MXXHI9K70/#6GZ;ID5Q.D$(N+E;;[1<&)&GDD90:** /2**** "BBB@ HHHH
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MXGAT^WUS7DLY;F[N=3O[72H+>PM&N;V\N7@M+='%I:^1;R7-Y+%)=S_45%%
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A>F:7I]L@"6]E8VL%M"GRQQJ.*Z"BB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img107301401_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img107301401_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  D < # 2(  A$! Q$!_\0
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M\7:E-86D%_J6K^)K;6EU#4+R:[TB/3]'.B:7:_U=?\$_?VXOVJ;J3P%\(/\
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M2_X)7Q3311_ G]OJY2.62-+F#X5_L]K#<(CE5GA6Y_:DM[A8I0!)&)X()@C
M2PQON1?XT?AMK.O?\%^?^"WWA%?VD_B3K?@7P7^TS\8?%][>7-YKNG1S?"G]
MGCX<>&_&?Q*T_P"%'@O4=:8^'] N-,^'?A"X\(:!J+V5U9/XQU6;Q=J6D>(-
M7U/4[?5O]$/PE_P0]_X($^#?#^G>'-._93_9?U2UTV$1)J'BWXB:SXS\07;8
M&^?4?$7BKXA:OK-]-(V78SWK11EBEO%#"$B4 [7_ ()8_P#!>#]D3_@KIX^^
M*OPZ_9N^'/[1_@G6_A#X0T7QKXENOC?X0^&/AO2K[2M=UI]"M+?0Y_ ?Q?\
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MJGPO^$L'ARSTKP1K#PM%]K\/^-/&7C2VUF[LHWD6XD^'*6VH*ME=>1>^+_\
M!N?_ ,&Z_P"Q#\;/V)/AI^W!^VQ\-YOCYX]^.UYXF\0?#GX=>(?$GB71?AS\
M.OA_X;\6:IX2T&ZO_#GA;4M";QCXJ\67/AW5O$=]/XHU/7/"\7AG6?#FF67A
MBPUG3]7U34@#[#_XC5O^"67_ $0/]O\ _P##6?LZ_P#T55?TY6_[5GP/L_V7
MO"_[8?C[QKI/P>^!/B3X3>"_C+<^+/BSJNA^$H/"GA+QYX=TCQ'H<'BJZ_M:
M_P!&L]=:'7-/TIM,TW5]6^V:]-'I.BW&K7%Q9_:?@W_AP3_P1N_Z1[?L_?\
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M_6I_Q&K?\$LO^B!_M_\ _AK/V=?_ **JOU7_ ."=7_!?G_@G%_P4U\<'X2_
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MO+AOV>BB2&*.&)=L<4:11KDMM2-0J+EB6.% &6))ZDD\UX;^S)\ /!G[+/P
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MM[R34;C3M&U6^AMGMM.O)8?4/B#^][]J_P#Y-:_:4_[(#\8__5=^(Z_R _\
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M0^.O">@Z1>>(+S2-"US5+71K>\DU&XT[1M5OH;9[;3KR6$ Y_P#:Q_X,UO\
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MKJF@:=K?A_4O%EL?%^B:;X6UNS\:>%?$VJG1O"_A6[T.PT^ZL?#?!G_!4?\
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M!/B%XQ\*^&TU3PIXYM++Q!8V>H^$M*T#5M$FEMH;*]T6_L+O3H+6RFAM+?\
M$'_@[M_X)8_%C]K;X;?L\?M<_LP_![Q]\9OC;\']5N_@Q\0_ ?PE\":]\0?B
M'XG^$'C&XO?$?A;7;3P]X4TW5?$FJZ?\,_'4>LPS6>FV%V;6U^*6JZU<I!I^
MEWUS&!=O=WZ_-[L_!+_@XZ_:$\8_\%5/^"T7PT_8@_9\FB\6:+\&]>\'?LH_
M# :9=KJ>AZU\8_B9K^CWOQ7\8FXM6EALM-TC6[_1/!GB._,BV-EI7PIGUVYN
M(K+S9H_]*#]E#]G#P+^R#^S5\#OV8?AJLA\%? SX:>%/ASHU[<0QV]]K9\/:
M7!::EXGU6*%GA76O%6KB_P#$FMF%C$^KZK>R1X1E _A+_P"#3_\ X)!?M#>!
M_P!L;XH?MJ?MF?LZ_&KX'W7P(\'OX=^!^B_'[X4^._ACKWBGXG?%FVUC2?%'
MCW0;+Q_H^AZCJUMX,\ V^O\ A^]OH[.YM'U/XD6D\-V+_2)%3_0WH _RAO\
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MM];FT!]3@TZ6_OI;&*Y6VDO+EHC,_P# ;_P^1_X.W_\ HP;X_?\ BL'XW_\
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M#?&'4H;.VE837IMO!WPN\3WEPEJK/!%#Y\@$*2$?RI? .7_@ZV_X(X^&KO\
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M'^UC^S%\3/V[[_\ :4_9?_:(_9ZL?%_@7X"V?A*]^./P4^)7PFM/%%WH^O\
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MO=W6J:QJ,MSJ&H7,]W<2RL"_38_R9OV8?V[/!?[&G_!5GP;^W/\ LU>#]?\
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M\/Z3K_B>S\5W&DD_8]9O?#MAI&M0W_A^]U;3+W_7;  & , < #H!Z5_FU?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img107301401_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img107301401_1.jpg
M_]C_X  02D9)1@ ! @$!2@%*  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ;-"&$# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[(_X(U_\
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M  P#^SY_TC?U/_P.F_\ B*/^& ?V?/\ I&_J?_@=-_\ $5_<#_9]A_SXZ?\
M^ <7_P 11_9]A_SXZ?\ ^ <7_P 10!_#]_PP#^SY_P!(W]3_ / Z;_XBC_A@
M']GS_I&_J?\ X'3?_$5_<#_9]A_SXZ?_ . <7_Q%']GV'_/CI_\ X!Q?_$4
M?P_?\, _L^?](W]3_P# Z;_XBC_A@']GS_I&_J?_ ('3?_$5_<#_ &?8?\^.
MG_\ @'%_\11_9]A_SXZ?_P" <7_Q% '\/W_# /[/G_2-_4__  .F_P#B*/\
MA@']GS_I&_J?_@=-_P#$5_<#_9]A_P ^.G_^ <7_ ,11_9]A_P ^.G_^ <7_
M ,10!_#]_P , _L^?](W]3_\#IO_ (BHI_\ @G_^SS)#)')_P3?U/RV7Y_\
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M^D;^I_\ @=-_\11_PP#^SY_TC?U/_P #IO\ XBO[@?[/L/\ GQT__P  XO\
MXBC^S[#_ )\=/_\  .+_ .(H _A^_P"& ?V?/^D;^I_^!TW_ ,11_P , _L^
M?](W]3_\#IO_ (BO[@?[/L/^?'3_ /P#B_\ B*/[/L/^?'3_ /P#B_\ B* /
MX?O^& ?V?/\ I&_J?_@=-_\ $4?\, _L^?\ 2-_4_P#P.F_^(K^X'^S[#_GQ
MT_\ \ XO_B*/[/L/^?'3_P#P#B_^(H _A^_X8!_9\_Z1OZG_ .!TW_Q%'_#
M/[/G_2-_4_\ P.F_^(K^X'^S[#_GQT__ , XO_B*/[/L/^?'3_\ P#B_^(H
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M%M)L%V1JPN#:0GS >JD[,\ GKGT]* /XB?\ A@']GS_I&_J?_@=-_P#$4?\
M# /[/G_2-_4__ Z;_P"(K^X'^S[#_GQT_P#\ XO_ (BC^S[#_GQT_P#\ XO_
M (B@#^'[_A@']GS_ *1OZG_X'3?_ !%'_# /[/G_ $C?U/\ \#IO_B*_N!_L
M^P_Y\=/_ / .+_XBC^S[#_GQT_\ \ XO_B* /X?O^& ?V?/^D;^I_P#@=-_\
M11_PP#^SY_TC?U/_ ,#IO_B*_N!_L^P_Y\=/_P# .+_XBC^S[#_GQT__ , X
MO_B* /X?O^& ?V?/^D;^I_\ @=-_\11_PP#^SY_TC?U/_P #IO\ XBO[@?[/
ML/\ GQT__P  XO\ XBC^S[#_ )\=/_\  .+_ .(H _A^_P"& ?V?/^D;^I_^
M!TW_ ,11_P , _L^?](W]3_\#IO_ (BO[@?[/L/^?'3_ /P#B_\ B*/[/L/^
M?'3_ /P#B_\ B* /X?O^& ?V?/\ I&_J?_@=-_\ $5%)_P $^_V<[C;#-_P3
M=U)968&*Z-]-^Y&>F-GO^G:O[AO[/L/^?'3_ /P#B_\ B*:=.TXLH>QTXJ<\
M&RASGC&"R$#\O_K '\.>J?L&_L]Z5::Q''_P3=U&61= U%EU4W\P%L5@8A\%
M "$Y8@]AFM?_ ((T?\$BOV'?VJ-#_:!OOB_\"TT^]\)^-UTG1M)^W@MIEM-)
M<.X8[')9?*$>"%SDG/&#_:=XOLK)_"GC"--/L%6/PUK84&SA^8G3;D]0H&,
M@# Y(.>*_"?_ ((;F%/%?[:T4=B+$1?%P!B'RDN9K\[PI.$'7@<#/6@#NO\
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M^& ?V?/^D;^I_P#@=-_\11_PP#^SY_TC?U/_ ,#IO_B*_N!_L^P_Y\=/_P#
M.+_XBC^S[#_GQT__ , XO_B* /X?O^& ?V?/^D;^I_\ @=-_\11_PP#^SY_T
MC?U/_P #IO\ XBO[@?[/L/\ GQT__P  XO\ XBC^S[#_ )\=/_\  .+_ .(H
M _A^_P"& ?V?/^D;^I_^!TW_ ,11_P , _L^?](W]3_\#IO_ (BO[@?[/L/^
M?'3_ /P#B_\ B*/[/L/^?'3_ /P#B_\ B* /X?O^& ?V?/\ I&_J?_@=-_\
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M^& ?V?/^D;^I_P#@=-_\11_PP#^SY_TC?U/_ ,#IO_B*_N!_L^P_Y\=/_P#
M.+_XBC^S[#_GQT__ , XO_B* /X?O^& ?V?/^D;^I_\ @=-_\11_PP#^SY_T
MC?U/_P #IO\ XBO[@?[/L/\ GQT__P  XO\ XBC^S[#_ )\=/_\  .+_ .(H
M _A^_P"& ?V?/^D;^I_^!TW_ ,11_P , _L^?](W]3_\#IO_ (BO[@?[/L/^
M?'3_ /P#B_\ B*/[/L/^?'3_ /P#B_\ B* /X?A^P#^SYD?\:X-3'_;]+_\
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M&(-.\%J!P0[I'&I.,*&8@9.>F<\4 ?AE_P 0Y_\ P2^_Z(RO_@8/_C=,N/\
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MT_\ \ XO_B*/[/L/^?'3_P#P#B_^(H _A^_X8!_9\_Z1OZG_ .!TW_Q%'_#
M/[/G_2-_4_\ P.F_^(K^X'^S[#_GQT__ , XO_B*/[/L/^?'3_\ P#B_^(H
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MTZFDJV5##(Z@$$CGN,\4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG/QC^SOXB\.W&C*]E+XBEL+U88A-,Y:23> BDB3EB 2%&3@"@#T;_@O,K1_
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M#^:;]C__ (*>^ ?A-^T#^U)\/OVIOBI>Z?J6F_$[7(?!FER0-<P0:(ETRVZ
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MXZ4 ?:%%%% !1110 4444 %%%% !1110 5&_WH_][^E25&_WH_\ >_I0!!(
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MBZVMIX=U&:"]O+CX)-<W$26\<LC9_<)&ZQLLF%2(C@*17Z$_\%!?^"@OA_\
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MHY>D;B06QD^1B#N# \<$5K6Z7HM5BR7U2)T,KL-J+&3DJAX&%4  #I@#&.
M=,.@^@I:09P,]<#/UQS2T %%%% !1110 4444 %%%% !3)-NQMXRNT[AUX]O
M?TI](>A^A]_T[T ?SR?\%S?$,OA2]_8\^)EIX:\5>);+X9?&_2?$.L6'A[1[
MG4IDL+66"1W:.!7(&U3C/IZ\5Z)!_P %Y_V692TMU\./CQ9:C:RK%<11_#K5
MY(Y(L L/,^SX*YR >HQ][& /VSU/1](OA&FO:;IVMP/*#;6]_IEI?I#,>CJM
MS%*JD#(W  K]:SQX.\)>86?PAX52)CY3I_PCNEL[G.<EA;8(QQ@@CGD9H _&
ME?\ @O;^R8F=OP[^.JYY.WX=:J,GU.+89IR_\%ZOV29I%6;X>_'0)SF1_ASJ
MK[ !G.#;C/X$5^SO_"!>!?\ H2_"?_A.:/\ _(=1S>!? L<;O_PA7A-MHSC_
M (1S1SGMC'V/GZ4 ?B#J'_!PC^QUH6@7^N:[X-^.%E8VUW/ )+OX>:I;PM#G
M;'NE: *JG[IRO /H,5\L_P#!*']J;X;_ +6W_!3G]I3XF_#C2M9L-(O/AAIT
MMNVLV,MC.UM+<P",^7(JDYZ?CT&*_4O_ (*@>'O"VE?LM>(38>&?"]@MXZ1-
M)%X:TD/&24)(=;53$!N(.W&3G)/&/RI_X(ZVNF:;^W5\3[+0]*LK6!_@3X>?
M4+BWMHK4O+YENRN$B5 V^7 S@X!/I0!_4_1110 4444 %%%% !1110 4444
M%%%% !7->-+::\\(>*+6"1XIKCP_K$,;Q@M(&>PN%&Q1R6;.T <DG%=+52]+
MB E&*G<F2 &^4M\P*G(((X((((H _D@_8E_X*%_"W]ASXK?M,^!?BY\-_C--
M-J_C.>\M=5T3P'JNIVMTJW<WW)8XBKI(&+ ANF#7Z.K_ ,%[/V3YFN&_X5Y\
M<WMX-H4R?#K55D)P>1&UN2,^F>/Y_LZ_A/PW-=7-T_A?PPS3 //<3>']/DN)
MF"[BTLIA$DI))YD9B.V>:J+X*\%RS0NG@3PD\4H?SKEO#FD*ZLO3AK,L02,?
M,3]30!^. _X+W_LG#I\/?CL/I\.]6'_MO41_X+W?LFHT4<?PY^.X:YFCA)B^
M'&JDKYA"[V"VV2%SR3Q[U^T?_"!>!?\ H2_"?_A.:/\ _(=1R>"?"%N8GL_!
M7A3S#-&DC+H&DQ,D+-B5U9;13E5Y R<XP10!_*W_ ,%!O^"WG[)'[0GP2\:?
ML_>!-%^)=QXJN=5TRVU(:KX3O;'^S6 E(,WF1 QD&9@Q)'W>@K]^O^">%G9V
M_P"QS\"!:223VX\)0RVTDH*NJS/*VUE/(( VX/>OYN/VKM$T.+]I_P#;02R\
M+>&XT77K80>3H^GV_P!@8QR;O)$<"^7@]"I'KSBOZ4/^"? ,?[(?P8A!\PQ>
M'O*D8 *H(GE;Y0, J RJ"!C@@4 ?:-%%% !1110 4444 %%%% !1110 4UMH
MP6['@\\&G5%, 5!/0')&.HP?\* *BK]H"LV5\J?*8[XQUZ>E?SZ_\%IO$,OP
MR^)'[+?Q;U'0_%VM>'?"?CVRO;V'P=HESKMZB6\D3.US!:QR-#%\K$2, />O
MZ"XW$T4FQ61D<D @@D#G]?\ ZU9U]I>G:FJ27^DZ=J7(29=1LH+P+&HY,2SQ
MNJDC() P<<@T ?B/!_P7G_9@?3HF'PT^.$Z0*EM=$^ -5(#QHL<F,6W&2#CC
MCI5V3_@O!^RE9SHW_"M_C>L$D"LLD?PZU0/YAP=IQ;9(QQG/O7[)6_@SP/(I
M2S\$^%$@,I,Z-X;TF)6?DE@@M K/WWL&/.,58B\%^!;D,1X,\+$1L8QO\.:1
MQMZXS9]/0"@#\96_X+V_LFO@/\//CJP'(#?#K56P?49MS67K?_!P1^QMH&G3
M:EK_ (+^.&FZ7"I\^\N?A[JJVT7!"^:[0JJ*S?+N)XZXQ7[9_P#"!>!?^A+\
M)_\ A.:/_P#(=?#7_!23P;X0L_V+/CC+9>&/"]A>CPTOV.YC\.:27BN/MD!5
MD*V@*,4$@WJ00"1GDT ?C]_P3+_:T^&/[8W_  4G^/'Q"\&P:S9:8_@RTE\.
MKK5C)ILUQ&WEO'A)%3<2H'&.3Q7]0MJT[L[W$"POC *G.X<>Y/'UK^3#_@D9
MI.F7/[65I<Z58VMG=6W@'13JLMM;PV?GE8(LNR0J@8,0>N<X&>E?UJ*LOVB1
MV;]T5547C@C&3U[DGMVP: +%%%% !1110 4444 %%%% !1110 55G5C+'E\1
M -YB==WOCOC\NIJU52Y&678664(Q3 R#@' /;DY[YH Y7Q"BR^&_%]N(F"2Z
M)JJ1HO,LK-87( 1.2225  ZD@=Z_D_\ V%OV^? G["GQB_:^\*?&_P"'OQ>1
MO%GQ(.L>%KG1? VIZA:7MG#<7<<@6>.(K@B4.&R00H&.01_6H\DZVHNIK<"X
M$JQC:-P9"<'<G0J1UR.@Q[57E\&>%+V>2YU#POX9O9Y2':6XT#3)9SG.=\TU
MM))(<]V8G.: /Q>;_@O=^R:PPWP\^.S#.<-\.]5(R.AP;<\BH9O^"^?[*$2A
MD^'7QW=ONJ!\/-6X_P#)?./85^TG_"!>!?\ H2_"?_A.:/\ _(=1OX&\#QLI
M_P"$*\)[3D;AX<TC<#U'2SX!QU_PH _&.+_@O-^R?-$#!\/OCA%++(JS+_PK
MK5 06^\6Q;?-UZGGMGO7Y??\%1?^"UO[(/[0OP'L/@_X/M/BCI_BV?XG^%H6
M75O!E_8K:2PS,!O:6/!#-+R<*!L/7/']:4/@GP,LTV_P1X27?.J1LGAG2 2<
M 99OL?S<C.[C!SQZ?QV?\%(]"T&+XP_%6U.B>'DATSXKZ5)8+:Z)IUN;9%F)
M  B@7:,@X(QUH _JJ_9&$<W[,?P@FN;R74;>]\':3<0M,GDRB*6 ,D;)PP9>
M25Z_-T%?3EMY0B"0@JB< 'MWP#WKYM_96GGNOV=?@]-%9Q/'_P (EIVW#! J
M+& KJ@PO)!&.@Q7TC;AAYNYB<OD+C 3L5'J./\\4 6:*** "BBB@ HHHH **
M** "BBB@ JBUTBWC0$%2L6]I6XC //WC\H(]#UJ]6=>E5R)D,L$R^6R*.>V<
ML.0.A_PH _!O_@N%J-UH?A;X$^+UL/$VOZ1X6\<1:QJ-KX4TF;6KL0PW,3,1
M%:K(V=D9& .WO4O@O_@O'^RGI_A+PYIEQ\._CVEUIFC:=I]W'+\.-71EN+.U
MCMY,!K?Y@QC+!@ /FQSU/[D3:1ILRQ6EWH.GWUA&?-B%];6][Y;N?O*MS'(%
M/4Y !]^:C_X0?P7-\\_@_P *2.?XF\/:4QQV!+VK-G\?PH _&$?\%[OV30<C
MX>?'8$]2/AWJH)_$6],D_P""]O[)K*?,^'7QTD0<[6^'6JOR.<[3;'^6>]?M
M#_P@7@7_ *$OPG_X3FC_ /R'4;>!_ JDJO@OPIO !&?#FD <].19_A]>* /Q
M*U/_ (."OV,-$T6_USQ5X+^-^@>']-*F]U"]^'>JK! -P$3',,0!8@!?G7/3
MIQ7R%^QU^VA\+?VTO^"H^J?%/X9:)XA_X0_5=!L+31]3\1:3-I%_(D4<91S:
M3*'6-D *MR3G&2>:_5;_ (*S^$="M_V OCU/HOASPQIFIQ:3I3VUTF@:3NA=
M=8L0\B$6HP_E-(@8'.TL.A-?E/\ \$[%TRP_:L^&USIVCZ?'/<?#+PK'<75K
M9V]D9KH:;;^<ZPP1QJ26.=P&3CDX(H _J99':20M+F#'* Y(P"2,#W_E]*=:
M2120AH00@9E /7(/-, 6W,KL69II&(7' W,<#Z?Y[U8BC6- JKM!)8J.Q8Y-
M $E%%% !111D#J<4 %%&1USQZT9!Z'- !1110 4444 %<=XP5;GPUXKBMRS7
MC^']4AACQ\S,UE.46)."Y+@#@$DX'?%=C6-+ 1/)= &XF0E(XF&U%4G!''W@
M><Y]?2@#^3O]C'_@HC\+?V(/B#^TYX.^,WPX^,=QK?B'XD2WVGW6C^!-4OM.
MN8OM-R55+F.!HRC%D<."1\OOFOT3?_@O5^RDO[JY^'7QT$BX+Q_\*\U5T&1E
M<$VV#Q[<5^S=SX6\)7,CF]\)>&[J\N5,\AGT+3)S+*N2#--);.9'SC#,2W/!
MIL/@?P3+&CS>"O"22D?,G_"/:.Q7!( R;//0>_M0!^,X_P""]_[)P&!\/?CN
M .@'P\U8 ?A]GJK)_P %XOV3I(V8>!/CM8H90TAM_AMJK23 8SN"VW)YQD\^
M_I^TQ\!^!1U\&>$A]?#NCC_VSJ,^!?!BR+Y/@WPBG!8.?#FDDG'8%+5<>H/Z
M>H!_+U^WY_P5K^"G[4GP#OOA;\)/A?\ '"\U[4-:M!%+JGP_UBQB0HX&<O!R
M'9B6.<$@'%?T#?L.V5]8?LH_ VWU*TNK"^C\#V!N;*]A:WN[:21I#Y<\+@/&
MZ@#*L,C(KW\^$/"^1GP=X7"1-YJL=!TP[2N#N0?9OE?'1@<C'MFNGA2&.*,V
M\:0Q;5"Q(BQHBCHJHH"J!C&% '<4 (R;ILYQ^'OCUJW2 #J!@D9_/FEH ***
M* "BBD+*,98#)P,D#)]!ZF@!:YYKB.'5C;_:)'N9;>1UL]N8RH1F4L_\.2![
M5T!('4@8&3D@8'K]/>O#?C-\5? /P&^'GB[XM?%/Q-8^%_#?A;3[J_O-5O+F
M"!KF"!"T-A9B5U,UQ-)Y<<<40=F+Y( !8 '\RME^WK\&O^"9_P"V]^T)XP_:
MAL?'G@WPQXM>>/1M1M/#5W=:#J%Q<72K"$U(H(2S2L@&V3Y2<D,!@_TK?L[?
M'7PE^T7\-M%^*7@BQFM_#?BG3[?6=!GO(MOVG3KQ ]O<;6 "LZ$,0,>^>E?S
M[^ OA;\3?^"V/QCTSXQ?&SPI:^$_V%O 6MF3PGX0U/1;:VU3XI&QE26&ZNIY
M8C<FPG:-9//&4"N-H(VBOZ4O!?@'P?\ #?P9HOP^\!Z19>'/"^@Z=!I>B:39
M+Y=O96%NH2""$'YF5%  R2<'K0!U2NEJL4;8E>X8C P5.0"1CICZ_2H6<9>)
M52VMU;$<J*%:27/S($'!X/7'8?@!H9$$5N";BV" EP5 (&&))]\^G/%9]Y*Z
M3K/>1E;"S"RPM'\TT]PY4%1&.H!/!QR?RH GN8KN>1#!=!7@ >73E89G1BH#
M2#(*@YSR,=L\U^<G_!1;_@H5X1_8K^']IH?AV'_A//VC_B5(?#WPG^&6C!=0
MU6]UVZ,,4%QJ=O;R/-96%NTRR++*B^9@N"$"E\[_ (*$?M[^$OV0/!Z:!HK?
MVW^T?\3+<:7\/O!6E?Z;K'G7<BP6%]<V",98K=',;[B@[L6&,#P#_@G5^P!X
MR@\5W/[:'[:SMX[_ &F/&4<>I:#I^KEKVR^'VCSF.>R_L^TN'D@MK\Q;$<HH
MDC/)&<$@"?\ !/3_ ()[^,M$\01_MA_M>7'_  D'[0OCC=KK^%-1==2T[P39
MZ@L5S:6EK'<M-''<VH?:RJH,;(02K"OV\B_ULTWF>6DL2I"K-M1  0I520JX
M SP!WQUJLWFI&\DZF6-RW[T##HC,-J+&.@4CC%(R0SQ)9W'F"0[7B<*0 IVD
M D>PY!Y_6@#R?XO?!OP+\=/A[KGPO^*NBVFO:-KMK<V@DNK6*XDM_M".D=Q;
MRRJ[12Q;LJZD$8'((!'\\OA#Q7\9O^"*OQYL?AUXZ76?%W[!?Q&UQD\.^*2]
MQJ4GP\O;VY6)1?2R/)]CM@S !7V(L>, "OZ@&%S$BI'&LQ4!1(Y&<8QGZCT[
M^]>/_&/X/^ ?C7\/]?\ A;\2?#UEXP\.^+;2:QU#3;Z*.0VYFC*1W<$SJS6L
MEF6$L;QE6W*<$9R0#M?#'BSPW\0_"VC^-?!6LV&N:)X@L[;4-'UG3;F.YM9[
M2YC6:,F2)F19 C@2)G*.=O/4]LF[:H;J%7)SG)QR?SK^7+PCXJ^.W_!%+XWK
M\/?B'>^(/B9^P!XUU9%T/Q3/'<7]_P##&XU>X1+>S57D9_LEFS".0Y5%B1N0
MN2?Z7_!OC?PUX[\-Z-XP\)ZQ8ZYX6\0Z=::IH^LV%Q%<6D]I>0I-"IEB=T69
M4=1+$6W1N=C88$4 =@5!.2/U-+4<@) *\^F,'KC\^*D&<#/7'/UH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKR/XP?&'QGX<TGQ/XM\=VWCV]O==TCQ'=1QW=U:36$5X\EL]M*&\V.55^8*
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MW?$KM_QCWX7SCC/[VTZXZGW/-?K9_P %4?\ DTSQ;_O-_P"AI7Y)_P#!'_\
MY/N^)7_9O?A?_P!&VE ']2U%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?QU?M7$_\ #4?[<')X\06V/;]U)7](W_!/?_DT'X+?]BT/J?\
M29NI[GW/-?S<?M7?\G1_MP_]C!;?^BI*_I'_ .">_P#R:#\%O^Q:'_I3-0!]
MGT444 %%%% !1110 4444 %%%% !1110 8 Z#%%%% "  = !]!BEP!T&***
M"O@__@I?_P F5_&W_L7X_P#TJBK[PKX/_P""E_\ R97\;?\ L7X__2J*@#\+
M/^"0/_)W.J8X_P"+::'TX_Y81^E?U@_Q_P# ?ZU_)]_P2"_Y.YU3_LFFA_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<_#C_@H__P $Z/C9XRT=XOA'H?Q!\,Z?KGB>YW?V78S?;(C()V<FW1U+ ;F
M8+CG&*_M#N!=3?9X[:%5D5P9FR0/(&,J#V;I@9Z<5\(_\%'/^"?7PN_X*.?L
M_P!_\$OBD'L$M;Y=9\*ZY:Q@WVF:U!&?LTT4P!FB D2+)C(/&<9&:^43J/6J
MDIO>VVR[-GUE)05.*IJT+>[Z?U_5CTO]H/0OB-^T)^SQ.W[,GQ3'@/6?%&CV
MM_X.\=:%)'<@V-U:HT+0E7"%5<E<*3C:1V-?RM_!_P".'_!3W]CW_@K]\&_V
M*/VAOVDKKXW>!_B3X7C\3#^TWCC*VUU'("J 2L&*@LI S@C!YSCO_A-\#O\
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M$_@?1H9-4@GU^PDC-R;B"$.!(7B9F5T.#WXKQK]O[]N?XG7W[=G[)G[;&O\
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M% !1110 4444 %%%% !1110 4C=#]#_*EI&Z'Z'^5 #5Z+]3_)J_B]_X*/\
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MMY,(B-@*"<= < \^GJ,=*U3R"/4&LF9&F@FCO8CLC8,ACY8\Y7&,_C0!X_\
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M^(-#\4:+IWB#PYJUEK>AZI:Q7>G:KI]Q'=6=Y:R*&2:*>(E'!7KT*G(8 @@
M&S130RL P8%3T((Q^=.R.N>/6@ HI,@]"#^-+0 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?P[?\$\?^3;?^"6'_7[JO\ Z-6O[=[3_4Z?_P!>=O\ ^BTK^(C_ ()X
M_P#)MO\ P2P_Z_=5_P#1JU_;O:?ZG3_^O.W_ /1:4 :5%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'YJ_\%4?^33/%O\ O-_Z&E?D
MG_P1_P#^3[OB5_V;WX7_ /1MI7ZV?\%4?^33/%O^\W_H:5^2?_!'_P#Y/N^)
M7_9O?A?_ -&VE ']2U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?QT_M7?\G1_MP_]C!;?^BI*_I'_ .">_P#R:#\%O^Q:'_I3-7\W'[5W
M_)T?[</_ &,%M_Z*DK^D?_@GO_R:#\%O^Q:'_I3-0!]GT444 %%%% !1110
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M)(SD+C=^*.K?M&>*_P!F6V\&^,/AYX#;XA?$^Z\,VD.B6*0FY-S<7 \B$1(
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M<[F#!<$@D_K[]*YQX9;V8K,C6]U8N)8'B'[O8>1M((#$]P>N: /R _X)O?\
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M8QE5+AI-L+DLB*&67<1AG.. H(R2>/Y;A()*Y&[&<=P.F<?4BOQ(_P""A?\
MP4AUCP;XML/V/OV1]/B^)/[3/Q"$FBW[Z8WVRQ\ 6-^C6=SJ>IRQ96VN[1)&
MFB\QQM= %Y!) /*_^"O?[3'A3XJZ;'^P1\(/!=E\9/CC\39[;3Q)IL::A;_#
M."5S#<:GJ]U"CR:7<PJYEB_>QEBBYY''RS^S3XT_:G_X(I2> ?A!^U9K.K?%
M?]F;QM-"EEX^\R749OAUJ-^RJ=,FG:64Q6EO(3'LD8 1@$@<8_5S_@G-_P $
MZ=#_ &.M%U;Q]X\UJY^(W[0GQ*8ZQXZ\?:UOO-4^UWH6[FTNWDG:4P0V,CM;
MQ>2R_*N/6ONOXT_!CX>_'GX?>)?AC\3M%L_$7ASQ99W-JECJ$"2/IT]Q!+ F
MH6;D>9%/:NXGC9&&&3&.00 =#X(\3^&?B'X>TSQOX&\26^N^%_$%K;7^GW-E
M.DUFL<\23 !T9L/MD59$)RK9!SP:[U7D1UCD/R@ 9'? Z_AC-?S$^#OB!\</
M^",'Q0L?AG\6X]6\>_L9>+=<>V\&^-;82W\WA1-1NR(TUN9VF-G;V2,B_/L"
MQITP*_I+\">//"WQ+\,:+XS\'ZYIGB+PSXAL8+_1M8TNXCNK*[AN(UE"13(6
M#/$&"RC@JP(/(Q0!V$B^4 R9SN&>_'3G\S5FJL,C,SQD;@IP6Z@<9P>?YCK5
MK(ZYX]: "BDR#T(/XTM !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_6@!U%%% !1110 4444 %%%% !1110 4444 %%%% !2-T/T/\J6D;H?H?Y4
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M[(7AA_''CAH_B+^U-\0U_M/Q_P#$35\WMW:7=V!-<65K<3/+Y$$!9T7RF7.
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M<T +13/,3<%WKN(R!D9(]1[<4[(]1^8H 6BDR/4?F*,CU'YB@!:*3(]1^8I
MRD[0P+8SC/.* '44P21EBH==PZKD9'U%.#*W0@T +12!E.<$''7VHR/4?F*
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M9&#*>A!R#0 ZBFLZJ"68  9))Q@'UI001D$$$9Z]O7Z4 +129&<9Y'./K2T
M%%%% !1110 4444 %%%% !1110 4444 1R=OQ_I0WWU_#^9HD[?C_2AOOK^'
M\S4OXH_]O?D)[?./YH_.3_@K8&/_  3Z_:3*G@?#W6RP_O#^S[K ]^>U?@'_
M ,&T5G:7O_!/;51+:!\>*]94LP!&!JKYY(]^QK]_?^"MA(_X)\?M+%06(^'N
MM' [_P"@777V_KBOP1_X-IX+Z^_X)RZU'9-';3#Q1K0#M@?-_:;@8[XSC(!
M%?-\276"K-:>]#5.WV?ZU\CU,OLY6LOB6NFVE[_>DO5=KG[]II6B0*JM%;J<
M<8P#ZG@#/>IT@@C'^BO&N.F'_7@@=?K_ #KPN7P1\0)KJY<:U&ZA\1A93\JD
MY_O#'7\_K3QX$^(Z_<UE%X/_ "T)S^;&ORNG*7)%N3;:NVVVW\[GO25G;M;9
M6Z+IT/> ;@ ;IE/H=_\ B>>I_.EW3?\ /9?^^A_\57@__"#_ !+/77%XZ?O,
M_P!11_P@WQ*_Z#:_]]__ &57=]W][$>[QF1IIE9890;:3)=^G!.!R1].]5-+
MTF&&X@FD@L_G8D;BO<^_7].M>,Q>!/B!LG:;7BLAA95"R'!SG'&X<].GM4 \
M >/G73P/$<B'>-Y\TC:"W);YN  /PHIN7M%[SOS+J]M/S2U[V,K?O'HNM]/)
M:_E??\#\1/\ @X$TJSM_V*OB3,IAAG?7&9$1@58$Q_-@G&0<]A[]:_=#_@B-
MYT'_  3+_9D>Y(*_\(+9L#TR, ?3!XK\+/\ @OU\)_$&B_\ !/CXA>(M3UK[
M2PUW$;M(2'YC.U3D@DDCCJ#7[E?\$/I9+K_@E]^R^MP"63P);*QQR=JH>/7I
MQ]:_3>'5>R;;^_I;?ML^[[=3R,PW_P OTLONL?JXUW'$(W8LD<A"[@, '=CD
M]N.I]O:DN1>2.H18&M& W%V^8^GOR.N/Y9J*1B5W-"LMC%$<IMS*THS]P<''
M_P!:O$_CI\>_ '[,WPUU/XJ?$[4)=/\ ".G.&NKJ5E2+3XFZ/.SY5(U_B8C@
M9XYKZR?Q/2VNQY4=EZ?U]VQ[:B3(EQ&T2(WEYB1#F$KD8+'N21R?ZYJ#&H.M
MH(8[<JCJ9MIY50<G'/7C]<=Z\H^"OQO\$_M(> -%^)'PPU-=3\&:W"MQ9ZK"
MZR1W<1R?W#KPZ$CJ.O'3->'>!?V]_P!GKQ[\?_$G[+FB^(3I_P 8O#D,LMQX
M;U!DAO)H(F(-S!&Q#R0L5)#@$'T':1GVQN19&G#2$%S$8\<;N!DY[?AP#4**
MA:XMI8@L+9?+<*23TZ_3('Z8YPM6O8M*@O-4U>XDM;+1[%[^]EC.(/*@1I)&
M9SP"J*&.>@Y/-?ECXQ_X+6_L->%+#Q/>:IXYDO=(\)ZI<Z)JVJZ<5N+&WU2T
M<K+8RW$9(CN8RI#(=W(- 'ZWQ"96/VA88X50)"RL-P'\/Z#/Y>YJO%%-#.\T
ML[S1D_(H!*GT''Y<COZ5^%EK_P '%W_!-.\CCB?XC7<3$8MH9H4#W#J/]7#N
MD5Y&[=#FOI/]EG_@KY^Q[^V/XVN?AI\(?$U]>^*K8!CIDD82Z2,\K,8P@*IW
MR2P]Z /U2@E\U"VQDPQ #C!P/3VJ>JUK%Y,>PS/,0<EG^\,@'!&3CKG].U6:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?U@_Q_\  ?ZU_)]_P2"_Y.YU3_LFFA_^B8Z_K!_C_P" _P!: '4444 %%%%
M!1110 4444 %%%% !1110 4444 %(W0_0_RI:1NA^A_E0 U>B_4_R:OXO?\
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MC5;/CW_UP_G50?&'X1K(DC_$CPJTC,(UVZO:C<PQ\H02,<YK^:E?A7_P2S#
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MP9AP .:BN/BO\+E N7^(7AJ&)',;,-7M=FY?E*DB3@@_7OVK^,7_ (*.Z?\
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MN)&W!4X#$%EH _T]D^,7PH,C*GQ%\*9BX='U2V++GUW2KC\C^E3?\+B^%?\
MT4/PE_X-;/\ ^.U_,[/\*?\ @EK+/;WTO_!0'4;BXN])TV6>33?$T\UH]R]L
MAG"M',RE@Y.Y<Y4G:3D4S_A57_!+7_H_C7O_  H+G_X[0!_3+_PN+X5_]%#\
M)?\ @UL__CM'_"XOA7_T4/PE_P"#6S_^.U_,U_PJK_@EK_T?QKW_ (4%S_\
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MUQP7_!PI^S&?VC/V /&6K:9;D^,?@S<1_$CPO/"JO>&ZTV2)]MK)&6<,PAW
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MS0AW*,\A+LT9RI)QT/H.@':K-4K&*:"'R90BB,E(@G3RA]W/^UZU=H ****
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M5\V?L@?\FS?!C_L3-+_E)7TFO\7^\?Z4 .HHHH **** "BBB@ HHHH ****
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MU#A51<<"O[3="_;6AU;P1!\1+6_TB7P1>Z=_;G_"6F>+^RYK!H?M+0QREO\
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M%WA?Q!87%C=/_8JSRVD%PC1M=V[&,[)X8S\KHRMD#)X&/YVO ?\ P62^*/\
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MXKF,E%W(Y2?8P4EESY2EB">YQ_+YKG[ O_!4+XE?&/PQ^T!\6?CQX \7>+O
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MKL)*G^Q@2-W7YS.TGY/GCK4I_P""9'[!A)/_  S)\-.?^H7/_P#)-?A^=/\
M^"R87;_PNWX:$XP"+P?T;%0_V;_P65_Z+;\-/_ M?_BJ /W&_P"'8_[!G_1L
MGPT_\%<__P DT?\ #L?]@S_HV3X:?^"N?_Y)K\.?[-_X+*_]%M^&G_@6O_Q5
M']F_\%E?^BV_#3_P+7_XJ@#]QO\ AV/^P9_T;)\-/_!7/_\ )-'_  ['_8,_
MZ-D^&G_@KG_^2:_#G^S?^"RO_1;?AI_X%K_\51_9O_!97_HMOPT_\"U_^*H
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MP%\!>.M(^%/BR?3/#GC;5+:6^NM2M9;N5&B><3@M)&%4 ^8P4(PVY((_9_\
MX=C_ +!G_1LGPT_\%<__ ,DU_-W^S3^R;_P5&_9#\ 7/PS^'?QD^&FH)?WD^
MI:CXGN[M'U34KFXD,S/>3EV9Y%9F RW&>,]_?O[-_P""RO\ T6WX:?\ @6O_
M ,50!^XW_#L?]@S_ *-D^&G_ (*Y_P#Y)H_X=C_L&?\ 1LGPT_\ !7/_ /)-
M?AS_ &;_ ,%E?^BV_#3_ ,"U_P#BJ/[-_P""RO\ T6WX:?\ @6O_ ,50!^XI
M_P""8W[!AQ_QC'\-#@@_\@N;J/K<TVX_X)D?L&W(59/V7OAI\O0_V6Q QGDA
M[N13_P!\9K\.FL/^"RT8W+\:_AHQZ8^UK_\ %#TJ1M+_ ."RNS</C?\ #+<1
MG;]L3()[?>_7]* /W"3_ ()B_L%*H _9A^&(/'S#2'1NG3]W.B_^.T[_ (=C
M_L&?]&R?#3_P5S__ "37X:)I'_!9@'S&^.'PT]-GVU3USVW'@?X5+_9O_!97
M_HMOPT_\"U_^*H _<;_AV/\ L&?]&R?#3_P5S_\ R31_P['_ &#/^C9/AI_X
M*Y__ ))K\.?[-_X+*_\ 1;?AI_X%K_\ %4?V;_P65_Z+;\-/_ M?_BJ /W(7
M_@F3^P8N[_C&+X8MN4KA])E<#/<*UR5S]01[4RU_X)C?L%6C.\?[,'PO+/G)
M.C,G4YZ0S1#CKR#]37X=C2/^"RLK*O\ PN_X9+@ALO>*!@=1][J?QI)]+_X+
M,BYCC7XW?"]HQM!<7BXXYY^?'Z=* /W);_@F5^P8V?\ C&+X9#)W$C2IP<_^
M!72F?\.Q_P!@S_HV3X:?^"N?_P"2:_#J>Q_X+,>>L0^-?PQ\I4SN6[7EL=/O
M?7I2?V;_ ,%E?^BV_#3_ ,"U_P#BJ /W&_X=C_L&?]&R?#3_ ,%<_P#\DT?\
M.Q_V#/\ HV3X:?\ @KG_ /DFOPY_LW_@LK_T6WX:?^!:_P#Q5']F_P#!97_H
MMOPT_P# M?\ XJ@#]O[C_@F3^P?'&9D_9E^'A\H&1X+?3I5^U!1_J95-R=Z'
M^Z"I]#FEC_X)H_L(2_99X_V6_AK;RVX^U6I.ER*8I2#MBR+N3 4G)!4@8[]#
M^'ZVG_!9>WGMRGQH^&,LCR;$$ETIC5C_ !/\W0=:TK+PM_P6/UW4X_#DWQS^
M&5M->&>X74;>]18K>1())74L& "G:4 Z8H ^??V0_P#@G-^R%^V?_P %$/VA
M/'_Q?^&7A'PU=?!?5=1\,>%O@,BLEAJ=KI]P((O$UYILDGERVDZ@/YHB8$'K
M@YKX9_X+Y_L<?LX_\$T_CW^S%^VE^RIX;T+1?C#X<\?6>I1?!G06:/3;Z6!X
MU1H=,MY&+$JS#:T&3N)V$;37TK^Q/^S!^VM^U1\0/CA^T=X"^*?ASX??M1_#
M/QGJOPOUR^@G:#PYXIT_39F@^VW:1$+,L[(&,A1B<_>R:G_:O_X)[?$3X:?M
M-?L'?'']L[XB'XP_%+Q?\=;?0KWPU9SR7?@I+;?;,&-I(Q3:!(G)CP2IYR#0
M!E?\$B_^"AWQB_X*(_\ !3>_^(7QC^&6I?##7+#P386XTF]LI+*W80K&@-ND
MD41Q^Z!7@_*17]OD_P!Z+_>/\A7\]EIX)\*^!?\ @L>NE^#O"VB>&-)?P#I4
MQ@T6TBM(VF,5N&W)$BJ-QRQ Z$D#T/\ 0G/]Z+_>/\A0 ^+HW^^W\A4M11=&
M_P!]OY"I: "BBB@ HHHH **** "BBB@ HHHH **** (95#8//0BF 8 'I5@J
M&QG/%05R0@UB95.[5KWM9)?\'7\C.:V?:_Z'YS?\%:?+/_!/K]I(2/L!^'FN
M@9Z$_8+KKZX]/>OYQ?\ @W-M_B#+_P $_-37PPL,D#>*]:!+] /[5D&.O&<?
MKT-?T=_\%:(UF_X)]_M(Q&,R,WP]UXJ%Y88T^Z)/MU%?SI_\&W_Q1\.^%?\
M@GYK%A<277GKXKUE95A!RA_M609)QV&,\_GD5XG$M9K"SY5>TTOE*+ET^_\
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M(R:?&LJ!A*S-YK,%"_\ +-2..?4?7KC\(+:-DAD6168M*RY;J4XP<GV/XXH
MT5.5!SG<,_GV'M3J:G"@ $  #G_ZW:G4 %%%% !1110 4444 %%%% !1110
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MA>;PAX-62))U/A?P^6:<9VR+I=L2YZ_.<C/O^@!VXQ@8Z8&/IVI::"  ,C@
M<'BER/4?F* %HI,CU'YBC(]1^8H 6BDR/4?F*-RCN/S% "T4SS$_O"CS$_O"
MG9]G_7_#K[P'T5'YJ>O\O\:/-3N0/J1_C0TUNFO4;36Z:]58DJ&X"F&0/'YJ
ME2&C/1Q_=([Y].](;B$?Q@_0C_&E,Z!&<9;:,X'4^PHL^S^YF2JTF[*I!OMS
M+U[_ -:]F<^D:V;J]LTCO+_RQ8_N+0'G&#P-IR!Q^E7AMNM\>TM*5.^YMR%
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MT-P]1^=9Y1W\T8(!8XSU(/IUZ#_ZV:PG5G3Q&&@HMPJR<:CLW:-KW>C7;?\
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ME1+AD(19&&YI2P&'![D9')/!'.:JQ S1W$L7[R.T)%RP_P"6+=2&'4X]AQ0
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M"M/_ $9:T 6]=_Y3)0_]B%IG_H%O7[SS_>B_WC_(5^#&N_\ *9*'_L0M,_\
M0+>OWGG^]%_O'^0H ?%T;_?;^0J6HHNC?[[?R%2T %%%% !1110 4444 %%%
M% !1110 4444 %1. ,8'K_2I:8X)Q@$]?Z4HI.;OHM-?EKJ1.^B5];W_  /S
ME_X*QFX7_@G]^T>+0JL\GP_UQ%=AE5#:?=!L@ D]!V[5_,S_ ,&[WQ\_9 \
M_L&>(O"GQ7^,/PX\,^,W\9:H);'6;N*"^19-4=AE7D5@2#NP0!SWP!7]E'QM
M^$_AKXX_"[Q9\*O%ZR-H'C+3+C2-02+'F&WNHWB<@'C@2'VK^9"X_P"#1/\
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M_9BS_P! [5/_ $= ?\:_<)U+QR1ABIDC= P_A9U*AOJ,YS7X=?\ !NBRQ_\
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M_5EM#2MG/"BOY2_^"3[K%^V7<K(P5I/A[HQ0'^(>1&<\=!CUK^K-'5G=E8$
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M=2T/5["5)8+^SEC5Q(@1F*[=VTAL$$$8H TZ*%^<NJ\F,X<#^$^]% !1110
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MOX@?$_4'U'Q7J6B0Q:C?N[.\[HH#2%V^8[F0GKW[9H _6R&198DE7&'&>/\
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MC_:3P+&I6%K>Y:0G:% 7YCN/'J:_L8TN!;;3["&%0L<-A9P+%T$0A@2,+C(
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M[K/_ 'Z;_P"1Z/\ A[=^S+_=UG_OTW_R/7YB_P##I?\ ;M_Z*_\  S_PF/\
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MQ]>GL<')_P .;_CEQ_Q>K3^_:3\/X>/KT]C@Y^N_UN\)_P#H'I=/^7?I_?\
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M9KV?=_9=AR!%<?\ +>74,X$L+'/DJ> ",8J9BQ9BX42;CY@7A ^<L$ X"@]
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M ()>_P#7WJ__ *&E?V@6W_'K!_UY6O\ Z)2OQCQ!;]O'7K3_ $ GHHHKX_\
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M1@\X- "443?N #*-H.,=^OTH!R,CH>10 4444 &,\>O'YTMU9RB-&CEW;,D
M9)QP?\>G>@<LH/ ) )]!ZGZ4N&M[S"2^;;D#)SD#(.1S_G@4 .N3IVJ:9/IV
MK0^=;36\EO>PX!^TVK(RS0L/XA(F5*]"#7\KG_!4C_@F!\2_@=XLLOV]OV"O
MM.B:SX7OO[<\3^#-&5HIK^.WD:ZO-UO;AWD\PAB1L.XFOZI&\LW?F*@90,@'
M[KMS\I'OWJO)<I9W$VH75C%KVB21/:Z]X6= \$MM+D2@PGY7S'D' (YYQUH
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MQF&V">&&10"$!!7@]:_5[[1)+=/=2E1); ;(@/\ 1)0H&U88\;0% VCC(]:
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MU[_P40_:VT:R^(VM#XA7FB?"/3_$D2:GIOA33=,U26*.73+6X5EML1(%550
MEAS@8K^G[]L+]C;X!?M2? 3X@_"GXG_#+P=?1ZCX.U[_ (1NZ31;-;O2;^#3
M+@:9=6,XB5X9H+@0[<.%')4 @$_S%?\ !MY\>O#7[*?Q]_:U_P"">/Q[U!?
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MWB#(3D'> ">_T-_P;E?"WP;\>_V%/VJOA)XU6T\3>#OB'XX\8Z+J=K<QI/!
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M&P&0JS=2H8FO#/\ @CO^P3^S+^WC^V!_P4<TSX_:9K.KW6D?$_4[#1TT6_\
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M"(/_ (JB@#^(C_@GS_R;O_P2]_Z^]7_]#2O[0+;_ (]8/^O*U_\ 1*5_%_\
M\$^?^3=_^"7O_7WJ_P#Z&E?V@6W_ !ZP?]>5K_Z)2OQCQ!_WB/K3_0">BBBO
MC_\ F&AZ/_TE %%%%( H_+\>GX^WK12,VV*9@,D1.0/4\8&>@S2E\+]&9U9<
MM*I+^6+?W*_F<W;:[I=WJ=W86^LV4VH6F0^F++$95QG@Q!MV<C'([?A71K<7
MK6JS1&%7W!9(@!E5)(/&?T]_PK\<?@A<:]?_ +='Q!:X\07KV%I-< :*UP[0
MQD,X7,9^7! ''4#IV%?L#8Q*C7EU*LB[Y,(A8[3VR!Z=_P .O6N#!UHU6U&2
M;3=U&3=VNM]5972LM'MZ>/D>9U,8Y<J<HQE*+:<K/E?Q-N^D5H[;]'N7Z4G/
MY ?D,4E'^?\ /^<5]#2C3A#WI*-H]6EK9)63UO?^NI[5=N<M-7S1;25]$E]U
MOQ"BBBO.&M$O1!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHI0"<X_A4L?95&2?RH2;=EJV-)MI)7;T20E%0I<0R
M0M<(Q,"ML:3& &SC'7U_/CUJ1G1$C=W4"3&P9!9L]/E!SCW_ "S3:<=):>H2
M3A\2<=MU;=V6_F[>HZBGK&[':HRV,X!&<?G_ )^M1Y&2O=>"/0\\?I0DVFTF
MTNJ\QJ,FN9)M=TKBT444B0HHHH **** "BBB@ HHHZ4 %%.1&<%D!8#J?_UT
MPD*<$@?4@?YZ4";23;:26[>PM%1+/"\<DJN#'$Q5V]"" >.IZ]N/>I"0"H.<
MN@=>."AQ@Y_$<46?8</WBO#WD[:QUWVV%HHHH>FCT?9Z ]'9Z/L]']S"BBB@
M HHHH **** "BBB@:3;LDV_(***1F51EC@>O;\3V_P ^Y#L^S^X?+)?9E]S_
M *_IBT4K@1Q^:[(J  DEAQGI300P#*<J>A[&D*S[,6BBB@04444 %%%% !11
M10 4444 %%%(&4N(]RAVY ) S^)(_+K05"$ZCY81<I6O9:NR%HJN]Y;1W#VK
MRA9T0RLK<*(QU8.?E/KP:?#/%<)YD+^8AZ,!P<<?SXH$DV^5+WKVMUOVL2T4
M44%RI5(+FG"45M=II;7_ %"BBB@S"BBB@ HHHH ****!I-NR5V%%%,,B!UC+
M ._W1ZT"::5VFEYH?137=(PS.P 7[QZD>V/4]J8L\3MM1\MC."".*#)UJ2:B
MZD$WLKK^E\^NA+13@K'D#]1_C3>E!HFI?#KZ:A111059K=-?(****!!1110
M4444 %%%+CK[#/Z@?UH*C"4W:$7)]DKB445$9X0SHTBJR*78,<?*!DD9ZG&>
M!S0*2</C3C?:ZLWMTWZHEHIL;I*B2(P*2*S(20N]5ZD \_YXH5E=0Z'*G(!Z
M=.#Q0/DDHJ?*^5[2MIT6_P QU%%%!(4444 %%%% !1111==P"BBE52Y(49(.
M#]?QH 2EN1(@C\D$$X!Q[]"?3GO22?NO]9\OU]OIFH9+LVB;YB,OS%GG(./Y
MY'YFA2W4=6U:RWW6WGTU_.P#KB>."'?<X) YSR<\X]?3'UK+TVPN-8G+S F
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M /!3+XHV/P9^'PO6^%B:U'I7PS\+Z?'<23ZK$9FMTOY$C#B$(55PT@&.N<4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^1/V^O^3+OVFO^R/>,_\
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M &<%:?\ HRUH MZ[_P IDH?^Q"TS_P! MZ_>>?[T7^\?Y"OP8UW_ )3)0_\
M8A:9_P"@6]?O//\ >B_WC_(4 /BZ-_OM_(5+4471O]]OY"I: "BBB@ HHHH
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M7/UQ<G_)IG_"Y_@G_P!%<\&_^%#I?_R17X"+_P &J$F.?VMOB+U[Z[JQI?\
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M:_\ HE*_&/$'_>(^M/\ 0">BBBOC_P#F&AZ/_P!)0!1112 *9-_Q[R_[C_\
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M\3_'_P 3@:;I]AI+^?\ V-#<@P7.I7UU;%OLILL^;LFVE]N,5O?L6?L8Z/\
ML]Z!?_%KXE ?%#]H[QT1J/B7QIJ8%Q)HL]R1,UEIHG4R6OV1V:)C$1NQGGN
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M6S\-^$-!M]#\(^'8(M.T[2;2%(;:>YBC5%NFACPFYF7S"V,Y)/O3?#?AO0_
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M /LL_B3_ -+7KJ_^"S/_ "7#_@G3_P!G!6G_ *,M: +>N_\ *9*'_L0M,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHHK(84444 %%%% !1137(526Z <X]^*%HT^PXQ4Y1B]I247\W8=10I#,BY
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M=_\ /NKTZ/R_N^3_ ![Z!;Y_N#\Q_A1S_<'YC_"H//O?^>'_ (Z?\://OO\
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M_EY>OX!]5?;\/^!Z_P!;]'Y?O^G_ ->CR_?]/_KUS?\ PDVG?\_"_F?\:/\
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M<?\ /.3\G_QI^QSS^2?3I+^[Y^2^]?,-+R6YX';'/Y]S_7\*/);GIVQ_7O\
MX_A6;]LN/^><GY/_ (T?;+C_ )YR?D_^-'L<\T]R?3I+^[Y^GX>=PTO);GIV
MQ_7O_C^%'DMST[8_KW_Q_"LW[9<?\\Y/R?\ QH^V7'_/.3\G_P :2HYWI[E3
MI]F7]WS]/Z3N&EY+<].V/Z]_\?PH\EN>G;']>_\ C^%9OVRX_P"><GY/_C1]
MLN/^><GY/_C0J.=Z>Y4Z?9E_=\_3^D[AI>2W/3MC^O?_ !_"CR6YZ=L?U[_X
M_A6;]LN/^><GY/\ XT?;+C_GG)^3_P"-"HYWI[E3I]F7]WS]/Z3N&EY+>@Z_
MI^?^?7T/);VZ_I^?Z?K6;]LN/^><GY/_ (T\7-R0#Y;\^TE"HYWI[E3I]F7]
MWS]/Z3N%_P E_;KZ]OS_ ,^M'DM_G'^-4/M-S_<?\I*3[1<?\\F_)Z'0SII)
MPJ/;I+^[_P #Y/Y@:'DM_G'^-/0E<J8SA>-W'/7)S_G%9GVBX_YY-^3U&]]J
M.=IM2(\?*P!R<]3ZXJ?JN<M?!46VMGY/6_EKIKJ^X&P3"?O2[#G)&?SYQTZ_
ME5%HIM3E$$)W)&<,V>",CZ]<="/KFH8M-N+\9RR9/N.O89/3_)SW[[2M+CL;
M=%5<R;1O8]23S_G_ /4!]!P[DN.Q^)J1QD)<E.,91<N]XWU=EV>@TK[[=;>O
M]?Y,-/LUM(%C0#S0.G\1/?ZY(]?<\UM("$7=UQS]:B$"AQ+_ !@=.Q_IGW_G
M4]?LV68&.$HQBM+)?.R72WE;MV0@HHHKOIR;G)/MO]VX!1116P!1110 4444
M %0*G!(]<_7/^ Q]:G/ )]*KQR[BX'.TG/;\?_K5+FE[C=N?3_+4ERLXQ6CF
M[+Y->37WC!$<Y_N]>Q'?^E,DSE<>V>G3G/\ ,4BW"2.RCJ,[CZ8X]/\ /6E>
MX@'4X&<8/K]/_P!?I[47AA-9M*^MGIO9ZW_S]>K+3AA;.;Y4UIS/O;OZ]-M+
MDPC\Q02>F/SX/H>G%3@8 'I5)IXRRI&27?HO7&>?3T_^N<];HZ#/7 S37++W
MXV?/J[6;Z63?Z$\L>9U%:\]79WT5K7^6W<4C((]1BL\+(J2AD53%EX7XRQY;
M _$ 8ZG-:%9!N1)<72.Q"6X&Q0#EF(R,#DGGT'KG%,9\#_MN_L+>"_VRO 4O
MVJWA\-?$C3(GE\/>)H8U2\2XMUWVT<DZKYODR2*H92=KJ"&'.:_@T_:\^$_Q
M:_8Q_:,NO%GV[5?A!\?_  !?PC1I;&QN(/"_[05M!/BUB:2%%LX+E515)9M\
MSYZY&?\ 2_6=XH)[W4)([>&W229WDD$4-O;Q@N\TTI(6,*BEFW$8 ST!K^'7
M_@X7_;]^&W[6WCCP_P#\$^?V3_!&G_%[]H!?$.G73_$+0+.*[NOAWJ>F7>5,
MVK6HEE:$7"*TL3.%(R&!SR ?SY?M@?MX?M5_M^^)?!OP4^(WA'7="^(E^UII
M^F>!%CN]/;57!2&#43 P!N;<$"7?M963!S@XK^CO_@E#_P $C_#_ .S)X?T_
MXO?&S3H->^-^JVMO/9/=VZO9>&DF1)(;.&WD0)Y[_<$B#<K?-UQ7AWAW_@D9
M^TQ<^"? O[5OCSXAZ9K?[;'PITFQE\.:#9:1#:Q:EI6GVZ$:1-!'&#+<O"HM
MC*WSE_F/-?1S?\%=KN?X::I\.K_PS>6W[7&@-%X8G^#*V<IN+#6F'V.UUJ2;
M!D,?VI1<!3P%XH ^T?VX_P!MCPI^S)X<TKPOH]DWCC]H'Q2ATGX?_#+1F-YJ
M-NUX/)CU"]6W+SVT=NQ$@610 HQTR*\B_8J_8Q\0Z#J]S^U%^TW.?$_Q7\4@
MZAIWA35C]J3P^M[MN+:*".Y4^2]LCA#MP0RTW]B7]C;6/"OBVY_:F_:A+>+_
M -IGQI&;[3TU9?[1L/#%A=_OK>&VM;@.EJ]M%)MS'M;<OK7Z=W+W&JS/:W]Q
MY36Q9X-40$)(3EA$L0X54SM4 8P !0!+/<7%W8RV,PVW5S(LUO*2=UI I)$$
M;')5-F% ''.,8JOC  /50 ?J!@G\:;%&S%I)IB)83L1L?ZU1QN]LXSCW-.H
M**** "BBB@ HHHH **506(4=2<"F(PDEFB7(:#_6%AM4?1CP: '>4)OW18H)
M/E+C@KGO^%#W5]*@TW3+9)DL\B:\< G;R2=Y&>^.OM]&NXBA-QD,B]U.?7CC
M/H:;$+ZXB.DZ;OM[[5,LK;2!Y;9)(?'7&<C/7Z4 -O4T^>&"&""74-1E(C>*
M'<$9\_,KNO 4<Y)/0'T.?SH_;K_;5UWX6+H/[._[/\L/CW]HOQVT>DZ9;Z,!
M>/\ #N.[VQC4-1GM2S0K;+(2PE"@;:C_ &T?VVYOA ;;]F_]FN!/B%^T3XQ"
MZ6PTU1?+X6N;HB)[J\G@+?9G@5W9A(5((YS72?L1?L2Z5^S78WWQ2^)3GX@?
MM)_$I3=^./%FKR?;F\/I>$RS:7IOV@,UNT(EVK)"01MX[4 /_8D_8GT/]GJV
MU#X@>-ISXQ_:-\91G5O'WBO73]M:"\NP9)X=)GN59K?87PJPL"-H K[[+,S%
MV9F9N69B2S'IEB>23[U-.HNA%I=Q()K:V(N+2_!$4JR+RMO/+PTB]OF.&&!5
M>)A/!=W*@I#99$K2CRO.(R-MKN $[9'"Q@D_G0 , 5(*>8.Z?WO\]?PJGJ.H
MZ/X8L[[QOX@U2W32/#MF]Y/J-].D%IHD<,;.6F$I6.5<C8$;C)_"JVKZ_H?A
MWP_J/BOQ+JL'A_P]I-G)?7^I:@ZVP@@C5G.U92N]R%*A>I)'KBOQC\0>)/BU
M_P %0_C)>?"3X67VH_#+]D;P5)]I^(OCY?.MF^(MI;2"2;1[0C *3^6Z!TR"
M& YH I>-]7^(W_!6#XF2>$]!MDT+]EKP%KY&J^(Y[?RAK]_8SJ\LVE.P**DI
MC;8T!QSQ7[,^!_#>E_#3PIH_@#PC87&HZ-X5TFWTRTU.Y9I76&WC\M6#L,CC
M'3N,UE_#GX7?#OX2_#W2/!?POT--&\':"RZ9I]O !#<W<T"E/[2O&15:X:;!
M+&4$DGGK7>Q-J$9\A-22.TG4"X01C/(.>?Q_.@"H%>RTFRD247$E_?R>>K89
MH@>>"1P 3C/H?;%62,$CT.*41V]MOMHU,\0.^.8DC:YZ\=N.,BFT %%%% !1
M110 4444 (Q(!(_SS5@2&2,*#T&#Q[_0>E0KC(SP.YJ1&5&/.1G@XZ]?\: )
MK2*[GG6RTU(WO9L*@EQY8C8_.[;L@;1D_A^%?FK^V5^VS??#;5+G]FG]F'3F
M^(/[3_BE#8Q6%A_I46C1W>Z&YOIY8"PM#99\P*X7=M]Z]X_;-\=_$KX9?L^>
M//'/PJTVXU3QAIT/DV$5H':X@AGC99KQ$B^=OLJDRX'4C![X^8O^"6WPH^&L
MW@S7?VCHM>L_'O[2'BF:23QMXBU5XI=4T)I2&>RBM92UQ8M Q,0P5WD< YH
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M9]J;;7]M=-*D+DM#(8F# IEQG(3=C=T/(K]*)+E%9=SK>BV4ZVUYJ^EVERY
M2WN=0M()V)Z!8I9DD8GL I)[5;-W;K*D+2!6D021LV!'(IQ_JY"=KGD' )..
M1Q0!9HJC=:IIMB";S4+*U S_ ,?%U!">.H D=23[ $D\ 9J>"ZMKI/,M;B&X
M3 ;=!*DHPPRO*,<;@#@'&<'TH GHJM+>V<"!YKJVA1F**\L\4:EAU4,[*"P[
MKG([BJKZWHT?^LU;3(^<#??VJ9/' W2C/4=/6@#3HJJ+ZS(1OM,"K*1Y1:5%
M$N0"#$68>8"",%<YHGO(+?R_,8XE;:A4%@2?4C@4 6J*J?;[+S1 +JW:<XQ
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MK_PHCX::>UN^F:;/NU&-I]:Q?2 B[R2HX/S\]SG'/I5QO@I\. J'[%=!BN7
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M/^VU(8P#@R-^M'U#!=:$%ZI>7^?X/L*_I]R_KI^?=D?V:/\ YY)^2T?9H_\
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M4E13G96@W=*]]=]=F]'J?3O[/O[3/P[_ &B-+O-5\ 7-W*MBQCD:\MGMRI!
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MSP(%9KN5 LDYD89:63+-DG.:[:!H$FEN$B$%I =MKI0Y24+PN]NAR 3ST/-
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M;1H7D*Q1C)QGK7Z5_ #X^?#+]I?X=Z-\7/AOJUM?:M%"(O%WA]I$35=$U%5
MNK:\T\'S8"DQ*()%!; P".: /;[N[DU)UDBB6WALUV2H %+-@<D 9)X/KCVS
M58<<C@GJ1Q1;-'?O=W:2O;.S#=:7"F$EN>JM@]3QQR.:F,$@9D #LH+$(=_
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M?M7?M ^'? /[& _9Q^)M]\)(?VE/%6C06]]9>9.RG69+=@^Z-LX47&-F>,<
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M^R_AI\1O^"\$DGPH&K?#RPL?!B6GAV/49UN0SS:*R6\(GF4-\S"R 8ALGN0
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M^%XKA8+&3RKGSXC"PD#;2%7N <]./TKA_M"52:YF]7N]7T>E]7H>1EF9Y?\
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MUXQ,3^$KJ3J=WDOQTR.!U')X./TKW"9+"$X;2[=CDY*0(1U'HI''Y_6F@VY
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MS%(/]AL_E_D5\O7DFY*+NMM-GHK/M_D<N)UP]9=Z4_\ TEGXE? #46;_ (*
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M;$0ICRR+B,%L<989XX[''L*5U>UU?_,ZI0E%VE%K^N^QYU_PBOQ6_P"@VO\
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MX8"X0D\]<9/3_/M7/'O^#_R-^:/=' Q>%OBJI:8ZL',,18G=D\!CZ^WX8S7
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M%[;D9\P ;MF3Q\WI_P#7Z5I*,HI.2:3V;5D5=<SA?WDDW'JD]M//H6JP+A"
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M_@GC_P $Z[A_B)^T=\3A)X:\8^)_#[+>Z?\ #.RNLVMS<I?V;8CN?+D_>@R
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M/C'X BG.>K-J5JHVG^++ YZ8K]L?#DB-X4\'*S"/9X3\/DM(=JDMI5L0H/\
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MW[5Q[?%3Q.J[SX/;!&1B-LU OQ;\3.P5?!DA/_7)N/T[_P!* .Z_X5/X"_Z
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M63O\2>.CCI_HMU^/!)_R*CFTGXALR^9JOC>\ P,O#>(8\#G #<YQW!],5?\
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MIY'0Y'][) (Z$=O?K7*CXK>*S_S(]P.,\P./Z4/\5_%[1QVZ^&9[*W>0"1A
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M  IZ?='X_P S3!]QOK_A3T^Z/Q_F:^EE_$?H_P#THXH[+T7Y#J***8PHHHH
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M:G>VZOYVV^5M]1:***1J!Z''7M7.-//$U_*KPQR0H9/)G8)!'$/F>:20]%1
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MI:;:>FAHXQY;O=]_^#LK:]BM-&^496P!USP.2??Z=.>.#Z59[J( 1F+<^,9
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MIK1*Q*3GGZ?RHH'Y]:*['&/1K^K;:>GW>6GU/M)1;45ILK:)KW5ZVM_78/\
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MWU]-?:_L^G_] >U_\!8?_B*0VNGG!.CVW&0/]%A_^([=OP]J\9_X5EXS//\
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M*,EEY( - %V-K?49H;/1X_L\UOQ+=R_+"H4?,SL?E .".>XK\TOVS_VWM0\
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M;PH#,Z@+] /;%1?$K5+KX\_MG^(=*N)7ET#1=0CM[!+@DE9HKE%EP#]U2>X
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MH]S9&:YUZ\U&1IKJ>\+ PMNRHC(/(ZY)KY3V.;*NG:6ZULTMU>WY7[:ZZ,^
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MK\K#/7(/]:Y8X:TN9I[=+ZWMI=6]7;7[F#G?2Z^5OZZ7-3_A./!O_05TX?\
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MDEE+;\@. >1_=/OC_)JE-\+/ ,8&_1D 7Y0&+ACSCID?7Z5UG8:O_"<>$/\
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M3I\2<C[PN7R#]* /SH_X)%?\H^/@/_U[:=_Z3)7F'@3_ )2__%7_ +$_2O\
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M:;927&N>(=4G2"YO)(8V?[$^XC#Y4Q6RJ,L=HQ4GCCQUX/\ A;X)U/XC>/\
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M"&'_ ",_[7__ &6?Q)_Z6O75_P#!9G_DN'_!.G_LX*T_]&6M %O7?^4R4/\
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M[J=S+8V\\;1AX9KAWW(K=05<$X R/8"OT,_:4^&4WQ,^&&L:!IMU+:76FO\
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M\'?';]HO0/"VA+XALI&2]T_0=0M;"WFF@DWK*9V66>0L&#98=0 :^K?V//\
M@WJ_8A^&'P[T/6_VE?"=W^TG\9_$EK9WOC/Q?\1[C4+F>V\27EN)M3-O&UXI
M2..XD94D8A0JY59!T_'K_@K6#\'?^"A?_!)W]HKQN+X?"""P\#Z5=>))HV$&
MC78CTY-TDC QQQHQ!!8#@CFOZ]?VF/AUXC_:K^!+>&?@Y\3]3\ ?\)IID6J:
M/\2/"\ZF2.QNX!Y,MI<)(N92#D ,,8(SE3@ \P_9N_X)J_L;_L@>.O%?Q'^
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MBN.6+H.S4(R:[)=+:ZOY=]]>_-A*U>&,=26%E&/-?F<5^&FORT=WIH?CT/\
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M>UUK?:VW]/LP-=5<*\NJ7^O4)NI*#3Y_9Z*,FWT>O;Y7-4^)_$@&?[?EZ?\
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MZ5Y5X"_Y2^?%'T_X0S2?_145 'ZS7/\ Q]ZQ_P!?,O\ Z&:IKT'T'\JN7/\
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MH?\ N9 P> ?QJ.E!$$]Z(6:YM;O:T7V@Y>S?^,09S@9R!BDH **** "BBB@
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M\+?'7P'9--K?@R^FAMV"W%QJ<4Z6MLN>?F!XX&<]OI@5T_PF^-7Q$L]1?_A
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M::=[)O;=Z[WLK*W4M1N(!%GS7*Q$LJ#*$@=S]./3-?@3_P %]O\ @GK\:?\
M@H3\"?AAX?\ @)/I\?BOX?\ CZQ\5Q+>/MQ-:RQRH2 XP04&?3C'I7[Y0-<2
MQ1M;,O$@\P/T\O(W 9[X[$5<6V,#SR6ZHK2@MM/W3(1U/3 SGTSW]*^GLX^Z
M]6M#MG#V<I0_E=C^3SP]\+_^"^_A3X=>#_ 'A&_\!0V?A72K'2C+=WJI>26M
MGY<8V*TH.!$K <]#UY&?<?\ @IW_ ,$]?VJ_^"@?[-7['7A[Q9)HEI\5/A1\
M3?#_ (L\<7.F2EEE%A);&Z)8./O&W9CD@ L3@Y.?Z5C$[)'(RI]I1<;\# /.
M5!_NG/\ 45#%!*DSD1Q0I(I+O'C>92?O8^F>:"3\R/VNO^":_P +_P!N+]CO
MPS^S=\7S)8Z[X9\,:;8>'O%ME&/[3T#7M/LX8X[RUG&V2,>= CY21>03SDU^
M(7PD_9/_ ."XG_!/X6WPW^#_ (\T/X\?"#PX)+3PTGC+4#=:E;:4F8;=5WSR
M,3&C#@GC:!UQ7]>]U:FXM9H Y5Y8RGFCAP2>OUX']:J6EK>K;PI<2JL]N0BR
MH QDA7[H?<&Y.!G\2>: /Y6OV&/^"7?[9NO_ /!1/5/^"A7[96KV-OX@UCPY
M/H5AH>ES%HM/M7MI8XH4&\[0CD # &!R,U]-?L#_ /!-SXM?L]_\%&?VCOVE
M=?U!CX'^(5SJ$FF12$@NERY*@[F.>#Z=#QVK^A-K.5KO[4;AV58PB6YP(@W=
M_J>3]?K4S).67#*R-Q*C!0,'J00 >GU_&@#XN_X*"_ _Q/\ M(?LC_&#X-^#
M+Y;?Q!XYT.73=.E)&%9R?E7ISRAZ]CT/3YV_X(^_LA^/OV)/V2-)^#'Q-U$7
MNO6NJRWH=3DK%*'^7EB1R5[\8XZ5^J<FGHXB".T8AD\U2O7=Z'H"/\XI?LK[
MFE=A-*<!0V BJ#V P ?Z8^E '\[_ .U3_P $O_C'\6O^"J_P7_;:\/W.D/X
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M?$7Q*\11-IOAZRT]Q<2V=_,PB!E5-Q4J'!QE2.?[HJK^VA^V3IGP0TU_!'@
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MK^IKB^&<ESK!RQ&54W"I"-^2NX56FM$U9VE%O6_;>S1^K5E/9Z-8P(7::XU
MJ%.2VW=G(!SV)XK?U.72=(L!XAUFXTO2-/LH"MUJ6N2K! @4;B0S,HP!^?2N
M+\M3]FMYES>1-YMNQ'R':V1&/]L@].M?DY^VO\0/''[2?Q]\*_LD^ -4O=$M
M+?3(]:\9W,4KQ6[:<A43VZM$5/GL@8 'KZ'OZV(Q:PN'I--WJ/EML[)15M^O
M_ [GS?"G#&>9CG6)RZK/!+!8.G[2K)45>--]7?1)*ZU?X'V'\0_^"EW[(G@3
M4&\/W'B__A*M4T^0^?#X3D:[@C="0P)16 P0>_!!Z]:E^&?_  4>_9*^(U[.
M/#_C5_#D1?;>KX@F^R@7I^4QDRA0"3],<=.16[\%_P!A?]F;X0Z+IFFV?PG\
M->*-3NK)'UO6_$%L;C4I[AU!F:.1]Y)+%L8ZY'L!1^/O_!/?]F?XN^$-7T+P
M[X T7P!J-Y9RMI]_X=A-I>?VN%+I<7#1E/DWJ,GT.?:O&:J.?M+Q:NG+F3:=
MVK+F5D]/SMOJ>_3P_ V%X@AE\Z6)5>2M[2%6$8\^D7+V6K2Y]8II^[>6JLCZ
MY34;#4=,TWQ#IFJZ7>Z=K[JNBZQ:RK)%*LO,;>8A((((QD\]1DCC#NK66WGF
M2X<23HS>;*F"DC=V!QT/'>ORX_X)T_%3Q7\//B'XP_8D^- &JZWX#BGUCP-J
M]PS/;2Z5 6%JGF.3NFV;<@$_0]_U9U,L9;E"@\Z-?.F5.8P.?E08Z>V3G.?6
MO3P>8<\E1U:5KK?E7NVU=OE?OUZ?'\3Y%B<NSS$U;TYY;.G3>$E""C)MN^LE
MH]-'JM3EY\-^'!]>N>/;BI"VRT//;I]!WZ>E0"1GB2<Q.L<DAC4,!NW9/./3
M'^1S4J127D<L,:F-H\Y+_*& S]WIG/3_ .OQ7O1H8=Q51N/-9/\ ".^M[K;I
M?L>%[>,?<NK)ZZ[:I7Z]E_6VUHH\VW89)XX'7KGKUJ^1@D>A(_*JGAM2L%P6
M4YA&&!ZG&,D9[<'KU'-3/.I9FPP')Z=^N/KWKA=3FG*"O:&W;ILOZZDR@HVD
MMI;^JMKVUO\ F25 W4_4_P ZC-Y&#@AJ4.')(SSS^?\ ^NF2.K\F_P#@N?\
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MQR[S,Q"@(.6R1P* '6VGM*'^UND2,IDC,K!4,PP44EB -Q*]3@#]?SB^._\
MP4X^!7P(^*.B_"CQ=HNH>)=5O+R*SUK6M B>YL?"&]]HFU>:)72%(UP[DL,
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M@CA^56>+KT*,Z\[WNFGI;E^&RVO;1+KIL?!_AS_@GA\"_#R.EUHW]N+*%/\
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MC[.=:UOWD=4]N_9O[DPWC]<?AZ]/THWC]<?AZ]/TH\F3V_.CR9/;\Z?U*/\
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M?LY4N;54Y6YHKSMIYZ:&T%-12J2YII6DUU_S]0HHHJRPHHHH **** "BBB@
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M=./USE2VM3:O%"BP2!8H8(E"K"  %) P% XXQV^M1I8B/"1+'&F.448 4<<
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MW_Z]'F?['_CO_P!>H\2_WE_[YHQ+_>7_ +YH D\S_8_\=_\ KT>9_L?^._\
MUZCQ+_>7_OFC$O\ >7_OF@"3S/\ 8_\ '?\ Z]'F?['_ ([_ /7J/$O]Y?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]N<UO>&3CQ;IUE$//BO(+N47T?,$(:TF.V0] 1@CF@#YO_X(8?\ (S_M?_\
M99_$G_I:]=7_ ,%F?^2X?\$Z?^S@K3_T9:UR7_!# RGQ3^V*PA<VD/QL\2P"
M]R/*ED6\<E5]\ _YZ=7_ ,%EV+?'/_@G4NTA?^&@+-E?JK'S+7Y1[]/SH NZ
M[_RF2A_[$+3/_0+>OWGG^]%_O'^0K\%M;,A_X+)Q!X7C'_" Z859NC#9!@CZ
MU^],_P!Z+_>/\A0 ^+HW^^W\A4M0PG*L?]MOZ5-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% '\.'_  3Y_P"3=_\ @E[_ -?>K_\
MH:5_:!;?\>L'_7E:_P#HE*_C#_X)\(3^SI_P2\<<@W6K_4?O8QZ\\9K^SN$N
MEO;+L8[[&U(/&,>4@/Y8_E]:_&O$&+]M!I73</PM>X%BBG!6P.,?B*-I')X'
M<Y' [GK7Q:DOJ\$G=I:KM=) -HHW0\XF0X]B/Y\?K29/& 6STQ[>])3B^O\
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M]NVKNU_5C=2]VS6OR\OSMU?8LH%P#GD8QTZ<8]^:!]X8_O?UJ%%D.#D ]._
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M6)?D)P""2?I2-="("W@4/)@Y(ZCMU'^'K^+T:)23-*(4(*AVSAI&!"Q\=V.
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M_3KM]P=%ZO\ 0F P,49&0.Y_3OS2U'_RT_S_ ':^TB]9+S;$244458!1110
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M^TS'<^-?#$&E6T_@/XJZ+#/>:1XJ\/20+_9MH/LJ28U&VMMINF<[FD#;N>:
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M+_\ !=.0'_@EQ\?(<'/V.P&>W_'R?QH ^<_^"1W_ "8%\%?^P?IG_I*E>4^
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M"CDY/KGTH FB-RKO=6,2QVT:M('DP$"@9!).,#'/X5^</[9W[:&M?#J_T/\
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M\+_X:M_99_Z+5H/Y)_\ %T?\-6_LL_\ 1:M!_)/_ (N@#W2BO"_^&K?V6?\
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MT7EX;)/L?8G\17;K9,488&'Z<=!V..Y_^M6-<6#0*<GIU 'X\?CUH SI91M
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M9;G_ (^]8_Z^9?\ T,U37H/H/Y5<N?\ C[UC_KYE_P#0S5->@^@_E0 M%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%$_BA!\(/A6VH^%_@AI5VH\6^(D\V"'4X8Y5,X655\MQ(N\  G/N:_83X#_
MSP9\!?!^D^!/!>F10:;IEM&)]6:-/.U&[VJ)7,H =RY&<EN,]/5?@I^SYX+^
M"G@JP\%>%K*WMH8H8TU+4((DBNM1E4?/(TJJ&(<YX)]<]L>Z"V6+RH%DS:6Z
M@6\>1O#@8+.<?-G\>>>X%9JFU-2T4V[R?:]ERJVFJ;N[75K*RU,,@R.M7G+&
M9PDYJ3JT93=^26Z4=XW>S:M;965RR23W./3.:2CK176?7;!37^Z?P_F*=2$;
M@1T_^MS_ $I-)IWVZ_+4"K?+NCCD'.,?ACG/^177:'<B:!!G)3KS^/X=<?AW
MKE'/VBVE0?*4!Z\YQZ?G6CX2E)2=6S\K$8/7@X[CZG^=?0<*UE3Q\$W9\R72
M[U5K];OTV''=>;7SUV.X(P2/2I$'?/48Q^/_ -:F$[L#'.,=>O\ GFIJ_<Y?
MO*=%N[M[/]+[::=?004445L 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 57N2RQ%T4NZ$,B#^-L]/?CG\*L54O-RQB6-=\D1WI'NV^801
M\O4=N: /Y[/BR(I/^"WOA>]C?[/J=I\'],2WB8C]^!8I&A /7=D'\:Y'X7_\
M$W? /QO_ &SOVB/%_P >_!6LW>CZL+F72+BTF:R22:6=3(?-*'?NCW!<!N2,
MX!)%;]O7Q!JO[)W_  5"^$?[8/Q)\)ZG<? '7O#6B^ -1\:V4,T]IX:U.%+:
M!I[Y(5(6(%ANDD8+C.<5_0AX2\4^#_B#X>T+QSX*U'2]6\.>)K>VU'2];T@P
MR)J5I=1!XO-F@SAB,Y21MR%<, 0: /YY/VXO^"2'P1\ :?\ !CQ;\ ? FNMJ
MOACQS:ZE<1F\:^6.)9X)=\FV)2I!SE=I P/G.<5_0!\.I;G3/A9X-D\00?9F
MM?#>F0S0,-LMK)%;(F><$$!0">,9YX-=O=&QM+.ZEO!:W&F1%I6-WY;K;R)C
M=@2=U/9<-G&#V/X^_P#!17_@HYX9_9H\++;:1)#K7BS5$FT[PQX0L)!+?:]>
MRAK>WACMH7,L*QR/&P9DQCI0!2_X*3?\%)OAG^S%X173;_[)X\\;ZYOTWPE\
M)HD%_)XDU&X)M[5-0M(B^^%)VBDQ/&5X%?C;\&OV!=9_:NLO$_Q[_P""A\)-
M]XHM#J7PI^%E@!#:_#FTO%:72+BSMB%CLYK9C$6,8!&TC@UM_LD?LD^,OB?X
M@O?VP_VPXF\0>/\ Q7J4EWX \"ZG&9E\(Z?*XEL2L%PH\J:$!0749W#.37[
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M.L_M8WMY^U;^U;<7GPQ_8L^&5Y-)\*/AI=O)#JGQ2U:SE9]-!L)-LUW%?2;
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M_P#B:_HVQ%_SYV?_ 'Y7_P")HQ%_SYV?_?E?_B: /YR?^%=^ /\ HS7XC?\
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M  7,B(_X)9_'\D];*P.,=/\ 2?K[T ?/G_!)'_E'[\$?^P?IG_I*E>5> O\
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M!QYA?&.,Y)!Z_F*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU>F^Z?9'QF=9M#+DXN7-BZSY,)15VIU9)1IMN+M9RT2;5DG?0A^('Q5^*O\
MP42^*5W\(?AI;W^A? _1[W9K?B6(2PPZI:Q2+YA67!1Q(H88!(Y-?L)\ ?@3
MX(^ _@_3/!/@BP@LK:QBC6_OVC07&I7"J!([2X!<LQ+8]^#GD6O@M^S[X4^!
M/@_2?!O@VWM+.TL88HM0O$A1;O4F1 )'DE"[BTC GDD#/UKW9X+>1HE,96*
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MJ*O6?^"2W_)@7P17UT[3#GZVR=OQKR?P&,?\%??BD/3P9I(_\A14 ?K+<_\
M'WK'_7S+_P"AFJ:]!]!_*KES_P ?>L?]?,O_ *&:IKT'T'\J %HHHH ****
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MVG.2&Q@$]JZG_@L9<::/C7_P3LU&:XCN+&^^/UK8:5+9LL\*:B)+1]XFAW(
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MO@KP=9V]E;6T4:ZE?QQ*MUJ<BK^\EDE4!R9#V)QSZU[9):6[I;Q$'R+3#6R
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MNJF"BD[_ +N[WWM!)._S^X;_ $7X):$]%%%?1B"BBB@ HHHH **** "BBB@
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M:<+1+<6\@8LT;2!9C'G)^4X;I^7UIRF(JHA5E50%(?.[>O#9S[U_,/\ &?\
M:\_;6\ Z_P"&?VK-9UEM.A\::C'+X$_9:M4:?7/$&@O,)(KVZMTS<67G6@#[
M)$7[V*_<?]DS]L3P1^U[X:TJ71[9/"OQ3BL86\8?#O5"MC?Z%<B)6G7RIBLL
MG[TE00G)^E 'UE14K1^3<SV]VZVWD%D8R,%9I <;45L%QNR 1U[4V*.24XPJ
M$GA78*VWG#%3S@@9S]* &=:FMW?^TK"2Z?RTMTD%B5.T-,_W4EQ]^-CPZ-PP
M)'(J"::SM3BYG92,_<0OT^@/_P"NHOM%O= 16I^U$N&3S6$!C*D?=WX/4C&#
MVQQ0!^5G_!0+_@G3IOQHT#7OC/\ !2*ST[]I+14DOM1T:WAC32-<TN$-)<)_
M9R#RI+J:+<%E,9<.<AJ_%OX2?&?PU>V]]\"/CSI&IZ9X+%XNCZ_JFI":+5OA
M%XP$GV:QU/36G"S?8_M@%R1;X1$'/ K^P>*Y31M3AU&!7&M,@BRFZ59D(^XZ
MC/F*>5(.<^G-?A1_P6$^!OP.\.^$HOC;;76F:5\9];OH+!_A]HT,'V[QBEZW
MEO<SZ3;CSO/C+$K,\996^8'(S0!]/_L1_MS>)OV8O&OAG]E#]L_Q++XA\$^(
M#"G[,_[3-J[W6B^(M*OF L-+UJ:-C!'-!!L@)N7W*>N*_H,U%+S3O(N]36TU
M?2+R**>RU"PECN8)[6=0\,R21%D&^-@Q )QFOXFO"V@_$#X/?!WP3X:_::\)
M:EKW[.?C^SC?PIX@O();WQ!\&M>OXT.FW"WDRFYLK>*:593M9%C5<'I7ZM?L
M*_MT:K^S+XO\%_LL?M9>*#J_@'QSQ\$OC)<7?]I:1XATR];-C;:AJ;N;>QFM
M(&BB\N:0-N7&,T ?T(1R16L8^P-Y5GJ2A';J4# @\]L#UZ&MBPM8[ +;0R>;
M'%EA+P=VX@D>O!)Y_P :YZ.VBL-4-K/<1WOABYBBO='UFW82VM_%<()8/LLJ
M$QRHR,A+1DJ!U/.:UC?6EC#+)?[K%20+:/!D\Q><-N YR,$^GTH Z.?5/-C-
MMN' P.G7'\L^W-9Z6S2WF+!O,E%I*94DSY:R[3MX;C/_ .HUSWF.S17MLIN(
MF8$KTP.@R.W;/3\:Z"WFE99-J[7D(8LAP0,<J2#W^N>,=Q3M6E"I&B[2<;22
MW:OLBXNT:BU]Z-OE='Y_?\%$+C7+;X3>%TCM;];LZW:K='21*)3;F10X/D?-
MC;[8'<BOF#]D!K__ (6Z!++XA^P&W0V\>HF[\I?E&[ FPN,]?;UXK]C-2LM/
MUF6.'7=+M]5LX<>7;7D*3JLO\,FV0$9 P>>_MQ5%= T&TU)+ZQ\/:=9210-!
MNM;2*!FW9(8%%&<=?\\?GF*R+-)XY55S6Y_/NFNW3=VNMG<^!Q652ECG52=N
M=-_?%^:TMO=>5]C.N_-D:<?((?/7)BQNZ#C"\\]^Y[U)' "V%SM^4#=UQP#G
M)'.:L0Z:UDT[QJY>:43#>2RJ <XP<C/O],]:NK'*["61,;L$X&!Q[# '&>E?
M>82EBJ.%IPKR;2223Z-)7\MUK;R/N<.N3"4J=K)):6\HO7SMI^FC$A@&  .F
M#U[C''7]:O1QHN,\=^_MQP:1'CC W,!W&>,'C'4\]*JRW01F91GD_0@?XXZU
ML47G9%Z>F>_OQTJG)?,N5!("_7H >.E5#<>=G VGGOQ_GG]*JR#.><XR3QWY
MXH M/J#<')]._O6,3-)*[[CM8EASD D@XYQTSBI'!R#VQC\>:F5,J,'!Q@<>
MG'K0 R-"3RQ^[SGUX]ZN/:V@TS>EW,TIG;Y$9LA\<@ #/?\ 08ZU4,+DYWXX
MQP,?TJQ;O- T)MML9@F\QRR[UE/?(/\ @>..>RK4L16PF*IX>_,Z;O;L].NE
MWI;>VKMLSBQM)U:<8I7U>GW=%T/QC_:ODG7XSZHDUOXDDTE=$!7[*;LQ&[XZ
M;!C.[!)&>_&<5]V?L7W6LK\!(FUL7*WQUQTLEN]XN1IW/EA_,^;@'G=QGTZU
M]1ZCH&D:O*;K6=&TO4+EIO-:::QAD=H>&$1+(3@=/PYZ4Q=*TZTN =)LH]-T
MX(/]!A18XA,  754PJY/;CK]*_.LCR',X9G4K7E95&[ZO2Z=TF]UM=;[J[1X
M%'+)1K*7+:SO>UK7:?2_??;\6;EJ4CN-2FX"_P!FJ8_4R=P/0]L?7VS3LY/,
M6,L<$J#CW(SGVP>WYU&-XC:/G<Q.Y_5<C"YR...GH:EMXHE8 R@'&3[$8^7Z
M\5^D2^LQ:IXB3:@ERI]-%?K^>J\NOUJ?[N$+I\J^[1==FMWH7RI8'C@=_0X^
MM5WC/7ISC/J.>V:N*\2J!YG08Y _Q%,?9\WSCG...O7I4B,J2,Y(ZY//;W]>
M_7VK\HO^"Y__ "B[^/?_ %Y6/_I4U?K,X7/7\<'GIV[8K\G/^"Z"$?\ !+?X
M^..<65CQT/-T>_XT >!_\$E?^3!/@A_V#=+_ /29*\G\!_\ *7[XI?\ 8FZ5
M_P"BXJ]6_P""2K9_8 ^",N.!IVEC'?\ X]D.:\I\!G/_  5]^*1]?!FDG_R%
M%0!^LMS_ ,?>L?\ 7S+_ .AFJ:]!]!_*KES_ ,?>L?\ 7S+_ .AFJ:]!]!_*
M@!:*** "BBB@ HHHH **** "BBB@ HHHH **** &OYVQOLZ"2XP?)B;@228^
M523P,GO5=Y-+N=(U#1)[*#5[+5X)+/QEIU["LUI;13J5FB6%P8Y&VY < _6K
M)!((!*D@X8'!!]01R*0I'A B*C8VSLHP;A<Y/FX^^3D\L?Y4 ?BQ\:?@AX^_
MX)[^/)OC[^S=-JOB#X)>);TW_P 3?A[9M-<1Z=I$LADU"_LX(0RP&+S781HH
MQMXK]'M _:S^ GB3X%6_Q_TGQUIMI\.M*TDZEJOA>ZN(5UR":&,?:$:"1Q<F
MY68,JPX\QL8V\XKZ%^R64EO?:5>6=MJ'AS5()+;4M'OH4NH;B*4$21[) 5",
M"?EQCZ\Y_*C6_P#@D[\.-3^-9\?Z=XPU'2?A'=:F-;U?X/V]U)'IE[JPD,A8
M6ZXMQ9LQ!:VQY9'!!H \J\!^"OB-_P %,_BVWQA^)=MJG@[]FOPG=$^!_#TX
MFM8_&VEVTA6&[FAD"AC,(U^1\DA@>0:_9_1],TKPUX<T_0?"^D0Z1X8T%$AT
MK0H(EB8I"JJF]5 W9(SR.Y]*M:7I^E^'_#]AX1\.Z=9Z-X8T:&*/1M,L8([:
M.S>%5"$B(!67*[BN,$GI5SSKAE6:5U:_4 >>J@1<<?ZL8'([X]Z *K;+>5-<
M:3S;R^ M7TOK]DC;CS=G;&<\C\*GI52W#-<F(F^D&)9B<HRG^ZG13UZ"DH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **7=&H+2N(T )W'U[ #N3V%-MUGFCDN6C$5G'DF9SABH[A#R?PS0 ]8K>
M8@7-QY"(?,09QYT@Z0^^_ &.^?K2;KB_G7 .D7$)Q;V7W?MN.!QWWX!^I]A4
M436EY'-="$W5I9JTJN6\MXYX\A7V'E@I'0#M7C/[07[0WP\_9K^&%Q\8?BUJ
MB+"5:Q\*01#;J5[K;#;8V-OI^5GN5E8HOF1JP^O8 G^//QZ^&7[-O@/6_BQ\
M7-8M]+;0[29M"\++(ANO$.LI&6M+"&W!$DDERY55"@DD@8/%?D]\!?@G\5?V
M]_B+#^VA^U=HVH:+\&]*U,+\,/A'=++''=VZ3LME>W5C*H#!XQ%)ET(((/:K
MWP3_ &>_B-^W=\4K#]HW]K&RU"R^$&BZ@FK?#[X571EB35KBWE+Z;K-Y#(H7
M8L?E,8)!\P/(K]OEN#"]E:6EO:67AS3K*.QL]!M($ALH(HHUCC,=N@$:L%1<
ME0.1ZF@"-K.RT>UT[3=)B@M=(>TC?3],@18TTF"- JVL:KPJ@*!A<#C-1TR*
M( 7#L#-=-)_H1)P(HLX$)'H>YJ0I*ZV\=M&UQ>2R"*6V0%FA8]VVY.P#JV,?
ME0 ^,3/YD45F+T21[981_K-A/+1]PXY.1SQ]*^!?VR_VS[/X':=9?![X*O\
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M;X4_8[WX]_%PP^&M'%_)''+9W.H+]G.JKYI#%]LY?RP"P':@#\O_ -@CX/\
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M2> /6@"2BBB@ HHHH ***4*1F:3Y;.+_ (^95YDCW?<V(.7R2,D=/PH 2E0
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MCF82Q(VG2@VY:U!V[L G;VK]*/"7A/PCX LQI_@CPUHWA^V50J&ST^VAG
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M &.OVJ]=.M_#OQ=;L?V=_CO)+]KTGQ38S'_0+._U!V-O93VZ>5;%78.2.F:
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M?I>_S_K8Y)K<$<@]N.1SZ9)Q4JJG (/0 ]>.F>2"/R_ UVJZ9 X^8#KV _\
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ME>(=4_9B\9^(Y4\!WMM!<ZH?!6DW-Y((VO K,MO;Q(49I) $51S7]FV@^(=
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M'[ __!1>_C+"XB\0>(GCCD<M$\?VV?;#Y;':2!WQR?K7]2W[%WPA\"_M _\
M!/CX>?#SXMZ%8>(?"_B'PO;VYL[JWB=[)YHG5)[61U8PS1NP=&3;@CD]" #]
M'?A_XS\._$7P_IOCCPAKFG:]X4UVSAN]$O\ 3+F*Z@FLYE#Q.[0EUBE*D;XB
MVY. W/7NSAAP>A_7'3G'K7\NO@OQ-\8?^"*WQW_X5]XSEUWXA?L4?%'78X_#
MVMW4MU=Q_"R2ZNHP)YKJ4^7#:Q(S1>6Y5 N5P*_I3\#?$+PI\2/".D^-_ >L
M67B3PSK5G'>:;J=C,DL4\,@#*<HQ .T@D9XH [./.]L],<=/;/ZU-56VG^T*
M7VA3T(W G/<$5:H **0$'H:6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH _AP_X)\_\F[_\$O?^OO5__0TK^T"V_P"/6#_KRM?_ $2E?Q?_
M /!/G_DW?_@E[_U]ZO\ ^AI7]H%M_P >L'_7E:_^B4K\8\0?]XCZT_T GHHH
MKX__ )AH>C_])0!1112 **** "BBB@ HHHH&MU?N@HHI5 + $X!.,T&S7(GI
MV=O6WJ)37;8C/_=&>F>GT_GVIS!M[+&-V!U)QSQQ[YYZ>U,42,S)*@10#R6!
MW#D'CMG'OUYHVU>W<QJ8EJ#C%^\URQLUH]+=+VU6I&UW/)'#Y P[D#!]/4Y
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MM3;P,THWOE,$9R,=: /J9;>ZO+ATMKZ;59D7,VFI9E;6V51DE[A5V@)SECT
MKYS^.G[4?[//[-.DS:I\0/B)I]_XHFC9K#PGH4\&KZE;R(#_ *,]G SS1N[#
M9C8#G@<U^=-[^T!_P4(_;8:30?V;_!'_  SS\%IW:WO?C!J,1BUO4=/<[))4
ML9MLJM)$1(-HSGI7T+\!_P#@F1\$/A;JL?CWXFZEJ/QQ^*5[(MYJ7BSQ#<SS
MVKWVXR2M%IUV9(403%OE5<$$#I0!\Z:A^T]^VK^U/Y@_9B^$]W\,?!%[(UO<
M?$C6I)8;N6TD;8]Q'IMP5*Y0K(-J]#7M7P>_X)>?#VTUFP^*G[4'BO4_CGX_
MN'2_A2[O)_[+TB8-YCP/IDC/;NH<LN"N"".@K]-+.UL;!H8+*QM+#2K:-8H-
M,TV".QMT15"J-D 1"<#J15B..,R7*VC&WGN3NA5V\Q5P2=BANF3QQ]>M $-A
M'8Z/8V_AWPI9:?H_A2SB6&'P_HFE0:<5C0!5$DEI''N.T#);)/.>M.M%2YO&
MM6CMM(L+=#<RZ]-.JKHZ1X9WNYF/R*OWF$A QG(JY:R72QW4%M=0:;>6L3RW
M][,J""*),EGGD8!88^[.Q  Y) K\2OVK?VI_$W[2_C;5OV0OV7=7E\*:+8M*
MW[07QQCE,>AZ+I<.Z/5;.PU=&%N97B1]H23(9N/2@"W^TO\ M4>,/VI?B+XS
M_9&_90U]O#_AS1([A/CI\?1*;?1K33HE:/4;6QU)&6W,VR-U4))N+'UKY.^'
M?P\U+]H:"S_8Z_9D34O!?P \(ZFA^-?QXM%FAU7XE:Q%+B_@.I1!9KFVNIUD
M4@R.A5N>*T_AI\+=4_:7U&W_ &.?V-=.N_!W[-/@F]C7X]_M'D20:[\0]>CD
M)U""VOAMN;RRGN$D5I%=T"L<\5]\>)OVOOV7?V&&\/?LQ?![0+WQCXBT.TCC
MUV+PWI+:G)>7D:+]HFU.ZM8S(+B29)&(F.XDXH ^_?A7\+_AK^SQ\-="^&OP
MM\+6NC:58VD-K<7EG!&+G7=0")OU'4)8E5W=Y0TA:8L<L<GO78>(/#/A?Q7X
M2UCP7XYMK/Q/H7B&RFM?$.AWD<4]O#:7",LLT D#(LJH1M*@,"/QK\RY/^"J
MUDDP:U^!/B^"T*XOV;0;UPA(.<9CQ&<#/'(SD>M,M_\ @J1X<DOHK:+X ^,Y
M5NH_W,@T6_,<K8/SR2>7\JYSE3QU^E 'Q[\9?@;XA_8=N/$/AK5O#MY\7?V%
MOBC>3M=6<T,E]=_#.XOG9WN=/+AVM4LRX93"%";>#Q7E7A\_!/X2WNC_  E_
M8-U.\^//QO\ C':"UT[XHW8;46^#WA34_P#CYT5KIM[65S9^9)&J%T<>7P..
M/OS6_P#@IUX/\2Z'XC^'7CGX$>*=5T+4X)X9=(D\,75[;/%*,,J,\+K&Q4XW
M  @CCFOF3X-?M<?LA_L1:#XM\<^ OV8/$7@6TUS4IM7\0ZUJVD74[6\SLTDD
MUK=W,6;*(%\B")U0 XQ0!^H'[%'['/A3]D3P_K6HZTK^-?C/XHM9)_%_CO40
M;K5&O[I#--:V4LP:=4#2%%$;] ,5^<?QN\>>+OVR/VSM*_8\\9^(+GX:_#+1
M[;^U=9TRZN'TE/&-DC'S+8WK,GFSSJI A)8G=C'--\(_\%AOBOXZ\5V'QFL?
M@'K,?[(YOH]%E^+KV5P;NPU9W"+<_82")K"/(+71!C Y+ 5]W?M%?LH_#3]N
M_P"'6C_%?X-^*[#1_B[:V$?B?PA\1_#UW%#-<WD*"2+3+][-E*%F3RWMY&')
M.5YH ^+/BQ\!/BW_ ,$MO$6H_%[]BS3+SX@_ F73V7Q=\'K=)39?V@R9GU(S
M1@1W%WO=G#,&D)'6L7X>>+O^"BW[0'@W6OC?HEN=+\'>.(I='_X5M?QM%_8]
MC=!HFC^SR??:,,WS[220.:^F?V,OVX-2U6\UG]D/]K_38?AW\1/#9;0],CUB
M%#9_$2Y@8Q0ZXMU=95S<JJ,(E)!)]<9_4&VT>?2K9=,\.Z5!IL6F6PGFL[51
M!9O:J-WVZ"*/;'(Q7! 49]J /BK]@']F'Q'^S#\(M8\+>(M5F?Q9XW\8S>-[
M_1[EF^R6B7;O(\<:R810ID(  '3BOMH.SS7.Z7S6$[@X^Y&?^>:=MJ^W%2B>
M?7HUO[RZ:]$47V6VGC79<Q;1_JWB7Y@H((R0!U/:F!K7'EVR[3%B.8DDEI1]
MYFSW/?O0 M%%% !1106A5'9I K)SY9P&D'I$"<R/T^49(H *C,ELEW8++'-!
M$\C+?:E&&VP0X^7)'3/3&?TZ)),JPI<)EHF;!5AB6/\ ZZ)U4=LD=<<5XE^T
M-^T?\//V:OAU>^-?B'K"0V9B*:/X5V*=5\1ZA+F.UM;2W.)I0UPR#]V#PU %
M/]H?]I#X:?LI> _$7C'Q.9+SQ'J4;6W@3P_$QEN=?U.4M':@0CYVWS&/E0>N
M.<U^'?C+Q'K>IZ[H'[7'[=FHSZC\0-1N"W[)WP)T?36O==\(:Q<'&FZYJ,<2
MO=VT$DODR!Y J>^*TO%WQ!UI]?L_VK/VK;5-6U_7)%_X9X_96E827TZ79 T/
M6)]/;=+EG,,S QC'(.*XB^^#7[97[.7Q3\._\%*?CKI!^*]MXNE@CU7X*S6?
MVZQ^&'@69E&EMI^ER+)#%<V4"@R-%&DB[26- %?P1%^T-^SG^T[X:_;A_P""
MA?@N?QOH_P 4+FWTSP+XVO99-:M?A5HL\B+IDTFA7!FALY F%:7:A0@L>E?N
MM^TM^SC\'/VWOA%8BU:R+>*;"+5_ 'Q4T6XCDO='U)T^U6DIN;<F2T62<1@V
MX=1&/E XKIO"'BOX$?MB?!6'4M0L]-\<>!/%UC*FLZ!*\5Q<Z!<WL#K%:):'
M>U@^FRNI^54*%/:ORI\*>)?C%_P2C^*FH^#_ !V=1^('[''CK5FDT#6BTU^?
M $6ISB.TMC(Q?[/%:^8%/W0BIF@#N_V5OVJOB'\!OB5;_L(_MFO+X>U[093;
M?";XTWP9-$\4Z>FV*RM;O4)C]GDF>,JH#N6W$C&:_9(2P95(,>3@>5,C;XKU
M3G%Y"XX:&<#?&5RI4C'%?*'[0G[.WP7_ &Y_@K:Z9J&H66H/#91^)/ GCC1Y
M$-]I-W/&UUI076;8&9I$G,7FP";*X*D"OB#]EW]K'Q]^SYXXL_V._P!L\3Z=
MK^FSFP^%WQ5O0R6GB_1XRL&E6%W<RGRT>*':N]F)<]R2: /V,FB(P0/PX]AU
MS44>=@W=<GTZ9]JOI(&A\["RVHC299X#Y@GAE^:&2VV_ZY67!+)D '/2J1;]
MQ=2LT:2P["D98 ,'("[C_"<<L.,9QUH 6BIK>UNA=1Q:DL=K:S0--%<1L'+L
M%+*@P<G=C%4;6=KB-I&C:/$KQJK @E5)"M_P(#/OF@"Q1110 59M&LEU"QT^
M]!BMM3(,MZ!\\+!@!&A'(W<J,<56J>S$?VA/M,8N%$BFW#''D2!@5<>H!Y([
M].U '\\_[2WC]/#/_!0*^\$:Y\,$^*_@G6_#&K6=Q9&S6[U/2[:XAE26_M,J
M\Z/ A+JT>&!Y!]?@:#]H6+X5>,I_V5_VE?A_KD?P"^(6JW.H?L\?$/4+:Y3Q
M'\/[U[AY('MKF9?M<%I:3$%O+9(U1>>*_:?PW;QS_P#!4W3+LPVLFJKH6HH]
MW=6\=S#);;9 \#6\JLGS)\A./3%8O_!1?P3X)^)'[=?[)G@CQOH&F/H6M>$]
M8T]+>SL+>,VEI<&1+F[BAB0?O57<R2*-RG!!!P0 ?1G[#G[:NM?![Q;X&_9G
M_:K\:Q>*O"_B?2R_P?\ CI<W"SZ9%I\N38Z->7\C- EZT7EPJCOYI88 SS7[
MV6MS%I-B8]7M([W1-1*/HFL(1)Y]M* T4_F '*LK*ZD'&#QQ7\=WQZ^ S_LG
MZG?_  .^-]IJGBO]D/X@ZG;:A\*/B[:>?<>(?A)XEFQ)IDK7"[KF"SLKAD=T
M++'M4[ACI^EO[ _[=GBOX,>.?#O[)O[8WB.W\4^!/$&E[_@9\>I)EDTKQ5IK
M@?V7;ZK?NQ@L;R*W$4 A=P^\<B@#^@1+ Z;_ &7(E_\ ;K6\DC:&$,6$8;!"
MGG QG';'TKJ;R0133*H"@ 94= 2OT/7C./2O-M$N;2'3;JZ2?[9$+A1ITJ,9
M(VBG(:">R/W9X=CJV^/*\YSCIT5G?QW"SQ32RFZCX,DJ%!(?Q_R<^E '-ZI<
M 71(ZEOZG_9K $@-Q(1SEAGMT('IWK1U".822S2A4VD[54Y+<DY_R,<U@0S,
MTA<K@$Y;)P1@^E &R9,@>N,?3].<53$_[QAUP>.W)/':HY9\#@ @<]_0_2JD
M)W.6Z%B/PY'^- &@[;N_4<^Q.?IZ_2JQDVDKNZ<=/_K5;$9P"3['COCZU2DC
M^=N>Y[?_ %Z %\W_ &OT_P#K4>=GOCMTZ^_3O55B5[>W7OSQ1&F]LYQSD#WR
M/\: +6<\^O/YU/"^"/7H/8<8[5&L6!U]SQW_ #J80(HW"49))*]_IC\!Q0 ^
M9SCGKC@^_.!C%4I)#@<XQR>,^N3T_2I)2,$;N,D=#UYY_P#K54DP0,G  &#U
MR.<'';- &O8."!Z<<_B.V/6NYAD^2,YXVKCVX'/3M7!:>&( 12W3IQQD8Z^M
M=Y91K+M$C>7\H'/;I_\ 6JHRY7>U_P .M_Z^147RN]KZ6+R2^^.,9_+VX_I5
M[[7#@!B,@#/S <@8[52EBA@4E9M_?@?ICZ Y-4HYH9%9E 9MQ7:3Z'D^QZ]<
M5A4I>TVW]+W_ *MY=^A7M/+\?^ 6+N:!B<#UYSR<YQCU%?D-_P %VR#_ ,$L
M_C\1T-C8X_"X/?KWK]?UL([B,RNZQ%0?E!X/4C)[$].HK\EO^"[NE,G_  2J
M^/\ =M)BW%A9?,!D@+<,#_(_7%8JG5H-2IIIST=KWT:WWLO/2Z\KE0]G4NYM
M+E6E^NW6W6Y\B_\ !)C_ )1_?!3_ *\-,Y_[=D_/..H],5Y!X!Y_X*^_%(#J
M/!FDY_[]1'^5>M_\$BYH;O\ X)Z?!R\W&.%;/3HK0MP;F5+:,,H&.@]J\?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,#Y(&.OO_P#6I=WS;<?C^&:4*D:BO%^3\GU^X!U%%%6 4444 %%%% !1110
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M+[PV^G>+_ 'BO36D\4:)J)A:]TN\N[=C):XD#26LU@[DJJ@,'0 <XK@_V/\
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MZ55\MR=VX\G./7OCK_3%6KTO&0H4'/?('."3GMW/Y>U9\=S#)9W=_+.MK8V
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ML=3\:^&]$OO#6BV5P8+&>))?*O0CX&&4[>1SQSQ]#7B?[<?CWQ-XT\ O\/\
M6GN]6TV[LTN=0T6X5S;ZD@!D:-]Q(?9@G&.HK[K+>&,3B:4ZLH0Y(J,E+FB[
M6L]M[/O>[[J]E\9F_$F%P]2A1I5)\\IM-<K5[-6]5NU;Y]3T?_@DV%N?V ?V
M=X+2,V]MI$%A/?PL-C-*]J@974@9PW!!SCKZUX_X*GTZY_X*\_&C2)[A(?$-
M[X/T=]%M+AA%#?[$B<1Q$X#G QM7O^OJ?_!-[XQ?";Q-\(XOA3X+UJRTWQ1X
M NI&U+P?++%#>,57;'#!;9$DD:/A=VW  SVKG/V[?V4_&WBW6/#7[1W[.NI7
M6C?M6?#N9M4U?0;%9/L7BG0+=A.EG+=1A=\BV\>TQLYP3C%?,YQA:6"DZ:LI
M6V5MT[[Z_G:VS;9[V45Z^-A&JTY)V5WWLEMT:MII^)^GVJP7EWJUY--C1Y[<
M_9[S24(5)S&V#(%!&<LIY[_EBKC' & . /3':OBO]C#]LGP[^U;H5UH7B5X/
M#G[0'@-/[/\ '?@S4)%M-4FOK52DTEC9.?/NEDG!^95.5(Y[U]IH^]WM94E@
MU:V=FU*RF0H;6 DE9,, <D<G)_#L/GX>TN^9)1:]U]7M^A[U2,(V47>7VET6
MG3?K\^XM%)/)"A3[.SS139$4Y&(2Z_?5Y,X&.@R>3Q2CISC/?'(_ ]QZ5H9!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44H,:Y,K[% Z^_H/<]J
M6WBFF26X<)#:Q9R\AVNX'/R*?O9 [#\?4 89+>(![E=T>=JK_>D/"+CW)Q^-
M-^S327,=U<7/V>Z&6LM)!PMUC)C4KGG/3I212V]TDLZ /:0$EFGQ&_F ?*T:
M'&_!QC'_ ->O&?CE\=? ?[/'PXUKXH>-]4MI-5M8)+;PGIE[,EOJ>J:U(A_L
MZWTZR<A[N&28JC/&"%'ITH E_:%^/?PZ_9X\!:U\6/BWJEOHE[X?MI/["\&P
MR*+GQ#J:H7LK5+7(:1[ABJ *"Q)P.>:_*[]G;X _$?\ ;A^(MM^V;^UUI=]9
M?#2WU+[=\'/@O=K+'')':3EM.N[^P?*%73RWS)'@@BM'X _LW_$K]M'XFZ5^
MU%^VO]ML/!VCWK7W@7X-J9CI6LF.=I=(U"]0EHMRQ&)_+<?-T]J_3S]H_P#:
M0^&W[)_PWU7XJ_$.\TS0K+0=*:#PQX2B,$#RQ6\&VTAMM/ 5<,BH"Z(#GF@#
M/_:<_:1^%7[(WPSN_B=\5]>TS1X_[, \/^!;>6&%8$MX%6TL+2V7"_O4"J5C
M4<BOX3?VG/VJOCO_ ,%0?VB8?!]K9ZWK.F7VK?8/A9X$TP7#V.EVDDSPP7>J
M0V[%%" )(3,G3D]JR?VD_P!HW]H'_@I[^T9<:#86>KZGHVN:TR_#GPUI<ES<
M6>G6HG>.*YU".%V2':-KE9% QVXK^M__ ()@?\$Q_"W[&/@'3/'NNZ#8>)/V
MBM?M(;C5[N[@CN/[%LY%#R"V$L9,4T:,<!"&W#CF@"#_ ()C?\$R/#?[%_@R
MP\6^*_#]AXK^/^N6,2ZU+<01SIX;^U)'(%M"Z,(WB5B/W9!!7K7I_P"W/^V9
M9?!:+2?V>?@U>/\ $W]IOQ^!)H\6G#[7_P (:DP V7IBRT'D,&&)"N HX%6?
MVTOVY9_AQKFE? K]FJ!?B!\?O'""+4+>T*W*>%+28;+G4+UXR7MKJR;>8X9,
M$[0,5T/['_[$?A?X%O=?'/XDW#?$+X^>/9$U'5/$NN SSZ.;HF:6QLXKD/Y"
M1>:T8,97 44 8?[%W[%Z?"":3XT?&J ^-?VA_',!N=1U?4LW/_"/7EW^]CBL
M_/WB*.+S-O[L@ C':OT6FGF>(6 O1+XLM?WDUXI #VJ@_P"C@C@_+@8]@.V*
M2[EU".YW-,KQ7"[XF(!-LN#^[7KP.Q'^&:,L$+-'/ I@O5(,ET&):4#'!Y)Y
MQCDXY].H!8EE35[9YOLL,>B*C6/B?1+B)6BU56!2:1HW!5MXW')4_P J_EY_
MX*A_\$KO'?@'QI=?M\?\$^K2[\+Z_P""Y6U[QGX5T7SH$U1+4^==J;6V\M7\
MP^8<$$<FOZBIFBN9(V8"#:N)%3 6=@/O,!@$GW&?6F6MW<>?<Z3((E\.ZC"U
MOJVDS1I);:G!("LD<B,"A$BMSD8/)H _'[_@E#_P5=\#?MP_#9_ /CS4(? G
M[0/A:%-%\4>'=3=+.]OX;8>3-+;0R[9GFD\HXVY?YC7TG^V_^Q)X8_:F\*V&
MM:/<GX=?&7P1BX^'7B[2&-IJ.IWEKB6UM=0EM]D\BRM&H83/SNYK\7?^"IO_
M  2U\7_"WQY<_MP?L+1WW@_XB^&;DZQJW@SP^)H;/5((&$TT[PV@CCE9QYA\
MLYZXY'3]!/\ @E9_P5)\"_ML^ [3X9_%%K?P7^TYX-C33=7T#4)TM9]4O[0^
M2]VD<C&3[0YB)$0Y);WH ]0_8S_;GU3QGK3_ ++_ .V%IA\ ?M$_"^T.@>'+
MNY3[+;^.M$M"8[?53*^!<2W$:(2Q+$ENN:_3VZMGTXP1^)Y$TV&]56TV"$@)
M=HX'EDX(!WJ5)/3GUKX;_;=_8BM_VB['2?%_AZ<>#_VCO!.S4O"_C33D^S3Z
MM#:A9(=!U1H55EM9=BJTTK8^;K7DG[%/[:5]XW\1ZM^R_P#M:647A'XX^#0U
MGX=U#6918Z;K<=KE+>32[RX;;>2RJL;*L;$L6QU- 'Z>RP&U+0!/)C*!XXQT
M93T?ZXQ7YN_';_DX+XT_]D$NO_2&6OT7@DG$%VE_)*;VTD,0%TAA:2W7&UK8
M, 9HB,%7&0<]^M?G-\<"US\?_C3/;J/LD?P#NC<22_(R+]BESL4_>/I^5 'Y
MS?\ !&#_ ),/_P""A/\ V,7B'_TKGK^N'_@F#_R9S\+O^P1%_P"BQ7\C?_!&
M26"3]@K_ (*$W-A();4>(_$*&2<B,^8+R<,O.!CN#SZ=Q7]:W_!-'4K33_V,
MOAG>S&9;*+0[=C(\9$DDA55=(4.#* S+M*@Y&3T% 'Z#7L]M:PQW-TQ2*!BY
M?.%0] 6/IVK&>"'4"]Y?(6M6BW1HC$1I @W_ &AG!P 54Y/IP.M3R_9];T[%
MW)'!921?:+F"218W-D5\Q9+C)'DC:H8NV H4DD"OP;_;J_X* ?$'XB_$&+]A
M+_@G_*WBGXP:T5TKQO\ $#3<7>B>!-'F98+U$U2V<PF\@MY94*;]RD'TR0#B
M?^"C7[4VN_M<>)G_ .":W[)>CZ?\3=5\:3?V/\;/B,L45YIWPP\.RS)Y\UG=
MC=##J4"G!<;;A"A 89(/B/P=\-_'#_@@_>>"O 7BG4->^,/[&'B::T@U36YG
MNM2F^&NN74D4-[KKS2M(R6TDK[MC8C5"#C;7[)?\$_/V /AS^P_\-KC3K+=X
MG^+?C<G6/B=X_P!0W7.JZWKNH1QSW\$=W*&FBM8IS*(T63!&,#;][[%^)7PU
M\'_%_P #:U\-OB#H-AK7@KQ'I]SI&MZ;J"1R[[>2,!&ADF#>3+'(J.DJ ."O
M4#J :WPY\<^#/B/X0T/X@> ]=LO$7A/Q3I]MJ>DZS97,=Q#<0W2+(B,8F98Y
M8PP62(X9'R",89NY8^6"R\CCC_Z_ZU_,I:^(/C/_ ,$6?BP=!UNWUOXE?L">
M-=:$MMJ>+F_NOA"-0N(D22$EVQ;0^848?ZM$0GH#G^B[X>?$KP;\5?!GA_Q[
M\/\ 7;#Q1X/\3Z;::CHNL:9<17<4T5U#',D5R87D6"X19%6:%COC;*G/!(!W
MZ.'&>A[C_#VI]4+6[,I,3QA)(R0X!^0+V(;H2>,@5;=RH!4;L_Y[4 245&DJ
M2$A3R "01@C-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_#A_P3Y_Y-
MW_X)>_\ 7WJ__H:5_:!;?\>L'_7E:_\ HE*_B_\ ^"?/_)N__!+W_K[U?_T-
M*_M MO\ CU@_Z\K7_P!$I7XQX@_[Q'UI_H!/1117Q_\ S#0]'_Z2@"BBBD 4
M444 %%%% !2,VQ6<]$&['K@BEI5V @R#*#[P]5[C\J.JZ:K7>VN_]?B-.S3[
M-?FOZ_S&S$36JW%J-DQ'T.?J<8![=^F.*Y#Q+XPTKP?HFH:[XKU:WTZPTVTE
MO+MYI43$$2DLP#L"S8' ]QG'6MG6==MM&TG5-;O(VAL-,AEN$6)<M*L:Y(QZ
MDC ^OY?@A\5_&OQE_;L^+<OPK\(VFI^#/ &EZD;/7M7@$T3W6E)(5GSL8 [E
M0D@@U4[--VYF[J,=U9-)MQO=Z[)K7\#P,]Q]:FN6E=]$EM96U^_9:IJS*GQ2
M^*7Q9_X*'_%V#X3?"5;_ ,/_  +T:^\OQ7XDA$L$.IVT<A%P//C8*X<1D8Y&
M#@5^Q/P+^!?@/X!^%]*\&^"=.M[/2;>&,7.IE8_/O]0V_,[R<,QD;)ZGD]<C
M-6?@3\!_!/P+\"V'@3P=91106\2)?:GY*+>:C+UDDGD $F78MP2>3UZ8]U.F
M682WC;FWMB&AM^<+*IX?=W(SW.<CUQ7FO#6G&;LVY)JRO9WV25M.M_2W<\W*
MLKCCIK$5TISBU43:;:DF]+Z726K]%RW5RXRE3TP.!P<]J0N1\I/48QCMT]*<
MS[NHQSV_(#\JAV<YSWST]\^M=ZV7HCZ]*R2[)+[A]%%%,84444 %%%% !111
M0 4444 %%%% !11150^./^*/YH I0^P[O3^O'\Z2FLNX8SCD'\JZ:NWRE^2
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M[-W[-'Q.^)>I-9Z,HL)?#ND:/:)%&]S?:U"]G9FWC4+O,<SH?EY&..E?-_\
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M;?MZ?#:TUWP-J-GX/^,GAZWCM/B#X!UEX;75['5+>/&J)!:2DW$RRR*Z;2"
M#C':OT @EBM5\FWMH19W,4EOK-E,BW%MJ]O,ACEBGAD#1D.C,#E>A]:_FP_X
M*'_\$[?B9^SC\5)?^"@O[ T-YH.N:-=G6OB#\,]&:>#3-8MDD$][(UE;&*!C
M+%')D%""3C/ S\YC,7/&UW.6S;=^O?;S[_T_JL'A(X.@H1MI'5:=6MNNG6WS
MZ6_0G]M3]B2]U_QQIG[67['PN/ O[3W@H_VAJ7A_33);:7X^6Q8W%[%J=M (
MH2TJQ,%,@)8MWSS[W^R)^V9HO[3?ARXC\<6L/A#]HSPP#I'Q \"7.RUN+ZYL
M08;F>"!OWDB22!F1@"#G@Y->5_\ !-K_ (*+^"/V[/AQ+J=AJ%IX+^.WAB)=
M/\7^!KR2*"_EO[=0MZ(;1CYKK)+E3P<@]\UC_MA?L<>*=7U^3]H[]F93X1_:
M-\+J=4U_1+5FM=,\66MIF>>&6.+RHWFFC0J0<L6:IG&*A#E\]+].[Z]B+MMW
M6G1_F?IHLKI9R7#6XB\/2L5-AC_28+G)W%5^\%#=\8(SFF#:54ID(5!0'J$Y
MV@^^.M?$'[$?[;'AO]JGPMJOA#Q/;1^!OVB/AVW]F^+? .L%;&?5KBU(AN;O
M2;67:]WYKAG#(&X(YQFON$F.&=A?[K2V(VI(XV-Y_1HR#P K_*,>GYYC&T5(
M\,D:D2J4>0YMI/\ EWD3KEI.@..< CZ#-1\]\9[XY&?;VH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHW1("TS[$ )+>_8<^M%O'/,LMPRI%:1Y(>1MLCJ,_
M<4G!)'(H :R02 +.VU,@K_M..57\3FHI+.?4)X8M2N#I\\?_ !X62L0+O"_N
MPP&,[L8_''7J12K>++);1AXH6P1<?NW+@X#1@XW8/(P.17B7[1/[07PZ_9@^
M&FJ?$_XH:O')J4,#Q>%])>1$U._U&1";."PM6(:X#2+L^3/7\* #]H7]H?X8
M_LT>!-;\>_%V[6SO-"LY&\/^%K(J]UX@U54W6%K]G^^ZW+A8VP#U'?BOPO\
M'/[(?[8W_!3#2]*_:_\ 'FJW/P];PI<R^)/@=\#C/-:Z7K>C:-(;B"/4;<.(
MWNKZ+;Y22)EBV!GBOIW]G7X"?%+]M;X@Z;^U#^US9WFD^!FO'N/A'\,KM94L
M?$-JLI:RO]<MY"T4#I'L>-9% 8=.IK]>OB!\3/AO\!O 6O>//B-K>F>"_!OP
MKT2YNDM+F:'3[>.YLH#+I]MI49V1W6X(B^6B_/T(- 'Y;?#K_@J[\*/#?P$\
M3W'QSTY/A+\8?@/ -#OOA9J\4>FW/BC4=,1;:SFTFUG"RWD-PT0(>,,""#D
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M7 &*UOV&?V*]'^ /]J_&3XF,?'?QD^(.[4]4U[Q"#-=Z==7!,WDVD=UO^SK
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MA#6/AK\3]/M_$.D:]#);:=I5[$C6D<$RE/->X96:UG7/R^6R$8R".X!\-?\
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M5%?#?KK;N]M]DOR^3Z(59QBEI>WEOI9_A_3U(P<<^F2/<@9 _$T^Q^>6ZO\
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MW>]N3'IY'V95RTMR=C;L9V@'!//^> : (**=F-1+%*2MVCD*@'[MD'5@<_\
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M=2UOXP?$;7M&\<?$)+9CIOAK0+NYF6<)=J!&CI#(X!#;LC@\5_;O_P $WO\
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M]^'VBV'A7P_H=G;6MEIFG1)$BI%&(\R% &DD8C+._+>M $'PW^%_@OX-^!]
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MO^"N'QBLKS7$U+P)^R!X%OA/X5#++97'CBUTV5D)U*-&02K*$4)N5MRD9'-
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M%% !1110 44JM$IW3$K$ 2Q'7V 'O2K;W4RO<1>4ELF2!*VV5U'(V+GDD<8
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MA#2,\9/+5]R3PR:Q,=+:1M(U&Q8M,$R@F$?!((QD$C/7G\:_B8\3^#?VF_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMM=!'*"HR.U?,O[7/['_ (JLO&]M^V1^RDECX;^*?@:Q\WQ_X(D(M]$\9Z1
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M[7OQGT_]G/\ 9R^(OQIO;VV6PL-*DT70[-Y +W4]8UN"2QMX8(R=TA2XE08
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M^FS6O@_XH^$H5U[X9_%O0&6%M9U:%1<6YCOK<(;FRN&2-49I&5@?QKVCXW_
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M]UX&N+G2--D7!#)(DH&\CH?0=P2:_7<%6E-PT2B</(H?G.PLP*\] >?_ -5
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M#_H&EW5S(S%FC1U!C#<$ 8K]BKA'M)9;24 7,+F-47&Q@#U4C.1SD$=??F@
MHHG#1W%E&@W1R_\ 'TQQ^Z&.WX_3C]7. '<*<J&(4^H!P"?K_*@!M%%% !11
M10 8)X R3P!ZD]!4B7%E'!>Z/KD46I:3+;R1ZMX?GC26VU"UG3:\;Q.&#;H\
M@C!ZGUQ4?(Y!P>Q]#V-2V\D4+/+);QW-S("IN9>9%4C '?( [=..10!_+_\
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M<_Z'+PW_ .!T7_Q= $E%1_;?#G_0Y>&__ Z+_P"+H^V^'/\ H<O#?_@=%_\
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M2+PH)/"US8:/\=_ EK'I'BOPU%+''-K=U"@C.J:9#\IN+-Q&9&E7<,DG.1R
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M_;7^(_C31F\3^*- _P""=OA;Q/<KX"T*YFNX+SQ/%;3EX+66+S5:31W5"(Y
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MYSC]SUQ_P&C_ (B0?%O_ $2:RZ9_U';U^[7\W/F3_P#/NWM\F?RX_E1YD_\
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MGX+8:UJ>FZ,XMM%\7:%:L+DQZ@L31PS-=6T1095MS.!S7L?[8O[(7PT_:_\
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MFOD#P/J/QH^+W@G7_!_[0OQ+U+P7^P9\$?$%ZUA?1WDD&N?M!P:3=%M'TRR
M=9M2CD2-8I%4."KX([5Z5^T]KG@[]NWXH:9^T/X[AOO '[&WP"U2]B\/ZK&'
MM-=^->M6DNV*RT[9Y4VH6$UP@C  D!B<<$&OJW]F;]E7Q=^V!K7AGXV?&KP\
MW@+]F[X?7"GX/?!P1-::==6=LRO9ZIJ5HOEM+<7L(620S(^YB>IH =^RY^SK
MJO[8?BC3_CU\7/![>#/V5OAN;73OV?O@9';&U.L1V++#'K6LV"B,R/<(BW!>
M:-LL2<\U^Z=A9:9HT%C9*('T_3;6.+PYHUJJ"R\-P",)&DJ(%6-HEPN&&1C\
MHG.FKIVA:%H6G1^'-/TJ);;3DM(EAA@M81L1450J[=@ R03CJ>M<7\2OB/\
M#[X+> _$GQ2^)NJ6_AWP9X4M9;F^>258KSQ;<1(TD=IIRD[IWF9-A55.2V.]
M %GXD>._!_P=\#>(/B1\5O$=IH7A;2[>:^AUXSK%)J3PJ94TVU.?WC3;1"%
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M/$-I< #3;.^U,EU.ILKQJZ/(#N!]. #]F[:>!;Y-'TX?;KB4[1<R<K'W&6/
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M2\<=M,ZK#WPB@# '';VH _2'36\R76H[@$,D DM\^C<KMSR#QQ]*B7.U<\G
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M_P#"1N?_ )&H_P"'X/[<O_2-KXN?^$C<_P#R-7.>J?H7_P .H/!G_1TWQ?\
M_ VY_P#CU'_#J#P9_P!'3?%__P #;G_X]7YZ?\/P?VY?^D;7Q<_\)&Y_^1J/
M^'X/[<O_ $C:^+G_ (2-S_\ (U 'Z%_\.H/!G_1TWQ?_ / VY_\ CU'_  Z@
M\&?]'3?%_P#\#;G_ ./5^>G_  _!_;E_Z1M?%S_PD;G_ .1J/^'X/[<O_2-K
MXN?^$C<__(U 'Z%_\.H/!G_1TWQ?_P# VY_^/4?\.H/!G_1TWQ?_ / VY_\
MCU?GI_P_!_;E_P"D;7Q<_P#"1N?_ )&H_P"'X/[<O_2-KXN?^$C<_P#R-0!^
MA?\ PZ@\&?\ 1TWQ?_\  VY_^/4?\.H/!G_1TWQ?_P# VY_^/5^>G_#\']N7
M_I&U\7/_  D;G_Y&H_X?@_MR_P#2-KXN?^$C<_\ R-0!^A?_  Z@\&?]'3?%
M_P#\#;G_ ./4?\.H/!G_ $=-\7__  -N?_CU?GI_P_!_;E_Z1M?%S_PD;G_Y
M&H_X?@_MR_\ 2-KXN?\ A(W/_P C4 ?H7_PZ@\&?]'3?%_\ \#;G_P"/4?\
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M[7O@N\M7ET_P=\7_  I8REX]&U5U:.VO-:U&%-BQMN9VDZ$GG]*_A[_P4_\
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M/&G3'GU'R]_Q_GG_ $GSH6B!@HTG3\>]K#G_ -%GM[_TH?0="&"VDV('&?\
M1H,8)ZG]W_\ K/&:FIX4Y-3BG+$UK2:2]Q-7=K;2[WWMT\QT_ITY_4DU#A/
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MG1[>=$\U+XJPC**VX,,=<5_/Y\2/V9_@/\9/VB?B'^V!'JFH_"#]DJ.] OO
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MPUXITB"Q^(.E6IU/P!\0K2%8]7T?6;9&-D8KM-C;68*"CL0.,''%?PR_M$_
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M"O;/:@#^AF!W=I-[1D$[H]F,^4Q)C+>Y7!.?PZ59JM:PI##$%R2(D7<?O%5
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M(_BX-2^!_P <M+?P-\?/A]C1-0L[U3:'QA/:YM1J6CF81B:%V0RN59L[NYH
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M5&,$\\9[Y[5^M\MQ+=2QSWC?:Y8^DDP!8^_  _2E2899IH8KER3L>90S1#'
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MUJ].CZEX.\-Z@QTLPF&6YU#3X9VA)1#N$3R;6&<K@Y&1Q:'B+Q&P5TU.8QN
M\>4CW;&Y7=\GWL=?>OR;_P""8WQT\0V/A_4OV,_C1<R+\4/@WJ.I0*;QRO\
M;F@+(R:2UKYN/-6"U1"0F[ '%?J;+=VT"B24LMO+,\%K.O$4DBL5$2]]RL-I
MX[=>E &P/$7B52"=2FP""<)%GCG^Y5W0M8UD>([.^;4KN075S#^YE6+!*L,<
M;?NYY''?J*YRY$]F88I^+^X426VG<FXFB//F #/RA2&.<<?6K5@'/B'0K@NZ
MLMS$IB!^0'>,JPYY!X/XT ?KAX<,CZ/HNI7LYRMI&NTX4%F3"Y50!G/MWKMP
M<@$=QG\ZYCPJB7'AO2?-17#6D+[3R =BXQ]#S]>:Z>@ HHHH **** "BBB@
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M2,F0DXR<U_3'$TUCI%N(;>!7T7;;Z?8:>H6R2RA"0P0Q1K@+]GME1-H "J@
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MGQ7=Q37:PR1Z/I4+J;J\N=C)#^Z7+MND*@G;U..V3^3GP(^#GQ)_;A^(UO\
M&SX^I=V7P\L[]KSP?X<N=ZQ7,'F+)!YD+[-PP!U4\8Z=Y_@]\#OB5^V[\58/
MC!\<Y;T_#2SN5O?#_A]"ZV<D8=985EA8*"/D RRG.3QUS^X7A_PMHV@P66CZ
M-916&C:+;Q0:?:VZ+'$%B38HVC / YZDY)YKS81J5IJHG:"=TNKLU^"C=.RT
MV[GQ6%IYAQ)B(XC!WIX6E-3E&O+V;J13CS<J:3DK-I6OV3NG;2\/^%M(\,:5
MI_A[PSIUKINA6,:QM!!&L:[$& , <M@<GN3^-:\96::58,PP6P V#A9&Z''
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M@9Q5JW^=8V&?E)Z^F3]?P_&J]N=]O;.>K6Z]/>,'BK%M\D:*O0L<YY/);O\
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M8A1G=U[5^K=TA%P\CW*W<TBH7N3S/(""1YS#@GG^F*B,CF]CO2WSI'Y3P_\
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M;_M/_#UOAQXTM++7M%U '4/ WBZT$<SV=Y*GFV=_H]U&Q$+"0QE6#C '4@4
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M)^O6_@OX_P"@6@UC0I=.E%GJ-]JU@@EO],U-0Z.T8O0\$BNAR 1C'7(_:&^
MGPP_;I^$'AG]L/\ 9;\3:?I'QATFP,E[)X>=($UY3%OO_#_BBV5A+<2R.QM'
M66(@D$5^57P(^-'Q9_9H^(GB#Q?\.-(OK+Q5H%\A^+WP9A5[>ZM;&"3=J6N^
M%+210L=F462ZNA"A+C)H _9G]A_]MJ'XHWFI?LY_M!64GA3]J?X?[M,U6WU
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MASZ3_NPO*6R>R6ZUT\CJIT)5(.ISTX):VG)*7W?-6[G]2/@__D6M'_Z\H?\
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MVJ+NZU'PSH-[JEJ'U"Y2,BU@>3]X9"H/(' ).,D#J1^4/P*\)_M(>+OVX?\
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M ->L'_HE*\S+_P"-F'_831_,_/N&?^2QXU_["L'_ .D2-2BBBOJ([+T7Y'Z
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MYBY[<_D?YXQ39%C:-A,Q2$C$C@\J.N1^7].]9T=[<7)V1P&U-N^RXDF^[<$
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M]U"Z1B(>2@4%1ZX R?\ /3B@#\?_ /AX#^TS_P!&<_$W_P !Y?\ XU61K_\
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M\_ SQ7_P@W[.G@'S;CXV?'JXD:ST(VE@3)>:987TA6*2:54D@Q%,2Q.,$]
M^/O[0?Q1_;B\9Z[\ /@#K1\&_LM>$7DF^-7QFDE-E;7.DVK&2[TO0K^7RU^V
M"W66*;RIF+$ "O#/"/PV3]K;5--_90_9=L]0\'_L6?"V]B;XE^/+=9+75/BG
MJMI(BWT9OV53>"9PQ<B9PP8\D&I_AUX(\2?MO>(4_97_ &8(+SX-_L>?!K4
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MS);E;V2.XGE8"-A"<Q+'C[P4=&(Y_+'I0 L\=NK017FHG6_$\(QHVFJQ9+&
M=%()VJ47CKQCTJ0[_P#EJ-LW_+5?[LN?G7CT-1B&",+J $<-A-S/>J -3C<]
M%CFZJ.H([C/%/RK?,C%T;F-V.6=#]UF/=F')/>@ HHHH .OIT(R?NKD8W..Z
MC.6'<58#;[4QQ:UI98'(AL$\M^3G:PP,MZ]BWO4 ZCZ]#T/;!'<'N*;&EC<7
M<\1M(+2[A0,LD2!(SQG<QR!SU.?T-+VT5?#*/-6KVC225VG>VB5_G]Y$ITZ<
MHU*K2A&[;>RM9_I]]ALZV=[;&RU318]1CZ/)>1))"5/WVD# @Q@<L#VR*_+O
M]O(_LY/\/]8\'7GPE\$7_B34&46FO:#ID,=Q;3E642,\?S"1'Y9AWKZ7_:,_
M:(L_AUX:O;/0]1BG\3O'):B%&W*0X,9 523N.<9['OD\?CWJMAXM\;ZUI&IW
MT=]KVMZO?J=-T"T$DK02SR[D>[B56/E[B"00?E[XZ?O7 7A=.ME=3-<W:C3Y
M.>,:CLK<OG\K:]C\-XZXWQU#,887*I3E'FC&2A?6/,ELNG???[OZ=O\ @E#X
MX^'G_#,7@#X5Z3XAAOO$/A^UD^TZ*TNZXLD;:41HR25"*, 8XV]1BOU<<-$%
M5> /7IP>G^1D?@:_(+_@F_\ L5ZK\& ?BSXRF>W\5>*+.*4:5;GRK6SADB4J
MC0<;7V$ \ D@_C^O\KY4\9'7/?US_3GU[&OR;B?ZI0S?%T,O:=*G4<;)\R4E
M[KY>73ENM+[:K<_2N'*TJ^6X?%XR$U644YW3MJHR5TU^OIU/%/C3J^L^'_ 7
MC/7-(#&_TCPOK&IVA 8A;FTLI)82PP20'49QR1QSTK\3/^"??[-O@C]ID^+O
MVC/CE%8?$;QE>>(;ZV&D7@6ZM=*2&]FBCW6<C;D*@#[T8!Q^%?T%W]MINKZ?
M>Z=J,4<UK=VLUK<Q2*&26WF7;*CJ<Y5D+ @_>!/6OP4^)'[,W[6O[&WQ:\6_
M&O\ 8_N[7Q)\/_%UW)J/B+X6W"&9<,[RRKI5KL=(I'9SM(488 ]17R%9SJ--
MP=E=-)-V?=QZ[K32]K7/V[A7/JV(P57 977PV$QE5Q4*]2I&C*:M']VJKUIR
MLI:JSCS746?K+)^SA\!+*&VT%OA7X5NK:ZMV>-CI%LUO;% 0HP4(!XP!D'T]
M_@'X]?\ !-.T\1>+_#OQ$_9E?1?@_P"-O#VIV][JNH:5!_9]MK%O!)OD@OA'
MA92Z@KR.17%>!/\ @KOH]G<VGA;]HSX4>+/@-JD%S'#?Z[XIM+E["XE5BLSV
MI2$;(I""RY) !Z U^K/PW^._P>^,/A]=:^&7CS1/%.GRB-W73;A1<C*Y_>V[
M$3  Y#9'7(R#S7"FZ:DI6:ERN-DDU:WNII+SYDD]+V[BQ=7CSA7$U9XN,L?3
MQ\*CH2]I/%1C"*492G!2G&/.FW!MQ=K72V/#OVBHO$.G_L>_$M?$<\<_B.V^
M&6N6&J7=J,0W,@TUH9;B)<9YPS;CCDYKQ3_@D58PZ=^QMX#M(9'D6Y>^G,S,
M69G:^EW?,3GC/KU)%?2O[7ES$/V9/C8D6%:\^'OB&&UGD ,*%[-P%"\X)/0X
MP/6OG'_@D?/ W[&'@&R4 W.F?;UOWSR7-]*[%#GI@]>!1AZSE5WOLDK6TZ[)
M;KOZ.XJ.-Q^+\..('B,$Z*EFN#G+1VC)U+VVNDFK<KORZ:(_4)E3SFMW)8.I
M"EN<-@<C)Z]._P"G3\5/^"V"-)\*?@G'!,\<L/QD\,1SLC$$PM<1EP2,8'(Z
MY! K]JXW601.@RK<H[<G@\\_RZ^]?BU_P661)OA]\)K2,G=)\5/#TK,PRJN)
M8\8)[Y_EZUU9Q)2P%]':=+OO[2.J?W[Z?KP<"X.G6XDPFK;>$QCMNE;"U':7
MEM9/5-[Z7/UC^%RPCX?^"1:C]Q#X?L<MTWLME$3VY//?IGO7XI_L?0P6/_!2
MGXYM#,\KWTVHR/$6W+$2TF1C) XQCT/K7[5?!^+9\,/!D9/*:%9EB.K8LHNI
MZX.:_$[]C.%3_P %)/C[,P._[3J* ]E&9>%]/;K^@KEK)O%Y79ZM):N]K6M9
M=EU-,CP\*;XR25TN>6NFG+.*71Z/MJVNCT/W;UG1],UJWO-'\06,&IZ==,2U
MM<QB6"53D&.1&!4@C@@\?@*\1U#X!?!>/3=44?"3PA$XCGE$ZZ1; CY'.X,$
MZ]^O.>G0U]%I;1JAC)9PPW$L=S!NO!_'I]*Q]:P^B:H'8@"TGC)S@[?+<?BV
M1WP>_%=./BY4,=;6TXW;2>T%?1WZI::]%KU^:RC&2PM?!X>G4K0]IB(22ISJ
M13<*R=VX-:ZM6>^Q^"7_  37^%GPW\0_&;]H^TUOX>^&;NUL_B%JD%G'<:?'
M*D4*S2;416&-H"@8&"/6OV8L_A!\);#4O[3TWX6^%M'U'3),65_!I5M#*2GW
M7CD2-"  .V3[YQ7Y3_\ !,4+-\;_ -I>!W811>/M7*,IPW$TI!8]L_CC\\_M
MC<1--&$G+!-W^CS+P,G  DZ9]3G(X_"N'AA2IX:N[-7YF]NJ6S:N]V[-]-4]
MS[/C3&_\9.X2J8F\J25G[16T3E[L9)-24FK6UC?HKGX3_$7PKX8\4?\ !8G1
M],\4^&]$\0Z<_P &[606E_:K<112X4;C&X(X]",D=:_8T_L]? TDC_A5'@4G
M .?[#LQVR/\ ED*_GX_:W_:$T?\ 9=_X*VZ5XM\1>'-9\6F[^#EKY-MHB22-
M&I";598U?!['(!_.OL*^_P""SW@.P;3O/^!GQ'9=2ECAB>.TF(0R%0I?_13A
M1NR>1@=,X)KAP</;8G'WERN&*U4HWELEJ^5O5]%9'I\699CI99PEBL#*M.A7
MR2$I58S=.FZGM7>,8\T6THI>\ULTKZ,_3Z?]G?X'>4V[X4^"(Q@'S(=&MDG0
M[N&B8(-K# .0?SQ7I6E:+INDZ?;Z1I=C'INDVD2)!;PH(T5% "@*.G&!C%<7
M\(/BE!\7_!.E>-+31;W0[3588Y8[/459;E%=0X#AE4Y&<=!CN!BO6V"G!QDX
M /IV' _G7TV%BUR[6T6B25O=V=KOIV_0_-L36KT/=KRDY1;T=253D>BWDY:Z
MWO?3MU?PU_P4=^&'B[XP?L2?'GX>_#^R74_%>L^$)5T2R9/,^TW-G<PW;1JN
M"68Q0N%XZU_+U\"?VH5^%WQ.^#W[4?A_P_J&N:I\+_"VA_!#]H#X8WB2#7?!
MUGX<6.SN_%%M;RJ)EL6:,RHT4>-G(.*_ME4*N54 A@05;E#G[P*XZ$<'^5?A
M#_P4>_X)G7'B?6W_ &COV5M,M?#_ ,5HA,_C+PC80QP^'O'MBB>9=)J^G1+Y
M=U-/&),AD.7Y& P [9WOTMJU;\;^9YT*L:W-)='9^MDW\_7]3]A_@Y\7_ /Q
MY\%Z%\4?A=XFLO$?AK7[6WD\VTG64V3O%'(]C=1+\\%W [%)0ZKEE)7H<>R5
M_$E^RQ^U!\4?V+O&NI?$?X6Z;JVN?#J#7!9?M.?L^W/FG5OAW'%=(M_XLT&P
MD4FUTYY%DDB:&-<1]\9Q_7Q\"OCWX _:*^'VA?%OX6>)M/\ $?@C7]/MIHUM
MG5KW3M0DBB>XT^^4?-'<6S2>7(KJA+!MJX4X@L]UHK!.JR)J$5C.HA5\-'<,
M,QW.[D11X PZ@C)Z'\ZWJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/\S3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#^';_ ()X_P#)MO\ P2P_Z_=5_P#1JU_;O:?ZG3_^
MO.W_ /1:5_$1_P $\?\ DVW_ ()8?]?NJ_\ HU:_MWM/]3I__7G;_P#HM* -
M*D;H?H?Y4M(W0_0_RJ*GP2] *DG;\?Z41]_P_K1)V_'^E$??\/ZUYB_@4?\
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M4]O,;:6YGCCC:>Z4I-,ZAI"I&#ANN:AMXEBA,"%A$)&E"$\!WR6./KT^GUH
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M_MN:!^R[X8G_ .$;LH_$GQ\\=(VB_#GP/9(;J_N)KL"&UG:*W+O",R*Q,B
M=>G'Y+NVK?LQ&S^*_P 5;8?&[_@I'\<91<?#SX?(/[7B^&]CJYQ:K-#'YHL;
MJRCFC)>1$*E3DC% $MYJ.O\ [/?B0?$SXKV5C\8?^"@7QG7R_ _A9X5U8_!V
MPU0;;::=$$GV"2RCF0DE$*E!TQ7Z5_L2_L4W'P:NM5_:%_:'OAXJ_:8\=*=3
MM]?U@B]M/#OVM2XAL1)EK8PJRA0J@C:.F#2_L;?L57OPG-]^T+^T/?Q^/OVF
M?'R_VKXB_M,B]/A."[R[:'8>9DVTUJ&5%"*,;< =*^Z_&7CKPMX(\/:IX^^)
MNIQV7@S3+&2>[-].B2:3%%&SB4^8RF168!%1,MR!B@"3QEXK\-?#[POK_CWQ
MCKEO;:)HMI+K.M:U?3QQ)JEP(V9[.T,KKO)9=JHA)Y Q7\\/QZ^-T7[9]Q?_
M !#^(VHZI\,_V-OAEJDEWH.B)++8ZE\;?$5K)N3PU# WERWUM-<1A57#QL'X
MX-:'QL^,][^W)=ZS\2/BOK]_\&_V$O@WJLT^@>%$FET_Q)\=]6L9"T%GHX/E
MSW%M?S1)M50ZE).XQ7L'[-'[-_C#]LCQ+X8^.'QA\&?\(!^S%X/EAL/@G\'(
M[86(,%B5_L_7M9L76,7%[.L0DFN'4EV8DDDYH ?^SA^S'XK_ &Q_$/A#XT?'
M'PVWPZ_9B\$-;V_PC^ <<!L]XLB&L-:U.P*HDOG[%9G93N+<GFOW,BL4@AM=
M*6XM- BM;==.\*VUBH@LK:Q@4+!;F),*KJF%)_*J=E;Q:-I[Z9"MO;Z180+9
MV)A0"TTVTA 6*)8P"JLH55XZ$=^W&?$CQWX&^$G@/7?B/\4/%.G^%/!_A_3Y
M+^76-6F1<F.)I(!;)(ZN&NI$6) N3EUZ=P"G\2/BE\.O@AX(\0_$#XKZM#HG
MA?0;::6Y@GF1+S7[R*-S'':(6627S9E"J$#<MP#7XY> O ?Q<_X*E_%-/BM\
M:H=2\#_L>^!=2-QX!\%R>9:MX_6VE66V6XMY%C^T1.(]V&W @^E0^"/!WQ9_
MX*M?$NS^.7Q/TK5/!W[(G@36&M?!7@UY'A?QV+"97MM=F5]HGL+Y4$R*V<JW
M4U^YVE:!I&AZ9HOA?P\-.T3PEX<M(8M$ALX5@TVWAA3$<)@0;!<J@VR2=SGF
M@!=%TS2-$\-:?X3\+Z;:>$_ VDVT5EHMOI\2VW]C16RA4:9$ .Z5?D)'7OVK
MGO&7CSP%\,/ OB?XB^+M6MM)T/PS8R3ZE#=31PS7@MXW>*6T1V1Y7NV3:1$&
M8LWYQ>*?&OAOP/H7B'QOXZU:U\)>"-#M)KJY\7:G-&FC7QMT:7[+%;2.IEFE
M\LQIL!.YAQFOQHT[1/B=_P %5_C#;>(7L-8\-_L@>"]6:#PU);/)IL?C&]T^
M8/-<:A',(S>:=<[2T",678>#CF@#,T?3/BE_P5S\?Q>(O&L&J?#O]C_X?:QN
MTC2%$MC/XT-C<*Z,Z.L9N(9\-D$LK*Q ..*_<'P[X7T+P1X;T/P/\--'L_#_
M (3T&SM["QMK2%( 8[>,1B>15&&ED4!G;J3GN:9X=\/>'? =GIO@'PCI5GX;
MT?P]9Q6=O8VUJ(=/NA @B$AC0>6TL@'+]R<FNGABU"%'46,RAF8%@"%.22"N
M. ISP,>W2@"IJ-K)$T,ID\Z1=K2X.X\'+9ZXZGO]*AO'69(YXQM "J0.Q Z_
MSS5^*WD@,C$$&3AA,0<>PR?;C\/6JUXGV6V$DIM_*F<!7-Q"@CW9W%E+@@#G
MKVZT ?)G[>_B5O"O['/Q-U2&39+=01:;N!P3]M1H<''KOY!K._X)^>&%\)_L
M3_##2E0)/-+>:DPP 2;[]]NXYYW=?QKS7_@JYJ%OH_[&/B;3X?$.D&?5O$OA
MB&*$7MJ75)KV))00)<\*Q'\^]?1OP,USP)X%^ _PUT*]\8Z%:+:^%-%NI8I+
M^S,BRSZ="TA*^<&&6)[?0=Z /?+.)OLKEQEO7GMSD\?0TD.?+&?4UXMJW[47
MP \/AH=4^)&BP[3M95EC?V;E';/Y^O/%>6:O^WU^R1HCR1W/Q4T\M$"3'';7
M$A)')&Y 02?:@#[!SCD=1R,]/QI)H(;O3]0\*:K:6=_X-\5VD\7BG2=1C6==
M1@=&5Q C @#82"#C.<U^=6L?\%4/V7-.9H]'N=3\5.IQBPL+\!^3P,1\9'H>
M_N*\X\1?\%9O BQVZ>%/@+X_\774[A;26SMK]4LW8X02+Y7,;$_,.A&1WH \
M7^)OPD^)W_!-CXL7'[27[,,>KZQ^SMK.K"Y^(OPOMC-+%HL$L[2WNJ:?8Q*_
MD6]HK&23:%R%->T?M!_ CX>?\%!?AQH?[6G[)%Y8Z/\ &[1M.$PU711'96_B
M>U2)6U70?%-LI\Z[>64R6[K<1^H/!KGK[_@HI\>O&R:AX4T?]A;QS)8:Q92P
MZIKNMHS>%KW2YX]EQ \$\8A1Y8CM/F%1D]NE?@W\$_VXOVL_A_\ MQ?$#X%?
ML=_#[4]#TWQM<7-AXT\#R;Y]%\!-J#RI>:O:21![*RAM&=IGPZ8VY- 'N'AS
MXY?'#]GK5/'E]^S3!::-\8;-I]-^-7PSN'1=.T-,,E]X@\/6H)BLPA#W+/&J
M'?SG->\? SQ2OQ$T#4+/]DB__MWXV_$JUN[C]H_]H[Q.3/!\.-.F)_MZRL=6
MN,BWEM=TZ1".12" !7G'Q+_9 L_B3\5-(^%'P(\>ZC/\9]>MI=7_ &I?C_#J
M!C\*:)ITY:;6]"N+DOY$ERL;RP(/,R&'3/%?3/PL^#\'Q:-O^Q!^Q#ILOPU^
M!/@R55_:"^.SC['+\0]7BPNK0VVK':LUM>7$<H;]Z48/R>> !_PS\!WOQPM)
M/V,_V*?%@\/?">UU59_VH/VF8DDLM:^(6L^<6U;3K3Q X!FMYYA-" 9MA4X.
M!7NOQB\8V$'ABV_X)J_L'^#1IMM((M%^,_Q%,*S2:C%<A8M7>\U"$2I/<3ND
ML@D:3(+\]ZN_%'XF6>GV>A_\$X?^";7AG3KGQ,\4=E\;?B_H-D(+3P9;.%CU
MA]5OX5:&YU0LDTT=PLA968GK7Z&_LN?LK> _V4_"\&E^'-0E\6^,[RS(\5>/
M-1;[3?:UJ-R!)=S"Y?=(3'.TB(200!@8[ '=_ CX6:?^SO\ !+P-\'M(9[_0
M?">FKI6J9(>\.H70$L]U'(,_N4E9L@'@#%>LI!%;(MO!+YT,8_=RG.6#$GG/
M.1TYYIL<0C*'<[[7\QMYSYK9)_>_W\YP<YX&*GED,LC2%50MC*H-J#Z =* &
M4444 %%%% !1110 4444 %%%% !112N-J!AUXZ].: $SC)] <'T..#^!KR7]
MH+XY?#G]FGX43?&;XK:U;VUC:/-;VUC#*HU'4)!N6WMH;97%Q(S2[5^6,]<#
MK7K]LJR%B_1%9\#IE%+C([C*X(]*_$K4?A6/VSO^"BVOZ1\9-2N[OX4_"/2K
M75?#_@OSB/#UWJ=NT4GFZCI[D0W 9U!.5.<GN: .4\$_LV^./^"I/BC4?C;^
MT[+JG@/]DI-[> O DS2VUQXJ<Y:PNI[60(TBA]LN6!]<YKR[XO\ @*Z_95?4
MOV7OVJM$/Q#_ &-M:</\!?B5I%LTFI?"[4+R01Z<L]\B;K9+*61"Q$F%5,]*
M_HMM!96D3:5I6DV<?AW0K6*PT+0K&%(=&LXH1LB:WLUQ'&P7J0,XR.E<'\2_
MAAX1^,G@G6/ 7Q#\-6GB/1KRRN7U*WNEA-MHEL89"M[;RS$0P/;@F7=N# J"
M.: /Q_\ V7_VCO$7[('B'PW^SU\?_%\OQ ^$GCEH+GX,_%%;AKNT@TZ\VC3M
M.O\ 4,M"DEO$X#)+*"&4Y[U^X8F.D066M:9=6OB#POK,,;6]Y;LL\(CG'[LA
MT+*?E;J&/MUS7\G=Q\1OA#\,?BUXY_87^+TUW\3?V6-8OIH_!_QILR\E_P#!
MKQ#+*([. Z[S'%;6MTZ(8XI\!5(X'%?H3^RW^U/XU_8T\9VW[)'[4FJMXO\
MA)XP%N?@'\;;>5KO1[W2;HA-%MKV^C+0+.L3Q"5I91E@230!^VE[';6T\5I<
MDO:ZEB6.%>0I89''<#( _/UI-JI\B<(GRJ/15X _*E:)X[WP^JO!K\LT(N[7
M4;*6.:Q33IT+6LC2QLT3%H\$#=D=QWJ68-&\KW-N\"F1AOSE23GD=05Z=/3B
MG;W9STM!7M?5^B_7_)CBN9I+J[$-%3FSDM(?M]S<1WEFYVI%#CS$+G"$@9X!
MQD8_&H=\4<1MF4RZ@^7B=?N)&W*A\#JHZ_KUKCPV+CBL0L/3IU>9OEYG%J-[
MI;]M=WTU*K05"#J3E&R5VD[NVE[=[7 #/ ZGA?\ >[5Y3\5_&(\%Z!<%6']K
M7D4B(5.) &4@$8RWIC.<X/)Q70Z]XQMM'"V4+"?6'8*J(<@.2,94>^.Q_/KX
MY\4O#&M:_8V>HW,,E_K,YC2WTV%2S+O VY0 GKCVZ@^WZKPQPK2HXO#YGF_(
MZ%&2G!0:E.WNMW5KV_#[]/S[B;/J53!U<'@W4^M54XTVE9)W2]Y]%[UE>ROJ
M?F1KVBZQXK\;^9+:WFM:CJ%T%M+4+)-MGG?$1*A6P Q'./PK]VOV"_V!8/AV
M\7Q>^)UE#?\ B34(HI[+2+N))(K!'"M"ZQ."J,BD<8Y_ Y[+]DK]C?2_"UOI
M_P 6/'MA%=:I<%);329X5=K<L04=D=>JM[9X/89K]6TL(!&@3<D;1(%C4@*B
M;?E51T 4= , =!T!KZ;Q!\2I5<#').&Y3I8:--T:\F_9\WPJ5.+6WNWNUJKI
M*SO;YC@;@O%O$SQW$2HU5)\]&*_>2M?FC*7-?3LM4^UK,S?)MK=UAAD\M711
M'&ORQPJ@^6-0,!> !@5KPQ%HCNW'(_/KSQGCW]JC?2;22V$)\S:K^8'!Q)E3
MG&X<X]L\_C5],(NT=, #Z#CGW_K7XESTY0C6DG[>27M6]5=.*T=NMM;ZJU^N
MGZQ3P\*#JX>G&+H5+*'1PBM[+HFNG1/0PY(!&Y.1@9+ GC'H<XX^IQQ^56Y,
M=RD8,RQ6XX_=X!?\><Y)XYYZ]N:_B6TU#4-&UFPTFX2SU6]TR]M-+O) 3':Z
MA/"Z6MS(.Z12LKL.X4C'K^&_A+]N7X\_LI?$7Q7\*OVO?"-_XE\,6FKRCP]\
M5]$LYSHT5A-.[Q&X6*$A_*B*ACG QU'-8U,3A;+FYU=+7EV:\UK;?:]K[=O9
MRKAR#52IA,97HXE<LXP4H1YTUJXW7+[KOH[)]T]3]<?'?P3^%7Q)BO+;QM\,
M_#GBR,VLJQ2:YI=O>R.2K#$+S(=KG.$;(//&#BOPO_:9_9TU']@+7] _:K_9
MTO=5T31)_%^FZ'XU^&U[.S:.UIJ%RPF>SL5S%&%5R%XP %)(S7Z4#_@IO^RB
M^DK<W'Q5TY8Y(_.M=EG="5W !%L%$9/F$G:,C />OSG_ &G/VH?'O[?]SH'[
M/_[/GP]U:Y\'-X@L;WQ9XNN;6=(6BM9L&>.66+  0%A\V?FZUXN/Q5"I*G&C
MS<TE>*:?-S<R?1;\NZ;;M;?0^ZX=CQ7D\L2L9B89AA:JG%/'5(N%.DX64(7O
M:,FX*\+-6:?NM\WZB_'37[_XC_L:_$#QEHFG/M\2?"?6;Z.P8%C'=2:2QS&
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M([U8BEO&C(>2/[3'-F0;1\\(YX''/4?6JNN QZ1J#2C=;O;3N8E^_CRFR!C
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M^@&)8KFV=C%(60+O7@D'  /:**S+*\GE1/M,)CD>1E7!&"@P58@=-PYP:TZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_"AGW'R/B]I[H"<JQ$4!Q(.C+TR#QQ7PQ_P;9SO<:M^T@TBQ@)XMO1&B*%5
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M^R+^R#<_9=9CMOL_QC^+%O)C0_!>A2)Y6L-!J"[K6&5+5IF&R96W*.015_\
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MOEG< /(4<I&3C?@!3WSB@#^7;Q)'\0OC#H7C_P#:#_8RO)OA3^W7\/+::/\
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M-2+<B=DLS:"S96V1W 7!NRY(WJPZ!<\G/\J /+=(_9Y^ ?AV-1IOP7\&V84
M^;-HUHYP!G)PN>@'/^1WND>%O".C^9+HGP]\$:8D4;?Z1+I%I#;O; _O;D.P
M")Y(R221C&>U::VT0N;JQN-4%H;",WFHZE=2@6-O:1@O*KR.PB4A#_$PZ8ZC
MC^<G_@H9_P %&_B;\??BS!_P3]_8!:XOOB/XHF_LSQ7\2].:1]%\(Z&S-:ZU
M<W.IQ"2SMFAC623]Y+&<T =7_P %$/\ @H[\3?BQX]C_ .">/_!/2VB\3^//
M$D_]F_%CQ[H2%+#X>V<[&VO[@ZE$)+:V%F-SY\U-H7DCJ/"_@7\(5^#ESJ7[
M*'[)^N6_BOXUZA83:E^UE^U9K>VZA\-V\\?G:YIMGKTV^-9H@T\2>5."I  Y
M(KR/05^$O["QLOV1/@CXNAU/X[_% *W[3_[74\+7EEX?_M#']NZ;;:S'YB13
MJ[3I&RS(5.,8XQ]8?#[2?#7QJT^Y_8[_ &-O%.E^%_A)I4T5U^T%^T;>:E:V
MVM^/)IP)=9M5U2283RK<R>:B*92 'Q0!H?"[X:ZS\;M1NOV7_P!D.2[T3X)V
M%XR_M!?'V\<QW_C+4?,9-7:RUF3E[8SB5?EFV!3G->W_ !%^(^G:)IMK_P $
M[O\ @GCI\OB'Q/!)%9_%7XQ:.C):>&[%L1ZW'J5^@:.ZU O'*T<PD+JS YJQ
M\1_B3I7A33?!/["/_!._37U&P?3V\._%3XJ:2#Y7AZZO@(=2DU:]@WQW5S+,
M7ECG:0%2V<BOT/\ V7?V3_!7[)'@N#PUX?6'4/'5_MO_ !KXW4(VI:_J-UBX
MG\^\4F2:,2LZLK$C''T +7[*G[,'@W]DKPE;:5X4M8]9\5>)+%KSQ;XZ4+_:
MNJW\R^;>+JET"9KC,[2(!(3\O KZ)!4@E51%+,VV,;4!)).T#ISU]348BQ//
M.LDB&Y;<\2-B%3W")T4-U8 #)J8G)[#Z4 )1110 4444 %%%% !1110 4444
M %%%% !3I?\ 5#_@--JP;=I[B:)6$4=M;"=T8_,^1QMSZ^E #+3I+[Q2C\3$
MP%?DI^SNLES^WY\;-/OYV@B70%D*QG:S)E#R0>01].!Z"OU/N_$>A^%/"^M^
M,/%^JVNBZ1X?@NKR^DNY$B%Q:I%(R)%O9<L0N..>?3 K\BOV$_$4?[1?[9GQ
MD^-OA+3KGP[\*[>PNM,N/%VK!H=)O%T]2\GE3S[85!2)B&\S!QP30!^QD%N+
MZ686&HP:+H>GH[W^I7CK#$D,*L\\C2.54$1JQ!+=<XK\9OVH/VI_'O[5WQ.U
M?]C#]CKQ$WA+X3:%%+)\<OVD9Y'M].L+2W!?4M/M-5D(@#^3YT2K'/G('%5_
MVL?VJ_$G[3'C/5_V8?V7]=_L#P;H5]=V_P 7?C!%(UOHVB:3:N3>[+[/V>5I
M(!+&OERY)(X/6OS)^(GQCT/PZWPS_9$^$&FW/@?]C[Q+XL72?C7^T6)#8:EX
MLUF.Z1-2:'56*27%M=RM* JS,I4XZ4 >U^&O@9X:_:\A7]C+]G[P?.WP,^&&
MJ7#_ !A^.VHPEM2^(.LV[E;FYT[5I5W2IY^Z>-DE88 *GI70_$CX=:E^QK;6
M?[-_[4EO>_%;]EWQP8M$^&?Q::.6\UGX2:BS"VTZXEU,*TEK%!.R'=YJJ F<
MXK^@'X+_  H^%_P9^$O@71/@)!877@"YTZV\S6-+:+[1JT0A7&HZC<0,QN'N
M$_>/YC$L3SG-:GQ,^&O@+XW>"-:\"?$K1;+Q%\/?%-K-IMU)/;(\VC7>QH[:
MZL_,&Z"6&=A)YJX.4S[T ?CY^R_^TUXD_8U\>^&/V3?VE_%<_B?X+_$=HKKX
M(_'\3/=64UC?;/[,TR^U5"8HV@C=499IP1Z<5^X<D,MA+!+_ &I;>)?"EU$D
MUGJ=DZ3QR6<H!AFWQLZL'C.X,2>N>17\X/Q-^%[_ +*T&N?L?_M;V\_Q%_9=
M\:7QG^"?Q3CADN==^&=]/-C2U36 I>T@M9&3*B50JKSQFO>/V4_VIO'7[&?C
M;2_@)^T3K1\>? [Q_##I_P '?BR)6N]-6QG"0Z/:7EXNZ&*:%'C61I90<@DG
MO7-4=1XG#TXKW*DN679IM+76W?= ^91E**ORJY^W4T, NO.T>=IM.;[\3G<L
M>3@\9.-IP1^8Q7FGCOXA6?@Y6L;,B^U.Y!"LGSE-V  ,9P%)QCMR#4/C+QI#
MX)TJTT.R>#4M3UI&U"WO[*>.:UDTZ]!>SVRPLT88QE21NS_3PGPSHFMZ_KTU
MUJ$#MJ<LH^RV<@,Q8.>&7ACSG_#W_8<FX<RVE@XXN?L_:J"EK:]TE9WZ??IT
MZ,^*S;-:SE*E!N^J[WU3M]W1_E9GI?@;PSJFLZE%XBD1]0U&\N(_+M,%V1Y'
MRI*\G +#/&.O-?JU\(/@+8V,]GXH\76R7.L>5%-!:RH&BC!0,OR-\H*\=1G(
M^E<S^S9\!(?#&G6?C#7K9I-5G".EC(H\M ?NL(V'!!(/(Q^ K[L,$;1H&4#"
MJ1C 91C(7(Z8[#L*^?SK/ZE+FPF'J6II.$I1>JVTANMFT^R;2:9P9+D\\95J
MUL3#6+BZ:DGL[7?3Y6O>SON9T5I:H\;; HB 2*T4!85 ^483&W/<?2M;.?8C
M&0.@SV%-P%4*J@GLQ +#&#U_SS2J,#W/4^M?!5:TJM352VTNKZ:7UZM[7>M[
M;ZGZ'AZ$,/#E22:6KZ;+;MVM]Q.OW,>Q_K453C&!CIV_R:" >HK2RM:VG;_A
MC*2O)M)NVFFO;_+0IS0AHW?;T5FZ<D@9&.X/'XY[UY?XP^'O@_Q[IQTCQ9X5
MT;Q%87D4BSVNJ64-V[#../,4]1T/&*]<  &.W/ZU4,,9F2?;B2,%5QPH!SGC
MW_ST%8SHJ7;I>_6WE:UG]YV4,=/#V<6TTT[I\MFE96L^C[]SX>C_ &#/V7A?
M"]B^%6@(80[-9RZ=;M )-Q/[N/;M!)Z=".Q/6OH3P#\)_AU\,-/,?@_PQI?A
M6*\Q%,+&TC@N,MD*"\8W8XR,],C/:O75B12S <NP9B3GD'(]3@4@M;=3*Q!D
M,KJY$GSA2/[@88'<_7&:XIX).<)\BO'K%*ZVUT6FBMHEI<[:F<8S$T_9^UJ2
M@M.64G)=&T]W*[M\6JVM;0Y]+.WMF>S:)A:3HRM=R$-(6?)^5NJL<D ]LCKV
MPO$O@'PAXZTA_#GB[0M/\0Z-: JMMJ]NEX\@XP09!W'''TST%=RMD@\W!9EE
M;>0Y# $<#:"?E^E2&V4*JL.%(((.&.,_>(Z__6KTI1BZ7L]=%JN[27ZVZ>JU
M/(CB<;[533EI)--MWNXJ.CO=66FFFKTT/DC2_P!C+]FJQU5M?TSX1^$8KR)R
M1%=:-:2#>#G=$K(0K9'!Q_\ 6^C?#_A_1/#EB+31]%L_#]HN%CM;&!+>,8P
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M0C%4[>PAMXS$"\BF1I#YK%R2W;G^$=AZ?CG T/PQ_P""EG_!-1OBC+>_M'?
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MX!\)_![X;>'['1?"7AK2X[<1V-M%;FZN(@6>YO&C4&:YGF!EDDD9F)8 '@4
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M **** "BBB@ HHHH ^:/VP_^3:_B]_V)FM_^F^XK^6WX#_\ )=O^"4WT\?\
M_I?<U_4E^V'_ ,FU_%[_ +$S6_\ TWW%?RV_ ?\ Y+M_P2F^GC__ -+[F@#^
MRFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7;I*K)(JON\U6[#D\=*]%MUD 65(FA5MV^&3(<DG .",@#J/RH T:*AWR_\
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M3V/Y?2O-?B#X'^&'C3PWJ%K\0/!FG^)K*Z46TWFV4=P;7[1F,RJC LS@$L&
MR#@^E=:HM+(R6Z:M_;^IEB+ZWA!1=#<]8)#TD:-OE.,Y(YKR+X^?M#_#_P#9
M8\!WGQ.^)FH64+6UI<+X8\.R>7/<^);]X66&,V0/F8CE"C>4P!S0!^1/[4?P
MBUO_ ()<^(O#7[2/[._CYSX"UN^MU\0_"Z_O/M3SV6JS*ET+"QW,UJ((7;&%
M 0<^];'Q@_;B\8?M9Z'X6_9M_8OL;O19?%5E:ZG\<_B5=&0P>!],U*-9=;)U
M5MT*&.VEDV()%9, 8&#7Y?ZCK'[2W_!4']H6\L]-N;K1?">DW-UJ>M6%W.Z^
M']!\);O.EN'DDS9K*MAN9(RP=6 '6NT^-?[3GPU_9M\#0_LI?L9:%/<Z'J]R
M^E_$KXIV$33:]XUO(6-OXBTZQO;;=<Q06I\U$.=FP#L: /K3PCX)U/Q/JDW[
M#G[#]S-:_#BU:$_M"_M2.KR7_B?5+@A==TNRUM [E'F\V( 3!0#V'-?M]\!/
M@-\-OV9_AS8_"SX?>&(-+TO3XA)XK\0ND<FI:YJ,@S<W[W:Y>5KF7=-DL3EQ
MD>OSI_P3?U+X&WG[+EEX=^ MK%X?UI4%UXV^W&.76;O5&C5KX7KY,XDEGW!3
M* 0V3P<BON:VO8KBS@MEMIK.6U^2YM;AC([N <RR.?OK(064=AQVY )X(GNH
MFM[1\>'P"3<3'_2!C/1F^?C'U_*F&6,_Z/ A^S096&9A\THR=V3U.#_/FB8F
M=1&28XP,>5%^[C/U4<<]Z<7)1(\*%3.T  8SUZ>M #*L6@F@N!J%M&MQ<PH;
M<6KD;/)ER'N<$XW1#Y@>V*KTQTWC&YT[$QL4)!Z@D=0>X^M %NW2%II9M%NG
MDO=*W7+:],2(HI1^\:U=6YF0GY-HR" 0!7Y@_MI?L7Z[XOO(_P!K?]FNY'@[
M]HGPJ&O=4T_2A]DL_'MC9DR7-K<6, W3M=J&0[T.XMD]>?TWE/FP06V!## =
MP2 >6)6SG,^/]9D]<YS3/,O+"Z77],F":E;E+>.T(+6\L#<,OV<9X8<$XQ[T
M ?R&?M/?LTZ-^W+X13]IW]G"P_X4C^WC\#)/M'Q(\!6872;KQ)<:1@7-_':+
MLFNFF>.68%(B6)SUKUW]C'XM_M5?\%9-3\$_ _XU3/X6\.?L\O ?'.GZH&MK
MGQ9?Z!(L/F/!<JDDV_[.<$IENU?K1^VS^QAJ\^L6?[4W[+%_'X/_ &@-%3[;
MKG@BRQ':?$"",>9<6]S;0#$OVHLRE9 <[@"*_-C2/$7B+QSJ^H?'G]FO2Y/A
M+^UW\-6,WQ^^!W.GGQ99Z=SJFI:?9_*;@3!99-L<9+EO4B@#^DW0=*TRQT+3
M/#OA^W33CHFF+'I5HJ"-([6PC6*5$3 P)#&3@<$FK<<@BLCJ]S9M<QW5M+;2
M6Z8\Z*=OE7:OWL%L=L<FOF?]E+]K7X>?MB?#K2_B!X"0:=XR^'\8T/XI>&K@
M_9-4T_5(6\B]_P")=(1=21F5)26$84CG.*^E&U&TMAKWB2SE:\?3M#O-8TO2
MMC>7<26L;-Y;1D8$C.",$9)Z"@#G=2\0^&]!T_3&UGQ5H_AIH+I)OL=S?6MM
M>,H(;#K)*DA YZCZ\5YG^T%\$/A=^UKX"O\ P[XS?1M?6]B/_"&>)M%EM9M3
M\/:L8]MI?_:H'>2+R7523D$'Z\_D=^S-^SSJ_P#P4#^(?[0OQ9^-?CCQ MEX
M4\;W'AKP]X0T35IM.CT:%IYH(UGB1U7<%"GD=O:NN\>_ /\ :D_8+U&;XE_L
M[>,-3^*/PWT-OM?C/X9:E-/JFHKI<1\RY>SG8.4=$W!=A!RN!TH _/7Q?\&/
MBK^SO\5_^$(\<>)[G0/CGX9N6N/@A\2(3);:3XXT>)V:Q\-:S< )%=7MU&J1
M>;.SGFOVO_9F_:<^&'[;?PTUKX*?'[POI\'QU\'6;:/XZ^'NLQ1+'=P1IY4F
MMZ))<E8IY#&GG(]H&8DC%=1%!^S_ /\ !4#]GG^V-0:+1-=L],D5-439'XD^
M'GC*)1'%8-.6^UQO%<J3\N,#\*_#SQ[X'^+'P%^*_AOP1\3+BX\-_%?PT?MO
MP=^-FG))8V7CG38)&:Q\/>);I%07UW=1B.-C<NQ.[D'- '0?MT_L(_M"_LK^
M)O#/C/X&?$[Q+??L5>,M7A3XR>$K2[NY;SPWX<N9E;4K>."(,Z)'&[J-H "K
MQBOTJU_]KW]EK]D+]E/P[X-_8OT#3OBOXQ^+&A0^&?"OPWCM8]3U*[U+4HTA
M;5M:MHFFEC=9YI7=[I 5VY;I7GNK?\%5="U3X+ZK\*/%WP]3Q+^UWKT;>"+#
MX(0P#4+3Q1-=QBWA\3+#'OBCMF4B5BT>!U.>M?#/PO\ A1I/_!/&XN_%T&C_
M /"U_P!O#X_WC_\ "-_"Y2NJZ?\ !9-8<M"D-I'O33)+%+D,"$0J4]C0 _P3
M\-? O_!/^UG\?^*XI/B?^WG^T#J+7_A?X66*G5K#X3:KK,C-;3O86_F)8I8B
MXW',2A/+YZ<?KG^QG^Q))\%O/^/7[1.KKXT_:3^)/_$_N/$NH$7L'@J*]7S$
ML+.-_FM6MXY%14105(''%._8?_8J?X,ZYJ_[0O[0LUM\0/VGO&$#:OJ7]OQK
MJL'AJUN@9/LMB+@,;26W20*A0 J4XZ5]Y^)_$6@_#_PWJWQ1^).MVD/P]T\2
MZOK=]?W$<2Z%!&K,9E69U^T1QE546Z$DCC;0 [Q7XN\+^$O#NK^._%6K6]CH
MNAVDMWKU]J,\<":C;0(6:]MUG9-SOMPJ)ENG%?SZ?M#?'S4?VW-0UWQU\0O$
M%]\'_P!@'X3SR^1(LDEAJWQ5\26,AV:190G9/>6]Y-$%7R]Z,'Z$8J#]H7]H
M.?\ ;$U/7_B/XVU?4/ /[$G@>]EA\.FVDETN_P#C-J5J^(=,TVU8QRS6][)&
MJJL8="']^?7_ -E_]E'Q)^UE>^$_C5\<]$_X1;]F+P!<P)\(O@)! =/36DM"
M#8ZAKE@RI'?3R^6KR2RHS-N)SDT 1_LG_LK>)_VP/$?A7X^_%WP:WA3]FKP"
M\-I\#/@*T7V)-;M[+ T[QCJUE($2Y:Z\I97:0,S;N<YK]T+*5K-EC6"V:PTR
M-;73?#-G$MOI_AZVB79&R0#$6Z)1U49R..N*FB2!+6VMM'T]=&@M+6/3]#\*
M6.+2V\/Z=$H6+ 7$2*B?P@@ Y'>O/_B9\5/A]\$/ .N_%+XH:_:V7A#PU:RS
MW,+2)!?ZIJ$:MMLX59DDNR\H4 1[LYX'- $GQ&^)/P\^#?@;Q#\4?B+XBAL?
M!EE;S2W5S<S+#>RWD:,196,4CI-)NE54"Q@]>.U?C+X"\#?%O_@J_P#%E?BC
M\5+/4O"?[)O@74 GP^\$W'FVB^-9+"17M[RY@F5%FCN1%OW.2K!N:?\ #[P)
M\6_^"L7Q=M?BM\68K_X>_LG>%=3\WP'X"82Z;%XU6U?S+::Z@E5(YDN/*!)?
M(;=7[B:18Z)H>C6GA3PEH\'A/PQX7A32K2SL(EMH!!:KL1(XXAM,N!AI5^\2
M>: (-+TO1-'\+6'A[0=-MM(\*>$H(]-M=&TV);5='CM<1I,R1X60\<E.O0>I
MR?&_Q$\'?"?PA?>.?B3J]CH/@RRL9[HZUJ$D2>6(H7=&AAD97DFE("!4RV2#
MCM5+X@?$'P1\*/"6L^.OB)KMIX4\+Z5927#WMY(B">1$8Q*T3LIO7GE"Q[%W
MMENF:_'OPCX2^*'_  4]\9^)_B1\6K/6/"O[)_@"'4YO!G@99)].E\7O86\L
M]OK4J2*JSV%XT/F)"25V' ZB@#;_ &7_ /@LM^S;^V!\3/B?^S)XP\(-H/@'
MSKW1]%\3^,;)I=%\7%F:V6338KTB&%Y-_F1.O((#KP0:^3/VP_V+[G]E75M4
MU[P;8ZC\0/V0OB#<+=^)UA>2[U3X43W$H>UUO1KE0[6=I]H(D5+=U"QC&<#%
M>@_LC?L>?"C]J7X;_''[/X9T_0O%WA#Q3K>B?"S7=!M8-,?0IM*FD^PM>R1*
MIGD5EC\QCDM@]:^A?V;/VE]:^'?BH_L!?\% X(1_;D4VD>!/B!J5J1X?\=VS
MH;>TT>::X$=HL]MYRXDE/WQD<]0#EOV+_P!MJ'P]IUC^RO\ M%ZI;>*?AQXH
MM(K/X6?$W4L75A?Z1<QB*PT6ZN)#Y5O>6\$@CE:9P2PY!Q5?X^?!OXJ_\$XO
MBCI_[4/[/%E=>*OV<O$MW!+\3?!&CLU[:Z-I]Y,@?6+:WM!*@#Q^9,73H.IQ
M7SU^V1^QMX@_9%.N:S)X6U'XD?L?^(M2DNI;[19&N=;^$=S=S@6>M6%];AI%
ML8Y2) ENX18EXX KW?\ 8A_;0U#X:?V?^S3^T1KEG\1/@]\7+!+#X2_$[5MM
M[H\VFWL/E6^AZV)V\FVN[&WE$;/=8/FJ3UH _8'X/_&?P%\=O">@^,/!/B&V
MN/#7B^RANHK^&:.2^T&^>(37-A=QHS36Y5LQ%90H!ZC/3TG,>YTBM_LT<3M"
M!C'VC8<"Z]_.'S9[YR:_#WXP_!/XF_\ !.3XCK\?OV5VO?B'^SQKU^-1^)/P
MTAE?4+=K.[E#W=[H A$D-I#;1AI@(-H*# R.GZW_  6^-_PO_:2^'_A[XF_"
M[Q?:WFE:I"G]IZ85'V[2=31%>[T:[MR6FA>TDS;F215#$9% 'J=2QGY3'_SU
MDB5OIO&/TR/Q_*&24M,UX;5K*&',4>D,V^2_YVB9)>0J\%\9_4U9ACVZA8P2
M.)(Y'69L?P$L&6,G')3H3WQGN: /R"_:L<>(_P!O7]G_ ,+OEUT61YUC/(4-
MA^ ?<\X'O[C]?;E1&T40Z1011XQC&Q<8K\>_$>?%_P#P4OLI[TF?_A%HT6RV
M?=A!QR_KQZ].O:OV0OHHGNTD:98%!5/)&"UX6RH91T4(>3]/>@#+ZU+&\]Y8
M:K,MQ;V5MHL3/>:A=E(HK2UVDSR^9(57]TF6R&XQ[TZ*W6;4KS1Y;F&T%E;O
MJ%YK4SK'8V5I$IEE26=B(E8IQ\S"OYR_^"@__!0#XB_M-_%2U_X)_?L"74][
MXYUZ\;1O'7CW2#(=+\.:=O-IJC7^I6Y>V0;=[!Y74*!DX% &1_P4?_X**^/?
MCYXMT_\ X)^?\$\X[S6_%VO7HTSXN_%[3S))8^'+.61K;46?4X1+#"L"[CEG
M4 #FO*OA-\#[SX*16_[!?[#\*^-?C9\35@O?VL?VLID%Y<_#Y[A1)JNDZ9KJ
MB1H'E;SH\0R)R>0#UZ3X3?!VQ^!EQ<_L1?L2Z6GC/]H[6HXS^UI^T:T8O[?P
M3>:@H&HV%GK$8D66:68RA7BD_=L>0#7[N_LJ_LN^!_V5/AVWA7PROV_Q7KV+
MSQSXQG(EU77]3FQ)<O->_P"MDC^T;RJ.3M4XXSB@#R7PE_P3F_9HT#X"S?L\
MZ_H!UNTUFT:X\7?%JZ\N?7_$6N2QJUY+'J3YN GVK>0"W>O%/!O_  1N_9=\
M&:1/I?A'Q+X[\#Z+>2R?VA#IVOW%FWB&5V)2X(BE&57.2& !^E?JR8D:!;9A
MF!'$BQ'E P.<A3P,GEACFI;O%[Y7GHA$ VQ*HVJ@Q@87H/PH ^??V??V:?@W
M^R]HVI:+\,O#MYI:ZCO7Q%XBU>3[9J7B6X?E+Z.Y):0&/@Y+$D\U[Y;QPQ0)
M'!/)<Q9)6>4EI'R23N+<G;G'-6I)GECCADVO'$-L:NH8*/QJ( #A551Z*  /
MH!0 4444 %%%% !1110 4444 %%%% !1110 4444 !&?S!_(YJ><->S"^A?R
M0D:PW"9 S&F<D@]CZX'Y'%0=.V?_ *_&?PZTU6BEDO-.L93>:C!;BYNHQ^ZC
M>W.2(U8X4N@Y.#SB@#\I/^"KMUK'B*']F_X4:=XA?PEX<^*7CI-#\6WXG-K$
M=(@FCDF\YR578T.]?F(!R<8R17A'Q?\ B!>?$EM/_P""</[ OV3X??![PQHT
M$_[1'Q[4QV-I:65I%YFKRPZT#]G>XGA\]<+,'8GIGBNM_P""WGP@^)7Q+^ G
MPM\8_#6^>>X^%WBDZYXRU&UD^R?V/H2SJ;B);D *9EMUD7(;DU\(?#O7=!_:
M!^"4?@CX175U\!OV3_".DQ:W^T#\:M2N3IVM^/-7M8S<:QHMMK$K)+=0W$B3
MP+$)2&#!>: .IT]/ WQ&\*^)?@E^S7J ^'W[(7P&$K_M#?'S5W^P:G\7-5T@
M.VKV.F:O.4>\6]DBE1/+F8-N!&:\J_9K'[-G_!67XLR_!G3=?M_A=^RW^SF9
MHO!?P\29+#Q!\2/$\(,1UEKXNIO4EG"W. TA(/2N-\$^&?'/_!4376^"W[-V
MC7_PG_X)T_!*WU"V\5:MIT,NC7GQ0OM'M9'GU*]OD1$U,7_EO*SN[[]Y.<$5
MZ=^QA_P3;T/7O@I\2_B7^SEJ=WX'^)GP=\8ZS!X)UN*?R[?5QI-Q(5M;R&,9
MN6F6!(N0V2WY@'VU\)OB9\5_^"8WQBD_9G^/6H:GXQ_9R\<Z@/\ A5GQ0(GD
MT_P5!<S*EEI&IW)582+9&$+%Y"O&<]Z_<."^74+&T\4P75CJG@N^M(9M.BTR
M2*:WU.&13Y=U&8"R;Y ?,(SN!//2ORN^ OQY\"?MY?#/Q!^QE^U_X6MO#_QF
M\*Z>]IJ4NIPI9:@TD41BMM?TF\NMC,9KAEG5;?+# 'M7BGPR^*/Q5_X);?$_
M0OV?_CW=ZI\3?V8_$>M2V_P^^*\QGNH?"JW4RQ6EAJ$CC:8K;>(\NP4 9' S
M0!^Q_P 3?ACX"^./@#4O /COPW;>)?#VL6T\4(NXHY+_ ,/O)&RQW,,TOS0&
M%CYBL"""!CFOY^/BI\,)_P!DN\D_9P_:=BO?&W[(WQ)U&6W^%OQ/6.6ZU/X7
M:Q/+LL6;4-N^VAM[AXR#Y@553/2OZ+K/4M$UB"X\2>&]9M]7T/Q'86]]/?:=
M*DEI8Z=*HDM)%DB9HP\B$;DW9&<$=:XSXG?#GX<_&?P#>>#/BMHEMKO@'5[>
M:Q6ZN;=)I--N)(VBM+^S5P?(EBD82^8@!# '-;494X3YYIN46G&R\T_E]]OR
M-Z<X1IUH23;G&T=$[/MZ=_SZ'X-?LS>)OB1^R_\ &*Y^ /[2/CJ3QY\&/B&E
MJW[/GQF>X:[LDL[LH-+L+K4B?)1[>)D0J\IP1CU)_K,_9I_9LT+PGX=TOQ;X
MPU"S\4:O?K%<Z5>VS+-;FRE"O:/N3<CDQD$D$CZ&OY%_BM\,=6_9(U.7]G']
MI:>]^*'[*?C'46D^#'Q)M$EEU3X7ZE>RXTEY]6"[K>WLIG1BOFA55".!C'ZD
M?\$_?^"A/B3]D7QUX;_9,_:LUN7QC\//%CV;?!SX]M*;G0+K2KPI'I6E7E\Y
M-K%+;V[)%*7E#;QG(((/L5<]Q3H?5Z5248.R=FT[*VE^G5:?+JSY2633J8OV
ML^3V=[K6[TLM5KTVUWMT5G_48R00/:QPJJ$*OEQK@1A<<?*!M'!&./4#FMH(
M>Y X'3U[UBI]DU5=/U+3KF"\TZ[A2YBO;69)K>X@D4/!-;SQLT<D;J0RM&Q#
M#!SBM*:XDM\ 1-(.FX$<# Y/Z9[U\XO;5)2E6?I9^CZJ[ZW9]'&G2HTX1H+E
M=O?TLKI+9K=;VT6NK6I9\OW_ $_^O0R?W1^O^-4GFE3%RTJBWX!BV_-N)*XS
M^OZUH Y /J ?SK112V7]?U_6K$_:/1R7WLA!(Z&I=Z^OZ'_"D**1C'ZFEV+Z
M?J?\:F:F[<MEKJV_\OF6E%7NFO2WXAO7U_0_X5#QW_EG^HJ;8OI^I_QI-@]3
M^G^%./-;7_@_/\@<:;TL_N1%3R%P<$Y]_P#]0I2@ )&20"0/4XX'2L59YXW=
M9)% )+H"!\D8Y.X8Y&#RW0?6G.484Y3;?NJ[6FNJM;]?/7UQG4=.=.G3A)^U
M=KK92;25[=[];6[]#8!; QTS@=.M!W$9/8D=NOX5\C_%#]MO]F_X0:_'X8\<
M_$S2=,UME:5].@*7LT,:D[O-6!W9&X.5<!LCIZ>?Z/\ \%+?V/=9G%O8?%JP
MFGEOHK&&&:VDM0992%',VQ1&#G+L>PX')KPO[6H^W]FU43OOI;;KK>^NSU;T
M/?GD.<TZ=*K/+L5"-9<U*<L-4BJB=ES0<HKF5W>Z=NM[;??.% Y)SC/KV^G]
M:8<=CTZYXQ^IKAM/\5:9K.DVNNZ5XAL-0TB_GA:RO[&6.[B:*7!6!S SA6<$
M<$Y'<"NHGN'@(F$@>&0*HC &Y78 *3@>O7'ZXQ7M^TBXQE%W<DGZ7U_KOOY'
MBU/:T:LX5U[/V-^93;C+FC:Z2>J:=TTTFG=/4T@,C/;N?\]:1I8PV,#ZYX_'
M_)S^8KFVU&[LA*+IEG9@TD00;?+C (PW Y'!//Z=/%?B%^TG\'/A3IDNI_$'
MQWHFC^7N+VIO;:6]4+U'V19A.<9&?ESU &1QC4Q2IKFE&3BK7>KLWT?=]TM2
MZ6&S',,,\3@L+6J1A*SCR/GL[.Z4$U;1ZMV;VUT/HYL/M*8Z@_CS_B/3\*<S
M\;3QZDGT_P#KU\5_#[]N7]F_XG7T5CX(^*VCZC=RRK$ME>/%ISF0L1Y:FYDC
MW<CC&2>.37U =9FFNDBM+F.\>:V%Q%:P?O(WB(!$B7"91ASG@GO6>'QL<34C
M32<;M).6RO:U]?=OMK;8US+ 9EEF P^*QV!Q-%8B,72C*A4C)IR47)*:2E&+
MLG*%XJZ5SK^2>3A0<].WJ.@/YTOF)TR#V[Y!KE%O]4@C:.1DGG<[VC0?\>\?
M38YQ]X>G'/K5A[JZ25&2)IHS&&9%4D[^.!@=<GT_G79BI2PJBYR3YK6LY/=V
M\F^^B>FIR^QIT,+3Q56*FJTHQC&*4JB<G&RE&S<;=W?\#HF7=CGCO]#Z>]'V
M=.Y'_?63_P#7KP;XE?'OX=?"'3;G5_'?COP_HVGP1F29)=1LS=VQ .8C:"7S
MVD4#!78#Q7SIX9_X*4_L@^*];M?#>E_&.PBU+4&6&TDOK66SM7G)  %Q<;(<
M$\?>K.6+]DH*<G%U-8I.][V[_P!?IV_ZO5YT5BY8>2I3CS0YJ<OATOHE:ZMY
MO\3]!?LR'O[]3T]?_K?K0;9?<\^O;U_^MS7G^G^-=-UL:?<Z#K>FZMI]SMC6
M\T^[M[N.9B.#_H\CA<Y!Y(X.3C%=-)/J$,<Q=P[ DQX&0!VY/!X'7I_.NJ'M
M:JO"HDFDTWI?;7L]/)]NIX^98>AE<*,\1AY2C6A*<>2/-RJ+LU*VJ:?1:^6I
MMK;J"#SD'_/?_/IVJS7,P7]Y(;7>0-\FV0=RN>OL>,_AUZ5TW2LW&I'2HTWT
M:VM9:?(ZJ,(*A1K4X\M/$056*UYDGI[R;=G:VEPHHHI%D,ZAHG4[<$<[QD8^
MGOTK TV213-!):M!;L74,S[RRD$,V>RL!D+D$#I[=(0&!!Z$8/XU1MM.M[6%
MX(_,9)',C>8Y=@6.2 2.%[8]* /Q8_X*)_\ !.^Y^(^GGX_?LQV6FZ!\7O!/
MVS5-3\/K:+]A^)%F,/J&E7L"(R7,TUMYB1&8$[^5R<U^%G[-7[2OC;]C3XCZ
MA\;?@5IFMS^";O5X=._:Y_9-U>63^V/AW.EPB7GC#P[;7 )CMKJ19+A4M(QB
M([2"I(/]P+0B-$\A<&,_*HX4@_>W#OGOW[]AC\0_^"D?_!,RV^*LU]^T?^SM
M%#X-^-NB6]S>^*]+L(T@TGXF:7% KRZ;JUC @CO9RB2*@G4Y:3<HX( !^I7P
M'^//PR_:/\$>'OB/\+]=L]6T75-.M+R6.WD3[38W4\*23Z9>VZG?%/:,QCDW
MJHW*#CL/>J_AJ_9/_:N^*/['/C_4O'G@S1=5'A71-7:U_:!^ MUYRZAX;C\Y
M8[GQ#I%FP$AMI</.@MTPB <\ U_8Q\"OVA_A[^TA\*_#GQB^%6N6NN>$]:M$
MED2&1'O+.\"H+O3[R%2SV]Q9RN$=9 CG!;8!0![[161;WJM-M>[1S,JM%&%X
M0'!P6'RY'0]_I5QYW4L&0J@!S*""![X'/Y>^.E %NBLV*^216$+-<R*?N!2I
M/XD8&/?%6$FG9<M T9]"03^G^!_K0!:HJG///''NBMVE?.-OW1C/7.!T'^?4
MEN&55PI5\ N",[,\\GGIS_GH 7**IM=*5&QNN,N1P">BXZ9/]*&FDP"<1M_"
MC$?O.N<=?3_)H ?=LB0,717!(50RA@';A#@@]&QVZ5F6@D1Y/M%TDET%+DCY
M8X(,<EB?E4*O7/3BEFGD:9(I)UC8X<0,F0=I)RS@$(O Y;&.I-?AW_P4=_X*
M+:EX;U:]_9>_9<O+2_\ BGKEA=GXD_$*"59=$^%6@B*6+4KB^OT+6Z7D5N6D
M6-G#\;5'+%@"'_@I!_P4CU#PY>ZI^RQ^S3)'J'Q9\36K6_B/Q_:W$<VD> O#
M#K+%KNK7%U$7BAN;2#>Z(\BN"F H).?R"_9,_9)\8_MA^)-;^"OPPN]9T_\
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M1PS1VS9:X:$N\@Y!(ZY/3)]^N!6C4,<$<1+*OS-U8X+=^ <9 YZ5-0 4444
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M\: /"_\ A^3=_P#1"6_\'D7_ ,DT'_@N5=@9/P); Y/_ !/(N@Z_\O->Z?\
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M\+:SJFG2W*F95FL;.6>-MAY(W*IQWZ<]O\QSPA^VA^T%\3_VI/%W[6&N>/\
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MIP*S?+<I+I:<[)VC=Q(!T)  VY/K_*E6"^(;RK>">W0;HKG[0BR7)'\ B)W
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M"@7BK5_B+\0O&LL?B+P_\,I+^X32O!*7NV^BTRZM75HIC9+((74J<LN'(SR
M:?BO_@KA\8OB1J\GA/\ 8^_9B\2_%RXOV=-.\2_9KS2[/8AYF_>J(RI&T@X.
M0>#SQRDOC?\ X+9^/F-_I?@73?AA$3G^R]2MTO)$/=-S1-DCIG)Z9K]X_!/@
MCP1X$MH/#_@WPEH7AZSTJW2VA_LG2[*RDC@VA5626"%9)&9?OEG(.#QVKT*@
M#^=N/XX?\%BOA6RZKXV^#\'Q4T>QXO=,T2W6QNKP9X,<L<:,%_O#/_UO5_AS
M_P %EM"T?Q)8^"_VL?A'XD_9[U6[DBMH[S4;.]OM/>1F\M?-O,""(9!W,S
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M7D=>M7:@@MHK<,(P?F.26.XY]B>@]A4] !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /PT_X-S/\
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MZ)IUOIVF:7%'!8V]M&L2I%$H1%;8%+8 Y+9SGW-;XBCC,DBKM>0!6(X!&3U
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M,=Y<"70_A>UY)_8WA>R<B2!Y+5R8)S#\@)VG.#0 MY_P4R^(GQ:NKV/]F?\
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MQY;:7<Q%P'NQ'J$)"*.O!Z#VY]" ?;'[,&B1^$?V;/@%HR($CG^&OAF]=<
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M</G@KGT]<= .3VH OSK(T3B)MKX)4D9Y /'X]O0\U^?7[>/[<?P]_8L^%?\
M;NK/!KGQ8\0E-(^'W@33R+S7M6UB_)AM96LX"US%91R;1+.R;$R<G )K2_;C
M_;L\"_L<> )]2O\ R?$?Q*\01-9?#KP!82+<:GKNL3)Y=J+BVB)GMH?M+(K.
MZ!-N2<BOY2O$7C/XD>(?BMXB^-7Q$,?Q4_;4^*EO._AOX?7UP+GP7^R]X.F5
MC)>7S2EM/34%L6\Z$2;)4=0%P: -7Q=XV^,7B_XN7GQ#\5_9?&/[4VNZ3>ZA
M!IFIW,=UX1^!'A.\C>>6_OIIRUA_:EK9-YT$3E9Q*@506KN?V/\ ]E;Q'^UG
MXJ'A#X7ZYK#?#ZZU9[S]H#]H#48;B.]^(5]%<$W>@:!=RCS;+3D8O9A()!"\
M8'!4YIG[*?[)_C3]KCQ#<?"7X:ZIJ\OPKAUZ&\_:@^+MP;BWU#QKK;3M-_9'
MA[6'Q*NF6TB2VKPVDWD/$H4@CBOZ^?@S\&_ 'P'\#>'/A7\,O#VGZ'X7\/Z?
M%;.MI;10RW<T<:J]U=2QJK3W$[IOD=\DL>N020"#X1?!_P"'?P(\!^'?AE\.
M-$L?"GA+1+,6XTZP@B2YOKA1B6]O;B$!I9IF!=I)"6.XYKU=T(MC'IG$A(W2
MN,E5/7+$9[^F!^M%E;VD-U=*BG?(^2)#O]?N[LD# Z#_ !K7$:+NVJ%W_> &
M/4=OJ: *UMF)8H7<22E,R.#G+#GGZ\X]?UJY4$-O%!N\L'+')).3GV)J>@ H
MHHH **** "BBB@ HHHH **** "BBB@ HJ&9Y%4", EB022!M'=N>N!GBJ$M_
MY'F3ON:SAC DD5=S"08W?*!DXR/?ZYH U:*R[._%S)B-D>%XQ+&[,%E(89"M
M$3N4?[1'6M'>?0?]]"@!]%,WGT'_ 'T*-Y]!_P!]"@!]%,WGT'_?0HWGT'_?
M0H ?13-Y]!_WT*-Y]!_WT* 'T4S>?0?]]"C>?0?]]"@#\C_^"X2P'_@GA\5&
MN+9KJ*/7O!C-&LIB*_\ $Y4;R01N SC;W+ ]J^C_ (%Z%K_BS]C#X3^'_ 6O
M?\(?K5]\-- AM+^2,R&&1](@Q]<'#<=<'ZU\T_\ !<G!_P""=GQ4)WDKX@\%
M,D4>6,[KK*D1';V;EC_NBOJ']GGQJW@3]B[X5>,]3TJ:7^Q_AMX<N180Q,]P
M8DTF #:BC>S8#8 Y)[\T ?SS?MM>#_\ @I#^S#\1/A)X9T;]KJ&'3OB]XDEL
M5MVLGE,"M>>6(U./EP& !X!)S[U^YG[%W[/7[2_PLDO=;^,GQG3QV-:T_3KI
M8A;D!FG@61\9&$QGO[=^OX,_\%,/V]O#WQV^*G[/NM^ _AKX[U6/X->*Q=>-
MX_\ A'-4$=J#?!P()?)VR+D9!4DX/).*_H#_ &1OVX?#O[3V-"\/>$-?T%M*
MT?3TE?5K"ZL]DJ6J*^//1>%V@ =>,>N0#]!(\!F&/F'WF_O'UK\#O^"AW_*5
M#_@FY_V#?%O_ *<;ZOWFM'4//"TIGN8R/-.-H /W0/H",^]?@Y_P4-!_X>F_
M\$WB$W?\2[Q;R!T_XF-[QU'UH _?.BD!.2",# .<]SU'X?YZTM !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!^'?_!NRI7_@DU^SAABVZRU=E(&=P+VP&, 9&1U'?H:_;B#=]F&X-DD\
M&-B2-W0J1G!'<\=J_@!_X)O?$C_@HE\+?V2?V,_AQ\*/BXOAKP-\6)-0M_#.
MEFU\TP!61)=LAY(.%R!GE03G Q_0G#^SU_P5PE2"-?VD8H%$23,3:#;N==P7
MG^)2>5Z]J /W(F\#>#KR]EO[SP;X2N;N<$RWL_A[2Y+Z4G_GK<2VC3.3U^9R
M??-5[?P3X+M)#?P^"/"]G=Q,!#=VGAW2X[U><!EFALTN$(.#N#C/7N:_#J3]
MF[_@K5),T[_M-MYK##%;!PN!Q@* !^([<"B']FW_ (*TPL3'^TT<L>=^GL5&
M>^&!''./J:-PO;7MJ:7_  7FMHS\"_@Q(Y953XU>!(P2"J\:M!@$G 4@<D$Y
M'>OW!\)_+X.\*[0#CPYH0W#^[_9EK@C/8U_.=\8_^"<G_!0K]I!O >E?'#X^
MQ^+O"'A/QKH'B:YT8VPMS(ND7D=R0K$9/"<8]>.*_HSTF V6B:7802KY6F:5
M8:>S=07M+6.#\>8\=!W/O3<?9T/)-NR=VKI;OHVWL[/K;<F27LI5DG9*[EIT
MLUZ7OUZ=]C:,R[N>N>OUZ]L#\ZF=@PR.1M/_ -<5^<W[17[5.J_![X__  ?^
M'$2-)I?CB-EO%$9;S9#,Z!@W\.,#CTK]!+*29UAE9MXNH(9DCP 8U=%;\>I[
M?I7F8":G4J)7ZIWU2N[?GM]_KPX+,*>+JSIIZT]VKZ6MIY7U[6?E8N$OM( .
M.Q['/7\CZ_A3(O,R!SGO^).#C]/3O[U9+ ''^1QQQW_"JL\[+&P0['*D*_7:
M<<-WZ9!&<]:]&"^JT)\UI**<FWOLNO\ 5WY,[I8^C!6LFGUM^M]-W]RU6A8_
M>@\XX'ZCT[X].]1-]H:1<9V[AGW&>^.?;'I^&/BSXZ_MA>'O@?K6G^&]2LKG
M4]1O8&G#HC@87)/ Q],]?7CFNF_9\_:?T/X_6NH2:+!/ITVE7:07"2HP#')R
M,MG&?3@YKYJAQ/@(8EX=I<\IJFI6O>4FDDWIU?IYG&\XPOM%"ZO*T=E;F=DU
M=O>_7KIJ?2UZ]O/:7]IJT27UC?2-ITMFRB2.6*=6CDBE3D%)%)5@1@@G/6OY
MK/CGX5^*?_!(O]IW4_V@_AMI>J>)?V//BYJCWWQ9\+:1;S7*^&=8NYG-SJ4=
MI;C;#'#YI<-@#:,\ D5_3A%9VR;W6,$S.LSEOFS(!PP!Z'Z5SOBOP5X4\9>&
MM:\*^+=$L=?\.:Y:W-KJNE:G;Q7MK<PW,9CE'E3JZJQ5OD=0&5@"#D5]*G=)
MKJK_ 'G=N>7_  7^./PW^.G@#PC\2?A!KNE^*O!OB*PAN$DL+B&[U#37G&?L
M^HP0O)+9RPL6CD6;805)P 17K +R7,EJQ,,RRK,J#)$L7=R_ID=,_CTK^=WQ
MU_P3Q_:@_8-\>>*/C+_P3J\97^L?#WQ/J<NKZ_\ L^ZE=SW%@#*S32PZ:9"(
M[6)M[[%A5-N "JD8KU_P1_P6/O? ?]F:+^UY\ ?%'PAU\-'I]W<Z3IM]K5N"
M@\N2Y>5=RQQD@R,-P7D].M16=J51K1J+:?8:U:]4?N\'!([9'ZYQC_Z]>?\
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M_(U^HNAV#Z3X8\+V"QL!:Z'80*H4\".$*!T/8?KCK7\R7[7G[6GQ^^,'QX^
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MP%XB^+?[2?C(1VL,VF>)[S5+'PA9W6(A=7TL$CK;R*DBO(DFTAL@CM7Z/?\
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MPC\.[#;<>(=?UBX#+;/8Z7&3=W%M!,%,\D495$R688)K]#IF98RR*&8<X)P
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MVM__ !5? O\ P[$_; _Z#'@/_P )K2/_ (Q1_P .Q/VP/^@QX#_\)K2/_C%
M'WU_P^M_X)^?]#_XL_\ "&UO_P"*H_X?6_\ !/S_ *'_ ,6?^$-K?_Q5? O_
M  [$_; _Z#'@/_PFM(_^,4?\.Q/VP/\ H,> _P#PFM(_^,4 ??7_  ^M_P""
M?G_0_P#BS_PAM;_^*H_X?6_\$_/^A_\ %G_A#:W_ /%5\"_\.Q/VP/\ H,>
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MK^)C_@GK^]_9N_X)8L_)-[JN>V1YJ\'U''>O[=[0#[-81[5V&TMR1M&,^6E
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M;Q)K%VVF?&#XQZ6LDEGX>TR20PZE(VI6S%8%A@DD8[F  3GI7G7P<^%GACX
M:#J/[$/[''C+P]J_QOUNR6__ &L?VDKZ]M+B_P!&M;J/_B=VEIJ['SHIXU:1
M0JR!E9?7%6?V?_A>OPYU>3]C[]AO2H];^)=_#$G[47[2[1+??8FN0(]8M=+U
MH@F6?YW5EBF+)MR>1D?5?Q8_X(J6<O@.?0OV:/BIJW@/QWXF F^*OC%;VX;4
M/%EU+EM0#W.]9ECF8MA-Y4 X'I0!X;\-_@]?_'2[7]BK]C*>_P!&^$7A;4!?
M_M)?M.WRRBZ\6W@E#ZW:0ZZW[QX)&\U,"4KL/3%?2OQK^-NG?#VRT3_@G/\
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M?3TCAT?0=.M5 U;3%U2W"0/<@),"S/O);KGK\S>'_#VA?$+2?$WPI^ ^MO\
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M%D7+26WV4GS%:+:1P<T >5?\$]O^"@'BC]C3QOX8_8Q_:A\13^-?@IJMNC?
M[]H2YG>YTRZTJY9I],TN^U>60P^<B.D6QI V3P>N?ZF=.UNQU/2[#6]'O8=5
MT75(H9[.Z@<2QRP7"AHI$="592I&".O![@U_GM>+?'?P/_9X\2+^R3\8/B?I
MGQF_9?\ '6IK/\)/B>]] VI_"W5KN0G2D&J[FN$BLV,?[OS%7"$8P./V9_8
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M#3]B^GZG_&C8OI^I_P : &;3_M_]_#1M/^W_ -_#3]B^GZG_ !HV+Z?J?\:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVB/VA/!_[./@J]\7^-+NUM+TPR)HVF+,ANM4N,$0JD>2Q+N0/ESR"!S7Y'_
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MC9KVM_%'Q(O]I_$#QC<7=T]]9ZO?#S[FPM-\A=8[:X=XU$;;5"C&!Q7=:/\
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M"9*KC(77M;+'GC -W@_CQ42?\$?_ /@GO!?+J-M\"E:Y:W5)+M?$>L*B1<(
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MX%5(I9P)%W;YMI>)#@!QCJ3_  Y.._>@">\B61$9HUD:-P\89MJA^@)['C.
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MRY)Z\XS0!%%*WG& J&18E;SAT9SC(XXSW[&K=,2-(UVH,"GT %%%% !1110
M4444 %%%% !1110 4444 ?-'[8?_ ";7\7O^Q,UO_P!-]Q7\MOP'_P"2[?\
M!*;Z>/\ _P!+[FOZDOVP_P#DVOXO?]B9K?\ Z;[BOY;?@/\ \EV_X)3?3Q__
M .E]S0!_931110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?P[?\$\?^3;?^"6'_7[JO_HU:_MWM/\
M4Z?_ ->=O_Z+2OXB/^">/_)MO_!+#_K]U7_T:M?V[VG^IT__ *\[?_T6E &E
M2-T/T/\ *EI&Z'Z'^514^"7H!4D[?C_2B/O^']:).WX_THC[_A_6O,7\"C_V
M]_Z33'5WCZQ_-GXP?MW?\GE?LT_]<F_]*9*_9>R_X]+'_KU@_P#1*5^-'[=W
M_)Y7[-/_ %R;_P!*9*_9>R_X]+'_ *]8/_1*5YF7_P ;,/\ L)H_F?GW#/\
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MF^+-)?=+JMQ9::0(9)# 9"/+B/)]:_8VXE>ZF6><AI%1$4J-BA8P N%7 !
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M2P\6:I\)?V&?A/J"S?$+XG;GT^?XDW&GLWF:/X9N%9%U6&^"^01!O#;_ %-
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MW\,['PI\.XXM07652ZU_Q1?*&\0:OJ#!6O;F:653<KMN/,VY<@@YQ5G]F?\
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M3WEAX12XDS/- A)BAM(#,S;P@0*O08K]TXX9!IDD98XNV)@!)WA6YX?[P&.
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M_!/?]@'3[R]\2>-[W[/\1?B581L;#PQH]QE+V\O-1MROV14MI96+NP^Z3GU
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BCZ].^.OX4DGVU0)%MH)8EZ+
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MR_9,_8STW_A8/Q^\2E;+6?$&GG[78^ ].F_=W.IRSV[[([VT)9@K'(*8'')
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MW$::OX?U6-/]+@6TDE-P]F'#>7/M;C[[<[JY+_@I-_P3F^%/_!1+X,W?A3Q
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MHS"21I%C!&"@89(_$)/V5OVA_CW=:1^SV?V@?B3\6?V@/BKKJMK7@J*>]NO
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M;W"SW&H>&XI)YI$CF,ERBK&)'#JWS87T[=\<^K:WX?\ #7B&PL[?Q5X6T3Q
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M[79+6W_"21&TCC#$!0S-LQ@'GGBOV'AOY+%Y/L\-A#&FGBWA$>GV2X0=(P1
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MD":0Y5< \D=R<  ^KXD)@7!*,SB1F"@%L<X)[GZ_2OQC_P""VO\ R13X2?\
M95M*_P#0[6OV2M+R651(876W<='&'20C@*.Z>A'M7XV?\%MN/@C\'SW;XN:.
MI/J"UID'VH _57X$_P#)'/AM_P!BCH__ *3+7K%>5? T ?!_X< < >$M(_\
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M0#Y&_P""DVM^!?V@_P!M'X._"K]C;3[F3]ISX<>)K74O'7Q \%Q%M*LM/-S
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M<Z5<VU_H=W;I<V-[;R))'-%*H>-HI$)$D3!@5?G//.<UOU^:/_!)OXSGXO\
M[&GPT@O9Y;KQ!\.M-B\#>(;BX=GN)M1TMID:2<L2?,*C:<DDA 3S7Z74 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?-'[8?_ ";7\7O^
MQ,UO_P!-]Q7\MOP'_P"2[?\ !*;Z>/\ _P!+[FOZDOVP_P#DVOXO?]B9K?\
MZ;[BOY;?@/\ \EV_X)3?3Q__ .E]S0!_931110 4444 %%%% !1110 4444
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MBW?^$;B6/49)QQ7IPMV6.%$? 3:,#T3@#ITQT'6O)RZGRUJSZ.;GKLM]OO\
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MU''''I7Z[AEFQ'( [VN8=QZ\?_7!H 1IUDRDT!53PS*".".3P/0DY/\ 04]
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M_;F^)]K\/_A)8W.O>"M?U7_A%_ '@C3!(]EJ>I&58)-0\3QP8,>DF-VECF;
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M/]FS]HGQ##XT^"/C^5+'X4>/]2D2\TJ_TZ_8"'3/$=W-YJQ3+N2!E8JP"X-
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M/B3XOU1A=:QINHW>6N[32Y)_,=;>)F*IY;*, 8P*^U1]H>RTVYE5M3>>^/\
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M\6O!'BKP5\0=!LM:\&:LMQI#PWT2R"WGG0H-0MY&5I(WC)4@QE<8&* /T\^
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M[(2#;IG.(&S]XE2,?7&* .LD8JC,HW$#@>O.*RYHXS')$L_DG'G74I8*T40
M8DDD84 ')S@8)Z9-4+:_CEFYN)=EHI5U<@-Y,8;-W-DC;&5^;<>.*_!_]O?]
MMGXF?&+XE1?L$_L*W4VN_$[Q/(+3XJ?$?1Y1-%X!T.>18[MEO8G5()H8)'#'
M>-N., DD J?MS?\ !03XD_%OQZW[%_[#4:^*/'VN7!\/>./&&FEIT\'6DDBV
MVH3W$\+$6QCADD8-N4EER>P'WQ^P)^P%X#_8A^&KZ7I%P_BCXK^-7.K?$_XF
MZN1<Z]J6IWB13W=C%=2M++]CM;H.(4WJ %W;?NM5S]A']@_X8?L4> HX+6"/
MQ'\6]>A%U\0_B=?I]IUO7-4N!FZB>\E9V$(D+#:A.X'J%X;[QVQPS,Z2 RWB
MXAMRWRACG,ASSEAU]03^(!&T45Q&]L\CND(7?,,G[001P2#@MQR,\<BIU@83
MO+%@RM"B1I)]V)$P"WUP1R?7ZU5<S0(EK:(LMZ6+A1@V\?S?,96SQ@ X!.<D
M #I7XA?\%*/^"G#^ [V]_9<_9<N[+Q5\??$%O/I_BSQ!:2K-HWPQTIHA'>ZA
MK%TORV4R1&1X69U^=5 ZDD /^"BO_!2W7_AW/JG[/'[*<VB^(?BO=V]S:>,?
M&.HW"C0?AY87"O#?7U]=JP2UNX(&9[0LP)E4!><U_./X?\.>%;+1?%][IWBK
MQ+KF@ZWJ!U']H+XP^+&E'B;XH:U-/YJ^%? 4\K-)?Z7#>?Z(HM6Q]G([=;.C
M>'O!^JZ/K%AX\\;:]9_"G0]5DUKXL?$^"60^.?CCXQDE\Z/P=X>E<F34-(BU
M/_19$@=@+<G(Y K]KO\ @GE_P3_\9_M >)?#_P"U#^U'X-TWP/\ #3PY''!\
M"_V>M/B$.@C1;%472?%'B2RW(SZIJ5N([JY,JLSSE@.,E0#._P""?7_!._5O
MV@]:\(?'[]I;PS_8?P8^&[PW'[/'P$GB^SZ)"R!98O$VN6A*&:ZNU5;A_/21
MFE;C RR_TFV-G!:Q0SB6"*QM+>*TMM/M@J6=E!;QB*&"!$ 4!(T5%4 !0 %
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M-K%<,I8CLH/)_"L^3SH8Y)K8)+F0.2_1L 9V^ISP/QZ&M<@$$$9!&"/:FB-
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MRU2UB4 *D;;1MC10 H"C 4 # %::J R(@ A6+:JJH5 H "J%4 *!C    P
M.*D\J,(4"#8W5>Q^M ',Z5=R:@AM_LQM$M)?*E#+M#3*<YMSCYHN#\PR.U8_
MQ&TV+5? /BK2EB2XAU#2+ZTO$(#!HI+=_-!7H>!@@]CWKM[B$>6&CPC0_,FT
M8'&#@XQP<5XC\>?%J^ O@Y\3_'8E,,>B>#]3N[F,MA(0(61KKT7[YY]J /R@
M_P""(]Y'9Z+^U-X0LV/]G:#\;-7%LF3MB/G72%%'0#YSP !P,"OW8K\3/^")
M7A6:V^#WQ:^(<D)6/XE_$S4?$-M<E2/M<$TMRPE0GAD.1R"1DBOVSH ****
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MRB'N,'H/0?3_  K\:_VX?VM?BQ\%_C'9^$_ VJV=C:G2H+F[.L.4M)/-5#B
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M!$4%F8DD   $DD@  DFOS)_:_P#^"I'[-W[+>AW=AINN0?%[XLO))9:+\+O
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MRRB,J[%%DRA<?P;AP:_#'_@M-^TGJW@SX1>$_P!F+X<S"X^+7[2'B6S^'/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8>.KN*_\3ZK;74O@OPYO1[G5=:6-A9$Q9:00B<@D[<$#&<5_ [XI\2?M4?\
M!7/]K""TTVUU/Q'\3/%>K,VF.!/-X3^&'A*2=T=I /\ 1[;5(;4AX<X8,H[U
M'XI\4?M9?\%@OVN[31KQ=8U_QIXHU@BP\/6XFF\'?"'PM//(IAU>, 06NL1V
MI#P\J0P&/;^\K_@FY_P3;^#O_!/SX7VWAGPIIT>M?$758;>\\<>.=2B675KS
M4IK?=/;VETP=A9J\KH CJ"% /'%:@9?_  3A_P""<GPJ_P""?GPEM_#_ (4M
M(=:^+OB"RM;SXA>,]5C5]1UK6G DNI(YV#/Y*,P1-C@;0PQ7Z;6TMT[PB01*
M!$?.5?O"3ML_V>GUZU<,,32+*44R*I57(^8*>HSZ<FG;%W;MHW>N.: '4444
M %,?H/K_ $-/JM<DJF1U&?;_ #_C65=R5*3A\6EGU6O3SN)R4%S/9-/\20R
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M%:,S^6X*<;U)*^@(&./QS7YU?LH_M71^,+>/X=?$Z(>&?B9HKBR>QNP8!=I
M/+5XPX&YCM!XSD$9ZBOT.CV7$@G9\ H%VDY'0$%?;GMQ@#/I7W&1YK&M"*K2
MLVE[LFKINVZ>K75>1]9DV-A4IQ]L]6OAE]F]DTV^TDVM?A=[VN7K:1V W'KG
MM_GMT^GIFHKPL0PP3@\8]/\ ZWMZ'O0?.@^= '3I@=@>Y'..,X[4H0.?,#LS
M,/FC)X7/)X/O^&:^@E:=2+ARN/-=VVM:][:J_P"7WGKN:]M&4;*',M=$E>VN
MN^M]M'OYE4G=-L*96.(."!T8],#U_GP.]?-'Q:_9F^%OQ?UJVU_QKH=IJ>IV
MP6-7GC#,L28"C/&.W.<8!KZG5 N3@98#/ [<8^@Z>E1M:Q2%F**S'@G;GCT_
M^O7#F^&IYAA7AG:2>EM;)Z:Z:WOLUTN>/F& IXNJVX\RNM[VNN7WM.MEIZWT
M/$?A1\&O!/PFM[JR\(Z1;:=:LF\I"NW)Z_CTQG/:O:=.F$_F2@ #A !_L_\
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M3D[T/0L^  >^1CWKQ2QRF?;N-SYKYD8$1RL#Q)S@'=Z]^?8$ FHINR_7)G$
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M)G?'BPDM;?\ 8F\21'X8^.?%$6L^(?#T-QOT2QN+UQ+)=^&XA(R(B)(3&5
M(]J_4?\ 81_8ET;]E#P'8>(?$%POBG]HK5-'BCO-0U?_ $F&QTYT.ZW=I"X2
M5=QP%P1@8QB@"W^Q?^Q9H?[,_AJ?QSXEO6\8?'3QK.;WQ=XPUEOM5]8ZS=D2
M3VNFRRF7R]/C+D($V@ 8[5]SE;Z65(ECA&K1G[0^K)C[+>R=6MIGX4D#)(/'
MYYIH-W/';>;%_IEQ,3.I_P"/=KK'SK 0<! "2,D8Q7YN?MS_ +;K_"ZVM/V=
M/V;["?XC?'WQY<_V9?0Z0IO(/!4=VRPR:A=-$LBP- DK,S%UQL]B* #]M_\
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M_@/]H#PPHLO#WB6Y!M;#QO90*([.."=U6*XGN-R"7YVSN- 'KG[&G[:'AO\
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M=:-Q&VJ>'=+U&0A[C3TF,D<:12%?*&>%!-5?V,?V3_'?[87C37])^"#ZI/\
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M))(QA0%P>Y/.?\GU^M2444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'X:?\&YG_*)#]F+_ +!VI_\
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M=2P)P7&.5.2".XZ],4ZC]G%2M>[6BWUM_7]6!-O>+7S]/3O_ %J?SU?\%LO
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M6OHM?U+47*]O3U]/^#8***4<'Z?Y_P _UK,R?ME:]&:NUT?7E_S_ "\Q*"<
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MMY)45V0HCLT>TD##*O/Z]0F]88TF_P"/@ M(#C(#8*@_@<?A7\\GPF^+]_\
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MC_@J+\/C9>(;+PEX'\6^,)YK-8]"_P"$9M)W%S?D_+%GR^3O*AN>AKZM@_9
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M]D:*;PK\=O"CQS^.?!>D;K?2_B=ID9WWEW]DB(2[E:,LQ81MECG..#U&A?\
M!3/X(:G\!O$'BSXAVC:3\3X=,N='UOX321_\3?6M:,/DRZ2EBR%W@U*Y#1,O
ME\JV#VKQKX._\%3K7X<>#_&/@?\ ;*\/W7@']I[X+V,GAS0-"GB>*/XI8B-M
MIQT*WVYN3=B-3*0CAF<DGM7YU:G;Z?\ #OQ5??MS?&_P!!K'QB^+NH2I\ /V
M>M+MO,O;>ZN9F_LS6?$.D1@X97=)@\D P.>O- &;X/\ AMX-_9SU[5_VR_B[
MHUS-X]^,.H7=S^S[^R.P>;0?"-W=S;].U:_T!2ZV\K2LESN> ?,Q-<%^VO\
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M .>* /RH_P""RW@[X;V7Q?\ V-FL_">AMJ%SXT1$^S16J0RPR7Z*RW@0XDC
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MK:=(5=RC1AB7BY))%?NM:Z5"T.FZ?X=EM[#P[I*QV;:-&%B@BM;/]W:PVD8
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M_98^#T%K\3?CQ\38#;S^'-.07X\,)? 1.?%)C$L2VT"RL95<J05[=]C]@/\
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M+Q#^TS\2/'W[=0U'3_VS/$=S+J'PSTOQD6_LRRTVZD66UM/#"W6R&VGVE8Y
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MT4R:A\1/V'OB-J3_ &/4B9;R;X8/?394R,%D-K!;IU&5 5?05I?&OX%_%?\
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M,O",UU\-/VCO!T$FO>!_'_ADC3=<NM7L$\VRT?6;V(QO<:5=2KLGB?<71RK
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;3,9H@J2X(V;@ -N!C'';]=;.V$4R17D,4?E*J:5'$@6);91M4;0 !A0 /8
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MPYIFV40:?IFHSJI59(LK&3)(%SGG%?9G[7W[$O@[]KCPSH_C33-7M_#'QO\
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M)8@9R,LL('/I7L7_  53^&?@3X%/X6_:X^'6M+X4_:1T*XM8[/3O#DJP6_Q
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M_/+_ ,='^%6** *^]/\ GE_XZ/\ "C>G_/+_ ,='^%6** *^]/\ GE_XZ/\
M"C>G_/+_ ,='^%6** *^]/\ GE_XZ/\ "C>G_/+_ ,='^%6** *^]/\ GE_X
MZ/\ "C>G_/+_ ,='^%6** *^]/\ GE_XZ/\ "C>G_/+_ ,='^%6** *^]/\
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M.PUS1(F;0(;9D2/Q9*@<6^EZ79*RRF]9U6-G1"6)[YQ7QA^RQ^WG\$_V]_\
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M^]'FSV6E7DNZ6 1SDH%0@ #IW'W,TLMWOENEE9FD8JUPQ=Y4R2D^3SA_O"@
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M/^"A/P4)NO%EC<)_97A_XU:=HV3(]G WE17EW?)&WELJN[.X(ZU^H/@;Q?\
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MT\EHDDNK&+_C^U2,DM>B7A88&&67R2?GQVR* /QD^"GQG^)__!/#XG)^R?\
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MZ5Z%H?A[P;IECX7\*:'IVA:+9J$MM-TBTBL[&!" &$<$*JH)"@%N6( !)P*
M/D?]C']B3X2?L0?#.U^'OPNLC)K-TZ7?C7QSKJK=^)O%FIRJ9;FZN-1<&>6-
MIWE9 [9'RY&0,?8!\N*1KE;5DB7,,=OCB=R?]=@#GOR1^M;12W,X1@6D"' ;
MD!1C@9_S^%62JG&5!V\KD#CMQZ4 4;*2.3)B!/)\U3G]S)C[@ST[]*T*:J(F
M[8JKN.6V@#)]3CJ:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?-'[8?\ R;7\7O\ L3-;_P#3?<5_+;\!_P#DNW_!*;Z>/_\
MTON:_J2_;#_Y-K^+W_8F:W_Z;[BOY;?@/_R7;_@E-]/'_P#Z7W- ']E-%%%
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M-_9#_97L[CQA^TQXVD.EZUXCTSS)]*\ :;<D0R:AJC0B2+'DRDKYFW:0,]*
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M;4/@]\.KHLEOX0T)V=[&.^LIU7?<11F%BY3/'6@!G[,_[-WB/XY>.KW]NO\
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MLOV3_P!L2[%MX^T=4L/A+\1YI"=+^)>@1J(M+0:@Q%M)+-%L<EI&Y/K7ZT2
MALLJJ'^8%2#$<]HY =CKZ%20>U?S:_$_X9:SX$\0VW[(_P"UDUW?Z;<3[?V:
M/VB+/?'>^"+J$@Z1;ZMK0P=BN(8V5Y0#R*^Y?V+OVO\ Q)X=\7#]B7]LO4HM
M%\=>%84;X9_%:4[-(^(VBJNS2HHM18I;27-PIC+L9&+,V3S0!^L7;/;U[?B>
MU'I[]/?Z4U7,%Q<%XO*AES;K8%M[/!&=L5]#.,JZ3X!4H2.>#ZO;]W;6AV^5
M<6LS/<HW+6D#$F)I5ZR&08 '.#@&@!,;OE.<$A6XZ!N#D=N">M>'_M!?M'>
M_P!ESP3J7BKQC=Q"SAMG;0?#^?M&H>(]7E5OLMG:6D9,X:6XV1$B,CYN?6I/
MVBOVD?AQ^RI\.=7^+GQ;N$T6P>#R/#'ALN)M6\:ZM(K+8V^G6,;?:D\RY$:'
M;&1AN>*_ ?QW\1O&7B+58_VO?VB+.36?&GC*<P?LZ?LVR@W<FG1W+@:-K&J:
M3@L!\T,^98<J<GK0!5\9_$/Q-XO\20?M;_M=VMQ>>-KV\DM_V6?V5'9KQ[.2
MX?;IFO:WI SOC8F.XC\Z(E,]>,C](/V(_P!D'Q);^,)OVKOVIM/B\7?&/QE"
MMSX)\/ZHB7>A>"M-E7S;"TLM/F&VS>SC*Q@*J[=HZ8J/]C']B?4(-=M/VJ_V
MPI!XT^-OB:);WPMX3F43:3X"TJ8++IMM!8/\EJ]O'MCPJ+C;TQT_5>69YF#%
MF"1D_9TS\MNG\*1#^!5'  Z"@"NS75\]Y!J4KF6W;==JS$QK&QS#%:*3B..(
M$!57A1QTS3@   OW0 !GK@=,_A2DY+,>6?[['[S^FX]\8XS_ (44 %%%% !1
M110 U^$<_P"RW\C5G3\FYTXD_>5EY]"V!],=,<'BH*<N?M=LJY&V:-N#C ##
M(QZ=S0!^1'[/F-"_X*3?%;0H\I'KJ75[(I^4.R&1LX/WB!C&/6OUXDXDD'H[
MC\F(_I7Y$QXT'_@J#I]P?]'35]"NR"GR"4XE&6Q][MG/OWXK]=I/]8Y_O,6'
MN&).?KSS[T ,HHHH <@RRC&[)''K5,&<7!CEA_T9;D'&.,=<].1VJR20"0<'
M!Y'TI\A)#9)/[ECR>X P?J/6@#Y/_;G>VN/V7/BA'9QE#'871<= 5"K[#/3W
MZ]Z_*.R.?C3^P/\ ]B#IH_*4"OU=_;@ 7]E3XA%0%+:1>%F P6/R\L1U/O7Y
M,QD_\+M_8$Y_YD33/_1PH _HIUC_ )"-_P#]=(/_ $1'636KKW_'[=_]=8/_
M $6@_E650 4444 %%%% !4<?W)/^N=U_Z3RU)4<?W)/^N=U_Z3RT ?SB>/O^
M1%_;%_Z_Y/\ TZQU_:)^Q9_R:-^SA_V2KP=_Z:X:_B[\??\ (B_MB_\ 7_)_
MZ=8Z_M$_8L_Y-&_9P_[)5X._]-<- 'U0/OM]/\*?3!]]OI_A3Z "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH 9)_JY/]QO_ $$UEW'_ ""KW_KP
MN_\ T3)6I)_JY/\ <;_T$UEW'_(*O?\ KPN__1,E '\0'Q(DMD_:G^($=U$9
M4N?VC_#MNB@9(DDU(@']17]M&D6I&@:#IS#8]KI>E;"WS!DCLX5=?0X(*GDY
MQ7\2WQ( /[57CK(!Q^TGX;(R,X/]I#D>A]QS7]P&B#.BZ*QY8Z9IV6/+'-I$
M3D]>3R?>@"80*7:218E 8")D4"39W^8#OGG\<U-)(P&8(?,88Y( Q^)YST[U
M)%R\P/(#X /.!SP/2I\ =!B@"O$X<@N@28#!!'..^#Z9JQ28&<X&?7'/YTM
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M.:\#\1QP=:%2K@542E=:."DDN5M-)V6CU]3^P-&PQ1GW9/RG/'..<YYXY_\
MU@U)&A61FWD@@8'3!R#T/) '0],>]?#G[)?[7_@7]H;PQ8Z>NI06GBJQMXTN
M;6654E:9%VG 9@S,2#D=R3WR*^WH 5D/F2!Y0F!M^Z4/?IU[?YY_GS&Y/C<D
MQ=?+L12E%.4DI25UR7LI1;6L6MMVGOJ?O6 S/!9WA</CL-5C=PC*4%*S4FHW
M@[;KY=.IICD#Z"H"<NR^F3G/^?6FMG P<9('\Z@NV,<2*%9C(<%AQLX'S'UQ
MR<__ %JX:DEA*?/RWM=ZO>UNUWV_/5*QZ+OR\VVE_P FUL^CZH=)C)^< GZ
MCJ/T^H-,1P0P#!^.W8@]3W_^OUKY$_:>_:7L_P!F_P /:-KU_H=QXC36-1;3
MX[>VD\ID88Y)_'],X.:YW]E3]KC3?VC-9US3+'PQ>>'GTBW%RYN9A+Y@/\(
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M5Z  #C%4BHD4:@\)MKN:3-[;'&891TRW?@DY_E6_>6#V+'2M<MY$MX"397+
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M<\R.L[/'OD7C;[F@#U1)I3<SKI*MA]SRBX_>RVDXY&F8Y93*> W  _&O@O\
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ME(CN5-U8![>-X8FD4IO4C'Y?6O['?[(/@[]D[X<RZ1I4RZK\7=8(U+QAXOO
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M^@HB?"+XCS2J-,^)6@A1%IFV_8K;R3-$8Y&!=F)]Z^T/VC/C[\/?V6_ =_\
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M>?R6OR8C_P"2W?L!_P#8B:9_Z.% ']%&O?\ '[=_]=8/_1:5E5JZ]_Q^W?\
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MG_(#T7_L&:;_ .DD- &A%]^;_?']:GJ"+[\W^^/ZU/0 4444 %%%% !1110
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MF^.?B^PGM/AOX#L[A)KVZNYXY(1JNH>7)YEI;Z>X%QLF10X0-DKPW\/GP6^
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M7[=/+1G$?\(!X-_Z  _\=_PJ.7X?^$8X_.30RJHPW  ,3WSC'0#K_P#7KMT
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MG*LO..F./>@#]MS#,O#12J?1HW4GZ @$_P"?0T>5+_SRD_[X;_"OR<G\4_\
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MVQ_6IZK0,-\HSSN'Z U9JUS6]Z/*]-'YI,[-'MKHOQ5PHHHI@%%%% !1110
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M6_9W?;\1>PHO5VTVZ:WOK=][/;?KH7.E%%%7L,*:_P!T_A_,4ZFO]T_A_,4
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M%N8/$LPME4#'G-@H.@ZX(QP!V!(^N#KOP,FUDQ7-WXLN8A$=WE#?/$Q!SN*
ME58=CU!]J_BO-L9]9=[M].^]E^>_:Y_4N7890@KK32[M;]-M%L_D>]VJ6B:7
MI85(F$EA9.^+I3\WDHQ!PW4'K4TDPC+/!<6MJI $@EE23S, <KN/'?H?>O#H
M/A)J$%B(8/']XI "C>LA     R<@ ]AT]*K7?P=UC[%^^^(=T[2.-@57R "#
M@GWQQUQ[YQ7SRO#=;^:OIZ'IU(.LO8Q^*6WK:_Z;_P!+W8W$$O']I6L;$8!
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M3:$:A,J>=CY"07&<-_/WY^;O&VE_M2_LE75CJ5]KMYXL\$7EY%$T\;23_8[
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MMZ3X@\-G4+36&_XFT.JM8:=.$Q'=)G@ICY2",<C/?Z'Y_P#VHOVB_A5^R/\
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M0PVD";;2!K<R?/=1LV[_ $@GYR">@]NG>IB22"221T)/(^A[?A25TFP4444
M%12!H'ANI&W0[L+!R1*W (8#L1ZYX]\5+0>0 >0#D \@'U /0T /+W>G//);
MQ1/I^J1-#?Z)*HDMKJW<;7C>(_(?,0LIR.YR*_'']K;]D'QC\$_'6H?MI?L;
M0&"2*(GX]? 98O/T7Q-X<8@7LUEIB VPN'M5E<ND9?)K]C"2<9)..F2>/I35
MDN;8RW)>*'3BCPWZS()8KZ"4%)+>>$_+,KHQ0!P0.<T ?SD^ O'=Y\,]:C_;
MC_8>BN[_ .%FJRBW_:*_9O:5UU#PMJ&Y?[<O[;2Q^]2.-A*ZA8U&..E?NO\
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MG\6%'U)YR17ZU_MP@']E7X@D@$_V/><X&>B]^M?DRG/QN_8#SS_Q0FF=>?\
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MB"XC$.X),5RO7!S@$GN/;CFC_AZ1^V[_ -%1N^F>DO\ A7A_\1!P_P#S[_\
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M=/\ EP_[O_3_ /JS\K?Z*OVS3QG_ $FSXQG_ $F/OT[T?;-/&?\ 2;/C&?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#^'7_@GBR_\,V?\$KFW+M>]U7RVR-LG[Y<[#T;'M7]O%H1Y.G\
M];.#'O\ NTK_ #QOV"?VK/%6G?LV?L#7&E_L_>+_ !!X8^#<VKR?:[/1[^9)
M&=U8@R)&0X!Q@D^F#Z_T?6?_  6[U65+M#^RU\0(VTY(HXLZ-JP#\!6\OY1M
M4 #"KC '< 4 ?T&9'J/S%&1ZC\Q7\_O_  ^[U/O^RY\0\]_^)1JW7_OBD;_@
MMYJ2JS']ESXAD*I)']D:KR ,X^YS2:NFNX'[_%MW0Y7MCH?\:%/X@@YQSG -
M?S6_$7_@X:T#X5Z3I^M^,_V=O&GA[2+S4K?31=:EIVIVT0DN)/+&&D*)G)SC
M^>:[5_\ @OAX,N);.32?A)J]Q97-I%<AV2Y!/G1B51D., A@,\9XHIKDAR/7
M5Z]K_P#!5S)TVYJ?,TENK;ZKS\NU]MS^A*29@XP#COQP<]STQ_3'2KH^=03P
M1U_+GC_/2OYW?^']FB<_\61U3@D<W%R.AQ_?H_X?V:)_T1'5/_ BY_\ BJRI
M4O92DT[WV[K^M--OUWG)3227*UU3NWMZ?T]//^B$2<=,_I^F*7S/;]?_ *U?
MSN_\/[-$_P"B(ZI_X$7/_P 51_P_LT3_ *(CJG_@1<__ !5:N_1V\]R7_7]*
MQ_0\TC<\<?AT_+/XTP2<CCN._P#]:OYY/^']FB?]$1U3_P "+G_XJ@_\%ZM(
M;Y8O@?JC2MQ&OGW)W.>BGYQU^M*TOYOP1E[.5U:>G:WWV^7]=OZ)00>A!QUP
M<XI:_G4M_P#@O?X<&H#3;KX):S:2M;.\DJ"[>-+O'R1%@^TY.>#EN.O-6$_X
M+SZ']H%@OP8U6>[2$S2Y-U%\HST7S.N,8P.?3K5&I_1'37^Z?P_F*_G<_P"'
M]V@_]$/UO_ONY[?\#I\?_!>WPZ9$$WP3UJ&$L/,E9[DB-.[8W\X^HII7:2W;
M2^\#Z-_X+!D?\(Q^S+R/^2Y:5W_Z905\??\ !'?Y?VE?VOU;Y6/CF_(5N&*_
M-\P'4COFO"OVB_\ @HGKW[<_C#]GWX3>"/@E>VLEG\7])UQM=GDGVQ64"%7:
M-6+8W  D 8)4'TKW7_@D);W&G_M2?MC6FH$3Z[;>/]1@EMF_=FTM1D8*]25^
M[DC(_ U\'QE3ERN#W5K]=N7;U:T*A\4?\2>S>SOLKL_H.HH/MS17Y'15FU_7
MV20HHHI %'XX]S12, RLIX#<$YQZCO\ 6FE=I=VE][''EYESRY8W7-+LNK%X
MZ@@_3)_I02!R3@>IIB($ P>,  =>>.O^./7WQ(46;*/\Q./E'4\=>#GW/X8]
M*TE",?M_A?M]_78WJ4+P<\++ZPEVT73KY)W$[9[>O;\Z21IDC9H$W2X^3/ Q
M_$<\=LU2DNR+A;6W F0#]ZX.1 !]X,1UV\GD]N^#7Y]?MG_MNZ1\"M$N?!'@
MYQXD^)>O1"RT&ST\K<RVUU<$1%I$B<NK1E@>>0<\ CC*R=KMJ/,ES;.^^GFN
MK6BZV/ QN:TL%2JRQ"5.4$^2'.E*I42OR1UOKLI+:Z;6MBK^VE^V#IOP"T*3
MPAX$DBUGXA>)]UFEO82K=W5E+<@1;FCC)="K.#C (P.F#CPK]C;]C/4-=U:V
M^/\ \<Y)M?\ %FHRMJVC6&K!Y/L1N?WJ@13@[=IV@ #\!5+]CK]CK6-:\0G]
MHC]H47&I:]K134;#2]39YTLY9MK@&"<,$".!@#N*_8JRLH;?8S;19E5&DPP*
M$C@0+A1M3Y0 ,# P!QQ4/ RYO:2J>ZG>,+723LTY;NSOO9\SWT/C<!EV)XDQ
MM/%9K)RP,9\U' --JG%6<6]WRM/1M/FDWT'VUI!]G^QO BV4(_X]T0*L2K_<
M  '!X QZ8'&*O*]NX6.R+/%!PPD&#$!@80D=.<8ZXJ3U]^OO]:0 #. !GK@8
MS]:]&E65*E*$H\[<6N:[5E;3[NFUD?I;H0PL*-'#I4J%/E4*:WM%)1C=?95[
M>6FG9:***X1U)RGUM^/Y_P!;A1110*,N6+5KWW;^73Y!11102%%%% !11103
M*3CLN;SVZ_Y;!112A0W![TF[*_;^OZ_0SC.;:3A97U?R3OZ:H2BE*[>.W;_/
MXTF3T['K^'_UZ49<SM:WX]4OU-9<RTBN;5+1^=O^&"D)(VX_O"EICGC\>/8C
M-;^SO>SV5]?E_7]:BC6WE3M'OKIM^5^GR))@3+&@&0V.>W7_ #WYJG%)]GUF
M- =J,IR>0N2!QW!Z#O\ K6DO0?0?RK)U,#,+ ?,)D.>AXP>OI2RW_9\?"JFY
M-2BTMDM8^KTW?IL%];>3?W6_S/2@X$&[K\JD>XP0.WN*0.PA4YR2Q.,<XZ#C
M&?TJO8R"6WBY! 4$]^@'';CGTJZ@_>^Q7IV&*_H'*:JQ&#IU&K-)=W=VBKKI
MK>Y3LFO2+:^2_,1')Z @X';K^F >G%#.P/?'X]>O';_"K6 .@Q28'H/R%>E-
M.47%:-WU];7^7EYLSG%R=XOE=UMTM:UOUU6I!DN,D9XY]ASZ ?7-5+L.MN[0
MIOFQ^Z'7Y\C'7I]:T\ =!BF.<#\?\?\ .:S]E%TI4I6:GN[)6;:U3WTLBE*<
M8VYW?37MM^'X=SE-0ABOK)++4;=-MR#%?P% R31.I5U88P0>A!SGD>F?PF_X
M*$?\$\H"=0^+WPBLC;I-'+)XDT6S@.V2W(+331PH/F8C<>!GH.,<_OQ*@9@Q
M //)(R>.WOD\^W-5K^UM[RRFM+N&*>"XC>)X98UDC='4AE9&!5@5)X(_49KZ
M'A3B?,^%LPIU,-C)5,-*4(U,/?DA4@N56E9ZR2^&;3:6FS:/G.*>%\LS[+Y\
MV'IQQ2@Y0KI7DG9.R22LF[O2W>Y_!3\/O'7B_P" OC23QGX#NK[39M$U#_B:
M:6?-AF/DRCS ;8;6*D!NJD?T_K%_80_;>\/?M,^#[>&ZO+2U\5Z99Q?VC!<3
MQQSRE5^;$;L'+\=,9.>]?"G_  4)_P""=::DNI?&3X+V8L[ZR\Z^\3:1!$!%
M>0(=T^RW1%4L0#G"D=.>>?PE\'?$/Q;\&?'5G\1/!-W?^'(M$OE@\2Z0CRP,
MS0.HF?[,K+O1MK+R"N& ]J_H?&T>'O$+(*N)DZ6#S"G",H5$O:5*=5634XWC
M)<RW@]))IVT1^!X"MG/!.=4XIU<5@_:6E2ORP<-$E?5:=&EIWT:/[Y3+'-$"
MKKR W!R![$]O3-&V4HGEN!@\G'&/8]^V#7Y0_LV?\%(/@[XN^"]_\0/BOXGT
M?P3:^'-+$^H#4]0MX=2U%(8R6>TL994FN)9"IVQQ?,S$**^!_$G[;W[=/_!1
M_P 5WOP^_8"\)ZI\)O@1I&HO8ZO^T;XBM+FPO]4@+"%H=/TZY*[X0A=DEA7;
M+MW9;-?S1FV#GE&)GA:C=2<)N,91LU-+:2=^JN^ZVM?0_H_(\<\XP<<7R1H)
MI-QE)MI63;V\U;7O\_Z&?$?Q-^&7A%F'BOX@^$-#FC!+0:KXCTJRG4CJ#;S7
M2S @CIL!R?>O*)OVO?V<H;I;(_%3P2\A?:I3Q)II4GGH1<'/X=*_*SX>?\$1
MO#.HB34OVK_C-XW_ &A/$^HL9;O6!K&HZ%%8SN TGDVT<@#Q!RVTD X'*C(K
MV*R_X(I_L+VVZS/A?Q/(T7S6NI'Q=?M-"YZJR^:3QS@G ]^IKSX5.;ENN6]N
MJ=MK^JU_3<[7-JHH)775Z??;>UOENK['Z<^'?C)\(?%DT4'ASXE^"-4O)<!+
M&S\4:/->,6Z*MH+SSV;H,"-CG ZUZ>FX99W4H0"K9&,'H<Y[@]>GZ5^&/CO_
M ((@_!$H^J? +QEXU^"_Q#LMLVG>.X/$NHZJHN%.Z-FTQIO+90P!8$#A>Y(%
M?.;?'C_@HU_P2^UZW7]J&/4_VK_V8M3N%L=5^+>EVMPVM?#RP@8+'??V7 3)
M<B2/<[K(I4##$9 (Z.2#2M47-:[5GUZ7_J_D6W97MI_PVW??R/Z7MRY(W+D#
M)&1D#U(SP/K65J]S!;0B2\9([$!FN9F8*(T4$DY(/;DX/3\*^</V;_VHO@S^
MU9\.-*^*WPA\3VVJ:%J2NEU975Q%;ZU:QVX!*WNF;_M%M(!\V'1<G(^\.?*O
MVC/V@=/L]-U?P]H=QO,%LT<DH<)(7V%67:"",$$9XR>]=F6Y7B<RQU+")O#T
MYR3EB&F^1*TM5;JOOON>1FV<4<KP5;%.DL3.$/=P_-9U'/W59V>SOTW5G;<^
M9/V[/VMSX<TB[\$^ +[:LT3P7&H6\F'5BI1ERIW8Y(SD'M7\[>IV_BKQ[KD]
MO*+R\N+^Z/GW<223R2B9QNWE03QG/)_QK[%\6Z-XJ^)?BZXMHH+J:"XNR"QW
MR AY.2#SC@D^GXFOT?\ V:_V6/#?@&"+7?$EK#/<:BD;Q)<Q))L8!2<"13MY
M Z?EUS^V1XHR/@O(Y8.EA*5;&QIROC'*,9SJ-:SDFG>3;OJ[_=<_#:O#N:<7
MYO'&5\?4PN$<U+ZGR.<;77NWV26EFK>2/+_V0?AO\+?@EX9A\0WNF3S>+)XA
M([36C%PY4$XW#(.['3%?=FE_$KPQXLN_*2WNQ=3MM=6BDC2(8.S&0 /3ZYKI
M;S0?#,U_'%::?;"*,!<+;QA1MSV"],$?RJ1=$T2QG>2)8;24XVF.",;B.!@@
M C!^GX"OXSXVXTS3.<XJ2DYU*$IRT4VU%7TV=NRZ+]?Z;X8R'!97E,<+0HP]
MJHP3JV2;:LV[>?6_DO2Z(+I9!!"L@M'&02QX!SU/ X';M^%30K*JW$-BRIY6
M!<F3#[LD9*[LX_#J :-U^PP+@R6ZCJJ?-@<=0.G?\:8UY8* D:3B3CS2(V^8
M\\G .<>_I7R]+%SF_>@M>N^O7;?^KVZ_1P=/#I<TK7\F_+?IJ]_^"9FLZUIF
MBV)GU"Y)9<DI%"'(X&<!>>OY5YZ_QB\'F'RU:Z+128<M:.-N,=,CH.3Z5Z/-
M;:7=C]]#(^>2LD)88XS]Y2.23GIUK-ET#PRN(FTZ*5IV6,,+51M+$#^[UYZ\
M=.N*Z50]M9.7(DF[V?6W33LMPHXJA&LI4YJK4Y9)4TOBV_*WFCF;?XQ>#A<P
M3NMRPBC)4_8VP=H!(4X()Z<<^G/2OS#_ &EOB:_[1?QR\(_"CP]K%W9>&;=U
MN?$MK' ^R46[$E;A0-JY48P_7T[5^LLOAO17L=5AM[&%&\/Z?/>;OLJ9/EQM
M(024R>G?L:_,G]BC2])\:?M"_''Q7J6FQW4EKJTUO:9@7$"QRR(5CXP@//0X
M]>3SX.,Q#H5.3EYK.U]M^77\^^VY^?Y[.G7QBC6M%*5G&^][>>Z:?1_AK]V>
M#O'OPN\*^'-&\(>%)'T>V\)6T4.K36^E[6NI(U7S&W(H,A9EYZ]22:UY?B]X
M!N;J34(-5U*6:=O]&C^R2H#L^5MZ[0.3D_,/TKMK'P]X:BAOKL:5:P[[C:VZ
MVC!;+'(?Y?FST ;/'M4K>%_#:-YJV-FPF^8;;:$!.O  7"\Y)QUKIPD%)1K2
MLU:W(^MTNMM;?CU1]5EU/*L'EZQ*RRG7J^[%2NE9RLKM6=M&NO?8\]G^+G@.
M9Q_:MK?-+G]W)'!(#GG:3@=>!TS]!@&J]_\ $+X6^)M/U#PKXOTZYU+PWJUA
M/$AN+5IGM[B12L;+O#%<''S#'3WKTS_A'O#V?FTZU8]MT$9]N,J?\\5!)X>\
M/H7F:RM0# \0#01XRPPI *\''?J,9K2I-/:"2_/_ "]/NVUY\WR3!5<-]>]C
M&DK<W):]G9:7M;IIUZWW/R"^!_Q#'[,/[1/B+PI+?:@?!/BR>=M"AN1*L,<,
M[RF,0AB%P%91\N,<?C]T?"SX@Z!HE_X\EO[J^M1JNM?;+7-G(ZS1R98,C$<C
MYN,$@_6OG3]OGP[HNB>(?@AXBM-.B,PUK3M/E\F)5D;SY4!WE5#$?-C!/Z5^
MB6CZ-H5]HVE>9HUO"T5A:;F^RQEI2UO'\S-M))^;J<_UHP-2,<2I-W7*TXV=
MMUY/UV/GLCQ5&>-6&A24))2]]-M<J2V[;+=[MZ'(_P#"WO"/_04O<?\ 8/;_
M  J:+XQ^#D4QO+?73,21(+21-HYP,8&3V!_PY[C_ (1CP]_T#8/_  %3_P"(
MI?\ A&?#XZ:; /\ MU3_ .(KLQ*51N2BDNR22ULM;*^_7H?<1@EJ]_Z_K]#B
M1\6_!X(9_M[*.WD2]#^'./Y5(/C%X'N&CMC#J$%N'5QJ$5O+YR2@XV_*-VP]
M.H'U&*[/_A&M _Z!\/\ X#+_ /$4B>$](NC=16:6VG36%LU].\MK'LF@3!:*
M+<N'F(X"@9[UCA_:0J1Y&U):IK2]O-=-;.US2;BXN+22NO/\UWZ]M#PGXY_M
M)_"CP9\)OB!X[\2:=?WC?#SPY>Z[I3V]E)-<W=[;1,8@R(NYV+[<@\XZFOY,
M8?B1\5OB#\<O#'_!0/\ :F\(W/Q0_9)GU"/2_"/@FTWZA;>"M3\\QV_B36M-
M020P&W^1GCN$&W;R.,U_95K?AOX;0^"]?UCQGI6E7GP_FTNY/C2[U>&WAMM-
MTCRG%Q<L)U\MI$&2L3=>X-?Q]>.OVGO#W[+WQR\=ZK\+]%D\=?\ !-/QUK=W
MX5\?:/J%F;TP:G>3-#<ZGX?LI@T2+&\C-$UJF!M!7I7Z1D.<5(*-*I%O1)MO
M6VG=K;JNBTZ:^'C8:;V7HM//;?5?<]D?TP>!_B!X3\?^#?#?C_X9ZS9:AX!U
MZSMGL5TMH[FSTI70 0M;PEHK4Q?=-OA=N,8R*ZIU1&?;=?; S;_.V[1@]@O\
M(YZ=!BOY]O!OC77?V _$'AWXP?!#6[SXF_\ !.[XR2P:GJ,$3R:K>_"F74F1
MI)[R!2WV V;S.&MY0@0*>!BOW9\%>._#?Q/\$:-XX^'5]9^)/"NOK%=Z?JUC
M/'</-ILRAEEN8XBPMY0?O1MR,=*^YJ4Z;PRQ-.7/.\%R6UM*R;^6M_GML_!C
M%JLWY;]+/EOT\NO^1UA( W$@+TW$X&?3)XIV",9!Y&1[CU'J*LK;6DUQ%:&=
M9]/"!YF!&Z*8<E6.3C#$\'G'7GK4\Z2624,,1PR-#;\=85Z'/0\CKW]:X54G
M=<U.R]=>EM.EKZ_>=(M%%%;)II/J^GY]>X!1113 *9)(;,+=2P_V@A.R+3LX
M5V)QO;MA.'&>N.>:?1_3I[4 "3ZAIT<[1722V6JIY=]J<L8DCTZW<8>P-FV5
MD5US 21T).,&OQZ_:P_93\:? KQWK/[9?[%FE"UO[N!4^._P2C3SM&\7>'R?
M].U2VTQ1]G^T75J))&5(RX9^>M?L+_"5/*'JAY1O]Y>A_$>M2VK&.Y$C[+:/
MRWA7S4$EMJD4@V26]Q&V4DC"D@*X*X.,4 ?SB> -5N/">I)^V7^PD]S<>'+N
M82_M%_L[32-'?^';Q'637+NST/(D"HRRL"D(! '.*_<[X!_M)> /VE/!.F>.
M_ %S'-!=JMOJ^BL0NJZ+JT*@7UM>6',UND$H909$ XS7YU?M9_LB_$3X$>-]
M8_;-_8VM-WBG3V-WX]^#]L"-$^(^DS-NUB-=*B"VQDBLUE(/EDL3[X'P!XO_
M &D? G[/3^&OVUOV8_$%SI&K_$?6].T'XR_LTB,K=Z9XCO+N.#6WM-$&V2WC
MANGD E2,9 [F@#^H"Y*JZF,@9.,#')[CGH<\'Z\TC@AB&!!P#@\'D"N8\&^(
MD\9>"_"^NOICZ;<ZQX;TGQ*Z2961)]7M4NFMRI.=T#N593R-I!Z5T,?G[1]I
MG6YEX_?+TV8X7CC(Z'W% #Z*** "C^)5/#O_ *M/XI/78.K8[XHX[\CO].]!
MAN+B>U@W;=5)WZ#<X_<P1*?WT=PV-JA^A9_N@@YXH <J,[B,85F('SG:%R<9
M8GH >I/ [U^7_P"V3^V?XGM=6G_9=_9#L(_%G[1'B.-K#6M9MB)]*\&:7<CR
MKW4KS48]T5D]FFZ4>8Z'*]L9J+]MW]M75=%UZT_9=_9@T]?B%^T=X\0Z=KDV
MF2>?I7PSL9PUO>:MJ%_;$QVKVHS.!,5(*U^=N@^%?%NDZM)^R1^R5K+^-/CU
MXOD5_P!JW]IHJ;Q?##:D=]]HNEZLN3;^1ODM\Q2#:5YH I>$_"FJ^&M8O/V8
M/V6]<G\<_M1^/F<_M)?M$,&U.#PK_:!/]J:/INJ?.L31EI808I05(& #S7[K
M_LE?LN_#[]D[X<P^#/!]BD^J:K$US\4_%MW^_P!;\6Z]<8FFNOM[_P"DJB3M
M(0N\@ X''6']E_\ 98^%O[*'@"W\&>$+<?\ "47:+=^,/'5ZHN]3\:ZW/B6Y
ME&HR@W&P7.XA0^ &Q[5])%IR#]IC\F5N9(NV/X6/KN'.: '1LDD$EIX@3S-.
MA+'PS*F?.MB?NB=Q\TGS<DL>/<U$@N H%RXDF!.YP,;ESA./4*!GUIQ^8 -R
M!T!Y ^@/3\** "OB'_@I$AC_ &/O%!1F"OK</F./N(=J##-T7Z$__6^WJ^)O
M^"D<XD_9"\1Z>RFWLKC5XOM("D^?(549\S)\OH?IP,T ? 6E?98?VB_V  ZL
MS3?"5@LP&49B1@*_1B2<  G&:_>F_A9M=N+!( ER\$<T1D.T)B%6\^0$?(J]
M2QP.,&OP5M8;@?M,?\$^-,\Z&VTJS^$#WD4S$&&&2(J5\Z?&%4<'YB,XKW_]
MM;]LSQ]\3O'-W^QC^QG:MXC^.7C"2&T\7_&"PS)I/PVT":-8;U#=V[&%;FW0
M2,J,P?(&!Z@&7^UQ^V'X\^('BJY_8]_9+NVU+XF^(9&TCQMXLTB/[9;^'+6<
MF.Y\R^M]PM9(@).&8$$=,BOKO]CK]D'P)^QMX"?PEX>G7Q!\9_&2#5_B)XVO
M0+J_GU.Y_?W(AU&4&9(PTCKY0? [BI?V1?V0?A]^QKX&&DV,@U_XR^*XED^(
M'Q/U%5OM0\4Z[>8EN+FVEG4RVL0EDE3]VP4 #%?526LMGB"X(>[B!$MP#ND=
MFYSYOWB#UZGGZ4 #LV/LFA$6:6X(\37#KN.HG/[X(#_&W.''(X([4+]GVK]C
M5TM<?N5<EG"]]Q)R23SSSCC)IPXSCC=]['&[_>Q][\<]!Z4  < 8'H* "BBB
M@ HHHH **** %') ]>/SXK\+O^"T'[1WC3X1Z!X%^%5CX@;X8?#SXQ:D/#7B
M_P"(4<9GC@M;DB$QFU&%W.9/+W[<KG=U%?NA_GZGL/Q/%?$'[=O[%_@_]N+X
M$>,OAYXDL/-^(VBZ9<:KX"A8;9+&\MTDN1>Q_*68LJ#;M P<$<T ?S__ /!*
M_P"(OQF_8?\ VL;+]G;Q/X@.I?LK_&$)?Z'XNO;XWND:S=:@JLEZNI2L;;3)
MKAI2QMU=60\8R*_KKOX+>WNK@6)WZ9YC'3YE;S(I;//[F6.;[LL;+RKJ2I'0
MU_$I\)_"OCKP3\-+KP9XXL]1\>_"?PGXEN_!_B2YC:=M?^#FK:3*T2^*S= F
MZCLI+E58*S)&%7@5^XG[!_[=4FARVGP3_:'\50ZE:6\$-O\ ";QE-*GV7QCH
MS 1Z7I<]X[&,721LH?YC)N&#0!^S61M#_P !X#_PD^@;H32U$R W5OI]Y_HE
MG>PKJ'A](B9+>_:?Y_LYN1E=J C!SCI^,S(T;-&ZA'1BK(#D*1_"#W Z9[T
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M8?R5>GV7_=\O/\O,/^)F/!O_ **B'3I+^[Y^3_#MI^$>;CU_\<'^-&;CU_\
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MQ"^/?Q"UKQ!\/-*TNPO;'X;VMU<V6EF^B:*0"XBC(@G7S%P\<BLN"001G/\
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M][',"\]UH]M$.5 OXE8C''1O4CC^51"[AED=8;[3-L75UO8VP.3Q\W;MZY_
M0W3AJK)KMMTO^'YZ@HT:[M7FH1ZW=NWIZ=M>YXP^L_&=D('A^V7/8N !ST_'
MW)J&+4_C3-F0:):XMR)&PX)!09YYXR0?H<>E>U+?6"\3ZU:GL4\]-OT)R./?
MIV/-2QW6F(XNHM9L88HCB6T2[1WO,]@ V?PQCTIQQL;M75U=7_"R2U[:]/N.
MK"X'*\/65>.(IRJ*-E!23;<M-%=WU[7\]CQ>+7_BN9+U9-*MS_;]K)92K&X8
MH)$,1WJ.5 !R<U^;/P,\1>/O@E^U%XU\$2V5O:0>*;N6[625E1)S+([GRV.
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MRM]S>Y_.1\=?V>O&W[ =UKGBS1/!]Q\2OV/_ (R3RZ?\3_@Z\,FJ6O@JTO\
M]W<^(-+216CM?L_F-*L4**%V<=*^<O"'B_Q)_P $[-3T/XU?!GQ-J/Q;_88^
M)=]"1I]DTNKS_#O4+YU\S1;^WC+KIL=BTC(ZR! @0Y'%?U7:S_PC%YIFL>"?
MB"MG>>'M9LIK*9;Z&*YB$<R-&Q59E90<-UQQ^%?SN?M#_!*]_P""=WBGQ#XT
M\!VP^+7["GQ-NIQ\2OAG.O\ :_\ PCNIZ@Y6[US3[>0.MDL1E:1?)1 H7(QB
MOJ\CSN]:,*\[T[?:T5TE9;_AMH[]6>=7P_LXN;[KYWMO9^;?W>9^K?A#QEX,
M^*G@SP[X^^%^K6>IZ-XOM8+^X:SN8[A-.>=07@N&C++#(F6#1L00<BNM<;"(
M<<P*$=L8#%?O.#W'3YN]?SY^ O'FL?\ !/?Q)I/QX^%=W??%O_@GM\:+R.?4
M[>TEEU+4/A5J&I.H>":V1F^Q16+RN&#*@54Y':OWC\$>-?"WQ0\&Z+X]^&VO
MV?C'PCXEBBOK'4+*:.XEL-/N%#I:W2PDB*:,<.K$,-IS7W$94<1#FIM)V3>W
M9:_\-\SC.F'(W#E>FX<C/IGI2D$=01D9&>X]?I5BVBMX;XV\4ZW.FLF^4[@3
M%* "5.,XP>"#CI5"*6>5YS,,!)GC@&.L(^Z?R [5YZNJ[3OLGI>VK5UK^/SW
M FHHHKI **** "I;>7S&EAO(Q/8JIVOG:UD<#YUZ;L?C_*HJ9)<):(1-EUOF
MCMT51]TRN(\G'IN[_K0!Y[\7?BKX8^"_PS\1?$/Q/JL5AX6\-V5X\_B*ZV&*
MRFFAD%M9+%)B.Y-_)M@*')^?&*_%K]A/]B_0OCS\8OB+^W-\9/ BZ#8^,M1D
M'PJ^',J[-#U.&";S8?$LFF,IM(6OT N@X3)+ @FO5/V[+K7?VB/VJ?@U^P'H
M4DD_PS?4;3Q)\:Y[1V"VVGQS1WEBMW)&?E0DJI$@(/2OV-T[0=(\):1HO@[0
M(XHM%\'Z9:>'-*6!%CC^R:5$+6&150!=SQHI9P 6/7F@!!8LD,$MILMX=)B2
M"+3HPJ1B'!7[.@&!LA4;4 X Q@8XJV4CB52BF.)PK_.3M#L,MACVR3@9HR>>
M3SU]_K3&'5KV3S;3(,=LO4'@\D#//(^A^F !P!9=RC*CDL.5 '4Y''%* 3MP
M"=^=@ SOQUV_WOPIJ3W[9CM[**WT[&&DE;:Q3GNW.2O/I_5\EO<7+QQ:5*LE
MPO\ QY^6?,C@#<R&5ER @R2S'A0,GC@@"PQM/(8XAO9#B7;EO)&?O38SY:CJ
M2W0=:_,#]LK]LO6[?6F_90_9HA3Q+\=?%P-G>Z_IKBZL/!%E./)N;S4;^ D:
M>;9293YK+C9S4/[:'[;OB'0=9_X98_8]TA/B#^TEXP3^S?'5]8G[5HW@33KG
M=!=ZO=:A 2EH^GQEK@AV7&S':OSF\)>"M;\)ZK>_LG_LR^('\>?M'?%"8/\
MM&?M,N?[03PH^I$C4-$TG5,M]G-JSRV^8901LR>@P 0^$?"/B#1?%5_^R?\
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M9_;;N/A4FG_##X V2_$+]HWQ^RZ!%INC$7]IX"BO@8?[5U.2W)^QFS8EW,V
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MHL4R&.9"2X/+98YW%CR2V>_(Q0!:A<W,<EQK.%,:E;(@!GTULG;9*>2X8_\
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MK:R_\*#^"(+2>)-;FN QT2_M]+D+740^:*3=#&-I.016KXO\2-\:[N#]N/\
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MK_3M5ND48 & , =.F>_%+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M^73Y!11102%%%% +== HHHH%-\JNK2[=KV?J%(2!]XA1G&6( R>@R>Y[4O\
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MO$M"V8D5&W%O./+L.RDG%7))Y;ES/-S*X&_'3*C&/PQ3.^<G/KGGZ9ZX]J*
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M?:?&V+))=6N#L9F4QKAI,^V>O[*@,6'ELZ2E@5DB&Z92#U7'S,<X[_SKQ/\
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MO\QK[;XB_P"AF\1=<?\ (=U#KZ?Z[K1]M\1?]#-XBZX_Y#NH=?3_ %W6LO\
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M-/\ ^1/].7_AI+]G_P#Z*SX'_P#"AT__ ./T?\-)?L__ /16? __ (4.G_\
MQ^O\QK[;XB_Z&;Q%UQ_R'=0Z^G^NZT?;?$7_ $,WB+KC_D.ZAU]/]=UH_P"(
MKS_Z%4/_  ;+R_S?W>8?\2#8'_HN\3_X0T__ )$_TY?^&DOV?_\ HK/@?_PH
M=/\ _C]'_#27[/\ _P!%9\#_ /A0Z?\ _'Z_S&OMOB+_ *&;Q%UQ_P AW4.O
MI_KNM+]L\1?]#-XB]/\ D.ZAU]/]=1_Q%>?_ $*H?^#9>7^;^[S#_B0; _\
M1=XG_P (:?\ \B?Z<G_#27[/_P#T5GP/_P"%#I__ ,?H_P"&DOV?_P#HK/@?
M_P *'3__ (_7^8U]M\1?]#-XBYZ?\3W4.?\ R-1]M\1?]#-XBYZ?\3W4.?\
MR-1_Q%>?_0JA_P"#9>7^;^[S#_B0; _]%WB?_"&G_P#(G^G+_P -)?L__P#1
M6? __A0Z?_\ 'Z/^&DOV?_\ HK/@?_PH=/\ _C]?YC7VWQ%_T,WB+GI_Q/=0
MY_\ (U'VWQ%_T,WB+GI_Q/=0Y_\ (U'_ !%>?_0JA_X-EY?YO[O,/^)!L#_T
M7>)_\(:?_P B?Z<O_#27[/\ _P!%9\#_ /A0Z?\ _'Z/^&DOV?\ _HK/@?\
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M$*^"IU)NT*T$IR7:7*FWZ*[TWO;?4HV5D(K:16<]QO[,#GD'IZ?C2(9[9 (
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M]4>0.\BM*S[\>6QV@Y[@9'0=L?H3)&#DXSGCU//]/_U=#4'V?+9QT'IC]/\
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M[:*_<_JZ"S;,^"L@P7"U3+X5?JU>I7A&6&55IP4Y:-<SM9Z=MV>X_P#!0_\
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MWQ4;B0QOY*"2;'[J-ONNYZ*?8_44_"6]WI[O=3A+F,6UYI%JGFR3WL@(6'8
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M_46OVETZ>GEYK[W\G_Q.IX/?]!./Z?\ ,#7\ORT^Y]C^,C[7IW_/[%TQ]_\
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M%_J+7[2^[_@>M_GVT/\ B=3P>_Z"<?T_Y@:_E^6GW/L?QD?:]._Y_8NF/O\
M^>??K1]KT[_G]BZ8^_\ YY]^M?V;_P#$.Y^S=_T-^K],_P"K;_XCK_GUP?\
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MH7MS*UUT\P"GICYLG^$X_(GO[@"F4AZ'Z&NI5VL+]6Y=.6W,GUTUM\GU_P"
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MV_7/Y8HNHM.24DGJGMVZI_D3*_*[-IZ6:WW1D7ME;:K9R07< ?<K*-ZC@D$
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M7B.&&*_9B\O&N))+O4X;32?#5E;E--6-8[>/3+2W5CLOXT");00QJ0K,JC:
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M>YKPQ),IE1L.W)& <'H1^>?Q].,3>0W]X_DO^?Y_2H[=0+E?+.8]I)P<C=D
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M^9UT<6Z<E:3MHDKVMLO/NO+Y-7_**#XI^.+C*#X=QRLF0VV)B<KUSQR>,_\
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MQ=^&]S::W9P01K)HQD5M4T'4F"_;;?4[<$/ T-R711(HX4BOS@_:Y_9(\9_
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M#]I3]E[PC^U#\)=0\*>-]/\ .U>:%[?PUK\$2?;O">H1J7M]6M)HQYBW/F!
MPW@ 4 > _L:_ME>&_P!I/2D^'OC22S\(?&OP);))XB\&B18KS7;)$*?VO80D
M*]PEP/G5E+ AOQKX]_:*U;5_V-OVW+#X[:C=WNB_"/XHV%EX;\1>((4(MM,2
M26*,KJ4Y^6$#.T[L?GT_.'QY\.OC-^SQ\2?#OA;Q-+9?#W]H'X>:DLWP\^--
M[.UC8?%7PO:N#9>&=<NPRP3S2PJL;1NS.7.#R:_:_P#9[_:(^$?[>_PE\0?
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MDN'4/;V]]'?V<PP4E1462&1&!((*%6!''>OP%^$?BEOB'\/[C]GG]J$WEEX
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M*** "BBB@ IX1VSA6..O'3ZTPEQS&-TG\*CDD^P[]:E\J\O5"VTGDR+@SJ,
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M2&)E1K7K3C"',XQ;DG>,VK12:3TTT5[O^BZ&*V,31.5+Q E8F?"F09VY.?4
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M?XD76I/*?%5FBM?P@3N3#(X3*ELGC)Y/3U_I6_9;U>[UCX"?#74=1D>6YO\
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MK;1[=VNK[355Y5VQLA*;% XXQ6]*L\;!4IW@G:6][.Z6]_NU0TKNVWG\K_\
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M=]G_ -"?KW_@*_\ \10_QRABCW1>!M<DR3F4VCY3&.^T>G?^M$I.7EZ=^_\
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M1_LQS[K&+Q9'8L%UGQ+HVC9B6YN;A8YY%9(GR3WS7[H_LH_M1?#C]K'X8/\
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M2LD_P.(^P7FHQRVVI1+;V^]O(%N!G&3C>.1@#G\JEMK*33HQIUI 'A)R\L@
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M!'P+^SC\,]/^&WP@TV.+3;>&*VUS4EC7SM4NHQLN;Z:8CS)))R6=F,AR3DT
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M23M;[ON_S/.?'?QK^&WPTFMK7QAXHTS1;B\0RVD5]*$>XB7.YXP3RHP>1_\
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M;);K7=-\:O#\SM<)X<\30K.0P@\EL1 9&T#9P.X'&:];%AI?_/K;$#CB-?\
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MXY\*_%OP9X=\=?#76[/Q+X+U2!;Y[RUF66>*.9/.^SW #%EEMU8(X8##9[T
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M$*.,<XSQ7\V5SX[U/XL^(KW]MK]C+1+CX7_&OPIJ#:A^T+^SCK*&Q.H^%XY
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MI7Q;^R-^R#I'[,6B>*-,BOSJ/B/Q7K^H:W>WY.^-X+V42);R.26.P'[N<#T
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M *_=5_\ 1JU_;O:?ZG3_ /KSM_\ T6E &E2'@$^@-+2'D$>H- $.3ZG\Z:2
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MIP,@$X&>GKSV&,U;AACC+*F\^K-T.3GW!_7\QFK&UL$,#]0/_K ?Y--PW(&
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M>%/&%E'JL=U:3)+#"TD?G>1(Z.P5E+;"&((/4 UTD6V:>:U@(DGM1B>->L8
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M^);=7=@HE-N+9)HRV^(%?+]J_;C_ ()M?\$VM4\-^+;O]LG]L2ZF^(7[1?Q
MC_MGPOX1UO9?:=\-M&N"6M[73+*<-':75M$T84B-/+VY R * -O_ ()I?\$T
MKWPCJ<?[7?[6"GQI^T%XYCCUG2-&UY1<VWP]M[H,\&GV$$F4MIK9"@1!&NS
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MZM[*ZD$UK#!,^\J$1@,*1W%?K,ENC;G<F9IB2_ PI;KL' &">..W7.:_(_\
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M_P"Q@7_TH>OZ0/V4O^3>/AC_ -B[:_R%?NWB7_R1O#?_ &$2_P#45'Y1P/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD7CWP/-,UO%XMT%YU7<8QJ5KD*!DGF0 ]1T/X5_()_P6*_8O\1_L5_L\:/\
M$GX:_&WXM:WJ6J^/_#6B?\(]9>(+L7U^+Z[BB\J(+(2?,W[1Z\X[&O)+3P3\
M?AX:TV6?]G_]K6/41I6BW)UN+6+Q;>_6ZLH)BZ$=5DW9Y'>JYI=_P7^7D9JG
MO=W[;^7GY;?BFS^UD?$#P.O'_"6:#QD'_B96O4'G_EIZT'X@>!R,?\)9H/\
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MP/W1_P""O?C/PC=^'OV7+:T\1:7=7-Y\=M(CM(+6ZAN'F9HH0H B=B,D$9(
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ML8?L\?%J6YU/QE\.M/MM4OE9YM9BLXDN1,Y),JRJ%<$,2>2>O7.!7P!\5?\
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M_;+R==L:GYV5B,GCKU_(UV_AY96\,>'9Y\FXNM/268'[RN0I(;'0@5\_^+=
M^,7C"SM;&?5]+5;1P4RF>5(QC(Z8 ';I716FD_&O3K&RLH]8T5TMX!&"\88@
M#  Z=L<?_7KJE##*DYQJMR322]W=VW6FB_/Y(V5].;9WU2O9Z66_:_\ 6_N6
M#Z'\C2A&/13_ "_G7B7V;XW_ /04T+_OT*@>V^-I<*^I:25/\4<? ]?QZ\]O
MQ J(1INUY;[+1=5YO?7\PDVE=+U]#W5D9?O #ZD?XTB(TC;4PS 9(#+T_.O$
M6T#XIW(!NO$>G0;NH Q@]#QT_,>_%0?\(9\3I<1V?B&"X>5RIN('VH.VWGOS
MQ_\ 7Q2K*G3IJ49-RNE9K1JRU6M]]O\ +;/VCZI>6_\ 7]?(]W,3@$D  '!)
M=, _]]5#+I5EJCPV>J6%I=P0D7").J.[D#(&2<$'CC/)_3Q*^^'WQ!M4AL)/
M$KR7<V&*I*203].F>_XUYG\:O%R?LX?#GQ1\2_C5X\M/#7A3P]HTUYH%[<WL
M<$^JZU#$[)IZ R*[AW55" 'K@#I1A*4\3)1LXW=G;32Z6[V>IE.O*/;1K;=K
M2^_5?TCUKXW_ !8^#7[/?P_\2?%7XM7'A[P5X?T"PN9=*.KF")=3N[>)VCMH
M(RZN[2.B(,*?O#UK_/L_;8_;E_:'_P""O'[38^$OP#\*:C<>'CK*Z!X4\'Z5
M!<&QMXQ<QQ#Q1JD<:&%K":$F5"23SSBO./\ @H=_P4J^-/\ P4-^)6E?#W4-
M9NM+\*CQ0NB>!O"D<\BVFI(]W'!#JM]""(Y8)8V##=GGZU_<S_P1&_X(Z_";
M]BKX,^"?BOXDTRRUOXV>,-*L?$=YK[10O-8V]_ L\=A#*0S"!%=-D8(PN,^_
MZ'D614\-46*;G*3BE:3TZ7LMGS;.ZTMH^IYN+Q4ZE/DT2ONGJ[6T_7T+O_!%
MW_@B7\.O^">_P[T[X@?$*QTWQE^T/XKTJUO-=U2_MH[F+0);B%'DL+!I%;RO
M)+;0$ V8(R&''] <<,J%I%Y9N"K'(4CD!,=%!SC/&.W:I#YK;Y"NT]!QT4-[
M9[=:LPA0@VL7]6)R<GK7V<9<L>51C;;;IV_R;U1YJE;=)^NNG8J&.6166901
MUZ?UZ?YYJY$NR-5YX'<YQ_\ 6J2BHM[SEU?3ITZ?(')M6LM.P5$\T4;(LCJK
M2'" ]6/H*EJC*()IMLH :$!D8\8)X)%,DN,ZH,L0!51U6-Y+A_+*D*(R02=Q
MZ8^I/I^![5V9K:%C,3*\CX12<DKG(XZCGG\\]:^.OVW_ -L'X>_L3?!CQ!\5
MO%LS:AXCOH4TWP1X,A?S=2\1>([G]SI]O8V2H\LD<=T\1N&120ORCDDJ >D_
MM!?M,_!3]E_PE<>-?C/XTTWP[91QEX+.ZN$-Y=M@[([:T!:5RV, [3R<!37X
MS^)_^"I7[7_[2E[J>A?L&_LXZL-'25;?0_BQXXTEYO!^LK,VPW%HLUL%Q"K+
M)NP,!21WKG_V7?V!/C+^VWXCTS]JC_@HK?7$USJ5XFN> ?@^KD:!;^'[D1W^
MD1:II3E$+BSDA$@:/)W$8SQ7]"G@OPAX0\!>'[;0/ WA[3?"WA[38!;V6@Z-
M:166GVRQ?*IBMHE50VT %LDL!EB6R2 ?SOZ[^PC_ ,%4OB5X<\4^/?CM^U;I
M/AO5D\+:WK,>A?#^ZNM/MK"\M],N+V*W81HL0,;IL;#?(1@X(Q7T3_P11\5>
M-_C'^Q7K'A'X_P"L3_$G4;3Q/XM\.:QJOB.0:C%J>G6=W)8D3O<;@R^6 <D\
M8#!AC-?L;X[:6[^&GCP,O[Z7P;XKC4=#EM$OE4?F0..,U_&S^QE^V;X_LO@/
MXB_8B_9CL;G6?CS\1/B?XULM9\368=[7X=:;<ZS/!<RZDZ!A!))$VZ-B5YQS
M0!Z-XV^%&E? K_@HQHW[,G[-Z1?';]G3]H6/6U^.7@"R3^T]-^&%W.\J%DC3
MSK:SD5B3&0Z8P,5YAXW\$?&#_@CQ\=+B?2X]=\4_LG>/=8\R33'\ZYA^'\.H
M7!>XCO(T5Q#%&C[5 *A54U_2-^PQ^POX4_8S\#SZIJ&/&?QL\;>7J7COQA>!
M;G5;G4[E=]S'974@:1+>*X9MVT@%< < [OH?X]_L]^!_COX(UKPUX^T.SUJP
MUG3[BWU2"XMTEB"SQ&-9%5@<30JV0>#D4 ?F-X"\:^ _BGX:TSQK\/\ 6;*[
M\%:W91WR:C:R(\ NY8Q*]L55BR.LC[=K!2,<CM73Q;C&[E2$C)4L>FT'"L?]
MX<CVK\.O%?A?XT?\$=_CA=W<=CJWQ*_8U\>ZNXN-)C6:\E\$K=7!+7$:(LGV
M>WM4(9ON@*OK7[.^"/'/A7XL>$_#GQ!^'FN66O?#W6+6.[^TV4L;S1^;&LLM
MM<*KM(KVN_RF#@$%,$<T =801&LQ'[IL!7[$G_\ 6/SI!\S;1RWH.OK_ "I;
M:\;[3<BT3S]"F4QQ.XSY4A&W(SG&#C]*6TL+]BT&G7-O+/%DR^81N /0<GL"
M!CT_4 0@@X(P?3N?IZT $G Z^G>HYI/+E%O/<1B_! P!\F[I], ^XQCOCE4*
MP2,;V*61SU,0(4DC@C Q@\8')YH 61A$,R':.O/_ -;-1O-%&BR2.$1^58@X
M/T_^OBIF)4&:,I!%C.;Q2Z@ ]^.A'IUJV'$L"2BZTVZD?[D*H JD>@P,9P/Z
MYQ0!30[T,B\H.2W0 8SDDX[5$VQ[1RYD:6.X$L$L1_>JBG 1&Z[3Z<_GBK#?
M:YMT>HK#:69R-\ "C;VZ>W?I3 D,8"6SF2!.(I#U8=S^!_+- $=U]HO[:*>>
MVL)+B"=);6>5 ;U$7'R,_7FIHYD@E-Q)")9+@@S!1\JGG@=>!WXQCM3:* (+
ME&><2P@H,CY1P #P1@>P]_>I0P8LN?F5-[CGA>Y.?Y9S3P,GL/K4$^H6EOIU
M]K/B Q:+X<T&.2[UG4IW2'^S]/A4R2ZG<LY4O9HJ_,HSUZ=* &W5[I^G:?J6
ML:K?V^EZ-HME+J>KZG>.L-M8:? I>6YE>0H"J@8PI+<]*_G*_;@_;?C_ &FM
M<U+P9X+\1ZGX4_97\$226VOWFE230:M\4O$UNVQM'T%HOWD\=W,FU54LI5CV
MJA^W!_P4'D_:7O/$?A#X1^/=-M?V8O!FK2^&O%FI^'F>+Q#\1M9@<Q3>'-(,
M6;B2.ZD78JA2AYS7$>!?"?@W]FSX9^'?CI\;?"$$OB&^NHYOV=OV<[FW%QJV
MI22D+IFMZ[IB!I)9W>2.9Y9HLG)R10!ZE^S1\#OA/I=QX#_:3_;=U/1?A-X*
MTBZ@MO@E\$K\)%?ZGID8 T[Q%XJTU2LD\\I"R2RS1DDG)-/^./P"_9O^.?[2
MUS^T)IW[8VE:7J-O:BT\'>&]6OICX8\(QH!]GDTBR9O+M6A55",J#! Q[_5/
M[,/[$6O?'?7]0_:F_;HNQJ?BWQ5IA_X0?X/W7SZ+X2T"8$V=O;Z:VU+:6!-F
M (P1CBOM+_AA+]E.90[?">P^8 D"TC"CZ#(P../:@#\HH/"R7-O=CQ!_P47%
MY=1.8-.>/7+KR[9U^Z\(#@+;@8"CC QZ5'%X-CM;MM)3_@HV ]S;+-)JR:[=
M"-22"8=V_P"\.C5^L7_#!_[*?_1)['_P$C_^*H_X8._92QM_X5/8X]/LL??_
M (%0!^('Q'_9)^$GQ>\6>#O'WC'_ (* 6L'B/X=ZC;7^F7^F:Q<17FH-:2I(
M$N)%=6D681[6!SD-CO7UU^T7X1^ W[1&@>$/%G[-_P <O#6G?MB?"W2;*.R.
ME3?8=2\?Q:6JN87F9D%W=720@-G<69N?2OT$_P"&#OV43@GX3V/'3%I'U[?Q
M>N,^U>/_ !K_ .";'PL\>Z)(GP;CLOA+\7O#=N=7\">,-(5=/9M1@!FBL[^X
M0KN20QK$RL2#G'K0!H?L2_MM6/Q[L8/@I\4;,> /VH?!B+IVM:7K?^B7FK?9
M%*R7T+S^6LZ7!52K(7SN&.U?H7+:7D-U-9W(WWUN6%S@CYG4G?(#TVG'!Z<=
MJ_F0N+#6_C=XO7P+\3[V+X"_\%#?@U,5\">+HU.D:=\:;323O@@:Y/DQ7TM\
ML2+RSEC)TY-?K)^Q3^VC+^T$=1^"?QDM9/ '[4WP\7^S?%.@ZB3:?\)596 V
MB^TDR^7',;K"L&B+;LY&10!^@18"%;C/[AI#"LG8RJ<,A'48/&2 />I#&X&X
MCC&<Y'3UZT]XG,MW+ITL*VUO&+?Q+ID_,EI''QYUH"1BX)^^Z9))S5!'L\!H
M+F:2' \M7))\L] V>X'!H F:6-3AF _7^5/!R,CH>13%F P5@64<\D ?UI_7
MG&,]O3V_"@ J(SP@A2X!/0'/^'ZU+22F.1@6M@,#!8* <CW_  &>HYH ?M;
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MH!U-*/FC\X<P]I.@]^N/_P!?%*,=U##NIZ,/0_6H81/J=V;.0?8[-#S_  C
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M /37:T =%\PZ;?UH^?\ V?UIU% #?G_V?UH^?_9_6G44 -^?_9_6D)8 DE0
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MG:A5@BPH 5  @ XQ@ #'&,<#BO'_ (\_ 7PG^T3X;TOP[XMVFSTC6;?6X(Y
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M2N<=._&>]?LI8%4\.^'N&(DT>R*[>"5-O$=V/3H>>G'>O%_CI^S7X-_:'LO
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M/V&_ _[,_C75?&'A;Q?XT\176J:9_9DMKXCU::_LXH<8\V&%W<++ZM]:_1N
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MXR^#=<^#?BC4%!CBUN"XCMRV=I*R^6L2#.3AF' Z5^F5Q=:@\'E:E(^H1$#
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MBV7]WA857C:, 8XZ<//_  46_92=FD?QU*&?!8):WH0'OM&SA?08%?G)<_\
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M?W_O/TDWGV_S^-&\^W^?QK\V_P#A[O\ \$^/^CAO#7_@-J/_ ,C4A_X*[?\
M!/@DG_AH;PURN/\ CUU'\_\ CVJ76A=:Q7S2ZI=WTN_D^K#ZO4=M)OY7[7M_
M7;MK^DN]CV'Z_P"-.R_H/\_C7YK_ /#W;_@GQ_T</X:^[M_X]M1_/_CVI?\
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M<FOHK_A\#^Q5T/CNZXX(_LN[QQ_VQI#_ ,%@?V*2"&\>W2J00S'3+S"KW/\
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M3P?H?B']J+0],A\#^)X/$=LT%GJ+O<S0F#<7WV\(/%NI# G))RJYY^%!\?\
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MZ?HTVD64VHO;K)=V\<;PQJ#%+E2/8\#M^P#?"K]FRWD#VOPF^%-S)>!@T/\
MPC6FC>"/FSE<''.?7W/3W#X":#\-_"6KM;?#SPOX0\,O+(?.@T+3[6T.2XW
M"#'.<CIS_+T<MX@Q&-JJG.E2BKI7BV]VE^-WUTZF&)P<*"34I.Z2UMOI=_.[
MT[=%N?;-LDS3B2$B!/,?[5#+\TC\_(RG!P",$= ,^];%9A9(KV(%)'DF4%Y
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M_(E'_#R#_@H+_P!%\^#W_A'1?_(E ']=-%?R*G_@I#_P4$'7X^_![_PCHO\
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MID9%/K.L!)$&M94)>!5!G./WP8D@YZG X_"M&@ HHHH **** "BBB@ HHHH
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M-&NF*"H@%E;KMQC!$*CZ9X.,9K\:_P!NHD?MD_LRJ.?D)R#CK<R'GI[#K_\
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MB$;J%D$NP]SP<\U8CLOB]_P4E^,<%W=M?^'O@#X9O1+;1,)8K;6K>&12H*,
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MQC4DU&G.44FU=13NUM:_IU9</4\YYZ^OO24IZG'3)Q24&JV70**** "BBB@
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MS10!C&WVL;!+>7R77<UUN&=Q.3S]?\YZ7((V$8CE5_W7R(W4LHZ$_P JNT4
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M,8HW#')9U&,X/K@_I6]$'5%#G+ <G^A]Q4E% !61<V]Q<3%XU,'V=\@]/M6
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M)EDO1 H@?0K2UP-(TUCON=510-K32#NP&3OY^E/^8??3RW_CC/6-NZ9[X]:
M#K[>A]#V/X'!IJPQ%(C+(9-2M'>6*^4<.K [(3Q_!\O'L13OZ\9]">A_#K3?
M](TJ(_:RC6<YR+Q%\UTW=%\I,OD<\XQG'H: /A7]N+]D2Z_:7\ Z#XK^&6H_
M\(=\?/A3?2^(]'\0V[K!=>)5MF-TNE><O[Q_.$:P*A&!NKD?V.?V_='^.%N/
M@'\=[3_A3_[2/@(1Z&_AK7T-C)KXL/W"ZQ'>77E1R+?D"12"2=W>OT1O;S2_
M"]F?$OB2YT[0_#T2F?\ X2&_UNRL&58AYF197$\4Q! /RA>>F,FOQ[_;?\=?
M\$T_CG;:AXFUGXLV_@?XTV(^SZ7\0/"6G2P7DMQ9$F%+B^L@9)4,B(&8L5(Z
MT ?LMJ?VIKFV^T@7-UIZ*)Y;8^=%M(VJPGCW(X8#^$XY_"L?Q&&E\#?$,*,L
M/!?B.0KU95_LJX8^YX.3WK\(/@/^TG^VSX \':5J?@L1_M'?!N"1[6VU6T1O
M[7N;.U7:GVB=P9C)Y:ECN.<GUQ7TG<?\%4?"T7A/Q'8^._@WXI\!:Q=>&O$&
MEW:7-K>W*-<W6FW$$0PL9!7S' '8XXH Z#_@D!(EW^RMXLEMVWQK\3?&2ER-
MHW+J4P(YZ_A7Z=#H/H*_+S_@CI?3WG[(>H6[:)=^5<_$+Q9K3"2&2PE^RZA?
MS36[/YRQEOD<8!SGIUS7ZB#&  -J@852<E1V4GN1Z]Z "BBB@ HHHH  ,G Z
MG@4T,&G%JN3.<83&.O3YNG4X]J<0S JGWV&V,^CG[M-03I";&:,#46Z7*@;E
M1NAW]L# Y[B@">:,VLB)<X0EAD!@W&><8]OH/>JT<TEI_:+V[B!I&$%@[ MN
MFD&%4'^'+$8SGFHPEI:&. 3RZGJ<CJI0$R;2YSCC.,>X[X^GRU^UC^UEX-_9
M3\'7MM>V+^+_ (G>-"NG^!/ &EDW>K7.M7:B.PNECMRTL,<4S*7+)@8.: &_
MM8?M@^&/V.? L-M=VL7BWX[^-HS9>!_"5F!?ZC/J=XH%BXA@+RQIYA4%F0!>
MI-?C2^G>-?@_K\7QW_:)3_A>'[<7QF?R/@=\#;0'55^&UKJ[L=.OM5LHQ(;6
M6S69'W2Q*4V8[5H3_P#"3_"CQ7H?Q5^-EN_QB_;N^*$JCX+_  AVG6$^'&GZ
MFX>PN]3M4$GV::S1U.Z5$9"AZ8X_H)_X)F_\$RO^%,:UJO[4G[45P?'_ .U/
M\36760NN.-0LO EK(KRPZ?HT,Z,+(P+*J!8MFT1\ GII"RIU.]TTO^W;?=OK
MI_G$OBI^4X_A*+_0M?\ !,?_ ()J/\"8S^T?^TL8_''[4OQ)7^V+K^W574+;
MP%#.3)'I>DI<(?L3VT3B,>4$VE<+\PX_;.YM]0EG4"=1:/ T=U& !+*6!!,+
M=5XR !R",G-9\H<O#]KF\V.-]K3#F4RD_*JL"2$Y((Z8Y/2NE/WH_P#<&/I\
MV/TQ7/.RP\K)*\9;_%;R\MU^ KOZ_7=U>\).R:3NHV=GK9]'>_336_\ '_\
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MOU'_ .JK%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#?LV^"O$/C[QYJEK9V^D6,XL;$2QF]\2WYA+VL-C &$K/(^V/]V"<^]?F?\
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M&O#6E/X5\.Z+9Z#X?FP?(T6!+".-E[E80H.XCYO4''-7@JH BY*H BD\DJO
M)/<XZFBB@ HHHH .M1F6,7"6I)$\APBXX;_@73_Z]2;2V$4X9_E4^C'@'\#S
M5E$^1M*GB5KZ,;UN@ 613R#NZC Z^V/:@"&:-X9C;/M6XV%E56#D$<@\=P.W
M7M5=VN;:WBF0_;+FYE6%R/\ 61%C@;EY90..3Z<#%%O;P:?<K=6\LFJ:BD@
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M('_Q5&8?^>D7_@0/_BJ\/_X53XB/_,QW/_?]O\:;_P *G\0_]#%<_P#?]_\
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M_7HU9OITMO<TEF-/!T^6M92::OO+1*]E^/:W2RU9JLT43QS.R6]G#&TUU,9
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M%-)+RL_RWTW[GLRI8B=:DL!'FJ*4>2"^&4KI)=]-7;S] 6Y1I)\./W! D/
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M (B,/C;_ -$R'3/^L;IZ_?Z4?ZZ9=_T$/_P%>7][U_'R'_Q*9XO_ /0LP_\
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M;/K9)NZTT6^Z)J?13\0H*F\XP'LZ:J_N_9>UFG9+63E"&JLDTDUU6MTOZS?
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M6_XG%AU)R?\ EK_^JO?4&H\^K3ZM_IY_UY_GU.<*F!HSC;F;:;3OHE'?I?\
MRTZFIO7U_0_X4;U]?T/^%9O_  D'A3_H;_#?_@XL/_CM'_"0>%/^AO\ #?\
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M\.]3\0_LU?"_QGX0N&T[Q]IOC?3DUJ\@)6YET1]2AC\AY%^=D\HE=I.,>F:
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M%]JJ1RIX0LFD2*R("$!0<%1ZXZ=NF._NK?%3X?H@D;6K@(<\^3(?;V[UX_\
MLM^#O#R?LL? ^Y?1K>YN+GP;8*SF!&/*J>N.QXY[ XKWQ/!/AB:$6\NB6ZMC
MO G?TRO^'?I7)5VMW4O3IU,RSHGB7P_XCC:;1KZ6ZCC&YF973CZ$_3K_ "KH
MQ$IB,P),8&2P8G@8_P ?K6+IOA^TT)&@T^SC@BF^4[$"\'C@+C QS6BT5S;I
MY2HSQYYX)XZXZ>@.?Z5R <IJ?Q!\%Z--]GU+4YH)MVT*(G;G.,9'TJF?BAX!
M"ESJ\X7&<^2^?R_^O7077A;PWJ+^??Z5%+,/F!:)2<X/]X>N3]:H'P/X?E.U
M-)@$?H8DP1Q_L^A]L4 9'_"VOAXAW+K,Y9>0/(DZBF-\6? [+=2_VK<%S&-A
M\A^>?\/\]:W3X)\)Q'R?[&MC)(,9\B/C\=HZ\TX>#O#4"E7T>V"@D#,$?3IS
MQS0!\]?%_P"(_@K79/A^=(U*XN;C2]6$^I*()!Y$6X'<2.O3\.GO7LD?QA^'
M,MK9$:S/NCC42#R),KP 3W/&/SK=7P#X(F=9I=%M%5>7801@XQ_NYQR3UJI<
M>!?""RDVVC6WEYP!Y,>#WSG'3C'7Z\T 9-K\9/APMQ<;]8N"TJ[8U^SR88],
M9/ P?\\5,WQ:\ ,21JTZGC!\A_IT'3CZYK53P9X1!XT&U,N.&%NA(/J/E]/\
M],2_\(=X:_Z <'_@,G_Q- &*?BEX"8;O^$@F8X'[O[,^3_GK[>]3+\6/ATL8
MSJ,KN.YMF)Z]>@/'I6JG@WPSN!_L*WSSS]E3T/\ LU/_ ,(=X:_Z <'_ (#)
M_P#$T <W%\4? 2S^>VO3)& 08VMW*D$'MW_$<8]123?%'X=VELZQ:U=SR7$F
MYE6*18T!.>%X  R3CH>F2*Z&7P;X:*D?V';GZVT?H?5:23P9X: 3_B0V_;I;
MQCL.>!SBMJ?3_$OT'+^&_5_D?F-_P5R^)/@_5OV$?'&D6.O1S1S>(_"DL\'V
M#;<J8]0B;"SD;EYZX()YYYKR_P#X(Z>)=(U#]K/QP--$LYF^'G@ZWGE;=E!'
MI5N@))// )Y__7[-_P %;?"GAZU_89^(T\&C012+K_A8"06Z*5S?Q]"!G_/T
MKR;_ ((PZ98V_P"T_P"/)H8$C<^ /"1)50.?[-A /0=^3G)^E?;9#K."[J*_
M \+&ZI^E_NDF?U+1Q?9Y52-R$9F8I_O$GT SD_7O[U>J( ,Y;^Z2!^&1_3-2
MU]XMH_X5_7]?CN_+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"I>L5AW
M!@H4Y+$9P,'I[UY;\7?BEX<^"OPX\0_$KQ;,Z^&O#.GS:IJUPB%VALX%9Y)
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MU[E2W2:-W#\H^7!S]T\84#L!SQ^-6Z**L04444 %%%% !1110 4444 %%%%
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MZ^G'N,4T"7(^4]?R_7M5JBCE_O2^_P#X!G[)73YI>:OH_P#+T"BBBJ-0IDF
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M[F*Q2[ L6F>X8X=N=HP ",\CZ?\ UZ^S_P#AW7^V9_T374/_  'F_P#B:/\
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M6#;XHY'3>^2TCGL3R% /.!^ ()Y[4U 9'54CQ"#ECCL,\=.QZ'^57W"?)Y.
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MV:44_>+]]/E4'&<\CW]17WQXT^*7@[5_B+X2UNUMM5%MIK1%RMC+@;0,Y..
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M&?X>C/RZQQC_ )<I._\ P#^6?PI9?C/\._(4[=7+(XS_ *%+P'('0+W''O\
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M2AZ9P0.!Z5^1O_!##RKS_@GKX.:W4A6^(7Q"89Z@C5HNOIZ=^#]<_L!]E8
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M_H&V'_@)!_\ $4?V9H?_ $#;#_P$@_\ B*TOL\?O_P"._P#Q-'V>/W_\=_\
MB:%EV!T]Q=.B_N^7I_P?M']HU/YL1T^W+^[_ 'O-?=Y(S?[,T/\ Z!MA_P"
MD'_Q%']F:'_T#;#_ ,!(/_B*TOL\?O\ ^.__ !-'V>/W_P#'?_B:%EV!T]Q=
M.B_N^7I_P?M']HU/YL1T^W+^[_>\U]WDC-_LS0_^@;8?^ D'_P 11_9FA_\
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M]Q*$8,8B[X?!'RDECU'^?3U_PW9)X>L1#YRW4@!^^P/48/4\?GV&.3D^5?\
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MU+_T.EQ_WVW_ ,55[_A<7P[_ .?;6/\ P#D_^)H_X7%\._\ GVUC_P  Y/\
MXF@"B?@U*!G_ (3.Z;'978G\/F-'_"FI^O\ PF%X![E\_P#H0K?TCXH^"=7U
M.UTS3(-234+MBELT]K(D(;C.]RH51T&2:]&2.>2=Q/RJ$EMO(X/08H \5D^#
M4DB%?^$ONGSC*L[@$ Y/?_/>O5_#>BQ^&=.CMDOQ?2*F"TC@Y.#ZG^N>G3I7
M->)?'/AOP]>)%?07+1 GSO)C9W/^ZHR3R#TS]*P/^%Q_#OM;:P1V/V.3D?\
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M&;"_PDAOPX_G3Z;C!&!@');I]?KUS3J_1H_#'_"OR/)"BBBJ **** "BBB@
MHHHH **** "BBB@ HHHH @N.$#=E))_*OAG]O.-IO@O<21E=L=ZLC!F"L4"G
M)4'KC_(K[BOI&BM9G0;G"'8OJ<'@#OQFOA/]NZ$7/P/EN7+K<Q3J_D(3N?CE
M2@[<9/UQ[U[7#37]NX)=J]-Z=U9KM9/OLCY_BG7)JUUM>SO;=QOOOJEHK,_
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M+;\!_P#DNW_!*;Z>/_\ TON: /[*:*** "BBB@ HHHH **** "BBB@ HHHH
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M@'KR!U=G;Y:VVZ7W\V:X6K2:5G?YZ=-[KT2[WOL/BCG@29WN3=>:<K;NORQ
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MQT^"-8H8H8U55C"( N"%Y(!_'DUFZ/I6GV^GV=AI=N-+T_2E2%(D01(R1*
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M(/[2?#(<A01WZC.<]NU71="C;E4;JWQ6?9^?H^]N^Q9=E]R/P1_;^^/'P?\
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M]+IU[<O_ ,C^(?)?C_G_ %=^5F$@9X/R@#J>A_S_ "]!02!G@_* .IZ'_/\
M+T%/HH]G_>ETZ]N7_P"1_$/DOQ_S_J[\K-.!C@]0O4]",_Y^@]!29'H>&V=3
MT_S_ $YX%/HH]G_>ETZ]N7_Y'\1#,CCCHVT<G_/X?X5$Z,=Q09.2#VSWQ^>/
MJ/RJQ151BXWM*6JM^"_R_&P=];75M"D$FR.#@=A^GU_ECM2E)2<8XSWS^GH,
M5<HJ)4KN_-+^K?Y$4X>R=U*3=[^\[_U_D0"-L $=L'D5,. !Z 4M%:)**LK_
M #+>LG+J]^VEO\OS"BBBF AY!^AK+F) ER.#N_$[>/\ 'IU&*U:R9^DOX_\
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M?HOU/\JF?POY?FC+$?P*GK#_ -**Z]1]1_.KH_UH_P"N;_TJDO4?4?SJZ/\
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M^". $G[2G[8$FQ@1XZU$ACE<\<\8Q^'U^M? <9_PU;NE^$;=.]NB;*C\4?\
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M^>_YFFI.C*TG(6-L,3QR",@#'J1_ABL77/$6D>'K)]1U.YCM(0VPS2L$!P0
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M\$2OAUX7OKRW^%/Q5\3?#_P29)GT;P9&7U*RT(3R-+(+6:XEW K(Q90%"K@
M< 8?#_P1;\*%!]H^./BNYO&D\ZZOFCS)/..0^PS;% )' 8_SS^Y!4*I5>N.>
M_;OQTSCK[9J!5"GD\DG@9/)XS7-B)77.]5S1WTUT2VVTO^O4ZZ^(J5JL;N\%
M:[T25K:*V_S^;/Y+_P!LO]DOQU^Q#\0O /BWX;_M >(M0F\50'1-7T6\M3&A
MTF21HYLE7*Y=0<#<>#TY-?2__!'Y7'PJ_:8=;E7S\56:6Y8*'N)7=V:1QV+,
MQ/X\>_>_\%H$=_$?PC"<?O!GG'_+9\#\>?UKYI_X)8^!_$/B+X:_M&7NG^+[
MSPY9P_$[R9;:V4LDK[F'F,0>OX\5XG%%3_A/@D]HM*SZ:/=?=]YZ&%Z/SMUZ
M-?IY;]VS]J6CF@LVFDN(65ONJA#.>>R^N,_CQ[54BGG*@DN@)R Z;21Z@''!
M&#WKP:+X-^*DC@OD^*>IS01.&:+8Q!PP)XW'_/0U[A8V[VMC:V\FJRZQ)%$J
M/<S($=64'*X'7DXS_/K7Y=3J<V%DENY+;=V:U77=:GL1V7H7O.F_YZ?^.C_&
MCS'ES%(=R-U)7 ^GIVS^=1UQ/BCPUJFN7"2Z=XJNM""Q;#:P(61F/ DSZGZ^
MOI6/O_WOQ&=N;6&('RV0;N"#)MZCH>?UYQS206LY8FUNT@.[&TMN!).0VXY[
MX[]/KBO!G^#GC&>0N_Q/U-(R<\(0!W]1V/I6?X@^%/B_2](GN[?XHZFQA0N3
MM;@CU^;MSQ]*/?\ [WXEP^+Y?U;^MKGTB]KJ44X\W483)D<!4;/OGUY_2F7%
MQ/Y@6>[220# *J@X^@ ]*^4O!'P^\9^(M.N;^3XGZHWDLRABC'@'CN>0!_GF
MN[L/A+XPAG2[?XB7%S",'%PQ1SC'\);H>!^ QS1[_P#>_'^M/R-3V[?+C/F-
MC&<[1TI!)(>DI_[Y%9^G:;<Z= L4^J#4'" ;L@Y('USST_KS5]<D<IL/]WG\
M^?\ /%'O_P![\0';Y?\ GH?R%1O)<AHHX0[QW# 7S[#L$(.1ANA(&..@_*GU
MFZFLE[ VFQ:K=::S @/##N53]T'?CGJ21GMSSBCW_P"]^(&M<0>=<37:N&;R
M(X(8U?HJ=\ \'U]CFE57E56\L1$*%*MG.1R3T[Y_2O$KOX->)KFX:ZMOBSJ5
MFI8L(BI_ED#@<?RSUJ%_A!XM<@O\7-9=@ "T4!9#CI@@XSC&<=Z3<FE>]NE[
M]O\ ) >Z>0_JOYG_  H%J['$J1F(GY7,I&#U^[D8SQR1R3[5X1_PIWQ7_P!%
M:UW_ ,!C4I^#7BQHD8?%35I!G@O&RMTR<C/'7TI >ZSQ7IEL8;:X2+=/&LI$
MISLWJ.Q],>U?A!_P4/66W_:]T.**[$H'@_7,MG<2W]FW!/.<],C]:_6K_A3/
MBS[7:#_A:6IC]ZF3M;(RZ\]?RK\0_P!O+P%XBT3]KO08;GQ?/J:IX4UUC<3D
MJ[YTVXR""<@#G'0<_E[616^N?]N?FU^MK'+B_P"'_7]?IW/V@_X(;,S?\$^O
M!Y<DM_PL#XA D@C)_M> _P"//]*_8#&./\\\U^.O_!"]&B_X)Z^#4>Z\YA\0
M/B$#)D<G^UX1CK[$CZ<5^Q0& !G/ .?7/(_G7ZMA=:%-]XK\D?.5/CE_B?Z=
M/UZDR?='X_S-.IJ?='X_S-.KH("BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "LF?I+^/\ Z"U:U9,_27\?_06KFG_OF"_Z^_JCGQG^Y8K_
M *]_J?S8?MF?\C+\7O\ KRNO_0Q7Z%?\$E/^35=._P"P[=_^RU^>O[9G_(R_
M%[_KRNO_ $,5^A7_  24_P"35=._[#MW_P"RU^Y\:?\ )+Y/_P!>Z7_I"/QK
MAO\ Y'M7UK?^DL_53^!/H?Z5,O0?0?RJ'^!/H?Z5,O0?0?RK\4ZKT?YQ/VR'
M\.'HO_28BT444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 (W0
M_0_RJC/T7ZG^57FZ'Z'^549^B_4_RJ9_"_E^:,L1_ J>L/\ THKKU'U'\ZNC
M_6C_ *YO_2J2]1]1_.KH_P!:/^N;_P!*<_\ =Y?]>I_H%+^-6_QT_P#TW$_D
M,_X.4?\ D;OA%_V"I/\ T8:_F?@($MJ3_=7_ -!K^F#_ (.4?^1N^$7_ &"I
M/_1AK^9Z+_66O^ZO_H(K\!XR_P"1Q3]5_P"DP/\ :CZ*_P#R9#AO_L$Q'_J1
M,^7-142_$S6T&W#0L"6.U0"ZYR3C QW/%?U3_M11B]_9$_X)<VUH^Y+#XJ>!
M)9(X(Q<02LMS:'RI>"K!L'(;/OD&OY5-2(_X6-XAW*SH;:3<J9+L,@80#DL<
M\8K^L_XH? 3XW^(/^"=_[%GCWX(::_CG7O /BCPYXU?P?<!GF>RT]X)6C*$[
MPIVD9X'>NO*E>C#O:-O+W4C^-OI4:YS5_P"ODMO*2M>_DGMYWT/Z/_B;K5[<
M^"?B%IMO:Z';10?#F2[DLH=)L7DG8:8@:(8B+;V&<+CCH!C K^7[X3J;[_@F
M[^T]:RJ8-.G^/NH375O+&+9[=S?2[HDC 7 !Q@ #\J^VO%/_  46_;KUOP!X
MDT5?V(++1O%.O:6VC6^L'SO.6-[=+47*1DX?&W<$Y')X-?,5A\'OBW\*O^"7
MWQ3F^-6D-X?\8^/?BW)XI?3=C12):W-T9B#$>< .!GIQCCDU[-3[.M]_Q]3^
M0FOW=#W=;:M[27NI/J]DTKI.RVL?MW^RK//<?LB?!2?]_;6=KX?LM-M#;Q&6
M:6)0H#,!\VT\_-7OEB]Y;2O O[U&&T"[7RS@G'(;OW^O>O"_V1[I_P#AFSX+
MW&F7_D:3%X%LHIHRH;R[S8,RJK#!D!)YQGOSFND\3_#WQ+XGOOMEM\0M1L(0
M20$A,8&<>F <<C\C7FU/A5^SZ^2Z_J=-/_V[_(]3-F8IRTYBADD/RK&_RDGG
MG!QC _7&.*M?97_OQ?\ ??\ ]:O!YO@[XID11'\4=4D*_>8HWR@'KG)XZ_E4
M'_"FO%__ $5+5/\ OEO\:Y#J/?7M)2K!9(U8C 828(]P<#!Q[U'+9SP6ZK97
M2O*3F0F4\$G/7)/KZ<UX-_PIKQ?_ -%2U3_OEO\ &C_A37B__HJ6J?\ ?+?X
MT >\+:71,<KW*B7HX$AQCH#DGGH3T_K5KRI?^?A?^_O_ -E7S[_PIKQ?_P!%
M2U3_ +Y;_&C_ (4UXO\ ^BI:I_WRW^- 'T \5QM/E7*B3'RGS>__ 'UZ9IJ6
MC[-\UTKS#'R&0XR1S@YZ9^OUR:\!_P"%->+_ /HJ6J?]\M_C1_PIKQ?_ -%2
MU3_OEO\ &@#W9]/-P29I$3' Q,V#]0#@\>N1[FIH[:YC'E"=!%R#F7/R^X.1
MT_\ U5X'_P *:\7_ /14M4_[Y;_&C_A37B__ **EJG_?+?XT ?0(MFC&$FBD
M7JR9"Y]1GD^W^-02P2.V5@@QZ>:>.E>"_P#"FO%__14M4_[Y;_&C_A37B_\
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MS@^HP:6J]N" 0THE( SC'!//8_Y^N:L4 %%%% !1110 4444 %%%% !1110
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MYX! /_%I?%0/MIUR/Y+T_P ]J[/_ (<D>'_^CC?'O_@GT_\ ^2:/^')'A_\
MZ.-\>_\ @GT__P"2:RG!3FJC=FNVBTMI9;7Z_>32@J4.2+;7F[OIU^6WYO4X
MS_A^YX#S_P DC\5XSU_LVZZ>N<8_'I2'_@NUX#=U5/A)XJ(+ <Z;<X.??;QU
MKM/^')'A_P#Z.-\>_P#@GT__ .2::_\ P1(\/[6S^T=X]08.6_L?3AM]\FY
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MTN?/XO"2K3YFVK--637\J?PWT5M/G9:7&P1R;6SD13HIC#?*<GJ"#R#]/IV
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M_P"35=._[#MW_P"RU^>O[9G_ ",OQ>_Z\KK_ -#%?H5_P24_Y-5T[_L.W?\
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M[0[/4O#5P+754EO+<)!,6V[=YD&[# AL#@@]<4O@#]D/]G']GSP[XYNO@YX
MTWPI=:MX?U5[K[+<SR [;*4K_K9'9 & +$L>F,X(-?C[^P7^R3^SM\;O''[0
M-_\ %?P/IWBN[B\6W"!FU"YE49O)<*1'*#GG! 88Z5.89AG>&JX.E3IX:]?F
M=24HR:48[6V:7VGN];6OH>-P_E7!^:8'.LRK1SFIALLCAE&&%J4'-SK-\W/)
MIK711C:.][O9?K-+_P %(_V1DCFEB^*WA^Y2W8)*8+ZV<HS>PD/ SR<\<>HK
M1T7_ (*'?LIZ]?Z?IFF?$_1+F_U.ZAL[2VBN[>25YYV"QJ5$@(R3[UY];_\
M!,3]B&$72:9\$]+MC,0TJFZO51^G3?*_I@G-:NB?\$V/V-/#NKZ=K&C_  @T
M_3];TZ>.]M;J.[NR$GA;<CDLY7@C.,#IU/2N]5LX<8/DPUY65E3JW=[:QOI;
M7=VTV6AIC*WA/'*Y3PV'XH69J\4ZN*P4L.IV32<(1]IO[OR;V/OJWU&UO(([
MB"59()XDFAF4@QR1RH'1E;H<J01BEDPZY!Z9/^'X'U_'UKF8FM=#AL-.>#R;
M"-([:TAAR_EJ@$<0R.2 J@$\]^"*ZHQ@19'1@.#GIU&??''UKUU#$1IQE7Y4
MYJ]DFEO;1VUL]_Z1^:54JE&<HTJT*4W>BZBLZD8M.ZMI;KH^Z[%(<$?@>_X_
ME22:C;0S(K%MS@HO&!\Q&,Y_R>@YI-I0N3Z'ISC(.,_G65/"99+=R/XQTSR,
M_P#U_7C&/:NFK!+"U&MXTW:[WNDVK?U9_)'G8NKB*&"AB\/%2K5,30A44DVE
M%RC%V26C4=-7K]Y_)A_P<I''BSX1O_"-*DR1_P!=#_G_ "*_F=@.Z:S0#YF1
M2,GCH._;U]OQQ7],/_!RASXL^$2@\#3&R">P=N<#K^5?S/H0SPN@QY48''/;
M&3]>^<?3K7\Y\75^7.I>W32B[0MHE916_7_AC_;SZ+\8+P'X6EATYUW@L0IJ
M]TI/%54G;?9+??\  ^6M3+P?$CQ&XD6*2"SEF\P\B,*0=_(VG&"<'D?6O[2/
MV)_^"JG['_PT_9G^$&@Z[XQU:?Q3H7A:WTC6T>S26UM[M5593"DB%&"X&.,Y
M/J,U_&=XA\*WTWB+Q#J0222.[L9H< '+AP1MR/QZ9[<YKU'P19PZ;X.TK3Y-
M,FC88+ AP<[B<C./7UR?UK&EFT<-17L[:)+7O9-;?DGY>1\5QIX)X#Q#SCVF
M?PQL*4JK;>&ER-IM-ZVT7XNV^Y_<C_P^0_8O@N$NKWQ5<:U,R!+9)](M$^S*
M>0ZX@P2H(QGTS7P/_P %$_\ @I[^RO\ %S]G+6=-\->,M4O?$)U$0V.E2VD=
MO9$;U/.Q%08YY]>V17\R]Q:V3W4*_9ID<(",;N#C/(R!SZ'/3Z5YY\1_#_\
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M=OJ[+78****]L^("BBB@ HHHH **** "BBB@ HHHH **** &/T'U_H:^*?\
M@HK_ ,F5_M!_]D^U/_T$5]K/T'U_H:^*?^"BO_)E?[0?_9/M3_\ 010!_/\
M?\$I?^3GO@K_ -D1A_\ 1CU_6F_63_<'\Z_DL_X)2_\ )SWP5_[(C#_Z,>OZ
MTWZR?[@_G0 D?WD_W3_(58JO']Y/]T_R%6* "BBB@ HHHH **** "BBB@ HH
MHH **** /F;]KG]ISP/^R#\$/%7QW^(T=U+X1\(I;G4(["/S[^66\E$%M%:P
M $RR-*1\H!.,\>GY"6'_  7:T758+>\T;]G+XR:OI.H6\-[INIP>#M2>"XL[
ME!+!(K1Q!&W(P8D?A7T]_P %Q9+>V_X)X_%2\FMDN7MM;\'&!74.B2R:S&F]
ME(*LH7((8$9(K[$_8VTRTD_9@^",]QINDRM-X \-LPBTNT4[7TV!CDQQJ">3
MEW!/0$D8% 'Y:/\ \%P[-/)0?LS_ !CO))CC;'X1U,^2>1B3;'\N<=^:27_@
MN%:Q"4G]EWXQN(=H<)X2U0D;NF/W>._-?NW_ ,(_8"Y9X-)T6UBZLR:78M)<
M$]1(1$&7![@Y/K4W]D6*2D)HND&-AEY!96J,YQP"H0D\Y!SG';K0!_.C\<?^
M"P]U\1O@S\0O!^B?LS?&"#7=>\.ZC8Z;%+X0U(QS27%G*B!M\9"Y=E!/!QQP
M,U^3_P"R/\?/$OC;]M?_ ()F?#;Q)\+/%7@SQ1X8L/'$VLP>(M&N-,@2.[NK
MB2(PO*J[B4P<9/:O[B!9Z5*&,>D:7YT)*E9;&W7CGA',8(SZ5^$/_!0'^S=&
M_P""IG_!.1;>WMM*FO\ 2?%:226%E!%+(5OKQ0'>*-795 V+N)PJ@#&* /WX
M@\H/(J(RNI'F$@X)Q_"<X('M5FJ5H'0M&TCR@*A#N,$\?_7J[0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3_\ 6']::0"0?2MD^7;M;7L>K6_>2BZ+]SFBW;1:<OXW;ZVT8M%%%!J%%%%
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MJS;?F_7?:]KN]KG\E1RN$,4\96JN<FTT[WO=1TUV6R>NJ2^;8U"EF[]3^O\
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MR&0@L(C@8ZG_ !%>6?\ "Y/A_P#W[O\ [X'_ ,51_P +D^'_ /?N_P#O@?\
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M.W)-/^,:SGI_R\H_W;_:\W^/8_SG,77]V[_[]-_A1BZ_NW?_ 'Z;_"O]&/\
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MNUUY?TO.QU9((.& /UJ)KA;<@R'(?@$<X]>?PKF_^$HL_P"X/\_C3)/$=A,
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MZ?\ !6S0?@]HUY\#/@7?KJ_Q&UB.YL-=U.V=6AT>.1&B'E3(Q(E!/+!AU
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MC?L,_L*^"/V5? 2Z98Z98IXJU6VM9=>U6&&,M'<1HI9;68H6QO!SANO)J/\
M84_84^'W[&GP\L/"^CZ9:7GB">T@DUS5Y8D:YFN&B0RE965I,;P>C=:_033G
M91+$J[;5<F  _, >6W#KUZ$_AGJ/W+AGANCAHJ<Z;52RYT_L+3W=K7UW3O%J
MU[[?Y%?2+^D;C?$'-ZF397BE1R&E4<:'L/<EBXIKEFVFI>Q332B]*MU)^[HY
M!;2$QOYI9[=2(SDYEP,#S,_09/KD$8I;*WN%>:65OWDIYC!^2/!_A],],]#^
M56(B=[<\<C'N3G^AJZB@9/'/'']??_/>OT1R=.'LHI<KBDG9725GR][7L]>O
MW'\G5J-ZU.I&4E>[?*U%2NDW=)=.VFUUJ-V-W'\A_4U$T<Y92NT+SD$_E_GG
M\*MT5SM7[Z6_#;^O^ #I75G.?_@3OT_57^?D5S'(4(R V.N< \^W]?UI+=)$
MW>8?IU]3Z^WXU9HJKZ-=[?@:Q]R#@K-.UVUKI;;LM HHHI %12$CIG[O3UZU
M+2,!@\#H:RJ[1]5^<0/Y]_\ @L^%;Q)\)-V,>9'UQ_SWD]:\H_X)!:#HFH_"
M3]I>XU/2+?4I$^*ABCFF&609?Y0<=,D?XYKU#_@M(S#Q)\), _ZV/UY_?29Z
M>E?.G_!*6V^)5U\+/VCW\%M8+IX^*>VY^UR!',V6P5!(R.H^GZ^!Q+_N;V6_
MZ?CT^X]/ _K^J_KY^1^P%OX.\*KMC/ABSW.?EX[<^WT[\4]O!_A(,5?PI9.5
M &=F?YJU>4Q:9\>C-#^]T<=.DR__ !7^>:5](^/LDLFVXT10",AIQGG)]>GI
M7Y33^"6E_>7R\_T^9[T/X7S_ %1ZI_PA_A#_ *%&R_[]C_XW4UMX7\-VUPLE
MKHD&G,!D-&H'//.=J\COBO)/[$^/_P#S]:'_ -_Q_C4%YH?Q\%N7:XT5B"?N
MSCIGIU&.AJA'OGV1;?<)KP30LI @9B5 ],9/O^7TK!F\.^%+V5IKO0+"ZER0
M)64$X/4'@_TKE?!>D_$.-/,\1OI+8QG,P/;)/7UQC_ZPKT-LYP1;@KP?LS;H
M\]#DCC.10!A?\(EX+_Z%C3O^_8_^)IP\(>#2,CPOIV <9\M>O7TK9KSSQ9I?
MQ)N]1$WA&73TTD1;6%W*$E,V.>"1QQ[?C0!U:^#O!S' \+Z=GWC _FM.D\&^
M#XFVOX5T\DC(VHN/U6O'SHWQR5_EN-'QG_GN#WZ??]A4W]D_'<=)M'(]?.7^
MK&@#U;_A$?!G_0J6/_?"?_$TT^$?"6?D\*6&WU**/KT _P :\K_LGX\?\]-'
M_P"_R_XU-;Z3\<Y)#$\VCANH_? <$#N&_P \T >H2>#_  M$F\^%-.88SA5R
M>F>FT?IFH(_"_A)UW?\ "*6$?)&UU ;COP.A[5YE'I/QTM=019I]%:(OT,PQ
MCZYS@^Y_3%>PZ?'K45I&GB$VS:GC]X;0AH2O&.1WYH SO^$4\(_]"OIO_?(_
MPI?^$8\',%B_X1W38W!S@\#YN0>G/X>_I6[3;N*ZFLF2Q73OM)!"M<N%FR1\
MN><X'OWSB@#,B\&>$Y[NV$7A[36*R(3CG.67.!CH.<_2OPW_ &_=&T?2OVNM
M&2WLDLXQX2UX+;PC]VI_LVX^;^?N?QX_7E]"^,::JDFE3:0(C*GEYF[;Q@'G
M'08^OI7X;_MZV'Q'/[76@C7;FW%W_P (IKWF"W<-%M&G3]#GD]/PKVLB_P!\
M?;D?2]]5^EU_2.7%_P /[S]I/^"&F$_X)]^$"@('_"POB*1GL#K$/IVK]@,D
M\MC/?'3_ #BOQV_X(4QW$7_!/7P8MVP>5?B!\1-Q'.?^)O".>QYY_7TK]BB0
M3D=#T[5^J85MTH7_ )/^!_7_  Q\Y4^.7J2I]T?C_,TZFI]T?C_,TZNF_O6Z
M6O\ B0%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LNX7:
M),]6R<?13_G^7K6I6;>]?^ M_P"@&LG!/$X63O>-33MNE^IS8UVP>(7>F_P:
M/YK/VS,CQ+\7?^O.Z!_[[_Q&#^5?H5_P23Y_96TX?]1R[/Z#_"OSV_;/_P"1
MF^+G_7G>?^C&K]"?^"27_)J^G_\ 8;N_Y&OVGB^HY\-95&5K1C12MVY(O]?P
M/QSAW3/*S7\V(_".A^J@Y1!WQ^')_P#K5&Y4D8+ @\@ 8S[>Q/IS@4\<!#Z*
M/YFE9E&2!@?CG\LX]J_%X)3K2BTWR*+C9V2O:]]=?0_:5.%.G"4]5967=\J>
MWRT\]]RO/&\B !LGWZ]\=_YY]>]?,W[3?B?XL^%O@]XHU[X*Z/9ZQX^TFV-S
M%HUP?FN8(,R2>3&,%I&B4[%'4G 'I],-/@G S_D^G/I_2L1XU>6>[MP$ORFP
MM.!Y;Q_=VD,""-O8C..U9XG$8FFK4HIQT3:2;U:OI;?M_D:97B<-1QOMI24Y
M)IJE5=Z4K--0<=HQ?62U3Z/8_*W]E_\ X*;_  N^+.B7NC_&3[1\*_B-X5A%
MCKVE>*Q_9=K<:A;C9=/8^:%\R-I%.PC.1[U]0ZS^W#^S+HVCWFIS_%+PQJ-I
M;0[S86FIP37DKQ@EDAB!WL25PO;GJ*H?%_\ 8C^ 'QBOWUGQ9X(TQ]=N27N-
M0L(S;F21B&=I#;"/<6;J6['G->+:5_P2S_9CL]2M]2G\)QDV[HR1F:X:-]I!
M&]6D*G/3!'2O&CBLR<Y)PI-3;2;6J3L][Z.S6CNM;=$C]%P^&X.K*MCL54QM
M&O*,?9T:$[4E):N-.*A)*-TFI1<79[K8^*++XBW7[;7[</PX\8?#?0M0M?AG
M\.[T32:EJ=H;<W,B,A9H90JEHVY*_,<C![5^I?[;?P,?XY?!#Q1X6TV&.YU-
M+0SV5NN3NNK+=-;_ '<DG>BC/7I["O>_A_\ "#P%\,].AL/!?A72]&BMXU19
MK:!(Y65!_$X&XDC@G/)->DM%&5:6$""0\%9/N2$@9!!X()SGZ]>1F/J*E)U)
M)N;3<K:)2TLTG9.SUM==DM[^-#B">6YOA<9E]>K&.!;6'C6GSP<)I0E&=[M*
M</=>[6\KO0_$']BG]O70?A?X7L/V=OVE#J/@WQ[X6NI=,MM5U>/[+H;Z5:[8
M;)4NY1C.U0, D=^!G/VY\5/^"AG[,7PO\,W?B>Y^(&C^(+Q(632]"T*\BO=4
MNIPI$?E6R$L0[@8.#G/'4D=Y\:OV1/@E\<(6N/'W@O2+R^RS+?6L8BNBY)*L
M9(0CD D'D]ADD5X9X+_X)I?LP>%=5@UX^ [#Q!JEI(LEF-4>>=8-C H!&[LN
M%P.HYXZ]:NE4QL:L+1A)4;J+:M*SM=/9OROZ6=CUF^$\?&>,JO$TL74FYU:=
M*:=&5633<>9)VBVDV^:*U=TFY'Q1^QI\/OB+^TQ^U1XO_;'\?:'<Z3X-B,8^
M&J:K$\-ZL6]"7>)SA R9(("@X[U^T/Q\G23X*_$=P2S)X,U]RB_?;;I=QD(.
MY/( QSTZ<UUF@^'+'1-+M](T33;/3+*TC2.'2X(DAMXXT &%5%'0#OU'J*T=
M<T;3=1T?4;'5X_.L-3LY=/N8A\R>7=1F%UQC!7#D>]>A1PJC&O-7<\0KU+O1
MMK9;6TON^NU[V\7-,Y^LXS U5R066<BPD(I/E5.49)5$K*5VDVUI9):Z7_(K
M_@BC))_PS'J5W+;3VRW?CCQ4L4<Z%)/DU&7)(X.#@[3W'?O7[#S"==K1X W[
MF(Z;<G/Z']>_2O+OA%\)/!GP:\-CP;X,LX[.Q%W<ZCLC0(IEOI&ED)  ^\S$
M]N<5[#Y68MI/IGV./Y=OKTKJP$?J]"5&WNP;4%)7=FW)^3UMNM/F<F;YI4S;
M,:F:8N%.6(Q"IQG:/N>Y3C33C'I[D8WO>[N^NGAO[1G[_P"!_P 5+6WC8RS^
M O$SX49W%-*G) [Y) QW)XK\]O\ @BW'+'^Q[ICWB/;B7Q7XJ2**8%'RFJ2#
M+*0.#C(X_G7ZN:[H%MX@TC4-%O$WVFIV-SI]RK+D-!=1-#*N,8P48@Y_$XK@
M_A3\)?!?P>\+0>"/"-HEGIMG=75V(XE"?OKN4RRL5'&2YS^OTRM%5N91C:VV
MSNTKVT:^Y+16V.C#YJL/D6-R6$:?U?'U:-6O[B=5.A.,HN+TM%M6DGO=VO<Z
M?Q<SOX0\8 8ROA[5E.XD)M:REZG^[M/)[ 9],_@S_P $U_CO\&?AQXO_ &D=
M/\7>-?#?A^_7Q?,S)=:A'#N O)<E?,/)]<'/N:_H&U&R%YIMS9>4LD-W&\%U
M&PP)+>5#'+&P]'C9E/KG S7YK^)?^"7/[,VO>*-?\1-X-M=-N/%-Y]MU$6DD
M\0FF+^9*S!'&=SDD_CS7G9[1JUJV!K481;HN>CV2E&$==4^CV>ETSV^%LQR>
MEE^<9;F=6I0P^/>'=\/95']7:E9.TE9V;LXNZONV?1[_ +8W[-#26BR?%OPO
M(9D+)MU2 J<#!!()P,\\GV^N]9_M8?LZW]]9:79?%+PK=7^H.D5K9V^IP232
M,Y"J/+# \GCI^M?(;_\ !+;]F[SO*B\.F**V54C;[1<[FR,G;^\ZY_R.#6]X
M;_X)>?LX^'_$VC^+=/TN]AU32IXYX09KCR]\;;UR&FQC/L>*ZL/C,<Z<8U84
M^6&BMY6V5^FG2_74Y,RRS@^E0<<'B,?4<ES*-2;:O+WH\WNZ-WU2LN^I^AS2
MM>26OV";S+>Y1)8YT.87B(# JW?(((/.>V>VHMI.'4MMPI!R.3D=<X_PJM8V
MB:7'8Z; (H["R@CMX<$%@L:*JCN2< =^3^(KH*]159U(.,DDGIHM7MOY[?+H
MM3XN52BZE/V,(Q^K1E3@TK-J6[E9[[/UO>_3+GM99)58 %=PW ]-N>03]/2D
M^Q';,JHJC.Z(#/!'3GCO^/Y"M6BE3O35HN_KY--:?+^EH84J,:7MN2]J]N=-
MM[*VG;O^=S"CT^ZE7;/,4Q('PG0@'.T^H/0\Y'/7K6@UJ,_*%'3D>W^<U=HI
M12BY-)>\[NZOVZN[MI\@I4O8T_9PG44=?MN^KN9IMY@3@*1V]?R!_7]*!;3'
M.[:!CL<_U_S_ #TJ*>E[\L>G2RTVV)5%J7-[:M=VO[[Z6_!V*0M>.BY]OY^W
MX?RIGV:7_9_/_P"L:T**M3?\L7ZQO;T_K]+7.$IVO5JJRMI.W7R7]?@9_P!F
ME![$'@\CUY/(SGZ4_P"SMZ#ICJ/SZ=?>KM%#G?[,/E%(E4K?\O*K]9N_3_+^
MM;TOLS>@Z8.3GZ_C_G%-%N<#Y%ZX^[V'K]?7].M7Z*.=]H_=_7])=@=%O_E]
M67E&HTNFOKI_35W1^SG^XG7^[V_SW_3K@^SG^XG7^[V_SW_3KB]11SOM'[O^
M#Y+[B?8/_G_B.G_+Q^7^7]611^SG^XG7^[V_SW_3K@^SG^XG7^[V_P ]_P!.
MN+U%'.^T?N_X/DON#V#_ .?^(Z?\O'Y?Y?U9%'[.?[B=?[O;_/?].N#[.?[B
M=?[O;_/?].N+U%'.^T?N_P"#Y+[@]@_^?^(Z?\O'Y?Y?U9%'[.>/D3J1]W_.
M!^?X<X/LYX^1.I'W?\X'Y_ASB]11SOM'[O\ @^2^X?L7_P _Z_3_ )>/IR^7
M]W\2C]G/'R)U(^[_ )P/S_#G!]G/'R)U(^[_ )P/S_#G%ZBCG?:/W?\ !\E]
MP>Q?_/\ K]/^7CZ<OE_=_$R+NUF:!UA"K(> 0-OX\?IG/X<UX)^T'9>1\#OB
M ;@F26+P]JC-GH<V4^>?R';\17T?)]QOI7@'[2/_ "1+XC?]BWJ?_I%+7+F&
M)J4\NKQC&%I*=[Q3>L+;]DF]/T/9X1PBI<9\/8V-:NZO]HX"A:51N/)]9I/X
M=KMH_P TGQFRQ?$?XCYM8U6X\2ZN$<'YP1=N"0.^?RQC/:N1;BSNG'W1;7&<
M9[1-U_+\_7K76^//^2B^.?\ L9=:_P#2R2N3;_D&WG_7M<_^BI*_ES&U7+.9
M72_BWTTWE'R?J?\ 0KPU5>7Y!P]"C&,E5RS#5IN:NW-TXW:?;5M+74_LC_X-
MT\G]G36<=&OI<'GJ)5_3\.W'2OZ0J_F__P"#=#_DW+5O^OZ;_P!&5_2!7]"\
M*P4,J@HWLYMZZZN,6_D?X<^/<_:>+/&4VDG+-:[:2LK\\D_R^^X4445]*?CP
M4444 %%%% !1110 4444 %%%% !1110!%,Z1IN=@HSQD\D\\#U/M7Q/_ ,%"
MY4N?V*_VAR3]G6+X?:IN>X_=KP #@GK[?YS]IW:.ZQ[(DE*R!B'[ 9.1[YQ7
MPW_P4:L9;W]C+]H6>.5B8/A]JDBV<_R6TK*!\LA&#AL'/7CF@#^;W_@GE\;/
MAU\'?V@?@OXE\?ZW!H^A_P#"F(;9-0GD$=O)/YC_ +M)&^5F]LY^G?\ I-'_
M  41_90D!8?$S1SE <&XB!(],>9@?7/-?RX^!)?C+^T?H7P ^!7P6_9Z^"^J
M>+=%^&MMK%WKWB"X6WGGL8I3N#2@JQ9@I)RY&3TQFOI%O^"</_!16.[69/@)
M^S@8F3E5UM20?0@7/!'I^% '[^0_\%$?V4)!N7XEZ0-I*G-Q$2,8'3S,'/US
MCFI_^'AW[*?_ $4W2/\ O_#_ /'*_G^'_!.3_@HJ 2GP#_9R7+=#K:YZ>AN#
MQG^E'_#N7_@HQ_T03]G'_P ':?\ Q^@#^@'_ (>'?LI_]%-TC_O_  __ !RC
M_AX=^RG_ -%-TC_O_#_\<K^?[_AW+_P48_Z()^SC_P"#M/\ X_1_P[E_X*,?
M]$$_9Q_\':?_ !^@#^@'_AX=^RG_ -%-TC_O_#_\<H_X>'?LI_\ 13=(_P"_
M\/\ \<K^?[_AW+_P48_Z()^SC_X.T_\ C]'_  [E_P""C'_1!/V<?_!VG_Q^
M@#^@'_AX=^RG_P!%-TC_ +_P_P#QRC_AX=^RG_T4W2/^_P##_P#'*_G^_P"'
M<O\ P48_Z()^SC_X.T_^/T?\.Y?^"C'_ $03]G'_ ,':?_'Z /Z ?^'AW[*?
M_13=(_[_ ,/_ ,<H_P"'AW[*?_13=(_[_P /_P <K^?[_AW+_P %&/\ H@G[
M./\ X.T_^/T?\.Y?^"C'_1!/V<?_  =I_P#'Z /Z ?\ AX=^RG_T4W2/^_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'U%.5&FK125VM%;32"7FG:2Z]_5%%%%!A5]^49+;F4M/E_P?S"BBB@H****
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M6.3N&,8Z]?Y);[5_$_B2YU7Q3XQUN;6/$VHW,MY=7ES,9<F9MYB1V9L;2<$
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M[*\OQ-;"Y!3KV4(-QCB5&2]FVX--4XM-J#TJ;MV23K'39\KB4GR5PC$\R_\
M73\./3IZ<2V5M+;F1IGS)*>44YC0=B.N"1UZ#/KBK1,X/& /3/2K$:'&7QD?
M@._;K]/<5^D1A"C!0CRI=;:MVMO;M\]WZG\H2RRDJWUJM5YYWONWKH^NV]M.
MGH"KMR< D^G7N?;_ #]:EAD#[@ 1@]^/\^_TIQV@8')/?Z?R_ <T1J 6(ZG&
M1V_SQ_GME)N4K]$M5]WZW^_:[-I2E.<.7X(JS\]NO^2ULO(EHHHI%A1110 4
M444 %0RL1G&?NDX]<5-5:0DR[3POEGG\SUZ=>*RJ[+U_6('\_P#_ ,%H0HU_
MX1RO]TSQ1@8&=QF<]_8\_2OGK_@DM\1M&\-?#C]I#0;FPU*>ZN?BKYB2VT3-
M"H)8@.P& <?_ %^*]_\ ^"TI/_"1_!Q2<*;^WSZ$&9\^W^>:\V_X)(6&D#X6
M_M+2S68N+G_A:X*2*@8IUXS@X/\ ]:O XE_W-Z=_TU^__(]+ =?73TO']?ZU
M/U:TN;^THH+R$/'&R!@LN5?G!P16!XE\0Z=X?AGO]1^UNB-M*6H+,< ]AGT(
M^OY5NVRD20JJ2QQD#Y1P!]<<#Z=^M5[ZUM[EI+0Z>]["S@NS)N"G)R/3.?\
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M'T"UC('AU'=AR3",DD8R<@^_>H!HND39=_#R*Q.,&%!P.G5: /-_^%V^%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&1@%> ?H/\\U\[_\$P?A1=>%/B=KNM7$<:V\FF20QJHPPD.1N((^[[U]R?\
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M5?\ T:M?V[VG^IT__KSM_P#T6E &E2-T/T/\J6D;H?H?Y5%3X)>@%23M^/\
M2B/O^']:).WX_P!*(^_X?UKS%_ H_P#;W_I-,=7>/K'\V?C!^W=_R>5^S3_U
MR;_TIDK]E[+_ (]+'_KU@_\ 1*5^-'[=W_)Y7[-/_7)O_2F2OV7LO^/2Q_Z]
M8/\ T2E>9E_\;,/^PFC^9^?<,_\ )8\:_P#85@__ $B1J4445]1'9>B_(_0
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MY]J_D.DWBJ,JO15%?>UFT_3LNGEKH?I$O<PM"+WY8K\ONW_,****Z# ****
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MUX:*_5^>G3^MR*K<=%^&_2R6N[O;S&/-%'-';LX\^0;EB'WM@/+^@ KYH_:
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M.WZBM9-NU=OW<#'TH HO!<(T+VXC5N%G4_<*< E1Z\<5=\M <X[YZ#_"GT4
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M_P"('BWP[X*\(:YXT\17,-AI?AG1M3U1[FX<1HLEE;27"1%R1\TS1A47J6.
M.:VJUZBAI3;5KM;K=;ZZ6Z_Y'F9+7IXK$.<<+)J+LO<3N]'!)-:MVLUV;?0_
M&W_@I-X[U3XR^-OA'^R=X9N9IV\<:W;S>*;:U9F:TM+&Y1F6_5/N+(@(4/@8
M//6OV!^%'PNT?X8>!/"/@W1=.L[:Q\.:/86T$:(JXN([:-)I&V@?,S@DGKTR
M3V_&S_@F]X-U3]HSXT_%C]NGQA#(VC>*M<O=%^'6EWBDKIT&CW36\EU;QR#]
MVEPJ;@RK\VX<D'-?O-%+N#.1@!"0/3CCTXSR.YS7!@'+%U:U2M'6'+RZ6LKJ
MRL[IWT?WH^QXFS>G3H9;E&!I>PIVE[>,7K.K*UY2LD^9*4]]&IZHY7Q2W]B>
M&O%?B6.1Q=6/A[5K]D!_=@V5C-<C _O?N< ^I],5^*W_  20T^X\;_$7]JKX
MZ:LSW-YXZ\6R06<MQ\TD$>F7CQ% Q'"DCHO;ZG/[#_$RZE?X9?$M8<L__""^
M+#$!U,G]CW83').23C\R??\ )[_@BAJ,%W\!_&D$BB/6K;QGXD75$; E&=4D
M$/F+]X9'()ZCI[F8UH*K3I:67.]5HFTE9+;R6FZ\CV^'L)[/@7CS$KW:F!J9
M,E**7,HU<0KJ^_+)/E:O;5K:1^S%G9IYUU=///)]I*EX'.88BG9 >@SC/UXI
ML=NMK-=_OIIH[U2S)(<K"5! ,((.W&?KQ]#3;>62(NCD@;^.< @G'<<^F.OH
M,U=*"9Y"N"%  SDX)Z]><]#T]J[*M&G# <ZBDW!--+=JUUK9W?;U/R>G+&RC
MAL5[WLY5=;7^%5$K]+.R_#U/P7^-.FM\'?\ @J7\ O%FG[+;1/&^@:I!K[Q?
M)=WU[(\L<#3,,!U&1GJ,?G7[[6["6(.1E9HE=?I(I8?^.D>^<]Z_"[_@HG;;
M_P!L[]DV+22#JL18RK&09/(^UN&) .<;>3V_ U^Y]@0-/L<CYQ8VH;(& 1 F
M<YYR.:\G*IIU:L(R6E1:)[MK6SMTMJ[J_7S_ %'C*,:F3\*YE.+57'8"LYSD
MES26%JTX1E+1;V<DUI9I)6*LMN8MB @?.&&,^N<>O3)]!G K:7H/H/Y5GNRL
MPW$_>&.<G@XQG'KZ_CT-:/TKWW&2;<FWS:J]_G9O?^D?F=*+G5K8IZ^W:L[;
M\J2_"WE:_4****1TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 R3[C?2O /VD?\ DB7Q&_[%O4__ $BEKW^3[C?2O /VD?\ DB7Q
M&_[%O4__ $BEK@S3_<*WI+_TE'N\+?\ )3\/?]C? _\ J32/\TCQY_R47QS_
M -C+K7_I9)7)M_R#;S_KVN?_ $5)76>//^2B^.?^QEUK_P!+)*Y-O^0;>?\
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M .2[?\$IOIX__P#2^YH _LIHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMA&US>?M#P+;6NG16WC"]<Q6"+%'(^3DL%Z@GG'.<]Z^^?\ @X@_Y-3^&/\
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MD3#[AQQ@GH>/?/!R,U^*LO\ P6^_9FM)UD;PQK\D%W_';A3+L.1\^8"HX/.
MH^E78/\ @MS^S6Z7$=OX'\=_881N%RR*L$X(RWDN]K\^/]ESCV%5?1KO^AK#
MW(N"V=KWWTML][:;'[5B9&*A#OS_ '>W7K^1J0G'8GZ<X^M?B'%_P70_9;)>
M"#PGXT$BD@IMBR,9'7[,2>.>#QG@U8'_  7,_9:B&#X9\9>8?OH/+8J>V=UN
M>HZ=Z0'[9[O]EORI=P[Y'UXS]*_$O_A^C^RW_P!"SXS_ .^8/_D:G#_@N?\
MLOO]SPMXS8#KD0#!/_;J?2@#]LLCU'YBJ\S.7BC158.V78\JH7G''\1P<5^*
MW_#\O]F+_H5/&7YP?_(E*/\ @N5^S-DN?"7C1;5%W2W/[CRXF&/E;%J,'_\
M4?2@#YO^.]BG[97_  6'^$_P\O(9+SX7_LUZ7>3>+]$OB)=.U#Q-&\]S8WB0
MGY/,BE4>6S D8&#7]'$4<2CRHB$2)$A6-<+Y:Q95%   "@ 8 XZ#I7\U'_!(
M/XF>"?VLOVP?VVOC_P"$[;4X(T\96L%DVH%F,2EG411LP'RD,00.O.:_I5M&
MW(=Y4SJ=L^.H8$X!]\8R?7K0 Z*V6$LR,Q9LYW'(R>^/\\TY25.V5E#.V4 Z
MD Y_^M^?K4]9U^"Y@CB8+<&5&7UV DO] !S0!^$'_!1#SKS]N']F6-+>1%MK
MVP<ROPL@\\'Y?U_*OWD##RXI/6!&V]\;0W\OQXXS7\WO_!87X_>!/V>?VJ/V
M</&OC:QU:]L;>6T=UT]F"@)-_L@X^7KGG/Z_3 _X+??LQ7,MK8Q>&/%ZS&"&
M>/>R[&A$:G *Q*Q&TX^9F]2"<FDTI*S\FO5:HF=TG;NOS1Y/_P %H]TGB#X3
M".-I"DT1900#S*[=3V QG\?2OP9^$]_:6/Q/TF:YN4M3_P +TT93OX"'SUY8
M]..><]NG%?H5^V_^VSX%_;L\>>!?"/PF\+>)M.NO#1$][J%ZP59MLLCA5(2-
M"-OR@ #@#)SR?RP^$OQ$\-ZU^TSI'P.\1Z)=Z#XDA^+^E7:-?*1)?P1S#-W$
MV #&0I^;D<XS7S.?2JUZ/LE;EC=*T7MIU?\ 7S._"2Z.UUL^CUC96U_"]S^L
M7]H7Q7X=F\ 0;=5MY;B+4[ %HB20/)A^8XY '/88&.>U>@>'?%O@RU\-^%YF
M\3Z;-(-'B)@+;E23:,+*,]>>0?0^U9NL_!_P<FKV^B:S&+W3;F.TNB?O*/\
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MS!L.WC(_T4D].I)/J37Z;@92G2@I--^S3?2S[:Z/2S;^ZZ6G@-MN[W9^V*D
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MM\/E,QC3!"+&>54\X)'!.?0D>E?PKZ!XDTWX?>,/B;XD^"/Q?\;^%?"_Q/\
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MW7W\S7W?_P '$'_)J?PQ_P"RMZ?_ .B8:^$/^#:C_D)?M)?]C=??S-?!<8_
MO6'_ +85#XX_XH_FC^JZBBBOR2AU^?Z$A1110 4444 %%%% !36;:I;!..PZ
MGG'%.IDKM'&[HGF.HRJ==WU]AP:'_DEZMV0I35-.;T4/>?RU(KF?R/)4J<S@
M8/9<]B?QY^GTKY#_ &H/VG?#/[/G@W5]5DGCU+Q0L&W2-&@8/<7%Q-\D8$2D
MNVUB"5"YZ>YJU^TW^T_X,_9^\'WEYJU_%=^*KV&2/2=(BD$ERUQ(I6+]VA+
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MSP]XJTA- MPR6HN()&NEB+LP5FV?[7(SBMU?^"#.DJ-J>+M'A4<;8[>0!O\
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M#ZFFL%AT[\GY>7]U=OZOH>UJ?S-_TNUNR_X<_F^'_!!;2B#GQEI*L1C*V\@
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M65;::WAE#J)_+:/:=P#9 ^I/^"<W[%VC?L=_ ZTT*>1-6^*OC&-/$?Q'\77
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MG773^ON)E'EMKO\ \ 6BBBK)"HMC>H_,_P"%2T4FK]_DVAIVZ)^JOL1&-NQ
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MP?\ QRC^U=)_Z"NF?^#&#_XY6A1H^>W_ #R;\Q_A1Y[?\\F_,?X5G?VKI/\
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M,?6K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!>/M8^'_ ,1-:UJQET'S5OM<CT&_&EI(A;*F<0^42"""?,P<9]S4^"/_  6
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M,4?\([X9_P"A?T/_ ,%-E_\ &*"C^(__ (5?\6O^?3]H3_PJ=<H_X5?\6O\
MGT_:$_\ "IURO[</^$=\,_\ 0OZ'_P""FR_^,4?\([X9_P"A?T/_ ,%-E_\
M&* /XC_^%7_%K_GT_:$_\*G7*/\ A5_Q:_Y]/VA/_"IURO[</^$=\,_]"_H?
M_@ILO_C%'_".^&?^A?T/_P %-E_\8H _B/\ ^%7_ !:_Y]/VA/\ PJ=<IK_"
MOXM2QR1BQ_:%<NNT(OBK6PSY[*QZ'WK^W+_A'?#/_0OZ'_X*;+_XQ1_PCGAL
M\+H&AAOX3_9=FN#VY$((Y]"#332:;5TFG;T=P/X?_#W[,_P*^.GQ"\(? O\
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M\BT?\./_ (G_ /1Q^F?^":Z_^1:!GU3_ ,/B/AS_ -$U\1?^!D/_ ,:IDO\
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M!^B7[+/_  41^$'[77B?Q9X(\#176C>*? QMSK5G<.DOV8S8(B98E&-Y( W
M?E7Z$1)+<(\BHMO* %7=A@2,C<5'0, "./45_*=_P2^^"6K?L7?\%7?VHO@W
MX@\2VGBBV\?:?IMSI%VT'E^88(E?= LB*5;Y<LH7<,$,!@U_5M9+")KHJS^<
M96$J,254!B$V#H%(QT_EU )(;:1(F5S%YQ)_>1IMSUQG@'//^>TH#01' ,KA
M2QQP6(QZ]?\ /%6*JW0DVAH<F4?<].,DY'?/3^M 'R;^UA^V1\-/V1? UIXU
M^(AG9+Z[AM+73H65)Y))R N&8$'DXX'KZ8KX>C_X+)_#420SW7PP\76VC7D2
M26.M-N:RN?,561?-%OY:%@PQN>OGS_@OK\,]9^*7PE\ :#HWBBRT'58]5MKF
M-;B-6,CI,6/7.06Z#GBOQI\/^+/C=K'[*7CGX-77BOPC;:[I?Q-\$^%=&\12
MZ/$UU:6E_+;6[[)RF]05R3C@YY[4 ?T3_P##X+X>+=)%-\-/$,5K*I>.[:]A
MV,@Y#;?*SR.<=A4 _P""QGPT>258?AQXBE2-MHD%W$%?D\K^ZYZ<\]Z^0;3_
M ((D_%K5+#1+F^_:2TOSI=(M))84TNXVB6:UC9]H$!#J'9@K)O4A1AL5K1_\
M$/\ XI)!#"_[1VD@Q*1E=%N@3GIN_P!%&3SU/M0!]5?\/B/AS_T37Q%_X&0_
M_&J/^'Q'PY_Z)KXB_P# R'_XU7RM_P ./_B?_P!''Z9_X)KK_P"1:/\ AQ_\
M3_\ HX_3/_!-=?\ R+0!]4_\/B/AS_T37Q%_X&0__&J/^'Q'PY_Z)KXB_P#
MR'_XU7RM_P ./_B?_P!''Z9_X)KK_P"1:/\ AQ_\3_\ HX_3/_!-=?\ R+0!
M]4_\/B/AS_T37Q%_X&0__&J/^'Q'PY_Z)KXB_P# R'_XU7RM_P ./_B?_P!'
M'Z9_X)KK_P"1:/\ AQ_\3_\ HX_3/_!-=?\ R+0!]4_\/B/AS_T37Q%_X&0_
M_&J3_A[_ . ;A2T'POUZ1!D,SWT(QQSQY:D\8_#\J^5_^''_ ,3_ /HX_3/_
M  377_R+35_X(@_$])<O^T18RQD8/EZ;=1#'<%?LXW>O?T]:3JQHVG.+DDTK
M*]]6E?2[LKZC4(5+QGLUIMOTWT_X)]1M_P %<_!&HI)8:3\/=5MM2E5HXFFN
MD948Y ;" $D'D<G'%85G^WM\1R);B+3O+@N9#+!#*6#B-CD 9QP!QV';(KPS
MP]_P1.\?:%KL&K2?'*SNEAD60@V4PW;>?NF$=?ICBOL"+_@G!?RVMK'J/Q#@
MN+BTA6'S(+:2-&50!\RB/ ;([_IV^WR7$<-.DGCZ4KOXKRJ-W]U/9-I)[7LO
MS/C\WCF=.I;!MQCLK1NK*UDM%\]]+;;&)H_[=GQ&OF"?V-$<\98 YP<<<]3_
M )-<O\4/V^?BAX0M_/@TZUY@WB,HN[/OCIC\,=.N"/8-,_X)YSZ>P9?'0.""
M/W4N?S\NL'Q__P $WG\:0^5-\0%@;RO*&8I,XP!TV$\^O_ZZ^EPV*X"AB(NI
MAG.'5WJ-+5?W7T6_>Q\GFL.+JF"E' U7'$<T=7"]XZ)V3MW3TZ7/SE\1?\%:
M?CGILK/::;;%2Q 7 P,Y('4\]/3@_@,+1_\ @M#\0/">M0Z_\2=(9M"A,$=S
M%"66)(WE2(LS A5Y8C)P>.<C-?3.L?\ !$]=3RX^*JQ!F)QY$W&3G_GD0 .G
M7G\>?F/]J_\ X(GZKHW[.7Q8U:P^+UH\FC^&9-3M8GLI3.9;26.0A)C%@;AD
MJ-P.!@=Z^@QN/\*9X-^RPDEBW'EBTZR2D[)?8LK-][;=-3S\GH\>1KP6-K<U
M.-I/]U&/NJVN]K6Z6_%:?T>_!GXO^'?C=\-_"WQ!\-OYUAXDTJTU-$C.1#]H
MC5_++ D$J3Z]CP*]BMFC:/\ =DD D$$Y(;OS]:_)_P#X(^ZU&?V(? NEPZM'
MX@O_  FL7AZ]NHTPPN+-/*=&[@@J3@XQW&#7ZLZ<H$ 8 KYGSD$Y.3G/3W!_
MSQ7X!CL3AYYO4I8&,HX5N<HW=W;F7*N9;I)6ZNV[9^S82C6C@Z=3$2YJCM%Z
M6:T3MZ+UZE^JMQ<- \*B(NCLWF.#_JD5=Q=AR< <U:K*N@J3RW1<E;:UGDGB
MZAD\DD<?\!!XZ_I6AJ?EQ\8?^"LGP6^&GQFU?X'Z)HFJ^./&.AP&;4K;29D4
MPLIVN@C\MW8J3G@9(!XSTX9O^"PG@983.WPH\5QHDQ@F$\Z0R0R*<-NCDA5]
MH(ZX /K7\]?[27PX\:Z'_P %//&WQQ^'_BS3='LH79;[1;ZV65+I5G0NGE$?
M,752.>N:^B_@Q^S?\6_V^OVG/BO%8_%O0O .A^&O"NEW$GAZVTID474[PQO=
MK##$Q+2R."65"<$LV #@ _9'_A\'\-Q/! ?AUX@S.H96^V0X&1G;_J^3V'\N
MU5_^'Q'P[#.K?#/Q$"KL@_TR'D*<;A^ZZ&OE!O\ @A]\4)+F-Q^T?IFZV4;
M-(N2<@ #*BVW 9ZY_.EA_P""('Q496:?]H[2PY=CQH]RPP>1R+8_EG- 'U?_
M ,/B/AS_ -$U\1?^!D/_ ,:H_P"'Q'PY_P"B:^(O_ R'_P"-5\K?\./_ (G_
M /1Q^F?^":Z_^1:/^''_ ,3_ /HX_3/_  377_R+0!]4_P##XCX<_P#1-?$7
M_@9#_P#&J/\ A\1\.?\ HFOB+_P,A_\ C5?*W_#C_P")_P#T<?IG_@FNO_D6
MC_AQ_P#$_P#Z./TS_P $UU_\BT ?5/\ P^(^'/\ T37Q%_X&0_\ QJC_ (?#
M_#K_ *)KXB_\#8?_ (U7RM_PX_\ B?\ ]''Z9_X)KK_Y%IA_X(>_$YB2?VC-
M.8^HTF[&?P^RU<%%M\SLK.WK=?\ !(FY*W+U?:_5+]3ZM_X?#_#K_HFOB'_P
M-@_^-4H_X+ _#-TDF?X;:^'A!.&N868\#HWE=_TQ7RC_ ,.._B=_T<5I_P#X
M*KO_ .1:C/\ P1 ^+8$D?_#1FE26S !8?['N@_N"YM<=SWI47#VR55-P=GI=
M);;OMOU7H.JI*CS4VN>U[;N]D[**UWTMZ[VT^FF_X*>1?$V,GP7X3O="^RY^
M:\N%D>0@GKM*CZ84<#ZU!:?M[?$9G>(V*'R<@[F&3C(SDGVXYQ7+?"G_ ()$
M>(_ *.=9^+5OJC,"6,5M+&">"?\ ED,9 /7&!TR<FO<;?_@FJ5=YT\> >9U^
M20\YQU\O'8CKC/Z?>935X4P_O8RG[1N*BTW)J_=635UVU5UW1\'F/^LF(DZ=
M"HX<LN9)4^EU9K1.WGYV]*FC_MK?$6^M6NSID6V,$[.,G&<GCU_+CM7S7\3/
M^"F?Q9\*W=[#::+ (X"51<#<,<\GKSR>HZ'WK[.T[_@G_=:;:/ OCE6!S_!)
MWXQ]WUP37@WC?_@DW+XPN[N\E^):P?:F),7E2D+U[[,=QSWZ=J^LPN8>'',G
M7P:WBG_$U>G\L.N_W;]/F<7@N.U_ Q'12:]DGV25MM.JZ]/+X/NO^"O7QRA>
M1QI<*(I.%^F??(SZ]_TKZ5_8_P#^"LL_CWXN:7\,_B9"EK>^*64:=(TP"AF<
MJJ*A<9/3  _K52\_X(AQ7 9C\4TR3D@P2<=!_P \^I__ %U^?/[1/_!/F#]B
MK]IC]F[XCCQG)KD5[XGT?3Y$1VC4O+>;"CH0I&2#U SP1D'GEXDK<!8S!4Z>
M2T.3%*3G-\TTW!*.BYHK5-J^K?7HR\@_UVPN+J2S2MS8>45&/[I17-=;M7Z+
M3ONMC^P4:BAC+O"8X)#&$;IY@F (8=L8;Z=^>E:2.B (BDJN,'Z\\G\?YUBV
M;PW%AITTX"QR6%C-!%P=S&V1P!Z\M@ 9SC.<5LQ+O <J4W#.WT&<8'U'.:_'
M,4^6:5-\O1I._96;[_K?M8_7,*Y2IIUG=ZZM6O>UG9;;NRU=K;=+->9_%[XK
M>%O@K\.O%?Q,\:7/V/P[X2TJ[U6_E[M':Q-(8U.,*S[=H+<#GVSZ0[XZ=NI_
MITKX%_X*>6<6H_L)?M&:<Q$;WWP[UV*"=AN$$S6KA)AD<;2<]O3O514E&+D]
M7]^R_K^E>U.,I.*=VM_PZ_,^4="_X+3_  C\46>F:MX=^'7BO5]%U>.62RU*
MR)N('6.1X\EHH'4 E,Y) P>O:OI?]DW_ (*/?";]K/QYX@^'7A+3[S2O$GAV
MVFN;ZRO+B*295@!+J8U574\?Q+QSZ5_)#^SI)\;OV4/@1\%O"FF>-/".O67Q
M.^'^HZE::CJ.CQ7SZ ]Q=2[)))'0[3$'7)SQCG)Z_<G_  1R^"^M_"7_ (*2
M:SJ6O>)T\17WQ$^#^L>*+^[M&\O3KJ^FBFD\VVMUPD:C>  !Q@=.E,H_L)CE
M+1"21#$><JW48-.$@/(&0>AS_P#6JJA><RF7Y(XY6V@CJ@..?7I^O%2JZD@J
M1ZCKC'X__KII7NNMM/O1G.:ARW^T[?Y_-=.X]I@#C'O^'Z5\B_M<?MC?#K]C
M_P &:/XO^(T<DB:]K"Z/I>GQ2(D]Q<.P165G!&"3TP37UTVT@?WLY/7KW]NO
MI7\YG_!?CP?'\8M+_9;^">GZ]_8&O^*/C'I8.H[#)]GLYIH?F8*&8(,DG@#'
MOUG#U(.O&-9>ZY6T=M';=I^KU]&][F(<E0<J6D^CWN]->JMKW5]D?2<W_!4^
M+QV)+#P3X,N](4V_VB"^NKA9/-4\JHVX49!!QM'O5>W_ &^/B0JQJ^G1RM@!
MLD$GZ]>?U]NM>=?!S_@D%XE^&>V35OC#;^++62)(HXH8'A,"F-<*'9%4@;N"
MIP1@\@\_1T/_  378.)H_'(1&Y6,I(VP?W=P0@CKG!-?HF3U>$L-3G/,*2J.
M<4HIRDVII*[:2;VTU5GKTU?P>8?ZR8JHZ>%J65-\W\-;-I)]FF]M=7=;;5=%
M_;=^(6H* ='@4X;DJOH3R?08SCZ_A\U_%#_@I5\7?",]]#;Z=:L(971 J ,
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M  6$^'3)?;/AGXFFN+*)93;07"3S2ANHCCBA9B1UX!KY/_X<>?$X=?VBM/\
M_!5=\XYQ_P >O?I[5\>_M*_L=_&#]@'XP_LP^.M#^)>B^.=(\8^,-1T3Q?H.
MH6!=+FWM[>"57\F>-2T?[XJ&P4RK '(($R4>6+3][[2N:)RYY)_"K6=N^MK]
M;7/U_P#!7_!8GX*>)_B=\/?AGJOA;7?#.H?$.^_L_3KG4W6,6]SE5V20/&DC
M?,V, "OV BE2:*.:-@T<L:2QL.C)(H9&'L5(/XU_!SXB\%>/OB#_ ,%$/V?_
M (W>+_%>A:#X)M/'UQ#HGA#3;*.$2RK>IE/)C7MC;TS_ "K^[K2W633-.D3[
MDEA9NG&/E:WC9>.W!'';I4%E^JDEVD;[,$DD =LG./2K9. 3Z#-4D*3XE*#(
M)&/IU_S_ /6IV?+)I-V5UZW7]?\ #HB4N5Q3V;MZM['.^+/&%CX1\/>(?$>H
MQM]A\.Z?/J-V0P&Z&WA>:3!/'"(>O%?D';_\%H_@]J]_>P>%? NLZ]:V5_>:
M=-?VUY;I$+FSD:*49"-D;U/ ;..V:^^OVU-=A\/?LO\ QDU6286OF>%-5LQ.
M6V^6]U92P(X/'*LV?<BOYCOV$?\ @CYX\^+G[,^G?$30_C;;Z1?>)_&'B+51
M;RVDS.8)KT2^4TBQ,H(68 ;F (''%&$G3=:,,1\+>MM-+ZN_DDW^?6QB8U51
M<J+M.S6JYKOE3NO*[MH]]C];;G_@HUK_ (IF77?"^@76GP3LP339&+N@7U.2
M#P <Y/MBM"S_ &^?B3*5+Z/%EB!@A<Y)(YR>2#UX],^M6O!O_!,3Q-X4\.:/
MHTWQ0L)K^UC"7-U]C?,QVX?:3%G)Z=">_85WT7_!-^>+83X\4L#N<B-P"QY)
M *=">F<\5][EU;A7#Q_VJBJCFE?FE)VMNT[=^UTW;U?PV,I<28J<E0J\JIMV
M7)KTMKVU6CZ/5MF;??ML_$33M&?4VTRWE'D.ZQA4W*P4D9(&1[]/\/AKQO\
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MBBBOHC\A"BBB@ HHHH **** "BBB@ HHHH **** *MU;_:%0;F4HP<%3CD=
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M?7,9*)&,K1F,A0H(D[-GL*FJ*+>%VN/N\ ^HZ#_]=2T %%%% !1110 4444
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M!@$@P/G!K^'?X]130_'>:"WD1+%?VL?#S-"P!D9O[0)R6YSSC\OQK^XK5?\
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M(%?T3PO_ ,BJG_B_]MB?X:^/'_)UN,/^QI7_ /3D@HHHKZ(_(0HHHH ****
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MT)+\8[*.U@M]-B2">U^RQVZ;4#)(J$%57&&4'TSQ0!^D-NLPGG9Q'Y38,3(
M"P./O$=>GJ:_!;_@H=_RE0_X)N?]@WQ;_P"G&^K]W=)N5N3/Y<S/%&0B0LA5
MH<$@Y8_>SV]O3-?A%_P4._Y2H?\ !-S_ +!OBW_TXWU '[[4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1:<5=N3LY7MMT]WK?57%3G3E.*D]&U=1>O3K;UV^\HZKXOM=+GL[:7RQ<7I
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M .BV>"O_  "T[_"OVJ_X=7?L8_\ 0CZS_P"%'>__ !FC_AU=^QC_ -"/K/\
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MHHU*K)AF+G< ,=>#COFOEO\ X*W_ +/WAOPK)I?Q6T"TBM-6\37!TS45B14
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M -(8*W8O]6OX_P#H1K"\/_\ ( \/?]@33/\ TA@K=B_U:_C_ .A&@"2BBB@
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MGKJ_'?\ R47QW_V,VM?^E3URC?\ (/OO^N%S_P"BGK^8\3_R.O\ N*_S@?\
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MU^M)]B4,3EF&-NW)Z>I]>@]?RJ_134FKVZ_UH4I2C>SM?_.^G8J?9V  1S&
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M>'O_ $JM:^P?^"P/_),?AK_V-4G_ **BKX^_X(R_\G,?M&?]B=X>_P#2JUH
M_I$M_N'_ 'V_I4]06_W#_OM_2IZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *;_'_ ,!_K3J;_'_P'^M '\>7_!77_D[FZ_[%RY_]EK^ES]AK
M_DU'X(?]B99?^A25_-'_ ,%=?^3N;K_L7+G_ -EK^ES]AK_DU'X(?]B99?\
MH4E 'UBO\7^\?Z4ZFK_%_O'^E.H **** "BBB@ HHHH **** "BBB@ K\!?^
M"W7_ "'OV//^RE:S_P"D=I7[]5^ O_!;K_D/?L>?]E*UG_TCM* .G_X(^?\
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M#U*JA3:MY/F5]$DW=6WOMKJ?NY\4_C'\.O@SX5U/QG\3O&'AOPAX<T:QFO\
M4KC6-4M+6Y,,2%O+LK2XD1[R=W*JL,8+MGCUK^<GQ'XE^*W_  6:^.6C^#?
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M  3Q_P"3;?\ @EA_U^ZK_P"C5K^W>T_U.G_]>=O_ .BTK^(C_@GC_P FV_\
M!+#_ *_=5_\ 1JU_;O:?ZG3_ /KSM_\ T6E &E2-T/T/\J6D;H?H?Y5%3X)>
M@%23M^/]*(^_X?UHD[?C_2B/O^']:\Q?P*/_ &]_Z33'5WCZQ_-GXP?MW?\
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M17WCZ/\ ,_TB^@9_O/&?_8%@O_2HG+2?ZF7ZR_R:O[ O^#<C_DB?BS_K_?\
M]#-?Q^R?ZF7ZR_R:O[ O^#<C_DB?BS_K_?\ ]#-?8<$?\E!@O6K_ .FS]N^F
M+_R:?-?3"_\ J50/Z7Z***_H$_QP"BBB@ HHHH **** "BBB@ IK_=/X?S%.
MIK_=/X?S% '+^,/^12\8?]BWKG_IKO*_B'T'_D&?&[_LY[PE_P"I :_MX\8?
M\BEXP_[%O7/_ $UWE?Q#Z#_R#/C=_P!G/>$O_4@- ']P/A__ ) 'A[_L":9_
MZ0P5NQ?ZM?Q_]"-87A__ ) 'A[_L":9_Z0P5NQ?ZM?Q_]"- $E%%% !1110
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M_5?@+_P6Z_Y#W['G_92M9_\ 2.TH Z?_ ((^?\ASXV_]?:_^EL=?NG7X6?\
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M^)^D*ZT>Z[_A^'?4BCACC9F0 %N2< G/KGKSZ=*EHHIC"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#YH_;#_ .3:_B]_V)FM_P#ION*_EM^ _P#R7;_@
ME-]/'_\ Z7W-?U)?MA_\FU_%[_L3-;_]-]Q7\MOP'_Y+M_P2F^GC_P#]+[F@
M#^RFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH _AV_X)X_\ )MO_  2P_P"OW5?_ $:M?V[VG^IT
M_P#Z\[?_ -%I7\1'_!/'_DVW_@EA_P!?NJ_^C5K^W>T_U.G_ /7G;_\ HM*
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M]OZ5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3?X_\ @/\
M6G4W^/\ X#_6@#^/+_@KK_R=S=?]BY<_^RU_2Y^PU_R:C\$/^Q,LO_0I*_FC
M_P""NO\ R=S=?]BY<_\ LM?TN?L-?\FH_!#_ +$RR_\ 0I* /K%?XO\ >/\
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M5#6!;N1US[Y_*GY^4KCJ<Y_+_"FT4'.Z;D^9:):V\D[_ *_UH%%%% !1110
M4444 %%%% !1110 4444 %%%% !3X_OK]:93X_OK]:F?POY?FA/;YQ_-'E7Q
M_P#^2*?$S_L6=2_])Y*_S8?'7_)2O'?_ &-FK?\ HYJ_TGOC_P#\D4^)G_8L
MZE_Z3R5_FP^.O^2E>._^QLU;_P!'-7D5]X^C_,_TB^@9_O/&?_8%@O\ TJ)R
MTG^IE^LO\FK^P+_@W(_Y(GXL_P"O]_\ T,U_'[)_J9?K+_)J_L"_X-R/^2)^
M+/\ K_?_ -#-?8<$?\E!@O6K_P"FS]N^F+_R:?-?3"_^I5 _I?HHHK^@3_'
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MA0!_;WH7_(%TG_L&:?\ ^D<%:M96A?\ (%TG_L&:?_Z1P5JT %%%% !1110
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M8%4KNQD],]/T_P#KTJJ >IY(SFIM@]3^G^%&P=B?\_A67L:=E'ETC>WSM?\
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M8Z_=.OPL_P""/G_(<^-O_7VO_I;'7[IT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!0U7_ )!FH?\ 7E=?^B7K^'[X^?\ )=[G_L[#P]_Z<*_N
M!U7_ )!FH?\ 7E=?^B7K^'[X^?\ )=[G_L[#P]_Z<* /[>]"_P"0+I/_ &#-
M/_\ 2."M6LK0O^0+I/\ V#-/_P#2."M6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** (IVVQL?0<_3FO OVB_WGP2^(N3C=X;U7\,6,W^&?QKWN
MY_U+_0_R->"?M#_\D2^(?_8MZM_Z17%<.:Z9;B)+=*23]5%?JSW^&$EQ%PY+
MJ\]P$6_+V])V]+L_S2/'1W?$3QSD=?$^M#WP+M_\:Y1A_HMU%SM-M<C.>?\
M5O\ R_#//:NJ\<?\E#\<?]C1K?\ Z5M7+M_J;C_KWN?_ $6]?R_6USB5]?WR
M6O:Z/^@SA>$:V09&ZD5)T\@I3A?I)4Z;3^3;/[)/^#=--O[.>L8)^6_D_'=*
M/RX[=.OUK^CZOYQ/^#=7_DW/6O\ K_;_ -&K7]'=?T1PFV\JA=W]]K7R2/\
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M"Q1110 4444 %%%% !1110 4R1MB,V57 )RW"CZ^U/IDL:RQO&XRKJ58>H-
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M?L.0>"O3IC]:_BIJ?P4^#?AZT\8^,]#\.Z9I:WUOI*W#:9I\:22W;,J*6-N
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MI!HUD?"/ATK;:=#';P&8VUL93Y<2HJ[FR3QWSD]_Z/Z "BBB@ HHHH ****
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M<\9EVD,J_P"T.GZU1C9E<7,X^8[A'''SA I)) QV&!GG/'T /QI^(W_!<_\
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M2,^]0J9RA'=?7]?TJS5&V*O([!BI7*"+IA1CYL>Y%7J "BBB@ HHHH ****
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MYO?AM\2_!&M^";/QJ\\?BO19]/9FU&ZGEM=XEC4A2"-V>.3R*_MM/P^\$!W
M\%>&SY6S[,ATJP".0.I!M\#!P<'/ZYK\,_VY-$\.Z/\ \%8?^"=MIIVF:5X?
M?6-"\5-?3V-K;6JS2P75XL*_N8D!";50'N!F@#]_[6:1]T<X5;A%!D5#E0&+
M%,'UVX)JW5&PBECA!N&5YV^_(#G>H/R'/^[Z^E7J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\.?\
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M6TL1F/RHF%!*2LG '#=/3YI_X+?AO^&*%9U"2/\ $KPFTBCIO:XN2WZ@8[4
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M !7$>.86C\%>,F$SL9=$U0KG_ED/LLHPOU!_SS7;UQ_CS_D2?%G_ & ]4_\
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MF!1<!5\[9TS@=/;I_/O7X)?\%#O^4J'_  3<_P"P;XM_].-]0!^^H55&%
M X]!T'X4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO^$4T*2[>&ZRMM,-*MO,A8%>71@5/(YX'K7^<O\ MI_\''O[6?[;GPE?P?\
M%3X;?"^W\/>$?&&C:G'INFPS_9M4G@FADVW\;6<09'PJL%)^48 %;O@[_@N]
MXVUOPY;W?_#(_P"SM8GPUIEG8)':Z?<JFH"WMHXA/>?Z ,RN%#,1G)S0!_HN
M_P##SS]C;)Q\6M$."1GS>N#C/3O1_P ///V-_P#HK6B?]_?_ *U?YS/_  _Z
M\?@D?\,A?LY?*67_ )!UQ_"2/^@>?2C_ (?]^/\ _HT+]G+_ ,%]Q_\ *Z@#
M_1F_X>>?L;_]%:T3_O[_ /6H_P"'GG[&_P#T5K1/^_O_ -:O\YG_ (?]^/\
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M #Z=/U]J/^'F7[%W_15M$Z_\_+_GTZ?K[5_G@?\ #_+QS_T:!^SC_P""Z?\
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MW_ZU'_#SS]C?_HK6B?\ ?W_ZU?YS/_#_ +\?_P#1H7[.7_@ON/\ Y74?\/\
MOQ__ -&A?LY?^"^X_P#E=0!_HS?\///V-_\ HK6B?]_?_K4H_P""FO[&]U^Z
M7XLZ$[$C"?:-K'GJ, DXP<_0YK_.8_X?]^/_ /HT+]G+_P %]Q_\KJ+;_@O5
MX^U+4K2(_LE?L[VV WS0Z?<!OS^P#_ZW..M '^B+XL_X*<_L:3>'_%&E0?%[
M0'U-O#FKK!9>>1+,SV$\2(G!R2TBC//?FOS[_P""#'B?1/&UU^V'XET!Y9=.
MU;XJB:&Y.?+F1Y+[:\)/!4K@@U_&5>_\%\?&L,^HZ/\ \,=?LV//>:1?0?VL
MVFW!OH-\+C?$W]GD!EQD9/6L+]BG_@X=_:F_8OTGX@Q?#+X;_#.ZL?B7X@;7
MK_3]3BG%KI=W')/L73T6SD_=JLKH X P>5R!@ _U=%@4$G<Q)(Y/4#T^AZ?2
MF-;0[UD5$213PXX;'<#V/>O\V;_B,"_;[S_R2KX-?3[-+C_TV9_6GO\ \'@'
M[?0QCX5?!OO_ ,N\OM_U"Z /])">RBG^;<(Y<@^=&?GP.-O;@]^:_'+_ (+F
MSV5C^Q)//J&HVVG6EIX^\-7<]_>MM@C6"2X=C(V>-VX_D:_CY_XC OV^_P#H
ME?P;_P# :3_Y5U\K_MH_\'-W[7W[5/P,F^%/Q$^%/PC_ .$;U7Q!975Z+6WG
M+S&RCEDA1D^Q1+@;I%!!!_>$L&P!0!_>-^S!_P %(?V1/"GP ^$?A[Q%\6O#
M]G?V_A6QLKAS<$0-/$I#A7QU.X *#U!Z9Q7OJ?\ !3O]CQ'EBE^*&E6R1MB"
M260A+I,_ZR!B,LASG/I7^;IX>_X+R>-_!/A+P1\-$_9$_9SUFPMM.B6/5=2T
MZX?4@0JG=O%@PS_P*NPN?^"]_P 1+"7[+)^R?^SU>QQA?L_VC3[@F!& /EQ_
MZ ?EYQ]* /\ 1?\ ^'GG[&__ $5K1/\ O[_]:C_AYY^QO_T5K1/^_O\ ]:O\
MYG_A_P!^/_\ HT+]G+_P7W'_ ,KJ/^'_ 'X__P"C0OV<O_!?<?\ RNH _P!&
M;_AYY^QO_P!%:T3_ +^__6H_X>>?L;_]%:T3_O[_ /6K_.9_X?\ ?C__ *-"
M_9R_\%]Q_P#*ZC_A_P!^/_\ HT+]G+_P7W'_ ,KJ /\ 1F_X>>?L;_\ 16M$
M_P"_O_UJ/^'GG[&__16M$_[^_P#UJ_SF?^'_ 'X__P"C0OV<O_!?<?\ RNH_
MX?\ ?C__ *-"_9R_\%]Q_P#*Z@#_ $9O^'GG[&__ $5K1/\ O[_]:C_AYY^Q
MO_T5K1/^_O\ ]:O\YG_A_P!^/_\ HT+]G+_P7W'_ ,KJ/^'_ 'X__P"C0OV<
MO_!?<?\ RNH _P!&;_AYY^QO_P!%:T3_ +^__6H_X>>?L;_]%:T3_O[_ /6K
M_.9_X?\ ?C__ *-"_9R_\%]Q_P#*ZC_A_P!^/_\ HT+]G+_P7W'_ ,KJ /\
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MO_T5K1/^_O\ ]:C_ (>>?L;_ /16M$_[^_\ UJ_SF?\ A_WX_P#^C0OV<O\
MP7W'_P KJ/\ A_WX_P#^C0OV<O\ P7W'_P KJ /]&;_AYY^QO_T5K1/^_O\
M]:C_ (>>?L;_ /16M$_[^_\ UJ_SF?\ A_WX_P#^C0OV<O\ P7W'_P KJ/\
MA_WX_P#^C0OV<O\ P7W'_P KJ /]&;_AYY^QO_T5K1/^_O\ ]:C_ (>>?L;_
M /16M$_[^_\ UJ_SF?\ A_WX_P#^C0OV<O\ P7W'_P KJ/\ A_WX_P#^C0OV
M<O\ P7W'_P KJ /]&;_AYY^QO_T5K1/^_O\ ]:C_ (>>?L;_ /16M$_[^_\
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M]G([L<?V=<<9&>OV#^E-_P"'_?C\?\VA?LY?^"^X_P#E=0!_HS?\///V-_\
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M0D2>'M(4 ?>#?8;=OY%<_0^];3V*O+--YSH\RJF 1^Z"_P!W/0G&#TZG\?\
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M@ (/*  _#'HTW_!?WQ^\LLG_  R#^SBOFR/)L73K@*FYC\J_\2[H.@]J /\
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M $9O^'GG[&__ $5K1/\ O[_]:C_AYY^QO_T5K1/^_O\ ]:O\YG_A_P!^/_\
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M_.9_X?\ ?C__ *-"_9R_\%]Q_P#*ZC_A_P!^/_\ HT+]G+_P7W'_ ,KJ /\
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M]&;_ (>>?L;_ /16M$_[^_\ UJ/^'GG[&_\ T5K1/^_O_P!:O\YG_A_WX_\
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MI<_/)[.?3\35EHPQ!W@8Z*"-H/'(SGGC_P"OVK_-E_XC OV^_P#HE?P;_P#
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(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img108224922_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img108224922_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %6 BT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]2-,M[FVM
M0EW<K=S;B3*L?E@C/ VY/0<5;HHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Y7XJZQJOA_X:>*]3T,*=9L]+N;B
MR#KN7SEC8ID=_F XKC5US75N)K1-7UN_N;01I<O9Z3&\:R-&LFW/T=?SKMOB
M9_R3OQ-_V#;C_P!%M53P'_R&O%__ &$(?_2*WH YC^U_$?\ S\^)O_!-%1_:
M_B/_ )^?$W_@FBKUBB@#R?\ M?Q'_P _/B;_ ,$T5']K^(_^?GQ-_P"":*O6
M** /)_[7\1_\_/B;_P $T5']K^(_^?GQ-_X)HJ]8HH \G_M?Q'_S\^)O_!-%
M5+5[OQ=?VRI9ZOXGT^4-DRKH4+Y'I@U[+10!X%]E^('_ $./BO\ \)JVJGJU
M]XUT.T^TWOC;Q7#!N5-W_",6Y)8G   Y))KZ)KD?B9_R!;#_ +"5K_Z,% 'B
MW_"3>,!_S-_C?_PCHO\ "C_A)O%__0W^-_\ PCHO\*^EZ* /F:U\5^*;O6+?
M2E\<^+H]0N(WEA@G\*01M(J_>(SZ9%;GV7X@?]#CXK_\)JVKL?%/_)>? W_8
M.U#^25Z6: /F&3QQXBCU*[T__A/_ !5)>VC!9X8O"T#&,GH#CZ5@:A\=O[*O
M9K.]^*WB&UNH#MEAE\,VX9#UP174^&++3'^+WQEU+5-.DU>/3/)GCM8P69OD
M8L$4'ECM _"J7Q ^''AWXEWGPZDTW1_^$8GUEIYV,UOB8%(]RK*IZCCH>QH
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MM]KDFKVLE^+>*.&Y:&0*Y8ID;". N#BNOLO!_P 0;VS@N%\1Q(LT:R!3=RY
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MGOCUX+^)/PXATG0-4-Y?+J,,YC\IE^10X)R?]X5]8:"W_$CTX'@_9H^O^Z*
M-"BBB@ HHHH **** $/2OG27_BFOVT8F)*1ZYH^T+V8JO7\XS^M?1E?./[0.
M?#GQW^%/B( HCW#6+2#L"V#G\)#0!]'44B].*6@ HHHH **** "BBB@#F?B9
M_P D[\3?]@VX_P#1;54\!_\ (:\7_P#80A_](K>K?Q,_Y)WXF_[!MQ_Z+:JG
M@/\ Y#/B\_\ 41A_](K>@#L:*3/L:,^QH 6BDS[&C/M0 M%%% !1110 4444
M %%%% !1110 4444 %%(3B@'(H ",TM%% 'E,'_(_6O_ &-$_P#Z;&KU4#%>
M50_\C]:G_J:)_P#TV-7JU !1110 4444 %%%% !1110 4444 %%%% !1110
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M@8Y8* 3ZT 0W^FVFJV_V>]M8+R#(/E3QAUR.AP1BLW_A!_#G_0 TO_P"C_\
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M[_K_ (TO]NZ:?^8A:_\ ?]?\: +U%4?[=TW_ *"%K_W^7_&D_M[3/^@C:?\
M?]?\: +]%4/[>TS_ *"-I_W_ %_QH_M[3/\ H(VG_?\ 7_&@"_15'^W=-/\
MS$;3_O\ K_C0==TT?\Q"U_[_ *_XT 7J*H?V]IG_ $$;3_O^O^-']O:9_P!!
M&T_[_K_C0!?HKF9?B/X<A\1PZ$VK6PU.6/S5BWC!7!.=W3H#QGM6O_;VF?\
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M-_+C5][R2JP.!R,(/UHLF2M-CT/5_A]X#UT@WVA:#=/U\QK>'>#ZA@,C\#6
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M1\6?^1U\)_\ 79?_ $:M &/XI_9YFEO-./A_4X;:V#XO5O;.W=F3*G,>(>N
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M:MSX ZMJ&M^%;PZG?W&I2070CCEN2I<(8HVQ\H ZL:ZSXG?\DW\5?]@NZ_\
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MY$,"/@#*KCCI5[PK\%+3PQXIM=>D\0:UK%W;1211+J5R)44/C<0,=>!7H]%
M!1110 4444 %%<A\5M%\4^(/ VH6/@S6(M!\0R;/L]], 53# L.4< D9&=K8
MSTKP\_"O]H7)Q\1(P/\ L(P__*V@#Z?HKY@_X55^T+_T42/_ ,&,/_RMH_X5
M5^T+_P!%$C_\&,/_ ,K: /I^BOF#_A5?[0O_ $42/_P8P_\ RMKTWX)>$_B/
MX8.MGQ_XGA\0I.\1L$C=9&MP WF;G6"$'<2N!M.,=: .[\3>%K#Q;IK66H1%
MTW!TD0[9(G!RKHW56![BN%\6?##Q1XCTC^QAXN#Z;YBR^;=6@:Y^4\*6! 8
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M2P\7AH_6YZ?R^<NZ\H[W[JQL^+OV<M(\1^+I==MGBLS<Q>7<VLL FAD<$;9
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MKPOM4 #]SV_[XH ^A:*^?/[)_:-_Z#7A;_OS_P#84?V3^T;_ -!KPM_WY_\
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MH UJ*R?^$LT3_H,Z?_X%)_C1_P );HG_ $&=/_\  I/\: -:BLG_ (2S1/\
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M?$3PIC_D9]&_\&$7_P 51_PL7PI_T,^C?^#"+_XJM(Q459'+5K5*\N>H[O\
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M  L7PI_T,^C?^#"+_P"*H_X6+X4_Z&?1O_!A%_\ %4 >0_LK?\?/BW_MR_\
M1-?0%?/W[*C!Y_%C @J?L1!!R"/)ZBOH&@ HHHH **** "BBB@ HHHH *^4/
MB%_R=_!_V#K3_P!#:OJ^OE#XA?\ )W\'_8.M/_0VH ^KZ*** "BBB@ HHHH
M^7? VG>#O$%R-)?X<'7-:6.2YN+T20A)/WAR2S./FY'R]1FNU/PK\.?]$?7_
M ,"K;_X[786?P1\)Z;<O/9VES9R,\CDV][*G+MN?HW<\GZ5??X9Z+&C,TVI*
MJC))U.< #_ON@#PSQ1\*K#1O#?B*ZE^&ZV_FW<3VDPN(#Y$9>-=N ^>3NZ9^
M]7:_\*K\.9/_ !:!3S_S]6W_ ,=KEK%Y?B/I_B"ZT70KRZ\,V<S0177]LS-=
M2R1/\S1Q,2C%2 P#<'&.]>B^$?BS<3V0M=0TK4=5O8HTD^VZ39F6&YB<923
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M,?E6EI$L,2>B@8%>%2>,_BC#;74IU_PJ1;ZDNFD?9WRS%U7>/FZ?-G\*Z/\
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MM;[X/'(JKX6ME\;:QIUWJ7AQ](\.:EKTDEC:W&Z%W4V4Q=BO!3<Z*Q P">U
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MN*\7^)$#P?$#4&_X1"YUM[NV@2#46LY9K:V !W;O+!+'_9'7U%>YTW:,Y[T
M?)FI_"_3KCQWHUP++Q1)9?99VO=1ATFYC$<_R^4$BV8"<'Y<'/<GK79^$[%_
M^$V\/VZ^$[N"6UN3(=<BTZ:VMY(]A&'60 H^<<#(/J.E?0.*"H/7F@"LVF6<
MMXEXUM$]TBE5G* NH/4 ]:L@8%+10 4F1BEKR_QQ_:=_\5O#.D6NN:AI-G=V
M%U+*MDZ#+QE-K?,I_O'ZT >H45Y_)KVN> ;F!?$,ZZMH4TBQ+J\<8CDM6/"^
M>@X*D_QCIGD"M;Q3XPFT^]M]'T>W34=?NT,D5N[[8XHP<&65AT4?F3P* .IS
M1UKQWXC67B7P[IVAW\_BR^>\N=9L[.6*S2.&W$<D@#@*02>.,EOPKV%1M&*
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M_0Q6G_CW^%<#=VL/Q,^,"6HMXWT31OF9E0!6*,-V?]Z0!?I'(.]>U?V=:_\
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M!RJ$A<D'CVH ]P_X7/X)_P"ABM/_ ![_  H_X7/X)_Z&*T_\>_PKK?[.M?\
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M2MDZ=:_\^T/_ '[%<7XO>/PIXM\/Z^8DBTT^9IUY*J@"(2%3$Y]%WC!/^T*
M.W2[BDDEC1PSQ':X!^Z< \_@:XG4OC=X/L2\4&J'5+P2&(6>FQ-/*[C.0 HQ
MQ@Y).!BNV9%$,C!0"P)) Z\5\E?#;[?!;7\FCQ(VJ"VO#"-F26_?YP,C)QG
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MFTAOF_A!&",Y).*Y"&W\-Z;XM\"7WP\L[]@]\JWFH2NS-=Q.1NX8[I3P<MC
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M*^&GBO-<:3Q1J:C):\&(%/\ LQ_X_E7MUG9PV%ND%O$D$*#:D<:A54>@ X%
M'AWPU_9)\->$Y(=0U^5O$VK)AAYXQ;QG_9C[_5L_A7ND,*6\2QQHL<:C"H@P
M /0"I** "BBB@ IK(KC# ,/0C-.HH C^SQ?\\D_[Y%'V>+_GDG_?(J2B@!.E
M+110 4444 %)BEHH **** "BBB@ HHHH **** "L/Q9X)T/QQISV.N:9;ZC;
MN,8F0%E^AZC\*W** /EWQG^Q39J9;CP=K,NGNW/V&_\ WL3>V[J/QS7E<VE?
M%/X$79F:WU"PMD.#<Z>WGVD@'JG0?B!7WM3)(DE1E=0RMU!&0: /E?P/^V4Z
MQ*GB33HKN,8#7NGL%<#U,9Z_@17NWA3XQ^$/&(C&GZW;>=(,BWN#Y,GT ;&?
M^ YK!\>_LU^!?'J3//I8TV]DY-YIV(GSZD=#^(KPKQ3^QQXIT O/X9UBWUN
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M_P"U;X4:(275GJEHG&9&A4H">G.X'WZ=*VK+]I'P->R%5U*5<+NR821C\,T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img108224922_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img108224922_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %6 BT# 2(  A$! Q$!_\0
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M8L$4'ECM _"J7Q ^''AWXEWGPZDTW1_^$8GUEIYV,UOB8%(]RK*IZCCH>QH
MCF^(NNV]A]NE^('BN.SVAS._A6 (%/\ %GTYZUTML/'E[;0W$'C3Q5)#*HD1
MAX:M@&4\@_E6!\5#H.L? OQQ=6'ANYT.]TB5+(37$+0F5A(@+QC/*$$BOH?P
M6 /"&B <#[%#_P"@"@#S67Q/KME<65I/?^)!<W.Y8E.C19D*KN;'X FK?]K^
M)/\ GY\2_P#@FBKJO%'_ "/7@K_KM=_^D[5UU 'S?KNM^/=6\2Z99:%XNUC3
MDGOC9W2WNB0!(0L#2MM8]6P <>A->V_#N^O-3\$Z/=:A<"[OI+<&:<($$C#@
MMM' SCH*XD_\CK'_ -C)<_\ IK>NR^&7_(AZ+_UP_J: .GHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0G
M R: %HHHH **** "BBB@ HHHH ***2@!:*** "BBB@ HHHH **** .9^)G_)
M._$W_8-N/_1;54\!_P#(:\7_ /80A_\ 2*WJW\3/^2=^)O\ L&W'_HMJSO!%
M[;P:WXO$EQ%&?[0AX9P#_P >=O0!V]%0PW<%P2(IHY2.H1@<?E4U !1110 4
M444 %%%% !7"?&;5H-!\'+J5UN%M:7MO-*4&2%$@SQ7=TQXED&& 8>A&10!Y
M!)^U9X"B90UW=KN.T9M^I_.G_P##4_@3_GYO/_ ;_P"O7IU]X=TO4Y+9[O3K
M6Y>VD\V!I858Q/\ WER.#[BK?V2#_GC'_P!\"@#PFV^(MO\ $[XMZ%J'@Z%=
M1DTC3[DW$-\YM@1(5488*W.1TQ7IYU?QIC_D6M+_ /!NW_QBNI6WBC;*1JA]
M54"I* / =+\ _%'PU\0O$_B;1H/#:KKK1M-:7]S+($*#"E65%/<U/KOA;XQZ
M[XCT36I$\)07.D,[P0PRSF.0N-K;\J3]WI@BO=Z* / _B+X.^,'Q)\(7OAV^
MB\(V=G>!1++:S7'F8#!L#<I'4"O0]%G\::1H]C8_\(]I<OV:!(=_]K,-VU0,
MX\CVKN:* /.M5@\::EKNB:C_ &#I2?V:\S>7_:K'S-\93KY/&,YK8_M?QI_T
M+6E_^#=O_C%7O'.N7GAWPY/>6$<4MV'CCC6<D)EG"Y..<<UY[!\3/&-VC26V
ME6D\&]D64*4#[6*D@,X.,B@!FF37D_B>W?4+:*TNSXDNM\,,WFHO_$K?HVU<
M_D*[WX9?\B'HO_7#^IKQO4=7\6:9-<ZY<:="L=K=3:M)M0,%S:F%A@/G 4EO
MK7L'PK9G^'F@LV-QM@3CIG)H ZNBBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK#(IU% 'SC\7M8\;?!_PW)K
MM]KDFKVLE^+>*.&Y:&0*Y8ID;". N#BNOLO!_P 0;VS@N%\1Q(LT:R!3=RY
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MGOCUX+^)/PXATG0-4-Y?+J,,YC\IE^10X)R?]X5]8:"W_$CTX'@_9H^O^Z*
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M50_\C]:G_J:)_P#TV-7JU !1110 4444 %%%% !1110 4444 %%%% !1110
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M@8Y8* 3ZT 0W^FVFJV_V>]M8+R#(/E3QAUR.AP1BLW_A!_#G_0 TO_P"C_\
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M[_K_ (TO]NZ:?^8A:_\ ?]?\: +U%4?[=TW_ *"%K_W^7_&D_M[3/^@C:?\
M?]?\: +]%4/[>TS_ *"-I_W_ %_QH_M[3/\ H(VG_?\ 7_&@"_15'^W=-/\
MS$;3_O\ K_C0==TT?\Q"U_[_ *_XT 7J*H?V]IG_ $$;3_O^O^-']O:9_P!!
M&T_[_K_C0!?HKF9?B/X<A\1PZ$VK6PU.6/S5BWC!7!.=W3H#QGM6O_;VF?\
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M-_+C5][R2JP.!R,(/UHLF2M-CT/5_A]X#UT@WVA:#=/U\QK>'>#ZA@,C\#6
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M1\6?^1U\)_\ 79?_ $:M &/XI_9YFEO-./A_4X;:V#XO5O;.W=F3*G,>(>N
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M:MSX ZMJ&M^%;PZG?W&I2070CCEN2I<(8HVQ\H ZL:ZSXG?\DW\5?]@NZ_\
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MY$,"/@#*KCCI5[PK\%+3PQXIM=>D\0:UK%W;1211+J5R)44/C<0,=>!7H]%
M!1110 4444 %%<A\5M%\4^(/ VH6/@S6(M!\0R;/L]], 53# L.4< D9&=K8
MSTKP\_"O]H7)Q\1(P/\ L(P__*V@#Z?HKY@_X55^T+_T42/_ ,&,/_RMH_X5
M5^T+_P!%$C_\&,/_ ,K: /I^BOF#_A5?[0O_ $42/_P8P_\ RMKTWX)>$_B/
MX8.MGQ_XGA\0I.\1L$C=9&MP WF;G6"$'<2N!M.,=: .[\3>%K#Q;IK66H1%
MTW!TD0[9(G!RKHW56![BN%\6?##Q1XCTC^QAXN#Z;YBR^;=6@:Y^4\*6! 8
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M2P\7AH_6YZ?R^<NZ\H[W[JQL^+OV<M(\1^+I==MGBLS<Q>7<VLL FAD<$;9
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MKPOM4 #]SV_[XH ^A:*^?/[)_:-_Z#7A;_OS_P#84?V3^T;_ -!KPM_WY_\
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MH UJ*R?^$LT3_H,Z?_X%)_C1_P );HG_ $&=/_\  I/\: -:BLG_ (2S1/\
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M?$3PIC_D9]&_\&$7_P 51_PL7PI_T,^C?^#"+_XJM(Q459'+5K5*\N>H[O\
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M  L7PI_T,^C?^#"+_P"*H_X6+X4_Z&?1O_!A%_\ %4 >0_LK?\?/BW_MR_\
M1-?0%?/W[*C!Y_%C @J?L1!!R"/)ZBOH&@ HHHH **** "BBB@ HHHH *^4/
MB%_R=_!_V#K3_P!#:OJ^OE#XA?\ )W\'_8.M/_0VH ^KZ*** "BBB@ HHHH
M^7? VG>#O$%R-)?X<'7-:6.2YN+T20A)/WAR2S./FY'R]1FNU/PK\.?]$?7_
M ,"K;_X[786?P1\)Z;<O/9VES9R,\CDV][*G+MN?HW<\GZ5??X9Z+&C,TVI*
MJC))U.< #_ON@#PSQ1\*K#1O#?B*ZE^&ZV_FW<3VDPN(#Y$9>-=N ^>3NZ9^
M]7:_\*K\.9/_ !:!3S_S]6W_ ,=KEK%Y?B/I_B"ZT70KRZ\,V<S0177]LS-=
M2R1/\S1Q,2C%2 P#<'&.]>B^$?BS<3V0M=0TK4=5O8HTD^VZ39F6&YB<923
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M,?E6EI$L,2>B@8%>%2>,_BC#;74IU_PJ1;ZDNFD?9WRS%U7>/FZ?-G\*Z/\
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MM;[X/'(JKX6ME\;:QIUWJ7AQ](\.:EKTDEC:W&Z%W4V4Q=BO!3<Z*Q P">U
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MN*\7^)$#P?$#4&_X1"YUM[NV@2#46LY9K:V !W;O+!+'_9'7U%>YTW:,Y[T
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M1UKQWXC67B7P[IVAW\_BR^>\N=9L[.6*S2.&W$<D@#@*02>.,EOPKV%1M&*
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M_0Q6G_CW^%<#=VL/Q,^,"6HMXWT31OF9E0!6*,-V?]Z0!?I'(.]>U?V=:_\
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M!RJ$A<D'CVH ]P_X7/X)_P"ABM/_ ![_  H_X7/X)_Z&*T_\>_PKK?[.M?\
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M2MDZ=:_\^T/_ '[%<7XO>/PIXM\/Z^8DBTT^9IUY*J@"(2%3$Y]%WC!/^T*
M.W2[BDDEC1PSQ':X!^Z< \_@:XG4OC=X/L2\4&J'5+P2&(6>FQ-/*[C.0 HQ
MQ@Y).!BNV9%$,C!0"P)) Z\5\E?#;[?!;7\FCQ(VJ"VO#"-F26_?YP,C)QG
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MFTAOF_A!&",Y).*Y"&W\-Z;XM\"7WP\L[]@]\JWFH2NS-=Q.1NX8[I3P<MC
M7/K0!Z?X>\+2_!CPAK6NZGJ']J>(;PNPYVPJ[ME(T7@8W')( XR<"K_P0\*[
M/#=SJ^HHEQ<:LQ;]X-VZ$$X)!_O,6<_[U8WQ/N)?'OCS2O"$ 8VT#A[F1#PK
M$9<_\!CR/J]6/$<!^&VLVUKX7U0:/:K;27M[;:D[36%M;I@*V#ED+-P-IQPW
M% &GK/[/_AUM4&K:%;V^CZCNWM$T FM)CU^>(\#ZK@UQ6K:[KGPKOO%M[K?@
M6/5-.U<"0WNF%9(FD";2DN0&2(XSR..>3UKJ_#7[1GA^]O;:PUG.D3W 'V:^
M*LUC>?[44Q'0]@V#71_$/53JNE:?HFES++-X@D^S+/ P94M\9FD!'8)Q_P "
MH Q/V>/!UYX9\%-=ZA-YM[JDOVG:)#(L46 (HP<D<+@9S7JE5M.L8-,L8+2V
MC$5O!&L<<8& J@8 _*K- '$_&/\ Y$#4/]^'_P!&+1H/B"W\+?"RQU2Z262&
MWM5)CA7<[DG 51W)) _&CXQ_\B!J'^_#_P"C%JI;:%<>)/A!8V-H\<=V889H
M6FSL\R.59%W8YQE!F@#&\&_'6;Q1J%G)<^%M1TC0+]_*L]5N.5:0OL57 &$W
M'@<FNI^&L,;Z)>L8UR=1NLY4?\]#7 >#M ^(4UIH_A?7=(TZQT;3KA)Y=3@N
M=[3+'+O143'&[ !)Z?6O0_AF<Z%>?]A&Z_\ 1AH ZC[+#_SQC_[Y%!MH3UB0
M_P# 14M% $8MHATB0?112?98?^>,?_?(J6B@",VT1ZQ(?^ B@6\0&!$@'^Z*
MDHH B^RP_P#/)/\ OD4&VA/6)#_P$5+10!']FB'_ "R3_OD4GV6'_GC'_P!\
MBI:* ..\<QQQ:MX2<(JXU0<@ 8_=25R.K?'NYTO43*OA#4[OP\UQ]FBU2 9,
MS<C<B$#*DJP^]GCIS77^/4$FI>%$/ ;4PI_&*2O-M7\._$J6UM_"MGI&E2:9
M978E@UB>Y90\0+$;D SN^;!QZ9[T >L^%/'FA^-8V?1]0BO?+56D6,_-'GLP
M['KQ[5Q7A3_DM_B7_=F_]%6-;OPQ^'=UX LYXI];FU07&)&BDB5$CD_B*D#)
M!Z<^E87A3_DM_B7_ '9O_15C0!T_AS_DH7C'_<LO_1;UX<K> S\6_$__  F<
ML N!'/E;QG&/](? ZX/[O9C':O5XK/7;KXC>+#I&IVEA&([+>MQ:&8L=C\@A
MUQ4VK^ -:U]HVU.[\/:BT8PC7>AB4K]-SG% &5^SF)!X7UL.9S$-8G%N;@DO
MY&U/*SGG[FWKS5?X_P"COK=YX+B%@=5AAU&2YN-/5=QNH4B)>,#N2#G'?%=1
M\,8;JW/B6*\FBN+E-58/+#%Y:']U%C"Y..,=ZYWXZ:Q<:-JG@DVMVNG27>H2
M61OGQBV62(AI.>!@ C)XR10!P^FZG:^+_B[ILW@K0[B"QM/+>^NIH/L\4#QE
MDQMZ[C&Y4J0#PI[5](U\\V]MJ/PV^*]A8:!XBN]9TR^$0O;34IO/W/*S%61A
MT?8CMP ,8]:^A1TH X_XD?$.+P%IJRI;"^OI59HK<R>6NU1EG=L':HX'0DD@
M 5YU??M%O<>'=;M)]$O?#'B:.Q^TV=KJ&T>:&( 9"< L,Y"GKC'J*WOC=\/-
M6\27.CZ_H$BRZII4@9].G($%[$&#[&SW# 'KVJG\,]*O_&?CW5_&?B+[/'>V
M@&F66F02B>.S  :1PXX)<]QVH \=O+.PT+X9VNMZ#XUM]2\1I+#]J5"AN8YY
M'!<+(F' &6.'W# Z5[/:3B+XX2S3-Y8%I&[M(<;?]'8G-:'Q1\%:%I&E3^*[
M'2[*SU[3I$NX[J*!5>9@W,;$#YMX)7GGFLRZL(M4^-FI64^[R;BS\E]IP=K6
M[@_H: +.F?M&^"O$_B!?#R33JUU(UM'+/$!%*>GKD*W0%@ >U<)KWP^&@ZK>
MZ;;^/;T65YL5M"TBW::[>-  FYD;((&%+$8( STIMQ^S;XOENKZW?Q7;/I,E
MI';($@*SR) 2UM&> %VMC+!LFMZ#X\^ OAYH4$%E8;=9* W>E:?#B2*;'S"9
MST;.>6/- '3?#&ZN-"\2:GH5QI4FB6-ZO]H:;:SR(SA0%253MR%.0K;03U)J
MK^TA>>'SX!ECU74XK"^MI4O+(+,%N#*AZ1@<[BI8#W(S7SCX_P#VEM6\<ZA:
MWMK=P>&X+)W%O]B'F7C!UVL-[<#(.,8SZ=*H>#/A%XX^)EY]LT_39;*UE($F
MMZVS-+(/[PW?.>?3'IS0!T^J_$OPYX#U,Z_I;:KXEUN*-4BU#7)62*V&T@!8
M1@N?G;E\<G@UR>F:5\2_VB-;:ZB>>]M\D?;KS,5G;@]D&/T4?7-?1/P__9+\
M*^&GBO-<:3Q1J:C):\&(%/\ LQ_X_E7MUG9PV%ND%O$D$*#:D<:A54>@ X%
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M^ YK!\>_LU^!?'J3//I8TV]DY-YIV(GSZD=#^(KPKQ3^QQXIT O/X9UBWUN
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M_P"U;X4:(275GJEHG&9&A4H">G.X'WZ=*VK+]I'P->R%5U*5<+NR821C\,T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img117130267_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_0.jpg
M_]C_X14Z17AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    ?    ?@$R  (    4
M    G0$[  (    -    L8=I  0    !    P    .P /0D    G$  ]"0
M "<0061O8F4@4&AO=&]S:&]P(#(T+C4@*%=I;F1O=W,I #(P,C0Z,#(Z,C<@
M,#DZ-34Z-30 =VEN9&]W<R!U<V5R      .@ 0 #     ?__  "@ @ $
M 0  !C>@ P $     0  !-@         !@$#  ,    !  8   $:  4    !
M   !.@$;  4    !   !0@$H  ,    !  (   (!  0    !   !2@("  0
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M34ZPB8X'B3PLNRRRUVZP[C^ _JM3>*O%=P7X,K/JWT/+P6T9'3ZJVV!KK65
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M?Z;=T220 !W),!5OVA7I)8)\7D>>OL4KK]75N8"WCGYH'KX^K?;_ "F^H?\
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M_>/WE NQ*+K!<0:L@?1R:CLM'_7 /TK?^"O;;3_P:7!'Q'_._P"]1QRZT?\
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M;F1O=W,@=7-E<AP"!0 74&]W97)0;VEN="!0<F5S96YT871I;VXX0DE-!"4
M     ! 0!"7_&+6X&:N/1:5&SS?#.$))300Z      %#    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    P $@ 4  @ $, ;P!L &\ <@ @ $P 80!S &4 <@!*
M &4 =  @ $, 4  T #  ,@ U "\ -  U #( -0 @ %  0P!, #8 ( !# &P
M80!S ', ( !$ '( :0!V &4 <@      #W!R:6YT4')O;V93971U<$]B:F,
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M      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M     %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6)
M;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M             $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X
M;$!Y            "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !0
M9U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N
M=$8C4FQT                4V-L(%5N=$8C4')C0%D            08W)O
M<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M   ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M        "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 9     !
M  $!D     $  3A"24T$)@      #@             _@   .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))301$       0
M     @   D    )      #A"24T$'@      !      X0DE-!!H      U$
M   &              38   &-P    X 1 !$ $0 ( !0 &D 8P!T '4 <@!E
M ', +0 Q     0                         !              8W   $
MV                      !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $
MV     !29VAT;&]N9P  !C<    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P  !-@     4F=H=&QO;F<
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M# P,# P,# P,# P,# P,_\  $0@ ?0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M94#40Z&^I7ZE);9M]OI6-W_S?Z-7.I,?9B665B;Z/UBG_C*OTK6_]=A]#_\
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M;?0?_A5DT7XG5F9#>O48YZKB5%[:R(#:VAKW,R=UK,9_I6?I+:K,CV4Y'O\
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M5[-SK@UKGW^E6UNW^I6E=]6^GE_ON>QCFO#FDM#B7EGN;86[O;M]]G\_D?\
M:BZRO]&I.Z'TPV>H+W- =N8UKJP&>YUVVK]'NK_2/^DUWJ?X/U/33APC42_!
M!XB"#'3^\Z=3:*6MK;L87DD-8 T.=])[FM_Z2H=6M=?:SIK"6L>WU<QS2015
M.QE+7#Z+LNP.9_Q%61_(38/1.FXMM=E+S9;4XO:YQ8YT%ME99+6#;7^G>_V?
MGJHU]EF3D6M)8[(R;&;MNX!F.WT&;OW?>RY__7$R==#:"30!%7_T6T   UH#
M6M #6@0 !]%K0/S6H-MS8>&V>F:G!MC]I=!(W;-OYWM^F[\Q,RQUVYM-[0\
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MIN9B4Y3!M%K XM/+2?I5N_E,=[%3GNI]&,4Y-0^C5E7M;\'/-W_HU"7R^13
MU+S'Y/\ _]3U5))))36NQK'O+F/VS!D:'0;=O#O9_P!_0_L61&E[@3R=T_\
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M9HT&)<[W?O[$%6&QAM L=K^;&I\U$=5=@9>4YF'DY@ML8PG'9O#=E>,QP?\
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M+Y:)$A6JX ) )@=R>P\5/H<NP!D$1]KLLR!_5M>ZRG_P$UJG>TYEIZ943NL
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M(0      5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
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MT  ' !H !0 I #5A8W-P05!03     !!1$)%                     0
M]M8  0    #3+4%$0D4
M                      ID97-C    _    '1C<')T   !<    "MW='!T
M   !G    !1!,D(P   !L   H@9!,D(R   !L   H@9!,D(Q  "CN   H@9"
M,D$P  %%P  ".+1",D$Q  -^=  ".+1",D$R  6W*  ".+1G86UT  ?OW
MD)%D97-C         !I5+E,N(%=E8B!#;V%T960@*%-73U I('8R
M
M                                     '1E>'0     0V]P>7)I9VAT
M(#(P,# @061O8F4@4WES=&5M<RP@26YC+@  6%E:(        +5:  "\9P
MDC!M9G0R      0#"0   0                    $
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MU.OE[/7N!.\2\"#Q+/(X\T/T3O59]F/W:OAN^6_Z;/MD_%;]1/XO_Q?__P
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M@H.;:*KD@9F)?J;:@.!V^Z,3@&-CJ)^;@"9/4YQ_@",Y=)H%@$P?H9F6@1<
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MKP.7HJ=]JKB%PJ-RIL-S0)^LHT-@*9PVH$],09D<GCLV]I: G7T=\Y7(E$
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MB=6-FK/>B$E\SZ\:ANYK5:JCA>U9'J9ZA31%X:+&A,PP^I_LA,07@: <A@0
M (_+@ "=:+?SDA",^+,/C^=\&JY2C?MJJJG.C&-8?:6KBRU%6:'VBE<PE9\3
MBBP77)\<BK   (\^@ "<U;=&FFF,8K)AEZ9[>ZVFE31J!JDDDQA7[:3PD5U$
MX:$_D#4P/IY2D"H7/IXVCK@  ([$@ "<.[:_HNZ+V;'1GY)Z^JT/G(]IBZB/
MF?A7>:1:E]9$?:"2EG O^)V>EJ07)YUGCZ@  (Y>@ ";R+8VJZ"+<+%$IZ5Z
MF*R"I!-I+Z@$H057):/4GI=$.: (G4DOQ)SPG"<7%9RHCYL  (X*@ ";2K77
MM(R+(K#4K]MZ5ZP#JZMHZ:=YJ#%6WZ-+I;!#_)^5I)XOG)R&H#$7%9P7CYL
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MD&N Z+TCCE]PZ;>\C)5@:[*&BR9/.JVRBB4] *EJB9,H]J9(B>,/VJ<$B0(
M (R,@ "0+,'HF$^ E+Q;E;5PDK;PDW1@"[&[D95.Z*S6D"8\PZB2CVDHUZ5C
MD!L0!*7ABM0  (Q>@ "/Q\%0H&* 0KNUG3=P3;9 FG-?S[$)F"Q.KJPFEG$\
ME:?0E;(HPJ26E;P0*Z3CBNX  (PX@ "/9L#5J)1__+LJI-!P%K6JH8=?HK!O
MGM].B:N3G0<\?:<ZG*PHN*/@FFX03J0&BP8  (P9@ "/)L!1L/5_S+JAK)-O
M]K4?J,M?C:_CI=A.=ZL)I!H\;Z:\HO\HLZ-3FX40;*-$BQL  (O_@ ".U+_P
MN<E_KKHMM)MO[;2;L"U?AZ]1K/I.>ZIPJUP\@*8@I_4HW*+(FZ 0L**XBT@
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MEH5U6,9XE =F'<!PD?!6:KJ7D$E&(;45CR0TQ+!5CM\A6JT@CWL)S*Q"AJ
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M>(,@@*;>A(%*C:O)3H#AB]ZS48"'BB^<9X!1B,.$U( RAXQLAH NAH%3#(!
MA8XVYX"-A.(1/(&RA'/<YX JF)?'I'_%E=6QJG]VDSJ:ZG]&D-2#?'\\CL)K
M6'](C-Y2"']DBR0U^G^LB>$0*X!UA\';8'\]HY+&)'[8G^JP,GZ0G&N9@7YI
MF22"+WYAEA=J.GY^DVA1%7ZCD/,U(7[BCTH/0']EBE#:#7Z%KJW$VGX@JB2N
M[7W5I;V82WVQH8^!%7VPG:EI,GW+FAM0.'WYEPLT7GXRE5\.>WZ B<K8\WWS
MN>K#R'V.M(&MVGT^KS&7/'T8JB" (WT>I6]H87T_H2=/?'UGG8PSN'V9FV8-
MV'W#B5S8$'V%Q5G"ZWT?OPZL\GS(N->64'R9LN-_1'R@K6UGG7S+J)5.VGSW
MI-DS+'T;H%@-4WTHB0+79'TUT1?"/'S0R>>L,'QNPL:5@GPTN_=^A'PXM<UF
M]WQEL)=.5'R7K)8RNGRWHDP,Z'RMB+K1P8U1=I*]M8OK=P:I XJI=WZ3?HF.
M> E],8B7>+)F!8?%>7I-GH<H>DDR.(<E>S$,UHDD?'G0/(OQ@,>\?(J9@#ZG
MVHEC?\Z2:(A5?WY\'X=N?U=D^X:N?U%,E(8>?UPQ-88:?Y@+[(>+@%K.XHJI
MBQN[(8E?B9RFK(@KB#>1+X<PAPUZ\H98AA-CXH6IA49+CX4FA)8P1(4AA$0+
M'H8D@\+-?HF/E76YL8A)DQ>E)H<ED-J/S88NCL]YL85LC0MBQX3,BW9*G(11
MBA4O;H1&B5D*:X3LAK?,)HBPG]JX5X=LG*NCSH9.F9Z.@85=EL)XA(28E!YA
MPH0(D=%)P(.3C] NKX-^CO$)TH/AAJ3*]H@ JFBW+X:]IFJBJH6>HHB-:(2P
MGMIW@H/OFV]@TX-8F%Y(^X+JE>,N!X+0E0T)48, ADS)^8=RM1FV-X8QL$ZA
ML84/JY>,=80@IQIVIX-FHO=@%X+2GT=(58)8G'4M>X(XFDD(YH)&A@3)+(<#
MO_^U;87%NF>@WX2?M-Z+H8.IKY)UWH+OJL)?9X)FIJ1'QX'MH_DM!(&ZGG (
MCX&NA<G(D8:NRSVTS85TQ-B@+X1)OGJ*ZH-+N&AU-8*.LP!>U8(&KK5'2H&3
MJM8LEX%>GB8(2H$UA9O"!Y:]=82O692*=@N<#9*#=I>'\)"N=S9R^(\'=_-=
M!HV4>,M%N8QR>:8K XQ.>HP&J8S_?)S O)5]?RRN4Y-0?LN;%)%3?GZ' 8^(
M?E-R"8WM?D]<'(R(?FU$SHMO?IDJ)XM#?OH&+(ML@!>_CI17B-BM&)(TAYV9
M^Y VAG6%Y(YXA8EP_XSJA,9;*(N2A"]#\8J!@[HI8XI-@[D%OHH*@R:^;Y-!
MDJ>KY)$HD)F8N8\WCJ&$R(UPC.-OZXOTBV9:,(JHBAQ#&8F>B1$HJHEEB.<%
M7XC7@Z&]1Y)GG(6JSY!.F;*7F8YAEP.#E8RJE(5NV8LHDD%90(GKD%)"4XCD
MCL<H"(B@CLH%#8?0@VJ\/)&_IH:IQ8^IHOB6D(V\GX>"EXP'G$IM\(J'F5%8
M;8E EKM!IX@\E-\G?(?PE#L$R(;S@SR[6Y$YL*>HZ8\EK%^5M(TUJ"R!P(M^
MI#1M+(H$H)A7QHB]G8-!&8>IFY4G"X=5F+X$CX8\@Q6ZI)#/NP&H-HZ]M@"4
M^8S*L0^!!(L.K%YL>8F4J#!7*(A7I-= G8= HMPFJH;6FB0$8(6F@O:Z&I!\
MQ;JGIXYMP .46XQXNE* 8(JVM/)KXHDWL$Y6IX?[K1) +8;LJ,0F2(:!F>($
M.X4O@MVRPZ!Z=,.A2)V(=4Z//)K'=>)\:)@]=HQHL97I=U-3Z)/:>#(]H9)%
M>0PC9Y))>=0!2I!9?+JQL)]@?>:@?9QK?9B.?)FL?6-[JI<D?5%G[)38?693
M))+2?9T\VY% ?>$BN9$S?E0!+([,?]VPNYY&APZ?>9M<A?2-CYB;A/EZMI8@
MA#-G!9/=@YQ24)'A@S$\'9!3@NXB'I U@SL!$8UO@+FOO)U3D#&>:)IMCF",
M;I>TC+9YMY4PBS-F$Y+ZB?I1?I$%B/,[;H]XB#DAE8]*B+, ^HQ @*FNU9QP
MF8J==IF3EP2+<I;BE*=XLY1EDG-E,9(;D()0MI SCNXZRHZGC=PA%XYMCB\
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M=#F3GZ;L=+R"L:-\=4]Q!:!%=?Q><YU*=L5*O)JH=Z(U5YB^>&L;0)EK>.P
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MG]Z/[:*)G/-^_)\6FC5M5IO:E[9:^)C:E89'H)8YD^4RNY0[DXD9A)16D.H
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M? &&'Z_%>[1V-*N>>Y!ECJ>R>Y93^Z01>\A!.*#I?!HLCY[)?&D25*"=?*\
M (C$@ "4U;,9A"R%C*[#@S1UL*J3@F5D_*:I@=A3;Z,'@7] O9_@@5LL+YVT
M@6<2/Y\_@@D  (@A@ "43K(?C%.$[*W/BL)T^ZFDB6!D6:6QB#]2UJ(8AVA
M/9[RAM@KTIRZAL$2*YX&ALH  (>3@ "3N[%3E)*$5*T$DG!T6:C<D(ACLJ3I
MCM]22J% C80_R)X?C*$K@9O;C*@2&YSNBN(  (<9@ "3*K"WG/F#RZQFFDMS
MU*@XE]5C+Z1!E:U1SJ"4D^4_9IU9DL,K0)L+DQ,2$)ORC#8  (:S@ "2OK E
MI86#8*O5HDMS:*>EGTIBQJ.MG*=1;J !FHX_&YR_F7HK$)I&F)02"9L,C#(
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M@NEY8KC]@?1J7K0F@2Y:EJ^/@+5)]JM,@'0X&J>L@&PD$Z6!@)0*WZ:#@28
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MJI5WU;5:IQYHQK!KH_99#ZNSH65(FJ=>G^4W%*.FGPHCJJ#\F!T+P*"TA_(
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MB11M?<)SAYY?%[T1AF=0);?4A85 7K,!A0(O2J\"A-\;K:T=A80%$JJ;@VX
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MKSYM/K[AJY-?";DXJ%M0*K/,IC- A:[7I,XON:JPH$4<LZ@QDV<&R*5&A)8
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MHGT5@R9."WUV@I@RDWWM@B4-3'[2@8/1;GJ&DAB]97J\D!FHH7KWCC"3#7M
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MDH9R<MJ,&X71<^YVMX5'=0M@7(3<=C5(M(2>=U4MQ83T>%((W(9/>6#%1H:
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MBD"5PI3JB1^$QI+'B UR]I#-AP]@&X\3AD%,.8V6A94VP(Q^A1L<_(S=A68
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MN9J22)'@M5N!(X^NL/-O.(VAK+]<JHO8J5))-XI@IT@T4HDPHM<;-XD8DF<
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MD-V(0YU\CT)X1YJAC;UG=)?WC%A5T96!BQI"_)-[BC4N;)(,B=$4RI,;B4
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M;@!^5ZM[;Q=O7:@#<"]?>:3 <4M.C*&[<F@\09\W<W<GS9WW="0-+Z"X<\4
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MEL1[KJ:6E,ULF*,%DNQ<NI^AD3E,"9R%C]$Z,IG=CO0F6Y@_CUL-0IDGB/<
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M=5!QQ[3)=8QCD;">=>E4BJRI=F)$=JD)=O RZZ8F=W4>Q*4P=Y(&(*4A>,4
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MF^9P"[ 2F;9AQJO)EYE2OJ>OE<1"XJ/VE((QTJ#>E'H>?I\NDJ<'3IUXA/$
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M>[AEJKYR>T58)KFU>OU)UK4D>O<ZB+$#>Q(IGJWR>S@5;JW>>P0 HZ?3?2X
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MH&!E/;G,GAI7L;35F^Y)9+ 6FCHZ.JO2F;8IMZA]F'D6A:=-CSH"C:"S@;H
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M<V6<!XCX=%6*[H@,=3)XN8<_=@AE<8:-=N)1!X8&=[P[$87 >'@@]H9J>,<
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MHS*6R(-%H(B%K8)VG:QSF8'"FLI@Q($WF"9- (#-E?(WQX!VE+H>48!LDE<
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M>TZ.$)!B>WU^(8[&>Z=M (U8>]A:X(P-?!A'CHL!?%\R?HIC?)$8?HM\?&P
M (!:@ "<&9"WA"N,_8\+@[-\]HU^@S5L"8P0@KA9^HK6@EA&SHG3@@DQY8DP
M@<T8$8H2@=D  (  @ ";)H^$C2R, (WBC!![^(Q>BNEK"(KVB;]9+8FUB+)&
M'(B^A]PQ68@7AU 7L(C&AU@  (  @ ":4HZ@EE&+/XT&E)A[-XM^DL1J-8H4
MD/!87HC5CT9%;8?4C?$PRX<IC4T728>LC 4  (  @ "9I(WOGX**AXQ:G3!Z
M>8K-FK5I>HE>F#U7K8@AE@I$U8<<E%LP7H97D_06_X:RCXT  (  @ "9'(UH
MJ,R)]8O8I>EYW(I$HLUHW(C)G[=7$H>(G0]$0(:+FTDOYH6]FBD6OH7ACV$
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M@CV DIAN@=MQA)8M@7EAD)03@290>Y(W@.H^*I"S@,(IWH_B@*D/TI&2@*H
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MK<1]PY3TJMQND9*:IZA>@I!6I)%-M(Y;HE$[SXS&H/4H'XNOFR$/'(OYBC<
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MB$=S\*$DAWAEM9X\AJU6GYMYA?%&EICZA5PU&Y</A0(A6I9"A10(O)7?@]$
M (  @ " V*-+D%]S:*!.CQEE+IUAC<M6%9J8C(]&$Y@2BX@TR)8'BO$A*Y4D
MBV((S)1@A?,  (  @ " ;:*0F(=R]Y^9ELYDN)RHE0)5G9G:DTU%II=1D?(T
M=Y4\D5LA%90>D.@(XI,.A@(  (  @ " %*(4H--RPY\;GKED?IP7G&U549DL
MFCA%4):5F*8T%Y2.F&$@QI-OE7\(Z)( A@8  (  @ !_T:&\J5QR?9ZWINQD
M+INFI#)4^IBMH:5% I8-H"TSV9/\GGP@F9+8E@H(XY$[A@(  (  @ !VM+/!
M9W]I]; X:0A<@*SE:HQ.&*F\; (^AZ;B;5PM/:3K;FL8N:67;FP!B:*J< (
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MC8IH**IUC'):KZ;CBUA,7Z-YBE@]'J!HB9HL7YX8B6@8TIVVB8,#(YBV@A\
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M;C)=S[HY;MA0];9";YQ#1;)W<&XT6Z\N<3$C<ZU*<9P.M:[H<.8  )W >"D
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MD?Y=%+1'D,A0/[ 8CX)"E*P;CFPS\:B;C>$CIZ8RCD40(J99BND  )C?@
M (  @ !I#;?SF5E=%[.>E^901*]9EE5"DJM-E0@SY*?'E+8CG*5>D\P0/Z59
MBOP  )A(@    (  @ !H^K>/H.M=([,3GTE04:ZUG7Q"EJJ;G"4SZ:<+FVXC
ML:24F"(05J2#BPP  )>R@    (  @ #-4&QM9D2YYVXP:'6ETV_8:I"0X'%C
M;)1[#G+?;HUD571/<'U,;'6D<E QK7:I<]8-QW@Q<[;+7&GN<52X6&OG<F>D
M;6VV<W>/GV]G=(9YXW$&=9=C/G*6=J5+87/Z=YLPL73<>%4,YG9T=^7)B&?)
M?&"VD6G<?%RBX6O+?%^.)FV9?'UXD6]6?*IB$G#_?-Y*67)O?00OQG,K?00,
M(73N?(/'NV7BAU"TPF@*AE"A&VH+A6",FFORA(=W*FW-@]-@VV^,@R])5'$%
M@HTNZ7&9@>L+=G.;@+C&&&1&DC2S*69\D%2?@VB-CGZ+#VJ#C+MUUVQNBQ=?
MLFY#B:)(8&_"B$$N'G KAQ\*Y')XA%+$Q6, G2&QW64_FG">.&=5E[6)RFE3
ME0ITIFM'DH5>I6TAD#-'@FZFCBDM:6[FC,4*:'&$APG#MF']J!.PU&1 I)>=
M*F95H/J(NVA4G6MSJ6I2FA-=R&PSEO]&QVVQE%0LTFW+DO,* G"YAL3"[6$\
MLPFP#6-_KL2<4V6-JDR'VV>%I=MRRFF$H;A<_VMMG@5&)&SJFOTL3VS9F%P)
MKW 4AHS":F"[O?ZOA6+ZN.>;LF3XLY.')6;BKDYR%VC:J7-<76K"I3Y%BVPW
MHCXKQFP G*@);7 2AE^^KW2.96"M!'6"9[Z:;'9Q:>^&OG=::_UR#WA";?M<
M6GDL;^Y%4WH/<;LK WK?<QD'@'T6<WV]1G(];_"KZ7-F<3N96G1U<G"%MG5V
M<YAQ#G9S=+U;:G=Q==]$=GA==N0J.'D%=Y &]7M;>!2[P' N>FNJ/G%R>K:7
MTW*:>OF$/W.V>T)OP73/>Y5:1'7D>^Q#<W;6?#(I6'=.?#\&>GG6?&RZ*6Y=
MA,JHFF^RA#.6,7#L@Y:"UW(;@OYN>'-/@H!9)W1X@@Y"A75N@9\HD76W@2X&
M#WB%@#&XKFS1CRFG)VXRC<.4OV]\C%"!;'"XBM]M1G'WB818&G,TB%)!J'0M
MASLGWG1$AGD%M'=D@VRW>&N6F9JE]&S_EVV3CVY-E2. 0V^1DMIL,'#9D*]7
M*7(6CK= XG,3C1(G/G+[C%8%9W;>@Z>V@FJ;I!2D_&P(H222DFU4G@5_26Z:
MFN9K1V_KE_E68'$NE59 /G(?DS@FO''>DB,%)W=*@WRURVG?KI>D/FM,JN>1
MQ6R1IOA^=FW/HP9J=V\BGV%5HW!NG#<_IG%=F?,F27#JEN($]'>A@UFU5FEB
MN22CN&K)M+>1(VO^K_A]QFTOJSYISVYZIO)5#V_%HV<_&'"NH0TEQW 5F8L$
MRG?G@SVP<'S_9*R@37T=9QV/$7U4:5=\EGV<:V=H_GWQ;6541'Y6;U,^$7[5
M<0\D '^K<B8!]X%G= &O4WK1;J"?,WLG<!.-WWMZ<6A[=7O5<JEG\WPZ<^-3
M4WRO=10].'TL=ATC0WW)=I\!MG^N>'&N'7C5>)&=X'E->1F,OGFV>9%Z2WHF
M>@!FY'J<>G929GL?>NT\<'N=>TPBG'P">U0!?7XK?%>LN'<0@F><<W>8@B6+
M-W@6@<]X^GB6@7)EKGDG@2916GF\@.4[CWHZ@*,AYGID@%8!2WW1?[JK9G67
MC$";('8JBT")Y7:TBB5WL7<_B0!DG'?7A^M09GA]AOLZQWCZABLA27CHA<P!
M('X8@,.J3W1IEC*:"74#E'B(T761DI9VI'8CD*ECH7;!CM9/DG=CC3<Z&7??
MB_D@OW>8B[8 _7Y5@*NI<'-XH"^9)707G;Z'ZG2CFQ9UP74UF&5BS'7:E>).
MVW: D[$YBG;KDB@@479SD,P WWZ'@)>HRG+!JCF8<W-BIQ:'*W/HHZQT_W1R
MH#EB#G48G1-.*W7'FG@X_78LF1 ?[W5ZE/0 QWZP@(:H7')$M%B7\'+BL(J&
MCW-;K&)T6G/7J#AA<W1VI(%-I74BH; X?'6#GX8?=W2HE48 M'[1@'FB?X7%
M9!F3H(469HF#EX2<:,)R/X1':M%?N(0+;,I+\8/R;JPV@80@<$@<985A<.8
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MDNZ.)'UED95^"GTZD ]L\GT9CG=:]7T.C/A'UWT9B[$S''TDBMT9QWS[BF8
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M;'J&*XOW;?YW#HKE;VAFRXGT<,!568DE<@M"D8B3<S\MWXA]=!X38HI]<ZP
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MF+6!FH5XEQ=RA82)E3EB9X.IDT91;8+RD8H_58)ED$(K;X'[D!T1Y8(>C!D
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M<]MX[I.(=*5JTI'9=61;>Y!1=AY+#([U=M0Y+HWZ=W0E#HW4=[L+'([(=WT
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MG<YU=HY"G 5G.HR7F>]8!(KVE\Q'ZHF3EAHVCXB,E6LC-(?IE!4*MH<0ASX
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M>AUL,IN[>F%>S9EX>IQ0?)=8>MQ [)6!>QTOTY0\>T\;]Y1G>S$$=)' ?$P
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MHBMJ I>-H'M<BY4GGEQ.')+,G$0^TI#$FQDN)X]+F? ;!X[-DD8$V(M2@T8
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M?VQ@.*2O?U!3@:'9?RM%XY\F?P0W,9S0?O0FG9MP?O(2DIR&?N,  )+H@
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M8(E5]+5\8E))H;*09!@\8:_#9<,MNZV,9R4<DJU$9[@(7*ZD9VL  )-8<M@
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M@_%4QZZ!@Y=(HZLD@RH[FZ?Q@L$M;Z5(@H,=):00@J *)Z/,@CD  (WC@
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M>_>2C7$7?$^"6'(??(QQ&7,>?+E>N'0E?.E+/'4>?1@V-775?38<\W5W?0,
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MK)>."&L]J7)]P6Q4I?)LEVU?HFM:I6Y]GTU'M6^*G0,S5F__FW@:Q&Y'DAD
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M@PZ%KG=_@O-VA'?J@K!F37A2@E)5'WC'@?M"EGE(@;0N5WF2@784Z7E-@5,
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M7?!^$8>M8,=OTX<=8VI@1X:X9=M/=(9Q:"<]*X9F:CLHO(;M:[D.!HC^:T<
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MB4]Y-G[8B--K GZ;B"-;PGY>AU9+C7XWAI<Y_7XLA@DF47XDA=D-#7YZA*,
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M9:AQ*HZP9Z!CLHV9:7]5&8RD:T-%-HO<;.4SM8M];D4?CHPG;N &:HOV;O
M (  ?]Y\KHW7;=%P.HS%;R-BY(N\<&)43HK0<8Y$BXH-<J,S+HFI<X8?-HHC
M<\P&=XF?="L  (  @ ![R8OM=>EO1(KN=JIAWHGY=U13A8D3=_%#UXA=>'LR
MHX?V>.<>W8A&>.T&?(>2>;\  (  @ !ZZ8I*?@5N>(E8?D1A&8AK?F12L(>.
M?FI#48;+?FTR-H9G?G<>G8:,?F,&C(7&?J\  (  @ !Z(HCZAD1MN8@6A?M@
M7H<JA8=2"X9"A/A"NH5\A'$Q\H3WA" >;H3YA#L&D80\@ML  (  @ !Y@X?T
MCHQM.H<:C<Y?XX8GC,I1=X4PBZ="&81IBK(Q8(/>BC(>*8.CBHD&BX+SA&P
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M;$)DHI9J;8Y8#I3+;LQ*/Y--;_L[-)(1<0DJ5I&"<<H6%9+<<84 <XYP=#,
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MDPIAL9 7DC55$HYYD0%':8S3C[$XO(MTCM,H<(J>CP05&8K'C* !&H;1@+X
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M<:M8:Y[B<GI,:)S)<SP_=9K1<_4Q$9E(=(T@D)C>=,,,CIH9=%4  (D4>^4
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MELU6OYFNEB1*Q9=LE.\]O94HDZPOJY-*DV<?L9);D>\,OY'LB)\  (2<@
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M=AQ,BJB"=HI!!*7_=NHTBJ.F=S,FNJ'U=VT6":)==RD$PI\&>.$  (0^@
M (  @ !6_ZFM?2-,4*<J?4I U:2=?4XT7J(W?3\FDJ!T?3,6&Z"7?18$_YSO
M?A8  (->@    (  @ !6NJB@A"U,*:82A!9 N:-U@\<T0:$"@VPF=)\T@T<6
M'9\M@X<%/ILA@GH  (*M@    (  @ !6A:?2BT-,$Z4RBOU JJ*#BF<T,I_^
MB<\F79XAB<H5_YX1B38%39FK@Y8  ((6@    (  @ !68J<TDGY,#*1ZDB)
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ME720,ER\D\R &E\^D?MO!F&;D"1=$6/BCF]*$V7<C/,UOV;EB^$=CV4SBXP
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M;""*/VQ ;<=[$6V];U5JA6\F<,98[G"#<BA&&'')<W0QF7*E='P88W(F=),
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MFXF$LF,[F:%UCF4.EW5E;F;#E3I47FAMDSU"+VG2D;(NDVHND2465FH5C>4
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M<[)]:W&H=,!O*7*A=:U?Z'.-=H=/3W1Z=TL]9W5/=_LICG6]>&D0 W;L=_
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MH+-Y3VI_GK1K"FN>G%%;T&RAF=Y+IVV=E](Z16Y?EJXG%6X)E64.IW"1B>@
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M>DMP^7@+>MQCC'AY>TE5+'C:>YE%M'D_>^$TBWFI?!LA&7G ?" (JGNA?)8
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M5]II@(G[6O!<LHE\7=Y.I(DG8)L_-(C^8QLM\XE*92D9?XKY9?,!]8H49Q@
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M?_)D[W]_@"-84G]5@"=*M7\A@ P\!W[X?_ KLW[I?^48,W[S?^@"C7^]?_@
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M7JA='Y$48/U1"9 A8SA#S(]194XU%X[,9Q\D/H\<:%L/:9%M9_H  (8B;F0
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MA(M94H?FA'=-:(<@A"] =H94@] R6H6P@XHB@(58@XD/,X4A@T<  (  @
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M9$-0]9D;9?Q%GY>]9Z(Y!9:$:28JZI7%:E8:)I:':K4'%Y6<:N0  ("7=Q0
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MB&!.+Y$ZB#M"YX_FA\0VD(Z&AS8HW(U^AP88MXUSAT<'*XJCA-D  (  @
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M:*=$HZ)9:=XYI*"V:P$MH9]);  ?P)Z_;)$.QJ _;"@  )AW;RL  (  ??\
M (  @ !.2Z(+;W%$*Z!K<$XY,Y[%<1$M*YU,<:0?C)RE<?8.P)W9<8X -98
M=0D  (  @    (  @ !-UZ!J=F!#RI[3=O XY)TH=U4LZYN>=Y$?6)K7=YP.
MV)NI=UX <9/:>E0  (  @    (  @ !-<Y\3?55#?YV#?:(XJYO/?; LMYHW
M?9X?)IE=?8P.T9GE?;4 L)()?LX  (  @    (  @ !-))X#A%E#2IQSA'$X
M@9JVA#(LF9D(@]\?"I@2@^0.JIAW@WL M9"9@'L  (  @    (  @ !,\9TI
MBX]#*)N4BX8X9)G0BP@LAI@0BHX?$Y;SBJ\.V9<>B$0 W8]G@)8  (  @
M (  @ "ISEKJ4ZF9K5W'5WR(\V"&6S5W4&,L7LQDJ&6Z8D-0X6@5994[PFG=
M:*,C)6EP:ND#YWEG;,NGPE:C7B"8%%G@8/Z'AUSN8\9V#5_89GAC@&*?:1!/
MUF4B:XTZTV;G;= B9678;VP#R'F<<6>EW%+,:(V61U95:G.%^UFG;$QTE5S&
M;AQB,E^[;]].MF)><9 YY608<Q4AL6*Q=!D#K7G*=F*C^4]3<MV4>E,@<]J$
M/%:A=-1S'UGQ=<A@X5T4=KM-F5_0=Z@Y 6%\>'@A"F $>/D#E7GR>O6B,DQ
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M4X".I&1E5UA^]F:56P9N.FBW7HA<86K%8>9)46RI91<TLVX&9^T;UVV":9L
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MA+6'/%4!A&1X*U@Q@_IH%5LE@X)7#%WC@Q)$U6 D@KDQ&F#T@H$92&&E@J$
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M7+Z"4V? 7[=SMFFA8HED VMO93=3&6TG9\! V&ZN:AHLQV^2; (387#G;%(
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MBT][YUI]BIYMQ5T8B;Q>EE]_B,A.9&&NA^T\^F-+AT(IZ6,GAO\1LV>PAD,
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M9-UUTFP!9Q=H6&V#:3)9C6[N:RE)F'! ;/\X(W%>;IXD@G&\;[(+976";XH
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MD.5PLV#4C_9C9&+0CKM5#&24C6M%GV8>C% TU&<*BZ4B+F78B^D*LVWJASP
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M:]]I<W$Z;7U<NG)/;OY/$'-%<& _XG0N<9HO(73?<I8;IG2Z<N($GWFQ="@
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ME8UEA&@:E(Y8]VEPDR)+96J#D9X\O6M8D( LBFN%D%\9T&JTCH@$;'B'@OT
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M<=-=5'>0<O5177@E<_5$47BB=-$V(WD+=8TER'E@=@,1]7GX=9X  (  >>(
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M49A6!XOM5-Q*=XNI5_T]G(N56N0O&HO7764>"(TI7OH)@(YJ7RD  (  :6D
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M=L11B'\*=X5&/7\?>!PYW7\7>(XL(W\4>.(<)7\H>/$)6G^T>9D  (  @
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M5S])O)-$6> ^Q9*G7%TRB))$7ILD9Y*(8$\2V)3G8)D!U)$*8FD  (  <?@
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M>JE&#(>X>RT[6(=4>W4O@(;5>Y<B!(:3>Z81J(;E>XL"<(2"?5<  (  @
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M6YT]-)PM7:PRPIMO7XXFVYKY8208PYN]8>H(EYO.8E   (Q#:5$  (  >:D
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M?9 Z;9'V?>TP,I%/??@DPY"(?=H70I!S?<@(4HWP?G@  (-%@    (  @
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MS7SU@3B3@UJ^3>Z%0UUA4B!V6U_]5CEF?6**6B]5@63Y7?M#/6<788\O3VA
M9+$6JFEU9E0  (  ;=*1>5695YF#U5B[6OYU+5NV7DIE?UZ-8794HV$Q9'A"
M@&-J9THNN61=:;<63F9@:MH  (  <K"/FE#D84F" E1M8]=SF5>Y9E!D EK/
M:*]35EVE:O)!8U_Q;1 MT6"=;MH5L6/@;XH  (  =V*-RDR3:NN 1U!S;*=Q
M]50!;E9BM%=2;_)2*5I9<7A :ERO<N<M$UT*=!@5.&&X=',  (  >W:,'$BN
M=(9^Q4S;=7MPDE"M=F-A8%0L=SQ1-%=<> T_E%F[>-0L<5FZ>7L4U5_G>:P
M (  ?O.*L45(?AM]A$FX?DUO>DW$?G)@9E%V?HQ03E2_?JD^]%<=?M0K]5;
M?PD4AUYD?U@  (  @ ")B$);AYY\?D<&APUNETM$AFU?GD\>A<U/E%)^A4,^
M6%34A-\KFU1,A,0455VBA/H  (  @ "(H3_PD/][LD3*CZUMXDDPCDI? 4TF
MC/-/ U"5B] ]RU+<BODK+5)'BL84*EWKB9L  (  @ "'_SX1FAY['$,,F!9M
M5D>*E?5>ADN2D_).H$\*DD4]@E%%D1TJX5"MD1,3WUYIC4   (  @ "('6'L
M3@QZPV0'4AULL68F5A==FV@Y6>Q-5FHN79$[I&O:8.\G\FR88ZD.DW#K9&@
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M>Z=S@%#A?!=F-E1'?&]7WU=6?+5(>UGV?/DWLEN0?4,D]EK,?8D-4FE\?@D
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M5I%NG&:W6=QA@VBI70M36&I]8!5#XFPA8NHRTFUE96@?1&U/9PH''W3J9[\
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M@;EH8%7/@<9;X5BQ@:9.4%LR@7,_H%TF@4\O=5W$@4L=#%Y^@8@&V'1O@6D
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M7?=B4FIX8)%6-FPC8Q%(V&V=96DZ)F[=9X@IFF^?:3<5QW!]::T X'Z&;"H
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MAL!=1%N[AH]1>5X+AA=$H%_CA8DVB6$(A2DFM&!AA284!F54A40!,'W^@,X
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M9#)6&V]19C1*L'"7:!T^-W&L:=\P'G)^:UD?U7*S;#\,,'98;"   (  =-$
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MBNQ2)F*JBJ5&_V1NB?4ZS&65B2TM2V78B,P=J&4FB2H+66T^AJH  (  @
M (  @ !8\X-<3&!.JX.63]U#A(0$4SXW"H2:5F$HO(6 60(75H>)6EP$<8?5
M6Z(  (  :34  (  ?AI7>'].4WQ-A'_55HI">8!@67$V+(#Q7!LH$X&Q7DD6
M\8,S7T,$C80(8&X  (  ;?$  (  @ !62'M:6K-,5'P?74!!>WS)7ZHU/GU?
M8=<G4WX"8Y$6:W[[9"\$BH"V958  (  <R0  (  @ !5*W>B8?5+,7B28_U
M5GE59>0T6'GW9YHFB'I_:.85TWKX:2\$<WW<:F\  (  >"   (  @ !4&G0Y
M:4=**752:LX_578O;#8S8G;0;6PEXG<W;E@51W>$;EX$6GMI;^,  (  ?'(
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M2M=#8(UJ3C8XU8V#46DLO8W_5$0>58]?5E<,@)'=5O8  (F*7#0  (  ;*T
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M;4P^37RP;G S_GTV;V@H<7U]<"(:^WVF<&P+$WZ&<(<  (  =E4  (  @
M (  @ !&^'DQ=%T]E7HM=1TS7'K+=:<GYGL%=@,:<GKG=A,*U'PV=FP  (
M>T<  (  @    (  @ !&3W;0>VP\ZW@#>] RO7B\>_@G77CM?  9^GB$>_L*
M;7IO?*T  (  ?W@  (  @    (  @ !%TW3;@KP\AW9$@N R;W<@@I\G.G<Y
M@DL:)'9R@EL*SGBU@@8  (  @    (  @    (  @ ! F9E%2*LWLIBM2^4M
MHYB43M0AJIE143L2>9PR4E,#4IF^5&   (2R7XH  (  < T  (  @  _-Y6\
M3P0V5)6.4=DL+)695&(@2Y9 5F81;IBA5R\#"94563\  (&N9$   (  =0$
M (  @  ^09(657@U.I(95^$K'I(^6@(?.I+76Z 0H)3#7!\"TI#/7BX  (
M:2,  (  >70  (  @  ];XY]6_TT4(Z?7?8J&([57ZD>9X]D8.@/_Y#782H"
MJHT&8SH  (  ;E8  (  ?5@  (  @  \FHL48IHS=(MI9"8I1(NM970=F8PB
M9DL/IXT09F<"F8G%:(<  (  = 0  (  @    (  @  [RX?R:5TRIHB':H$H
MD(CE:VL=!HE":_$//XFD:]8"IH<#;C   (  >3L  (  @    (  @  [%84I
M<"DQ](7^<.\G^(9W<7D<C8:_<;0.YX:N<88"EH3%=%,  (  ?9@  (  @
M (  @  Z?(*[=PHQ78//=WPG=H1E=ZX<+H27=Z@.HX1)=Y(";H,">BL  (
M@    (  @    (  @  Z#8"J?B<PYX'V?D\G"X*L?C$;XX+,?@$.D8)<?BX"
MB8&(?O\  (  @    (  @    (  @    /__  #__P  __\  &UF=#(
M! ,)   !                     0                    $   $   (
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M>9P4?Z-^98-,?\9^A6J%?_Y^P%&_@&-_/3D @1* #_S%?GR+-.2U?F.);,Q
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MWWRR@Q>=RFBD@G.8H%39@=V3/4%7@7*-?BZ @1:')\J@AL>\#[><A8JV :0
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M.X7J<W6K?G!@=0JCIUL3=KV;=T7W>)R2QC%1>J^)8=<@?Q5R&L.:?QES.:^
M?RAT3IK)?T!U:(6J?V1VEW!B?Y9WY5LS?]AY3D8>@#YZ]3%^@-Y\_=6C?69\
MF<)R?8M\FJYH?;-\HYFX?>)\P82>?AY\^V]I?FU]3UI1?M%]LD5F?UU^-S$
M@"%^Y-0C>_.'%,#7?"B&!*SM?&"% IA2?*F$*(-E?0&#:VY<?7""PEEQ??&"
M&$2X?IB!<#"1?W6 M-*>>K*1=+]$>N^/::M@>S6-;I;U>XR+C((N? &)U&U5
M?(F()5B??26&9D0=?>>$BS O?MR"9]$N>:B;QKW=>>J8S:G^>CF5W96B>IV2
M_($%>QV0+6Q;>\"-=%?=?'.*ET.0?4R'@2_:?E6#]\_Y>-FF$KRL>1VB,*C2
M>6V>0I2#>=B:6H ">F26?6MW>Q"2G%<M>]F.GD,3?,B*22^2?>*%8<[]>#6P
M3+NS>'JK?:?7>,>FC)..>32AE'\G><N<IFK!>H27I5:8>U:2;4*K?%>,V2]7
M?8&&G\XY=[RZ:+KO> "TJJ<(>$>NKI*\>*^HFWYA>4NBCFH9>A.<;588>O&6
M!$)2>_J/*2\F?3"'L<VO=VK$7KI<=ZR]IJ9?=^BVE)((>$6O6GVY>."H)&F)
M>:^@UE6D>IJ9/$'_>["1+B[_?.^(E<@)A])Q!;8ZANAR1J.WAA]S=I!VA6]T
MIWS!A,YU\&C?A#MW7%4E@[%XZD&'@T-ZO"Y[@OE\^<;<AD=ZY;4TA7Y['Z*G
MA,E[6H]TA"E[I7O-@YM\"F@!@R%\BU1?@K1]($#N@F9]W"XG@CI^R\6SA.&$
MRK0 A"V$ J&B@X&#0HY:@O6"GGK%@GF"&F<;@A>!K%.?@<J!1$!A@9V YBW>
M@8Z @\1:@Z6.CK*9@O2,Y* B@EF+/(T,@=R)IWF?@7^(-F8G@3B&SE+B@0.%
M7C_>@.Z#V"V=@/:"'L,.@J280+%.@?:5OI[@@663-HO;@/*0L'B5@)Z.-F5+
M@'&+TU([@%&)4C]M@%.&H"UF@'&#E<'U@=NA]; [@3*>FYW2@**;)(K;@#27
MI'>P?^F4*62(?\"0KE&I?[>-&S\)?\Z).BTW?_^$Y,$2@3VKFZ]9@)BG8ISM
M@ 2B]HGY?Y>><7;G?U>9\F/E?SJ595$N?S.0K3ZW?UZ+G2T0?Z"&"<!D@,:U
M*JZF@"6P#9PM?XNJH8DV?Q:E"78R?MF?>&-'?LR9UU"X?M*4 #YP?P*-PBSP
M?U&'!+_M@'2^H:X>?]6XF)N*?S&R&HB)?J^K7W66?F^DKV+*?FF=\E!;?GV6
M_#XR?KN/G2S7?Q*'U;EWD*YP1JD2CN9QDI?XC4QRT(8>B]1T$7/1BFEU;F%:
MB0=V\D\9AZ5XFST#AE!ZCRNFA0=\\[A^CT1YE:@LC9QYZI<%C!1Z0X4WBJ=Z
MKG+WB4I[-F"5A_Q[W4YLAK!\FCR)A75]B"M^A$-^LK=ZC?F"RZ<$C&."/Y7[
MBN&!MH0LB86!2W(+B#N ^5_-AP2 ODW,A=" C#P=A*Z :BM:@Y. 5+9HC,6,
M *7;BSF*G93#B<B)-H,FB'"'Z7$:ASV&ME\&AAJ%CTTTA/^$8CN[@_F#+"LZ
M@OF!U[5.B\R5)J37BD.2]I.[B-F0P8(2AX^.CW LAF2,:%X^A5N*3TR@A%*(
M'3MA@UZ%R"L@@G.#-K1:BPV>2:/@B8F;39+(B""8.8$MAMN5'&]@A;:2 5V4
MA*V.X4PD@[>+J3L5@MF(-"L)@@"$;;.2BG:G5:,8B/>CAY'_AXR?C(!JAD:;
M?&ZRA2F7:ET)A"F31DN_@S*.^CK8@F:*:"KV@:&%?++VB@*P2*)WB(BKI)%4
MAQFFN7_ A<RAIFX4A+&<D5R @\"79TM=@M*2"SJB@@B,7BKG@5*&8K*(B:ZY
M(:'ZB#BSGY#"AL*MLW\IA6RGCVV.A$ZA:EP6@V&;,$L)@H&4Q#IK@<2."RK:
M@1.''ZM:F<!ONYPCERMQ"HQ.E,=R47O2DH%SHFKKD$-U$5G?C@)VJ4D:B[9X
M9CB:B61Z<RD&AP-\[*J3F']X@9MQE@%XYXN/DZ=Y6'L:D65YWFHZCR]ZA%E!
MC/Y[2TB4BL)\+#A(B(1]0BD'AC5^F:G#ET.!+)I_E-B OHJRDH* 7GHZD$^
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ML8Q"FN*51'V-E\:2SFY^E+>05%]7D;*-W5!(CKB+:$&UB[J(YS/)B+6&2"=
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MZ['T9&"T4I\99I^N5XO8:.BH+7B1:VNB!V5M;BF;T%*G<1657$ _=$".C"[
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M?Q]^II>O=YB"W8I\>"6"NGR2>+&";FX0>4B""5]*>@"!IE!=>N:!3$'F>^6
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M@5!YV&9J@0AZ>5B8@-I[)4K&@,%[WCUI@+A\IC"<@-1]@R4G@0Y^<HOZ@%"
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MC=I\I3 YBM5]:B>]A]Y^12"IA1-_(FK*FM: 2V$]F$R 4E=8E9* .DU DK*
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M36-9A^)]KUEHANE][T\MA>%^'D3LA.%^53KF@_%^HC%<@Q]^_"B7@FY_6B%
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MCG5[N$@%C'=\*S[BBG!\L#7_B')]5"VPAHM^!28HA,A^OQ_]@SA_<F*"D,&
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M83][/$439UM\/S=$;=-]:BKC=&I^O9DJ0NZ =HP92*^ 97YX3D" 5' \4]>
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M>F]_8WI(6 Z!CF_E6_"!D&4#7\*!:%FI8ZB!+4X<9\" ^T*B;!: V#?'<)6
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M^3$D@0]_,"M4@,I_?"8H@)9_T2&:@)Z &QX%@,2 5   __\  /__  #__P
M;69T,0     #!"$   $                    !
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M=)=USG>8<\UYFG+->YMQS'V;<,M_G&_+@)UORX"=;\N G6_+@)UORX"=;\N
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M@*:<T("CI<^ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
MH:;.@*&FSH"AILZ H:;._Z(V(O^?0S?_HT5'_ZI"4_ZQ05_VN$%J\<%$<^K,
M2WG@VE9\S]5>C<#,:9NSPW*HI[MYLYZU?[N7L8/"CJV%QH>KB,J!J8W-?*B6
MSGNHHLU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;->ZFFS7NIILU[J:;-
M>ZFFS7NIILU[J:;-_Z,V(O^?0S?_I4-&_ZQ 4O^T/EWYO3]F[LA#;>/636_5
MW4Z!Q--9D;7)9I^IP7&KH+MYLYFV@+J4LH7 C*^&Q(:MB,> JXS)?*J2RGJK
MG,IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?RGFKG\IYJY_*>:N?
MRGFKG\IYJY_*_Z,U(O^@0C?_ID%%_Z\]4/ZX.UGSQ#QAYM%#9-G?0W/(W$J%
MM]!7E:K'9:*@P'"LF;IYM)2V@+J1LX6^B[&&P86PB,.!KHO%?:V0QGJME\9Z
MK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJMFL9ZK9K&>JV:QGJM
MFL9ZK9K&_Z0T(O^A03?_J3U#_[,Y3?F^-U7JS#I9V]T[8LOE/W>[V4B)J\Y7
MF*#&9:28P'&LD[MZLY"X@;B,M82[B+.&OH6RB<"!L8O!?K"/PGNPE,-ZL);#
M>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-ZL);#>K"6PWJPEL-Z
ML);#_Z0T(O^C/C;_K3E!_[@T2/#&,TW?V390S>4V9[[D.WNMUTB,H,U8F9?&
M9Z22P7*KCKU[L(RZ@;2(N(.WA+>%N8*UB+M_M(J]?+.-OGJSD;]ZLY._>K.3
MOWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._>K.3OWJSD[]ZLY._
M_Z8R(O^F.C3_LC,]]\ N0N32+T'/Y"Y5O^\S:Z_A.WZ@UDJ-ELY;F9#(::&,
MPW.HB<![K(:^?Z^"O(&R@+N$LWVZAK5[N8BV>;B+MW>WC[AWMY"Y=[>0N7>W
MD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y=[>0N7>WD+EWMY"Y_Z<Q
M(O^L,S'_N2LVZLPF-M+A)D'![RQ:L.TS;J'A/7^5UTV,C=!>EHG+:YV&QW2B
M@\1ZIG_#?:E\P8"K>L""K'F_A*UWOH:O=;Z)L'.]C+%SO8VQ<[V-L7.]C;%S
MO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ<[V-L7.]C;%SO8VQ_ZDN(?^S
M*BORQ2(LUMX<+</M(T>R^2M=HNPV;Y7B0GV+VE*(A=1@D(+0;)9^S'.;>\IW
MGGC)>Z!VR'ZB=,> HW/&@J1QQ82E<,2'IF[$BJ=NPXNG;L.+IV[#BZ=NPXNG
M;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG;L.+IV[#BZ=NPXNG_ZPJ(/J]'R+<
MV1(;Q>L:,[3Z(TJC^2Y>E>X\;8KE27F#WU:"?MIDB7K6;(YVTW&1<])UE''0
M>95OSWN7;<Y^F&S.@)EKS8*::LV$FVG,AYQHS(B<:,R(G&C,B)QHS(B<:,R(
MG&C,B)QHS(B<:,R(G&C,B)QHS(B<:,R(G&C,B)QHS(B<_[8>&.30#A/(Z1$@
MM?D;-Z7_)DN7^C1<B_%":(+J3W)\Y5MZ=^%D?W+>:H-NW'"&;-MTB&K9=XEH
MV7F+9]A\BV;7?HQEUH"-9-:"CF/5A8]BU86/8M6%CV+5A8]BU86/8M6%CV+5
MA8]BU86/8M6%CV+5A8]BU86/8M6%CV+5A8]BU86/Z<<-#,K:"P^W]Q(DI_\=
M.9C_*TF,_CI7@_9)87SP56EU[%YO;NEC=&KG:7=GY6YY9>1R>V/C=7QBXG=]
M8>)Y?F#A>W]?X7U_7^!_@%[@@H%=WX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=
MWX.!7=^#@5W?@X%=WX.!7=^#@5W?@X%=WX.!R] ) [KB"Q.H_Q0FFO\A-XW_
M,46$_T!0?/Q.6'3X5U]M]%UD9_)B9V/P:&IA[FQL7^UP;5WM<F]<['5O6^QW
M<%KK>7%:ZWIQ6>I\<ECJ?W)8ZG]S6.I_<UCJ?W-8ZG]S6.I_<UCJ?W-8ZG]S
M6.I_<UCJ?W-8ZG]S6.I_<UCJ?W-8ZG]S_YPX&O^:1BW_EU%!_YI33_Z<55[U
MG%IL[)M?>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_
MGKK!?:*[P'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL
M[)M?>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!
M?:*[P'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?
M>N299X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[
MP'NFO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]NWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N29
M9X?<EG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NF
MO,!YJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
MNWBSO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<
MEG&2U9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!Y
MJ[V_>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBS
MO;MXL[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2
MU9-[G,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_
M>+*]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2U9-[
MG,^0A*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_>+*]
MNWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]_YPX&O^:1BW_EU%!_YI33_Z<55[UG%IL[)M?>N299X?<EG&2U9-[G,^0
MA*3+CHRKR(J0L,6'E+3#A)BWPH&;N<%_GKK!?:*[P'NFO,!YJ[V_>+*]NWBS
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
M_YTX&O^:12[_EU!!_YM13_^=5%WUGEAK[)U=>>2;9(;<F&Z2U95XG-"2@:3+
MCXFKQXV/L<6)D[7#A9>XPH*:NL%_GKO ?:*]OWNGOK]YK;Z[>+&^MGFROK9Y
MLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^_YTX
M&O^:12[_F$] _YU03O^?4ESVH%5J[:!:>.6?8(7=G&J1UIASF]"5?:3+DH6K
MQX^-L<2,D;;"AY6YP8.9N[]_G;Z^?:*_O7JHP+QYK\&T>;#!L'JPP+!ZL,"P
M>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# _YTW&O^;
M12[_F4Y _YY.3O^A4%OWHE-I[J-7=^:B78/>GV:/UYQOFM&8>:/+E8*KQY*)
ML<2.C[;"B9.ZOX28O;V G<"\?:/"NWNJQ+1ZK<2M>Z[#JGNOP:I[K\&J>Z_!
MJGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!_YXW&O^;1"[_
MFDU _Y]-3?^B3EOWI%%H[Z55=>>E6H+?HV*-V*!KF-*<=:',F7ZIR)6&L,22
MC;;!C)&[OH:6O[R!G,.Z?J3%MWRKQZU[J\:G?*W$I'VNPZ1]KL.D?:[#I'VN
MPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#_YXW&O^;1"[_FTQ
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MA(;@@(N-W'R1DMIYEY;8=IR9U7.@F]1QI9W3;ZF?TFZNH-)MLZ'1;+FBT6O
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M#O^4/1[_G4 I_Z0^,O^K/SO_L4)"^+A'2>V^3D_EQE=3VL9>7\N^9'&^MFJ
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M=LR:FG?-F9EWS9B9=\V8F7?-F)EWS9B9=\V8F7?-F)EWS9B9=\V8_WXB!O^
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MD7Z%IHR&C*"(C9&:A966EH*>FI* IYV/?[*>C8#!GHR R9Z+@,J=BH#+FXJ
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M6$#\J5A _*E80/RI6$#\J5A _*E80/RI6$#\J5A _*E8QK@$ +;$! "JTP4
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M?<ICX'[#9.!_O6;?@+=GWX"W9]^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
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M9TK@[&=*W^QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG_YP- -NQ!@#*O0<
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ML4<CRZM2,L&E6D"XGV),L)EI5ZB4<&"ACW=GFXM^;I:(AG.1A8YXC(*6?(B
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M=%2PYW56K.=U5JSG=5:LYW56K.=U5JSG=5:LYW56K.=U_X,2 ?^6$0#_J!$
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M<F62ZG%GC^IP9X[J<&>.ZG!GCNIP9X[J<&>.ZG!GCNIP_W,5 O^%$P'_E!0
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M3$;:[4Q$V/E/0]C[3T/8^T]#V/M/0]C[3T/8^T]#V/M/VYH  ,JI @"[LP(
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M)0/_920$_VXJ!O]V- O_>CT1_WI&&/]X3R#[=%@H]F]A+_%K;#;M9W8\Z6.
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M6D^K[EM/JOI;4:;Z6U&F^EM1IOI;4:;Z6U&F^EM1IOI;_X ) .&2 0#1H 0
MQJL% +RT! "SO0, J\<+ *3)' &<R"P&D\<Y#XK%1!F!PTTC>L%4+'._6S-M
MOF(Y9[QI/F*[<$->NG='6KF 2U:YB4Y3N)104+B@4DVXKE1,N+]42[G85$NW
M[51*MOE52K/^5DJS_E9*L_Y62K/^5DJS_E9*L_Y6^H<" -:8  #)I0, O:\#
M +.X 0"IP@0 H<T( )K0%@"2T"@$BL\V#('.015YS$H><LM2)FS*6BUFR6$R
M8<AH-US';SQ8QG8_5<9_0U'%B45.Q91(2\6@2DG%KDM(Q;]+1\;82T?%[4M&
MP_E-1<+_3D7"_TY%PO].1<+_3D7"_TY%PO].WY   ,R?  "_J@$ L[,! *F]
M @"?QP4 EM() ([:$@"(VR0"@-HR"'C9/A!QV$@8:M=0'V366"5?U5\J6]1G
M+U?4;C-3TW8V4--_.4S3B#M*TY0^1].@/T74KD!$U+]!0]780$33[$!"TO9"
M0='^1$'1_D1!T?Y$0='^1$'1_D1!T?Y$T9@  ,.E  "UK@  J;@  )[# @"4
MS08 BMD* (3C& %]Y"8#=>0R"&[C/ ]GXT458>--&USC52!7XUTD5.-D)U#B
M:RI-XG,M2N-\,$CCAC)%XY T0^.<-4'DJ39 Y+@W/^7+-S_EY#<_X_,V/>+[
M.#WB^S@]XOLX/>+[.#WB^S@]XOLXQJ$  +>K  "JM   GKX  )/) @"(U 8
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M2(@L_T:2+O]%FS#_1*(R_T.I,_]"L#3_0K<U_T&_-O]!R3;_0-<W_T#E-_U
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M65^,[EE?C/M888K]5V&)_5=AB?U788G]5V&)_5=AB?U7_V\, /]_"0#?C0,
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M2DBP_TI(L/]*2+#_2DBP_TI(L/]*XH8  ,Z4  #"H0  MJD  *NQ  "AN@$
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M4&YW[T]N=_Q.;G?_36]W_TQO=_],;W?_3&]W_TQO=_],_V0- /]R"@#P?@8
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M2EB._TE8CO])6([_25B._TE8CO])_W$! ."   #/C   Q)8" +N> @"RI
MJ:H% **L%0";K"8"E*LT!XRJ/P^%J$@7?J90'GBD6"5SHEXK;J%E,&J?;#1E
MGG,Y89U[/%Z;A$!:FHY#5YF:1529IT=2F;9(49G*2%&8YDA1E_5(49?_1U&6
M_T=1EO]'49;_1U&6_T=1EO]']G<  -B%  #)D0  OYL! +2B  "KJ   H;
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M-T"W_S= M_\WSHL  +^8  "RH0  IZD  )RP  "1N   AL " 'O(!P!TRQ(
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MCPXK]9T/*O:K$"GVO! H]LX1)_?F$2?U\1$G]?$1)_7Q$2?U\1$G]?$1HZ@
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M1'QG[T-\9_Q!?&C_0'QH_T!\:/\_?&C_/WQH_S]\:/\__UL, /]G"0#W<0<
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M:W/_0FQS_T%L<_] ;'/_0&QS_T!L<_] _V$% /IN 0#=>0  T((" ,>)! #
MC@0 N9$, +&2&P"IDBL#HI X")N-0P^4BDP7CHA4'8F%6R.$@V(H@(%I+7Q_
M<#%X?G<U=7Q_.'%[B#QN>I(_:WF=06AXJD-F>+A$97C,165XYT1E>/=#9GC_
M0F9X_T%F>/] 9GC_0&9X_T!F>/] _V0# .YQ  #8?   RX4" ,., P"[D0,
MLY0) *R6& "EEB@"G90V!Y:200Z0CTH5BHU2'(2+6B)_B6 G>X=G+'>%;C!S
M@W4T;X)]-VR!ACMI?Y ^9GZ;06-^J$-A?;9$8'W)1%]]Y4-@??9"8'W_06%]
M_T!A??] 87W_0&%]_T!A??] _V<  .-T  #2?P  QX@! +Z/ @"VE0$ KI@&
M *::%0"?FB8"F)DS!I&7/PR+E4@4A9-0&G^16"!ZCU\E=HUE*G*+;"YNBG,R
M:HA[-F:'A#ECAHX\8(69/UV$ID%;A+1"6H3'0UJ$XT):@_1!6X/_0%N#_T!;
M@_\_6X/_/UN#_S];@_\__VH  -YX  #-@P  PHP  +F3  "PF   IYT" *"?
M$@"9GR,!DYXQ!8R=/ N%FT82?YE.&'J75AYUEETC<)1C*&R2:BQHD7$P99!Y
M-&&.@C=>C8PZ6HR7/5B,I#]6B[) 5(O%0%2+X4!4BO,_58K^/U6)_SY5B?\^
M58G_/E6)_SY5B?\^[V\  -9\  #(AP  O9$  +28  "JG   H*(  )FD$ "3
MI2 !C*0N X6C.0E_HD,/>:!,%G2?4QMOG5H@:IQA)6:::"ECF6\M7YAW,%N7
M@#18EHHW5965.5*5HCM0E+ ]3Y3#/4^4WSQ/D_(\3Y+]/$^2_SQ/D?\\3Y'_
M/$^1_SQ/D?\\Y'0  ,^!  #"C   N)8  *V<  "CH0  F*@  )"J#0"+JQL
MA:LJ GZJ-@9XJ4$,<JA)$FVG41AIIE@<9*1?(6"C9B5=HFTI6:%U+%:A?B]3
MH(@R3Y^3-4V?H#=+GJ\X2I[!.$F>W3A)G? X29S\.$F;_SE)F_\Y29O_.4F;
M_SE)F_\YVWH  ,B'  "\D@  L9H  *:@  "<I@  D:P  (>Q" "!LA8 ?+,F
M 7:R,P1QLCT):[%'#F:P3Q-BKU887JY='%JM9"!7K&LC5*QS)E"K?"E-JH8L
M2JJ2+TBIGS!&J:TR1:F_,D2JVC)$J.\R0Z?[,T.F_S-#I?\T0Z7_-$.E_S1#
MI?\TT($  ,&.  "UF   J9\  )ZE  "3K   B+(  'RY @!VNA$ <KLA &Z[
M+@)HNSH&9+I#"E^Z3 Y;N5,25[A:%E2X81E1MVD<3K=Q'TNV>B)(MH0E1;:0
M)T.UG2E!M:PJ0+:^*C^VV"H_M.XJ/K/Z+#VR_RT]L?\M/;'_+3VQ_RT]L?\M
MQXD  +F5  "LG0  H:0  ):K  "*L@  ?[@  '._ P!JQ P 9\4: &/%* %?
MQ34#6\4_!5?%2 E4Q% ,4,18#TW$7Q)*PV852,-N%T7#>!I"PX(<0,..'C[#
MG!\\PZL@.\.\(3K#U2$[PNXA.<#Y(CB__R0XO_\D.+__)#B__R0XO_\DO9$
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M""3QN @C\<P((O+E""+P\P@B[_4((N_U""+O]0@B[_4(GJ8  )&O  "$N
M=\$  &K)  !=T   4=<  $;=   _Z@4 //8. #GV%P V]R  ,_<H #'X,  N
M^38!*_D] 2GZ1 $G^DH")?M2 B/[6@(@_&,#'OQN QS]>P,;_HD$&?Z8!!C_
MJ 07_[<$%O_(!!;_X 06_^0$%O_D!!;_Y 06_^0$DZX  (6W  !XP   :LD
M %W2  !0V0  1-\  #KD   U]P, ,O\, "[_$@ K_QH */\A ";_)P C_RT
M(/\S ![_.0$<_S\!&?]% 1?_30$5_U4!$_]? 1'_:@(0_W@"#O^' @[_E@(-
M_Z0"#/^P @S_O@(,_\("#/_" @S_P@(,_\("A[8  'F_  !KR0  7M,  %#;
M  !#X   ..4  "_P   K_P  )_\( "3_#@ A_Q, 'O\9 !O_'@ 8_R, %?\H
M !/_+0 1_S( $/\X  [_/P ,_T8!"O]/ 0?_60$$_V4! ?]R 0#_@0$ _X\!
M /^; 0#_IP$ _ZD! /^I 0#_J0$ _ZD!_RPO ?\P+ '_,BP"_S,P O\Q-@/_
M,$$#_R]-!/\M6@;_*V8'_RES"/\H?@K_)X@+_R>1#/\GF0W_)I\-_R:E#O\F
MJP[_)K$/_R:X#_\FP __)LD/_R;7#_\FY@__)O /_B;Y#_LG_P_Y)_\/^2;_
M$?@F_Q'X)O\2^";_$O@F_Q+X)O\2_RXL ?\S*0'_-2H"_S8M O\V- +_-3\#
M_S-+!/\R5P;_,&0'_RYP"?\L>PK_+(4,_RN.#?\KE@[_*IT/_RJC#_\JJ1#_
M*J\0_RFV$/\IO1'_*<<1_RG3$?XIXQ'[*N\1^"KX$/8K_Q#T*O\2]"K_$_,J
M_Q3S*?\4\RG_%/,I_Q3S*?\4_S$I ?\V)@'_.28!_SHI O\[,@+_.ST#_SE(
M!?\W5 ;_-6 '_S-L"?\R=PS_,((-_S"+#O\ODP__+YH0_RZ@$?\NIA'_+JP2
M_RZS$OXNNA+]+L02^R[/$_@NX1+U+NT2\2_W$N\O_Q/N+O\5[2[_%NPN_Q?L
M+O\7["[_%^PN_Q?L+O\7_S0F ?\Y(P'_/2,!_SXF O]!+P+_03D#_S]%!/\]
M4 ;_.UP(_SEH"O\W<PW_-GX._S6'$/TTCQ'\-)82^C.=$_DSHQ/X,ZD4]S.P
M%/8SMQ3T,\ 4\S/,%/ SWA3M,^L4Z33V%><S_Q?F,_\8Y#+_&>0S_QKC,O\:
MXS+_&N,R_QKC,O\:_S@C ?\]( '_01\!_T4C ?]'+ +_1S8#_T9 !/]$3 ;_
M05@(_S]D"_L^;P[Y/'D0]CN#$?0ZBQ/S.9,4\3F9%/ XH!7N.*86[3BM%NPX
MM!;J.+T6Z3C)%N<XVQ;C.>H6X#CU&-TX_QK;-_\<V3?_'=<W_QW6-_\>UC?_
M'M8W_Q[6-_\>_SL@ ?]!' '_11H!_TL@ ?]-* '_3C("_TT\!/]*1P;Z2%,(
M]D9?"_)$:@[O0G01[$%^$^I AQ3H/XX5YCZ6%N4^G!?C/:,8XCVJ&. ]LAC?
M/;L9W3W&&=L]V!K6/>D:TCWU'<X]_A_,//\@RSS_(<D\_R')//\AR3S_(<D\
M_R')//\A_S\< ?]%%P'_2Q<!_U = ?]3) '_5"T"_U,W _=10@7Q3DT([$Q:
M"^A*90_E2&\1XD=Y%-]%@A;=1(H7VD.1&=A"F1K50I\;TT&F'-%!KAW/0;<>
MSD'!'LQ!T!_)0N4?Q4+S(<)!_B/ 0?\DOD'_)+U!_R6]0?\EO4'_);U!_R6]
M0?\E_T(8 ?])$P#_4!0 _U89 /]9( '_6B@!]UHR N]8/03H54D'XU-5"MY1
M8 [93FH2U$QT%M!+?!C.280;S$B,',I'DQ[(1YH?QD:A(<1&J2+"1;$CP46\
M([]%R22]1M\EN4;O)K9&^R>T1O\HLT;_*+)&_RBQ1O\HL4;_*+%&_RBQ1O\H
M_T85 /]-$0#_51( _UL6 /]>&P#Y8",![V L >9>-@/?7$0%V%E0"M%76P_,
M5&44R%)N&,50=QO#3W\=P$Z&'[Y-CB&\3)4CNDN<)+A*I":V2JPGM$JV*+-)
MPRFQ2=8IKDKJ*JM*^"NI2O\KJ$O_*Z=+_RNG2_\KITO_*Z=+_RNG2_\K_TD2
M /]0#@#_61  _U\2 /]C%@#R91T YV4E -YD,0'48C\%S6!+"L==5@_"6F 5
MOEAI&;M6<1RX5'D?ME.!(K-2B"2Q4) FKU"7**U/GRFK3J@KJ4ZR+*=.OBVF
M3LXNHT[F+J%/]2Z?3_\NGD__+IU/_RZ=4/\NG5#_+IU0_RZ=4/\N_TP0 /]4
M#0#_70X _V,/ /EG$0#K:14 WVH< --J+ '+:#L$Q65'";]B4@^Z8%P5MEUE
M&;);;1VO674AK%A\(ZI6@R:G58LHI523*J-3FRRA4Z,NGU*M+YU2N3";4LDQ
MF5+B,9=3\C&64_\QE53_,914_S"45/\PE%3_,)14_S"45/\P_T\. /]8"P#_
M8 L ^V8, /!K#0#D;0X UFX6 ,QO* '$;3<$O6M$";=H3P^R95@5KF)A&JI@
M:1ZG7G AI%UX):%;?R>?6H<JG%F.+)I8ERZ85Z PE5:J,I-6M3.15L4TD%;=
M-(Y7\#2-5_TSC%C_,XQ8_S*,6/\QC%C_,8Q8_S&,6/\Q_U$, /];"0#_8P@
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M-W)H_S9R:/\U<FC_-7)H_S5R:/\U_UD" /9E  #=;@  SW8! ,=[ P# ?P0
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M-5YX_S5>>/\U]60  -QP  #*>@  P(,  +:)  "NC0  I(\  )V1$ "7DB
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MFRQ(FJDM1YFZ+4::T"U&F.LM1I?Y+D:6_RY&EO\N1I;_+D:6_RY&EO\NT7<
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M&#:]RA@WO.<7-;OV&36Z_QHTN?\;-+G_&S2Y_QLTN?\;N(\  *J8  "?GP
MDZ8  (>L  ![LP  ;[D  &.^  !8Q 0 4,@, $W(%P!,R24 2LHQ $?*.P%%
MRD0"0\I, T'*5 0^REP&/,ID!SK+;@DXRW@*-LN%##3+D@TRRZ(.,<NR#S#,
MQP\PR^4.+\GU#R[(_1$NQ_\2+L?_$B['_Q(NQ_\2KI<  *&>  "5I0  B:T
M 'RT  !PNP  9,$  %G&  !.RP, 1= ( #[5#@ ]U1H /-8F #O7,0 YV#L
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M A#[W0(0^^D"$/OI A#[Z0(0^^D"CZL  (&T  !SO0  9L8  %G-  !+TP
M0-D  #7>   LXP  )O$  "3^"@ A_Q  '_\6 !S_'  9_R( %_\H !7_+@ 3
M_S4 $O\\ !#_0P ._TP #?]6  O_8@ )_V\ "/]_ 0?_D $%_Z !!/^N 03_
MO $#_\<! __' 0/_QP$#_\<!@[0  '6]  !GQ@  6L\  $O5   _W   ,^$
M "GE   A[   'OT  !K_!0 7_PP %?\0 !+_%  0_QD #O\>  W_(P +_R@
M"/\N  ;_-0 #_ST  /]&  #_40  _UT  /]K  #_>P  _XL  /^9  #_I0
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M(*=&\R&E1O\AHT;_(J)&_R&B1O\AHD;_(:)&_R&B1O\A_T4. /]+"@#_4PP
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M*H!8_RJ 6/\I@%C_*8!8_RF 6/\I_T\" /U9  #B8   U6<  ,QJ P#&; 4
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M*VIG_RMJ9_\K_E@  .%C  #/;   Q',  +MX  "S>@  JWH$ *1[$@">?"(
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MG"M6>ZDL5'NY+5-[SBU4>NHM5'KY+%1Y_RM5>?\J57G_*E5Y_RI5>?\JX64
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M(T.4R"-#E.4C0Y+U)$.1_R1#D/\D0Y#_)$.0_R1#D/\DRG4  +N!  "PBP
MI)$  )J5  "/F0  @YT  '2B  !NHPL :J07 &:E)0!CI3$!7Z0[ UND1 58
MI$L(5:-3"U*C6@U/HF$03:)H$TJA<15'H'L81*"&&D*?DQQ GZ(=/I^R'CV?
MQAX]G^,=/9WT'CV<_Q\\F_\?/)O_(#R;_R \F_\@PGP  +6(  "ID   GI8
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M""G"^PDHP?\**,'_"RC!_PLHP?\+J)4  )V;  "1H@  A*D  'BO  !KM0
M7[L  %2_  !)PP  /\@$ #;-"0 SSA$ ,L\< #'/)P PT#$ +] Z "[10P M
MT4P *])5 "K27P$HTVD!)]-V 273A (DU)0"(M2F B'5N0(AU=("(-/K B#2
M]@,?T?\$']'_!!_1_P0?T?\$GYL  )2B  "'J0  >;$  &VX  !@O@  5,,
M $G'   ^RP  -= ! "W5!@ EVPL )-X2 "/>'  BWR4 (> N "#@-P ?X4
M'N%* !WB4P <XUX &^-J !KD>  8Y(@!%^6: 1;FK $5YL !%.?= 1/E[P$3
MX_H!$^/Z 1/C^@$3X_H!EJ(  (FI  ![L0  ;KD  &'   !4Q@  2,H  #W/
M   STP  *MD  "+> @ >ZPH '.P0 !OM%P 9[1\ %^XF !7N+0 4[S4 $_ ]
M !'P1@ 0\5  #_);  [R:0 -\W@ #/2*  OUG  *]:X "?;"  GVV0 (]>T
M"/7M  CU[0 (]>T BZD  'VR  !ON@  8L(  %7)  !'S@  .](  #'8   G
MW0  '^$  !GH   6^ 8 %/H- !+[$@ 0_!< #OP=  W](P ,_2D "OXP  C_
M.  &_T$  _],  #_6   _V8  /]W  #_B0  _YL  /^K  #_NP  _\X  /_/
M  #_SP  _\\ ?[(  '&Z  !CPP  5LL  $C1   ZU@  +]T  "7A   <Y0
M%.D  !'W   /_P$ #?\)  O_#0 (_Q  !O\4  /_&   _QX  /\C  #_*@
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M"L8Q]PS#,?\.P3'_#\ Q_P^_,?\/OS'_$+\Q_Q"_,?\0_S83 /\Y#P#_/A
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M&Y1&_QN31O\;DT?_&Y-'_QN31_\;_T(% /]* 0#R4   X50! -E6!0#350D
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M(758_R%U6/\A_TT  .57  #37P  R&0  +]G  "W:   L6<' *EH% "C:20
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MG"-B9JDE8&:Y)E]FS29?9N@F8&;Y)&!F_R-@9O\C86;_(F%F_R)A9O\BZ%@
M --C  #$:P  N7$  +!U  "G=P  GG4  )9V#0"0=QD BW@G (9W,P*!=CT$
M?'5&!WAS3@MU<E4.<7%<$6YP8Q1K;VH6:6YQ&69N>AQC;8,>86R.(5]KFB-=
M:Z<E6VNW)EIKRB9::^<E6VOW)%MJ_R-<:O\B7&K_(EQJ_R)<:O\BXUL  ,YF
M  # ;@  MG0  *QY  "C>P  F'D  )!Z"P"*>Q8 A7PD (%\,0%\>SL$=WI$
M!G-Y3 IP>%,-;'=:$&EV81-G=6@69'1O&&%S>!M><H$=7'&,(%IQF")8<*8D
M5G"U)55PR"55<.4E57#V)%9O_R-6;_\B5V__(E=O_R)7;_\BWU\  ,II  "\
M<@  LG@  *E]  "??P  DGX  (I_!P"$@!, @($A 'N!+@%W@#D#<H!"!6Y_
M2@AK?E$+:'U8#F1\7Q%B>V847WIM%UQY=1E9>'\<5WB*'E1WEB%2=J0B47:S
M(U!VQB10=N,C4'7U(U%U_R)1=/\A473_(5%T_R%1=/\AV&,  ,5M  "X=@
MKGT  *6"  ":@P  C8,  (2$ P!]A1  >88> '6'*P%QAS8";88_!&F%1P=E
MA$\*8H-6#5^#7 ]<@F,26H%K%5> <QA4?WT:47^('$]^E!]-?J(@2WVQ(4I]
MQ")*?>$A2WST(4M[_R!+>_\@2WO_($M[_R!+>_\@T&<  ,!R  "T>P  JH(
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M%CF7_!8XEO\7.)7_%SB5_Q<XE?\7NWH  *^%  "DC   F)$  (V5  "!F@
M=9T  &B@  !;I   5J4, %.F%P!1IR, 3Z<O $RG. %*IT$!2*=) D:G4 1#
MIU@%0:=?!C^F: @]IG(*.J9]"SBFB@TVI9D.-*6I#S.ENP\SI=0/,Z3N#S*B
M^Q RH?\1,J'_$3*A_Q$RH?\1M((  *B,  "=D@  DI<  (:<  !YH0  ;:4
M &&I  !5K   2Z\% $>P$ !%L!P 1+$G $*Q,@!!LCL /[)# 3VR2P$[LE,"
M.;); S>R9 0ULFX%,[)Y!C&RAP<OL98(+K*F""VRN DLLM (++#L"2NO^0HK
MKO\+*JW_"RJM_PLJK?\+K8L  *"2  "5F   B9T  'VC  !QJ   9*T  %FQ
M  !-M   0K@  #NZ"@ XNQ, -[P> #6\*0 TO3( ,[T[ #*]1  QODP +[Y5
M 2Z^7@$LOF@!*KYT BF^@@(GOY$#)K^B R2_M ,CO\L#([[H R.\]P0BN_\%
M(KO_!2*[_P4BN_\%I)(  )B8  ",G@  @*4  '.K  !GL   6[4  $^Y  !$
MO   .L   ##$!  JQPL *,@3 "?)'0 FR2< )<DP "3*.0 CRD( (LM+ "'+
M50 @S%\ '\QL !W->@ <S8H &\V< !G.K@$8SL4 &,WD !C,] $8ROP!&,K_
M AC*_P(8RO\"FYD  (^?  ""I@  =:T  &BS  !<N0  4+T  $3!   YQ
M,,@  "C, 0 @T 8 &=4+ !;7$  5V!D %=DB !39*P 3VC0 $]H] !+;2  1
MW%, $=U? !#=;0 0WGX #M^1  [@I  -X+@ #.#2  O?[0 ,WO< #-W[  S=
M^P ,W?L DI\  (6G  !WK@  :K4  %V\  !0P0  1,4  #C)   NS0  )=$
M ![5   6V@$ $=X& !#G#0 .YQ( #>@9  SH(0 +Z2D "NHQ  GJ.P 'ZT4
M!>M1  3K7@ #ZVX  >N   #JE   ZJ<  .N\  #KT@  Z^D  .SO  #L[P
M[.\ AZ<  'FO  !KMP  7KX  %'%  !#R0  -\T  "W1   CU@  &]L  !/?
M   .XP  #.X"  KV"@ ']@X !?82  /V&   ]1X  /4E  #U+@  ]3<  /9"
M  #V3@  ]ET  /9N  #V@0  ]I4  />G  #WMP  ^,<  /C0  #XT   ^-
M>Z\  &VX  !@P   4L@  $3-   WT0  *]<  "'<   8X   $>0   SG   '
M[P  !/H   '_ P  _P@  /\-  #^$   _A0  /\:  #_(0  _RD  /\S  #_
M/@  _TL  /];  #_;   _X   /^2  #_H0  _ZT  /^S  #_LP  _[, _QPF
M /\<) #_&B4 _Q4G /\1+@#_$#H _PY' ?\-4P'_"U\!_PIK ?\*=0'_"G\!
M_PJ' ?\*C@'_"I4!_PJ; ?\)H '_":4 _PFK /\)L0#_";@ _PG! /X)S #\
M"=X ^0GK /4)]@#S"?\ \@K_ /$*_P'Q"_\!\0O_ ?$+_P'Q"_\!_Q\C /\?
M(0#_'B$ _QDD /\7+ #_%3< _Q-$ /\14 '_$%P!_PYG ?\.<@'_#GL!_PZ$
M ?\.BP'_#I(!_PZ8 ?\.G0'_#J,!_@ZH ?P.K@'[#K4 ^@Z^ /@.R0#U#ML
M\@[J .X.]0#L#O\!ZP__ >H/_P'J$/\!Z1#_ >D0_P'I$/\!_R(? /\B' #_
M(1P _Q\@ /\?*0#_'#0 _QI  /\73 '_%5@!_Q1C ?\3;@'_$W<!_A.  ?P3
MB 'Z$HX!^1*5 ?@2F@'V$J !]1*F ?02K 'S$K,!\1*\ ? 2QP'M$M@!Z1/H
M >83]0'D%/\!XA3_ N$5_P+A%?\"X!7_ N 5_P+@%?\"_R4; /\F%P#_)!8
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M"ZXP_PNN,/\+K3#_"ZTP_PNM,/\+_S,, /\V!@#_/ D _SX, /T]$ #O/!4
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M%85'_Q6%1_\5_S\  .Q(  #=3P  SU,  ,95  # 4P, NU$, +-2&0"M4RD
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MG!IN5JD;;%:X'&M6RQUJ5N8<:E?W&VI7_QIJ5_\9:U?_&6M7_QEK5_\9ZTP
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M85ZT'6!>QQU@7N,=8%[U'&!>_QM@7O\:85[_&F%>_QIA7O\:Y%(  ,]<  #
M9   MFD  *QL  "C;   F6D  ))J"P",:A8 AVLD ()K, %^:CH">FE#!'9H
M2P9S9U((<&=9"FUF8 UK968/:&1N$69D=A1D8X 68F.+&&!BEQI>8J0<7&*R
M'5MBQ1U;8N$=6V+T'%MB_QM<8O\:7&+_&EQB_QI<8O\:X%4  ,M?  "]9P
MLFP  *EP  "?;P  E&P  (QM" "&;A, @F\A 'UO+0%Y;S@"=6Y! W)M205N
M;% ':VM7"FEK7@QF:F4.9&EL$6%I=!-?:'X676>)&%MGE1I99J(;5V:P'%9F
MPQU69M\=5F;S'%=F_QM79O\:5V;_&E=F_QI79O\:VUD  ,=B  "Z:@  KW
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M&$=V_!A'=O\81W7_%T=U_Q='=?\7R64  +IO  "N=P  I'T  )A_  "+?P
M?G\  '.!  !L@PD :(03 &6%( !BABP 7X8V 5R&/P)9A48#5X5.!52%50=2
MA%P)3X-C"TV#:PU+@G0/2()_$4:!C!-$@9H50H"I%D& NA9 @-(607_M%D%^
M^Q9!??\607W_%D%]_Q9!??\6PFH  +5U  "J?0  GX(  )*#  "%A   >84
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M"BV;_PHMF_\*KX   *.)  "7C@  C9,  '^5  !RF   9IP  %N@  !/I
M1:<  #ZI#  \JA0 .JH? #FJ*0 XJS( -ZL[ #6K0P TK$L ,JQ3 3&L7 $O
MK&8"+:QQ BNL?P,JK(X#**R>!">LL 0FK,4$)JOD R6I]00EJ/\%):?_!26G
M_P4EI_\%IXD  )N/  "1E   A)D  'B>  !KH@  7Z8  %.J  !(K0  /;
M #2S P OM0X +;46 "RU(  KMBD *K8R "FW.@ HMT, )[=, ":X50 DN%\
M([AK "*X> $@N(@!'[B9 1VYJP$<N< !'+C? 1RV\@$;M?P"&[3_ ANT_P(;
MM/\"GX\  )25  "(FP  >Z$  &ZF  !BJP  5K   $JS   _M@  -;D  "R\
M   DOP8 '\(- !W"%  <PAX &\,F !K#+P 9Q#@ &,1! !?$2@ 6Q54 %<5A
M !3&;P 3QG\ $L:1 !''I  0Q[D #\?4 !#&[@ 0Q/H $,/_ !##_P 0P_\
MEY8  (N<  !^H@  <:D  &2O  !8M   2[@  $"[   UO@  *\$  "/%   ;
MR0$ %,P& !#0"P .T1$ #=$9  W1(0 ,T2H #-$T  O2/@ *TDD "=-5  G3
M8@ (TW( !M2$  74F  $U*L  ]7   '5W  !U>T  =7V  '5]@ !U?8 CIT
M ("D  !SJP  9K$  %FX  !,O0  /\   #3#   JQP  (<H  !G.   2T@
M#=8!  G;!0 &W T !-P1  /=&  !WB   -XH  #?,0  X#P  .%'  #B5
MXV,  .-T  #DB   Y)L  .6N  #EP0  Y=4  .;G  #FYP  YN< @Z0  '6L
M  !HLP  6KL  $W!  ! Q   ,\@  "C,   ?T   %]0  !#9   +W0  !>$
M  #D    Y0<  .8-  #G$0  Z!8  .D=  #J)0  ZRX  .TY  #O10  \%,
M /%D  #Q=@  \HH  /.<  #SK0  ]+L  /3(  #TR   ],@ =ZT  &JU  !<
MO0  3\0  $#)   SS0  )]$  !W6   4W   #N    CC   !Y@   .H   #N
M    [@   .\$  #P"@  \0X  /,2  #T&   ]B   /@J  #Z-0  _4,  /Y2
M  #_8P  _W8  /^)  #_F@  _Z8  /^P  #_L   _[  _Q8C /\5(0#_$2$
M_PTD /\)*P#_!C< _P-$ /\ 40#_ %T _P!H /\ <@#_ 'L _P"# /\ B@#_
M )$ _P"6 /\ G #_ *$ _0"F /L K #Y +, ]P"[ /4 Q0#S -$ \@#D /$
M\0#O /H [@#_ .X _P#M /\ [0#_ .T _P#M /\ _QD@ /\8'0#_%1T _Q ?
M /\.*0#_##0 _PI! /\'30#_!5D _P1D /\$;@#_ W< _P.  /\#AP#_ XT
M_0*3 /L"F0#Y IX ]P*D /4"J@#S ;  \0&X .\!P@#M <\ ZP'C .H![P#H
M OL YP3_ .8%_P#F!O\ Y@;_ .8&_P#F!O\ _QP; /\;&0#_%Q@ _Q4= /\3
M)0#_$3  _Q ] /\.20#_#%4 _PM@ /\+:@#]"W, ^PM\ /D*@P#W"HH ]0J0
M /0*E@#S"IL \0JA .\)IP#M":X ZPFV .@)P #F"<T Y GB .(*\ #?"_L
MW@S_ -P-_P#<#?\ VPW_ =L-_P';#?\!_Q\7 /\>$P#_&Q( _QP9 /\;(@#_
M&"P _Q4X /\31 #^$E  ^1%; /409@#S$&\ \!!W .X0?P#L$(8 ZA", .D0
MD@#H$)@ Y@^> .4/I0#C#ZP X0^T . /O@#>#\P VA#A -41\ #2$OL SQ+_
M <X3_P'-$_\!S1/_ <P3_P',$_\!_R(2 /\B#P#_(0\ _R(4 /\B' #_("<
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M")PQ_PB<,?\(_S   /\U  #O.   XCH  -LY! #6-0D SC03 ,8V(@"_.#$
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MGP]^1*L0?$6Y$7M%RQ%Z1>81>4;W$7A&_Q!X1O\0>$;_#WA&_P]X1O\/\#\
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M%&91PQ5E4MX595+R%&52_Q-E4O\295+_$F52_Q)E4O\2Y$H  ,]3  # 6@
MM5X  *Q@  "B7@  FED  )):"P"-6Q8 B%PC (1<+P" 6SH!?5M# GE:2P-V
M65($=%A8!G%87P=O5V8);5=M"VM6=0UI5GX/9U:)$655E1)C5:$48E6O%6%5
MP19@5=L68%;Q%6!6_A1@5O\385;_$F%6_Q)A5O\2X$T  ,M6  "]70  LF$
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M%5)A^Q128?\34V'_$E-A_Q)38?\2T58  ,!?  "S9@  J6L  )QK  "0:@
MA6<  'UI  !W:@T <VL7 &]K) !L;"\ :6PX 69K00)C:TD#86M0!%YJ5P9<
M:ET'6FEE"5AI;0M5:'8-4VB!#U%GC1%/9YH23F>I%$UGN11,9\\43&;K%$UF
M^Q--9O\23F7_$DYE_Q).9?\2S%H  +QC  "P:@  I6\  )AN  ",;0  @&P
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M#CUW_PX]=_\.O&@  *]R  "D>0  EGH  (AZ  !\>@  <'P  &-_  !<@@
M5X0+ %.%% !1AB  3X8J $Z'- !,ASP!2H=$ 4B'2P)&AU,"1(9: T*&8@1
MAFP&/H5V!SN%@P@YA9$*.(2@"S:$L0LVA,8+-H/D"S:"]@LV@?\,-H#_##:
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M=@$CI84!(J66 2"FJ $?I;L!'J77 1ZD[P$>HOL"'J'_ AZA_P(>H?\"HH8
M )>,  "+CP  ?9$  &^4  !CF   5YT  $VA  !#I0  .*@  #"K   HK@<
M)*\0 ".O%P AKR$ (+ I !^P,0 >L#H ';%" !RQ3  ;L58 &K%A !FR;P 8
MLGX %K*0 !6RH@ 4LK8 $[+. !.QZP 3K_D $Z[_ 1.N_P$3KO\!FHT  )"2
M  "$EP  =9H  &B?  !;HP  4*@  $6L   [L   ,;(  ">U   @N   &+H'
M !2\#@ 3O!4 $KP> !&])@ 1O2X $+TW !"^00 .ODP #KY7  V^90 ,OW0
M"[^&  J^F0 (OJP ![["  >^WP (OO  "+WZ  B]_  (O?P DY0  (>9  !Z
MGP  ;*4  &"J  !3KP  1[,  #RV   QN   )[L  !^^   7P0  $<0!  S(
M"  (R0X !\D4  ;)'  %R20 !,HL  /*-@ "RD   ,M,  #+60  RV@  ,MY
M  #,C   RY\  ,NS  #+R   S.(  ,SO  #,\0  S/$ BIH  'RA  !OIP
M8JT  %6S  !(N   .[L  #"^   FP0  '<0  !7(   /RP  "LX   32 @
MTPH  -,/  #4%   U1H  -8B  #7*@  V30  -H_  #<2P  W%H  -UJ  #=
M?0  W9$  -VD  #>M@  WL@  -[>  #>X@  WN( ?Z(  '&I  !DL   5K<
M $F\   \P   +\0  "3'   ;RP  $\\   W2   'U@   -L   #>    WP,
M . )  #A#@  XA(  .,7  #E'@  YB<  .@Q  #J/0  [$L  .Q:  #M;
M[H   .Z4  #NI0  [K0  .["  #NQ@  [L8 =*H  &:R  !8N0  2\   #W%
M   OR0  ),T  !G1   1U@  "]L   />    X0   .4   #H    Z0   .H
M  #K!@  [0L  .\/  #P$P  \AH  /0C  #W+@  ^3L  /M*  #\6P  _6T
M /V   #^DP  _J(  /ZM  #^KP  _J\ _Q ? /\.'0#_"AT _P$@ /\ * #_
M #4 _P!! /\ 3@#_ %H _P!E /\ ;@#_ '< _P!_ /X A@#\ (P ^P"2 /D
MEP#X )P ]P"B /8 IP#U *T \P"U /( O0#Q ,D [P#< .X ZP#M /< [ #_
M .L _P#J /\ Z@#_ .H _P#J /\ _Q,< /\1&0#_#1D _P8< /\#)0#_ #$
M_P ^ /\ 2@#_ %8 _P!A /\ :P#] ', ^@![ /< @P#U (D ] "/ /( E #Q
M )D \ "? .X I #M *L [ "R .H N@#H ,8 YP#6 .4 Z #D /4 XP#^ .(
M_P#A /\ X0#_ .$ _P#A /\ _Q48 /\3% #_#Q0 _PT9 /\+(@#_""T _P0Y
M /\!1@#_ %$ _@!< /H 9@#V &\ \@!W .\ ?@#M (4 ZP"+ .H D0#H )8
MYP"< .8 H0#D *@ XP"O .$ N #? ,, W0#1 -L Y@#9 /, UP#] -4"_P#4
M O\ U /_ -0#_P#4 _\ _Q@3 /\5$ #_$@\ _Q(5 /\1'0#_#B@ _PPT /\*
M00#Y"$P ]097 /$&80#M!FH Z05R .8%>@#D!8$ X@6' . &C0#?!I( W0:8
M -L&G@#9!J4 UP:M -0&M0#2!L  T ?/ ,X(Y0#,"?0 R@O_ ,@,_P#'#/\
MQPS_ ,8,_P#&#/\ _QL. /\9# #_& T _Q@1 /\7& #_%"( ^Q$N /,0.@#M
M#D8 Z U2 .4-7 #A#64 W@UM -L-=0#8#7P U0V" -,-B0#1#8\ T V5 ,X-
MG #-#J, RPZK ,D.M #(#L  Q@[/ ,,0Y@# $?4 O1+_ +P2_P"[$O\ NA+_
M ;H2_P&Z$O\!_Q\* /\<! #_'P@ _Q\- /\=$@#X&AL [A8F .84,P#@$S\
MVA-+ -035@#0$U\ SA1H ,L4;P#)%'< QQ5] ,85A #$%8H PQ61 ,$6F #
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MI 26+Z\$E2^]!),OSP21,.@%CS#X!8TQ_P6-,?\%C#'_!8PQ_P6,,?\%_RT
M .HU  #<.@  SCT  ,8\  # -P( NS,- +,T&0"N-B< J3<T *4W0 "B-TH
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M"G5 PPMT0-T+<T'Q"W)!_PIR0?\*<D'_"7)!_PER0?\)Z3P  -5%  #%2P
MNDX  +!.  "G2P  HD8  )M&#@"61QH D4@G (Y(,P"*2#T AT=& 81'3@&"
M1E4"@$9< WY%8@1\16D$>D5P!7A$> 9V1($(=$2+"7)$E@IP1*(+;T2O#&Y$
MP QM1=D-;$7O#&M%_0MK1O\+:T;_"FM&_PIK1O\*Y4   ,])  #!3P  M5(
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M#EM1^@U;4?\,6U'_#%M1_PM;4?\+UDH  ,-3  "V60  JUP  )Y:  "360
MBU0  (16 P!^5A  >E<: '97)@!S6#$ <%<Z &U70@%J5TD":%90 F965P-D
M5EX$8E5E!6!5;0=>578(756!"EM5C0M95)H-6%2G#E95N ]65<P/5E7I#E95
M^0U65?\-5U3_#%=4_PQ75/\,T4T  ,!6  "S7   IUX  )I=  "/7   AE@
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M"TE@_PM)8/\+Q%@  +5@  "J9@  FV8  (UF  ""90  =F0  &YE  !H9@4
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M? 0T?XH$,G^:!3%^J@8P?KT&,'[:!C!]\ 8P>_T&,'O_!C!Z_P8P>O\&L&P
M *1U  "4=0  AG4  'EV  !N=P  8WD  %=]  !/@0  1X0  $*&#  _AQ,
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M !B?GP 7G[( %I_) !:>Z  6G/< %IO_ 1>;_P$7F_\!G8,  (^&  ""A@
M=(<  &>+  !;CP  4),  $:8   \G   ,Z   "NC   CI@  '*@+ !JI$0 8
MJ1@ %ZDA !:J*0 5JC$ %*HY !.J0P 3JTT $JM8 !&K90 0JW0 #JN&  ZK
MF0 -JZP #*O!  RJWP ,J?( #:C\  VH_P -J/\ EHH  (F,  !ZC0  ;)$
M &"5  !4F@  29\  #^C   UIP  *ZH  ".N   ;L   %+,!  ^U"@ -MA
M#+86  NV'P *MB< ";8O  BV.0 'MT, !K=/  2W6P #MVH  K=[  "WC@
MMZ$  +:T  "VRP  MN4  +7Q  "U]P  M?< CY$  (&4  !REP  99P  %BA
M  !,I@  0:L  #>O   LL@  ([4  !JX   3NP  #KT   G !0 #P0T  ,$1
M  #!%P  PAX  ,(F  #"+P  PSD  ,1$  #$4   Q%X  ,5O  #%@0  Q94
M ,6H  #%O   Q-$  ,3F  #$[@  Q.X AI@  'F>  !KHP  7:D  %"N  !$
MLP  -[8  "RY   BO   &;\  !'"   ,Q0  !L@   #+    S <  ,P-  #-
M$0  S18  ,X=  #/)   T"T  -(X  #41   U%(  -5A  #5<P  UH<  -:;
M  #6K0  U[\  -C.  #8W0  V-T >Z   &ZF  !@K0  4[,  $6X   XO
M*[\  "'"   7Q@  $,D   K,   "T    -0   #7    V    -H%  #;"P
MW X  -X3  #?&0  X2$  .,J  #E-@  YT,  .=3  #H9   Z7<  .F,  #J
MGP  ZJX  .JZ  #JPP  ZL, <*@  &*O  !5M@  1[P  #G    LQ   (,@
M !;,   .T   !]0   #9    W0   .$   #C    Y    .8   #G 0  Z0<
M .L,  #L$   [A4  / =  #S)P  ]C,  /=#  #X5   ^68  /EZ  #ZC@
M^IX  /NI  #[L   ^[  _PL; /\'&0#_ !D _P < /\ )0#_ #( _P _ /\
M2P#_ %< _P!B /\ :P#_ ', _0![ /L @@#Z (@ ^ "- /< D@#V )@ ]0"=
M /0 H@#S *D \0"P .\ N #N ,, [ #1 .L Y@#I /, Z #^ .@ _P#H /\
MZ #_ .@ _P#H /\ _PX8 /\*%0#_ 10 _P 8 /\ (@#_ "X _P [ /\ 1P#_
M %, _0!> /H 9P#W &\ ]0!W /, ?@#R (0 \ ") .\ CP#N )0 [ ": .L
MGP#I *4 Z "L .8 M #D +\ XP#, .$ X@#? /  W@#[ -X _P#= /\ W0#_
M -P _P#< /\ _Q 3 /\-$0#_!A  _P(5 /\ '@#_ "D _P V /\ 0@#Z $X
M] !9 /$ 8@#N &L [ !R .H >0#H '\ YP"% .4 BP#D )  X@"6 .$ G #?
M *( W0"I -H L0#8 +L U0#( -( W0#1 .T T #Y ,\ _P#. /\ S0#_ ,T
M_P#- /\ _Q$/ /\.#0#_# T _PL2 /\'&0#_ B0 _P P /8 / #O $D Z@!3
M .< 70#D &8 X0!M -\ = #= 'L VP"! -D A@#6 (P U "2 -( F #0 )X
MS@"F ,P K@#* +@ R #$ ,8 UP#% .H PP#W ,( _P#! ?\ P +_ , "_P#
M O\ _Q0+ /\0!@#_$ D _Q . /\.% #_"AX ]08I .L$-@#C T( WP-. -L$
M5P#6!&  TP1H - $;P#.!78 S 5\ ,H%@@#)!8@ QP6. ,8%E #$!9L P@6C
M , &JP"^!K4 O0;" +L(U "Z">D MPOX +4,_P"T#/\ M S_ +0,_P"T#/\
M_Q<$ /\4  #_%@, _Q0) /\1#@#R#A4 Z PA -X*+@#6"SL T Q' ,P,40#)
M#%H Q@UB ,0-:@#"#7$ P UW +\-?0"]#H, O Z* +H.D0"Y#I@ MPZ@ +8.
MJ0"T#[0 L@_! +$0U "N$>L JQ+Z *D2_P"H$_\ IQ/_ *<3_P"G$_\ _QH
M /\;  #Y&P  ZQD  .44!@#E$ X V0X7 ,\1)@#($C0 Q!-  +\42P"\%%0
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M HTIQ@*+*=\"B2KR H<J_P*&*O\"ABK_ H8J_P*&*O\"]"@  .,Q  #1-@
MQ3@  +PV  "V,   LBL) *LL% "F+2( HBXO )XN.@";+D0 F"]- )8O50"4
M+EP DBYB ) N:0&/+F\!C2YV 8PN?@&*+H8"B"Z/ H<NF@*%+Z4#@R^R X(O
MP@.!,-H#?S#O WTQ_@-],?\#?#'_ WPQ_P-\,?\#[2\  -LW  #)/0  OCX
M +,\  "L.   IS,$ *(R$0"=-!T F34J )4U-0"2-4  CS5) (TU4 "+-5<
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M!V9 ^09E0/\&94#_!F5 _P5E0/\%W#X  ,=&  "Y2P  K$P  *!*  "71P
MD4,  (M#" "&0Q( @D0> 'Y$*0![130 >44] '9%10!T1$P!<D13 7!$60%N
M1& ";$-G FM#;P-I0W<$9T.!!69#C09D0YD&8D.G!V%$M@A@1,H(8$3F"%]%
M^ =?1?\'8$7_!F!$_P9@1/\&UD$  ,-)  "V3@  IT\  )M-  "22P  C$<
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M!U%/_P913_\&R4L  +E3  "K5P  G%8  (]5  "%5   ?%   '51  !P4@D
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M?01 8HL%/V*:!CYBJ@8]8KP'/&+6!SUA[P8]8?T&/F#_!CY@_P8^8/\&N5D
M *MA  ":80  BV$  ']A  !T80  :6$  %]B  !99   5&8) %%G$0!.9QH
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M BMXHP(J>+4"*GC, BIWZ@(J=OD#*G7_ RIT_P,J=/\#JFH  )IM  ");
M?&T  '!M  !F;@  6W$  %!U  !(>   07L  #I^!0 V?PX -( 6 #.!(  R
M@2@ ,($P "^".  N@D  +8)( "R"4  K@EH *H)D "B"<  F@G\!)8*/ 22"
MH $C@K(!(H+) 2*!YP$B?_<!(G[_ B)]_P(B??\"I7$  )-Q  "#<0  =G$
M &QR  !@=0  5G@  $Q\  !#@   .X,  #.&   MB0H *HH1 "F+&0 GBR(
M)HLJ "6,,0 DC#D (XQ" "*-2@ AC50 ((U> !^-:P =C7D '(V* !N-G  9
MC:X &(S$ !B,XP 9BO4 &8G_ 1F(_P$9B/\!G7<  (QV  !]=@  <G<  &5Y
M  !:?   4(   $:$   \B0  -(P  "V0   EDP( 'Y4, !V6$@ <EAH &Y<B
M !J7*@ 9ES( &)@Z !>80P 6F$T %9A8 !289  3F', $9B$ !"8E@ 0F*D
M#IB_  Z7W0 /EO( $)7\ !"4_P 0E/\ E7T  (5\  !X?   :WX  %^!  !4
MA@  2HH  $"/   VDP  +9<  "::   >G0  %Z # !*B#  0HQ( $*,9  ^C
M(0 .I"D #J0Q  VD.@ ,I$4 "Z10  JD7  )I&H !Z1[  :CC@ $HZ$  J.T
M  .BRP #HN8  Z'S  .A^P #H?L C8,  '^"  !QA   9(<  %B,  !-D0
M0I8  #B:   OG@  )J(  !ZE   7J   $:L   RN!P 'KPT  Z\2  *O&0 !
MKR$  *\I  "P,@  L#P  +!'  "P4P  L&$  +!Q  "P@P  KY<  *^J  "O
MOP  KMD  *[K  "N]   KO0 AXD  'B*  !JC@  79,  %&8  !%G0  .Z(
M #"F   GJ@  'JX  !:Q   0M   "[8   6Y P  N@H  +H.  "Z$P  NQD
M +LA  "\*   O#$  +T\  "^2   OE8  +YE  "^=P  OHP  +Z?  "]LP
MOL<  +[>  "]ZP  O>L ?Y(  '"5  !BF@  59\  $FE   ]JP  ,J\  "BT
M   >M@  %;D   Z\   )OP   L(   #$    Q00  ,8*  #&#@  QQ(  ,@8
M  #)'P  RB<  ,PP  #./   SDD  ,]9  #/:@  SWX  ,^3  #/I@  S[@
M ,_(  #/VP  S]L =YP  &BA  !;IP  3JX  $&T   TMP  *+H  !V]   3
MP   #<0   ;'    R@   ,X   #0    T0   -("  #3"   U0P  -80  #9
M%0  VQP  -TD  #@+P  XCP  .-+  #D7   Y&\  .6#  #EF   Y:D  .6V
M  #EPP  Y<, ;*4  %^L  !1L@  1+D  #6\   HP   ',0  !+(   ,RP
M \\   #3    V    -P   #?    WP   .$   #C    Y ,  .8(  #H#0
MZ1$  .P8  #N(@  \2X  /,\  #T30  ]5\  /9S  #WAP  ]YD  /BE  #X
ML   ^+  _P,7 /\ %0#_ !4 _P 8 /\ (P#_ "\ _P \ /\ 2 #_ %0 _P!>
M /\ 9P#] &\ ^P!V /D ?0#X (, ]@"( /4 C@#T ), \@"8 /$ G@#P *0
M[@"K .T LP#K +T Z@#+ .@ X0#G /$ Y@#] .4 _P#D /\ Y #_ .0 _P#D
M /\ _P<3 /\ $0#_ !$ _P 5 /\ 'P#_ "L _P W /\ 1 #^ $\ ^@!: /<
M8P#T &L \@!R /  >0#O '\ [0"$ .L B@#J (\ Z "4 .< F@#E *  Y "G
M .( KP#@ +D W@#& -P V@#: .P V #Y -8 _P#6 /\ UP#_ -@ _P#8 /\
M_PH0 /\##@#_  T _P 2 /\ &@#_ "8 _  R /< /P#T $H \0!5 .T 7@#J
M &8 Z !N .4 = #C 'H X@"  .  A0#> (L W "0 -L E@#8 )P U0"C -,
MJP#1 +4 S@#! ,P T0#+ .< R0#U ,@ _P#( /\ R #_ ,@ _P#( /\ _PP,
M /\&" #_ @H _P / /\ %0#\ "  \0 L .P .0#I $4 Y0!/ .$ 60#> &$
MVP!H -< ;P#4 '4 T@![ -  @ #. (8 S ", ,L D@#) )@ QP"@ ,4 J ##
M +$ P0"\ +\ RP"] ., O #R +L _0"[ /\ N@#_ +H _P"Z /\ _PX% /\)
M  #_"04 _P8+ /\!$ #P !D Y@ E .$ ,@#< #\ U@!) -$ 4P#. %L RP!C
M ,@ :@#& '  Q0!V ,, >P#! ($ P "' +X C@"\ )0 NP"< +D I "W *X
MM0"Y +, R "Q -\ L 'O *\!^P"N O\ K0/_ *T#_P"M _\ _Q   /\.  #_
M#0  ]@L# /('"@#B 1$ VP(= -(#*P#, S< R 1# ,0$30#!!%8 O@5= +P%
M9 "Z!6L N 5Q +<%=@"U!7P LP:# +(&B0"P!I$ KP>9 *T'H0"K!ZL J0BW
M *@)Q@"F"MT I0OP *,,_0"B#?\ H0W_ *$-_P"@#?\ _Q$  /P2  #L$P
MXA,  -L/ P#6"0L S@@4 ,8*(@# ##  O T\ +@-1@"U#4\ L@Y7 + .7P"N
M#F4 K0YK *L.<0"J#G@ J Y^ *</A0"E#XT I ^6 *(0GP"@$*D GQ"U )T1
MQ0";$=X F1+Q )<3_P"6%/\ E13_ )44_P"4%/\ _Q4  .T;  #@'P  TA\
M ,D;  #$% 4 P1 . +H2&P"T$RD L!0U *P50 "I%4D IA52 *0660"B%F
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M 7<K^0%V*_\!=BO_ 74K_P%U*O\!Y2P  - T  #!.   LS@  *@U  "B,0
MG2T  )DJ#@"4*Q@ D"PD (TM, "*+3H ARU# (4M2@"#+5$ @2Y8 ( N7@!^
M+F0 ?2YK 'LN<P%Y+GL!>"Z% 78NCP%T+YL!<R^H G$OM@)P,,D";S#E FXQ
M]P)M,?\";3'_ FTQ_P)M,?\"WS(  ,DY  "[/@  K#T  *$Z  ":-P  E3,
M ) Q"@",,10 AS(@ (0S*P"!,S4 ?S,^ 'TS1@![,TT >3-4 '<S6@!V,V$
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M UD__P-9/_\#S#\  +Q&  "K2   G$<  )%&  "(1   @D   'P_  !W0 P
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M?0))3HL#2$Z9!$=/J 1&3[H$1D_1!$9/[01&3OP$1D[_ T=._P-'3O\#O4P
M *Y2  "<40  C5$  (%1  !W4   ;DP  &=.  !B3P  75 - %I0% !741X
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M CA=HP,W7;4#-EW+ S9<Z ,W7/D#-UO_ SA;_P,X6O\#LE<  *!:  "/60
M@5D  '59  !K60  8%H  %9;  !170  3%X" $A@#0!%8!0 1&$> $)B)@!
M8BX /V(V #YC/@ ]8T4 /&-- #MC50 Y8UX .&-H 39C= $U8X$!,V.1 C)C
MH0(Q8[,",6/( C%BYP(Q8?@",6'_ C)@_P(R8/\"KEP  )M=  "*70  ?%T
M '!=  !F70  7%X  %)@  !,8@  164  $%F"@ ^9Q$ /&@: #MH(@ Y:2L
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M !I[W@ :>?( &WC^ !MW_P$;=_\!F6D  (AI  !Y:0  ;6D  &-J  !9;
M3V\  $5S   ]=P  -7H  "Y]   G@0, (H,- ""$$@ ?A!H '80B !R%*@ ;
MA3$ &H4Y !F%0@ 8ADP %X96 !:&8P 5AG$ %(:! !*&DP 1AJ8 $86[ !"%
MU@ 1@^\ $8+[ !*"_P 2@?\ D6X  (%M  !T;@  :6X  %UP  !3<P  27<
M $!\   W@   +X,  ">'   AB@  &HT& !6/#0 3D!, $I : !*0(@ 1D"H
M$)$R !"1.P /D40 #I%/  V17  ,D6H "Y%Z  J1C0 (D)\ !Y"S  >/R0 '
MC^8 !X[T  B-_  (C?\ B7,  'MS  !O<P  8W4  %=X  !-?0  0X$  #F&
M   PB@  *(X  "&1   :E0  $Y<   Z:"  +G X "9P3  B<&@ 'G"( !IPJ
M  2<,P #G#T  IU(  "=5   G6(  )QR  "<A   G)<  )NJ  ";OP  FML
M )KL  ":]0  F?@ @GD  '9Y  !H>@  7'X  %&"  !&AP  /(P  #*1   I
ME0  (9D  !F=   2H   #J,   FF!0 #IPP  *<0  "G%0  J!P  *@C  "H
M*P  J30  *D_  "I2P  J5D  *EH  "I>@  J8X  *FA  "HM0  J,L  *?D
M  "G[P  I_, ?8   &^!  !AA   58D  $F.   ^E   -)D  "J>   AH@
M&:8  !*I   -K   !Z\   "R    LP<  +,,  "S$   M!4  +0;  "U(@
MMBL  +<U  "W0   N$X  +A=  "X;@  N((  +B7  "XJ@  M[X  +?2  "W
MY@  M^H =H@  &>+  !:D   3I8  $*<   WH@  +*<  "*K   9KP  $;,
M  NV   $N0   +P   "^    O@   +\&  # "P  P0\  ,(3  ##&0  Q"
M ,4I  #'-   R$(  ,E1  #)8@  R74  ,F*  #)GP  RK$  ,K!  #)T0
MR=D ;I,  &"8  !3G@  1J0  #JK   OL   )+4  !FX   0O   "K\   '!
M    Q    ,@   #*    R@   ,P   #- P  S@@  - -  #1$   TQ8  -8>
M  #:*   W30  -Y#  #?5   WV<  .!\  #@D0  X*0  ."R  #@O@  X,,
M9I\  %FF  !,K0  /[0  #*X   DO   &+\  !##   (QP   ,H   #-
MT0   -4   #8    V0   -L   #=    WP   .$$  #C"@  Y0X  .<3  #J
M'   [2<  / U  #Q1@  \E@  /-K  #S@   ])0  /2C  #TK@  ]+( _P 3
M /\ $0#_ !$ _P 5 /\ 'P#_ "P _P Y /\ 10#_ %  _P!: /X 8P#[ &L
M^0!R /< > #U 'X ] "$ /( B0#Q (X \ "3 .X F0#M )\ [ "F .H K@#H
M +@ Y@#% .4 VP#C .T X@#[ .( _P#A /\ X0#_ .$ _P#A /\ _P 0 /\
M#@#_  T _P 2 /\ &P#_ "@ _P T /X 00#[ $P ]P!6 /0 7P#Q &8 [P!M
M .P = #J 'H Z0!_ .< A0#F (H Y0"/ ., E0#A )L X "B -X J@#; +0
MV0#  -8 T #3 .@ T@#W -$ _P#1 /\ T #_ -  _P#0 /\ _P - /\ "0#_
M  H _P / /\ %@#[ "( ]P O /0 .P#P $< [0!1 .D 6@#E &( X@!I .
M;P#> '4 W !Z -H @ #8 (4 U0"+ -, D0#1 )< SP"> ,T I@#+ *\ R0"Z
M ,< R0#% .( Q #R ,, _@#" /\ P0#_ ,( _P#" /\ _P,& /\  0#_  8
M_P , /D $0#Q !T ZP I .< -@#C $$ WP!+ -L 5 #5 %P T@!C ,\ :@#-
M '  RP!U ,D >P#( (  Q@"& ,4 C ## ), P0": +\ H@"] *L NP"V +D
MQ "W -H M@#M +0 ^@"T /\ M #_ +0 _P"T /\ _P0  /\   #_    _P &
M .P #0#E !8 W@ B -< +P#1 #L S0!% ,H 3@#& %< Q !> ,$ 9 "_ &H
MO0!P +P =0"Z 'L N0"! +< AP"U (X LP"5 +( G@"P *< K@"R *P OP"J
M -$ J #H *@ ]P"G /\ IP#_ *8 _P"F /\ _P8  /\%  #Q P  Z    .$
M!P#5 !  S0 ; ,< )P## #, OP ^ +P 2 "Y %$ M@!8 +0 7P"R &4 L !J
M *\ < "M '8 K !\ *H @@"I (D IP"1 *4 F@"C *0 H0"N *  NP"> <T
MG0+F )P$] ";!/\ F@7_ )H%_P"9!?\ _PH  /$.  #D$   V0\  ,X+  #(
M PL P@ 3 +P"'P"W RP LP0W + %0@"M!DH J@92 *@'60"F!U\ I0=E *,'
M:P"B"'$ H AW )\(?@"="(4 FPF. )H)EP"8"J$ E@JL )4+N@"3"\P D@SE
M ) -]@"/#O\ C@[_ (X._P"-#O\ ]A$  .87  #6&P  QQD  +X5  "Y$
MMPH- +$+%P"L#20 J XP *4..P"B#D0 GP], )T/4P";#UH F@]@ )@09@"7
M$&P E1!R ),0>0"2$($ D!"* (\1E "-$9\ BQ&J (H2N "($LL AA/F (44
M]P"#%?\ @Q7_ ((5_P""%?\ [1H  -PA  #*)0  NR(  +$?  "K&@  J10&
M *42$0"@%!X G!4J )D5-0"6%CX E!9' )(63@"0%E4 CA=; (P780"+%V<
MB1=M (@7= "&&'P A1B& (,9D "!&9L @!JG 'X:M0!]&\< ?!SB 'H=]0!Y
M'?\ >!W_ '@=_P!X'?\ Y2(  - I  "_+   L"H  *<G  "@(P  G1\  )H:
M#@"5'!@ D1TD (X>+P",'CD B1Y! (<?20"%'U  @Q]6 ((?7 " 'V( ?Q]I
M 'T@< !\('@ >B"! 'DAC !W(9< =2*D '0BL@!S(\, <B/? ' D\P!O)/\
M;R3_ &XD_P!N)/\ W2D  ,@P  "W,@  J#   )XN  "7*@  DR<  ) C"@",
M(Q, B"0? (0E*@"")30 @"8] 'TF1 !\)DL >B92 '@F6 !W)EX =29E '0G
M; !R)W0 <2=] &\HB !N*)0 ;"BA &LIKP%J*< !:2K; 6<J\0%G*_\!9BO_
M 68J_P%F*O\!U"\  ,(V  "O-@  H34  )8T  "0,   BBT  (<J!@"#*1
M?RH: 'PK)0!Y*R\ =RPX '4L0 !S+$< <2Q- ' L5 !N+%H ;2QA &LM: !J
M+7  :"UZ &<NA0!E+I$!9"Z> 6(OK %A+[T!83#5 6 P[P%?,/T!7S#_ 5\P
M_P%?,/\!S30  +P[  "I.@  FSH  ) X  ")-0  @S(  '\P 0![+PX =S 6
M '0P(0!Q,2L ;S$T &TQ/ !K,4, :C%* &@R4 !G,E< 93)= &0R90!B,FT
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M? %2/8D!43V7 4\]I@)./K<"3C[- DX^Z0)-/OH"3C[_ 4X]_P%./?\!P#\
M *Y#  "<0P  CD,  ()"  !Z0   <ST  &T\  !H/04 9#T. &$^%P!>/B$
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M 4%)H@) 2;,"/TK' C]*Y0(_2?<"0$G_ D!(_P) 2/\!MDD  *)*  "12@
M@TH  '=*  !N20  944  %Y'  !92   54D( %%*$ !/2A@ 3$HA $I+*0!)
M2S$ 1TLX $9,/P!%3$8 1$Q. $--5@!"35\ 04UH $!-= $^38$!/4V0 3Q-
MH $[3K$".D[& CI.Y ([3?8".TW_ 3M,_P$\3/\!LTT  )Y,  "-3   ?TP
M '1,  !J3   8$H  %E+  !43   4$T% $Q.#@!)3Q4 1T\> $5/)@!$4"X
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M 2E=W@$J7/(!*EO^ 2M;_P$K6O\!HU4  (]5  !_50  <E4  &=6  !>5@
M5%<  $Q9  !%6P  /UT  #I?!  V8 T -&$3 #)B'  Q8B, ,&(K "]C,@ N
M8SH +6-" "QC2@ J9%, *61= "AD:0 G9'8 )F2& "5DEP D9*D (V2] ")D
MV@ C8_$ (V+] 21A_P$D8?\!G%@  (E8  !Z60  ;ED  &-9  !:6@  4%P
M $A>  !!8   .F,  #1F   O: H +&D0 "II%P I:A\ *&HF "=J+@ F:S4
M)6L] "1K1@ C:T\ (FQ9 "!L90 ?;'( 'FR" !ULE  <;*8 &VNZ !IKU  ;
M:NX '&G\ !QH_P <:/\ E5P  (-<  !U7   :5T  %]=  !67@  3&$  $-D
M   \9P  -6H  "]M   H< 0 (W(- "%R$@ @<QH 'W,A !YS*  ==#  ''0X
M !MT0  :=$H &714 !=U8  6=6X %75^ !1UD  3=*( $G2V !%TSP 2<^P
M$G+Z !-Q_P 3<?\ CF   'U@  !O80  96$  %MB  !19   2&<  #YK   W
M;@  ,'$  "EU   B>   ''L' !=]#@ 6?1, %7T; !1^(@ 3?BH $GXQ !%^
M.@ 1?D0 $'].  ]_6@ .?V@ #7]X  Q_B@ +?IT "GZP  E]Q@ *?>0 "GST
M  M[_0 +>O\ AF4  '=E  !J90  868  %9H  !,:P  0F\  #ES   Q=P
M*GH  "-^   <@0  %80  !"'"  -B0X #(D4  R)&P +B2, "HDK  F),P (
MB3T !HE(  6)5  $B6$  HEQ  &)@P  B98  (BI  "'O@  A]H  (;L  "&
M]0  AOH ?FH  '%J  !G:P  6VP  %!P  !&=   /'@  #-]   J@0  (X4
M !R(   5C   $(\   R2!@ &DPP  I,1  "4%@  E!T  )0D  "5+   E34
M )5   "53   EED  )9I  "5>@  E8X  )2A  "4M0  D\P  )+F  "2\@
MDO< >'   &UP  !@<@  5'4  $EY   _?@  -8,  "R(   CC0  &Y$  !24
M   /EP  "IH   2= P  G@D  )\.  "?$@  H!<  * =  "A)0  HBT  *(W
M  "C0P  HU   *-?  "C<0  HX0  **9  "BK0  H<(  *'<  "AZP  H/(
M<W8  &9W  !9>P  38   $*%   XBP  +I   "25   ;F@  %)X   ZA   )
MI    J<   "J    JP0  *L*  "L#0  K1$  *T6  "N'   KR0  + M  "Q
M.0  L48  +)5  "R9@  LGD  +*.  "QHP  LK<  +'*  "QX   L>D ;'X
M %^"  !2AP  1HT  #N3   PF0  )IX  !RC   3IP  #:L   >N    L@
M +4   "W    N    +D"  "Y"   N@P  +L0  "\%   O1L  +\C  #!+0
MPCH  ,))  ##6@  PVP  ,2"  #$EP  Q*L  ,2\  #$RP  Q-H 98D  %B.
M  !+E0  /YL  #.B   HJ   ':T  !2Q   -M@  !KD   "\    OP   ,,
M  #$    Q0   ,8   #'    R00  ,H)  #+#0  S1$  ,\8  #2(0  U2T
M -8\  #830  V5\  -IS  #:B@  VYX  -NN  #;N@  W,, 7I8  %&<  !$
MHP  .*H  "RQ   @MP  %;L   V^   $P@   ,4   #)    S0   -    #2
M    T@   -4   #6    V0   -L   #>!0  X H  .(/  #E%@  Z"   .PM
M  #M/@  [5$  .YE  #O>@  [X\  /"?  #PJP  \+, _P 0 /\ #@#_  X
M_P 2 /\ '0#_ "D _P U /\ 00#_ $T _@!6 /L 7P#X &8 ]@!M /0 = #R
M 'D \0!_ /  A #N (D [0"/ .L E0#J )L Z "B .8 J@#E +, XP#  .$
MT@#@ .H WP#Y -T _P#= /\ W0#_ -X _P#> /\ _P - /\ "@#_  D _P /
M /\ & #_ "0 _@ Q /L /0#X $@ ] !2 /  6@#M &( ZP!I .D ;P#G '4
MY0!Z ., ?P#B (4 X "* -X D #< )8 V@"= -@ I0#5 *\ T@"Z -  R@#.
M ., S0#T ,L _P#+ /\ RP#_ ,L _P#+ /\ _P ( /\  P#_  4 _P , /P
M% #W !\ \@ K .\ -P#K $( YP!, .0 50#@ %T W0!D -H :@#8 '  U0!U
M -( >@#0 (  SP"% ,T BP#+ )( R0"9 ,< H0#% *H PP"U ,$ PP"_ -H
MO@#N +T _ "\ /\ O #_ +P _P"\ /\ _P   /\   #_    ^0 ' /$ $ #J
M !H Y  E -\ ,0#; #P UP!' -( 4 #. %< RP!> ,D 90#& &H Q0!P ,,
M=0#! 'H P "  +X A@"\ (T N@"4 +D G "W *4 M0"P +, O0"Q ,\ KP#H
M *X ^ "N /\ K0#_ *T _P"M /\ _P   /\   #]    [@ ! ., # #: !0
MT0 ? ,P *P#( #8 Q0!  ,( 2@"_ %( O !9 +H 7P"X &4 M@!J +0 ;P"S
M '4 L0!Z +  @0"N (@ K0"/ *L F "I *$ IP"K *4 N "C ,@ H@#B *$
M\P"@ /X H #_ *  _P"@ /\ _P   /8   #J    X    -, !@#)  \ P@ 8
M +T ) "Y "\ M@ Z +0 0P"Q $P K@!3 *P 60"J %\ J0!D *< :@"F &\
MI !U *, >P"A (( H "* )X DP"< )T F@"G )@ M "6 ,, E0#< )0 [P"3
M /L DP#_ ), _P"2 /\ ^04  .H+  #<#0  RPH  ,(%  "\  H M@ 1 +$
M' "N "@ J@ S *< /0"D $4 H@!- *  4P"> %D G !? )L 9 ": &H F !P
M )< =@"5 'X DP"& )(!CP"0 9D C@*D (P"L0"+ \  B076 (@&[0"(!_H
MAPC_ (8(_P"&"/\ [P\  -X4  #*%0  O!(  +,0  "N#   JP8- *<#%0"B
M!2  GP<L )P(-@"9"#\ EPE' )4)3@"3"50 D0I: ) *7P"."F4 C0IK (L*
M<@"*"WD B N" (<+C "%#)< @PRB ($-L " #<  ?PW8 'T.[P!\#_T >P__
M 'L0_P![$/\ YA<  -$>  "]'0  KQP  *89  "A%0  GA $ )T-#P"8#AD
ME XE )$/+P"/$#D C!!! (H02 "($$\ AQ!5 (406P"$$6$ @A%G ( 1;@!_
M$74 ?1%^ 'P2B !Z$I0 >!*@ '<3K@!U$[X =!35 ',5[@!Q%OT <1;_ '$6
M_P!P%O\ W!\  ,8E  "S)0  I2,  )PA  "6'@  DAD  )$4"P"-%!0 B14?
M (86*0"#%C, @1<\ ( 70P!^%TH ?!=0 'H75@!Y&%P =QAB '88:0!T&'$
M<QEZ '$9A !O&I  ;AJ= &P;JP!K'+L :AS0 &D=[ !H'OL :![_ &<>_P!G
M'O\ T28  +TJ  "K*@  G2H  ),H  "-)0  B"(  (8=!@"#&Q  ?QP: 'P=
M) !Z'2X =QXV '8>/@!T'D4 <A]+ '$?40!O'U@ ;A]> &P?90!K(&T :2!V
M &@A@0!F(8T 92*: &,BJ !B([@ 82/- & DZ0!@)/H 7R3_ %\D_P!?)/\
MRBP  +8O  "D+P  EB\  (PM  "%*@  @"@  'TD  !Z(@T =B,5 ',C( !Q
M)"D ;R0R &TD.@!K)4$ :B5' &@E30!F)50 925: &0F80!B)FD 829R %\G
M?0!>)XH 72B7 %LII0!:*;4 6BK* %DJYP!8*O@ 6"K_ %@J_P!8*O\ Q3$
M *\S  ">,P  D#,  (8R  !_+P  >2T  '4J  !R* H ;R@2 &LI&P!I*24
M9RHM &4J-0!C*CT 8BI# & J2@!?*U  7BM7 %PK7@!;+&8 62QO %@M>@!7
M+8< 5BZ5 %0NHP!3+[, 4R_' %(OY0!2+_< 4B__ %(O_P!2+_\ P38  *HV
M  "9-@  BS8  ($U  !Y,P  <S$  &\O  !K+@8 :"T0 &0N& !B+B$ 8"\J
M %XO,0!<+SD 6R]  %DO1@!8+TT 5S!3 %8P6P!4,6, 4S%L %(R=P!1,H0
M3S.2 $XSH0!-,[$ 333% 4PTXP%,-/8 3#3_ $PT_P!,,_\ NSD  *8Y  "5
M.0  ASD  'PY  !T-P  ;C0  &DS  !E,@( 83(- %XR% !<,QX 6C,F %@S
M+@!6,S4 530\ %,T0P!2-$H 4310 % U6 !.-6  339J $PV=0!+-X( 2C>0
M $DXGP!(.+ !1SC# 4<XX0%'./4!1SC_ 4<X_P%'./\!MSL  *(\  "1/
M@SP  '@\  !P.@  :C<  &0V  !@-@  7#8+ %DW$@!6-QH 5#<C %(W*P!0
M-S( 3S@Y $TX0 !,.$< 2SA. $HY50!).5X 2#IH $<Z<P!&.X  13N. $0\
MG@!#/*X!0CS" 4(]WP%"//,!0CS_ 4(\_P%"._\!LST  )X^  "-/@  ?SX
M '4^  !L/0  9CH  & Y  !;.@  5SH( %,[$ !1.Q@ 3CL@ $P[* !+.R\
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M #-(V0 T2/  -$?] #1'_P U1O\ ID0  ))%  ""1@  =48  &I&  !A10
M640  %%$  !,1@  2$<  $1'"@!!2!  /TD8 #U)(  \22< .DHN #E*-@ X
M2CT -TM$ #9+3  U2U4 -$Q? #-,:@ R3'< ,4R& #!,EP O3:@ +DV[ "Y-
MU0 N3.\ +TS] "]+_P P2_\ H4<  (Y(  !^2   <4@  &9)  !=2   54@
M $Q)  !'2@  0DL  #],!@ [30X .4X5 #=.'0 V3R0 -4\K #-/,P R4#H
M,5!" #!02@ O45( +E%< "U19P L474 *U&$ "I2E0 I4J8 *5*Y "A2T@ I
M4>X *5#\ "I0_P J3_\ G$H  (E*  !Z2P  ;4L  &-,  !:3   44P  $A-
M  !#3P  /5   #E2 @ U4PP ,U02 #%4&0 P52$ +E4H "U5+P L5C< *U8^
M "I61@ I5D\ *%=9 "=79  F5W( )5>! "17D@ C5Z0 (E>W ")7SP B5^P
M(U;Z "-5_P D5?\ EDT  (1.  !U3@  :4X  %]/  !63P  35   $52   _
M4P  .58  #-8   O6@@ *UL/ "I;%0 H7!T )UPD "9<*P E7#, )%TZ "-=
M0P B74P (5U6 "!>80 ?7FX 'EY^ !U>CP <7J$ &UZT !I=S  ;7>D &USY
M !Q;_P <6_\ D%$  'Y1  !P40  9%(  %M2  !24P  2E0  $%7   [60
M-5L  "Y>   H8 , )&(, ")C$0 A8Q@ 'V0@ !YD)P =9"X '&0V !ME/@ :
M94< &651 !AE70 796H %F5Z !5EBP 499X $V6Q !)ER  29.< $V/W !1B
M_P 48O\ B50  'A5  !K50  8%8  %=6  !/5P  1ED  #U<   V7P  ,&(
M "ED   C9P  '6H' !EL#@ 8;!, %FT: !5M(0 4;2D %&TP !-M.0 2;D(
M$6Y, !!N6  /;F4 #FYU  UNAP -;IH #&VM  MMP@ +;.  #&OS  UK_0 -
M:O\ @ED  ')9  !F60  7%H  %1:  !*7   05\  #EC   Q9@  *FD  "1L
M   =;P  %W(  !)U"0 /=P\ #G<4  YW&P -=R, #'<J  MW,P *=SP "7='
M  AW4@ '=U\ !7=O  1W@  #=Y0  7:G  !VNP !==4  73K  )T]@ "=/P
M>UT  &U=  !B7@  65X  $Y@  !%8P  /&<  #-K   K;@  )'(  !YU   7
M>0  $GP   U_!@ )@0P !8$1  .!%@ "@1T  8$D  "!+0  @C8  ()   ""
M3   @ED  ()H  "">0  @HT  (&@  " M   @,L  '_G  !^\@  ?OD =&(
M &AB  !>8@  4V0  $EG   _:P  -G   "UT   E>   'GP  !>    1@P
M#88   B)!  "BPH  (L.  "+$P  C!@  (P?  "-)@  C2\  (XY  ".1
MCE$  (Y@  ".<0  CH4  (Z9  "-K0  C,,  (S?  "+[@  B_8 ;F@  &1G
M  !8:0  36P  $)Q   X=@  +WL  "9_   >A   %H@  !",   ,CP  !I(
M  "5    E@<  )<,  "7#P  F!,  )D8  ":'P  FR8  )LP  "<.P  G$@
M )Q7  "<:   G'L  )R0  ";I0  F[H  )K0  ":YP  FO$ :FT  %YO  !1
M<@  1G<  #M\   Q@@  )X<  !Z,   6D0  $)4   J9   $G    *    "B
M    HP$  *,&  "D"P  I0X  *82  "G%P  J!X  *HF  "K,0  JSX  *Q-
M  "L70  K'   *R%  "LFP  JZ\  *O#  "KV0  JN@ 9'4  %=Y  !+?@
M/X0  #2*   ID   'Y8  !:;   0GP  ":,   &G    J@   *X   "P
ML    +$   "R P  M @  +4-  "V$   MQ4  +D=  "[)@  O#,  +U!  "]
M4@  O60  +YY  "^D   O:0  +VW  "]Q@  O=< 7'\  %"%  !$BP  .)(
M "R9   AGP  %Z0  !"I   )K@   +(   "V    N0   +T   "_    OP
M ,    #!    PP   ,0%  #&"@  QPX  ,D3  #+'   SB8  - U  #110
MTE<  -)K  #3@@  TY<  -.I  #2N   TL0 58P  $F3   ]F@  ,*(  "6H
M   :K@  $;0   FY    O0   ,$   #$    R    ,L   #-    S0   ,\
M  #0    T@   -0   #8    V@8  -T,  #@$0  XQH  .8G  #G.   Z$H
M .E=  #J<@  ZX@  .N;  #LJ   [+( _P - /\ "P#_  L _P 0 /\ &@#_
M "8 _P R /\ /0#_ $@ ^P!2 /@ 6@#V &( \P!I /$ ;P#P '4 [@!Z .P
M?P#K (0 Z0"* .@ D #F )8 Y "= .( I0#A *\ WP"[ -T RP#; .8 V0#W
M -@ _P#8 /\ UP#_ -< _P#4 /\ _P ( /\ ! #_  0 _P - /\ %0#^ "$
M^@ L /< . #T $, \ !- .T 50#J %T YP!D .0 :@#B '  X !U -X >@#=
M '\ VP"% -D BP#5 )$ TP"9 -$ H #/ *H S0"U ,L Q #) -T R #Q ,<
M_P#& /\ Q@#_ ,8 _P#' /\ _P   /\   #_    _P * /@ $0#Q !P [  G
M .D ,@#F #T X@!' -T 4 #9 %@ U0!? -( 90#0 &H S@!P ,P =0#* 'H
MR0!_ ,< A0#% (P PP"4 ,$ G "_ *4 O0"P +L O0"Z -  N #K +< ^P"V
M /\ M@#_ +8 _P"V /\ _P   /\   #]    \P % .D #@#A !8 VP A -4
M+0#1 #< S@!! ,H 2@#' %( Q !9 ,( 7P#  &4 O@!J +P ;P"[ '0 N0!Z
M +< @ "V (< M ". +( EP"P *  K@"J *T MP"K ,@ J0#C *@ ]0"G /\
MIP#_ *< _P"F /\ _P   /X   #Q    Y0   -< "@#- !$ QP < ,( )@"_
M #$ O  [ +H 1 "W $P M !3 +( 60"Q %\ KP!D *T :0"L &\ J@!T *D
M>@"G ($ I@") *0 D0"B )L H "E )X L@"= ,$ FP#: )H [P"9 /T F #_
M )@ _P"8 /\ _0   /    #A    T0   ,8 ! "]  T MP 5 +, ( "P "L
MK0 U *L /@"H $8 I@!- *0 5 "C %D H0!? *  9 "> &D G0!N )L =0":
M 'L F "# )8 C "5 )8 DP"A )$ K0"/ +L C0#/ (P Z0"+ /@ C #_ (P
M_P", /\ \P(  .('  #,!P  OP0  +<   "Q  @ JP 0 *< &0"D "0 H  N
M )X -P"< $  F@!' )@ 3@"6 %0 E0!9 ), 7@"2 &0 D !I (\ ;P"- '8
MBP!^ (H B "( )( A@"= (4 J0"# +@ @0#* (  Y0"  /4 ?P#_ '\ _P!_
M /\ Z T  - 0  "^$   L0X  *@-  "C"   H (, )P $P"8 !T E0 G )(
M,0"0 #D C@%! (P!2 "* DX B0)4 (<"60"& E\ A -D (,#:P"! W( @ 1Z
M 'X$A !]!8X >P6: 'D&IP!X!K4 =@?( '4(XP!U"?0 = K_ ',*_P!S"O\
MW14  ,07  "Q%P  I18  )P3  "6$0  E T$ ),(#0".!Q4 BPD@ (@)*@"%
M"C, @PL[ ($+0@" "TD ?@M/ 'T,5 ![#%H >@Q@ '@,9P!W#&X =0UV '0-
M@ !R#8P < V9 &\.I@!M#K4 ; [) &L/Y@!J$/< :1#_ &D0_P!I$/\ T!T
M +D>  "H'@  FQT  )(;  "+&0  B!4  (<1!P"%#A  @0\: 'X0) ![$"T
M>1 V '<1/0!V$40 =!%* ',14 !Q$58 <!%< &X28@!M$FH :Q)S &D3?0!H
M$XD 9A.6 &44HP!C%;, 8A7& &(6XP!A%O8 8!?_ & 7_P!@%_\ QR(  + C
M  "?)   DB,  (DB  ""(   ?AT  'P9  !Z%0T =Q45 '06'P!Q%B@ ;Q<P
M &X7. !L%S\ :Q=% &D82P!H&%$ 9AA8 &487@!C&68 8AEO & 9>0!?&H4
M71N2 %P;H0!;'+  6AS# %D=X !8'O0 6![_ %@>_P!8'O\ OR<  *DH  "9
M*   BR@  ((G  ![)0  =B,  ',@  !Q' D ;AP1 &L<&@!I'2, 9QTL &4=
M,P!C'CH 8AY! & >1P!?'DT 7AY4 %P?6P!;'V( 62!K %@@=@!6(8( 52&0
M %0BG@!3(JX 4B/  %$CW0!1)/( 423_ %$D_P!1(_\ N2L  *,L  "3+
MABT  'PL  !T*@  ;R@  &LE  !I(@4 9B$. &,B%@!A(A\ 7R,G %TC+P!<
M(S8 6B,] %DD0P!7)$H 5B10 %4D5P!3)5\ 4B5H %$F<P!/)G\ 3B>- $TH
MG !,**P 2RF^ $LIV@!**?$ 2BG_ $LI_P!+*?\ LRX  )XO  ".,   @3
M '<O  !O+@  :BL  &4J  !C)P$ 7R<, %PG$P!:)QL 6"@D %8H*P!5*#(
M4R@Y %(I0 !0*48 3RE- $XI5 !-*EP 3"IE $HK< !)*WP 2"R+ $<MF@!&
M+:H 12Z\ $4NU@!%+N\ 12[^ $4N_P!%+?\ KC$  )HR  "),P  ?#,  '(S
M  !K,0  92\  & M  !=+   62P) %8L$ !4+!@ 4BP@ % L* !.+2\ 32TV
M $PM/ !*+4, 22U* $@N40!'+ED 1B]C $4P;0!#,'H 0C&) $$QF !!,J@
M0#*[ #\RTP _,NX 0#+] $ R_P! ,O\ JC,  )8U  "&-0  >38  &XU  !F
M-0  83(  %PP  !7,   5# & %$P#@!.,!4 3#$= $HQ)0!(,2P 1S$R $8Q
M.0!$,4  0S)' $(R3P!!,U< 0#-@ #\T:P ^-7@ /36' #PVE@ [-J< .S:Y
M #HVT0 Z-NT .S;\ #LV_P [-O\ IC8  )(W  "".   =3@  &LX  !C-P
M738  %<S  !3-   3S0# $LT# !)-!( 1C4: $4U(@!#-2D 034O $ U-@ _
M-CT /C9$ #TW3  \-U4 .SA> #HX:0 Y.78 .#F% #<ZE0 W.J4 -CJX #4Z
MSP V.NP -CK[ #8Y_P W.?\ HC@  (XY  !^.@  <CL  &@[  !?.@  63D
M %,V  !.-P  2C@  $8X"@!$.1  03D7 #\Y'P ^.28 /#DM #LZ-  Z.CL
M.3M" #@[2@ W.U, -CQ< #4\9P T/70 ,SV# #,^DP R/J0 ,3ZV #$^S0 Q
M/NH ,3[Z #(]_P R/?\ GCL  (L\  ![/   ;CT  &0]  !</0  53P  $XZ
M  !).P  13P  $$]!P ^/0X /#T5 #H^'  Y/B, -SXJ #8_,0 U/S@ -#]
M #- 2  R0%  ,4!: #!!90 O07( +D*! "U"D0 M0J( +$*U "M"RP L0ND
M+$+Y "U!_P M0?\ F3T  (<^  !W/P  :S\  &%   !9/P  4C\  $D^  !$
M/P  0$   #Q!!  Y0@T -T(2 #5#&0 S0R$ ,D,H #%$+P P1#8 +T0] "Y%
M10 M14X +$58 "M&8P J1F\ *49^ "A&CP G1Z$ )D>S "9'R0 F1N< )T;X
M "A%_P H1?\ E4   ()!  !S0@  9T(  %Y"  !50@  3D(  $5"   _1
M.T4  #=&   T1PH ,4@0 "](%@ N21X +$DE "M)+  J23, *4HZ "A*0@ G
M2DL )DM5 "5+8  D2VT (TM\ ")+C0 A3)\ (4RQ "!,QP @2^8 (4OW ")*
M_P B2O\ D$,  'Y$  !O1   9$4  %I%  !210  2D8  $%'   \2   -TD
M #)+   N30< *TX. "E.$P G3QH )D\A "5/*  D3S  (U W ")0/P A4$@
M(%!2 !]170 >46H '5%Y !Q1B@ ;49P &E&O !E1Q0 94>0 &E#V !M/_P <
M3_\ BD8  'E'  !K1P  8$@  %9(  !.2   1TD  #Y+   Y3   ,TX  "Y0
M   H4P( )%0+ ")5$  @518 'U8> !Y6)  =5BP '%8S !M7.P :5T0 &5=.
M !A760 76&8 %5AU !18AP 46)H $U>L !)7P@ 25^$ $U;T !15_P 45?\
MA$D  '1*  !F2P  7$L  %-+  !+3   1$T  #Q/   U40  +U0  "E6   D
M60  'EL' !I=#0 871( %UT9 !9>(  57B< %%XN !->-P 27D  $5]* !%?
M50 07V( #U]Q  Y?@P -7Y8 #5^I  Q>O@ ,7MH #5WP  U<_  .7/\ ?DT
M &Y.  !B3@  6$\  $]/  !(4   0%(  #A4   P5P  *EH  "1=   ?7P
M&6(! !-E"0 19@\ $&84  ]F&P .9R( #6<I  UG,@ ,9SL "V=%  IG4  )
M9UT !V=L  9G?0 %9Y  !&:C  )FMP #9<\ !&7I  1D]0 $9/P =U$  &E2
M  !=4@  5%(  $Q3  !#50  .U@  #-;   K7@  )6$  !]D   99P  $VH
M  ]M!@ +< P "'#_XO_B24-#7U!23T9)3$4 ! D1  =P%@ %<!T !' D  -P
M+  "<#4  ' _  !P2@  <%<  '!E  !P=@  <(H  &^>  !OL@  ;L@  &WE
M  !M\@  ;?D <%8  &-6  !95@  45<  $=8   ^6P  -E\  "YB   F9@
M'VH  !EM   3<   #G,   MV!  %> L  7@/  !Y$P  >1D  'D?  !Z)@
M>B\  'HY  !Z1   >E   'I?  !Z<   >H,  'J8  !ZK   ><(  'C?  !X
M[P  =_< :EL  %];  !66P  3%P  $)@   Y8P  ,&@  "AL   @<   &70
M !-W   .>P  "7X   2! @  @@@  (,-  "#$   A!0  (49  "&(   AB@
M (<Q  "'/   ATD  (=7  "':   AWL  (>0  "&I0  A;H  (73  "$Z@
MA/0 96   %Q@  !180  1F0  #QI   R;0  *7(  "%W   9>P  $H    V#
M   (AP   HH   "-    C@0  (X)  "/#0  D!   )$4  "2&0  DR   )0I
M  "5,P  E4   )9.  "67P  E7(  )6(  "5G0  E+(  )3(  "3X@  D^X
M864  %9F  !*:@  /VX  #5T   K>0  (7\  !F$   1B0  #(T   :1
ME    )@   ":    FP   )P"  "=!P  G@L  )\.  "A$@  HA@  *,@  "E
M*0  IC8  *9$  "F50  IF@  *9]  "FE   I:D  *2]  "DT0  I.0 6VP
M $]P  !#=0  .'L  "V!   CAP  &8T  !&2   +EP  !)P   "@    HP
M *8   "H    J0   *H   "L    K00  *X)  "P#0  L1$  +,7  "U(
MMBL  +<Z  "W2P  N%P  +AQ  "XB   N)T  +BQ  "WP@  M]  5'8  $A\
M   \@@  ,8D  ":0   ;EP  $IT   RB   #IP   *L   "N    L@   +8
M  "X    N    +H   "[    O0   +X   # !0  P0L  ,,0  #&%@  R2
M ,HN  #+/@  S%   ,QD  #->@  S9$  ,VD  #-M   S<  38,  $&*   U
MD0  *9D  !Z@   3I@  #*P   .Q    M@   +H   "^    P@   ,8   #(
M    R    ,H   #+    S0   ,X   #0    T@$  -4(  #9#@  W14  .$A
M  #B,0  Y$,  .56  #F:P  YH(  .>6  #GI0  YK  _P ) /\ !0#_  8
M_P . /\ %@#_ "$ _P M /\ . #] $, ^0!- /4 50#R %T \ !C .X :0#L
M &\ Z@!T .D >@#G '\ Y@"% .0 BP#C )$ X0"9 -\ H0#< *H V@"V -<
MQ@#5 .$ TP#T -( _P#1 /\ T0#_ ,\ _P#* /\ _P ! /\   #_  $ _P ,
M /\ $@#Z !T ]@ H /, ,P#P #X [ !( .@ 4 #E %@ X@!> -\ 9 #= &H
MVP!O -D = #6 'H U !_ -( A0#0 (P S@"3 ,P G #) *4 QP"P ,8 O@#$
M -0 P@#N ,$ _@#  /\ P #_ +\ _P"^ /\ _P   /\   #_    ^@ ' /$
M#P#K !@ Y@ C .( +@#@ #@ VP!" -4 2P#1 %( S@!9 ,L 7P#) &4 QP!J
M ,8 ;P#$ '0 P@!Z ,$ @ "_ (8 O0". +L E@"Y *  MP"J +8 MP"T ,H
ML@#F +$ ^ "P /\ KP#_ *\ _P"P /\ _P   /\   #W    Z@ " .$ # #7
M !, T  = ,P * #) #( Q@ \ ,( 10"_ $T O !3 +H 60"X %\ MP!D +4
M:0"T &X L@!T +$ >@"O (  K0"( *P D0"J )H J "E *8 L0"D ,$ HP#<
M *$ \@"A /\ H #_ *  _P"A /\ _P   /<   #H    V0   ,L " ## !
MO0 8 +D (@"V "P M  V +( /P"O $< K !- *L 5 "I %D IP!> *8 8P"E
M &@ HP!N *( = "@ 'H G@"" )P BP"; )4 F0"? )@ K "6 +H E #/ ),
MZP"2 /L D@#_ )( _P"1 /\ ]P   .<   #3    Q@   +L  @"S  P K0 2
M *H ' "G "8 I  P *, . "@ $  G@!' )P 3@": %, F0!8 )< 70"6 &,
ME0!H ), ;@"2 '0 D !\ (\ A0"- (\ BP": (H IP"( +4 A@#' (4 Y "$
M /4 A #_ (, _P"# /\ [    -,   #! 0  M    *P   "F  < H  . )T
M%@": "  EP I )4 ,@"3 #H D0!! (\ 2 "- $T C !3 (L 6 ") %T B !C
M (< :0"% &\ @P!W (( @ "  (H ?@"6 'T HP![ +  >@#" 'D W0!X /$
M=P#] '@ _P!X /\ W@H  ,0+  "R#   I@L  )T(  "9!   E0 * )$ $0".
M !D BP C (D + "' #0 A0 [ (, 0@"" $@ @ !. '\ 4P!] %@ ? !> 'L
M9 !Y &H > !R '8 >P!T (8 <P"2 '$ GP!P *T ;@"^ &T!U@!M NT ; /Z
M &P#_P!L _\ SA   +<1  "F$@  FA$  )$0  "+#@  B0L# (<%# "$ 1,
M@0$< 'X")0!\ RX >@,V '@$/ !W!$, =05( '0%3@!S!50 <059 ' &7P!N
M!F8 ;09N &L'> !J!X, : B0 &<)G0!E":P 9 F\ &,*U !C"^P 8@SZ &(,
M_P!B#/\ PQ8  *T7  "=&   D!@  (<6  "!%   ?1$  'P.!@!\"@X > H6
M '4+'P!R"R@ < PP &\,-P!M##X ; Q$ &L-2@!I#4\ : U5 &<-7 !E#6,
M8PYK &(.=0!@#H$ 7PZ. %T/G !<$*L 6Q"] %H0U@!9$?  61'] %D1_P!9
M$?\ N1L  *4=  "4'@  B!X  'X=  !X&P  =!@  '$5  !Q$0D ;Q 1 &P0
M&0!I$"( 9Q$J &81,@!D$3D 8Q$_ &(110!@$DL 7Q)1 %T26 !<$E\ 6A-H
M %D3<@!7%'T 5A2+ %05F0!3%:D 4A:Z %$6T@!1%^T 41?] %$7_P!1%_\
MLB   )XB  ".(@  @2,  '<B  !P(0  ;!X  &D;  !G& 0 9A4. &,6%0!A
M%AX 7Q8F %T6+0!<%S0 6A<[ %D700!8&$< 5AA- %485 !3&%P 4AED %$9
M;@!/&GH 3AN( $T;EP!+'*8 2ARX $H=SP!)'>L 21W[ $D=_P!*'?\ K"0
M )@E  "()@  >R<  '$F  !J)0  9B,  &(A  !@'@  7AP+ %L;$@!9'!H
M5QPB %4<*0!4'#  4QTW %$=/0!0'4, 3QU* $T>40!,'E@ 2Q]A $D?:P!(
M('< 1R"% $8AE !$(J0 1"*V $,BS !#(^D 0R/Z $,C_P!#(O\ IB<  ),I
M  "#*@  =BH  &TJ  !E*0  8"<  %PE  !9(P  5R$' %4A#P!2(18 4"$>
M $XA)0!-(BP 3"(S $HB.0!)(D  2")& $<C30!%(U4 1"1> $,D:0!")74
M0":# #\FD@ ^)Z, /B>T #TGR@ ]*.@ /2CY #TG_P ^)_\ HBH  (XK  !_
M+0  <BT  &@M  !A+   7"L  %@H  !4)@  428$ $XE#0!,)1, 2B8: $@F
M(@!')BD 128O $0F-@!#)SP 02=# $ G2P _*%, /BE< #TI9@ \*G( .RJ!
M #HKD  Y*Z$ ."RR #<LR  W+.8 ."SX #@L_P X+/\ G2P  (HN  ![+P
M;S   &4P  !=+P  6"X  %,K  !0*@  3"H  $DJ"P!&*A$ 1"H7 $(J'P!!
M*B4 /RHL #XK,P ]*SD /"M  #LL2  Z+%  .2U9 #@N9  W+G  -B]_ #4O
MCP T,)\ ,S"Q #(PQP R,.4 ,S#W #,P_P T+_\ F2\  (<Q  !W,@  :S(
M &(R  !:,@  5#$  $\O  !++0  1RX  $0N" !!+@X /RX4 #TN'  [+B(
M.2\I #@O+P W+S8 -C ^ #4P1@ U,4X -#%7 #,R8@ R,FX ,3-] # SC0 O
M-)X +C2P "TTQ0 M-., +C3V "\S_P O,_\ E3$  (,S  !T-   :#4  %XU
M  !7-   430  $LR  !&,0  0C(  #\R!0 \,@T .3,2 #@S&0 V,R  -#,F
M #,S+0 R-#0 ,30[ # U0P P-4P +S95 "XV8  M-VP +#=[ "LWBP J.)P
M*3BN "@XPP H..( *3CU "HW_P J-_\ DC0  '\U  !Q-@  93<  %LW  !4
M-P  338  $<V  !"-0  /38  #HV @ W-PL -#<0 #(W%@ Q.!T +S@D "XX
M*P M.3( +#DY "LY00 J.DD *CI3 "D[7@ H.VH )SMY "8\B0 E/)L )#RM
M ",\P@ C/.  )#ST "4[_P E._\ C38  'PX  !M.0  8CD  %@Z  !1.0
M2CD  $0Y   ].0  .3H  #4[   R.P@ +SP. "T]%  L/1H *CTA "D]*  H
M/B\ )SXV "8^/@ E/T< )#]0 "- 6P B0&@ (4!V "! AP ?09D 'T&K !Y!
MP  >0=X 'T#S !] _@ @/_\ B3D  '@Z  !I.P  7CP  %4\  !-/   1SP
M $ \   X/0  -#X  #!    M004 *D(, "="$0 F0Q@ )$,> "-#)0 B0RP
M(40S "!$.P ?1$0 'D5. !U%60 <164 &T5T !I%A0 91I< &4:I !A&O@ 7
M1=P &$7Q !E$_0 :1/\ A#P  ',]  !F/@  6S\  %(_  !*/P  1#\  #U
M   V00  ,4,  "Q$   G1@$ )$<* "%(#P @210 'DD; !U)(@ <22D &THP
M !I*.  92D$ &$I+ !=+50 62V( %4MQ !1+@@ 32Y0 $DNG !)+O  12]D
M$DKP !-*_  42?\ ?S\  &]   !A00  5T(  $Y"  !'0@  04(  #I#   R
M10  +4<  "A)   C2P  'DT& !M/#0 84!$ %U 7 !90'@ 54"4 %% L !-1
M-  243T $5%' !%14@ 045\ #U)M  Y2?@ -49$ #5&D  Q1N  ,4=$ #5#L
M  U0^@ .3_\ >4,  &I$  !=1   4T4  $M%  !$10  /D8  #9(   O2@
M*4P  "1/   ?40  &E,  !16"0 15PX $%@3 !!8&0 /6"  #E@H  U8,  -
M6#D #%A#  M83@ *6%H "%AH  =8>0 &6(P !5B?  18LP $5\H !5?F  57
M\P &5OP <T8  &1'  !92   4$@  $A(  !!20  .DH  #)-   K4   )5(
M "!5   :6   %5H  !!=!@ ,8 P "F 0  E@%0 (8!P !V C  5@*P $8#0
M V ]  %@20  8%4  &!C  !@<P  8(8  %^:  !?K@  7\0  %[B  !>\
M7O@ ;$H  %]+  !52P  3$P  $5,   ]3@  -5   "Y3   G5@  (%D  !I<
M   57P  $&(   UE!  (9PL  V<.  !H$P  :!@  &@?  !I)@  :2X  &DX
M  !I0P  :4\  &E=  !I;0  :8   &F4  !HJ0  :+\  &?<  !F[@  9O<
M9D\  %I/  !13P  2D\  $%1   X5   ,%<  "A;   A7@  &F(  !1E   0
M:   #&L   =N P !< D  ' -  !Q$   <10  '(:  !S(0  <R@  ',Q  !S
M/   =$@  '-6  !S9@  <WD  '..  !SHP  <KD  ''2  !QZP  </0 85,
M %93  !/4P  154  #M8   R7   *F   ")D   ;:   %&P   ]O   +<@
M!G8   !Y    >@8  'H*  ![#@  ?!$  'T5  !^&P  ?R(  ( J  " -0
M@$$  (!/  " 7P  @'$  ("&  " G0  ?[(  '[*  !^Y0  ??$ 7%@  %18
M  !)6@  /UT  #5A   L90  (VH  !MO   4<P  #G<   E[   #?P   ((
M  "$    A@$  (8&  "("@  B0T  (H0  "+%0  C!L  (XB  "/+   CS@
M (]&  "/5@  CV@  (]^  "/E0  CJL  (W!  "-W   C.L 65T  $Y?  !#
M8@  .&8  "YL   D<0  ''<  !1\   .@0  "(4   ")    C0   )    "2
M    DP   )0   "6 P  EP@  )@,  ":#P  FQ,  )T:  "?(P  H"X  * \
M  "@3   H%X  *!T  "?C   GZ(  )^W  ">RP  GN  4V0  $=H   \;0
M,7,  "=Y   =?P  %(4   V+   &D    )0   "8    G    )\   "A
MH@   *0   "E    IP   *@$  "J"0  K T  *T2  "P&0  LB,  +(Q  "R
M0@  LE0  +)I  "R@   LI@  +&L  "ROP  L<X 3&X  $!S   U>@  *H$
M !^(   5C@  #I4   ::    GP   *0   "H    K    *\   "Q    L0
M +,   "U    M@   +@   "Z    O 8  +X,  # $0  PQD  ,4F  #%-P
MQDD  ,9=  #'<@  QXH  ,B?  #(KP  R+P 1GH  #F!   NB0  (I   !>8
M   /GP  !Z4   "J    KP   +,   "W    O    +\   #!    P@   ,0
M  #%    QP   ,D   #+    S0   ,\#  #2"@  UA   -P:  #=*@  WCP
M -]0  #@90  X7L  .&1  #BH@  XJT _P " /\   #_  , _P , /\ $P#_
M !T _P H /X ,P#[ #X ]P!( /, 4 #P %< [0!> .L 9 #H &D YP!O .4
M= #C 'D X@!_ .  A0#> (P W "3 -D G #6 *8 TP"Q -$ P #/ -H S@#Q
M ,P _P#+ /\ RP#_ ,8 _P#! /\ _P   /\   #_    _P ( /L $ #V !D
M\@ D .\ +@#M #D Z !" ., 2P#@ %( W0!9 -D 7P#6 &0 TP!I -$ ;@#/
M '0 S@!Y ,P ?P#* (8 R ". ,8 E@#$ *  P@"K ,  N0"^ ,T O #J +L
M_ "Z /\ N@#_ +H _P"V /\ _P   /\   #^    ]  $ .L #0#D !0 WP ?
M -L *0#8 #, TP ] ,X 10#* $T QP!3 ,4 60## %\ P0!D +\ :0"] &X
MNP!S +H >0"X (  M@"( +0 D "R )H L0"E *\ L@"M ,0 K #A *L ]@"J
M /\ J@#_ *H _P"J /\ _P   /T   #N    X@   -4 "@#- !$ QP 9 ,0
M(P#! "T OP W +L /P"W $< M0!. +( 4P"P %D KP!> *T 8P"L &@ JP!M
M *D <P"H 'H I@"! *0 B@"C )0 H0"? )\ K "> +L G #2 )L [@": /\
MF@#_ )D _P"9 /\ _@   .X   #>    RP   ,$ !0"Y  T M  4 +$ '@"N
M "< JP P *H .0"G $$ I !( *( 30"A %, GP!8 )X 70"= &( FP!G )H
M;0"8 ', EP![ )4 A "4 (X D@"9 )  I@". +0 C0#( (P Y@"+ /D B@#_
M (H _P"+ /\ \    -L   #'    N@   +    "H  H I  0 *  & "= "$
MFP J )H ,P"8 #L E@!! )0 2 "2 $T D0!2 (\ 5P". %P C !A (L 9P"*
M &X B !U (< ?@"% (@ @P"4 (( H "  *\ ?P#  'X W0!] /( ?0#_ 'T
M_P!] /\ X    ,8   "U    J@   *(   ";  4 E0 - )( $P"0 !P C0 D
M (L +0"* #0 B  [ (8 0@"% $< @P!- (( 4@"! %< ?P!< 'X 8@!] &@
M>P!P 'H >0!X (, =@"/ '4 G !T *H <@"Z '$ T0!P .P < #[ '  _P!P
M /\ S00  +<&  "G!P  FP8  ),$  ".    B@ ( (8 #P"$ !8 @0 > '\
M)P!] "X ?  V 'H / !Y $( =P!' '8 3 !U %( <P!7 '( 70!Q &, ;P!K
M &X = !L 'X :P"* &D F !H *8 9P"V &8 RP!E .< 90#W &4 _P!E /\
MP P  *L-  ";#@  CPX  (8-  "!"P  ?@<! 'P!"P!Y !$ =P 8 '4 (0!S
M "D <0 P &\ -@!N #P ; !" &L 1P!J $T :0!2 &@ 6 !F %\ 90!G &,
M< !B 7H 8 &' %\"E0!> J, 7 .S %P#QP!;!.0 6P7T %L&_@!;!O\ M1
M *$2  "1$P  A1,  'P2  !V$0  <PX  '(,! !Q!PT ;@02 &P$&P!I!2,
M9P4J &8&,0!D!C< 8P8] &('0P!A!TD 7P=. %X(50!="%P 6PEC %H);0!8
M"G@ 5PJ% %8+DP!4"Z( 4PNS %(,QP!2#.0 40WU %$-_P!1#?\ K14  )D7
M  ")&   ?1D  '08  !M%P  :A0  &<1  !G#@< 9@P. &,,%0!A#!T 7PPE
M %T-+ !<#3, 6PTY %H-/P!8#44 5PU+ %8.40!5#ED 4PYA %(.:P!0#W8
M3A"# $T0D@!,$*( 2Q"R $H1R !)$>4 21'W $D2_P!)$?\ I1D  )(<  "#
M'0  =AX  &T=  !F'   8AH  %\7  !>% $ 7A$* %L0$0!9$1@ 5Q$@ %41
M)P!4$2X 4Q$T %$1.P!0$D$ 3Q)' $X23@!,$E4 2Q-> $D39P!(%', 1A2
M $45CP!$%9\ 0Q:P $(6Q0!"%^, 0A?V $(7_P!"%_\ GQT  (P@  !](0
M<2(  &@B  !A(0  7!\  %D<  !7&0  518& %05#@!1%10 3Q8< $X6(P!,
M%BH 2Q8P $H6-P!)%ST 1Q=# $872@!%&%( 0QA: $(99 !!&7  /QI] #X;
MC0 ]&YT /!RN #L<PP ['.$ .QWU #L<_P \'/\ FB$  (<C  !X)   ;"4
M &,E  !<)   5R,  %,@  !1'@  3QP" $T;# !+&A$ 2!L8 $<;( !%&R8
M1!LM $,<,P!"'#D 0!Q  #\=1P ^'4\ /1Y8 #P>8@ Z'VT .1][ #@@BP W
M(9L -B&M #4AP0 U(=\ -2'S #8A_P V(?\ EB,  (,F  !T)P  :"@  %\H
M  !8)P  4R8  $\D  !,(@  22   $<@"0!$'P\ 0A\5 $ @'  _(", /B I
M #P@+P [(38 .B$] #DA1  X(DP -R)5 #8C7P T(VL ,R1Y #(EB0 Q)9H
M,"6K # FOP O)MP ,";R # F_P Q)?\ D28  '\H  !Q*@  92H  %PJ  !5
M*@  3RD  $LH  !()0  1"0  $$D!0 _) T /202 #LD&0 Y)!\ -R0F #8D
M+  U)3, -"4Z #,F00 R)DH ,2=3 # G70 O*&D +BEW "TIAP L*9@ *RJJ
M "HJO0 J*MH *RKQ "LJ_@ L*?\ C2@  'PJ  !M+   8BT  %DM  !1+0
M3"P  $<K  !#*   /R@  #PH @ Y* L -R@0 #4H%@ S*!P ,B@C # H*0 O
M*3  +RHW "XJ/P M*T< +"M1 "LL6P J+&< *2UU "@MA0 G+9< )BZH "4N
MO  E+M@ )B[P "8N_0 G+?\ BBL  '@M  !J+@  7R\  %8O  !.+P  2"X
M $,M   _+   .RP  #<L   T+ D ,BP. # M$P N+1H +2T@ "LM)P J+BT
M*BXU "DO/0 H+T4 )S!. "8P60 E,64 )#%S ",Q@P B,I4 (3*G "$RNP @
M,M0 (3+O "(Q_  B,?\ ABT  '4O  !G,   7#$  %,Q  !+,0  13$  $ P
M   [,   -C   #,P   P,08 +3$- "LQ$0 I,A< *#(> "<R)  E,RL )3,R
M "0S.@ C-$, (C1, "$U5P @-6, 'S5Q !XV@0 =-I, '#:E !LVN0 ;-M(
M'#;M !TV^P =-?\ @C   '$R  !C,P  630  % T  !)-   0C,  #TS   W
M,P  ,30  "XU   K-0( *#8+ "4W$  D-Q4 (C<; "$X(@ @."@ 'S@P !XX
M-P =.4  '#E) !LZ5  :.F  &3IN !@Z?P 7.Y$ %SND !8[MP 5.]  %CKL
M !<Z^@ 8.?\ ?3(  &TT  !@-0  538  $TV  !&-@  0#8  #HV   T-@
M+C@  "HY   F.@  (SL( " \#@ >/1( '3T8 !P]'P ;/B4 &CXM !D^-  7
M/CT %C]' !4_40 4/UX %#]L !- ?  20(\ $4"B !% M@ 00,X $3_K !(_
M^0 2/O\ >34  &DW  !<.   4CD  $HY  !#.0  /3D  #<Y   Q.@  *SP
M "<]   B/P  'D$$ !I""P 80Q  %T,5 !5$&P 41"( $T0I !-$,0 21#H
M$45# !!%3@ 015L #D5I  Y%>0 -18P #46?  Q%L@ +1<D #$7E  U$]@ -
M1/\ =#D  &4Z  !8.P  3SL  $<\  ! /   .CP  #0\   N/@  *$   "-"
M   ?1   &D8  !5("  22@T $4H2 !!*&  /2QX #DLE  U++0 -2S8 #$M
M  M+2@ *2U8 "4MD  A+=  '2X< !4N:  1+K@ $2L0 !4K@  5*\  &2?H
M;CP  & ]  !4/@  2SX  $0^   ]/@  -S\  #%    J0@  )$4  !]'   :
M20  %4P  !%.!0 .40L "U$0  I1%  )41L "%$B  =1*0 %43( !%([  -2
M1@ !4E(  %)?  !2;P  4H$  %&6  !1J0  4;\  %#<  !0[@  4/< :$
M %M!  !000  2$$  $%!   [0@  -$,  "U%   F2   ($L  !M-   64
M$5,   Y5!  *6 H !E@.  )8$@  61<  %D=  !9)0  62T  %DV  !900
M64T  %I:  !::0  67P  %F0  !9I0  6+H  %C5  !7[   5_8 8T0  %9%
M  !-10  144  #]%   W1P  +TD  "A,   B3P  &U(  !95   16   #5H
M  E= P $7PD  & -  !@$   810  &$9  !B(   8B<  &(Q  !B.P  8D<
M &)5  !C9   8G8  &*+  !BH   8;8  &'/  !@Z@  8/4 74@  %))  !*
M2   0T@  #I*   R30  *E   "-3   <5P  %EH  !%=   -8   "&,   -F
M 0  9P8  &@+  !I#@  :A$  &L5  !L&P  ;2(  &TJ  !M-   ;4   &U.
M  !M70  ;6\  &V$  !LF@  ;+   &O(  !KY@  :O, 6$T  $Y-  !(3
M/DX  #51   L5   )%@  !U<   68   $&0   QG   ':P   6X   !P
M<@,  '('  !S"P  =0X  '81  !W%@  >!P  'DC  !Z+0  >CD  'I'  !Z
M5@  >6@  'I\  !YE   >*H  'C!  !WWP  =^\ 5%$  $Q1  !"4@  .%4
M "]9   F7@  'F(  !9G   0:P  "V\   5S    =P   'H   !\    ?@
M '\"  " !@  @0H  (,-  "$$0  AA4  (@<  "))0  BC   (H^  ")30
MB5\  (ES  "(BP  B*(  (>Y  "'T0  AN@ 4E8  $=7   \6@  ,E\  "AD
M   ?:0  %F\  !!T   *>0   GT   "!    A0   (@   "*    C    (T
M  "/    D 0  )((  "3#   E1   )<5  "9'0  FR<  )LT  ";1   FE8
M )IJ  "9@@  FIH  )BP  "8QP  E]X 2UP  $!@   U90  *VH  "%Q   7
M=P  $'T   F#   !B    (P   "1    E0   )@   ":    FP   )T   "?
M    H    *(   "D!0  I@H  *@.  "J%   K1T  *TJ  "M.0  K4L  *U?
M  "M=P  K)   *NG  "KN@  J\L 168  #EK   N<0  (W@  !E_   0A@
M"8T   "3    F    )T   "A    I0   *@   "K    JP   *X   "O
ML0   +,   "U    MP$  +D'  "\#0  OQ,  ,(?  #"+@  PD   ,)4  #!
M:P  P8,  ,";  #!K0  P;P /G(  #)X   G@   '(@  !*0   *EP   )T
M  "C    J    *T   "R    M@   +D   "[    O    +X   #     P@
M ,0   #&    R    ,L   #.!0  T0T  -84  #7(P  V#4  -E)  #:7@
MVW4  -N,  #<GP  W*L _P   /\   #_    _P ) /\ $ #_ !D _@ D /P
M+P#Y #D ] !# /  2P#M %( Z@!9 .< 7P#D &0 X@!I .  ;@#> ', W !Y
M -H ?P#7 (8 U ". -$ E@#/ *$ S "L ,H NP#( -( Q@#N ,8 _P#% /\
MQ0#_ +\ _P"Z /\ _P   /\   #_    _@ % /< #@#R !4 [@ ? .L *@#I
M #0 XP ] -X 10#9 $T U !3 -$ 60#. %X S !C ,H : #) &T QP!S ,4
M>0## (  P0"( +\ D "] )L NP"F +D M "W ,@ M@#F +4 ^P"T /\ M #_
M +, _P"N /\ _P   /\   #X    [0   .4 "P#= !$ UP : -( ) #/ "X
MRP W ,< 0 ## $< P !. +X 4P"\ %D N@!> +@ 8P"V &@ M0!M +, <P"Q
M 'D KP"! *T B@"K )0 J0"@ *@ K0"F +X I0#; *0 ] "D /\ HP#_ *,
M_P"B /\ _P   /8   #F    UP   ,L !@#$  X O@ 5 +L 'P"Y "@ MP Q
M +0 .@"P $$ K0!( *L 3@"I %, IP!8 *8 7 "D &$ HP!G *$ ; "@ ',
MG@!Z )T @P"; (X F0"9 )< I@"6 +8 E0#, )0 ZP"3 /T DP#_ ), _P"3
M /\ ]P   .0   #0    P0   +<  @"O  L JP 1 *< &0"E "( HP K *(
M,P"? #L G !" )L 2 "9 $T EP!2 )8 5P"5 %L DP!A )( 9@"0 &T CP!T
M (T ?0", (< B@"3 (@ H "' *\ A0#" (4 X@"$ /< A #_ (0 _P"$ /\
MY0   ,T   "\    KP   *8   ">  < F@ . )8 % "4 !T D@ E )$ +0"0
M #4 C0 \ (P 0@"* $< B !, (< 40"& %8 A !; (, 8 "! &< @ !N 'X
M=P!] ($ >P"- 'H F@!X *D =P"Z '8 TP!V .\ =@#^ '4 _P!U /\ T
M +L   "K    GP   )<   "0  ( BP + (@ $ "& !< A  @ (( )P"! "\
M?P U 'T / !\ $$ >P!& 'D 2P!X %  =P!5 '8 6P!T &$ <P!I '$ <0!P
M 'L ;@"' &T E0!K *, :@"T &H R0!I .@ :0#Y &D _P!I /\ P    *P
M  "< @  D (  (@   "#    ?P & 'L #0!Y !( =P : '8 (@!T "D <P P
M '$ -@!P #P ;P!! &T 1@!L $L :P!0 &H 5@!H %P 9P!D &4 ; !D '8
M8P"" &$ D !@ )\ 7P"O %X PP!> .$ 7@#T %T _P!= /\ M <  * )  "0
M"P  A L  'P*  !W!P  = 0  '$ "0!O  \ ;0 5 &L ' !I ", :  J &<
M,0!E #8 9  \ &, 00!B $8 8 !, %\ 4@!> %@ 70!? %L : !: '( 6 !^
M %< C !6 )L 50"K %0 O@!4 -H 4P#O %0 ^P!4 /\ J0T  )8.  "'$
M>A   '(0  !L#@  :0P  &<) P!F! L 9  0 &( %P!@ !X 7@ E %T *P!<
M #$ 6@ W %D / !8 $( 5P%' %8!3@!5 E0 4P)< %(#90!1 V\ 3P1[ $X$
MB@!-!9D 3 6I $L%O !*!M0 2@?M $H'^0!*!_\ H1   (X2  !^%   <Q0
M &H4  !D$P  8!$  %X/  !=#04 70D- %H&$@!8!QD 5@<@ %4')P!3!RT
M4@@S %$(. !0"#X 3PE$ $X)2@!,"5$ 2PI9 $H*8@!("VT 1PMZ $8,B !$
M#)@ 0PRI $(-O !"#=4 0@WN $(-^P!"#?\ FA0  (<6  !X&   ;!D  &,9
M  !=&   618  %83  !4$0  5 X( %,-#@!1#10 3PT; $T-(@!,#2@ 2PTN
M $H-- !)#3H 1PY! $8.1P!%#D\ 1 Y7 $(/80!!$&P /Q!Y #X0B  ]$9@
M.Q&I #L1O  Z$=8 .A'P #H2_0 [$?\ DQ@  ($:  !S'   9QT  %X=  !8
M'   4QL  % 8  !.%@  3!,# $P1"P!*$!  2!$7 $81'@!%$20 1!$J $(1
M, !!$3< 0!(] #\21  ]$DP /!-4 #L37@ Y%&D .!1V #<5A0 V%98 -!:G
M #06N@ S%M, ,Q;N #06_  T%O\ CAL  'P=  !N'P  8R   %H@  !3(
M3AX  $H=  !(&@  1A@  $46!P!#%0X 0143 #\5&@ ^%2  /14G #L5+0 Z
M%C, .18Z #@600 W%TD -1=1 #086P S&68 ,AES # :@P O&I0 +ANE "T;
MN  M&]  +1OL "X;^P N&_\ BAX  '@@  !J(@  7R,  %8C  !/(@  2B$
M $8@  !#'@  01L  #\: P ]&@P .QD1 #D9%@ W&AT -AHC #4:*0 T&C
M,QLV #$;/@ P'$8 +QQ/ "X=60 M'60 +!YQ "L?@0 J'Y( *1^D "@@MP G
M(,X )R#K "@@^@ I'_\ AB   '0C  !G)   7"4  %,E  !,)0  1R0  $(C
M   _(0  /1\  #H>   W'@D -1X. #,>$P Q'AH ,!X@ "\>)@ N'RT +1\S
M "P@.P K($, *B%, "DA5@ H(F( )B)O "4C?P D(Y  (R.B "(DM0 B),P
M(B3I ",D^0 D(_\ @B,  '$E  !C)@  62<  % H  !))P  0R<  #\F   [
M)   ."(  #4B   R(@8 ,"(- "XB$0 L(A< *B(= "DB(P H(RH )R,Q "8D
M.  E)4$ )"5* ",F5  B)F  (2=M " G?0 ?)X\ 'BBA !XHM  =*,H '2CH
M !XH^  ?)_\ ?B4  &XG  !@*0  5BD  $TJ  !&*@  02D  #PH   W)P
M-"8  # F   M)@, *R<+ "@G$  G)Q0 )2<: "0G(0 C*"< (B@N "$I-@ @
M*3X 'RI( !XJ4@ =*UX '"MK !LK>P :+(T &2R? !@LL@ 8+,D &"SG !DK
M]P :*_\ >B<  &HJ  !=*P  4RP  $HL  !#+   /BL  #DK   T*@  ,"H
M "LJ   I*P  )BL( ",L#@ B+!( ("P8 !\L'@ >+24 '2TL !PM,P ;+CP
M&BY% !DO4  8+UP %R]I !8P>0 5,(L %#"> !0PL0 3,,< $S#E !0P]@ 5
M+_\ =BH  &<L  !:+0  4"X  $@N  !!+@  .RX  #8M   Q+0  +"T  "<O
M   D+P  (3 % !\Q#  <,1  &S(5 !HR'  9,B( &#(I !<S,0 6,SD %3-#
M !0T30 3-%D $C1G !$U=P 1-8D $#6< ! UL  .-<8 #S3D ! T]0 0-/\
M<BP  &,N  !7,   33   $4P   ^,   .#   #,P   O,   *3$  "0R   A
M,P  '34" !HV"0 7-PX %3<3 !0X&0 3.!\ $C@F !(X+@ 1.38 $#E  ! Y
M2P ..5< #CID  TZ=  ,.H8 ##J9  LYK  *.<$ "CG>  LY\0 ,./P ;B\
M %\Q  !3,@  2C,  $(S   [,P  -C,  #$R   L,P  )S0  "$V   =.
M&3D  !4[!@ 2/0P $#X0 ! ^%0 ./AP #CXC  T^*@ ,/C, ##X\  L_1P *
M/U( "#]@  <_;P &/X$ !3^4  0_J  #/KP !#[7  4^[  %/O< :3,  %LT
M  !0-0  1S4  #\U   Y-0  -#4  "XU   I-P  (S@  !X[   :/   %C\
M !)!!  .0PH #$0.  I$$P )1!D "$0@  =$)P &1"\ !40X  -%0@ "14X
M $5;  !%:@  17P  $60  !$I   1+D  $31  !$Z@  0_4 9#8  %<W  !,
M.   0S@  #PX   W.   ,3@  "LY   E.P  (#T  !I    60@  $D0   Y'
M!  +20D !TH-  1+$0 !2Q8  $L<  !+(P  2RL  $LT  !+/@  3$D  $Q7
M  !,9@  3'<  $N,  !+H0  2[4  $K.  !*Z0  2O4 7SH  %([  !(.P
M0#L  #H[   T.P  +CP  "<^   B00  '$,  !9&   220  #DL   M. P '
M4 @  E$,  !1$   4A,  %,8  !3'P  4R8  %,O  !3.0  4T4  %-2  !3
M80  4W(  %.'  !2G   4K$  %'*  !1YP  4?0 63X  $X^  !%/@  /CX
M #@^   P0   *4(  "-$   =1P  %TH  !)-   .4   "U,   95 @  5P<
M %@+  !9#@  6A$  %H5  !;&@  7"$  %PJ  !<-   7#\  %Q-  !<6P
M7&P  %R!  !;EP  6ZT  %K%  !:Y   6?, 5$(  $I"  !"0@  /$(  #1#
M   L1@  )4D  !Y,   73P  $E,   Y6   *60  !5L   !>    8 0  &$(
M  !B#   8PX  &01  !E%@  9AP  &<C  !G+0  9SD  &=&  !G50  9V8
M &=Z  !FD0  9:@  &7   !DW@  9/  3T8  $=&  ! 10  -T<  "]*   F
M30  'U$  !A5   260  #5P   A@   "8P   &8   !H    :@   &L$  !L
M"   ;0P  &\.  !P$@  <A<  ',=  !T)@  =#(  '0_  !T3@  <U\  '1R
M  !SB@  <J$  '&X  !QU   <.P 3$H  $5*   [2P  ,DX  "E2   @5@
M&%L  !)?   -9   !V@   !K    ;P   '(   !U    =@   '<   !Y @
M>@8  'P*  !^#@  @!$  ((6  "$'@  A"D  (0V  "$10  A%8  (-J  "#
M@0  @ID  (&Q  " R0  @.4 2DX  #]0   U4P  *U<  ")<   98@  $F<
M  QL   %<0   '4   !Y    ?0   ($   "#    A0   (8   "(    B0
M (L$  "-"   CPT  )(0  "4%@  EB   )8L  "6.P  EDP  )5@  "5=@
ME)   ).G  "2O0  DM4 1%4  #E9   O70  )&,  !II   2;P  #'4   1[
M    @    (4   ")    C0   )$   "3    E    )8   "8    F@   )P
M  ">    H 8  *(+  "E$   J!<  *DC  "I,0  J4,  *E6  "H;0  IH<
M *>>  "FLP  I<< /EX  #)C   G:@  '7   !-X   ,?P   X4   "+
MD0   )8   ";    GP   *(   "D    I0   *<   "I    JP   *T   "P
M    L@   +4"  "W"0  NQ   +X8  "^)@  OC@  +Y+  "]80  O'H  +N4
M  "ZJ0  NKD -VH  "MP   @>   %H    V(   %CP   )8   "<    H@
M *<   "L    L    +,   "V    MP   +D   "[    O0   +\   #"
MQ0   ,@   #*    S@@  -(0  #5&P  U2P  -1   #45P  TVX  -2&  #4
MFP  TZL _P   /\   #_    _P % /\ #@#_ !4 _  @ /D *@#V #0 \0 ]
M .T 1@#I $T Y@!3 .0 60#A %X W@!C -P : #9 &X U0!S -, >0#0 (
MS@"( ,L D0#) )P Q@"G ,0 MP#" ,P P #L +\ _P"^ /\ O0#_ +< _P"R
M /\ _P   /\   #_    ^@ ! /, "P#M !( Z  ; .4 )0#D "X WP X -@
M0 #2 $< S@!. ,L 5 #( %D Q@!> ,0 8P#" &< P !M +\ <P"] 'H NP"!
M +D BP"V )4 M "A +( KP"P ,( K@#C *X ^@"L /\ K0#_ *D _P"F /\
M_P   /\   #R    Y@   -T !P#2  X S0 6 ,H ( #( "D Q0 R ,  .@"\
M $( N0!( +< 3@"U %, LP!8 +$ 70"P &( K@!G *P ; "J ', J0![ *<
MA "E (X HP": *$ J "? +D G@#2 )T \@"< /\ G0#_ )P _P"9 /\ _
M .X   #=    S    ,$  @"Z  P M@ 2 +( &@"P ", KP L *T - "I #P
MI@!" *0 2 "B $T H !2 )X 5P"= %L G !@ )H 9@"9 &P EP!T )4 ?0"3
M (< D0"3 )  H0". +$ C0#& (P Z "+ /T C #_ (P _P", /\ [0   -@
M  #%    MP   *P   "F  @ H0 . )\ %0"= !X FP F )H +@"7 #4 E0 \
M ), 0@"1 $< D !, (X 40"- %4 BP!: (H 8 ") &8 AP!M (4 =@"$ (
M@@", (  F@!_ *D ?0"\ 'P W !\ /4 ? #_ 'P _P!\ /\ V0   ,$   "Q
M    I    )P   "4  , D  , (T $0"+ !@ B0 @ (D * "' "\ A0 V (,
M/ "" $$ @ !& '\ 2P!] $\ ? !4 'L 6@!Y &  > !G '8 < !U 'H <P"&
M '$ DP!P *( ;P"T &X S !N .T ;@#^ &X _P!N /\ Q    *\   "@
ME    (P   "&    @0 ( 'X #@!\ !0 >P ; 'D (@!X "D =P P '4 -@!T
M #L <@!  '$ 10!P $H ;P!/ &T 5 !L %L :P!B &D :@!H '0 9@"  &4
MC@!C )T 8@"M &$ P@!A .0 80#X &$ _P!A /\ M    *    "1    A@
M 'X   !Y    =0 # '$ "P!O !  ;0 6 &P '0!K "0 :P J &D , !H #8
M9@ [ &4 0 !D $4 8P!* &$ 3P!@ %8 7P!= %T 90!< &\ 6@!Z %D B !8
M )@ 5P"H %8 NP!6 -@ 5@#Q %8 _P!6 /\ J $  )0%  "%!P  >@<  '(&
M  !L!   :0$  &< !P!D  T 8P 1 &$ & !@ !\ 7P E %X *P!= #  6P V
M %H .P!9 $  6 !% %< 2P!6 %$ 50!8 %, 80!2 &H 4 !V $\ A !. ),
M30"D $P M@!, ,T 3 #K $P ^@!, /\ G0D  (L+  !\#0  < T  &@-  !B
M#   7PH  %T& 0!< 0D 6@ . %@ $P!7 !D 5@ @ %4 )@!3 "L 4@ Q %$
M-@!0 #L 3P!! $X 1P!- $T 2P!5 $H 70!) &< 1P!S $8 @ !% )  1 "A
M $, L@!# ,@ 0P#F $, ]0!# /\ E0T  (,/  !T$   :1$  & 1  !:$
M5@X  %0-  !3"@0 4P8+ %$#$ !/ 14 3@$; $P!(0!+ 2< 2@(L $D",@!(
M C< 1P,] $4#0P!$ TH 0P11 $($6@! !60 /P5P #X&?@ ]!HX / >? #L'
ML0 Z!\8 .@?C #H'\P Z"/P CA   'P2  !N%   8A4  %H5  !4%   4!,
M $T1  !+#@  2PT& $H*# !)"!$ 1P@6 $4('0!$"", 0@@H $$)+@! "3,
M/PDY #X*0  ]"D< / I/ #H+6  Y"V, . QO #8,?@ U#(X - V? #,-L0 R
M#<< ,@WC #(-]  R#?X B!,  '<5  !I%P  7A@  %48  !/&   2A8  $<5
M  !%$P  0Q " $,." !"#0X 0 T2 #\-&  ]#1\ / TD #L-*@ Y#3  . XW
M #<./0 V#D4 -0Y- #,/5P R#V( ,1!N "\0?0 N$(X +1&@ "P1L@ K$<@
M*Q'F "L1]@ L$?\ @Q8  '(9  !D&@  61L  %$;  !+&P  1AH  $(8   _
M%P  /A0  #P2!  [$0H .A 0 #@0%0 W$!L -1$A #01)P S$2T ,A$S # 1
M.@ O$D( +A)+ "T35  K$U\ *A1L "D4>P H%(P )Q6> "85L  E%<8 )17D
M "45]@ F%?\ ?AD  &X;  !@'0  5AX  $T>  !''@  0AT  #X<   Z&@
M.!@  #<6   U%0< -!0- #(4$@ P%!< +Q0= "T4(P L%2H *Q4P "H5-P I
M%C\ *!9( "<74@ F&%T )!AJ ",9>0 B&8H (1F< " 9KP ?&<0 'QGB " 9
M]  @&?\ >AL  &H>  !='P  4R   $H@  !$(   /A\  #H>   W'0  -!P
M #(9   P&00 +A@+ "P8$  J&!0 *1@: "<8(  F&28 )1DM "0:-0 C&CT
M(AM& "$;4  @'%L 'QUH !X==P ='8@ '!Z; !L>K0 :'L, &A[@ !H=\P ;
M'?\ =QT  &<@  !:(0  4"(  $@B  !!(@  .R(  #<A   S(   ,!\  "T=
M   K'0  *!T( "8=#@ E'1( (QT7 "$='0 A'20 (!XJ !\>,@ >'SH '1]#
M !P@30 ;(5D &B%F !DA=0 8(H< %R*9 !8BK  5(L$ %2+? !4A\@ 6(?X
M<R   &0B  !7(P  320  $4E   ^)   .20  #0C   P(@  +"(  "DA   F
M(0  )"$& "(A#  @(1  'B$5 !TB&P ;(B$ &R(H !HC+P 9(S@ &"1! !<D
M2P 6)5< %25D !0F<P 3)H4 $B:8 !$FJP 1)L  $";= !$E\0 2)?T <"(
M &$D  !4)@  2B8  $(G   \)@  -B8  #$E   M)0  *20  "8D   B)0
M'R4# !TF"@ ;)@X &2<2 !@G&  7)Q\ %B<E !4H+0 4*#4 $RD^ !(I20 1
M*54 $2IB ! J<0 /*H, #BJ6  XJJ0 -*KT #2K7  TJ[@ .*?L ;"0  %TF
M  !1*   2"@  $ I   Y*   -"@  "\H   K)P  )R<  "(H   >*0  &RH
M !@K!P 6*PT %"P1 !,L%@ 2+!P $2TC ! M*@ 0+3( #RX\  XN1@ -+E(
M#2Y?  PO;@ ++W\ "B^2  DOI0 )+KD ""[0  DNZ0 *+O< :"<  %HI  !.
M*@  12L  #TK   W*P  ,2H  "TJ   I*@  )"H  " K   ;+0  &"X  !4O
M!  2,0H $#(.  \R$P .,AD #3(@  TR)P ,,B\ "S,X  HS0@ ),TX "#-;
M  8T:@ %-'L !#..  ,SH@ ",[8  C/-  ,SYP $,O, 9"H  %8L  !++0
M0BT  #HM   T+0  +RP  "LL   F+   (BT  !TO   9,0  %3(  !(T P /
M-@D ##@-  HX$0 ).!8 "#@=  <X)  &."P !#@T  ,X/@ ".4H  #E7   Y
M90  .7<  #F+   XGP  .+,  #C*   XY@  -_( 7RT  %(N  !(+P  /S
M #@O   R+P  +2\  "DO   D,   'S$  !HS   5-0  $C<   \Y P ,.P@
M"#T-  4^$  #/A0  #X:   ^(0  /B@  #XQ   _.P  /T8  #]3   _80
M/W,  #^'   ^G   /K   #W'   ]Y   /?( 6C   $XR  !$,@  /#(  #4R
M   P,0  *S$  "8R   @-   &S8  !8X   2.P  #ST   P_ P (00@ !$,,
M  !##@  1!(  $46  !%'0  120  $4M  !&-@  1D(  $9.  !&70  1FX
M $6"  !%F   1*T  $3$  !#XP  0_( 530  $HU  !!-0  .34  #,T   N
M-   *#4  "(W   =.@  %SP  !(_   /00  #$0   A& 0 #2 8  $D*  !*
M#0  2Q   $P4  !-&0  3B   $XH  !.,@  33T  $Y*  !.6   36D  $U]
M  !,E   3*H  $O!  !+X0  2O( 4#@  $8X   ].   -S@  #$W   J.0
M)#L  !X]   80   $T,   ]&   +20  !TL   ).    4 0  %$(  !2"P
M4PX  %01  !5%0  5AL  %<C  !7+   5S@  %=$  !74@  5F,  %9W  !6
MC@  5:4  %2]  !3W0  4_  2SP  $(\   [.P  -3L  "T\   F/P  'T(
M !E%   32   #DL   M/   %40   %0   !7    6 $  %H%  !;"   7 P
M %T.  !?$0  8!8  &(=  !B)@  8C$  &(^  !A3   85T  &%P  !@B
M8*   %^W  !>U   7>X 1T   #\_   Z/P  ,4   "E#   A1@  &DH  !-.
M   .40  "E4   18    6P   %X   !A    8P   &0!  !E!   9P@  &@+
M  !J#@  ;!(  &X7  !O(   ;RH  &\V  !N10  ;E4  &YH  !M?P  ;9@
M &RP  !KR@  :N@ 1$0  #Y#   U1   *T<  "-+   ;3P  $U0   Y8   (
M7    F    !D    9P   &L   !M    ;P   '    !R    = (  '4&  !W
M"@  >0X  'P2  !^&   ?R(  '\N  !_/0  ?DT  'UA  !]=P  ?)   'NH
M  !ZP   >=\ 0T<  #E)   O3   )5   !Q5   46P  #F    =E    :@
M &X   !R    =@   'D   !\    ?@   '\   "!    @P   (4   "' P
MB@@  (P-  "/$0  DAD  )(E  "2,P  DD0  )%7  "0;0  CX8  (Z?  "-
MM0  C,T /4X  #)1   H5@  'EP  !5B   .:   !VX   !T    >0   'X
M  ""    A@   (D   ",    C@   )    "2    E    )8   "8    FP
M )X&  "A#   I!$  *8;  "F*0  ICH  *5-  "E8@  I'L  *.4  "AJP
MH;\ -E<  "Q<   A8@  %VD   ]P   '=P   'X   "$    B@   (\   "4
M    F    )L   ">    GP   *(   "D    I@   *@   "K    K0   +
M  "S!   MPP  +L2  "['P  NS   +M#  "Z6   N7   +>+  "WH0  M[,
M,&(  "5I   :<   $'@   F     B    (\   "6    FP   *$   "F
MJ@   *X   "P    L0   +0   "V    N    +L   "]    P    ,,   #'
M    RP,  ,\,  #3%0  TB4  -(X  #13@  T&4  ,]^  #-E@  S*D _P
M /\   #_    _P # /\ "P#\ !$ ^0 ; /< )0#S "\ [@ X .D 0 #F $@
MX@!. -\ 5 #< %D V0!> -4 8P#3 &@ T !M ,X <P#+ 'H R "" ,8 C ##
M )< P "C +X L@"\ ,@ N@#J +D _P"X /\ L0#_ *H _P"G /\ _P   /\
M  #[    ]@   .T !P#G  \ X@ 6 -\ ( #> "D V0 S -$ .P#, $( R !(
M ,4 3@#" %, P !8 +X 70"\ &( N@!G +D ;0"W '0 M0![ +( A0"P )
MK@"< *P J@"I +T IP#> *8 ^0"E /\ HP#_ )T _P"; /\ _0   /8   #K
M    WP   -$  P#*  P Q0 2 ,, &P#  "0 O@ L +D -0"V #P LP!# +
M2 "N $X K !2 *L 5P"I %P IP!A *8 9P"D &T H@!T *  ?0"> (@ G "5
M )H HP"8 +0 E@#- )4 \0"4 /\ E0#_ )  _P". /\ \P   .8   #1
MP@   +@   "Q  @ K0 / *H %@"H !X J  G *8 +P"B #8 GP \ )T 0@";
M $< F0!, )< 40"6 %4 E !: ), 8 "1 &8 D !N (X =@", ($ B@"- (@
MFP"& *P A0#! (0 Y@"# /T A #_ (, _P"! /\ Y    ,L   "Z    K
M *(   "<  0 F  , )8 $0"4 !D DP A )( * "/ #  C0 V (L / ") $$
MB !& (8 2P"% $\ A !4 (( 6@"! &  ?P!G 'X ;P!\ 'H >@"& '@ E !W
M *0 =0"W '0 U !S /0 = #_ '0 _P!T /\ RP   +8   "F    F@   )(
M  "*    A@ ( (, #@"! !0 @0 ; (  (P!_ "H ?0 P 'L -@!Z #L > !
M '< 10!U $D = !. ', 5 !Q %H < !A &X :0!M ', :P!_ &D C0!H )T
M9P"N &8 QP!E .H 9@#_ &8 _P!G /\ N    *0   "5    B@   ($   !\
M    =@ $ '0 # !R !  <0 6 '  '0!P "0 ;@ J &T , !K #4 :@ Z &D
M/P!H $0 9P!) &4 3@!D %0 8P!; &$ 8P!@ &T 7@!Y %T AP!; )8 6@"H
M %D O0!9 -\ 60#X %H _P!: /\ J    )4   "'    >P   ',   !N
M:@ ! &< " !E  X 9  2 &, & !C !\ 8@ E &$ *@!? #  7@ U %T .@!<
M #X 6P!$ %D 20!8 $\ 5P!6 %8 7@!4 &@ 4P!S %$ @0!0 )$ 3P"B $X
MM0!. -  3@#P $X _P!/ /\ G    (D   ![ P  < ,  &@#  !B 0  7P
M %T ! !;  L 60 / %@ % !7 !D 5P @ %8 )0!5 "H 4P P %( - !1 #D
M4  _ $\ 1 !. $L 30!2 $L 6@!* &, 20!O $< ? !& (P 10"= $4 L !$
M ,< 1 #H $0 ^@!% /\ D@0  ( '  !Q"@  9@H  %X*  !9"0  50<  %0$
M  !2  < 4  , $\ $ !. !4 30 ; $P ( !+ "8 2@ K $D , !( #4 1P Z
M $8 0 !% $8 0P!. $( 5@!! %\ 0 !K #X >  ] (@ / "9 #P JP \ ,$
M.P#@ #L ]  [ /\ B0H  '@,  !J#@  7PX  %<.  !1#@  30P  $L+  !*
M" ( 200) $@ #0!& !$ 10 6 $0 ' !# "$ 0@ F $$ *P _ #$ /@ V #T
M/  \ $, .P!* #H 4@ Y %P . !H #8 =0 U (4 - "6 #0 J  S +P ,P#8
M #, [P S /L @@T  '$/  !D$   61$  %$1  !+$0  1Q   $0.  !"#0
M00L% $$'"P _!0X /@,2 #P"&  [ AT .@,B #D#*  X RT -P,R #8$.0 U
M!#\ - 5' #,%4  Q!EH , 9F "\'<P N!X, +0>5 "P'IP K![H *P?2 "L'
MZP K!_< ?1   &P1  !?$P  5!0  $P4  !&%   0A,  #X2   \$   .@X!
M #H-!@ Z"@P . D0 #8(%  U"!D - D? #())  Q"2D , DO "\*-@ N"CT
M+0I% "P+3@ K"UD *0QE "@,<P G#(, )@V5 "4-IP D#;L (PW2 ",-ZP C
M#?< >!(  &@4  !;%@  41<  $@7  !"%@  /18  #D5   W$P  -1$  #,0
M P S#@@ ,@T- # -$0 O#18 +0T; "P-(0 K#2< *@TM "D.-  H#CL )PY$
M "4.3@ D#UD (Q!E "$0<P @$(0 'Q"6 !X0J0 =$+T '!#8 !T0[@ =$/D
M<Q0  &06  !7&   31D  $49   _&0  .A@  #47   R%@  ,!4  "X3   M
M$00 +! * "L0#@ I$!( *! 8 "80'@ E$"0 )! J ",1,0 B$3D (1%" " 2
M2P >$E8 '1-C !P3<0 :$X( &125 !@4IP 7%+L %Q/4 !<3[@ 8$_H <!8
M & 9  !4&@  2AL  $(<   \&P  -AL  #(:   O&0  +!@  "H6   H% $
M)A,' "43#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4+@ <%38 &Q4_ !H620 9
M%E0 &!=A !87<  5&($ %!B3 !,8I@ 2&+H $A?2 !(7[  3%_H ;!D  %T;
M  !1'0  1QT  #\>   Y'0  -!T  "\<   K&P  *!H  "89   D&   (A<$
M " 7"@ >%PX '!<2 !H7%P 9&!X &1@D !@9+  7&30 %AH] !4:1P 4&U(
M$QM? !(<;@ 1''\ $!R2 ! <I0 /'+D #AS0  X;Z@ /&_@ :1L  %H=  !.
M'P  11\  #T@   V'P  ,1\  "T>   I'0  )1T  ",<   @&P  '1L! !L;
M!P 9' T %QP0 !8<%0 5'!L %!TB !,=*0 2'C$ $1XZ !$?10 0'U  #R!=
M  X@;  -('P #2"/  P@H@ +(+4 "R#*  L@Y0 ,'_0 91T  %<?  !,(0
M0B$  #HA   T(0  +R$  "H@   F'P  (Q\  " >   ='@  &2   !8@!  4
M( L $B$. !$A$P 1(AD $"(?  \B)@ .(R\ #B,W  TC00 ,)$T "R19  HD
M9P ))'@ ""2+  <DG@ ')+$ !B3'  8CXP '(_$ 8A\  %0A  !)(P  0",
M #@C   R(P  +",  "@B   D(0  (2$  !XA   :(0  %B,  !,D P 1)0@
M#R8-  XG$0 -)Q8 #"<=  LG(P *)RL "2@T  @H/@ '*$D !BA5  4I9  $
M*70  RF'  (IFP !**\  "C%  $HX0 !)_  7B(  %$D  !&)0  /24  #4E
M   O)0  *B0  "8D   B(P  'R,  !LD   8)0  %"8  !$H P /*0@ #"P,
M  HL$  (+!0 !RP:  8L(0 %+"@  RTP  (M.@ !+44  "U2   N8   +G$
M "V$   MF0  +:T  "S"   LX   +/  6B0  $TF  !#)P  .B<  #,G   M
M)P  *"8  "0F   A)@  '28  !DG   5*0  $2L   \L P -+@< "3 ,  8Q
M#@ #,1(  3(7   R'@  ,B4  #(M   R-@  ,T(  #-.   S70  ,VT  #.!
M   RE@  ,JL  #'!   QWP  ,?  5B<  $HI   _*@  -RH  # J   K*0
M)R@  ",H   >*0  &BH  !8L   2+@  #S    TQ @ *- < !34+  (V#@
M-Q   #@4   X&@  ."(  #@J   Y,P  .3X  #E*   Y60  .6D  #E]   X
MDP  .*@  #>_   WW@  -O  42L  $8L   \+   -"P  "XL   J*P  )2L
M " L   ;+0  %R\  !,Q   0,P  #34   DW @ %.@8  3L*   \#0  /0\
M #X2   _%P  0!X  $ E  ! +P  0#H  $!&  ! 5   0&4  #]X   _CP
M/J8  #Z]   ]W   /?  32X  $(O   Y+P  ,B\  "TN   H+@  (B\  !TP
M   8,@  $S4  ! W   ,.@  "3P   4^    000  $((  !#"P  1 T  $80
M  !'%   2!D  $@A  !(*@  2#4  $A!  !(3P  2&   $=S  !'B@  1J(
M $6Y  !%V0  1/  2#(  #XR   V,@  ,#$  "LQ   E,@  'S0  !DV   3
M.0  $#P   P_   (0@   T0   !&    2 (  $H%  !+"   3 L  $X.  !/
M$0  414  %(<  !2)0  4C   %(\  !12@  45H  %%M  !0A   3YT  $ZU
M  !-T@  3>X 0S8  #LV   T-0  +S0  "<U   A.   &CL  !0^   000
M#$0   ='   "2@   $T   !/    40   %,"  !4!0  50@  %<+  !9#@
M6Q$  %T7  !='P  72H  %TV  !<1   7%0  %MG  !;?@  6I<  %FO  !8
MRP  5^H /SD  #@Y   S.   *SD  ",\   </P  %4,  !!'   +2@  !4X
M  !1    5    %<   !:    7    %T   !?    8 0  &('  !D"P  9@X
M &@2  !K&0  :R,  &HN  !J/   :DT  &E?  !H=0  9X\  &:H  !EP@
M9., /3T  #<\   N/0  )4   !U$   620  $$T   I1   $50   %H   !=
M    8    &,   !F    :    &H   !K    ;0   &\"  !Q!@  = H  '8.
M  !Y$P  >QL  'LG  !Z-0  >44  'A9  !X;0  =X8  ':?  !UMP  =-(
M/$$  #)"   H10  ($H  !=.   05   "ED   )>    8P   &<   !K
M;P   '(   !U    =P   'D   ![    ?0   '\   ""    A ,  (<)  "*
M#@  CA,  (\>  ".*P  CCL  (U.  "+8P  BGP  (J5  "(K0  A\4 -D<
M "Q+   B3P  &54  !!;   *80   6<   !M    <@   '<   ![    ?P
M (,   "&    B    (H   "-    CP   )$   "4    EP   )H!  "=!P
MH0T  *44  "D(0  I#$  *-$  "B60  H'   )^+  "=H@  G;< ,%   "55
M   ;6P  $F(   MI   !<    '<   !]    @P   (@   "-    D0   )4
M  "8    F@   )P   "?    H0   *,   "F    J0   *P   "P    M <
M +@.  "Z&   NB<  +DY  "X3@  MV4  +9^  "UE@  LZL *5L  !YB   4
M:0  #'$   )Y    @0   (D   "/    E@   )L   "@    I    *@   "K
M    K    *\   "R    M    +8   "Y    O    ,    #$    R    ,T'
M  #2$   TAT  -$O  #01   SUL  ,US  #+C0  RJ$ _P   /\   #[
M^@   /P " #X  \ ]0 7 /0 ( #Q "H ZP S .8 .P#B $, W@!) -H 3P#6
M %0 TP!9 -  7@#. &, RP!H ,D ;@#& '4 PP!] ,$ A@"^ )( NP"> +D
MK@"V ,, M #H +, _P"O /\ I0#_ )X _P"; /\ _0   /<   #R    \
M .<  P#A  P W  2 -@ &P#6 "0 T@ M ,P -@#& #T P@!# +\ 20"\ $X
MN@!3 +@ 6 "V %T M0!B +, 9P"Q &X KP!V *P ?P"J (H J "7 *4 I@"C
M +D H0#9 *  ^0"> /\ F #_ )( _P"/ /\ \P   .P   #C    TP   ,@
M  #!  D O0 / +L %@"Y !\ MP G +, +P"O #< K  ] *H 0P"H $@ I@!-
M *0 4@"C %8 H0!; )\ 80"> &< G !O )H > "7 (, E0"0 ), G@"1 +
MD #( (X \ "- /\ B@#_ (4 _P"" /\ YP   -T   #&    N    *X   "H
M  0 I0 , *$ $@"A !D H  B )\ *0"; #  F  W )8 /0"3 $( D@!' )
M2P"/ %  C0!5 (P 6@"* &$ B !H (< < "% 'L @P"( ($ E@!_ *< ?0"\
M 'P XP!\ /T ? #_ '@ _P!V /\ U@   ,    "O    HP   )D   "3
MCP ) (T #@"+ !0 B@ < (H (P"( "H A0 P (, -@"" #L @ !  '\ 10!^
M $H ? !/ 'L 5 !Z %H > !A '8 :0!U ', <P"  '$ C@!O )\ ;@"R &T
MSP!L /0 ; #_ &L _P!I /\ P    *L   ";    CP   (<   "     ?  $
M 'H # !X !$ >  7 '@ '@!W "0 =0 J ', , !Q #4 <  Z &X /P!M $0
M; !) &L 3@!J %0 : !; &< 8P!E &T 9 !X &( AP!@ )< 7P"J %X P@!>
M .D 7@#_ %X _P!= /\ K    )D   "*    ?P   '<   !Q    ;0   &H
M" !I  X :  2 &< & !G !\ 9P E &4 *@!C "\ 8@ T &$ .0!@ #X 7P!#
M %X 2 != $X 6P!5 %H 70!8 &< 5P!R %4 @0!4 )$ 4P"C %( N !1 -P
M40#Y %( _P!2 /\ G0   (L   !\    <0   &D   !D    8    %X !0!<
M  L 6P / %L % !: !D 6@ ? %D )0!7 "H 5@ O %4 - !4 #@ 4P ] %(
M0P!0 $D 3P!0 $X 6 !- &( 2P!M $H >@!) (L 2 "= $< L0!' ,P 1@#P
M $< _P!' /\ D    'X   !P    9@   %X   !9    5@   %,  0!2  @
M4  - $\ $ !/ !4 3@ : $X ( !- "4 3  J $H +@!) #, 2  X $< /@!&
M $0 10!+ $0 4P!# %T 00!H $  =0 _ (4 /@"7 #T JP ] ,, /0#F #T
M^P ^ /\ AP   '4#  !H!@  70<  %4&  !0!@  3 0  $H!  !)  0 1P *
M $8 #@!% !$ 10 6 $0 &P!# "  0@ E $$ *@!  "\ /P T #X .@ ] $
M.P!' #H 3P Y %D . !D #< <0 V ($ -0"3 #0 I@ T +L - #= #0 ]0 U
M /\ ?@8  &T)  !@"P  5@P  $X,  !("P  1 H  $((  ! !0$ /P$' #X
M"P ]  X /  2 #L %P [ !P .@ A #D )0 W "H -@ P #4 -0 T #P ,P!#
M #( 3  Q %4 , !@ "\ ;0 N 'T +0"/ "P H@ L +8 + #0 "P [@ L /P
M=PH  &<,  !:#@  4 X  $D.  !##@  /@T  #L,   Y"P  . D# #<%"  V
M @T -0$0 #0 $P S !@ ,@ = #$ (@ P "< +P L "X ,@ M #@ + !  "L
M20 J %( *0!= "@ :P G 7H )@&, "4 GP E +( )0#* "4 Z  E /< <@T
M &(.  !6$   3!$  $01   ^$0  .1   #8/   S#@  ,0T! # +!0 P" H
M+P8- "X%$0 L!!0 *P,9 "H#'@ I R, * 0I "<$+P F!34 )04] "0%1@ C
M!E  (@9< "$':0 @!WD 'P>+ !X'G0 >![  '0;& !T&XP =!?, ;0X  %X1
M  !2$@  2!,  $ 3   Z$P  -1(  #$1   N$   + \  "H. P J#0< *0L+
M "@)#@ G"1$ )0@6 "0(&P C"2  (@DF "$)+  @"C, 'PH[ !X+1  ="T\
M' Q; !L,:0 :#'D & R+ !@,G@ 7#+  %@S% !8,X0 6"_  :1   %H2  !.
M%   114  #T5   W%0  ,10  "T3   J$@  *!$  "80 0 D$ 0 (PX( ",-
M#  B# \ ( P3 !\,&  >#1T '0TC !P-*@ ;#3( &@XZ !@.1  7#E  %@]<
M !4/:@ 3$'L $A"- !$0H  1$+, $ _) ! /Y  1#_( 91(  %<4  !+%@
M0A<  #H7   T%P  +Q8  "H5   G%   )!,  "(3   @$@, 'A$& !T0"0 <
M$ T &P\0 !D0%0 8$!L %Q A !80*  5$3  %!$Y !,10P 2$DX $1): ! 2
M:0 0$WD #A.,  X3G@ -$[$ #1+%  P2X0 -$O$ 8A0  %06  !)&   /QD
M #<9   Q&0  +!@  "@7   D%@  (18  !\5   <% ( &A,$ !D2!@ 7$@L
M%1(. !02$@ 3$Q@ $A,? !$3)@ 1%"T $!0V  \500 .%4P #A97  T690 ,
M%W4 "Q>'  H7F@ )%JT "!;!  @6W0 )%>X 7Q8  %$8  !&&@  /1H  #4;
M   O&@  *AH  "49   B&   'Q@  !P7   9%@$ %Q8# !46!  3%@D $18-
M ! 7$0 /%Q8 #A<<  X8(P -&"H #!DS  P9/  +&D< "AI3  D:80 '&W$
M!AN#  4;EP $&JH  QJ_  ,9V@ $&>P 7!@  $X:  !#'   .AP  #,<   L
M'   )QP  ",;   @&@  '1D  !H9   7& $ %1@" !(9!  0&P< #AL,  T<
M$  ,'!, "QP9  H<'P )'2< "!TO  <>.0 &'D, !!Y0  ,?7@ "'VX  1^
M   ?E0  'JD  !Z]   =V   '>P 6!H  $L<  !!'@  .!X  # >   J'@
M)1T  "$<   >'   &QL  !@;   6&P$ $QL" !$<!  .'@< #!\+  H@#@ (
M(!( !B$7  4A'0 $(20  B(L  $B-0  (D   "--   C6@  (VL  "-^   C
MDP  (J<  "*\   AUP  (>T 51T  $@?   ^(   -2   "X@   H(   (Q\
M " >   ='0  &AT  !8=   3'@  $1\"  X@!  -(@< "B0+  8E#0 $)1
M B84   F&@  )B$  "<I   G,@  )ST  "=)   H5P  *&<  "=[   GD
M)Z4  ":[   FU@  )>T 42   $4A   [(@  ,B(  "PB   F(0  (B$  !X@
M   ;'P  &"   !0@   1(@  #R,   TE P *)@8 !B@*  ,I#0  *P\  "P2
M   L%P  +!X  "PF   M+P  +3D  "U&   M5   +60  "UW   LC0  +*0
M "NZ   KU@  *NX 32(  $$D   X)   ,"0  "DD   D(P  (2(  !TB   9
M(@  %2,  !(D   /)@  #2@   HJ @ &+ 4  BX)   O"P  , X  #(0   S
M%0  ,QL  #,B   S*P  ,S8  #-"   S4   ,V   #-S   RB@  ,J$  #&X
M   PU@  ,.\ 224  #XF   T)P  +2<  "@F   C)0  'R0  !LE   6)@
M$B@  ! J   -+   "BX   8P 0 ",@0  #0'   U"@  -PP  #@.   Z$@
M.A<  #H?   Z)P  .C(  #H^   Z3   .EP  #IO   YA@  .)X  #BV   W
MU   -N\ 1"D  #HI   Q*0  *RD  "8H   B)P  '2@  !@I   3*P  $"X
M  TP   ),@  !34   $W    .0(  #L%   \"   /@L  #\-  !!$   0Q0
M $,;  !#(P  0RX  $,Y  !#1P  0E<  $)J  !!@0  0)H  #^R   ^SP
M/N\ /RP  #8L   O+   *BL  "4J   ?*P  &2T  !0O   0,@  #34   @X
M   $.@   #P    _    00   $,"  !%!0  1@@  $@+  !*#@  3!$  $T6
M  !-'@  32@  $TT  !,0@  3%$  $MD  !+>P  2I0  $FM  !(R@  1^P
M.S   #,O   M+P  *"T  "(O   ;,0  %30  ! W   -.@  "#T   )
M0P   $8   !(    2@   $P   !. 0  3P0  %$'  !3"P  50X  %@2  !9
M&0  6"(  %@N  !7/   5TL  %9>  !6<P  58T  %2G  !2P@  4N8 .#,
M #$R   L,0  )3(  !TU   6.   $3P   Q    '1    $<   !*    30
M %    !3    50   %<   !9    6@   %P#  !>!P  80L  &0.  !F$P
M9QP  &8G  !F-   940  &17  !D:P  8H4  &&?  !@N0  7MP -3<  # U
M   H-P  (#H  !@]   10@  #$8   9*    3P   %,   !6    60   %P
M  !?    80   &0   !E    9P   &D   !L 0  ;@8  '$+  !T#P  =Q4
M '<@  !V+0  =CT  '5/  !T8P  <WL  '*5  !PKP  ;\D -3H  "L[   B
M/P  &D,  !)(   ,30  !5(   !7    7    &    !D    :    &L   !N
M    <0   ',   !U    =P   'H   !\    ?P   (($  "&"@  B@\  (P7
M  "+)   BC,  (E%  "'6P  AG(  (6+  "#I0  @KP +T   "5$   <20
M$TX   U4   $6@   &$   !F    :P   &\   !T    >0   'T   "
M@P   (4   "'    B@   (P   "/    D@   )8   "9 @  G@D  *(0  "B
M&@  H2D  * [  "?4   G6<  )J!  ":F0  F:\ *4D  !].   55   #EL
M  5B    :0   '    !W    ?0   ((   "&    BP   (\   "3    E0
M )<   ":    G0   *    "C    I@   *H   "N    L@   +<*  "[$0
MNA\  +DP  "W10  M5P  +1T  "QC@  KZ0 (E0  !A;   08@  !VH   !S
M    >P   ((   ")    D    )4   ":    GP   *,   "F    J    *L
M  "N    L    +,   "V    N@   +T   #"    QP   ,P!  #3"P  U!4
M -,F  #1.@  T%$  ,UH  #+@0  RI8 _    /8   #R    \0   /, !0#T
M  P \@ 3 /  ' #M "4 Z  N .( -@#> #X V0!$ -0 2@#1 $\ S@!4 ,L
M60#) %X Q@!C ,0 :0#! '  O@!X +P @0"Y (T M@": +, JP"Q ,  KP#F
M *X _P"E /\ F@#_ )0 _P"/ /\ ]    .P   #H    YP   -\   #9  D
MT@ 0 ,\ %P#/ "  S  H ,8 , #  #< O  ^ +D 1 "W $D M0!. +, 4P"Q
M %< KP!= *T 8@"K &D J0!Q *< >@"E (4 H@"3 *  H@"= +8 FP#4 )D
M^0"6 /\ C0#_ (@ _P"$ /\ Z    -\   #9    R0   +\   "X  0 M0 -
M +, $@"Q !H L  B *T *@"I #$ I@ X *0 /0"B $, H !( )X 3 "< %$
MFP!6 )D 7 "7 &( E0!I ), <@"1 'T CP"+ (T F@"+ *P B0#% (@ [@"&
M /\ ?P#_ 'H _P!X /\ V0   ,T   "[    K@   *4   "?    G  ) )D
M#P"9 !4 F0 = )@ ) "4 "L D0 Q (X -P", #P BP!! (D 1@"( $L A@!0
M (4 50"# %L @@!B (  :P!^ '4 ? "" 'H D@!X *, =P"Y '8 X !U /\
M<@#_ &X _P!L /\ QP   +4   "E    F0   (\   ")    A0 $ (0 # ""
M !$ @@ 7 (( '@"  "4 ?@ K 'P ,0!Z #8 >0 [ '< 0 !V $0 =0!) ',
M3P!R %4 < !< &\ 9 !M &X ; !Z &H B@!H )L 9P"O &8 S !E /4 9 #_
M &$ _P!@ /\ M    *    "0    A0   'T   !W    <P   '  " !O  X
M;P 2 &\ & !O !\ ;0 E &L *@!I #  :  T &< .0!F #X 90!# &, 2 !B
M $X 80!5 %\ 7@!> &< 7 !S %L @@!9 ), 6 "F %< OP!7 .H 5P#_ %8
M_P!4 /\ H0   (X   !_    =0   &P   !H    9    &$ ! !@  L 7P /
M %\ $P!? !D 7P ? %T )0!< "H 6P O %D ,P!8 #@ 5P ] %8 0P!5 $D
M4P!0 %( 6 !1 &$ 4 !M $X >P!- (P 3 "? $L M0!* -P 2@#Z $H _P!*
M /\ D@   (    !R    9P   %\   !:    5P   %4  0!3  < 4@ , %(
M$ !2 !0 4@ : %$ 'P!/ "0 3@ I $T +@!, #, 2P X $H /0!) $, 2 !*
M $8 4@!% %P 1 !G $, =0!" (8 00"8 $  K@!  ,L /P#R $  _P!  /\
MA0   '0   !G    70   %4   !/    3    $H   !(  0 1P * $< #0!&
M !$ 1@ 5 $8 &@!% !\ 1  D $, *0!" "T 00 S #\ .  ^ #X /0!% #P
M3@ [ %< .@!B #D ;P X (  -P"3 #8 IP V ,  -@#H #8 _@ V /\ ?
M &L   !> @  5 ,  $T#  !' P  0P$  $$    _  $ /@ ' #T "P ]  X
M/  1 #P %@ \ !H .@ ? #D )  X "D -P N #8 ,P U #H - !! #, 20 R
M %, ,0!> #  :P O 'L +@". "T H@ M +@ +0#= "T ^  N /\ <P$  &0%
M  !7!P  30@  $8(  ! "   .P<  #@%   W P  -@ $ #4 "  T  P -  /
M #0 $@ S !8 ,@ ; #$ (  P "0 +P I "X +P M #8 +  ] "L 10 J $\
M*0!: "@ 9P G '< )@") "8 G0 E +, )0#/ "4 \  F /\ ;08  %X)  !2
M"P  2 P  $ ,   Z"P  -@L  #(*   P"   +@8" "X#!@ M  H +  - "P
M$  K !, *@ 7 "D '  H "  )P E "8 *P E #( )  Y ", 0@ B $L (@!7
M "$ 9  @ ', 'P"% !\ F0 > *X '@#' !X Z0 ? /H : D  %D,  !-#0
M0PX  #P.   V#@  ,0T  "T-   J#   * L  "<)!  F!@@ )@0+ "4##@ D
M 1  ) $4 "(!&  A 1T (0 B "  *  ? "X '@$V !T!/P < 4D &P%4 !H!
M80 : 7  &0&" !@ E@ 8 *H & #! !@ X0 8 /0 8PP  %4.  !)#P  0!
M #@0   R$   +0\  "D.   F#@  (PT  "(, P @"P8 ( D) !\'#  >!@X
M'@41 !P%%0 ;!1H &@4? !H%)0 9!2L & 4S !<&/  6!D8 %@92 !4'7P 4
M!VX $P>  !('E  2!J< $@6\ !($V0 2 ^\ 7PX  %$/  !&$   /!$  #41
M   O$0  *A$  "80   B$   ( \  !T. @ <#04 &@T' !H+"@ 9"@T & D0
M !<)$@ 6"1< %0D< !0)(@ 4"BD $PHQ !(*.@ 2"T4 $0M1 ! ,7P /#&X
M#@R   X,E  -"Z< #0NZ  T*T@ -"NH 7 \  $X1  !#$@  .A,  #(3   L
M$P  )Q(  ",1   ?$0  '!   !H0 @ 8#P0 %@X' !4."0 4#0L $PP- !(,
M$  2#!0 $0P: !$-(  0#2@ #PTP  X..P -#D8 #0Y1  P/7@ +#VT "@]_
M  D/DP )#Z8 " ZY  @.T  '#N@ 6!$  $L2  ! $P  -Q0  # 4   I%
M)10  "$3   =$@  &A(  !<1 @ 5$04 $Q ' !(0"0 1#PH $ X,  X.#@ .
M#Q( #1 8  T0'@ ,$"4 #! M  L1-@ *$4$ "1%-  @26@ '$FH !A)\  42
MD  $$J0  Q&X  ,1SP "$>@ 51(  $D4   ^%0  -18  "T6   G%@  (A4
M !X4   ;%   &!,  !42 P 3$@4 $A$' ! 1"0 /$0H #1$+  P2#@ +$A$
M"A(5  D3&P )$R( "!,J  <4,P %%#X !!5*  ,56  "%6<  15Z   5C@
M%:,  !2W   4SP  $^D 4A0  $86   [%P  ,A<  "L7   E%P  (18  !P6
M   9%0  %A0! !03!  2$P8 $1((  \2"  .$PD #!0*  H5#0 (%A  !A83
M  46&0 $%Q\  Q<G  (8,  !&#L  !E'   950  &60  !EW   9C   &*(
M !BW   7SP  %^H 3Q8  $,8   Y&0  ,!D  "D9   C&0  'Q@  !L7   8
M%@  %14" !,5!0 1% 8 $!0&  X5!P ,%@@ "A<*  <9#  $&@X  AL2  $;
M%@  &QT  !PD   <+0  '#@  !U$   =4@  '6(  !UU   =B@  '*   !RV
M   ;T   &NL 3!@  $ :   V&P  +1L  "8;   A&@  '1D  !D9   7&
M%!<# !(6!  0%P0 #A<$  P9!0 *&@< !QP)  ,="P  'PT  " 0   @%
M(1H  "$B   A*@  (34  ")!   B3P  (E\  ")R   AB   (9\  ""V   ?
MT0  '^T 2!H  #T<   S'0  *QT  "0=   @'   '!L  !@:   6&0$ $QD!
M !$9 0 .&@$ #!P"  H= P ''P4  R$(   B"@  ) P  "8.   F$@  )A@
M "<?   G)P  )S(  "<^   G2P  )UP  "=N   FA0  )IT  "6T   DT0
M(^X 1!T  #D?   P'P  *!\  ",>   >'0  &QP  !@;   4'   $1P   X=
M   -'P  "B$   8B 0 #) 0  "8&   H"   *@L  "L-   M$   +14  "T<
M   M)   +BX  "XZ   N2   +5@  "UJ   M@0  +)H  "NR   JT   *>\
M0"   #8A   M(0  )B$  "$@   ='P  &AX  !8>   2'P  #R$   TB   *
M)   !B8   (H    *P(  "T$   O!@  , D  #(,   T#@  -1(  #48   U
M(   -2H  #4V   U0P  -5,  #1F   T?   ,Y8  #*O   QS0  ,.\ /",
M #(D   J)   )",  " B   <(0  %R$  !,C   0)0  #2<   DI   %*P
M 2X    P    ,@   #0!   V!   . 8  #H)   \#0  /A   #X4   ^'
M/B8  #XQ   ^/P  /4X  #UA   \=P  .Y$  #JK   YR0  ..T -R<  "\G
M   H)@  (R4  !\D   9)0  %"8  ! H   -*P  "2X   4P    ,P   #4
M   X    .@   #P    ^ 0  0 ,  $('  !$"@  1@T  $D1  !)%P  2"$
M $@L  !'.@  1TD  $9;  !%<0  1(L  $.E  !"PP  0>@ -"H  "PJ   G
M*   (B<  !PH   6*@  $2T   TP   ),P   S8    Y    /    #X   !!
M    0P   $8   !(    2@   $P#  !.!@  4 H  %,.  !4$P  5!P  %,G
M  !3-   4T,  %)5  !1:@  4(,  $^>  !-N0  3.  ,"T  "LL   F*P
M'RP  !@N   2,@  #34   @Y   "/0   $    !#    1@   $D   !,
M3@   %$   !3    50   %<   !9 0  7 8  %\*  !B#@  8Q4  &,?  !B
M+   83P  &!.  !?8@  7GL  %R6  !;L   6<\ +S   "HO   B,   &C,
M !,W   ..P  "#\   %$    2    $P   !/    4@   %4   !8    6P
M %T   !@    8@   &0   !F    :0   &T%  !P"P  =!   '08  !S)0
M<C0  ')%  !P60  ;W$  &V+  !KI@  :L  +C,  "4U   =.   %#P   Y!
M   '1P   $P   !1    50   %D   !=    80   &4   !H    :P   &T
M  !O    <@   '0   !W    >@   'X   ""!   A@L  (H1  ")'   B"L
M (8]  "$4@  @V<  (&!  !_FP  ?K( *3H  " ]   60@  #T@   A.
M5    %H   !@    9    &D   !N    <@   '8   !Z    ?0   (    ""
M    A0   (@   "+    C@   )(   "6    FP,  * ,  "B$P  H"$  )\S
M  "=1P  FEX  )AW  "7CP  E:< (T,  !E(   13@  "54   !<    8P
M &H   !Q    =@   'L   "     A@   (H   ".    D0   ),   "6
MF0   )P   "@    HP   *<   "K    L    +8$  "\#0  NA<  +DH  "W
M/   M%(  +)J  "OA0  K9P '$X  !-4   +7    60   !L    =    'P
M  "#    B0   (\   "4    F@   )\   "B    I    *<   "J    K@
M +$   "T    N    +P   #!    QP   ,T   #4!0  V!   -4>  #3,0
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M__________________________________________\
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M_/W^_VUF=#$      P0A   !                     0
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MA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VJR%G=JLA9W:K(6=VO?
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MQ\S-"0S+TPHMQ]0*6;+8"X">S2N:F,%0JY:X9[>5M76\E+1^OI2SA;^0LH7
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MFW^YP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+.
MG=&R?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZD
MT;!^I-&P?J31L'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^Y
MP)N(O;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R
M?Z/1L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^
MI-&P?J31L'ZDT?^X% [_N!XG_[0J1O>O-FG>IT*/QYMBL<2;<K;"FW^YP)N(
MO;Z9B<"\E8K#NI&+QKB-C<BWBH_*MHB1S+6%D\VT@Y;/LX&9T+. G=&R?Z/1
ML'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P?J31L'ZDT;!^I-&P
M?J31L'ZDT?^X% [_N!TG_[4I1O>P-6G>J$&0QYQAL<2<<;;"FWZYOYV&O;V:
MB<&[EXG$N9.*Q[>/C,JUC([,M(F0SK.'DM"RA)72L8*9T[&!GM2N@*+4K("C
MTJR H]*L@*/2K("CTJR H]*L@*/2K("CTJR H]*L@*/2K("CTJR H]*L@*/2
MK("CTO^Y$P[_N1PG_[8H1O>P-&K=J$"0QYU@L<2<<;;"G'RZOYZ%OKR<B,*Z
MF8C%N)6)R;:1BLRTCHS/LHN.T;&(D=.PAI35KX29UJ^#G]>J@J'5IX*BTZ>"
MHM.G@J+3IX*BTZ>"HM.G@J+3IX*BTZ>"HM.G@J+3IX*BTZ>"HM.G@J+3IX*B
MT_^Y$P[_N1PG_[8H1O>Q,VK=J3^1QYU@L<2=<+;"GGNZOY^#OKR>B,*YFXC'
MMY>(RK64B<ZSD(O1L8V-TZ^*D-:NB)/8K8:9V:J%GMFEA*'5I(2BU*2$HM2D
MA*+4I(2BU*2$HM2DA*+4I(2BU*2$HM2DA*+4I(2BU*2$HM2DA*+4I(2BU/^Z
M$@[_NALG_[<G1O>Q,FK=J3Z1QYY?L<2=;[;!GWFZOJ""O[N@B,.XG(?(MIF(
MS+.6B-"QDHK3KX^,UJZ,CMBLBI/;JXF9W*:'G=JBAJ#6H(:BU*"&HM2@AJ+4
MH(:BU*"&HM2@AJ+4H(:BU*"&HM2@AJ+4H(:BU*"&HM2@AJ+4H(:BU/^Z$@[_
MNALF_[<F1O:R,6K=JCV1QYY>L<2=;[;!H'BZOJ&!O[NAB,2XGH?)M9N'S;*8
MB-&PE8G5KI*+V*R/C=NJC9+>J(R:WZ**G=J>B:#6G(FAU)R)H=2<B:'4G(FA
MU)R)H=2<B:'4G(FAU)R)H=2<B:'4G(FAU)R)H=2<B:'4G(FAU/ZZ$0[_NQHF
M_[@F1O:R,&K=JCR1QYY=L<2>;K;!H7:ZOJ)_O[NCB,2WH(?*M)V'S[&:A].N
MF(C7K)6*VZJ3C=ZHD9+BI)"9X)Z-G=N:C*#7F8NAU9F+H=69BZ'5F8NAU9F+
MH=69BZ'5F8NAU9F+H=69BZ'5F8NAU9F+H=69BZ'5F8NAU?Z[$0[^NQHF_[@E
M1O:S,&K<JSN2QY]=L<2?;+;!HG2ZOJ1^O[JDA\6WHH?*LY^'T+"<A]6MFHC9
MJIF*WJB8CN*EEY/FGY69X)J1G-N7CY_7EHZAU9:.H=66CJ'5EHZAU9:.H=66
MCJ'5EHZAU9:.H=66CJ'5EHZAU9:.H=66CJ'5EHZAU?V[$0[^NQHF_[DE1O:S
M+VK<JSJ2QY]<L<2@:K;!HW.ZOJ5\P+JEA<6VHX?+LZ&'T:^?A]:LGHG;J)R+
MWZ2:C>&?F8_CG)J8X9>6G-R4DY_8DY*@UI.2H-:3DJ#6DY*@UI.2H-:3DJ#6
MDY*@UI.2H-:3DJ#6DY*@UI.2H-:3DJ#6DY*@UOV[$0W]O!DF_KDD1O:T+FK<
MJSJ2QZ!<L<2A:+;!I7&ZOJ=ZP+JGA,6VIH?,LJ2'T:ZBA]>IGXC;I)V)WJ";
MBN":FHSAEIN3X96;F]V2EY[8D96@UY&5H->1E:#7D96@UY&5H->1E:#7D96@
MUY&5H->1E:#7D96@UY&5H->1E:#7D96@U_R\$ W]O!DF_KHC1O:T+6K<K#F2
MQZ!;L<2C9K7!IFZZOJEXP+JI@L6VJ(C,L*6'TJJBA]>FGX?:H9Z'W)N=B-Z6
MG(K?D9N0WY&=F=V/FY[9CYF?UX^9G]>/F9_7CYF?UX^9G]>/F9_7CYF?UX^9
MG]>/F9_7CYF?UX^9G]>/F9_7CYF?U_R\$ W\O!@F_;HB1?:U+&K<K3>3QZ%:
ML<6E8[7"J6NZOJQUO[JM?\6SJ8?,K:6&TJ>BAM:BH8;8G9^&VIB>A]N2G8G=
MCIV-W8R>E-R-H)[9C)Z?UXR>G]>,GI_7C)Z?UXR>G]>,GI_7C)Z?UXR>G]>,
MGI_7C)Z?UXR>G]>,GI_7C)Z?U_N]$ W[O1<E_;LB1?:V*VK;K3:3QZ)9L<6G
M7[7"K6:YO[%POK>M?L:PJ8?-JJ:&T:2DA=2>HH76F:&%V)2@AMF/GX?:BY^+
MVXB?D-N(H)C8B*&=UXBAG=>(H9W7B*&=UXBAG=>(H9W7B*&=UXBAG=>(H9W7
MB*&=UXBAG=>(H9W7B*&=U_J]#@WZOA8E_+P@1?:W*FK;KS24R*15L<:K6+3#
MLU^WN[)NO[*M?L>LJ8;,IJ>%T*"EA-*;I(34EJ.$U9&BA=:-H8;7B:&)V(:A
MC=B$H9/7A**7UH2BE]:$HI?6A**7UH2BE]:$HI?6A**7UH2BE]:$HI?6A**7
MUH2BE]:$HI?6A**7UOF^#@SYOQ4E^KT?1?:X)VK;L#&4R*A-K\>R3K+!N%BX
MM+%PP:VM?\>IJH7+HJB$SIVG@]"7IH/1DJ6$THZDA=.+HX;4B*.(U82CB]6"
MHY#5@:.3U8&CD]6!HY/5@:.3U8&CD]6!HY/5@:.3U8&CD]6!HY/5@:.3U8&C
MD]6!HY/5@:.3U?3 #0SWP!,D^;\=1/:Z)6K:LBZ5RJ] K<B]/:^WMEVZKK%R
MPJFM?\:EJX7)GZJ#RYFI@\V4J(/.D*>$SXRFA=")IH;1AJ6'TH2EBM*!I8W2
M@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
MI8_2@*6/TNS!"PSUPA(D]L$:1/>](6K:M"F6S;PHJ;N[0[.NM6&\J+%SP:6N
M?\6AK83'FZR#R9:K@\J1JH3+CJF$S(NIA<V(J(;.AJB'SH.HB<Z!IXS/@*>-
MSX"GC<^ IXW/@*>-SX"GC<^ IXW/@*>-SX"GC<^ IXW/@*>-SX"GC<^ IXW/
M@*>-S]_$"0ORQ1 C\\060_3!'&G>PA6/P< CK*^Y3+:FM&6]HK)UP*"P@,.=
MKH3%EZV$QI.MA,>/K(3(C*N%R8FKALJ'JX;*A:J(RH.JB<N!JHO+@*J,RX"J
MC,N JHS+@*J,RX"JC,N JHS+@*J,RX"JC,N JHS+@*J,RX"JC,N JHS+@*J,
MR]K%" KKR0TB[L@20N_&%6C0T@J'L;XOKJ6X5+B?M6B\G;-VOYNQ?\&9L(3"
ME*^$PY"OA<2-KH7%BJZ&QHBMAL:'K8?&A:V(QX.MB<>!K8O'@*R+QX"LB\>
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M'DZ-^B];AO(_9X#K3G%[Y5MY=N!E@''=;(1NVG*(:]EWBVG7>HUGUGZ.9M6
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M#$FI]!1EF>8E>([<.8:(U$^0AL]@EX3,;9R#R76@?\=XHGW&>Z1ZQ7VF><2
MIW?#@:AVPH.I=<*$JG3!AJMSP8>K<L")K'&_BZUQOXNM<;^+K7&_BZUQOXNM
M<;^+K7&_BZUQOXNM<;^+K7&_BZUQOXNM<;^+K<_&!P+0S0D2P-D)+*SW#TB;
M^AY<C^\Q:X;G0G: XE!^?MU?A7O9:8IWU6Z/=--SDG'1=Y1PT'J6;L]]EVW.
M?YELS8&9:\V#FFK,A9MIS(><:,N)G6?*C)UGRHR=9\J,G6?*C)UGRHR=9\J,
MG6?*C)UGRHR=9\J,G6?*C)UGRHR=9\J,G<K(" '"T@<3KN8)+9W_%4&1_RA0
MA_HY7('S2&9\[51N=^A>=7'D97IMX6M^:M]P@6C>=81FW'B%9=M[AV/:?HAB
MVH&)8=F#BF#9A8I@V(>+7MB*C%[6C8U>UHV-7M:-C5[6C8U>UHV-7M:-C5[6
MC8U>UHV-7M:-C5[6C8U>UHV-7M:-C<3*!P.QV@05G_\-*)+_'3>)_RY#@O\]
M3GS]2U=W^%9?;_-=96CP8FID[6EN8>MO<5_I<W-=Z'=U7.=[=EOF?G=:YH!X
M6>6#>5CEA7I8Y(AZ5^2+>U;CCGQ6XXY\5N..?%;CCGQ6XXY\5N..?%;CCGQ6
MXXY\5N..?%;CCGQ6XXY\5N..?/^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3
M;I//DGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>
MP;Q]H<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"
MN'FOPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3;I//
MDGBEQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>P;Q]
MH<*\>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FO
MPKAYK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3;I//DGBE
MQI*"M,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>P;Q]H<*\
M>Z3"O'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPKAY
MK\*X>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3;I//DGBEQI*"
MM,22B;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>P;Q]H<*\>Z3"
MO'JHP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X
M>:_"N'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3;I//DGBEQI*"M,22
MB;;#D8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>P;Q]H<*\>Z3"O'JH
MP[QYK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"
MN'FOPO^J' 7_JB<7_Z<V+_^B1$KZG5)EZI=??MR3;I//DGBEQI*"M,22B;;#
MD8ZXP8Z0NL"*DKR_AY2]OH26O[Z"F<"]@)O!O7Z>P;Q]H<*\>Z3"O'JHP[QY
MK<.X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FOPKAYK\*X>:_"N'FO
MPO^J&P7_JB<7_Z<U+_^C1$KZG5%EZ9=>?MN4;93/DG>FQ9*!M,23B+;#DHVX
MP8^/NL"+D;R_B).^OH66O[V"F,&\@)O"O'Z>PKQ]H<.[>Z3$NWJIQ+IYK<2U
M>:[#M7FNP[5YKL.U>:[#M7FNP[5YKL.U>:[#M7FNP[5YKL.U>:[#M7FNP_^K
M&P7_JR87_Z@T+_^D0TKYGE!EZ9A=?]J5:97-E'2HQ91^M,25AK;"E8RYP9&.
MN[^-D+V^B9*_O8:4P;R#E\.[@9K$NGZ=Q;I]H<:Z>Z7&N7JJQK5ZK,:Q>JW$
ML7JMQ+%ZK<2Q>JW$L7JMQ+%ZK<2Q>JW$L7JMQ+%ZK<2Q>JW$L7JMQ/^K&@7_
MJR47_ZDT+_^D0DKYGT]FZ)E<@-J69I;,E7&IQ95\M,26@[?"EXNZP).,O+Z/
MCK^]BY#!O(>3P[J$EL6Y@9G&N7^=Q[A]H<BX?*;)M7JJR;![J\>L>ZW%K'NM
MQ:Q[K<6L>ZW%K'NMQ:Q[K<6L>ZW%K'NMQ:Q[K<6L>ZW%K'NMQ?^L&07_K"06
M_ZDS+_^E04KYGT]FZ)E;@=F88Y;,EF^JQ99YM,.7@;?!F(FZOY6+O;Z1C<"\
MC8_"NHB2Q;F%E<>X@IC)MW^=RK9]HLNV?*C+L'NIRJQ\JLBH?:S%J'VLQ:A]
MK,6H?:S%J'VLQ:A]K,6H?:S%J'VLQ:A]K,6H?:S%J'VLQ?^L&07_K"06_ZHR
M+_^E04OYH$YGYYI9@=F989?+EVVKQ9=WM,.9?[?!FH>[OY>*OKV3C,&[CH[$
MN8J0Q[B&D\FV@IC+M7^=S;1^H\ZQ?*;.K'VHRZA]JLFE?JS&I7ZLQJ5^K,:E
M?JS&I7ZLQJ5^K,:E?JS&I7ZLQJ5^K,:E?JS&I7ZLQO^L&07_K2,6_ZHR+_^F
M0$OXH$UGYYQ7@=F:7I?+F&JLQ9ETM,.:?;?!FX6[OIF)O[R5BL*ZD(S%N(R/
MR+:'DLNT@Y?.LX"=T+)_I-&L?J7/J'ZGS*1_J<FA@*S&H8"LQJ& K,:A@*S&
MH8"LQJ& K,:A@*S&H8"LQJ& K,:A@*S&H8"LQO^M& 7_K2,6_ZLQ+_^F/TOX
MH$UGYYU5@=F<7)?*F6BLQ9IRM,.<>KC G(.[OIR)O[N7B<.YDXO'MXZ-R[2)
MD,ZRA);1L8&=TZR HM.G@*70I("GS:"!J<J>@:O&GH&KQIZ!J\:>@:O&GH&K
MQIZ!J\:>@:O&GH&KQIZ!J\:>@:O&GH&KQO^M& 7_K2(6_ZLQ+_^G/TOXH4QG
MYYY3@=F=69?*FV6LQ9QOM,.=>+C GH&\O9Z(P+N:B,2XE8G)M9"+S;*+C]&P
MAI75KH2>UZ>"H=2C@J31GX*GS9R#J<J:@ZO'FH.KQYJ#J\>:@ZO'FH.KQYJ#
MJ\>:@ZO'FH.KQYJ#J\>:@ZO'FH.KQ_^M%P7_KB(6_ZLP+_^G/DOXH4MHYY]1
M@=F?5I?*G&*LQ9ULM,.?=;C H'Z\O:"'P;J=B,:WF(C+LY.)S[".C=2MB939
MJ(:=VJ*%H=6>A:31FX6FSIF%J<J7A:O'EX6KQY>%J\>7A:O'EX6KQY>%J\>7
MA:O'EX6KQY>%J\>7A:O'EX6KQ_^N%P3_KB(6_ZPP+_^G/DOXHDMHZ*%/@=F@
M4Y?*GE^LQI]IM,.A<KC HGR\O:*$P;F@A\>UG(?-LI>(TJZ3B]BJCI/?HHN<
MW)R)H-:9B*/2EXBFSI6(J<J4B*O'E(BKQY2(J\>4B*O'E(BKQY2(J\>4B*O'
ME(BKQY2(J\>4B*O'E(BKQ_^N%P3_KB$6_ZPO+_^H/4OXHDIHZ*)-@-FB4)?+
MH%RLQJ%EL\.D;K? I7B\O*6"PKBDA\BTH(?.L)V(U:N9BMVEEY/FFY&;W9:/
MH->4C:/3DHRFSY&+J,N0BJO(D(JKR)"*J\B0BJO(D(JKR)"*J\B0BJO(D(JK
MR)"*J\B0BJO(D(JKR/^N%@3_KR$6_ZTO+_^H/$OWHDEHZ*1*@-FD39;+HEBK
MQJ1AL\2G:K? J72\O*E^PKBHA\BSIH?/K**'UZ2=B=V:FHWAE9J;WI&5G]B/
MDZ+3CI"ET(Z/J,R-CJK)C8ZJR8V.JLF-CJK)C8ZJR8V.JLF-CJK)C8ZJR8V.
MJLF-CJK)C8ZJR?^O%@3_KR$6_ZTN+_^I/$OWHTEIZ*9(?]JG2)7,I5.JQZA<
MLL2L9+;!KFZ[O:]XP+:LA,FNIX?0IJ.&U9V@AMF3G8G=C9V4W8V=G]B+F:'4
MBY:DT(J3I\V*D:G)BI&IR8J1J<F*D:G)BI&IR8J1J<F*D:G)BI&IR8J1J<F*
MD:G)BI&IR?^O%03_L" 6_ZXN+_^I.TOWI$=IZ:A$?MNK0Y3-J4RIR*U4L,:S
M7+/"MV:YM[!WPK"KA,FIIX;/H:2$TY>BA-:.H(?9B)^/VH>AFMB'H*'4AYND
MT8>8ILZ'E:G*AY6IRH>5J<J'E:G*AY6IRH>5J<J'E:G*AY6IRH>5J<J'E:G*
MAY6IRO^P%03_L" 5_ZXM+_^J.DOXID1HZJM ?=RO/)+/KT*FRK5)K<:\4K&Y
MM6>[L+!XPZNLA,FDJ83-G*:#T).DA-.+HX;5A:*,UH*BE-:#I)W4@Z*DT8.>
MILZ$FJC+A)JHRX2:J,N$FJC+A)JHRX2:J,N$FJC+A)JHRX2:J,N$FJC+A)JH
MR_^P% 3_L1\5_Z\L+O^K.4OXJ4!GZZ\[>]ZV,X_2NC2AS,(YJKNZ5;6PM&J]
MJK!YPZ>MA,>?JH3+F*B#S9"GA-")I8;2A*2*TX"DD--_I9?2?Z:@T'^EILZ
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MQXJ1L<2(E+;#A9:XPH.9N<*!F[G!?YZZP7VAN\%[I+O >J>[P'FJO,!XKKS
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ME)O3>IB?T7B<HM!WGZ3.=:*FS72FJ,URJ:G,<:VJS'"RJ\MPMJO+;[RKR'#
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M)"J4_S YBO\Z18'_1D]Z_5%8<OA87FOU7F-E\F5H8.]L:UWM<FY:ZWEP5^J
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MKRD1^KLI$^S(+!/>V#<0T^%!'LG?23"\VE%$K]-85J'-7V:4R&5TB,1L@'S
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M.B[_P#LN_],[+?_K/"W_ZSPM_^L\+?_K/"W_ZSPM_^L\+?_K/+BP  "HO
MFLD  (S9  "!]0, >?\0 6[_%@-E_Q\&7O\G"U?_, ]1_S<32_\^%T;_11E!
M_TP;/?]2'3G_6!\V_U\A-/]F(C'_;B0O_W<E+?^ )BO_C"@I_Y<I*/^B*B?_
MK2LF_[DL)O_)+2;_R2TF_\DM)O_)+2;_R2TF_\DM)O_)+:JW  ":Q0  B],
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M3D+F^T]#W?M11-3\4T7/_%1%S_Q41<_\5$7/_%1%S_Q41<_\5.&5  #+I@
MN[   *Z[ 0"BR ( F-4% )#X#P&)^" $@O@N"WGY-Q-P^3\;:/E&(F#Z32A:
M^E0M5/I<,4_[935+^VTX1_QW.T/\@ST__9 _//V?03K^KT,X_\9$-__J13;\
M_44[\O]$/NK_1#[F_T8^YO]&/N;_1C[F_T8^YO]&/N;_1M"?  "]K   KK4
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M'QO_\!\;__ ?&__P'QO_\!\;__ ?&__P'Z2U  "5P@  AL\  '?>  !K]
M8O\# %G_"P%1_Q$!2O\7 D3_'P,__R8$.O\M!3;_- 8R_SH'+O] ""O_1@@H
M_TP))?]2"2+_60H@_V(+'?]K#!K_=@T7_X0.%?^2#Q3_H! 3_ZT1$_^Z$1/_
MPQ(3_\,2$__#$A/_PQ(3_\,2$__#$I>^  "&S   =]L  &GG  !<_0  5/\
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M45X>_T]J)?]-=RO_2H,O_TB.,_]&F#;_1*$X_T.I.O]"L#S_0K@]_T'!/O]
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M7TZQ]F!1JO9@4Z7V8%6A]F!5H?9@5:'V8%6A]F!5H?9@5:'V8/]W" #KC
MTYL  ,:H @"[L0( LKL" *K'!@"BTPH G=8: 976+ :,U#H1@])&'7K03R=R
MSE@Q:LU@.&3+:#]>RG)%6,I\253)B$U/R9513,FE4TK)N51)RMQ31\CW54C
M_%A*N/M93++[6DZM^EI.K?I:3JWZ6DZM^EI.K?I:3JWZ6O]_  #<DP  RJ(
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M-CGE_S@YY?\X.>7_.#GE_S@YY?\X.>7_.,B>  "VJ0  J+(  )N]  "/R
M@]0  'GH!P!S_!(!:_T= F3])P1>_C$(6/X[#5/_0Q%-_TL52?]3&$7_6AI!
M_V,=/O]L'SO_=B$W_X(C-/^0)3+_GR<P_[ H+O_(*2W_ZBHL__\J+/__*B_Y
M_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*KFF  "JK@  G+D  ([%  "!T0  ==X
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M"0W_TPD-_],)#?_3"9&\  "!R0  <M<  &3D  !4ZP  2_\  $3_   ]_P0
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M\E24//!2G3_N4:9![%"O0^I/ND3H3L=$YD_=1>%/[D7=3OM(U$__2<A1_TK
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M7UZ0^%YAC/E<8XKZ6V2'^UIEAOM998;[666&^UEEAOM998;[6?]F#0#_=P,
MXX<  -.3 0#*G@0 PJ<$ +NO! "UM@T KK<A J6V,@F=LS\5E+!*((RM4RN$
MJELT?:AC/':E:D-PHW)*:J%[3V6@AE1@GI%86YV?6UB=L%U6G<==5IWK7%>:
M^EM:E?I:7)'[65Z._%A?C?Q77XW\5U^-_%=?C?Q77XW\5_]J"@#_?   W(P
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M2TFM_TQ*J_],2JO_3$JK_TQ*J_],2JO_3.E_  #1D   PIX  +6G  "JKP
MH+@  );! @",RP< A-4- (#5'@%YU2X%<M0\#&S31Q1ETE ;7]%9(5K18B=5
MT&LL4=!U,$W/@31)SXXW1L^=.430KCM"T,8[0]#J.D#-_3X^R_] 0,/_0D&]
M_T-"N?]$0KG_1$*Y_T1"N?]$0KG_1-V(  #'F   N*,  *NK  "@M   E;X
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M'2KW_QTJ]_\=*O?_';.C  "DJP  E[8  (G!  ![RP  ;]8  &/?  !;]08
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M56YZ_%-O>?]1<'?_3W%V_TUQ=?],<77_3'%U_TQQ=?],<77_3/];#@#_:00
M]G<  -V"  #0BP, R9,% ,29!@"^GA  MI\D JZ=- BFFD$3GY9,'9B352>1
MD%XOBXUE-X6*;3V B'5#>X5^2':#B$QR@I-0;H"@4VM_KE5H?\)69W_C56B
M^E-I?O]1:GS_3VM[_TUL>?],;'G_3&QY_TQL>?],;'G_3/]># #_; $ YGH
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M3%F-_TM;BO]*6XK_2EN*_TI;BO]*6XK_2O]H  #E>0  T8<  ,62  "[G
ML:(  *FI  "AL0( F[,5 )6S* *.LC8)AK!"$G^N3!MXK%0C<JI<*FRH9#%G
MIVPV8J5U.UVD?T!9HXI#5:*71U&AITE/H;I*3J+924Z@]4E.G_])4)G_25*6
M_TA4DO]'5)+_1U22_T=4DO]'5)+_1_]N  #>?P  RHT  +Z8  "SH   JJ<
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M-SVX_S<]N/\W/;C_-]&&  # E0  LI\  *6G  ":KP  CK<  (._  !XQP,
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M":*G  "3L0  A;L  ';&  !IT   6]H  $[@  !#Y0  /OL! #K_#  V_Q,
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M1W]G^$5^:/]#?FC_07UG_S]\9_\^?&?_/7QG_SU\9_\]?&?_/?]2#@#_70,
M_6D  .%R  #6>@( SG\% ,J#" #%AA( O(<F ;6&-@:N@T,/IX!.&*%\6"";
M>6 GEG=I+9)T<#..<GDWBG"!/(9NBS^#;95#?VRA17QKKD=Z:[](>&O=2'AL
M]D9X;/]$=VS_0G=K_T!W:O\_=VK_/G=J_SYW:O\^=VK_/O]4# #_7P  \FP
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M0V=X_T%H=O\_:';_/VAV_S]H=O\_:';_/_];! #W:0  W78  ,V   ##B
MNXX  +23 0"MEPD IY@: *"8+ .9ECH*DI1%$HR23QJ&CU<B@(U?*'N+9RYV
MB6\S<H=W.&V%@3QIA(M 9H*70V*!I49@@;9'7H'-1UZ![T9?@?]$8'__0F%]
M_T%B>_\_8WK_/V-Z_S]C>O\_8WK_/_]>  #I;0  UGD  ,B$  "^C   MI,
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M.U"/_SM0C_\[4(__.^MM  #3?   PXD  +>3  "LF@  HI\  )FE  ".JP
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M(;Z/  "OF@  HJ$  ):I  "*L   ?;@  '&_  !FQ@  6\P" %#2!P!'V@P
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M Q7_LP04_],$%/[T!!/\_P,3^O\#$_G_ Q/Y_P,3^?\#$_G_ YVE  "/K@
M@+@  '+"  !DRP  5M,  $G:   ^WP  -.0  "[T   K_PH */\0 "7_%P B
M_Q\ '_\F !S_+0 9_S0 %_\\ !3_1 $2_TX!$/]9 0[_9P$,_W<!"_^* @K_
MGP()_[4""/_5 @?_] ('__\"!___ @?__P('__\"!___ I&M  ""N   <\(
M &3,  !6U0  2-T  #OB   PYP  )^X  "/_   @_P0 '/\, !G_$0 6_Q8
M$_\; !'_(0 ._R< #?\N  K_-@ '_SX !/](  #_5   _V(! /]S 0#_AP$
M_YT! /^R 0#_R@$ _^H! /_S 0#_\P$ __,! /_S 82W  !TP0  9<P  %;8
M  !'WP  .>4  "WJ   C[@  '/T  !C_   5_P  $?\$  __"P -_PX "?\1
M  ;_%0 #_QH  /\@  #_)@  _RX  /\W  #_00  _TT  /]<  #_;0  _X(
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MX#O"%M\[TA;:.^@7U#KV&M Z_QS-.O\>RSK_'LHZ_Q_$._\?P#S_'L \_Q[
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M-)-5]C.25?\RD5;_,8]6_S"-5O\NC%?_+8Q7_RV,5_\MC%?_+?])#@#_404
M_UH! .YB  #?9P, V&H& -5K"@#-;14 Q6XI ;YM.02W:T<+L6A2$:QF7!BH
M9&4=I&)M(J%@=2:>7GXIFUV&+9A<CR^56IDRDUFD-)!9L#:.6< VC%G;-XI9
M\S:)6O\TB%O_,X=;_S&&6_\PA5O_+X5;_R^%6_\OA5O_+_]+# #_5   ^UX
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M-G-H_S5S9_\S<V;_,G-F_S)S9O\R<V;_,O]1! #_7   XF<  -)P  #'=@
MP'H  +I] @"T?PP K8$= *>!+@*@?SP(FGU'#Y5Z41:0>%H<BW9B(8=T:2:#
M<G$K?W%Z+WQO@S)X;HTU=6V8.')LI3MP:[0\;FO)/&UKZ3MM;/XY;6S_-VYL
M_S5N:_\T;FK_,FYJ_S)N:O\R;FK_,O]3  #T7P  WFH  ,US  ##>@  NWX
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MC ( G(X4 )>/)@&1CC0%BXQ "X6*2A& B%,8>X9;'7:%8R)R@VHG;H)R*VJ
M>R]G?X8S8WZ1-F!]GCE=?*XZ6WS!.UM\XSI;?/HX7'O_-UU[_S5>>?\T7W?_
M,U]W_S-?=_\S7W?_,_Y<  #A:@  S74  ,!^  "VA@  KHL  *6.  ";D0
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M*]=R  ##@   MHP  *J4  "?F0  E)X  (FC  !^J   <*X  &JP#@!HL1T
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M#S#(TP\PQO00+L3_$RW"_Q4LP?\6*\#_%RO _Q<KP/\7*\#_%[B-  "JEP
MGIX  )&E  "$K   >+(  &NY  !@OP  5,,  $K( @! S0< .M(. #G2&P X
MTR@ -],U #;40  TU4L!,]55 3'68 (OUFP#+==Z!"O8BP4JV)T%*-FQ!B?:
MS08GU^\&)M3_"272_PLDT?\,(]#_#2/0_PTCT/\-(]#_#:Z6  "@G0  E*0
M (:L  !YM   ;+L  &#"  !4Q@  2,L  #[0   UU00 +=T* "SA$P KXA\
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M  #_\   __\  /__  #__P  __\  /__ (VK  !]M0  ;K\  &#(  !2T
M0]<  #?=   KX@  (N8  !GJ   5^0  $O\  !#_"  ._PX #/\1  G_%@ &
M_QP  _\B  #_*@  _S,  /\]  #_20  _U<  /]I  #_?@  _Y4  /^L  #_
MQP  _^@  /_Z  #_^@  __H  /_Z ("U  !POP  8<D  %+3  !#VP  ->$
M "GF   >Z@  %>X  !#X   ._P  "_\   C_   $_P8  /\*  #_#@  _Q$
M /\5  #_&P  _R,  /\K  #_-@  _T,  /]3  #_90  _WH  /^1  #_I@
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M&J]!]QRM0?\=JT'_':E!_QRI0?\<ID'_&Z5!_QNE0?\;I4'_&_\]$ #_0@D
M_T@% /]-" #_4 L ^5$/ .M0%0#A3R  V% Q ,]000+)3TX%Q$Y:"<!,9 V]
M2VT0NDIV$[=)?A6U2(<7LT>/&;%'EQNO1J <K4:J'JM%MA^I1<8?IT;@(*1&
M]""A1O\AGT?_()Y'_R">1_\?FT?_'II'_QZ:1_\>FD?_'O] #0#_1@0 _TP
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M*(-6_R>"5O\E@5;_)(%6_R2!5O\D@5;_)/]' P#_3P  YU@  -E@  #-9
MQF8! ,%F! "[9@X M&D@ *YI,0*H:#\%HV9*"I]E5 ^:8UT4EV%E&)-@;1R0
M7G4?CEU](HM<AB6(6Y HA5J:*H-9IBR 6;0M?UG'+GU9YBU\6OHL>UK_*GM;
M_RA[6_\G>UK_)GI:_R5Z6O\E>EK_)?])  #[4@  XUP  -)C  #':   P&L
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M*&IF_R=J9O\G:F;_)_]0  #G6P  TV8  ,5N  "[<P  LW<  *MY  "D> ,
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M(#^:R" _F>L?/YC_(#Z6_R$^E?\A/Y3_(3^4_R$_E/\A/Y3_(<UP  "\?0
ML(@  *2/  "9E   CI@  (.=  !WH   ::0  &"G" !=J!0 6ZDD %FI,0%6
MJ3P"4ZE%!%"H3@9-J%<)2JA?#$>G: Y$IW,10:9_%#ZFC18\IIT7.J:O&#FF
MQQ@YI>H8.*/_&C>A_QLWH/\<-Y__'#>?_QPWG_\<-Y__',1X  "UA0  J8\
M )V5  "2F@  AI\  'JC  !NJ   8JP  %6P  !0L@X 3K(; $VS* !+LS4
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M Q[+_P0>RO\%'<G_!AW)_P8=R?\&'<G_!JB4  "<F@  D*$  (*H  !TKP
M9[8  %N\  !.P   0\,  #G'   OS   )] $ !_6"@ ;VA  &]L: !K;)@ :
MW#$ &=T\ !C=2  8WE4 %]]B !;@<@ 5X(4 %.&: !/BL0 2X\\ $N#T !+>
M_P$1W?\!$=O_ A';_P(1V_\"$=O_ IZ:  "2H0  A*D  ':Q  !HN   6[\
M $[$  !"R   -\P  "W0   DU0  '-L  !7?!0 4Z0X $NH4 !'K'0 0ZR8
M#NPP  [M.@ -[D8 "^Y3  KO8@ )\'0 "/&)  ?RH  %\KH !/'D  +Q_0 "
M[_\  ^W_  /M_P #[?\  ^W_ )6A  "&J0  >+(  &FZ  !;P@  3<@  $#,
M   TT0  *M8  "';   9X   $N0   _P 0 -^0H "_H/  G[%0 '^QP !/PD
M  '\+   _#<  /Q"  #\4   _&$  /UU  #\C   _*0  /S!  #\ZP  _/\
M /W_  #]_P  _?\  /W_ (FI  !YL@  :KL  %S$  !.S   /]$  #+7   G
MW0  '>$  !7E   .Z   "O$   C]   %_P,  ?\)  #_#@  _Q(  /\7  #_
M'P  _R<  /\Q  #_/@  _TT  /]?  #_=0  _XT  /^F  #_P@  _^<  /_\
M  #__P  __\  /__ 'RS  !LO   7<8  $[/   _U@  ,=T  "7B   :Y@
M$>H   SN   %\@   /\   #_    _P   /\   #_!0  _PH  /\.  #_$@
M_Q@  /\A  #_*P  _SD  /]*  #_70  _W,  /^,  #_I   _[D  /_4  #_
MW@  _]X  /_> /\8+ #_&2D _QDH /\5*P#_$#  _PLX ?\#1 '_ %$!_P!>
M ?\ ; '_ '@!_P"" ?\ C '_ )0!_P"< /\ H@#_ *@ _P"O /\ M@#_ +X
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M ](D^07/)?\&S27_!\LE_PC*)?\(RB3_",HD_PC*)/\(RB3_"/\N% #_,1
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M-/\/L33_#[ T_Q"O-/\0KC3_#ZXT_P^N-/\/KC3_#_\U#@#_. < _SP" /]
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M%YA!_Q>80?\6ET'_%9=!_Q670?\5ET'_%?\[!@#_/P  ^48  .5+  #<3@
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M''96_QMV5O\;=E;_&_]%  #L3@  VE@  ,E>  "_8@  MV0  +%C  "K80@
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M(DYYPR)->.4B37?[(4YW_Q].=O\>3W7_'4]U_QU/=?\=3W7_'=]<  #(:
MN7(  *YZ  "E@   FH(  (Z"  " @P  >84" '2&$0!QB"  ;H@N 6J(.0)G
MAT,%8X=,"&"&4PM=A5L.6H1C$5>$:Q14@W4748* &DZ!C1Q+@9L>28&L'TB
MP2!'@.,?1W_Z'DA^_QY(??\=27S_'$E\_QQ)?/\<27S_'-9A  #";@  M'@
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M$#.<_Q(SFO\2,YG_$S.9_Q,SF?\3,YG_$[UW  "O@P  HXL  )B1  "-E0
M@9D  '.<  !GGP  6Z(  $^F  !'J0@ 1*H2 $.J'P!!JRL 0*LW #^L00 ]
MK$H!.ZQ3 CFL7 ,WK&<$-:QS!3*L@08PK)$'+JRC""VLN DLK-D(+*KU"BNH
M_PLJIO\,*J7_#2JE_PTJI?\-*J7_#;6   "HBP  G)$  )&6  "%G   >*
M &NE  !?J   4ZP  $BO   ]L@  -K4+ #2U%0 SMB$ ,K8L #&W-P PMT$
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M  O2_P$+TO\!"]+_ 9J8  ".GP  @*8  '*M  !DM   5[H  $F_   ]P@
M,L8  "C)   ?S0  %]$  !'6   ,VP4 "-X+  ;?$0 %WQH !. D  +A+@ !
MXCH  .-'  #D5@  Y&<  .5[  #FD@  YJH  .?(  #G\   Z/\  .C_  #H
M_P  Z/\  .C_ )&?  ""IP  =*\  &6W  !7O@  2<,  #S'   PRP  )<\
M !S4   4V0  #MT   GA   "Y0   .D&  #I#0  Z1$  .H8  #K(0  [2L
M .\W  #Q10  \E8  /-H  #S?@  ])<  /6P  #VT   ]_,  /?_  #W_P
M]_\  /?_ (6G  !VL   9K@  %C!  !*R   .\P  "[1   CU@  &=P  !'@
M   ,XP  !.<   #J    ]0   /0   #U!0  ]0L  /8/  #V%   ^!T  /HG
M  #\-   _T,  /]5  #_:0  _X$  /^:  #_L@  _\\  /_M  #_^0  __D
M /_Y 'BP  !HN@  6<,  $O+   [T0  +=@  "'=   6X@  #N8   CJ
M[0   /    #X    _P   /\   #_    _P   /\&  #_#   _Q   /\8  #_
M(@  _S   /]   #_4P  _VD  /^!  #_F0  _Z\  /_#  #_U0  _]4  /_5
M /\3* #_$R4 _Q$E /\-)P#_!BT _P U /\ 00#_ $\ _P!< /\ :0#_ '0
M_P!^ /\ B #_ )  _P"7 /\ G0#_ *0 _P"J /\ L #_ +< _P#  /\ S #_
M -\ _P#L /\ ^ #_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\6
M)0#_%B( _Q0A /\0(P#_"B@ _P P /\ /0#_ $L _P!8 /\ 9 #_ '  _P!Z
M /\ A #_ (P _P"3 /\ F@#_ *  _P"F /\ K0#_ +0 _P"\ /X R #] -D
M^P#I /H ]@#Y /\ ^ #_ /@ _P#X /\ ^ #_ /D _P#Y /\ ^0#_ /\:(@#_
M&AX _Q@= /\3'@#_#B( _PHL /\'.0#_ T8 _P!3 /\ 8 #_ &L _P!V /\
M?P#_ (@ _P"/ /\ E@#_ )T _P"C /X J0#\ +  ^@"Y /< Q #U -( \P#F
M /( ] #Q /\ \ #_ .\ _P#O /\ [P#_ /  _P#P /\ \ #_ /\>'0#_'AD
M_QP7 /\7& #_$QX _Q$H /\.- #_#$$ _PI. /\(6P#_!V8 _P9Q /\&>@#_
M!H, _@:+ /P&D@#Z!ID ^ :? /8&I@#T!JT \@:U / %P #M!<X ZP7D .D&
M\P#F"/\ Y0K_ .0+_P#D"_\!Y O_ >0+_P'D"_\!Y O_ ?\A& #_(1, _R 1
M /\;$@#_'!H _QHD /\6+P#_$SP _Q%) /\050#\#F$ ^0YK /8.=0#T#GX
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M!;8E_P6U)?\&M27_!K4E_P6U)?\%M27_!?\L#0#_+04 _RX! /\Q!0#_,0L
M_2\0 /$K& #G*24 WR@S -@H0@#1*D\ S2M: ,DK90''*VX!Q"QV L(L?@+
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MD3S_#9$\_PV1//\-D3S_#?\U  #_.0  ZD$  -U&  #01P  R48  ,9!!0#
M0!$ N4(A +-$,@"O14 !JT5+ J=%50.D1%X%H41F!Y]#;@B=0W8*FT)^"YE"
MA@V708\.E4&9#Y-!I!&10; 2D$' $HY!V1*+0?$2B4+_$HA"_Q&(0O\0AT+_
M$(="_P^'0O\/AT+_#_\X  #S/0  XT<  -),  #(3@  P$T  +M* @"V1PX
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M%/)#  #?3P  RU@  +U=  "S80  JV(  *)@  ";7   E5X0 )!@'P",82X
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M'%IBOQQ98M\<66+W&EIB_QE:8?\76V'_%EMA_Q5;8?\56V'_%>=-  #/60
MOV(  +-H  "I;0  GFT  )-K  "):0  @VL) ']M%0!\;B4 >&XR 75N/0)Q
M;D8$;FU/!VML5@EH;%X,96ME#V-J;1%@:78476F!%EMHC1A89YL:5F>J&U5G
MO1Q49]P<5&?V&E1F_QA59O\7567_%E9E_Q569?\55F7_%>)1  #*70  NV8
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M%D-Y_Q5#>/\41'?_%$1V_Q-$=O\31';_$\U?  "[:P  KG0  *1\  "7?@
MBGT  ']^  !R?P  9H,  &&$" !>AA, 7(<A %J'+@!8AS@!58=" E.'2@-0
MAU(%3H9:!TN&8@E)A6P+1H5W#4.$@P]!A)(1/X2B$CV$M1,\A,\3/(+P$CR!
M_Q(]@/\2/7__$CU^_Q$]?O\1/7[_$<5F  "U<0  JGL  )^"  "2@@  A8(
M 'F#  !MA@  7XH  %B- 0!4C@\ 4H\; %"/)P!/D#, 39 ] 4N010))D$X#
M1I!6!$2/7P5"CV@'/X]S"3V.@ LZCH\,.(Z@#3>.LPXVCLP.-HWO#C6+_PXU
MB?\/-8C_#S:'_P\VA_\/-H?_#[YM  "P>0  I8(  )F'  ",B   ?X@  '**
M  !FC0  6I$  %"5  !)EPD 1Y@3 $68( !$F2L 0YDV $&:0 ! FD@!/II1
M CR:6@(ZFF0#-YIO!369?08SF8P',9F=""^9L @NF<H(+ICM""Z6_PHME/\*
M+9/_"RV2_PLMDO\++9+_"[9U  "J@0  GH@  ).-  "&C@  >(\  &N2  !?
ME0  5)D  $F=  ! H   .J(- #BC%P WHR( -J0M #6D-P TI$$ ,Z5+ #&E
M5 $PI5X!+J5J 2RE> (JI8@#**6: R>EK00FI<8#)J3K!"6B_P4EH/\&))__
M!B2>_P<DGO\'))[_!Z]^  "CB   EXX  (V3  !^E0  <)@  &.;  !7GP
M3*(  $*F   XJ0  +ZP# "JN#@ IKA@ **\C ">O+0 FL#< );!! "2P2P C
ML58 (K%C "&Q<0 ?L8( 'K*4 1RRJ0$;LL$!&['G 1NO_@(:K?\"&JS_ QJK
M_P,:J_\#&JO_ ZB(  ";CP  D90  (2:  !VGP  :*(  %NE  !/J0  1*T
M #FP   OLP  )K8  !ZY!0 8NPX %[L6 !>\(  6O"H %;TU !2]0  3ODL
M$KY8 !*^9P 1OW@ $+^, !# H@ .P+H #L#A  ^]^P /O/\ $+K_ 1"Z_P$0
MNO\!$+K_ 9^/  "4E0  AYL  'FA  !KIP  7JP  %*Q  !%M   .K8  "^Y
M   EO   ';\  !7#   /Q@4 "\H-  G*%  (RAT !\HG  ?*,@ &RSX !<M+
M  3,6@ #S&H  LQ^  ',E   S*L  ,W(  #,[0  S/\  ,O_  '*_P !RO\
M <K_ )>6  "*G   ?*,  &ZJ  !@L   4K8  $6Y   YO   +K\  "/#   ;
MQ@  $\H   W-   (T0   =0)  #4#@  U14  -8>  #8)P  V3$  -L^  #<
M2P  W5L  -YN  #>A   WYL  -^T  #>V0  W_<  -__  #?_P  W_\  -__
M (V=  !_I0  <*P  &&S  !3N@  1;\  #C"   LQ@  (<D  !C-   0T0
M"]4   3:    W@   . !  #A"0  X@X  .03  #E&P  YR0  .DO  #K/
M[4L  .Y=  #N<0  [XD  /"B  #PO   \.,  ._Y  #P_P  \/\  /#_ (&E
M  !RK0  8[4  %2]  !&Q   -\@  "K,   ?T   %=4   [:   'W@   .(
M  #F    Z0   .H   #L    [@4  .\,  #Q$   \Q<  /4@  #X*P  ^SD
M /U*  #^7@  _W0  /^-  #_I@  _\   /_A  #_]0  __4  /_U '2N  !E
MMP  5L   $?(   XS0  *M(  !W8   3W0  #.(   /F    Z0   .P   #P
M    \P   /0   #V    ^    /H   #]!P  _PT  /\2  #_&P  _R@  /\W
M  #_2@  _UX  /]V  #_CP  _Z8  /^Z  #_T0  _]$  /_1 /\/) #_#B(
M_PLA /\#) #_ "D _P R /\ /@#_ $P _P!9 /\ 90#_ '  _P!Z /\ A #_
M (P _P"2 /\ F0#_ )\ _P"E /\ JP#_ +( _P"Z /\ Q0#_ -, _P#G /\
M] #_ /\ _@#_ /\ _P#^ /\ _@#_ /X _P#^ /\ _@#_ /\1(0#_$!X _PT=
M /\''P#_ ", _P M /\ .@#_ $@ _P!5 /\ 80#_ &P _P!V /\ ?P#_ (<
M_P". /\ E0#_ )L _P"A /\ IP#^ *X _0"V /P P #[ ,T ^0#B /@ \ #W
M /P ]@#_ /4 _P#U /\ ]0#_ /4 _P#U /\ ]0#_ /\5'0#_$QH _Q 9 /\+
M&0#_ !T _P I /\ -@#_ $, _P!0 /\ 7 #_ &< _P!Q /\ >@#^ (, _ "*
M /H D0#Y )< ^ "= /< HP#U *H ] "R /( NP#Q ,@ [P#< .X [ #M /H
MZP#_ .H _P#J /\ Z@#_ .H _P#J /\ Z@#_ /\8&0#_%A4 _Q,3 /\.$P#_
M"QH _P<D /\", #_ #X _P!+ /\ 5P#_ &( _ !L /@ =0#U 'X \@"% /$
MC #O ), [@"9 .P H #K *8 Z0"N .< MP#F ,, Y #4 .( Z0#A /< WP#_
M -T _P#= /\ W0#_ -T _P#= /\ W0#_ /\;$P#_&A  _Q8. /\2#@#_$A4
M_P\? /\,*P#_"3@ _P9% /L#40#W EP \@)F .X"< #J G@ YP*  .8#AP#D
M XX X@.5 .$#G #?!*, W02K -L$M #8!<  U@70 -,&YP#0"/@ S@K_ ,P+
M_P#+#/\ RPS_ ,L+_P#+"_\ RPO_ /\?$ #_'@L _QH' /\9"P#_&!$ _Q89
M /\2) #Z$#  \PX^ .X-2@#I#%8 Y0QA .(,:@#>#7, VPU[ -D-@P#6#8H
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M Z$F_P.A)O\#H2;_ _\I  #_*   ]BT  .<P  #?+P  V2L$ -8B"@#.(Q8
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M"O8V  #F0   T4@  ,--  "Y3@  L4T  *E)  "D108 GT83 )I((P"623(
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M$V90O!-E4-@39%#S$F10_Q!D4/\/9%#_#F5/_PUE3_\,94__#.Q!  #43
MPU0  +99  "L7   H%H  )=7  "15   BU4, (97&0"#6"< @%DT 'U9/P%Z
M64@#=UA0!'186 9R5U\';U=F"6U6;@MK5G<-:%6!#V95C1%D5)H28E2I$V!4
MNA1?5-,47E3R$UY4_Q%?5/\/7U3_#E]3_PU?4_\-7U/_#>=$  #/4   OU@
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M$D]A_Q%/8?\04&#_#E!@_PY08/\-4&#_#=E/  ##6@  M&,  *EI  ";:
MCV<  (1G  !Y90  <V<  &]I#@!L:AL :6LH &=L- !D;#T!8FQ& E]K3@1=
M:U8%6FI=!UAJ90E6:6X+4VEX#5%HA ].:)(03&>A$DMGLA))9\D226?K$DEF
M_Q!*9O\/2F7_#DME_PU+9/\-2V3_#=%4  "^7@  L6<  *9M  "7;   BFL
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M"CAX_PHX>/\*.'C_"KYD  "P;P  I7@  )9Y  "'>0  >WD  '!Z  !D?
M6(   %"#  !+A0H 2(84 $>'( !%B"L 1(@U $.(/@!!B4<!0(E/ 3Z(6 (\
MB&$#.HAL!#>(> 4UB(<&,XB8!S*'J@<PB, ',(?D!S"%^P@P@_\(,(+_"#"!
M_P@P@?\(,('_"+=K  "J=@  H'\  )!^  ""?@  =G\  &J   !>@P  4X<
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M :.&  "7C   C9$  'V2  !ME0  8)@  %2<  !(H   /J0  #2G   JJP
M(:X  !FQ   2LP< #[40  ZU%P .M2$ #;4K  VU-@ ,MD$ "[9.  JV7  )
MMFP "+9_  >VE  &MJH !;;%  :VZ@ 'M?\ "+3_  BS_P )LO\ ";+_ )J-
M  "0DP  A)@  '2<  !EH   5Z0  $NH  ! K   -;   "JS   AM0  &+@
M !&[   ,O@( !L +  + $0 !P1D  ,$B  #"*P  PC8  ,-"  ##4   Q%\
M ,1Q  #$AP  Q)T  ,2U  #$V@  Q/8  ,/_  ##_P  P_\  ,/_ ).4  "'
MF@  >*   &JF  !<K   3[$  $&U   UMP  *;H  !^]   6P   $,,   K&
M   #R@   ,P%  #,#   S1$  ,X8  #.(0  T"H  -$U  #30P  U%(  -1C
M  #5>   U8\  -6G  #6P@  UND  -;]  #6_P  UO\  -;_ (J;  ![H@
M;*D  %ZP  !0M@  0KH  #2]   HP0  '<0  !3'   -RP  !LX   #2
MUP   -D   #:!0  W L  -T0  #?%0  X1T  .,G  #E,P  YT(  .A4  #H
M9P  Z7X  .F7  #JKP  ZLX  .OO  #K_@  Z_\  .O_ 'VC  !NJP  7[(
M %&Z  !"P   -,,  "?'   ;RP  $L\   O3   "V    -T   #A    Y
M .4   #G    Z0   .L'  #M#0  [Q$  /$9  #T)   ]S$  /E!  #Z50
M^FH  /N$  #[G0  _+8  /S2  #][0  _?0  /WT '&L  !AM0  4KT  $3$
M   TR0  )LT  !K2   0V   "-T   #A    Y0   .@   #L    [P   /$
M  #S    ]0   /<   #Y 0  ^P@  /X.  #_%0  _R$  /\O  #_00  _U8
M /]M  #_AP  _Z   /^V  #_R@  _]0  /_4 /\+( #_!QX _P = /\ ( #_
M "4 _P N /\ .P#_ $D _P!6 /\ 8@#_ &T _P!V /\ ?P#_ (< _P". /\
ME #_ )H _P"@ /\ I@#_ *T _P"U /\ O@#_ ,L _P#A /\ \ #^ /T _0#_
M /T _P#] /\ _0#_ /P _P#Y /\ ^0#_ /\-'0#_"QH _P09 /\ &@#_ !\
M_P J /\ -P#_ $4 _P!1 /\ 7@#_ &@ _P!R /\ >@#_ (( _P") /\ D #_
M )8 _P"< /X H@#\ *D ^P"P /D N0#X ,8 ]@#9 /4 ZP#T /D \P#_ /(
M_P#S /\ \P#_ /, _P#S /\ \P#_ /\0&0#_#A4 _P@4 /\ % #_ !D _P E
M /\ ,@#_ $  _P!, /\ 60#_ &, _@!M /P =0#Z 'T ^0"$ /< BP#V )$
M] "7 /, G@#R *0 \ "L .X M #M ,  ZP#/ .D Y@#H /4 Y@#_ .< _P#F
M /\ Y0#_ .4 _P#E /\ Y0#_ /\2% #_$!  _PP/ /\#$ #_ !4 _P @ /\
M+ #_ #H _P!' /H 4P#W %X ] !G /$ < #O '@ [0!_ .L A@#J (P Z "3
M .< F0#E *  XP"G .$ L #? +H W0#) -L X #8 /  UP#^ -4 _P#4 /\
MTP#_ -, _P#3 /\ TP#_ /\5$ #_$@P _PX) /\+# #_"1( _P,: /\ )@#]
M #, ] !  .\ 30#K %@ Z !A .4 :@#B '( X !Z -X @ #< (< V@". -@
ME0#4 )P T@"C -  K #. +8 S #$ ,H V0#( .T QP#[ ,4 _P#$ ?\ PP'_
M ,0!_P#$ ?\ Q '_ /\8"P#_%04 _Q   /\0!@#_#PT _PP4 /P''P#Q RL
MYP Y .( 1@#> 5$ V@); -4"9 #2 VP SP-T ,T$>P#+!(( R@2) ,@%D #&
M!9@ Q 6@ ,(&J0#!!K0 OP;! +T(U0"[">P N O] +8,_P"U#?\ M W_ +0-
M_P"T#?\ M W_ /\;!0#_&   _Q<  /\6  #[$P8 ^A . .X,%@#C"2( V@DP
M -,*/@#."TH R@Q5 ,<-7@#%#6< P@YO ,$.=@"_#GX O0^% +P/C0"Z$)4
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M O\F  #R*0  XS$  -(T  #(-   P#   +LI @"X(PX L28< *PH*P"H*C@
MI"M$ *$L3@"?+5< G2U? )LM9P&9+6X!F"YU 98N?0*4+H8"DRZ0 I$NF@./
M+J8#C2ZS XPNQ0.*+^$$AR_V!(4O_P2$+_\#A"__ X,O_P.#+_\#@R__ _LI
M  #K,0  V3@  ,D\  "_/   MCD  + R  "L+0L IR\7 *(Q)@">,S0 FC1
M )@U2@"5-5, DS5; 9$U8@&/-6D"C35Q HPU>0.*-8(#B#6+!(8UE@2$-:(%
M@C6O!8$UP 9_-MP&?3;T!GLV_P5[-O\%>C;_!'HV_P1Z-?\$>C7_!/4M  #D
M-P  T#\  ,)#  "W1   K4   *<Z  "C-@8 G3<3 )DY(@"5.B\ DCP[ (\\
M1@",/$\!BCQ7 8@\7@*&/&4"A#QM X(\=02 /'T$?SR'!7T\D@9[.YX'>3NL
M!W<[O AV/-4(=#SQ"',\_P=R//\&<CS_!7(\_P5R._\%<CO_!?$R  #>/0
MR40  +Q(  "P20  ID8  )]!  ";/0$ E3T0 )$_'0"-02L BD(X (=#0@"$
M0TL!@D-3 8!#6P)^0F(#?$)I!'I"<05X0GH&=D&$!W1!CPAR09L(<$&I"6]!
MN0IM0= *;$'N"6M"_PAJ0O\':D'_!FI!_P9J0?\%:D'_!>TW  #60@  Q$D
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M#%A/_0M83_\)64__"%E._P=93O\'64[_!]]#  #'30  N%0  *Q9  "=5P
MD54  (A4  "!4   >U($ '=3$0!T5!X <54K &]6-@!L5D !:E9( 6A64 )F
M5E<#9%9>!&)59@5@56\'755X"%M4A I95)$+5U2@#%53L U44\4-4U/F#%-3
M_ M34_\)5%+_"%12_PA44O\'5%+_!]I&  ##4   M5@  *A;  "96@  C5@
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M"$5?_P=%7_\'15__!\A2  "X7   JV0  )MD  ",8P  @&,  '9C  !J8@
M8V0  %]F!@!;9Q$ 66@= %=I*0!6:C, 5&H\ %)J10%0:DP!3FI4 DQJ7 -*
M:F4$2&EO!49I>@=$:8@(0FB8"4!HJ0H_:+T*/FC>"3YG]PD^9O\(/V7_!S]E
M_P<_9/\'/V3_!\-7  "S80  IVD  )9H  "'9P  >V<  '%G  !E:   7&H
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M [%J  "E=   E78  (5U  !X=0  ;74  &%W  !7>@  3'X  $.!   [A0
M-8@) #*)$0 QB1L ,(DE "^*+P NBC@ +8M! "R+2@ JBU0 *8M? "B+:P F
MBWH!)(N+ 2.+G@$BB[,!(8S. 2&*\0$@B/\"((;_ B"%_P(AA?\"(87_ JMR
M  "A?   CWL  (!Z  !S>@  9GP  %M_  !0@@  1H8  #R*   TC0  +)$
M ":3#  DE!, (Y0< "*5)@ AE2\ ()4X !^60@ >EDP '998 !R69  :EW0
M&9>& !B7F0 7EZX %9?) !:5[@ 6D_\!%I+_ 1:1_P$6D/\!%I#_ :5[  "9
M@P  B8$  'N   !L@@  7X0  %2(  !)BP  /Y   #64   MEP  )9H  !V>
M 0 6H P %*$2 !2A&P 3H24 $J$N !&B.  1HD, $*)/  ^B7  .HVL #:-]
M  VCD@ ,HZ< "J+   NBY@ ,H/X #9__  V>_P -G?\ #9W_ )Z$  "2B0
M@X@  '.(  !EBP  6(X  $R2  !!EP  -YL  "Z>   DH@  '*4  !6H   /
MJP0 "JX,  >M$@ &K1L !:TD  2N+@ "KCD  :Y%  "N4@  KF$  *YS  "N
MAP  KIT  *ZT  "NU0  K?0  *W_  "L_P  J_\  *O_ ):+  ",D   >Y
M &N2  !=E@  4)H  $2?   YHP  +Z<  "6K   <K@  %+$   ZT   )MP
M ;@)  "X#@  N10  +D<  "Z)0  NB\  +LZ  "\1P  O%8  +QG  "\>P
MO)$  +RI  "\Q   O.L  +O^  "[_P  N_\  +O_ )"2  "#F   <YL  &.?
M  !5HP  1Z@  #NM   PL0  );0  !NW   2N@  #+T   6_    PP   ,0"
M  #%"@  Q0X  ,84  #'&P  R"0  ,HN  #,.@  S4D  ,U9  #-;   SH,
M ,Z;  #-M0  SMH  ,[V  #-_P  S?\  ,W_ (:9  !WH   ::8  %JL  !,
ML@  /K8  #"Y   DO   &;\  !'"   *Q0   LD   #,    T    -$   #2
M 0  TP@  -4-  #7$0  VA@  -PA  #?+   X3H  .)*  #C70  Y'(  .2+
M  #EI0  Y<   .7F  #E^   Y?\  .7_ 'JA  !KJ0  7*\  $VV   _O
M,+\  "/#   7QP  #\H   ?.    T0   -8   #<    WP   .    #B
MY    .8#  #H"0  Z0X  .P5  #N'@  \2L  /0Z  #U30  ]F$  /=Y  #X
MDP  ^*T  /G&  #YY   ^?,  /GS &VJ  !>L@  3[H  $#!   QQ0  (LD
M !;.   -T@  !-@   #=    X0   .0   #H    ZP   .T   #O    \0
M /,   #V    ^ ,  /H+  #]$0  _QL  /\I  #_.P  _T\  /]F  #_?P
M_YD  /^O  #_PP  _]8  /_6 /\$' #_ !D _P 9 /\ ' #_ "( _P K /\
M. #_ $8 _P!3 /\ 7@#_ &D _P!R /\ >@#_ (( _P") /\ CP#_ )4 _P";
M /\ H0#_ *@ _P"O /\ N0#_ ,4 _P#9 /X [ #] /L ^P#_ /L _P#[ /\
M^@#_ /0 _P#P /\ \ #_ /\'& #_ 14 _P 4 /\ %@#_ !L _P F /\ - #_
M $( _P!. /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#] )  _ "6 /H
MG0#Y *, ^ "K /< M #U +\ ] #. /, Y@#Q /8 \ #_ .\ _P#O /\ [@#_
M .X _P#J /\ Z@#_ /\+% #_!A$ _P 0 /\ $ #_ !8 _P B /\ +@#_ #P
M_P!) /\ 5 #^ %\ ^P!H /D < #W '@ ]0!_ /, A0#R (L \ "2 .\ F #M
M )\ [ "F .H K@#H +D YP#' .4 W@#C /  X@#^ .  _P#@ /\ X0#_ .$
M_P#A /\ X0#_ /\-$ #_"0T _P$, /\ # #_ !( _P < /\ * #\ #8 ^0!#
M /8 3@#R %D [P!B .P :P#J '( Z !Y .8 @ #D (8 X@", .$ DP#? )H
MW0"A -L J@#8 +0 U0#  -( TP#0 .H S@#Z ,T _P#- /\ S0#_ ,P _P#,
M /\ S #_ /\0# #_# < _P," /\ " #_  X _P 6 /8 (@#P "\ [  \ .D
M2 #E %, X0!< -X 90#; &P UP!S -0 >@#2 (  T "' ,X C@#, )4 R@"=
M ,@ I0#& *\ Q "[ ,( RP#  .4 O@#U +T _P"\ /\ O #_ +P _P"\ /\
MO #_ /\1!0#_#@  _PH  /\( 0#_! H ^  0 .D &@#C "@ W@ U -D 00#3
M $P SP!6 ,L 7P#) &8 Q@!N ,0 = #" 'L P0"" +\ B0"] )  O "8 +H
MH0"X *L M@"W +0 QP"R .  L0'R *\"_P"N _\ K03_ *T$_P"M!/\ K03_
M /\4  #_$   _P\  /(-  #J"@  Z0,) -T $@#4 !\ S0$M ,@".@#$ T4
MP -0 +T$60"[!6$ N05H +<&;P"U!G8 M =] +('A "Q"(P KPB5 *T)G@"K
M":@ J@JU *@*Q0"F"]\ I WT *(._P"@#O\ GP[_ )\._P"?#O\ GP[_ /\7
M  #_$P  [Q@  .09  #;%@  TA " ,\)"P#("!8 P0HD +P,,@"W#3X M Y)
M +$.4P"O$%L K1!C *L0:@"I$7$ J!%X *81@ "E$8@ HQ*1 *$2FP"@$Z8
MGA.S )P3PP";%-X EQ;T )46_P"4%_\ DQ?_ )(7_P"2%O\ DA;_ /\:  #T
M'0  Y2,  -4E  #*)   PAT  +X6! "[$!  M!,= *\5*P"K%C@ IQA# *49
M30"B&58 H!I= )X;90"=&VP FQQS )H<>P"8'(, EQV- )4=EP"3'J( DAZO
M ) >OP"/']@ C"#Q 8D@_P&((/\!AR#_ 8<@_P&&(/\!AB#_ ?H>  #K)@
MVBT  ,HP  "^+@  M2@  + B  "N&PP J!T7 *,?)@"?(3, G"(^ )DC2 "7
M)%$ E219 ),E8 "2)6< D"9N (XF=@"-)G\ BR:( 8HGDP&()YX!AB>K 80G
MNP&#*-$!@"CN 7XI_P%]*?\!?"C_ 7PH_P%\*/\!?"C_ ?4D  #C+@  SS4
M ,$X  "T-@  JS$  *4L  "B)@8 GB83 )DH(0"5*BX DBLY (\L1 "-+4P
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M!60\^@1D//\#8SO_ V,[_P-C._\"8SO_ N4U  #-/P  O48  *Y'  "?10
ME4,  (Y   ")/   A#P* ( ]% !]/B( >C\N 'A . !U04( <T%* ')!40%P
M05D!;D%@ FQ!9P)J07 #:$%Y V=!A 1E09$%8T&?!6%!K@9@0<(&7D'B!EY!
M^05=0?\$74#_ UU _P-=0/\#74#_ ]\Y  #(0P  N4H  *E+  ";20  D$<
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M!$U-_P1.3/\#3DS_ \Y$  "\3@  KE0  )Q3  ".4@  @U$  'I0  !R30
M;$\  &A0"P!E414 8U(A &%3+ !?4S8 750_ %M41P!:5$X!6%16 59470)4
M5&8#4E-O U!3>P1.4X@%3%.7!DM3IP=)4[H'2%/5!TA2\P9(4O\%2%'_!$E1
M_P1)4/\#25#_ \I(  "Y4@  JE<  )A6  "*50  ?U0  '93  !L40  9U,
M &)4" !?5A( 75<> %M7*0!96#, 6%@\ %991 !564P!4UE3 5%96P)/6&0"
M35AM TM8> 1)6(8%1U>5!D57I09$5[@&0UC2!D-7\@9#5O\%0U7_!$15_P1$
M5/\#1%3_ \9,  "U5@  I5H  )19  "&6   >U@  '%7  !F5@  85@  %U9
M! !96A  5UL; %5<)@!373  4ETY %%>00!/7DD 35Y1 4Q>6 %*7F$"2%UK
M T9==@-$78,$0EV2!4!=HP8_7;8&/EW0!CU<\04^6_\$/EK_!#Y:_P,^6?\#
M/UG_ \%0  "Q6@  H5T  )!<  ""6P  =EL  &U;  !A6P  6UT  %9>  !2
M8 T 4&$7 $YB(@!-8BP 3&,U $IC/@!)8T8 1V-. $9C5@%$8UX!0F-H D!C
M<P,^8X$#/&.0!#IBH00Y8K0%.&/-!3AB[P0X8?\$.&#_ SA?_P,Y7O\#.5[_
M [Q5  "M7P  G&   (M?  !]7P  <E\  &A?  !=8   56(  $]D  !+9@H
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M 25ZF0$C>JP!(GK% 2)YZ0$B=_\!(G;_ 2)U_P(B=/\"(W3_ JQH  "=;@
MBFT  'ML  !O;   96P  %IN  !0<0  174  #UX   V?   +G\" "F!#0 G
M@A0 )H(> "6")P D@B\ (X,X "*#0@ A@TL ((16 !^$8@ >A'$ '(2" !N$
ME0 :A*D &(3! !B#Y@ 8@?T &8#_ 1E__P$9?O\!&7[_ :9P  "5<P  A'(
M '9Q  !K<0  7G,  %1V  !)>0  /WT  #>!   OA   )X@  ""+!0 ;C0X
M&HT5 !F-'@ 8CB< %XXP !:..0 5CD, %(]/ !./6P 2CVH $8][ !"/CP /
MCZ0 #H^[  V/X  .C?H #XO_ !"*_P 0B?\ $(G_ *%Z  ".>0  ?G<  ')W
M  !D>   6'L  $U^  !"@@  .88  "^*   GC@  ()$  !B5   2F 4 #IH.
M  V:%  ,FAT "YHF  N:,  *FCL "9I&  B:4P &FV$ !9IR  2:A@ "FIL
M )JQ  &9SP "F?   IC_  27_P %EO\ !9;_ )F!  "'?P  >GX  &M^  !=
M@0  4(4  $6)   [C0  ,9(  "B6   ?F0  &)T  !&@   ,HP( !J4*  &E
M$   I18  *8?  "F*   IC(  *<]  "G2@  IU@  *=H  "G?   IY$  *:H
M  "FPP  I>D  *7\  "E_P  I/\  *3_ )&'  ""A@  <H8  &.(  !5C
M29$  #V6   RF@  *)X  !^B   7I@  $*D   NL   $KP   +$&  "Q#
MLA$  +(7  "S'P  LR@  +0R  "U/P  M4T  +5=  "U<   M88  +6=  "U
MM@  M=P  +3W  "T_P  M/\  +3_ (N/  !ZC@  :I$  %N5  !-F@  0)\
M #6D   JJ   (*P  !:P   /M   ";<   &Y    O0   +X   "^!@  OPP
M , 0  #!%@  PAT  ,,G  #%,@  QD   ,91  #'8P  QW@  ,>1  #'J0
MQ\<  ,?L  #'_@  Q_\  ,?_ (.7  !QF@  89X  %*C  !%J0  .*X  "RS
M   @MP  %KH   Z]   &P    ,,   #'    R0   ,H   #,    S0,  ,X)
M  #0#@  TA,  -0;  #8)0  VS(  -U"  #=5   WFD  -Z!  #>G   W[4
M -_9  #?\P  W_\  -__ '>?  !HI@  6:T  $JS   [N   +;L  !^_   4
MP@  #,8   /)    S    -    #5    V0   -H   #<    W@   .    #B
M!0  Y L  .<0  #J&   [20  / R  #Q1   \E@  /-O  #TB@  ]*0  /2_
M  #TWP  ]/,  /3T &JH  !;KP  3+<  #V]   MP0  '\8  !/*   +S@
M -(   #7    W    .    #E    YP   .D   #K    [0   .\   #Q
M\P   /8'  #Y#@  _!8  /\B  #_,P  _T<  /]=  #_=@  _Y$  /^I  #_
MO@  _]@  /_; /\ & #_ !8 _P 5 /\ & #_ !X _P G /\ -@#_ $, _P!/
M /\ 6@#_ &0 _P!M /\ =0#_ 'T _P"$ /\ B@#_ )  _P"6 /\ G #_ *,
M_P"K /\ M #^ +\ _0#/ /L YP#Z /@ ^0#_ /D _P#Y /\ ]0#_ .X _P#I
M /\ YP#_ /\ % #_ !$ _P 1 /\ $@#_ !< _P C /\ ,0#_ #X _P!* /\
M5@#_ &  _P!H /\ < #_ '@ _0!^ /P A0#Z (L ^0"1 /@ F #W )X ]0"F
M /0 K@#R +D \0#' .\ X #N /( [ #_ .P _P#L /\ ZP#_ .4 _P#@ /\
MW@#_ /\#$ #_  X _P - /\ #0#_ !, _P > /\ *P#_ #@ _P!% /X 4 #[
M %H ^ !C /4 :P#S '( \0!Y .\ ?P#N (8 [ ", .H D@#I )D YP"@ .8
MJ0#D +, X0#  .  TP#> .L W #[ -L _P#: /\ V@#_ -D _P#4 /\ T@#_
M /\'#0#_  D _P & /\ "0#_  \ _P 8 /L )0#X #( ]0 _ /( 2@#M %0
MZ@!= .< 90#D &P X@!S .  >@#> (  W "& -H C0#7 )0 U "; -( I #/
M *T S0"Y ,L R0#) .0 R #V ,8 _P#% /\ Q@#_ ,< _P#' /\ QP#_ /\*
M!@#_ 0  _P   /\ ! #_  L ]  2 .\ 'P#J "P Y0 X .( 0P#= $X V0!7
M -0 7P#1 &< S@!M ,P = #* 'H R "  ,8 AP#% (X PP"6 ,$ G@"_ *@
MO0"S +H P@"Y -L MP#P +4 _P"V /\ M0#_ +4 _P"U /\ M0#_ /\,  #_
M!   _P   /X   #V  , Z  - .  %P#9 "0 T0 Q ,T / #* $< Q@!1 ,,
M60#  &  O@!G +P ;@"Z '0 N0![ +< @@"U (D LP"1 +( F@"P *0 K@"O
M *P O0"J -  J #K *< ^P"F /\ I@#_ *4 _P"E /\ I0#_ /\-  #_!P
M] D  .H)  #B!   V@ ' ,\ $0#( !P P@ I +X -0"[ $  MP!* +0 4P"R
M %L L !B *X : "L &\ JP!U *D ?0"H (0 I@"- *0 E@"C *  H0"K )\!
MN0"= \P G 3H )H&^0"9!_\ F C_ )<(_P"7"/\ EPC_ /\0  #W$   Z!0
M -P5  #.$0  Q@T  ,($"P"\ !0 MP$A +(#+@"N!3H JP9$ *@(30"F"%4
MI E< *(*8P"@"FH GPMQ )T+> "<"X  F@R) )D,DP"7#)X E0VJ )0-N "2
M#<P D [J (X0_ ",$/\ BQ#_ (L0_P"+$/\ BA#_ /L3  #M&@  W2   ,PA
M  "_'0  MQ<  +,1  "R"PT JPT9 *<.)@"C#S, GQ ^ )T11P":$5  F!)7
M )827@"5$V4 DQ-L )(3<P"0%'P CQ2% (T5CP"+%9H BA6G (@6M0"&%LD
MA!?G ((8^P" &?\ ?QG_ '\9_P!_&/\ ?QC_ /4:  #D(P  SRD  , J  "S
M)@  JB(  *4<  "D%0@ H!03 )L6(0"7&"T E!DX )$:0@"/&TL C1Q2 (L<
M60")'6  B!UG (8>;P"%'G< @Q^  ((?BP" 'Y< ?B"C 'T@L@![(,4 >2'D
M '<B^0!V(O\ =2+_ '0A_P!T(?\ ="'_ .\A  #;*P  QS$  +8Q  "I+@
MH"H  )LF  "8(0$ E1X0 ) @&P"-(2@ B2,S (<D/0"%)$8 @R5. ($F50!_
M)EP ?B9C 'PG:P![)W, >2=\ '@HAP!V*), ="B@ 7(HKP%Q*<$!;RG@ 6TI
M]P%L*?\!:RG_ 6LI_P%K*/\!:RC_ >@H  #0,@  P#@  *XW  "A-0  F#(
M )(M  ".*0  BR<, (<H%P"#*B, @"LO 'XL.0!\+$( >BU* '@N40!W+E@
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M  "00@  A4   'X^  !Y.P  =#H  '$Z#@!M/!@ :STD &D^+P!G/S@ 93]
M &1 2 !B0$\ 84!7 %] 7@%=0&8!7$!O 5I >@)80(<"5D"5 E1 I -30+8#
M4D#/ U% [P-00/\"4#__ E __P)1/O\!43[_ <\[  "]10  JD<  )E&  "+
M10  @40  'E"  !T/@  ;S\  &M # !G014 94(A &-#*P!A0S4 7T0^ %Y$
M10!=14T 6T54 %E%7 %8160!5D5M 51%> )2184"4423 T]$HP--1;0#3$7,
M TM%[0-+1/\"2T3_ DM#_P),0O\"3$+_ LH_  "Y2   IDH  )5)  "'2
M?4<  '5%  !N0@  :4,  &5$"0!B11, 7T8> %U'* !<2#( 6D@[ %E)0P!7
M24H 5DE2 %1)60%326$!44EK 4])=@)-28("2TF1 TI)H0-(2;,#1TG* T9)
M[ -&2/\"1DC_ D='_P)'1O\"1T;_ L9#  "V3   HDP  )%,  "$2P  >4H
M '!)  !I1@  9$<  %])!@!<2A  6DL; %A,)0!63"\ 54TX %--0 !234@
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M C=4_P(W4_\".%/_ KI/  "I5@  E54  (54  !X5   ;50  &14  !85
M4E8  $Y7  !*60D 1UH1 $9:&P!$6R4 0ULN $)<-@!!7#X /UQ& #Y=3P ]
M75< .UUA #I=; $X77D!-EV( 31=F0(S7:L",5W" C%<Y0(Q6_P",5K_ C%9
M_P(R6?\!,EC_ ;94  "D60  D%@  (!8  !S5P  :5<  &!8  !460  3EL
M $A=  !#7P0 0& . #YA%P ]82  .V(I #IB,@ Y8CH .&-" #=C2P V8U0
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M :9F  "190  ?V0  '%D  !F9   760  %)F  !(:0  /VP  #=O   P<P
M*78  ")Y"  ?>Q  'GL7 !Q['P ;>R@ &GLP !E\.0 8?$, %WQ. !9\6@ 5
M?&< %'UX !)]BP 1?9\ $'VU  ]]U0 0>_4 $7G_ !%X_P 2=_\ $G?_ )YK
M  "*:@  >FD  &UI  !B:0  5VH  $QM  !#<   .70  #%X   I>P  (G\
M !N"   4A0D $880 !&&%P 0AQ\ $(<H  Z',0 .ASL #8=&  R'4P +AV$
M"H=Q  F'A  'AY@ !H:N  6&R0 &A>P !X3_  B#_P )@O\ "8+_ )5Q  "#
M;P  =&X  &EN  !<;P  4'(  $9U   \>0  ,GT  "J!   BA0  &XD  !2,
M   /CP, "I(+  :2$0 $DA@  I(@  &2*0  DC,  ),^  "32P  DUD  )-I
M  "3>P  DI   )*F  "1OP  D>4  )#Z  "/_P  C_\  (__ (UW  !]=0
M<'0  &)U  !5>   27P  #^    TA   *XD  "*-   :D0  $Y0   Z7   )
MFP   9T(  "=#@  G1,  )X:  ">(@  GRL  )\U  "@0@  H%   *!?  "@
M<0  H(<  )^=  "?M0  GMH  )WV  "=_P  G/\  )S_ (9]  !X?   :7P
M %M_  !.@P  08@  #:,   LD0  (Y8  !J:   2G@  #:$   :D    IP
M *D#  "I"@  J@X  *L3  "L&0  K2(  *XK  "O-P  KT4  *]4  "O9@
MKWL  *Z4  "NJP  KLD  *[O  "M_P  K?\  *W_ (&$  !QA   88<  %.+
M  !&D   .98  "Z;   CH   &J0  !*H   ,K   !*\   "R    M@   +<
M  "W @  N @  +D-  "Z$@  NQ@  +TA  "^*P  P#@  ,!(  # 6@  P6X
M ,&&  #!H   P;H  ,'C  # ^0  P/\  ,#_ 'F-  !HD   690  $N:   ]
MH   ,:4  "6K   :KP  $;,   NX   "NP   +X   #!    Q    ,4   #&
M    QP   ,@%  #*"P  S \  ,X5  #0'P  TRL  -4Z  #53   UF   -AW
M  #8D@  V*P  -G)  #9[   V?L  -C_ '"9  !@G@  4:0  $.J   UL
M*+8  !RZ   1O@  "<$   #%    R    ,L   #/    T@   -,   #6
MV    -L   #=    WP<  .(-  #E$P  Z!T  .PJ  #M/   [5$  .YG  #O
M@0  [YP  /"W  #PTP  \.P  /#T &>F  !8K0  2;0  #JZ   JO@  ',(
M !#&   'R@   ,X   #2    U@   -P   #@    XP   .0   #F    Z
M .L   #M    [P   /("  #U"@  ^!$  /P<  #_+   _S\  /]5  #_;@
M_XH  /^D  #_N@  _]$  /_A /\ % #_ !( _P 2 /\ % #_ !D _P E /\
M,@#_ #\ _P!+ /\ 5@#_ &  _P!H /\ < #_ '@ _P!_ /\ A0#_ (L _P"1
M /\ F #_ )X _@"F /T K@#\ +D ^@#( /D X@#X /0 ]P#_ /8 _P#V /\
M[P#_ .< _P#B /\ W@#_ /\ $0#_  X _P . /\ #P#_ !0 _P @ /\ +0#_
M #H _P!& /\ 40#_ %L _P!C /X :P#\ ', ^@!Y /D @ #W (8 ]@", /4
MD@#S )D \@"@ /  J0#N +, [0#! .L U@#J .X Z0#^ .< _P#G /\ Y0#_
M -T _P#5 /\ T0#_ /\ #0#_  H _P ( /\ "0#_ !  _P ; /\ * #_ #4
M_P!  /H 2P#V %4 \P!> /$ 9@#N &T [ !T .L >@#I (  YP"& .8 C0#D
M ), X@"; .  HP#> *T W "Y -H R@#7 .8 U #X -( _P#2 /\ T@#_ ,X
M_P#) /\ Q@#_ /\ " #_  , _P   /\  P#_  T _  6 /< (@#S "X [P Z
M .P 10#H $\ Y !8 .$ 8 #> &< VP!M -D = #5 'H TP"  -$ AP#/ (X
MS0"5 ,L G@#) *< QP"S ,4 P@## -P P0#Q +\ _P"_ /\ O@#_ +X _P"]
M /\ NP#_ /\   #_    _P   /\   #V  @ [@ 1 .< &P#A "< W0 S -D
M/@#3 $D SP!2 ,L 60#( &$ Q@!G ,0 ;0#" ', P !Z +\ @ "] (@ NP"0
M +D F "X *( M0"M +, NP"Q ,X L #J *\ _ "M /\ K0#_ *X _P"N /\
MK@#_ /\"  #_    _0   /(   #H    W@ , -, %0#, "$ R  L ,0 . #!
M $( O0!+ +H 4P"X %H M@!A +0 9P"R &T L !T *\ >@"M (( K "* *H
MDP"H )T I@"H *0 M0"B ,8 H0#C )\ ]@"> /\ G@#_ )X _P"> /\ G@#_
M /\&  #[    [@4  .($  #5    RP & ,, #P"] !D N  E +0 ,0"Q #L
MK@!% *P 30"I %4 IP!; *4 8@"D &@ H@!N *$ =0"? 'P G@"% )P C@":
M )@ F "D )8 L "5 ,$ DP#< )( \@"1 /\ D #_ )  _P"/ /\ CP#_ /T*
M  #P#@  X1$  ,X0  #"#0  NP<  +< "@"Q !( K  > *@ *0"E #0 H@ ^
M )\ 1P"= $\ FP!6 )D!7 "7 6, E@)I )0"< "3 W@ D0.  ) $B@".!)4
MC 6A (H%K@")!KX APC8 (8)\ "$"O\ @PO_ (,+_P"#"_\ @PO_ /80  #F
M%P  TAP  , :  "S%@  K!(  *@-  "F!PT H@46 )T'(@"9"2X E@HX )0+
M00"2#$H D Q1 (X-6 ",#5X BPUE (D-; "(#G0 A@Y] (4.AP"##I, @0^?
M ( 0K0!^$+X ?1#; 'H1] !X$O\ =Q+_ '<2_P!W$O\ =Q+_ .\7  #;(0
MQB0  +0C  "H(   H!P  )L7  "9$00 F X0 ),0&P"/$2< C!(R (D3/ "'
M$T0 A11, (,44P"!%5H @!5@ 'X6: !]%F\ >Q9X 'D7@P!X%X\ =AB< '08
MJ@!S&;L <AG4 &\:\0!N&_\ ;1O_ &T:_P!M&O\ ;1K_ .<@  #0*0  O"L
M *LJ  ">*   EB0  ) @  "-'   C!<, (@8%@"$&B( @1LM 'X<-P!\'4
M>AU( 'D>3P!W'E4 =A]< '0?8P!S'VL <2!T ' @?P!N(8L ;"&8 &LAIP!I
M(K@ :"+/ &8B[@!E(_\ 9"/_ &0B_P!D(O\ 9"'_ . F  #(+P  M#$  *,P
M  "6+@  C2L  (<H  "$)   @B ( 'X@$@![(AX >",I '4D,P!S)3P <25#
M ' F2P!N)E( ;2=9 &LG8 !J)V@ :2AQ &<H>P!E*(@ 9"F5 &(II !@*;4
M7RG+ %XJ[ !<*O\ 7"G_ %PI_P!<*?\ 7"C_ -@L  ##-0  K34  )TT  "0
M,P  AC$  ( M  !\*P  >2@# '8G$ !R*1H <"HE &TK+P!K+#@ :BQ  &@M
M1P!G+4X 92Y5 &0N70!C+F4 82]N %\O> !>+X0 7"^2 %HOH0%9+[(!6##(
M 58PZ0%5,/X!52__ %4O_P!5+O\ 52[_ - Q  "].@  J#D  )<X  "*-P
M@#8  'HR  !U,   <BX  &XN#0!K+Q8 :3 A &8Q*P!D,C0 8S(] &$S1 !@
M,TL 7S12 %TT6@!<-&( 6C1K %DU=0!7-8( 5360 50UGP%2-; !437& 5 U
MYP%/-?T!3S7_ 4\T_P%/-/\!3S/_ <LV  "X/0  HSP  )(\  "%.P  >SH
M '0W  !O-0  ;#,  &@T"@!E-1, 8C8> & W* !>-S$ 73@Z %LX00!:.4@
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M 3]!_P% 0?\!0$#_ ;]!  "J10  ED4  (9%  !Y1   ;T0  &="  !@/P
M6T$  %="  !40PT 4405 $]%'P!.12@ 3$8Q $M&.0!*1T$ 24=( $A'4 !&
M1U@ 14=A $-(; !"2'@!0$B' 3Y(EP$\2*D!.TB^ 3I(WP$Z1_@!.D;_ 3I%
M_P$[1?\!.T3_ ;M%  "F2   DD<  ()'  !V1P  :T<  &-&  !;0P  5D4
M %)'  !.2 H 3$D2 $I)' !(2B4 1THN $9+-@!%2SX 0TM& $),30!!3%8
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M :]1  "840  A5$  '90  !J4   8%   %A1  !.4@  1U,  $%5   [6
M.%D* #5:$0 T6AH ,ULB #);*P Q6S, +UP[ "Y<0P M7$P +%Q6 "M=8  I
M76T *%U\ "9=C@ D7:$ (UVU ")=T@ B7/, (EO_ "-:_P C6?\ )%C_ *A5
M  "25   @%0  '%4  !F5   7%0  %15  !*5@  0U@  #Q;   V70  ,& %
M "UA#@ K814 *F(= "EB)0 H8BX )V,V "9C/@ E8T< (V-1 ")D7  A9&D
M'V1Y !YDB@ <9)X &V2S !EDS@ :8_$ &V'_ !M@_P <8/\ '%__ *%9  ",
M6   >U@  &U8  !B6   65@  %!9  !'6P  /EX  #=@   Q8P  *F8  "1I
M"0 A:A  (&H7 !]J(  >:R@ '6LP !QK.0 ;:T( &FQ, !EL6  7;&4 %FQT
M !1LA@ 3;)H $FRO !%LR@ 1:^\ $FG_ !-H_P 3:/\ $V?_ )E=  "%70
M=5P  &A<  !>7   55P  $M>  !"80  .60  #)G   K:@  )&T  !YP 0 7
M<PL %701 !1T&  3="$ $G4I !%U,@ 1=3L $'5&  ]U4@ .=5\ #75N  QU
M@0 +=94 "G6J  ATPP )=.< "G/]  MQ_P ,<?\ #'#_ )%B  !_80  <&$
M &1A  !:80  3V(  $5E   \:   ,VP  "MO   D<@  '78  !=Y   1? 0
M#7\,  M_$@ *?QD "7\B  A_*@ &?S0 !7\_  1_2P "?U@  7]G  !_>0
M?XX  '^C  !^NP  ?>   'WW  !\_P  >_\  'O_ (EG  !X9P  :V8  &%F
M  !49P  26D  #]M   U<0  +'4  "1Y   =?   %H   !"#   ,A@( !HD*
M  &)#P  B10  (H;  "*(P  BRP  (LW  "+0P  BU   (M?  "+<0  BX8
M (N<  "*LP  B=,  (CS  "(_P  A_\  (?_ ()M  !S;   :&P  %IM  !.
M;P  0G,  #AW   N>P  )8   !V$   5B   $(P   N/   $D@   )0&  "5
M#   E1   )85  "7'   F"0  )@N  "9.0  F4<  )E6  "9:   F7T  )F4
M  "8JP  E\@  );N  "6_P  E?\  )7_ 'MT  !O<P  87,  %-V  !&>@
M.W\  #"$   FB   '8T  !22   .E@  "9D   &<    H    *$   "B!@
MH@P  *00  "E%   I1P  *<D  "H+P  J#T  *E,  "I7@  J7(  *B)  "H
MH@  J+P  *?E  "F^P  IO\  *7_ '=[  !H>P  67X  $N"   ^AP  ,HT
M ">2   =EP  %)P   Z@   'I    *@   "K    K@   *\   "P    L00
M +,*  "T#@  M1,  +8;  "X)   NC$  +I   "Z4@  NV4  +M]  "ZEP
MNK$  +K2  "Z\P  N?\  +G_ &^#  !?A@  48L  $.0   VEP  *IT  !^B
M   5IP  #:P   6P    M    +<   "[    O@   +\   #     P0   ,,!
M  #$!P  Q0T  ,<1  #*&0  S20  ,XS  #/1   T%@  -!N  #1B   T*0
M -#!  #1Y@  T?@  -'_ &>/  !7E   29H  #NA   NIP  (:T  !:S   .
MN   !KP   #     PP   ,8   #+    S0   ,X   #0    T0   -0   #6
M    V@(  -P)  #?#P  XQ<  .8D  #G-@  Z$D  .E?  #J>   ZY0  .NO
M  #KS   [.@  .SV %^>  !0I   0JL  #2R   FN0  &;X   ["   $Q0
M ,H   #-    T0   -@   #;    WP   .    #B    Y    .8   #I
MZP   .X   #Q!0  ]0T  /D6  #\)0  _3D  /Y/  #_9P  _X(  /^=  #_
MM0  _\L  /_D /\ $0#_  \ _P / /\ $0#_ !8 _P B /\ +P#_ #L _P!'
M /\ 4@#_ %L _P!D /\ ; #_ ', _P!Z /\ @ #_ (8 _P", /X DP#] )D
M^P"A /H J0#X +0 ]P#" /8 V@#U /$ ] #_ /, _P#S /\ Z0#_ .  _P#8
M /\ TP#_ /\ #@#_  L _P * /\ "P#_ !$ _P = /\ *@#_ #8 _P!! /\
M3 #_ %8 _@!? /L 9@#Y &T ]P!T /4 >@#T (  \@"& /  C0#O )0 [0";
M .P I #J *X Z0"Z .< S0#E .D Y #[ ., _P#B /\ W@#_ -$ _P#, /\
MR #_ /\ "0#_  0 _P ! /\ ! #_  X _P 8 /\ ) #] #  ^P [ /< 1@#S
M %  [P!9 .P 8 #J &< YP!N .8 = #D 'H X@"  .  AP#> (X W "5 -H
MG@#6 *@ U "S -$ PP#/ -\ S@#T ,P _P#+ /\ RP#_ ,4 _P"_ /\ O #_
M /\  @#_    _P   /\   #]  L ]P 3 /$ '@#M "H Z@ U .< 0 #B $H
MW0!2 -D 6@#5 &$ T@!G -  ;0#. ', S !Z ,H @ #( (< Q@"/ ,0 F #"
M *$ P "M +X NP"\ -  N@#M +D _@"X /\ N #_ +< _P"S /\ L #_ /\
M  #_    _P   /D   #N  4 Y0 . -X & #8 ", T@ N ,\ .0#+ $, QP!,
M ,0 5 #! %L OP!A +P 9P"[ &T N0!S +< >@"U ($ M ") +( D@"P )L
MKP"G *P M "K ,8 J0#D *< ^ "F /\ I@#_ *4 _P"E /\ I #_ /\   #_
M    ]0   .H   #>    T  * ,@ $@#" !T O@ H +L ,P"Y #T M0!& +(
M30"P %4 K0!; *P 80"J &< J !M *< <P"E 'H I "" *( C "@ )8 GP"A
M )T K@"; +X F0#8 )< \0"6 /\ E@#_ )< _P"7 /\ EP#_ /\   #U
MYP$  -0   #)    P  $ +@ #@"S !8 KP A *L + "H #8 I@ _ *, 1P"A
M $\ GP!5 )T 6P"; &$ F@!G )@ ;@"7 '4 E0!] )0 A@"2 )$ D "< (X
MJ0", +@ BP#- (D ZP"( /T B #_ (@ _P"( /\ B #_ /D&  #I#   U X
M ,,,  "W"0  L (  *L "0"F !  H@ : )X )0"; #  F  Y )8 00"4 $D
MD@!0 )  5@". %P C0!B (L :0"* '  B !X (< @0"% (P A "8 (( I0"
M +0 ?@#( 'T!YP!\ OD >P/_ 'L$_P![!/\ >P3_ /$.  #>%0  Q14  +04
M  "I$0  H0X  )X*  "; PP EP 3 ), '@"0 2D C0(S (H#/ "(!$, A@5+
M (4&40"#!E< @@=> ( '9 !_"&P ?0AT 'P(?@!Z"8D > F6 '<*HP!U"K,
M<PO' '(,Y@!P#?L < W_ &\-_P!O#?\ ;PW_ .@6  #0'@  N1T  *D<  "=
M&@  E18  ) 3  "/#@, C@H. (D+%P"&#", @PTM ( --@!^#CX ? Y& 'L.
M30!Y#U, >!!: '8080!U$&@ <Q!Q '$1>P!P$8< ;A&4 &P1H@!K$K( :1+'
M &@3YP!F$_T 913_ &44_P!E$_\ 91/_ -\>  #&)   L"0  * C  "4(0
MBQ\  (8;  "#%P  @A(( '\1$@!\$AT >10H '84,0!T%3H <A9! '$62 !O
M%T\ ;A=6 &P770!K&&0 :1AM &@9=P!F&8, 9!F0 &,:GP!A&J\ 8!K$ %X;
MY !='/L 7!S_ %P;_P!<&_\ 7!O_ -4E  "]*@  J"D  )@I  ",*   @R4
M 'TB  !Y'P  >!L# '89#P!R&A@ ;QPC &T=+0!K'34 :1X] &@>1 !F'TL
M91]2 &,@60!B(&$ 82!I %\A<P!=(7\ 7"&- %HBG !9(JP 5R+  %8CX0!5
M(_D 5"/_ %0B_P!4(O\ 5"+_ ,TK  "V+@  HBX  )(N  "%+0  ?"L  '8H
M  !R)@  ;R,  &TA# !J(A4 9R,? &4D*0!C)#$ 8B4Y & F00!?)D@ 729/
M %PG5@!;)UT 62=F %@H< !6*'P 5"B* %,IF0!1*:H 4"F^ $\IW@!.*?<
M32G_ $TI_P!-*/\ 3BC_ ,@P  "P,@  G#(  (PR  " ,0  =C   ' M  !K
M*P  :"D  &8H"0!C*!$ 8"D< %XJ)0!<*RX 6RLV %DL/0!8+$0 5RU, %4M
M4P!4+5L 4RUC %$N;@!0+GH 3BZ( $POEP!++Z@ 22^[ $@OVP!(+_8 1R__
M $<N_P!'+?\ 2"W_ ,0T  "K-0  ES4  (<U  ![-0  <C0  &LR  !F+P
M8BX  %\M!0!<+A  6B\8 %@P(@!6,"L 53$S %,Q.@!2,D( 43)) % R4 !.
M,U@ 33-A $LS:P!*,W< 2#2% $<TE0!%-*8 0S2Y $(TU@!"-/0 0C3_ $(S
M_P!",O\ 0C+_ , X  "G.   DS@  (,X  !W.   ;3<  &8V  !A,P  73(
M %DR @!7,PT 5#05 %(U'P!1-2@ 3S8P $XV. !,-S\ 2S=& $HW3@!).%8
M1SA? $8X:0!$.'4 0SB# $$YDP! .:0 /CFX #TYTP \.?, /#C_ #TW_P ]
M-_\ /3;_ +L[  "B.P  CSL  '\[  !S.P  :CH  &(Y  !=-P  6#8  %0W
M  !1. L 3SD3 $TY' !+.B4 2CHM $@[-0!'.SP 1CQ$ $4\2P!$/%, 0CQ<
M $$]9P _/7, /CV! #P]D0 Z/:, .3VV #@]T0 W/?( -SS_ #@[_P X._\
M.#K_ +8]  ">/@  BSX  'P^  !O/@  9CT  %X]  !8.P  4SH  $\[  !,
M/ @ 23T1 $<^&0!&/R( 1#\J $,_,@!"0#H 04!! $! 20 ^05$ /4%: #Q!
M9  Z07  .$%_ #=!CP U0J$ -$*T #)"S@ R0?  ,D#_ #- _P S/_\ -#[_
M +%   ":0   AT   'A!  !L00  8D   %M   !4/P  3C\  $I   !&004
M1$(. $)#%@! 0Q\ /T0G #Y$+P \1#< .T4^ #I%1@ Y14X .$98 #9&8@ U
M1FX ,T9\ #%&C0 P1I\ +D:S "U&S  M1N\ +47_ "Y$_P N0_\ +D/_ *Q#
M  "60P  @T,  '1#  !H0P  7T,  %=#  !00P  2$,  $1%  !!1@$ /D<,
M #Q($P Z2!P .4DD #A)+  V230 -4H[ #1*0P S2DP ,DI5 #!+7P O2VL
M+4MZ "Q+BP J2YT *$NQ "=+R@ G2^T )TK_ "A)_P H2/\ *4?_ *=&  "1
M1@  ?T8  '!&  !E1@  6T8  %1&  !,1P  1$@  #]*   [2P  -TP) #5-
M$  S3A@ ,DX@ #%/*  P3S  +T\X "Y/0  L4$@ *U!2 "I07  H4&@ )U!W
M "50B  D4)L (E"O "%0R  @4.L (4__ ")._P B3?\ (TW_ *%)  ",20
M>DD  &Q*  !A2@  6$H  %!*  !)2P  0$P  #M.   U4   ,5($ "U3#0 L
M5!0 *E0< "E5)  H52P )U4S "95/  E5D4 )%9. ")660 A5F4 'U9T !Y6
MA0 <5I@ &U:L !E6Q0 95ND &E7_ !M4_P ;4_\ '%+_ )M-  "&30  =4T
M &A-  !=30  5$T  $U.  !%3P  /%$  #93   Q50  *U@  "9:"0 C6Q
M(EL7 "%<'P @7"< 'UPN !U<-P <74  &UU* !I=50 876$ %UUP !5=@0 4
M794 $UVJ !%=P@ 17>< $EO^ !-:_P 36O\ %%G_ )11  " 40  <%$  &11
M  !940  45$  $E2  !!4P  .%8  #)9   K6P  )5X  !]A P :8PP &&01
M !=D&0 69"$ %60I !1E,0 393H $F5$ !%E4  095T #V5K  YE?0 -99$
M#&6E  IDO  *9.  "V/Y  QB_P -8?\ #6'_ (U5  !Z50  :U4  %]5  !6
M50  3E4  $17   \60  -%P  "Q?   F8@  'V4  !EH   3:P4 $&T-  YN
M$@ -;AH #&XB  QN*P +;C0 "FX^  AN2@ ';E< !FYE  1N=@ ";HH  &V?
M  !MM@  ;-8  &SS  %K_P ":O\  VK_ (5:  !T6@  9EH  %Q9  !360
M2%H  #]=   V8   +F,  "9G   ?:@  &6T  !-Q   .= , "G<*  5W$  !
M=Q4  '<<  !W)   >"T  '@W  !X0P  >%   'A>  !X;P  >(0  'B9  !W
ML   =LT  '7P  !U_P  =/\  '3_ 'Y?  !N7P  8EX  %E>  !-7P  0F(
M #EE   P:   )VP  !]P   8=   $G<   U[   (?@   H (  "!#0  @1$
M ((7  "#'@  @R8  (0P  "$.P  A$@  (17  "$:   A'P  (23  "#J@
M@L4  ('K  "!_@  @/\  (#_ '=E  !I9   7V,  %)D  !'9P  /&L  #%O
M   H<P  ('<  !A\   1?P  #(,   :'    B@   (P#  ","0  C0X  (X1
M  "/%P  D!X  )$G  "2,@  DC\  )).  "27P  DG,  )*+  "1H@  D;P
M )#E  "/_   CO\  ([_ '%K  !F:@  6&L  $MM   _<0  -'8  "I[   @
M@   %X4  !")   +C0  !)$   "5    F    )D   ": P  FP@  )P-  ">
M$0  GQ8  * >  "B*   HC4  *-$  "C50  HVD  **   "BF@  H;,  *#8
M  "@]@  G_\  )__ &YQ  !?<@  474  $1Y   W?@  +(0  "&*   7CP
M$)0   J9   !G0   *    "D    IP   *@   "I    J@   *P&  "M"P
MKQ   + 5  "R'@  M"D  +0Y  "T2@  M5T  +5S  "UC@  M:@  +3&  "S
M[0  LO\  ++_ &9Z  !7?0  28(  #R'   OC@  (Y0  !B:   0GP  ":0
M  "I    K0   +    "T    MP   +@   "Y    NP   +P   "^ @  P @
M ,(.  #$%   QQX  ,@L  #)/0  RE   ,IF  #*?P  RIL  ,JX  #*W0
MRO4  ,K_ %Z&  !/BP  09$  #.8   GGP  &Z4  !&K   )L    +4   "Y
M    O0   ,$   #&    R    ,D   #+    S    ,X   #0    T@   -0%
M  #9#   W1(  .$>  #B+@  XT(  .17  #E;P  YHP  .:H  #EQ0  Y><
M .;V %:4  !(FP  .J(  "RI   ?L   $[8   N\    P0   ,4   #)
MS0   -(   #6    V@   -L   #>    X    .(   #D    YP   .D   #M
M    \ H  /01  #X'P  ^3(  /I(  #[7P  _'H  /V7  #]KP  _<<  /WD
M /\ #@#_  T _P , /\ #@#_ !, _P > /\ *@#_ #8 _P!" /\ 30#_ %<
M_P!? /\ 9P#_ &X _P!T /\ >@#_ ($ _0"' /P C0#Z )0 ^0"< /< I0#U
M *\ ] "\ /, SP#Q .P \ #^ .\ _P#O /\ XP#_ -< _P#. /\ R@#_ /\
M"@#_  8 _P $ /\ " #_ !  _P 9 /\ )0#_ #$ _P ] /\ 1P#^ %$ ^P!9
M /D 80#V &@ ] !N /, = #Q 'H [P"! .X AP#L (X Z@"6 .@ GP#F *D
MXP"U .( Q@#@ ., WP#X -T _P#= /\ U #_ ,D _P#" /\ O@#_ /\  P#_
M    _P   /\  0#_  T _P 4 /T ( #Z "L ]P V /, 00#O $L [ !4 .@
M6P#F &( XP!H .$ ;@#? '0 W !Z -H @0#8 (@ U "0 -( F #/ *( S0"N
M ,L O #) -, QP#P ,8 _P#$ /\ Q #_ +L _P"V /\ LP#_ /\   #_
M_P   /\   #W  @ \  0 .L &@#G "4 Y  P .$ .P#< $4 U0!- -$ 50#.
M %L RP!B ,D 9P#' &T Q0!S ,, >@#! ($ OP") +T D@"[ )P N0"G +<
MM0"U ,@ LP#F +( ^P"Q /\ L #_ *X _P"J /\ IP#_ /\   #_    _@
M /$   #E  ( W  - -, % #- !\ R@ J ,< - #$ #X P !' +P 3@"Z %4
MMP!; +4 80"S &< L@!M +  <P"N 'H K "" *H BP"H )4 IP"@ *4 K0"C
M +X H0#; *  ] "? /\ G@#_ )\ _P"= /\ FP#_ /\   #\    [@   .
M  #0    Q0 ( +X $ "Y !D M0 C +, +@"P #< K0!  *H 2 "H $\ I0!5
M *, 6P"B &  H !F )\ ; "= ', FP![ )H A "8 (X E@": )4 IP"3 +<
MD0#, )  [ "/ /\ C@#_ (X _P". /\ CP#_ /P   #O    VP   ,D   "]
M    M0 " *X # "I !, I0 = *( )P"@ #$ G0 Z )H 0@"8 $D E@!/ )0
M50"3 %L D0!@ )  9P". &T C0!U (L ?@") (D B "5 (8 H@"% +$ @P#$
M ($ Y "  /D ?P#_ (  _P"  /\ @ #_ /0"  #@"0  QP@  +<'  "L P
MI@   *  !P";  \ F  7 )4 (0"2 "H CP S (T / "+ $, B0!) (< 4 "&
M %4 A !; (, 80"! &@ @ !P 'X >0!\ (0 >P"0 'D G0!X *P =@"^ '4
MW0!S /0 <P#_ ', _P!S /\ <P#_ .D-  #/$   N1   *D0  ">#@  EPL
M ),&  "0  L C  1 (D &@"& "0 @P N ($ -@!_ #X ?0!$ 'P 2P!Z %$
M>0!7 '< 70!V &0 = !L ',!=0!Q 8  ;P*- &X"F@!L ZH :P.[ &D$U@!H
M!O$ : ?_ &<'_P!G!_\ 9P?_ -\4  ##%P  KA<  )X6  "3%0  BQ(  (80
M  "$# ( @P8- ( #% !\!1X >0<H '<(, !U"#@ <PE  '()1@!P"DP ;PI3
M &T+60!L"V$ :@MI &D,<@!G#'X 9@R+ &0-F0!B#:D 80V[ & -V !>#O,
M70[_ %T._P!=#O\ 70[_ -0<  "Y'0  I!X  )4=  ")'   @1H  'L7  !X
M$P  >! & '<-#P!S#A@ < XB &X/*P!L$#, :A [ &D00@!G$4D 9A%/ &01
M5@!C$ET 81)F & 2;P!>$GL 7!.( %L3EP!9$Z< 5Q2Z %84U0!5%?, 5!7_
M %05_P!4%?\ 5!3_ ,HB  "P(@  G2,  (TC  "!(@  >2$  ',>  !O&P
M;A<  &T3# !J%!0 9Q4> &46)P!C%B\ 81<W & 7/@!>&$4 71A+ %P94@!:
M&5H 61EB %<:; !6&G< 5!J% %(;E !1&Z0 3QNW $X;T !-'/$ 3!S_ $P<
M_P!-'/\ 31O_ ,,F  "J)P  EB<  (<H  ![)P  <B8  &PD  !H(0  9AX
M &0;" !B&Q$ 7QP: %T=(P!;'BL 6AXS %@?.@!7'T$ 5B!( %0@3P!3(%<
M42%? % A:0!.(70 32&" $LBD0!)(J( 2"*T $<BS0!&(^\ 12/_ $4B_P!&
M(O\ 1B'_ +PJ  "D*P  D2L  ((L  !V*P  ;2H  &8I  !B)@  7R0  %TB
M! !;(0X 6"(6 %8C'P!4)"@ 4R0P %(E-P!0)3X 3R9% $XF3 !,)E0 2R=<
M $DG9@!()W$ 1B=_ $4HCP!#**  02BR $ HRP _*.T /RC_ #\H_P! )_\
M0"?_ +<M  "?+@  C"\  'TO  !Q+P  :"X  &$M  !=*P  6B@  %<G  !4
M)PP 4B@3 % I' !.*24 32HL $LJ- !**SL 22M" $@L20!&+%$ 12Q: $0L
M9 !"+6\ 0"U] #\MC0 ]+9X /"VP #HMR  Z+>L .BW_ #HM_P Z+/\ .BS_
M +(P  ";,0  B#(  'DR  !M,@  9#(  %TQ  !8+P  52P  %$L  !/+0D
M3"T1 $HN&0!)+R( 1R\J $8P,0!%,#@ 0S _ $(Q1P!!,4\ 0#%7 #XQ80 ]
M,FT .S)[ #DRBP X,IP -C*O #4RQP T,ND -#+_ #4Q_P U,?\ -3#_ *TS
M  "6-   A#4  '4U  !I-0  8#4  %DT  !4,P  4#   $PQ  !),08 1S(/
M $4S%@!#,Q\ 0C0G $ T+@ _-38 /C4] #TU1  \-DP .C95 #DV7P W-FL
M-C9X #0WB0 R-YH ,3>M "\WQ0 O-^@ +S;^ # U_P P-?\ ,#3_ *DV  "2
M-@  @#<  '(X  !F.   73<  %8W  !0-@  2S0  $<U  !$-@, 03<- #\X
M%  ^.!P /#DD #LY+  Z.3, .3HZ #@Z0@ V.DH -3I3 #0[70 R.V@ ,#MV
M "\[AP M.YD +#NL "H[PP I.^8 *CK] "HZ_P K.?\ +#C_ *0X  "..0
M?#H  &XZ  !C.@  6CH  %,Z  !-.@  1C@  $(Z   _.P  /#P+ #H\$0 X
M/1D -STA #8^*0 T/C  ,SXW #(_/P Q/T< ,#]0 "X_6@ M0&8 *T!T "E
MA  H0)< )D"J "5 P0 D0.4 )#_\ "4^_P F/?\ )CW_ )\[  "*/   >#T
M &H]  !?/0  5CT  $\]  !)/0  0CT  #P^   Y/P  -D$( #1!#P R0A8
M,4(> "]#)0 N0RT +4,T "Q$/  K1$0 *D1- "A$6  G16, )45Q "-%@@ B
M194 ($6H !]%OP >1., 'T3[ !]#_P @0O\ (4'_ )H^  "%/P  =$   &=
M  !<0   4T   $Q   !&0   /D$  #A#   T10  ,$8# "U'#0 K2!( *D@:
M "E((@ H22D )TDQ "5).0 D24$ (TI* ")*50 @2F$ 'TIO !U*?P ;2I(
M&DJF !A*O0 72N  &$GZ !E(_P :1_\ &D?_ )5"  " 0@  <$,  &-#  !8
M0P  4$,  $E#  !"1   .T4  #5'   P20  *TL  "9-"0 D3A  (DX6 "%/
M'0 @3R4 'T\L !Y/-0 =3ST '%!' !I040 94%T %U!K !90?  44(\ $U"D
M !%0N@ 14-X $4_X !)._P 33?\ %$W_ (]%  ![1@  :T8  %]'  !51P
M34<  $9'   _1P  -TH  #%,   K3@  )E   "!3 P <50P &E81 !E6&  7
M5B  %E8G !56,  45CD $U=" !)730 15UD $%=H  ]7>0 .5XP #5>@  M7
MM@ +5M0 "U;T  Q5_P -5/\ #E/_ (A)  !V2@  9TH  %M*  !12@  2DH
M $-*   [3   ,TX  "Q1   F5   (58  !M9   57 < $5X- !!>$P 07AH
M#EXB  Y>*@ -7C, #%X]  M>2  *7E0 "%YB  =><P %7H8  UZ;  )>L0 "
M7<P  EWN  -<_P $6_\ !5O_ (%.  !P3@  8DX  %=.  !.3@  1TX  #Y/
M   V40  +E0  "=7   A6@  &UT  !5@   08P, #&8+  AG$  &9Q4 !6<<
M  1G)  "9RT  6<W  !G0@  9TX  &=<  !G;0  9X   &:5  !FK   9<<
M &7K  !D_   9/\  &/_ 'I2  !J4P  75(  %12  !+4@  0E,  #E5   P
M6   *%L  "%?   :8@  %&4  !!H   ,:P$ !FX)  !O#@  ;Q(  &\8  !P
M'P  <"<  '$P  !Q.P  <4@  '%6  !Q9@  <7D  '&/  !PIP  ;\$  &_G
M  !N_   ;?\  &W_ '-8  !E5P  6E<  %%6  !&5P  /%H  #)=   J80
M(F0  !IH   4;   #F\   IR   $=@   '@%  !X"P  >0X  'H3  ![&0
M?"   'TI  !],P  ?4   'U.  !]7@  ?7(  'V(  !\H0  ?+H  'OB  !Z
M^@  >?\  'C_ &U=  !@7   5UP  $M=  ! 7P  -6,  "MG   C:P  &F\
M !-S   .=P  "'L   )^    @@   (,!  "$!@  A0L  (8/  "($P  B1D
M (HA  "+*P  BS<  (Q&  "+5@  BVD  (N   "+F0  BK,  (G8  "(]P
MB/\  (?_ &AC  !>8@  46(  $1E   X:0  +FX  "1S   :>   $WT   V!
M   &A0   (D   "-    D    )(   "2    E 4  )4*  "7#@  F!(  )H8
M  ";(0  G"T  )T\  "=3   G%\  )QV  ";D0  FZL  )K)  ":\   F?\
M )C_ &5I  !7:0  26P  #UQ   P=@  )7P  !N!   2AP  #(P   21
ME0   )D   "=    H    *$   "B    I    *4!  "G!P  J0P  *H1  "M
M&   KR(  *\P  "O00  KU0  *]K  "NA0  KJ$  *Z^  "MY@  K/P  *S_
M %YQ  !/=   0GD  #5_   HA0  '8P  !.2   ,F    YT   "B    I@
M *H   "N    L    +$   "S    M    +8   "X    N@0  +P*  "^$
MP1<  ,,D  ##-0  Q$D  ,1>  #%=P  Q9,  ,6O  #%T0  P_(  ,/_ %9\
M  !'@@  .H@  "R/   @E@  %)T   VC   #J0   *X   "R    MP   +L
M  "_    P@   ,(   #%    Q@   ,@   #*    S0   ,\   #2"   U0X
M -L8  #=)P  WCH  -]0  #@:   X(0  .&A  #AO0  X>(  .#T $Z+  !
MD@  ,ID  "6A   8J   #J\   6U    N@   +\   #$    R    ,X   #1
M    U    -4   #8    V@   -T   #?    X@   .0   #G    ZP4  .\.
M  #T&0  ]2L  /9!  #W6   ^'(  /F0  #YJP  ^,0  /CA /\ "P#_  @
M_P ) /\ # #_ !( _P : /\ )@#_ #( _P ^ /\ 2 #_ %( _P!: /\ 8@#_
M &D _P!O /\ =0#^ 'L _ "! /L B #Y (\ ]P"7 /4 H #S *H \@"W .\
MR0#M .8 [ #[ .L _P#K /\ W0#_ ,X _P#& /\ P@#_ /\ ! #_    _P
M /\ !0#_  T _P 5 /\ (0#_ "P _P X /\ 0P#] $P ^0!4 /< 7 #T &,
M\@!I /  ;P#N '4 [ ![ .H @@#H (D YP"1 .0 F@#B *0 X "P -T P #:
M -P V #T -4 _P#3 /\ RP#_ ,$ _P"[ /\ MP#_ /\   #_    _P   /\
M  #_  H _0 1 /D &P#V "< ]  R /  / #L $8 Z !. .0 5@#A %P W@!C
M -P : #9 &X U0!T -( >P#0 (( S0"* ,L DP#( )T Q@"H ,0 MP#! ,P
MP #K +X _P"] /\ O0#_ +0 _P"N /\ JP#_ /\   #_    _P   /H   #R
M  4 Z@ . .4 %@#@ "$ W0 K -L -@#3 #\ S@!( ,H 3P#' %8 Q !< ,(
M80#  &< O@!M +P <P"Z 'H N "" +8 BP"T )8 L@"A +  KP"N ,$ K0#@
M *L ]P"J /\ J0#_ *8 _P"A /\ GP#_ /\   #_    ]P   .@   #<
MT  * ,H $0#% !L P@ E +\ +P"\ #@ N !! +4 2 "R $\ L !5 *X 6P"L
M &$ J@!F *@ ; "G ', I0![ *, A "A (X GP": )T IP"; +@ F@#0 )D
M[P"8 /\ EP#_ )8 _P"4 /\ D@#_ /\   #V    Y    -(   #%    NP %
M +4 #@"P !4 K  ? *H *0"H #( I0 Z *( 0@"@ $D G@!/ )P 50": %H
MF !@ )8 9@"5 &P DP!T )( ?0"0 (< C@"3 (P H0"+ +  B@#% (@ Y@"'
M /L A@#_ (< _P"' /\ A@#_ /@   #E    S0   +T   "S    J@   *,
M"@"? !$ FP 9 )D (P"7 "P E0 T )( / "0 $, C@!) (P 3P"* %0 B0!:
M (< 8 "& &8 A !N (, =P"! ($ ?P"- 'X FP!\ *H >P"\ 'H VP!X /4
M> #_ '@ _P!X /\ > #_ .T   #1 @  NP(  *P!  "B    FP   )8 !0"1
M  T C0 4 (L '0"( "8 A@ N (0 -@"" #T @ !# 'X 20!] $\ ? !5 'H
M6P!Y &$ =P!I '4 <0!T 'P <@"( '$ E@!O *4 ;@"V &T S@!L .X :P#_
M &L _P!K /\ :P#_ -\+  #"#   K@P  )X,  "3"P  C <  (@"  "%  D
M@0 0 '\ %P!\ "  >@ H '@ , !V #@ =  ^ ', 1 !Q $H < !0 &X 5@!M
M %T ; !D &H ;0!H '< 9P"$ &4 D@!D *$ 8P"R &$ R0!@ .D 8 #\ &
M_P!@ /\ 8 #_ - 0  "V$0  HA(  ),2  "($0  @ \  'P-  !Y"0$ > ,+
M '4 $0!S !H <  C &X!*P!L 3, :@(Y &D#0 !G T8 9@1, &4$4@!C!5D
M8@5A & %:@!?!G0 70:! %P'CP!:!Y\ 60>P %<'Q@!6">< 5@K[ %4*_P!5
M"O\ 5@K_ ,85  "M%P  F1@  (H8  !_%P  =A8  '$3  !N$   ;0T% &T)
M#0!J"10 9PH= &4*)@!C"RX 8@PU & ,/ !?#$( 7@U( %P-3P!;#58 60U>
M %@.: !6#G, 50Z  %,.CP!1#I\ 4 ZQ $X.R !-$.H 31#] $T0_P!-$/\
M31#_ +P;  "E'   DAT  (,>  !W'0  ;QP  &D:  !F%P  9!0  &00" !B
M#Q  7Q 8 %T0(0!;$2D 6A$Q %@2. !7$CX 5A)% %023 !3$U, 41-; % 3
M90!.%'  3!1] $L4C !)%)P 1Q6N $85Q0!%%>@ 11;^ $46_P!%%?\ 117_
M +4?  ">(0  BR(  'PB  !Q(@  :"$  &(?  !?'0  7!H  %L7 @!:%0T
M5Q84 %46'0!4%R4 4A@M %$8- !/&#L 3AE" $T92 !+&E  2AI8 $@:8@!'
M&FT 11MZ $,;B0!"&YH 0!NL #\;P@ ^'.4 /1S\ #X<_P ^&_\ /AO_ *\C
M  "8)   AB4  '<F  !L)@  8R4  %TD  !9(@  5A\  %0=  !3' L 41P2
M $X=&@!-'2( 2QXI $H>,0!)'S< 1Q\^ $8@10!%($T 0R!5 $(@7P! (6H
M/R%W #TAAP [(9@ .2&J #@BP  W(N, -R+[ #<B_P X(?\ ."'_ *HF  "4
M)P  @2D  ',I  !G*0  7RD  %@H  !4)@  42,  $\B  !,(@< 2B(0 $@B
M%P!'(Q\ 120F $0D+@!")#0 024[ $ E0P _)4H /293 #PF7  Z)F< .29U
M #<GA  U)Y8 -">H #(GO@ Q)^$ ,2?Y #(F_P R)O\ ,R7_ *4I  "/*@
M?2P  &\L  !D+0  6RP  %4K  !0*@  3"@  $HF  !')P0 1"<- $(H% !!
M*!P /RDC #XI*P ]*3( /"HY #LJ0  Y*D@ ."M0 #8K6@ U*V4 ,RMR #$K
M@@ P+)0 +BRG "PLO  K+-X +"SX "PK_P M*O\ +2K_ *$L  "++0  >2X
M &LO  !@+P  6"\  %$N  !,+@  2"P  $4K  !!*P  /RP+ #TL$0 [+1D
M.BXA #DN*  W+B\ -B\V #4O/@ T+T4 ,R]. #$P6  P,&, +C!P "PP@  J
M,)( *3"E "<PN@ F,-P )C#W "<O_P H+_\ *"[_ )PN  "',   =C$  &@R
M  !=,@  53(  $XQ  !(,0  1#   $ O   \,   .C$) #<Q$  V,A8 -3(>
M #,S)0 R,RP ,3,S # T.P O-$, +31, "PT5@ J-6$ *35N "<U?@ E-9
M(S6C "(UN0 A-=D (33V "(T_P C,_\ (S+_ )@Q  "#,P  <C0  &4T  !:
M-0  434  $LT  !%-   0#0  #HS   W-   -#4& #(V#@ P-Q, +S<; "XW
M(@ M."D *S@Q "HX.  I.4  *#E) "8Y4P E.5\ (SEL "$Z?  @.HX 'CJB
M !PZMP ;.=4 '#GU !TX_P =./\ 'C?_ ),T  !_-@  ;C<  &$W  !7-P
M3C<  $@W  !"-P  /#<  #4X   R.0  +SH" "P["P J/!$ *3P8 "@]'P F
M/28 )3TN "0]-0 C/CT (CY& " ^4  ?/EP '3]I !L_>0 :/XP &#^@ !8_
MM0 5/M( %C[S !<]_P 8//\ &#S_ (XW  !Z.   :CD  %XZ  !3.@  2SH
M $4Z   _.@  .3H  #(\   N/@  *4   "9!"  D0@X (D(4 "%"&P @0R,
M'T,J !Y#,@ <0SH &T1# !I$30 81%D %T1G !5$=P 31(H $D2> !%$LP 0
M1-  $$/R !%"_P 20O\ $T'_ (D[  !V/   9CT  %H]  !0/0  2#T  $(]
M   \/0  -CX  "]    J0@  )40  "%& P =2 P &TD1 !E)%P 821X %TDF
M !9)+@ 52C8 %$I  !-*2@ 12E8 $$ID  ]*=  .2H< #4J;  Q*L  *2LH
M"TGL  Q(_P -1_\ #4?_ (,^  !Q/P  8D   %9   !-0   14   #]    Y
M00  ,D(  "M%   F1P  (4D  !Q+   63@< $U . !)0$P 14!D $% A  ]0
M*0 .4#$ #5 [  U11@ +45$ "E%?  E1;P '4($ !5"6  -0JP "4,4  T_H
M  -/^P %3O\ !DW_ 'U"  !K0P  740  %)$  !*1   0T,  #Q$   U10
M+D<  "=*   A3   '$\  !=1   25 , #E<*  M8$  *6!4 "%@<  =8)  &
M6"P !5@V  -80  !6$P  %A:  !8:0  6'P  %B1  !7IP  5\   %;E  !6
M^0  5?\  %7_ '9'  !F1P  64@  $]'  !'1P  0$<  #A(   P2@  *4T
M ")0   <4P  %E4  !%8   -6P( "5X)  1?#@  7Q(  %\8  !@'P  8"<
M & P  !@.P  8$<  &!4  !@8P  8'8  &"+  !?H@  7[L  %_B  !>^0
M7?\  %W_ &]+  !A3   54P  $Q+  !$2P  .TP  #).   K40  (U0  !Q7
M   66P  $5X   U@   (8P   F8'  !G#   9P\  &@3  !I&0  :B$  &HI
M  !J-   :D   &I-  !J70  :F\  &J%  !JG0  :;8  &C=  !H]P  9_\
M &;_ &E1  !<4   4E   $I/   _4   -5,  "U6   D60  '5T  !9@   0
M9   #&<   9J    ;@   &\#  !P"   <0T  '(0  !T%   =1L  '8C  !W
M+   =S@  '9&  !V5@  =F@  '9^  !VEP  =;$  '33  !S]0  <_\  '+_
M &-6  !850  4%0  $15   Y6   +UL  "9?   =8P  %6<  !!L   *<
M!',   !V    >@   'P   !\ P  ?@@  '\,  "!$   @A0  (0;  "%)
MAB\  (8]  "&30  A5\  (5U  "%CP  A*D  (/)  ""\0  @?\  (#_ %];
M  !66@  25L  #U>   R80  )V8  !YK   5<   #G4   EY   !?@   ($
M  "%    B    (H   "+    C0$  (X&  "0"P  D0\  ),4  "5&P  ER8
M )<T  "71   EU8  )9L  "5A@  E:(  )3!  "3Z@  DO\  )+_ %UA  !/
M80  0F0  #9I   J;@  'W0  !5Y   .?P  !X0   ")    C@   )(   "6
M    F    )H   ";    G0   )\   "A P  HP@  *4-  "G$P  J1P  *HH
M  "J.0  JDL  *IA  "I>@  J)D  *BU  "GW0  I_@  *;_ %9H  !(;
M.G   "YV   B?0  %X0   Z*   'D    )8   ":    GP   *,   "G
MJ@   *L   "M    KP   +$   "S    M0   +@%  "Z#   O1(  , <  #
M+0  P$   +]5  "_;@  OHL  +ZH  "^R0  O>\  +S^ $YT  ! >0  ,G\
M "6'   9C@  $)4   ><    H@   *<   "L    L    +4   "Y    O
M +T   "_    P0   ,,   #&    R    ,H   #- @  T L  -42  #6(0
MUS0  -A)  #98   VGP  -J:  #;M0  V]D  -OR $:"   XB0  *Y   !V8
M   2H   "J<   "N    M    +D   "^    P@   ,@   #+    S@   ,\
M  #2    U    -8   #:    W0   -\   #B    Y@   .H*  #O$P  \"4
M /(Z  #S40  ]&L  /2)  #UI0  ];\  /7= /\ !@#_  , _P % /\ "P#_
M !  _P 7 /\ (@#_ "T _P Y /\ 1 #_ $T _P!5 /\ 70#_ &0 _P!J /\
M< #] '8 ^P!\ /D @P#W (H ]0"2 /, FP#P *8 [@"S .L Q #I .0 YP#Y
M .8 _P#E /\ TP#_ ,< _P"_ /\ NP#_ /\   #_    _P   /\  @#_  L
M_P 2 /\ '0#_ "@ _P S /\ /@#\ $< ^ !/ /0 5P#Q %T [@!C .P :0#J
M &\ Z !U .8 ? #D (, X@"+ -\ E0#< )\ V0"K -4 NP#2 -0 SP#R ,T
M_P#, /\ Q0#_ +H _P"T /\ L #_ /\   #_    _P   /\   #_  8 ^0 /
M /4 %P#S "( \0 M .T -P#G $  X@!) -\ 4 #; %< UP!= -0 8P#1 &@
MSP!N ,P =0#* 'P R "$ ,4 C0#" )@ P "D +T L@"[ ,8 N0#H +@ _0"W
M /\ M@#_ *T _P"G /\ HP#_ /\   #_    _P   /4   #K  $ Y  , -X
M$P#9 !P TP F -$ , #, #H R !" ,0 2@#  %  O0!6 +L 7 "Y &$ MP!G
M +4 ;0"S '0 L0!\ *\ A0"M )  J@"< *@ J@"F +L I0#: *, ]0"C /\
MH@#_ )X _P": /\ EP#_ /\   #^    [P   -\   #0    QP ' ,$ #P"\
M !< N0 @ +< *@"U #, L  [ *T 0P"K $D J !/ *8 50"D %H HP!@ *$
M9@"? &T G0!T )P ?0": (@ F "4 )8 H@"4 +( D@#) )$ ZP"1 /\ D #_
M )  _P", /\ B@#_ /P   #L    V0   ,<   "Z    L0 " *L # "G !(
MI  ; *$ ) "@ "P G@ U )L / "8 $, E@!) )0 3P"2 %0 D !: (\ 7P"-
M &8 BP!M (D =@"( (  A@", (0 F@"" *H @0"^ (  X "  /D ?P#_ '\
M_P!_ /\ ?@#_ /$   #8    P@   +,   "H    H    )D !P"5  X D@ 5
M )  '@". "8 C0 N (H -@"' #T A0!# (0 20"" $X @0!4 '\ 60!^ &
M? !G 'H ;P!Y 'H =P"& '4 E !T *, <@"U '( SP!Q /$ < #_ '  _P!P
M /\ <0#_ .$   #$    L    *(   "7    D0   (L  @"&  L @P 1 ($
M& !_ "$ ?0 I 'P , !Y #< >  ] '8 0P!T $D <P!. '( 5 !P %H ;P!B
M &T :@!K '0 :@"  &@ C@!G )T 90"O &4 Q@!D .@ 9 #] &, _P!C /\
M9 #_ ,\%  "V!P  HP@  )0(  ")!P  @@,  'X   ![  8 =P . '4 $P!R
M !L <0 C &\ *P!M #( ;  X &H /@!I $0 9P!) &8 3P!E %8 8P!= &(
M90!@ &\ 7P![ %T B0!< )D 6P"J %D OP!9 .$ 6 #X %@ _P!8 /\ 60#_
M ,(,  "J#0  EPX  (D.  !]#@  =@T  '$*  !O!@  ;0 * &L $ !I !8
M9P > &4 )@!C "T 80 S &  .0!? #\ 70!% %P 2P!; %( 6@!9 %@ 8@!7
M &P 50!X %, A@!2 )8 40"G %  NP!/ =L 3@+T $X#_P!.!/\ 3@/_ +@0
M  "A$@  CA,  '\3  !T$P  ;!(  &<0  !E#@  8PL# &,&# !A!!$ 7@,9
M %P$(0!;!2@ 608O %@&-0!6!SL 50=" %0'2 !3"$\ 40A6 % )7P!."6D
M30EV $L*A !)"I0 2 JF $<*N@!&"M@ 10OS $4,_P!%#/\ 10S_ + 4  "9
M%@  AQ@  '@9  !M&   91<  %\6  !<$P  6A$  %H.!@!:# T 5PP4 %4,
M' !3#20 4@TK % -,0!/#C@ 3@X^ $T.10!+#DT 2@Y5 $@/7@!'#V@ 10]U
M $,0A !!$)4 0!"F #X0NP ]$-P /1'V #T1_P ]$/\ /A#_ *D9  "2&P
M@1P  '(=  !G'0  7QP  %D;  !5&0  4Q8  %(3  !2$0H 4! 0 $X1& !,
M$2  2A(G $D2+@!($S0 1Q,[ $430@!$$TD 0Q12 $$46P _%&4 /A5R #P5
M@0 Z%9( .!6D #<5N0 U%=@ -1;U #86_P V%O\ -Q7_ *,<  "-'@  >R
M &TA  !B(0  6B$  %0?  !0'@  31L  $P9  !+%@8 218. $<7%0!%%QP
M1!@D $(8*@!!&#$ 0!DX #\9/P ]&48 /!I/ #H:6  Y&F, -QMO #4;?@ S
M&Y  ,ANB # ;MP O&], +QSS "\;_P P&_\ ,!O_ )T?  "((@  =R,  &DD
M  !>)   5B0  % C  !+(@  2"   $8=  !%' ( 0QP, $$<$@ _'1D /ATA
M #P>)P ['BX .A\U #D?/  W'T0 -A], #0@5@ S(&  ,2!M "\@?  M(8X
M+"&@ "HAM0 I(=  *2'R "DA_P J(/\ *R#_ )DB  "$)0  <R8  &4G  !;
M)P  4R<  $PF  !')0  1"0  $(A   _(0  /2$) #LA$  Y(A8 ."(> #8C
M)0 U(RL -"0R #,D.0 R)$$ ,"1* "\E4P M)5X *R5K "HE>@ H)8P )B6?
M "0ELP C)<X (R7P "0E_P E)/\ )23_ )0E  " )P  ;RD  &(J  !7*@
M3RH  $DI  !$*   0"<  #TF   Z)0  -R8& #4F#@ T)Q0 ,B<; #$H(@ P
M*"D +R@P "TI-P L*3\ *RE' "DI40 H*EP )BII "0J>  C*HH (2J= !\J
ML@ >*LP 'BKO !\I_P @*?\ (2C_ ) H  !\*@  ;"L  %\L  !4+   3"P
M $8L  !!*P  /"L  #@J   U*@  ,BL# # K#  N+!$ +2P8 "PL'P J+28
M*2TM "@M-  G+CP )BY% "0N3P C+EH (2]G !\O=@ =+X@ '"^; !HOL  8
M+\H &"[M !DN_P ;+?\ &RW_ (PK  !X+0  :"X  %LO  !1+P  22\  $,O
M   ^+@  .2X  #0N   P+@  +2\  "LP"@ I,1  )S$5 "8Q'  E,B, )#(J
M ",R,0 A,SD (#-" !\S3  =,U< &S-D !HT=  8-(8 %C2: !0SK@ 3,\@
M$S/L !0S_P 5,O\ %C'_ (<N  !T+P  93$  %@Q  !.,@  1C(  $ Q   [
M,0  -C$  #$Q   K,P  *#0  "4U!@ C-@T (382 " W&0 ?-R  'C<G !TX
M+@ ;.#8 &C@_ !DX20 7.54 %3EB !0Y<0 2.80 $3F8 ! YK0 ..,< #CCK
M ! X_P 0-_\ $3;_ (,Q  !P,@  830  %4T  !+-   1#0  #TT   X-
M,S0  "TU   H-P  )#D  " Z @ =.PL &SP0 !D]%0 8/1P %STC !8]*P 5
M/C, %#X\ !(^1@ 1/E( $#Y?  \^;P ./H$ ##Z5  L^J0 */L$ "CWD  L]
M^P ,//\ #3O_ 'TT  !K-@  73<  %$W  !(-P  03<  #LW   U-P  ,#<
M "HY   E.P  (#T  !P_   7008 %$,- !)#$@ 10Q@ $4,? !!$)P /1"\
M#D0Y  U$0P ,1$X "T1;  E$:@ '1'P !D20  1#I0 "0[T  T/@  -#]@ $
M0O\ !D'_ '@X  !G.0  63H  $XZ  !%.@  /CH  #@Z   S.@  +3L  "<]
M   A0   '$(  !=$   31@, #TD*  U*#P ,2A0 "TH;  E*(P (2BL !THT
M  5*/@ $2DD  DI6  !*90  2G<  $J+  !*H0  2;D  $G=  !)]0  2/\
M $C_ '(\  !B/0  53X  $H^  !"/0  /#T  #8]   O/@  *4   "-"   =
M10  %T<  !-*   /3 ( "T\)  =0#0 #41$  %$7  !1'@  428  %$O  !1
M.0  440  %)1  !28   47(  %&'  !1G0  4;4  %#8  !0]0  3_\  $__
M &Q   !=00  44$  $=!  ! 0   .4   #)!   J0P  )$8  !Y(   72P
M$DX   Y1   +4P$ !E8'  !7#   6!   %@3  !9&0  6B$  %HI  !:,P
M6C\  %I,  !:6@  6FP  %J!  !9F0  6;$  %C1  !8]   5_\  %?_ &5%
M  !810  344  $5$   ^1   -44  "U'   E2@  'DT  !A0   24P  #E8
M  I9   $7    %X$  !?"0  8 T  &$0  !B%0  8QL  &0C  !D+0  9#@
M &1%  !D5   9&8  &1[  !CDP  8ZT  &+,  !A\@  8?\  &#_ %]*  !3
M2@  2DD  $-(   Y20  +TP  "=/   ?4@  &%4  !)9   -70  "&    )C
M    9@   &@!  !I!0  :@H  &L-  !M$0  ;A8  ' =  !Q)@  <3$  ' ^
M  !P3@  <%\  '!S  !OC0  ;Z<  &[&  !M[P  ;/\  &S_ %I/  !03@
M2$T  #U.   S40  *50  "!8   87   $6    QD   &:    &L   !O
M<@   '0   !U    =P0  '@)  !Z#0  ?!   'T6  !_'@  @"@  ( U  "
M10  ?U8  ']K  !_A   ?J   'V^  !\Z0  >_\  'K_ %94  !.4P  0E0
M #=6   L6@  (E\  !AC   1:   "VT   -R    =@   'H   !]    @
M (,   "$    A@   (<"  ")!P  BPP  (T0  "0%@  DA\  )(L  "2.P
MDDT  )%B  "1>@  CY<  (^T  ".X0  C/L  (S_ %59  !(6@  .UT  "]A
M   D9@  &6P  !%R   *=P   GT   ""    A@   (L   ".    D0   ),
M  "5    EP   )D   ";    G00  )\*  "B#P  I!8  *8A  "F,0  ID,
M *57  "D<   HXX  *.K  "AT   H/4  )__ $YA  ! 9   ,VD  "=N   ;
M=0  $7P   N#    B0   (X   "3    F    )T   "A    I    *4   "G
M    J0   *L   "M    L    +(   "U"   N X  +P6  "\)0  O#<  +M,
M  "Z9   N8$  +>B  "WP   M^H  +?\ $9K   Y<   *W<  !]_   3A@
M"XX   &5    FP   *$   "F    JP   +    "S    MP   +<   "Z
MO    +\   #!    Q    ,<   #*    S04  -$.  #4&0  U"L  -1   #3
M6   TW0  -.2  #2L   TM,  -+R #YY   Q@   (X@  !>1   -F0   Z
M  "G    K@   +,   "X    O0   ,(   #&    R@   ,H   #-    SP
M -(   #5    V0   -T   #?    XP   .<%  #K#P  [!\  .TS  #N2P
M[V0  .^"  #PGP  \;D  /'8 /\   #_    _P $ /\ "0#_  X _P 5 /\
M'@#_ "D _P T /\ /P#_ $@ _P!0 /\ 6 #_ %X _P!E /T :P#[ '$ ^0!W
M /@ ?@#V (4 \P"- /$ EP#N *( ZP"O .@ P #F .  XP#X .( _P#; /\
MRP#_ ,$ _P"Y /\ M #_ /\   #_    _P   /\   #_  D _P 0 /\ &0#_
M ", _P N /T .0#Y $( ]0!* /( 4@#N %@ ZP!> .D 9 #F &H Y !P .(
M=@#? 'T W0"& -D CP#5 )H T0"G ,X M@#+ ,X R0#P ,< _P#% /\ NP#_
M +0 _P"M /\ J0#_ /\   #_    _P   /\   #[  ( ]@ - /$ $P#M !X
M[  H .D ,@#C #L W0!$ -@ 2P#3 %$ T !8 ,T 70#+ &, R0!H ,8 ;P#$
M '8 P@!^ +\ AP"\ )( N@"? +< K0"U ,$ L@#D +$ _0"O /\ K #_ *4
M_P"@ /\ G #_ /\   #_    ^P   .X   #D    W  ( -, $ #/ !@ RP B
M ,D *P#& #0 P0 ] +T 1 "Z $L MP!1 +4 5@"R %P L !A *X 9P"L &X
MJ@!V *@ ?P"F (H HP"6 *$ I0"? +8 G0#1 )P \P"; /\ G #_ )8 _P"3
M /\ D #_ /\   #V    YP   -,   #&    O0 # +@ #0"S !, L0 < *\
M)0"N "X J0 V *8 /0"C $0 H0!* )\ 3P"= %4 FP!: )H 8 "8 &8 E@!N
M )0 =P"2 ($ D ". (X G ", *T B@## (D Z "( /\ B0#_ (< _P"% /\
M@@#_ /,   #C    S    +P   "P    IP   *$ " ">  \ FP 6 )D 'P"8
M "< E@ O ), -P"1 #T C@!# (P 20"+ $X B0!4 (< 60"% &  A !G ((
M;P"  'H ?@"& 'P E !Z *0 >0"X '@ V !W /< > #_ '@ _P!W /\ =0#_
M .8   #+    MP   *@   ">    E@   (\ ! "+  P B  2 (< &0"% "$
MA  I (( , !_ #< ?0 ] 'P 0P!Z $@ >0!- '< 4P!V %D = !A '( :0!Q
M ', ;P!_ &T C0!L )T :@"O &D R !H .T :0#_ &D _P!I /\ :0#_ -(
M  "X    I0   )<   "-    A@   ($   !\  @ >0 . '< % !V !P =  C
M ', *P!Q #$ ;P W &X /0!L $, :P!( &H 3@!H %0 9P!; &4 8P!C &T
M8@!X &  AP!? )8 70"H %T O@!< .0 7 #[ %P _P!< /\ 7 #_ ,(   "J
M 0  F ,  (D$  !_ @  >    '0   !P  0 ;0 , &L $0!I !< :  > &8
M)0!E "P 8P R &( . !@ #T 7P!# %X 20!< $\ 6P!6 %H 7@!8 &@ 5P!S
M %4 @0!4 )$ 4@"C %$ MP!1 -8 40#U %$ _P!1 /\ 4@#_ +8'  "?"0
MC0L  'X,  !S"P  ; H  &@'  !E P  8P ' &$ #0!? !, 70 : %P (0!;
M "< 60 M %@ ,P!6 #D 50 _ %0 10!3 $L 40!2 %  6@!/ &0 30!O $P
M?0!* (T 20"? $@ L@!' ,P 1P#O $8 _P!' /\ 1P#_ *P,  "5#@  @Q
M '40  !K$   8P\  %X.  !;#   6@D" %D$"@!7  \ 50 5 %, ' !2 ",
M40 I $\ +P!. #4 30$[ $P!00!* D@ 20)/ $@"5P!& V$ 10-M $,#>@!"
M XL 0 .< #\#KP ^ \@ /03J #T%_  ]!O\ /@;_ *00  ".$@  ?!,  &X4
M  !D%   7!,  %82  !3$0  40X  % ,!0!0"0P 3P<1 $T'%P!+"!\ 20@E
M $@)*P!'"3$ 1@DX $0*/@!#"D4 0@I- $ +50 _"U\ /0MK #P+>0 Z#(H
M. R< #<,KP U#,< -0SI #4-_0 U#?\ -@S_ )T3  "'%0  =A<  &D8  !>
M&   5A@  % 7  !-%0  2A,  $D1  !)#@< 2 T. $8-$P!$#1H 0PXA $(.
M* ! #BX /PXU #X//  ]#T, .Q!+ #H05  X$%X -A!K #00>0 R$(H ,1"<
M "\0L  M$,D +1'L "T1_P N$?\ +Q#_ )<6  ""&0  <1L  &0<  !9'
M41P  $P;  !'&@  1!@  $,5  !"$P( 01(+ $ 1$  ^$A< /!(> #L3)0 Z
M$RL .!,R #<3.0 V%$  -!1( #,440 Q%%P ,!5H "X5=P L%8@ *A6: "@5
MK@ G%<< )A7J "<5_P H%?\ *17_ )$:  !]'   ;1X  & ?  !6'P  3A\
M $@>  !#'0  0!P  #X:   ]&   .Q<' #D6#@ X%Q0 -A<; #48(@ S&"@
M,A@O #$9-@ P&3T +AE& "T:3P K&ED *AIF "@:=  F&H8 )!J9 "(:K0 A
M&L4 (!KH "$:_@ B&O\ (QK_ (T=  !Y'P  :2$  %PB  !2(@  2B(  $0A
M   _(0  /"   #D>   X&P  -1P$ #0<#0 R'!( ,!T8 "\='P N'24 +1XL
M "L>,P J'CL *1]# "<?30 F'U< )!]D "(?<@ @'X0 'Q^7 !T?JP ;'\,
M&Q_G !L?_0 ='_\ 'A[_ (D@  !U(@  92,  %DD  !/)0  1R4  $$D   \
M(P  .",  #4B   S(   ," ! "XA"@ L(1  *R$5 "HB'  H(B, )R(I "8C
M,  E(S@ (R-! "(D2@ A)%4 'R1A !TD<  ;)(( &225 !<DJ@ 6),$ %23E
M !8D_  7(_\ &2/_ (4B  !Q)   8B8  %8G  !,)P  1"<  #XG   Y)@
M-28  #$E   N)   *R4  "DE!P G)@X )283 "0G&0 C)R  (B<G "$H+@ @
M*#8 'B@^ !TH2  ;*5, &2E? !@I;@ 6*8  %"F4 !(IJ  1*<  $2CD !$H
M^P 3*/\ %"?_ ( E  !N)P  7R@  %,I  !)*@  0BD  #LI   V*0  ,B@
M "XH   J*   )BD  "0J!  B*PP ("L1 !\L%@ =+!T '"PD !LM*P :+3,
M&"T\ !<M10 6+E  %"Y= !(N;  1+GX $"Z2  XNIP -+;T #2W?  TM^0 .
M+/\ $"S_ 'PH  !J*@  6RL  % L  !&+   /RP  #DL   T*P  +RL  "LK
M   F+   (BX  !\O   <, D &C$. !DQ$P 7,1H %C(A !4R*  4,C  $S(Y
M !(S0P 1,TX $#-;  XS:0 -,WH ##..  HSH@ (,KD "#+9  @R]  *,?\
M"S'_ '<K  !F+0  6"X  $TO  !#+P  /"X  #8N   Q+@  +2X  "DN   C
M,   'S(  !LS   7-04 %#8, !(W$0 1-Q8 $3<= ! X)  /."P #C@U  TX
M/P ,.$H "SA7  DX90 '.'8 !3B*  ,XGP !-[4  3?3  (W\0 #-O\ !3;_
M ',N  !B,   5#$  $DQ  !!,0  .3$  #0Q   O,   *S   "4R   @,P
M&S8  !<X   3.@( $#P)  T]#@ ,/1, "ST9  H](0 )/2D "#TQ  8^.P %
M/D8  SY2  $^80  /G(  #Z&   ]G   /;(  #W0   \\   //\  #S_ &TR
M  !=,P  4#0  $8T   ^-   -S0  #(S   M,P  )S0  "(V   =.   &#H
M !0]   0/P( #4$(  E##0 &1!$  T06  )$'0  1"0  $0M  !$-@  1$$
M $1.  !$7   1&T  $2!  !$F   0Z\  $/-  !"\   0O\  $+_ &@V  !8
M-P  3#@  $,X   [-P  -38  # V   I-P  (SD  !X[   8/0  $T   !!"
M   -10$ "$<'  -)#   20\  $H3  !+&0  2R   $LH  !+,@  2ST  $Q)
M  !,5P  2V@  $M]  !+E   2JP  $K*  !)[P  2?\  $G_ &(Z  !4.P
M23L  $ [   Y.@  ,SD  "PZ   E/   'S\  !E!   31   $$<   Q)   (
M3    D\%  !0"@  4 T  %$0  !2%0  5!L  %0C  !4+   5#<  %1$  !4
M4@  5&,  %1W  !4CP  4Z@  %+&  !2[0  4?\  %'_ %P_  !//P  13\
M #X^   W/0  +SX  "=    @0P  &48  !-)   /3   "T\   92    5
M %<"  !8!P  60L  %H.  !;$0  718  %X=  !?)@  7S$  %X]  !>3
M7ET  %YQ  !=B0  7:,  %S!  !;ZP  6O\  %K_ %9$  !+0P  0T(  #Q!
M   R0@  *44  "%(   :2P  $TX   Y2   *50   UD   !;    7@   &
M  !B @  8P8  &4*  !F#@  :!$  &H7  !K'P  :RD  &LV  !K10  :U8
M &IJ  !J@@  :9T  &B[  !GYP  9O\  &7_ %%(  !(2   048  #='   L
M2@  (TT  !M1   350  #ED   A=   !80   &0   !G    :@   &P   !N
M    <    '(%  !S"0  =0T  '<1  !Z&   >R$  'LN  !Z/0  >DX  'EB
M  !Y>0  >)8  '>S  !UX   =/P  '/_ $Y-  !'3   .TT  #!/   F4P
M'%@  !-<   -80  !F8   !J    ;P   '(   !V    >0   'P   !]
M?P   ($   "# @  A@<  (@,  "+$0  CA@  (XD  ".,P  C40  (Q8  "+
M;P  BHP  (FJ  "(SP  AO<  (7_ $U1  !!4P  -%4  "E:   >7P  %&4
M  UJ   %<    '8   ![    ?P   (,   "'    B@   (T   ".    D0
M ),   "5    F    )H%  "=#   H!$  *,:  "C*   HCH  *%.  "@90
MH($  )Z@  "=P0  F^X  )K_ $99   Y7   +6$  "%G   6;@  #G4   5[
M    @0   (<   "-    D@   )8   ":    G0   )\   "A    I    *8
M  "H    JP   *X   "Q P  M L  +@1  "Y'@  N2\  +A#  "W6@  M78
M +27  "TM0  L>(  +#\ #]D   Q:0  )6\  !AW   /?P  !H<   ".
ME    )H   "@    I0   *H   "N    L0   +(   "U    MP   +H   "\
M    OP   ,,   #&    R0   ,X*  #2$P  TB,  -$W  #03P  SFH  ,V*
M  #*JP  R\L  ,OO #=Q   I>   '8   !&)   (D0   )H   "A    IP
M *T   "S    N0   +X   #"    Q0   ,8   #)    S    ,X   #2
MU0   -H   #>    X0   .4   #J"P  ZQ<  .HK  #J0P  ZEX  .IZ  #K
MF0  Z[4  .O5 /\   #_    _P ! /\ !P#_  T _P 2 /\ &P#_ "4 _P O
M /\ .@#_ $, _P!+ /\ 4P#_ %H _0!@ /L 9@#Z &L ^ !R /8 > #T (
M\0") .\ D@#L )T Z0"J .8 O #C -P WP#W -T _P#, /\ O@#_ +4 _P"P
M /\ K0#_ /\   #_    _P   /\   #_  8 _P - /\ % #_ !\ _P I /L
M,P#W #T \P!% .\ 30#L %, Z !9 .4 7P#C &4 X !J -T <0#: '@ U@"
M -( B@#/ )4 S "B ,@ L@#% ,D P@#M ,  _P"[ /\ L #_ *@ _P"D /\
MH0#_ /\   #_    _0   /H   #X    \  ) .P $0#H !D YP C .4 +0#>
M #8 U@ ^ -$ 1@#- $P R@!2 ,@ 6 #% %T PP!C ,  :0"^ '  O !X +D
M@0"W (T M ": +$ J0"N +P K #A *H _ "H /\ H #_ )D _P"6 /\ E #_
M /\   #Y    \@   .<   #;    T0 $ ,H #0#' !0 Q  = ,( )@"_ "\
MNP W +< /P"T $4 L0!+ *X 40"L %8 J@!< *@ 80"F &@ HP!P *$ >0"?
M (0 G0"1 )H H "8 +$ E@#, )4 \0"4 /\ D0#_ (L _P"( /\ A@#_ /<
M  #L    W@   ,D   "\    M    *\ "@"K !  J0 7 *@ ( "G "@ H@ P
M )\ . "< #X F@!$ )@ 2@"6 $\ E !5 ), 6@"1 &$ CP!H (T <0"+ 'L
MB0"( (< EP"% *@ @P"^ ($ Y "  /\ @ #_ 'P _P![ /\ >0#_ .D   #7
M    P0   +$   "F    G0   )< !0"4  T D@ 2 )  &@"/ "( C@ J (L
M,0") #@ AP ^ (4 0P"# $@ @0!. '\ 5 !^ %H ? !A 'H :0!X ', =@!_
M '4 C@!S )\ <0"S '  T !O /8 ;P#_ &\ _P!M /\ ; #_ -H   "_
MK    )X   "3    C    (4   ""  D ?P / 'X %0!] !P ?  D 'H *P!W
M #$ =0 W '0 /0!R $( <0!( &\ 30!N %, ; !: &L 8@!I &P 9P!X &8
MA@!D )< 8@"J &$ P@!@ .L 80#_ &$ _P!A /\ 8 #_ ,4   "M    FP
M (T   "#    ?    '<   !R  4 <  , &X $0!L !< ;  > &L )0!I "P
M9P Q &8 -P!D #T 8P!" &( 2 !@ $X 7P!5 %T 70!< &8 6@!R %D @ !7
M )  5@"C %4 N0!4 -X 5 #[ %0 _P!5 /\ 50#_ +8   "?    C0   '\
M  !U    ;@   &D   !F  $ 8P ) &$ #@!@ !, 7P 9 %X ( != "8 6P L
M %H ,@!8 #< 5P ] %8 0P!5 $D 4P!0 %( 6 !1 &$ 3P!L $X >@!, (H
M2P"< $H L0!) ,X 20#S $D _P!) /\ 2@#_ *H!  "4!0  @@<  '0(  !J
M"   8P8  %X$  !;    60 % %< # !6 !  5  5 %, &P!2 "( 40 H %
M+0!. #, 30 X $P /@!+ $4 2@!, $@ 5 !' %T 1@!H $0 =0!# (4 00"8
M $  JP!  ,4 /P#J #\ _P!  /\ 0 #_ * (  "*"P  >0T  &P-  !A#0
M6@T  %4+  !2"0  4 8  $\"" !.  T 3  2 $L %P!* !X 20 C $< *0!&
M "\ 10 T $0 .@!" $$ 00!( $  4  ^ %H /0!D #P <@ Z (( .0"4 #@
MIP W +X -@#C #8 ^0 V /\ -P#_ )@-  "##@  <A   &41  !;$0  4Q
M $X0  !*#@  2 T  $<* P!'!PH 100. $0"$P!" AH 00(@ $ #)0 ^ RL
M/00Q #P$-P [!#X .@5% #D%3@ W!5< -@5B #0&<  R!H  ,0:2 # &I0 O
M!;L +@7= "X&]0 M!_\ +@?_ )$0  !]$0  ;!,  %\4  !5%   3A0  $@3
M  !$$@  01   $ .  ! #08 0 H, #X)$  \"18 .PH< #D*(@ X"B@ -PLN
M #8+-0 U"SL ,PM# #(,3  P#%8 +PQA "T,;P K#'\ *@R2 "@,I0 G#+L
M)0S= "4-]0 F#?\ )PW_ (L2  !W%   9Q8  %L7  !1&   21<  $,7   _
M%0  /!0  #H2   Y$0$ .0\( #@.#0 W#A( -0X8 #0.'P R#B4 ,0\L # /
M,@ O$#H +1!" "P02P J$%4 *!!A "80;P D$(  (Q"3 "$0IP ?$+T 'A#@
M !X1]P ?$/\ (!#_ (84  !S%P  8QD  %<:  !-&P  11H  $ :   [&0
M.!@  #46   T%   ,Q($ #(2"P Q$A  +Q(5 "T2'  L$R( *Q,I "H3,  H
M$S< )Q0_ "842  D%%, (A1? " 5;0 ?%7X '161 !L5I0 9%;L &!7> !@5
M^  9%/\ &A3_ ((7  !O&@  7QP  %,=  !*'0  0AT  #P=   W'   -!L
M #$:   O&0  +A8  "P7"  K%@X *1<3 "@7&0 G&"  )1@F "08+0 C&#0
M(AD] " 91@ >&5$ '1E= !L::P 9&GP %QJ/ !4:HP 4&;H $AG; !,9]@ 4
M&?\ %1C_ 'T:  !K'0  7!\  % @  !'(   /R   #D?   T'P  ,1X  "T=
M   K'   *1L  "<;!0 E&PP )!P1 "(<%@ A'!T (!TC !\=*@ >'3( '!XZ
M !L>1  9'DX %QY; !8>:0 4'WH $AZ- !$>H@ 0'K@ #A[8  \>]0 0'?\
M$1W_ 'H=  !G'P  62$  $TB  !$(@  /"(  #8B   R(0  +B$  "H@   G
M(   )!\  "(@ @ @( H 'B$/ !TA%  <(1H &R(A !DB)P 8(B\ %R(X !4C
M00 4(TP $B-8 !$C9P 0(W@ #B.+  TCGP ,([0 "R/0  LB\  ,(O\ #2'_
M '8?  !D(@  5B,  $LD  !!)   .B0  #0D   O(P  *R,  "@C   D(P
M(",  !TD   ;)0< &28- !<F$0 6)A< %2<> !0G)0 3)RP $B<U !$H/P 0
M*$H #BA6  TH9  ,*'0 "BB'  DHFP ')[$ !2?,  8G[  ')OX "";_ '$B
M  !@)   4R8  $@G   _)P  -R8  #$F   M)@  *24  "4E   B)0  '2<
M !DH   6*@0 %"L+ !(L$  1+!0 $"P; ! L(@ .+"D #BTR  TM.P ++48
M"BU2  @M8  &+7  !"V#  (MF   +*X  "S)   LZP !*_P  BO_ &TE  !=
M)P  3R@  $4I   \*0  -2D  "\H   K*   )R<  ",G   ?*   &RH  !<L
M   3+@( $# (  XQ#0 -,1( ##$7  LQ'@ *,28 "#(N  <R-P %,D(  S).
M  $R7   ,FP  #)_   RE0  ,:P  #''   PZ@  ,/P  ##_ &@I  !8*@
M3"L  $$L   Y+   ,BL  "TK   I*@  )2H  " K   <+   %RX  !,P   0
M,@( #C0'  HW#  '-Q  !3<4  ,W&P "-R(  #<J   X,P  .#X  #A*   X
M6   .&@  #A\   WD@  -ZD  #;%   VZ@  -OT  #7_ &,L  !4+@  2"\
M #XO   V+@  ,"X  "LM   G+0  (BT  !TO   8,0  %#,  ! U   .-P$
M"CH'  8["P "/ X  #T2   ^%P  /AX  #XF   ^+P  /CH  #Y&   ^5
M/F0  #YW   ^CP  /:<  #W#   \Z0  //T  #O_ %XP  !0,0  1#(  #LR
M   T,0  +C   "DO   D,   'C(  !DT   4-@  $#D   T[   */0  !4 %
M  !!"@  0@T  $,0  !$%   11H  $8B  !&*P  1C4  $9!  !&3P  1E\
M $9S  !%B@  1:0  $3   !#Z   0_X  $+_ %@T  !+-0  034  #DU   R
M-   +3,  "8T   @-0  &C@  !0Z   0/0  #4    E"   $10   $<#  !(
M!P  2@L  $L.  !,$0  3A4  $\<  !/)0  3R\  $\\  !/2@  3UH  $YM
M  !.A0  3:   $R\  !+YP  2_X  $K_ %,Y  !'.0  /CD  #<X   Q-P
M*3<  "$Y   ;/   %3\  !!"   ,10  !T@   )*    30   $\   !1!
M4@<  %0+  !5#@  5Q$  %D7  !:'P  62D  %DV  !91   650  %AG  !8
M?P  5YH  %:W  !5XP  5/T  %3_ $X]  !#/0  /#P  #4[   L/   )#X
M !Q!   51   $$@   M+   %3@   %$   !4    5P   %D   !;    70(
M %X&  !@"P  8@X  &02  !G&   9R(  &8N  !F/   9DT  &5@  !E=P
M9),  &.Q  !AW0  8/P  %__ $E"  !!00  .C\  #!    F0P  'D8  !5*
M   03@  "E(   -6    6@   %T   !@    8P   &4   !G    :0   &L!
M  !M!0  ;PH  '(.  !U$@  =QL  '8F  !V-0  =48  '19  !T;P  <XL
M '*I  !PS0  ;_<  &[_ $9&  ! 10  -48  "I(   @3   %U$  !!6   )
M6@   5\   !C    :    &L   !O    <@   '4   !W    >0   'L   !]
M    @ ,  (,(  "&#0  B1,  (H=  "**P  B3P  (A/  "&9@  A8$  (2@
M  ""P@  @?   '__ $9+   Z3   +D\  "-3   86   $%X   ED    :0
M &\   !T    >    'P   "!    A    (<   "(    BP   (X   "0
MDP   )8   "9!P  G0T  *$4  "@(0  H#$  )Y$  "=6P  G'8  )F6  "9
MM0  EN4  )7^ #]2   R50  )EH  !M@   19P  "6T   !T    >P   ($
M  "&    BP   )    "4    EP   )D   "<    GP   *$   "D    IP
M *H   "M    L08  +4-  "X%@  MR8  +8Y  "U4   M&H  +*)  "PJ@
MKL\  *WU #=<   K80  'F@  !-P   +>    (    "'    C@   )4   ":
M    GP   *0   "H    K    *T   "P    LP   +4   "X    NP   +\
M  ##    QP   ,L%  #1#@  T1L  - N  #/10  S5\  ,M^  #)G@  R+X
M ,7I "]I   C<   %GD   V!   !BP   ),   ";    H@   *@   "N
MM    +@   "]    P    ,(   #%    R    ,L   #.    T0   -8   #;
M    WP   .0   #H!@  ZQ$  .HC  #J.@  Z50  .=R  #EDP  X[,  ./4
M /\   #_    _P   /\ ! #_  L _P 0 /\ %P#_ "$ _P K /\ -0#_ #X
M_P!' /\ 3@#_ %4 _ !; /H 80#X &8 ]@!M /0 <P#R 'L [P"$ .T C@#J
M )D Y@"G ., N0#? -4 VP#W -8 _P#  /\ L@#_ *H _P"E /\ H@#_ /\
M  #_    _@   /P   #\  , _@ + /\ $0#_ !H _0 D /D +@#T #@ \ !
M .P 2 #I $X Y@!4 .( 6@#? %\ W !E -@ :P#4 '( T ![ ,T A0#* )$
MQP"> ,, K@#  ,4 O0#K +L _P"P /\ I #_ )P _P"8 /\ E0#_ /\   #Z
M    ]    /$   #R    Z@ % .< #@#B !4 X0 > .$ * #8 #$ T  Y ,L
M0 #( $< Q0!- ,( 4P"_ %@ O0!> +L 9 "Y &L M@!S +0 ? "Q (@ K@"5
M *L I "H +@ I@#< *, ^P"? /\ E0#_ (\ _P"+ /\ B0#_ /D   #O
MYP   -\   #/    R    ,$ "@"_ !$ O  8 +L (0"Y "H M  R +$ .@"N
M $  JP!& *@ 3 "F %$ HP!6 *$ 7 "? &, G0!J )L <P"9 'X E@", )0
MFP"2 *T D #' (X \ "- /\ A@#_ (  _P!] /\ ? #_ .T   #@    T0
M +\   "S    J@   *8 !0"B  T H0 3 *  &P"? ", FP K )@ ,@"5 #D
MDP _ )$ 1 "/ $H C@!/ (P 50"* %L B !C (8 :P"$ '8 @@"" (  D@!^
M *, ? "Z 'H X0!Y /\ =P#_ '( _P!P /\ ;P#_ -T   #+    M@   *<
M  "=    E    (X  0"+  H B0 0 (@ %0"' !T AP E (0 + "" #( ?P X
M 'T /0![ $, >0!( '@ 3@!V %0 =0!; ', 8P!Q &X ;P!Z &T B0!L )H
M:@"N &D S !H /8 9P#_ &4 _P!D /\ 8P#_ ,H   "T    H0   ),   ")
M    @@   'L   !X  4 =@ , '4 $0!T !@ <P ? '( )0!P "P ;@ R &P
M-P!J #P :0!" &@ 2 !F $X 90!5 &, 70!B &8 8 !R %X @ != )( 6P"E
M %H O@!9 .D 60#_ %D _P!8 /\ 6 #_ +D   "B    D    (,   !Y
M<0   &T   !I  $ 9@ ) &4 #@!D !, 8P 9 &, ( !A "8 8  L %X ,0!<
M #< 6P \ %H 0@!8 $@ 5P!/ %8 5P!4 &  4P!L %$ >0!0 (H 3P"> $X
MM !- -H 30#[ $T _P!- /\ 30#_ *H   "4    @@   '4   !K    9
M &    !=    6@ % %@ # !7 !  5@ 5 %8 &P!5 "$ 4P G %( + !1 #$
M3P W $X /0!- $, 3 !* $H 4@!) %L 2 !F $8 <P!% (0 1 "7 $, K !"
M ,D 0@#Q $( _P!# /\ 0P#_ )X   ")    > ,  &H$  !A!   6@,  %4!
M  !2    4  " $X "0!-  T 3  1 $L %P!* !P 20 B $@ )P!' "T 10 R
M $0 . !# #X 0@!% $$ 30 _ %8 /@!A #T ;@ [ 'X .@"1 #D I@ X +\
M. #H #@ _P Y /\ .0#_ )4#  " !P  ;PD  &(*  !8"P  40H  $P(  !)
M!@  1P,  $8 !@!$  L 0P / $( $P!! !@ 00 > #\ (P ^ "D /0 N #L
M-  Z #H .0!! #@ 20 W %( -@!= #0 :@ S 'H ,@", #$ H0 P +@ +P#>
M "\ ^0 O /\ , #_ (P)  !X#   : T  %P.  !2#@  2PX  $4-  !!#
M/PH  #X( @ ]! @ / $- #L $  Z !4 .0 : #@ (  V "4 -0 K #0 ,  S
M #< ,@ ^ #$ 1@ O %  +@!: "T 9P K '< *@") "D G0 H +, )P#1 "<
M\@ G /\ )P#_ (8,  !R#@  8Q   %81  !-$0  11$  $ 0   \#P  .0X
M #<-   V"P0 -@@* #4&#@ T!1( ,@07 #$%'  P!2( +P4H "X&+@ M!C0
M*P8\ "H&1  I!TX )P=9 "8'90 D!W4 (P>' "('FP @!K  ( ;+ !\%[0 ?
M!OX 'P?_ ( .  !M$0  7A(  %(3  !($P  01,  #L3   W$@  -!$  #(0
M   P#P$ , T& # +"P O"A  +0H4 "P+&0 J"Q\ *0LE "@,*P G##( )@PZ
M "0,0P C#$T (0U8 " -90 >#74 ' V( !H-G  9#;$ & S* !<,ZP 7#?P
M& S_ 'L1  !I$P  6A4  $X6  !%%@  /18  #@5   S%0  ,!0  "T3   K
M$@  *A # "H/"  I#@T * X1 "8.%@ E#QT ) \C ",/*0 A$#$ (! Y !X0
M0@ =$$P &Q!8 !D09@ 7$'8 %1") !00G@ 2$+, $1#. !$0[@ 2$/X $A#_
M '<3  !E%0  5Q<  $L8  !"&0  .AD  #08   P%P  +!<  "D6   G%0
M)A0! "42!  C$@L (A(/ "$2%  @$AH 'A,@ !T3)P <$RX &A,V !D40  7
M%$H %A16 !049  2%'0 $12' ! 4G  .%+$ #13*  T4ZP .$_X #A/_ ',5
M  !A&   4QH  $@;   _&P  -QL  #(:   M&@  *1D  "88   D&   (A<
M " 6 0 >%@@ '18- !L7$@ :%Q< &1<= !@8)  6&"L %1@T !08/0 2&4@
M$1E4 ! 98@ .&7( #1F$  P9F  *&:T "1C&  D8YP )&/H "A?_ &\8  !>
M&@  4!P  $4=   \'0  -1T  "\=   J'   )AL  ",;   A&@  'AH  !P:
M   :&P4 &!L, !8<$  5'!4 %!P; !,<(@ 2'2D $1TQ ! =.P .'44 #1Y1
M  P>7@ *'FT "1Z   <>E  %':H  QW"  ,=Y@ $'/@ !1S_ &L:  !;'0
M31X  $(?   Z'P  ,A\  "T?   H'@  )!X  "$=   >'0  '!T  !@>   5
M'P( $R ) !(A#@ 0(1( $"$8  XA'P .(B8 #2(N  PB-P *(D$ "2)-  <B
M6@ %(FD  R)\  $BD0  (J@  "'    AY0  (/@  "#_ &<=  !7'P  2B$
M $ A   W(@  ,"$  "HA   F(   (B   !\?   <'P  &2   !8A   2(P(
M$"0'  XF#  ,)A  "R85  HF'  ))B( ""8J  8G,P $)ST  R=)  $G5@
M)V8  "=Y   GCP  )J8  ":_   EY   )?D  "3_ &,@  !4(@  1R,  #TD
M   T)   +B,  "@C   D(@  (2(  !XA   :(@  %R,  !,D   0)@( #B@'
M  LJ"P (*PX !BL3  0K&  "*Q\  2PG   L,   +#H  "Q%   L4P  +&,
M "QV   LC   *Z0  "N^   JY   *OH  "G_ %\C  !0)0  1"8  #HF   R
M)@  *R8  "8E   C)   'R0  !LD   7)0  %"<  !$I   .*P( "RT&  <O
M"P $, X  # 1   Q%0  ,1P  #$C   R+   ,C8  #)"   R3P  ,E\  #)R
M   QB0  ,:(  #"\   PY   +_L  "__ %HG  !,*   0"D  #<I   O*0
M*2@  "4G   A)@  '"<  !@H   4*@  $2P   XN   +, $ !S(%  ,T"0
M-0P  #8/   W$@  .!@  #@@   X*   .#(  #D]   Y2P  .5L  #AN   X
MA0  -Y\  #>Z   VY   -?P  #7_ %4J  !(+   /2P  #0L   M*P  *"H
M "0I   >*@  &2L  !0M   1+P  #3$   HT   '-@   C@$   Z!P  .PH
M #T-   ^$   0!0  $ ;  ! )   0"X  $ Y  ! 1P  0%8  $!I  ! @
M/YL  #ZW   ]XP  //P  #S_ % O  !#+P  .2\  #(O   L+0  )RP  " M
M   :+P  %3$  !$S   --@  "3@   4[    /0   $ !  !!!   0P<  $4+
M  !&#@  2!$  $H6  !*'@  2B@  $HT  !)0@  25$  $ED  !(>P  2)<
M $>T  !&X   1?P  $3_ $HS   _,P  -C,  # Q   J,   (S$  !PS   6
M-0  $3@   T[   (/@   T$   !#    1@   $@   !*    3 0  $X'  !/
M"P  40X  %02  !5&0  52(  %0N  !4/   5$L  %->  !3=   4I   %&N
M  !0UP  3_L  $[_ $4W   \-P  -38  "\T   F-0  'C<  !<Z   1/0
M#$$   =$    2    $H   !-    4    %,   !5    5P   %@"  !;!@
M70L  %\.  !B$P  8AL  &(G  !B-   844  &!7  !@;0  7XD  %VG  !<
MS   6O@  %G_ $$\   Z.P  -#D  "HZ   A/   &$   !%#   ,1P  !DL
M  !/    4P   %8   !9    7    %\   !A    8P   &4   !G 0  :@4
M &T*  !P#@  <Q4  '(@  !R+0  <3T  '!/  !O90  ;H   &V?  !KP0
M:?$  &C_ #]    Y/@  +C\  "1"   :1@  $DH   Q/   $5    %@   !=
M    80   &4   !H    :P   &X   !Q    <P   '4   !X    >P   'X#
M  "!"@  A0\  (<7  "&)   A30  (1&  ""70  @78  '^6  !^M@  ?.<
M 'K_ #]$   S10  *$@  !U,   34@  #%<   -=    8P   &@   !M
M<0   '8   !Z    ?@   ($   "#    A@   (D   "+    C@   )(   "5
M 0  F0D  )X0  ">&@  G2D  )P\  ":4@  F&P  ):+  "4J@  DM0  )#Z
M #A+   L3@  (%,  !59   -8    V<   !N    =    'H   "     A
M (H   ".    D@   )4   "7    F@   )T   "@    HP   *<   "K
MKP   +0)  "X$   MQX  +4P  "S1@  L6   *]^  "LH   J\$  *GN #%5
M   D6P  &&$   YI   %<0   'D   "!    B    (\   "4    F@   )\
M  "D    J    *D   "L    KP   +,   "U    N0   +T   #!    Q@
M ,L   #1"@  TQ0  -$E  #0.P  S50  ,IQ  #(D@  Q;,  ,/> "EB   <
M:0  $7$   =[    A    (T   "5    G0   *,   "I    KP   +0   "Y
M    O    +X   #"    Q0   ,@   #,    T    -0   #:    WP   .0
M  #J    [@P  .T:  #L+P  ZDD  .AE  #FA@  Y*4  .+& /\   #_
M_P   /P  0#\  @ _@ . /\ % #_ !T _P F /\ , #_ #H _P!" /\ 20#^
M %  ^P!6 /D 7 #V &( ] !H /( ;P#P '8 [0!_ .H B0#G )4 Y "C .
MM0#; -  U0#V ,H _P"V /\ J #_ )\ _P": /\ E@#_ /\   #[    ]@
M /,   #S    ]@ ) /H #@#] !8 ^P @ /< *@#R #, [0 [ .D 0P#F $D
MX@!/ -X 50#; %L U@!@ -( 9P#/ &X S !V ,D @ #& (P P@": +\ J@"[
M ,$ N #I +8 _P"G /\ F@#_ )( _P"- /\ B@#_ /H   #Q    Z@   .<
M  #G    Y  ! .  "P#; !$ V@ : -L (P#1 "P R@ T ,8 .P#" $( OP!(
M +P 3@"Z %, N !9 +8 7P"S &8 L0!N *X =P"L (, J0"1 *8 H0"C +4
MH #8 )X ^P"5 /\ BP#_ (4 _P"  /\ ?@#_ .\   #C    V@   -,   #&
M    OP   +D !@"W  X M  4 +0 '0"S "4 K@ M *L - "G #L I !! *$
M1@"? $P G0!1 )L 5P"9 %X EP!E )4 ;@"3 'D D "' (X EP", *D B0#$
M (@ [P"% /\ ? #_ '8 _P!S /\ <@#_ .    #0    Q@   +8   "I
MH0   )T  0"9  H F  0 )@ %@"7 !X E  F )$ +0"/ #0 C  Z (H /P"(
M $4 AP!* (4 4 "# %8 @0!> (  9@!^ '$ ? !] 'D C0!W *  =0"V ',
MWP!R /\ ;@#_ &D _P!G /\ 90#_ ,P   "^    JP   )T   "3    B@
M (4   ""  4 @  - '\ $0!_ !@ @  @ 'T )@!Z "T =P S '4 . !T #X
M<@!# '  20!O $\ ;0!6 &P 7@!J &@ : !U &< A !E )8 9 "K &( R0!A
M /8 8 #_ %P _P!; /\ 6@#_ +T   "I    EP   (D   !^    >    ',
M  !O  $ ;0 ) &P #@!K !, :P 9 &H ( !H "8 9@ L &4 ,@!C #< 8@ \
M &  0@!? $@ 70!/ %P 5P!: &$ 60!M %< >P!6 (X 50"B %, NP!2 .D
M4@#_ %  _P!/ /\ 3P#_ *T   "8    A@   '@   !N    9P   &,   !@
M    70 % %P "P!; !  6P 5 %L &P!: "$ 6  F %8 + !4 #$ 4P V %(
M/ !1 $( 3P!) $X 40!- %L 2P!F $H = !) (4 2 "9 $< L0!& -@ 1@#\
M $4 _P!% /\ 10#_ )\   ")    >    &P   !B    6P   %8   !3
M40 " $\ " !/  T 3@ 1 $X %@!- !P 3  A $H )@!) "P 2  Q $< -P!%
M #T 1 !$ $, 3 !" %4 0 !@ #\ ;@ ^ 'X /0"2 #P J0 [ ,< .P#S #L
M_P [ /\ / #_ ),   !^    ;@   &$   !8    40   $P   !)    1P
M $4 !0!$  L 0P . $, $@!# !< 0@ = $  (@ _ "< /@ L #T ,@ [ #@
M.@ _ #D 1P X %  -P!; #4 :  T '@ ,P", #( H@ Q +P ,0#G #$ _P R
M /\ ,P#_ (D   !V P  9@4  %D'  !0!P  208  $,%  !  P  /@$  #P
M P [  @ .@ - #H $  Y !0 .0 9 #< '@ V ", -0 H #0 +@ S #0 ,@ [
M #  0P O $P +@!7 "T 9  L ', *P"' "H G  I +4 *0#< "D ^P I /\
M*@#_ ($$  !N"   7PH  %,+  !*"P  0@L  #T*   Y"0  -@@  #4%   T
M @8 ,P * #( #@ Q !$ ,0 5 #  &@ O !\ +@ D "P *@ K #  *@ W "D
M/P H $D )P!4 "8 8  D &\ (P"" "( EP A *X (0#, "$ \P A /\ (@#_
M 'L)  !H#   6@T  $X.  !%#@  /0X  #@-   S#0  , P  "X+   M"0,
M+08( "P$#  K @\ *@$2 "D!%P H 1P )P A "8 )P E "T )  T ",!/0 B
M 48 (0%1 !\!70 > 6P ' %_ !L E  : *H &@#% !H ZP 9 /\ &@#_ '4,
M  !D#@  50\  $H0  ! $   .1   #,0   O#P  + X  "D.   G#0$ )PP%
M "<*"@ F" T )0<0 "0&%  B!AD (08? " ')  ?!RL '@<R !T'.@ <"$0
M&@A/ !D(7  7"&L %@A] !4'D0 4!Z< $P:_ !(%Y  2!?H $@7_ '$.  !?
M$   41$  $82   ]$@  -A(  # 2   K$0  *!$  "40   C$   (@X$ "$-
M!P A# L ( L. !\+$@ ="Q< ' P< !L,(@ :#"D &0PQ !@,.0 6#4, %0U/
M !,-7  2#6L $ U^  \-D@ .#:< #0R^  T,X  -#/4 #0S_ &T0  !<$0
M3A,  $,4   Z%   ,A0  "T4   H$P  )1,  "(2   @$0  'A$# !P0!0 <
M#P@ &P\, !H.$  9#Q0 %P\: !8/(0 5$"@ %! P !(0.0 1$$0 $!!0  X0
M70 -$&L #!!\  L0D  )$*4 "!"\  <0WP '$/0 !P__ &D1  !8%   2Q4
M $ 6   W%@  ,!8  "H6   F%0  (A4  !\4   =$P  &A," !D2!  7$@8
M%A(* !42#@ 4$A( $A(8 !$3'@ 1$R4 $!,N  X3-P -%$  #!1+  L46  )
M%&< !Q1X  84C0 $%*,  Q.[  (3W0 !$O0  A+_ &43  !5%@  2!<  #T8
M   T&   +1@  "@8   C%P  (!<  !T6   :%0  &!4" !85!  4%04 $A8(
M !$6#0 0%Q  #A<5  X7&P -%R( #!<I  L8,@ )&#P !QA'  485  $&&,
M AAU  $8BP  %Z$  !>Y   7W0  %O4  !;_ &$6  !2&   11H  #L:   R
M&@  *QH  "4:   A&0  'A@  !L8   8%P  %A<" !07 P 2& 4 $!D'  X;
M"P ,&P\ "QL3  H;&  ('!\ !QPF  4<+P $'#@  AQ$   =40  '6   !UR
M   <B   '*   !NY   ;W@  &O8  !K_ %X8  !/&@  0AP  #@<   O'0
M*1P  ",<   ?&P  '!H  !D9   7&0$ %!D" !(: P 0&P0 #AT'  P>"P )
M'PX !B 1  4@%@ #(!P  2$C   A*P  (34  "%    A3@  (5T  "%O   A
MA@  ()X  ""X   ?W@  'O@  ![_ %H;  !+'0  /QX  #4?   M'P  )QX
M "(=   >'0  &QP  !@;   5&P  $AP  ! = @ .'P0 #"$&  DB"@ %(PT
M B00   E$P  )1D  "8@   F*   )C(  "8]   F2@  )EH  "9L   F@P
M)9P  "6W   DWP  (_D  "/_ %4>  !'(   /"$  #(A   K(0  )2   " ?
M   ='@  &AT  !8>   3'@  $"    XA   ,(P( ""4%  4G"0  * L  "H.
M   K$0  +!8  "P=   L)0  +"X  "PZ   L1P  +%8  "QI   L@   *YH
M "JU   IWP  *?L  "C_ %$B  !$(P  ."0  "\D   H(P  (R(  !\A   <
M(   %R   !,A   0(P  #B0   LF   (*   !"H$   L!P  +@D  # ,   Q
M#P  ,Q,  #,9   S(0  ,RH  #,U   S0P  ,U(  #-E   R>P  ,I<  #&S
M   PW@  +_L  "[_ $PE   _)@  -2<  "TF   G)0  (B0  !XC   9(P
M%"0  !$F   .*   "RH   <L   #+P   #$"   S!   -0<  #<*   Y#0
M.A   #L5   ['0  .R8  #LQ   [/@  .TX  #M@   Z=P  .9(  #BP   W
MVP  -OP  #7_ $<I   [*@  ,BH  "LI   E)P  (28  !LG   5*   $2H
M  XL   *+P  !C$   $T    -@   #@    [ 0  /00  #\'  !!"@  0PX
M $41  !%&   12$  $4L  !$.0  1$@  $1;  !#<0  0HT  $&K  ! T@
M/_H  #[_ $(M   X+@  +RT  "DK   D*@  '2H  !<L   1+@  #3$   DT
M   $-P   #H    \    /P   $$   !$    1@   $@#  !*!P  3 L  $X.
M  !0$P  4!P  % G  !/-   3T,  $]5  !.:@  388  $RD  !*R@  2?@
M $C_ #XR   U,0  +B\  "DN   @+@  &3$  !(S   .-P  "3H   (]
M0    $0   !'    20   $P   !/    40   %,   !5 0  6 8  %H+  !=
M#@  7Q4  %X@  !>+   73P  %Q.  !;8P  6GX  %B=  !7P   5?(  %3_
M #HV   S-   +3(  "0S   ;-@  $SD   X]   (00   $4   !)    3
M %    !3    5@   %D   !;    70   &    !B    90   &@%  !K"P
M;Q   &\8  !N)0  ;30  &U&  !K6P  :G4  &B4  !FM@  9.D  &+_ #@Y
M   R-P  *#D  !X[   5/P  #D0   =)    30   %(   !6    6@   %X
M  !B    90   &@   !K    ;0   '    !S    =@   'D   !]!   @0L
M (41  "$'0  @BP  ( ^  !^5   ?FL  'N*  !ZJ@  =]8  '7] #@]   L
M/@  (D$  !=&   /2P  !U$   !7    7    &(   !F    :P   &\   !T
M    >    'L   !^    @    (,   "&    B@   (T   "1    E@,  )L,
M  "=$P  FR$  )HS  "720  E&(  )-_  "0H   CL4  (SS #%$   E2
M&DT  !!3   (6@   &$   !H    ;@   '0   !Y    ?P   (0   ")
MC0   )$   "3    E@   )D   "=    H    *0   "H    K    +(#  "W
M#0  MQ<  +4H  "R/@  L%8  *QS  "JE   J;0  *7E "I/   >5   $EL
M  IB    :@   ',   ![    @@   (D   ".    E    )H   "?    I
M *8   "I    K0   +    "S    MP   +L   #     Q0   ,L   #1!
MU0X  -,=  #0,@  S4L  ,IF  #&AP  PJD  ,'+ ");   68@  #&L   %T
M    ?0   (<   "0    EP   )X   "D    JP   +$   "V    N@   +P
M  #     Q    ,@   #+    SP   -0   #:    X    .8   #K    \08
M / 3  #N)P  [#\  .I;  #G>@  Y)L  ."[ /\   #[    ]@   /,   #T
M  4 ]@ , /H $0#_ !D _P B /\ + #_ #4 _P ] /\ 10#\ $P ^@!2 /<
M6 #U %X \P!D /$ :@#N '( [ !Z .D A0#E )$ X0"@ -T L@#8 ,X T@#V
M ,$ _P"M /\ G@#_ )8 _P"0 /\ C #_ /H   #R    [    .D   #I
M[  % /( # #X !( ]P ; /4 )0#P "X ZP W .8 /@#B $4 W0!+ -@ 4 #3
M %8 T !< ,T 8@#* &H R !R ,4 ? #" (@ O@"6 +H J "W +\ M #H *X
M_P"= /\ D #_ (@ _P"# /\ @ #_ /    #E    W@   -H   #;    W
M -@ !P#1  X T0 5 -( '@#+ "< Q0 O ,  -P"] #T N@!$ +< 20"U $\
ML@!5 +  6P"N &$ K !I *D <P"G '\ I "- *$ G@"> +( FP#5 )D _ ",
M /\ @@#_ 'L _P!V /\ = #_ .(   #3    R@   ,<   "\    M@   +
M 0"O  L K  1 *T & "M "  J  H *0 +P"@ #8 G0 \ )L 0@"9 $< EP!-
M )4 4P"3 %D D0!A (\ :@", '4 B@"# (@ E "& *< @P#" (( \ !\ /\
M<P#_ &T _P!J /\ : #_ ,\   #!    N0   *T   "@    F    )0   "1
M  8 D  - )  $@"/ !D C@ A (L * "( "\ A@ U (0 .@"" $  @ !% 'X
M2P!\ %( >@!9 '@ 8@!V &P = !Y '( B0!Q )T ;P"T &T WP!L /\ 90#_
M &  _P!> /\ 7 #_ +X   "Q    H    )(   ")    @@   'P   !Z  $
M>  ) '< #@!X !0 =P : '0 (0!R "< <  M &X ,P!L #@ :P ^ &D 1 !H
M $H 9@!1 &0 6@!C &0 80!P %\ ?P!> ), 70"I %P R !; /< 5P#_ %0
M_P!2 /\ 40#_ +    "?    C0   '\   !T    ;@   &H   !F    90 $
M &, "P!C !  8P 5 &, &P!A "$ 7P G %T + !< #( 6@ W %D /0!7 $,
M5@!+ %4 4P!3 %P 4@!H %  =P!/ (D 3@"? $T N@!, .D 2P#_ $D _P!'
M /\ 1P#_ *(   "-    ?    &X   !E    7@   %D   !7    50 ! %0
M!P!3  T 4P 1 %0 %@!2 !L 40 A $\ )@!. "L 3  Q $L -P!* #T 20!$
M $< 3 !& %8 1 !A $, < !" ($ 00"7 $  KP _ -< /P#_ #X _P ] /\
M/@#_ )0   !_    ;P   &,   !9    40   $T   !*    2    $< ! !'
M  H 1@ . $8 $0!' !8 10 < $0 (0!" "8 00 K $  ,0 ^ #< /0 ^ #P
M1P Z %  .0!; #@ :0 W 'H -@"/ #4 IP U ,8 - #U #0 _P T /\ -0#_
M (@   !T    90   %@   !/    2    $,    _    /0   #P  @ \  <
M.P , #L #P [ !( .@ 7 #D '  W "$ -@ F #4 +  T #( ,P Y #$ 00 P
M $L +P!6 "X 8P M ', + "( "P H  K +L *P#J "L _P K /\ + #_ '\
M  !L    70$  %$"  !( P  0 ,  #L"   W    -    #,    R  4 ,@ )
M #( #0 Q !  ,0 3 #  &  O !T +0 B "P *  K "X *@ U "D /0 H $8
M)P!1 "8 7@ E &X ) "" ", F0 C +, (@#> "( _P C /\ ) #_ '<   !E
M!   5@8  $L'  !""   .@@  #4'   P!@  +04  "P#   K  , *@ ' "D
M"P I  X *0 1 "@ %0 G !D )@ > "4 )  D "H (P Q "( .0 A $, ( !.
M !\ 6@ > &D '0!\ !P DP ; *P &P#- !L ]@ ; /\ ' #_ ' %  !?"
M40H  $8+   ]"P  -0L  # +   K"@  * D  "4(   D!P( (P0& ",""0 B
M 0P (@ / "$ $@ @ !8 'P ; !X (  = "8 '  N !L -@ : #\ &0!* !@
M5P 7 &8 %@!X !4 CP 5 *8 % ## !0 [@ 4 /\ %0#_ &L(  !;"P  30P
M $(-   Y#0  ,0T  "P-   G#0  (PP  "$,   ?"P$ '@H% !T("  =!@L
M' 4- !P$$  ;!!0 &008 !D$'@ 8!", %P0K !8$,P 5!#P % 1' !,#5  2
M V, $0-U ! "B@ 0 :( #P"\  \ Y0 / /X $ #_ &<+  !7#0  20X  #X/
M   U#P  +@\  "@/   D#@  ( X  !T.   ;#0$ &0T$ !@,!P 8"PD %PD,
M !<)#@ 6"1( %0D6 !0)&P 3"2$ $@DH !(),  1"3H $ E%  \)4@ ."6$
M#0ES  P(B  +")\ "@>W  H&VP *!?8 "@3_ &,-  !3#@  1A   #L1   R
M$0  *Q$  "40   A$   '1   !H/   8#P$ %@X$ !4.!P 4#0D $PT+ !,,
M#0 2#!  $0P4 ! ,&0 0#!\ #PPG  X-+P -#3D # U%  L-40 )#6  " UQ
M  8-A@ %#9T ! RT  ,,T@ "#/$  @O_ %\.  !0$   0Q$  #@2   O$@
M*!(  ",2   >$0  &Q$  !@1   5$ ( %! % !(0!P 1#PD $ \* ! .#  .
M#@X #@\2  T/%P ,$!T #! D  H0+  )$#8 "!!!  803@ %$%T  Q!O  $0
MA   $)P   ^T   .U   #O,   [_ %P0  !-$@  0!,  #84   M%   )A0
M "$3   <$P  &1(  !82   4$0, $A$& !$1"  0$ H #A +  T1"P ,$0T
M"Q(1  H2%0 )$AH "!(A  83*0 %$S,  Q,^  (32P  $UH  !-L   3@@
M$IL  !*T   1UP  $?4  !'_ %@2  !)%   /14  #,6   K%@  )!4  !\5
M   :%   %Q0  !03 0 3$@0 $1(' ! 2"0 .$@D #1()  L3"@ )% T !Q4/
M  86$P $%A@  Q8?  (6)P  %S   !<[   72   %U@  !=J   6@   %ID
M !6T   5V0  %/<  !/_ %44  !&%@  .A<  # 8   H&   (A<  !T6   9
M%@  %A4  !,4 P 2$P8 $!,'  \3!P -% < "Q4(  D6"0 && P  QH.  $:
M$0  &A8  !L<   ;)   &RT  !LX   ;1@  '%4  !MG   ;?0  &Y<  !JS
M   9VP  &/D  !?_ %$6  !#&   -QD  "X:   F&@  (!D  !L8   8%P
M%18! !,5!0 1%00 #Q4$  T6!  +%P4 "1D&  8:"  "' H  !X-   @$
M(!,  " 9   @(0  (2H  "$U   A0@  (5(  "!D   @>@  'Y4  !^Q   >
MVP  '?H  !S_ $T9   _&P  -!P  "L<   D'   'AL  !H:   7&   %!<"
M !(7 @ 0& $ #1D!  L: @ (' , !1T$  (?!@  (0@  ",+   E#@  )A$
M "86   F'@  )R<  "<R   G/P  )DX  "9@   F=P  )9(  "2O   CV@
M(OL  "'_ $@=   \'@  ,1\  "@>   B'@  '1P  !D;   6&@  $AH  ! ;
M   -'   "QT   @?   $(0   2,"   E!   )P8  "D)   L#   +@\  "X3
M   N&@  +B,  "XN   N.P  +DH  "U<   M<@  +(X  "NL   JU   *?L
M "C_ $0@   X(0  +B$  "8A   @(   '!X  !@=   4'0  $!X   X?   +
M(0  !R,   ,E    )P   "D    L 0  +@,  # &   S"@  -0T  #81   V
M%P  -A\  #8I   V-@  -D4  #57   U;0  -(D  #*H   QSP  ,/H  "__
M #\D   T)   *R0  "0C   ?(0  &R   !8@   1(0  #B,   HE   &*
M BH    M    +P   #(    T    -P   #D#   [!@  /@H  $ .  !!$@
M01H  $ E  ! ,0  0$   #]2   ^9P  /8(  #RB   ZQP  .?@  #C_ #HH
M   P*   *2<  ",E   ?(P  &"0  !(E   .*   "BH   4M    ,    #,
M   V    .    #L    ^    0    $(   !% @  1P8  $H*  !-#@  314
M $P?  !,*P  2SH  $I,  !)80  2'P  $>;  !%OP  0_,  $+_ #8L   M
M*P  )RD  ",G   ;*   %"H   XM   *,   !#,    W    .@   #T   !
M    0P   $8   !(    2P   $T   !0    4P$  %8&  !9"P  6Q   %L9
M  !:)0  630  %A&  !76@  570  %23  !2M0  4.H  $__ #,P   L+@
M)RP  !XM   6+P  $#(   HV   #.@   #\   !"    1@   $D   !,
M3P   %(   !5    6    %H   !=    8    &,   !G!@  :PP  &P2  !K
M'@  :RP  &D]  !G4@  9FH  &2)  !AJP  7]P  %W_ #$S   L,0  (C(
M !DU   1.0  "CT   )"    1P   $P   !0    5    %@   !;    7P
M &(   !E    :    &L   !N    <0   '4   !Y    ?08  ((-  ""%@
M@"0  'XU  !\20  >V$  'A_  !VGP  <\8  '#W #$V   F.   '#L  !)
M   +10   DL   !1    5@   %L   !@    90   &D   !N    <@   '8
M  !Y    ?    'X   ""    A0   (D   ".    DP   )@&  "<#@  FQH
M )@K  "60   DED  )%S  "-E0  B[4  (CH "L^   @00  %4<   U-   "
M5    %L   !A    :    &X   !S    >0   'X   "#    B    (P   "/
M    D@   )4   "9    G0   *$   "E    J@   +    "W!P  N!$  +4A
M  "R-0  KTT  *II  "HB   IJ@  *+1 "-(   83@  #E0   1<    9
M &T   !U    ?    (,   ")    CP   )4   ";    H    *,   "F
MJ0   *T   "Q    M0   +D   "^    Q    ,H   #2    V@H  -86  #2
M*0  SD$  ,I<  #%?   PIT  ,&] !Q5   17   !V4   !N    =P   '\
M  "(    D    )@   "?    I0   *T   "S    N    +H   "^    P@
M ,8   #*    S@   -,   #:    X    .<   #M    \P   /0.  #R'@
M[S8  .Q1  #H;@  Y)   -^Q                       ! P0%!@@)"@L-
M#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&
M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
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M________________________________________________
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M^/GZ^_S]_O]M9G0Q      ,$(0   0                    $
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MH#X:_ZA')O^N433_KUM%_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN
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M_ZUE5_BI;VCMHWAYXYM_A]N2A934BXR>SX61ILN E:S'?)FQQ7F>M<)VH[G
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MQVZLG\=NK)_';JR?QVZLG\?_GAX$_YTI"?^I,@[_MCH4^L)#'_#.2B[GW4]
MXNE25]+H6FW!X&* L=1GD:'*:YZ4PVZHB;UQL("Y=+9YMG>Z=+1[O6ZR@<!J
ML(C"9["2PV:PEL-FL);#9K"6PV:PEL-FL);#9K"6PV:PEL-FL);#9K"6PV:P
MEL-FL);#9K"6PV:PEL/_GQX$_YXI"?^M,0W_NCH3],="'>C52BO?Y$P_U^Q1
M5LGN66NWXV%\J-AGBYK/:Y>-R6Z@@\1QIWO =*QUO7BP<+M[LVRY@+9HN(:X
M9+>/N6.VD;ICMI&Z8[:1NF.VD;ICMI&Z8[:1NF.VD;ICMI&Z8[:1NF.VD;IC
MMI&Z8[:1NF.VD;K_H!X$_Z$H"/^Q, O[P#D1[,Y"&=_?1RC3Z4Q RO%15;[R
M6&BMYF%WGMUGA)+5;(^'SV^6?LMSG'C(=J%RQGFD;L1\IVG"@:EFP(:L8K^-
MK6&_CZYAOX^N8;^/KF&_CZYAOX^N8;^/KF&_CZYAOX^N8;^/KF&_CZYAOX^N
M8;^/KF&_CZ[_HAT#_Z8G!_^W+PGRQS@-X=A!%-+F1BK'\$Q OOA04[+U5V.B
MZV%PE>-G>XK=;82!V'&+>M1UD'32>9-PT'R6;,Y_F6C,@YMDRXB=8<J-GV#)
MCY]@R8^?8,F/GV#)CY]@R8^?8,F/GV#)CY]@R8^?8,F/GV#)CY]@R8^?8,F/
MGV#)CY__I!T#_ZTF!?N^+0;FT#0(T^(\%L?N1BN[^4H^L/Y/3Z;Z5UR8\6%H
MC.MH<8/F;GA[XG-]==]X@7'=>X1MVW^':MJ#B6?9AHIDUXN,8=:0CF#5D8Y@
MU9&.8-61CF#5D8Y@U9&.8-61CF#5D8Y@U9&.8-61CF#5D8Y@U9&.8-61CF#5
MD8[_IQP#_[4C ^[))@/5WRD'Q^P\&;KX1"NM_T@[H_]-29K_5U2-^6%=A/1J
M97SP<&IV[79N<>MZ<6WI?G1KZ()V:.:%=V;EB'ECY(QZ8>.1?&#CDGQ@XY)\
M8..2?&#CDGQ@XY)\8..2?&#CDGQ@XY)\8..2?&#CDGQ@XY)\8..2?&#CDGS_
MJQL"]\ = =G<$@''ZR@*NO<[&JS_02F@_T8VE?],08W_5DN#_V%2>_UK5W3Z
M<5QO^'9?;/9[86GU?V-G](-D9?.&9F/RBF=A\8YH7_"2:5_PDVI?\)-J7_"3
M:E_PDVI?\)-J7_"3:E_PDVI?\)-J7_"3:E_PDVI?\)-J7_"3:E_PDVK_MQ4!
MUL\+ ,?J$P*Y]RD-K/\Y&I[_/B:2_T0PA_]+.8#_5$!X_V%&<O]J2FS_<$UI
M_W909O][463_?U-C_X-48?^&56#^B59>_HU77?V26%S]DUA<_9-87/V36%S]
MDUA<_9-87/V36%S]DUA<_9-87/V36%S]DUA<_9-87/V36%S]DUC6Q @ QM0)
M +CW% 2K_RD.GO\T&)#_.B&$_T$I>O]),'+_4C9L_UXZ:/]H/63_;T!A_W1!
M7_]Y0U[_?41=_X!%7/^$15O_AT9:_XI'6/^/1UC_D$A8_Y!(6/^02%C_D$A8
M_Y!(6/^02%C_D$A8_Y!(6/^02%C_D$A8_Y!(6/^02%C_D$C$QP< M]L' :G_
M%@:?_RH-D/\P%8/_-AQW_SXB;O]'*&;_4"QA_UHO7?]D,5O_;#-9_W$U6/]U
M-E;_>396_WPW5?]_-U3_@CA3_X4Y4O^).5+_BCE2_XHY4O^*.5+_BCE2_XHY
M4O^*.5+_BCE2_XHY4O^*.5+_BCE2_XHY4O^*.5+_BCG_DAT$_Y I"?^--1#_
MF#L7_Z!$(?^F3BW_IUD\_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\
MFYG4>*">T76DHL]SJ:7-<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]
MKL-IO:[#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7
M_Z!$(?^F3BW_IUD\_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4
M>*">T76DHL]SJ:7-<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-I
MO:[#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$
M(?^F3BW_IUD\_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">
MT76DHL]SJ:7-<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#
M:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$(?^F
M3BW_IUD\_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">T76D
MHL]SJ:7-<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VN
MPVF]KL-IO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$(?^F3BW_
MIUD\_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">T76DHL]S
MJ:7-<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VNPVF]
MKL-IO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$(?^F3BW_IUD\
M_Z5D3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">T76DHL]SJ:7-
M<:ZHS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VNPVF]KL-I
MO:[#:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$(?^F3BW_IUD\_Z5D
M3/^A;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">T76DHL]SJ:7-<:ZH
MS&^UJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#
M:;VNPVF]KL-IO:[_DAT$_Y I"?^--1#_F#L7_Z!$(?^F3BW_IUD\_Z5D3/^A
M;EOWFWAJ[I6!=^>.B8+AAH^+W("5D]A\FYG4>*">T76DHL]SJ:7-<:ZHS&^U
MJLIMOJW#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VNPVF]KL-IO:[#:;VN
MPVF]KL-IO:[_DQT$_Y I"?^/-!#_FCL7_Z)$(/^I32W_JE@\_ZAB3/^D;%SU
MGW9L[)E_>N21AX;>B8V0V(.3F--^F9_0>IVDS7:BJ<MTIZS)<:VOQV^TLL%L
MN;2\;+NQO&R[L;QLN[&\;+NQO&R[L;QLN[&\;+NQO&R[L;QLN[&\;+NQO&R[
ML;QLN['_E!T$_Y$H"?^1,Q#_G#H6_Z1#(/^L3"W_K58]_ZU@3?ZI:E[TI71N
MZI]]?>&6@XO9CHJ6TX>0H,Z!E:?*?)JMQWB?LL1UI;;"<JNYP'"TN[=NM;FS
M;[BULV^XM;-ON+6S;[BULV^XM;-ON+6S;[BULV^XM;-ON+6S;[BULV^XM;-O
MN+7_E!T$_Y(H"?^3,@__GCH6_Z=#(/^N2RW_L54]_[!?3OVN:%_RJG)PYZ1Z
M@=Z:@(_5DH><SHN,ILF$D:_$?I>UP7F<N[YVH[^\=*O"M&^NPZYRL[RK<[:X
MJW.VN*MSMKBK<[:XJW.VN*MSMKBK<[:XJW.VN*MSMKBK<[:XJW.VN*MSMKC_
ME1P$_Y(H"?^5,@__H#H6_ZE"'_^P2BW_M%0]_[1>3OVS9V#QKW!RYJEX@]N?
M?I/2EX.ARXZ)K,2&CK7 @)2]O'N:P[IZH\6W>:O'K'.LQJ=UL;^E=[6ZI7>U
MNJ5WM;JE=[6ZI7>UNJ5WM;JE=[6ZI7>UNJ5WM;JE=[6ZI7>UNJ5WM;K_E1P$
M_Y,H"?^6,0__H3D5_ZI"'_^R2BS_ME,\_[==3ONV96'PM&YTY*UUAMFD>Y;/
MFX"EQY*%L<&*B[N]AY3 NX6=Q+:"I,>P?JK(I7>JR*%YL,&?>K.\GWJSO)]Z
ML[R?>K.\GWJSO)]ZL[R?>K.\GWJSO)]ZL[R?>K.\GWJSO)]ZL[S_E1P$_Y,H
M"?^7,0__HSD5_ZQ"'_^T2BS_N5,\_[I<3OBZ9&+ON&QUX[)SB-BI>9G-GWZI
MQ9B$M+^3C+RXC9/!LXF9Q:Z&H<BJA*G)GWRIRIM]KL*9?K*]F7ZRO9E^LKV9
M?K*]F7ZRO9E^LKV9?K*]F7ZRO9E^LKV9?K*]F7ZRO9E^LKW_EAP$_Y,H"?^8
M, [_I#D5_ZU!'O^U22S_NU(\_;U;3O:]8V+NO6MVXK9QB=6N=YO+I7RJPIV#
MM+F6B;RRD9#!K(R6QJ>)G<BCAZ;*F8"HRY:!KL25@;&^E8&QOI6!L;Z5@;&^
ME8&QOI6!L;Z5@;&^E8&QOI6!L;Z5@;&^E8&QOI6!L;[_EAP$_Y0G"?^9, [_
MI3D4_ZY!'O^W22O_O5$\_+]:3O3!8F+LP6EWX;MPB]*Q=)W'J'NJO*"!M+2:
MA[RLE(W"II"4QJ"-F\F<BZ3+E8:HRY&%K<60A;&_D(6QOY"%L;^0A;&_D(6Q
MOY"%L;^0A;&_D(6QOY"%L;^0A;&_D(6QOY"%L;__EAP$_Y0G"/^:, [_IC@4
M_[!!'?^X22O_OU$\^L)93O+$86/IQ6AWW;YMC,VT<YW"JWFJMZ1^M*Z=A+RF
MF(K!H)21QIJ1F,F6CZ'+D(NHS(R)K,6,B;# C(FPP(R)L,",B;# C(FPP(R)
ML,",B;# C(FPP(R)L,",B;# C(FPP(R)L,#_EQP$_Y4G"/^;, [_IS@4_[%!
M'?^Z22O_PE [^,983O#(7V/FR&9XV,%KC<FW<9V]KW>ILJ=\LZFA@KNAG(C!
MFIB/QI26ELF0E)_+BY&HS(>.K,:'C;#!AXVPP8>-L,&'C;#!AXVPP8>-L,&'
MC;#!AXVPP8>-L,&'C;#!AXVPP8>-L,'_EQL#_Y4G"/^=+PW_J3@3_[- '?^\
M2"K\Q4\[]LE73NW-7F/BRV1XTL1JC,2[;YRXLG6IK:M[LZ.F@+N;H8;!E)V-
MQ8Z;E,B*F9W*AIFHRX*3K,:"DJ_!@I*OP8*2K\&"DJ_!@I*OP8*2K\&"DJ_!
M@I*OP8*2K\&"DJ_!@I*OP8*2K\'_EQL#_Y4G"/^>+PW_JC@3_[5 '/^^2"GY
MR$XZ\\U63>K37&+>SV)XS<=HB[^^;INRMW.HI[!YLIZK?KJ5IX3 CJ.+Q(BA
MDL>#GYK)@*"GRGV:K,9]F*_!?9BOP7V8K\%]F*_!?9BOP7V8K\%]F*_!?9BO
MP7V8K\%]F*_!?9BOP7V8K\'_F!L#_Y8G"/^@+PW_K#<2_[= &_W!2"CVRTXY
M[]-43.;96F+8U&%WQ\MGBKG#;)JMO'*GH;9WL9BQ?;B/K8*^B*J)PX*HD,9]
MIYG(>J>ER7>BK,5XG[#!>)^PP7B?L,%XG[#!>)^PP7B?L,%XG[#!>)^PP7B?
ML,%XG[#!>)^PP7B?L,'_F!L#_Y<F"/^B+PS_KC<2_[D_&OG$1R?QSDTXZMM3
M2^#?66#0VE]VP=!EB;/):YFFPG"EF[UUKY&X>[:(M8"\@;*&P'NPC<-VKI;%
M<ZZAQG*MK<1RJ;# <JFPP'*IL,!RJ;# <JFPP'*IL,!RJ;# <JFPP'*IL,!R
MJ;# <JFPP'*IL,#_F1L#_Y@F"/^D+@O_L381_KT_&?3(1R7KU$TVY>-02=GC
M5U_)WUYTNM=DAJS/:9:=QVVCD<!QK(:[=;-^MWJY=[1_O7*RA;]ML8W!:K"7
MPFFQI<%LM+*];+2RO6RTLKULM+*];+2RO6RTLKULM+*];+2RO6RTLKULM+*]
M;+2RO6RTLKW_FAL#_YDF"/^G+0K_M38/^<$_%^[.1B/DW$PRW>=/2<_H5E[
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M5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU16_Z-45O^C5%;_HU39N@4
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MVH?38-J'TV#:A]-@VH?38-J'TV#:A]-@VH?_@QP#_X G!_][,PW_AC@1_XY
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M9DC_F'%6^Y-\8O2-AFWNAXYWZ("5@.1ZG(?@=:*,W7*HD=IOKY78;;>9U6O
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M8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF+_HPL UK@& ,;$!P"[U D
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M?53#X7U4P^%]5,/A?53#X7U4P^%]5,/A?53#X7W_AQ,!_YP2 ?^N$0#:P@H
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M:EVD[VI=I.]J7:3O:EVD[VK_>1$!_XP. /^>#0#<K@@ TKL) ,S("0#'U@X
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M)CK_KR8Y_[HG./_*)SC_W"@X_]PH./_<*#C_W"@X_]PH./_<*#C_W"BUKP
MI[H  )K&  "-U   @>8! 'K_$ %P_Q@"9_\A!5__*0=8_S$*4O\Y#4W_00])
M_T@11?]/$T+_511 _UP5/?]B%CO_:1<Y_W 8-_]Y&37_@ADS_XP:,O^7&S#_
MH1LO_ZH<+_^U'"[_OQPN_[\<+O^_'"[_OQPN_[\<+O^_'"[_OQRIM0  FL(
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M7VZ,]U]NC/=?;HSW7VZ,]U__;!,!_WT/ ?^-$ #_FQ  ]*@/ .6U#0#5OQ
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M1T7AS$=%X.A'1=_V1D7>_T1%WO]$1=[_1$7>_T1%WO]$1=[_1$7>_T39EP
MQZ8  +BP  "LN0$ HL4" )C1!@"/ZPT B>X? H#N*P9X[30,<.T]$VCM1AEB
M[4X>7>U7(UGM8"=5[6@J4NUQ+4_M>2],[8,R2NZ--$?NF#5%[J4W0^^S.$+P
MQ#A!\-\Y0>_O.$#M_3A [/\X0.S_.$#L_SA [/\X0.S_.$#L_SC+H   NJL
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M%B?_PA8G_\<6)__'%B?_QQ8G_\<6)__'%B?_QQ:DM   EL   (?,  !ZV@
M;>L  &3_!0!<_PX!5/\4 4W_' )(_R0$0O\L!3[_,P8Z_SD'-O] "#/_10@P
M_TL)+O]1"BO_5PHI_UT+)_]D"R3_; PB_W8-(/^ #1[_C X=_Y<.'/^A#AO_
MK \;_ZX/&_^N#QO_K@\;_ZX/&_^N#QO_K@^7O   B,D  'G6  !KXP  7_8
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M O]M& +_=QT"_WXD _^$+ 7^AS4)]8@^$.V'2!CE@U0BWGY?+M1X:3C.<W-
MR6Y\1\1KA$S :(Q1O6645+ICG%>W8J5:M&"N7+)@N5ZP7\=>K5_?7ZQB\5FL
M9?Y3JF?_3JAG_TJF9_]&IF?_1J9G_T:F9_]&IF?_1J9G_T;_5QT"_V08 O]P
M%@+_>QP"_X,B O^)*@3YC#('[XX[#>>.1!;>BE$AU(1<+<Q^9CC%>&]!P'1W
M2+MP@$VW;8A2LVJ05K!HF%FL9J!<JF6I7Z=DM&"E8\)AHV/58J)E[5VB:?M7
MH6K_49]K_TR>:_])GFO_29YK_TF>:_])GFO_29YK_TG_61P"_V<6 ?]S%0'_
M?AH!_X<@ O^-)P/TDB\&ZI0X"^&40A/6CTX@S(E9+<6#8S>^?6M N'ET2+-U
M?$ZN<H13JF^,5Z=ME%NC:YQ>H&FE8)YHL&.;9[UDF6?.9)AIZ&&:;?E:F6[_
M5)=N_T^6;O]+EF[_2Y9N_TN6;O]+EF[_2Y9N_TO_6QH"_VD4 ?]V% '_@1@!
M_XH= ?R1) +PERP$Y9HT"-R:/Q'/E$P?QHY7++Z(8#>W@FE L7YQ2*QZ>4ZG
M=X!3HW2(6)]QD%R;;YA?F&VA8I5LK&23;+EFD6O)9I!MY&21<?9<D7+^5I!R
M_U&0<O]-D'+_39!R_TV0<O]-D'+_39!R_TW_71@!_VL3 ?]Y$P'_A!8!_XX;
M ?B5(0'KFR@#X: P!M6>/1#*F$H>P9)4*[F,7C:QAV8_JX)N1Z9^=DZA>WU3
MG'B%6)AVC5R4=)5?D7*>8XYQJ66+<+5GB7#%9XAPX&:*=/1>BW;\6(IV_U*)
M=O].B7;_3HEV_TZ)=O].B7;_3HEV_T[_7Q<!_VX1 ?][$@'_AQ0 _Y$8 ?29
M'0'GH","W:4K!,^A.P_%G$@=O)93*K207#6LBV0_IH=L1Z"#<TV;@'I3EGV"
M5Y)ZBER.>))@BG:<8X=UIF:$=+)H@G3":(!TVVB#>/)@A'K[681Y_U2$>?]/
MA'G_3X1Y_T^$>?]/A'G_3X1Y_T__814!_W 0 ?]^$0#_BA( _Y05 /"=&0#C
MI1X!UZ@H \NE.0[!GT8;MYI1*:^56C2GD&(^H8MJ1IN'<4R5A'A2D(%_5XQ_
MAUR(?9!@A'N98X!ZHV9]>;!H>WF_:7IYUFE\?/!A?G[Z6GY]_E5^??]1?GW_
M47Y]_U%^??]1?GW_47Y]_U'_8Q0!_W(/ ?^!$ #_C1$ _)@2 .RA$P#?JA8
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M64^NQEE/KN184:[V5%.N_U!4K/]-5*S_352L_TU4K/]-5*S_352L_TW_?0
MWX\  ,Z=  ##J ( N; " +"Z @"HQ 4 H<P/ )O,(P*2RC,*B<@_%8'&21]Y
MQ%(H<L):,&O!83=FOV@\8;YP05R]>$58O(%)5+R+3%&[ED].NZ-13+NS4DJ[
MQE)*N^113+OV3DVZ_TM.N?])3KG_24ZY_TE.N?])3KG_24ZY_TGOA0  U)4
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M+CWH_"X]Y_\M/>?_+3WG_RT]Y_\M/>?_+3WG_RW%GP  M:D  *BQ  "<O
MD,<  (32 0!ZWP8 =/03 &WT( )F]"H$7_0T"%KU/0M4]44/3_5,$DSU511)
M]ET71O9E&$3V;AI!]G<</_>!'3WWC1\[]YD@.?BF(3CXM2(W^<@B-OGC(C;X
M\R(V]_PB-O?\(C;W_"(V]_PB-O?\(C;W_"*WI@  J:X  )RY  "0Q   @\\
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M"A3_LPH4_[,*%/^S"A3_LPJ3NP  A,<  '73  !GX0  6.@  $[[  !(_P
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M.-A<BSS36I0_T%B<0LY7HT3+5:Q&R56U1\=4P$G%5-!)PE/F2<!6]46^6?]
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M08]Q_T&/<?]!CW'_08]Q_T'_6Q0!_V@/ /]U#P#_@!$ _XD3 /*0%P#EEAP
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M65^-PUI>C>!88H_U4F20_TUFD/](9H__1V:/_T=FC_]'9H__1V:/_T?_; @
M_GP  -Z*  #0E@( R)\$ ,"G! "YK@, LK(4 *JQ* .AKS<,F:Q#%Y&H32&)
MI54J@J-<,GR@8SEWGFH^<IQQ1&V:>4AHF8%,9)>+4&"6E5-=EJ)56I6P5UF5
MP5=8E=Y66Y;S4%V7_TQ?E_]'8);_1F"6_T9@EO]&8);_1F"6_T;_< , ZX$
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M0TJU_T%+M?\^2[3_/4NT_SU+M/\]2[3_/4NT_SWB@P  S9(  ,&?  "TIP
MJJ\  *"X  "6P , C,H' (;-% "!S28">LPU"'/+00]LRDH79LE3'6'(6R-<
MQV(H6,9J+%3&<C!0Q7PS3<6&-DK$DCE'Q)\[1<2N/$3%P3Q#Q=\\1,3S.T3#
M_SE%PO\W1<'_-T7!_S=%P?\W1<'_-T7!_S?5BP  Q9H  +>D  "KK   H+0
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M&3'Q_QDQ\?\9,?'_&3'Q_QFRI   I:L  )BV  "+P   ?LH  ''5  !EW@
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M_Q#_-BT"_SLL O] + /_0R\#_T,U!/]"/@;_0$H(_SY7"_\\90W_.G,/_SB
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M4&YWQ%!M=^!/<'GU2')[_T-T?/\^=7W_.W5]_SMU??\[=7W_.W5]_SO_80H
M_V\" .A\  #9A@$ SXX$ ,B5!@##F@8 NYP6 +.<*@.JF3D+HI5%%)N13AV4
MCE<FCHM?+8F(9C.$AFTX@(1T/7N">T%W@(1%='^-2'!]ETMM?*-.:GRP3VA\
MP5!G?-U0:G[S26V _T-N@?\_;X'_/&^!_SQO@?\\;X'_/&^!_SS_9 @ _W(
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M1UJ2_4)<D_\^79/_.UV3_SM=D_\[79/_.UV3_SO_;@  X'X  ,Z+  #$E0
MNIT  +&C  "IJ0  H:X+ )NO'0&4KBX$C*P[#(6J1A5^J$X<>*96(W*D72IM
MHF0O::%K-&2?<SA@GGL\7)V%/UF<CT)5FYQ%4YNJ1U&;ND=0F]%'49ON1%.;
M_$!5F_\\5IO_.E:;_SI6F_\Z5IO_.E:;_SKQ=   V8,  ,B0  "^F@  LZ$
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M+4&\_RU!O/\M0;S_+4&\_RW.B@  OY@  +&@  "FJ   F[   )"X  "%OP
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M"B#\_ JBIP  E;$  (>[  !YQ@  ;,\  %_9  !2WP  2.@  $/_"  __Q
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M$JUU51JH<5XAHVYF)I]L;BN;:G4OF&A],Y5GA#:298PYCV25/(QCGSZ)8JI
MAV&W0H5AR4*$8N1!A63W.X9F_S6'9_\QAVC_+H=I_RV':?\MAVG_+8=I_RW_
M5PP _V$$ /YL P#D=0$ VWL% -. " #0@PH QX4: +Z$+0.V@3P)KWU($JAY
M4AFB=EL@G7-C)IEP:RN5;G(OD6UY,XYK@3:+:8DZB&B2/(5GG#^"9J=!@&:T
M0WYFQ41\9N%#?FCU/']J_S> :_\S@6S_+X%L_R^!;/\O@6S_+X%L_R__60L
M_V,! /1O  #?>   U'\$ ,Z#!@#*AP@ PH@8 +F'*P*QA3H(JH%&$:-^4!B=
M>ED?F'=A)9-U:"J/<V\OBW%W,XAO?C:%;H8Z@FR//7]KF4!\:J5">6JQ1'=J
MPD1V:MU$>&SS/GEN_SAZ;_\T>W#_,'QP_S!\</\P?'#_,'QP_S#_6P@ _V8
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M0&A[_3IJ>_\V:WS_,FM\_S)K?/\R:WS_,FM\_S+_80  ZF\  -EZ  #,A
MPXL  +N1 0"TE0$ K)<. *67(0&>EC$%EY,^#)"02!2*CE$;A(M9(7^)8"=[
MAV<K=X5N,'.$=31O@GTW:X&'.VB D3YE?YQ!8GZI0V!^N41??L]$8'_L0&*
M_#ID@/\V98'_,V:!_S)F@?\R9H'_,F:!_S+_9   Y7(  --^  #'AP  OH\
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M,%*6_S!2EO\P4I;_,%*6_S#F<@  T(   ,*,  "XE@  K9P  *.A  "9I@
MCJT  (BN$0"#KB(!?:TQ!'>L/0IRJD<0;*E/%F>H5QMCIUX?7Z9E)%ND;2=8
MI'4K5*-_+E&BB3%.H98T2Z&D-DFAM#9(H<@W2*#G-4F@^3)*G_\P2Y__+DN?
M_RU+G_\M2Y__+4N?_RW=>0  R88  +R2  "QF@  IJ   )RF  "1K   AK(
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M'#;$_QR^D0  L)L  *2C  "8J@  C+(  ("Y  !TP   :,<  %W-!0!3TPH
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M!![YF@4<^:L%&_K !1KZW@4:^?(%&O?]!1GV_P49]O\%&?;_!1GV_P6>I@
MD:\  (.Y  !UP@  9\L  %K3  !-V@  0M\  #CE   U^P< ,?\/ "[_%@ K
M_Q\ *?\F "7_+0 C_S0 (/\[ 1[_0P$;_TL!&?]3 1;_70(4_VH"$O]X A'_
MB (0_YH"$/^K P[_O@,._]4##O_M P[_\ ,.__ ##O_P P[_\ .3K@  A+@
M ';"  !GS   6M4  $S<   _X0  ->8  "WT   J_P( )O\+ "/_$0 @_Q<
M'?\= !G_(P 6_RD %/\O !+_-0 0_ST #O]% 0S_3@$*_U@!!_]E 07_= $#
M_X4! O^6 0'_I@$ _[4! /_& 0#_R@$ _\H! /_* 0#_R@&&MP  =\$  &C,
M  !:UP  2]X  #[D   RZ0  )^T  "/_   ?_P  &_\% !?_#  4_Q  $?\4
M  __&  -_QT "_\B  C_*  %_RX  O\U  #_/0  _T<  /]2  #_7@  _VT
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M,Y-5RC.15>4SD5?W+9%9_RF16O\ED5O_(Y%;_R&16_\AD5O_(9%;_R'_3PL
M_U<" /]A @#J: $ WFT$ -AP" #5< L RW(; ,)Q+@*Z;ST&M&Q)#:YI5!.I
M9UT9I&1E':%B;2&=870EFE]\*)A>@RN578LMDEN4,)!;GC*-6J@TBUFU-8I9
MQC:(6>$VB%ST,(A=_RN)7O\HB5__)8E?_R.)7_\CB5__(XE?_R/_40D _UH
M /5D  #@;   UW$# -!T!@#-=0D Q'87 +QV*@&T=#H%KG%&#*=N41*B:UH8
MGFEB'9IG:2&697$EDV1X*)!B@"N-88@NBV"1,8A?FC.&7J4U@UZR-X)>PC>
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M-G1I_3!U:O\L=FO_*7=K_R=W:_\G=VO_)W=K_R?_5P  ]F,  -]M  #1=0
MR'L  ,%_ @"[@ , M($0 *R"(P&E@3($GGX_"9A[2A"2>5,6C79;&XET8B"%
M<FDD@7%P)WYO=RM[;G\N>&V(,75LDC1S:YXW<&JJ.6YJN3IM:LXZ;6OK-V]M
M_#%P;O\M<6[_*G%O_RAQ;_\H<6__*'%O_RC_60  ZV4  -MP  #->   Q'X
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M*V%\_REA?/\I87S_*6%\_RGU8@  WF\  ,QZ  # @P  MXD  *^.  "FD0
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M)$>:_R34=P  PH0  +:/  "KE@  H9P  ):@  "+I0  ?ZH  '2N!0!OKQ0
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M$C7#JQ,SP\ 3,\/@$S/!]1,RP/\4,K__%#&^_Q0QOO\4,;[_%#&^_Q2XD
MJYD  )^@  "3IP  AZX  'NT  !NNP  8\   %C% 0!-R@4 1,\, $/0%P!"
MT"4 0- R #_1/0$]T4<!.]%0 CG260,VTF,$--)N!3+2>@<PTH@(+M*8"2W3
MJ0DLT[X*+-/?"2O1\PHJS_X+*<[_#"G-_PTIS?\-*<W_#2G-_PVNF   HI\
M ):F  ")K@  ?+8  &^]  !CPP  5\@  $S-  !"T@, .=D) #7?$  TWQL
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M 0C_N@$'_]0!!__K 0;_]@$&__8!!O_V 0;_]@&/K   @+8  '*_  !CR0
M5M$  $C8   [W0  ,.(  ";F   ?\   '/\  !G_"0 6_PX %/\3 !'_&0 /
M_QX #?\D  O_*P )_S( !O\[  /_1   _T\  /]<  #_:P  _WT  /^0  #_
MHP  _[0  /_&  #_U@  _]8  /_6  #_U@""M0  <[\  &3)  !6TP  1]L
M #K@   NY0  (^D  !KM   5_0  $O\  !#_ @ ._PD "_\-  C_$  $_Q,
M ?\8  #_'@  _R0  /\K  #_,P  _ST  /])  #_5@  _V8  /]X  #_B@
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M';!#V1ZM0^T=JT7\&JE%_QBH1O\6J$;_%:='_Q.G1_\3IT?_$Z='_Q/_1 X
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M*8-8_B2#6?\@A%K_'H1:_QR$6O\<A%K_'(1:_QS_3@$ _U<  .5?  #89@
MSFH  ,=L P##:P4 O&P2 +1M)0"M;#4#IVI"!Z%G30R<9581F&->%91B91B1
M8&P;CE]T'HQ>>R&)78,DAER,)H1;E2B!6J J?UJL+'U:NRU\6L\N>UOL*WQ<
M_"9\7?\B?5[_'WU>_QU]7O\=?5[_'7U>_QW_4   ]5D  .%C  #2:@  R6X
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M(FQJ_R!L:O\@;&K_(&QJ_R#_5P  Y&(  -)L  #&<P  O7@  +5[  "M?
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M(%=\_R#E9   SW   ,%Z  "V@P  K8D  *.,  "9C@  C8\  (:0#@"!D1T
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M($.7J"%"E[HB09?3(D&6[R!"E?X>0I7_'4.4_QQ#E/\<0Y3_'$.4_QS,=0
MO($  +&,  "FD@  FY<  )&;  "%GP  >:,  &JG  !EIPX 8Z@< &"H*P%=
MJ#8"6:= !%:G2093IE$)4*99#$VE8 Y*I6D11Z1R%$2D?19"HXD8/Z.7&CVC
MIQL\H[D<.Z/2&SNB[QL[H/X:.Y__&3R?_Q@\G_\8/)__&#R?_QC$?   MHD
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M!"7+[@0DR?P&(\C_!R/'_P<CQ_\'(\?_!R/'_P>IE@  GIT  )*C  "%JP
M>+(  &NX  !?O@  4L(  $?&   ]R@  -,\$ "O4"0 FV0\ )=D9 "7:)0 D
MVC  (]L[ "/;10 BW%  (=U; "#=:  >WG8 '=Z' 1S?F0$:WZP!&=_$ 1C>
MYP$8W/@!&-O_ A?:_P(7VO\"%]K_ A?:_P*@G   E*,  (>K  !YLP  ;+H
M %_!  !2Q@  1LH  #O.   QTP  *=D  "'>!0 >Z X '>@5 !OI'@ 9Z2<
M&.HP !;J.0 5ZT, %.Q. !+L6@ 1[6< $.YW !#NB@ .[YX #O"S  WPS0 ,
M[^P #.W\  SK_P ,Z_\ #.O_  SK_P"7HP  B:L  'NT  !MO   7\0  %+*
M  !%S@  .=,  "_8   EW0  '>$  !CL @ 6]PL %/<1 !'X%P 0^!X #ODE
M  WY+0 +^C4 "?L_  ?[2@ $_%<  _UF  +^=P  _8L  /V?  #\M0  _-$
M /SM  #\_   _/T  /S]  #\_0"+JP  ?;0  &Z]  !@Q@  4LT  $32   W
MV   +-T  "+A   9Y0  $^H  !#Z   ._P8 #?\,  K_$  '_Q0 !/\:  '_
M(   _R<  /\P  #_.@  _T4  /]3  #_8@  _W4  /^*  #_GP  _[,  /_'
M  #_Y0  _^4  /_E  #_Y0!_M   <+T  &''  !3T   0]8  #;=   JX@
M'^8  !;J   0[0  #/H   G_   &_P   O\$  #_"0  _PT  /\0  #_%
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M!M4KYP;0*_4'S2S_!\LL_P?)+/\'R"S_!\<L_P;'+/\&QRS_!L<L_P;_-1(
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M%YE%_Q681O\3F$;_$9A&_Q"71O\0ET;_$)=&_Q#_0@4 _T<  /=/  #E4P
MW54! -=5!@#54@L RU,9 ,-4*P"\5#L!ME)(!+%14@>M4%P*J4YD#:9-; ^D
M3'01H4M[$Y]*@A6=2HH7FTF3&)E)G!J72*8;E4BR')1(P1V22-@=D$GO&X]*
M_AB/2_\6CDO_%(Y,_Q*.3/\2CDS_$HY,_Q+_10  _TL  .E3  #>6   TUL
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M&7=9_Q=W6?\6=UG_%G=9_Q;_3   Z58  -E?  #+90  P6@  +II  "T:
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M&6)H_QGL5P  V6(  ,=K  "\<@  LW<  *IY  "A>0  EW<! )!X$0"+>"$
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M(5%WIB)0=[<C3W?.(T]W["%0=_T>47?_&U)W_QE2=_\94G?_&5)W_QG>8@
MR&X  +MW  "P?P  IX0  )V'  "2AP  A(<  'V'"0!XB!8 =(@F '"(,@)L
MAST$:(9&!F6%3@EAA54,7H1<#UN#8Q)9@FL55H%T%U. ?AI0@(D<3G^6'DQ_
MI2!*?[8A27_,(4E^ZQ]*?OP<2W[_&DM^_QE,?O\83'[_&$Q^_QC59P  PW,
M +9\  "LA   HHD  )B+  "-C0  ?(T  '6.! !OCQ( ;9 A &F0+@%ECSD"
M8HY"!%Z.2P=;C5(*6(Q9#%:+80]3BV@24(IQ%$V)>Q=*B8<92(B5&T:(HQU$
MB+0=0XC*'4.'ZAQ$AOL:1(;_&$6&_Q=%A?\7187_%T6%_Q?-;0  O7@  +&"
M  "GB@  G(X  )*0  "&DP  >94  &R7  !FEPX 8Y@; &&8*0!>F#4!6I<^
M U>71P55ED\'4I96"4^57@Q,E&8.2I1O$$>3>1-$DX450I*3%T"2HA@^DK,9
M/9+)&3V1Z1@]D/H7/H__%CZ/_Q4^C_\5/H__%3Z/_Q7%<P  MW\  *R)  "A
MCP  EI,  (N6  !_F0  <YP  &2?  !<H D 6: 4 %>A(@!5H2\ 4J$Y 5"A
M0P)-H$L$2J!3!4B@6@=%GV,)0Y]L"T">=@X^GH,0.YZ1$3F=H!(XG;(3-Y[(
M$S>=Z!(VF_H2-IK_$C:9_Q$WF?\1-YG_$3>9_Q&^>P  L8<  *6/  ";E
MD)@  (2<  !WH   :Z0  %^G  !2J@  3:L. $NK&@!*JR< 2*LS $:K/0%$
MJT8!0JM. D"K5@,^JU\%.ZMH!CFJ<P@WJH )-*J/"S*JGPPQJK ,,*K'##"I
MYPPOI_H-+Z;_#2^E_PTOI?\-+Z7_#2^E_PVVA   JHX  )Z4  "4F0  AYX
M 'NC  !OJ   8ZP  %>O  !+L@  0;4& #ZV$0 ]MAX .[8I #JW-  YMSX
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M !#2_P$0T?\!$-'_ 1#1_P&<F@  D:$  (.H  !UL   :+<  %N]  !.P0
M0L4  #?(   MS   )-   !S5   5V@4 $.(+ !#C$0 .Y!H #N0C  WE+0 ,
MY3< "^9"  KF3P )YUT ".=M  ;F@  %YI4 !.:K  +FQ  !YN8  .?Y  #G
M_P  YO\  .;_  #F_P"3H0  A:D  '>Q  !IN0  6\   $[&  !!R@  -<X
M "K2   AU@  &=L  !+?   -XP  "_$(  GS#@ '\Q, !/(:  +R(@  \BH
M /(T  #R/P  \DP  /)<  #R;0  \H(  /*8  #SK0  \\8  /3E  #T]@
M]/L  /3[  #T^P"'J0  >;(  &JZ  !<P@  3LD  $#.   STP  *-@  ![=
M   5X0  #^0   KH   %\P   _T!  #\"   ^PT  /L1  #[%@  _!X  /PF
M  #\,   _3P  /Y)  #^6@  _FT  /^"  #_F   _ZP  /_   #_V   _^0
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M ,T _P#? /\ [ #_ /@ _P#_ /T _P#] /\ _0#_ /T _P#] /\ _0#_ /T
M_P#_'R, _Q\A /\>(0#_&2, _Q,I /\.,@#_#$  _PE- ?\'6@'_!&<!_P-S
M ?\#?0'_ X<!_P./ /\"E@#_ IP _P*B /\"J #_ J\ _P&V /\!O@#_ <D
M_P'; /\ Z@#\ /8 ^ #_ /<"_P#W _\ ]@3_ /8$_P#V!?\ ]@7_ /8%_P#_
M(A\ _R(< /\A' #_'A\ _Q@D /\5+P#_$CP _Q!) /\.5@'_#&(!_PMN ?\+
M>0'_"X(!_PN+ ?\+D@'_"ID!_PJ? /\*I0#_"JL _PJR /\*NP#]"L8 ^PK4
M /<*YP#S"O0 \ K_ .\+_P#N#/\ [0S_ >T,_P'M#/\![0S_ >T,_P'_)1L
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M!K@L_P:V+/\%M2S_!;0L_P6T+/\%M"S_!;0L_P7_- P _S8% /\Y P#_/ @
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M#HA&_PV(1O\-B$;_#8A&_PW_0   \D<  .-/  #44P  RU4  ,14  # 4 0
MN4\1 +)0(@"L43( IU$_ J)02@.>3U,%FTY<")A-8PJ53&H,DTMQ#9%*>0^.
M2H 1C$F)$HI)DA2(2)P5ADBH%H5(M1>#2,<8@4CD&(%*]Q6 2O\2@$O_$(!+
M_P^ 2_\.@$O_#H!+_P[_0P  [$L  -U3  #.6   Q%H  +U:  "X5P$ L50.
M *I6'@"E5BX GU8[ 9M51@.75% %DU-8")!27PJ-468,BU!M#HA/=!"&3WP2
MA$Z%$X).CA6 39D7?DVD&'Q-LAEZ3<,:>4W?&GA.]!=X3_\4>$__$GA0_Q!X
M4/\/>%#_#WA0_P_]1@  YT\  -97  #(7   OU\  +=?  "Q7   JED, *1:
M&@">6RH F5LX 91:0P.064P%C%A5"(E77 J&5F,,@U5J#H%4<1!_4WD2?5.!
M%'I2BQ9X4I48=E&A&711KQMS4< ;<5';''%2\AEQ4_\5<53_$W)4_Q%R5/\0
M<E3_$')4_Q#S2   XU,  -!;  #$8   NF,  +-C  "L80  I%X) )U?%P"8
M7R< DU\U 8Y>0 .*74H%AEQ2!X-;60J 6F ,?5EG#GM8;A!X6'42=E=^%'16
MB!=R5I,8;U:?&FY5K!ML5;T<:U;5'6M6\!IK5_\7:UC_%&Q8_Q)L6/\1;%C_
M$6Q8_Q'Q2P  WU8  ,Q>  # 9   MV<  *YH  "G9@  GV(& )AC% "29"0
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M&EUBIAQ;8K8=6F+,'5IBZAQ;8_P87&/_%EQC_Q1=8_\376/_$UUC_Q/F50
MSU\  ,%H  "V;@  K'(  *1T  ":<P  CF\  (=O#0"";QL ?7 I 'EO-0%U
M;C\#<FU(!6YL4 =K;%<*:6M>#&9J90YD:6P186EU$U]H?Q9<:(H86F>6&EAG
MI!Q69[0=56?*'55GZ!M69_L85V?_%E=H_Q189_\36&?_$UAG_Q/A6   RV,
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M&$1ZY!A%>?@61GG_%$9X_Q)'>/\11WC_$4=X_Q'-90  O7   +%Y  "G@
MG(0  )*&  "&A@  =X8  &N&  !FAPT 8X<9 &"()P!>B#,!6X@\ EB'10-6
MATT$4X94!E"&6PA.A6,*2X1L#$F$=@]&@X$11(./$T*#G11 @JX5/X/"%3Z"
MXA4_@?<3/X'_$D" _Q% @/\00(#_$$" _Q#&:P  MW8  *Q_  "BA0  EXD
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M!RF@_P@IG_\(*9__""F?_PBQ@@  I8L  )J1  "0E@  @YH  ':?  !JH@
M7J8  %*I  !&JP  /*T  #6O#  SL!4 ,K A #&P*P OL#4 +K$^ "VQ2  L
ML5$ *[%; "FQ9P$GL70!)K&# 22QE (CL:8"(K*[ B&RVP(AK_,#(*[_ R"M
M_P0?K/\$'ZS_!!^L_P2JBP  G9$  ).7  "'G   >J(  &VG  !@JP  5:\
M $FQ   ^M   ,[<  "JZ P DO T (KT5 "&](  AO2H (+TS !^^/0 >OD<
M';Y2 !R_7@ :OVP &;]\ !B_C@ 7P*$ %L"V !3 TP 5OO$ %;S_ 16[_P$4
MNO\"%+K_ A2Z_P*AD@  EI@  (J>  !]I   ;ZH  &*O  !6M   2K<  #ZZ
M   SO0  *L   "'$   9QP4 $\L+ !',$@ 1S!L $,PE  _-+P .S3H #LU&
M  W-4@ -SF  #,YP  O.@P *SI< "<ZL  C.Q@ (SN@ ",W[  G+_P )R_\
M"<O_  G+_P"8F   C9X  '^E  !QK   9+,  %>Y  !*O0  /L   #+#   H
MQ@  '\H  !?-   1T0  #-8%  C9#  &V1( !=H;  3:)  #VRX  =LY  #<
M10  W5(  -YB  #><P  WH@  -^=  #?LP  W\X  .#N  #?^@  W_\  -__
M  #?_P"/GP  @:8  '.N  !EM0  6+T  $K"   ]Q0  ,<D  ";,   =T
M%-0   [9   )W0   ^$   #C!P  XPT  .02  #E&0  YB(  .<K  #I-@
MZT,  .Q2  #L8@  [78  .Z,  #NH0  [[<  ._1  #OZP  \/8  /#V  #P
M]@"$IP  =:\  &>W  !9OP  2\8  #S*   OS@  )-(  !K8   2W   #.
M  7C    YP   .L   #K    [04  .X+  #P$   \14  /,>  #T)P  ]S,
M /E   #Z40  ^V,  /QW  #]C0  _:,  /ZV  #^R0  _]\  /_?  #_WP!W
ML   :+D  %K!  !,R@  /,\  "[4   BV@  %]X  !#B   )Y@   .D   #L
M    \    /8   #V    ]P   /@   #Z!P  ^PT  /T1  #_&0  _R,  /\O
M  #_/@  _T\  /]B  #_=P  _XT  /^?  #_K@  _[H  /^Z  #_N@#_%B,
M_Q4A /\2(0#_#B0 _P8J /\ ,P#_ $$ _P!. /\ 7 #_ &@ _P!T /\ ?@#_
M (< _P"/ /\ E@#_ )P _P"B /\ J #_ *X _P"U /\ O0#_ ,< _P#6 /\
MYP#^ /, _@#^ /T _P#\ /\ ^P#_ /L _P#[ /\ ^P#_ /L _P#_&B  _QD>
M /\6'@#_$"  _PHE /\$, #_ #T _P!+ /\ 6 #_ &0 _P!P /\ >@#_ (,
M_P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"Q /T N0#[ ,, ^@#0 /@ XP#W
M /$ ]@#\ /0 _P#T /\ \P#_ /, _P#S /\ \P#_ /, _P#_'1P _QP9 /\9
M&0#_%!L _P[_XO_B24-#7U!23T9)3$4 " DA /\,+ #_"3D _P5& /\"4P#_
M %\ _P!K /\ =0#_ 'X _P"& /\ C@#_ )0 _@"; /P H0#Z *< ^ "N /4
MM0#S +\ \0#+ /  WP#N .X [ #Y .L _P#J /\ Z@'_ .D!_P#I ?\ Z0'_
M .D!_P#_(!< _Q\4 /\<$P#_%Q4 _Q8= /\3* #_$#0 _PU! /\,3@#_"5H
M_PAF /\(< #^!WD _ >! /H'B0#X!Y  ]@:6 /,&G0#Q!J, [P:J .T&L@#J
M!KL Z ;( .8&W #D!NP X@CZ . *_P#>"_\ W0O_ -T,_P#<#/\ W S_ -P,
M_P#_(Q( _R,0 /\A#@#_'A  _QX8 /\<(P#_&"\ _Q0[ /\220#\$%4 ^ ]@
M /0/:@#Q#W0 [PY\ .T.A #K#HL Z0Z2 .<.F0#F#J  Y ZG .(.KP#@#K@
MW@[% -P.V@#6$.P TA'Z ,\2_P#-$O\!S!+_ <L3_P'*$_\!RA+_ <H2_P'_
M)P\ _R<, /\E"0#_)@T _R43 /\C' #_("@ ^QPU /4:0@#O&$\ ZA=: .86
M90#C%FX X!9W -X6?P#<%H< V1:. -86E0#4%IP TA>C - 7JP#.&+4 S!C!
M ,L8T@#'&N@!PQOX < ;_P&^'/\!O1S_ KP<_P*\&_\"O!O_ KP;_P+_*PP
M_RL% /\K P#_+0D _RP. /\I%0#W)B  [B,M .<A.@#A'T@ VQ]4 -4@7P#1
M(&@ SB!Q ,PA>0#*(8$!R"&( <8ACP'$(98!PR&> <$BI@&_(J\!O2*[ KPC
MR@*Y(^,"M23T K,D_P.Q)/\#KR3_ Z\D_P.N)/\#KB3_ ZXD_P/_+P8 _R\
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M"X\Z]PJ-.O\)C#O_"(P[_P>,._\'C#O_!XP[_P?_.   \3X  .-%  #420
MRTH  ,5'  #!000 NC\1 +-!(0"M0C$ J$,^ *1#20&@0E,"G4%; YM!8@28
M0&H%ED!Q!I0_> >2/W\(D#^("H\^D0N-/IL,BSZF#8D^LPV(/L0.AC_@#H0_
M] V#0/\+@T#_"H) _PF"0?\(@D'_"()!_PC_/   ZT,  -Q*  #,3P  PU
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M#FQ/_PQL3_\+;$__"VQ/_PON10  W%   ,E7  "]7   M%X  *Q>  "D6P
MG%8$ )56$@"05R$ BU@O (=7.P&#5D0"?U9- WQ55 5Z5%L&=U1B"'53: ES
M4W +<5)X#6]2@@]M48T1:U&9$FE1IA1G4;859E'+%652Z11E4OL19E/_#V93
M_PUF4_\,9E/_#&93_PSJ20  U5,  ,5:  "Z7P  L&(  *AB  "?7P  EEH
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M#5=>_PW>4P  R%T  +MD  "P:@  IFT  )UN  "3;0  A6<  'YG"0!X9Q4
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M$$ENFQ%';:L21FZ^$T5NW!)&;?011FW_#T=M_PY';/\-1VS_#4=L_PW,7P
MO&D  +!Q  "E=P  G'L  )%\  "&>P  =7@  &MW  !E=PP 87@7 %]X) !=
M>3  6GDZ 5AY0@)6>$H"4WA1!%%W6 5/=V '3'9H"$IV<@I(=7T,176*#D-U
MF0]"=:D00'6\$$!UV1! =/,/0'3_#D%S_PU!<_\,07/_#$%S_PS&9   MVX
M *MV  "B?   EW\  (R!  "!@0  <H   &5_  !=?P@ 67\3 %> ( !5@"L
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M!BR2T08LD>\&*X__!BN._P8KC?\'*XW_!RN-_P>S>   IX(  )R(  "1C
MAY   'J3  !ME0  89<  %69  !)FP  /YP! #F=#@ WG1< -IXB #2>+  S
MGC4 ,IX^ #&>1P PGU  +I]: "V?9 $KGW$!*9Y_ B>>D (FGJ$"))ZU B.>
MS@(CG>X#(YO^ R*:_P0BF?\$(IG_!"*9_P2L@0  H(@  )6.  "+D@  ?Y8
M '*:  !EG0  6:   $ZC  !"I   -Z8  "ZH!0 IJ0\ **D8 ">J(@ FJBP
M):HU "2J/P CJD@ (JM3 "&K7@ @JVH 'JMY !VKBP ;JYT &JNQ !FKR@ 9
MJNP!&:C] 1BG_P(8IO\"&*;_ ABF_P*EB0  F8\  (^4  "#F0  =9X  &BB
M  !<I@  4*D  $2L   YK@  +[   ":S   >M08 &;</ !BW%P 7MR$ %K<J
M !6W-  4N#X $[A) !*X5  2N6( $;EQ !"Y@P /N9< #KFL  VYQ  -N.<
M#K;[  ZU_P .M/\ #K3_  ZT_P"<D   DI4  (:;  !YH   :Z8  %ZK  !2
MKP  1K(  #JU   OMP  );H  !V]   5P   $,,&  O&#@ *Q14 "<4>  C%
M*  'Q3( !L8]  7&20 %QE<  \9F  +&=P !QHL  ,:@  #%M@  QM(  ,7O
M  #%_   Q?\  ,7_  #%_P"5E@  B9P  'NC  !MJ0  8*\  %.T  !&N
M.KL  "Z^   DP0  &\0  !/'   .R@  ",X!  '0"@  T!   - 6  #1'@
MTB<  -,Q  #4/   U4D  -98  #6:0  UGP  -:2  #6IP  UK\  -;@  #6
M\P  UOX  -;_  #6_P",G0  ?J0  &^K  !AL@  5+D  $:]   YP0  +<0
M "+'   9RP  $<X   S2   %U0   -L   #< P  W0H  -X/  #?%   X1P
M .(D  #D+@  YCH  .=)  #H60  Z&L  .F!  #IF   Z:T  .G%  #IX@
MZ?(  .GU  #I]0" I0  <:T  &.U  !5O   1\(  #G&   LR@  (,X  !;2
M   /U@  "-L   #?    XP   .4   #G    Z $  .H'  #K#0  [1$  .\8
M  #Q(0  \RL  /8X  #W2   ^%H  /EM  #ZA   ^IL  /JO  #ZP@  ^MH
M /K?  #ZWP!TK@  9;8  %:^  !(Q@  .<L  "O0   ?U   %-H   W?   %
MXP   .8   #I    [0   .\   #Q    \P   /4   #V @  ^ D  /H.  #]
M$P  _QP  /\H  #_-@  _T<  /]:  #_;@  _X4  /^:  #_JP  _[D  /^\
M  #_O #_$2  _Q > /\,'@#_!"$ _P G /\ , #_ #X _P!, /\ 60#_ &4
M_P!P /\ >@#_ (, _P"+ /\ D@#_ )@ _P"> /\ I #_ *H _P"P /\ N #_
M ,( _P#. /\ X@#^ /  _0#[ /L _P#[ /\ ^P#_ /H _P#Z /\ ^@#_ /H
M_P#_%!P _Q(: /\.&@#_"!P _P A /\ +0#_ #H _P!( /\ 50#_ &$ _P!L
M /\ =@#_ '\ _P"' /\ C@#_ )0 _P": /X H #] *8 _ "L /L M #Y +T
M^ #) /< W #U .P \P#X /, _P#R /\ \0#_ /  _P#P /\ \ #_ /  _P#_
M%Q@ _Q46 /\1%0#_#!< _P4= /\ * #_ #8 _P!# /\ 4 #_ %P _P!G /\
M<0#_ 'H _ "" /H B0#X )  ]P"6 /4 G #T *( \P"H /$ L #P +@ [@##
M .P TP#J .< Z0#U .< _P#F /\ Y0#_ .4 _P#E /\ Y0#_ .4 _P#_&A,
M_Q@1 /\4$ #_#Q$ _PT9 /\*) #_!3  _P$^ /\ 2P#_ %< _@!B /H ; #U
M '4 \@!] /  A #N (L [ "1 .L EP#I )X YP"D .8 K #D +0 X@"_ .
MS0#> ., W #R -H _0#8 /\ U@#_ -4!_P#5 ?\ U0+_ -4"_P#_'A  _QP-
M /\7"P#_%0X _Q05 /\1'P#_#BH _PLX /T(10#X!E$ ] 1< .X$9@#J!&\
MY@-W .0$?P#B!(8 X 2, -X$DP#=!9H VP6@ -@%J #5!;$ T@6[ - &R0#.
M!^  S CQ ,D*_P#'"_\ Q@S_ ,4,_P#%#/\ Q0S_ ,4,_P#_(0P _R & /\<
M P#_'0H _QL0 /\8& #_%", ]A$P .\./@#J#DH Y0U6 .$-8 #=#6D V0UQ
M -4->0#3#8$ T0V( ,\-CP#-#I8 RPZ= ,H.I0#(#JX Q@^Y ,00R #"$-\
MOA'R +L2_P"Y$_\ MQ/_ ;83_P&V$_\!MA/_ ;83_P'_)08 _R,  /\C  #_
M) , _R$* /T=$0#Q&AL Z!8G .$4-0#:$T, TQ1/ ,X560#+%6, R!9K ,46
M<P##%WL P1>" , 8B0"^&)  O!B8 +L9H "Y&:D MQFT +4:P@"T&M8 L!OM
M :T<_ &K'?\!J1W_ :D=_P&H'?\!J!W_ :@=_P'_*   _R<  /XJ  #O*@
MYR<! .<B"0#D'1  V1L= ,\=+0#)'CP Q"!) +\@4P"\(5T N2%E +<B;0"U
M(G0 LR)\ +$B@P&P(HH!KB*2 :PCFP&K(Z0!J2.O :<CO &F),X!HR3H J E
M^0*>)?\"G27_ IPE_P*;)?\"FR7_ ILE_P+_+   _RT  .TR  #B-   VC,
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M!GP[_P5\._\%?#O_!7P[_P7T-P  Y4   -)'  #%2@  O$L  +5)  "O0P
MJ3X+ *(_%P"=0"8 F$$T )1!/P"104D!CD%1 8M 60*)0& #AT!G X4_;02#
M/W4%@3]]!G\^AP=]/I$(>SZ<"7H^J0EX/K@*=S_-"G4_Z@IT0/P(=$#_!W1
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M"&!._PCC1P  S5   +Y7  "S6P  JET  *%=  "86@  C5,  (92# " 4Q@
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M"U19F@U26:H.45F\#E!9V Y06?(-45G_"U%9_PI16?\)45G_"%%9_PC440
MPEH  +1A  "J9@  H&@  )=I  ",9P  ?6   '5? P!O7Q  :U\< &A@* !F
M8#, 8V \ 6%@1 %?7TP"7%]3 UM?6@197V$%5UYI!E5><PA37GX)45V*"T]=
MF0Q-7:@-3%ZZ#DM>U Y+7O$,3%[_"TQ=_PI,7?\)3%W_"$Q=_PC/5   OEX
M +%E  "G:@  G6T  )1M  ");   >&4  &]D  !I9 X 9609 &)D)0!@93
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M"CMPS0HZ;^P).V[^"#MN_P@[;?\'.VW_!SMM_P>_8@  L6L  *9S  "=>0
MDGL  (=\  ![?   ;7H  &!X  !6=P$ 4'<. $YX& !,>"0 2WDN $EY-P!(
M>4  1GE( 41Y3P%">5<"07E@ C]X:0,\>'0$.GB"!3AXD08W>*$'-7BS!S1X
MRP<T=^L'-';]!S1U_P<U=?\&-73_!C5T_P:Y:   K7$  *)Y  "8?@  C8
M (*!  !V@@  :8$  %N!  !1@0  2( * $6!$P!#@1X 0H(I $&",@! @CL
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M 1N4_P$;D_\"&Y/_ AN3_P*G?P  G(8  )&+  "'CP  >I(  &V5  !AF
M59L  $F=   ]G@  ,Y\  "JA   AHPH 'Z,1 !ZC&@ =I"0 '*0M !ND-@ :
MI#\ &:1* !BD50 6I6$ %:5P !2E@0 3I90 $J6H !&EOP 0I.( $:+X !&A
M_P 1H/\!$:#_ 1&@_P&@A@  E8P  (R1  !_E0  <9H  &2>  !8H0  3*0
M $"F   UIP  *JD  "*L   9K@  $K ) !"Q$  0L1@ #K$B  ZQ*P -L34
M#;%   RQ2P +L5@ "K%G  BQ>  'L8L !;&@  2PM0 $L-  !+#O  6O_@ &
MKO\ !J[_  :N_P"8C@  CY,  (*8  !UG0  9Z(  %JG  !.JP  0:T  #6O
M   KL0  (;0  !BV   1N0  #;P#  >^#  #O1(  ;T9  "^(@  OBL  +XV
M  "^00  OTX  +]<  "_;0  OX   +Z5  "^J@  OL(  +WD  "]]@  O?\
M +W_  "]_P"2E   A9H  'B@  !JI@  7*L  $^P  !"LP  -;8  "JX   @
MNP  %[X  !#!   +Q   !,<   #)!P  R0T  ,D2  #*&0  RR(  ,LK  #-
M-0  SD$  ,Y0  #/8   SW(  ,^'  #/G0  S[,  ,_.  #/ZP  SO@  ,[^
M  #._@"(FP  >J(  &RH  !>KP  4+4  $*Y   UO   *;\  !["   5Q@
M#LD   C,    T    -,   #5    U@8  -@,  #9$0  VQ8  -P?  #>*
MX#0  .)!  #B40  XV,  .-W  #DC@  Y*0  .2Z  #EU   Y>H  .7S  #E
M\P!\HP  ;JH  &"R  !1N0  0[X  #7"   HQ@  ',D  !/-   ,T0  !-4
M  #:    W@   .$   #B    Y    .4#  #G"0  Z0X  .L2  #M&@  [R0
M /(Q  #T00  ]%,  /5F  #U?   ]I,  /:I  #WO   ]\X  /??  #WWP!P
MK   8;0  %.[  !%PP  -L<  "?,   ;T   $=4   K;    WP   .(   #E
M    Z0   .P   #M    \    /$   #S    ]00  /<*  #Z$   _!8  /\A
M  #_+@  _T   /]3  #_:   _X   /^6  #_J   _[8  /^_  #_OP#_#1P
M_PH; /\"&P#_ !X _P D /\ +@#_ #P _P!* /\ 5@#_ &, _P!M /\ =P#_
M '\ _P"' /\ C@#_ )0 _P": /\ H #_ *8 _P"L /\ M #_ +T _P#) /X
MW0#] .T _ #Z /L _P#Z /\ ^0#_ /H _P#Z /\ ^@#_ /H _P#_$!D _PT7
M /\&%@#_ !@ _P > /\ *@#_ #< _P!% /\ 4@#_ %X _P!I /\ <@#_ 'L
M_P"" /\ B0#_ )  _@"6 /T G #\ *$ ^P"H /D KP#X +@ ]@## /0 T@#S
M .< \@#V /  _P#O /\ \ #_ .\ _P#O /\ [@#_ .X _P#_$A0 _P\2 /\+
M$@#_ !( _P : /\ )0#_ #, _P!  /\ 30#_ %D _P!D /T ;0#[ '8 ^0!]
M /< A #U (L ] "1 /, EP#Q )T \ "C .X J@#L +, Z@"] .@ RP#G .$
MY0#Q ., _0#C /\ X@#_ .$ _P#A /\ X #_ .  _P#_%!  _Q$. /\-#0#_
M!P\ _P(5 /\ ( #_ "T _P Z /\ 1P#Y %, ]0!> /( : #P '  [0!X .L
M?P#I (4 Z ", .8 D@#E )@ XP"? .$ I@#? *X W "X -H Q0#6 -D U #L
M -( ^0#1 /\ SP#_ ,X _P#. /\ S@#_ ,X _P#_%PP _Q0( /\/!0#_#@L
M_PP1 /\'&@#_ 28 _  T /0 00#M $T Z0!8 .8 8@#C &H X !R -X >0#;
M (  V0"& -8 C0#3 ), T0": ,\ H0#- *H RP"S ,D OP#& -  Q0#H ,,
M]@#! /\ P +_ +\#_P"_ _\ OP/_ +\#_P#_&P8 _Q<  /\4  #_$P4 _Q$-
M /\.% #Y"A\ \ 8L .8#.0#@ T8 W -1 -8$6P#2!&0 SP5L ,P%<P#*!7H
MR 6! ,8%AP#%!HX PP:6 ,$&G0"_!J8 O0:P +L'O "Y",T N KE +4+]P"S
M#?\ L0W_ + -_P"P#O\ KP[_ *\._P#_'@  _QL  /\;  #Z&@  ]18% /81
M#0#K#A4 X@LB -@+,0#0##X RPU* ,<-50#$#EX P0YF +\.;0"]#G0 NP][
M +D/@@"W$(H MA"1 +00F@"R$*, L!&M *\1N@"M$<H JA+E *<4]P"E%?\
MHQ7_ *(5_P"B%?\ HA7_ *(5_P#_(@  _R   / C  #F)   X"$  -P9!0#;
M$ P T!$9 ,@3*0#"%3< O19$ +D73@"U%U< LQA@ + 89P"N&&X K!EU *L9
M? "I&80 J!J, *8:E "D&IX HQNH *$;M "?',4 GAS? )H=\P&8'O\!EQ[_
M 98?_P&5'_\!E1__ 94?_P'_)@  ]"<  .8M  #:+P  SRT  ,HG  #''P@
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M VTZ_P/J.0  U4(  ,1(  "Y2P  KTL  *=)  "?1   F#X! )$\$ ",/1T
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M!EY'F@=<1ZD(6TB["%I(U A:2/$'6DG_!EI)_P5:2/\%6DC_!%I(_P3;1
MQDT  +A3  "M5P  HUD  )I8  "15   ADX  'U+" !W2Q( <TP? '!,*P!M
M3#4 :TP^ &A,1@!F3$T!9$Q3 6),6@)A3&("7TQJ UY,<P1<2WX%6DN*!EA+
MF =73*<(5DRY"55,T0E43.\(5$W_!E5,_P953/\%54S_!55,_P752   PE$
M +57  "J6P  H%P  )=<  "-60  @5,  '=/! !Q3Q  ;E < &I0* !H4#(
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M"$99R@A%6>H(1EG]!D98_P9&6/\%1UC_!4=8_P7'4@  N%L  *MA  "A9@
MF&@  (YI  "#9P  <F   &A>  !A70D 7%T3 %I='@!772D 5EXS %1>.P!2
M7D, 45Y* 4]>4@%.7ED"3%YA DI>:@-(7G4$1EZ"!41=D 9#7J '05ZQ!T!>
MR = 7N@'0%W\!D%=_P5!7?\%05S_!4%<_P7#5@  M%\  *AF  ">:@  E6T
M (IM  !_;   ;V<  &1D  !;8@4 5F(0 %1B&P!28R4 4&,O $YD. !-9$
M2V1( $ID3P%(9%<!1F1? D5D: )#9',#06-_!#]CC@4]8YX&/&.P!CMDQ@8[
M9.8&.V/Z!3MB_P4[8O\%/&'_!#QA_P2^6P  L&,  *5J  ";;P  D7(  (9R
M  ![<0  ;&T  &!K  !5:0  3V@- $UI%P!+:2$ 26HK $AJ- !':CT 16M$
M $1K3 !":U0!06M< 3]J90(]:G ".VI] SEJC 0W:IP$-FJN!35JQ 4U:N4%
M-6GY!#5I_P0U:/\$-6C_!#5H_P2Y8   K&D  *%P  "8=0  C7<  ()W  !W
M=P  :70  %QS  !1<0  2' * $5P$@!#<1T 0G$G $!R,  _<C@ /G)  #UR
M2  [<E  .G)9 3AR8P$V<FT"-')Z C-RB0,Q<IH#+W*L RYRP0,N<N,#+G'X
M RYP_P,N;_\#+F__ RYO_P.S9@  IV\  )UV  "3>@  B'P  'Y]  !R?0
M9'P  %=[  !,>@  0GD# #QY#@ Z>A< .7HA #AZ*@ W>S, -GL[ #1[1  S
M>TP ,GM5 #![7P O>VH!+7MW 2M[AP$J>Y@"*'NJ B=[OP(F>^$")GKW B9X
M_P(F>/\")W?_ B=W_P*N;   HW8  )E\  ".?P  A((  'B#  !LA   7X0
M %&$  !'A   /(0  #.$"0 PA!$ +X0: "V$)  LA2T *X4U "J%/@ IA4<
M*(90 ">&6@ FAF8 )(9S ".&@P AAI4 ((:G 1Z&O $>AMX 'H3U 1Z"_P$>
M@O\!'H'_ 1Z!_P&H=   GGT  )."  ")A0  ?H@  '&*  !EBP  6(P  $R-
M  ! C@  -HX  "R/   ED P (Y 3 "*0'  AD"4 ()$N !^1-@ >D4  '9%)
M !R15  :D6  &9%N !B1?@ 6DI  %9*D !21N0 3D=@ $X_T !2._P 4C?\
M%(S_ 12,_P&C?0  F(,  (Z(  "$C   =X\  &F1  !=DP  4)4  $67   Y
MF   +ID  "6:   =FP( %IT, !6=$P 4G1L $YTD !*=+0 1GC< $9Y! !">
M3  /GE@ #IYG  V>=P ,GHH "YV>  J=L@ )G<P "9SL  J;_@ +FO\ "YG_
M  N9_P"<A   D8H  (B.  ![D@  ;98  &"9  !4G   2)\  #R@   PH0
M)J,  !VE   5IP  $*D%  NK#0 (JA, !ZH;  :J)  %JBX !*HX  *J1  !
MJE   *I>  "J;@  JH$  *J5  "IJ@  J<$  *CD  "H]@  I_\  *?_  "G
M_P"5BP  C)   '^5  !QF@  8YX  %:B  !*I@  /:@  #&J   FJP  ':T
M !2P   .L@  ";4!  *V"@  M@\  +85  "W'0  MR4  +<O  "X.0  N$8
M +A4  "X9   N'8  +B+  "WH   M[8  +?3  "V[P  MOP  +;_  "V_P"/
MD@  @I<  '2=  !FH@  6*<  $NL   ^KP  ,;$  ":S   <M@  $[@   V[
M   &O@   ,$   #"!   P@L  ,,0  #$%0  Q!P  ,4D  #&+@  R#H  ,E'
M  #)5P  R6D  ,E]  #)E   R*H  ,C#  #(Y   R/0  ,C]  #(_0"%F0
M=Y\  &BF  !:JP  3;$  #^U   QN   );H  !J]   1P   "\,   /'
MR@   ,T   #.    SP,  - )  #1#@  TQ(  -49  #7(@  VBT  -TY  #>
M20  WEH  -]N  #?A0  WYP  -^R  #>RP  WN8  -_T  #?] !YH0  :Z@
M %RO  !.M0  0+L  #&^   DP0  &<4  !#(   )S    ,\   #3    V0
M -P   #=    WP   .$   #B!0  Y L  .80  #H%@  ZB   .TK  #P.@
M\4L  /%>  #R<P  \XL  /.B  #SM@  \\D  //A  #SX0!MJ@  7K$  %"Y
M  !!OP  ,L0  "3(   7S   #M    ;5    V@   -X   #B    Y@   .D
M  #J    [    .X   #P    \@   /0&  #V#   ^1(  /P<  #_*0  _SH
M /]-  #_8@  _W@  /^0  #_HP  _[,  /_!  #_P0#_!QD _P$7 /\ %P#_
M !H _P A /\ *P#_ #D _P!' /\ 5 #_ %\ _P!J /\ <P#_ 'L _P"# /\
MB@#_ )  _P"6 /\ FP#_ *$ _P"H /\ KP#_ +@ _P#$ /X U0#\ .H ^P#X
M /H _P#Y /\ ^ #_ /@ _P#V /\ \P#_ /$ _P#_"Q4 _P43 /\ $P#_ !0
M_P : /\ )P#_ #0 _P!" /\ 3P#_ %L _P!E /\ ;@#_ '8 _P!^ /\ A0#^
M (L _0"1 /L EP#Z )T ^ "C /< JP#V +, ] "^ /, S #Q ., [P#S .X
M_P#M /\ [ #_ .L _P#L /\ [ #_ .L _P#_#1$ _PD0 /\ #P#_ !  _P 6
M /\ (@#_ "\ _P ] /\ 2@#_ %4 _0!@ /H :0#X '$ ]@!Y /0 ?P#S (8
M\0", .\ D@#N )@ [ "? .L I@#I *X YP"X .4 Q0#C -H X0#M -\ ^P#>
M /\ W0#_ -T _P#= /\ W0#_ -T _P#_#PT _PP+ /\#"0#_  P _P 2 /\
M'0#_ "D ^P W /@ 1 #U %  \@!: .X 8P#L &L Z0!S .< >@#E (  XP"&
M .$ C #? ), W0"9 -L H0#9 *D U0"R -( O@#0 ,X S@#F ,P ]@#* /\
MR@#_ ,D _P#( /\ R #_ ,@ _P#_$0@ _PT" /\'  #_!0@ _P . /\ %@#W
M "( [P P .L /0#H $D Y !4 .  70#= &4 V0!M -4 <P#2 'H T "  ,X
MAP#, (T R@"4 ,@ FP#& *0 Q "M ,( N #  ,< O0#? +P \0"[ /X N0#_
M +@ _P"X /\ N #_ +@ _P#_%   _P\  /\-  #_#   _P<) /@!$ #H !H
MXP H -T -@#8 $( T@!- ,X 5P#* %\ QP!F ,4 ;0## '0 P0!Z +\ @0"]
M (@ NP"/ +D EP"W )\ M0"H +, LP"Q ,( KP#8 *X"[0"L _L JP7_ *H&
M_P"I!O\ J0;_ *D&_P#_%@  _Q(  /<2  #L$0  Y@X  .4&" #= Q( U ,@
M ,T$+0#(!#H PP5& +\%4 "\!E@ N09@ +<'9P"U!VX LP=U +$(>P"O"((
MK@F* *P)D@"J"9L J JE *8*L "E"[\ HPS4 *$-[0"?#OX G0[_ )P/_P";
M#_\ FP__ )L/_P#_&@  ]QD  .H>  #?'@  U1H  - 3 @#.# L QPL6 , -
M)0"Z#C( M@X_ +(/20"O$%( K!!: *H080"H$6@ IA%O *01=@"B$7T H1&%
M )\2C@"=$I< G!*B )H3K0"8$[P EQ30 )05[ "2%OT D!?_ (\7_P".%_\
MCA?_ (X7_P#Z'0  [B,  -\H  #0*@  QR<  ,$A  "]&04 N1(0 +(5'@"M
M%BP J!<X *080P"A&4P GQE4 )P:7 ":&F( F1II )<;< "5&W< E!M_ )(<
MB "0')( CQR= (T=J0"+';< BA[* (@?YP"&(/H A"#_ 8,@_P&#(/\!@B#_
M 8(@_P'U)   Y2P  -,Q  #&,P  O#$  +8M  "P)0  K!T, *8>& "A("8
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M FTSG0)L,ZL":C2\ FDTU0-H-?$"9S7_ F<U_P)F-?\"9C7_ F8T_P+B-@
MS#\  +U$  "R1P  J$<  *!$  "8/P  D#D  (@T#0"#-1< ?S8D 'PW+P!Y
M-SD =SA" '0X20!R.%  <3A7 &\X7@!M.&4!;#AM 6HX=0%H.( "9SB, F4X
MF0-D.:@#8CFY V$ZT -@.NX#8#K_ U\Z_P)?.O\"7SK_ E\Z_P+=.P  QT,
M +E)  "N2P  I$P  )M*  "210  B3\  ($Z"0![.A0 =SL@ '0\*P!R/#4
M;ST^ &T]1@!K/4T :3U3 &@]6@!F/6$!9#UI 6,]<@%A/7T"8#V) EX]E@-=
M/J4#6SZV!%H^S 1:/^P$63_^ UD__P-9/_\"63__ ED^_P+6/P  PT<  +5,
M  "J4   H%   )=/  ".2P  A$4  'I !@!U/Q$ <4 < &U * !K03( :4$[
M &=!0@!E04D 8T%0 &%!5P!@05X!7D%F 5U";P);0GH"6D*& UA"E -70J,$
M54.S!%1#R0140^D$4T/] U-#_P-40_\#5$/_ E1#_P+00@  OTH  +)0  "G
M4P  G50  )13  "*4   ?TH  '5% @!N0PX :T09 &=%) !E12X 8D4W &%%
M/P!?148 745- %M%5 !:1EL!649C 5=&; )61G<"5$:# U-&D0-11J$$4$>Q
M!$]'QP1.1^<$3D?[!$Y'_P-.1_\#3T?_ T]'_P/,1@  NTX  *]4  "D5P
MFE@  )%7  "&5   >TX  '!*  !I2 T 94@6 &))(0!?22L 74DT %M)/ !9
M24, 5TE* %9)4@!52ED!5$IA 5)*:@%12G4"3TJ! TY*CP-,2Y\$2TNP!$I+
MQ01)2^8$24OZ!$E+_P-*2_\#2DO_ TI+_P/(20  N%$  *Q7  "A6P  F%P
M (Y<  "#60  =E,  &M.  !D30H 7TP3 %Q-'@!:32@ 6$TQ %9-.@!434$
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M SI8_P,[5_\#.U?_ SM7_P.\5   KEP  *-C  "99P  D&D  (5I  !Y9P
M:V(  &!@  !570  3EL, $M;% !)7!\ 1UPH $9=,0!%73D 0UU! $)=2 !!
M7E  0%Y8 #Y>80$\7FP!.UYX CE>AP(W7I<"-EZI S5>O0,T7]T#-%[U S5=
M_P(U7?\"-5S_ C5<_P*X60  JF$  *!G  "6;   C&X  (%N  !V;   9VD
M %QF  !19   2&() $1B$0!"8AL 06,D #]C+0 ^8S4 /60] #QD10 [9$T
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M 2!Q_P&I:P  GG,  )1Y  "*?   @'X  '1_  !G?P  6G\  $U^  !#?@
M.'T  "]] @ H?0T )GT4 "1]'  C?B4 (GXM "%^-@ A?C\ 'W]( !Y_4@ =
M?UX '']K !I_>@ 9?XP %W^? !9_LP 5?\X %7[O !9\_P 6>_\ %GO_ !=[
M_P"D<@  FGH  (]_  "%@@  >X0  &V&  !@AP  5(<  $B(   \B   ,H@
M "B(   @B 4 &HD. !F)%0 8B1T %XHF !:*+@ 5BC< %(I! !.*3  2BU@
M$8ME !"+=0 /BX< #HJ;  V*KP ,BL@ #(GJ  V'_  .A_\ #H;_  Z&_P"?
M>P  E($  (J%  " B   <XL  &6-  !9CP  3)   $&2   TD@  *I(  "&3
M   9E   $I8&  Z7#@ -EQ4 #)<=  R7)@ +ER\ "I<Y  F71  (EU  !I=>
M  67;@ #EH   9:4  "5J   E;X  )3@  "4]   D_\  9+_  &2_P"8@@
MCH@  (6,  !WCP  :I(  %V5  !0F   1)H  #B;   LG   (IT  !F>   2
MH   #:("  >C"P !HQ   *,7  "C'P  HR<  *,Q  "D/   I$@  *16  "D
M90  HW<  *.+  "CH   HK8  *'2  "A\   H/L  *#_  "@_P"1B@  B8X
M 'N2  !MEP  8)L  %.>  !&H0  .:,  "VD   CI@  &:@  !&J   ,K
M!:X   "O!P  KPT  *\1  "P&   L"   +$H  "Q,@  LCX  +),  "R6P
MLFP  +*!  "QEP  L:P  +#&  "PZ   K_<  *__  "O_P",D   ?Y4  '&:
M  !CGP  5:0  $>H   ZJ@  +:P  "*N   8L   $+,   JU   "N    +L
M  "[    O <  +P-  "]$0  OA8  +\>  # )P  P3(  ,)   ##3P  PV
M ,-T  ##BP  PZ$  ,.X  #"UP  PN\  ,+Z  #!_@"!EP  <YT  &6C  !7
MJ   2:T  #NQ   MLP  (;8  !:Y   .NP  ![X   #!    Q0   ,<   #(
M    R0   ,H%  #+"P  S0\  ,X4  #0'   TR8  -8R  #800  V%,  -EF
M  #9?   V90  -FK  #9PP  V>$  -GP  #9] !VGP  9Z8  %FL  !+L@
M/+<  "ZZ   AO0  %<    W$   %QP   ,H   #.    T@   -4   #6
MV0   -L   #=    WP<  .$,  #C$0  YAD  .DD  #L,@  [4,  .Y6  #O
M:P  [X0  .^<  #OL@  [\8  ._=  #OY !JJ   6Z\  $RV   ^O   +\
M "#$   4R   #,P   +0    U    -D   #>    X@   .4   #F    Z
M .D   #L    [@   / "  #R"0  ]0\  /@7  #\(P  _S,  /]&  #_6@
M_W$  /^)  #_GP  _[$  /_   #_Q@#_ !4 _P 4 /\ % #_ !< _P = /\
M* #_ #< _P!$ /\ 40#_ %P _P!F /\ ;P#_ '< _P!^ /\ A0#_ (L _P"1
M /\ EP#_ )T _P"D /\ JP#_ +0 _@"_ /T S@#[ .8 ^0#V /@ _P#W /\
M]P#_ /< _P#P /\ [ #_ .D _P#_ Q( _P 0 /\ $ #_ !$ _P 7 /\ ) #_
M #( _P _ /\ 3 #_ %< _P!A /\ :@#_ '( _P!Y /T @ #\ (8 ^@", /D
MD@#X )@ ]@"? /4 I@#T *X \@"Y /  Q@#N -X [0#P .L _@#J /\ Z0#_
M .D _P#G /\ XP#_ .  _P#_!PX _P - /\ "P#_  P _P 3 /\ 'P#_ "P
M_P Z /\ 1@#^ %( ^P!< /@ 90#U &P \P!T /$ >@#O ($ [@"' .P C0#J
M ), Z0": .< H0#F *D XP"S .$ OP#? -  W0#I -H ^0#9 /\ UP#_ -4
M_P#5 /\ U0#_ -0 _P#_"0H _P$% /\  P#_  D _P 0 /\ &0#[ "8 ]P T
M /0 0 #R $P [@!6 .H 7P#G &< Y !N .( = #@ 'L W@"! -P AP#: (T
MU@"4 -0 FP#1 *, SP"M ,P N #* ,< R #@ ,8 \P#% /\ PP#_ ,, _P##
M /\ PP#_ ,, _P#_"P$ _P,  /\   #_  , _P + /, $@#N !\ Z@ M .8
M.@#B $4 W@!/ -D 6 #4 &  T0!H ,X ;@#, '0 R@![ ,@ @0#& (< Q ".
M ,( E@#  )X O@"G +L L@"Y ,  MP#4 +4 [ "S /L LP#_ +( _P"R /\
ML0#_ +$ _P#_#0  _P8  /\#  #W    ]  # .< #0#@ !@ V@ E -, ,@#.
M #X R@!) ,8 4@## %H P !A +X : "\ &X N@!T +@ >P"V ($ M "( +(
MD "P )D K@"B *P K0"J +H J #+ *8 Y@"E /< I #_ *, _P"B /\ H@#_
M *( _P#_$   ^PP  .\.  #F#0  WPD  -H !@#0 !$ R0 = ,0 *@"_ #<
MNP!" +< 2P"T %0 L@!; *\ 8@"M &@ JP!N *D =0"H 'L I@"# *0 BP"B
M )0 H "> )X!J "< K4 FP/& )D%X@"8!O0 E@C_ )4)_P"4"?\ E G_ )0)
M_P#\$0  \14  .,9  #6&0  S!4  ,<0  #$!PH O0,4 +<$(0"R!BX K@@Z
M *H)1 "G"4T I I5 *(*7 "@"F( G@MI )P+;P";"W8 F0Q^ )<,A@"6#)
ME R: )(-I@"1#;, CPW% (T.X@"+$/8 B1#_ (@1_P"'$?\ AQ'_ (<1_P#V
M&0  YR   -8D  #()0  OR(  +D<  "T% $ L0T. *H.&0"E#R< H1 S )T1
M/@":$4< F!)/ )425@"3$EP D1)C ) 3:0".$W  C!-X (L3@0")%(L AQ26
M (85H@"$%;  @Q;! ($7W0!_&/0 ?1G_ 'P9_P!\&?\ >QG_ 'L9_P#O(0
MW2D  ,HM  "^+P  M2P  *XG  "H(   HQ<( )X6$P"9%R$ E!DM )$:. ".
M&D$ BQM) (D;4 "'&U< A1Q> (0<9 ""'&L @!QS '\=? !]'88 ?!Z1 'H>
MG@!X'ZL =Q^\ '8@U !T(?  <B'_ '$B_P!Q(?\ <2'_ '$A_P#H*   TC
M ,(U  "W-P  K34  *4Q  ">*P  F"," )(>$ "-(!L B2$G (8B,@"#(SP
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M 5LTQ@%:-.8!637[ 5DU_P%9-/\!633_ 5DT_P'2.   P$   +-%  "H2
MGD@  )5&  "+0   @CL  'DU! !S,Q  ;S0: &PT)0!I-2\ 9S4W &4V/P!C
M-D8 8C9- & V5 !?-EL 73=C %PW:P!;-W8!63>" 5@XCP%6.)X!53BO E0Y
MPP)3.>0"4SKY 5,Y_P%2.?\!4SG_ 5,Y_P'-/   O$0  *])  "D3   FDP
M )%+  "'1@  ?4   ',[  !L. T :#D7 &4Y(@!C.BL 8#HT %XZ/ !=.D,
M6SI* %H[4 !8.U@ 5SM@ %8[: !5/',!4SQ_ 5(\C0%0/9P!3SVL DX^P0)-
M/N$"33[X DT^_P%-/O\!33W_ 4T]_P')0   N$@  *Q-  "A4   EU$  (Y/
M  "$2P  >44  &Y   !F/0L 8CT4 %\]'@!</B@ 6CXQ %@^. !7/D  53]&
M %0_30!3/U4 4D!= %! 9@!/0' !3D!\ 4Q!B@%+09H"2D&K DE"O@)(0MX"
M2$+V DA"_P)(0O\!2$'_ 4A!_P'%1   M4L  *E0  ">5   E50  (M3  "
M4   =4H  &I&  !A0@@ 7$$1 %E"&P!70B4 54(N %-"-0!10CT 3T)# $]#
M2P!.0U( 341: $M$8P!*1&X!245Z 4=%B %&19@"14:I D1&O0)#1MP"0T;U
M D-&_P)#1O\!0T7_ 4-%_P'!1P  LD\  *94  "<5P  DE@  (A8  !^50
M<4\  &9*  !<1@4 5T8/ %1&& !11B( 3T8K $Y&,P!,1SH 2T=! $I'20!)
M2%  2$A8 $=(80!%26P 1$EX 4))A@%!298!0$JG C]*NP(^2]@"/DKS CY*
M_P(^2?\!/TG_ 3])_P&]2@  KU(  *-8  "96P  D%T  (9<  ![60  ;5,
M &)/  !73 $ 44H- $Y*%0!,2Q\ 2DLH $E+, !'2S@ 1DP_ $5,1@!$3$X
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M 2Y6_P&R5P  I5\  )ME  "1:0  AVH  'QJ  !Q:   8V4  %AB  !-7P
M0UT" #Q;#0 Z7!0 .%P= #=<)@ U72X -%TV #-=/@ R748 ,5Y. #!>5P O
M7F( +5YN "Q??0 J7XX *5^@ "A?LP$G7\P )U_M 2=>_P$G7?\!*%W_ 2A<
M_P&M7   HF0  )AJ  ".;@  @V\  'EO  !N;@  8&L  %1I  !)9P  /V4
M #5C"0 R8Q$ ,&,9 "]D(0 N9"D +60Q "QD.0 K94( *F5* "AE5  G95\
M)F9K "1F>@ C9HL (F:= "!FL0 ?9LD 'V;K "!E_@ @9/\ (&/_ 2%C_P&I
M8@  GFH  )5P  "*<P  @'4  '5U  !I=   7'(  $]Q  !$;P  .FX  #!M
M P I; T )VP4 "9L'  E;20 )&TL "-M-  B;3T (6Y& "!N4  >;EL '6YG
M !QN=@ :;H< &6^: !AOK@ 6;\8 %F[I !=M_  8;/\ &&O_ !AK_P"D:0
MFG$  )!V  "&>0  ?'L  '%[  !D>P  5WH  $IY   _>   -7@  "MW   B
M=@< '78/ !QW%@ ;=QX &G<F !EW+@ 8=S< %WA  !5X2@ 4>%8 $WAC !)X
M<@ 1>(, $'B7  ]XJP .>,, #G?F  YV^@ /=?\ $'7_ !!T_P"?<0  E7@
M (M\  ""?P  =X$  &J"  !=@@  4((  $2"   X@@  +H(  "2"   <@@
M%(() !&#$  0@Q8 $(,>  Z#)P .@S  #8,Y  V#1  ,@U  "X-=  F#;  (
M@WX !H.1  6"I0 #@KL !(';  2!\@ %@/\ !G__  9__P":>0  D'X  (:#
M  !]A0  ;X<  &*)  !5B@  28L  #V,   QC   )HP  !V-   5C@  #X\#
M  J0#  &D!$ !(\8  ./(  !CRD  (\R  "0/0  D$D  (]6  "/90  CW8
M (^*  ".GP  CK0  (W/  ",[@  C/L  (O_  "+_P"4@   BX4  (*)  !T
MC   9H\  %F1  !,DP  0)4  #26   HE@  'I<  !68   /F@  "IL   *<
M"0  G X  )P3  "<&@  G"(  )TK  "=-0  G4   )U.  "=7   G6X  )R!
M  "<EP  G*P  )O&  ":Z   F?D  )G_  "8_P".B   AHP  'B0  !JE
M7)<  $^:  !"G0  -IX  "F?   ?H0  %:(   ZD   (I@   *@   "I!
MJ0H  *D.  "I$P  JAH  *HB  "K*P  K#8  *Q$  "L4P  K&,  *QW  "K
MC@  JZ0  *N\  "JW@  J?0  *G]  "I_P")C@  >Y,  &V7  !?G   4:
M $2D   VI@  *J@  !ZI   4JP  #:X   :P    L@   +4   "U    M0,
M +8)  "W#@  N!(  +@9  "Z(0  NRL  +PX  "]1P  O5@  +UK  "]@0
MO9D  +VP  "]S   O.H  +SW  "[_@!^E0  <)L  &*@  !3I0  1JH  #BM
M   JKP  'K$  !.T   ,MP   [D   "\    OP   ,(   #"    PP   ,0
M  #&!@  QPP  ,@0  #*%@  S"   ,\K  #0.@  T4L  -%>  #2<P  THL
M -*D  #3NP  T]@  -/M  #3]@!SG0  9*,  %:I  !'KP  .;,  "JV   =
MN0  $KP   J_    PP   ,8   #)    S0   ,\   #0    T@   -0   #6
M    V0(  -L(  #>#@  X1,  .0=  #H*@  Z#P  .E/  #I9   ZGP  .N5
M  #KK   Z\(  .S5  #LY0!FI@  6*P  $FS   [N0  *[P  !W    1Q
M"<@   #,    SP   -,   #9    W0   .    #A    XP   .4   #G
MZ@   .P   #N!   \0L  /42  #X'   ^RL  /T^  #^4P  _FH  /^#  #_
MFP  _ZX  /^^  #_R@#_ !( _P 0 /\ $0#_ !, _P 9 /\ )@#_ #0 _P!!
M /\ 30#_ %@ _P!B /\ :P#_ ', _P!Z /\ @0#_ (< _P"- /\ DP#_ )D
M_P"@ /\ IP#^ *\ _ "Z /H R0#Y .$ ^ #S /< _P#V /\ ]0#_ /$ _P#I
M /\ Y #_ .$ _P#_  \ _P - /\ #0#_  X _P 4 /\ (0#_ "X _P \ /\
M2 #_ %, _P!= /\ 9@#^ &T _ !U /L >P#Y (( ^ "( /< C@#V )0 ] ";
M /, H@#Q *H [P"T .T P0#K -4 Z@#L .@ _ #G /\ Y0#_ .8 _P#@ /\
MV0#_ -0 _P#_  L _P ( /\ !@#_  D _P 0 /\ ' #_ "D _P V /\ 0@#[
M $X ]P!7 /0 8 #R &@ [P!O .T =@#L 'P Z@"" .@ B #G (X Y0"5 .,
MG #A *0 WP"N -T N0#: ,H UP#D -0 ]@#1 /\ T #_ -  _P#/ /\ RP#_
M ,< _P#_  , _P   /\   #_  0 _P - /H %@#V ", \P P /  / #M $<
MZ0!1 .4 6@#B &( WP!I -T ;P#: '8 V !\ -0 @@#2 (@ T "/ ,T E@#+
M )X R0"H ,< LP#% ,$ P@#8 ,  [P"_ /X O@#_ +T _P"\ /\ O #_ +P
M_P#_ @  _P   /\   #_    ]  ' .T $0#H !P XP I -\ -0#; $$ U@!+
M -$ 5 #- %P R@!C ,@ :0#& &\ PP!U ,$ >P"_ (( O@"( +P D "Z )@
MN "B +4 K "S +D L0#+ *\ YP"N /@ K #_ *L _P"L /\ K #_ *L _P#_
M!   _P   /8   #N    YP   -\ # #6 !4 SP B ,H +@#' #H PP!$ ,
M30"\ %4 N0!< +< 8P"U &D LP!O +$ =0"O 'L K0"" *L B@"I )( IP"<
M *4 I@"C +, H0## )\ W@"> /( G0#_ )P _P"< /\ FP#_ )L _P#_!P
M]@D  .D+  #?"@  U00  ,X !0#& !  P  : +L )P"W #( LP ] +  1@"M
M $\ J@!6 *@ 7 "F &, I !H *( ;P"A '4 GP!\ )T A "; (T F0"7 )<
MH@"5 *X DP"] )$ TP"0 .T CP#\ (X _P"- ?\ C0'_ (T!_P#Y#@  ZA(
M -P5  #-%0  Q!$  +X,  "Z @H M  2 *X '@"J "H I@ U *( /P"@ $@
MG0%0 )L"5@"9 EP EP-C )4#:0"3 V\ D01V ) $?P".!8@ C 62 (H&G@"(
M!JH A@>Z (4(SP"$"NL @@O\ ($,_P" #/\ @ S_ ( ,_P#Q%0  X!T  ,T@
M  #!(0  N!T  +$7  "L$   J D- *('%@"="2, F0HN )4+. "3#$$ D Q)
M (X-4 ",#5< B@U= (@-8P"'#6H A0YQ (,.>@""#H0 @ Z/ 'X/FP!\#Z@
M>Q"X 'H0S@!X$>P =A+_ '42_P!T$_\ =!/_ '03_P#H'@  TR8  ,,J  "X
M*@  KB@  *<C  "@'   FQ,# )8/$ "0$!L C!$G (D2,@"&$SL A!-# ((4
M2P" %%$ ?A17 'P47@![%64 >15L '<5= !V%GX =!:* '(7E@!Q%Z0 ;QBT
M &X8R0!M&>@ :QK\ &H;_P!J&_\ :AO_ &H;_P#@)@  RBT  +PQ  "P,P
MIS$  )\L  "7)@  D!\  (H7# "%&!8 @1DB 'X:+ ![&S8 >1L^ '<<10!U
M'$P <QQ3 '$=60!P'6  ;AUG &T>< !K'GH :AZ% &@?D@!G'Z  92"P &0A
MQ0!C(>0 8B+Z &$B_P!A(O\ 82+_ &$B_P#7+   PS0  +8X  "J.0  H3@
M )@U  "0+P  B"@  ( A" ![(!( =R$= '0B)P!Q(C$ ;R,Y &TC00!K(T@
M:2-. &@D50!F)%L 921C &,E:P!B)74 826! %\FC@!>)IT 72>M %LHP0!;
M*.  6BGW %DI_P!9*?\ 62G_ %DH_P#/,@  OCD  +$]  "F/P  G#\  ),\
M  "*-@  @3   'DJ P!R)@\ ;B<9 &LH(P!I*"P 9BDU &4I/ !C*4, 82I*
M & J40!>*E< 72I? %PK: !:*W( 62Q] %@LBP!6+9H 52VJ %0NO0!3+MP
M4B_U %(O_P!2+O\ 4B[_ %(N_P#*-@  NCT  *U"  "B1   F$0  (]!  "%
M/   >S<  '(Q  !K+ P 9RT5 &0M'P!A+B@ 7RXQ %TN.0!<+T  6B]& %@O
M30!7+U0 5C!< %4P9 !3,6X 4C%Z %$QB !0,I< 3C*H $TSNP!---@ 3#3S
M $PT_P!,-/\ 3#/_ $PS_P#&.@  MD(  *E&  ">20  E4D  (M'  "!0@
M=ST  &TW  !D,@D 8#(2 %TR' !:,B4 6#,M %8S-0!5,SP 4S1# %(T2@!1
M-%$ 4#19 $\U80!--6P 3#9W $LVA0!*-Y4 2#>F $<XN %'.-,!1CCQ 48X
M_P%&./\ 1CC_ $8W_P#!/@  LD4  *9*  "<30  DDT  (A+  !^1P  <T(
M &D]  !?-P8 6C80 %<W& !4-R( 4C<J % W,@!/.#D 33A  $PX1P!+.$X
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M 3A#_P"W20  J5   )Y5  "46   BUD  (!8  !V5@  :%   %U,  !32
M2D4) $9$$0!$1!D 0D0B $%%*0 _13$ /D4X #U%/P \1D< .T9/ #I'6  Y
M1V( .$AN #9(?  U2(T -$F> #-)L0 R2<D ,4GK #))_@ R2/\ ,DC_ #-(
M_P"T3   IU0  )Q9  "27   B%T  'Y=  !S6@  954  %M2  !03@  1DH%
M $!)#@ ^218 /4D> #M*)@ Z2BX .4HU #A+/0 W2T0 -DM- #1,5@ S3&
M,DQL #%->@ P38L +DV< "U.KP L3L< +$[I "Q-_0 M3?\ +4S_ "U,_P"P
M4   I%@  )E=  "/80  AF(  'MA  !P7P  8EL  %A8  !.50  0U$! #M/
M#  X3Q, -D\; #5/(P T4"L ,U R #)0.@ Q4$( ,%%* "Y14P M4ET +%)I
M "M2>  I4H@ *%.: "=3K0 F4\4 )E/G "93_  G4O\ )U'_ "=1_P"L50
MH%P  )9B  "-9@  @V<  'AF  !M90  8&$  %5>  !*6P  /U@  #56"  Q
M51  ,%87 "Y6'P M5B< +%8O "M7-@ J5SX *5=' "A74  F6%H )5AG "18
M=0 C688 (5F8 "!9JP ?6<( 'UGE !]8^@ @6/\ (%?_ "%7_P"H6@  G6(
M )-G  "*:P  ?VP  '5L  !J:P  76@  %%E  !&8P  .V   #%> P J70T
M*%T3 "9=&P E7B, )%XJ "->,@ B7CH (5Y# "!?3  ?7U< 'E]C !Q@<0 ;
M8(( &6"5 !A@J0 78,  %F#B !=?^0 87O\ &5[_ !E=_P"D8   F6@  )!N
M  "&<   ?'(  ')R  !F<0  6&X  $QL  !!:P  -FD  "UG   C9@@ 'V8/
M !UF%0 <9AT &V8E !IF+0 99S4 &&<^ !=G2  69U, %6A? !-H;@ 2:'\
M$6B2 !!HI@ /:+T #FC@ !!G]P 09O\ $67_ !%E_P"?9P  EF\  (QS  ""
M=@  >'@  &UX  !@=P  4W8  $9T   [<P  ,7(  "=Q   ><0  %G * !-P
M$  3<!< $G ? !%Q)P 0<2\ $'$X  YQ0@ .<4X #7%;  QQ:0 +<7H "G&-
M  AQH0 &<;8 !G#2  =P[P (;_\ "6[_  EN_P";;P  D74  (=Y  !^?
M='X  &9^  !9?@  37X  $!]   U?0  *GP  "%\   8?   $7P$  Q\#  *
M?!$ "7P9  A\(0 '?"D !GPR  1\/0 #?$@  7Q5  !\8P  ?'0  'R'  ![
MG   >[$  'K+  !YZP  >?H  'G_  !X_P"6=P  C'P  (.   !Y@P  ;(0
M %Z%  !1A@  18<  #F'   MAP  (X<  !J'   2AP  #8@!  :)"@ !B0\
M (D4  "(&P  B",  (DL  ")-@  B4(  (A.  "(70  B&T  (B!  "'E0
MAZL  (;$  "%Y@  A/@  (3_  "$_P"0?@  AX,  'Z'  !QB0  8XL  %:-
M  !)CP  /)$  #"1   DD0  &I(  !*3   -E   !I4   "6!@  E@P  )40
M  "6%0  EAT  )8D  "6+@  ECD  )9&  "650  EF4  )9X  "5C@  E:0
M )2\  "3WP  D_4  )+_  "2_P"+A@  @XH  '6-  !GD   690  $R7   _
MF0  ,IH  ":;   ;G   $IT   R?   $H    *(   "C 0  HP<  *,,  "C
M$   I!4  *0<  "E)0  IB\  *8\  "F2P  IEL  *9N  "EA   I9L  *2S
M  "CT   H^\  *+\  "B_P"&C0  >)$  &J5  !<F0  3IT  $&@   SH@
M)J,  !NE   1IP  "JD   &K    K0   *\   "P    L    + %  "Q"P
ML@\  +,4  "T&P  M20  +<P  "W/P  MU   +=B  "W>   MY   +:I  "V
MP@  MN0  +;U  "U_@![DP  ;9@  %^=  !0H@  0J8  #2I   FJP  &JT
M !"O   )L@   +0   "W    N@   +P   "]    O@   +X   #  @  P0@
M ,(-  #$$@  QAD  ,DD  #*,@  RT,  ,M5  #,:@  S(,  ,R<  #+M0
MS,X  ,SI  #,]@!PFP  8:$  %*F  !$JP  -K   ">R   :M0  $+@   >[
M    O@   ,$   #$    R    ,L   #+    S0   ,X   #0    T@   -4#
M  #8"@  VQ   -X8  #B)   XS4  .1(  #E7   YG,  .:-  #FI0  YKP
M .;3  #GYP!CI   5:H  $:P   XM0  *+D  !J\   /P   !<0   #'
MRP   ,\   #4    V    -P   #=    WP   .$   #C    Y0   .@   #J
M    [08  /$.  #U%@  ^"4  /DX  #Y30  ^F,  /M\  #\E0  _*H  /R[
M  #]RP#_  \ _P . /\ #@#_ !  _P 6 /\ (P#_ #  _P ] /\ 20#_ %0
M_P!> /\ 9@#_ &X _P!V /\ ? #_ (( _P") /\ CP#_ )4 _@"; /T HP#[
M *L ^@"U /D PP#W -L ]@#P /0 _P#S /\ \@#_ .P _P#B /\ W #_ -8
M_P#_  P _P ) /\ " #_  H _P 2 /\ '@#_ "L _P X /\ 1 #_ $\ _P!9
M /X 80#\ &D ^@!P /@ =P#W 'T ]@"# /0 B0#R (\ \0"6 .\ G0#M *4
M[ "O .H O #H ,T Y@#H .0 ^@#C /\ X@#_ .  _P#5 /\ S@#_ ,L _P#_
M  8 _P ! /\   #_  0 _P . /\ &0#_ "4 _0 R /L /@#W $D \P!3 /
M7 #N &, [ !J .H <0#H '< Y@!] .0 @P#B (D X "0 -X EP#< )\ V0"I
M -8 M #3 ,0 T #> ,X \P#, /\ RP#_ ,H _P#( /\ P@#_ +X _P#_
M_P   /\   #_    ^P + /8 $P#Q "  [0 L .H . #G $, XP!- .  5@#<
M %T V0!D -4 :P#2 '$ T !V ,X ? #, (, R@") ,@ D0#& )D Q "C ,$
MK0"_ +L O0#/ +L ZP"Y /P MP#_ +< _P"V /\ M #_ +$ _P#_    _P
M /\   #V    [@ % .< #P#A !D VP E -4 ,0#2 #P S@!& ,H 3P#' %<
MQ !> ,$ 9 "_ &H O0!P +L =@"Y 'P N "# +8 B@"S ), L0"< *\ IP"M
M +, JP#% *D X0"G /4 I@#_ *4 _P"D /\ I #_ *0 _P#_    _    /$
M  #H    X    -0 "P#, !, QP ? ,( *@"_ #4 O  _ +@ 2 "U %  LP!7
M +  7@"N &0 K !I *L ;P"I '4 IP!\ *4 A "C (P H0"6 )\ H0"= *T
MF@"\ )@ T@"7 .X E0#^ )0 _P"5 /\ E0#_ )4 _P#\ 0  \ 4  .,'  #5
M!0  S    ,4 ! "^  X N  7 +, (P"O "X JP X *D 00"F $H HP!1 *$
M5P"? %T G0!C )L :0": &\ F !V )8 ?0"4 (8 D@"0 )  FP". *< C "V
M (H R0"( .< AP#Y (< _P"& /\ A@#_ (8 _P#T#   Y!   -$2  #%$0
MO0X  +8(  "Q  @ JP 1 *8 &P"A "8 G@ Q )H .@"8 $, E0!* ), 40"1
M %< CP!= (X 8P", &D B@!P (@ =P"& (  A "+ (( E@"  *, ?@"Q 'T
MQ ![ N$ >@/U 'H%_P!Y!?\ > ;_ '@&_P#J$P  UAH  ,8=  "Z'   L1D
M *H3  "D#0  GP4, )D % "5 !\ D0(I (T#,P"+!#P B 5$ (8&2P"$!E$
M@@=7 ($'70!_!V, ?0AJ 'L(<@!Z"'P > F& '8)D@!T"J  <PJO '$+P0!P
M#-\ ;PWV &X._P!M#O\ ;0[_ &T._P#A'   RR,  +PF  "Q)@  J"0  * >
M  "9&   DQ " (X+#@"("Q< A PB ($-+ !^#34 ? X] 'H.10!X#DL =PY1
M '4/6 !S#UX <1!E ' 0;@!N$'< ;!"" &L0CP!I$9T :!&M &82P !E$M\
M9!/V &,4_P!C%/\ 8A3_ &(4_P#6)   PRH  +4N  "J+P  H"T  )@H  "0
M(@  B1L  ((3" !]$1( >1(< '83)P!S%#  <10X &\5/P!M%48 ;!5, &H6
M4P!H%ED 9Q9A &46:0!D%W( 8A=^ &$8BP!?&)D 7AFI %P9O !<&M@ 6AOS
M %H<_P!9'/\ 61S_ %D<_P#-*@  O3$  *\U  "D-@  FS0  )(Q  ")*P
M@24  'D= P!S& X ;QD8 &P:(@!I&RL 9QLS &4<.P!D'$$ 8AU( & =3@!?
M'54 71U< %P>9 !;'FX 61]Y %@?AP!6()8 52"F %0AN !3(=( 4B+Q %(C
M_P!2(_\ 4B+_ %(B_P#(+P  N#8  *LZ  "@/   ECL  (TX  "#,@  >BT
M '(F  !J( P 9B 3 &,A'0!A(28 7R(O %TB-@!;(CT 6B-$ %@C2@!7(U$
M52-8 %0D80!3)&H 425V % E@P!/)I, 3B>C $PGM0!,*,X 2RCN $LI_P!+
M*/\ 2RC_ $LH_P##-   LSL  *<_  "<00  DD   (D^  !_.0  =3,  &PM
M  !C)P@ 7B81 %PF&0!9)R( 5R<K %4H,@!4*#D 4BA  %$H1@!0*4T 3BE5
M $TI70!,*F< 2RIS $DK@ !(*Y  1RRA $8MLP!%+<L 12[L $0N_P!$+O\
M12W_ $4M_P"^.   L#\  *1#  "910  CT4  (5#  ![/@  <3D  &<T  !>
M+@0 6"L. %4K%@!2+!\ 4"PG $\L+P!-+38 3"T\ $HM0P!)+4H 2"Y2 $<N
M6@!&+V0 12]P $,P?@!",(T 03&> $ RL0 _,L@ /S/J #\S_@ _,O\ /S+_
M #\R_P"[/   K4,  *%'  "620  C$D  (-(  !X1   ;3X  &,Y  !:-
M4C , $\P$P!,,!P 2C D $DQ*P!',3( 1C$Y $0Q0 !#,D< 0C)/ $$S6 !
M,V( /S1M #XT>P ]-8L /#:< #LVKP Z-\8 .3?H #DW_  Z-_\ .C;_ #HV
M_P"W0   JD8  )Y+  "430  BDX  (!,  !U2   :D,  & ^  !6.0  334)
M $DT$0!'-1D 134A $,U* !!-2\ 0#4V #\V/0 ^-D4 /3=- #PW50 [.&
M.CAK #DY>0 X.8D -SJ; #4ZK0 U.\0 -#OF #0[^P U._\ -3K_ #4Z_P"T
M0P  ITH  )Q.  "240  B%(  'Y0  !S30  9T@  %Q$  !2/P  2#H& $0Y
M#P!!.18 /SD> #XY)@ \.2T .SHT #HZ.P Y.T( .#M* #<\4P V/%T -3UI
M #0]=P S/H< ,3Z9 # _JP O/\( +S_D "\_^@ P/_\ ,#[_ # ^_P"Q1P
MI$T  )E2  "/50  AE8  'Q5  !Q4@  9$P  %E)  !/10  14 # #\^#0 \
M/A, .CX; #D^(P W/BH -C\Q #4_.  T/T  ,T!( #) 40 Q05L ,$%G "Y"
M=0 M0H4 +$.7 "M#J@ J0\  *43B "I#^0 J0_\ *T+_ "M"_P"N2@  H5$
M )=6  "-60  @UH  'E:  !N5P  85(  %=.  !-2P  0T<  #I#"@ V0Q$
M-$,8 #-#(  R1"< ,40O #!$-@ O13T +45& "Q%3P K1ED *D9D "E'<@ H
M1X, )D>5 "5(J  D2+X (TC@ "1(]P E1_\ )4?_ "9'_P"J3P  GU4  )1:
M  "+7@  @5\  '=>  !K7   7U@  %55  !+40  0$T  #5*!P P20X +DD5
M "U)'0 L220 *THK "I*,P H2CL )TM# "9+3  E2U8 )$QB "-,<  A3(
M($V3 !]-I@ >3;L '4[= !Y-]@ >3/\ 'TS_ "!+_P"G4P  G%H  ))?  "(
M8P  ?F0  '1C  !I80  7%X  %);  !'6   /%4  #)2 @ J4 P )T\2 "90
M&0 E4"  )% H "-0+P B43< (5%  "!120 >4E, '5)? !Q2;0 :4WT &5.0
M !A3I  64[D %5/9 !93]  74O\ &%'_ !E1_P"C60  F&   (]E  "%:
M>VD  '%I  !F9P  660  $UA  !"7P  .%P  "Y:   E6 @ (%<. !Y7%  =
M5QP '%@C !M8*P :6#, &5@\ !A810 665  %5E; !19:0 36GH $EJ- !%:
MH0 06K< #EK5 !!9\P 06?\ $5C_ !%8_P"?7P  E68  (QK  "";0  >&X
M &YO  !B;0  56H  $AH   ^9@  ,V4  "EC   @80$ && + !5@$  48!<
M$V > !)@)@ 28"X $6$W !!A0  /84L #F%8  UA9@ ,8G8 "V*)  IAG0 )
M8;( "&'+  AAZP )8/T "E__  M?_P";9@  DFT  (AQ  !^<P  =74  &IT
M  !<<P  3W(  $-P   X;P  +6X  "1L   ;:P  $VL$  YJ#  -:A( #&H9
M  MJ(0 *:BD "6HR  AJ/  ':T< !6M3  1K80 ":W$  &J$  !JF   :JT
M &G&  !IYP  :?@  &C_  !H_P"7;0  C7,  (1W  ![>@  <'L  &-[  !6
M>@  27H  #UY   Q>   )W<  !UV   5=@  #W8"  EV"@ $=@\  '85  !V
M'   =B0  '4L  !U-@  =4$  '5.  !U7   =6P  '5^  !TDP  =*@  '/
M  !SXP  <O<  '+_  !Q_P"2=0  B7H  (!^  !V@   :8$  %N"  !.@@
M08(  #6#   I@@  'X$  !:!   0@@  "H(   *#!P  @@T  ((1  ""%P
M@AX  ((F  ""+P  @CL  ()'  ""50  @64  (%X  "!C0  @*(  '^Z  !_
MW0  ?O0  'W_  !]_P"-?   A($  'N$  !NA@  8(@  %**  !%BP  .8P
M "R,   AC   %XP  !"-   )C@   H\   "0 P  CPD  (\.  "/$@  D!@
M ) ?  "0*   D#(  ) _  "030  D%T  (]P  "/A0  CIP  (ZS  "-T
MC/   (O^  "+_P"(A   @(@  '*+  !DC0  5I   $B3   [E0  +I8  "*6
M   7EP  #Y@   B9    FP   )T   "=    G0,  )T)  "=#0  GA$  )X7
M  "?'P  GRD  * U  "@0P  H%0  *!F  "?>P  GI,  )ZK  "=Q@  G>D
M )SY  "<_P"#BP  =8X  &>2  !9E@  2YD  #V<   PG@  (Y\  !>@   .
MH@  !Z0   "F    J    *H   "J    J@   *L!  "K!P  K P  *T0  "N
M%@  KQX  +$I  "Q.   L4@  +%:  "Q;P  L8@  +&@  "PN@  K]T  *_R
M  "O_0!XD0  :I8  %R:  !-GP  /Z,  #&F   CIP  %ZD   ZK   %K@
M +    "R    M0   +<   "W    N    +D   "Z    O ,  +T)  "^#@
MP!0  ,,>  #%*P  Q3P  ,9.  #&8@  QGH  ,:4  #&K0  QL@  ,7E  #%
M\P!LF0  7IX  $^D  !!J   ,JP  "2O   6L0  #;0   .W    N@   +T
M  #     Q    ,8   #&    R    ,D   #+    S    ,X   #0!@  TPT
M -@3  #<'@  WBT  -]   #@5   X6L  .&%  #AGP  X;<  .'/  #AY@!@
MH0  4J<  $.M   TL@  );4  !>Y   -O    ;\   ##    QP   ,H   #/
M    TP   -8   #7    V@   -P   #?    X0   .,   #F    Z0$  .P+
M  #P$@  \Q\  /0Q  #V1@  ]UP  /AT  #XCP  ^:8  /FX  #XR0#_  T
M_P + /\ "P#_  X _P 3 /\ 'P#_ "P _P Y /\ 10#_ %  _P!9 /\ 8@#_
M &H _P!Q /\ =P#_ 'X _P"$ /X B@#] )  _ "7 /H G@#Y *< ]P"Q /8
MO@#U -( \P#L /$ _@#P /\ \ #_ .8 _P#< /\ T@#_ ,T _P#_  < _P $
M /\  @#_  8 _P 0 /\ &P#_ "< _P S /\ /P#_ $H _@!4 /L 70#Y &0
M]P!K /4 <@#S '@ \@!^ /  A #O (H [0"1 .P F0#J *$ Z "K .8 M@#D
M ,< X@#C .  ]P#> /\ W0#_ -D _P#, /\ Q0#_ ,$ _P#_    _P   /\
M  #_  $ _P - /\ %@#\ "( ^0 N /8 .0#S $4 [P!. .P 5P#I %X Y@!E
M .0 ; #B '( X !W -\ ?@#= (0 VP"+ -@ D@#5 )L T@"D ,\ KP#- +X
MRP#5 ,D [P#' /\ Q0#_ ,0 _P"^ /\ N #_ +4 _P#_    _P   /\   #^
M    ]P ) /$ $0#K !P YP H .0 ,P#A #X W0!( -@ 40#3 %@ T !? ,X
M90#, &L R@!Q ,@ =P#& 'T Q "$ ,( C #  )0 O@"> +L J "Y +8 MP#(
M +4 Y@"S /H L0#_ +  _P"P /\ K #_ *D _P#_    _P   /H   #Q
MZ  # .  #0#8 !8 T0 B ,T +0#* #< Q@!! ,( 2@"_ %( O0!9 +H 7P"X
M &4 MP!J +4 < "S '8 L0!] *\ A0"M (T JP"7 *D H0"G *X I0"^ *(
MV "@ /( GP#_ )X _P"> /\ G@#_ )P _P#_    ]P   .L   #A    U@
M ,L "0#% !$ OP ; +L )@"W #$ M  Z +$ 0P"N $L JP!2 *D 6 "G %X
MI@!D *0 :0"B '  H !V )X ?@"< (8 F@"0 )@ FP"6 *< E "V )( R@"0
M .D CP#\ (X _P"- /\ C #_ (T _P#X    Z0(  -L#  #, 0  Q    +T
M @"V  T L  5 *L ( "G "H I  T *$ / "> $0 G !+ )H 4@"8 %@ E@!=
M )4 8P"3 &D D0!P (\ =P"- (  BP"* (D E0"' *$ A0"O (, P0"! .
M@ #U '\ _P!_ /\ ?P#_ '\ _P#N"@  W X  ,H0  "^#@  M0L  *\#  "I
M  < HP 0 )X & "9 ", E@ L ), -0"0 #X C@!% (P 2P"* %$ B !7 (8
M70"% &, @P!J ($ <0!_ 'H ?0"$ 'L CP!Y )P =P"J '4 NP!T -0 <@#P
M '( _P!R /\ <0#_ '$ _P#C$0  S1<  +\9  "S&0  JA4  *,0  "="@
MEP$* )$ $@"- !L B0 E (4 +P"# #< @  ^ 'X 10!] $L >P!1 'D 5P!X
M %T =@!D '0!:P!R 70 < )_ &X"BP!L Y@ :P.F &D$MP!H!<X 9P?L &8(
M_0!F"?\ 90G_ &4)_P#6&@  Q"   +8C  "K(P  H2   )D;  "2%   C X!
M (8'#0" !!0 ? 8> 'D'* !V"#  = @X '()/P!P"44 ;PI, &T*4@!L"E@
M:@M? &@+9P!G"W  90QZ &,,AP!B#)4 8 VD %\-M@!>#<X 7 [M %P/_P!;
M$/\ 6Q#_ %L0_P#-(0  O"@  *\K  "D*P  FBD  )(D  ")'P  @A@  'L1
M!0!U#0\ <0T7 &X.(0!K#BH :0\R &<0.0!E$$  9!!& &,030!A$%, 7Q%:
M %X18@!<$6L 6Q%V %D2@P!8$I( 5A.B %43M !4$\L 4Q3L %(5_P!2%O\
M4A7_ %(5_P#&*   MBX  *DR  "?,@  E3$  (PM  "#)P  >B$  '(:  !K
M$PL 9Q,3 &04' !A%"4 7Q4M %T5- !<%3L 6Q9" %D62 !8%D\ 5A=6 %47
M7@!3%V< 4AAR % 8?P!/&8X 3AJ? $P:L !+&\< 2QOI $H<_0!*'/\ 2AS_
M $H<_P#!+0  L30  *4W  ":.   D#<  (<T  !]+P  ="D  &PC  !D' <
M7AD0 %L:& !9&R$ 5QLI %4;, !4'#< 4AP] %$<1 !/'4L 3AU2 $T=6@!+
M'F, 2AYN $D?? !''XL 1B"< $4AK@!$(<0 0R+F $,B_ !#(O\ 0R+_ $,B
M_P"\,@  K3@  *$\  "7/@  C3T  (,Z  !Y-0  ;S   &8J  !>) ( 5R -
M %0@% !1(!T 3R$E $XA+ !,(3, 2R(Z $DB0 !((D< 1R). $8C5P!$(V
M0R1K $(D>0!!)8@ /R:9 #XFJP ])\$ /2?C #TH^@ ]*/\ /2?_ #TG_P"X
M-@  JCT  )Y   "40@  BD(  ( _  !V.P  ;#8  &(P  !9*@  424+ $TE
M$0!+)1D 224A $<F* !%)B\ 1"8V $,F/0!")T0 02=+ #\H5  ^*%T /2EI
M #PI=@ [*H8 .2N7 #@KJ0 W++\ -RS@ #<L^  W+/\ -RS_ #@L_P"U.@
MIT   )Q$  "11@  AT8  'U$  !S0   :#L  %\V  !5,0  3"L' $<I#P!%
M*A8 0RH> $$J)0 _*BP /BLS #TK.0 \*T$ .RQ( #HL40 Y+5L ."YF #8N
M<P U+X, -"^5 #,PIP R,+T ,3'> #$Q]P R,?\ ,C#_ #,P_P"Q/@  I$0
M )E(  "/2@  A4H  'M)  !P10  94   %L[  !2-@  2#$$ $(N#0 _+A,
M/2X; #LN(@ Y+RD ."\O #<O-@ V,#X -3!& #0Q3P S,5D ,C)D #$R<0 P
M,X$ +S23 "XTI@ L-;L +#7; "PU]0 M-?\ +33_ "XT_P"N00  HD@  )=,
M  "-3@  @TX  'E-  !N2@  8D4  %A   !./   13<  #TS"P Y,Q$ -S,8
M #8S'P T,R8 ,S,M #(T-  Q-#P ,#5$ "\U3  N-E8 +39B "PW;P K-W\
M*CB1 "@XI  G.;D )CG8 "<Y]  H.?\ *#C_ "DX_P"K10  GTL  )1/  "+
M4@  @5,  '=2  !L3P  7TD  %9&  !,0@  0CT  #@X"  T. \ ,C@5 #$X
M'0 O."0 +C@K "TY,@ L.3D *SI! "HZ2@ I.U0 *#M? "<\;0 E/'T )#V/
M ",]H@ B/;< (3[4 "$^\P B/?\ (SW_ ",\_P"H20  G4\  ))3  ")5@
M?U<  '56  !J4P  74\  %-,  !*2   0$0  #9 !0 O/0T +3T3 "L]&@ J
M/B$ *3XH "@^+P G/C< )C\_ "0_2  C0%( (D!= "%!:@ @07H 'D&- !U"
MH  <0K4 &T+1 !M"\0 <0O\ '4'_ !Y!_P"E30  FE,  )!8  "&6P  ?5P
M ');  !G6   6U0  %%2  !(3@  /4H  #-'   J0PL )D,0 "5#%@ D0QX
M(T0E ")$+  A1#0 ($4\ !Y%10 =14\ '$9: !M&:  91G@ &$>* !='G@ 6
M1[, %$C. !5'[P 61_\ %T;_ !=&_P"B4@  EU@  (U=  "$8   >F$  '!@
M  !E7@  65H  $]8  !$5   .5$  "].   F2P8 ($H. !Y*$P =2AH '$HA
M !M+*  :2S  &4LX !=+0@ 63$P %4Q7 !1,90 3374 $DV( !%-G  03;$
M#D[,  ]-[@ 03?\ $4S_ !%,_P">5P  E%T  (MB  "!90  =V8  &UF  !C
M9   5F$  $I>   _6P  -5@  "M6   B5 $ &E(* !92$  54A8 %%(= !-2
M)  24BP $5(T !%2/@ 04T@ #U-4  Y38@ -5'( #%2$  M4F  )5*T "%3%
M  E4YP *4_L "U+_  M2_P";70  D60  (AH  !^:P  =&P  &ML  !?:@
M4F<  $5D   Z8@  ,&   "9>   =70  %5L% !!:#  .6A$ #EH8  U;(  ,
M6R< "ULP  I;.@ )6T4 !UM1  9;7@ $6VT  UN   %;E   6Z@  %O   !:
MX@  6O8  5K_  )9_P"79   CFL  (1N  ![<   <G(  &=Q  !9<   3&X
M $!L   U:P  *FD  "%G   89@  $68!  QE"@ '90\ !&44  -D&P "9",
M &0L  !D-0  9$   &1,  !D6@  9&D  &1[  !DCP  8Z0  &.[  !BW0
M8O0  &+_  !A_P"3;   B7$  (!U  !X=P  ;7@  &!W  !2=@  1G4  #ET
M   N=   (W(  !IQ   2<0  #7$   9Q"   < T  ' 2  !P%P  ;Q\  &\F
M  !O,   ;SL  &]'  !O5   ;V0  &]U  !NB@  ;:   &VV  !LU@  :_(
M &O_  !K_P".<P  A7@  'U[  !S?0  97X  %A^  !+?@  /GX  #)^   F
M?0  ''P  !-\   -?   !GT   !]!0  ? L  'P/  !\$P  ?!D  'PA  !\
M*0  ?#0  'M   ![3@  >UX  'MO  !ZA   >IH  'FQ  !XS@  =^\  ';^
M  !V_P")>@  @7\  'B"  !K@P  784  $^&  !"AP  -8@  "F'   =AP
M%(<   V(   &B0   (H   "*    B08  (D,  ")#P  B1,  (D:  "*(@
MBBP  (HX  "*1@  B58  (EH  ")?   B)0  (>K  "&Q@  A>H  (7[  "$
M_P"%@@  ?88  &^(  !ABP  4XT  $6/   XD0  *Y$  !^2   4D@  #9,
M  24    E@   )<   "8    EP   )<%  "7"P  F X  )@3  "9&@  F2(
M )HN  ":/0  F4T  )E>  "9<P  F(L  )BC  "7O   EN(  );W  "5_P"
MB0  <HP  &2/  !6DP  2)8  #J9   LF@  'YL  !2<   ,G@   Y\   "A
M    HP   *4   "E    I0   *4   "F @  IP@  *<-  "H$0  J1D  *LC
M  "K,0  JT$  *Q3  "L9P  JX   *J:  "JLP  JM   *GO  "I^P!UCP
M9Y0  %F8  !*G   /)\  "VB   @HP  $Z4   NG   !J0   *L   "N
ML0   +(   "R    LP   +0   "U    M@   +@$  "Y"P  NQ   +T8  "_
M)   OS4  ,!'  # 6P  P'(  ,"-  #!I@  P,$  +_C  "^\P!JEP  6YP
M $VA   ^I0  +ZD  "&K   3K0  "[    "S    M0   +@   "\    OP
M ,$   #!    PP   ,0   #&    QP   ,D   #+    S@@  -$/  #5&
MV"<  -DY  #:30  VV0  -M^  #<F0  W+   -S)  #<XP!=GP  3Z4  $"J
M   RKP  (K(  !2U   *N    +L   "_    PP   ,8   #+    S@   -$
M  #1    U    -8   #9    VP   -X   #@    Y    .<&  #K#@  [QD
M / J  #R/P  \U4  /1M  #TB   ]*$  /2V  #TQP#_  D _P & /\ !P#_
M  P _P 1 /\ ' #_ "@ _P T /\ 00#_ $P _P!5 /\ 70#_ &4 _P!L /\
M<@#^ '@ _ !^ /L A #Z (L ^0"2 /< F0#V *( ] "L /, N0#Q ,L \ #H
M .X ^P#M /\ [ #_ .$ _P#2 /\ R0#_ ,0 _P#_  $ _P   /\   #_  0
M_P . /\ %P#_ ", _P O /\ .P#] $8 ^@!0 /< 6 #T %\ \@!F /  ; #O
M '( [0!X .P ?@#J (4 Z0", .< DP#E )P XP"F .$ L0#? ,$ W0#= -L
M] #9 /\ U@#_ ,\ _P#$ /\ O0#_ +D _P#_    _P   /\   #_    _P +
M /P $P#W !X ]  J /( -0#N $  Z0!* .8 4@#C %D X !@ -X 9@#< &P
MV@!R -< > #4 'X T@"% -  C0#. )4 S "? ,D J@#' +@ Q0#- ,, ZP#
M /X OP#_ +X _P"V /\ L #_ *T _P#_    _P   /\   #Y    \@ & .L
M#P#F !D X0 D -X +P#: #D TP!# ,\ 3 #, %, R0!: ,< 8 #% &8 PP!K
M ,$ <0"_ '< O0!^ +L A@"Y (X MP"8 +4 HP"S +  L0#" *X X "L /<
MJP#_ *H _P"H /\ HP#_ *  _P#_    _P   /4   #K    X0   -8 # #/
M !, R@ > ,8 *0#" #, OP ] +L 10"X $T M@!4 +, 6@"Q %\ L !E *X
M:@"L '  JP!W *D ?P"G (< I0"1 *, G "@ *D G@"X )P S@": .X F0#_
M )< _P"6 /\ E@#_ ), _P#]    \0   .4   #9    S0   ,0 !@"]  \
MMP 8 +, (@"P "P K0 V *D /@"G $8 I !- *( 4P"@ %D GP!> )T 9 ";
M &H F@!P )@ =P"6 (  E "* )$ E0"/ *( C0"P (L PP") ., B #Y (8
M_P"& /\ A@#_ (8 _P#S    XP   -$   #%    O0   +8   "N  L J  2
M *0 ' "@ "8 G  O )H -P"7 #\ E0!& )( 3 "1 %( CP!8 (T 70"+ &,
MB@!J (@ <0"& 'D A "# (( CP!_ )L ?@"I 'P NP!Z -4 > #R '@ _P!W
M /\ =P#_ '< _P#G!P  T0P  ,,-  "X#   K@@  *@   "B  4 FP . )8
M%0"2 !\ C@ H (L ,0"( #D A@!  (0 1@"" $P @ !2 '\ 5P!] %T >P!C
M 'H :P!X ', =@!] '0 B !Q )4 < "D &X M !L ,H :P#J &H _ !J /\
M:@#_ &H _P#:$   QA0  +@6  "M%0  I!(  )P.  "6!P  D  ) (H $ "%
M !@ @0 A 'X *@![ #( >0 Y '< 0 !U $8 <P!, '( 40!P %< ;@!> &T
M90!K &X :0!W &< @P!E )$ 8P"? &( KP!@ ,0 7P#D %\!^ !> O\ 7@+_
M %X"_P#.&   O1T  + @  "E'P  FQP  ),7  "+$0  A P  'X$"P!Y !(
M=0 ; '( (P!O "L ;0$S &L!.@!I D  9P-& &8#3 !D!%( 8P19 &$$8 !?
M!6D 7@5S %P&?P!:!HT 60>< %<(K0!6",$ 50GA %0+]@!4"_\ 5 O_ %0+
M_P#&'P  MB4  *DH  ">*   E"4  (LA  "#&P  >Q0  '0. P!N"0T :0@4
M &8)'0!D"B4 8@HM & +- !>"SH 70M  %L,1P!:#$T 6 Q4 %<-7 !5#60
M5 UO %(->P!0#HH 3PZ: $X.K !,#\( 3!#C $L0^0!+$/\ 2Q'_ $L0_P"_
M)@  L"L  *0O  "9+P  CRT  (8I  !])   =!X  &P7  !E$0< 7PX0 %P/
M%P!:$!\ 6! G %80+@!4$#4 4Q [ %(10@!0$4@ 3Q%0 $X15P!,$F  2Q)K
M $D2> !($X< 1A.7 $44J0!$%+X 0Q7? $,6^ !#%O\ 0Q;_ $,6_P"Z*P
MJS$  * T  "5-0  BS0  ($Q  !X*P  ;R8  &8@  !>&0$ 5Q0- %04$P!1
M%!L 3Q4C $X5*@!,%3$ 2Q8W $D6/@!(%D0 1Q=, $475 !$%UT 0QAG $$8
M= ! &8, /QJ4 #T:I@ \&[L .QO; #L<]@ \'/\ /!S_ #P<_P"U,   J#8
M )PY  "1.P  ASH  'XW  !S,@  :BT  &$G  !9(0  41L) $P9$ !*&A<
M2!H? $8:)@!%&RT 0QLS $(;.@!!'$$ 0!Q( #X<4  ]'5D /!YD #L><0 Y
M'X  .!^2 #<@I  V(+@ -2'6 #4A]  U(O\ -2'_ #8A_P"R-   I#H  )D^
M  "//P  A3\  'L\  !P.   9S(  %TM  !4*   3"(% $8?#@!#'Q0 01\;
M #\?(@ ^("D /2 P #L@-@ Z(3T .2%% #@B30 W(E< -B-B #0C;@ S)'X
M,B2/ #$EH@ O);8 +R;2 "\F\@ O)O\ ,";_ # F_P"O.   HCX  )9"  ",
M0P  @D,  'A!  !N/0  8S@  %HS  !1+@  2"@! $ D#  ](Q$ .R08 #DD
M'P X)"8 -B0L #4E,P T)3H ,R9" #(F2@ Q)U0 ,"=? "\H;  N*'L +"F-
M "LJH  J*K0 *2K/ "DK\  J*_\ *BK_ "LJ_P"L/   GT(  )1&  "*1P
M@$<  '9%  !L0@  83T  %<X  !.,P  1"X  #PI"0 W*!  -2@5 #,H'  R
M*", ,"@I "\I,  O*C< +BH_ "TK2  L*U( *RQ= "HL:@ H+7D )RV+ "8N
MG@ E+K, )"_- "0O[@ E+_\ )2__ "8N_P"I/P  G44  )))  "(2P  ?DP
M '1*  !J1P  7D(  %0]  !+.0  030  #@O!@ R+0T ,"T3 "XM&0 M+2
M*RTG "HN+@ I+C4 *2\] "@O1@ G,$\ )3!; "0Q:  C,7< (C*) "$RG0 ?
M,[$ 'C/+ !XS[0 ?,_\ (#/_ "$R_P"F0P  FDD  )!-  "&3P  ?%   '-/
M  !H3   7$8  %)#  !)/P  /SL  #8V @ N,@P *S(1 "DR%P H,AX )C(D
M "4S*P D,S( (S0Z "(T0P A-4T (#58 !\V90 >-G4 '#>' !LWFP :-Z\
M&3C( !DXZP :./\ &S?_ !LW_P"C1P  F$T  (Y1  "$4P  >U0  '%3  !F
M4   6DP  %!)  !'10  /4$  #,]   J.0D )3<. ",W%  B.!L (3@B " X
M*  ?.#  'CDX !TY00 <.DL &CI6 !D[8P 8.W( %CN% !4\F0 4/*T $SW&
M !,]Z0 4//T %3S_ !8[_P"@2P  E5$  (M5  ""6   >5D  &Y8  !D5@
M6%$  $Y/  !%2P  .D<  #!#   G0 4 (#X- !T^$0 </A< &SX> !H^)0 9
M/BT &#\U !8_/@ 5/T@ %$!3 !- 8  207  $4&" !!!EP /0:P #D+$  Y"
MYP /0?P $$'_ !! _P"=4   DU8  (E:  " 70  =EX  &Q=  !B6P  5E<
M $Q5  !!40  -DX  "Q+   C2   &T4) !=$#P 51!0 %$4; !-%(@ 212D
M$44Q !%%.P 01D4 #T90  Y'7@ -1VT #$=_  M'DP )1Z< "$>^  A'X  )
M1_8 "D;_  M&_P":50  D%L  (=@  !]8@  <V,  &IB  !@80  4UX  $=:
M   \5P  ,E4  "A2   ?4   %TX$ !%,#  /3!$ #DP7  Y,'@ -324 #$TN
M  M--P *34( "4U-  =.6@ &3FD !$Y[  ).CP !3J0  $VZ  !-VP !3?(
M 4W_  ),_P"66P  C6(  (1F  !Z:   <6D  &AI  !<9P  3V0  $)A   W
M7P  +5P  "-:   :6   $E<!  U6"0 )50X !U43  95&@ $52(  U4J  )5
M-   53X  %5*  !65P  5F4  %5W  !5BP  5:   %6V  !4U   5/$  %/]
M  !3_P"38@  BF@  (!L  !W;@  ;V\  &-N  !6;   26H  #UH   R9@
M)V4  !UC   58@  #F$   E@"  #8 T  %\1  !?%P  7QX  %\F  !?+P
M7SH  %]%  !?4P  7V$  %YR  !>AP  79P  %VR  !<SP  7.\  %O]  !;
M_P"0:@  AF\  'UR  !U=   :G4  %UT  !/<P  0G(  #9P   K;P  (&X
M !=M   0;   "FP   )K!@  :PL  &H/  !J%   :AH  &HA  !I*@  :30
M &E   !I3@  :5P  &EM  !H@@  :)@  &>N  !FR@  9>T  &7\  !D_P"+
M<0  @G8  'IY  !P>P  8GL  %5[  !(>@  .WH  "]Z   C>0  &7@  !%W
M   *=P   W<   !W @  =P@  '8-  !V$   =A4  '8;  !V(P  =BX  '4Z
M  !U1P  =58  '5H  !T?   =)(  '.J  !RQ   <>D  '#[  !P_P"&>0
M?WT  '9_  !H@0  6H(  $R"   _@P  ,H0  "6#   :@P  $8,   J#   "
M@P   (0   "%    A ,  (,(  "##0  @Q   (,5  "$'   A"8  (0R  "$
M/P  @T\  (-@  ""=0  @HP  (&D  " O0  ?^,  '[Y  !^_P""@   >H0
M &R&  !>B   4(H  $*+   UC0  )XT  !N-   1C@  "HX   "/    D0
M )(   "2    D@   )(!  "2!P  D@P  )(0  "3%0  DQT  )0H  "4-@
ME$4  )-7  "3:P  DX(  )*<  "1M@  D-@  (_S  "/_P!^AP  <(H  &&-
M  !3D   19,  #>5   IE@  ')<  !&8   )F0   )L   "<    G@   *
M  "@    H    *    "A    H00  *()  "C#@  I!0  *4=  "F*@  ICH
M *9,  "E8   I7@  *62  "DK   I,D  */K  "B^@!SC@  9)$  %:5  !'
MF0  .9P  "J>   =H   $:$   BC    I0   *<   "I    K    *X   "N
M    K@   *\   "P    L0   +(   "S!@  M0T  +<3  "Y'@  N2X  +I
M  "Z5   NVH  +J%  "YH0  N;L  +K>  "Y\@!GE0  6)D  $J>   [H@
M+*8  !VH   1J@  !ZP   "O    L0   +0   "X    NP   +P   "\
MO@   +\   #     P@   ,0   #&    R ,  ,L+  #/$@  T2   -$R  #2
M1@  TUT  -1V  #4D@  U:L  -7$  #4X@!;G0  3*(  #VG   OK   'Z\
M !&Q   'M0   +@   "[    O@   ,(   #'    R@   ,P   #,    S@
M -    #2    U0   -@   #;    WP   .(   #F"P  ZQ,  .PD  #M.
M[DX  .]G  #P@@  \)P  /"R  #QQ0#_  , _P ! /\ ! #_  D _P / /\
M& #_ "0 _P P /\ / #_ $< _P!1 /\ 60#_ &  _0!G /P ;0#Z ', ^0!Y
M /@ ?P#V (4 ]0", /, E #R )T \ "G .X LP#L ,0 ZP#A .H ^ #I /\
MYP#_ -D _P#+ /\ P@#_ +T _P#_    _P   /\   #_    _P , /\ % #_
M "  _P K /X -P#Z $( ]@!+ /( 4P#P %L [@!A .P 9P#J &T Z !S .<
M>0#E '\ XP"& .$ C@#? )8 W0"@ -L K #8 +L U #1 -, \ #0 /\ S@#_
M ,@ _P"] /\ M@#_ +( _P#_    _P   /\   #_    _0 ( /< $ #S !H
M[P F .T ,0#H #L XP!% .  30#< %4 V0!; -8 80#3 &< T0!L ,\ <@#-
M '@ RP!_ ,D AP#' )  Q0": ,, I0#  +( O@#% +P Y0"Z /L N #_ +<
M_P"P /\ J0#_ *4 _P#_    _P   /X   #U    [  # .4 #0#? !4 V@ @
M -0 *@#0 #4 RP ^ ,@ 1P#% $X P@!5 ,  6P"^ &$ O !F +H ; "X '(
MM@!X +4 @ "S (@ L0"2 *X G@"L *H J0"[ *@ U0"F /, I #_ *, _P"A
M /\ FP#_ )@ _P#_    ^P   /    #E    V    ,X "0#' !$ P@ : +X
M) "[ "X MP X +0 0 "Q $@ K@!. *P 5 "J %H J0!? *< 90"E &L I !Q
M *( > "@ ($ G@"+ )P E@"9 *, EP"R )8 QP"3 .@ D@#^ )$ _P"0 /\
MC0#_ (L _P#Y    ZP   -T   #/    Q@   +P ! "U  T L  5 *P '@"H
M "@ I0 Q *( .0"? $$ G0!( )L 3@"9 %, EP!9 )8 7@"4 &0 D@!J )
M<0". 'H C "# (H CP"( )P A@"J (0 O "" -P @0#V (  _P!_ /\ ?P#_
M 'X _P#L    V@   ,D   "^    M@   *X   "G  D H0 0 )P & "8 "(
ME0 J )( ,@"0 #H C0!! (L 1P") $T AP!2 (8 6 "$ %T @@!D ($ :P!_
M ', ?0!] 'L B !X )4 =@"C '4 M !S ,P <0#M '  _P!P /\ < #_ '
M_P#?!0  R@H  +P+  "Q"0  J 0  *$   ";  , E  , (\ $P"* !L AP D
M (0 + "! #, ?P Z 'T 00![ $< >0!, '< 4@!V %< = != '( 9 !P &T
M;P!V &P @@!J (\ :0"= &< K@!E ,, 9 #D &, ^@!C /\ 8@#_ &, _P#0
M#@  OQ(  +(3  "G$@  G1   )4+  "/ P  B0 ' (( #@!^ !4 >@ > '8
M)0!T "T <0 T &\ .@!N $  ; !& &H 3 !I %( 9P!8 &8 7P!D &< 8@!Q
M &  ? !> (D 7 "8 %L J0!9 +P 6 #< %@ ] !8 /\ 5P#_ %< _P#&%@
MMAH  *H=  "?'   E1D  (T4  "%#P  ?@D  '<!"@!R !  ;@ 7 &H 'P!H
M "< 90 N &0 - !B #L 8 !  %\ 1@!= $P 7 !3 %H 6@!8 &( 5P!L %4
M=P!3 (4 4@"4 % !I0!/ ;@ 3@+2 $T$\ !-!?\ 307_ $T%_P"_'0  L"(
M *,E  "9)0  CR(  (4=  !]&   =1(  &X- @!G!@P 8P,1 %\"&0!= R$
M6P0H %D$+P!7!34 5@4[ %0&00!3!D< 409. % '50!.!UX 30AG $L(<P!)
M"8$ 2 F2 $<*HP!%"K8 1 O0 $0,[P!##?\ 0PW_ $0-_P"Y)   JBD  )XL
M  "4+   BBH  ( F  !W(0  ;AL  &84  !?#P4 60L- %4*$P!3"QL 40LB
M $\,*0!-#"\ 3 PV $L-/ !)#4( 2 U) $8-40!%#EH 1 YD $(.< ! #G\
M/P^0 #X0H@ \$+8 .Q#1 #L1\0 [$?\ .Q'_ #P1_P"T*0  IB\  )HR  "0
M,@  AC$  'PM  !R*   :2,  &$=  !9%@  41$( $P/$ !*$!8 2! = $80
M) !%$"L 0Q$Q $(1-P!!$3X 0!%% #X230 ]$E8 /!)A #H3;0 Y$WP -Q2-
M #84GP U%;, -!7- #,6[@ T%O\ -!;_ #06_P"O+@  HC0  )<W  ",.
M@C8  '@T  !N+@  92H  %PD  !4'@  3!@$ $84#0!"%!( 0!09 #\4(  ]
M%2< /!4M #L5-  Y%CH .!9" #<62@ V%U, -1=> #,8:@ R&7D ,!F* "\:
MG0 N&K$ +1O* "T;[  M'/\ +AO_ "X;_P"L,@  GS@  )0[  "*/   @#P
M '8Y  !K-   8B\  %DJ  !0)0  1Q\  $ :"@ \&1  .AD6 #@9'0 V&B,
M-1HI #0:,  S&C< ,AL^ #$;1P O'%  +AU; "T=9P L'G8 *AZ( "D?FP H
M'ZX )R#' "8@Z@ G(/X *"#_ "@@_P"I-@  G3P  )(_  "'00  ?4   '0^
M  !I.@  7S4  %8P  !-*P  1"4  #L@!P V'@X ,QX3 #(>&0 P'B  +QXF
M "X?+0 M'S0 +" [ "L@1  J(4X *2%8 "<B90 F(G0 )2.% ",CF0 B)*T
M(23% "$EZ  B)?T (B3_ ",D_P"F.@  FC\  (]#  "%10  >T0  ')#  !G
M/P  73H  %,V  !*,0  02P  #@F P Q(PP +B(1 "PB%@ J(AT *2(C "@C
M*@ G(S$ )B0Y "4E00 D)4L (R96 "(F8P A)W( 'R># !XHEP =**L &RG#
M !LIY@ <*?L '2G_ !XH_P"C/@  F$,  (U'  "#20  >DD  '!'  !F1
M6C\  %$[  !'-P  /C(  #4M   L* D *"</ "<G%  E)QH )"<A ",H)P B
M*"X (2DV " I/P ?*DD 'BI4 !TK8  ;*V\ &BR! !DLE0 7+:D %BW! !8M
MY  7+?H &"W_ !DM_P"A00  E4<  (M+  ""30  >$T  &Y,  !D20  6$0
M $]   !&/0  /3@  #,T   J+P8 )"P- "$L$@ @+!@ 'RT> !XM)0 =+2P
M'"XT !LN/  :+T8 &"]1 !<P7@ 6,&T %3%_ !,QDP 2,:@ $3*_ !$RX@ 2
M,OD $S'_ !,Q_P">10  DTL  (E/  " 40  =E(  &U0  !B3@  5DD  $U&
M  !$0P  .S\  #$Z   G-@, 'S(+ !PR$  ;,A4 &3(; !@R(@ 7,RD %C,Q
M !4T.@ 4-$0 $S1/ !(U7  1-6L $#9]  \VD0 .-J8 #3>\  TWW0 --O8
M#C;_  \V_P";20  D4\  (=3  !^5@  =58  &I5  !@4P  54\  $Q,  !"
M20  .$4  "Y!   D/0  '#H( !8X#@ 5.!( %#@8 !,Y'P 2.28 $3DN ! Y
M-P /.D$ #CI,  T[60 -.V@ "SMZ  H[C0 )/*( !SRX  <\U0 (//  "3O_
M  H[_P"83@  CE0  (58  !\6P  <EL  &A:  !>6   4U4  $E2   ^3@
M-$L  "I'   A1   &$(# !) "P 0/Q  #C\5  X_'  -0", #$ K  M -  *
M0#X "4%*  =!5@ &064 !$%V  -!B@ !09\  $&T  !!T  !0>X  4'\  )
M_P"55   C%D  (->  !Y8   <&   &9@  !=7@  45L  $57   Z5   +U$
M "5/   <3   %$H   Y("  +1PX "$<2  ='&0 &1R  !4@H  -(,0 "2#L
M $A'  !(4P  2&(  $AS  !(A@  2)L  $BQ  !'S   1^T  $?[  !'_P"2
M6@  B6   (!C  !W90  ;F8  &5F  !99   3&   $!=   U6P  *ED  "!7
M   750  $%,   M2!P %40T  5 1  !0%@  4!T  % E  !0+@  4#@  %!#
M  !04   4%X  %!O  !0@P  3Y@  $^N  !.R0  3NL  $W[  !-_P"/80
MAF8  'UI  !T;   ;&T  &%K  !3:0  1F<  #ID   O8P  )&$  !I?   2
M7@  #%P   9<!@  6PL  %H/  !:$P  6AD  %DA  !9*0  63,  %D_  !9
M3   65H  %EK  !8?@  6)0  %>K  !7Q0  5ND  %7[  !5_P",:   @FT
M 'IP  !R<@  9W(  %IQ  !,<   /VX  #-M   H:P  '6H  !1H   -9P
M!V<   !F P  9@D  &4-  !E$0  9!4  &0<  !D)   9"X  &0Z  !C1P
M8U4  &-F  !C>@  8I   &&G  !@P0  7^8  %_Z  !>_P"';P  ?W0  'AW
M  !N>   8'@  %)W  !%=P  .'8  "MV   @=   %G,   YS   '<@   '(
M  !R    <04  '$*  !Q#@  <!$  ' 7  !P'@  <"<  ' S  !O0   ;U
M &]@  !N=   ;HL  &VB  !LO   :^(  &KX  !I_P"#=P  ?'L  '-]  !E
M?@  5W\  $E_   \?P  +X   ")_   7?@  #WX   =^    ?P   '\   !_
M    ?@   'X%  !^"@  ?@T  'X1  !^%P  ?B   'XK  !].0  ?4@  'U9
M  !\;0  ?(0  'N<  !ZM@  >=H  'CU  !W_P" ?P  =X(  &F#  !;A0
M388  #^(   RB0  )(D  !B)   /B0  !XH   "+    C    (T   "-
MC    (P   ", P  C @  (T-  "-$0  C1<  (XB  ".+P  CC\  (U0  "-
M9   C'L  (R5  "+K@  BLT  (GO  ")_P![A0  ;8@  %Z*  !0C0  0H\
M #21   FD@  &9,   Z4   &E0   )8   "8    F@   )L   ";    FP
M )L   ";    G    )T%  "="P  GA   )\7  "@)   H#0  *!&  "@60
MGW   )^*  ">I0  GL(  )WH  "<^0!PC   88\  %.2  !$E@  -ID  ">;
M   9G   #YT   6?    H0   *,   "E    J    *D   "I    J0   *H
M  "K    K    *T   "N 0  L D  +(/  "S&   M"<  +0Y  "U30  M&0
M +1^  "SF@  L[0  +/5  "S\ !DDP  59<  $>;   XGP  *:(  !JD   .
MI@  !*@   "K    K0   +    "T    M@   +@   "X    N0   +H   "\
M    O0   +\   #     PP   ,4'  #)#P  RAH  ,LL  #,0   S58  ,YO
M  #-BP  S*@  ,S"  #,X@!8FP  2:   #JE   LJ0  '*L   ^N   $L0
M +0   "W    N@   +X   ##    Q@   ,@   #(    R@   ,L   #-
MSP   -(   #5    V0   -T   #A!0  Y@\  .<>  #H,@  Z4@  .I@  #K
M>P  ZY<  .RN  #LP@#_    _P   /\   #_  8 _P - /\ %0#_ "$ _P L
M /\ . #_ $, _P!, /X 5 #[ %L ^@!B /@ : #V &X ]0!T /0 >@#R (
M\0"' .\ CP#M )< ZP"A .D K0#G +T Y0#8 .0 \P#B /\ X #_ -  _P#$
M /\ O #_ +8 _P#_    _P   /\   #_    _P ) /\ $0#_ !P _0 G /D
M,@#U #T \0!& .T 3P#K %8 Z !< .8 8@#D &@ XP!N .$ <P#? 'D W0"
M -H B #8 )$ U "; -( I@#/ +0 S #) ,D Z0#( /\ QP#_ ,$ _P"W /\
MKP#_ *L _P#_    _P   /\   #_    ^  % /( #@#N !< Z@ B .8 + #A
M #< W0!  -@ 20#3 %  T !6 ,X 7 #, &( R@!G ,@ ;0#& ', Q !Y ,(
M@0#  (H O@"4 +P GP"Y *P M@"^ +0 W0"S /< L0#_ +  _P"H /\ H@#_
M )X _P#_    _P   /D   #O    Y@   -\ "P#6 !( T  < ,P )@#( #
MQ  Z ,  0@"] $H NP!0 +@ 5@"V %L M0!A +, 9@"Q &P L !R *X >@"L
M (( J0", *< F "E *4 HP"T *  RP"? .X G0#_ )P _P"9 /\ E #_ )$
M_P#_    ]@   .H   #=    SP   ,< !@#   \ NP 7 +< ( "S "H L  S
M *T .P"J $, IP!) *4 3P"C %4 H@!: *  7P"> &4 G0!K )L <@"9 'L
MEP"% )0 D "2 )T D "L (X OP", .( BP#Z (D _P") /\ A@#_ (, _P#T
M    Y    -0   #(    OP   +4  0"N  L J0 2 *4 &P"A ", G@ L )L
M- "8 #P E@!# )0 20"2 $X D !3 (X 60"- %X BP!D (D :P"' ', A0!]
M (, B "! )4 ?P"D 'T M0![ ,\ >0#Q '@ _P!W /\ =P#_ '4 _P#E
MT0   ,,   "X    KP   *@   "@  8 F@ . )4 %0"1 !X C@ F (L +0"(
M #4 A@ \ (0 0@"" $< @ !- '\ 4@!] %@ >P!> 'D 90!X &T =@!V ',
M@0!Q (X ;P"= &T K@!L ,0 :@#G &D _0!H /\ : #_ &D _P#5 P  PP<
M +8(  "K!@  H@   )L   "4    C0 * (@ $ "# !@ ?P @ 'P )P!Z "X
M=P U '4 .P!T $$ <@!' '  3 !O %( ;0!8 &L 7P!I &8 9P!P &4 >P!C
M (@ 8@"7 &  IP!> +L 70#< %P ]@!< /\ 6P#_ %L _P#)#0  N1   *P1
M  "A$   EPT  (\(  "(    @@ % 'L #0!W !( <P : &\ (0!L "@ :@ O
M &@ -0!G #L 90!! &, 1@!B $P 8 !2 %\ 60!= &$ 6P!J %D =0!7 ((
M50"1 %0 H@!3 +4 40#/ %  [P!0 /\ 4 #_ %  _P"_%   L!@  *0:  "9
M&0  CQ8  (<1  !_#0  =P8  '$ " !K  X 9P 4 &0 &P!A "( 7@ I %T
M+P!; #4 60 [ %@ 00!6 $8 50!- %, 5 !2 %P 4 !E $X < !, 'T 2P"-
M $D G@!( +  1P#' $8 Z0!& /L 1@#_ $4 _P"X&P  JB   )XB  "3(@
MB1\  ( :  !W%0  ;Q   &@+  !A! H 70 0 %D %@!6 !T 5  C %( *@!0
M #  3P U $X .P!, $$ 2P!( $D 3P!' 5< 1@%A $0"; !# GD 00.) $ #
MF@ ^!*T /03$ #P%Y0 \!_@ / ?_ #P'_P"R(@  I2<  )DI  ".*0  A"<
M 'LC  !Q'@  :1@  &$2  !:#0, 4P@, $\%$0!,!1< 2@8> $@&) !'!BH
M10<P $0'-@!#"#T 00A# $ (2P ^"5, /0E= #L*:  Z"G8 . N' #<+F0 U
M"ZP - S" #,,Y  S#?D ,PW_ #0-_P"M)P  H"P  )4O  "++P  @"X  '<J
M  !M)0  9"   %P:  !4%   3 \& $8,#0!##!( 00P8 #\,'P ^#"4 / TK
M #L-,@ Z#3@ . T_ #<.1P V#E  - Y: #,.9@ Q#W0 , ^% "X0F  M$*L
M+!## "L1Y0 L$?H +!'_ "T1_P"J+   G3$  )(T  "'-0  ?30  '0Q  !J
M*P  8"<  %@A  !/&P  1Q8  $ 1"0 [$ \ .1 4 #<0&P V$"$ -! G #,1
M+0 R$30 ,1$[ # 10P N$DT +1)7 "P28P J$W$ *1." "<4E0 F%*D )17
M "05XP E%OH )A;_ "85_P"F,0  FC8  (\Y  "%.@  >SD  '$V  !G,0
M72T  %0H  !,(@  0QT  #L7!0 U% T ,A,1 #$4%P O%!T +A0D "P4*@ K
M%3$ *A4X "D60  H%DH )Q=4 "878  D&&\ (QB  "$9DP @&:< 'QF^ !X:
MX  ?&O@ (!K_ " :_P"C-   F#H  (T]  "#/@  >3T  &\[  !E-P  6S(
M %(M  !)*   0",  #@> 0 P&0H +!@/ "H8%  I&!H )Q@@ "89)P E&2T
M)!HU ",:/@ B&T< (1M2 " <7@ ?'6P '1U^ !P=D0 :'J4 &1Z\ !@?W0 9
M'_8 &A__ !L>_P"A.   E3T  (M!  "!0@  =T(  &U   !C/   63<  $\S
M  !&+@  /2D  #4D   M( < )QT- "4=$@ C'1< (1T= "$=)  @'BL 'QXR
M !X?.P ='T4 '"!/ !HA7  9(6H &")[ !8BCP 5(J, %".Z !,CV@ 4(_4
M%2/_ !8C_P">/   DT$  (E$  !_1@  =48  &Q$  !B00  5SP  $TX  !$
M-   /#   #,K   J)@, (R(+ " A$  >(14 '"(; !LB(0 :(B@ &B,P !DC
M.  8)$( %B5- !4E60 4)F@ $R9Y !(FC0 1)Z( $">X  XGU@ 0*/0 $2?_
M !$G_P"<0   D44  (=(  !]2@  =$H  &I)  !@1@  54$  $P^  !#.@
M.C8  #$R   H+0  ("D) !LG#@ 9)Q( &"<8 !8G'P 5*"4 %"@M !,H-@ 2
M*4  $BE+ !$J5P 0*F8 #BMW  XKBP -+)\ #"RU  LLSP ,+.\ #2S_  TK
M_P"91   CTD  (5,  !\3@  <T\  &E.  !>2P  4T<  $I$  !"0   .3T
M "\X   E-   '3 % !8M#  4+!  $RT5 !(M'  1+2, $"TJ  \N,P .+CT
M#2](  TO50 ,,&, "C!T  DPB  (,9P !C&Q  8QRP &,>L !S#\  @P_P"7
M2   C4T  (-1  !Z4P  <50  &=2  !=4   4DP  $E*  ! 1@  -4(  "L^
M   B.@  &C<! !(T"0 /,PX #C,3  TS&0 -,R  ##0H  LT,0 *-3L "#5&
M  <U4@ %-F  !#9Q  (VA   -ID  #:O   VR   -N@  #;Y  $U_P"430
MBE(  (%6  !X6   ;UD  &58  !;50  45(  $=/   \3   ,4@  "=$   >
M00  %C\  ! \!P +.@T "3H1  @[%P &.QX !3LF  0[+@ ".S@  3Q#   \
M3P  /%X  #QN   \@0  /)<  #RL   [Q0  .^<  #OX   [_P"14@  B%@
M ']<  !V70  ;5X  &-=  !:7   3E@  $)4   W40  +4X  "-+   :20
M$D8   U$!@ '0PP  T,0  !#%0  0QL  $,C  !#*P  0S4  $-   !#30
M0UL  $-K  !#?@  0Y0  $*J  !"PP  0>8  $'Y  !!_P".6   AEX  'UA
M  !S8P  :V0  &)C  !780  25T  #U:   R6   )U4  !Y3   540  #D\
M  E-!0 "30L  $P.  !,$P  2Q@  $L?  !+*   2S(  $L]  !+20  2U<
M $MG  !*>P  2I   $FG  !)P   2.0  $CX  !'_P"+7P  @V0  'IG  !Q
M:0  :6H  %YI  !09@  0V0  #=A   L7P  (5T  !A;   060  "E@   -7
M P  5PD  %8-  !5$   514  %0;  !4(P  5"T  %0Y  !410  5%,  %1D
M  !3=P  4XT  %*D  !1O0  4.(  %#X  !/_P"(9P  ?VL  '=N  !O<
M97   %=N  !*;   /6L  #!I   E:   &F8  !%D   +8P  !&(   !B 0
M808  & +  !@#@  7Q(  %\7  !?'@  7B@  %XS  !>0   7D\  %Y?  !=
M<@  78@  %R@  !;N0  6M\  %GW  !8_P"$;@  ?'(  '5U  !K=@  774
M $]T  !"<P  -7,  "AR   =<   $V\   QN   $;@   &X   !N    ; (
M &P'  !K"P  :PX  &L2  !J&0  :B(  &HM  !J.@  :4D  &E:  !I;
M:(,  &>;  !FM0  9=@  &3U  !D_P" =0  >GD  '![  !B>P  5'P  $9\
M   Y?   +'P  !][   4>@  #7H   1Z    >@   'H   !Z    >0   'D!
M  !X!@  > L  '@.  !X$P  >!H  '@E  !X,@  =T$  '=2  !W90  =GP
M '65  !TKP  <\X  '+Q  !Q_P!^?0  =8   &>!  !8@@  2H,  #R$   N
MA0  (84  !6%   -A0   X4   "&    AP   (@   "(    AP   (<   "'
M    AP0  (<)  "'#@  B!,  (@<  "(*0  B#@  (=*  "'70  AG,  (:-
M  "%IP  A,4  (/L  ""_@!XA   :H8  %R(  !-B@  /XP  #&.   CCP
M%H\   V0   "D0   )(   "3    E0   )8   "6    E@   )8   "6
MEP   )<   "7!P  F T  )D3  ":'P  FBT  )H_  ":4@  FF@  )F#  "9
MGP  F+H  )?B  "6^ !MB@  7XT  %"0  !!DP  ,Y8  "27   6F   #9D
M  &;    G0   )\   "A    I    *4   "D    I0   *4   "F    IP
M *@   "I    J@0  *P,  "N$P  KB$  *XS  "N1P  KET  *YV  "NDP
MKJX  *W-  "L[P!AD0  4Y4  $28   UG   )I\  !>A   -HP   *4   "G
M    J@   *P   "P    L@   +0   "S    M    +4   "W    N    +D
M  "[    O0   +\!  ##"P  Q14  ,4E  #&.0  QT\  ,=H  #&A0  QJ(
M ,:\  #&W@!5F0  1YT  #BB   II@  &:@   VK    K0   +$   "T
MMP   +H   "_    P0   ,0   ##    Q0   ,8   #(    R@   ,T   #/
M    T@   -8   #;    X P  .$8  #C*P  Y$$  .5:  #F=   YI$  .6L
M  #EQ #_    _P   /\   #_  $ _P * /\ $@#_ !T _P H /\ - #_ #X
M_0!( /H 4 #W %< ]0!= /0 8P#R &D \ !O .\ = #M 'L ZP"! .D B0#H
M )( Y@"< .0 J #B +< WP#- -P [@#9 /\ V0#_ ,H _P"^ /\ M0#_ +
M_P#_    _P   /\   #_    _P & /\ #P#\ !@ ^  C /0 +@#P #@ ZP!"
M .@ 2@#E %$ X@!8 .  70#> &, W !H -D ;@#6 '0 U ![ -$ @@#/ (L
MS0"5 ,H H0#( *\ Q0#! ,( XP#  /L P #_ +L _P"P /\ J #_ *0 _P#_
M    _P   /\   #[    \P ! .T # #H !, XP > .  * #: #( TP \ ,\
M1 #, $L R0!1 ,8 5P#$ %T P@!B ,$ 9P"_ &T O0!T +L >P"Y (0 MP".
M +0 F0"R *< KP"W *T T "K /( J@#_ *D _P"A /\ FP#_ )< _P#_
M_P   /0   #I    X    -4 " #. !  R0 8 ,4 (@#! "L O  U +D /0"V
M $4 LP!+ +$ 40"O %8 K@!; *P 80"J &8 J0!M *8 = "D 'P H@"& *
MD@"> )\ G "N )D PP"7 .< E@#_ )4 _P"2 /\ C0#_ (H _P#\    \
M .,   #4    R    +\  P"Y  T LP 3 *\ ' "L "4 J0 N *4 -@"C #X
MH !$ )X 2@"= %  FP!5 )D 6@"7 %\ E@!F )0 ; "2 '4 D !^ (X B@"+
M )< B0"F (< N "% -8 A #V (( _P"! /\ ?@#_ 'P _P#M    W0   ,P
M  #!    N    *X   "G  D H@ 0 )X %P": !\ EP G )0 +P"1 #< CP ]
M (T 0P"+ $D B0!. (@ 4P"& %D A !? (( 90"  &T ?@!W 'P @@!Z (\
M> "> '4 KP!S ,< <@#L '$ _P!P /\ < #_ &X _P#=    R0   +P   "Q
M    J0   *$   "9  , DP , (X $@"* !D AP A (0 *0"! #  ?P W 'T
M/0![ $( >0!( '@ 30!V %( = !8 '( 7P!Q &< ;P!P &P >P!J (@ : "7
M &8 J !E +P 8P#A &( ^@!A /\ 80#_ &$ _P#- 0  O 4  *\%  "E @
MG    )0   "-    A@ ( ($ #@!\ !0 >  ; '4 (P!R "D <  P &X -@!M
M #P :P!! &D 1P!H $P 9@!2 &0 60!C &  80!I %\ = != ($ 6P"0 %D
MH0!7 +0 5@#0 %4 \@!5 /\ 5 #_ %4 _P#!#   L@X  *8/  ";#@  D@L
M (D%  ""    >P " '4 "P!P !  ;  6 &@ '0!F ", 8P J &$ , !@ #8
M7@ [ %T 00!; $8 6@!, %@ 4P!6 %L 5 !D %( ;@!1 'L 3P"* $T FP!,
M *X 2P#& $H Z@!) /X 20#_ $D _P"Y$@  JA8  )X7  "4%@  BA,  ($0
M  !Y"P  <0,  &L !@!E  T 80 1 %T & !: !X 6  D %8 *@!4 #  4P V
M %$ .P!0 $$ 3@!' $T 3@!+ %8 20!? $< :0!& '8 1 "% $, EP!! *D
M0 "_ #\ X@ _ /@ /@#_ #\ _P"R&0  I!X  )@?  ".'P  A!P  'H8  !R
M$@  :@X  &((  !< 0@ 5P . %, $P!0 !D 3@ ? $P )0!* "L 2  P $<
M-@!& #P 1 !" $, 20!! %$ /P!: #X 90 \ '( .@"! #D DP X *4 -@"Z
M #8 VP U /0 -0#_ #4 _P"L(   GR0  )0F  "))@  ?R0  '4@  !L&P
M9!4  %P0  !4# $ 3@8* $H"#P!' !0 1  : $( ( !  "4 /P K #X!,0 \
M 3< .P(^ #D"10 X TT -@-6 #4$80 S!&X ,05^ # %D  O!:, +0:X "P&
MU  L!_  + C_ "P(_P"H)0  FRH  ) L  "&+0  >RL  '(G  !H(@  7QT
M %<7  !/$@  2 X$ $$*"P ^!Q  .P85 #D'&P X!R$ -@@F #4(+  S"#(
M,@DY #$)00 O"4D +@I3 "P*7@ K"VP *0M\ "@,CP F#*( )0RW "0,TP C
M#?  ) W_ "4-_P"D*@  F"\  (TR  "#,@  >3$  &\N  !E*0  7"0  %,?
M  !+&0  0Q,  #P0!@ U#0P ,PP1 #$,%@ O#!P +@TB "T-*  K#2X *@TU
M "D-/0 G#D8 )@Y0 "0.7  C#VH (@][ " 0C@ ?$*( '1"W !P0U  =$?(
M'1'_ !X1_P"A+P  E3,  (HV  " -P  =C8  &TS  !C+P  62H  % E  !(
M(   /QH  #@5   P$0@ +! . "H0$@ H$!@ )Q > "40)  D$"H (Q$R "(1
M.@ A$4, (!). !X26@ =$V@ &Q-X !H3BP 8%*  %Q2U !84T0 6%?$ %Q7_
M !@4_P">,P  DS<  (@Z  !^.P  =#L  &LX  !A-   5R\  $XK  !%)@
M/2$  #0<   M%P4 )A,, ",3$  B$Q4 (!,: !\3(0 >%"< '10O !P5-P ;
M%4$ &A9+ !D65P 7%V4 %A=V !08B0 3&)X $ABS !$9S@ 1&>\ $AG_ !,9
M_P"<-@  D3L  (8^  !\/P  <S\  &D]  !?.0  534  $PP  !#+   .B<
M #(B   J'@$ (AD) !X7#@ <%Q( &A<7 !D8'@ 9&"0 &!DL !<9-  6&CX
M%1I) !,;50 2&V, $1QT ! <AP /'9P #AVQ  T=RP -'>P #AW_  \=_P"9
M.@  CS\  (1"  ![1   <4,  &A"  !>/@  4SH  $HV  !!,@  .2T  #$I
M   H)0  (" & !H=#  7'!  %1P5 !0=&P 4'2( $QTI !(>,@ 1'SP $!]&
M ! @4P .(&$ #2%Q  PAA0 +(ID "B*N  DBQP )(N< "B+[  LA_P"7/@
MC$,  (-&  !Y2   <$@  &=&  !<1   4C\  $D[  ! .   .#0  "\P   G
M+   'B<# !8C"@ 2(0X $2$3 ! B&0 0(B  #R(G  XC+P -)#D #"1$  LE
M4  *)5X "29O  <F@@ &)I8 !":L  ,FQ  $)N4 !";W  8F_P"50@  BD<
M (%*  !X3   ;TP  &5+  !;2   4$0  $=!   _/@  -SL  "TV   D,0
M&RT  !,J!P /* T #2<1  TH%@ ,*!T "R@E  HI+0 )*3< !RI"  8J3@ $
M*UP  RML  $K?P  *Y0  "NI   KP0  *^,  "OV   J_P"21@  B$L  ']/
M  !V40  ;5$  &-0  !:30  3TH  $='   ^1   ,T   "D\   @.   %S0
M !$Q!0 ,+PP "2X0  <N%0 &+QL !2\C  ,O*P ",#4  # _   P3   ,5D
M #%I   Q?   ,9$  #&G   POP  ,.$  ##U   O_P"02P  AE   'U4  !U
M5@  :U8  &)5  !84P  3E   $5-   Z20  +T4  "5"   </@  %#L   XY
M!0 )-PL !#8/  $V$P  -AD  #8@   V*0  -C(  #<]   W20  -U<  #=G
M   W>0  -X\  #:E   VO0  -N   #7U   U_P"-4   A%8  'Q:  !R6P
M:5L  &!;  !760  3%8  $!2   U3@  *DL  "!(   71@  $$,   M!!  $
M0 H  #\.   ^$0  /A8  #X=   ^)@  /B\  #XZ   ^1@  /E0  #YD   ^
M=@  /8P  #VC   \NP  /-X  #OU   [_P"*5P  @EP  'E?  !P80  :&$
M %]A  !47@  1UL  #I7   O50  )5(  !M0   230  #$L   9* P  20D
M $@-  !'$   1Q0  $8:  !&(@  1BP  $8W  !&0P  1E$  $9@  !%<P
M18D  $2@  !$N   0]P  $+U  !"_P"(70  ?V(  '=E  !N9P  9V@  %MF
M  !.8P  06$  #1>   I7   'UH  !57   .5@  !U0   !3 0  4@8  %$+
M  !1#@  4!$  $\6  !/'@  3R<  $\R  !//P  3TT  $Y=  !.;P  3H4
M $V=  !,M0  2]@  $KU  !*_P"%90  ?&D  '1L  !M;@  8FT  %1K  !'
M:0  .F<  "UE   B9   &&(  !!@   )7P   %X   !>    70,  %P(  !;
M#   6@\  %H3  !9&0  62(  %DM  !9.@  64@  %A8  !8:P  5X$  %>9
M  !6L@  5=(  %3T  !3_P"!;   >7   '-S  !H<P  6G(  $QQ   _<
M,F\  "5N   :;   $6L   EJ    :@   &D   !I    :    &<#  !F"
M9@P  &8/  !E%   91P  &4G  !D-   9$,  &13  !D90  8WL  &*4  !A
MK0  8,T  %_Q  !>_P!]=   =W<  &YY  !?>0  47D  $-Y   V>   *7@
M !QW   1=@  "G4   !U    =0   '8   !U    =    '0   !S @  <P<
M ',,  !R$   <A4  '(@  !R+   <CL  '%,  !Q7P  <70  '".  !OJ
M;L8  &SM  !K_P![>P  <GX  &1^  !5?P  1X   #F!   K@@  'H$  !*!
M   *@0   ($   ""    @P   (,   "#    @@   ((   ""    @@   ((%
M  """@  @@\  ((7  ""(P  @C(  ()#  "!5@  @6P  ("&  !_H0  ?KT
M 'WF  !\_ !V@@  :(,  %F%  !+AP  /(D  "Z*   @BP  $XL   J+
MC    (T   "/    D0   )(   "1    D0   )$   "1    D0   )(   "2
M @  DPD  )0/  "4&0  E"<  )0X  "43   DV(  )-\  "3F   DK,  )'8
M  "0]@!JB   7(H  $V-   _D   ,)(  "&4   4E0  "I8   "7    F0
M )L   "=    GP   *    "@    H    *    "A    H@   *,   "D
MI0   *8'  "H$   J!P  *@M  "I0   J58  *EO  "IBP  J*@  *?'  "F
M[ !?CP  4)(  $&6   SF0  (YP  !2=   *GP   *$   "C    I@   *@
M  "L    K@   *\   "O    L    +    "R    LP   +0   "V    MP
M +H   "]!P  OQ   +\?  # ,P  P$D  ,!B  # ?@  P)L  ,"W  "_V !3
MEP  1)L  #6?   FHP  %J4   NG    J@   *T   "P    LP   +8   "[
M    O0   ,    "_    P0   ,(   #$    Q@   ,@   #*    S    ,\
M  #3    V@<  -L3  #=)0  WCL  -]3  #@;@  WXP  -VI  #=P@#_
M_P   /\   #_    _P ' /\ $ #_ !D _P D /\ +P#\ #H ^0!# /4 2P#S
M %( \0!9 .\ 7@#M &0 ZP!I .D ;P#G '4 Y@!\ .0 A #B (T X "7 -T
MH@#: +$ U0#% -( Z #0 /\ SP#_ ,0 _P"X /\ KP#_ *D _P#_    _P
M /\   #_    _P " /L #0#W !4 \P ? .\ *0#J #0 Y@ ] .( 10#> $P
MVP!3 -@ 6 #4 %X T@!C -  :0#. &X S !U ,H ?0#( (4 Q@"0 ,( FP#
M *D O@"Z +L V0"Y /< N #_ +0 _P"I /\ H@#_ )T _P#_    _P   /\
M  #V    [@   .< "@#A !$ W  : -< (P#0 "X RP W ,< /P#$ $8 P0!-
M +\ 4@"] %@ NP!= +D 8@"X &@ M@!N +0 =0"Q 'X KP"( *T DP"J *$
MJ "Q *8 R "D .T H@#_ *( _P"; /\ E0#_ )$ _P#_    _    .X   #C
M    V    ,T !0#&  X P0 5 +T '@"Y "< M0 P +( . "O $  K !& *H
M3 "H %$ IP!6 *4 6P"C &$ H0!G )\ ;@"> '8 FP"  )D C "7 )D E "H
M )( O "0 -\ C@#[ (X _P"+ /\ A@#_ (, _P#X    Z0   -P   #,
MP0   +@   "R  H K  1 *@ & "E "$ H@ I )X ,@"< #D F0 _ )< 10"5
M $H E !0 )( 50"0 %H CP!@ (T 9P"+ &\ B0!X (8 A "$ )$ @@"@ (
ML@!] ,P ? #Q 'L _P!Z /\ =P#_ '4 _P#F    TP   ,8   "[    L0
M *<   "A  4 FP - )< $P"3 !L D  C (P *P"* #( B  X (8 /@"$ $0
M@@!) ($ 3@!_ %, ?0!9 'L 8 !Y &@ =P!Q '4 ? !S (D < "8 &\ J0!M
M +\ :P#F &H _P!I /\ :0#_ &< _P#3    PP   +4   "K    HP   )L
M  "2    C  * (< $ "# !8 ?P = 'T ) !Z "L >  R '8 . !T #T <@!"
M '$ 2 !O $T ;0!3 &P 60!J &$ : !J &8 = !D ($ 80"1 %\ H@!> +8
M7 #5 %L ]P!; /\ 6@#_ %H _P#%    M@(  *D"  "?    E@   (X   "'
M    @  % 'H # !U !$ <0 8 &X '@!K "4 :0 K &< ,0!F #< 9  \ &,
M00!A $< 7P!- %X 4P!< %L 6@!D %@ ;@!6 'L 5 "* %( FP!1 *X 4 #(
M $\ [@!. /\ 3@#_ $T _P"["@  K T  * -  "5#   C @  (,"  !\
M=0   &X " !I  X 90 3 &( &0!? !\ 70 E %L *P!9 #$ 6  V %8 .P!5
M $$ 4P!' %$ 3@!0 %4 3@!> $P : !* '4 2 "$ $< E0!% *@ 1 "_ $,
MY !" /P 0@#_ $( _P"R$0  I10  )D5  ".$P  A!$  'L-  !S"   ;
M &4  P!?  L 6P / %< % !4 !H 40 ? $\ )0!. "L 3  P $L -@!) #P
M2 !" $8 2 !% %  0P!9 $$ 8P _ &\ /@!^ #P D  [ *, .@"X #D V0 X
M /4 . #_ #@ _P"L%P  GQL  ),=  ")'   ?QD  '45  !L$   9 P  %T&
M  !6  8 40 , $T $ !* !4 1P : $4 ( !$ "8 0@ K $$ ,0 _ #8 /@ ]
M #P 1  [ $L .0!4 #< 7P V &L - !Z #( C  Q )X , "S "\ S@ O .\
M+@#_ "X _P"G'@  FB(  (\D  "$)   >B$  '$=  !G&   7Q,  %<.  !0
M"@  20,( $4 #0!! !$ /@ 6 #P &P Z "$ .0 F #< +  V #( -  X #,
M/P Q $< , !0 "X 6P M &< *P!V "H B  H )P )P"P "8 R0 E .H )0'[
M "4!_P"B(P  EB@  (LJ  "!*@  =R@  &TE  !D(   6QL  %(5  !+$
M0PP" #T'"0 Y PX -@$2 #,!%P Q 1P , $B "\")P M BT + ,T "H#.P I
M!$, * 1- "8%6  E!64 (P9T "(&A@ @!IH 'P>N !X'Q@ =!^< '0CX !T)
M_P"?*   DRT  (@O  !^+P  ="X  &HK  !A)@  6"$  $\<  !'%P  /Q(
M #@.!  Q"PH +@@. "L'$@ I!Q< * @= "<((P E""D ) DP ",)-P A"D
M( I* !\+50 ="V( &PQR !H,A0 8#)D %PRM !8,Q@ 5#>8 %0WY !8-_P"<
M+0  D#$  (8T  !\-   <C,  &@Q  !?+   52<  $PC  !$'0  /!@  #03
M   M$ 8 )@T+ "0,#P B#!, (0P9 !\,'P >#24 '0TL !L--  :#CT &0Y'
M !<.4P 6#F$ % ]Q !,0A  2$)@ $1"N ! 0Q@ 0$.@ $!#[ !$0_P"9,0
MCC4  (0X  !Z.0  <#@  &<V  !=,@  4RT  $HH  !")   .1\  #$:   J
M%0$ (Q$' !T0#0 ;#Q  &0\5 !@0&P 7$"$ %A I !40,0 4$3H $Q%% !(2
M40 1$E\ $!)O  X3@@ .$Y8 #1.K  L3P@ +%., #!3Z  T3_P"7-0  C#D
M ((\  !X/0  ;ST  &4Z  !;-P  4C(  $DN  ! *@  -R4  "\A   H'
M(!@# !D4"@ 5$@X %!(2 !,3&  2$Q\ $10F !$4+@ 0%#@ #Q5"  X63P -
M%EP #!=L  L7?P )&), "!BH  88OP '&.  !QCU  D8_P"5.   BCT  (!
M  !W00  ;4$  &0_  !:/   4#@  $<S   ^,   -BL  "XG   G(P  'Q\
M !<:"  2%PT $!<1  \7%@ .&!P #A@C  T9+  ,&C4 "QI   H;3  )&UH
M!QQI  4<?  $'9$  AVF  $=O  "'-T  ASR  ,<_P"3/   B$$  ']$  !U
M10  ;$4  &-$  !900  3ST  $8Y   ^-@  -3(  "XN   E*@  '24  !0A
M!  /'0L #1T0  P=%  +'1H "AXB  @>*@ ''S, !B ^  0@2@ #(5<  2%G
M   A>0  (8X  "&D   AN@  (=L  "'R   @_@"00   AD4  'U(  !T2@
M:TH  &))  !81@  3D(  $4_   ]/   -3D  "LT   B+P  &2L  !(H!  -
M) H "2,.  8C$@ %(QD !"0@  (D*  !)3$  "4\   E2   )E4  "9E   F
M=P  )HP  ":B   FN0  )MD  "7R   E_@".10  A$D  'M-  !S3P  :D\
M &!.  !72P  34@  $1%   \0@  ,3T  "<Y   >-0  %3(   \N P *+ H
M!2L.  $J$0  *A8  "H>   J)@  *R\  "LY   K10  +%,  "QB   L=0
M+(H  "N@   KMP  *]8  "KR   J_P",20  @DX  'I2  !Q5   :%0  %]3
M  !640  3$X  $-+   W1P  +4,  ",_   :/   $C@   PV P &,PD  #(-
M   R$   ,10  #$;   Q(P  ,2P  #(W   R0P  ,E   #)@   R<@  ,H<
M #&>   QM0  ,-0  ##R   O_P")3P  @%0  'A7  !O60  9ED  %Y9  !5
M5P  25,  #Y/   R3   *$@  !Y%   50@  #D    @] @ !/ @  #L,   Z
M#P  .1(  #D8   Y(   .2D  #DT   Y0   .4X  #E=   Y;P  .(4  #B<
M   WLP  -](  #;R   U_P"'50  ?UH  '9=  !M7P  95\  %U?  !27
M1%@  #A5   M4@  (D\  !A,   02@  "D@   -& 0  108  $0*  !##0
M0A   $$5  !!'0  028  $$Q  !!/0  04H  $%:  !!;   0($  #^9   _
ML0  /M   #WR   \_P"$7   ?&   '-C  !L90  9&8  %ED  !+80  /EX
M #);   F60  '%8  !)4   ,4@  !%$   !/    3@,  $T(  !,#   2PX
M $L2  !*&0  2B(  $HL  !*.0  2D<  $I6  !):   27X  $B6  !'KP
M1LT  $7Q  !$_P"!8P  >6<  ')J  !K;   8&L  %)I  !$9@  -V0  "IB
M   ?8   %5X   U=   &6P   %H   !9    6    %<$  !6"   5@P  %40
M  !4%   5!T  %0G  !4-   5$(  %-2  !39   4GD  %*2  !1JP  4,H
M $_O  !._P!^:@  =VX  '!Q  !F<0  6'   $IO   \;0  +VP  ")J   7
M:0  #F<   9F    90   &4   !E    8P   &(   !B!   80@  &$-  !@
M$   8!<  & A  !?+@  7SP  %]-  !>7@  7G0  %V-  !<IP  6\4  %KM
M  !9_P![<@  =78  &MW  !==@  3W8  $%U   S=0  )G0  !ES   0<@
M!W$   !Q    <0   '$   !Q    ;P   &\   !N    ;@(  &X(  !M#
M;1$  &T:  !M)@  ;#4  &Q&  !K6   :VT  &J&  !IH0  :+X  &?H  !F
M_@!Y>@  <'P  &%\  !3?0  1'T  #9^   H?@  &WT  !!]   '?0   'T
M  !]    ?@   '\   !^    ?0   'T   !\    ?    'P   !\!@  ? P
M 'P2  !\'0  ?"P  'P\  !\3P  >V4  'M^  !ZF@  >;8  'C?  !W^@!S
M@   98$  %:#  !(A   .88  "N'   =AP  $8<   >(    B    (D   "*
M    C    (T   "-    C    (P   ",    C    (P   "-    C00  (X,
M  ".$P  CR$  (XR  ".1@  CEL  (UT  "-D   C*T  (O.  "*\P!HA@
M6H@  $N+   \C0  +8\  !Z0   1D0  !Y(   "3    E0   )<   "9
MFP   )P   ";    FP   )P   "<    G0   )X   ">    GP   *$#  "B
M#   HA8  *,F  "C.@  HT\  *-H  "BA@  HJ(  *+   "AZ !<C0  39
M #^3   PE@  (9D  !*:   'FP   )T   "@    H@   *0   "H    J@
M *L   "J    JP   *P   "M    K@   *\   "Q    L@   +0   "W 0
MN0T  +D:  "Z+0  ND,  +I;  "Z=P  NY0  +NQ  "YT@!0E0  09@  #*<
M   CH   $Z(   BD    IP   *H   "L    KP   +(   "W    N0   +L
M  "Z    O    +T   "_    P    ,(   #$    Q@   ,D   #-    T@$
M -0/  #5'P  US4  -A-  #8:0  UX8  ->C  #6O0#_    _P   /\   #_
M    _P # /\ #0#_ !4 _P @ /P *P#X #4 ]  _ /  1P#N $X ZP!4 .D
M6@#G %\ Y0!D ., :@#A '  WP!V -T ?@#; (< V "1 -, G0#/ *L S0"]
M ,L X #) /L QP#_ +T _P"Q /\ J0#_ *, _P#_    _P   /\   #_
M_    /8 "P#Q !$ [0 ; .D )0#D #  WP Y -H 00#5 $@ T0!. ,\ 5 #-
M %D RP!> ,D 8P#' &D Q0!O ,, =P#  '\ O@"* +L E0"X *, M@"T +0
MS0"R /( L #_ *P _P"C /\ G #_ )< _P#_    _P   /H   #Q    Z
M .  !@#9  X T@ 6 ,X 'P#( "D Q  R ,  .@"] $$ N@!( +@ 30"V %,
MM !8 +( 70"P &( K@!I *P ;P"J '@ J "" *8 C@"D )L H0"K )\ P "=
M .8 FP#_ )H _P"4 /\ C@#_ (H _P#_    ]@   .@   #<    S@   ,8
M 0"_  L N@ 1 +8 &@"R "( K@ K *H - "H #L I0!! *, 1P"A $P GP!1
M )X 5@"< %P F@!B )D : "7 '  E0!Z )( A@"0 ), C0"B (L M0") -,
MAP#W (8 _P"$ /\ ?P#_ 'P _P#R    XP   -(   #%    N@   +$   "K
M  < I0 . *$ % "> !P F@ E )< +0"4 #0 D@ Z )  0 ". $4 C0!* (L
M4 ") %4 B !; (8 80"$ &D @@!R '\ ?0!] (L >P": '@ JP!V ,0 = #K
M ', _P!S /\ < #_ &X _P#?    S    +\   "T    JP   *$   ":  (
ME  + )  $ ", !< B  > (4 )@"# "T @0 S '\ .0!] #\ >P!$ 'D 20!X
M $X =@!4 '0 6@!S &( < !K &X =0!L (, :@"2 &@ HP!F +@ 9 #> &,
M^P!B /\ 8@#_ &  _P#,    O    *\   "E    G0   )0   ",    A@ '
M ($ #0!\ !( >  9 '4 'P!S "8 <0 M &\ ,@!M #@ :P ] &H 0@!H $@
M9P!. &4 5 !C %L 80!D %\ ;@!= 'L 6P"* %D FP!7 *\ 5@#+ %4 \@!4
M /\ 5 #_ %0 _P"^    L    *0   "9    D    (@   "!    >0 " ',
M"@!O  \ :P 4 &< &@!E "  8P F &$ + !? #( 7@ W %P / !; $( 60!'
M %< 3@!6 %4 5 !> %( : !0 '0 3@"# $P E0!* *@ 20#  $@ Z !' /\
M1P#_ $< _P"T"0  I@L  )L,  "0"@  A@4  'X   !V    ;P   &@ !0!C
M  P 7P 0 %L %0!8 !H 5@ A %0 )@!3 "P 40 Q %  -@!. #P 30!" $L
M2 !) %  2 !8 $8 8@!$ &X 0@!] $  C@ _ *( /0"X #T W0 \ /@ / #_
M #P _P"L$   GQ(  )02  ")$0  ?P\  '8,  !N!0  9@   &   0!9  @
M50 - %$ $0!. !8 2P ; $D (0!( "8 1@ K $4 ,0!# #8 0@ \ $  0P ^
M $L /0!3 #L 70 Y &D -P!X #8 B0 T )P ,P"Q #( S@ R /$ ,0#_ #$
M_P"F%@  FAD  (X:  "$&@  >A8  ' 2  !H#@  7PH  %@#  !1  0 3  *
M $@ #@!$ !( 00 6 #\ &P ] "$ /  F #H +  Y #$ -P W #8 /@ T $8
M,P!/ #$ 60 O &4 +@!S "P A0 K )@ *@"M "D Q@ H .H * #^ "@ _P"A
M'   E2   (HA  !_(0  =1\  &P:  !C%@  6A$  %(-  !+!P  1  & $
M"P \  \ .  2 #8 %P T !P ,P A #$ )P P "P +@ S "T .@ K $( *@!+
M "@ 50 F &$ )0!P "0 @0 B )4 (0"I "  P0 @ .0 'P#Y !\ _P"=(@
MD28  (8H  !\)P  <B4  &DB  !?'0  5Q@  $X3  !&#@  /PL  #@%!P T
M  P ,0 0 "X $P L !@ *@ = "D (@ G "@ )@ N "0 -@ C #X (@!' "
M4@ ? %X '0!M !P ?@ : )( &0"G !@ O0 7 -\ %P'U !<"_P":)P  CBL
M (0M  !Y+0  <"L  &8H  !=)   5!\  $L:  !#%   .Q   #0- @ M"0D
M*04- "8#$  D 1, (@(9 "$"'@ @ B0 '@,J !T#,@ ;!#H &@5$ !D%3P 7
M!EP %@9J !0'?  3!Y  $@>E !$'NP 0!]L $ CR ! )_P"7*P  C"\  ($Q
M  !W,@  ;C$  &0N  !;*@  424  $D@  ! &P  .!8  #$2   I#@0 (PP)
M !\)#0 =!Q  &P<5 !D(&@ 8""  %PDG !8)+@ 5"C< $PI! !(+30 1"UH
M$ MI  X,>P .#)  #0RE  P-NP +#=D "PWQ  P-_P"5+P  BC,  '\V  !V
M-@  ;#4  &,S  !9+P  4"L  $<F   ^(0  -AT  "X8   G$P  (! % !D.
M"@ 5# X % P1 !,,%@ 2#!P $0TC ! -*P /#30 #@X_  T.2@ ,#U@ "P]G
M  H0>0 ($(T !Q"B  80N  %$-0 !1#O  80_P"2,P  B#<  'XZ  !T.P
M:SH  &$X  !8-0  3C   $4L   ])P  -2,  "T?   F&@  'A8! !<3!@ 1
M$ L #@X.  X/$P -$!D #1 @  P0*  +$3( "A$\  @22  '$E4 !A-E  03
M=@ #$XL  12@   3M@  $]$  !/N   3^P"0-@  ACL  'P^  !S/P  :C\
M & ]  !7.0  338  $0Q   \+@  -"H  "PF   E(@  'AX  !8: @ 0%0D
M#!,.  H3$@ )%!< "!0?  <5)@ &%2\ !!8Z  ,61@ !%U,  !=B   8=
M&(D  !B?   8M0  %]   !?M   7^P"..@  A#\  'M"  !R0P  :$,  %]"
M  !6/P  3#L  $,W   [-   ,S   "PL   D*0  &R0  !,? @ -&PD "1D-
M  89$0 $&18  AD=  $:)   &BT  !LX   ;1   '%$  !Q@   =<@  '8<
M !R=   <LP  ',X  !OM   ;_ ",/@  @D,  'E&  !P2   :$@  %Y&  !5
M1   2T   $,]   [.@  ,S<  "HR   @+0  %RD  ! E @ +(@D !2 -  $?
M$   'Q0  !\;   @(@  ("L  "$V   A00  (4\  "%>   B<   (H4  "&;
M   AL@  (<T  "#M   ?_ "*0P  @$@  'A+  !O3   9DT  %U+  !420
M2D8  $)#   Z0   +SL  "4W   <,P  $R\   TL @ '*0@  2<,   F#@
M)1(  "89   F(0  )BD  "8S   G/P  )TT  "=<   G;0  )X(  ">9   F
ML   )<P  "7N   D_0"(2   ?TP  '90  !N40  95(  %Q1  !33P  2DP
M $%)   U1   *T   "$\   7.0  $#8   HR 0 #, <  "\+   N#@  +1$
M "T6   M'@  +2<  "TQ   M/0  +4H  "U9   M:P  +8   "R7   LKP
M*\L  "KN   J_@"%30  ?5(  '55  !L5P  8U<  %M6  !350  1U$  #M-
M   P20  )48  !Q#   3/P  #3T   8Z    . 4  #<)   V#0  -0\  #04
M   T&P  -"0  #0N   T.@  -$<  #17   T:   -'T  #.5   RK0  ,<H
M #'N   P_P"#4P  >U@  '-;  !J70  8ET  %M=  !/6@  0E8  #92   J
M3P  ($P  !9)   .1P  "$0   !"    00,  #\'   ^"P  /0X  #T1   \
M&   /"$  #PK   \-P  /$0  #Q3   \90  .WH  #J2   ZJP  .<@  #CM
M   W_P"!6@  >5X  '%A  !I8P  8F0  %=B  !)7@  /%L  "]8   D50
M&5,  !!1   *3P   4T   !,    2@   $D$  !("   1PP  $8/  !&%
M11P  $4G  !%,P  14   $50  !$80  1'8  $./  !"J   0<8  $#L   _
M_P!^80  =F4  &]H  !H:@  76D  $]F  !"9   -&$  "A?   =70  $EL
M  M9   "6    %8   !6    5    %,   !2!   40D  % -  !0$   3Q@
M $\B  !/+@  3SP  $]+  !.70  3G(  $V+  !,I0  2\(  $GJ  !(_P![
M:0  =&P  &YO  !D;P  56T  $=L   Y:@  +&D  "!G   490  #60   -B
M    8@   &$   !@    7P   %X   !=    7 0  %P)  !;#0  6Q(  %L<
M  !:*   6C8  %I&  !96   66T  %B%  !7H   5KT  %7H  !3_@!Y<
M<W0  &EU  !;=   3',  #YS   P<@  (W$  !9O   -;@  !&T   !M
M;0   &T   !L    :P   &H   !I    :0   &D#  !H"0  : X  &@5  !G
M(0  9R\  &<_  !F4@  9F8  &5_  !DF@  8[<  &+A  !A_ !W>   ;7H
M %]Z  !0>@  0GH  #-[   E>P  &'H   YY   $>0   'D   !Y    >@
M 'H   !Z    >    '@   !W    =P   '<   !W 0  =P@  '<.  !W&
M=R8  '8V  !V20  =5\  '5W  !TDP  <Z\  '+3  !Q]P!Q?@  8W\  %2
M  !%@@  -H,  "B$   :A   #H,   2$    A    (4   "&    B    (D
M  "(    AP   (<   "'    AP   (<   "(    B    (@'  ")$   B1P
M (DL  "(/P  B%4  (AM  "'B0  AJ<  (7'  "$[P!FA   5X8  $B(   Y
MB@  *HP  !N-   /C0  !(X   "0    D0   ),   "5    EP   )@   "6
M    EP   )<   "7    F    )@   "9    F@   )L   "=!P  G1$  )TA
M  "=,P  G4D  )QB  "<?P  G)P  )RY  ";X@!:BP  2XX  #R1   MDP
M'I4  !"6   $F    )H   "<    G@   *$   "D    I@   *<   "F
MIP   *<   "H    J0   *H   "L    K0   *\   "Q    LPD  +,5  "T
M)P  M#T  +55  "U<   M(X  +2L  "TS !-D@  /Y8  "^:   @G0  $9\
M  6A    HP   *8   "I    K    *\   "S    M0   +<   "V    MP
M +@   "Z    NP   +T   "_    P0   ,0   #'    RP   ,T,  #.&@
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M_____________________________________________________P
M               ! P0%!@@)"@L-#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK
M+2XO,#(S-#8W.#D[/#T^0$%"1$5&1TE*2TU.3U!24U155UA96UQ=7F!A8F-E
M9F=I:FML;F]P<7-T=7=X>7I\?7Z @8*#A8:'B(J+C(Z/D)&3E)66F)F:G)V>
MGZ&BHZ2FIZBJJZRMK["QL[2UMKBYNKN]OK_!PL/$QL?(R<O,S<_0T=+4U=;7
MV=K;W=[?X.+CY.;GZ.GK[.WN\/'R]/7V]_GZ^_S^____________________
M__________________________________\  0(#! 4&!P@)"@L,#0X/$!$2
M$Q05%A<8&1H;'!T>'R A(B,D)28G*"DJ*RPM+B\P,3(S-#4V-S@Y.CL\/3X_
M0$%"0T1%1D=(24I+3$U.3U!14E-455976%E:6UQ=7E]@86)C9&5F9VAI:FML
M;6YO<'%R<W1U=G=X>7I[?'U^?X"!@H.$A8:'B(F*BXR-CH^0D9*3E)66EYB9
MFIN<G9Z?H*&BHZ2EIJ>HJ:JKK*VNK["QLK.TM;:WN+FZN[R]OK_ P<+#Q,7&
MQ\C)RLO,S<[/T-'2T]35UM?8V=K;W-W>W^#AXN/DY>;GZ.GJZ^SM[N_P\?+S
M]/7V]_CY^OO\_?[_;69T,0     # 2$   $                    !
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M________^X Q        "6',____________________________TEH"
M     %W,____________________________J#4          %S3________
M____________________?0T          %36________________________
M___N?44          $34___________________________\JF0O @  !"(W
M25C.____________________________Z:1K02@_8W^5I[K:____________
M___________________5LJRRS.3Z________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___ENY=W8LC_________________________________VYYG-@H  HS_____
M___________________________(?S\%     %[/____________________
M_________]F!.0       #RJ_____________________________YY,
M     ".0____________________________W&\:         !!]^?______
M____________________KT@           !O[O______________________
M____A!,           !DYO_________________________L40
M  !7WO________________________^X%0            !(UO__________
M______________]T%              XS_________________________FB
M6A,            CQ?_________________________?FUPL           -
MNO__________________________[[%]53DB$0<! A$BLO______________
M________________W[^EF9B:H*R]VO______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________X[Z=@'S[____________________
M____________\K>$5S . !VL_______________________________2BDP5
M      !R\____________________________]9_-@        !+R?______
M____________________^I$^           OJ_______________________
M____P%H            :E?__________________________C20
M   (A/_________________________G7@              =___________
M______________^T)0              :O________________________]]
M                6_3_______________________TK
M3.O______________________Z4                 /.'_____________
M_________S ,                +=G_____________________F8IA)P
M            )]?______________________^V^B54G            )=S_
M_________________________LJ==EU*/#(M+# Y1][_________________
M______________WFW=;2T-/9Y/__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___OU+O6_________________________________^>XCVI++Q5O________
M_______________________DH6<T!P     \R?______________________
M_____]:".P         2E___________________________[84Q
M    ;___________________________ID(             4.'_________
M_______________L:0              -\G_______________________^S
M+P              (K;_______________________]Y
M$*?_______________________(T                 )G_____________
M_________ZD                  (S______________________T8
M             '______________________WP                   '3_
M____________________EP                   &K_________________
M____S@                   &/______________________RDB 0
M         &'______________________[FC@%<W%P           &C_____
M______________________K3KI2&?'5Q<')W@93_____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________V[J=@FEIT_______________________________R)-E/1D
M   =GO___________________________]N.3!,         ;O__________
M________________VWPL            1=?_________________________
MBRH             (K3________________________"1
M Y?_______________________]] 0               '______________
M_________^<V                 &K______________________YT
M             %C______________________T8                  $?X
M____________________Z0                   #7I________________
M____E@                   "7;____________________O
M         !C.____________________ZP                    _"____
M_________________P                    JY____________________
M_R<                   JU_____________________W
M      VY_____________________^"<C'!50C,F&Q0/#0X2&B:_________
M____________________^>38TL[,R\S/UN#\________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________Z].\X___________
M_____________________]*IA65(+!(!A?__________________________
M__&K<3P/        3^#_________________________U7\U
M'[+________________________C=1T              (G_____________
M__________^0(P               &?______________________]5#
M             $CV_____________________XH                  "[=
M_____________________S@                  !?(________________
M____O@                    2V____________________G
M          "E____________________N@                    "3____
M________________W                     ""____________________
M_P                    !T_____________________Q,
M      !H_____________________T(                   !@________
M_____________WH                   !=_____________________]$
M                  !A______________________\D
M  !F_______________________)K)F)?79Q;&EG9F=K<'J,____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________XL6JD7EA
M=______________________________=IG=0+ P     ,<3_____________
M____________X)).$P           (_________________________2<!T
M             &#______________________^YO#P               #?B
M_____________________Y8<                 !3 ________________
M_____T                    "C____________________K@
M          ")____________________G@                    !R____
M________________O                     !?____________________
MV@                    !-____________________^@
M       [_____________________PX                    J^?______
M_____________S,                    ;Z?___________________UX
M                   /V____________________X\
M   &T/___________________]                      RO__________
M__________\K                    R/____________________^
M                R______________________W%@$%!0,!       !!@T8
MR________________________.OAV,_,S<_0TM37W.+J________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________':QO______________________________
M\<:CA&A-,A@ %:O__________________________[E\1A@          ''_
M_______________________7?"\              #OC________________
M_____]]D"0                RU_____________________W0#
M          "-____________________Q14                   !J____
M________________F0                    !+____________________
MM@                     P_?__________________UP
M       9Y___________________]@                     %T_______
M_____________PX                     P?___________________R\
M                    K____________________U(
M    GO___________________WD                     CO__________
M_________Z4                     @/___________________]@
M                =/____________________\V
M;?____________________]\                    :?______________
M_______7#0                  :/______________________<
M            8?_______________________U \1DY465UA9&AL<'9^B?__
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________[]6[HXMS6I7_________________
M__________B_CF1!(04      %+\_______________________WG588
M         !?!_____________________^5L%@                "-____
M_________________V,                   !>____________________
MG0                     U_/__________________H0
M       1V?__________________R@                      N_______
M____________[@                      H?___________________PP
M                    BO___________________RT
M    =O___________________TT                     9/__________
M_________V\                     4O___________________Y0
M                0/___________________[P
M,/___________________^H.                    (O______________
M______]$                    %?____________________^!
M            "_7____________________("P                   NS_
M____________________7@                   .7_________________
M____R1P                  -K______________________YT!
M      <.%\7________________________5N;S!Q\[5V^'F[?3[________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______XW\______________________________[,:EB&U4.R$' #+>____
M____________________UY)9*0            "@____________________
M__^)-@                !G_____________________V8
M       R]O__________________E0                     #R/______
M____________IP                      H/__________________UP
M                    ?/___________________P
M    7O___________________R4                     0___________
M_________T@                     +/___________________VH
M                &/___________________XL
M!?/__________________Z\                      .'_____________
M_____]4                      ,____________________\D
M             +[___________________]4                     *[_
M__________________^+                     )__________________
M___+#@                   )+_____________________5P
M         (;_____________________J@H                  'G_____
M_________________VT                  &;_____________________
M__=5                 $7_________________________:B,K-3]*56!J
M=7Z'D9S_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^C/MIV#:4ZY_________________________^RR@UPZ'0(
M      ![_______________________%;2D               ! ________
M_____________X,;                   'R___________________D@
M                    F/__________________I
M    :O__________________W0                      0?__________
M_________PX                     '?___________________SD
M                 .C__________________V
M ,[__________________X4                      +?_____________
M_____Z@                      */__________________\L
M             )#__________________^\6                     'W_
M__________________\^                     &S_________________
M__]I                     %K___________________^9
M         $G____________________2%@                   #G_____
M________________6                    "G_____________________
MH@                   !G_____________________]58
M      3______________________[LO                  #X________
M______________^K*0                #/________________________
MR4<     !Q,@+CY2:(3M________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________]-7)________
M____________________^M*PDG==0B@,  !*________________________
MQ7U%%P             1V/___________________\10
M    G___________________H@P                     :/__________
M________E                       -O__________________V@
M                !^S__________________Q4
M ,3__________________T@                      *+_____________
M_____W4                      (/__________________YT
M             &G__________________\,                      %+_
M_________________^</                     #[_________________
M__\S                     "O___________________]8
M         !C___________________^!                      7_____
M______________^L                      #____________________>
M(@                    #R____________________7
M      #?____________________GP                    #,________
M____________Z$H                   "W_____________________Z 6
M                  "<______________________]Z @
M  !W________________________>@L               5,____________
M_____________Z)7:'2 C9RKO-#G________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_^WC___________________________2HWI8.BDC'!8.!@  G___________
M__________^L4@X                 :?__________________Y$,
M                -/__________________>0
M ./_________________S0                       ++_____________
M_____Q,                      (7__________________T\
M             %W__________________X,                      #K_
M_________________[(                      !S_________________
M_]L#                      +___________________\J
M          #[__________________]/                      #G____
M______________]T                      #4__________________^;
M                      # ___________________$!P
M      "M___________________P,P                    ":________
M____________9P                    "&____________________HP
M                  !R____________________XT0
M  !<_____________________Y$&                  !!____________
M_________^M?                   =_______________________*2P
M                ________________________RU<   P8)#$_3F!TBZ?'
M___________________________7Y_+_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________KU,W'PKZZM[.PK:FH
MI?___________________]U^4S\P(QD1"0(          -O_____________
M____=@                       *?_________________N@
M             '7__________________P<                      $;_
M_________________TX                      !K_________________
M_XP                       #]_________________\$
M          #;__________________$9                      "^____
M______________]$                      "D__________________]K
M                      "-__________________^1
M      !Y__________________^W                      !F________
M___________>(0                    !3____________________2@
M                   _____________________=P
M   K____________________K H                    6____________
M________YT4                     _____________________XH
M                _____________________]9-
M_?____________________^G+@                  U?______________
M________F"H           88+45@X/_______________________ZAC=(&/
MG*N[S>+Z____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________GR[>IG96.B82 ?'AT<&QH99#_
M________________O&I(+1D*                 #'_________________
M_P                        /__________________T(
M          #<_________________XX                       "R____
M_____________\X                       "-__________________\I
M                      !K__________________]:
M      !.__________________^&                       T________
M__________^N                       >___________________4%P
M                   *___________________Z/0
M    ____________________90                      ____________
M________C@                      ____________________O!D
M                [___________________\4X
MV/___________________XL                     O_______________
M_____\Q#                    H?____________________^1&0
M            >O_____________________R= H                17___
M____________________Z'03'RPX15-B<H6;M-+U____________________
M_______7Z/3_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________________OW
M\_'N[.OK[/'__________________]FRF8=Y;61=5E%+1D$\.#(M*"/$____
M_____________TLE"P                    "2_________________X@
M                      !F_________________]<
M       ]__________________\S                       8________
M__________]L                        __________________^=
M                    ___________________)#
M    ]O_________________Q-0                      W___________
M________6P                      R___________________@@
M                M___________________J08
MH___________________TR\                     C?______________
M_____UX                     =____________________Y,'
M            7O___________________\U#                    0/__
M__________________^'$                   '/__________________
M___87@                   /______________________OTX       X<
M+#Y2:H:ER/_______________________\)\C)JGML76Z/W_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________________^[AU\_)P[ZZMK&M
MJ:>FIJ>N_________________[Z&;5M,0#<O*"(<%A +!      4________
M_________]<%                        __________________\T
M                    ]O________________]V
M    TO________________^P                        LO__________
M_______A)                       EO__________________40
M                ?/__________________>0
M9O__________________H                       4?______________
M____QR,                     //__________________[DL
M            )____________________W0                     $/__
M_________________Z,6                     /__________________
M_]A,                     /____________________^(#P
M         /_____________________+4P                   /______
M________________I3@           D=-$YKC/______________________
M_YDY0U%?;GV.H+7+Y?_____________________________K^?__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________KS+FLH9F1BX:!?'AT<&MH
M9F9H\?________________]A13(C& X&                GO__________
M______]^                        =?_________________#
M                4O_________________[-P
M,O__________________:@                      %O______________
M____E@                       /__________________OQL
M             /__________________YD(                      /__
M_________________VD                      /__________________
M_Y "                     /___________________[DL
M         /3__________________^A<                     -G_____
M______________^1&                    +S____________________*
M4P                   )W_____________________F"X
M$"E&9L3_____________________[G\=#!HH-T97:7Z5K\SN____________
M_____________^>@JKG(V.G\____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________?7P
MZ^;BW]O8U-+1T-+7X/_________________.GHI\<6EA6U913$A#/CHV,B\N
M,?_________________2)1$#                     /______________
M____0@                       /__________________?0
M             /__________________L L                      /;_
M________________W3D                      -S_________________
M_V(                      ,7__________________XD
M         *___________________Z\B                     )G_____
M_____________]9(                     (+___________________]R
M                     &G___________________^A*
M     $[____________________37                    #/_________
M____________EBX              !4R4G?_____________________X'(3
M   !#Q\O0EAPBZC([/_______________________\IO;GZ.GK##V.______
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________^>#2R,"ZM;"L
MJ*6BGYV;FYR@I___________________@F162T,\-C K)R(=&!,."00  -3_
M________________D@                       *W_________________
MS!X                      (O_________________^U(
M         &W__________________X                       %'_____
M_____________ZD;                     #K__________________]!"
M                     "/___________________5H
M      S___________________^/%                     #_________
M__________^X/@                    #____________________E;0,
M                  #_____________________GS<              ! O
M4'3_____________________W7(4      87*D%:=92VVO______________
M_________[Q81%1D=8::K\CC_______________________________2S>'Q
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________\^_K[_?______________________[KFHG9:/BH:"?WMX
M=G1R<W5X?Y#_________________ZT\Z,"@A&Q40"P<"         "/_____
M_____________VD                       #__________________YL*
M                      #__________________\@Y
M      #___________________!C                      #_________
M__________^*#@                    #___________________^P-
M                  #____________________56P
M  #_____________________A1H                   /L____________
M________L4D              !@Y78'_____________________Y7L>
M   ,(3A2;X^SV?_______________________[M8*3E)6FR E[#-[?______
M______________________^SGK3%U^O_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________________Z
M[^?AW-G6U-+0T-#1T]G@Z_?__________________[B*?G=Q;&AD85Y;65A7
M5UE>97'__________________[\Q'Q80"@4               #_________
M_________^U6                      #H__________________^"!
M                  #,__________________^K+P
M  "S___________________25P                    ";____________
M_______W?!                    "%____________________HC<
M            !2N4____________________RV$"            #"Q0=I[1
M____________________]8TP       -(SM7=IF^Y?__________________
M_____\-C&"H[3%]TC:?&Y_____________________________^H?Y:HN]#G
M_____________________________________?______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________=SL6_
MO+FVM+.QLK*UN<#)U>/___________________^7;&1>65513TQ*2$=&2$M0
M66:A__________________^G)@X' @                !6____________
M_______.4                      Z___________________T>0L
M               A____________________GS(                    .
M____________________Q%@                (,5J$________________
M____Z7\?           &)TMQFL+I_____________________Z=)      (7
M+TIHBJ[5_/_______________________]-U'B8X2EYUCZO+[___________
M__________________^N<H68K,+;]O______________________________
M____W^______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________O[*JIJ.A
MH)^?H:.FK+3 S=WL____________________BEI33TM(1D1#0D%"0T=.66E]
M____________________GBX&                    ________________
M____PU8                  !5!____________________YWL:
M      DT8(NT_____________________Y\_          0E2G&9PNO_____
M_________________\9F#P   !,J1&*#I\WU________________________
M_^N.-2L^46B!G;S>______________________________^^=G^4J<'<^?__
M________________________________TMCS________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______V\O#O[^_Q\_C]____________________________^+"?FI>6EI:8
MFY^DK+;"T>'N_____________________HY02D=%1$1$149'2U%::(.I____
M_________________Z9! 0          !S9CC[KA____________________
M_\9E"@      !"=,<YS$[/_______________________^6(+P  $RI$8H*F
MS/3___________________________^K4#9*87N6M-;Z________________
M_______________2AWR8L<OI____________________________________
MU,[M________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___MY>/CY.;H[?'Y______________________________VQE)*2E9F=HZFR
MO-#M__________________________^=4T=)35%68'.*K];\____________
M______________^R5@ :-5!MBZ[2]______________________________-
M;SY?>YFWU_G________________________________NGX.FPN'_________
M____________________________X\[K____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________
M
M
M              #_____________________________________________
M____________________________________________________________
M____________________________________________________________
M_____P   /_N "%!9&]B90!D0     (# ! # @0(                _]L
MA  " @(# @,$ @($!00#! 4&!04%!08(!P<'!P<("PD)"0D)"0L+"PL+"PL+
M# P,# P,# P,# P,# P,# P,# P, 0,# P<$!PT'!PT/#0T-#P\.#@X.#P\,
M# P,# \/# P,# P,#PP,# P,# P,# P,# P,# P,# P,# P,# P,# S_P@ 4
M" 38!C<$ 1$  A$! Q$!!!$ _\0!-  !   ' 0$!              $#! 4&
M!P@""0H! 0 !!0$! 0             ! @,$!0<&" D0   & 0(#!@,&!00!
M! ,  P ! @,$!081!Q(3"! @,"$Q%$ 5"5!@<#(6%T$B,S0W(S4V&"0E)C@9
MD*!"@"<H$0 " 0($ 08&# 8-!P@& Q$! @,1!  A$@4Q05%A(A,&<8&1,A0'
M$" P0*&QT4)RDB,SP5)BLC054&!PX8*BTD-SLR1T%O#"4[0U=0AC@Y/3E)4V
M=O&CP]0E%^)$5&2$Q+4WD*"DY*48\E5E1J9'$@ ! @(%!P@'!@8 !00" P$!
M  (1(3%!41(#87&!D:&Q(A @,$#!T3($4/#A0E)R$V!P8H*2HO&RPM(C%.(S
M0W,%4Y.S-*!T8R05D/_:  X$ 0$"$0,1!     #\_P"??P
M
M
M
M
M
M
M
M
M
M
M
M         G33YV/G:RR;"S=;9K]>QZ2;,>;3:O5.$XN==-8X&VOMGM7JD
M
M
M"NKMRNJO0^1U_P!>^E\9KC>^W\]BDZ:/6OL+8WS L387JPV<BLEQ,;I<M4^:
M96#:=DYVLL-PKHI-<8.TO')OG?8;#XY\Q[;9>%XN=<P
M
M                                          -M[+38[]'?;\RTIT/N
M_,XAS'H/4[#Y.\[Z[96DM5O,MEQ/H     SW,P++U-Z#R>NNNO2>.UE9[63Z
M^>/B^D[EY(\W[+8L
M
M             &SL_56+ZJ]#Y%S_ );D8--\]?&=&W?SUI?19N         !
MGF9@6;OSV//=+;YV^@PCY@^!ZOO7DOSGL=B
M
M                             !454^/I;[KENCNN_2^+U_\ ,3P/4NA-
M%ZG?9@            &59&+;OI5[KF.@\EOX]G^0G->S]'8!A[&[@
M
M                                            !LG.U=D^SO4>'\R\
MG><];L_@[R'O]R^"(;XMY/*NPJ+NH>1;^#]"  /:9>PJ+NHLMBO7^+31G6MJ
M[.YP      WOM]!AOU+Z!RGG3Y>^!ZSO7C[S/M-D
M
M                               '2>]\OA'URZ1QKGCY.\ZZYTKIW6;G
M*0 /N=KO1_EPSFFYJWX,;+S?ZM=J47M#9'37AMMFF][VMY/*_0]K*X_X4R-=
M]3<*JM[-OL58KD,58AB=5&?:AKL=#=DV,_YQ<ZW<7L.2BJS*FYKC8%-W4?'U
M_ ^B0!>+EFE^LG1N1<U\^Z7TN4?,3P75M[
M
M                        =>^E\9KCZ9^\Y5I+X\<S[-U)B^/E7  #85-W
M47U_P-[^=[FV]B=H:\JM;@[MQ]C\K>',C7_4/Z/XFU^,_!>3K?JWT7:RN.=
MW<;K/7=5K<'T9Q=K\<> <G6?6CLNQG_-[35S'Z0LLTY-UM8SOGYQI?P/I#E4
M5X%ORUD\G_'_ #M'^B+3MS'Z+ (CZ3>YYEH2[7*+7\A.;=GZ.\1,0
M
M                                        .M?1^.UW],O><JTG\;^8
M]IZGM-N[4@ !](,3;?&;LFQG_.+!:K6T\@BO$:Q-M^(NP\]^G7[JZ[T?Y9/F
MAEZC[7[RMY/+E(BX8C-O87;^/L?F%\E,[2?H$^KF%NO@?A]5O8VK:[.];E%5
MDLDT9/S[=QNN>O+&=\\OGOE:OZ\Z(N8W5   ?07V?.])9SEX>.?(#FG:.D
M
M                                             #H#<^<P_P"N_2>,
M<\?&'E_;.K;/:O50  !]*,3;?%O@/)UOUFQ.JWGWU2P]S\(+'-.3_-[*U7V;
M^DN)MOB]P=DZWZK_ $[Q-O\ #_C^_@_1'7E5K;_>F-LOE);)B^;BMW^<_DOG
M:3] 'TEQ-M\7^>+N+V!A-5O9FM:K.ZM[6\GE?EJ]A]UZTKL[I   /I)[GF>A
M<:Q\WU\O_ ]7WP
M                                                           !
MFV5@6O[H=;X#RI\;.8]IZJPW%S+J          'I/CZVX6[_ #\YO1<UAPMD
MZWZF\A7\'Z%@       1'UUZ3Q[F/A/R/0MH<:>7]OLP
M
M                            /2(?<OK7 ^5/G=XKHN^=":?T&9@
M                 %TN6J?[5]3XAR7\2^5=WZ?UG@;6^@
M
M                             ?0KVG-]-[2V&EMOSD\1TK>P  ?5S"W7
MP0V!3=U)/*;Y&YND_0=AU5O8H        5::'N;&V/RWYFO8G;/0]K*Y X@R
M-=]/       W)L]+BOTQ]YS'GGX5<C^@.L(
M
M                  ,ZR]?:?N)UC@?+7Q+Y7W+KBFIJ]@ !]T-=Z/\ +7\:
M\_0_I ^CV)M?C/HB[C=5=&V<OC>CF+AH.YC=8=AV,[YU?/C*UGUVZ+M97'>]
M;>3ROPGD:WZH2"J[\QME\F>+,C ^EEIFF_\ 1MK*XWVK;OZ%XMR-?]*_K?A;
MO\^WQRSM%^C/*8KP;8M%W3F<4W-84Y5_-/+U'VK^NF%O/SW8-5;VCRS>PN[.
M0K^#]#   ^DWN>9:$T/J/29#PAY#H.V@
M
M              ^Q_3N)\T\>>9]AMSG32>DSH   ^Z&N]'^6O&IHS6W3%Y^3
M>;I?OS]\=;Z3\GOYW=IY?]A'Z*M5ZG\=O%&1K_IATA:R^,];UV=S4Q6\'Y.M
M^JOU1PMS\(.7;V'W/V78S_F]PODZ[ZE:EKL= =76,W@?@W)UOU9^FN)M_B-\
MO,S3_<WM?'V'S,WO;R>5OC#GZ#])OW$UWH?R^?.K*U?V*S>FYK'#*K>R,^IN
MZG^:.7J/M:  %QKMR/MGU7AW(_P3X_\ 0W6UFM7ZD
M
M                      VYLM-COUYZ5Q?GCXU\P[3U2   !]T-=Z/\M?QK
MS]#^D# ZK6U*M-!]\=9Z7\GOP#V?F?UH_=37>C_+-R5>POH%KFNSN/H^UE\:
M6J:;]M.B_HFG15Z&N8W5ECFG*,PBYKO1-S&ZHZ\L9WSRX1R=;]4_L/@;W\ZG
MRYS-/]S^DK67Q?O>WD\K?$78>>_3K]U==Z/\LGR<S=)]^/I]A[CX>8S-&:Z"
MNXW6?S1R]1]K   #M;U/B-37F[;LWS/\)U/>0
M
M                 !]D>G<2YIXE\K[?<NB=1OLQ    WI;R>6M-5V.D*":;
MK[3+WY:R>3] 7<7K2_Q7BF][63RKH&[B]:7>*L>W7;R.9^?;N+US3E7T-:RN
M0-(7<;I[**:\'L,TY5E]-S7FO:[6WMOV[_/.$56]FW--DOT58II&YC]/;UM9
M/+%BFG*/I9B;;XK2Y3.=;N)V-P!DZSZT@  $^8\?;SJ_"^1/@;Q[Z(ZWMMN[
M/
M                                         R_)PK=]ONK\%Y=^*?+.
MW]9@                    $U,GKZQG?/"OB;5QU?P/HQ13%R    [Z]CS[
M2^NL';5G!/C^A[<
M                                                       ^C_N.
M8Z3H*%VXP\O[;:P          !5)HL]HNZGUS79W) B 7**K->XJQFM3;,*J
MM[,E(G          9!>QZ+[!]+XWRO\ !OD/T)UJ
M
M                   !]Z^P?//)'QIYAVGJ^UV[M0          &Q:+VG?L
MY@;[\VV@KN-UEM&B]HSXE;#SWZ;,TIN:VQV:<PWW;R>4>U\?8?,S=EO(YE^*
M&P\_^F;'IHRX          /L'TOC7+WR+YOV?H/5^OVU^
M
M                       #8^=K++]@>E\4YV^/',^S=1@          'T?
MQ-M\:,9JHS;@;)UGUAR&*\1ZGLYG"/=^-LOE9E5->!_+W,T_W*[%L9_SFW9;
MR.9?BAL//_IFQZ:,N          #L#TOC=7Y'?M6+YM^&Z?NT
M
M                           /H%[+G.GKS=Q9W$OE?<;;           /
MH%C;3Y(W^FK$_F_EZG[,_1?%VOQRV71>TKF5->N+#-.5\JWL/O'I>UE\4;LM
MY',OQ0V'G_TS8]-&7          !?;UBC^N_2./\N?"KDG?^KP
M
M                            ^U/4^&<P?-?PO2^A-?X>PO8
M !>8JQWZ[8.\_/7D45X=S;=Q.T.7[V'W)]/\3<?#C%9MYY\[LK5_83K6QG?/
M[;U%_GGY#9VC_0S8IHR@           ^V?5>'<D_!3C_ -#=94U-<P
M
M                               #[Y]A^=^1OB;RON'7(
M                   !]3N@\HYT^=/B.G;>T-J/0Y:
M
M                    7J[8I?N1UG@/+GQ>Y=VWJT               "KJ
MIDW:Y:I*ZNB1/FF6$B*IE#17/M-N[5TE-4X         [=]7X;4>*XV>X+\A
MT+;@
M                                        !OG;^>Q+Z(^VYEJ/Y;<_
MZMT2             !554RLKR,6TY+?Q[7<[ENF    "V6[E3C5C(NF*8^5=
MJ6FJ:       ;_W/GL*Z9WOFM9_*;GG7N@0
M
M           #LGT_B-9[WW'G+#P!XWH6Z@            F2\YIE8=DS')Q+
M-,F/(      !+B?6'8V7><+Q<R]RX>@     ,URL*T_3/WG,>=OBMRSN?3X
M
M                                   !]!/9\XT].FU6\;>8]IM0
M       "XUT4VRL_78S<J[=,         !;:+E3K7 V.36ZBNI     )DQY^
MS/3^+<G?"'D7T%UF
M                                                     ?2_W?+=
M&ZSP-AE_+N@]5L,           NMRW2;0S]9BU15$L           IZ9F:OP
M-GE-JMW*L     ^TO4N)\E?!GD'T)UJ
M
M        ?4'W_*-#Z/U.ZSSF_1^ESP          *RJF3M;8ZO$JNJF4
M        %)35-U3KMIEM'35.    #[4=2XER5\%N0?0O6H
M
M                      !]0??\HT/H_4[K/.;]'Z7/           V=GZ[
M%[_>L6\             "P6;]PUC@;'*     ^U'4N)<E?!;D'T+UJ
M
M                               ?2_W?+=&ZSP-AE_+N@]5L,
M  "_7K-!L_/UN+               &L,#9938;-ZO    ^TO4N)\E?!GD'T)
MUJ
M                                       ?03V?.-/3IM5O&WF/:;4
M         V9GZ[&,AO6+<               8]9OW'6>!L<G   )DQY^S/3^
M+<G?"'D7T%UF
M                                                 =D^G\1K/>^X
M\Y8> /&]"W4         3)>=R[/3X7,EY               )</6FM9N,TEP
M]  !FN5A6GZ9^\YCSM\5N6=SZ?
M
M   -\[?SV)?1'VW,M1_+;G_5NB0        "ZW+=)MC8ZO$@
M    U/KMIEMJMW*L  -_[GSV%=,[WS6L_E-SSKW0(
M
M                 !>KMBE^Y'6> \N?%[EW;>K0        "_WK%OV=GZ[%
MP                UC@;'*+!9OW   .W?5^&U'BN-GN"_(="VX
M
M                            !]\^P_._(WQ-Y7W#KD         OUZS0
M;/S];BP                :PP-EE-ALWJ\  /J=T'E'.GSI\1T[;VAM1Z'+
M0
M                                      /M3U/AG,'S7\+TOH37^'L+
MV        %QKHIMN;+58@                &H];M<OMU%=2  'VSZKP[DG
MX*<?^ANLJ:FN8
M                                                  !] O9<YT]>
M;N+.XE\K[C;8        1&Y-GJ,+J*HE@              %/3,S3>LV^:0
M %]O6*/Z[](X_P N?"KDG?\ J\
M
M    -CYVLLOV!Z7Q3G;X\<S[-U&         ;!S<#'<LR,:T@
M   &)X^3=M?86?D0  =@>E\;J_([]JQ?-OPW3]V@
M         !$ D0 $ $0    $ $0   0 1     )(0
M                         !]Z^P?//)'QIYAVGJ^UV[M0        %RKM
MTVV=EJ\1]$              /)'4VMVF76VBY4@ !]@^E\:Y>^1?-^S]!ZOU
M^VOP                              >QF>+E2LYU^;+G1'@"0B(*D "$
M"81@) AZ!* @0A($8DAZ"$O,*D(P) @**JB;J_::^HM=5$?*
M                                 ?1_W',=)T%"[<8>7]MM8
M  SS,PK!F.3B68             ##L;+O.!X>;?P  R"]CT7V#Z7QOE?X-\A
M^A.M0                              #9NOSZ6MM79FM\_$G>9A&)0DB
M@2@$$9((121""22* 0 1$$D021$!$$B!4($JRB6X]7GT&E-SJJZU5VHI$
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MH9IFU5-<-F8.12Z8VNKJX20@
M        ^R/3N)<T\2^5]ON71.HWV8@        %1,2]G;#6XO=[EJC
M      +1;NUFL=?LLHIXF8  $^8\?;SJ_"^1/@;Q[Z(ZWMMN[/
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MCG)J9<TT%Q34:WB,OME,S=H8&13:5VVKJH
M                    ^Q_3N)\T\>>9]AMSG32>DSH          +[>LT&=
M9>%8;M<M4@      !:;=VKP7$S;]8K-ZO    N-=N1]L^J\.Y'^"?'_H;K:S
M6K]2                               !M7 V%'3Q<]X'E8M3YF%9$><C
MBNUXC5%VA,(Q ()99%5KQ2JBZ( @$@1@RRFNT8G51=P" BD 0 1$) JJ*VW]
M=FV_46SUE;9;MGW
M &=9>OM/W$ZQP/EKXE\K[EUQ34U>P          B+S=M462W\:UWZ]8H*^NB
MGB  ("@HKJ+#9OU^-6,FZ6:U=K8     /I-[GF6A-#ZCTF0\(>0Z#MH
M                           /<RV)@9<C,,3+\4M;RF2F(PJF$::8PJF
M1B28@A&"20"( 3%#U$A"4(Q$8THPJF$!$  @$!54TM3[/ J[%=L1@
M                                        ^A7M.;Z;VEL-+;?G)XCI
M6]@            "=,>*ZNB1/FF6$B*IE#17/DQ/L      -R;/2XK],?><Q
MYY^%7(_H#K"                               21@
M             @                                           #TB
M'W+ZUP/E3YW>*Z+OG0FG]!F8                      !=+EJG^U?4^(<E
M_$OE7=^G]9X&UOH                            !&1 D)(
M               !,$$1Y
M     &;96!:_NAUO@/*GQLYCVGJK#<7,NH                     $1]=>
MD\>YCX3\CT+:'&GE_;[,                        "(@    )B69:_(54
M5D@)"0                      $ 1*,4L=RK:P7[
M                           .@-SYS#_KOTGC'/'QAY?VSJVSVKU4
M                 ?23W/,]"XUCYOKY?^!ZOO@         B"HFE-IJ5U-;
MT"0  1! ()  !$$ @/ H*J'B8$(   +Q8O,[MWDG(LHH0220JJ
M            1B  0A54CJ[C6FSPWF1
M               !UKZ/QVN_IE[SE6D_C?S'M/4]IMW:D
M    #Z"^SYWI+.<O#QSY <T[1T@         !$7*FYYVMJ]C3*JO-(CT/12
M ""8",8$P   (",2A)Z3YKHGS;Z[+56QP*V1-*   OEB\S6FXEY% A&" A,@
M                     (@ 3"-L8N0UEG8*$B
M                       .O?2^,UQ],_><JTE\>.9]FZDQ?'RK@
M          !$?2;W/,M"7:Y1:_D)S;L_1WB)B         1%QHN>=V:K9T,C
M+QL3TSDVL\V?$X-K&8SE![$J2=!*DFQ+)XFQ6F8O=HEZG02T/<DN)3%+-Z;F
M-X-51DD9+]1-!C]<5^48]Z5G>)>I-'[;67"7-*  +YCWF:KJ7D64:))D   0
M! (I!!"*4$(I    ! $(I  !! (I   $ ! E'!OM9;#!0D0
M                                '2>]\OA'URZ1QKGCY.\ZZYTKIW6;
MG*0                O%RS2_63HW(N:^?M-Z7*/F'X'JV]@":2,\BK6>'3&
M?[)BK4&O)IVM:47W*8G"J65;(*FSHOX  >AN_4;6CU7L,:LZ&JC36L8C/LV3
MC&,E^N<54GF4:6(F38CU5IM,N9N=;--@\4S<K;,5&41504$1YDRF628O%?"C
M\W)I[%#)<ZHC#?%,^+!*_9)<6G56-=V3<:(\:PV.!/@@ 7O'O,V74O)M(VQ,
M@  #,C6MRA:<(EM/*3 ,6,]N!8Q-EGNS&1P  ! E4%/7ELRB)Q+ )IV1%*
MAD:<6LIDE,38@    A!*.#?:RV&"A(@
M                 V3G:NR?9WJ/#^9>3O.>MV?P=Y#W^Y?!$
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M,;_M9<P   A!*.#?:RV&"A(@
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M@SC(37>MIC==B,A   "$$HX-]K+88*$B
M                    #9V?JK%]5>A\BY_RW(P:;YZ^,Z-N_GK2^BS<
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M]0)4HF9!#$[!++LAAA]AEETLJ<DA@N 2VU2%6   $()1P;[66PP4)$
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M32:4VFLK @ OF/>9JNI=^VC$$2   (2  $"1 D$1 9##%K<7BWRN(    1$
M! E$(   !5"$$</(:RSL%"1
M              %=7;E=5>A\CK_KWTOC-<;WV_GL4G31ZU]A;&^8%B;"]6&S
MD5DN)C=+EJGS3*P;3LG.UEAN%=%)KC!VEXY-\[[#8?'/F/;;+PO%SKF$1 10
M52W!K+EJ^IW.[^O=F<QU&T=D^=Q'QJ^E=E'E'V%V;  'W.Z9\1N8M+TM\_\
MRO>GWQZE\)/D5X'ZR<I:/J0  /4F9XF7*R[$S)6K=A@U48A"0D ; HJQ.W54
MW29+QFENK&+;=72@HB?5Q-'EDU8_KRNC/LAMU6!4GV2E.U_51DX1!!,IDRW'
MJ<^CT_M=966>]9(E! +YCWF:U7DJ];>J8                          0
M4HTC$R&LL_"0D0
M       $Z:?.Q\[66386;K;-?KV/239CS:;5ZIPG%SKIK' VU]L]J]4@
M$V:7T.YM;I_IEP7!F8#['VE'C678D9AY;R5?\"_J?95%AR*@!6567W2Z9\1.
M@=MX)\8N=_8CCWS_ %P  "0(Q+8>%F4^78F9XP',QI]FNT3/,PC $0 $/:4L
M1'N9>(A[@\2!  'N)9';N2,[U^1XU?M==-Q7(QYH0@ +Q9O,ZLW4G*H>J*4)
M                         !,E9# R&M<_ >9$
M                                            $1G>#5#]#OR'I:;
M??>_M6H<'W=ZN>99I^;O=\LE_-7J=BXVI2 ,QR-0^^/4OA);+>4XA\WVE\SO
M&_2(   "(25--;8^OS)%VMW),52,4Q"!!,@@0]T1[O%=F595_P!0JDIB/J!(
MB !"9AX1'&LBQ48)FXLV7-*$   3(EF^%DJJ*D4  D
M     !"(*JF.7K+'<BP
M                        +Y=PEFM9K[$<#L2.PO#WZ/"]SU2GY3]KI[MR
MUT?3V[<NJW<KYM>S\#>Z>8!]]>I?"+YF>-^DG).AZL^YG2_B5\^O*]\<6><[
M(     (@    (@EO2_Y:AT98]/7>4@      @   !)$( 2
M           'N#,Z:['A55N^>4@
M                               [*]#Q]]P>E?%3\^O*?OAJ+0>ZA]/.
M4Q2?/CJ>PJNL]%ZFQ=A^(];+Z*\9Z>=\?^V<FK^)_4>0KH(7JYAK+;S 5E5E
MZ0H:;X     B 20@  #T WK>\O0Z*L^HKO("("  (R( @     B/8\"
M                     /0Z!IN:>T-5;W!2D0     /42V!KMPV=JM^SW7;
MAEN'L5[L9:LHN)4TK5=QV-9>"PG.U+6^TTC5VV\^MEVP
M                                 -MY_E'Z0>O_ )V-;8?HWYR>1?H<
MLUO-=C^?]-:_LGPOL]'S![WR4OH+R.\4$U>_A!W?B=]U9F:V8'V:LYWY[J4K
M-8S1N7/XJU=J2JC>V*HS7.(JUOU)3=XLXYKL=_R"I^>ES&^K(  !$!"2(!!&
M);UR/*T>BK'J:SR(B B( (@ @      -ZTW=5Z:JM[2MZ/0
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M<>^VWI-^W5HO2-YZ#TS#<W5N2O9<Y<L>MYZM5VP
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MG.OV+C#W/+W(7M.:J&NT)00B(
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M8ZTY%*,0           (0>JY;;TF\=C^'Z"R'&R'S\Z/QIH#T7CD)$$
M                                     !UAO>5ON1TOXG;)S/.*6FXY
MITW2'YZ.4??SS%Y]>N9]/L_;W,?;^.0^E>7E=;\]]*YA]9YV9\2>S\>ODBF
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M^^NQ4       +K=OPZF]IT.EZ!])[*FY8\1S:?H_G/*< UM;Q\VQ::;M
M !TWHO<2^G-%[B7B>1K_ %<*+T/G)[7C,\ #I?1^V\=)Z3VLOYJ^WXI/"(20
M@",D(          +C;OOI+R_N38^LWCA_P!_RY8-MH\2D7J9&$VLC-/-VLHA
M$                0'NDZW\=[UU%Y'V;YE=6X*TWN_,O,
M                 >TO<2\J20D@ES /<P3**'B)9KD:5^C'KGYZOF;XWZ1?
M,WQGTD\) &=Y6C?I%Z_^=:TV\I^:/CGZ0*5>5%-Q]D?)^RX[^07J?&]?]8:_
M<8315(\?[/29U"(;Y]/[63] .J=NH]5Z;S7KE/Q7.:K%<;$G>*8*A3(@!(
M  A"9;.Q>?VG661[Z[)J       " AL':;J7VC[_ *G1R,'78[\[.7<4R_7>
MIT7OR     B-MZ[T/FNHNPTYL_-^Y$T@ ,ILYT,GQ\^&LL[0^O*4Q)$/"$9(
MU03+Q1*         N=J^^G?*>]+M9RG"_O\ E[!MIBH1;;IG7Z<TI&SW&0@E
M$                ! 1DZ%\SZQV]X'H[YG=4X0T=OO)H
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M>]MAYVS\GZ[WETYEM^NNGA+-/5YS?_6]M*RO;Y<OF+BOGZG7GB]>\I
M1DJ[=Q].>5=Z7FUEN#N@<O8GFXR$D!G4XN%2HF?A;(RZ$RC
M      &^/.>F=U\_Z:^7W6>!-0;GS*$'F0
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M\P     $4OHOS/MC;&F]$^?O2.4L2S\9YF4:8![BF&XKNOT_INC8[A\Q*(
M                5$$NC/*^K=F^'Z$^478/G=@V?J7D
M          !$1B6Q[&OE_I:TGSYH*NZES"%_\UUKY?3..>UZKF<?Z'U'\^^K
MV\F^<'T5[O+^P/KGTE6RZ*+9GPALM4;J\]ZJV\H?2_C,H^1_$^7;CH[$
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MBDF0                 0@J=A>*]\W3H-Z^4W7_ )Y6ZY9
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MSO/.N/?<^&>**'FNI&(  )(H;%M8F!V._<OF*49&0*B-( 0  $0
M    !&(9'CY;Z><F[2^:?4^$-&;[R8(                           /4
M@>Q]2N=M0]?Z7O4G1.V]7L?E#T7-;SPSZ;DDSS!['F3S         '1GKO>2
M.]>H=IH^'^<\?J-7ZS35?B) "        J8IIU,0GU1*MZJN5U(3*OMVZ*73
M$REN5U,(J1JA[IB%;3106ZJNX7BBBTV>NY=D@1@!)MG4ZO2&IMOM-WJ8 F1
MD0Z-]5[FGZ0]3[BF^7'$_G*X8YBZ^,(      (CT)E1]Z>'Y6D>?_7?3VY,K
MMZ^CX*]1\UV_EW>T9-"80@\P      =D^)Z<ZP\?T5\V>H\?6N]02!&   $$
MR:?.YHUVI=*5;/;D:8)EZB5PHJ5M%:MM2FP1%-44%VE0U4J2JA"J!*$R4PC6
M*0        D0Z-\QZYU;X_VKY(]D^<%)5;0
M  !&3W$MYZ.Q([T\CW7QM2KV5LZ6TW-N>/B-T/F70_,>^Q+Z         !G.
MRW'CZD]L^CK?R5X?E\W0V@\Q6R:*(P2C        )(#*<3&P_-;.+K"TUU93
M8;^7EL^U:EWB;>,>[<R:(N=<BAL]=R\UT46_(K-G"\?O7L\IJZO-^L6,3LUZ
M]E=J7+GBF9D9HID&48^+A=1"DP[*RL_C   $*A$.UN@=6HI=FR^<?(>"5OE"
M       ";)FV!5Y^D'C/H^1LJUL9&P;7A]>_&/H'-]I:YR_-O,UH1"     #
M(<;-?8#BWTJX"Z3RMIO=: 2      V+<P=<6"W>RBAM9E_OV-6N%BI[IE&1)
M"  0*BEKA9K]MCF5;>*X1B$)J*8        $@C!])^6]@<L^NYRX^]KS5"(
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M^>AWN8?-+V7S_48!D^>>(       "(ZD]KT>G['Z%U6DX,YOQRMQ/"PIT9D
M      !%!) 9CCX^!6&Y7EM+-R=<8M6RIMK=**FJ44-!5=NW@J+K3;QJUS5?
MZJY-!3Q-1.HHF03(FPD^:J8TJNML^1>OL;<,BLV<4N=-FQX3DYNQU4HTP
M 2;6W7HI7:_ONJT7RGX?\U7''</ C        &S-9$O[8\/S<4X#Z5Z#).%O
M;^=J[7.(ES(    (B\V<E]BN)_33YV]+Y&U;M].!,@  00KJ1BE[B648=U?<
M:XS*_KM9V.C)RZUVLB_0 0F0     $4+%D4,5S;+R@I@D3(       @/5,/H
MYS+K[EWU?.G(WL^;(20@                            BE] ^:X])D%E
M)^?_ $K9W&P7\-+B4$       B+QD9</K#W/Z8MW)_B>83="Z#S%;YH
M    3""55%$FZVK=DL%Z_D,::4*ZD:8$H(!,B(>*IC!+U,O:$(E"3P(Q!327
M*BB&U-=JM&:OV&UWC+EZ@E$    $$':_0NK46$ZK3>N$N8<6JX20@
M/H/ZO@C4>#ZMRUH>GI4R@     ])=>^,Z0Z@\GT)\XNH<D>4"0   $)E-IJ9
MMK[JX8]2%PFS33YUDZK46O\ &V^Y?5N$*Y02      0>D+5D4,+SK*$P4P3(
M       A)&#>?G_2NQ?$>]?(KLWS:\B
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M<5OJCR'MSYI]3X0TSNO+O,P                              C)"
M    "]9&7#ZT]V^G+;Q;S[DM3IS3Z"J\R(AZI      $D)(TPW]H='R)9KM[
M+=/[?:]%RJY]Y%CV,8V'A8FK+9>7B73-3<+E=FN,*>%5^,+D4]3:MT<VU9M<
MF_?N/NE+IKU5XC0DTV1?OV/['9;8(A$ADNFT^B-9Y^?OVPVK-1XF2((D
MDA('8/N>FT=HPL!P5RWBE9YD       /U2]O_+UPCYCN+XD<W^T0     &Q]
M9NGU@X_]%OE+V'AJBKH     &9X60NV-4A,@C$(Q";=BGSB[J]38#C;;<,*I
M(       "(C%+#\^TLM^T)        !"9=G>%Z&I*M>^?W1^.(1
M   [A\KU&5P]ZKETT              .[_)]6DZIV&@]<S;SQ$P    ,DL9L
M.F='[?QR%Z/G<P   Z[][U"FZ0]A[VFX6YUR2X6FFWZ!$/5(      0A7*ZV
M:+5NK3:;E?!LW+W#@.?G[6D3,Z]V[-DSO%Q-7X[<R,TRJ_>Q[U7=G^T*BW:L
ME%DY&0S[-J@JK%G'*3)R,GKL;&Q2BR+N1>Z%/+N55%ASMCM/T*NS9QZYXF'@
M=@V>RV[(MTL7Q\>HL]JU,0     J RK,V/GZ(]/[7;ODSPKYEN..8F!Z
M   /U2]O_+UPCYCN+XD<W^T0     ':'A^H-T:'V#@?I'+B)    0&18UUD^
M#=1J()!ZB'FJ7JBEF^3J]3XI1L=AT5NY=8)       "#U,)-4-?[''2ZH
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M)OH!H'T/FG.?JO*HQ    1"?%;/M9D/<"9 $4$$*I5-=NDS')UNI<'P-KN6
MC402Z7O8W!WU$S]7^?C%*:]C6^)O/Q\UVW_3388JS   (@ACF3;4V9CXO]KK
MF!^9SYO4Y?V:Z36>+_F%3F?<$    ( (CU-3ZP\;[D^4G8/G=K?9:,
M     ?<'EGU#2?$+J7R_5_;GEOT_2?,CW7#ZCZ.^*[/(X2]9RF=TCI/:R_F=
M[GB,_P"X/*_J&D^4_0."5/9_F>E2OEO[WA-1]D^:?2-+\[?9\<G_ $*\;V"1
M\=.E?.-5]E^9_25+\\/9\>G_ $:\5V:1\D.B?/=3VIYCIDK56PT'JW5V6^]1
MZSQ;J[,<"S-3'3VR\YZ[N\EU:3P1Z[DT[8V%N8=L>7Z=)^>_L>03_J3X+NU/
M\I>@<#J)T5.VO+].E?+#WW!Z@ ",FW]]ZF5]'.N]ZH?GER_B%=CMBQ-C3 D
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M_P#/-\M:<S[J=4+/"/R5IS?T!       DZY\3[M<:*'SUZ/Q<
M?5OGW?:?E/T'@9F2V<V&^M1ZSQB]_!C\[/9\<G_3[PO<J?&;V%'JK0>]E_#/
MJORS5_1_Q7:)%_LY<--[/S?KG;<^-F?4[P/>*?2.U\QZQN]A1XX]+S>;W7Y3
MJLGYB^ZX=4= :?UWCNWR?59.&96MC@>7J?5!7:;:UWH/-WMY,.'_ %/+IVV]
M=Z'SO35>I\7"B]#BWT_-)W?GD.M2/CMTGYRJLRQME#ZC>"[K3_.?VG&Y^G]E
MYST 1'U?[G],6[F#R'.YVC//^7J\^Q<;6591:MV/WK^=9?BX>L]3Y^RWA$
M  7ZU9Q_.<+#U!@&9F[DSS'Q=46*NYG&#9F9G4)E?;]Z5E61DR/4
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M<S[SQ$SK[SG19?QUZ3\XU( &VM=Z#S]#?&]AD?)CH?S]4@
M 9AG[7S]7NY_2UM^<?*>%5^-6<6;LG68.IJ6[-99[MZ^YO@8.LZ2[>N$3U
M !%$*VFU9,TUN#I7'<S+V5B5_,VQ6UV[+JS.V&Z*VY=\YUEY5)ZF8@@
M   #)=3J-+6+:;+:=/5<NJ9B@  !(DQW'L3<9QL>>    F'0/I_:4^U]OOY/
MS=XYP*NA,/" 1'H38AXFH2B(H>4DPC3#U)V-XFF@S'!II\3RE3QK[JNND3)2
M>IJ=J^%ZDV1K/3.'O>\U0J(P   DRW"OKYC5H)    1@]4TH25==JUY1FX6M
ML+UNSVZKENN[8Y3[]S,#XV!A-%S:OSHP]A]OK'%66!VODX7RHZ&O8_%/#.+G
M?6_'*:LX^@.9@?&;3=J[U!PS:S/K%WKLM7\2^,(R/I+NF;?-7#M.1]00
M  2;!UFT?0_FG6'QP[9\R((              !GV)MH9OB;3SJ/8^>]6:[C1
M  NUO(;$PMQYU+L?/^@               .C?6^\D=D]#ZM1\"<WX[<J&W;C
M?+5K'LIQ[.,X5EW\VO%NW:,7OY.4((B$D4()!&"XV[=ON-%NS8Y>OY3>K=FR
MJ9F6>_=NV<9>925UVY (U"B($Q0     "0B$VBBCR'5:O3V,;G<;NC$01,0
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M5Y*9;/-4@     (H7&;%HR'+Q=>89A;';29       $8@@P+:8ZCKI
M  !&3Z]<5[X^,G;_ )A8_DX(
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M*I1BE];>,]Y?(/L_S8P[-U0                 ",B $B)$   @     "(
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M9DPL%.VKR6![*PH;M!        02K+=3ZZ<9[T^*7=/EM;;N,
M      (B*6^=+MZ/3&TP:SQ,,^HJQ?#:HR6GF/?E+V$0O<**^U5VG!E&1WU7
M16-36RT)@EB8A?XKH[!--9*$U*4A.IEM[6YE'HS<ZFL@)]5;[)_0GU=:^%N.
M_)E)@%K877&KN]JKM8MV;([=K!,%S<S:D::0!!)!&8>Z8A-E*IJIG1"DA<E6
MV+='MN*=-V#:;7<B   $D9((A"9BB(!/M46WW3$FFNW;R$) 21F(03&-%'BM
MLZZU4M[-N-U\_%O6;%/?L#08]9?07;K/OZZ12ZCV5YC1%-,R-=)H]Y158%3M
M<EL6+CS4R  #I?UWO*:ZS7XX&Y;Q.L@    /I+[#YT;5SO+/D-X'ZT=T^FX@
M[,]%QY\2>;_:    #T.Z/ =;9+B[EQA[GG94(   @,YP,E<,>HJ B@D4D8(2
M 2]4TH20JE&(7>Q;\Y31K+?*KI\4UO/KO%>)3V/853+7C[2KA<DH(Q"(NEBW
MYMUZOU+JJ00U]LL53W",       !"J67X6>^G')^ROB[W'Y=2YH
M         5,5-QZ?;4VI=IKZD-Q45X79JTV67*LB;9?RDH(I\)F3<TTMAED%
M5*STU,7>>FC]HC[F::BI7">I]5<54%/51YO\54.OYC(-?HS#=NJR:29Z'PWE
M,1G57(_1+OOVK3<B<:^&+=-Q]/4ZFJZ358O5ZV3DEJQ@>"9V;M132G4Q+S#&
MQL#MMZY?J954U]NW:DS&O6\?DS578C7D9[XKGU"HN-$6[:U-.H;!L]GN-
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M,H"(0$ LV32P[.L$0B        .F_*^S;7TNV?,WJ?!@
M  12V?K\ZF]Q>]:_R\6?XFAZ2]P>9(I>!['E "7L5Z*.ZPD8O*YA$0 3(/,R
MV7@9=-8\C']:^S,*? !]@>_?4ULX+YOQNMU_KM5.(7>Q;L^1V;&!X+G9NU(T
MTJJB*3,[&+KZAKF[S:8MD;4UE-<FMES5&[1;LV%Y.5L"F3/A,KRBU;.HHU'8
M-EL]RH   21DK=78M=^U_B,6H+/L+MXSL+S=-9KK5)WNLE67+]/EE=Y;82:K
M*TUGETY"1G8DZ[:[56ZFW=CU:,CTF2VW)W=X01B491A @2 $(B 6:U:FXABX
MM1%(  .LO;='I,;U^KCQ)S;C]5     =U>FX@^B/K?GU\'N8?<KZR>[^5D4/
MD!X#ZV    >A?,?+?9CB'T^^2_9.$J"[0C$   21IAGF!E*NU4C$+G:H\WZ]
MH;769.JM'BJCU3:_T=UFW<7S+R,&C\Z[>W>LW/E++C.H]ODM9%/FTW+GJBKK
M]>AYF0     "(8CG6EDR;8A&        (=R\_P"F-<[/SKB'WG)D
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M:87#*UE')LWYOBUES\DQ;$J=E:FWQV.JIK+B;VX6:C;UT:80NU%,%,H2
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M&!;7'25(         Z9\I[)N_0^@?+KK'S\\(
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ML=2"(   (5%^Q+S*\*XBE"0          (P!"2%,,5V-E8;UM$        0
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MMHSW%7O.=$B   (",D$LEP[K),:X]6SS7(         #U3 (26+(H8GFV"0
M       A":F:8&P?3GE'9GQU[9\T,?R->\@
M            #W,OKMWKZBMO$O/.25>KM5HI\*JE133*S'%Q<!P;+RMAQB4
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M!%"Q9=#$\NR@A"91B        "(=J>%Z,FQ:?.GIG#T(/(
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M?K&2^IG(>VOE3U_Y\:MVOG1"
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MNO4,8R;2W9,(Q           AVAX7HK(,:X^:/4^$/,0
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MNNTE4H#U$$         !FV!LGTTY3V1\H.Q?/#6NRT"
M                        #N;I?8Z38>XWDKC/GW*Y\N(C&(A1UW*D
M 3#W3$+Y9M62V7;EUKJ*+;05UW&GN7*C.<O*HZR:O%5Y3#A2>,P:JJN52&]O
M^:;H&S]H$       *HA'71&UZGQ5158>PA4^P]-3*B%4^D1"RV+4W$<;'J(J
M0(D !<KM^'THZSW:V_-CCO *[3^@\I-@                 SS7[=];..?1
MKYV],Y*U3NM*0(      A!** $IM,JBF4Q(E)F%/-*75"*$)D@C$$D)E&
M     "$R]Q2^B_,>NM-;SRK@WH7'4!"
M            ,XV6X\?5/M_TE;OGIR_B5?AF#KIL0!(     ($B"0$RGU5PS
MC,R:6X:NBFK_ "6#)DYUV/G87%#Z3+K4"       "($*[R>/;8WTFW^GR;Q&
M2$%BLVI^*XN/.((   #ICUOO*;;VY]#3_,7C7SU<:6W:
M $1V/XGIKKKQG2GS3ZIQY:,FTC1           D$1!       (H02     (#
MJ+RGMG3ODO7ODOV+YS6N[CO*
M     !$?0CJW<:*YY&1YXS\+S*O\P$@       @"2$RB)\S#;/F*+!;?49M7
M+OU3+_XK!L^/^WS[W"N?2       $Q!,0RG3:G1T^U9LV';O>=%>2.+6;-39
M,?'F02"$D8 !)7W+T/I!U7N5NX0Y?Q:IYS\EX.I\@                 B)
MD2^H7)^_+?=I<&=$YHEJ$*I1@         E$0!       ,GOZCSCMG9^I47
M  0$1 ;-U>Y?1OE_7'RXZUP-J'<^6$H(0
M              1&=[+<^/J=V_Z0M_ O-.,5FO-9JI\:Q0   0","8$H! "1
M,H(55IYS[F&&\^WSZ.LVMVEH.7ZF\5_4MQ;*7;WIZF(1B8@     0D(A7XV/
MC=1;MVC$\G)S_&,7%GTE,>@   ""3JGV'0J7:.VWM/\ ,CC7SY<K?:QT
M               &3XV>^LG'?HIS7ZGQKDSVGB4J81I@2
M "IJLPSG*\]XL-K8^L;L;;T   $,FQLY]+>5=B<3>[Y6Y(]ES1X
M                                  1!+N+I78:3</H/4R>$N=\BN%-3
M3%$@  A41IA>+=%BH9FYW>FU:KU8MXC27*[O9;MR]W.W;H[C31B]BKNY9;)N
MY#GW+\*-A]AE>:397/&1\[PIU?T_;6ZDW5^;&F$4@     0(>91I<3&MU'BX
MEJP_(O9DMTBH    0RW,V7CZ'=2[9;_GCR7A-7H;S'BZ@/(
M     "(VEJ?0/J=R3Z"<<^VYRYH]5Y1*KA&                 +M<PH9)?
MU7FVT93%\?;^R0 $(+W;R7T?Y;UYH/T7C7 W1.-O"$
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M5Z69Y                      &[=%ZI]-.5]X<M>M\*Y1]AXA07B,0
M            RO(TOG&+&W]2XK! 10S/ V3Z(<TZPT=Z#R3YZ](XNIYM@
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MHW>G.NH./_:\U<2>\Y0\*4
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M^?,H/4;*K[\Z9V:@TQYOQSA?F?':^P8V%Z"
M"8EU[XOI+N7P'66EM]Y7SR![3PGK!=AA)54$D8            AE>1IO.,X^
MW];X\[ZUVGX3HC5>V\X^>G2N,,.S-6
M                     ,HS=CY^FG9?H6@UYJ]'ZXZ\/S2NE4VXP5 1 D 1
MJAO'#Y)9=49'1KG9)VL^%4HP   JAG?F+5#AV'YNJQC+PYFZ)R-)>41P>*<_
MG(H\G7+!9%%SII7*\U5V=3;MV"0V;FL-<XW53F29C=Z:[#E2NU8E--Y]*9>!
M+6P-EY'H9/?W:_H6WZCU?FIO"/,>.5V)8&J]^0
M   !$>Y.I_-[K$M[>4ZMEO1'F?:M'^B\33\F>Q\C48'L->I:H $!$)$  $!$
M D0 $!-B71^CV\.G_#]+C6VZG!_0^1.<_2^(>4(
M                               #*<W8>?I5V'Z"H<:Q<"/%_A.6UUNM
MVXA&((D$8AE-'G:/>-KD=!A;U7O3&1U2\1D@D  $$-B>+PJ'3VP\Q73J3:=5
M[3>"TV=E[%G(US<S%*.(RNSHE0A?LQFK5^%FT\Y5:IM,Q?(4T5MDF;A73734
MT43JB9\2J+?BQ[S?;E^@/8?H.AUEX7Q]/PAY3E-WPK6:CWYD0
M               !LG#KL,(>M<9U%\W1I/02>Z/ ]2H=NZ+VMTU/N//- >C\
MHTOO/.,<S+*CK@4B1"%52--(  D0A,O5$MCZ[;-_^;]2Z+\QZ]2Y&##B;V_,
M(\M>L\ I:J
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M@E7V;J_8V6RW$V#/]=M&S-1N6VM/ODVDYU]+XER]ZWP"S;OS?G6=5KU2H
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MTH    #:E-WSK.JWZIT
M                "(O&1E0[2Z+UNEZ=]GT2GYU\QXFIYG\CX*IL^/BQV78\
M);=<7O<7*7-P     )(2((P(A&3S(@C!"J0 0V;MM]*ZO]ET*DSK-R)','C_
M  \WF7Q?@:S7>LT<Z732@ @                          /4F]=%=M?1'
MCKM5&#']I%NON),+7<B;Q][?'NF+Y4>XC8<5XCF<58M92^7<M>!33EVRHKP/
M7\T9KGD58;HVJWMBD1Z      #:E-WSK.JWZIT
M                                     B-@[7>>.T.B=:I=[^H]I)T'
MYOQT_7?D>)R-#8>]N?F:D$HR("")   D $0""2H *BJMN;?>HD]'^I]S39UL
M-K)T_P"+XM;]5^-X'<.;-9[:OP.UDS@@(B                       B(
M "(",G6/C[]JV7YZJL7YI+)G1+OFMFMA4\<Q^ULM/;:W7!OFF]JO3M5K96YJ
M;NL-33;V5LJ*M94Z;ADL3:,"FG++!-.08?--W      #:E-WSK.JWZIT
M                                                       #U DS
M[:[SQU?[GIE/TI[#WU/B>'@>])>?\G/T_HO,S<$U^HF>4(P(      (27"[>
MAM3<^AE;FWOJ).Z_0>KDV7&PH:1\YXWWSKY'PT_!M)Y6=EEOS5#IZSZ"X^0
M                 $0D"$ 1 0$9 "$ 1"0$%\LSXWAH+M,K2]X^9KE1M34V
M7,ID\2^_Q[E2U@;MHN:LOBJS2"N]E!BR,OV9%6J\.F,_OL,:T%7:WE9T3@
M    VI3=\ZSJM^J=
M                C F1#T-]YOGZ:Y>BZ[[Z ]3[B1O#TGKY/JNN.NM5HYF!
MZW3^\/P=;[QK$P/5FL8OJAM68RXA45UPN=W(A?LG,AE.;L/&:Y^U\;!VFZEY
MUL=O+Q+ U4=9Z?SD=)>9\?-T]H?,S\,UVJFVK&Q(W2<9LO(T]!IW']#7P
M               $R*E\M7E9$^8$8P  @ "( "4 "$D2,:3T-]>>NT>U=)-#
MHWTE%9I_<45R00HYCU9KMEXFD$!$0'L2A       !M2F[YUG5;]4Z
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MN^=9U6_5.@
M          $0&]+_ )FGT?8])42U0(Q(A"93*JE;=OKQ>O\ FJFKQ,JJCZF8
M2XIC)IB-MM6O5KLXT:>BT@"1!)"  NTXS9ES3T&G;7H:\
M#T)DRWIH]M2:RV./462Y9]D  (#-8KQR]1/BPJ:RDJ55GE6T1[]H0%^BJFL-
M5-3Z'J"4)@SJBK',$N49'*BI&*0  02R&U<E[#PLJET?M]572II
M&U*;OG6=5OU3H
M       1 0     1 ;UR?,TVCL;TM3+5 (1$  ! 1$!$!   1 !"1 %VG&;-
MNZ>@T[9]#7P               !&3:6LV,BQ7J?>-WK,P@D  0;25:_K",Q,
MJO*>DIFMPR8S'+3$KY$VK&ZXOM=3%HNZJBHXFY8A51DVQ8JP>PS$V93-=I6N
MC8DM"(  @DB65V+TFOBGSK7.PJB"         ;4IN^=9U6_5.@
M                                       !$ D0 $) C     "0-Z7O
M,T^C['I:B7,D  DA        !&2,!**075C-EW]/;M08_H;C"0 0   D AY"
M80@      #U)O/1[BFTWML"IB@   (ELA7A^/*;UFT58U;JJ:XKF7,I92*6^
M4K9C5<7^GIB/FN?4BF:N^%HNLK=:D5<VF?6"33EN,(N,4   "$2W%K,^FT=N
M=/4^0        &U*;OG6=5OU3H
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M&?TU8W@%5&2>00""2!)N35Y]#HS<ZBN\H        !M2F[YUG5;]4Z
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M0I;G$V^1$UF(5TY3LJF=8XY-.0S*9]Z9KIV+X 0"(7&F[#8.'D4NG=KJJN$
M        ;4IN^=9U6_5.@
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M5=WB;932O=KFE.A(F$J>FHDHE5LU4EF4WV\4S:=-33GNV=;ETVD]QJJF
M B-XZ?;T^GMG@5$0B5:2[A"GM]4U%S3(MD14S)2_1"0F;"F"J8W)%':T5=ZB
MJCMR*JAF)E;$^*67J9"%)-/HELW7YE+K;88%5:;MD     1&38]_QM#7;"GP
M_(LS\:R*)DJ8 'N#RAZ'D1$ $9/0\B(\CU! 0$0$4O,GH>$(P34LELW9&7XU
MV3JG9:^JQ^]8]P         !M2F[YUG5;]4Z
M                         3XJ;XTFWI=/;3"J5=*0B,PA 2R,(*F:H4L4
MQK*I\TM-/JIFKS3H]3XGS C(F(U43YI9CUY%9$^:68]>R$Z"4/4RV5K\VCP;
M-P:G$LC&F    !$;QT^WIM/;+!J8S! 2NT3(MM43Y(RZFNT8A51=[Y35)N<K
M=B,TW>]Q53TBGW0(FA"0$'H)D0@EM+7YM)J_9:ZKME=H     !&3W$LXP\KQ
MDV-?I9R98>HA"$8D8P0(PE 0$?4 B(! C"7E("$0C (A"IX@)$O>+9EBJPO)
MQ9GA"           VI3=\ZSJM^J=
M                 (BOHKAN'5[.FG4W(*42"44!, C$12A )D(!%" $4(B
M "4$GN:?.M,["J<2RL69Y     >ANK4[:DU;G8E73U4B$$LX58S?I4-\MK/2
MW'NHMHXK6R#+4X?;H7BS51>,]58#AU-.:54*6>4E/5-?XIB;J2NG,XQ"$R#=
M.JV%%HG=:>MEH      !$ $ $0 )(01   ! !$ $  1 0 1$9(00D0
M    ;4IN^=9U6_5.@ 1$
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MI2@
M             (@+I:NMB8.7(KHK(F((!&(2 $((B "(@ 2A(KIEX-E8M1C.
M1C^H                            R**E8J6B:4L(@    !(@      DB
ME7Q*YI8;-M+
M                      1D1**!" @D"0 0 $0  "1 $
M             3DLLBMA\VV8Q7)ED<4FB;Z$!<XGQ*/5%,1B)0F#P)@N<3XM
M$Q[]B @/8JTJ%#*XJDXK-,X*E*^Q4Q2:
M                                            $1     1  $   "1
M                            !>%2 HD,LBJEQ6::K-J:J2:F$\E"-"CW
M"9F^" A71/BDF)GJ$;RFEM2)UTA"BE*IBIG3,NC1/F1%/=T^+83J&4S"9MS\
MOBY##YMQ
M                                  "*4$
M   K4KW%3&IH9[%RFI3W,B/$V9A0H4J)EQ3*])F4J/<],NH/-E1/R:)I[9,3
M?</%OF)\Z%/[F?=6GQ3DSVB56Q,,?FFHOT5R-?U6JO*XN,/FV
M
M               "(@                         B,TBY#'YIC;%(("(@
M B "  (B B @ B( (@)@S.+D,1FB-(@
M
M                        >AD$5KHF$1 B           !$@$@CC,T*9"
M
M
M
M
M
M
M
M
M
M#__:  @! @ !!0#_ /0"2DU&W52' C&YB@6*33!XG,"L8F)#E)*;#C*VOP\0
MV;AQ,4E2!%P=M(*F@0@=]"C!S,F""\U!YHL?K183FIAO,VS#>4Q' ;5?-$G"
MXS@EX7(;$J"[%/\ #6!4/SC@82A 5-A512\R,Q)O),@&>OA1[!Z.(N7OMB-D
ML644S%8LLK'%I,3\,H%8].568@S&*=D[$0IU_(E_ Q)[L4X&8$8E5,2W3:XR
M_!_"Y*34=/AQK$VXCU2;&[>G'\)&EN1E5>6I<%KB[,XIT!V$O\*J^N=G+K::
M/4(M\I6\#/7M<=) 1()1]U*R4''20$+)9>'673L V9,:[;N\;<@?A32T3EDI
MUZ/1LV=L[/5W'U<2EIY:DGJ2G4I-;Z4!#Q+$A9:1W"2'>$-Z:+>) 0^E02ZE
M1F>@.2D@APEA;A(!O)(DR$GW&7E,JI<C3,&08KP?A/08^JP59VK52W)E+DK[
MBU<)1T\2I21&5J4C\R(Y:$7"J2V6C#1+$L,'HAM/,4Y'+2/^:4OS;;1IKRU2
MPPR2B?;)!M'JGN4.2Z#(\9)\&6GX28_0JL5V]NW5MNO*=5W92O)#:]#:<,1U
M<*I'YD^B_P \G\L4Q+#):H85PJ=622C_ )I)?S-L)47*0)0C?EE>K/Y>[CV0
M\H9-CG/+\(J2G59.65@U3LO/*>5WG6%+-*>$@J,>KC!K,BT"HYFI:.,O:F'F
MC6&D<!+;2LRC<)1OS.-DLCBF&X_";[1K#2#03S)K-M/"7>QJ^T&58_P_A#"A
MKF.$3-'&F3%RW/@EQCU-I9AEG@\?&[KW2<EH_8+_  >(M1CM2FL9NK4[!W[$
M:=4TJ%);NHUE7K@N_@[B-/[A>5V_$?=>=4E7,<!2%$$JXB\8PA_C4X9D3"E'
MXE39*@.Y!6)M&/P<@0U3'9\E%/%4HU'W9'YD>DK01ORIE&&GE*4\_P  YRR#
M+W&'9!D?-609>XP\]P#G+#+_ !A]TT#W!F12%)-YW0D+X#YA\##QK#KYI4I]
M2@U(,S4KA(Y"E'[A1$PZ:^]B5KH>6U/M7?P;PZKY+=]9^^>[TC\Q(<"8ZC!)
MX2:3Q*"C_F.5J&#T4ZV:5%),-.DH/GJHI6@0K^:6(Q?RRB\V_P D?\S_ .6+
MZR/S(+0E%HN4?\L4O*2GRB=YMPVU)X+N(^RIE?X,U%><Y_))Q0H_?D?F1Z P
MQ^8.I-"O=%HR\:PMY236^E11DF:I"-#*46C3YK.6(WY97JW^1I? :U\:(OK(
M_,GT7^=Y'$EEWEAY[C$3OXK8^W>S2LX%?@SAE=RFKR?[U_OJ:2HR+3M2RE)@
MTD8Y"01:!224.0D$6@,M1R$A*22%MDL)2226V2@1:!3*5#@+1#9)"F4J,&RD
MS<4:2)Q*S=<3I%+0N\E1I-E2;F&ZT;2OP7AQ52G+R05?$^PE1TF"C)($6G@8
MA.Y;F90.2_\ @OA,'C<RR;SG_@^87=,] 2B,&LB^"COFPN_CE8P_P7I62KH3
MKINJ^!6OA(N)XSBF&G308-9$"/4/_EB^LC\R?3X'$Y?.8M8?M'_P5K8ONG\M
ME<F/\%*/RBEY#A(2'. FV#67FRIX]41?61^9/I\#BLKDR<WB<+GX*X5%YC^7
M2>9(^"E)U**KR'N?.5ZMMJ41QU&%EHB+ZR/S)]/@8[QLKRE@I4/\%<+C<N/8
MR/</?!&6H4PI)F;B@RQPFZWQD25MA#2E&Z6J8R3(WT&:D^GP5,938*TFD_P4
MCE[*O^T,,?U1?L<B5^";#7-7E+A-1/B209@HZC!1C'MA[8'&,''40-!E\!B#
MW#(S5G@D_@G0-<V7FCNB/ADI-03&"6B3X*FB4%1@I)I\7'W>7*SIKR_!/$&^
M.7F;FKOPA%J&XX(M/%,M0Y'!EIX<%? ]FK?%&_!/"$:R,M5K)^#0V:PALD?
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M@1<(T(ST))ZZGIHK@XCT))F7F1$$((PDM#3Z)/S(B"?1*",B21A'D:$Z$2=
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M9^=V933J2JDMDV3/J#[3+4<L@9#E$$I(NPDZ&I)&$IT[SA:E /0^_H-.W0:
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MDJDM"B&EIR$O'\,?L!,NH],BJS)$]PNVDC1X<>\O%3U(6:#H;XII9+"9C/?
MZ=C9:I[=1KXQ'V']E$K4:_>.AI2L%(A-H;N*Q4!V9$1+;B[7)0Z5<QPRLS9C
M.9E$4ZII9LJQFY*<UV$\HD]B%F@UK-9_!&&4_P OV\?EXAGH'[B,R'<NBH#F
M;((+S5PPK,Y!C]8R06922"<T>",V#69,*#.1Q'0T^ATON76V"H+L:2F0BVK4
MSVGF5,JU%^3W*=U)=!8HF-VE:N"[4V*H+L&:F6WV>:SX32'/3EAM06K0-GH1
M)-02>I->G>T[I]C:OY?A#^RC($??T$B8W&*7F##8DY9)=#\QU\-17'0BDD*#
M>..&$8QJ"Q=(_3* >,)!XN%XPL@YC[Z0Y6O-A*C;.-D$I@1<U,0[V-*^Y6-7
M'M%C)Z?GI"T\19;1<M4:0II3C2;V,^1MJP^ZY*B42NQL] I6@<]""3\R4$GY
M(/R1Z->G?CUC[X9Q&8X&L%>,(P-)!&#QR!85%(%AL4@>%10K"6 [@Q!W"'B#
MN*26P_7.LFIM21IXA@NQQ9(2W?'(>^'M)KJ'X:C4UX%C9)A)I[!<PNX?EWK#
M(8\,3LL??"E+>5'HWW1'QUI(8J6T!,<R')2"80";(@1:#B'$#4-0:2,<M)AZ
MO;=$C&&7!*Q9UL/Q'&#A7<B&(&8MN!E]#R?N/C%Q[A(R2G]HL38B9*+ZM5 =
MI;!4!W+*=MUMITVE8K>E+1H%(U!-Z!2>(<H)3H#+4)3H#;!)\N4$HT[8L%V4
M<3"9#@BX9&:$>M8CAQY+8<N8[8<R9A(7E:2"LL4#RIP?JYW4LK<"<L",K;,-
MY)&4&K-AT&1+*12QWQ)PUI12L1D-!Z"MHS29>"8+LOK!<<HSYL+I[!<Q-AD1
MI4=O,9%7;)FE+E)C(<OI#RF;YYD5MZ[)>??2PF1D3KJOG,N.=;9HFIM9BHK4
M?)5:/6\Q(J;OW)VLQ45IK)5\-;;R'WI]\ZP[%=-UNXMW(:ZF:J6W;_W'SEY:
M6<@?:5&D)D(MKSVROF<U15^1*-3JN%,?)5FIS('U*L[%R4<"V<ADVKB3VF0+
MML\@8@BQR)^8(T-R2<7'$I$:"ELDQ2"64I!$- 0,B&A#R&HU&O9KVZD- MLE
ME-QIET3*)^,(LUV*JMS!*PTZEU/W%KFW5NM\7#*C)DHL8"H3HO*--@VN/[9>
M,W?">1TBH3L&>J*JELBGL^$A)J.!B$B2(.)18P_E:3(O6&A(RE1AZY?="G#4
M->X8_P#Z[K4A;08R&0T(^5),1K-F0)$1N04_$6WA88\]%"VC3V:C7N%VSOZ5
M1_<6[QLL5+C3;KUO%>36/&R_E#IZXU'(F[R.3K%%_<Y/(/7&HI$B;%*2W5OF
MP]D/]O01B>><;)PE:QG;]7%&IHB9+S<1ML[C^XK_ .CD_P#5QO\ H6_]Q51R
M99R>.6F+NF93:N*DW<B8;)YPEK>/5MEOF*;K&6RRGTQ?\G=4>AS)K<1-KE+L
MD1XRY"H..H;#<8B)$<@7\OP9CR%A1,RQ84;T05]H]!54Y(U.!EH"^X530N3S
M@U[<))F1$A9+*]J2GMJ2:3-0S6BYA<:TBN>3?1'8:HB\(D/H?T+P&VU.'686
MX\(%2Q!*59-1A+R91A^:M\S,S[YA0_\ Z[I=R+</QA#RA"PT\A],_'6)0L\9
M=C&XRI'<,P7;-_I5']Q=MFN/5Q4275XXP@HU=#6K*&SX\:=)35R\3<>B_N<G
M:/BQI\E-2'B917M&\]D/]OCKQ-OF>@>5SW;]/#&QG^L+@O\ R*U7$QDJR4]C
M?]"W_N*QXG6<G=(D8PWH3[RICC&,MI$E*4N/?TZ[^N,I],7_ "=VZR-N&)4Q
MR6N!0*6(T$FR0V#TT(C'G\&1@QH#\Q9XTW($J&Y%53Y4N.&'TOI^WTI-1T^*
MZ!*224V<W#1;W[DX\6N.68RJGU['&DN)R2C7#=J9QP'I% U;$F(BF6A9*+O5
M&*/3!75#, IMLU&$V^=>"G3,'Y@O(:]W7M,+\E=_4:]AEJ&)"V#@Y09!B2B0
MFQQUJ2+.D=B*4DTC4</<<02TN5DB*NH4^XF=0NM*<7-?33TAQSL(*9;9094)
M;\.3(11?W,R(F4A=5)AJ<:FS14U)0RR'^WKH)RU2#G+*FI%-*O6E.,8[%<:=
M%W3K>5%]ZT4RH>05 TIIFTA.K?.%+@&BMDS5PXB8J+&D<:6V4Z04JI=96E1N
M,P(+J7A>0%2FXK<N.&=>'L4HDE>92:Q%B+E*K:9N$&F3(_(B3J9<)#B,&>OP
MF@(] ?F"+02HJ)*;6A7$%7<.UZJVT;GH^V2+N0(#DU=31M0"%QD+<(2YCDI8
M(]!CUO[UM2245]4G <%I7)G-RL,]HFLGE*9=ADZFM>5%7IW(%<[.738LU!$J
M8B,4^_6\%.F84>O81^&Y^?Q8\E;"J_)4K"VT/IN<5U$B.I!EX5[S4H@9 MI5
MCD"7V\;AFI?<R'^WQG^KVF7;I\"\\EE-[D*IQU]8N6<2"EE*6B(+/B! ST(O
MBU^8N,:\HLMR(NFND6*?3[1(:@CT!GW"'FH]- 9:")*5%<B63<AFXRDW09Z]
MR'+7$<@S43&[.(W*:6GA,E:#0C#Y'5OH62RLH//373N>G34&8H\9<GB)#;AH
ML+TFP_+4XI7F"('V:>#KV.?G\;B%=;.PSK[1N:5OC[<XK.J7"5X3M2PZ;=-'
M0:4DDNY)BHD)C5K,8^P^PC[/(R\=]Y+";R\58*JZHY1Q8A$2"))K+0(/R_BK
MS/XHPGS!EJ+NA3))MQR(Y1WB;%/V<7JF.M1E!<,TU#RDM52W"EU?)29:D1:@
MO(8KM1*L58KMW"J2OL&B7;5[M7.K6U%H"<42>]1W)UZ[6[=GGVRHR9"*F2J(
MYJ)\949R.^3R<?Q,//HCIL[A<@*<,QIXW"1!UPTC@U,C/B,M 7C./J;.FR+G
M%,A(EHN\?7#49:>.9#0C)#1J)J,XL-TSJTNQG(YEYD0I,'G7!4^T#3#]]M9%
MFQ[S YU.UX9&'%DV5_>JL%4]3[HX\8D!1]I'H-- ?F9EI\;H+JE*:33KD5RE
MN4V*--/LS45[3;KAMK21N+X20HDNK6:YEC&,(6E1K\BVUPI_(9*W^$7-RW!<
MB7++R3T=3FL.+$G^+=5WN$5%A[I!M<X87@Y5 G3T1$SK%;ZE*-0('XRC\M"4
M7,\F5:D1^,H]":+F*,5%\; 6A$A&0XXJ*9EIXI%J"3QJ* TT2S28BF:SDN$A
M5_=L*4D]2C5[MM,QJJ.FB7MDW7%79)&G-S&VY3-^AA,PRT\+709+>^Y55UIR
MU1HA(3IH->T_(UEY-^0UU^-2%)T%[2^Z*',7#<K;%$]O[,E*-*,=W/;E//6#
M+2;O)$$,YW'4EJ3)D:X+DC<-O#JN%;2Z2OC5;3S;3B,]R [5VESF75DO>-E<
M"2Z;R_%(383D=_&\=*"FSM$PTR92G5>HU&HU\8O($%^1D6A:^(7GV27=!&;Y
M22'J*BY5"-*D2$9%CBHJC\O#($>@D.I;12;F^TE?K."PFRW'+6YS278O5[CI
MKQN\:DHV]*#RY,Q@E[NWS<F33Y0_#6QO-Q5IN&I7@Z#*;KDE!A*E+A0TLHU&
MHT[3]&S_ )5>8(APC7XS4%Y#):@A36JJ]UEU+J?LNUB'*8FM.P946[E/*O,?
M<A1?9R)CJ,+LGA/KS0BIB&1XGE4:9"SW-YDQV2VIT18I/% KR9/QB+48UCI0
MTV=FF(F2^;AF?8?P)>0UU\8_(&>A)+FJ(NPNRIME0E$:)*,BQ\X2O#U#K?,1
MDE6NFDX[22[)=[AZC9H=N)#KK&/-5(H<<_GV_P C3C[N;YY\V(ZIP@W5N(<B
MPDM _"NK0H#7\\E=36E%1H1%WB"3(:&0U!%K\<224+^I]DYBESRE']EZZ#+,
M';NE8KC":AM2"41Q6B59V+<A")/)*LF<XM?(_,FV$)+ED-?'Q/'^$K&P3$1)
MD&ZHU:]I_ $7P!%J<MWA$9OA+L+MI;8XBGFD247M,J YX9'H+6DCVB:NI9KT
M(%ODK<$'8(DKCSG3>($O0)+L,]?"6LD%=69SWL>K#($DC))'J9:=Y*@XC^;C
M)9J()]/C3\A+AIF-RHRHKF/6WOV2^R]09Z]F=S'(HIS4IF=&XQ3O-MJU[3/Q
M\6HO>KE24QD3IBI"U*,QZ#4:^*XHDDTOC(G",R(]0GS!KT'%J1%Y$0(B,$%*
MT,S\S7YD-/,RT[4GH'$FZYH1%W->S'[?EG95Z)S4Z&N(X7BI49#-T+:FD1,$
M])Y;=!=-VK)$%>0U\/+K3@34P#EN,(X"3Y#4&>O>(O,SU"$:%IJ->PU$0YR0
M;Y Y YYCGF$OF">($Z0XR,%Y@ST'K\ 8(9+6<]NHL3@/(62R^R]>S(J0K9BK
MK'Z]#2G5NV*EM.45R5@CX"IK56#L=A$1NVLO=*-6O8?C&)GY(CG"2"_G0[Q*
M)\R4E\PITS)+G"AR7P!V09@W#2;CJB4:_-3GFE?\ZY!$;+_$9GKVRU\*8:/(
M^^0H+7W"<GI2FMF6GB$>@2G43H#4Y$IAN*HF&C<JH!5[T>23P(P9^%,E)BMR
M9"I+E%7%&:\-!\)),R);Q("I!F%+,P1#0<(T&ACS'F-0E>@1("?YAZ?!'YE=
M5_LW<0L^8@_LWS%Q#YZ"</1;II*(M3(AS"D%XQ%J>.4Y5S-]8:$XO4^P_&,2
M2U0EO5+#IFIHB2HW-5-.$1+61E(UX%,$X.'@6\HC4M6BG]#46A*-1&HF]5,M
M$1]A^07_ *BD%PEZ^ P^IE5?-3,;RVF]LOQ2];B*@TI2THE--D=5$)/B9C8Z
MGCT#W#I?R^(N01"0[J2DFH: _(>HT&@(QJ-1J?:1Z!#QI"'^(%VZ^-H+VO\
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M'G.YKH.$(<#R>)*2U)7EX\=SB^!RZ+HK#)G X9?!R,AXE_#Y')<:7C[RG6?
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M<1F$*U&9Q>!W$9.A^O>T!>0,M0ZCA-((] K^8)220HN(%Y$:=1H. @1Z$1:
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M]FO87;KVEVZC7MU&HU&HU&O@&""?R_<VUH(MF5KMHZV$6-E1G!W$28AY-#E
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M),G;AKFY%B5?"B46"19T6SC)BR,0Q-BX9RNF;J9.)_V!X?$9=F8#!E-V->Y
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M%Y#30*/4_#1Z']V_4:Z=F@L93D>16;A2HY5^X,20(MBS*$B$U($C$8;H>P1
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M-0)A"!S4#FH'-0)9I<;I(I1!S4F.:@<U YJ!SD#G('.0.<@<Y YJ!S4#FH'
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MS 'SF /G, ?.8 ^<P!\Y@#YS 'SF /G, ?.8 ^<P!\Y@#YS 'SF /G, ?.8
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MP..,Y1GN^M5DU[B..; [KXM:;T8XWE>#]%5$RF'UDY;+E7_33ELO&,ZZG?\
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MNYL+<+;>YVVL/M(T]A$#+P-IMI,BWHO^GKI1Q386..H_K,QO95.XFY62;JW
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MN7B^==4U&U<;>[6[NYIA*+;8_=/=RXV/VXG[6XWU0MI;W)Q+_8\WWVS"^O\
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M%;@6!C]?V@_7]J8_7UJ$[@V)")N&ZV[;;AUTN260XU-!P\>GG(PPW"D8_8Q
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ML*'LL*2&\BQ"D&29?,R!S7P2&WDENUJY<9<-[7MV_K(UM:8A25DQ^K5C.4#
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MQ^EI_@+ZQ7^2NE2M>N.F?I%WJK>G#=7J'WIJ>H/I&^C7_P H^IG_ /(C;_\
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MU$3565)9O0*BIP^ _&Q%?Z=HJFRQNT@X)82K&M"?ZWW%RNA1DE7MC?KQRY^
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M@R$ZI8/1?COV+,=9W<=)Q[!J4OXJZKDVT#;&<Y!+LZS]B[[J*VQ_^G[>0?\
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M/B-0($6I]W70,EHGO+/539:)VF=C'U\[F76*X[BW61FN'Y[TL_3J_P#COO\
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MFV^W]' MW)=7$JJS"\)KLCQW#LCD<6$WE+5.T3D>RRSP=",<"1RTCEI'+2.
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MC)I-<LG#B1N0?$0XB'$7PJ@7W??_ #=JV4K'MB!QU$#:60X%$-.S0:&-!H.
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M8YIVA V/&X_<HXV,.TA0L:.T]O5)*749J?113C\IVCO^Y3$.0;RG9+O\HZI
M=3@>C=\K3M!^Y3$S-_J3]'\HZE * ZK J!Z$_P#;&X?<IB9F_P!2?H_E'I(_
M]L;A]RF(,@WE.RW?Y1Z2=\K1M ^Y1PM8=A"C:T=H[/2,$X?*-H[ON4 M#ALC
MV)CK6PU'V^D6-M<T;0@+7C<?N4PS^(#]7#VIC["1K /9U =;/.8,L=0)[%AL
M^8[@.W[E \5$'48HN%1#NSM](EUC3K) [T&_"T:R2=T/N5 I)PX?F:(;QZ1?
MB6D#4(_U+$=^*'Z>'L^Y4L^%QU&>^*>RQQAFJV=..MGG!Y^$O.T[H(DTG[E7
M89]YNUL]UY!_Q#:);H=0CUF/.#!22!K*+&RC!@S5[!]RS,2PB.:O9%#$'NF.
M@R/9U"'68<Z\:& G30-\=";@CW1$YW>P;?N7#76%AT2W0*+'4@D'1T\>LQYQ
MQ#[QC^42':GXMIEF$ALAZ1RKA!U!4; J-RHW*C<J-RHW*C<J-RHV!4; J-RH
MW*C8%1N5&Y4; J-@5&Y4; J-@5&P*C<J-RF-RHW*C<J-RHW*C<H/!41]AG8)
M]X1&<4ZQN7U!0\1TB1[#IZA ]7@.<&-I) UHL96 QNJ?[8Z?2-UM*O.$^OP(
M46T($?85N(VEI!]FFA7V3@ ]N:$]FWT:<8T-D/F/<-Z&$*&#]QIU" U^D2X\
ML^:.EGTD"BRS[#' =2R8^4]QWA%HH,VYCW4=0B.JQ/.@%%U+1$Y7FK7+,BYT
MR22<Y](',4>< I(*?,AR34E-24^4CFD<R:AR'[#-Q10*<K33[,J^JR9;Q#*T
MT[)Z.HR4#U& 4^?]5U#-KJM5.I#R[:!-V>H:!/2/2,$6'1RT*:@HCG4<R)'+
M)1114.6?/B4YY^PY\N^EM&5O_"=A"('A=-O:-&Z'HD-;,DP&=1/NC]3S[99
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M=J@XM/SB'\PAM46@9VN/88+A<X:CV!2Q-;?^)2>-1[UXQJ*GB?M_XEQ/<<P
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M@HE04NG!82#412$&8\G5.H!SV'9F5QX[QF41,&@^M!ZC*>:E1@9Y"H%IM"G
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MCQ2:G#*+;#H-4"UT"XTG(IKZA ! I7TL-U-8,(0]9A%LA$@ FM$.F1ZCDI4
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M-'$>8 3)L 7UL,BZ?>M]?8@YAF-4U]2)R#/7T@\NVKB=GJ';I"O&AN^KOU*
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MQ+"(YJ#LZF', ,3"<;,A"O6&*<'@" %$>TE7&B+M@S]ROB-W(T7=<.U##Q8
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MUVQWMCU,?,-Z@KKY0,#KFJ7:QW(M.(008&)%/Z4&LF&P.CU*+36)9Q/=%1-
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M2H.*I5(5(5(5(5(5(5(4E-0"FKPZH2OJV]3N_"8:#/O3<85BZ<XF-^SGP<X
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M2&HD(AQ +@TTY(=BI&M4C6J1K7B TJ(<-86(,-\ *(!IJR@J/U#^EO\ :O\
MF']+/[5'ZAU-_M0/U#^EG]J_YA_2S^U$?4,Q#PL_M3&/<71< 9-K.98E]I(+
M"",X1A$#,>Y8;A'QM-!J(R+%#ISA#0%A_P"/W;76G*A_CVN[U$LAI=WH$,$L
MKN]%F&(" E_%%QIO'<.K00:H=?.<[TSY6[AZ:PQ^$'7/M3M V#DDB33!1/+
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M8L,_,-W30*=C"5XQ,S3K56MW>@]PC @TNI&E0',_*.U.'XCN'6+ILIY*)%&
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MOFX9_"!J$.Q.SQU@'E.8H<V:@.@.9'H8O;$BN?842!,Y3WH#X:$'N/>B\>,
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M9A"\XT 3/KEH0Q/,P<[X?=;G^([,]*O/,-YS!?Y' 8=3!'6XUG8*K5P"'HP
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MY_70IUQ!1!J5X"6<*(D,JB:+0K\)(71&$4?IZ:.U<=.CL411:5$SS*+A+.%
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MHAU7>KI7TYPVT10(C.U!QCZZ%_D,S5&"+F55*Z*UQSRDP46F60[D(1G;SO\
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MDC^KJ!ZV.=B&T0_40WM6-B?*W7>)W#[E'89]X$:Q!!A]X.;JXOZ?2(9\3QJ
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MLN22GSASY*/V(=@&DB+38X>$]AR$HX&)(/-T@^Z\4;>$Y\G48%1'48E0'/\
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M7F$.!LFH@7#DHTM[H(NAPVB)'>-*F.@PO^XS^8+%^7M"PR:"2W2X$#;!''P
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M!!$B")@@U$&A0Q"!CX4&XH^+X<0"Q]?PNB*+L5?JK%H]:%<;$=J+GF5(0#!
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M#FPT9,A]9Z^EC)%I&<5*Z! !%HK4&&E7X2[4<=\WFBQL:!WU543)?C5TP40
M6RSH'$( .6:-QS3"J-.7*@SPL!C=M-IS5>L.B&'0T3>;&V9S0-=2@(-:T:
MB\T"318.\UJ//(4#0?0,0KKO&VG*/B[\N=?[>$.)HXQ\31[V=M?X<WHV*CRG
M&QF@M<(".V(*A  &0@O]EKO$9MRPI;W552HY XO(@("!A"%$((Q<Z<C,SS]0
M'G,<3IPVFK\9R_#939"\9N/A%OL%:+WF)/H6 K43SKCYL-/X3:.T=J+'0<UP
MV6CL*(I:9M-H[Q7TTN1N&91-*&$T2:/6.5%CA!HE$UIS6T D<DU'HPUHB28
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M.Q+!+/0-OH<E%YKZB&&AXNZ:6]VE8F&)D"\WYFSVT:>EQ/G=_,5B_P#Z[O\
MY,+H@T4DP3<,4- :- @GOM<89JMG4QB"HQU(.YIC8J1K40@#RP;K43N4#2LJ
MB-@4'<@Y#TH;\)(_J[4W%'O-AI:>XCJ;OD/\J!L7U<&!);>;&@DB+:*C)0+,
M/]+O[T,1N PM<+P(:XQ&8/CF$(E'$Q@&N?>!$"(.IA Q(\,)IKV^X\$YB"(Z
MX:T&-$23 "TFA-P_A:!J$$ ?>:YNFD?RH8C1&XZ)^4B$=<.3#PWR,(F-5XET
M#FC!#%;0[%)&:)AL6(QLS .'Y2''8#R83'2-V/ZB7=J&(V@XIAFB8;%B9V?S
MMY,4?B;N*8ZW# U.=WISZFL.LD0&PZEA_/\ TE8OS#<F8U3FW=+2>PC:L(-J
M<''(&\79!/!I<6M&L'<"AC@<6)&)K@"0&YI1SG($[ P&#A,"7QF:X-!$K)SI
M1QO,3)>0V @+H#?ZKRQ/R?R-3/D'\HY,+.[^1R/S-[><_P P:7&Z,S9G63^U
M-PA6;QS"0[=7+3T\.JW H#J(<*001H3<04. .M8F$* Z(^5W$-AAS_\ 4\J,
M,LN-=QM+C%T8S#A98J,']#O[U1@_H=_>J,']#O[U1@_H=_>B]U+B2<Y,4[S/
ME TN<PL-\%PNDM=0"V<6A48/Z'?WJC!_0[^]48/Z'?WJC!_0[^]/\UYL-#FX
MKF"X"T70QCA(ETXN-?-PF_B!_3Q=B>^QI.F$MO5"U%AJYL JO70IJ/(3R0*B
M$4! J(0.1#D/2XF'F(V@]B9B?"Z&AP[VCJ;6XKVM<&P<'D-$A P+I$'/&U-'
MDBV]>XKKB^1%L7"FH'0AY?S4;H\+@(W18X"<+"(FJ$%]=YPBXSF^[$_B;> .
MELT</RAO.(@"!!K-=)%0$K:((8K3!P,0:XTQ5S'+6.(@YK_ ;8$\,#89U3I)
MQL$-<^H,)Q#708N:S+1+0$W$,HM!UB*#FF!!!!L(H*^GYOA="!,(L=JC"-8(
MAEJ7UVG"B)^.]#,R\0",C9(X'E(P,G/HE6&BF=9,)2A6L+Y@CCPO72V(R%P!
MTS7^P/IAU,'.N0/R.(;&-@(1P?*&\YP@7#PM!IA:ZR$A3&(@L)[R  X1), ,
MY*>S#Q&.)+8!KVD^(5 QY#]2)8\ .A2"*'981,<^A#ZS\-P$Q%UUPVM>,U:;
MY7RMUK#$N>>%H@TPXG3<XD 1.LE,;A8C'D/C!K@XPNFPE8@Q7M82X0O.#8RJ
MB0G^5\R6N9(M=XF&5K8W7 QGM!1=@OPQ&FZZ^XY*7.T4(!@AAMC=!I)^(]@J
MTK_6\P;H!):ZH1F6F%$Y@T3,8+Z^.[#<;0^9SM88NT@V)V&PMPVL@&WBU@<)
M^$&$ (;10OJX3VO#FB;7!T".&!@34 4T'%PXW (7VV9^1F/"-T@D6BO8KF+B
M,+32'.N&VLM<,X4/)PN711$B,XS--4^;AX58:"?F=Q.VE.L'"-%.V/)=40J5
MQ'H9*?(;RB.J$E'$MZG<-+"1H,QVIGF![PNG.V8U@[%'G7\'"Q'M^DP1:QSA
M'BE$ A?_ %\;_P!I_P#:O_KXW_M/_M7_ -?&_P#:?_:O_KXW_M/_ +5_]?&_
M]I_]J_\ KXW_ +3_ .U?_7QO_:?_ &K_ .OC?^T_^U?_ %\;_P!I_P#:O_KX
MW_M/_M6(S'8YA^N\P>TM,/IX4X. ,)&>3FWOA8XZX-[2G"T@;8[AU4/&=!PK
MYAC8J1K0 J1/(0IJ*A!9U0,LE"Z-BE)#D/2@?$"/ZNQ8F0!VHCLCUAC\< LC
MQ B\($0B0:81CH1^DQK21PN:3 $T&1@X+_(]@;:+Q=#,0!M1,9W;K!63" U4
MG)S<+Y@L3.W^=O6L/"J<X1S1B[9%.>:@3J$5$TDQ/(#E1(,E-1"IV*G8J=BI
MV*G8J=BIV+Q;%,QT*B*B)(AZE1U1K6UF!4!U-V&?>;M;[(IQ%+"'=AV$J'.D
MJ%0J%0J.9 \D!S<5_P HUWCV!-;:Z.H'OZJ04664<L JO70JO70N(ZE <L1)
M4A95 J1"BZ:AR0"GTN&?Q :Y=JQ&6L<-AZS#!Q'-%,(Q;^DQ&>4ZU XO[6#:
M&Q5_%<7&TDGU&3FC%PS!S3$&1@<QB$<+&?>:81%UHH,1,-!IZU?/N-)TGAW$
MIWXH#;/8#S($J"B.AARQ*EU,DU!'$-!A 6=48_\ $!H,CL*?A?$TC6((F%"C
M=.I>$ZEX3J4FG4IM.I W1K/>HW1M[UX1M[U-@.D]ZC<&WO7@&WO7@&WO1(:*
M,O>BUH-,*T3==^D]RB6NU'N0B#(J(Y8)[K7PU =ZPV_,=W=U8.%LT".OM=8X
M':B#6B+#Z:Q<6TM;J!)_F"8RTDZA#M/+'IRBH\E*I&M2Z8,%<BH=4BFO^( Z
MQ%8F$V0#C"55(IR*%[8.Y4[!W*G8.Y"!V#N0$=@322)BT*D:QWJD?J'>O$W6
M.] Q&L=ZI&L*D:QWIQB)-)I%B#H4E$01A8H*/*2CE>3L:.Q,;^&.LGNZL1D5
MP^@(IXL<=_IH.^)SG;;O]*#;&[23[.6Z@H\D50H0HY05'FE'EB#)042I=(2B
MXT2AU;#-@A^DD=B+FB-X-.P-[%10J%0A$5J(%2:(4#*J!M5 V]ZFT:SWJ :-
MO>O"-J\(V]Z< !,$5V*Z'!$Q",ZBJ:U#DS*!$4TM$(ER:34P?S.ZN'!1Z^W,
M-RQ?G=O/IK"'X ?U<7:GZ!J Y)(N-*BZ:AR$9$":T2%XAL1B8R*:AS3F1/+
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M=G&52N/:YAJO2ZF!D"Q#^-V_K\%)4JE4JE4JE4JE4JE4JE4JE4\E*I5*G/G
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MB-CK["HX;8:3VGK+&_B;O"<ZQI.H(]=&=#F1Y(*7)#DCR04>6"'++D,4Z[3
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M"'?;&YLI#D%N87B/D<#]SR/;=HMY;J[E-(X8(VDD8\RJH)/B&$N+K;H]DM'
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MVB6JD C(YTIQQ>;G9H)+[8W3<X2HJ3&@*S"O-V;%SSE!C8OZ2_\ ]<EQN?\
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M\YB6-0%]UJ,?_+'OW*)=_M82L$DU#Z;;**$-7SI$7SJYNG6S(<X'>?NQ$?\
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MTDBMMZD>^0H 6)A:9P#3SJQ4%> RQ!?6,[W_ '8OW*6MTX DCD U=C-IH-5
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MS;)9]T+F_N4W**YDF-])$Y!B9 NGLXHZ><:UK[9_4UWAF^SDUW&TNYX-FTL
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M^,8[S_W:'_6(_87NANDP>\BVT[-NUN& E4=EV0E'+21*,K4IJJ.*G AW+?K
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MY[PV-L;;<(9<_3+5AH$U.6H.F6G!^MD'48?:P'EV.\+3;;<M\Z.N<;'AKCJ
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M50*\..6#%MUJQD S 0CXP,7.[6,8-LS_ &D;4!ZH%:#C6F'@,1%P!UNJRD>
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MS=+]3M)L-#W6M=QWJ4#J-'$+:$TY"TI#C_HCA[;N=96.PP,.K(%-W<+_  Y
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M0GG Y?Q$X(.=B3B'=-KFDM[RWD66&:)BCQNAJK*PS!!S!&$[A=_7B@[YP1$
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MT>":4M;,BO5!49NKBG/EC;;+N=>7BP322&_N+QXI!%$@%-"I'&2[$T )IRY
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MPP4W&X!G'\S'UW\8&0_A$8:WV2-;9>21QVDGB%-(\C>'':WT\DK<AD8FG@'
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MV4:6MT0<@OV;$\X&:^%?(<,+F B(U*L#56 _%/+\?.,:7!4CD.(K* 5>5U0
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M3<[A2.&NI8D/5!Y\='N4>TKJ3;X:2WLP^9$#YH/XS^:OC:E%. B!+7;;&$
M9*D:"@ \7C/AQ)>2$K H*6L7^C3G/Y3<6\G #&?+Q/MCA)XSUT8,/$<"]MLY
MHU)H,R"HJ1C2<B.?]@!+"Q5U((89$$<"#SX]"W)Q^NK)0LX.1E3@)0.G@W,W
M,&&&]86PQ5O[1*7R*,Y85&4F7SHQQYT^@/V,H>&)]CW."3=-D8$V]OK56@D8
MU)0L#DU!4<.4"I-;;=]DEO[3;H(8F-K-(H5+E2P+QB/+@11CUJUX"F!<6DKQ
M3#@Z,58>,8N>Y-KN%R=FOY4EGLQ(3')*I&EBO/D/#05X8O\ O!W_ -M%OHA1
M;6VN80\QD+!PX0@Z0 .)SSI3CBWCVGMRUE#KNED&E$H<RJI0"N1K09Y4H*X'
M?#:I2+2_F,9@E+-(LJ#KFI)J"1EGE\ ZO#%5R84.71A-RW3<+B6YCC2.-^T(
M*K'32!0Y4I7PY\<3(UU,4N,I@9&(>AKUL\\P...CW>+U@=Z(OMV >P@<>8IX
M3,#RGYG,.MQ*T-S)1[N2JP15\YN<_DCE\G+B6\O)3)>SDEB>3HZ .0<V"S$D
MGE]YT]C+W<W;C[.$@UZ>..QC-8H@!T5]M^K=S9GV6=^N,R86/SU'-^,.7B,Q
MF]E>*ES87<?(0596%001Y01X</;%6?;YJO;S4R9:\#^4.4?@(]TRQ+O/<2_D
MLYIHC#,H *.I_&4\HY&'6'/0D%>\G?.<7%\L:Q]H%TE@N0)IQ-.7B>6N,L1=
M[ !#W:>&>07$;J\ADAR$92M5)R-6I5::>.6V6VR2+%##$MK$L[EY9=)ZP8#.
MA8\ -.=%&61V7O2%W"XOX6NIDC($D# $J8F (4URKF.*T<5K+!&"%5R!7C0'
MEQ4<#BBG+'1C+A[E'96:-)/,ZQQHHJS,QH !SDY8AVDA6W&:DU[*/G2D>:#^
M*@ZJ^-N+'#=U-N?^SP&MPP/GRC@G@3E_*^CCM)34G%1[<XDVJ<TBG'4K^-2G
MPX8::12C6AY,^(^#%#[_ *8M^\.U&DT#59:]5T/G(W01Y.(S&(-\VTB2TNHZ
MZ6H:'@R,.<&H(PS;>A&S;@6FM#R(:]>+^ 3E^25Y:_L;48SXX[R;+WQV_;=P
MF,=K+;B[C229"A<EH]0) !()*TZVDUR&+IN[8CCENH8X7+*&TNB#KK6O$$#Q
M<,7G=N4,J[@"&O%<K(M#6H' CG_R&(;_ &NRO;VRMYGFNKY(&:"/*E&E H">
M)J1R<>3IQ7'3BGN_^)-]CKLEDXHC#*XE&83I5>+<^2\II)NE^=,48HJCBS<B
MJ.<_O\!B7=-P:MQ)E&@X(G(HZ!\/'!>0U8\_O 6]JNISR8,%XNA^-.@X_6&@
M]A^-E@XZPP:X%K;GKMA[27-TXXX>P#R<^"ZJQ0<2 ?CP]["E84K5J\*#'1SX
M;=13LEJ>3DQ7V,^/LZ5S8\/#R##?-G=3X=1%,%V\YC4^W3N?OTG]BE:EK*Q^
MZ=CYA_)8\.9N@Y3;%N:@:@3%)3..2F3#\(Y1B?8MWC,=Q Q!'$$<A!Y01F#S
M>[ UQ>;#M\"-NFQ!D-O"P,\D;AFU:.-"30:0:T.98Z<2R;);R&661M$88J8V
M+5H1G3//EY>7B.Y/>&<;>7UQ2W,I[1H@W5_RS -.G5A]IOY6N=JO"TMC=2D!
MY5H"VH#E!8 F@\ .6*CA[%!P]SD]8N[1UM[1C#8AADTM.O)X$!H/RB>5</<P
ML!?W%8[<'D-,W\"C/PT'+@R.Q.9-2:U)S)Z:XS]PIA;B T="&!YB#A=R4ZI8
MD#+3CU15ABA'# ]BD:DGH&*Z*#I(Q64T'+0C'69L9EL9%L?9,U<=05\8QUHS
M3%&R.,O>=<'NGN;TV[<7'9%CE'<'(>)\E/3IZ<7/=^72MT!VMI*WS)U!TFO,
M<U;\DGEQ+M]]&T5Q!(T4J,*%74T8'I!'[&9XKB'OQ:VPNU$3V\L6HJ2CTJ0>
M%13ERY.D0[]W5O)I;B[5I;RVNHY%,<@I4*3U6'0#512H%<;?M/=Y$FWAB!/*
M2PS/$ &F0QO'JFW\PR[:;8&:UIV09)!I<ZA0U(J* YUJ<2PVQCF[N[B\EQMD
MT)8J(2Y'9-J)(>/S34FO'E('O"#N_855&Z]Q+2HBB4]9CT\@'*Q Q#M6W*MO
MM]G%I6IH JBI9CSG,L>4U)PT\1*[?;U6W0Y:CRN1SM\ RY\&60YGAT>\8QB6
MXA^^MZG+,F@K3!4U%01GBWN8*EI.-<0W\))FE95\9('#")N,GVLG.U..(# Q
M:&05'1BY5R5BCTEB/!B2*PD(FB!KGRTQ+=[DQ6*)B*<*TPUUM4E>S!J*U&6)
M(48&%@=;$Y@TSSQ>M93,(4UT ((-%K@;CN[4U"M*T%,2QV+:HBI(SKA+K=7.
MJ3DK3CA+NS:L#\AS]G/ ED%8H2&/,3_D,>AQG[*(#(?C>WIC/'^&]XDKNEH@
MT.QSFB&5>EEX-SBC9];#;UMD==YL8V9-(SEC&93I(XKXQRX*GB#3W44Q;]X^
MY]_+87L1^]C.14Y,K+P92.(.1P.^]KO1O+BX<W$MS'!ITN>*L!PI6E>7SZYU
MQ_B&^@TR7;+-%= GK4H0,J'AGQ&7#+";1WNM?1-R5(S#=O""874&I+$5 :IJ
M12G*IS7$2;B%83!W01G40BM0,U,@#R<]#3*A.7N=GW:VL5N;R58U-*A1Q9CT
M*M6/0,6VP[:!'964(C4F@R459F/.35F/.2<2R6['T*.L5N.9 ?.\+'/R#D]S
MKAMHNC6*0ZE!Y^!'CPT, )BDHZ#/EY,%V.A0<ZXK(-;=./LU \6,\\<,4]G/
M&6*',8I*@SY1@M ].@X*R*01[RSP'0D,N8(X@XBN;I@=RM*078Y2P'5?^&,_
MI:AR8A[_ .V1TMK\B&["C)9U'5?^&HS_ "EJ<V_8[+!]7VY ?JZ_<NL@0%HY
M /.X5X<W3SXD_6&Z13;8(UE@NX!IU.PKI8',$<"!RYUPU_:7DEM#:"J2.QK.
M"0 J@&AU<>@=-,#NUWJ9;JPN'20O,E0E..@CA3,9'PGC@R1W%MV=[))+!:0L
MQ>*&O5U:L^CPUI6GNZQ1*6=B%50*DD\ !A%O%'ZWO LMVW*IIU8@>9 <^=BQ
MX4PW=7;WH  UVX\HC_"WB'/BB_=KD![QSPG@Q+'(:V\I56!X"N5</V!&ANME
MR<,6HM5+T')BR6Z%"LD=1S=88BGM4,D910*<AJ<6JWDQD)4]4\F-QAR,E P'
M/U</'!MY5LP6JH%/+B>.V6DU6U(#R\V+JXO5,<9!R)YAB\6 59FDH/",7D<H
M(95D!'\'$#V +A0"0,%+Q=)'6(/-EB&:&V])C(Y*9>7"+/;=C&QR)(R\AQS]
M/L4&9X#PG#3M3MY 3_"(H,-+(:LQJ?<8=WVQS'<V[AT8='(><$9$<HRQ#O=G
M168:)HZU,<@\Y3\8YP0<?XMV>/3MM\Q[55&4<YS(IR!N(Z=0X4]VH<?_ "TL
MT:<;O)HCAR<,YRTZ3PKQ%/G>7$G<S>;.2XN8G">AD%C RYY#X:C(^<#3%UM7
M>2/T>;K"OFDA,EH.6F7R\N+;N]:3VKW4A:&4A?MUA' 5Y-1K4UJ<Z#,G%#D/
M<[GUB;@GVDVJULJC@@/VKCPL @/Y+#EP=IM&I=WX*FG%8AYY_A>;X"W-AI'X
MG%/<J8CNX^H(V#5X9 UQZ:BAI8T)4D<H&*,*'F'LY^X9^QIE4,*<1QQVMJ=2
MC,@\1BGP>\<L0R7+Z=MO:6UU4Y ,>J_\!LR?Q=7/B][L;A017<156I70XS1Q
MTJP!\6+C9MR3L[JUE>&5>9D-#\7['1WVWR-%<1,&1U-"",6OK%A3M[Z:[]$C
ML(E^TE8'1VJC@ "*MF*9F@'#;+][@-?F8((ED ,-!6I(X \ >7#2[H"JV ?T
MF0L).N&I12O.<L3[]"I5'"(NKSB$  )S-.'#D]W;OONJ5L=O?3;!AD]Q2NKP
M1C/Z17F.)+X4-R_V=NAY9#P)Z!Q/DY<.&<O-*2TK',DMQKC+/W:OL5PUYN-4
MA()&=/'@RV;!]!H#R$8:ZN*:V_%'-PP=ME8&,BA-,Z8%LNEE7AJ'#'H]R5TU
MKD*' A8JX' L,Z87<78&5!0"@I3!W%& E:E:#++!C70A(\X#/#/;/7M#5@PJ
M"<&!V5$;(A!QP8K;248U*L*YXFMR5TSUU #G%,&W@8-'R*PKA[.<IV;BAH,>
MCH0Z#AK'# %RP*+F% H,4QX,*7'V43!F/@SI@;="?LXP"WA]S6.[:FUWI6.X
M!X(:]63^"3G^23T8N>[^YC5;W4974,RIXJZ]*FA&+GN_NBZ;BVD*D\C#BK#H
M89CH]VV;OG/ EQ'M]W',R.2N0/G C,%>(Y^' XO.\UA/%N>^[A&\P:.WI.P:
M@[)RU0I!X@DY*VFHTAMJN?5Q<1&R>SUW$$EO22"<DU!<^=45(/$ T(%%)EW3
M<G[2XF8N[<*D] R'@&7-[G:=W]M&JYO)DACY@6-*GH'$]&+78=O 2TLH%B4G
M+)!FQZ3Q)YZXN+R%B;13V4(YHT) \OG'I/N7@P(XA5C@37F;<BXT 4&'V^XS
M4\,'2.HXU _@]V->7X<&6UZLGXN#'**,/>(7$ NGU7]A2UGKQ.D=1_X2TJ>5
M@V+;OQ9)2WW%>QN*#(3QC(GZ:#^(3R_L=48B[G;CMUU>RVLLDMM-'.J!%8$A
M*,I--6=0>7AEF-TW+:()>[36SV\VWM)66776KF8 4;@!1:#CGPQ<NLLRVL\C
M,(7E=P%+5"DL233G))Y?=[78-K75=7<JQH.05XL>A14D\PQ:]WMM%+>TC":C
MD6/%G/2QJQ\.)+J)JV5O6*V'/SO_  C\%,-(^9)KBON_RX%RT;=B?G4-,?JU
M6 ' M05T\V*G%/9RQ08H,#M%8$\XIBN*8H 3CS6\F-6AJ#H.*E6\AQ7\&,\5
M]C+$EY-E*X+BO&M,AAIY?.<U/NA[O7[UO]O4!23F\'!3X5\T]&GGQ'WYVY*W
M5D!'= #-H2>JW\ G/\D\R^[P;C#N_=\17$23*&GN]0#J"*TMCG0\^+;O=WOO
M]KNK.ZO4L42QEG>02/')("1)#&--(SRUK3+!)]SO.^UTE8MO3L+<D<9I1UB/
MHID?IC$\<3:;J^K;QYYA2.N?JY>%A@NYS8XR]Q$4 U$Y=& S9R\IYL9^PEPO
M$$'P]&#=PYF, BGPC%>')GBONE,99XUQ"D@'EP8W\X>\,\1[;<-IL]T MGKP
M$E:Q'PZNK_".-PV!%U71C,UMSB:/K(!]+S3T,<:6%".(_8ZH]BHY,4]VN/6!
MN"=9]5M95'S1]XX\)Z@/0XY<?JRU:EW?53+BL?SSX_-'A/-CLU/43+PGW>IP
M^X0UUJ3H7GH,)!N%8D##74=.!M6WT9&6A8#(#%#@0P*6=L@ ,&8P-I KE0GR
M<<&][,]B*U;+*G1QPUS;1EHUK4Y<F ! :$5K44PMF\+!VH>2E*YY\,0/8JSQ
MU4R$D99XA%JH4*N9& EP6KR8U)%4=-,=B(J/S:<:C$#X ,25CKQSIPRQ6*.H
MYR*8TSQ =-,5!(/1BL3UZ,5,9H.49X2-EHD95VKT'"[9":K& 6IS\V.?W2VW
MVVJ1$U)4'SXVR=?&.',:''S;BPO8.'S7CD7XB#B\[NSU,<;ZH7/SXFS1O)D>
MD$>[;9_<K;^K7&S_ /F&W_U2Y]TV[:Y$T74L?I5SS]K-UB#TJ*)_!Q^IH&K;
M[<G99<.T.<A\M%/T?<A'$"2<L!0.N<R?::CP&>#93$: =8'*13,?!@H11&ZZ
MUYC@=.*>Z98KRX]*A7KJ,P.7%,5/NZSP,5D1@R,,B&!J"/!BP[Q1TU7,*F0#
M@)%ZKCQ,#B_MX5T6EZ1>P<VF8DL!T!PP'0!^SUIL&W"MQ=RK$O,-1S8] &9Z
M!BVV6P 2TLX5C6N62C-CTGB3SYXN=S#$1'[*W!Y$7)?+YQZ3BIX^[Z5\[AB&
MV8=8#,X-S9@"X \N#;S JZ\AQ4YX$MR*+2@-*TPUY87"S0$9Q98OMJN%TR'5
M1>:J_+A+,]6:5P#TU(&+:/;9.SJ.L<OPXMK@G[;(%O'B%%)TL14<^>(EA;37
MCBV,F9+"OEP-$P1%IU<L"1B.LM*C//#RQR"1"/-RQ<%UH3JR\6!#"_924RK^
M_A8KCK4^>*8RQT^PURZA78$U^+#W,9UZS4UIC3(ND\Q]BGN6>)NZ-X]9[.LL
M%>6%CF/X+'R,!R8A[Y6:5N=N(CG(&9@<Y'^ Y\C,?=ML_N5M_5KC9_\ S#;_
M .J7/N>U[#(NJW><2SCD[*+KN#X0NGPG%WO=S3L[6%Y2#RZ14#QG+$VX7;%Y
MIY&D9CREC4GQD^XZ4S8F@QVD@K,V8Z,5/LYXTX2>.HTD5IS5PM] *A%J/!RX
MIS8S]V).?.,=O&/LV^#&?O#<.Z4[=:!Q=P@_B/U7 Z P4^%L6'>Z!:R6,QMY
M2/\ 1S9@GH5UH/I^]+GO-ZPKG5/%:2SQ6-JW5#*A8=K)R]*I3Z9'OC>)N\>U
MV.X21742QM=VT4Q4%"2%+J:#P8M[#N_96UA;-MD,ABM84A0L9906*H *D "O
M0/<;7NML01KZ\8K'VC:5&E2S$GF"@GGY@3B3O%?7;WV^M<01%EZD$:N34(O%
MCR:F/@5?;WG?B[6L=J#:VQ/^D<5D8=*H0/X9PUE"VFXOB85YPE.N?)U?X6-*
MFJ(*>/WA#"<UUACX 1@=M(H8#@#4^3!BVX"GXQ&?PX-Q<MJ<\M!^#%!ECM+D
M!HFR-17#[A;R4D8>:"U*^#'IUNA[.1AJ(&5!A!(*B.A',,\1B(UH,\1(AJRD
M&F%D+?:)PQ&T1KI&>(&@-60@D8$TQHPXBI&,E^RI3A7#31&I(R%3B82&C/4@
M>+ BN1I<<O# MK?/G/LJOS003@6J>:!G[&B90>D<<%X:M'R\XQE[G:;[&3HB
MD E4?.C;)QY.'33$MA<@2V5Y"T;4X-'(M,CT@Y8O>[U[][:3-'6E-0'FL.AA
M0CP^Z[9_<K;^K7&S_P#F&W_U2Y]SW7O;,N4$26<)/XTAUO3I 5?K8CV>)J2[
MC.%(YXXNLW\;1BGN)NI1DOF^'%<4]I7&7'$FWS&M*E0>8C,8:$B@)J/!CQ>[
M4PT,G*"!X<&*09@^\-NN';3#<OZ)+S%9NJ*] ?2?%C=>[VG5)<VL@B'_ "JC
M7'_'"X(.1'O*]V;O%-=0PVUIZ0AM716+=HJT)='%*'FQ+M,I80S0M Q4C5I9
M=)(J"*T/-C;;WNY<7L[WDTL<@NY(F "*"-.B-,\^6N#WCW^:2Q[OJQ1&C [:
MX89-V>H$*JG(N0V?5 -&TIW7OQ;+O#K1(YMTD2Z8O4J1%VJU/-U*&G XF[V]
MQ)IKK;K<&2YM9J-+%&,RZ, -:KR@C4HSJV=([.T1I)Y76.-$%69F-  !Q).0
MQ%N/K(>2\W!U#O:12F.&*H\UF2CLPY2&5:Y"HZQGVSU>[C!:;O IJMI?"["L
M"1]K&\CL!7(T9:4\(-L_>6\W*/=3&OI*V\\'9"3YVC5 3IKPJ:TXX"("6)H
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M:L-H/1H^;4/./UJCP 8+<IS/O#7"Q5N<8U2,6/.37VE<":ZJ$Y .7 @@0"G
M\N#))R^S3%!PQ3%,9>Q7%,5]BIPUW(.L17#2,:DXKC/V.TBZLE.3A@Q2BC#W
M('FPNW3M6YVUNP:O'LSG&?)51]'%EWSMEZETOHMP1_I(Q5">EEJ/ GNNV?W*
MV_JUQL__ )AM_P#5+GW.QD==,M^TEX__ #ATH?J*N(]F1JQV%LBD<TDO7/\
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MMUA&TMS/(L44:YEG<T4#I).+'9V.HVEM# 2.7LT"U^#%M!<MI%_;3VBD\-1
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MCR6=V5+1J)#J:-]-2.L2RM2F9U4H*_XN[UW>SW5XH4M)#>DR/I&6N*W>LA
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M^\+?^7C_ ,2;/_WA;_R\?^)-G_[PM_Y>/_$FS_\ >%O_ "\?^(]G_P"\+?\
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MV\UW>2DB.&"-I)&H"3I502: $Y#ABGLV]]>VTT-M>*SVTLD;*DJHQ1C&Q%&
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MO(Q .+9+9F6.@\W%I!=Q-V E6DA!SS'+AG< D0K3RMAYM<AGK0J6)^##SP9
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M1BP[\]P+F2][G[HXB7M7$KP2LI=!VB@!XY%!*-QR().1-KW3@U1;5#2YW.Y
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M!#9"E333F.M7&X=X^YJ17=_%8R7=FDBLT<I5-:BBE6.H< ",R,\!5VW8R3D
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MMFD5B[<H X>7!EC! !IGAH9$<@U4Y#Y<9</;0[)LD1FNIC15' #E9CR #,G
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M9X!4O#TKRL@\J](S%7S3D(]]GZ9^(8?Z1^/VF>!MFR1]44,T[5[.)3RL>?F
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ML=@K3LP:23@<LI')^0,N?5D13]ID&^;+*8;RW<,C#X01R@C(CE&!N%K2*_A
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MT905N;A3YHY44\_.>3@,^!AB.BW3(*.7&7[%!5S)RIB&YV20)N=Z_:,CYJ>
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MI1''P5>+.>91RG_(X;M#Z-9+4I#JZSTX%N<_ /AQI=M, X*/8S_8IKRT"QP
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M<N5F04[2,Y21D\CIQ!^ \A(PVX;218[CF:J/LG/Y2C@>E?&#@VN^6[1@GJ2
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M\^@_S,742G,0O'QUP4L(P#^,V>";F4D'D&0QQQ:?T\?YPQ:_T(^,^_@J DG
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MP#'75E'$5!&+S=I$K=1RD(V=0-*_+@&166O."/CQG[:Y=LFG+TKT@#!]W?\
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M7_!CK[A(?!$!^$XROY?^C7Y<?9;DP\, /^>,?V6]@?Z:LGQ:L:K:..8CEBE
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MRDZ:D\IS]J^]]V8Z-FTMLHX\[1C_ #?J\V$V+O$Y-KDL4[<8^96_)YC\WP<
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M!'!$H5$7@!_EQY_;[GZR]NWCNS!LS106>V6]W=WJS16T"9!PEFZ@M(9)" S
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MFC&^]\MRB:*UWW=QZ$6!':Q6D?9M(O.O:,Z5_&1N;V[12 ,C A@<P0>(.-<
M.BWE$D?Y<+\E?HDJ>G$=W;MJBE171ARJPJ#Y/W&)]TN?NX(V<CG(&0\).6!?
M7_72-VNYR>!.JH'C8C+FK^P3VMTBRP2JR21NH965A0JP.1!&1!Q)N=A9[GW=
MEED[5TV6[6.(G.H6*XCG1%)-=**H% %H*@C<MT7>]_565EM]TOD$(*UXBTAM
MV8$D$AF(.D"E-0:VV+8;:&RVVSB2"WMK=%CBBC045$10 J@9  >X1;_"OVMJ
MW9R$<L;G+R-^<</M$S5FLFHM>6-ZD>0U'@I^XQ;[%$W7N6[20#\1. /A;/\
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M&56*ZHI5;267-^]/>K8Y.VVW<]HV^]MI!\^&>YMY(V\:L#COO_NVP_KGQO\
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M)/,/8H.#K7QCW?8ZBO5MN2O\^V)MNO%#Q3(R,#S,*8W?N](Q*6LVI <Z5JI
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M<2!#(0**&( /6RY>7$6[7%PVXVS,IEBC57H*YY 5 Z5Q:[KLY,,D\L=0Z D
MYT(8&F+>6P%;Z\ 6-B!130$DURY>7"=X3=&]C-'E@30]%Y@ *</Q<0;A)$\+
M2H&,;BC*>8C]J;12J&1@0RL*@@\00<-?]UB(Y#F;9C13]!CP\!RZ1C]5WJ.\
M$9HUM/4%1^03FOPKT8"64O9W5,X)**_BY&'@\=/>IO-UG2"(<K'B>8#B3T##
M67=E3!$<C.X^T/T1P7PYGP8_6>],]O;.=9:2IEDKG4 YBOXS>$ XN-AM[1;&
M\M9&$D0.HL :!B_%CSGAS<P]KMGKU[Y0RCNON9M[I;A8RX%O+MWZMN2 OG-"
M=3E!5M)3(ZEK?=]>Z7>G9=^WLVKG:]LL[M+B6:Y9?LEFBB;M(D#$&0OH(4,!
MUJ#'??UG]]-D@V1KG;MP@M%MY7D2YAATJ9E#J"@,FM -3^837&W=WN^W>_N_
ML^Z)N&X.]IN.ZVEM.JO,2K&.616 89@TSY,=Q-N]44Z[IM.S2;5;RWUN"8W2
MSNI+ZZE0D"J1QL5#4HS*:$@J3N/KE[U^J;O1WUV;NM<SV'=>UMK.^ALXUMI"
ML-VDBVEPLNHZI@0*=HRL'I&@QWM]8&U]P-UW/>>\DNX6VX['"9_2-HCO-SMY
M)I9]-L[Z;9E$;ZXHA5AJ9#D>_C^LZ_@V?;M]@O8HKR]D6*W4WSVU_$7E:B(I
M"%=3$*&ZI-<#OMW N$W/NYL=G,QO;<ZXG2#:S:LZNN13TF8*K5(?BI(8>W+<
M['VI&X]F-J@:*6!$)UO(A# N>96&0''E]K=;9 P62>)D4G@"<*G, />$9Y34
M>[['G3JVW]>^)=ROY%CBB0L2W+0<!SDXW;O#*M$NIZ(2*5H-1IY1C>XV&I&G
M (/ UK48O(=E!39]UB*E>*C4"K"IS!%:CPXN]QG.F*">>5B>98D)Q>=\.[-N
ML[7$C1M*YC Y. <C@".&+'OIWLMQ#HDC0O&8R-"M4@Z">()PEQ"0T;J&4CE!
MQ;[%WLDT27#?V<C6"&)H"&44&?/EA]RV'<Y)MKA()CGT/0$@4ZPX>#$ET\=9
M9;9I445RE0$BGC&-D[H7HUPVLZ]H*4J@85KX%!&-G1<@+H #H!7&Y_W*?^K.
M+P?\E=_U>)>B\D_,3'>'D^U7XVQW>K_I+;^O.%@]*:S>X6$Q3#(YC2 #SU%,
M4[P;].ULIJ>V9=(/)Q''%AW2[Q3$76A5M'JX>IZH(91IS(Y<L#<-LW)KG:HV
M4%)]#$:C0 ZA6G@QMVYH".WEC<+PXC/CBRV3O;($:X"^CGK@AJ 5#**#QY8;
M<N[NZ23;7#1C',48@$TIUAF/!BUW=@%>9*L!P!&1I^U7T?=H5DH.JXR=?HL,
MQX.'.,&\V!C=P*=0493+3H^=_!S_ "<>A;NINX4.DK-595IR:N/U@?%@1PSB
M"X/\U/1&KT'S3XC7H]X]KNUS'"*5"DU8^!14GQ##6_=J#2.';SBI_@H,O*3X
M,#<+DNT;?_6+@D(!^2.4="BG@PMS(OI=Z,^UE HI_(7@/#F>GV(^^>Q ^FVE
M.VC4?>Q#C6G,/@Z!B+=+(]209CE5N4'P>U/<_P!:6UQ[E8JQD@>K1S6\M*=I
M#*A#HW/0Z6'5<,M1A=YO9-_W2W5]8L+V^A%L>L&"GL((I2!33G+F#G4YXOO4
MO)&^V=VKW;_U8(]M$<+06] H6$,CHND"@JA'1C_;G>[_ +9M_P#[CB:?U<;?
M*V[7,2PW&Z7\O;W<B"G5U45$4D:F6-$5C2HZJTQWC_X@>[M]NTW>+O.MZEY;
MW4UNUH@O;J.ZD[)$@204>-0NJ1Z+4&IH1;;KZP+>[M=[M(A!%N>V3)#<]B&U
M=F^M)(W4&M-<;%=3:"NHXN[/U;6UP][?Z!=[C?RK-=3+'YJ%E5$5023I1%!.
M9K04]LRGD=O=I]TBN6AL()WMUMU1#KT 59F92PJ3P4C(>R\]D24CD:(U%.LO
M'$AD %"=%.44''IK7$5]=$&5RX-!3@Q')[A$HX %C[O#O+W<UM/!&J*8J?-8
ML#4YUJ<))ONYWU_$A![*:7J&G/3/"V5E&L4"C2JJ* #%VUI-)+Z7)VAUTRZ!
M08DVK<AU6%4<><C<C#$_="VNYEAN'+/+1=5& !7A2A Q%L]C4QQ ]9N+$\2<
M3;-?5$<HR9>*L.!'@Q#M7;/.(5TAY *TY!D!PQZ%N:D.M3%*AHZ-SC]_"6VZ
M[S?7-DC ]B[]5@#P.%@&B"UA2@4D !0.G&Z][+>(+"9C%;C/+E8CP@C%KZ7-
M)%Z+)VBZ*9\.-0>;%QM,K%4N(7A+#B RTJ,'NZCM/;MK#%Z D.*$94P;W;MP
MN?0RS,;4D:"6%,\N3%]NUM-)(]\P9U?31:9Y4 Y\6/>.::1);$H510-+:'UB
MM17CA)+S7#=PT[*XB:CK0U\!S_>Q'_B#=;V^MHB"('>B&AK0TS_#B.*[#13P
M@=C/&:.E,Q3G\>(H]]W>]O+2(@]B[]5J'E_RKB'9G=[>"!E9.RID%Y,P<+MF
MXJ:Q+2*531T-*5'R'+"VNZ[S?7-DA'V+/D0#6AQ'86*".")0J*.0?M7T[K;J
M\E*"5>K(/ PS\1RZ,--W?G$Z<1%-17\ ;S3X].!:S-/#&,A%<+JC('XM:BGT
M3@1[Y9E3RR6YJ/J-P^L< 6U[$KGYDI[,^#K4KXJX#H05.8(X'W(_K*[AA8?-
M9QJ^J,SY,%-KBENW' T[-/*W6_BX]%VX^C*^2I;*2Y_A9M7Z-,>E[I_94<U:
M2X):0_P>-?I%<+-+'Z9<C/7. 0#T)P'CJ>G%!P]IVJ C8-Q<!B<Q#*>3P<WX
M34@.A!4BH(S!!]@A&4D<:$'WC2E(W7,_E5]PO;S;Y&AN$12CKQ!U@8N-VAO;
MW]86MN\R2>D/0M&NH Q_=D$C,:>&+;<]WNKD7LL*MJ@F>)4)S!"(0I/T@?)B
MXWG<3VES9B=:MEK:,D+6E..0./2=SO;PWTHU%XKAXUC)&01%(2@Z5->6N+[9
M]V=NVMIWM'EB8HS#0K!P5II)#<G-BZO%EG8K=31Z6E8I1:9Z*Z2>DBN+C<MX
MW":WTR/%%!%/)"(T7@QT4JQ-34DC@.3&Y;$+N6YM[:18X[E69)2CH#0L I+*
M0>MRBG'%S-'+.Y])E32\C%:"@KIK2O3QQNPN9&D[*_EC34?-41H0!S 5.+?P
MR?GGVY)X##SL"#72*\P]]1)NXD(B)TZ)"G'C6G'";=MD8B@3@H^,DYD_MG,%
MPBR1MD5< @^$'!>.%K60_.MVTCZIJOD P6VF\CE''3,I0^"HU _!C79Q72=-
MK(6KXHS7RC'8W4\F7S;B$5\9*AOAP!<VUM)T@.I_.(^#%)]M!/.L]/@*?AQU
M]OD'@E!_ ,96$O\ TB_)C[+;6/AG _S#C^RV4"?39G^+3C3;21PD\D40/Y^H
MXTL+^6-_QBR1GRZ5P&OY(;5>4%M;>1<OXV ^Y2RW;CB*]FA\2];^-CLMKMHH
M%I0Z% )\)XGQ^WEVR_4-%(".E3R,.D?O<,3>K[=EEFN[-0\<RKJ0Q,.KJ8>:
M>8-F?(,:9AU3Q7D(Z<%4(!!K5>(.#J%&4T8=/R<WO KP/(>G'8ST$H^$<_M[
MRRL8S+.ZJ%1>)HX.+VU@4M+):S(JCB69" /+BTM[A2DJ0HK*>((' XO=ENXS
M#+<-<A0W(6)TMX*T.([/=K6Y%^JA2D4#R(YX JZ H >EA3EIBZO-R4)<WMRU
MPR @Z!I5 M14&@7X<7$%[$8B]W,X4\JM2A\>)]MW>Q>2-IWDBGCMWG#HX&3:
M S!@:C, <*8:6TM3;*YX% A84XD#,<W6H>C%WM%Y#+',+B256*,4='I0AP--
M>.5:]&-U])C,9EOY9(Z_.4QH PZ*@XAM;Q#'*I?4IY*L3[?L[<B@-&8<G1B@
M_<&*2 ,IX@BHP?2+"U<GE,*5\M*XZ]A&/HLZ_$PQE9$>":7^5C.T8^&:7^5B
MJV"^.24_&V/LMNMO"T:N?*U<:;2*.)>9%"_%[F88>LR^<>1?">?HP3Q8\33,
MX,-LHDE7)LZ(OTCS] SYZ#/#3M&%N8LI40EM49K0C($GC3+CJ7IPMS&:BF=/
MG+_EP_?]XA^#KP88TSJ:?C 5&-2&H]Z@2-F>  )/P8*I5$(\[E\6-$8I7,])
M_<8RPCT(8CK \=7+7QXBCN]4)DD,4I!II-#0!AP#<AR-.8X$,"A$7@ *#"WD
M(^VB!I^4IXJ?#3+I P+FWD9X)3K KEX.%>/$'EJ#S>\ZU*GG7+&4L@\8^3'W
MTOUA\F/O9?K#Y,?>R_6'R8^]E^L/DQ3M9?K#Y,4$LOUA\F*]K+]8?)C[V3RC
MY,!3-(&/ :A\F/O9?K?O8^]E^M^]C*67ZP^3'WTOE'R8^^E^L/DQ][+]8?)C
M[V7ZP^3'WLOUA\F/OI?K#Y,9RR'PD?)CJ\><\?W&RZY*WG>'GP9&%5*Z9%YU
MXU'Y2G,8.UWD@$\:@J3EK0\&'DS\!Q0Y(1X\1[:0PED4NJ1QLPH#3,@4%2>4
MYYGD.)+6[C5(' -NP)U&@ZRL.%1Q%.(/Y))]]QGF4_L_=6%B[&>S<),K*5()
MX4J,Q^V>AS!QV1DK'X,Z<U?WL:R!J&0/+B9$BE:."3LY)%"Z!SFM<POSLLJ'
M#;B7+13HD8K2B%:TIT-7R^$8*L2&J"&'%6' CP8*RBD\9TR*.?G'0>(^4'WW
M']$_L_:=ZK;J6%X8[:\IPKJIJ/BIY,5&8/[:*[=)V<BL&84KJ4 U4<QY<N:G
M+A5MP!%2FD9 =&#LEWG X/8$GYO*GA7BO1]'#6<YJZ9AOQEY#\O3@7UN"S**
M.H^>G*/".(\G*<+-$0R, 01R@^SOG<+N/OS[%ZL-B:13I>3T?T?6T*2RQ1LO
MI$]Q1F578(L>M0R@'7M'??\ X;-^O.]27%T(;FUL+62WJ=)?3=VAEEB>W<(5
M,C/U7T4TN4..X6Y;[9MMVY7&Y"6ZLF=)#;S/9%I(BZ$HQ1B5U*2II4$C%KWL
M[I^L&([Q+:P7EK!-M+VZ"1U5U!N([J5DTUR=8F-1YHY.\?\ PS^N.YGO-][L
MI++9S7;F2XC2UG%M<VTDA)+]E(R=F220NM:Z54 >H+U8,\W?3O+:7$M\;8UD
ML]JBC9YV-/-:5$<5^;"LK]4Z&QWZ[_WBZX-DWK>=R=*TU"UVFSET^%M-!CO-
M_P 5F_=[7BWZPN[EMMMY8Y9'GEM8UG*0R+(/18T+!(0BO1E(TH%#'OK;]^+F
M2]W[NYM>\;9)=S-JEN(#8-) \C?.<!FC)-6;LP[$LQ.-\_\ -UY_^+['W9/H
MGWK8=S-J>2*6Z=)9Y8B0Z1!^((X<"<! 2: "I-3XS^Q-SM4PKVL9"GF<9J1X
M#B3;=RRO=OD-NX/G%0!I8CIS'B_;3Z0OZ/*>N/Q6/+X_\N3&D&C5#(XXJPS!
M'@QJ%$O[<T(X"O*/HN.'RK@RI4%20RMD5(X@X.TQU:SF)(D%=,<Y/F<U'XC,
M=;+/6/8EMJZ>T1DK2M-0I7'?GU-^L&>':^\.X&T@@CNG$>JYVR6XCFMU+4!D
M/;5"UJ0C4!IC;3O,/ZYWG<+D1_JNUN8X[B*W",S7#!@U%!TJH;3K+=4]5L>K
MWO:+2XL!N=^MZ+2["B>$3V1<)($9E#J#1@":'&U;OO=S#9V-OM5F\UQ<2+%%
M&HA7K,[$*HZ2<>N'_B0V*![ONSM.U=YMZ!'5[6.2Z$T"5(ZK2QQLPKPTGFQZ
MS?65ZY;;>=U]:G?G;-SVJPGM;>W>QL;>[MC&BJTEPDBBI1#IC8I#&%4L7<'U
ME?\ "]:6E_+WNW6P[Q;];2QQ1&U,,>V0)V9<RB3M6:%J 1E<UZU:@=X)]TO+
M:'_#EUNLNX)*ZJ4CDB66-G5B.K)4HAX,RE :@X]<&]R*PMKF#<((V/FEX-K=
MGIT@2K7Q8WS_ ,W7G_XOL?<,R,<:XR!QD,<!CDP)_G 4IR8X#' 8S'PXS!QQ
M^ XHI^ ^[3;A<DB*"-I'IF:**FF+WOQN()FN9.RMJ_-A4#@.&?X.GV*X '#W
MP:' \'N.>*GVL/>.$!=MW'LX+NF?VE2 U..0(X=/[:6BD%584(PVWS9Z<T8\
MJX&XQ9R1T$B YO'7.G2.*].51J.(]XL96%O(R&<1YJR'Y_Q5/-GSX-O$H,4@
MI0=/X<&PO6#740K7AK3D;P\C=/01[$G?JTO)^[7>V=0MQ>6L2307)5=*O/;L
M4U.* :TD0E11M75*V_>CUC[]/WM%G*)H+'T);*U9E(*]NG:SM*H()*ZU5L@P
M*U#;1W6_7_\ A_\ 55\][VWH/IG::HC'IT]M!IXUK4\U,1M>>L=Y+<.ID2/8
M0C,M>L%8WK!21P)5J<=)X8;N?ZOHY7DN7$U_?W15KFZE H"Y4* J@D(B@*H)
MXLS,V^]Q/2/1/UWM=[MOI'9]IV7I4#1=IHU+JTZJZ=2UI2HXXW#U:3[RO>*/
M<-UGW-IVLA: ":W@@,1C,L^H?8UU:A7533E4S;_W+[U76P[#<3]L^U&P6Z,:
MLU6C@G,T>A>(37'(5RKKIG<_\/\ W$=[/:Y]LO;#TN8":9I;R-UDN)0"@=RS
MEB 5% $72H%/_P I/_\ KW_[?A_69_C#]>Z]NN+#T3]5>B4[9XVU]IZ5-PT4
MIHSKQ%/9ZQICJYXRRQF3C+'#&=!C,XXXXG MOFE0:\M<<3C(_!C(C'/C,'V.
M)\N,\\=:HQ53[E;=R-L8BZW!E$K**Z(2U"3T9&O0,1;?9KIAB4*HZ![%!RXJ
M,5.*+BIQTXJ<98HV*'%3CJXSQTXJ,9XKPQ0\<5&,\4Q08!Q08J<'%%&,\5&*
M#%>3P8HWL9\/8H>3%![6XVPC[5D+1'\61<U/EPUKN-1?V3]A,&R)H,F\?#Q?
MMI"ZBDBFJNO$''I=^0]U&S1N!D,B16G3CT5@/0KEB #P21N*T_%?\[Z6!M.?
M8N"T+L:Y<JUYQ\5.G"S04](C)*$\M>*GH;Y#R8$T=0#Q!X@C(@](.7NF69QE
MEX,9XR&.L<<*XH/;)]$?'[;,5QPIX,=4XS'L4.>.M48J/;275P=,42L[L>15
M%2?)B][]W2D*Y]&M :BD:#,^.OQ^R?!@8.*MBA.!@#%?8& ,5Q3 /L9XH<>#
MV,\9#!P/!@>P<# .",5.,L5]BF.&!@^V7>%!&V;KV<4YY$EK2O0*4/E_;5Z?
M$.J<I0.;GPT+T:&04IX<-MEX:7,-'1Z9L/FN/B8>'@&&##33/$=+CI'X#Q!Q
M2T 99!_:!6FD@=5J<YX$<HH?F^XU.*)GCK'V*G+'/X?<D^@/C]RS&.J:XH<L
M:@<=;+%1[2+NCMS5W#<F6,*.2,M0D]!H1Y<0[;:BD<*!1XN)\?LGP8&#BAQ7
M/&1P#BF#@8!Q3%< >T\/L>+V#@>R< X P3[&>#3V!X?8&#[9]JOBRQN5.I*:
M@5-:BO+A8EK10%%34Y?MI*MF#QQV#G[-S]GX>; O$8)<6]7C)- 1RJWY+#(\
MV1X@8AW0F:WD,8U(" 2#GI<9BHS&1Y3T4B[T),3L&ZM%:7D<SLS12@GLVC))
M-,S4>'E:H6:%@\;@,K*:@@Y@@CB#[>@S..L?8J:KX<9>Z+] ?&?=*,*XJGD.
M*,*8ZIQI''P>PTTI"H@+,3P &9.-P[Z3=:WA(M+/4. 458CR_#[;K8JN*&N*
MG%,98JW)@8H<5&*'%>7V*#%#7%6QEC,<GL5&*"N*\2<9X-!CJ\,9_#B@QEPQ
M3%./L#(\?8RQ05]O:6]RVC:Y=*C2O%F-.LWX,OVU&!S0\5:E=+#@<+OW<Z^,
MVX;9,EV]F(5 O(HVJT534JQ%2",BP -%U5@[R=VI!()%7MH:]>&2F:..((YB
M >< U ?;MZ@2Y@?/3(H(!I2HYCTXD]6G>%RVFLFV7#9]K#Q*$_C+_EQ4>UJV
M*#(8K@&F7/C+W9?H#XS[M1L\53/HQ3A@*<QTG"[!M;!K[<G6V"J:L%<T)Z*\
M,0[59"D<2@5Y2>4GPGW*HQULQB@QJ]MXO?ES"BDW$<;20D<=:BHIY,1O<&MS
M">REYZKS_MK?OQM\(7N-WIN(HMV"B@L[UV(284^9(6SR\\\\C,$N+=UDBD4.
MCJ0592*@@C(@C@<#T-^PW6T;M[.=:ADD7@*C.C<#Y1F!@F]0P[I:-V%Y"U*K
M(N5:#D:E1XZ5 J?8H,SBK8SY>3%6\GO!?H#XS[PSX\^,^'/B#?62EY!32P.1
M X CHY^.,N/N?#'#VU#BH]^]F 5V[=C'3\59"=/'PY^/]J3/-(!I(! ZS5.0
MR%3@:)*UX4!^3%2&T<"Q%/@\N&,2&2(!:.#0%B349TR  -16M>C#;3'<PM(V
MO0@85#(!5 >4TJ:><-+'@.K[1@G%213"O<*$E*U*UX>[W7=KO! MQM]Y$T,T
M;C(JPIY<3^H+O[.TUW9H9MDO),_2[+D4MRR1\&KRYY:T7V%]96Q1ZPH";G",
MNTAR&OPK3,\P!STT,6Y[=();:90Z.O @_A' CD.6-*>7&6*#QG%!Y?>"K&H.
MK*I.#.=((6E,\+&ZJ0U<U/"GO"/;ML9EO[UA'&R\5J0*XA%^XDN0@[1@*5:F
M9H,5!H<:3YWO$R3NJ*.5C08T":.M-5-0X<^'UN%""I)X$<XY_%AYK, FK*LC
MD=F*?.:AKIZ.)Y.?"7J  FH8*P8 CF(X@\1T<@]IV5>L16F#K4H0Q%#R@<OO
M5Y4RN;2MQ"PXZDZU/'3"7;FL\9[*6HIU@ >'C_:@DT#,JK(.TT@>;0\:]-.'
MQ5Q///&5MJE$ '6->6N%EA=C#\Q7Y#R_#B=[<H(]!2DASJ<ZU'#/%O&98I)V
MI+]HPKH3-J \1R8OKS;]SA4/)#,8X$I(ERKZN(!*L",OK9C$>[[8Q[*05TN*
M.IYF')[$=GMAB]#2.L[%6:3M&-$5:=6A%2Q/#+(UJK13ZE70 S@C2I/)7B#_
M )<^-FDDW.TL(3?I%?QW4H666!$)TQ!AFVHI5JTTY$58.D&Z[!=I<VTXJKIF
M%IR,>0^'%![O%N'=^7T3O3L\AO-JNUJ&650?LV*YZ)!U6'34=8 @7US$UIO5
ME(;3<[.2FN&YCR8$#D)!(/ _-JM"6BF :-@0P/ @\:XNMOM)V>PDG,EO"1E"
MI&:@\2*^("G+4G+',.?GQ0>\:$9C,>$89G8=7SJTP9'XDY>#W<R.:*H))Y@,
M3;]("VW[=ICAKP+C/\-?8U)QQS'&EN/N\GHYTR:3I-*T-.-,.-7:1)P.D:G)
MY<A3/ :>0,Q!S8 4&(X(2"S%7#5H1GR$8IWDN8X+!T[&8R$&FO($Z<P :@FE
M!SC"6D4=P=OE01-*T+1QIH8A7!(HPSH>L<LQP((DC(9& ((-00>!&!'L[JM]
M+)$B53M*!G <Z:C@M34FF6>(UNR7F9Z%E4+RU- >0<.<C/%YWI+F,QZ9/2F5
MGCC!:A+::\E=(- S46O 8AW[NK>"[MV4:C2C(>!#@TH:\V5,Q52":K0CG]Z4
M.8.&L"-.U[H5,?,LI-*?M0:,BH92*5(X](S&(_\ $YDW';+Z\C@@N+.VJMOV
MAH%ETDG2#PD(YRU!YLS;[?6]M>3H?182X#N: #2!4G,BO)SXAL.Z6Y?K"XH9
M)V6(RQDYU):FG+JT4$@4HU>M7:N\7K3VY&CVAI&@O=3)Z1J0JR:5(( Y>D99
M''9;)!:69DU*;)$C4DQFFLKQ)R!)X\^-Q3<K4V-]VJVZHJDQRHC,$E4Z01KK
M4J<A09G,XC&\3) D[: TC:%%<LV- ,S09^# ,)70:G56M:\23RG$\MM2>"[?
M5(R.2&9*"H-:9%>3+&W[EZS;:&2WM+^W> W4(?LI)Y1&@\TD4#A:Y#4H-3D<
M;M>]RK7L9VMFF[&SD=4>0 JE(U8 FO(!GR9G%G<]\+![#<XP8I%(>CA,A(&<
M G4,_+6G#WA;>NSN!9R7<5XT=GW@V^!2S3QNRHDZ*N9D0T#9&JT)KH52* @'
MD/'%3PQ5A0<WO2B+6*0=<UQ0<![NUA;=:^O?L(DY>OU2?AQ'9D4F<F68\[L/
MD ]FH\[%#QQI?CR>[^E[-JW2WN[K3-$"$[%6S++X.2IHP%*ZC7 [DVGI,F_W
MU50+&1'&E*DEB,N04X\^6+(]R9YX[.V>.*0]F7+R ]8*"#QX"H-3P!'&W]:/
MK VV(WE[!#VX<EDB1@"9*5.= /-J30"K**FQ?U3);WFW"5%G2,*28ADX4<-8
MY*Y</FXGNG@EA]%.AXVH6J%!H*$BN=./AICTN*/3=#4N<3BBAN 9@*T.1I\X
M'A2F&L*AKVSC$C @C0)!0&IRS Y.'#&]_K.-8]J@6L2@@"A4#+5D.O3PG/.N
M+K_".UK'<RVQ]':)%0=H0 E=-#0$\*#A3+*EKMGK(TR;S I$DT>G0PKU<P34
M@9$\>>OG-[T-W;#^V65;B$CC5<R*=-,L17U?MAU)1P(<<<OVGM&V88$$'IPU
MM)&6B)KH8U49\@YL)OU[&R7-K;2Q%80I,P(.D,6!R&>0H#4ZJY4@18UFECE[
M2^)J%D0_-C6M$"FE*9GEJ2<?X4V17$I4M#;E&%0_ A:  <YX#BQ&(N_L:31;
MT(2LK]N61F?SC0\O(:4%*4Y<67JE[I035AB-Y=S!&8&B:TJZJVE*E5/FDLV9
M4 :K._WV;TAXZN\3Q)H8E:#J\E#UN7/%QM=Q"39R*:'BK!QU@?'7Q8@VONV1
M;6UK1888P55$SJH (!X\OBZ;*U]*N88;6<LZF,HS21@KU@U#D:D4/EQ#:/!1
MHM)U@\2IK6O+4C,>\=*^;CHP'.0')^PA9C0#,DX.X)5K#:]"J>0N#7X_:].*
M<",4/G>[!I%3.HU$"IKR8I?644\RIV:2LH#A2<Z$\:"M <J^/&W;CW;M88O0
M08FM0!&D@=A]HS $EUXFM=0R%#QAVF]TQV:4$L8 <R*!D 3PSXFA.65#F+P]
MR[:-]Z=&2S@BCHLEPYR.@:@H%:DFH&0HQ(1H=U]9!G;<[M&GNX)90ZK+J!0$
MJU&*BO(149$^<8XK=%3LF+)Q--1JP&? \W#R8,-U4$E3J0Z3U34 \XKR'+QY
MXN>[V_VHFL1(CI(S_>Y5J0,P5.7-PIPQ#86R)V"=2@% %Y*#X/>U#P.)]JE!
M&W;D5DA:G5#G*E?#^U H>7'8K32":4%,O*?86Y9%,R JKD#4 U*@'B :"O@P
MIB(9#6K!AI%.GGKB26<QPB[G 1LR[LW ,S$DD$FE3CK<>CV<O>.A?'[&? </
MV%FCB)-U<J88E7C5\LO+B."9:7$I[64GC4\_MJCSL5&1&*\O+[KID (YCT8$
M<8HHK0#I]B+:.\%_%;W\[0B*!R0[B9RBE:C,:@0:5IP/$8D@D!;2:D@4 J,J
M'GIB>>&-H8896BB=Z]?3D25-",^0Y\N5??<EY:J3>68[>$CC5.M3IX8@W 'K
MLH$@YG'$?M26?N3=2VNZB8"-D74IJ":,#E2H'/E7+&W;9WQF>ZOK=G9WJ5U'
M6QH:4J!TXM=PO!K:T+&-&H4JPXD4XBF7-@0EE#D5"US(',/>>E>)Q3%1YH^/
MWB]W=N(X8P69FX #"W5E(LL3<&4U!Q^JS*OI>G7V5>MIYZ>+VDNX7K:((5+N
MU": = PEY:MJBD4,IX5!]I0G/$6WW$RI<S?=QDYMX/879&D_MC)V@2A\W/.O
M#D]M4X 'VFV[;IK^+K!KR=.*>WUKQY<5&*CA[O9=Y;B4LL "M#( 4#*RLCC*
MH((SJ2.!R(P9;EPD4:]9V-  !Q.&W*W';*5U1JGSR14 'IY\1[I;45S598PV
MK0X-"M<J^^BC"H(H1B[[O3U2PO2DMJ#P#-D0"<S4Y?M2,$HJII\!J,=C)IHN
M2E>;IZ<7$EZRBRX0H*5\)/'&S=^-BGGM;F&Z$+2Q)VXT,&ZC1,"M&K74:%2
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MAC]6F9/2BH<1UZQ4\H\F([2YE5)I?,0G-O ,-V]] I4T(+BODXX?=8[F-K1
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M+%66,>9U 26ISTQ<7T&ZV^VPQN5AA/9EFH.+:JFA.6-W_6'9FZMTEB<QD%6
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M(*F2-@AYFIU3XCB7NSN#?VJQ(4 T!TGX?:Y_ ,(35FD.E HK4X2(6Y)8YT/
M<YPQBJ"IH0>CV,B,NG]EJ,XKY<9O\!QY_P !^3'G_ ?DQY_P'Y,>?\!^3'G_
M  'Y,>?\!^3'G_ ?DQY_P'Y,>?\  ?DQY_P'Y,>?\!^3'G_ ?DQY_P !^3'G
M_ ?DQY_P'Y,>?\!^3'G_  'Y,>?\!^3%(W!/-[8GIP3[-\3_ /99OS#@U_\
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MVN"YB9FDD*$.9KB8$4&5 /#CN[LWJ^L-FO(=WM+FXG.Z07$K*T4BJH0PW$(
MH<ZAO#BV]9G?:VL;7=)KV[MFCVZ.6.'3"^E2%EDE:I''K^(>P!TC# \AI\&&
M')I^7&?#!/ML\>'/VY/3@#HQW@_Q25:\-SNJV!FH3V@LOLM)/ BW#!?R<L;K
MOGK3-J.Z=K;/)N7IL/;P&$<0\6E^TJ: (%8L:  FF.^&^>JB^L+_ +O!+.&)
M]N*]BCIN=OK32H&D@FI! -"&X,">Y/\ 0[A_^,;C'= [$%]+-QL1O.RIJU:#
MKU]/8:?X%,6OJQ[]=Y-KV+U.=P+AY[[]:W\%DFZW\+&.1$[5TU@M6):9I")G
M# RJ,>L:+<=XVNQBWFZ-MM"RW<$2WCR;A)V4=J&8"5F#+H6/434:1F,>N9]R
MSW3TO<ZEJ:L]V?M?XVFM,=[/U53T?T6Z[:E./H%OKX9?>^/GSQZV_P"Y[Y_^
M-;+VGK+._E6[QM#?,AEH92/UB/2:'GUF/53C@;]Z[9-OB[N)>6J!]R@$\*W+
MR 0D(4>C*W6#TZ@!<E54L-@[Q]R;JVO=BN^\.WO9SVC*T+1"TNP-&G( 4TE<
MM)!4@$4QW$_\K[+_ *E%CO5>[8Z1;;#+O<MZZ4"*%M-4S/X)LV_*QOWKB]:_
M>/9]I[@]RK*ZMNZ6S;MN%O;2WERT;%)^PED5FJZB9B!YPMX>N(VQWP[G-NUE
M;]Z=QOC+MNW27427EQV5DS,T,+,'<(%)8JI"A23D#CONR >EG<[$2'*O9]B^
MCII773QX]<?ZKI^K?2KS12E*?K.7LZ:<O-KPRYOVY@\QP#[+1S %&!# \"#Q
MP;-9HTTDGLH06-3T+7%MM^P+V=O)+&C,R@L0S 'CPR]UN-LF *SQ,F?(2,CX
MCBXN-R2DX<JA/XH'$>UG[N=[=OM-TVFY"B>SOH([B"0*P==<<@96HP#"HR(!
MXC'_ .3SNE_W#8?]3C>]LLX8XK.+?;R&.&- L:1K=,JHJ@4"@9  4 RQ_P#D
M\[I?]PV'_4X78.Y.U6.S[6KM(MIMUM%;0AG-681Q*J@D\33/V'NKIUBAB4N[
MN0JJJBI))R  S).)]B]6^TW?>Z>V<QO=).ME9.P:A[*5DED<#/K"$(V6AF5M
M02U]8'<[<-FLW=5](L;V/<-"FM6=&BMC132NG6U*D D!6LN^G<N]BW'9-QB$
MUK=0DE)$)IRT(((*LK ,K JP# C$3]^;B6ZWN[0R6>T6*J]U*H--;!BJQQZL
MM;L*T;0'92N##/ZO[A=L[1@)UWA&F[,5TMV)M0NHY57M:#\9J9S;EZN;N5;Z
MS"F]VV\017=OJX,R!F5D/(Z,RUR)#98W3_>6V?UXQWS_ -U6G]>V.Y/^[;[^
MN3%C_O7<OZP8RP*\:X;Z7X!AOH_+C/V].?%/;$XH/8L_7SZA]SCV;UA68@[<
M/*\ N&MZ"&>.= 6CGC4!,QI953K(5ZUKZM?7;N2V'=..2-Y9+N[VP1,(R*&1
M-MU2W#+36HFJ-8#%E;K8W+_AJ]2MHVZ;FMK:1VZO)# ]W.+^*XN)7>5TC4M1
MVHSY !%)HN++U>=P+/\ 5_=_;ED6UMA-W8E[,2R-*_VDKO(:N['-C2M!D ,7
M/_$A_P 2VXQ[CWWF$K6EN)_27BEG0I)-/+309 A,<:1ED13DV2JMUON[=S^U
MOKV>6YGD_6NZ+KEE8N[:5N@HJQ)H  .08WWOAZZ>Z7HVR[3?QW_="?\ 6BOV
M<UO>&2!]%K<L[:45#2X4@\&!-1C</^(W_@ZNT-[OPD-[:K+9Q2Q23:>W!2]I
M;S12NHEZQ++)GIJJ-C?_ %[>O^Y2Y[_]XHS%V0F%Q) DT@FN&FD2L9ED=4%(
MRRHJ$*Y#T7OOZYO^'G9_1$WV^OXX+[TO9).VLKBX68#LKR5M.IHT;-%<4ID"
M0=F_QM_X=_6-I^LO_"_Z)VR]O]U]I]WJ\SK_ (N=/9G_ .)#_A)W5=L[S73R
M75Y8"?T60W+J1+);RM]FWI%3VL<Q5"S,=15M*[;M7_%+NZ[7W8V^82,9)]O;
M(U#/#:[;]D\U"55YM)56-&I53L'J6]06S^G/L>Y[=V%IZ1;VY2TM;2>'67N'
MB1FJRZL]3%BU#F<67<C9T:SV:RM(=OMT2;NR&AMXHQ$@$H8RU5 .MJ+Y5J6Q
MO??GUQW<6[]]^\EO+:7 AEDE2"VG;7,IG8*[S3-0RN.&D!6:I8WWZB[E_P#Q
M/T:;T7_XONGWV@]GY]WI\ZGG9<^6+SUB>O7NQ^KN_.W7C?J.Z_6*3:+>:U:&
M;[.TN'A-0[+]JI85JM* X[Q[]_P=7G:]VN\[.TB07-A#+#&[NZPR1WQ5-4)=
MA%-$=85J@H688W6^[^7$-WWT[QW$<U^\#M(D44(;LHA(P!=M3R/(P !+!>MH
M#']N1'L ^PUDTTL!Y&B<J:]/1@^FQ/)#6HF4$BG21B"UVPE;@R+V;9#20>.>
M*QW(F0<E(C^"N/,'U(\>8/J1X\P?4CQ]V/J1X^['U(\?=CZD>/NQ]2/'W8^I
M'CS!]2/'F#ZD>,T'U(\'0@K]"/$,FX"ESH':#AUO;[__ .8;[_6W]I9]R=CE
M:&?O7?FTN74T)LX$[29!R]=C$K<Z%E/G8WSUK^L_;HMXM=JNXMOVZQNE#VO;
MZ!++)+&>K*0K1JJ."G68LK'25VO</4?8[+W0WV"[5+YHH3;6DUDRD,1!;H4[
M:-@I2BH'!<2/YI7=NZW>_O-#O6V3W/IUO#%;/$EF0A$Q#O(Q99 $)4(@5E9J
ML7-!WB]8NZIMFW=Y-\ABGO;J98HK#;WF" !Y3H18(,AJ.FHJQS)P?5^-P]7T
M5KV'8K?1;OMHW%3IH)/3.U,Y<'K=9V4GSE*Y8VW=N[VXQWNW;9OK[7<W5JX>
M"]V]IS;S,A0E722/[2,@LNK0XK08W3_>6V?UXQWS_P!U6G]>V.Y/^[;[^N3%
MC_O7<OZP>P/#AO#^##?1^7 QGPPUO#(C2+Q4,"?)C7=NJ#D+,!A7N)HXPWFE
MF !\%<:FO+>HS^]7Y<>D22((B*ZB0!3PX[:)U:$"NI2"/+BAN8:_TB_+@1QS
MQ,[< '4D^ 5]K3GP/+^X65YL4]EH9U#HPH0>!!Q%OVVEXBC5:*M5/@KF/+[L
M1[??_P#S#??ZV_M.Y?>V)6-K8;G>V<K 9!KN%'2OA]':F.]G<M9%_6-KO,>X
M-'4:C#<VZ1*P'&@:!@3R5'.,+ZP?6%Z2VW/>06*1V:)),\LU2-*N\8(559VZ
MU=*F@)RQOO=KU6W]S+>06CQW,=S9S0&-+A"B/K93&034 !B_58Z*9G9NXWK1
MEN-MV>XW>#;MTE@=(YK97F$4C:G5T7LR:L2K  '(X+OOO>U545)-[MX  _\
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M616=F85 R&0.9Q'MV[P,UO*">V*$Q*PY&8>:>8FF+6WV"XDN=OE#^D19211
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M3%?-J>1>4X07]XFXV,BT>L21/&W.--*CHX^U$(S" ,>@\G[EY1N!%,&VF)U
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9"E&KE4URRYQ^Y=7]TGCCC[UX_P#YS#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img117130267_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )*!>H# 2(  A$! Q$!_\0
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MAX?_ .1#DG_8HRW_ -0J)_,N?_\ (]SK_L;9C_ZF5@HHHKUSR0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***_HT_X-
MR?V%OV2/VYOC=^TSX;_:[^$\GQ:\(_#3X)Z5XV\-:5#XX^(_@:73-8;Q=;6%
M[>Q7?PX\:>"KV_DFTQI;9+35+ZYL59A*L,4P$R\&9YA1RK XC,,1"K4HX:,9
M3A0C"562G4A32A&I.G!OFFF^:<=+ZWLGW9;E];-,=A\!AY4H5L3*483K2G&E
M%QISJ-S=.%2:7+!I<L).]M+:K^<NBO[,?V9OA+_P;+?\%-O&]Q^RI^SY^S]^
MTW^R5\>_'>C:ZGPM\6^.?&GCZYN]2US2=%O]>G3P[#J/[0OQ]\!7]]IFFZ7>
MZG/HOB_3-%&L65K=V6E7O]HR6SQ>%_\ !*O_ ()B?L<^'M6_X+/V'_!2GX'Z
MQ\=8?^"9]EX=UQ4\(>-?B3X'UFY\-^#](_:9\2>/-3\':;X*^*'PWT_7+GXA
M^&_A;X9U;PK:>,==%I;AM.B75-$BO]5NI?'GQ5A*5+&3Q& S7#5\''"U)X&O
MAJ,,76I8S%4\'1JX=+%2H5:?MZD83?MXN+337-9/UX<+XNK5PD,/CLKQ-#&2
MQ5.&-H8BM/"4:N#PT\76I8AO#1KTJGL(.<%["2DFG?ENU_*%17].'Q#_ &I/
M^#6_4? 'CG3_ (<_\$WOVT- ^(5_X/\ $UEX$UW5O'/B^;2M%\9W6BWL'A?5
MM3AE_;UUJ*73].UN2QO+V.31M6CDMH9%?3+]2;67F/\ @I?^P3^R,G_!*C]@
MC_@I/^Q#\*!\-=-^(2V?@C]IS0M$\:_%3XAZ3!\0]:T233+^\>Y^)OC'Q5>>
M&M-\#?%7X>^/? P?3X].L-9N/%7A_P [<ZZ8UST4^(*;K82CB<LS7+_KN)^J
M4*F-HX6G2==T9UH1DZ6,K27M53E"G:+;J6C)17O+"ID,U1Q5;#9EE>/^IX;Z
MW6IX*MB:E54%6IT9SBJN$HQ?LW5C.=Y)*G=IMKE/YMJ*_J)E_P""=_[&?[/O
M_!&_]CGX\?'OX,OXL_;+_;F^/_PTT?X>>)+KXA_%'3$\)_"7QMX^M]=2X@\)
M>&/'7A[P9=Z;>_!#PXLHU/4O#VJZS8^(_BMIS&Y==/T\Z9^@_P#P40^$?_!M
M+_P3/^.FC_L^_';_ ()W_M(>+/&>M_#?0/BA::G\)/BQ\7M>\,1Z!XBU[Q5X
M>LK.XO?&/[:7@/54UB*]\(:E+=6\>BRV26L]B\.H3RRW$%MS2XKPCK+#X?+\
MUQM2>(Q^'IK"T<+-5?[.G2IXBM3=3&4N:A[2JH0FTI2<*EX12BY=$>%L5[%X
MBOC\KP=.&'P%>H\56Q4'2_M&%6IAZ-14\'5Y:_LZ?/.%VHJ<+2;<E'^&^BOZ
MP?V#OV?_ /@C5_P4I_X*RZ#\,OV>/V1OBIX+_9 L/V-O%.N>*/A/\7OB+\3=
M$\2ZC\?/#7Q&D:X\<6/B/PC^T3\0O%":&W@CQ+X4T:VTM?B!8:5)?Z;J<\_A
M2*?9JFI?S9_M1>#?#?PZ_:9_:*^'W@W3?['\(>!/CK\7/!OA72/ME_J']E>&
M_#'C_P 0:)H>F_;]5NK[5+[[#I=C:VOVS4KV\O[GRO.O+JXN'DE?T\%FU+&8
MJI@OJV+PV)I83#XRK3Q5.E!PAB9U80IR]G7J_O8NE)SC\"3BXSDVTO-QF55<
M'AJ>,^LX3$X>KBL1A*=3#3JS4YX>%*<YQ]I1I?NI*M%0>DVU)2A%)-^%45_3
M;_P3"_X)D_L'Z-^PSXD_X*F?\%6/%7B0?LZ7WBZ]\ _![X4>#[_Q1IMWXSO]
M-\17/A"\UC4KCP%<6WCG6M6U7QAINN:!X=\,Z!J/AVUT;3_"WB'Q=XJU:XT*
M9)-"^L?A]^P3_P $/?\ @L)\*?BYX-_X)=^'/B[^R+^V!\+O"MSX]\-_#SXQ
M>*/%NL+XWTJPF&FJ-;TGQ/\ %CXV:3>>"]3U>_TO0]2\0^"?&-AXA\#ZQJ_A
MK5M:TB^TRZ&@Z]P8CBC X>MB(2PV8U,+@\0L+C,RI853R_"U[QC4A5K.K&K^
MYE*,:TJ=&<:<FDWJF^_#\,8[$4</..)RZGB<90>)PF6U<4X9AB:-I2A.E2]F
MZ:]M&+E1C4K4Y5(IN*T=OXX:*_KF_P"">?[&O_!*3P5_P1T\:?\ !0/_ (*'
M_LG?$;XPZ_\ #7X[>(_AWXN_X0'X@?%GPUX^%G=>.?!7@#P[H]OX+T[XY_![
MP5'-H>M^* =7>_N--U2.TCO&E>_O+>"S>_\ M5_\$]O^"4_[5'_!)KXO_P#!
M17_@F_\ !+XY_LO:M\"==5[OPW\9-9^(=S;^/=)TK7_#>E>*K&6#QC\0_C/I
M%_;-H?B9=:\*^)OA]XQFTYO$&G-X6\1R6-T-9BT27Q5@HXN6%E@\RC3AF:RF
M6/='#O K&R<%&#J1Q4JRC)U(6DZ"LIIR25VJ7"^,EA8XF.,RZ52>6O-8X'VU
M=8UX.,92E/DEAHT>:*A.\?;ZN+46W:_\A5%?W=_\%CO^"&?[ WP1_P""</Q*
M^.G[(OP%O?AW\=/A!I7PS^*>KWEC\5OC'XRDU[X<7NO6?AGX@6]SH7Q*^(?B
M[P^NF:5INMW/C2_O=*TZPU?3SX6MH;>_2SO;G2]4/V'/^"'W_!/?Q+_P20T+
MXY_'_P""EMX]_:MUS]D_QI^TM<^*(_BM\;_#4^CZ%X\TKXB^+_@5?MX0\+_$
MG0O![6UOX6T+2XD>;PX]MK.H:/JK7\=]$TAEY(\<9//+Z>8JEC_9U,P67*@Z
M5#ZS&JZ<:OM9P^L^S6'Y9P7M%5<G*2BH-WMU/@K-HYA/+G5P*JPP']HNM[6O
M]7E2]HZ?LXS^K>T=?FC)\CI**C&4G-*U_P"$2BO[ /V._P!DS_@CE\)/^"*G
MP2_X*'_M\_LD?$CXV^(_%'Q(\<_#_P 4:Q\*_B7\5]-\5ZG?'XQ_$?PIX2D3
MPG9_M"?"'P%::?I>A>%[.QO+BRDL[R40Q74MMJ%[/=7#?F[^W7\??^"!'C[]
MG+Q1X:_8(_8B_:@^"7[2MWK7A.?PK\0?B?XL\2:MX0TS1+37[*X\76=[9:E^
MUY\7+22YU3P\E]8V#/X(U!H[J:-TNM.8"\B]&AQ!#%8NMA</E>;U84,?5R^M
MC(T<+]3IUJ%54JLY3>-57V4&U-R]CS\CO[._NGGXC()X7"4L57S/*:<Z^!I9
MA1P<JV*^N5*->E[6E",/J?LO:R5X*/MN3G37/;WC\(:*_M3_ ."^_P#P01_9
M[_9O_9HTC]J7]@;X4WO@'2O@]>S+^T)\/;3QA\4?B3<ZMX$\275C9:1\3+"?
MQ_XO\;ZMI47@+5H9+7Q/:V#6VER^&M<N_$]])8V_@^_EO/SX_P""@?['W[!?
M[('P1_X( _'N?X&:XG@_]I;X5^"/B]^W/IOACQU\1];\2_&OPUI/A']D#QG\
M0K'P]9^)_B98Z7X-US7=+^(7Q,@TFV\!ZQ\-;"*_\26\4>IZ-;Z9I%UI&6!X
MJRW,:6!J86GBYO'UL90IT73HJM2K8+"U,7.G7BJ[C%U:--.A[.553=2FI."<
MG#3'<+YCEU7&TL5/"P6!HX.O4K>TK.C5HXW$T\)"I0DZ"E*-*M4M6]I&FXJG
M4<5-J*E_-G17]WO[./[./_!MS^T]^QO^TS^V_P" ?^">_P"T#I'PH_95_MS_
M (6'X>\7_%WXS6'Q#UG^P/">G>,;S_A#-)T7]LCQ!X;U'S=,U2W@MO[<\6>'
M=]^DT4ODVZI=2?R??\%&?B%_P3V^)7QN\+:[_P $U_@5\5/V??@9:?"O1-)\
M5^#/B]J^IZUXEU/XL0>+O'%YKOB>QNM5^,?QNN(]#O?!]_X$TJVMT\5Z?"E_
MHNIR+X>M'EDU+5MLMS^GF>*KX2GEF:X:6&DZ>(JXNCA84:-50C45*I*EC*TU
M4G"<912@T[ZR1EF60SRW"T<74S+*\3'$Q53#T\+6Q,ZU:DYRINK"-7"48.$)
MQDI-S35M(L^ Z*_K_P#V8/\ @G+_ ,$K_P!E;_@EA\%O^"A'_!0CX'_M!?M@
M:G\>"-:ET+X :MXVNM#^%^A:A>:[_8]M>GP)\0_@[IFB0Z3HNC^;X[U[X@^.
M?LMEXN-SX7TB(7-M!;:A\*?\%,OV;O\ @D'\+-:_8W_:I_8<^+NA?$+]G7XK
M>,?#$G[0G[(^F_&2R\9?&KP!X1M9=$\0ZC%#X8O_ !C'\6?!4WB'PU:^*O#.
MOV7CWQ98W.A^,CHRZ-XGLK/5X3I<X?B3"8G&3PE'"9C*,<1BL+'&+#1>#JXG
M"*3JT(555<XS?+*-.5:E2IU)*T9NZ*K\.8O#X2&+JXK+HRE0PV*EA'B9+&4\
M-BY15*O.DZ2A*"4XRJ*C5JU*<7>4%J?SUT5_<Y^R'\%O^#:K]M+X(_MG?'OX
M6_\ !/']HS0/!_[#/PKB^+WQ:TWQ_P#%GXP:7XE\0^&IO"/Q4\9K8_#JS\._
MMH>*M+U;7!I?PA\2P-;>)=8\(V O[[0XAJ9M[F_NM,_![X\>"?\ @G'_ ,%
M?VM_V./V=O\ @DE^S=\;_P!G*/XG>+G\ _%C_A;>IZKXIO+J77M>T&2#QMI-
MOK/[0/QK/]D?#[P99^,?$/B""'5?"XEL[0EH+]T2:UG"<24<5B,3AYY9FV#6
M"C*6-KXRAA84,(EAOK<?;RI8RM.+G1<90Y:<KN44^75JL5PY6PV'PV(AF658
MMXR2C@Z&$K8J=?%-XCZK+V,:N#HP:A6O&?-4C;EE;F:2?XB45_9Y_P %L?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\ 9>\"_P#(
MD>#?^Q5\/?\ IHLZ_P :&O\ 9>\"_P#(D>#?^Q5\/?\ IHLZ_(_%/_F1?]U3
M_P!YQ^L>%_\ S//^Z9_[T#_,9_X+S?\ *6S]LC_L:OAW_P"J6^&M?D/7Z\?\
M%YO^4MG[9'_8U?#O_P!4M\-:_(>OT7A__D0Y)_V*,M_]0J)^>Y__ ,CW.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTG6JNA&4*+J3=&,GS2C2<FZ<92ZR4+)OJTV?NM_P7G_Y*C_P3L_[1&_L3?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML?3Y\*W>348'\C]%%%?9GQX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 445_2[^UY^U)X6_8>^&W_  34^'OPH_80_P""</C]_BY_P3&_
M99^.GCCQ7\:/V+/A;\3/B+XI^)OC>]^(7AO7]6U+Q5<6FGZEJ]QJT'@W2+NX
MEU%;[4[O5KC4;VYOKB2\"Q\&,QE3#5,+1HX?ZS5Q4JJC%UHT8Q5&G[2<I3E&
M731)+5]4=^#P=/$4\36K8CZO2PT:3E)495I2=:I[.*C&,H[/5MO;9-G\T5%?
MV\_!C]D+]FOQ-^WI_P $]/B/XB_8Y^!_@CXD?M1_\$V_C=\:OC?^Q?>_"CP_
MKOPD\/\ Q5\(>&KFV\!^.M ^ 7C*S\1-X+C\>W2W4^C^&I[9UM)_#ODVGF>)
MXO$VHW_C?[#_ (6_:S_:*_:)\(?"_P#;*_X(4_L@_![]E37+3Q%'\=_BMKW_
M  3F_P"&/KKX=>!1X=U7[5XR\._&O7K/PHVA:]H5\+*[MH-*N;O5+N%;B.S3
M3)S'X@TCPWQ31Y*M2.%2AA\*L3657&X:C4?[[%T)4\/"3<<3)5,'54'"HHU.
M>ERM>T5O:CPO6<Z--XEN>(Q+PU%TL'B:U-?NL)6A4Q$H+FPT7#&4W.,X2E3<
M*JDKP9_'517]4G[$_P +]"\+?\$[/VZ/BG^R%^Q-\&OV_/B;X#_X*)0?#3X,
MW/Q0_9$TC]K7QA>?L_S>&K8VNJVNB)X0N?%MMILNFII>NW4]C#I6F6>H:G-=
M76GV\EX\5?G'^W?\2/VS+_X+V.@_M$_\$I?@/^Q+X.UOQKHT6E_%GP;_ ,$W
MKO\ 90\4ZGXAL+'5]1M_!NE_$S5/#NDFYBU33[;4=2U#PS97#7.I6>CR7+QF
MUL+@COP^<_6<75PU/#TXQI8E8>4JN,HTJ[?LJ-9SCA'%U9)1K)6O=RC)=#@K
MY/\ 5\)2Q-2O4DZN&>(C&EA*M6@E[6I2498I25*+<J;?-9I1<7U1^.]%?H=_
MP2O_ &._#_[=/[;WPC^ ?CG5M1T#X6W,?BWQ]\7==TBZL[35=/\ AI\-/">L
M>-/$=OIDUXX,5_XA.DV?A.SO+6VOY](N-?CUN2QFLM-NVC^P[;_@J_\ LLP?
M%BW\(+_P2D_8,B_8F3Q!%X8F\)S? FTU7]JG_A3ID72+C6!^T7>^,T\7S?&C
M^P-^KP:\^O1:>/$HCB>])WZ^_3B<PJ4\1/"X7!U<;6HX>&)Q"A5I4HTZ=6=6
M%&"E5DE.O6="LX4URQ48<U2I34X<W/A\!3J8>&)Q.+IX.C6KSPU"4Z=6JZE2
ME&E*M-QI1?)1HQKTN>HVY.4^6G3J.-3D_"ZBOVY^%GP]_9>\6_\ !/W_ (+C
M_$[X2_#J;4O"OP\^)7[ LO[,WBKXS^$?!>H?''X5>!?B#\?_ (GV&K:):^*-
M.F\0MX<U?6?#MIIOAOQI>>$=?MK;QC9:3:/JL1A,>GVOR]_P2,\#^"_B3_P4
MN_8P\!_$7PAX7\?>!_%/QP\-:3XG\&>-= TGQ5X4\1Z5/'>&?3->\.Z[:7^D
M:OI\Q53+9:A9W%M(57?&V!@69P=#,Z_L:D5EC:J0G:,ZC66X7,6DM>22ABHT
MFI-VG"3VL']FS]OEM!5J<GF7+[.<;RA#FS#$Y>FWHYQ<\-*JFDKPG%6O<_.>
MBO[#_P!AG]D_]@WXM?";_@K_ .!/VF/A[\-? ^AZO^W_ &?[./P;^-EEX"\,
MV_B;]F[7_'OC_P 9>'/A)<>!]?M=/M=5\'>!['X@0>#=+U_PYHVHZ1X4OO#<
MMSI?B6 ^%FU.,?GW^QU^Q8OP9T3_ (+D?!/]J'X0> =<^,?[+/[&?C5] O/%
M7A+1_%<G@GQKIOB&U_LCXC?"[6O$NB_VGHH\0:#=6&O>$O&.C0Z-J>I>&=6T
MV_B>&&[6,<$>(\+)XZ'L:L:N"J8*+A)Q7MX8QX./M:,MI*A/&4XUX_%"]-O2
MM [GP]B4L%-5J4J6,IXR2FE)NA4PBQ<O95H[Q=>&$G*A*_+.U1+6C.W\^E%?
MU$>)?^"?'P;_ &H_BO\ \$ _V>-#\/>#O@QI_P"TI^Q=;>._CUXX^'WA#PMX
M8\4>,K3P+I?BWXD>/_$NO:M8Z;;#7O'VK^#/!6L:/I?BWQ2FNW%CJ%W9WEY;
M:K;6KZ;<_)>H_P#!5G]EKPS\6V\#_#[_ ()7_L!W_P"Q3HOBF#PQIFA^-?@.
MOBS]I_Q'\'K*[@TJ[UW5?VA]<\4CQO;_ !:U[0H+C6[+6'OGMM UR]MK2[;7
M/L-SJVI;4\ZEB;1P>!K8FK&E4KUJ?M:-)4J4<7BL'2]^HU&=7$5,'B'2IJT5
M&E)U:E/W.?*IDT</[V+QU'#TIU*5&C4=*K5=2K/"87%U/<IIN%+#T\9AU5J-
MN3E4C[*G4M/D_"NBOUM_8W_9K_9Q_;&_X*G^&_ GP8TSQQX;_8DTWX@ZS\;O
M%-O\;8=&F\1^#/V9?A78-\2/B!H7Q$O-#\2ZCI,%G/INDW7PZL_$2^(=1F$>
MN:)JVH_;=1DNK*7UK_@KUX ^!7Q7\!_LF_\ !23]DGX/>%O@=\!OVHO"_C+X
M8>-/A-X&\&>&?!&@_#/X\_ OQ3JGA[5(KSP_X+D3PIH=U\1_ [Z!XET[3]'L
M+:._&BZSXAN9KJ^U:[,.[S:E''X7 RHUH3Q-"%1SFHQ5"K5A7JT,-65WRUJM
M/"XN5DVHNARMMU:=\%E566!Q..C5I2AAZTZ:A!R<J]*E.A2KXFB^5*5&E4Q6
M%BVTG)5G))*G4M^'%%?M!_P7&^%GPQ^$O[1W[-VA_"KX<^ _AGHFN_L#?LK^
M,=;T?X?>$/#_ (,TO6/%WB'P_KTVO^*M5T_PYI^FVFH>)-<FAAFUC7+N&;4]
M3EBCDO;J=T4C\7ZZL#BXX[!X?&0A*G'$4U4C"33E%-M6;6C>G0Y<=A)8'%U\
M).<:DJ%1TW.*:C)I)W2>J6O4****ZSE"OW6^(7_*N;^SY_VE.^)/_K/VH5^%
M-?NM\0O^5<W]GS_M*=\2?_6?M0KQLX^/)_\ L<X7_P!,8H]C*?@S?_L3XC_U
M(PA^%-?9G[#'[;_Q*_8$^+_B#XR?"_P3\*OB%JWBGX7>-/A!K_A7XRZ%XH\1
M>"=3\&^/?[+7Q%;W6F>$?&?@359+JXM]*BM(V;7#:"VN;N.>RG:2)X?C.BO4
MKT*6)HU*%>"J4:L7"I3E>THO=.S3^YIGF4*]7#5J=>A-TZU*2G3G&UXR6S5T
MU=>:9^NMU_P5@\-75K<VP_X)2?\ !(JV-Q!-!]IM?V:/BQ%=6_G1M'Y]M*?V
MBW$<\6[S(9"C!)%5BK 8+O!'_!93XX^%OA?\#O /BC]FS]AOXT>,/V:O ^E?
M#CX$?'_XV?L[CQS\<?AKX/\ "]]=ZAX!TG1M:/C'3/!%]%\.;FZ$_@P^(/ .
MLFRO(%U;4?[4UJ[U/4K_ /(BBN%Y-EKCRRPRFN937M*M>HTU&</=E.K*45*$
MY1G%-1J)VJ*5E;M6;YBI<T<2X-Q<'[.E1IIKFA-<T84XQE*,Z<)4Y-.5.2O3
M<6W?].?CE_P5=_:&^/[?MWR>,?!/P6TR?_@H?9?LT6GQSN/#/A_Q[:2Z/-^R
MSJ7A[5? NI?#@:O\2=;BT*]\1W?AJQ;QROB"/Q787R37B>&['PMYD)M^"\,_
M'WXJ?M2? _\ 97_X)OZEK7[/7PM^&GPL^*?Q(\7^!OBO\3=?U+X;V6GZ]\4W
MNM5UZ3XL?$G7O$FI>#=)\*VDT1M=(NK;PEHKVDLUO%J6H7OF&9?@.BM(Y;@Z
M5.,,/0IT72G"M0DHN2I5Z6#C@*-51<ES.EA(0H*+=G3BHO74SEF.+JU)3KUZ
ME5583I5TY*+JT*N+>.K4G)1T57%2G6DTKJI)R\C]N?\ @M)^UW'\:]9_8_\
MV8M!^,/A#X]>'_V*_P!F+X??#;QM\8O .I?\)#X/^*?[0VJ^%/"UC\7/&/AK
MQDDB1^.O#MMI/@[X?>$-)\4SV,%[J5WX9UJ]DFF@OH(X/SX_8O\ VQ_B=^PO
M\9I/CE\)-"\!^(O%LO@'Q[\.FT[XBZ9X@U?PZ-$^(F@7'AS6KH6GAGQ1X1U,
M:K:V-P\NESG5S:0701[NQOH08&^3:_JW_P""HO[4WAO]BW]K?PM^S3\ O^"<
MG_!,GQEX?O/@K^SYK^F6?C3]@[X7>-/'?B/Q9\0O ^D7FHV(U+0[31=4U2\U
MC6+CR[**TM_[7EN;O9!<R7+Q,OF5*='+L/@\CHX)8V&)PV.G4C.K3PU.4*52
MC/%2G:'*G6J8QR4(*,8KF5TDCTJ=2KC\1B\ZJXR6"GAL1@H4Y4Z=3$5(SJ0J
MPPL:?OJ35&EA%%SFW*5DW=MG\X'[,'[0WC3]D[]H'X3?M(?#K2_"^M>./@YX
MPT_QMX8TKQK9:MJ/A2^U735E6"WUZQT+6_#FKW6GN)F\V+3]=TNY8A=EW'@Y
M^U/A1_P5F^,WPXT#X[>!_%WP#_9#_:*^%_Q[_:$\1?M2ZQ\*OVCO@YJWQ&\#
M^!/CAXIBN;+6/&WPU@MO'7A[7]#O9]$GA\-A-8U_Q$G_  C]HNG2>8NHZY)J
MW[C>+?V$?@==_ME_MM^#_AI^R-X=T[QY\6/^" 'B7]JC3/V3+#P5IOQ3U#]G
M/]L;Q_J?PKL7\'_!KPNNCZUK7AGQ[X=O9E/A2+PW;1^(],O?%^I6_A Z;H&K
M:7I%O\ _\$=_^"9W[3%O_P %$O@3/^UI_P $_/CI!^S_  :'\>YO'DW[17[*
M7C^/X.PRQ_LW_%U_!\OBZ3XE^ E\%1R1^.U\,/X:?66#)XM&@MI9&L#3S7)5
MS7)L9A<9C<3AZ?/A\!1Q*IUJU*&(K0ITJF,I4J$H5/CA5YX0J4I24ISO"4H2
M5^REE6<83%8/!8;$3Y,1CZV&]I1HU)X>C.I5I82I5KJ5/X)T^24Z=6*<8PM.
M*G'3YP\0?\%M?VL?$_Q]M/VCM7\#?L\GQU9_L7>)OV%+?2M-\!>+-!\$P?!S
MQ-K_ (LU^74[+PQH/Q$TVWTGQEHS^+[W2?#S:+/IO@G2M$T[1[!/!$AM)IKK
MX63]J[XB1_L9W7[#8T;P6?A-=_M.6/[5TGB$Z=KG_"Q%^(FG_"O4?A##HR:L
M/$8\-#P6WAK4Y[Z73F\)-KC:XD-RGB-+!7TR3[H_X)'?#OX3:'J/[6/[<O[0
M_P -/ GQ?^"7["W[/^H^*XOA?\2[#1]<\#_$O]H#XQW-U\,_V?/A[XF\.ZYI
M6N:=JNDZUK<WB?6#-<:1J<>D:EX:TS4VL)S ICU?V_?V5/V?/A+_ ,%2OA]H
MUKK&E>$?V&?VMO%/P#_:5^'OB?0)]-T+1_#/[*W[2'B/3=2\17.C1V-E_9WA
M;1OA_(?B!X>T&U2RFATG1/"NG2F&1%\JNJG/*L/CZF74L#R?5J,*ZJTXWINO
M@HQQ$<+3BI<WUBA0QM/$4X62E"O+E3Y)6Y*D,TQ&!IX^KCN=8BM.A*E4E:HJ
M.,DZ#Q5235O85Z^"G0J3NW&="/,USQOPOPY_X+$?M,_#?Q=X)\06W@']GGQA
MX8\+_L4^!OV!_$_PD^(/P\U_Q;\*OB]\!OA]+JUSH:?%+0+WQS'JNI>+)KK6
M+BYU'5O"VO\ A'2[@QQV\.A6UC-?6MYJ?$7_ (+'?&WQW\$[K]G30?V</V+O
M@M\&C\6?A?\ &[1O _P*^#7B;X;Z;X<^)/POUQ]9@\1VDNG_ !*NKO7[SQE:
MIIWASQG<>.[CQ==3>'M%TBU\-7/AB^M#J,O[A?M)_#WXK_LI_'C4O#WBG_@@
M_P#LH?%;_@EWI_BZX\-:+\2/V?OV=;'XS_&_Q+^S:D+6FE_%BV_:4\+^+M6^
M(&D?$B]\)>1XO76?'U_X4L[GQ$3H-UKUA)<)XL7Y4_X)[>!_!-W^PM_P4W^.
M'[(/["W@']L;QSX)_:W^%NC_ +,G@K]H/]DWPO\ M3_%/2/@?XLU[68([#5/
M!^EZ?XSU:VUFP\"S6.I>+E\)Z_>:+9ZY8W%_)J&I6-N+F;R8XS**E".81RBA
M)>UR_P!A4AC<-.C[7$XJ-&E]8J4JLX8?$X:4U*K[2,G&GS4XU9QC.,?5>%S6
MG7E@'FM>+]GC_;4Y8+$0J^RP^&]K5]A2JTX3KX;$0A:E[.45.:4Y4H2E&4OR
M?LO^"IO[05A_P49U7_@IU#X.^#;?'K6+[Q;?W/A&7P_XV;X0QS>,O@SJ_P #
M=46#0%^(2>,UB@\)ZU=:C8+)X^E:+Q%';W=P]UIJ2:1+^:M?LS^W)\3_ -M*
M;X%SZ#^T/_P26_9^_8N\#^*/%GA[2+'XR>%O^":5U^RQXK;Q+9_;?$MAX1\.
M_%75?#FD^3>:YIWA_5[B_P##^GW37VLZ!IFL PO86U\R?G!^S#X7^ 'C/X[?
M#[PY^U+\3O$OP<^ 5]?:K-\2?B)X-\+7OC/Q5HNDZ;X>UC5;"R\/^'K#3]5F
MN=5\2Z[9:5X5L[V73;ZQT6;6UUO4[6;3=.NT/TF!E0AA9XJ&%ITE1P]/#*&#
MJK'.6%P,*DZ%&DZ$;SE3=:M&G1A%U&Y65W))?.XV->>)AA9XFI5]KB)XARQE
M/ZDHXK'2IQKU:BK22IJHJ-&52M.4::C"[LHMOHD_:N^(D?[&=U^PV-&\%GX3
M7?[3EC^U=)XA.G:Y_P +$7XB:?\ "O4?A##HR:L/$8\-#P6WAK4Y[Z73F\)-
MKC:XD-RGB-+!7TR0?]J[XB2?L9VO[#9T;P6/A-:?M.7W[5T?B$:=KG_"Q&^(
MFH?"O3OA#-HSZL?$9\-'P6OAK3(+Z+3E\)+KBZX\UR_B-[!DTR/]-/\ @LSX
M'_9'\._#_P#X)N^,/V,_@X/A#\)?B9^RYXI\167]NZ?H8^*7CA=+^+?B;P[8
M>,OC!XBT>-F\3>.]9L],%_?37-_J-MHB7B^'M$FBT33;&WC_  OIX!X7'86G
MBHX1T/:8JMB'2JI>UABJ-:IAY5*BA*455O3=TI2BMKNUQ8]8K XJIA98I5G#
M"T</[6DVZ<\-6HTL1&G!SC&3IVJ*S<8MVO97L?JIX(_X*^_M*^!?B1\'/B%:
M> _V??$5E\)?V$]#_P""<^J?#/QK\/-;\5_"_P",W[,NBZEJNLR:!\8_#VK>
M-9M0UG6M<U?4;6^U[4/"&N>"=.OCH>EV,6C6VES:W8:P[XR?\%;OC#\6OV:/
MBS^R%H_[.O[&WP(^ 7Q<UKX>^*]3\$_L]?!C6OAJGA[QM\/_ !*/$)\;Z)J2
M>/\ 5M2UGQ+XQM;30/"OBRY^(ESXZLD\+>%M LO"5AX4U"+4-4U'\J:*O^R,
MM]I"K]3I>TISI5(22DN6I1JNM2J64K.=.HVX3:<DFX)\C<2?[6S'V<Z7UNK[
M.I&I"<?=]Z%6FJ52%^6ZA.FDI0346TI6YTI'[%W?_!;/]I;Q#\:?VI?BU\1/
M@Q^R7\7?#7[8.H?#C6_C#^SW\5_A/XE\;? .3Q-\*/"^B>$O!7BKPMX>U'XC
M#QOX>\0:=IFA6TDU]%\0;A+R]D,\\#)8Z-%I?"_%7_@KO^T?\3O"OCKP#I_P
M\_9V^$/P^\4?L^:U^S#X.\ _!/X;ZQX"\'?!'X1^-OBCX8^+/Q:TKX1:#'XT
MU&RT_5_C3X@\(Z-IWQ.\0^-4\<ZMJV@I<VVC7&@ZA=3:HWY745,<FRN$J<HX
M*@G25%4U9\L/84Z=*DU%OEYX4:4*//;GE1C[*4G3<HMRSC,Y1J1EC:S55U74
MU7-+VU2=6JG*W-R2JU)U>1/DC5DZL8J=I(HHHKTSS3]UO^"\_P#R5'_@G9_V
MB-_8F_\ 27XB5^%-?NM_P7G_ .2H_P#!.S_M$;^Q-_Z2_$2OPIKQ\@_Y$^!_
MZ]S_ /3U0]?/O^1OC?\ '3_],TPHHHKV#R HHHH ***_4S_@B=\/? /Q6_X*
ME?L??#[XH^!_!_Q)\ ^)O'GB.S\2>"/'WAK1?&/A#Q!:0?#?QK?06NN>&O$-
MEJ.BZM;0WUI:WD4%_97$4=U;6]PBB:&-UY\9B(X/"8K%RBYQPN'KXB4(M*4X
MT*4JKBF]$Y*-DWHF]3HPF'EB\7A<)&2A+%8BAAXSDFXQE7JQI*4DM6HN2;2U
MLM#\LZ*_J&_91_:KT_\ :K_X*(>&_P!BSQ'_ ,$K_P#@G+\0?@[XP^-_B#X4
M>/\ _A4/[&G@WX9_$[P;\*6\4WO@[6?BC:?$[P5-9ZGX2E^'FF7%OXKU+6K=
M;(79L&TO39=.UC5-*NK;RCQ[^P WB[_@F?\ 'G0OV0_V<O%7[1_Q'^$G_!;_
M .//P;T3XE?"CX/7'Q<^-EY^S?X#^ .DV?ANVUOQ=\.O"FI^)I/AS<:[<Z3K
M\MLDEKX*?Q;KD.IVME#J&I0-)Y']NQI5H4,9AOJLZGU22D\31J4HTL7*M"$Y
MS7(Z;C*BTXSA%34DZ<I.,U'UO[#E5HSKX3$/$PA]:BXK#5J=657"1HSG"$/?
M512C65I0E)Q<6IQBI0<OYT**_=SX5?L-_$[X+_\ !*3_ (*O_$7]J?\ 8^\>
M?"?X@Z)KG[ 4/P(\=?M ?L_>(? GC+2(M6^.7C;2/BG%\)/$_P 1?"6E:WI\
M>IZ5>^%],\?IX.OHEO-/N] LO$0DMKC3HG^K/^"5/[.O['_A_P#94^$6B_M?
M?#OX9>(O'7_!7GX[_%7]F?X#>/O&FB>&O$/BKX$?#CX<_#+QMX#TKXQ?#"[U
MK1-4NO"'C35_VL?%?A#P"UUIUUHUQ<V]CI6J?VA<QZ5_9LU8C/L-1HXRO"G/
M$QPN-A@HK#SIU'B']1P^8UJE%I\LE0PM6M.4+N4GAJD8ZRBB,/D6(K5L)1G4
MAAGB<'+%REB(3IK#Q>.K9?1A635XNOB:=&$9M*,5B*<I.R;/Y=Z*_:__ ()1
M_LD_#_6O^"BGQ;_9R_:6\!_#SX@?%SX*?#_]HO3OA%\!/B=XS'A?X9?&/]L;
MX/WRZ)X)^$/B_64FL$U;PWJ&N:?XEO;O29+NTL-<BT%8-32]TF2]TJ^^J?VI
M-4\:> _@[^T1\-O^"F__  1C^'/[,-Y>_#34;C]F7]H[]C/]E+P[\(+'P)^T
M%'*8_ 6B^/\ XE>%?&7_  K?QS\+?$5U(VG^+81XJ\4>+-'MHX9[#POXEU'5
M+&XTBJ^=4Z>-C@Z5'V\G3PU5\N(P].I4I8F;C&IA:%6I&IBH4TG.JZ=DE[L/
M:5/<)HY-4J8.6,J5?8Q53$4O>P^(J4Z=3#0C*4,57IPE3PLJCER4E4NW)<TU
M3IVF?S3T5_5)\./#OQG^&O\ P2M_X)A_$#]D;_@E7^SW^VCXU^+FF_MCS?'O
MXA>*O^">%E^UAXQL[SP-^U!XF\/?#2/Q%XOT'PGJ&M:8TOAV;5=(TF+Q+J%R
MUSI'AJTL='$%GH<D2_CE_P %"_&O[2'B;7_ACIG[1_[!/PH_80US1](\2W_A
MOP_\-OV,KC]CN[^(>E:U>Z3;W6L^(-(O='T>Z\<VVA7FB?8M$U$Q36^B2W^M
M6T,BR:A<+5X/-GC,34HQHT80IXG&X9R>-HRQ%\%7K8>4_JBC[11G4HN44Y75
M.49OL3B\J6$P\*TJU:<YX;!8E16#JJA;&T*&(C#ZTY>S<H0KJ,K1UJ0E!:V9
M^=%%?I5^R)^UK^S!^RE\ OBEJFH?LI?#K]I3]L[QG\1/#6D^!M5_:;^''A;X
MK?LT?##X&:=HTU[XCU+3/!&J:_#>:W\8?$?BQH]*(U?PY+HNF^&([/5-,\1V
M-]:ZKX?\2?1'_!73X;?#*P^&/_!.[]H:Q^ /P]_9,_:&_:B_9\\8^.OV@OV<
M_A5IMMX3\ Z):>'?'K>'OA!\7?#_ ,-X=Y^'=O\ ''P?]M\3#PY#(EE91:;!
MIYMFUW3O$&JZMJ\QG#'4L)4PE6G3KU:M##XB4Z356I1PSQ4YJBI.K'#\D9TU
M7:M[:,82C%5:4YY++XSP57%T\72G4P]*E7KX=0JITJ=;$1PT(^V<52E7YYPF
MZ*=U1<IQE)TZD8?B;1117IGFA1110 4444 ?H!_P2C_Y2;?L ?\ 9X'[/?\
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M,TW_ !B45] ?M3>(O'OBKX__ !*UGXH_!#P?^S=\09-7LK#Q7\#_  '\(?\
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MBO0_&OAR&"UTK3])\.^.=-\)6&G1?\(K<LWYE_\ !33]IK]H_P#8?_X)(?\
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ME_0J'_@W&_X+-7$,4\7[&^^*:-)HG_X:%_957='(H=&VM\<59=RL#A@&&<$
MY%?IGHWQP^,O[;G_  ;+?MD^-OVR/%NK?%3Q!^S=^T=\--._9_\ C#\2+ ^*
M/'C72>+_ ((Z9<6,GBW4$F\0>(]9%I\4/&/@V7QM?WMWK\6B>,M0TO6-8O\
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MTMYH98Y&<?IOX?\ ^#G#X?\ BV3X;_$G]K#_ ()-?LL?M)?M5?#:UTFVT?\
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M^&_C6Q@NM<\2^(;W3M%TFVFOKNULXI[^]MXI+JYM[=&,TT:-\J_\,/?MJ?\
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M=I9WVD?SD?\ ##W[:G_1H'[47_A@/BQ_\R5'_##W[:G_ $:!^U%_X8#XL?\
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MJ\,^-])\ >*8[+0_B1I&E-X<A\0:+KUO:^)[#3SHD>HVT5L;!:^\/V>_BE\
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MUW6O /@K1=(\.6_QI^$=Y:W7]I^ /"FH?\)!,"MQI?B3Q3=MKVJVOAK\G?\
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MJ*&%K1@IUJDJDE"/(^6*E)J*N[*RN?+M%?47_##W[:G_ $:!^U%_X8#XL?\
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MX(_X3[_A9'_"(_\ "L?LWA3QOX8_M/\ X17_ (0+Q/\ \)IO_P"$R^W?8O\
MA(_">W^S?LWVMOMGVBU^3_\ AA[]M3_HT#]J+_PP'Q8_^9*C_AA[]M3_ *-
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MEJUR9)[B 2V5S^2O_##W[:G_ $:!^U%_X8#XL?\ S)4?\,/?MJ?]&@?M1?\
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MT4Z5X?TG@?\ AA[]M3_HT#]J+_PP'Q8_^9*C_AA[]M3_ *- _:B_\,!\6/\
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M_##W[:G_ $:!^U%_X8#XL?\ S)4?VA@/^@[!_P#A31_^3\U]X?4,=_T!8O\
M\)JW_P @?+M%?47_  P]^VI_T:!^U%_X8#XL?_,E1_PP]^VI_P!&@?M1?^&
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M_P!&@?M1?^& ^+'_ ,R5']H8#_H.P?\ X4T?_D_-?>'U#'?] 6+_ /":M_\
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MJITE%17NRD?UZ_\ "I?A;_T3KP3_ .$QHW_R'1_PJ7X6_P#1.O!/_A,:-_\
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MR_H$_P"%2_"W_HG7@G_PF-&_^0Z/^%2_"W_HG7@G_P )C1O_ )#K\+OVFO\
M@ISX\\7>)/\ @BA\1OV2_B2_AKX+?MU?M!:=X7^+.@S>%_!/B&]UOPT/&'PM
M\,>*/AYJNI>)?#>M:AX=UOPAKFJ^-?!VN:CX+O\ 1;Q=7M+U[359TM=/NH_E
M7_@KY\5_^"WW[$G_  MW]J;P/^V5\&/#_P"R9<?%/1_#?PO^&FB?#OX;>)_B
MAX;T7Q5O@T2RU=?&O[,D]E<_9)[.[>_N+CXE:[=HDL7DSWARD6> X)S'&XC+
M\)5QV59;BLS6+CA</F5;&4:KQ."S*IE=;!3C1P.(Y<5]9I5'&"<H>RBW*I&:
M=,US#CG+<#ALQQE+ 9MF>$RMX26+Q&64<'6I+#8W+*6:T<;"5?'X;FPGU:O3
MC*;49^UE:-.4/WA_3W_PJ7X6_P#1.O!/_A,:-_\ (='_  J7X6_]$Z\$_P#A
M,:-_\AU^2?[%^K?\%+OV;?A)^T!^TC_P5%_:=^#/QQ^$7A[X(6OQ9\!Z?\+=
M \/Z!K7A:U\,Z#KWC+Q>VN#1_@%\'(Y[O5M#72=/TVU_M/Q.AU."2&U@@:59
MKS\^O^".?_!4C]MKXU_M::%\)/VYO$L=_P"$OVO?@?XH^.?[(M@/!'@'PI'I
M%KX,\=^.;"_\.Z;?>$O"7A?5==LM1\*^#/&NHPS^)[WQ%JBZ3X+T'5DEB'B*
M\NKC+_4_'U*&=XK"8[*L?A<BA1E7KX3$8B5/&.=">)K4\O\ ;82C.O4P.'IU
M:V-52-!4J=.;C*I[O-I_KIE]/$9%A,7@,VP&*S^=:%##XS#X:-3!QA7IX:A5
MS'V.,KPH4\=B*M*C@I4IUW5J5(QG&G[W+_3C_P *E^%O_1.O!/\ X3&C?_(=
M'_"I?A;_ -$Z\$_^$QHW_P AU^%__!7N^_X+$_!C_A;7[4G[)7[6'P8^%?[)
MWPF^$^E^)M:^&NN^#/!GB7XGW.MZ-YZ>*KW1U\6?LY^.[*Z_M)[FP.GVU_\
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M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
M'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_
M  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7
MX6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]
M$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$
M_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A
M,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_
M\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?
M\*E^%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^
M%O\ T3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\
MT3KP3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP
M3_X3&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3
M&C?_ "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_
M "'7H5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7
MH5% 'GO_  J7X6_]$Z\$_P#A,:-_\AT?\*E^%O\ T3KP3_X3&C?_ "'7H5%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7R[X%_Y$CP;_V*OA[_ --%G7U%7R[X%_Y$
MCP;_ -BKX>_]-%G0!Z'\,?[>_P"$4;[$-(^S?\)5\0?*^U&]\_\ Y'_Q/O\
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M]- _/4?\*/\ BJ?30/SU'_"M^B@# _XJGTT#\]1_PH_XJGTT#\]1_P *WZ*
M,#_BJ?30/SU'_"C_ (JGTT#\]1_PK?HH P/^*I]- _/4?\*/^*I]- _/4?\
M"M^B@# _XJGTT#\]1_PH_P"*I]- _/4?\*WZ* .9NI_%%M;7%R4T!Q;P33E
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MH_XJGTT#\]1_PK?HH P/^*I]- _/4?\ "C_BJ?30/SU'_"M^B@# _P"*I]-
M_/4?\*/^*I]- _/4?\*WZ* ,#_BJ?30/SU'_  H_XJGTT#\]1_PK?HH P/\
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M&R_Z]+;_ -$I4>J_\@O4O^O"\_\ 2>2I+#_CQLO^O2V_]$I0!;HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;6.NE?]AFR
M_E-6S6-K'72O^PS9?RFH V:X'XH_%'P%\%O /B7XH?$_Q':^$O ?@^RBU#Q%
MX@N[>_O(K"WGO+;3[8)9:5:7^IWUU>:A>6EC96.G65W?7MY<V]K:6\T\L<;=
M]7 _%'X7> OC3X!\2_"_XG^'+7Q;X#\8646G^(O#]W<7]G%?V\%Y;:A;%+W2
MKNPU.QNK/4+.TOK*^TZ]M+ZRO+:WNK2XAGBCD7IP7U/ZYA/[1^L_V?\ 6:'U
M[ZE[+ZY]3]K#ZU]4]O\ N/K/L.?V'MOW7M>3VGN7//S;^U/[+S+^P_[/_MO^
MS\9_8_\ :WUC^R_[4^KU/[/_ +2^I_[7_9_UOV/USZK_ +1]7]I[#][RE+X0
M_&+X:?'KP%HWQ/\ A'XML/&O@;7_ +6NF:Y8P7]ENFL;J6SO;2\TS5[/3]8T
MJ_M;F%X[C3]5T^RO8AL=[=8Y8G?TNO-/A#\'?AI\!? 6C?##X1^$K#P5X&T#
M[6VF:'8SW][MFOKJ6\O;N\U/5[S4-8U6_NKF9Y+C4-5U"]O91L1[AHXHD3TN
MJQ_U#Z]C/[+^M_V;]9K?4/K_ +'Z]]4]I+ZO]<^K_P"S_6?9<OMO8_NO:<W)
M[MB,E_MG^R,K_P!8O[,_M[ZAA/[:_L7ZU_9']J>PA]>_LOZ]_MOU#ZS[3ZI]
M;_VCV')[;]YS'X\? +5?VE/VH?VAOV_-"U+]M#X\_"3PA^SY^TW#\)_AMX.^
M$W@/]C]](L?"<GPP\#^+6&IZE\6/V6OBMXLU;4AJVOZAB\NO$I'V4PPF$F+S
M&^-/#?\ P4I_:EL8?V4;>^U_6/C)I\W_  4H_:<_8WUGQ%\)_AY\-7UG]L[X
M9_"3PGK]C\,_&>@QZM_97P^\):EXN\9C3H_$7B_P?XJ^&_PNTG4-"US6-1\2
M>&?AY9ZK<V?V7\ O^"<GPT\0?M#?M^?%#]K7]DGX#?$B/XM?M-P^,?@GXL^+
M/P[^#?Q;U?4OAFOPP\#Z-)+ID^JVOBO6_"NF_P#"4:;K:G0-830[UKI9M0_L
MLPW<5U/ZU^TY^S#XKUOXV?\ !,J[^!GPRT#3/A'^R_\ '3Q1KWC'2O"K^#/!
M?AOX9_#J3X)>,/!/AV/0O"CW^AB72K?5M1TO1[+0?!FDZA-I\$B2?V=;Z=;R
MSQ?<+&Y!'&RPL\/EV)HRRVC4C-X3+<+AL/7H\-5G5IQQE!RKXO$8G'SA!^V=
M*5+&1O&-3%*E*G\6\#Q#+ PQ4,1F6&K1S2M3E!8W,\7BL10K\4894JL\%B(Q
MH83#X7+J=2:5%585,%-J4H8656-3L;7_ (*,_!/3?AY^T?XX^*7A'XO?!#7/
MV4M:\(>'_C)\)_B'X6\/ZS\3--U3XEPZ*?A+!X8MOA'XP^*'@OQTOQ9U#Q!I
M>A> Y?!_C768[_7)VT_4VTAXI'6Y8?M_> -$\=>*/AS\?/A'\;_V5O$_AOX(
M>-/VB[:/XRV7PG\3Z7XI^$?PSD9/B;XB\-:[^SE\7/CWH\E]X CDTV[U[POK
M5[HGBJZLM:TR[\.:+KL#7CV?Q9^T7^S)^VW=^,?^"GWCC]GBQU?PUK?QUU7]
MAK4/A1JWAKXI:%\.O&'Q.\&_!SPU%I_QV\$^"O&NG:_!K?PH\7:QI*ZCX0T'
MQ1XDF\%1_;=32ZTSQ%I]B9-?L?)_AU^Q%\0=&_;@\$?'KX8?L ?\*L^$Y^ O
M[5_@+XAQ_M,_'SX??$/XM_&;XL_$C3O">O:1J?[2GC[2/B3^U=XL\0_"[QU>
MRW?@'P]XA7Q/\=?&7AN'3_'DOB3X7^&?"I\&0>,^>EE?#=3#5JL\30A.IA'B
M(4Z>986-2C7CDF68]X2E]9Q=.5)SS&OC,##VF'S2=3V;P\Y8/$86=;$=-7-N
M):6)H4887$3A3Q<<-.I4RO%RI5Z$L\S++_KE1X7!U8U>3+</@\?.-/$Y3"E[
M18FG'&X?%TZ.&_5+X0?MB'XI:MX.@UW]F;]IWX,>$/B+\/\ 5?B7X%^*OQ/\
M-?"S4_AAJ_AK2M.T'7"/$GB7X.?%[XM3?"'5-3\/>(;77-!TSXZ:;\,+C78+
M'6]*TO[3XDT74M#M_*_!?_!3;X.^,_\ A6?BL_"OX_\ A3]G_P"-?Q'B^%7P
M=_:G\7^$_ ^F_!/XA>+M5U>^T#P;]CL++XD:G\;/"/AOXC:WI\NE> ?&OQ*^
M#G@CP?XAN[G2537+=->T-]1^&/AC^QA\9+GQ[\*_!7P&^!'[37_!//\ 9QOO
MA+^TQX8_:=^%GQ+_ &H_!'QJ_9]U&7XV^#KR'0] _9Y^"?@[]HGXZV'ASQ;X
M;^,/BK4_B%I_C/1-!_9QT"Q\.Z/K]K=Z7K%UXR/A%.&^&?[ OQM_X5'^SC^R
M[XZ_9A^+%]KWPC\9?"7PY\1/C9\4O^"@G[0OCW]B74_AM\"]0M+W3/B;\)_V
M>O"'[:6A^/F\>Z_#X1\)WWPW^$FN_ /X9?#3X;^*]2E\_5;;PKX-TO2]>U>5
M<+J56=3%TN6?LK4:&,P3J83#.>90JUVI9Q5H5,=%8;"5%0PV.S.#A53^J\V+
MHT\+FLVXI:HPIX.KS0]JG5KX+&JEB\4H974I45*&34:]+ R>*QM)U\3@,KFI
MT7_M/+@ZL\5^Z7[0VG?'W6/A/XCT7]F77OAWX1^+^M3:-I&A^-?B?:ZMJGAO
MP1I&H:S86WBWQA9^'M)TW4O^$I\7>'_"SZOJ'@?PWK'V+POJGB^+18_%5[_P
MCJZE:7?Q1\.OBC\9OA7_ ,%"M)_8[USX\>*/VH/ _C/]EG7_ (\:]JGQ,\-?
M!W0_BG\$?$?A;XC:9X/T9[G4O@-\+?@_X-O_  !\4['7Y;/2-%\3>")O%5EX
MB\&ZGJNG^,+O1[R70K3ZF_;#\8_M)^!_V>_'NL_LA_"2V^-'[0T]M8Z1\.?"
M6I^(?!?AG0+'4-6O[>SO_%_B*_\ '/B_P3I-WI?A'27OM<CT&WUN*_\ $NJV
MNF: KZ?9:C?:WI/RS^P#\.?$?P7G\1Z;XQ_9A_:MMOC)\9+F#QO^TC^V5^T1
MXE_8_P!9UWXR^/\ 0M(73=&@U>R^#'[5GQA\6>$_!/AO3FD\+?!?X3>$_"C_
M  [^%7A93I5G-#?ZAXB\2^(?#R^-&&2X^MB/[+JJ2Q-##864\OCF<L1.GAV\
M7.I6G'&T<)@XQ4\-##>]C,5*="-*I1>,G3]O,)5IYW@*&'_M6DXO#5\5BX0S
M%Y7'#PJUTL'"G0A+ U\7C9-PQ53%>[@\)&&(E5IUE@X5.8_X*6?M'>+_ ('?
M%;]A#P?;?M/_ /#)7PF^-GQ;^*7A?XV?%G9\![+^R_#GAKX2:QXJ\-+_ ,)3
M^T-\/OB+X#\+>?XNLM+T_P"VW.C+)??VC_9B2&YN;-HN!^ O[6/B'7_VE/CW
M\(_A%^VWX<_;F^"W@S]CJ\^-5Y\4)6_9TUWQ;\(OC2OBZ_T#PKX-LO%?[.'@
M?X:_#/QCX<\7^&K/Q!XEU31M1\#:QXA\%ZGX6TA=9U^'3O&FE:9=^V_MX?#'
MXV:]^T'_ ,$^/C?\)_@MXO\ C=H/[./Q@^+?B_XE^&_ ?BCX0>'/%MMH7C'X
M+^(? 6BW&C1?&;XF_"GPWJTKZ[K-N;FVB\31S6]E#<W#(S+!#/YKJWP/^/'[
M1W[:UI^U3J_[/_B[]FSPM\+?V,_B[\!]-TOXE^+_ ((:E\5OC?XX^+.M/?:;
MX?N+7X&_%#XO>$K'X4?#NTTLZY8W_C+XB:9JDGCKQ81I7@V#3[35/$<OKX1Y
M2\FP<*T<MC4>48^5>O*IE+Q$<?#-L7/"TZV&E1_M>=:K0CAZ5*K2Q,*=*A5I
M5*M*IA*5>%3Q\8LW6=XV=&>:2IK.<OCAZ$*6<+#3R^>48&&+J4<3&O\ V-"A
M2Q$L55JTJN%J5:M>E6ITJM/%U:$Z?RI^QY^V)X"^,'[,'P2^)W[0'_!=/_A5
MWQH\:^!-,UWXC_#W_A8'_!*KP3_PB7B:Z:<7NC_\(GXU_94U/Q7H/V=4C/\
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MOAGH'A'PEI5CIS:SXSU769?%\7A-Y^WQ^TL= \(:KXFUGPYX5\4_LF_\%,/
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MEX//CEOA5H>C6GA[]H63PKXEU'Q5\0M?\1?\)SX&T3QMKWAJWU*\^OOVH?\
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M1:S^+]W^T9HW@OQCXXTP>&?#?C#Q#\!](T*\DU30_$,]W:^#-9L/$LU7XI_
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M>((;#QMXC^'_ ,!?%NC6$&E^(=;TV\U;P]H&J:O;5?B7_P % O G@;Q]\8_
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MPLZ%?^T<5"AAZ%7$4Z<L91GA%";J*==4W3C.-2%'$T:-/V:BBBOECZL****
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M2_%'CRX\*Z0GA_PO/XSU^QLH-6\43>&]!CCT309=<N[Y]'TA$TW3VM[-5A'
M>+OV:?V<OB!K7C'Q'X\^ 'P3\;>(?B+X9T[P5\0=>\7?"KP+XDUKQUX-TC4M
M+UC2?"7C'5-9T&]OO$_AG3-7T/1-5T[0=;GOM*LM2T?2[ZVM(KG3[26'[JEQ
M=2GB,JECL-7KX?)'PW6RM0E2C5PE?)\/EF&S"G%M*,L+FD<%.I.,G[2G7AA:
MO,U"M"I\%6X.K0P^;+ 8JC0Q&>1XEH9JYQJRHXNAG.)S/$Y=5DE)RAB\JEC8
M4H2BO9U,//%TG&\Z,Z7X]Z:?V3D_X*L?\%%T_;B3X+KK$_PE_9BG_9Y?]IF'
MP5_PBK_LVQ?"N[A^+3?#N;XCI_PCHT3_ (7$?%2?$%+1Q++<1Q_;%>SM[TQ_
MEG\+O WP.\>?L5_L5_#SPEH]KXJ_9O\ $_\ P<2ZKX9\):!K$,AT[Q'\&;^/
MX]67AK2-:LA,1=:9J_@Q["SU;2[B2:TO[&XN=/ODN;2>>*7^N/XH_ /X%?'
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M>H>+$\0>#KR[NJO@WXS_ ++5KX@_X(>^._A<= ^!'P!^%OB+]J'X$^(?#_Q
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M,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\
M&@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1
M/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-
M'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?
M]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/
M,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\
M&@!]%,\R/_GHG_?2_P"-'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1
M/^^E_P : 'T4SS(_^>B?]]+_ (T>9'_ST3_OI?\ &@!]%,\R/_GHG_?2_P"-
M'F1_\]$_[Z7_ !H ?13/,C_YZ)_WTO\ C1YD?_/1/^^E_P : 'T4SS(_^>B?
M]]+_ (T>9'_ST3_OI?\ &@#\@O\ @M!_R;E\-_\ LMFD_P#J">/:_FGK^SK]
MICX0?#;XY:=\./!7Q0\/KXI\,#X@6>J'31K&N:+B]CTS4=.2<WOAW5-)U !;
M/4[Z'RS=^2?/\PQF6.%X_)/^'9'[#'_1%$_\.9\7?_G@5_6?@_X\<(>'_!E#
MAW.<NXDQ.-I9AC\7*KEF#RRMA73Q52$J<5/%9Q@JW/%1?.G044[<LI;G^7GT
MKOH3^*GCIXNXSC[A+B#P^R[)\1D6297##<1YKQ'A,S6(RVA5IUYSHY9PIF^%
M5&<IITI+&2G))\].F[)_R045_6__ ,.R/V&/^B*)_P"',^+O_P \"C_AV1^P
MQ_T11/\ PYGQ=_\ G@5^H_\ $UWAW_T)N-/_  W9'_\ 1&?S9_Q3$\>_^BN\
M(?\ P_\ &?\ ] !_)!17];__  [(_88_Z(HG_AS/B[_\\"C_ (=D?L,?]$43
M_P .9\7?_G@4?\37>'?_ $)N-/\ PW9'_P#1&'_%,3Q[_P"BN\(?_#_QG_\
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M_P"'9'[#'_1%$_\ #F?%W_YX%'_$UWAW_P!";C3_ ,-V1_\ T1A_Q3$\>_\
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M .'_ (S_ /H /Y(**_K?_P"'9'[#'_1%$_\ #F?%W_YX%'_#LC]AC_HBB?\
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M  YGQ=_^>!1_Q-=X=_\ 0FXT_P##=D?_ -$8?\4Q/'O_ **[PA_\/_&?_P!
M!_)!17];_P#P[(_88_Z(HG_AS/B[_P#/ H_X=D?L,?\ 1%$_\.9\7?\ YX%'
M_$UWAW_T)N-/_#=D?_T1A_Q3$\>_^BN\(?\ P_\ &?\ ] !_)!17];__  [(
M_88_Z(HG_AS/B[_\\"C_ (=D?L,?]$43_P .9\7?_G@4?\37>'?_ $)N-/\
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M+;+_ .,UKT4 9'_"/Z#_ - 32/\ P6V7_P 9H_X1_0?^@)I'_@MLO_C-:]%
M&1_PC^@_] 32/_!;9?\ QFC_ (1_0?\ H":1_P""VR_^,UKT4 9'_"/Z#_T!
M-(_\%ME_\9H_X1_0?^@)I'_@MLO_ (S6O10!D?\ "/Z#_P! 32/_  6V7_QF
MC_A']!_Z FD?^"VR_P#C-:]% &1_PC^@_P#0$TC_ ,%ME_\ &:/^$?T'_H":
M1_X+;+_XS6O10!D?\(_H/_0$TC_P6V7_ ,9H_P"$?T'_ * FD?\ @MLO_C-:
M]% &1_PC^@_] 32/_!;9?_&:/^$?T'_H":1_X+;+_P",UKT4 9'_  C^@_\
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M#(_X1_0?^@)I'_@MLO\ XS1_PC^@_P#0$TC_ ,%ME_\ &:UZ* ,C_A']!_Z
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M%4:N&I*]ZF(I5*,+U(2BO4?^$?T'_H":1_X+;+_XS1_PC^@_] 32/_!;9?\
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M+_A']!_Z FD?^"VR_P#C-'_"/Z#_ - 32/\ P6V7_P 9KR?XS_M%_"7X!?\
M"(0?$C6_$"ZY\0=4U/2/ O@KP%\._B1\8?B3XQN]#TJ;7/$$WACX7_"#PEXZ
M^(FN:7X:TB'^T/$^MZ;X8N=%\-6UQ8OKNH:?_:.GBY\+\0_\%(OV,/"GP_\
M!WQ-\1?&*;2O#'COXE^+_@MX>M+CX:?%P^-_^%R>!(M;D\4?"/7_ (81> I/
MB7X/^*-C-X?U#3;7X?>+_"6A>+M9UR;1_#^AZ/J.N>(_#VGZHJ.69EB(4ZF'
MR_'5Z=:3A1J4<)7JPJS2J-PIRA3E&<DJ-9N,6VE2J77N2M5;-,LPTZM/$9C@
M:%2A%3K0K8O#TIT82=)1G5C.I&5.+=>BE*:2;K4DG>I"_P!F?\(_H/\ T!-(
M_P#!;9?_ !FC_A']!_Z FD?^"VR_^,U\Z^#?VS_V9_&_@CXK_$.R^)UOX7\.
M? BX:V^-</Q6\+^-O@EXK^$TAT>V\06C_$3P!\8_#7@7Q[X0M=7T6\M]3\/W
MNN^&K&S\26DGF:!/J01PM/X5_ML_LX?&/5/$&@>$/%WBO2_$OAOX<P?&"[\)
M_$_X.?&KX(>,=5^%%Q<7%E_PLOP?X0^-/P\\ >)O'W@.VOX$TW4?%G@;2O$6
MAZ7JE_HNEZE?6FH:]HEMJ"EEN8QC6E++\;&.'<5B)2PM=1H.<82@JS=.U)SC
M4IRBI\KE&<&KJ4;D<SRV4J,8YC@92Q*D\/&.+P[E74)3A-T4JC=50E3J1DX<
MRC*G-.SC)+Z6_P"$?T'_ * FD?\ @MLO_C-'_"/Z#_T!-(_\%ME_\9KXK^&'
M_!2K]C#XQ:I\+].^'_Q6UO5+#XUZG!H'PE\;:M\&_CGX0^%'Q"\5SZ!=>(QX
M&\+?&7QE\-= ^$VJ?$*"RL-3L+[X>P>-#XVTWQ/I&L^"]0T&V\8:/JFA6F[>
M?\%!?V3;#QLW@>Z^(OB!)$^)L/P8D\?I\'OC;/\  B+XL3WL>DCX>2_M)0?#
MF7]GR+Q;%K\J^%;O1I/B:MY8^,EF\&WL<'BF"?2(]99-F\)RI3RK,H5(0=2=
M.6!Q49QIJ<J;G*#I*48*<)P<FE%3A*+=XM+*.=9/.G&M#-LLG2G-4H58X_"R
MIRJ.$*BIQFJKC*;IU(5%!-R<)PDERR3?UO\ \(_H/_0$TC_P6V7_ ,9H_P"$
M?T'_ * FD?\ @MLO_C-?*?Q/_;X_93^#WC7Q1X"\=_$G5;;5_ ">$W^*&M>&
M_A=\7O'_ ,.O@U_PF]W+:>&8_CE\6_A_X"\3_"OX'SZA'&FKS6WQ:\9>#;C3
M/#%WIOB[5HK'POJNF:Q=Z/Q&_;@_9J^%GQ3T?X)^)O&GB;5/BKK_ ,/M!^+.
ME>"?AQ\(/C1\8M7N?A=XDUOQ)X=T[XBO_P *B^'OCBUM/!$&L^$]8LM<\47E
MS;Z+X79]%F\37ND6_B?PS-J\1RK-)^S<,MQ\E5IRK4N7!XB7M:,(TYRJT[4W
MSTXPK49RJ1O&,:M.3:4XMW+-LJBZBEF>7Q=&K&C64L;ADZ5:<ZE.%&HG47)5
ME.E5A&G*TY3I5(I-PDE]-_\ "/Z#_P! 32/_  6V7_QFC_A']!_Z FD?^"VR
M_P#C-?)$W_!0?]D2#XA7?PW?XK737]A\38?@K?\ CF'X;?%BX^!%C\89].M=
M03X67O[2MOX%E_9XM/B&DE[:Z'<>#;CXH1^(+7QC,O@6ZT^'QH&T$8O[2W[?
MGP%_9^MOB_X7N/&%YJ'Q4^%GP\7Q9X@T_1_A=\7?B-X$^&>I^)M%U>^^&D7Q
M[\?_  X\(ZQX$^"FF^+[G3H[VT_X6KXV^'[W7AF0>(H[RUT.>WU@W#)\UJ5J
M-".6XY5:\(U*4983$)SI2G3IJM%>SNZ//5I1=5)P3J05[RBG%3.<IIT:U>69
MX#V5"<J56:QF&:A6C"I4="3]K95N2E4DJ3:FU3F[6C)K[1_X1_0?^@)I'_@M
MLO\ XS1_PC^@_P#0$TC_ ,%ME_\ &:\"_9H^-VK_ !7_ &/?V?\ ]H_Q]IL-
MKKWQ*_9J^%/QN\::/X \-^*-:M[?5_&7POT'QWXCTWP3X0TYO%OC35H8;S4;
MRU\-^&[%O$WBB_1;+3+9M:U:5#<_$W[-/_!6;X+^/_V;OA9\:/V@)/$WPI\4
M?%[XP?%'X2^"O">E_ /]I"^B\6^)?#_CCXCQ>!?!OP\B'PXUG4_B;XLU+X?^
M$M+M=2D\%IJ4&J_%%]1\!Z?I>C>.+BV^'UC4,ES.JL6Z&$K8GZCC(8&O'#4Y
MUY+$5(XN<5&%.,I3@HX*NY32M%*'-;GC>)YYE=)X+V^,HX98_!3S##RQ-2%"
M#PU.6#@W.=648PFYX[#QC!OFFW-1OR2M^JW_  C^@_\ 0$TC_P %ME_\9H_X
M1_0?^@)I'_@MLO\ XS7QCX4_;B^!M[>_M(>+?$OQQ\-Z)\-O@7X.^#/C?Q3H
M/C3X'?&3X'^-_@]H7Q2\,ZKK6@3?$35_BQ<6+^.M5^)#6<-QX)\*>%OAQX-\
M4^')OLWA/6-+\3^(_$&C,8]9_;Q^$6N^#/C_ &WPPU'Q3I_QK^#O[/OC/X\6
M/PN^.WP.^._P$\2ZQX:T/2O$4>E^+=-\$_&[P-\)O%GCCP#;^+-%@\/>*M>\
M#K?:?X?U#4=)TG6=8T/4O$6@"^7]CYGS\OU+%VB\.JE26%Q-.E1EB*>'J4U6
MG4HP]E:.*H-RDE"4:E.I3E4I5*52=_VSE?*I?7\'S26(=*G'%X6I5KQPU3$4
MJDJ$*5:;J^_A:Z487G&5.I3J1IU:=6G#[2_X1_0?^@)I'_@MLO\ XS1_PC^@
M_P#0$TC_ ,%ME_\ &:\5_9,^*WB+X\?LK_LT?''Q?9:+IWBSXR_L_?!KXK>*
M-/\ #=O?6?AVP\1?$3X<^&_%^M66@VFIZCK&I6NBVNI:Q<P:7;ZAJVJ7T%C'
M!%=ZC?7"R7,OT#7#7HSP]>MAZEE4H5:E&HD[I3I3<)V?5<T79]5J=N'KT\30
MH8FDVZ6(HTZ]-R7+)TZL(U(-KH^62NNCT,C_ (1_0?\ H":1_P""VR_^,T?\
M(_H/_0$TC_P6V7_QFM>BLC8R/^$?T'_H":1_X+;+_P",T?\ "/Z#_P! 32/_
M  6V7_QFM>B@#(_X1_0?^@)I'_@MLO\ XS1_PC^@_P#0$TC_ ,%ME_\ &:UZ
M* ,C_A']!_Z FD?^"VR_^,T?\(_H/_0$TC_P6V7_ ,9K7HH R/\ A']!_P"@
M)I'_ (+;+_XS7SIX%_Y$CP;_ -BKX>_]-%G7U%7R[X%_Y$CP;_V*OA[_ --%
MG0!ZU\)_^1,7_L:OB'_ZL+Q37I%>;_"?_D3%_P"QJ^(?_JPO%->D4 %%%% !
M1110 4444 %%%% '):1X_P# >O\ BSQAX!T'QMX1UOQU\/8?#=QX^\%Z1XDT
M;4O%G@>W\96=[J/A"?QAX<L[V;6/#4/BK3].U"^\-RZU9V2:Y9V%[<Z8UU#:
MSO'UM?@UIWQBUC]GO]M7_@O9\<?#_@;5/B7K?PH^ 7["'CS2_ FC&5;[Q->^
M'/@/\;M2@T[S+>"ZN;>R+P";5+JUM+RZM-,AO+FVLKR>*.VE]#_87_;A_:L_
M:1^(OPQDU7Q=_P $^/V@/@I\0?"WB75O'>L?LE?$?Q%IGQ._9KURQT"/6_#>
MD?$SP%\3?'NM^(_%]KKNI/'X.>X\.^%_#NIV.I7*>(=5T;2/#\<+7WTV)X9Q
M5.A5QE"I2>#H8#*\54JXBK"E*5?'9)@LXK8>FO@4H+%2AAXU94Y8IQC2P_ML
M0W3/E\-Q1A)UZ.#KTZJQN(Q^:X6E2P]*=:*H8#/<9DU+$5/M\M26&C4Q$J4:
MD<*I3JXCV.'2JGZY>!_B%X!^)VAMXF^&WCCP?\0O#::IJ^AOXA\#^)M%\6:&
MNM:!J$^DZ]H[:MH-[?V"ZIHFJ6MSINKZ>;@7>FZA;SV=Y##<121KV%?RP?L?
M_MH^-/V:?V.O@/\ !CX.:?\ "27X[_M2?ME_MU:-X%\1_M >)[[PC\#_ (?>
M%?A=\7/%'BCXC^/?B%J>E75AJ]_;:58ZMHFEZ+X;TG4]+U+7]:UNTM;*^-RD
M5C??2/CS]NC]IOQM\*OV]OV5/$?BG]DV[_:5\"?L:^*?VC/AA\:OV?-;\;>(
MO@IXR^"\<]WX4^+*-H,/CR_\>?#OXP>!X))M-\*I<>-=4L'\2>(?"?B^ZMCX
M>LI=,UOLQ/!N.IXRO2HU*7U2&-JT*56M4BJ\L'2S'^S*F82H03;H4L2IQJJ+
M]K:E6J0IRI4:E2/'A.-<!5P6'JUJ=7ZY4P-&O5HT*<G0CC:V6K-*>71K3:M7
MK8:4)4G)>RO5H4YU8UJU.G+^@ZO,_BC\:O@W\#]%M_$GQJ^+7PR^$'AV\N39
MVFO_ !1\>>%OA_HMU=JJNUK;ZKXLU72;&>Y",K&"*=I0K*Q7!!/Q[_P2C?XR
M3?\ !/7]DJZ^-&K_  ^UK4+[]GWX(7W@*[\ :9XITUX_A7=?![P'-X(MO'LG
MBO7M?GUCXFPVC7)\9Z[HTNF>'-4OWCN-(T338_,B;Y&_8V^%'@+]K[]L?_@H
MG^TA^T=X8\)?%WQ1\$?VH]:_9!^!GA/Q]86/B_1/@S\,/A+X4\,ZK=ZAX/\
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M#_T(?P$_\)?XA_\ STJ_(ZBOVK_B#'A;_P!$3DO_ (*K?_+C^0/^)NOI*?\
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M@_XFZ^DI_P!'BXO_ /"G"?\ S(?KC_P^<_:A_P"A#^ G_A+_ !#_ /GI4?\
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M/_"7^(?_ ,]*OR.HH_X@QX6_]$3DO_@JM_\ +@_XFZ^DI_T>+B__ ,*<)_\
M,A^N/_#YS]J'_H0_@)_X2_Q#_P#GI4?\/G/VH?\ H0_@)_X2_P 0_P#YZ5?D
M=11_Q!CPM_Z(G)?_  56_P#EP?\ $W7TE/\ H\7%_P#X4X3_ .9#]<?^'SG[
M4/\ T(?P$_\ "7^(?_STJ/\ A\Y^U#_T(?P$_P#"7^(?_P ]*OR.HH_X@QX6
M_P#1$Y+_ ."JW_RX/^)NOI*?]'BXO_\ "G"?_,A^L]K_ ,%D?VG;19UC\"_
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M !#_ /GI5^1U%'_$&/"W_HB<E_\ !5;_ .7!_P 3=?24_P"CQ<7_ /A3A/\
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M=3\43Z3XMCL/%T&NZ78_EKK7P"^-US\9?%NI'X*_%2XTJX_X.'_@G\;[6_\
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MGCVOYIZ_I8_X+0?\FY?#?_LMFD_^H)X]K^:>O]'OHR_\FMPG_8ZSC_T]3/\
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M3PIX@^%-WJUKX^M=7M$\.KHJ2SWM[>SRI&FG&TBS]NM[XD07-G(K13Q,P<
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MHH **** "L;6.NE?]AFR_E-6S6-K'72O^PS9?RFH V:**\#_ &HO@;_PTI\
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M5J5*TZ%ZKA64:--P^H?VA_VK?^%"_&_]CSX-_P#"!?\ "5_\-8_%#QC\-O\
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M4:*HP_H=\"?M1?LS?%+PMXU\<_#']HGX%?$;P3\-K&;4_B+XQ\"?%SP!XO\
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M<+_\@T?;-<_Z EM_X.%_^0: /SF_X*D_![XC?'#X.?#?P5\+O#O_  D_B?\
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MA_\ F_K^L?[9KG_0$MO_  <+_P#(-'VS7/\ H"6W_@X7_P"0:^Q_XFN\1/\
MH3<%_P#ANSS_ .B,_)_^*8G@)_T5WB]_X?\ @S_Z #^3C_AV)^W'_P!$0_\
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MN\1/^A-P7_X;L\_^B,/^*8G@)_T5WB]_X?\ @S_Z #^3C_AV)^W'_P!$0_\
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M;_P<+_\ (-'_ !-=XB?]";@O_P -V>?_ $1A_P 4Q/ 3_HKO%[_P_P#!G_T
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M(A_YDKX0_P#S?T?\.Q/VX_\ HB'_ )DKX0__ #?U_6/]LUS_ * EM_X.%_\
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MUS_H"6W_ (.%_P#D&@#;HK$^V:Y_T!+;_P '"_\ R#1]LUS_ * EM_X.%_\
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M_D&C[9KG_0$MO_!PO_R#0!MT5B?;-<_Z EM_X.%_^0:/MFN?] 2V_P#!PO\
M\@T ;=%8GVS7/^@);?\ @X7_ .0:/MFN?] 2V_\ !PO_ ,@T ;=%8GVS7/\
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M-"+N95:%&M*A.K3C.6&J^WH2EO2K>RJT/:1[2]E6JT^ONSDC;HK$^V:Y_P!
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M ,B8O_8U?$/_ -6%XIKTB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)I-PDX<LDKQ;/>Z*\$_X:K_9>_Z.1^ G_AX?AY_\T5'_  U7^R]_T<C\!/\
MP\/P\_\ FBKH_P!6^(O^A!G7_AKQW_R@X/\ B(/ 7_1;\(?^)+DW_P VGO=%
M>"?\-5_LO?\ 1R/P$_\ #P_#S_YHJ/\ AJO]E[_HY'X"?^'A^'G_ ,T5'^K?
M$7_0@SK_ ,->._\ E ?\1!X"_P"BWX0_\27)O_FT][HKP3_AJO\ 9>_Z.1^
MG_AX?AY_\T5'_#5?[+W_ $<C\!/_  \/P\_^:*C_ %;XB_Z$&=?^&O'?_* _
MXB#P%_T6_"'_ (DN3?\ S:>]T5X)_P -5_LO?]'(_ 3_ ,/#\//_ )HJ/^&J
M_P!E[_HY'X"?^'A^'G_S14?ZM\1?]"#.O_#7CO\ Y0'_ !$'@+_HM^$/_$ER
M;_YM/>Z*\$_X:K_9>_Z.1^ G_AX?AY_\T5'_  U7^R]_T<C\!/\ P\/P\_\
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MLOY34 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU?[.RK,<7*670P]"/MJ>#E&M+%PE*&'I4JE0_K;HK^2CP=X*\7?M3'_@A?\
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M -/4S_GZ_:+?\I*9I_V2'"?_ *B5PHHHK^@C^% HHHH **** "BBB@ HHHH
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M^V?[=_LK^Q?[2_X1?^T_MO\ HW_"6?V'_P )A_8?_%-?V]_PCG_$JKQKX_\
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M J2I:*QB8W%P1A58_8L_8L\9?M6^,EDD6[T#X6:!=PMXO\7M"0) "'.A:$7
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M% !1110 4444 %%%% !7R[X%_P"1(\&_]BKX>_\ 319U]15\N^!?^1(\&_\
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MHU[_ .3Z /?J*\!_X9F^$W_0+UK_ ,*C7O\ Y/H_X9F^$W_0+UK_ ,*C7O\
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M*<\_^;@_XE]\!/\ HR'A#_XK7@S_ .<IX/\ \.Q/V'/^B(?^9*^+W_S?T?\
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M^R3\/= M_B#\?O&_[;"Z%J'P*\-_ ;2?"GB.]U'PCXEFTZ#0_B#XEG\9>-/
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MF$Z>%Q3G@85*.)AB*E\+5A.6'<GK\U> /^#F/]A'XC:9\3M5T3X3?M;6MO\
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MTITLKP><X/FY\5#-LYPV)JT_JU2[C]5P%:&!I5Y.5YQS&,US*E)Q_I<^$O\
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M+$)7]C&)Y>6<<9UC<SP638CZOAL3C^),XPF#Q*PRG3Q62X2GGF'A.,.=)8K
M9EEM&.*CSP=2A6PSLO;RDO6_^(K+_@GE_P!$;_;._P##>? __P"B)K],?$O_
M  5C_9D\(?\ !/KPQ_P4A\0:+\5;#X*>,Y+&T\,>"WT'P@WQ?UG5-0\=:EX#
MAT:TT!?'9\'MJ27.C:QXAG1O'BVT?AC2[V^-R;Z(:8WY_?'S_E9P_8D_[,!\
M6?\ IQ_:ZKY,_P"#@W]MGX,>%_VR/V"_V=/B]!XQ\2_!3X'>/-$_:L_:*\)_
M#^#3=8U_Q+<0WLMA\-/!MMI&M>(O"&B+>RZ1I?B^'6IKWQ%97MOX6^(D=YI5
MU97*"+4YI\.9!FV9\-8#*\CS&@LQRN/$>826;2QM19?2681JY;2IRP=!*M7J
MX2C2I8Q3BU5Q$:?L%?G5U.)>(<GRSB?,,US[+<0\MS67#>71EE$<#3>8UO[-
ME1S.M4CC:[=##TL97JUL%R2O2P\ZGUAV]F?TH?L=_M:_"C]N']GOP-^TG\&/
M^$@@\#>.FU^VMM'\7VFDZ;XQ\/:GX9\0ZGX:U?1O%.DZ)K?B+3],U2&]TN2[
MAA@UB^AN](O-,U6VGEL]1MI7_#N]_P"#JC_@GM8WEW92_!S]LMI;.YGM96C^
M'OP1,;26\KPNT9;]H=&*%D)4LBL5P2JG('SC_P &XO[8OPCU;]H7]MK]DKX3
MCQ1H/P1\8>-?$'[3?[,'A;Q]!HVB^)?#GAB?6++PYXR\$7FF:-K?B+0_[4TW
M1=0^'SVECH6MW:3V'AKQ#KH@$;7_ -@^M?\ @M5_R?W_ ,$(/^SSM3_]6'^S
M-6-'AG)LNXQS#A[-LJQV)PU?#U\PRJ?]H2P5;"X.CE>,S:-&O&.&K_6:LXTH
M8&K/GI>PK4:U11JWY%O6XGSO,N#,MXCRC-L!AL30Q-#+<VI_V=''4,7C*V;8
M+*)5L/.6*H/"TH2JU,?2AR5G7H5Z--RHM*H>_?LY_P#!?#]C[]ISQ_\  'X<
M^ OAO^TII&M_M&?$3QM\,_!%UXO\'_"^PTK2]>\!:'X:U_6+OQ5/HWQCU^[L
M=(N;/Q5I\6FSZ18ZY>37,-XEU86<4<$UQU7[<?\ P75_85_8-^)Z_!?XA7WQ
M-^*?Q0L(WD\9^$O@;X8\-^)KCX<&6TTZ_P!)MO&NK>,O&OP_\.V^J:W::@;B
MTT/0=8U_6]-@M))_$NG:%#?Z')JWR'_P4K_Y3@_\$;?^ZC_^C[JN-_X-^_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_A*="_Y_6_\  .^_^1J .@HKG_\ A*="_P"?UO\ P#OO_D:C_A*="_Y_6_\
M .^_^1J .@HKG_\ A*="_P"?UO\ P#OO_D:C_A*="_Y_6_\  .^_^1J /C;]
MO#]@'X5_\%#? ?@CX7?&OX@?&;PS\./"'C6V\=:GX-^%/B?PQX7TKXB:I80_
M9M+L?']QK/@GQ3K%]HVE0S:B;"RT#4_#DD=UJD^I27,NJ6&A7ND<G^UI_P $
MP_V<?VME_9RO=4O_ (A_ [Q?^R?K6CZI\"OB%^SWJGA#P7XR\$V'A^+31H?A
M6SNO$W@CQQH[>%='O=#T#5M)TS^Q4FTK4-%MCIMY:6=[K5GJGWK_ ,)3H7_/
MZW_@'??_ "-1_P )3H7_ #^M_P" =]_\C5ZN&SO-L''!PPN.KT(8"6*GA(4Y
M)0HRQL/9XN7)R\LWB*:5.K[13YJ25-^XE$\G$Y'E&,EC9XK 8>O/,(X2&,G4
MBW.M' S]I@XN?-S06&J7JTE3<.2JW47OMR?X9?M1?\&[7[%O[7'Q[^(W[1GQ
M.^*W[5&F^//BCJ>G:OXDL_!OC3X0:7X:CO=.T'2?#R/I>GZM\#==O[5+BUT>
MWN+B.;5;I?MDMPT @MFAMH>I^"7_  0'_8Z^ OP2_:C^ W@_XD_M+ZEX0_:V
M\*^!?"'Q'U+Q)XQ^%MYXDT33?A_XAU#Q)HT_@B\TOX-Z/I>FWUS?:E/%J<NO
M:/XDMYK1(8[6VLIE>>3]I/\ A*="_P"?UO\ P#OO_D:C_A*="_Y_6_\  .^_
M^1J]%\9<4/"4<"\ZQGU/#K"*AA^:'LZ2P%2C5P?(N2Z^KU,/1G3UT=.-[ZW\
MV/!7"L<96QZR/!+&8AXMU\1RS]I5>/IU:.,<FYV;Q%.O6A4=M54E:S=SX$^,
MO_!+K]FGX\?L-?#C]@/XA7/Q#OOA/\)-%^'&E_#[QK9ZWX;M_BSX<U#X8:9_
M8.A>*;/7)?!]SX1/B34/#=QK7AS7)Y/ [:9=Z/XDUR&TTJPGGM+FRM^./^"7
M7[)'Q2_8V^&O[$'Q3\*:Y\1?A9\'_"&F>%OAMXK\0ZO:VGQ6\(WNBZ1+H^E>
M,M'\8>&=*\/VMGXIMX9%FNXX-#3PKKAB2P\1>%]7T1[C2IOO#_A*="_Y_6_\
M [[_ .1J/^$IT+_G];_P#OO_ )&KSXY]G,(THPS+&4U0Q]7-*+IUI0E1S"LN
M6KBJ4X<LJ=6HK\W(U%WDW&\FWZ$N'\DG*K*>5X.HZ^7TLJK^THQJ1K9=1:E2
MPE:,U*-6E3:7(IJ4E:*4K127X=?LQ?\ !N;_ ,$[OV9/BSH7QAAC^,_QOU_P
MG-:ZGX2T'XZ^,?!^N^#/#OB?3M3L-3TOQ;%X?\!_#OX=)KFL:8]D\%E8^+KG
MQ%X71+V>\E\.S:O:Z3J6F_K=^TY^SUX+_:N^ ?Q/_9U^(FI^*-&\$_%GPV_A
M?Q'JG@N]TG3O%-EI[WMI?&;1+W7-%\1Z3;7@FLHE$E]HFI0^6T@-N6*NGJ__
M  E.A?\ /ZW_ (!WW_R-1_PE.A?\_K?^ =]_\C56.X@SO,L;ALPQ^9XO%XS!
MRIRPM>M5<Y8>5*<:D'1B_<IM5(QF^6*YIKFES/4G <.Y'E>"Q.79?E>#PF"Q
MD:D,70HTE".)C5INE-5Y?'4O3DX+GD^6+<8V1\8^*?\ @GK\%_%W[!%K_P $
MZ]2\3_$^#X)VGPX\'_#"/Q18ZUX4B^*3:!X)UK1-=TJ\?6Y_!5SX2.L7%WH%
MG'J%PO@A;*6VEN4MM/M)7BFAW/BG^P5\!/C/^Q;I'["?Q%M/$7B#X/\ A_X7
M>!/A?X?UZXN]#_X6-H4?PUT#2M \&^.M(UYO#KZ)8>/])CT>UO\ ^U8/#"Z/
M=74M_97>@3:!J-]HL_UE_P )3H7_ #^M_P" =]_\C4?\)3H7_/ZW_@'??_(U
M8K.,SC*$HXVO&5+,9YM3E&7+*&95/9\^,C**35:7LJ=Y)V]Q62-WDV52C.$L
M#AYPJ9;#**D9PYHSRRG[3DP4HR;4J$?:U+1:O[SNS\ROA!_P2-^!7PJ^./[-
M7Q_UCXR?M*?&OQM^R5\(KSX*_!.S^-/B[X:^(?#OA_PC,_C)--N[VR\,?"3P
M;J.J^)/#NF>-]2T+0=;N=6$]KH^F>&;:XCO)O#NEW,'N7[9W[ 7P>_;?OO@%
MKWQ%\4?$_P  ^,_V:/BE9?%SX3>/?A'K?A?0?%NA^);.;3+W[))>^*_!OC:Q
M;1KG5=!\-ZS<P6FG66H-J?AO1Y8=3AAAN(+G[#_X2G0O^?UO_ .^_P#D:C_A
M*="_Y_6_\ [[_P"1JUGGV<5,9A\PECZSQF%I5*.'K+DBZ-&JZ\JM*$(P5-0J
MO%8AU(\EI^VJ<R?,S*'#^34\%B,NCE]%8/%U:5?$T7SR5:M0CAXT:M2<IRJ2
MJ4HX3#*G/GYH>PI\K7*CY#^ ?[!/P?\ V=/VF/VH/VJO!/B3XE:I\0OVL]1T
M74_B-HWBG6/"]]X,T6XT*YO[FT3P5IVD^#M#UO3H9)-1G%RNN^(O$CNB1"*2
M%E=G\:_9:_X)%?LB?LB?$/\ ::\<_"^Q\:ZGH?[5FCZKX9^(GPC\<:CX3\0?
M"72?".M:GK&H:CX/\)>'[;P7I6M6_AF>#7;_ $9M+\2^)/%$9T-H]/9V"M(_
MZ0_\)3H7_/ZW_@'??_(U'_"4Z%_S^M_X!WW_ ,C4GGN;N.*B\PQ/+C</@L+B
MHJI95Z&7*G' TYI)76%5&FJ,E:<%'27O2NUD&31EA)++<+S8'$8W%X23IW=#
M$9DZDL?4IMMM/%RJU'7B[QFY:QTC;^>J^_X-=O\ @FK=_$"3QE;ZY^TUIGAQ
M_%,?B!?A-8_%+PI)\/X=)CU%+YO \>I:E\,]1^*A\+36R-H\EW-\2Y?&HTZ5
MY8?&$6KB/5(_TQ\9?\$T_P!F_P 5?&3]C7XRZ6OC/X>7/["ND:CH'P-^'WP_
MU#PQI7PW31-0LK+3QIOBG2=5\(ZYK^I06-M80+:2:3XGT&ZDE::XU"XOKB9Y
M3]R?\)3H7_/ZW_@'??\ R-1_PE.A?\_K?^ =]_\ (U=>*XLXDQLJ,L9G6/Q+
MH4<1AZ3K5G/DI8NA+"XE6DFI2KX><Z52I)2J2A*2<]6<>$X0X9P,:T<'DF7X
M98BOAL16]C05-SJX/$0Q6%=XM.,:&(IPK4Z<'&E&<4^30Z"OYI]9_P"#6'_@
MGUKFL:KK5W\8?VR([K6-2OM4N8[?X@_!-+>.XU"ZENYD@27]GJ:185DF98ED
MEE=4"AY'8%C_ $<?\)3H7_/ZW_@'??\ R-1_PE.A?\_K?^ =]_\ (U<V4\09
MSD3KO*,QQ& >*5-8AT)17M51<W24^:,K\CJ5+6M\3[G5G'#V29^L.LYRW#9@
ML*ZKPZQ$92]DZWL_:N'+*-N?V5/FO>_(C\H?V;?^"*O[+/[,OQ3_ &:?BQX;
M\??'[Q]JW[)?P_\ 'GP\^"_AWXG>)_AOJ_@_0[+XB^-?BCX\U_Q%?:5X8^%'
MA"[O_%Z:W\7O%JZ?K0U.W6VLHO#\4MI<3Z!IUS%]-_MG?L!?![]M^^^ 6O?$
M7Q1\3_ /C/\ 9H^*5E\7/A-X]^$>M^%]!\6Z'XELYM,O?LDE[XK\&^-K%M&N
M=5T'PWK-S!::=9:@VI^&]'EAU.&&&X@N?L/_ (2G0O\ G];_ , [[_Y&H_X2
MG0O^?UO_  #OO_D:G5X@SJOCZ.9ULQQ%3'T(5J='$R<>>G#$2Q$Z\$N7DY:T
M\5B954XM5'7J.=^9BH\.Y)0P%;*Z.6X>GE]>=&I6PT5+DJ3PT,-3P\Y-R<^:
MA#!X6-)J2=-4*2C;E1\A_ /]@GX/_LZ?M,?M0?M5>"?$GQ*U3XA?M9ZCHNI_
M$;1O%.L>%[[P9HMQH5S?W-HG@K3M)\':'K>G0R2:C.+E==\1>)'=$B$4D+*[
M/YM^QG_P2O\ V9/V$/C1\>OC5\ KOXCZ??\ [0$@_M[P)K^N>&=0^'G@NR3Q
M%J/B6VTCX>Z;IW@[1O$.E:797>I36=G;:]XG\2M;Z;%;6J2[HO-;]!?^$IT+
M_G];_P  [[_Y&H_X2G0O^?UO_ .^_P#D:LIYWFU2&+ISQ^(E3Q^&P>#QD'/W
M,1ALOC3A@J56*5I1PT:5.-)VYHI-7]Z5](9%D].>#J0R_#1J9?B<9C,%-0]_
M#8G,)5)XZM2DW>,L5*I.597Y9MW:O&-ODGQ?^PA\(O&G[=7PM_X*"ZIXC^(]
MO\9OA'\(-0^"OAOPSI^K^&(OAC>^%=2F^(T\^H:WHUQX/NO%5SX@1_B=KPBN
MK#QIING*MII ?2I#;WIU"E\(/V O@]\'?VPOV@_VXM.\4?$_QE\<?VB]"T[P
MIXDN/'>M^%]2\.>#/"&ERZ ]MX3^'=CHO@WP_JVD:$8?"7A*SEM]=USQ+.]M
MX8TC%RMPEU/=_8?_  E.A?\ /ZW_ (!WW_R-1_PE.A?\_K?^ =]_\C5+S?,W
M2E1^N5O9RR^&5.-TKY=3Q"Q4<'=+F5!8A*JX)KFEI*\="UDV5JJJ_P!2H^UC
MF$\V4VI-K,JF'^J3QEG+E]N\-^Y4VO=A\*3U/CKXH?\ !/\ ^#?Q1_;.^!W[
M=UQXF^)O@WXY? GPQJ'@O2?^$&UGPKIOA+QUX3U)/$<,^@?$C2]7\&:[J^N6
M$=KXM\0VEO\ V1K_ (>N(H=1R+@SV=A-:7_VH/V$/A%^UE\7OV2_C3\1O$?Q
M'T7Q3^QM\39_BM\,;#P5J_AC3M UWQ%<:SX%UQ[+QY:Z[X/\2:CJFBB[^'^C
M1K;^']5\+WPM[G4T.HM+-:S67UM_PE.A?\_K?^ =]_\ (U'_  E.A?\ /ZW_
M (!WW_R-1#-\SIU,)5AC*T:N PE7 X.HFN?#X.M'$0JX>$FK^RE'%8B/*V^5
M59J-DPGDV5U*>,I3P5&5+,,91Q^,IVDH8C&T)8>=+$SBI)>UC/"8:7-&W-*C
M!RYFG?Y"^.'[!'P?^/O[5'[-'[7GC'Q)\2M-^)/[*_\ ;?\ PKW1/#6L>%[/
MP/K/]O/(]Y_PF6FZIX.UG7M0\LR-]F_L3Q+X=V #S?..2?DK]M[_ ((4_L'_
M +=OQ)/QB\?:3\1_A3\4-2=W\9^,?@7XE\.^%KKXBNMM:6EC<^,]&\7^#?'W
MA>YU338K9A'K^BZ%H?B'5!<-'XBU;6H;/2HM._7+_A*="_Y_6_\  .^_^1J/
M^$IT+_G];_P#OO\ Y&K?!\0YWE]7"5L%F>+PM3 X:>#PLJ-5P]EA:E:IB)X>
MR]V=&5>K.LZ=13C[5J:7-&+6&,X<R+,*6+HX[*L'BZ>.Q5/&XJ->DJGM<72H
MT\/#$7E>5.M&A2IT5.DX2]DG!MQE)/X)_8N_X):?LD?L&?##QI\.?@3X9\1?
MVM\2M$OM ^(WQ:\9ZU:>(?BOXRTZY;5UL;>_UB#2=+\,Z19Z):ZNUIIFD>$_
M"7AW09396>IZQI6JZ\U]JU[%\#?^"77[-/P+_8F\=_L":?<_$/X@_ GXBKXX
M'B.3XD:WX;U#QHS^.UMFO+C3]9\+>#_".E6-YH=[966J^&+Z+0#>:3JUG:WS
M3W,L$>W[[_X2G0O^?UO_  #OO_D:C_A*="_Y_6_\ [[_ .1JFKGV<UZF(K5L
MSQE6MBL7A<=7JU*TI5:F+P2FL'7=1WG&>%C4G&@H.,:47RPC&,8I51X?R3#T
M\/1H97@Z5'"8/%8##TJ=&,:5/!XYTWC*'LU:$HXJ5*G+$.:E*K.+G.4I2DW\
MI?L(_L-?";_@GM\##^S]\%_$/Q$\3^#3XS\0^.?[3^)^K>&M:\3_ -K>)(-+
MM[ZW^V^%/"/@K2O[.B32+8VD/]B_:8V><S7<X:-8OLVN?_X2G0O^?UO_  #O
MO_D:C_A*="_Y_6_\ [[_ .1JX,7B\3C\37QF,K3Q&*Q-256O6J-.=6I-WE.3
M22<F]7HCOP>$PV PM#!8.C##X7"THT</0IIJ%*E!6A"*;;M%:*[;\SH**Y>?
MQIX8M7MX[G5HH'NYA;VJ2P7<;7$Y5G$40:W!DD*J2%7))P "2 ;'_"4Z%_S^
MM_X!WW_R-7.=)T%%<_\ \)3H7_/ZW_@'??\ R-1_PE.A?\_K?^ =]_\ (U '
M045S_P#PE.A?\_K?^ =]_P#(U'_"4Z%_S^M_X!WW_P C4 =!17/_ /"4Z%_S
M^M_X!WW_ ,C4?\)3H7_/ZW_@'??_ "-0!T%%<_\ \)3H7_/ZW_@'??\ R-1_
MPE.A?\_K?^ =]_\ (U '045S_P#PE.A?\_K?^ =]_P#(U'_"4Z%_S^M_X!WW
M_P C4 =!17/_ /"4Z%_S^M_X!WW_ ,C4?\)3H7_/ZW_@'??_ "-0!T%%<_\
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M'Y-Q34 X5VC8I:WK;70X=&Q;'#J>&4X*G@@&G?\ "4Z%_P _K?\ @'??_(U
M'045S_\ PE.A?\_K?^ =]_\ (U'_  E.A?\ /ZW_ (!WW_R-0!T%%<__ ,)3
MH7_/ZW_@'??_ "-1_P )3H7_ #^M_P" =]_\C4 =!17/_P#"4Z%_S^M_X!WW
M_P C4?\ "4Z%_P _K?\ @'??_(U '045S_\ PE.A?\_K?^ =]_\ (U'_  E.
MA?\ /ZW_ (!WW_R-0!T%%<__ ,)3H7_/ZW_@'??_ "-1_P )3H7_ #^M_P"
M=]_\C4 =!17/_P#"4Z%_S^M_X!WW_P C4?\ "4Z%_P _K?\ @'??_(U '045
MS_\ PE.A?\_K?^ =]_\ (U'_  E.A?\ /ZW_ (!WW_R-0!T%%<__ ,)3H7_/
MZW_@'??_ "-1_P )3H7_ #^M_P" =]_\C4 =!17/_P#"4Z%_S^M_X!WW_P C
M4?\ "4Z%_P _K?\ @'??_(U '045S_\ PE.A?\_K?^ =]_\ (U'_  E.A?\
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MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
MY&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_
M\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"B
MN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO
M_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$I
MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
MY&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_
M\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"B
MN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\ D:@#H**Y_P#X2G0O^?UO
M_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*="_Y_6_\ [[_ .1J/^$I
MT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\ Y&H_X2G0O^?UO_ .^_\
MD:@#H**Y_P#X2G0O^?UO_ .^_P#D:C_A*="_Y_6_\ [[_P"1J .@HKG_ /A*
M="_Y_6_\ [[_ .1J/^$IT+_G];_P#OO_ )&H Z"BN?\ ^$IT+_G];_P#OO\
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M* "BBB@ HHHH **** "BBB@ K%3_ )&*Z_[ MC_Z7:C6U6*G_(Q77_8%L?\
MTNU&@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8UJ\:LJ5-WYIQHJ#JN.EK052'-=KXD>[T445D:A1110 4444 %%%% !1110
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M"JW_ ,N#_B;KZ2G_ $>+B_\ \*<)_P#,A^N/_#YS]J'_ *$/X"?^$O\ $/\
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M=PQ+E2H4!002?R8HH_X@QX6_]$3DO_@JM_\ +@_XFZ^DI_T>+B__ ,*<)_\
M,A^N/_#YS]J'_H0_@)_X2_Q#_P#GI4?\/G/VH?\ H0_@)_X2_P 0_P#YZ5?D
M=11_Q!CPM_Z(G)?_  56_P#EP?\ $W7TE/\ H\7%_P#X4X3_ .9#]<?^'SG[
M4/\ T(?P$_\ "7^(?_STJ/\ A\Y^U#_T(?P$_P#"7^(?_P ]*OR.HH_X@QX6
M_P#1$Y+_ ."JW_RX/^)NOI*?]'BXO_\ "G"?_,A^N/\ P^<_:A_Z$/X"?^$O
M\0__ )Z5'_#YS]J'_H0_@)_X2_Q#_P#GI5^1U%'_ !!CPM_Z(G)?_!5;_P"7
M!_Q-U])3_H\7%_\ X4X3_P"9#]<?^'SG[4/_ $(?P$_\)?XA_P#STJ/^'SG[
M4/\ T(?P$_\ "7^(?_STJ_(ZBC_B#'A;_P!$3DO_ (*K?_+@_P")NOI*?]'B
MXO\ _"G"?_,A^N/_  ^<_:A_Z$/X"?\ A+_$/_YZ5'_#YS]J'_H0_@)_X2_Q
M#_\ GI5^1U%'_$&/"W_HB<E_\%5O_EP?\3=?24_Z/%Q?_P"%.$_^9#]<?^'S
MG[4/_0A_ 3_PE_B'_P#/2K>\+?\ !:#X\P^(M&D\:_#?X1:AX36_M_\ A(+3
MPMI/C+2/$4VEE]MU_8VHZMX]UO3;:_1"9+<WNEW5O*Z>1((1)]HB_'"BHJ>"
MOA95IU*;X+RB*J0G!RIQQ%.I%3BXN5.I"NITYI.\)P:E&24HM-)FV'^F!]);
M#8BAB(^+W%-66'K4JT:>(G@<1AZDJ4XS4*]"K@I4J]&;BHU:-6,J=6#E"<7&
M33_N2^%'Q7\"?&SP)H?Q&^'.N6^O>&->M_,@GCQ'=V-W&%%YI.K698RZ=J^G
M2GR+ZQGQ)#( Z&2"2&:7T:OXYOV/OVP?'?[)GCL:MI)N->^'VO7%M%X[\"2W
M)CM-7M(R(UU72FD)BT[Q-IT18V%^%$=S&#I^H"2SD!A_K3^%'Q7\"?&SP)H?
MQ&^'.N6^O>&->M_,@GCQ'=V-W&%%YI.K698RZ=J^G2GR+ZQGQ)#( Z&2"2&:
M7^$O%SPCS3PTS3VM+VV/X7Q]:2RK-7%.5*33G_9V9<D5"ECJ44W3FE"ECJ4'
M7H*$X8C#X;_:OZ+'TI^&_I#\-_5L3]5R3Q(R3"TY<3<,QJ.-/$TXN%)Y_D"J
MSE5Q.38FK**K47*KBLGQ56&#QDZM*K@<=C_1J***_'3^L@HHHH **** "BBB
M@ HHHH Q=$_U>H_]AK5?_2MZVJQ=$_U>H_\ 8:U7_P!*WK:H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AJO_ ""]2_Z\
M+S_TGDJ2P_X\;+_KTMO_ $2E1ZK_ ,@O4O\ KPO/_2>2I+#_ (\;+_KTMO\
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M+Z;1+[XC_$"\L+;3-*LHM^L^([BT@L;&!7ABMXE]!\?_  \\ ?%?PCK'P_\
MBEX&\'?$KP'XA2TCU_P3X_\ #.B^,?".N1Z?J%IJUA'K'AOQ%9:CHVII9:K8
M6.IVBWME.MMJ%E:7D(2YMH9$^FCQ-7I8^CBY87ER^IAL/0=-8>C1K5:F$RIY
M7#%1QM"%#$UYX+$2EC</#ZW!QKTZ/[VC5ITZM+YZ7"^'JY?6P<<7S9C2Q.(K
M^T>(KUZ-*GC,VCFL\)+!5ZE?#4*>.P\(8+$2^J24\/4K/V5:G4J4JO\ *?\
MM->'?$OPY_9@_P""L_PFT3_A1WPD^'/AS6/V&M9L_P!G']E_XG?&7X@^#_V:
M/BOXC^/W@2\\82>$/&'B+]G+]G_X<> KSXBZ>WAOQM??#?X:?;-2\'>(;/\
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M"WA#]GG]G>'X9?$;0O"%MK_ASPW\)OAK'X$\=^&?"\TVL^ K?6-(TS0!X?\
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M3J4*=+&T%3E-U90C0JT52Y:U.K0SQ/"<IU\7/#_V>L-B,0IX;#5:#5/+8_\
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M<)_^HE<****_H(_A0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK\1R/\ /'L#6FC7GQ*\9_#WP/!<0Q2R7LC>(?&>@VAMK:=(;J6\:VM+CZY\
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M5PW_ (@^+/BCX!>)/B+\:/$GQ8\$0V?A#P9I/AWX%?%+XWZ O@7X5ZKX4'Q
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M[?L+^#OVE?B5\./#?P__ &#/ 7[47Q+^-^G>!_V?]5^-_P 1+_QYXOU?X>^
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M"2?_ .75'V;7_P#H+Z;_ ."2?_Y=4 ;5%8OV;7_^@OIO_@DG_P#EU1]FU_\
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M .=;1_PYC_:A_P"A\^ G_A4?$/\ ^=;7])OV;7_^@OIO_@DG_P#EU1]FU_\
MZ"^F_P#@DG_^75'_ !,UXI?]!>2_^&>C_P#+ _XIT_1K_P"A9Q?_ .)9B_\
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M1_Q,UXI?]!>2_P#AGH__ "P/^*=/T:_^A9Q?_P")9B__ )0?S9?\.8_VH?\
MH?/@)_X5'Q#_ /G6T?\ #F/]J'_H?/@)_P"%1\0__G6U_2;]FU__ *"^F_\
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MLJ5.E5=*JER5%3JTZCA*7)4A*TEQOPB^$7@/X'> ]$^'7PZT2#1/#NBP!%5
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M!?3?_!)/_P#+J@#:KY=\"_\ (D>#?^Q5\/?^FBSKZ(^S:_\ ]!?3?_!)/_\
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M\7O_ )@*/^'G?[#G_1;_ /S&OQ>_^8"C_B&_B)_T07&G_B+9Y_\ ,(?\3!>
MG_1[_"'_ ,65P9_\^C[VHKX)_P"'G?[#G_1;_P#S&OQ>_P#F H_X>=_L.?\
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M (1[X@?M0^.OV@/VR?CG\*/^"?5U\5/$^H^"=3^*/['7@6XB\3>&?VA_C/\
M%W7/"7B3Q6OP]\+_  UAU359/B1<^ _'/Q)^)<5QX(GT_P *ZY/XKN=8T[Z&
MOPKBZ=)RHRJU*D88"I)5\.L'AJD,=@98]RPN,K5W1JPPE"%2>,G5^K1HTJ=2
MNVZ5.I*'A8?BW!U*JC7C2I4ISQ].+H8AXW$TIX''0R]0Q6"HT%6HSQF(J4X8
M.%)XF=:I4I44E5JTXR_>2BOR5^)W_!4#5O@;\(_VM-?^+O[/)TKX[?L=ZC\#
MY_'OP:\%_%BW\7>&/'7@3]H#Q_H_@[P!X_\ A1\4M3^'_@_4M>TZ[M+S6YKK
M2O%'PP\%ZG8>*O#=UX3U)+"SO[#Q3+\\?M)^/OVY?B1^VE_P3W^!'Q,^&G@W
MX/>"/BA;?M,>*?$O@CX&_P#!0W]I'P=/XYMOASX-^%&H3ZAXP^(_PC_9U^#/
MC#3KGX9Q>,-2NO"_@2QN_$?A/XF>)9KZQ\1ZUX0T?2]&\2:KSX7AG,:T_P#:
M/882@J>.J^VGB\!-U8X#*X9Q5^JTGC*;Q2G@JV&J4ZU*?U9K$TYSKPIJI*'1
MBN*<MHP_V?V^+Q#JX"E["&#S""I2S#-JF34?K=58.HL(X8VABJ=2C5BL3S8:
MI"%"=1TXS_?&BOR)M_\ @J'XC?X.P?MFW/[.=E!_P3\F\?2^&7^.,?QF%Q\<
M+7X?CQ3/\-;?X]7/[.A^%T/AT_"=_B4D$%REI\?;OXC6_P -)S\28?A]>/$?
M";:7B+_@HQ\78?%G[>-KX*_9>\(Z]\//V !XGF^)7C;Q1^T/J/A#6/&MMH_P
M'G^-6EIX"\'Z7\!?&L,^I7$UI)X7\16>O^*-$M= BU7PWK^DZCXL^VZ[HWAC
M)<-9RY5(_5::=)SC5;QV C&E5IXC#86IAJDI8I1IXRGB,;A*53!3:Q=.6(I<
M]&*DF:OB?)%&G+ZU5:K*$J*C@<PE*K2J8?$XJEB:4(X5RJ8.KA\%BZM+&PB\
M)4CAZO)6DX-'ZR45^06C_P#!1C]I2^UG]DO1=0_8E\,6%W^W7X&\3^)_V<[:
M#]J/[3?Z%JWAGP=X6^)TUA^TG;7WP"T>#X4^'9OA?JOB;Q2^O?#*]_: \16N
MI^%[?PB_@237/$5HEIM)_P %.]1MO!OB3P_J?P -U^UCI/[85W^Q%H?[/WA+
MXJ0Z]X-\6?%IO"</Q)TKQ9IWQHU?P!X4OK#X.CX6W"^-/%?C+5?A-:^(/"!M
MKW0KKP3J&I-I']LN7#6<Q<5]6HS<DY6I9AEU;EIK$5L+.O4]EBY^RPU/$8>M
M1K8FIR8>C.G)5:L+7"/$^2RYG]9KPY6H_O<OS*CS5)8>ABX4*?M<)#VN*J8;
M$T*U+"T^?$UH58NE2G>R_6.BOS+US_@H[9?!%?VC?#W[7'PDG^%7Q*_9W^&W
M@3XS+X9^$/C9_CCX:^,WPP^)GB+_ (5_X/U#X/\ BWQ)X,^!VJW_ (MD^+,4
MWPMUWPIXY\%>!(-+\37>@7MEX@UGPUK#ZWI_C.O?'#]L;4?V_/\ @G#X*^-/
MPHMOV>_"_CW0/VH]<U[PW\*/VDM:^,?P_P#&EYI_P4LM4M/!?Q5MF^&?P;M6
M\;_#75XH=5TJ$:!XZ\&32:E<:IX-\<7=YI^J10*EP]F,_:RJQHT*5/"XS%1J
MSQ6%E'$1P>62S64,(H5Y2QC>'='GEA56CAW7INNZ:NAU>(\NA[*-*5?$5:F+
MP6$E2AA<7"6'EC,TCE49XQSP\5@E'$>VY(XMT)8A8>HJ"J.S/V:HKY+_ &CO
MVH_^&?OB5^R5\//^$&_X2W_AJ3XYR_!?^V/^$F_L'_A!?+\">*?&O_"2_P!G
M_P#"/:U_PDV[_A&O[,_L;[;X>Q]M^V_VJ?LWV2?YH_:1_P""E\?[/%K^W]>2
M_!2Y\8Q?L+>&/V7O$LL5EX_72KSXIQ_M(7MW:/8VENW@G4E\)7/@U;4O 6F\
M3KXHED2 CPZ,S5S87)<SQOU=8;#>U^M0IU*'[[#P]I"KF5'**;_>58<O-F->
MEA[3Y6N?VK2H1E5CTXK.\KP7UEXG%>R^J3J4\1^YQ$_9SI995SBHOW=*?/RY
M;0JXF\.9/E]BFZ\HTG^I=%?FV/V\?&?PO^,,?PM_:X^!GAOX%Z?X@_9X^*W[
M2?@SQCX'^-,OQKM(_!_P/72]0^*GA?XEZ:_PK^&C>"_'/A;P[K^B:R(O"6H?
M%'P1K#OJVGZ/XZO)--MI]4^1_CK^UM^UE\0['_@G;\0(?@EJ_P"S]\$OC_\
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M>,_&MS\(/AEXN^$GQ4T;Q1I&E:7JV@:U\*]>33M,U^#6&N)[FU.BW'I?PO\
MV^?B?K?CO]D32?C1^S5HOPE^'W[<7A_Q'>_ WQ1X=^.1^)_C;0O$ND_#VU^+
M.A>&/C3\/G^$W@72/!:^+OA_;^);W3M9\"?$7XL0:3K^C6&@^([328]9;5=+
MJIPWG-*,YU,)""A3E5UQF"YJE.&#>83E0@L2YXCEPB=:2H1J-*,H->TBX*:7
M$V2UI4X4L7.;J5(TDU@\<HTZD\;'+X0KS>&4,,YXR4:,?K$J2DY*:;IM3/TZ
MHK^?3]LC]N[]I'XN_L'^.?V@O@#\(-4^'W[._BOXF_"CP_\ #']H7PO^T-J/
MAWX_S^$;7]H?X>^&;WXHW/PAT#P!IUKX=^%7CR\L=>\'VTFD_'?6_'EWX1\1
M:5XA\1_#K3_"VK>(U\/_ '3XN_;>^,&M>/OVD/#W[,O[+UA\<_!?[)5U;^'/
MC!XT\4?&MOA'?>)OB7!X5LO'OB?X4_ ?PY#\*?B/8_$/QEX/\'ZQX>DUJ3QW
MXK^#WAS_ (27Q#I>@6VO2VK7&N0:SX9S.%"G5<<,IO$8S#UZ4L;@8+"2P;RV
M$EBJ\\3&A0K3K9E2H?5:M2&)A.$N>DDU;.'%&5SKSI1EB73^KX/$8>K# X^H
M\9'&+,JD982A#"RQ&(HPH9;5K_6J-.IAITYQY*K:L_TBHK\U-)_X*%S?'+Q)
M\'/!7[&'PKT+XW>)/BG^SWX<_:DUG4OBM\4[OX%>!/AG\(O&5_?Z#X0@\5Z_
MX;^&?QU\47'Q*\0^*-+U;1K;P/H_@*\L[*'0M=U75O%&GVEMIRZM1_X)6?$[
MXH?%KX0_M%>*OBX?'=CXJC_;L_:]T>#P=\1/%,WB_7OAAX?T[XJ7RZ'\*K?5
M/[2U738M%^'UG*OAO2-/\.7;>%[.TLE7P\BZ6UN6YZV1X[#8/$8S%QAAGAZF
M&IO#5*M'ZW?$SQ$(NIAHU'B*$4\/-IUJ4%-.,H-QE%OHHY]@,5C<-@\)*>)6
M)IXFI'%4Z5;ZHEAH8:<HT\3*DL/B)26*@FJ%6;IRC.,TI0E&/Z<T445XQ[04
M444 %%%% !1110 4444 %?+O@7_D2/!O_8J^'O\ TT6=?45?+O@7_D2/!O\
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MJ2<J-7]KJ***_.#]+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\?_\ @M!_R;E\-_\ LMFD_P#J">/:_FGK^EC_ (+0?\FY?#?_
M ++9I/\ Z@GCVOYIZ_T>^C+_ ,FMPG_8ZSC_ -/4S_GZ_:+?\I*9I_V2'"?_
M *B5PHHHK^@C^% HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *DBEEMY8IX)9(9X9$EAF
MB=HY8I8V#QRQ2(5>.2-U#HZ$,K ,I! -1T4-)IIJZ>C3V:[,:;333:::::=F
MFM4TUJFGJFMC^B;_ ()V?\%$XO&D6C? KXZZS'#XNACAT[P/XXU&98XO$L4:
MB.WT/7+B0JD>MQHJQV5[(P74% BE(N "W[95_!7%++;RQ3P2R0SPR)+#-$[1
MRQ2QL'CEBD0J\<D;J'1T(96 92" :_HF_P""<_\ P4-_X3O^PO@'\;M4_P"*
MT_T;2? /C*\?_D:ONP6?A[6)#_S'_N0Z?='_ )"?RPO_ *3MW?Q%X[>!7U+Z
MYQMP7A/]B_>8K/<CP\/]TWG6S++J4=\*_>J8S"07^S>]7H1^K^TA0_V/^A3]
M-3^V/[)\'O%_-?\ A6_<9;P3QGF%;_D:?#2PG#W$&)J/_D9?!1RK-*LO^%#W
M,%C)_7O8UL9^UU%%%?QX?ZP!1110 4444 %%%% !1110!BZ)_J]1_P"PUJO_
M *5O6U6+HG^KU'_L-:K_ .E;UM4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!0U7_D%ZE_UX7G_I/)4EA_QXV7_7I;?^B4
MJ/5?^07J7_7A>?\ I/)4EA_QXV7_ %Z6W_HE* +=%%% !1110 4444 %%%%
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M@^C^7XF@>^N?^$7C\8[-"*W47G:@3I:_4/AC]N/]E[Q/H/Q:\02?$JY\"0?
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MC#XFZ9X4TS0/AGXD\>0ZEI7A3P?\6O@W=7]_<76@K82K>>+([=;>Y:5(_,B
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M_AI^RO\ $WX3>*9=0>,#3[F#QAXI_;&^-.DV]G:S9>\L9/ US-?1D10:CIS
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M\ > ?^$2\7:IOO/[9\$Z5_PFNC:#Y%M]A\?^(_M4OV/Y-^%G[-/CKP/^W?\
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M^*M,TKP)H/B+3_$7Q4\5^"+/7=;\!>$=+TZUTG3]=Y[]M/1?B=^U;IL_QF^
M7[+'Q?\ AQX;_9[_ &K?V4/C=XG^,6C_  HT?X??M>_M.^"?@IX3^)%WXK'P
MV_9[_:1^"VG^)O$>J?LW:A\0]-USX0:;\7_#^LGXC>,-'\5:%\*?!MY='1+W
MQ/\ T T5-'B7ZO4P=6GE])SR^BL)A%6Q6)JTU@O;PKSIXBFY)8FM.:K+GDXX
M:G'$25'!4W0P;PU5N&7B*>,I5<QJJ&85GC,8Z.%PU&H\=["6'A4P]2,6\-AX
M0]B_914L35G0BZV.J*OC5B_Y^(?A#IOQE^*_[0GQ=^)'PX_X*,_MD?![1/V-
M->^!WB>Z^-7@'X6_LQ>-OBY;^(OB/X3^(UW\(?@W^S]#^S-^Q'\4?%.J^%8=
M!F\8V?Q@U'X@>%%TS7IKKP)\.;3Q;KVN7KZ3?\ Q?&#4/$OB+X!:==?M]?MW
M?L%WW[(_Q4\/_'?PI^V5^SM=?!CXSW/B:Z8:7X0\&_!_XP?%GX;?L=>/?C)X
MR^)'A^^\2Z=K\?BB[UMO!46DZ3K?_"U+'7/$>DV6C?OQ13EQ-)P=/ZE3=.%.
M$,+2G4C[+#SA3A36*A"G0I?5\;!Q=2EB<K>6-5.158UZ-*G12CPM%3C4^O5%
M4G.<\75C3G[7$PE4=1X6<ZN(J_6,#-/V57#9JLU4J;G*E.A6JU*TOQ"_9#UK
MX\^%/VB/@#\+O@A\0/V[?BU^R$OPN^*$GQMTC]OK]FWQ%\--=^!][#'8:Q\*
M+7P%\<OB/\%?@9\2/BGXJE\2WS^!I?"-WJ_QTTS1_ MOJ^I3>(K&WTOPQ=6W
MJ_\ P4>^!WB/XX?'W_@FEIUGX6^+&K^"/#G[2_CK5OB7XH^$VL_%'P5J?@'P
M[/\ !'QK96.NZK\3_A'JWASQ7\-["\UN2PTB+7;?Q3X>6]N+Q=%-[,FH26=Q
M^LU%<TL^FLRI9E0PM.A5I83%X;F@Z=.M6J8NEC:4\9B*V&H86%3%P^N/EK1H
M4Y2A0H*JZE53K5.F/#\'EE7+,1BZF(HU<9@\5RSC4G0HT\%6P-6&"P]'%5\5
M.G@YO!+FHSKU(0EB*[I*G2=.C3^$M9_8J^"/PT\.?&;XC^!?"GQ$\;?&76_@
M5XZ^'6C>-/BK\9?CQ^TG\1+'P]=Z)KUY'X+\!ZW\=?B)\3_$'A/3=>UJ^$^J
M:%X(N-'A\3Z@FG'5[;4Y]/TW[-^9&@? OXU^#_\ @G[_ ,$</'<OP>^)VO77
M[&'COX._%+X\?L^Z?X+U?_A:=MH"?##QUX(UOQ1IGPONH;'Q3X@^(OPMUGQ;
M;:_:^![#29O%FI6UWK[:78W6JP1:;J']$E%+"\0XVA'EK.>-D\33K3J8JO6J
M5)488+&X"6&4Y2<X1EA\=5]G.,N:C-1E!:6'B^&\#B)J5!0P,8X6K1A3PE"C
M2IQK3QV!S".)<(Q4)RCB,OH^TA*/+6@YQJ.S/YZ_VEOA9\5OVN/$O_!2'X__
M  B^#7Q:T?P1K_\ P3#UK]D+X;:=\1/AMXV^#WQ#^/WQ<GU3QQ\4+_4/"WPA
M^)OAOP=\3!HGA&R\0Z3X"TK7_&OAKP^WB/Q-J&K:;X#A\0Z7:W>H1^A> -9\
M0?"?]JC]GW]L+Q)\(?VD-?\ @9X__P"">?A3]D^YO] _9G^/'B'XG?!+XN?"
M[XF:WXPUK3?''[/^E?#EOC[X>\$_$:WM9K?3_'#?##4]'O=:\,>&9[G5XO"?
MB;P?JDG[I45TOB64L.L'+!1>$C1EA(PC7E&LL)/!8?"3BZSI23Q//A*&)C75
M.-)5/;4GA98:I"C2YEPPHXGZ['&R6+E6CBYS>'BZ+Q<,;B,7&4:"JQ:PW)B\
M1AI4)5)UG3="JL5'$TIUJW\WWP]^ _QS^'/C7X2?MT>*/@9\49/AMJ'_  4F
M_:O_ &I_$'P,T[PK?>*_CO\ #?X)?M7?!#2/@S\.OB?K/P3\,6VM>)I/%OA;
M6M+B^(7Q%^%7A+3/$OQ?\'6/C_63/X;E\5:+XRT;3_4OVC?^$Y^-WQ$^%W[7
M'PU_8L^)FF?#/]FO]L_X/_$GQM>7/PMUWP;^T7^U1X'\-_!_XB?#S6?BNG[/
MOBGP+X*^-5_<_LWZKXTTW3?A1H7BJWU7QGXXT*\\:7O@GPWI=AIVDV?BO][Z
M*N7%-2IB(8JK@:,J]+#UL!2Y<1B*=&.75ZU2M.@Z<9J53$)5JU*&*JU)QC"<
M:CP\L51HXBG$>%*=.A4PM+'UH4*V(HYA6YL/AJE:>9X>A1HT\0JLX.-+#MX>
MC5J82E2@YSA*FL1'"UJ^'J_S9?MM?#/XK?M6#_@H]^T7\(O@?\;K7P)J7_!.
MKP[^R?\ #W1O%?P>^)?P]^*GQ^^*47Q.U7XLZUJW@_X%^,?!WA_XPW6A>!](
MUS3O!EGKWBKP=HLFNZY<ZY;>"+?7]$T_4-4A_7O]H3X:>-/B1_P3Q^-7P@\*
MVNI6GQ"\<?L;_$'X>>']-6#[/J@\7>(?@OJOAW3='EM[J!IK:XN-7NH=-N8_
M*AO8#+*+>6TO$BGA^TJ*Y,1Q!6K0RVE3P].E3RG%4\1A%*<JLFJ6'P&'A"O)
MJ*J-_4(U:DXQIQE.M4C3ITJ4:=./7AN'J-&IF5:IB:E6KFV$J8;%N,(TH)U<
M3C\14G0BG*5**^ORI4X2G4G&%*G*I5JU95*D_P"<OX_6?@O]H?\ 9D_X(J_$
M2?X)>+?CO\ /#?CSX<Z]\:/!_AW]G[QU^T-9^&O"VC_LZ^*_!VN6'CKX5>!O
M GCW6+NT\.>.H4\+:E9R^%+VWM]?LQ L9>)''V+X7\=_L(_ 33_B%\2?V4_V
M _'WA3XRZ%\+/B!?^';3X;_\$HOVEO@7XG\=MHGA^Y\40?#>T\>7W[+'@#3(
MI/&6K:!I6F6&D:IXGLK/5=:.E0JLEVEKM_2;X:?"+X>?!^U\7V'PW\/GPQIG
MCGQ_XG^)_B#2+?5]=OM%'C;QI+;7?BS5- T;5=3O]+\(6GB+5H)?$6K:!X1M
M-#\.WGBS5?$?BZ;26\3>*/$>K:KZ371B<^H5H1PT:68O!T:F+=.A',?JU*O1
MQ6-K8UT\;0AAZZK2BZTJ$JD*U-U:<(24:4M%SX7A_$4:D\5*MEOUVO3PBJUY
MY:\55H5L)@J&"53 XB>)H2HPDL.J\*=2C5]E5G).56*][^>KPQ_P28^,7C[_
M ()V:[\-/'O[5'Q^T3XS_&G2-:_:9\;_  VBT+]F:T\#:?\ MC>,]13XS6NH
MZCXGUO\ 9SO?CW:+H/Q<CT.UUZ\@^-6GZ_-I^DW^DV&OZ/H]REG;V_@]\._B
M5^VK^V;^SO\ 'G]H3X/_ +5?P0M]2_X);2>'_B)<:'XD_:;_ &4KOPY^T%HO
M[3-M8>*?A_K'C+X7:_\ "'7IQJ4=GKOC+PWX(UK57T_Q#X/E\/\ CRQT.\T^
M+1-9A_H*HJGQ;F$XXQSIT%7Q%7&5:&(PT(X.I@WF%)4L9&D\-"FY^U5'!^_5
M<JD5A(1YVIR(CP?EU.6#5.I7=##T<#2KX?$SGC*>-_LVM[7!2J_6IU535%U<
M:G3I*-.;QDYN"E"-_G3X6_ 'X"?LKZ;\4/&7@W2+[0KKQE);>-?C#\4?B'\0
M?B%\5_B+XLA\$>&8](TF]\>?%OXO>*_'/Q'\0:+X)\*:<UAX:TK6?%-YHWA/
M2_MT.@6&G1WU\+CY7_X)!>'=<T3]@GX6:SK5MJ>F6_Q.\8?'/XV>$]"U6T>Q
MFT3X??&GXY_$3XG?#Z&&UDCAD@@U?P=XHT7Q3Y3PQ^7/X@GC0-$J2/\ >OQ2
M^&'@GXT?#_Q1\+/B1I=WKO@+QMIW]C>+= M=?\1>&T\0Z%)<03W_ (>U34/"
MVK:+JUUX<UZ&!M(\4^'GOSHOBWPW>:KX5\36.K>&M9U;2KWMK2TM-/M+6PL+
M6WLK&RMX;2RLK2&.VM+2TMHUAM[6UMX52&WM[>%$BAAB1(XHT6.-550!Y,\R
MG5R_$X>M4KXC%8S&X/$5Z]>;J.-'+\+B</AH1J3G.I4E/ZY4C+F4%1IX:C&G
M*:JSC3]>&60I9CA<30IX?#83!8#&X:AA\/!4U*MF.*PN(Q,Y4H0A3IPA]2IR
MBXN3K5<37E4C!TH2JV****\L]8**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KY=\"_\B1X-_P"Q5\/?^FBSKZBKY=\"_P#(
MD>#?^Q5\/?\ IHLZ .@\ ?$[X>^'O#T^CZYXQ\/Z5JEGXJ\>_:K"^U&""Z@^
MT>._$EU!YL3L&3S;>>&9,CYHY$8<$5VG_"Z/A/\ ]%"\*_\ @VMO_BJP?AOX
M-\(:KX8>_P!4\*^&]2O[CQ5\0//O;_0]+O+N;RO'WB:&+S;FXM9)I/+ACCBC
MWNVR*-(UPBJ!WG_"O/ '_0C>#_\ PF=%_P#D*@#!_P"%T?"?_HH7A7_P;6W_
M ,51_P +H^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\
M?]"-X/\ _"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\ T4+PK_X-
MK;_XJM[_ (5YX _Z$;P?_P"$SHO_ ,A4?\*\\ ?]"-X/_P#"9T7_ .0J ,'_
M (71\)_^BA>%?_!M;?\ Q5'_  NCX3_]%"\*_P#@VMO_ (JM[_A7G@#_ *$;
MP?\ ^$SHO_R%1_PKSP!_T(W@_P#\)G1?_D*@#!_X71\)_P#HH7A7_P &UM_\
M51_PNCX3_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\ R%1_PKSP!_T(
MW@__ ,)G1?\ Y"H P?\ A='PG_Z*%X5_\&UM_P#%4?\ "Z/A/_T4+PK_ .#:
MV_\ BJWO^%>> /\ H1O!_P#X3.B__(5'_"O/ '_0C>#_ /PF=%_^0J ,'_A=
M'PG_ .BA>%?_  ;6W_Q5'_"Z/A/_ -%"\*_^#:V_^*K>_P"%>> /^A&\'_\
MA,Z+_P#(5'_"O/ '_0C>#_\ PF=%_P#D*@#!_P"%T?"?_HH7A7_P;6W_ ,51
M_P +H^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\ ?]"-
MX/\ _"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\ T4+PK_X-K;_X
MJM[_ (5YX _Z$;P?_P"$SHO_ ,A4?\*\\ ?]"-X/_P#"9T7_ .0J ,'_ (71
M\)_^BA>%?_!M;?\ Q5'_  NCX3_]%"\*_P#@VMO_ (JM[_A7G@#_ *$;P?\
M^$SHO_R%1_PKSP!_T(W@_P#\)G1?_D*@#!_X71\)_P#HH7A7_P &UM_\51_P
MNCX3_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\ R%1_PKSP!_T(W@__
M ,)G1?\ Y"H P?\ A='PG_Z*%X5_\&UM_P#%4?\ "Z/A/_T4+PK_ .#:V_\
MBJWO^%>> /\ H1O!_P#X3.B__(5'_"O/ '_0C>#_ /PF=%_^0J ,'_A='PG_
M .BA>%?_  ;6W_Q5'_"Z/A/_ -%"\*_^#:V_^*K>_P"%>> /^A&\'_\ A,Z+
M_P#(5'_"O/ '_0C>#_\ PF=%_P#D*@#!_P"%T?"?_HH7A7_P;6W_ ,51_P +
MH^$__10O"O\ X-K;_P"*K>_X5YX _P"A&\'_ /A,Z+_\A4?\*\\ ?]"-X/\
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MUDW_ ,Q'S-_PKW]@;_HF'[+7_AM/AG_\S]'_  KW]@;_ *)A^RU_X;3X9_\
MS/U],_\ "O/ '_0C>#__  F=%_\ D*C_ (5YX _Z$;P?_P"$SHO_ ,A4?ZR<
M1?\ 0_SK_P .F._^7A_Q#[@+_HB.$/\ Q&LF_P#F(^9O^%>_L#?]$P_9:_\
M#:?#/_YGZ/\ A7O[ W_1,/V6O_#:?#/_ .9^OIG_ (5YX _Z$;P?_P"$SHO_
M ,A4?\*\\ ?]"-X/_P#"9T7_ .0J/]9.(O\ H?YU_P"'3'?_ "\/^(?<!?\
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M8?LM?^&T^&?_ ,S]?3/_  KSP!_T(W@__P )G1?_ )"H_P"%>> /^A&\'_\
MA,Z+_P#(5'^LG$7_ $/\Z_\ #ICO_EX?\0^X"_Z(CA#_ ,1K)O\ YB/F;_A7
MO[ W_1,/V6O_  VGPS_^9^C_ (5[^P-_T3#]EK_PVGPS_P#F?KZ9_P"%>> /
M^A&\'_\ A,Z+_P#(5'_"O/ '_0C>#_\ PF=%_P#D*C_63B+_ *'^=?\ ATQW
M_P O#_B'W 7_ $1'"'_B-9-_\Q'S-_PKW]@;_HF'[+7_ (;3X9__ #/T?\*]
M_8&_Z)A^RU_X;3X9_P#S/U],_P#"O/ '_0C>#_\ PF=%_P#D*C_A7G@#_H1O
M!_\ X3.B_P#R%1_K)Q%_T/\ .O\ PZ8[_P"7A_Q#[@+_ *(CA#_Q&LF_^8CY
MF_X5[^P-_P!$P_9:_P##:?#/_P"9^C_A7O[ W_1,/V6O_#:?#/\ ^9^OIG_A
M7G@#_H1O!_\ X3.B_P#R%1_PKSP!_P!"-X/_ /"9T7_Y"H_UDXB_Z'^=?^'3
M'?\ R\/^(?<!?]$1PA_XC63?_,1\S?\ "O?V!O\ HF'[+7_AM/AG_P#,_6[X
M;T7]BSP;K%IXB\(>$OV=_"OB#3V9[#7?#?@OP'H>L63LI5FM-3TO1[6]MF92
M59H9T)4D$D'%>^?\*\\ ?]"-X/\ _"9T7_Y"H_X5YX _Z$;P?_X3.B__ "%4
M5.(,^K4YTJV=YO5I5(RA4I5,RQDZ=2$DU*$X2K.,XR3:E&2::;331KA^!>"<
M)7HXK"\'<*X;$X>K"MA\1A^'LHHUZ%:E)3IU:-6G@XU*56G-*4*D)1E"24HM
M-)F#_P +H^$__10O"O\ X-K;_P"*H_X71\)_^BA>%?\ P;6W_P 56]_PKSP!
M_P!"-X/_ /"9T7_Y"H_X5YX _P"A&\'_ /A,Z+_\A5Y!]48/_"Z/A/\ ]%"\
M*_\ @VMO_BJ/^%T?"?\ Z*%X5_\ !M;?_%5O?\*\\ ?]"-X/_P#"9T7_ .0J
M/^%>> /^A&\'_P#A,Z+_ /(5 &#_ ,+H^$__ $4+PK_X-K;_ .*H_P"%T?"?
M_HH7A7_P;6W_ ,56]_PKSP!_T(W@_P#\)G1?_D*C_A7G@#_H1O!__A,Z+_\
M(5 &#_PNCX3_ /10O"O_ (-K;_XJC_A='PG_ .BA>%?_  ;6W_Q5;W_"O/ '
M_0C>#_\ PF=%_P#D*C_A7G@#_H1O!_\ X3.B_P#R%0!@_P#"Z/A/_P!%"\*_
M^#:V_P#BJ/\ A='PG_Z*%X5_\&UM_P#%5O?\*\\ ?]"-X/\ _"9T7_Y"H_X5
MYX _Z$;P?_X3.B__ "%0!@_\+H^$_P#T4+PK_P"#:V_^*H_X71\)_P#HH7A7
M_P &UM_\56]_PKSP!_T(W@__ ,)G1?\ Y"H_X5YX _Z$;P?_ .$SHO\ \A4
M<7I'QC^%D,=\)?'WA>,R:MJ4R!M5MANBEN6:.1<MRKJ0RGH1R*UO^%T?"?\
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MH7A7_P &UM_\51_PNCX3_P#10O"O_@VMO_BJWO\ A7G@#_H1O!__ (3.B_\
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MA4?\*\\ ?]"-X/\ _"9T7_Y"H P?^%T?"?\ Z*%X5_\ !M;?_%4?\+H^$_\
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MQ;'5O"NI:'X@N-.,6KPQ1\Q_P=&?\HV/#O\ V<]\+_\ U#OBC7X6_P#!<KX
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MWT61+;Q(UUIUOX/^%O@2^AU07V@V<0FN=1O+3[))<QFR,SQ3P_D9_P $,O\
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M'>:-XDM)K];.^GM(;G46\-Z5+%=VL^F7<>M,S12S6OV2\^U/V*_A-8?LW_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,;>9;QY=&*;XRCMZ!_;6H?\ 0J>(/^__ (8_^:2@#H**Y_\ MK4/^A4\0?\
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M:I9Z;XCTVSU34[2PUNSAAU.SMM1OX+>ZCBO+A).D_MK4/^A4\0?]_P#PQ_\
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M;S6E[97<,=S:7=I<QM#<6MU;S*\-Q;W$+O%-#*CQRQNT<BLK$'XY_P"'</\
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MTE']M:A_T*GB#_O_ .&/_FDH Z"BN?\ [:U#_H5/$'_?_P ,?_-)1_;6H?\
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M_MK4/^A4\0?]_P#PQ_\ -)0!T%%<_P#VUJ'_ $*GB#_O_P"&/_FDH_MK4/\
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M $*GB#_O_P"&/_FDH_MK4/\ H5/$'_?_ ,,?_-)0!T%%<_\ VUJ'_0J>(/\
MO_X8_P#FDH_MK4/^A4\0?]__  Q_\TE '045S_\ ;6H?]"IX@_[_ /AC_P":
M2C^VM0_Z%3Q!_P!__#'_ ,TE '045S_]M:A_T*GB#_O_ .&/_FDH_MK4/^A4
M\0?]_P#PQ_\ -)0!T%%<_P#VUJ'_ $*GB#_O_P"&/_FDH_MK4/\ H5/$'_?_
M ,,?_-)0!T%%<_\ VUJ'_0J>(/\ O_X8_P#FDH_MK4/^A4\0?]__  Q_\TE
M'045S_\ ;6H?]"IX@_[_ /AC_P":2C^VM0_Z%3Q!_P!__#'_ ,TE '045S_]
MM:A_T*GB#_O_ .&/_FDH_MK4/^A4\0?]_P#PQ_\ -)0!T%?+O@7_ )$CP;_V
M*OA[_P!-%G7T%_;6H?\ 0J>(/^__ (8_^:2OGWP+_P B1X-_[%7P]_Z:+.@#
MUKX3_P#(F+_V-7Q#_P#5A>*:](KS?X3_ /(F+_V-7Q#_ /5A>*:](H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \O^(7_(:^&_\ V.5M_P"B7KU"O+_B
M%_R&OAO_ -CE;?\ HEZ]0H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K%3_D8KK_L"V/_ *7:C6U6*G_(Q77_ &!;'_TN
MU&@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#%T3_5ZC_P!AK5?_ $K>MJL71/\ 5ZC_ -AK5?\ TK>MJ@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *&J_P#(
M+U+_ *\+S_TGDJ2P_P"/&R_Z]+;_ -$I4>J_\@O4O^O"\_\ 2>2I+#_CQLO^
MO2V_]$I0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L;6.NE?]AFR_E-6S6-K'72O^PS9?RFH V:**\#_ &HO'WQ6^%_P
M"^)?C[X'_#__ (6E\5/#>BVUYX0\"?8-5U;^W+R;6--LKUO['T*XM-;UK^RM
M)N=0UK^Q='NK?5-8_L[^S;":*ZNHG'3@L)4Q^,PF!HRI0K8S$T,)2G7JPH4(
MU,15A1A*M7J.-.C2C*:=2K4E&%."E.;44V<&:YE0R?*\RS?%0Q-3"Y5@,9F6
M)IX/#5L9C*E# X>IBJT,+@\/&=?%8F=.E*-##4(3K5ZKC2IQE.44_?**^:/V
M1/B7\:OB[\!/!GCS]H+X6_\ "GOBAK!U5=:\&?8M6TCRK>TU.ZMM-U3_ (1S
MQ!<WOB+PQ_:=G''/_86O7EUJ=K_KI9C#<P*OTO58_!5<NQV,R^O*A.O@L36P
MM6>&KTL3AY5*%25.<J.(HRG2K4W*+<*D).,HV?D9Y+FN&SW*,LSK!T\72PF;
M8#"9CAJ6/P>(R_&TZ&,H0Q%*&+P6*A3Q&%Q$85$JM&M",Z<TXM.UW\L^-?VY
MOV)_AMXJUKP+\1?VP_V6? /C;PW=_8/$7@[QK^T%\)?"OBK0+_RHY_L6M>'M
M=\76&KZ5=^1-#-]FOK.";RI8Y-FR12?>? GC_P !_%+PGHWC[X9>-O"/Q%\"
M^(X9[CP]XT\">)-&\7>$]=M[6\N-.N9]&\1^'[W4-'U2&WU"SN[&>6QO)TAO
M+6XMI&6:"5%_"']G/]I+Q)^SK\>_^"OGBFV_98_:2^/7A#0/VNY_%WB;Q%\!
M(/@3KTF@VFE_ OX;/>Z7_P (9X_^.WPW^)7B76TLK;^TH[+P/X)\51SVDT<<
M%S)?+<64'B?PZ^.7Q-_9J_8PU+]H7X5ZQX;\"I_P55_X*'VMU\#M+^'7A?5/
MVG%_99\ _'C0=4N/$/B?1?AI\)],\0VGQ)^.NB:-\+?&GBF?X6^&-)\0>%K;
MXO7FG^'?%6GZ\EAXLTBZ^LJ<)QG%4\+4G&O)Y3"C5K8K#UZ6*KYC@:>-KT7A
ML+2>+P<L+0E5Q'[Q8B56A0E&,'5J48S^8H\72A)U,5"$J$5F]2O2I87$X>KA
M:&78Z>!H5EBL75C@\;'%XA4\/^[EAXTZ]>+E/V5&O.'].]%?S^>+O^"@7Q^_
M9ATC]K'Q+$O[37[3?P<^'G[*>N_'3X9?%K]JS]C3XC?LNZIX3^-VA>)O#G@=
M?@EXMUZ+]G;]E_P)XY\)>(8?$=A\2-$ET+P3I/C&TL='\<:!<^)]3;^P9-.^
MG_BUK/[:7[#_ ,)?%O[2OCC]H_3_ -J3P'\-OV</B?XR^.7@3XD^"?AU\/YM
M-^+?A7P,VN^"-1_9UD^#/PF\':E'X!\0^/H9_#'B?PC\9O%?B_7="\#7VG:Y
MIGCW5O$FBW]KXC\N?#.-IRH1GB,'">,J>QP$)O%4YXVNJ-"M4H4H5<)"5"K2
M^LX>DXXY83VE6K"-!U8OF/5I\48&K&O.&&QLX8.G[?'U*:PE6G@</*M7I4\1
M5J4L94A7HU5AL15C+ 2QG)2I3E75*2Y3]9*Y+P;X^\"?$;3+W6OA[XU\)>.]
M'TW7=:\+ZCJW@WQ'H_BC3+#Q-X;OY=+\1>';V_T2\OK6UUW0-3@FT[6M(GEC
MU#2K^&6SOK>"XC>,?B!\$/VK/VI+7Q-^Q]XE;X@?M:?M-3_''QCX<\)?M.?"
M[Q=_P3D^,'P3^"7PA\/?%;1KG5=/^*WP-^,A_97^&,^B^%/@IXP7P_X<U4_%
M[XK?&&R^(/PRUK6O$?\ :.@:[I]IX@M\C]G#]M?]J"?Q)^S[\4OB[\4)_%OP
M/^(O[=O[7W[#?Q!T.7P7\-=(MO#OB&?XB:SIG[(7B2QU#PWX1T'Q';O::OX/
MO?A%K,ESK5WIVNMXV\-W^J6=SXFMXK[4]Y\)XZG#$-U<+*=*-X>]BZ,JDXPS
M&;H0P^(P%*O.M667R6'<E1I5)5:$:<ZKJ3]CA#B[ 5*F'2I8J,:SM-<F#KJG
M&=3+*<:]3$8;,*M"%&B\R@\0H.O4IQHXB52-)4H>W_H#HK^<B_\ ^"A7[1WB
M31/A!JVG?$SQGX9\$?MX_MF_'J+X$^-OAS^SQ)\</B+\)OV%_P!FS246:\^%
MGPH^'7PI^*'B'QI\5/C=J'AR^UG3/&OQ%\'_ !8\+^"O"OC(^);CPC+H&BP7
MEMU7B7]OS]J#X,^ ?VG/#UNWQF^(]C9^+OV7_"'[*?[47[4_[(?Q _9QEEUO
M]I+XG6WPL\<:%\4O#&M_"C]G'PQXVU#X%7%W:>,]!O/ /P]\-VGBW2-5T[1?
M$4,<NGZEKMU3X-S9.$>?"NI4J0I1AS8I+F>/AEE5.O+"K#*>'QSJT*]'V_UB
M*PV(K0HU,/&%:I*XTRAJI+DQ?LZ=.=653EPK?*LOEFE)JA'%RQ3AB<![&O0K
M^P^K-XK#T*E:GB)3HT_WCO\ QUX(TOQ=X?\ A_J?C'PKIWCSQ9I>N:WX5\$W
M_B'2+3Q=XET7PRVGIXDU?P_X;N+R/6=9TOP^^K:4FN7^G65S::2VIZ>M_+;F
M\MA(SQ#X^\">$=8\(>'O%?C7PEX8\0?$'5[GP_X"T/Q#XCT?1=8\;Z]9Z=<Z
MQ>:)X0TS4KRVO?$NKVFDV=WJESINC07MY!IUK<WLL*6T$LJ_CS??";XO?#'_
M (*L_L(2_$G]HKQ=^T/I.N?LR_MF6^B:O\1?!?PF\*>-="\3:+/\ V\:11R_
M!;X>_"WP?<^!M7MM7\)7/A72-0\*:CXNT'5K;Q>VK^./$>EZMX?TWPWZ7_P4
M*_=_M=_\$B[B3Y(%_:\^(%NT[_+"MQ=_L\_$9+6!I&P@FN71DMXBV^9E98U8
M@@<T<DP[Q.7T(8U5X8S)\PS*5>A"HJ?M<%'-FJ5)8BE0J\CEEL(3=2E"2E.I
MRII0;Z99YB(X;,:\\$\//!9UEN5QH8B=-U/98Z63*5:J\/6KTN>,<SG.FJ=6
M<7&%/G<9.<5^G'B+XA> ?"&N>#O#/BSQQX/\+^)/B)JEYH?P_P##WB+Q-HNB
MZYXYUK3M/EU;4-'\':3J5[;7_B;5+'2X)M2O-/T6WOKNUT^&6\GA2WC>0;FM
MZWHOAG1=7\2>)-7TOP_X=\/Z7J&MZ]KVMZA::3HNB:+I-I-?ZIJ^KZI?S6]C
MINEZ;8V\][J&H7L\-I9VD,UQ<31PQNZ_DW_P4&MYKK]N'_@CU' F]U_::^-5
MPR[E7$-I^SWXJNKA\NR@^7;PRR;0=S[=B*SLJGV[_@IC\(KKX[?L[Z!\+M!^
M+7P>^&'Q UOXX_!K7OA1H7Q^NHV^#WQS^)_PX\70?%#PG\!?'_AM;ZVU'QQX
M<\>W/@N:YU/PGHEAXCUF>TT&;6+/PWJPT:6),*>54)2X?]KBI4:>;TIU<36=
M)U%A*=/,\9@9SC"FG.<84L+[:5UHW*]HQN;SS;$*/$/LL)&O5R>M3H86BJJI
M/&5*F5X''0IRJ5&H0G*MC/8Q2W2A9.<K/Z8^$O[3W[-7Q]O]8TOX$_M#? WX
MU:GX>M+:_P!?T[X2_%KP#\1[_0["\F>WL[W6+3P=X@UFXTRTNKB.2"VN;V."
M&>:-XHG9T91[E7XR:/\ '+Q0_P"V1^S7I?\ P4%_85M_@I\:+3Q!XQ^&/[(7
M[6'P?^-D/Q@^#7Q"\8^(OAGXAG^*_AC5;;3;7X<?$/X>:#XN\/Z>MW\.O!7Q
MD\">+;/6-5M]1U=&T#7_  #9^)+[]FZPS; + 5<.H1FJ>(PT:\6\5@L?1E>K
M5I2^KX[ 5)X?%4U[->T;IX>MA\1[;"5J"GAW4J]&49A+,*6(<Y0=3#8J6'FE
MA<;@*\;4J-5?6<!F%.&(PE1^U;II5,31Q&&]AC*.(E#$*G2^:/B)^VE^QS\(
M/%VI_#_XL_M9?LS_  O\>:*EA)K/@GXB?'?X6^"?%VDQZII]KJVF2:GX;\2^
M*M,UFP34=*O;+4[!KJRB6\T^[M;RW,EM<12.:K^VC^QUH7@;PK\3M;_:Q_9H
MT;X:^.K[6M,\$?$+5?CM\+=.\#>,=2\-W!L_$.G^%?%EWXJAT#Q#?:#=@VNM
M6FD:A>7&EW ,%]'!*"M?FK\(->_:.T;_ (*<_P#!5U?@/\*?@E\2+6XU+]B)
MO$LWQ<_: \=_!.XTFXC_ &:HAID6AVW@W]FCX_Q^(8;R-[U[^>_N_##Z:]O:
MQV]OJJWDTMCZ;^T[<^*+S]OO_@BU=>-M'T#P]XPN/&7[94WB;0O"OB34?&/A
MO2-;D_8T\:-J.GZ%XKU?PIX%U3Q%I5K=&2&RUC4/!OA>[U"!$N9]"TV21K6/
MV'D>"AB,-0FZ\E/)?[7JU89C@74GR\,RS^>&C@HX>>(PB=1+#0Q%=U(^S7M5
M3FYQBO&6?8V>'Q.(@J"Y,[_L:E2J9=CXPAS<40X?AB98Z>(AAL8XTW+%3P^'
MC3;F_9>U@J<Y/]%OA)^T'\!/C]9ZUJ'P(^-_PA^-=AX;N;.S\17WPD^)7@SX
MCV>@WFH133V%KK5SX.UK68=+N;Z&VN)K."^>"6YB@FDA1TB<KNZI\6_A5H?Q
M$\,?"'6_B;\/M'^+/C;2]1USP;\+]4\9^'-/^(GBW1=(@O[G5M7\,>"KO4H?
M$NO:7I=MI>IW&HZAI6F7=I90:=?RW,T4=I<-'^9W[920^ _^"DG_  2V^(O@
M:*/3OB9\4_$WQ]^ 'Q!?3(KI=2^(/P"L_A'K_P 2[KP]XHCT^:&;6O#/PW\=
M:=IGQ T)-06XLO"WB&[N=8C$-O?ZM%?_ (__ !R^,MO\8-:_:C_X*/\ @GP5
M\>?%_P :O@C^T_\ "^]_8LET+]E7]J/QO\*->_9@_8O\0>)?"WQ"BL?CWX1^
M$M_\,-"\)?M!S>//VC]6\96]UXYL=/T6WMM BUVXT36K>ZN-)VR_A:GF3P]>
MC4Q5+"8S 4ZM#FIJM4HX_$9EB<JPV'Q%6$*<'AG6PF(QE7%JG2C#!T:L7&-6
MG>6&8\5U,L6(H5J6%JXO!9A.CB.6HZ%.OE^'RS"9MBL3AJ-2=2HL2J.-P^"H
MX/VM:4\;7HR4Y4JEE_7E7@/Q7_:N_9;^ VO6'A;XY?M*? 'X,^)]5TB+Q!I?
MASXK_&/X=_#O7M2T&>\O=.AUNPTCQ?XCT?4+S2)M0TW4;"+4K>WDLY+RPO;5
M)C/:SI'Z7\.?'WAGXK?#WP'\4?!5\-4\&_$GP9X7\?>$M3 0#4?#/C'0['Q%
MH-\!&\J 7>E:C:7 "2R(/,PKN,,?RM_X(Q>'-!^('["]M\<O'^F:1XN^-7[5
M_C/XQ^+OVH?$6OVVG:YK?B[Q3!\4/'_@N'P'XNEN8[F2;P[\/_"5C;>!] \$
M7Y.C^&]&CN["PTJP@U&[@E\/"X"BL)C\=CO;JG@,7@L#/"T7"EB)XC&QQTUS
M5*L*D:,*%/+\1[2]&I*55T:2C!3G5I^]BLPK/&9?@,!]7=3'X3'8^.*KJ=7#
MPPV!E@*;4:=*I2E6J5ZF8X=4[5J<(4E6K-S<(4JG["T5_+;X'^,WQZ^!?@+X
MF_L]?LU?$JX^&'P]T;_@NAH'[%'PH\3_ /"->&O'5K\-O@C\6=.BOO&GPQ\%
M:3X\TGQ%HB6/PC\4Z[=7?@RR:V,>DWMM9>'[N5] 6\TR;[P\(:;^VS\0/VV?
MVC/V8[3]O+XK^'_A)\ ?@7\!_%\'CFV^#W[(][\8-?\ B+\9M7^,T^B_VQ?7
MW[/S_#P^%;;1O"4UMXDTS1_AGI>H:I+X6\)2Z'KW@Z6Y\7'Q=ZF*X4JX95ZD
M\TR^GAZ-&>)C/$1QT*TL*JF!I0J5*.'PF+A3J3J9CA:;H1KU)PJ.I%MQIN;\
MK"\6TL3["G'*LQJ8BM6AA90PTL#4HQQ;IXZK.E3K8G&8.=2E"GEV*J+$2H4H
M3IJG*T95%!?KQJ_COP/X?\3>$/!6O^,O"FB>,OB"^O1^ ?"6K^(=(TWQ-XWD
M\+:8-:\3Q^$-!O;R'5?$K^'-&(U;7ET6TO6TC3"+_4!;VI\VNJK^8B'XP_&W
M]LGXP_\ !'+5=2^)%K\*?C=I/Q?_ ."EOP:^(WQ;^&OA3PMJ\-UJ'P0\$:OX
M$\4>,_AKX:\?Z;XN\'V5]\2/#OA5;G3_ /A*_#7B#0_!^K>)[ZZB\,Z_9:%I
M]CJ7TQ<_M??M#_#KP9^VO\(?%?[1WAF3Q5\"OVQO@A^SG\/_ -HWXA_">3Q-
M\7]2\"_M&^'_ (<>(+:S\%_ C]G3X4ZAH?QL_::\(P^.]3T;X0^&?#OPCTOP
M9XNU?3-(UWXD>&/^$7T;Q8NI77X1Q5/ZO2IXK#SQDJ4I8O"VQ,YTFN(,7D,:
MU!T<+4A7P\JU&A)1A.6,DZLG#"RBDWGA^,<)4^LUJN%Q,,%&K".#Q5\-"%52
MX>P6?RHUU6Q5.=#$QHXBO%RG".#BJ45/%1FY)?N_17\ZVC_MQ_M0^%O%G[:7
MP]_X2;]IZ7PYX7_X)J_'?]K?X#>-OVRO@E^SI\,/C;I7CGX1^*?%?P^LO%.B
M^!OA)X2\"6\'PQ\2WB:1XET+PK^T)\#_  K\2O/T@7.JZ'#X8UBWL[_V;X;_
M !N_:R^'.L_\$K?'_P 2/VD]<^-6D_MUPVWACXQ_"W7?AG\%_"'@7PAJ_C']
MG;4_C-X9\3_"#5O 7P\\-_$C1;SPGK7ALZ-J]CX^\;_$;2?%^E:SJTMMI_A&
M\71WT?&MPICJ$92GB\ONJ=2I2A&IBY2Q'LLOJYC5A2:P?)"=.E1J4IQQ,J%L
M1%T[\OOF]'B[ 5Y04,'F*3JTJ564J>$C'#.MF%'+:4ZJ^N\TZ=2KB*5:,L-'
M$7PTE42YO</V"^)OQ;^%7P4\+R>./C+\3?A]\)?!<-]9Z9+XO^)OC/PYX#\+
MQ:EJ#.MAI\GB#Q5J6E:2E]?-'(MG:-=BXN6C<0QN48#A?A/^U5^R_P#'K6M1
M\-_ S]I#X"?&?Q%H^EG6]7T'X3_&'X>_$76M+T5;NVL&U?4=+\'^(M8OK'2U
MOKRSLCJ%S!%:"[NK:W,WG3Q(_P *_P#!8'_DB_[+?_:17]A__P!7/I=4/^"O
MQA\'?#G]E;XZ>%_)TGXX_"3]MK]G2P^#_BFPMW7Q4$^*_C6T^''Q-^'VG7MD
MT.IWGA?XE_#K6-:TKQOX/6:72?%>G:;9#4["YN=)TJYL8P&387&4,JA*>(CB
M\XQ6/PE"I&5/ZOAZF&CAU0=:BZ3J5*=:K74:U2->F\/3O5C3K.'LIWF&=8K!
MU\VG&GAY83)L+@,77IRA4^LXBEBI8AU_8UE65.E4HTJ$IT:<Z%18BIRTI5*"
ME[6'ZZ45_/!XI_:(_;2O?@'_ ,%9_P!IG2_VJ/%WAZ3]C;XY?M;_  I^"/PL
MT#X5?L^WO@U/#WPR\%Z=K?AC7O&NH^(OA#KOCG7=<\,:CXULYM+:U\5:9H\F
MG>#+(>,+#Q8VLZPX^UOB9^T[\4_ _P 5_P#@F!8-XJN!X,^.G@?X]^*?CQI%
MIX>\*7%WXY'P]_92N?BGHYM;F\TJ.Y\/W%EXLMVU:&'PQJ/ANWO9"NG:B\ND
M$V@FKPSC*3@HXG UI2CC7*-*>*O3G@,ICG%:E/VN$I)U)86<(4W3<Z<J\N25
M2,%*HJI<48*HI.6%QU&*E@5&56&%M4AF&;RR6A5A[+%U6J<<7&4ZJJ*%6-"/
M/&G*;C3?ZDUS7C'QGX/^'?A?6_&_Q \5^&O W@OPS82ZIXD\7^,==TOPSX7\
M/Z9 5$VHZWK^M75CI.E6$)91+>7]W;V\990\@R,_SR^+/VB_V[[G]@_X ?\
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MOVL_V;/AK\2/"/Q T+]H#6?V2_V5[3XE?&KP+\?O#_C74_#GA2?Q?\"_CO\
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M#PO\$/VL?CUH?[/6I7^B?'[XK? 7X-VGC3X5?"#7=$LHM3\3:'XG\1ZMXO\
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MX]_M%?&+XT>(_@_XU^!_@OXT>.]:^$^D^+O@5X)^(%B;;Q1=? [PK\+/@_\
M#?X-^#O&FIW<6FZI>>/]0^%WB#QCJ,VB:1H^KZSJ/A2U;P]+]%_!'X$_#OX
M? WX=?L\> M+=OAM\,_ 6D?#O1K#7/L>I76J:)I>FIIUQ=>(WCL[2QU35?$#
M?:=1\17"Z?;6NI:EJ%_/]BACN/(7V*BJKYECL335*MB)RHQE3G"C%0I4:;HP
MG"BJ5&E&%.E&E&K5]G"G&,(2K5I1BI5:CDL/EF!PM1UJ.'A&M*%2$ZTI3JUJ
MD:TZ<ZSJUJLIU*LZLJ5'VE2I*4YQHT8RDXTJ<8_._P"RM^S7X._9$^"7A;X
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M:+=7U[XBT/4O$$;>'+35YKQ)Y8/B?]A7]L[5_@!_P3N_X)C_  +^#_P4U?\
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M$E?K8^FPF*HXW"X;&X>7/A\7AZ.*H3:LY4<13C5I2:>JYH3B[/:]@HHHK Z
MHHHH **** "BBB@ HHHH _/?_@HU_P DF\%_]E$MO_4:\1U^-]?LA_P4:_Y)
M-X+_ .RB6W_J->(Z_&^L9_$_E^2.NC\"]6%%%%2:A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH **** "L;6.NE?\ 89LOY35LUC:QUTK_ +#-E_*:@#9KP/\
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MGQ;^,_Q%_9._:$\!?#'PG^T'XQ;XJ?$SX0?&K]G_ %7XY^#+'XPWNCZ'X?\
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M!FI^-?$6J:5I=AXATX-+,?"G_P""P=K\/?#_ .UWI6L^+_V9_P!KOQ7^S_\
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M^$/A[]K3XS_M)?M)_LZ^(O%^LV/C/7/V>_!=A^Q[J'B&7XS_ !?TKP1:>*-
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MQE;+J>75OK.'K49PJQHPHNOA)*KI6QF(YZ2=&A-_S4_&/_@F_P#M ?"?P/\
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M4J6!PF&P=*4]9RIX:C"C!R:WDXP3EYW"BBBN0ZPHHHH **** "BBB@ HHHH
M^:OVD_AEH/Q;T[X?>#_$=WJ]EIEQXYMKAY]$N+*VO@_]FW]EA);^PU*W"^5>
MRM@VK'S%C.[:&1_&_P#AW3\$O^AH^*?_ (._"7_S$5]4_$+_ )#7PW_['*V_
M]$O7J%)I/=(I3E%64FD? W_#NGX)?]#1\4__  =^$O\ YB*/^'=/P2_Z&CXI
M_P#@[\)?_,17WS12Y8]E_7_#?GW8_:3_ )F? W_#NGX)?]#1\4__  =^$O\
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M^'=/P2_Z&CXI_P#@[\)?_,17WS11RQ[+^O\ AOS[L/:3_F9\#?\ #NGX)?\
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M- %55 ^K'+,2Q)-ZBFDELA.4I6NV[;7*&J_\@O4O^O"\_P#2>2I+#_CQLO\
MKTMO_1*5'JO_ ""]2_Z\+S_TGDJ2P_X\;+_KTMO_ $2E,DMT444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-K'72O^PS9?RF
MK9K&UCKI7_89LOY34 ;-%%% !1110!^.7P2_X*.^(M.U?_@I)XZ_:F\&^//A
MS\&/V6/C];^"O".L7&E?"G5+?0-+;P3\']%\/?":UTKX:_$/QKX^\8_%/X@>
M./%X\3:3*=+UKPU>R^/-(\/67BS1K^W_ .$(T#[*^%/[9/ASQ]\6=.^!7Q!^
M#WQJ_9I^+OB?X?3_ !2^'G@GX\67PN2?XG>"=+U"+3/%5[X)\0_!_P"*GQ>\
M'SZ_X'N[S2'\9> ->\1Z!\1=$TS7-*UZ3PE+X?DNM4M?S(^*?[#7[27CRQ_X
M*+_#K1_A[]@U?XE?MB_"7]M[]F[XGZSXO\!?\*:\?WWPPT_]G^^A^$?BZQLO
M%&H?%G0/$6KW?@'Q9H%Y<:W\*K?P1IURMCKT'BO6+:&VLM2^M]$\!?M ?M,?
MMF?LS_M&_$[X >(_V7_ '[)WPP^,D-EH'Q)\<?"3QOX^^)/Q:_:!TCP[X2UG
M3?#EO\#_ (D_$OPMIOPU^'_A?PM->OXM\6:_HGBKQ+KVO6.G6/P[LM/L[W6[
M;[G'83(:M*IB*4L!1O@IRDL-CJ<9X:K0R'+:V7QP^$>(J5,34S#-9XK"YBW"
MM4HM3G4CA)T:E:M\%E^,X@I5:>'JPS"MRXV$8_6L!5E#$TL1G^8T<QGB,8L/
M3IX:GEV4PPN*RY*=&G73A"G+&0JTJ-'ZP^/G[3OA7X#:W\+? Y\%?$3XL_%G
MXV:MXDTOX5_"#X56/A*;QGXNB\%:/%XA\<ZV-6^(OC+X<_#?PWX=\&Z+<6=[
MK>L^,_'OART:74-,TK2FU/6]3T_3+GQ&U_X*/_ ^#X9_&#QSXP\)_%[X>^-?
M@?\ %+P_\#/&?[/OB+PIH.N?'._^-7CM]#C^%7PO\#:)\-_%WCSP1\0_$GQ;
M/BCPU+X$NO!GC_6O#;6.LKJWB?7O#.D:1XCO]%X#_@H%\)/CW\3?B1^S/<>&
M/!OQJ^,7[+6F0?''0OVG/@;^SM\?XOV=OB?XRN?&'@O2;+X5>(+KQ%>?&O\
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MZ+HWQN:&P7P]XACU7PI%XJL])M[W[_\ B%^VC\%/AUXS^ 7@Z_N]<U]/VA_
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MG\%>(TUG]GWXO7?[27_!+GQ];^$?,\)?LZ?!G]HCPG\9=6_M_P ,)_PAVO\
MCKX0?";POX5L/L#ZTNI^(?[4UWPSK=C]J\*V>N65C]B^U:C<V=G<VEQ<;7[;
MWPH^+GB;XR_L%?&SX8?#76OBWIG[.7Q_\:>*_B)X,\(^(?AYH/C4^%O&_P #
M_B'\/K77M!'Q3\:?#KP;J=MHNOZWI1UNQE\8V>MBQNQ<Z-I6LO!=0P>+AZ>3
MT\RP,HPP4\/B,IS>5:ABL4IX:CC::SK"X&-2K*M3=*I66'R_$Q]I5@E5Q$:U
M%4J4Z$8>Y7JYU4RW'1G/&PQ&&SC)8T:^%PCAB:V J/(\7F$J=*-&HJU*B\3F
M.&E[.E-NEAI4*OM:M.NYM\5_\%+_ (0>&?\ A;'BJT^%GQ[\8? +X"_$*?X8
M?&S]J/P?X9\ ZC\&?ASXKT?5M*T/QL+G2K_XF:5\<O&GA_X:ZKK%K:_$/Q=\
M+_@SX[\+>&DM=;O9]8FT_P ->([O2OKKXR>,[O0_@)\5?B'X'UJT-_H_PA\<
M^,_"'B&P_L[6+ W>G^#-4USP_K5D9H[[2=4M#-#:7UMYL5YIU[#L\R.XMI2K
M_C=;?LV?MA_"O]E']KW_ ()Y>"?V?I/'^D?'OQA^T3HGPC_:A/Q)^%6D_"/P
M]\*OVL_$>OWOB;7?C3HFL>-],^/%GX]^$VB>._%?_$K\"?"3XE:9XTU;1?#=
MI9:[8:;J=_=Z+^L/B+X1:CH/[(NN_ ;P?O\ $>K:+^SCJ?PB\+>8UKI4FO:C
MIWPRG\&Z)O;4+\V6FOJES#:[FOM3-K9M.3<WYBC>XJ,QP>48:I@WA*V'J1_M
M%TDXXNEBEB<MA3P<Z6-QE-3G]3KU:E2NJN'J1HJ,?W+P].>&JSJZY;C,XQ5/
M&+&4<13E_9T:LHRP=7"O"YG.IC(5<#@JLH0^NX>E"G0=+$4_;.4G[98FI#$T
M:='\BT^)7[5WAG_@E'H/_!1#5_\ @H+\7/\ A9NG_LM>$?VCKSP1\0OAI^QG
M'\"O%?C*;PYI'BG_ (59J&F^$_V7?!GQ.M] ^(NK3+\/-#CT#XL:-XMM;_Q%
MICV/B4ZA%')+WWPM_P""A/[1-U^U]\</ /B'X%?'?XPZ#IG[)'[(OQQT7X$?
M!SPG\%[/6OA!KWQ"\'>(]=^+QUKQ/\5_''P=N-7U";6[CPYH.D>![KQOXH\:
M:E=V%\_@WP9+9:5XLO+#W;]@O_@G#^SI\'/V:_V4)/BK^QG^S3H'[3_PS^&/
MPHN_&GC*;X.?!;7OB-H?QC\)Z1I%WJ'B0?$W0M%U>ZU#Q?I?BJQ.I0>,=(\3
M7UR^JV\>JV.KRS"*Z/H7P;^!OQ3\*?\ !1[]M7X]:_X7^P?"?XM_!K]E;PI\
M/?%?]M^';K_A(-?^&]M\2X_&EA_85EJ]SXETK^QG\0:0/M6MZ/IMEJ/VO.DW
M-\+>Z,/K8G'Y#)\0T5@\OQ7L%CZN!K2PN!RZ%15,WR>EA\)@O[/FIUU2P]/%
M5H8F%95YX:=:-.%&E+$2J^-ALOX@C'AVM+&9CA?K$LNI8ZC'%X_,ITW3R?.*
MN)Q>._M&#AAW5Q-3"4)X:=%T(8JG1G4G5K*A&EK1?\%$O@OXG\)?LYZ[\&O"
M?Q3^/WBO]J?PIXC\>?"7X3_#32/!>D?$"?P3X(MK=O'_ (I\77/Q?\>?"SX=
M^!=+\$:O?:=X4U8>*O'^EWVJ^+-0M]#\'V?B:YBO3:4K7_@HU\(;WX:MXQM_
MAW\:F^(R?M.7G[&K?LWR:!X&@^,__#2MA:3^(+GX:#4Y_B)%\"F1?AY;R_%*
M/QXOQK/PQN/ @2XMO&LOB&6+PZ_Y:^ /V+OVO?"7P#_8<^#WQG^"WQS^*7[/
M'@_X ?M!?#3]I/\ 9>_9T_:@\*_!CQG/\1?B!X_N]4\+>(/&VN:1^T1\!_"'
MQ:^'-UX$FU#PU>>#Q\9-5T^RE\17]S=^%[SS;V&77^#'[#/Q \,_!#]L+X>?
M'#_@F1\/?'?PE^./[;-A\9?#/[,_PU^,'P<\$WO@/X0>(/AKX*T33==^!^I:
M9K/@GPCI7Q6^%FIZ==Z'XCTF7X@?L_6TJ-XOO_AWX_\ $&E7.DV7BFYY+PQ3
MC5MC:-=4<9/V;IYGESJXG#K-L1@X0;K9C@X-?48TL5.DJ&$4XKVU+-U3Q,88
M:*>=\55)47+ UJ$JV"I^UC5RK,HTL-B7D^%QM25J.6XV<7]>G7PE.JZ^+<)R
M=&KD\JN$E/$_JIK_ .WCX!^'GP<^*?Q@^-_P@_:(^ K?"KQ1H?@FY^&_Q&^'
M.FZIX^^(GB_Q@NCP_#_P[\$[GX6>*_B3\-_C1J7CS6-=L/#>C)\./B)XAAT;
MQ +ZR\<S>$8]*U.XM.R^#_[6N@_$WXL^(?@)XO\ A-\8?V??C9H?@:#XHV7P
MW^,UI\-+F_\ %WPR?6+3PW>>.O!GBOX,_$WXP_#G7M(T/Q-J&G>'O$>G1^-(
M?$_A_4]3TG^U] M++5]+O+S\@_&W["W[9GQ@^&7Q[-FOQYT'P+X,_:E_9D_:
M<_9'_9H_:@_:XU7Q?\<KZ^^#'AR<?'#P//\ M2?#CXI_%_Q=\&/#OQ8NM1M;
M/X*S67Q]\<ZEX \:^$Y/&]]=_#X>--4N-/\ K[]F?]FGQ1_PUQ9?'W4/V=/C
M!\%_!?P\^$'B+P'X;UW]K?\ :]^+?[4/[1'B'Q/X\UO2KW7].\$:99?ME?M)
M_!7X??":STKP_ITVMSZU<ZGXY\4^*?[._L[2?#6FZ(VJ:IQ8K+>'J6"Q52.+
MI5,2J=:I%8;%X:<</5^J9?6PF'ITZF/]M64Z^(Q%#%NC3S.-.490I8M+!5J^
M([L+FG$=;&X.G+!UJ>&<Z%*?UK"8JG*O2^N8^AC,35JT\N5&C*.'P^'Q&#5:
MIE4IQG&=7!MXZC0PWU7^U0/C#%<^#=9TK]I+P5^R/^S9X1L/%GBC]H/XV2W?
MPZC^*=O);V5MIO@'PWX5NOCI\-_B#\"O!_@FXUC4;K6?B!XQ\8:=J7B"0:5H
M/AOPM9:5_:^J:[!P_P#P3>^.OQ)_:%_9\UCQQ\0/$EM\1]*TKXQ?%7P'\)?C
MC;>%K;P2?VAO@[X(\1'0O!GQJNO"NGP6&C:5?^+)+?5;2^?P]H^@^&=7N='D
MU[PWH.DZ)JMA9Q>N?'+QS^TS\.O''PWU_P"%/P9T_P"/WP:O+/Q5H_Q;\"^#
MM8\(^%?V@M!U^2UMKWP#XT^'^J_%GXG_  V^#GB;P6ES::IX>\?>%-?U_P ,
M^*[%M6T+Q-X6U7Q!#8ZQX;;P_P#8"^!'Q7^%]U^U7\6?BQX9L_A5J7[5G[1V
MO?'32/@'IWB#1O$T?PFTZ[\->'?"CR>)=9\*7-SX'OOB7\0+CPZWC/XB3^#;
MO6M&_M;4+>W_ .$K\4W5M/J;>:EAWP_6599;&O%X:>"G2G@I8VH_K6(AB*%:
ME""S*%;DG*LZ^(J2P/U6C1I0HJK4PU5>FWB5Q%1='^TI8>4<53QL*L<;' TU
M]5PT\/B*%6<WEDZ//"-!4,/2CC_K5>O6E6=&EBJ3_0^BBBOG#Z4**** "BBB
M@ HHHH **** "BBB@ HHHH **** "OEWP+_R)'@W_L5?#W_IHLZ^HJ^7? O_
M ")'@W_L5?#W_IHLZ /6OA/_ ,B8O_8U?$/_ -6%XIKTBOQ9\?7U[#XZ\9QQ
M7EU%&OBKQ!MCCN)41<ZM=L<*KA1EB6.!R22>2:Y+^TM1_P"?^]_\"I__ (Y0
M!^Z=%?A9_:6H_P#/_>_^!4__ ,<H_M+4?^?^]_\  J?_ ..4 ?NG17X6?VEJ
M/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P# J?\ ^.4 ?NG17X6?VEJ/_/\ WO\
MX%3_ /QRC^TM1_Y_[W_P*G_^.4 ?NG17X6?VEJ/_ #_WO_@5/_\ '*/[2U'_
M )_[W_P*G_\ CE '[IT5^%G]I:C_ ,_][_X%3_\ QRC^TM1_Y_[W_P "I_\
MXY0!^Z=%?A9_:6H_\_\ >_\ @5/_ /'*/[2U'_G_ +W_ ,"I_P#XY0!^Z=%?
MA9_:6H_\_P#>_P#@5/\ _'*/[2U'_G_O?_ J?_XY0!^Z=%?A9_:6H_\ /_>_
M^!4__P <H_M+4?\ G_O?_ J?_P".4 ?NG17X6?VEJ/\ S_WO_@5/_P#'*/[2
MU'_G_O?_  *G_P#CE '[IT5^%G]I:C_S_P![_P"!4_\ \<H_M+4?^?\ O?\
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M?VEJ/_/_ 'O_ (%3_P#QR@#]TZ*_"S^TM1_Y_P"]_P# J?\ ^.4?VEJ/_/\
MWO\ X%3_ /QR@#]TZ*_"S^TM1_Y_[W_P*G_^.4?VEJ/_ #_WO_@5/_\ '* /
MW3HK\+/[2U'_ )_[W_P*G_\ CE']I:C_ ,_][_X%3_\ QR@#]TZ*_"S^TM1_
MY_[W_P "I_\ XY1_:6H_\_\ >_\ @5/_ /'* /W3HK\+/[2U'_G_ +W_ ,"I
M_P#XY1_:6H_\_P#>_P#@5/\ _'* /W3HK\+/[2U'_G_O?_ J?_XY1_:6H_\
M/_>_^!4__P <H _=.BOPL_M+4?\ G_O?_ J?_P".4?VEJ/\ S_WO_@5/_P#'
M* /W3HK\+/[2U'_G_O?_  *G_P#CE']I:C_S_P![_P"!4_\ \<H _=.L5/\
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M?^?^]_\  J?_ ..4 ?NG17X6?VEJ/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P#
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M?VEJ/_/_ 'O_ (%3_P#QRC^TM1_Y_P"]_P# J?\ ^.4 ?NG17X6?VEJ/_/\
MWO\ X%3_ /QRC^TM1_Y_[W_P*G_^.4 ?NG17X6?VEJ/_ #_WO_@5/_\ '*/[
M2U'_ )_[W_P*G_\ CE '[IUC:QUTK_L,V7\IJ_$7^TM1_P"?^]_\"I__ (Y2
M'4=0.,WUX<'(S=3G!'0CY^"/6@#]U**_"S^TM1_Y_P"]_P# J?\ ^.4?VEJ/
M_/\ WO\ X%3_ /QR@#]TZ*_"S^TM1_Y_[W_P*G_^.4?VEJ/_ #_WO_@5/_\
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M_G_O?_ J?_XY1_:6H_\ /_>_^!4__P <K(U/W3HK\+/[2U'_ )_[W_P*G_\
MCE']I:C_ ,_][_X%3_\ QR@#]TZ*_"S^TM1_Y_[W_P "I_\ XY1_:6H_\_\
M>_\ @5/_ /'* /W3HK\+/[2U'_G_ +W_ ,"I_P#XY1_:6H_\_P#>_P#@5/\
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+OA[_ --%G0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img117130267_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1A"08# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%U^>?_!)+_CQ^)'_ %TLOY35^AE<N84H4<3*G35DK?DCJR^K.OAH5*CNW?\
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M&7[PM;A)2/KM)IV=KBNKV-*N&^-_Q)?X0?"GQ)XQCT]=4?2+;[0+-I?*$OS
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MO.OP*\3>//$L7B/5$7Q#JJJMU* /MLG W'_:K]]:_GM\4_\ (S:M_P!?<O\
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M*2_%_P# ,;O'9G9?#%_@O\V?;U%%%?&GV@4444 ?DO\ \%0?^3C8/^P/;_\
MH3UZ+_P21_Y#_P 2O^O6Q_\ 0YJ\Z_X*@_\ )QL'_8'M_P#T)Z]%_P""2/\
MR'_B5_UZV/\ Z'-7VE7_ )%/R7YH^(I?\C=^K_)GZ1U^7/\ P4[\3:QHOQTT
MF+3]6OK&)M&B8QV]R\:D^9)S@'&:_4:ORG_X*G?\EYT;_L"Q?^C)*\;)U?%*
M_9GM9TVL([=T>*^&/VHO&/A#X2^(/!VFZK?Q7>M7L<UQJK7;-*ENB,#"F>4W
M,02P.<#'>O,?#EMJVK>)-.M-*><ZO>W*06QB<B1I78*N".<DFOH?_@G[\#M(
M^-'QHE/B*R74=!T2S:\GM) #'-(2$C1QW7))QWVCM7ZHS_ [X?7%[I%VW@W1
M4NM)E2:QFBLTC>!T^X05 Z>]>_BLPHX&HZ:A=O5_H?/X7+JV.I*I*=DM%^IR
MOQ4^)T'[+_[/::QJMQ)K5_I-A!8P-=,3)?76P(I<\GD@LQ] :_('XA?&+XA?
M'WQ3YNMZMJ.N7MU(5M].M]QB3))"10KP /0#-?LQ\<?@%X5_:#\.VFB^*TO&
MM+2?[3";.X,163:5R<<'@GJ*\Q^%'[(OPI_9@\87?C*#5Y8YQ:&&(Z[=0^7:
MJ2-TB$JI#'&,D]"0.M>+@<7A\-3E)QO4?D>WC\'B,54C!2M37G^)^6GB/]GS
MXG^#-,?4]9\#Z_IEC"OF/<SV,BH@&/F)QP!D<UN_ ?\ :D\<_ CQ/9WNF:M<
MWND"0"[T>ZE9[>>/(W#:3\K8Z,,$'\17ZC?$3]M?X(^%-,O;?4/&%EKF^)HW
ML=*4WC2@Y4I\N5&>1\Q'O7XQ:O-;W.JWDMHACM9)G:)&&"J%CM'Y8KZ'"5IX
MZ$EB*=E^?WGSN+HPP$XRPU6[_+[C^@;PKXBM?%WAG2M<L6W6>HVL=U$<Y^5U
M##^=?D!^VYXOU[2_VG_'-O9ZWJ-M;K<IMBBNY%1?W2= #@?A7Z>?LH2-+^S7
M\-F=BS'0[;D_[@K\K/VZ_P#DZCQW_P!?,?\ Z*2O$RB"CBZD.R?YGMYQ-RPE
M.?=K\C9M?VMO'5Q\%/#/PJ\&SZJNJ223'4-1@D>2\NS)(Q6"(C+!0#@XY/08
M Y\C\?\ PK^(/@<1W_C#PWK>E+<_,MUJ5M(H?GNS#K^-?=?_  2F^&ND2>&O
M%/CBYM(Y]9%Z--MII &,,0C5V*^A8N 3UPOO7V+\?/"=EXX^"_C31M0M4O(+
MC2K@K&X'$BH61P3T9656![$"NNIF$,)B71IPTOJ^MV<E/+:F,PRK5)ZVT72R
M/R6_9:_:Q\5? ?QKI44FJ7=]X-FN%CU#297\Q!$2%9X@Q^5U'(QC.,'@U^T<
M5Q%/;I/'(KPNH=9%.5*D9!!],5_.\.OO7[X_#=?[7^#7A80S.GVK0+4),O##
M=;KAAGOSFN?.Z,(N%1*S=[G1D5:<HSIR=TK6/R__ &POVU_$WQ5\9ZEH'A;5
M9]&\%Z?.UO$+&8H]^58@S.PP=IQ\J],8SDFO%/#G[/\ \4?'>G)JVC^"?$&K
M64WW;N*RD=7]PV.:XWQ3X>OO"'B;5-%U*(P:AIUU);3QL",.C%3U[9%??WPA
M_P""I^G:5H>E:/XU\'3H;2W2W;4=$E5E8* JGR'V[> ,X<^P'2O:FJF$HQ6#
MIJ7];^9XD)4\96D\94<?ZV\CX?L=?\=_!3Q2$M[S6?"6N63@F$M);R(>N&0X
MR/8C!K]9_P!BC]J)OVD/ %R-72*W\6Z*R0Z@L(VI<*P.R=5[;MK J. 1Z$"O
M)_B)XD_9F_;:U+1&U'QG+X?URR!C0RJ+&:96Z1,TJ%'P>1M/'KS7NOP#_9)^
M'WP"U.?6_"1OY[V\MOL[W-S>F5'C)#<*,+U YQ].M>)F&(I5Z*5:#C4]/U['
MNY?AJU"NW1J*5/U_3N:'[7EW/8_LT_$*XMII+>>/3&9)8G*,IW+R".17X[_#
MWXOZWX3\<Z#K6H:QJ]]9:?>Q74UJEZ^9E1PQ3EL<XQSZU^P?[8W_ ";!\1O^
MP4__ *$M?B/I6G3:QJ=I86Z[[BZF2&-?5F( 'YFNK)8QEAYJ7?\ 1'+G<I1Q
M$''M^I[GXZ^(7QF_;#\57]S:6.MZW8J6\K2-(BD:TM8QC"[5^4GIDMR3S7E5
MU#XO^$?BDPSKJOA37[1E?8WF6TZ$'*GL:_<OX/?#72OA'\-]"\+:1:I:V]C;
M(LFU0&EE('F2.1U9FR2:^?/^"D?PATKQI\";WQ8+2,>(?#CQS0W:J [0,X62
M)CW7#;@/5?<U.'S6FZJH1@E!Z(K$9345%XB51N:U9F_L%_MD77QMMI/!/C"5
M&\7:?;^;;WW"_P!HPK@,6&?]:N<G Y'/8UZW^VK_ ,FM?$7_ +!W_M1*_(W]
MG+QG/\/_ (Z>!]=@D,9M]5@20@9S&[>7(N/=&8?C7ZY?MJ_\FM?$7_L'?^U$
MKCQN%CA\;3<%92:_,[,%BI8G U%4=W%-?*Q^+W@[_D;M$_Z_H/\ T8M?T'5_
M/CX._P"1NT3_ *_H/_1BU_09(@D1D.<,"#BML]WI_/\ 0QR#X:GR_4_+']N+
M]M/Q)XI\>:OX'\&:O/I'A?2Y'LKJ>R<QR7TR_+)N<<[%;*@#@X)YR,?-'ACX
M)_$GXC:9)K6A^$=>UVQ).Z]M[221&(Z_-CGOTK]*/$G_  3(^$.HO/=)?:]I
M6Y_->07ZN!SELF13U]2<U[7J?QM^$GP:T>VT6Z\7Z!HEKIL*P0V"72%T10 %
M$:Y8G!';O5PS&E0IQIX.%WUT_P B)Y=5KU95,;4LNFO^>Q^*?VKQ=\*_$30>
M=JWA?6K1@3'NDMIHSU''!K]4_P!@/]I_5?CYX*U/2?%#I/XFT#RU>\4!6O('
MR%=E'&\%2"1UR#US7Q?_ ,% ?CGX#^.?C[0+_P $R2WK:?:26MY?O;-"L_S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<_Y.O\3?]>UE_P"DT=?KEX,X\'Z%SG_0(.?^V:U^1G_!1QL_M9>)U]+2Q/\
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M/@YJVI^*_"6G:YJ$6KR0I<7:%G"".,A>O3)/YU]51_L??!>-PP^'&AD@Y&Z
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M +#-W_Z-:OWOK\$/C@?^+R^. .<:U=C/_;5J^HR+XZGHCY7/_P"'3]6??W[
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M.*WK_P!I+$.%-^ZWH[+1?\ QH?V8\.IU5[R6JN]7_P $;_PZ/U#_ **;;?\
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M%!XSSSC%?EUI6G?$7]H_QR;6U_M7QGXCNMTK>9*9&5<\L2QVHH+>P&:^P_\
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M SQ=3FEB5;LOS.+'PPE/ECA7?N_R/W#_ &3/^3:?AK_V [;_ - K\KOVZ_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTJ-HX[JZ51(X9V?D* /XL<>E=K116$I.<G*6[-XQ4(J,=D>!_M._L?\ AO\
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MSTW9FM6E"M'DJ*Z/G;]F;]B_0?V8_$>KZQI/B/4]:EU*U6U>*^CB54 ?=D;
M#FO?]3TRUUK3;K3[ZW2ZLKJ)H)X)1E9$8$,I'H02*M44ZE:=:?/-W8J5&G1A
MR4U9'P%\1O\ @E#I&J:Q+=>"_&4NA64LC.;#4K7[2L()X5&5E.!_M9^M=S^S
M'_P3UMO@+\0+'QGJ/C&?6]5LHY4AMK6V%O;G>I4ELLS' /3.,U]B45V2S'%3
MI^SE/3Y'''+L+"I[6,-?F%%%%>:>D%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1137;8C-Z#- #
MJ*^</V5?VL[G]H[QA\2-$G\.QZ(OA+438K,EP93<?,PW$8&/N_K7T?0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)D.$9:M7$    & .PI:**@L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME?H=7YX_\$O?^2M_M$_]C W_ *,DK]#J "BBB@ HHHH **** "BBB@ HHHH
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MF*T*S] _Y MG_P!<Q6A7M4/X,/1?D>56_B2]6%%%%;F04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !3)O\ 4R?[II],F_U,G^Z: /ST_P""7O\ R5O]
MHG_L8&_]&25^AU?GC_P2]_Y*W^T3_P!C W_HR2OT.H **** "BBB@ HHHH *
M*** "BBB@ K\+/\ @KK_ ,G>WW_8*M/_ $$U^Z=?A9_P5U_Y.]OO^P5:?^@F
M@#Z \ ''@/2/^O2U_P#1(KZO_9=^,-M81Z?X&N+)U>625X;Q6R"Q.=I']:^4
M_AGXG_L'P9IL+6%EJ,-UIMLK1WBD[2(UP5(((-=7X9\57G@O7;?7-/6+[7:$
MR1K*,IGT(]*]KAO&87&Y%7PDXN]#FD_FY--?<]#P?$;)<SRGC; YI1G'EQWL
MZ<5U]U4HR4M-$[IIIW_7]):*^'_^&R/'7_//2O\ OR?\:T-!_;'\7_VQ9#4+
M/3KBQ:55E2*,JY4G!P<]:^%6>8-NUW]Q^Q3X#SF$7*T7;^]_P#[0HI%;<H;U
M&:6OH#\["O-_B+_R&XO^N _F:](KS?XB_P#(;B_ZX#^9KY[/?]S?JCVLH_WI
M>C.XT#_D"V?_ %S%:%9^@?\ (%L_^N8K0KVJ'\&'HOR/*K?Q)>K"BBBMS(**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDW^ID_W33Z9-_J9/\ =- '
MYZ?\$O?^2M_M$_\ 8P-_Z,DK]#J_/'_@E[_R5O\ :)_[&!O_ $9)7Z'4 %%%
M% !1110 4444 %%%% !1110 5^%W_!7>,I^UW>,3][2;0C\FK]T:_#+_ (*]
M?\G<7'_8(M?_ &:@#]7OV>?"&A:O\"O"-S=Z-8SW TBV!D:!=QQ G4XKYU^#
M>GVVH?&32[2Y@CGMGO)%:&1<J1D\8KZ@_9H_Y(#X2_[!-O\ ^B$KYF^!_P#R
M7#2/^OZ7_P!"-?7Y#"*PN,LMX_I(_+N-:U66995S2;M/35Z>]#8^S_\ A77A
M?_H :?\ ^ Z_X5\,_'"PMM,^-6L6UI!';6\=W&%BB7:J_=Z"OT)K\_?C^0/C
MGKA)P!=QDG\%K\GSV$8T(N*MK^C/ZIX!KU:N/K*I-OW'NV^J/O\ A_U2?[HI
M]<]'X^\-"-!_;VG]!_R\K_C3O^$_\-?]![3_ /P)7_&OI/:T_P"9?>?F+PN(
M_P"?;^YF_7F_Q%_Y#<7_ %P'\S74_P#"?^&O^@]I_P#X$K_C7GWC_P 8Z#<:
MS&T6L64B^2!E9U/<^]>!GDXRP;2?5'L93AJZQ*;@]GT9ZAH'_(%L_P#KF*T*
MY+1/'GAR/2+16UW3PPC&0;A?\:Z#3-9L-:B:6PO8+V-3@M!(' /OBO:P\XNE
M!)]%^1Y.(H583E*<&E=]&7:***ZCC"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<;A_9_:5W]Q[+SC$YSP]CZF*M>+LK*VET?9=%%%?<'X:%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4R;_4R?[II],F_P!3)_NF@#\]/^"7O_)6_P!HG_L8&_\ 1DE?H=7YX_\
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MGXW)8X;#/$TZRFD[:?YW9[>4\73S#,(Y?7PLJ4I)M7?;79I/OJ>_5YO\1?\
MD-Q?]<!_,UZ17F_Q%_Y#<7_7 ?S-?FV>_P"YOU1^OY1_O2]&'Q1_Y(7KW_8-
M;^5?/?[%+K'XUUDLP4?84ZG'\5?3'BGP]<>*_A5J&D6C*MU>6#11%S@;B.,U
M\6V_P!^)VFNPM] O8' VEX)U7=CW#=*X,7[6G6P]>$')1CT/T/ASZKB<JQN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4R;_ %,G^Z:?3)O]3)_NF@#\]/\ @E[_ ,E;_:)_[&!O
M_1DE?H=7YX_\$O?^2M_M$_\ 8P-_Z,DK]#J "BBB@ HHHH **** "BBB@ HH
MHH *_#+_ (*]?\G<7'_8(M?_ &:OW-K\,O\ @KU_R=Q<?]@BU_\ 9J /U9_9
M6_Y$'PU_V ;+_P!%)7NE>%_LK?\ (@^&O^P#9?\ HI*]TH **** /&/VM/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *9-_J9/]TT^F3?ZF3_=- 'YZ?\$O?^2M_M$_]C W_HR2
MOT.K\\?^"7O_ "5O]HG_ +&!O_1DE?H=0 4444 %%%% !1110 4444 %%%%
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MG K[#^''_(@^'?\ KPA_] %?(7[3?_(]V'_8,@_K7U[\./\ D0?#O_7A#_Z
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MD^J1^,XN$:>(J0CLI-+Y,****U.4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?ZF3_=-. "@ # ' %5KB]MD61&N(E< @JS@$<4 ?GW_P2]_Y*W^T3_V,#?\
MHR2OT.K\\?\ @EX0WQ:_:(((8'Q <$'(/[R2OT.H **** "BBB@ HHHH ***
M* "BBB@ K\,O^"O7_)W%Q_V"+7_V:OW-K\,O^"O7_)W%Q_V"+7_V:@#]6?V5
MO^1!\-?]@&R_]%)7NE>%_LK?\B#X:_[ -E_Z*2O=* "BBB@ HHHH *Y+XC_\
M@B#_ *ZBNMKDOB/_ ,@B#_KJ*\O-/]RJ>AZ& _WJGZCOAU_R!Y?^NIKJZY3X
M=?\ ('E_ZZFNKIY9_N=+T%C_ />9^H4445Z9P!1110 4444 ?!WB'_DX>[_[
M#H_F*^\!TKX+\57$5G\?]0GGD$4,6M[W=NB@$9)K[%_X6]X+'_,RZ?\ ]_17
MV^?4JE2&&Y(M^[T5^Q^0\%XFAAZN/5:HHWJ/=I=7W.PHKC_^%O>"_P#H9=/_
M ._M=/I^HVNK6<5W9W$=U;2C<DL3!E8>Q%?'3HU*:O.+7JC]4I8JA7=J512?
MDT_R+-%%%8G4%%%% !1110 4444 %%%% !1110 4444 ?-7[6_PO\1^,]1T+
M5=$T^34HK:%[>6*#F126W X[BOG?6/#?C[P1I*7&HVVL:/IRN(D9Y&2,,>@&
M#]:_1VO"/VRO^22P_P#82@_DU?+YEEL+5,6I-.US]7X7XGKJ6&RB=*+A>UW>
M]F[^G4B_8_\ %&J>(?!&I0:E>RWHL[K9"\S;F52,XSZ5[Y7S=^Q/_P BEKW_
M %]K_P"@U](UZF62<L'3;?0^3XJA"GG6)C!65^GH@HHHKU#Y0**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3)O]3)_NFGTR;_ %,G^Z:
M/ST_X)>_\E;_ &B?^Q@;_P!&25^AU?GC_P $O?\ DK?[1/\ V,#?^C)*_0Z@
M HHHH **** "BBB@ HHHH **** "OS7_ ."W'_)+OAS_ -A6Y_\ 1:5^E%?F
MO_P6X_Y)=\.?^PK<_P#HM* .L_X(X_\ )N%U_P!A6Y_]DK[\K\Y_^"3GB8>&
M?V9Y)?(\_P S6+I<9QC[E?H1H.LQ:]ID5Y$K(KY!5NH(ZB@#0HHHH **** "
MN2^(_P#R"(/^NHKK:Y+XC_\ ((@_ZZBO+S3_ '*IZ'H8#_>J?J.^'7_('E_Z
MZFNKKE/AU_R!Y?\ KJ:ZNGEG^YTO06/_ -YGZA1117IG %%%% !1110 4444
M ?/?[9G_ ")6A?\ 80_]D-:O[(W_ "3&3_K\DK*_;,_Y$K0O^PA_[(:U?V1A
M_P 6PD_Z_)*^QE_R((_XOU9^4TO^2VJ?]>_T1[?1117QQ^K!1110 4444 %%
M%% !1110 4444 %%%% !1110!X'^V9_R3*R_Z_T_]!:J/[$__(AZ[_V$?_::
MU=_;,_Y)E9?]?Z?^@M5+]B?_ )$/7/\ L)?^TUKYE_\ (X7^']#]3A_R1DO^
MOGZH^BJ***^F/RP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_(CRS_#_ .VQ-:BBBOIS\K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVQM'0^] 'V51110 4444 %%%% !1110 4444 %,F_P!3)_NFGTR;_4R?[IH
M_/3_ ()>_P#)6_VB?^Q@;_T9)7Z'5^>/_!+W_DK?[1/_ &,#?^C)*_0Z@ HH
MHH **** "BBB@ HHHH **** "OS7_P""W'_)+OAS_P!A6Y_]%I7Z45^:_P#P
M6X_Y)=\.?^PK<_\ HM* +_\ P35_Y,PTO_L8;[^2U]X?#7_D5H?^NC_SKX/_
M .":O_)F&E_]C#??R6OO#X:_\BM#_P!='_G0!U-%%% !1110 5R7Q'_Y!$'_
M %U%=;7)?$?_ )!$'_745Y>:?[E4]#T,!_O5/U'?#K_D#R_]=375URGPZ_Y
M\O\ UU-=73RS_<Z7H+'_ .\S]0HHHKTS@"BBB@ HHHH **** "BBB@ HHHH
M**** /DO]L__ )&GP[_UYO\ ^AU[E\ /^20^&_\ KW_]F->&_MG_ /(T^'?^
MO-__ $.O<O@!_P DA\-_]>__ +,:^RQW_(DPWK_F?E&3_P#)7X__  K_ -L/
M0J***^-/U<**** "BBB@ HHHH **** "BBB@ HHHH ^#?VL?^2Q:C_U[Q?\
MH-?;GA'_ )%31?\ KRA_]%K7Q'^UC_R6+4?^O>+_ -!K[<\(_P#(J:+_ ->4
M/_HM:^8RS_?<3Z_JS]4XI_Y$>6?X?_;8FM1117TY^5A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ K\U_P#@MQ_R2[X<_P#85N?_ $6E?I17YK_\%N/^27?#G_L*W/\
MZ+2@#0_X)J(S?L6Z:X4E5\17NXCMPM?5ND>,M1T:S6UM9$$*DL 5!ZUX1_P2
M B2;]D&-9$5U.N7G##(ZI7TY\5+:&WCT_P J)(\LV=B@9H [#PMJ\FN:);W<
MJA)'!#!>F16M7,_#K_D5;7ZM_.NFH **** "N2^(_P#R"(/^NHKK:Y+XC_\
M((@_ZZBO+S3_ '*IZ'H8#_>J?J.^'7_('E_ZZFNKKE/AU_R!Y?\ KJ:ZNGEG
M^YTO06/_ -YGZA1117IG %%%% !1110 4444 %%%% !1110 4444 ?)?[9__
M "-/AW_KS?\ ]#KW+X ?\DA\-_\ 7O\ ^S&O#?VS_P#D:?#O_7F__H=>Y? #
M_DD/AO\ Z]__ &8U]ECO^1)AO7_,_*,G_P"2OQ_^%?\ MAZ%1117QI^KA111
M0 4444 %%%% !1110 4444 %%%% 'P;^UC_R6+4?^O>+_P!!K[<\(_\ (J:+
M_P!>4/\ Z+6OCK]K#PGJY^*<M^FFW,UE=6Z>5-%&74D#!&1W]JY.W^*WQ5M+
M>*"'6-:CAB4(B"#A5 P!]VOB*6,6 QE=SBW=]#]WQ>2SX@R; 1P]6,>2.MWW
M272^UC]!Z*_/S_A;WQ9_Z#>M_P#?C_[&C_A;WQ9_Z#>M_P#?C_[&O1_MVE_S
M[E^'^9\U_J!C/^@BG][_ ,C] Z*_/S_A;WQ9_P"@WK?_ 'X_^QH_X6]\6?\
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M1F#%1G''>@#7^'7_ "*MK]6_G735Y7\/?$-Y!JMMII??:2;@$(^Z<$Y%>J4
M%%%% !7)?$?_ )!$'_745UM<O\0K>6?1HS&C/LD!;:,X%>9F:;P=1+L=^ :6
M)@WW&?#K_D#R_P#74UU=>06&L:GID)BM99(HR=VT)GG\JV?#OBO4Y=9MH+B?
MSHY6V,K*!BO"R_-Z-.G3P\HN^BOT_,];&9;5J3G6BU;<]&HHHK[ ^:"BBB@
MHHHH **** "BBB@ HHHH **** /DO]L__D:?#O\ UYO_ .AU[E\ /^20^&_^
MO?\ ]F->&_MG_P#(T^'?^O-__0Z]R^ '_)(?#?\ U[_^S&OLL=_R),-Z_P"9
M^49/_P E?C_\*_\ ;#T*BBBOC3]7"BBB@ HHHH **** "BBB@ HHHH ****
M&/$DH =%<#^\,TW[+!_SQC_[Y%2T4K#NT1?98/\ GC'_ -\BC[+!_P \8_\
MOD5+119#YGW(OLL'_/&/_OD4?98/^>,?_?(J6BBR#F?<B^RP?\\8_P#OD4?9
M8/\ GC'_ -\BI:*+(.9]SP_X@^ M9U7]H#P5KEGIAET>RB*W-PH&U#\W4?B*
M]K^RP_\ /&/_ +Y%2T5A2H1I2G)?:=_PL>ABL?4Q=.C3FK*G'E5NJNWK]Y\O
M_MOQ)%HWA'8BIFZGSM&/X%KN/V2/^2.V?_7S+_.N)_;B_P"0-X0_Z^I__0%K
MMOV2/^2.V?\ U\R_SKP:7_(WJ?X?T1^@XK7@S#_XW_Z5,]HHHHKZ8_+ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7AO[9_\ R-/AW_KS?_T.O<O@!_R2'PW_ ->__LQK[+'?\B3#>O\ F?E&3_\
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M_?AJ/KV%_P"?B^]!_8.:_P#0-/\ \!?^1ZY17D?_  U1\._^@M+_ -^&KM/
MOQ*\/?$>TGGT&_6\$#!94P5=,],@^M7#%4*LN6$TWZG/B,JQ^%INK7H2C%=7
M%I'44445U'E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >-:A^Q
MQ\$]5O[B]N_AKH-Q=7$C2RRO;Y9W)R2>>I->&_M%:9^Q_P#LPV<1\9>"O#PU
M2==\&CV-KYUW(O\ >V!OE7W8@5]HWEP+2TGG(+")&<@=\#-?FY^PY\%O#O[4
MGQ6^*OQM^(]LOBG4H/$DVF:98:BN^*U2(*5;8>,A610#P-I]: //K/\ ;&_8
MHGU 13?!*6VMBP N#I\;8'J5#Y_G7W1^S-X3_9]\465M\0O@]H>@K)L>V-_I
MT6R>#</GB=2<H>G!%>H:U\&? 7B'2)=+U'P;H=U82H8W@>PB *G@CA<U\,?!
M;X?V_P"R;_P4BO/A]X0FDB\#^,M%?4O[*W;A:R*"0!Z ,&QWVD#M0!^C-%%%
M !1110 4444 %%%% !1110 4R;_4R?[II],F_P!3)_NF@#\]/^"7O_)6_P!H
MG_L8&_\ 1DE?H=7YX_\ !+W_ )*W^T3_ -C W_HR2OT.H **** "BBB@ HHH
MH **** "BBB@ KYW_P""A'_)FGQ3_P"P4?\ T8E?1%?._P#P4(_Y,T^*?_8*
M/_HQ* /@C_@B3_R5'X@?]@F/_P!&K7Z_U^0'_!$G_DJ/Q _[!,?_ *-6OU_H
M \:\;?\ (X7?^^G\A7L%K_QZP_[@_E7C_C;_ )'"[_WT_D*]@M?^/6'_ '!_
M*@"6BBB@ HHHH 0]#7E.E_\ (X0_]?)_F:]6/0UY3I?_ ".$/_7R?YFOE\Z_
MB8?_ !?JCZ#*_@K>G^9ZO1117U!\^%%%% !1110 4444 %%%% !1110 4444
M ?)?[9__ "-/AW_KS?\ ]#KW+X ?\DA\-_\ 7O\ ^S&O'?VQ] U&[U70-2@L
MY9[*.!X7EB0L%?=D X]J\DT;XI>/O#VF6^G:=J&H6UE NV.)(3A1^5?HD,#+
M,LIH4J4DFFWK\S\)JYQ3R#B?&8C$TY-222LO*.NMM-#[_HKX-_X77\2_^@QJ
M7_?D_P"%'_"Z_B7_ -!C4O\ OR?\*\W_ %8Q/_/R/X_Y'T'_ !$3+_\ GQ4^
MY?YGWE17P;_PNOXE_P#08U+_ +\G_"NJ^$7QW\9W?Q%T73M2U1]0L[ZX%M+#
M<+]W.>1Z$8K*KPWB:=.53GB[*_7I\CHP_'^75ZT*/LIKF:5VEU=NY]D4445\
MD?IP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UT$B,C#
M*L,$4ZB@#YAUK]B:VO=6N[BQ\32VEK+(TB026PD*9.<;LC-4O^&'6_Z&X_\
M@$/_ (JOJNBO'>48)N_)^+_S/M(\99Y"*BJ^W]V/^1\J?\,.M_T-Q_\  (?_
M !5'_##K?]#<?_ (?_%5]5T5/]CX+^3\7_F5_KGGG_/_ /\ )8__ ")\J?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_4BC_T,*?X?_)'Z$45^>_\ PB/Q8_Y]/$?_ '\D_P :/^$1^+'_ #Z>(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQW,,BY*MT- 'O%%(O*CZ4M !1110 AZ&O*=+_P"1PA_Z^3_,UZL>AKRG2_\
MD<(?^OD_S-?+YU_$P_\ B_5'T&5_!6]/\SU>BBBOJ#Y\**** "BBB@ HHHH
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MO_74_:,US'A7.JRQ.*J3YK):)K]'W-__ (;!\">M_P#^ YH_X;!\">M__P"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F7]MW_D!>&?\ KZD_
M]!KL_P!DC_DC=C_U\3?^AFN,_;=_Y 7AG_KZD_\ 0:[/]DC_ )(W8_\ 7Q-_
MZ&:^:I?\C>I_A_R/U+%?\D90_P"OGZR/9Z***^E/RT**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KY5^.__  4H^#7P"\87'A;5+[4=<UVT;9=VVB6PF%J^ =KNS*-V". 3
MCOBOJ#4Y)(M-NWAYF6%V3']X*<?K7YV_\$Q?@WX6\=CXL^/O%NA6>N>+)/%M
MW8/)J42S>2B[78!6! ):0Y/L* .E/_!9KX)XS_8GBW_P"A_^.UWO[/'_  46
M\,_M-_%VS\'>$/".N16+VD]S<ZQJ"*D<#1@%4PI8$MGN1^->2?L(_#?PC'\6
M?VB/A1XA\.Z5K%OH^N?:+2*]LXY'CAD+AU#$9"\IC'2NB^!/A&S_ &1_VZM7
M^$_AP*G@7QQI+>(+&SE(+6%Q'D.BMC)4[2 ">!B@#[SHHHH **** "BBB@ H
MHHH **** "F3?ZF3_=-/IDW^ID_W30!^>G_!+W_DK?[1/_8P-_Z,DK]#J_/'
M_@E[_P E;_:)_P"Q@;_T9)7Z'4 %%%% !1110 4444 %%%% !1110 5\[_\
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M7Z_(:^X:^'OV8/\ DMNG_P#7&Y_] -?<-=/$_P#OL?\ "OS9Y_AW_P BB?\
MU\E_Z3$****^1/U **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N.^*?BS6O!OAM+[0=$?7[TW"1&UC."
M$(.6_# _.NQHK.I%SBXQ=GW.C#U(4JL:E2"FD]4[V?EIJ?#W[0?CWQ9XXTC2
MO[?\)S>'K>VG8QS2$D2,1]W\JXSPK\6?'W@K1X]+T34+FRT]&9UA%HK@$G).
M2N:^I_VK/"FL>+?!>E6VC:?-J,\=^DCQP+N(7!Y->LZ;HMFFG6JR6-N'6) P
M,2Y!P,]J^5EEM:KBIM56FDM;;W]+=C];I\38'"930A+"0E&4I>Y>ZC9K6TE)
MZW?Z'PM_PT+\5?\ H-W7_@"G_P 31_PT+\5?^@W=?^ *?_$U]X_V/8?\^5M_
MWZ7_  H_L>P_Y\K;_OTO^%;_ -DXG_H)E^/^9Y_^MV5_]"R'_DO_ ,@?!;_M
M'?$ZV=?-\02IW"R6D:Y_\=K[4^%'BNY\<?#O0=<O$2.ZO;822K']W=D@X_*O
MFO\ ;4MH;7Q%X<6&&.$&V?(C0+GYO:O>/V=/^2*>$_\ KT'_ *$:G+?;4L;4
MP]2HY)+K\O\ ,VXE6#Q61X;,</AXTI3E]E):6EI=)7V/2****^I/R8**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH 0C(P>E?"'A/]G3XU?LV?M7W^K_  [GM-8^$/C761>:Q8SL#)8L^3(^
MTX(P<X93R" 1Q7W=("R,%.&(.#7YW>*OVBOVLOV8O%NM2>+_ (?)\2O )OIG
MM-0TR,FXB@+DH"T0.-JX'S)VZT )^TM\,/C'^S7^U!?_ !T^#'AP>+=+\1V?
MV;7='12Y\P8)9U!#;250AEZ$8/6K7[(GP]^,OQP_:AN?C[\7="_X1*UT_3FT
M[1](=-F0RX.Q22P49)W'J37K/P5_X*9_!3XOO%976MMX,UIFV&Q\0 0#<.H$
MOW.OJ17U597UMJ=I%=6=Q%=6TJAXYH7#HX/0@C@B@">BBB@ HHHH **** "B
MBB@ HHHH *9-_J9/]TT^F3?ZF3_=- 'YZ?\ !+W_ )*W^T3_ -C W_HR2OT.
MK\\?^"7O_)6_VB?^Q@;_ -&25^AU !1110 4444 %%%% !1110 4444 %?._
M_!0C_DS3XI_]@H_^C$KZ(KYW_P""A'_)FGQ3_P"P4?\ T8E 'P1_P1)_Y*C\
M0/\ L$Q_^C5K]?Z_(#_@B3_R5'X@?]@F/_T:M?K_ $ %5[__ (\;C_KFW\JL
M57O_ /CQN/\ KFW\J /)_AU_R-,/^XU>P5X_\.O^1IA_W&KV"@ HHHH 0]#7
ME.E_\CA#_P!?)_F:]6/0UY3I?_(X0_\ 7R?YFOE\Z_B8?_%^J/H,K^"MZ?YG
MJ]%%%?4'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %9OB3_D7M3_Z]I/\ T$UI5F^)/^1>U/\ Z]I/_036E/XUZF-;^'+T9\8?
MLP?\EMT__KC<_P#H!K[AKX>_9@_Y+;I__7&Z_P#0#7W#7U7$_P#OL?\ "OS9
M^:^'?_(HG_U\E_Z3$****^1/U **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D/\
M;;_Y&/PY_P!>TG_H5>Z?LZ?\D4\)_P#7H/\ T(UX7^VW_P C'X<_Z]I/_0J]
MU_9T_P"2*>$_^O0?^A&OF<+_ ,C6MZ?Y'ZEFW_))8'_%_P#)GH]%%%?3'Y:%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_/R?^^:/KV%_P"?L?O0?5,1_P ^W]QO45@_\)OI'_/R?^^:/^$WTC_GY/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR%>GV_\ J(_]T?RKSLFA&G7Q$([)V_%G;F<G.C1E+=K]$24445]6?/!1110
M4444 %%%% !1110!XW^UA_R2"Z_Z^X/_ $*N6_8R_P"1>\0?]?2?^@UU/[6'
M_)(+K_K[@_\ 0JY;]C+_ )%[Q!_U])_Z#7V-+_D05/\ '_\ (GY5B?\ DM:/
M_7O])'T;1117QQ^JA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X;^V%_P DE/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#8P-_Z,DK]#J "BBB@ HHHH **** "BBB@ HHHH *^=_\ @H1_R9I\4_\
ML%'_ -&)7T17SO\ \%"/^3-/BG_V"C_Z,2@#X(_X(D_\E1^('_8)C_\ 1JU^
MO]?D!_P1)_Y*C\0/^P3'_P"C5K]?Z "BBB@"KJG_ "#+O_KD_P#(UX[X.U>#
M0]82ZN=WE!"/D&37M,L:S1/&XRK@J1[&N"U3X965K:W5S'=S*(T:18\ C@9Q
MF@#IM"\7:?X@F>*U=A*@W%)%P2/45M5Y+\,N?$B_]<6_I7K5 !1110 4444
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M'PK_ ->2_P S7=U\ABH1IUZD([)M?B?J6759U\%1JU'>4HQ;]6DV%%%%<QZ
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M, _]#K] ZG(ERPJQOM(TX^:G6PM6R3E"[MZA1117TY^5A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6%?&4J-.52Z=NB:/0P&38O'8F&&Y''F>[B[+U/H^BN,L_BUX,%G!O\5Z1O\
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M_P#&C_A;?@G_ *&O1_\ P-C_ ,:T]O2_G7WHYOJ&+_Y\R_\  7_D=;17)?\
M"V_!/_0UZ/\ ^!L?^-'_  MOP3_T->C_ /@;'_C1[>E_.OO0?4,7_P ^9?\
M@+_R.MHKDO\ A;?@G_H:]'_\#8_\:/\ A;?@G_H:]'_\#8_\:/;TOYU]Z#ZA
MB_\ GS+_ ,!?^1UM%<E_PMOP3_T->C_^!L?^-'_"V_!/_0UZ/_X&Q_XT>WI?
MSK[T'U#%_P#/F7_@+_R.MHKDO^%M^"?^AKT?_P #8_\ &C_A;?@G_H:]'_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J@VOZ6C%6U*T5E."#.H(/YU===Z,N<9&,U\!>*O\
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M*** "OD?]LK_ )''0_\ KR/_ *&:^N*XOXB_"/P]\3TM?[9@D\ZVSY4\#['
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[&WC">))!=Z9AU##+GO^%._X8Q\8_\ /YIG_?9_PK[4MXOL]O%%G.Q0N?7
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M\TS_ +[/^%?;%%=']AX/L_O/-_U\SK^:/_@)\3_\,8^,?^?S3/\ OL_X4?\
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M2?\ KTB_] %:=?:P^%'X76_B2]6%%%%69!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%-DW>6VS&_!VYZ9H _-OX[_M3?&S]HKX^ZW\'/V=RNE66@
MDQZKXA!"MO5MK-YAR$0'Y1@$L:^K/C!\8K_]EC]E)O%/BJYCUKQ3I.DP6S,S
M_+>Z@4"9SW!?+'V!KY=_X(\B,P_&QKO;_;7_  D*"4R_Z[9B3.<\XW9_&J__
M  6)\7SZW8?#+X5:;*C7WB#5!<21 Y8?,(HCCT+.WY4 >6_"/]E3]HC]LKPH
MOQ<UWXMW/AN?4B\^CVS23 ,H;Y6"H0$CZ@#D\5]#?L"_M+^/I_B1XJ^ GQBF
M:Z\;^'-[V6HR_P"LNX5/S!C_ !X!#*_=2/2OLWX<>$8/ /@#P[X<MHUBATNP
MAM B# RJ '\SDU^?-E<PZU_P6>OFTD8^R:,([R1#D,RV:!\^G9?J* /TIHHH
MH **** "BBB@ HHHH **** "F3?ZF3_=-/IDW^ID_P!TT ?GI_P2]_Y*W^T3
M_P!C W_HR2OT.K\\?^"7O_)6_P!HG_L8&_\ 1DE?H=0 4444 %%%% !1110
M4444 %%%% !7SO\ \%"/^3-/BG_V"C_Z,2OHBOG?_@H1_P F:?%/_L%'_P!&
M)0!\$?\ !$G_ )*C\0/^P3'_ .C5K]?Z_(#_ ((D_P#)4?B!_P!@F/\ ]&K7
MZ_T %%%% !1110!XOJ'_ "/,W_7[_6O9QTKQC4/^1YF_Z_?ZU[..E "T444
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MTA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 >6>+_\ D:;C_>3^0KT^W_U$?^Z/Y5YAXO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P
M1^U7_P EBU7_ *Y1?R%?>]?!'[5?_)8M5_ZY1?R%?-Y]_NJ]5^I^G>'W_(VG
M_@?YQ/N3PS_R+>D_]>D7_H K3K,\,_\ (MZ3_P!>D7_H K3KZ&'PH_-ZW\27
MJPHHHJS$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5\$_M5@_\ "X]4_P"N47\A7U-\6?A?
MXC\>:K87.B^+;CP[#!"8Y(8<XD8MG<<>W%?,/Q&^"VMVWQ4T?PU<Z^-7U36(
MMRWUT#\N,\-W[5\MG3JU:?LU3=KK6ZU_4_6>"(X3"8EXJ6(7,X2O&TKI+5MN
MUME<^K- ^+W@RVT'38I/$FGI(EM$K*9AP0@R*O\ _"Y?!'_0S:?_ -_A7S'_
M ,,4>+/^@QI'Y/\ X4G_  Q1XL_Z"^D?D_\ A5+&9DE;ZO\ U]YE+)>&)R<G
MF#U\O^ ?3O\ PN7P1_T,VG_]_A1_PN7P1_T,VG_]_A7S%_PQ1XL_Z"^D?D_^
M%'_#%'BS_H+Z1^3_ .%/Z[F7_0/_ %]Y/]A\,?\ 0P?W?\ ^G?\ A<O@C_H9
MM/\ ^_PH_P"%R^"/^AFT_P#[_"OF+_ABCQ9_T%](_)_\*/\ ABCQ9_T%](_)
M_P#"CZ[F7_0/_7WA_8?#'_0P?W?\ ^G?^%R^"/\ H9M/_P"_PH_X7+X(_P"A
MFT__ +_"OF+_ (8H\6?]!?2/R?\ PH_X8H\6?]!?2/R?_"CZ[F7_ $#_ -?>
M']A\,?\ 0P?W?\ ^G?\ A<O@C_H9M/\ ^_PH_P"%R^"/^AFT_P#[_"OF+_AB
MCQ9_T%](_)_\*/\ ABCQ9_T%](_)_P#"CZ[F7_0/_7WA_8?#'_0P?W?\ ^G?
M^%R^"/\ H9M/_P"_PH'QD\$$@?\ "3:=SQS,*^8O^&*/%G_07TC\G_PKSOXK
M_!;4_A%-81:I=6=X;U6*?90WRXZYR*RJYECZ,7.I022.K"\,</XVJJ&&QSE-
M[))?Y'Z(6]Q%=P1SP2)-#(H9)$.58'H0:DKR_P#9FD:3X(^&2[%R(7 +'/ =
ML5ZA7TM"I[:E&I:UTG]Y^88[#?4\55PU[\DG&_>SL%%%%;'$%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;=_Y"'A?_<D_G7UC7R=^V[_R$/"_^Y)_.O%SC_<I_+\T?<<%_P#(\H_]O?\
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M#^E;$W^ID_W33Z9-_J9/]TT ?GI_P2]_Y*W^T3_V,#?^C)*_0ZOSQ_X)>_\
M)6_VB?\ L8&_]&25^AU !1110 4444 %%%% !1110 4444 %?.__  4(_P"3
M-/BG_P!@H_\ HQ*^B*^=_P#@H1_R9I\4_P#L%'_T8E 'P1_P1)_Y*C\0/^P3
M'_Z-6OU_K\@/^")/_)4?B!_V"8__ $:M?K_0 4444 %%%% '&_%+_D Q?]=A
M_*H_A5_R!;K_ *[G^0J3XI?\@&+_ *[#^51_"K_D"W7_ %W/\A0!VU%%% !1
M110 4444 %%%% !1110 4444 %%%% 'EGB__ )&FX_WD_D*]/M_]1'_NC^5>
M8>+_ /D:;C_>3^0KT^W_ -1'_NC^5?+Y3_O6)_Q?JSW\Q_W>AZ?HB2BBBOJ#
MP HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /%_AEX.UK1OC=XZU
M>]L);?3;X?Z/<-]V7Y\\5[11177B<1+%34Y*UDE]RL>;@,##+Z3HTVVG*4M>
M\FV_S"BBBN0](**** "BBB@#SK]H0D?!SQ-@X_T?_P!F%>+_ +&/_(;\1?\
M7&/^=>T?M"_\D<\3?]>__LPKQ?\ 8Q_Y#?B+_KC'_.OLL%_R),1Z_P#R)^4Y
MM_R6&!_P/_V\^K:***^-/U8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OD[]MW_ )"'A?\ W)/YU]8U\G?MN_\ (0\+_P"Y)_.O%SC_ '*?R_-'
MW'!?_(\H_P#;W_I+/7_V8_\ DB'AG_KD_P#Z,:O4J\M_9C_Y(AX9_P"N3_\
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MA4N(#N#!>Y*,X_"OV \?^/-#^&'@S6/%7B2^33M#TFW:YNKEP3M1?0#DDG
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M^NP_E4?PJ_Y MU_UW/\ (5)\4O\ D Q?]=A_*H_A5_R!;K_KN?Y"@#MJ***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\G?
MMN_\A#PO_N2?SKZQKY._;=_Y"'A?_<D_G7BYQ_N4_E^:/N."_P#D>4?^WO\
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MZ#\'/A%X?^!?P[TKP5X76Y31--#B!;N8RR#<Q8Y;C/+&@#\</^"Q'_)W"_\
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MTWX[?#74OA]\/-#U/2M*U-D6^U?4V2.6: $,8EB4MM#$ $ECP.G-?6G_  Z
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MNH964C!!!Z@BODWQW_P2U_9\\=ZY<:J_AB[T.>X<R21:+?/;PECU(CY5<D]
M /3% 'Y;>#+'Q!^WS^W(-7MM,GMK;6-834+SREWC3[")EP7;IPBJN3U8C'6O
MUM_X*)1K%^Q;\3$4!573D  [#S4KTCX(_LY?#S]G;1;C3? 7ANWT2.Z*FZN
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MD=:]_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7R=^V[_ ,A#PO\ [DG\Z^L:^3OVW?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]_TKV'2[EKS3K:=P \D:L<=,D4 6J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,;QA_R+5_\ [@_F*YKX:_\ 'W>_[@_G72^,/^1:
MO_\ <'\Q7-?#7_C[O?\ <'\Z^7Q7_(VH^G^9[^'_ .1;5]?\COJ***^H/ "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BNO^/6;_</\J^&/@W_R
M7[3/^PA/_P"SU]SW7_'K-_N'^5?#'P;_ .2_:9_V$)__ &>OL<B_W;%_X?T9
M^5<9_P"_Y9_U\_\ ;H'W91117QQ^JA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\]^A[&6\7T,1*JI82$+0D]UK9?#LMSYN'BWXM$_\?'BC_OS-_A2_\)5\6_\
MGX\4?]^9O\*_0:BNO^QI_P#/^7]?,\?_ %WH_P#0!3_#_P"1/SY_X2KXM_\
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M445TGF!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** ,;QA_R+5_\ [@_F*YKX:_\ 'W>_[@_G72^,/^1:O_\
M<'\Q7-?#7_C[O?\ <'\Z^7Q7_(VH^G^9[^'_ .1;5]?\COJ***^H/ "BBB@
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M#_7_ "3^:7_@)]DT5\;?\-@>,O\ GRTK_OT__P 51_PV!XR_Y\M*_P"_3_\
MQ5'^K6/[+[P_U_R3^:7_ ("?9-%?,GPJ_:BUSQ5XWTW1=8T^S\B_D\E)+565
MD<]"<DY%?3=>-C<#6P$U3KK5JY];E.<X3.J+KX-MI.SNK.^X4445YY[84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !3)O\ 4R?[II],F_U,G^Z: /ST
M_P""7O\ R5O]HG_L8&_]&25^AU?GC_P2]_Y*W^T3_P!C W_HR2OT.H ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -TT^B@&?GCI_B3_ (0[XI?VW]G^U'3]2>;R-VW?ACQGM7MG_#:C_P#0I_\
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M8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\
M0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'
M_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R
M'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P
M-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!
M_9W&?_09#[E_\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,
MWP__ .@0W_?YJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_
M\@>8?\-J/_T*8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?Y
MJ/\ AF;X?_\ 0(;_ +_-1]9R'_GQ+[W_ /)!_9W&?_09#[E_\@>8?\-J/_T*
M8_\  T?_ !-'_#:C_P#0IC_P-'_Q->G_ /#,WP__ .@0W_?YJ/\ AF;X?_\
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MC/O:BBBO@#]M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4C?=/TI:* /YX_@3XZT;X:_MR:;XC\0W7V+1[+Q1=-<7.TL(U:61=Q
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M0%S,,HN[K^/X5?\ ^%>ZY_S[K_WW7H.I>')KWQ38:HLJ+%;KAD(Y/7_&NAH
M\=_X5[KG_/NO_?='_"O=<_Y]U_[[KV*B@#QW_A7NN?\ /NO_ 'W1_P *]US_
M )]U_P"^Z]BHH \=_P"%>ZY_S[K_ -]T?\*]US_GW7_ONO8J* /'?^%>ZY_S
M[K_WW1_PKW7/^?=?^^Z]BHH \6O?!.K:?:R7$\*K%&,L0^:K:9X<O]8=UM8P
MY09;+8KUGQA_R+5__N#^8KFOAK_Q]WO^X/YUXU?&5*>.IX9)<LE?SZ_Y'J4L
M+">$G7>Z?^7^9S?_  KW7/\ GW7_ +[H_P"%>ZY_S[K_ -]U[%17LGEGCO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]#J_/'_@E[_R5O\ :)_[&!O_ $9)7Z'4 %%%% !1110 4444 %%%% !1110
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M&MO]I;]J3P/^ROX)'B#Q?=N\TY,=CI-IAKJ]D Y5%)  '=C@#/7D5X?^RO\
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MU,VEB[@GY(4)"84Y&$7"^U4O$L7[4/[ 'B+3Y]0U77/#MI<R@0.MZ;S2[UD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%>4_'+]J'X;?LZ6MK)XY\11:
M;=78)MM/A1IKJ< X)2)<L1GC-5O@A^UC\+_VAIKBU\%^)8KW4[=/,FTRYC:W
MNXU]3$X!Q0!Z_112$X% "T5\V>._^"B'P*^'GBZ?PYJ/B\W=_;.8[J33;22Z
M@M6!P1)(@*K@]>:]R\!?$'PY\4/"]GXB\*ZQ:ZYHMVNZ*[LY ZGU!]".X/-
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M+^3%(5C4GOA<#/M7SI_P6Z_Y$KX<_P#7_/\ ^BZ]M_X)(_\ )F&@_P#84O\
M_P!'&@#I/^"E_CWQ)\-OV4-<UWPIKE_X=UF&^LTCO]-G,,RJTH# ,.<$<&OF
MS_@D)\=/B'\7?&WQ&MO&WC36_%-O9:=:26T6JWKSK"S2.&*AB<$@"O=?^"LO
M_)F'B+_L(6/_ *.%?*'_  0^_P"1_P#BG_V#++_T;)0!^NM?@[J7[6/QFB_:
MVN= 3XH>*5T5?&[6(L1JDODB#[?L\O;G&W;\N.F*_>*OYQM6_P"3V;O_ +*"
MW_IQH _HYHKQS]L+XC:]\)/V:/'WB_PQ=I8Z]I-B)[2XDA654?S47)1@5/#'
MJ*_-#X%_\%//C]XUM];\+6UJOC[XAZUY5MX=@@TN"*.S/SF:=Q&J[\+M(#?*
M,$GC((!^R5%?B!\>_BC^VS^SAK>E^)_'_BO7-(BU*7=;F"Z@GT\R 9\IHH\Q
M*<#.P@9&3ZU^A_[&/[5VN_M1?LO:WXD>&%?B!HJ7-C<0V47RRW*P[X)4C.1\
M^Y?EZ;@P'% ''?MT_P#!2>S_ &7];NO WAK0'UKQW]F28SWWR65FLB@HQ .Z
M4X/W1M'')[5]=?"_7;SQ3\-?"FLZ@ZR7^HZ5:W<[(H53))$K-@#H,D\5_.S^
MU)XE^*GBSXMW>H?&2RN;#QNUK DT-W8I9N(0N(SY:* !COCFOU)_X)Q?$+]I
M;Q+XLBTKXJZ1J%E\.;;PPK:/<7.C0VL;R*]NL 654#-F$N>2<@9[4 ?H)17X
MLG_@JM\9O OQTUBV\0:O#KOA/2]5O;<Z/!IEK$\Z(TB1)YH0,HW!,L#G /6N
MU_9X\7?ML?%/]H'PIKFKW/BK0O"6N7275U->:=MTF&RP';9"X"KE%"J?O$L.
M22: /UQHK\\O^"BO_!1S4/@1K3?#CX:M"?&2HLFI:M-&LJ6"L,K'&IR&E(()
M)&%!'!)X^9M4A_;Y\-> Y/B?>:YXKCT18/M\L+7\3R10_>+M9Y+*H R1LX'6
M@#]IJ*^&_P#@G5_P4"N/VGH;KP9XVB@MO'VG0&Y2[MD$<.I0 @,P0<)(I(RH
MX(.1CD!O_!2']N;Q%^S;::?X2\ V#MXKU*#[5<:Q/:F6#3X"2J[01M:1B#UR
M% Y!R* /N:BOQBTKPG_P4 \:>#(O'MCK_BMM,O+8:C!;IK$4,TD1&Y2EKN#<
MC!"[>0>G->E_\$YO^"B'Q!\=_%JR^%OQ+N_^$C74U>/3]5E1(KJVFC5F*2%0
M/,# $9/S @=1Q0!^@7[1_P"T'X?_ &9/A;>^./$EO>7EA!-';);6*!I)97R$
M7D@ <'D]*\6_8 _;!\1?M@+\1M9UC2[/1-,TJ^M8-,T^U)=HHW20MYDA^^QV
MCD!1Z"OE7_@KWXM^,QU?4/#_ /9]W_PI0)83?;/[.C\C[;\W'VC;NSG^'./:
MOF?]B3Q_^T=X-@UF#X(:3?ZCHUS?6QUE[/2(KU48 A=S.IV?*7Z$4 ?OW17R
M1^W=^W%!^R3\/]+M+"VCU/XB:];EK"TF'[JU5<![B8#G 8X5?XB#V4U\(>"=
M2_;Q_:#\,R?$;PUK_B)M%DWR6XM[Z"PCN F<^3;DKO&00,*<D8YH _::BOS
M_8'_ ."DGBOQ%\1;;X3?&9FGU:[G-EIVM2P"&>.Y7(^SW*@ $D@@/@'=PV<Y
M'VC^U[^T_I'[)WP@NO&&H6;ZIJ$\PL=+TY#M%Q=,K,H=OX4 4ECZ# Y(H ]N
MK\^/^"OGQ@\<?"+P;\-[GP3XLU;PK/>W]Y'<R:3=O 9E6.,J&*D9 )./K7R-
M\/?CE^V;^V3XPU*^\ ^(M71+##31Z5/'IVG6V22L9+$*S'T8LQ YKC/VWOC1
M\:_$>C>&?AM\<] ^P^*/#EU/>0:L42,WL$BJ@QY8\MP#&<2(>>_/- 'Z:_\
M!+3XB^*/BC^RZ-;\7^(-0\2ZN=<NX/MNIW#32^6JQ[5W-S@9/'O7U]7P_P#\
M$>?^3/U_[&"^_P#08J^X* ,;QA_R+5__ +@_F*YKX:_\?=[_ +@_G72^,/\
MD6K_ /W!_,5S7PU_X^[W_<'\Z^7Q7_(VH^G^9[^'_P"1;5]?\COJ_#/_ (+
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M0@CK@@]Z_97X!?L^^#/V;/ -OX3\%:>;2R5O-N+F9M]Q=S$ &65\#<QP!Q@
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M>/(#JWG.""K$$8[+SQS'^V1_P3V\(?M>:KINOW6LWGA;Q38VXLQJ-K$LT<\
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MB9+^^^WO/=0+"L;F-$940$X4[,\D]: /?**** "BBB@ HHHH **** "BBB@
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M2>2: /G73?VM_P!F;X5_L8:_\(O!7B/4;O5;O1+F!KB31[B,WU]+'AY'8J
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M5?[K'>P'Y,#^-?L'^SII<^B_ /X=V-R-L\.@62NN",'R5..:_$GP#X7\>?\
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M8_\ H35X]_P0]_Y$?XJ_]A&Q_P#14M 'R[_P5R_Y/.UK_L$V'_HJOVC^!O\
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M@I5,;3Q2>D5:WW_YGI4\5&&%GAVM9/\ R_R+-%%%>N>:%%%% !1110 4444
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M]W81M(><\MC)Y]ZM_#WX#?#KX4/O\'^"=#\.RX(\ZPLDCDP>HWXW8/UKO**
M"O-?B-^S7\+?B[KD>L^,_ FB^)=4CA%NEWJ%L))%C!)"Y] 2?SKTJB@#PO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSQ_X)>_\E;_:)_[&!O\ T9)7Z'4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7COQE_9#^$?Q]O!?>-/!=CJ6J!=G]HQ;H+DC&,-(A!;'&-V<8%>Q44
M ?'>G_\ !)S]G2PNXYSX:U.ZV'/E7&KSLA^H!&:^G?A[\,?"?PGT!-$\'>'M
M/\.:6AW?9M/@$88^K$<L?<DFNGHH Q?&?@O0_B)X7U#PYXDTV#6-#U!!%=6-
MR"8Y5!# ''N ?PKCOA;^S7\,/@GJUWJ?@;P7IGAG4+N#[-/<6*,&DBW!MIR3
MQE0?PKTNB@#EOB1\+O"GQ?\ #3>'_&6AVOB'16E2<V5XI*%USM;@CD9-9OPJ
M^!7@'X'VVH6_@3PM8>&(=0=)+I+%2!,R A2V2>@8_G7=T4 <I\1/A3X.^+>C
MII7C/PUIOB73T;>D&HVZRA&[E2>5/ Z5S_PT_9J^%OP<U%[_ ,%^!M'\.W[!
ME-U9P8EP0 1O.2 <#C.*]+HH \:TO]CCX*Z+XRM_%EC\.=%MO$=O>C4HM12-
MO,2Y#[Q*/FQNW<_6O9:** *>KZ-I_B#3YK#5+&VU*QF&)+6[A66)QZ,K @_C
M7C)_8=^ AU5=1_X53X;^UJ_F!A:?+N]=N=I_*O<J* *>D:-8>']-M]/TNRM]
M.L+==D-K:1+%%&OHJJ  /I69XT\ ^&_B-HSZ3XIT+3_$&FOG-MJ-NLR D8R
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M]3)_NF@#\]/^"7O_ "5O]HG_ +&!O_1DE?H=7YX_\$ON/BU^T23P/^$A//\
MVTDK]#-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBF[
MU_O#\Z-Z_P!X?G0 ZBF[U_O#\Z-Z_P!X?G0 ZBD# ]"#2T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %(P#*0>AXI:* /A#XG_\ !*?1
M?&'Q(UWQ1X6^)6O> K?6)!//IFF1ED\W'SMN\Q2=S9;!'&:YK_AT9?\ _1P7
MC#_OTW_Q^OT4HH _.O\ X=&7_P#T<%XP_P"_3?\ Q^C_ (=&7_\ T<%XP_[]
M-_\ 'Z_12B@#\Z_^'1E__P!'!>,/^_3?_'Z/^'1E_P#]'!>,/^_3?_'Z_12B
M@#\Z_P#AT9?_ /1P7C#_ +]-_P#'Z/\ AT9?_P#1P7C#_OTW_P ?K]%** /S
MK_X=&7__ $<%XP_[]-_\?H_X=&7_ /T<%XP_[]-_\?K]%** /SK_ .'1E_\
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M_P!'!>,/^_3?_'Z_12B@#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\
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M@O&'_?IO_C]'_#HR_P#^C@O&'_?IO_C]?HI10!^=?_#HR_\ ^C@O&'_?IO\
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M,$Q1,E@WS#OR!0!\D'_@D9?YX_:"\8X_ZY-_\?H_X=&7_P#T<%XP_P"_3?\
MQ^OT4HH _.O_ (=&7_\ T<%XP_[]-_\ 'Z/^'1E__P!'!>,/^_3?_'Z_12B@
M#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\ OTW_ ,?K]%** /SK_P"'
M1E__ -'!>,/^_3?_ !^C_AT9?_\ 1P7C#_OTW_Q^OT4HH _.O_AT9?\ _1P7
MC#_OTW_Q^C_AT9?_ /1P7C#_ +]-_P#'Z_12B@#\Z_\ AT9?_P#1P7C#_OTW
M_P ?H_X=&7__ $<%XP_[]-_\?K]%** /SK_X=&7_ /T<%XP_[]-_\?H_X=&7
M_P#T<%XP_P"_3?\ Q^OT4HH _.O_ (=&7_\ T<%XP_[]-_\ 'Z/^'1E__P!'
M!>,/^_3?_'Z_12B@#\Z_^'1E_P#]'!>,/^_3?_'Z/^'1E_\ ]'!>,/\ OTW_
M ,?K]%** /SK_P"'1E__ -'!>,/^_3?_ !^C_AT9?_\ 1P7C#_OTW_Q^OT4H
MH _.O_AT9?\ _1P7C#_OTW_Q^C_AT9?_ /1P7C#_ +]-_P#'Z_12B@#\Z_\
MAT9?_P#1P7C#_OTW_P ?KA_CA_P31U3X1_"'Q=XS@^.OBW49M#TZ6^2TD#HL
MI09VEA,2,^N*_4RN<^(W@/3/BAX%USPGK(D.E:Q:O9W(A;:^QA@X/8T ?EC^
MRC_P3_UC]H_X%^'_ !_=_&SQ7HEQJ9F#64)>5(]DK(,,903G;GIWKUW_ (=&
M7_\ T<%XP_[]-_\ 'Z^VO@E\'-!^ GPXTSP3X9$XT;3S(8?M,F]_G<NV3]6-
M=U0!^=?_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\ _HX+QA_WZ;_X_7Z*44 ?G7_P
MZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\ ?IO_ (_7Z*44 ?G7_P .C+__
M *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE% 'YU_\.C+_P#Z."\8?]^F
M_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\ #HR__P"C@O&'_?IO_C]'
M_#HR_P#^C@O&'_?IO_C]?HI10!^=?_#HR_\ ^C@O&'_?IO\ X_1_PZ,O_P#H
MX+QA_P!^F_\ C]?HI10!^=?_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\ _HX+QA_W
MZ;_X_7Z*44 ?G7_PZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\ ?IO_ (_7
MZ*44 ?G7_P .C+__ *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE% 'YU_
M\.C+_P#Z."\8?]^F_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\ #HR_
M_P"C@O&'_?IO_C]'_#HR_P#^C@O&'_?IO_C]?HI10!^*?@']DC7/&G[9OC/X
M(/\ %_Q1:V.@6+7B:NLLC2S$>3\IC\W _P!:><]J^F/^'1E__P!'!>,/^_3?
M_'Z^M/"_[+O@WPE\?O$'Q?L5N_\ A+-;MC:W1>8F'8=F=J]O]6M>P4 ?G7_P
MZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\ ?IO_ (_7Z*44 ?G7_P .C+__
M *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE% 'YU_\.C+_P#Z."\8?]^F
M_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\ #HR__P"C@O&'_?IO_C]'
M_#HR_P#^C@O&'_?IO_C]?HI10!^=?_#HR_\ ^C@O&'_?IO\ X_1_PZ,O_P#H
MX+QA_P!^F_\ C]?HI10!^=?_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\ _HX+QA_W
MZ;_X_7Z*44 ?G7_PZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\ ?IO_ (_7
MZ*44 ?G7_P .C+__ *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE% 'YU_
M\.C+_P#Z."\8?]^F_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\ #HR_
M_P"C@O&'_?IO_C]'_#HR_P#^C@O&'_?IO_C]?HI10!^=?_#HR_\ ^C@O&'_?
MIO\ X_1_PZ,O_P#HX+QA_P!^F_\ C]?HI10!^-/[:/[%FM_LJ?#O2?$ME\9/
M%/B"6]U..P-O<.\(4,#\P(E/(QTKW/0/^"3^H:UH6G:@?C]XOC:[MHYR@C8A
M2R@X_P!=[U]I?M!?LZ^%?VD_"MCH'BT71L;.\2]C^R2^6WF+TR?2O1]*TZ+2
M-,M+&#/D6T20IN.3M4 #]!0!^>O_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\ _HX+
MQA_WZ;_X_7Z*44 ?G7_PZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\ ?IO_
M (_7Z*44 ?G7_P .C+__ *."\8?]^F_^/T?\.C+_ /Z."\8?]^F_^/U^BE%
M'YU_\.C+_P#Z."\8?]^F_P#C]'_#HR__ .C@O&'_ 'Z;_P"/U^BE% 'YU_\
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MPZ,O_P#HX+QA_P!^F_\ C]?HI10!^=?_  Z,O_\ HX+QA_WZ;_X_1_PZ,O\
M_HX+QA_WZ;_X_7Z*44 ?G7_PZ,O_ /HX+QA_WZ;_ ./T?\.C+_\ Z."\8?\
M?IO_ (_7Z*44 ?G7_P .C+__ *."\8?]^F_^/U\T_&O]D37?A/\ M2_"WX30
M_%_Q1J-IXRV>;J<DLB26N963Y4$I#?=SR1UK]JJ\A^(7[,'@[XF?&;P;\3=7
M%X?$?A3;_9_E3%8N'+C<O?DF@#Y)_P"'1E__ -'!>,/^_3?_ !^C_AT9?_\
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M)'J7B"VT:*[U:*U=\VT*_:;C:I(C#8R2<  $]Z_+G]J#XZ>(OVA/&_@/P?\
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M%;/A7?6S,CZKH4MO<A3PZK#,!G]#^% 'Z!4444 %%%% !1110 4444 %%%%
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ML00:M5X9^P]K%QKW[)GPPN[EF>4Z-#'ENN$RH_0"O<Z "BBB@ HHHH ****
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MM/5X98&&8Q+(06!9<8.>^3C->5_M.>(KO5/^"9_P'M+F5Y5U6738[@N<[PG
MS7Z?^%["+2O#6DV4"A(+:TBA15Z!50 #\A0!X7^QE^TW?_M#>#]:L_%&E+H/
MC_PM>'3-=TY,A/-'21 >0K8/'.#WKZ(KX!_9MC.A?\%._C[86[L+:_L([N2,
M'Y?,+1G./7D_G7W]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'QI^TW^TE\2=3^/^B_ /X+QV-CXLN[/^T-4U_4XS)'8V^-PV+T)P,DG/4 #G
M-<'X_P#BC^T1^P]JOA[Q%\1O%NG?%?X;:E>QV6I7/V-;6[L7<\%=H P.<9SG
M&#BL7]M/7H_@?^V+X1^(WPUU(>(_BO>VJZ?>^ H[>29KVU*[0^Y ?+X]>3C(
MZ5P'[2_QP\9_M&^*? GP[^,WA2Z^ WPXO=0CN;K4=4MY)S>3)C$0<#;&.2 2
M>,Y/2@#[W_:;_:8T?]G?X%7?Q">(:F\R11Z59[MOVN>49B7Z8^8X[ U\WZ7X
M9_;6UWP2OQ'3Q[H-GJUQ;?;H? ;::I@\LKO6,O\ >$A'&-WMFJ/_  4NMK-U
M_9S\)6Q6309O$]JJ(#N1XT543GO\K?K7Z!P0K;01Q(,)&H50.P P* /$OV0/
MVE(?VG/A2->GT_\ L;Q%IUR^FZSIA/\ Q[W28W8SSM.<C/N.U> Z]\=/C-^U
M=\;?%G@;X'ZYI_@CP3X1F^R:GXOGMUN9KBYY!6)3E<9!P,=B2>U<M^Q#=R^$
M/VA/VNM.LY&6TM;G^T(D!X23-PQ(]^1^0KM?^"2=E$_P(\5:QM'VO4O$]X\[
MXY8J1C/YF@"U\-/C_P#%OX%_M :'\(OCI<Z?XCL/$Z$>'O%^GP^1YLJ]8I5Z
M9/X8..H-?;-? ?\ P5F@-II?P5UN!VAOM/\ %B"*1#A@'V9&?^ BOOF&3S84
M?&-RAL?6@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X+^V3^U
M!;_LM?"O^W(+ :SXEU*=;#1M+)($]PW0MCG:O4@<G@=Z\(TGP)^VQ?\ A=/'
M4GQ&T"WUUX1=Q^!I=-7[,5(W")GQN#]L;O;-1?\ !5_P[J5KX>^%GQ!AL7U#
M1/!_B*.[U2)%W;8F9"&(]/D(SVR*^E[/]K;X1WGPW7QROCK2$T P"<N]RHE4
MD9\LQYW;\\;<=: ,K]D+]IJ#]IKX:3:M<Z=_8?B?2+EM.US223_HMRO7&>=K
M=1GD=.U> ZK\<_C1^UK\9_%O@[X(ZY8^ _ _A&86>H>*[FU%Q/<W62"D0;*X
M&#QCH,D\BO+O^"=?Q%N_$GQ-_:=U.&TN=*M;Q)]8BM)D*-"S&0KE>S;<5ZS_
M ,$?+7?^S7KNK2MYM[JGB6[N+B4]6;9&.?R)_$T :7PL_:#^+'P3_:%T;X.?
M'6XT[7K;Q+&Q\.>+["(0">10?W<J=-S' Z#!(Z@UZ5^VK^U%??LY^#M%L_#&
MF1ZYX_\ %-W_ &=H>GR@LGF<;I' Y(7<O'&2>O!KQ3_@JM_Q)IO@1XAMQMU"
MT\90)'(H^8#&[ _$"J?[3,DGB+_@I5^SGIUQ(QM+/3?MZPG[IE,DN3_XZOY4
M 6?%NG?MD_ _P7<?$B]\=:'X[%C&+[5O"']GK&D-NOS2K#(H!)5<Y.>V1FOK
MOX"?&72/C_\ ";P]XZT53%::K!O>W9PS6\H.'C8CNK BNO\ $EC%J?AW5+.9
M0\-Q:RQ.K="K(01^M?$__!(O499/@=XQTLD_9=.\3W4<"]E#8)Q0!]U4444
M%%%% !1110 4444 %%%% !1110 4444 %(3@4M0W=LMY:36[DA)4:,E3@@$8
MXH ^%_VY_P#@HUHWPE\.ZQX2^&5\NO\ CX1LEQ?6*B>WT=> 9'894N"<!>@/
M7TKZ;_99\5ZMXZ_9R^''B'7KU]2UK4]#M;J\NY%56FE9 68A0 ,GT%?-/[8/
M[./@#X ?L2?%2/P;H,-A<Z@D<U[J$O[VZN6-PK?/(>2 6.!TKZ!_8N_Y--^$
MW_8N6?\ Z+% 'D'[3/[2GQ#U;XYZ3\!?@@MA%XRN+3[?K.O:@OF1:7;GIA?[
MV,$Y!^\H YKB?%/Q6_:#_8FUWPYJWQ3\26'Q3^&&IWB6%_JL%FMM>:=)(<*Y
M"@ J.>W.,<&C]CTCQ+_P4%_:4UJZ&^\M#;6L3L.53[N!^"+^5>N_\%+M(@UC
M]B_XA).H(@A@N4)[.DZ,#^8H [K]I[]I/2?V=?@A>^/6A&JRR+'%I=FC?\?<
M\H_=+QSM[DCM7S9IOAG]M?6O!*_$>+Q[H%MJ]Q;"^@\!OIJ^1Y97<(R_WA)C
MC&[J<$UXO^TIJ=WXI_9Q_8OTRZN9&AU2[MOM08Y\W8L(!)/U/YU^L 4*H4 !
M0, #IB@#P_\ 9!_:3@_:<^$R>()[%='\0Z?<OIVLZ6'W?9KJ/AL=PK=1GGMV
MKY_UOX[?&;]K#XV^+/ _P0UNQ\#>"_",OV34O%MS:BXFN+D,5*1!LK@$-QCM
MG/(K$_8LO6\+_M"?M9:+9YBL;._FO(XT' <;QD>];7_!'>!I_P!G;Q%K$[^;
M?:IXBN)[B0]6;:HY_4_C0!L?#+]H+XL_ S]H/0_@_P#'2ZT[Q%9>)T(\.^+[
M"(0>=*N?W<J]-Q.!T&"1U!K[:KX'_P""KH&DV7P2\0VZ[=1L?&$ BE'W@.&P
M/Q45]YVLAEM87/5D!/Y4 2T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %? 7_  4.+_"O]H7]G_XQ3QD:#I.I/INIW7:!9"I1C[8,A_X#7W[7._$#
MX?>'OBEX3U#PUXITJWUG1;Y-DUK<+E3Z$>A'4$<B@##^*'Q:\,>!/A!K7C>_
MUFT30(M/>XBO%E4I-E#L"'/S%C@ #K7S/_P2=\#ZCX>_9RU+Q)J<;PS^+]<N
M-8C21=I\HA8U8#T.PD?6K^E_\$K_ (.V.I6C75YXHU;1+2198= O]7>2R!!R
M 4QROM7U[I>EVFB:;:Z?I]M%9V-K&L,%O"H5(T48"@#H * +5%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P5^V3_ ,GZ_LR?]=KC
M_P!"%?7'Q[\$2?$KX*^-_"T)Q-JVD7-K'C^\T9Q^N*R/B+^S?X1^)_Q3\%?$
M#63?_P!O>$F=M.^SW&R'+')WKCYNE>J4 ?&7_!*SXB6&M?LT6?@J:Y6+Q1X1
MO;JPU#3I2%FB'G,R$H><8;&?52*X?XJZG:_'[_@IK\,=!T"5=3L?A]8SW^K7
M5LP>.W=AD(2.-P;RP1_M>U>V?&#_ ()]?"_XM^-+KQ<#K'A+Q%>#%W>>&[XV
MGVH]VD51@M[UW_[/O[+W@']FC1;NQ\&Z;)'<WS;[W4[V3SKNZ.21OD(Y R>.
ME 'RM:ZM:_ +_@J9KKZ_+'I>B?$/1HC87]PX2*2=5 *9/ )=2/R]:]2_X*9_
M%#3/ _[*_B71'O(QX@\3B+2]+L4(::=VD4L53J0%!Y]2/6O8_CS^SCX%_:0\
M,1Z+XVTK[8D#^9:WD#^5<VK_ -Z.0<K_ "KRGX8?\$Z/A7\-_&UCXKN)-<\7
MZMIS;K ^)+]KN.U.>"JD8R,=?TH ]-_92^']U\+?V<?AYX6O<B\T[2(4F!&"
M'8;V!]P6Q7J]%% !1110 4444 %%%% !1110 4444 %%%% !1110 53UG6++
MP_I-[J>HW,=GI]G"]Q<7$IPL<:@EF)]  :N5R7Q8^&>E?&/X>ZUX-UN:\@TG
M5X?L]R]A-Y4VS() ;!QG&#[$T ?GJWB76_\ @ICX^N_[4\1Q>!?V>M#O?+6R
M^V)!=ZY(IZMDYQCGT7/<\C] ?AW;> O ?A[2_"?A"XT:PTVT00VFGV-S&?R
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M"R#MGG!KSCX;_P#!.'X4> O%]EXFU!M;\;:M8G-HWB:_:[B@;((94/&1@=:
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M]7O=<T&VO=6\37BF.;7-;N3<W6PXRJL1\H.!GO[U[Q0 4444 %%%% !1110
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M219(=!U#5GDLE(/ *8Y7VXKZ]TW3;71M/MK"QMX[2RMHUBA@A4*D:*,!0!T
M% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @OII+:QN)H8?M$
MT<;.D0.-[ 9"Y[9/%?/7[)?[8EA^TO-XMTF_T9?"'B[P[J#VESH,]T)9C&./
M-'RKD;@RG XQ[U]&5\W_ !J_8&^%WQJ\8R>+KB+4_#'BF52)]5\.WAM)+C(
MS)C[QP!SQ0!\_P#_  5)U2R^)_BOX-?";P[<+?>-[CQ(E\8+4AY+6$(5+/C[
MOWMW/9":L?MU69^$'[3?[.?Q<U.21/#^E3IHVIW2C*Q+N)W,>P(D;\C7TG\
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M ()V?"OX9>-[/Q9,^M>+]:L#FQD\27YNTM2#D,BD=1ZG\J /6?V;? <_PR^
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M]G#4;_5_#UK>:EXCOUV7&N:S<&YNV7C*AS]T' Z5[I0 4444 %%%% !1110
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M &IX]_:T_;#\"^&I?B1J?PDT?3? T.)I--E;?<PPDC#2 -O7@C)QQFNIM?\
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MP#I&HQ-9:RR2*\17R&42.<Y.66/MVH _4&BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img117130267_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img117130267_3.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" )-!>0# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Y&_X(&_\
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M .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\
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M (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\
MB:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")
MH_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC
M_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^
M((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@
MBOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*
M_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]
MD_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3
M_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_
M .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\
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M (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\
MB:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")
MK]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FO
MVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;
MJB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ
M* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH
M _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#
M\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q
M%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7
M_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^
M((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@
MBOV3_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*
M_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]
MD_\ Z/4^(G_@GL/_ (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3
M_P#H]3XB?^">P_\ B:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_
M .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\
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M (FC_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\
MB:/^((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")
MH_X@BOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC
M_B"*_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^
M((K]D_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@
MBOV3_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*
M_9/_ .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]
MD_\ Z/4^(G_@GL/_ (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3
M_P#H]3XB?^">P_\ B:_;JB@#\1?^((K]D_\ Z/4^(G_@GL/_ (FC_B"*_9/_
M .CU/B)_X)[#_P")K]NJ* /Q%_X@BOV3_P#H]3XB?^">P_\ B:/^((K]D_\
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M (FOVZHH _$7_B"*_9/_ .CU/B)_X)[#_P")H_X@BOV3_P#H]3XB?^">P_\
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M!(GFLSA7B8'DGD, >*^UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-K=;=ES;,1_%%.DL1]T- 'K5%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ."K_P"S9\-=+M]+\':;X7;Q!I&B6,8CM[&?4?#9N+A(HU&V-3(Q(5< #
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M3PAX\\$_$#3&UKP!XRTG7+-93&UYH^H17,2N!DJ6C8C/(XSGFOSW_P"(4?\
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M89C(E13E<$@8Z4 ?2E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YJ_\ !1OX[?\
M!2?XQ_\ !4[P5_P3I_X)U?M;Z?\ "3R?A+=>,?'&O7W@G3]:C*M=^1;(RW<$
MA1B48 (5R&).<"O7?V'/V6/^"Q'PB^-R^+_VWO\ @J'H7Q;\$C2YXF\)Z?\
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M7WAG5_%O[.K6NHV<MK<B.S"L8Y$*-@]C@FO)_P!A7_@GU_P<Z_\ !.SX&?\
M#/'[./B3X#P^'/[;NM5V:U)]JF^T7!4R'>5'R_*,#'% '[A45^47]D?\'>/_
M $-_[./_ ( BC^R/^#O'_H;_ -G'_P  10!^KM%?E%_9'_!WC_T-_P"SC_X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_.O]M#]ESX<_#;_ (*X_LN?M#:!
MK/B>;7/&?Q(UF+5K74O%%U<Z?$J:#<8^SVDCF*W/RC)103SGK7Z*5\3?\%!?
M$?A_4?\ @HE^QOH=AKMG-?6GQ,UPW5G#=(TL(.@W6-Z Y7\10!]LT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%_IC:?>:E8ZE>S-);,ZN8R)YW7!9%.0,\=: /HRBBB@ HHHH **** "BBB@
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MA<Z7#.WBRZ^.NG>'6%TS.)+?[)<6DKD( A\S=AM^ !M.0#Z:HKX9_P"&YO\
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MTY_X.J?V7=O_ $1OQ)_Z1ZE7ZE$XZT (H(&#2T9STHH **** "BBB@ HHHH
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M?V'/^"RUU^RG^UM_P47^(GQ2CU?X7W6N?#NWUFXD.G:S;B6..X\^&2:0V]W
M5W* 75D9B&!&* /UTHHHH *"<=:*_&O_ (*.?\%=_P#@K-\7/^"C5Q_P3%_X
M)+?""U\.ZAIIF2Z^(/BK04?^T'MPANIK=KU&MDM(F<1E_+E9V.5*@C(!^R8<
M4M?B5_P3S_X+F_\ !2+X$_\ !2FS_P""5?\ P6!\-:#K'B#7-2AL=)\8:'8P
M6MQ:W4Z;X"XM52WN+:08 98XW0G)+@X7Z!_X+^_\%L?BK_P3GN_!/[,'['W@
MK3?$'QE^),BC2_[6MVN(=+MWE$,;"!67S9Y)#MC#'8-I+!A\I /TS5LTN<=:
M_!>#_@LG_P %OO\ @D1^TEX!\-?\%J=*\-^*OAS\1V!;6='TJQCN-&B5T69X
MI-.BB1I(?,5WAE1RZGY&SS7Z,?\ !:__ (*R^'_^"5/[%\?QZ\/:3IWB+Q9X
MHU!-,^'^DW4S&WNKAXFE-S)L8,T$<:[FVL-Q9%!&\&@#[.\SVKY?_P""U3WB
M?\$DOVC#80+))_PI_7 RL?\ EF;1]Y_!=Q^HK\B_&?\ P5L_X.7?V#_AGX'_
M ."AO[9/ACP?XA^#OCJ^M2OA&;P_8V[65O=QF:%&:T1+JT=H@3&TTDH#!1(K
M$[3^GW[?7[0O@;]K#_@@A\7/VD_AM*S:'XT_9YUC5=/63[T:RZ=(3&W^TK94
M^ZF@#\_?^"3WQY_X.,/#'_!.OX4Z!^R1^PU\*_$WPXMO#A3PGKFN>,K6WNKR
MV^T2G?)&]XC(V_>,%1P!7[;?"2]^(FJ?"GPSJOQ?T*UTSQ=<>'[*7Q1IMC,)
M(+346@0W,,;@L&192ZA@2" #D]:^6/\ @WM /_!&']G[C_F2V_\ 2RXK[+QS
MF@ )QUK\8]"_9G_X+W_L0?\ !0W]IKX_?L3_ +'O@+QAX7^-WC"QOX;[Q5XV
ML(6$%DMUY+)']J1T+?;)-P<9^5>E?LYCG.** /RIN/VHO^#K2T3S;O\ X)T?
M!.)>FZ3XA62C/XW]>.?LL_\ !9?_ (.%_P!LSQ-X\\(_ #]B+X-ZM??#?Q%_
M87BR&Z\516GV:^RX\M#->*)A^[;YDW+QUY%?IW_P44_X)[_#3_@I1\$-/^ W
MQ6^*WQ \'Z;IOBB#7(=4^&^NPZ??2316]Q (7DFMYU,)6Y9BNT$LB'<,$'Y%
M_9Q_X-7?V'?V6_CEX9^/OPV_:F_:(DU3PSXPT_Q&NGZAXWTPV6J75I<I<(EX
MD6F1M/$[)M<;U9E9@&!.: ,4_M,?\'7Q7/\ P[A^"W_A?V7_ ,GUZ9_P;A?L
M(_M0?\$^?V(=<^#?[6G@:U\/^)M0^(%]JT=E9ZQ;7R&WEBA"MYEN[J/F1N"<
M\5^@V.,4TY7@4 .HKXK\3_\ !PY_P1H\%^)M0\'^)OVZ-!M=2TF]EM-0MO[!
MU5O*FC<HZ96T*G# C()''%?17[+/[7'[.G[:OPJC^-_[+GQ0M?%WA6:^FLX]
M8L[6>%6FB.)$VSQH^03_ '<>E 'I5%%% !1110 4444 %%%% !1110 4444
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M<_!]O9:E-X$_L^\G\36B176S3;T/Y;F3#[20#M)P2,T ?H)17 _\-6_LN_\
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MXUZ/\3-?^#OBS0_@IXEL=%\:7OAF_M_".L:I"9+:QU1[=UM9Y5"L6C28QLP
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M_P"WYH.K>)_V<;F:Y_X1UO"_A&QC6\TZ5]T%W%<[%,ES!GRW@>:,$CD#<KD
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M@/X#^,K.WT_6)+GQ!J7BBRC6.QN)U2-YY#;R2*EM;Q>8[2,RL^<! < _9?\
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MF+X/CLM-NK?^U5F%U]J)^T7$V[RS%;_=VX\WG.1CZ<_:-^(-G\)OV?\ QO\
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MX)?_ !W\6>"O$VHZ-JVG_#/5)M/U72;Z2VNK640G;)%+&0T;@\AE((- %/\
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MU\WPTTTFQ!P-TLCN?4L37Z'5\-?L _\ *9?]O_\ ["OPQ_\ 44% 'W+1110
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MR^(G_92M7_\ 1BT4 ?L5_P &1?\ R:=\:O\ LHEG_P"D"U^W5?B+_P &1?\
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MTG3X[:+=Z[8U S^%7M0TVRU:QFTW5;.&YMYHS'-;W$8=)%(P593P0?0U:HH
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M!B2/?L;@<J>!7RW_ ,&]W_*&+]G_ /[$MO\ TLN*^RJ "BBB@ HHHH ****
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MCG_^4] 'V57S;_P6+_Y12_M%?]D<\0?^D,M</_PTE_P6]_Z1>_"/_P 2.?\
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M/6$T_P #:*S"XOEE2^BD9=JL?W<;M(>.B&OLS_@G#_P43_;]_:T^,VI?#_\
M:G_X)>^+O@GH-GH,E[:^)M>DE,-S<"6-1;#?&HW%69NO1#7B?[5HV_\ !U3^
MR[M'_-&_$G_I'J5?J50  DC-%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_V9OA9X@\9_&7]EGXE:;J'[27[36O>)M.\/V_AM9;CP?I]W9V\<$^M*)?\
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M;XBO(Y[7P7X7NF6PTM5ACC,<(%PO!*%S\HY<U^@U?#O[3?\ P<1_\$J/V/\
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M/B33TO=&U:R?='<0MW'H0<J0>000<$&OE[_@K+_R5_\ 8U_[.VTK_P!,&N4
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MV^%>N?&SXS^+K?0?"_ANS-WK6L7BMY=K"&"[VV@G&6 X'>OE?_B(B_X(T_\
M1]GA/_OW<?\ QN@#[4K\GO\ @UH_U'[6W_9QVJ?^C)J^C3_P<1?\$:<_\GU^
M%/\ OW<?_&Z_.?\ X-]/^"L/_!/G]DN+]H\?M#_M+Z)X7_X3+XX:AK7AG[<D
MW^GV+R2[9TVH?E.1UQ0!^]E%?%?_ !$1?\$:?^C[/"?_ '[N/_C=>A_LO_\
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M&X?_  1>^)/C/5OB%XY_8MBU#6M<U&:^U6_E\>>(%:XN)7+R2$+?A1EB3@
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M.7_T T ?CG_P:V_\F:?&+_LY;Q%_Z;]*K],*_,__ (-;?^3-/C%_V<MXB_\
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M_P"RB6?_ *0+7[=5^(O_  9%_P#)IWQJ_P"RB6?_ *0+7[=4 %%%% !1110
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MXX?MQ?!G7/"EOJ,3>)-+T;X8SVMY>68/SQ1S&8[&(Z,00* /MRBBB@ HHHH
M**** "BBB@ HHHH _%?_ (+(_M)?$#]DG_@X1_9Y^.GPQ_9TUWXK:UI/PCUB
M.U\#^&[CRKR^$R7T+LC>7)@1JYD/R'(0].M?:'_!.?\ X*G?M)?MN_&/4OAA
M\8/^"87Q"^"VG6.@R7\/B;Q9JAFM[F59(T%LH^RQ?.0Y;.X\(>*\-_:M_P"5
MJG]EO_LCGB3_ -(]2K]26Y&* !?NTM%% !1110 4444 %%%% !1110 4444
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MWP/X9\<?$+QAK=K8^!_#5UX>_M&\LVN[A84ED91FU@9\$EV 8(3@XH ^!?\
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MY1+_ +.'_9&/#W_I!%7TQ0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%(WW>E 'YD?\%"?V3?V^/A9^W?KG_!1O\ 9[_X*#? ?X%^%[SPW8Z)J<WQ
M'L/)CU.WAB4[-1EF_<R%)1*T4BLDB(VW=M  Z+]BWQ;_ ,%</CQ\1-'\86/_
M  5'_90^*GP_TW5X?^$NA^%ND_;9WMLG=$D\$CI%(P!P6/8UP7BKX)? C]N?
M_@X)^*7P7_;^TRW\1:3\.?A[H-S\#?A_XBN&&G7T%S:QR:AJ,<&0MQ*MR9HC
MUP(N1\O&=^W;^RS^R7_P3[_X*$?LK_$?]@CPII7@'XI>,OBE#X>\2>#?",WE
M1:]X9FBD-Y+<VBG 2(JC+)@#/') *@'ZR4444 %%%% !1110 4444 %%%% '
MXJ_\%FOV:/B'^UU_P<%_L\_ ;X5_M(:]\)M:U;X1ZQ):^.O#,+27EBL*7LSJ
MBK-$2)%0QGYQPYZ]#]E_\$WO^"4_[3?[#GQGU+XH?&?_ (*E?$7XW:;?:#)I
M\'AGQ=I\D5O:S-+&XN5+7LXW@(5^Z.'//8_)G_!5[]K+X&?L0_\ !QG^SC^T
M=^T?XM?0_".B_"'6XM0U*.QEN#&T\5_!$-D2LQS)(HX'&<FONK]B?_@LQ_P3
MW_X*&?$N^^$/[*/QFF\1:]INDOJ=Y9R:#=6H2V5T0ONFC53\SJ,9SS0!]3I]
MVEI%W#@TM !17.?%CXG>$/@G\+_$WQE^(-_):Z#X1\/WFM:Y=0V[2M#9VL#S
MS.$0%G(C1B% ).,#FO@#_B+%_P"")W_1PGB/_P -YJO_ ,8H ^E/^"C'[3_[
M9G[+_@'P_P")?V-/V&KSXZ:MJ6JR6^KZ+9^)$TPZ=;B/<LY=XWWY;Y<8%?G[
M\&/^#BW_ (*E_M$>/O&_PN^"7_!#VY\0^(OAOJ$-AXZTNS^*B"31KF5IA'%+
MOLU!+?9Y<;21\A_'VX_\'8G_  1.[?M"^(O_  WFJ_\ QBO@'_@D7_P7*_X)
MT?LD_MQ_MD?&_P"-_P 5=6TWP[\8_'FE:KX#NK?PI>W+WEM!)JID9XXHRT)
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M%*_5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCXI?$3P)XZMK:?4KK3[:ULHM-FM%FLY+6.!%"^8A8R*PR'4CD8)^X* /R?\
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M@5LY)KXU_P""B8_XS_\ V+_^RG:[_P"F&ZH ^S**** "BBB@ HHHH *^2O\
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M_%S]D7X!_MQ^+O@5\'_@);Z;8>(]6^'%PUMJ^NZW=(9BBW,;)(BQA"K .%&
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M\!^,FFCTVQC@5V_L351DA ,FO7/^(H;_ ((G_P#1V\G_ (1^J?\ R/7YN_\
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M2'3O)D/F1?9[F!O-\T1#EB-I;C."/CW_ (7U_P ';O\ T9[^R7_X%:M_\MJ
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ML9?L??%#_@D%\)?'/Q+_ &4?AMXBUJ^M=0-YK&O>!=/O+JX(OYU&^66%G;
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M* "BBB@ HHHH **** "BBB@ HHHH *CN/]1)_NG^525'<?ZB3_=/\J /XO\
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M3_$?Q7L_'FH0> ]'COO'&GZA]K@\13+91!]1CGR?.2X8&99,G<) <G-?&_\
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MOMRW)=LX]Z_1.OC/_@HD?^,__P!B_P#[*=KO_IANJ /LRBBB@ HHHH ****
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M@^''B#X3>/M+%]H/BC1+O2-:L6D*_:+.YA:&:/*D$;HW89!!&:^)5_X-E?\
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MJ.RQJ#SFOMC_ (2/P]_T';/_ ,"D_P :_,C_ (*7?L9?LMR_\%?/@O\ &O\
M:=^&LFL>"/CAI,WP]UB:'7K[3TM/$D(,^D3.]E-$S-,@FM0&)R63H$KZ#7_@
M@O\ \$J<9/[,]]_X<CQ%_P#+"@#ZS/B3P\.NNV?_ (%)_C2_\)'X>_Z#MG_X
M%)_C7Y1?#K_@DM^P/K7_  6(^)7[-FI?!K5)O ^A_!/0];TO06^(&NA(+^>^
MGCEG#B]\PED11@L5&. #7U3_ ,.%_P#@E1_T;-??^'(\1?\ RPH ^N+/4]/O
MPQL;V&;;][R9 V/RJQ7D/[*G["?[+?[$UOKEI^S/\-IO#L?B*2W?6%F\1:CJ
M'GM )!$1]MN)MF/-D^YMSNYS@8]>H **** "BBB@ HHHH **** "BBB@ HHK
MG_B9KGC/PSX UC7OAYX,7Q%KEG8R2Z7H;7RVPOI@,K#YKC;'N/&X\"@#H*^&
M?^#D[_E"9\<O^O'1?_3]IU;?_#9?_!6G_I$;;_\ AY=-_P#B*\$_X*:'_@KK
M_P % _V'/'G[(.G?\$Q['PW-XRM[&--:F^+6GSK;?9[^VN\E H+9$&WJ,;L]
MJ /U&HKXT_X;+_X*T_\ 2(VW_P##RZ;_ /$5I>"OVMO^"HFM^,M+T?QC_P $
MM+?1=)NM0BBU+5A\7-/G^QP,X#S>6J9?:N6VCDXQ0!]<T444 %%%% !1110
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MB,GK7Z^U^17_  :B>-?#7Q%T7]JSQ]X*U1;W1];^/L]]I=XL3()[>6$NC[7
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MB#QW5W)"WES2QS#<IP8@1@@$ 'ZG4444 %%%% !1110 4444 %%%% !1110
M4444 !Z5^/?[5OQ^_93^%'[0OBSP7\0/^#F+XL>#]8M]8G>]\(Z.FG3V^BLS
MD_9%9;%\>6/EVEBP &>:_82OQ\_83_;K\2?LH:A\8/@C^S/_ ,$P_BS\<O!-
MC\:O$5W:?%KP/X?@B36;R>\:2Z@G-P5\Z2VE+6PE5CF.*,%4QR ?4O\ P14A
M_82U#P#\0?&G['G[6FO_ !NUS7O%$5W\3/B%XJN/,U"^U#[.JQ(^(8D1%B&$
M1%P >I/-?;U>%_L1?M3_ !%_:E\+:YKWQ!_8L^('P6FTN_2"WTWX@6MO%-J2
MLFXS1"!V!13\IR0<U[H,XYH ^!OV*/C3?_$[_@IU^TEJO[0_[3VH:7X@^'OB
MH>%O OP?O-8CL].A\-M:6UQ#K(MVP;F6XE>4>;D[!'C@.*?_ ,$W?&5WX6_X
M*+?M!?LR_"3]H#6/B5\*]'TG2O$-O>:QKAU7_A&=>OI[DW.EPW>3NB**)!"2
M3%M XS@\_P"./@K^R!_P6)_;Q^(?P\^-G_!.WP[XH\$_!6;_ (176/C)J6L2
MV&J7GB!$BN'TJ#[%)'/);P1W 9C(^P-+E0-QSVW_  2@\0^$_@/\3?B=_P $
MWY/V.O"7P;USX?S0Z]I5MX'NFNM.\3Z'>2RQ6VI>?(/.:X'DK'*)OG!*XR,A
M0#[@HHHH ***^8_^"E7[</Q _8Z\-?#WPC\#?AGIOB[XD?%OXA6?A'P/I.O:
MD]GIT5Q,"SW5W+&K.(8D7+!%+$'@$C! /IRBOG7_ ()J_MJ>)?VV_@EX@\1_
M$?P#9^&/&O@/X@:IX*\=Z+I=\UU9P:I9>4[M;RNJL\3Q3PR+N4,-^".*\DN?
M^"PUIXA_X+*^&?\ @E[\+_ 5KJFAS:+JS>+/&TDDG^C:M9V;736-MCY',:^4
M)<Y*F4#C'(!]RU^='[9_PK^/7AK_ (*[?LN_$CQO^TM+XB\&ZU\2-97PSX!;
MPI!:KH#+H-QN<7B2&2YW8;AU7&[VK]%Z^,_^"B7_ "?_ /L7_P#93M=_],-U
M0!]F4444 %%%% !1110 4444 %!&1@T44 ?CE^TI^RG^UK_P5#7]K(6_[;'C
M;3Y/@G\6KB7X3^ [.QL3IR:CIUG'>61,C1>?&WFL4WJXP'/##*GVO]BG]E_]
MI[]LC]E3P+^TOX>_X++_ !WM8O%F@Q7=S8KIVAG['=#*7%N<V60T<RR1D'D%
M"#S7IG_!*$ _M$?MD#;U_:0NQC_N'VM87_!-*;4_V0_VY/V@/^"9FNR-#H+:
MNOQ1^#JR9V_V+J[L+^TC[!8-128[1R3-(W (H IZ;_P1/^,NB_&W5/VB],_X
M*X_'*/QIK6@V^BZGKBZ?HOF3V,$C210D?8]N%=F/ SS78_\ #L3]K_\ Z32?
M'G_P5Z%_\A5]G#/>B@#\]O#'@_\ :Q_9"_X*:? _X+>,/^"@'Q$^*7A?XC>'
MO%$^L:/XRL]/CCBDL8;5H60VL$9SF=LY)Z"OT)KXS_:W_P"4PW[)W_8K^//_
M $GT^OLR@ HHHH **** "BBB@ HHHH **** "C /4444 %%%%  !C@4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444UQWH _/G_@HM^U+
M^RMX2_:HB_9P^&7_  2UT/\ ::^/>H:'%JNL:2OAO3$_LO3]NR"74-3NK>8P
MA@ $7:YV@< ;0>/_ &6/VL/V<?#?[6?@_P#9\_;(_P""*7AO]F?X@>*KAW^&
M?B*/0]'U/3=1O(AN,,.HV]G;M#<@<JNSG^\#C,?[1'C#XT?\$J?^"K_Q*_;O
MU?\ 9:\>?%+X0_';PKHMOK6L?#?2$U#4O">I:9:QV@CDMVD0FVDBA67<& W,
M^,D8;G/B!^T5\6O^"V?[5?P*\%_ ']C7XH>"?AC\)?B9:^.?&7Q,^*'AU=)\
MR6TBD6&QLHO,=I&=I"&.=V.JA06(!^K]%%% !1110!\;_P#!3[]O[]H[X 7U
MC^S#^PU^RYKWQ&^,7C+19KO1]0:W\K0?#5N&,9O[^Y;"_*02L.1OVG+ #!\W
M_P"#9+XL?&CXT?\ !-.;QS^T!\1=4\3^*9/BEXCBU+5-6U"2YD++<+E$9R=L
M:G=M1<*HX  XK] O$BC_ (1_4'V_-]AE&?\ @!K\Z?\ @UB./^"86H'_ *K%
MXJ_]*UH \\^+'@S]IK_@LW_P5&^,7[-6A_MH>//A)\$/V?H=-TK4H?ACJ'V+
M4M?UNY3SG'VGGRUCVD,2KXVJH4[BR]%_P3YUC]IS_@G)_P %5-7_ ."6GQZ_
M:H\2_%KX>^,/ANWB_P"%/B3QI+YVIV'V:3R[BRGER3(P56;</E8*K80L5&[_
M ,$7XG\/_P#!2;]OSP9K%R5U1?C-8ZDUO)]\6MS;2/"^/[I7@'VJK^U=:2^*
M_P#@Y4_9[TG0)-UUH?P%\57NK1QJ"R03)-!$6[@&1AC..1^% 'CW[/\ ^SK^
MU#_P7P^*_P 8/VI/B7_P4%^*WPN^$OACXCZAX1^%O@_X2ZY_9CS+8A5DO9Y<
M,'1C(!MVEG;?\R!5!]]_X(K?&K]IOX>?M$_'S_@EY^UY\;[SXC^(/@WJ5AJ7
MA#QQJD.VZU;0;Y&,9E^9COC95# DX,F S 9JM_P:^2)9?\$]_%O@ZZN=VI>'
M_CQXLL-8A;[\-P+F-]K#L2KJWXUG_L=V[^(?^#E?]J;Q-HDGF6.C?!OP[I>J
M/&H*I=RRQ2HK$=&V1/QD'&>.. #A/V_OA/\ #+XV_P#!SE^S-\.?B_X TCQ1
MX?O/@]X@:\T77=/CNK:9H[;4'0M'("I*NJL,C@@&OT>^#_[&_P"R?^SWXBF\
M7? C]G#P5X/U2XMC;7&H>'/#=O9S20E@QC+QH"5)4''3(%?E'_P68\2?MB^$
M_P#@X0_9YUS]@SX=:%XJ^)\/PCU@:'HGB2^CMK.>,I?"X+R221J"L!D8989(
M YZ5Z;_PT)_P=J?]&"_!/_PM;+_Y.H _5NBO"_V??'O[;X_8IC\>_M+_  1T
MF/XT6^BWUQ=>!_#>KP&UN+M&D^S6\<YE,8WJ(\L9, L<D5^9?[)/_!?#_@H+
M^T!_P4?\1?L^>&OV-M3UJ2\U+0K'4O %QXPT=+?P5';>7%KMS;W2%3?MEC+M
M,C>4QV,.Q /VHHK\\/\ @L%\=?VV-6_:_P#V=/V"/V"_VH?^%5^)OB5_PD&J
M>)_$W_",V>K"UTZRA@\K?!<HV0TCR ;2IRAR>,'QC]K3X1?\%\_^">_[/?B;
M]LSQ+_P6D\+^/M-^'^GMJNH^#O$7PCTW2[?5X4^];B>(%UD;.$ *Y8@9% 'Z
M[48'I7'_  ,^)4WQ9^!?@_XNZKI#:7)XD\*V&KW%C,?FM&N+9)FC;/==Q!^E
M>-ZC_P %B/\ @E3I&I7&D:K_ ,%$?@[;W5K,T-S;S?$"Q5XI%)#*P,G!!!!'
M8T ?2E%><_L^_M;_ +,'[6FEZEK?[,?[0/A'Q]9Z1<)!JEUX1UZ"_CM)'7<J
M2&)F"L0"0#U%>!_\%F_VY_C'^Q1^S=X;T_\ 9DT33]1^*OQ5^(6E^!_AW%JT
M9>VM[Z]DV_:9%'WE0# 7^\ZY! - 'V%17Y.^(?B/_P %H?\ @E-\7OA3\3_V
MY/VW?"?QL^%/Q"\?:;X4\;6MMX)@TN?PM<7SF.&>WDAC0RP+(PRS_,0OW!DF
MOU@;*CB@!U%?ECXK^,G_  5A_P""H7[9?QF^'G_!/O\ ;#\/_ OX6_ OQ2WA
M&36[CP;;ZS?>(]>A7%XK+.I6.&.42)N4@@*IPVXX[W]@7_@H!^W]\4OV7OV@
M?@S\1/A3HOCK]J#]GSQ)-X?_ +%T>^M]/L?$LDT6[3[PO<2110HY6<MED!6#
M*X9PH /T1HK\>_VB?%/_  <)_P#!.S]GZ3_@I#^T3^V]\/\ QEI>B-97OCKX
M$0^";:WMK&UN)XDEMK34(AYDL\9?8"6*$[B&?"[OHW_@J!^W/^UWI/CCX$?L
M4?\ !/\ CT71?BE^T ]U<V_BGQ5:^=:^'-+M;3[5=7'EX(>58P^%*GE, $L*
M /O>BOS'^'OQO_X*@_\ !,O]KWX0_ S_ (*%_M7^'OCK\/\ XZ:])X<T;Q99
M^#XM%U+P_K@C,D,3Q0 1RP2_=#<MD<A0/F_3@<#% !1110 4444 %%%% !11
M10 5X_\ $/\ 8!_8?^+/C*^^(?Q._9)^'OB#7M4D634M8UCPG:W%S<L%"AGD
M="S$*JCD] !7'_\ !2GQM_P4G\#_  MT'4/^"9?P9\)^-O%DWB#R]?L/%VK1
M6<,&G>1(?-1I9H@7\T1K@$G#'CO7QI_PT)_P=J?]&"_!/_PM;+_Y.H H?\&K
MVB:-X93]K;P[X>TNWLK"Q_:&NH+.SM80D<$2Q%515'"J   !P!7ZU5^0/_!I
M3<^/-0\&_M17_P 4]+M['Q--\=I7U^SLY \,%X8,S(C D%0^X @D$#J:_7Z@
M HHHH **** "BBB@ HHHH **** "BBB@ J.X_P!1)_NG^525'<?ZB3_=/\J
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MH **** "BBB@ HHHH ,XZU7DU+3XG,<U_"K+]Y6D (_6K!YKX"_:P_X-LO\
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M_P! G]D__OJ^_P#BZ /U.HK\L?MO_!WA_P! G]D__OJ^_P#BZ/MO_!WA_P!
MG]D__OJ^_P#BZ /U.HK\L?MO_!WA_P! G]D__OJ^_P#BZ#>_\'=P'_()_9/_
M .^K[_XN@#]3J*_#[]B#_@HO_P '-G_!0+2_&FK_  "TC]FOR? ?B^X\-Z]_
M;FGWEL?ML)^?RP)FWIZ-QGTKW/[;_P '>'_0)_9/_P"^K[_XN@#]3J*_+'[;
M_P '>'_0)_9/_P"^K[_XNC[;_P '>'_0)_9/_P"^K[_XN@#]3J*_+'[;_P '
M>'_0)_9/_P"^K[_XNC[;_P '>'_0)_9/_P"^K[_XN@#Z!_X*]_\ !/7XV_\
M!1:X^!/@7P-XG\+V'@OP+\8K'QA\0K?7KRXCN+RVM8VCCCM$BMY5EDVSW'RR
M/$N=O)ZKJ?\ !:K]B#X_?\%%?V&-0_9)_9[\7>&=#NO$7B/2Y/$%YXHOKF"W
M.F6]P)Y(T^SP3,\A>.(JI55.WEAQ7S5]L_X.[O\ H%?LG_\ ?5]_\72_;?\
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ME_$S7&U/1[74HI+JS!T&YP98E8O&#D8W =: /N6BBB@ HHHH **** "BBB@
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M^._$FOZY%I]K\0_V=-:6^L;20G'FS1/&_DE2,L%G8KSP,<@'['T444 %%%%
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M(OB]_P %1$T"XM=2C^",/PV^&-FT;)]BU1].%UK3PAN5/]H/';JV <0/R0U
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M9%_\FG?&K_LHEG_Z0+7[=5^(O_!D7_R:=\:O^RB6?_I M?MU0 4444 %%%%
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M*^$]5U**TUSQ=HOQ,L93IMLQPT\B1Z9')<!1SM,@)]17Z<T4 %%%% !1110
M4444 %%%% !11D8S10!^*O\ P67^$?[3'QQ_X.#_ -GGX;?LB?'^/X8^/+[X
M1ZP^D^,IK$W"V21I?/,OECKOB5X_;?FOM#_@G%^Q;_P58_9T^,NI^,?VXO\
M@I%:_&#PO=:#):V/AV'0&M3;WAEC9;C<>N$5UQ_M5\O_ /!2;]H'X*_LP?\
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M+!>^=:$HHF7Y_+/SIT;F@#V_4=1T_2K";4]4O8;:WMXR\]Q<2!(XU R69CP
M!W/%31R)(BRQNK*W*LIX(]:_,'_@XQ\8_M>>+KCX'_L-_ &Q\#-I7QL^(EA9
M,VN:Y?VU]<75A<+>/#*MO ZIIQ5(1+*K-+E]HCV\G]&?@\GQ3B^%N@0_&VT\
M.V_BY-+A'B&W\)SSS:;%=;?G6V>X5)7B!X5G56(&2JYP #J,\XHR,9S7Y-_
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MQC'4]:^X:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "F22)&IDD;:JKEF/0"GU2U^*6?0[R"'[[VLBK]2IH _('P)X=_X*<_\
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M?&#QIX='AWP]X1NEOKO0X+?4+>[N+R_2++:<L443J_GB-E5F)&U6(\@_;-^
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M*XF4OL4,QR>]):_#;_@Y6L+75+*Q_P""7/[&L,.N3)+K4,.CZ>JZ@ZR"57G
MO<2L) '!;)# $<C-=-XUUS_@ZU^)/AI_!?Q&_8/_ &6?$&CR;?,TG6I+>ZMG
MP,#,4NH,IP.G% &K^P5\,?V,O&__  5ET?6_V</VV?VC/VEM6^&?@>^?4OB9
MXJ^*&G^(/"NA+>D)_9PN([)#/++L#[8)2H*9;)5@/5/^#<.&-/V>_C<ZHJL_
M[37C(NRCEL7Q'->)_#_5O^#K#X3: OA3X6?L%?LK^&=+21I%TSP^UO96X8]6
M$<.H*N3W.*D\&^(O^#KKX<V5UI_P]_84_9;T*WO+V2]O+?1IH+5)[F0YDF<1
MZ@H:1CRSG+$]2: /%/A5I][J7_!O=^WY;Z;8S32)\>O%\S1PQEF$<>H6$CM@
M=E168GL%)K]@?V!_C?\ !SX]_LD^!?%GP2^)^@^+-+L?"^G:=>:AX?U2.[A@
MO(K*#S;=WC)"RIN4,A^92<$ @BOSA\.W7_!U-X/T/4O#/A']@']E/2M-UJZF
MN-8T_3?LT$%]-,,3231I?A97<<,S EN^:=\.;[_@ZH^#V@OX3^$?[ 7[*?A7
M2Y+IKF33?#?V:QMVF8*&D,<-^JER%4%L9(4>@H ]&_;5^*OPPU+_ (.._P!F
MGP'\:_B#H_AO1OA_\)]>UOP_)XCU*.T@U+6]2F6RBMH&F(62<B.-E13O8QD#
M.,5]#?%7]C3_ (*:>,?C'J_CGX:_\%DM:\'>%;[5C<Z7X(A^!/AJ^33K7<"+
M47<\9FE &1YCG=SFOB+XH:__ ,'1FMM;_%'XK?\ !/W]E'6;KPC#+>Z;JVK0
MVUW<Z:$'F.]N\E^SQ-\@/R$$D#VKDOV)_P#@J'_P<Z_\%!/@M_PO_P#9F_9M
M_9_U3PS_ &Q=:7]JU"1[.3[3 5$B^7+J(; W#!Q@T ?17PW^*_PV^"?_  <N
M?%K0OC'\2-)T"^\;_ GPKI_@]=<O8[1_$%Y]I5/)M%<CSI2ZO^[3)^5N,*<?
M&G_!/3X0?LR? [PGX\_9E_;C_P""R_[0G[-?Q(^'_C35SK'@NS^-%KX8TC4K
M5[AI(=1TZ*YM&%SYZ,'*QR/(Q.=N"*]Y\5I_P=,>//%6D^.O'7_!/7]D[6M<
MT&59-#UK5H[6XNM.=6#AH)9+\O"0P# H001GK5/XB^'?^#GOXOZG::Y\6O\
M@FW^R+XHOM/S_9]YXBL[*^EMLD$^6\U\Q3E5/!'0>@H ?\ O!?['7A/_ ((_
M?M%?'1_V=OV@OC5\(/B)X\FU'Q%+\2O$%K<:YXIL8;I(Y/$UF8+:WECC1T%U
MN<&8>0S@_)7E7B+XZ_\ #".A_#SQO_P1X_X+4ZQ\>&\2^*-+T[1?V7_&&M6?
MB:\O+>YE^:V_= 7.F; WS%HX2I&68D$'WR#XI?\ !W3:6$>EVW['W[-L=K'"
M(H[6/5$6-8P,! HU' 4#C'3%<?X*\'?\'-WPV\4S>-_AS_P3-_8]\/ZU<;A<
M:QHNG6-K=2[CEMTL5\KMD\G)YH ]CN/B_P#"OX&?\'/'B2Z^,_Q"T?PK#XN_
M9AL]+\+3>(-02T35KYM9L]MK;M(0)IFV/B-26;8V <''V!\3_P#@F)_P3I^-
M_C_4OBI\8OV'?A7XH\3:Q,LNK:]KW@>RNKR\D"*@:262,LY"JJY)/"@=J_.O
MQM;?\'2GQ,UW2_%/Q'_X)X?LF>(-2T.3S-%U#6H;2[GL'W!MT,DM^S1'<H.5
M(Y /:NH_X7)_P=^?]&E_LY?^#E?_ )94 5?^#5?P]H/@^V_:T\+>%M&MM/TW
M3?VA+JVT^PLX1'#;PI$52-%'"JJ@  < "OUMK\Y?^#>7]A#]M+]B;P)\:M0_
M;=\%Z+H?B;XD?$P^)(;?0=8AO(&62#]Y@QN^P"0D!6)./6OT:H **** "BBB
M@ HHHH **** "BBB@ HHHH *CN/]1)_NG^525'<?ZB3_ '3_ "H _B_\$?\
M(Y?$3_LI6K_^C%HH\$?\CE\1/^RE:O\ ^C%HH _8K_@R+_Y-.^-7_91+/_T@
M6OVZK\1?^#(O_DT[XU?]E$L__2!:_;J@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /!?\ @J#\3-=^#/\ P3M^-/Q-\,2R
M1ZAI/PYU22SEA^]'(UNR!QZ%=V0>V*\Y_P""<.O?!S]A[_@BQ\$_''C&\NM/
M\+:'\&]"UK7+O3]#NKZ837]O#=7$JVUG%+-*7N;IV(1&;YB3W-?1'[2?P:T?
M]HO]GWQK\!M?E\NT\8>%[[2)IO\ GEY\+1B3_@)8-^%?-O\ P0M^(_BW5/V!
M=!_9P^+-N]GX^^ U]<?#CQEILS?-#)I;^1:2+TW1268MG1\8<<@D<T >F?LL
M?\%+_P!CW]M'QE?> ?V>/'7B+5-4TVQ^VW<.L?#?7M&C6'<%W"74;*"-SEA\
MJL6[XP":^)]$U>[^&O\ P41_X*._ '1W;^P_$'P1L/&S0*/W<&HR:-<P3N/1
MI%:+/KY"^E?JI(ZHI=V"JHR3Z5^</_!/SX+7G[9^M_M@_MR:?=K;V?[0%Q/X
M*^&NJ72L8FT'3;.XL8KY0.6BFN)I'!'WDAC(ZG(!\C_\$L]23]BS3OV _P!L
M5D6W\*_&KP'J?PC\>76W"QWC:C=W>CRN3@9,Z-$"3PC2GTSQ/_!8,:A^U3^R
M/^V#_P %&];5IM&E^)^@_"_X4RR+Q_8>BW0^UW$1Y_=SZC+<'.0=T;@@8%?H
M=JG_  1D\1^(_P#@B#X?_P""6>N_%;3(_&?A/3X)_#/CZRM9E@T_6+?47O+>
MZC7_ %BC#-$W?;(^.HI_[4W_  1F\0_&/_@C/H/_  2W^&OQ2TG2=4TF'37O
M/%&IV<K07=W%<&YN[AD3YMTTSRR?5SF@#P;_ (+"Z3^V7KG_  77_9CT[]@?
MQ/X&T?XF-\)?$YT>^^(\=PVDI"/--P)!;Q22;C%O"X0C=C.!S7B/[97CW_@N
M#\0/COHO_!+;_@IS^UM\)?A'X ^,EK_9T/Q&\"^%[J6Q\3*Y43:/#<R1J8)G
M0M&5G6 -N"AG#@']0/C+^P1XQ^)G_!53X-_\%!M/\>Z;:Z+\,_ ^N:'?>'YK
M>1KJ]DOHY%22-Q\BJN\9!Y..*Z+_ (*5_P#!/_X8_P#!23]E+7/V;OB&?L-]
M-MOO"/B:)3]HT#5XLFWO8B,$;6^5E!&^-G7OD '5:!^QC^SI8_L[>!_V7O%G
MPOT?Q5X0\ V>FQ:#I?B;3X[R%)+&,);SM'(I1G7&X$CAN1R!7RI_P2LCCB_X
M*F?M\11HJJOCSPF%51@ ?V;=U]8_L:_#_P#:#^%/[,_@_P"&/[4/Q#TGQ=XV
MT'24L-8\3Z+#+'#J?E?+'.RR ,)&C"[^Q?<1P<#SS]D']B'Q9^S;^U_^T9^T
MGKWC?3]2L?C9XBT;4M*TVUMY%FTU;*UFA9)6;ABQE!&WH!S0!]*T444 %?G'
M_P %E=0'Q#_X*&?L(?LR:_$\GAW6OC-?>)M5M6YBN;C2[$R6JLO1@#++G(Z/
M7Z.5\'_\%S?A7XJT?PG\'?\ @H1X L'NM2_9I^*-IXHUNUA7,EQX<GVVVJJO
M^[$4E;TCBD(YQ0!]!?M<7_\ P41LY-'_ .&%/"_P6U*%H9_^$D_X6UKVKV31
MM\GD_9O[/M9PX(\S=OVXPN,Y./SU_P"""6I_\%7H_P!GBXA^'W@K]GJ7X>M\
M;_$__"476L^*-=CUF.0ZS+]O^RQ1V30.JMYGD^9(I8!=^PDX_6CPUXBT3QGX
M;L?%?AV_CN].U2SCNK.YA8,LL,B!D8$=BI!KC_V>?V9?@E^RCX%NOAE\ ?!1
MT'1+S7K[6;BQ_M*YNM]]>3M/<R[[F21QOD=FVA@JYPH48% 'Q?\ \'&GF>!?
MV<_@W^TQX?N)+?Q%\,?VC?"VIZ+=0L5<K/+):S0_[KK*"1W\L#ID5\V_\% /
MV1T_;J_X*T?M3_L[6%LIUK5?V1]%O/"DLGRF'5[:\:YLFS_#F:-$8_W7:OIW
M_@K;X<U/]M+]KG]F_P#X)P^#?,N+:'Q]#\3_ (I3VZAETW0-)6184E.#L^T7
M4R1H#R753T!KV3P;^P=XP\-?\%7_ !I_P4.N/'>FS:'XH^%>G>%+?PZMO)]J
M@FMIVD:9G^X48'  YH ^1_%?[6"_\%2OV8?V-?V:%NY+C5OC-KMOK7Q8L64[
MX=-\-A9-4CF7G;YM\D$>#PP:09R#7D'PW 7_ () ?\%.D4<+\9/B6!_X$R5]
MJ?\ !/W_ (([6?[%/[=_QB_:\O/B+;ZUI?C(RV_PV\.I;.I\*V5W>RW^HQ9;
MY<S7+(P* 8 8'KBLGPO_ ,$@OB7H/[%?[67[+4WQ?T.34/VB/''BK7=#U1;*
M;R=(CU:5WCCG7[SM&&PQ7@]J /CO_A9'_!T)^RO_ ,$Z?"W[0/PSU3]GWQAX
M%T/P#IUY9Z#X7T6_N]=M=(%JA6:2&:&%)6CBPT@B=VX8@, 37U=_P0#_ &;M
M"@^&WB__ (*,^*/VM-/^-7Q"^/\ -9W7BCQ?I-BUK9V$=JLBIIT,+JKQ&-I&
M5PZ(243Y0 ,_:W[.?PIO?@O^SQX)^"FMZA;ZA/X8\)V.D7EU#&1%<-!;I$S!
M6YVMM)P>QKYG_8/_ ."8GQ+_ ."?'[8OQ4\6_!/XLZ2/@'\3+K^V8?A?/:2B
MX\/ZV<>9/:./W:PO\RM'QE1'_P \QD \+_X+6? _X._ G4?V/_#WP8^&.A^%
M[/4/VSM&U+48=$TV.W%W>3Q7DDMQ*4 ,DCLQ)=B6/K@"OU&KY=_X*2?L&>+_
M -N'5_@9J7A+QWINAK\)OC5IOC;4EU*WDD-_;VT4R-;Q[/NNQE!!;CBOJ*@
MI'SCBEH(R,&@#\]_@]JTOQ7_ .#D#XQ3>(4;_BU/P!T#1_#L;+\J#4)_MES*
MONQD1">,B)1V%>R?$S_@LE_P3\^$/Q5U3X)^//B=XNM_$>CZI_9^H6MK\'_%
M%W"EQD#:MS;Z:\$BY(^='9?>O,/C%X>/[*/_  7*\ _M+7S?9O"G[07P];X>
MZQ>,V(HO$%A(]WI_F$\*9X=\*\C+Q(H!+5]YCIQ0!\#_ /!QYI:Z7_P3DA^/
M.FS-#KGPI^+'@_Q/X;NH_P#60W?]L6]@2I]3#?3#Z&ODO]MK]EG_ (;[_P""
MGO[4WP6M;55UW6/V1O#>K>%9&X^SZS;3F[LR#_#F:-$)_NNWK7U=_P %J8-2
M_:I\<_ S_@EUX$CEN=0^)/Q$L_$_CS[.I(TOPGHL@NI[F4XP@DNEMHD)X9QM
M'S%<^N?#[]@;Q3X*_P""J/CC]OT^-=+?P_XI^%>E^$[/PU';R?:;:2TE+&5G
M/R%"#@ <^M 'R;XM_:FA_P""I?[.G[&/[.,=VUS??&#6H/$7Q6L'4[X]-\.!
M)-1BG7DJ);]88B#@,#(,Y%<?^R'G_AV;_P %&0!_S6KXH?\ HR>OI[_@GK_P
M1V@_8A_;E^,7[6%]\1[?7-)\9&2V^&OAV.U=3X5L;J^FU"_ARWRYEN9%8% .
M V>N*M?!3_@EA\0_A;^RE^T]^SYJ/Q3T:ZO?CUX\\7:_H^H0V<JQ:7'J[R-%
M',#R[1[_ )BO!QQ0!\&_ /Q1_P './P%_P""4GPU^./[..J? #Q=\/='^$NB
M7GA?PGI.DWUSXF71181-$9(Y88H9IXX-ID2.5F8AA&)#@'Z>_P"#??X"6_Q%
ML_&?_!63XG_M:Z?\8/BA\:+6VTS7-3T;2WLK3P_!:;0=+$,BI(DB,L2L'5,"
M*/ P=S?;G[$OP#UC]EK]CGX6_LS>)-=M=6OO /P_TGP]?:E9QLL-W):6<<#2
MHK<A6*$@'G!YKY^_92_X)@?$;]B+_@HA\2/C_P#L[?%32K'X)_%B%=0\3?"J
MZMYO,L-?Y+7UFP_=HK'.Y>,B0@Y\N,@ \B_X+T?!3X2?![]F_P"%]Q\+?AMH
MOA^7Q-^V%X6UGQ%-I.GQPR:GJ%Q+>2375PR@-+*[,268D]A@ "OTRQCH*^9_
M^"GO[#?BW]O3X4> ?A_X.\<Z?H,WA'XO:'XPNKC4K>21;B"Q,V^!0G(=O-&"
M>!@YKZ7 ([T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I\8
M/C7\(_V?? EY\4OCE\2]#\)>&]/V_;-<\1:E':VL)8X :20A03V'4UU=?G?_
M ,%Z]0\(^'/%/[)_CKXV7%C;_"W1?VDM+G\?7FMKG3+1?*D^S37A;]VD2R9)
M:3"*,EB #0!]V?"[XL_#/XW^!=/^*'P=\>:3XH\.ZK'YFFZWH=^EU:W*@D$I
M(A*M@@C@]:Y/P-^V?^R7\3OC#J?[/OP[_:3\%:YXXT7S/[4\)Z7XDMYM0M"A
MPX>%7+ KSD8XP<U\;_\ !"WXK_"7P3\#?BMJLOQ"\/Z7X/\ 'W[5WBQ/@?#-
MJUO!#KMB;>T(ATM691<AIX+YU2'=G:[#@$CY!^!_C']@C5O^"K_[+?Q5_8 F
MM]4TF^\3>*='O/@;=:>]IK_@"]G0MJ.O7S":2Y<.ZMB*\8QJF?*4;3M /W6!
MR,BOC/\ X*) #]O_ /8OP/\ FIVN_P#IANJ^C_VC_C!X@^!'PEU#XF>%_@MX
MI^(5Y8S0)'X5\&VJ3:A=>9*L9:-795(0,7;)X537Y]?%O]L?XA_M,?\ !2']
MD;0?&?[$_P 5/A7%IOQ UJ>'4/B!IL$$-ZQT2Z7RHC'*Y+@?,00.* /U"HHH
MH **** "BBB@ HHHH **** "BBB@#XU_X):?\G+?MI?]G,-_ZCFC5]E5\:_\
M$M/^3EOVTO\ LYAO_4<T:OLJ@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *#S110!^7/C+_ ()2_P#!67]DC]I;XF?%?_@D
M/^US\,=$\%?%GQ!)K_B#X>_%BQO#:Z9JDJXENK5K:WGR[87G"9 4-O\ +4CZ
M%_X)0_\ !-?XA_L,6OQ$^+W[2?QQ7XE?&3XOZ]#JGQ \76]D8+=_)5DM[:!"
M 1%&KOCA0-V J@ 5]@T4 %%%% !1110 4444 %?E7_P:R'_B@/VK/^SJO$'_
M **@K]5""1@5A^$/A]X%^'\=Y%X%\%Z7HZ:A>-=:@FEZ?' +F=OO2OL WN<#
M+').* -RBBB@ HHHH **** "BBB@ HHHH **** .7^-W_)&/%V?^A8U#_P!)
MI*_.G_@T=_Y1+?\ =5/$'_H<-?IQ<V\-Y;O:W$*R1R*4DCD7*LI&"".X(K-\
M%^ O!'PYT;_A&_ '@_3=#T_SFE^PZ38QV\/F-]Y]D8 R<<G'- &Q1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<?ZB3_=/\JDJ.
MX_U$G^Z?Y4 ?Q?\ @C_D<OB)_P!E*U?_ -&+11X(_P"1R^(G_92M7_\ 1BT4
M ?L5_P &1?\ R:=\:O\ LHEG_P"D"U^W5?B+_P &1?\ R:=\:O\ LHEG_P"D
M"U^W5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M51U[Q!H?A71KKQ)XFUJTTW3;"%I[[4-0N%AAMXE&6=W<A44#DL2 !5ZN2^./
MP9\ _M%_!SQ1\!_BEIDEYX;\8:'<Z1KEG#<-$TUK/&8Y$#KRI*L1D<B@#!/[
M9W['A&/^&K_AK_X76G__ !ZN8\/?&W_@GAX3^(_B#XN^'/CS\)['Q)XIAM8?
M$6L6_C;3UEU%;=2D'FXFPQ125#$9VX&<  ?+'_$*E_P1@_Z-_P!;_P#"RO?_
M (NC_B%2_P"",'_1O^M_^%E>_P#Q= 'UWXM_:C_8?\=^%M2\$^+/VGOAI=Z7
MJ]C-9:E9MX]L56>"5"DB$K." 58C@@\U#\/_ -H_]@KX5^"=+^&WP[_:+^%.
MCZ#H=C'9:3I6G^--.CAM+>-0J1HHFX  KY*_XA4O^",'_1O^M_\ A97O_P 7
M1_Q"I?\ !&#_ *-_UO\ \+*]_P#BZ /L_P#X;/\ V//^CK_AK_X76G__ !ZC
M_AL_]CS_ *.O^&O_ (76G_\ QZOC#_B%2_X(P?\ 1O\ K?\ X65[_P#%T?\
M$*E_P1@_Z-_UO_PLKW_XN@#[/_X;/_8\_P"CK_AK_P"%UI__ ,>H_P"&S_V/
M/^CK_AK_ .%UI_\ \>KXP_XA4O\ @C!_T;_K?_A97O\ \71_Q"I?\$8/^C?]
M;_\ "RO?_BZ /L__ (;/_8\_Z.O^&O\ X76G_P#QZC_AL_\ 8\_Z.O\ AK_X
M76G_ /QZOC#_ (A4O^",'_1O^M_^%E>__%T?\0J7_!&#_HW_ %O_ ,+*]_\
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MW"!V+;1@$\G.!CJ/^&S_ -CS_HZ_X:_^%UI__P >KXP_XA4O^",'_1O^M_\
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MO_!&;3X_B]^U_P#MG?MJW*"0>)OC1'X-T6=LEA8Z';>6=IR1M,URZ\=XO84
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#XH?M0?L2?M7?%?2_'7BWX%:19:IX:^)6G^&[?39=7L[^TNI83<VD($"31/
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MGX,^%OQ@N]&\/^)X_AGI.K:JJ!<Q:;%%+$L'D(J[WFF669C,H5E"G.[\9/\
M@EZO_!/7_@HM\ /VQO\ @EW^RA'9^&9M0NO"?QI\*^#HU1&T:\"@:@Z22#=Y
M#XEX.285&#FO5_\ @CG^S9\=/@!\7_VLM>^,GPUU#P_9^.OV@+S7/"=Q?;-N
MIZ>UNBK<1[6/RD@CG!]J /'/ W[1W[;/[87_  3%_:T^ 'QD^.>GZ)\4/@CK
MFM>%-6^(_ASPG:R1^(+*UM5N7<V<P,,+W-N7A<HJ^7YF^,*RBO!/A_\ '/\
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M'[2WP8\1?!3XQ>&K#5?#^OZ3<6=];ZA;K(B*\97S!N^ZRYW!A@@@$$5^3?\
MP1B_X**ZO^R__P $+_#^G3PW'BSQU_PM36?A]\$_";3%I]8O&N!);1$GE;:#
MSW>60_+%#%C(^45WGQB_;X_X.!/VN/A_J7[/7P-_X(SO\&-4\36<EC<?$'QM
M\38=1MM,MY<1R21I':V^V4*[%6)?&,[&(P?6_!'_  ;H?L%:W^PI\)_V-OVF
M_"VH>,O^%:QW5[+J]GKEWIYO-7OF$E_<GR)%)1I.$5B=B*@R2"2 >!>&_P!E
M_1_V3_\ @L%^R'+XU\<V7B7XB>,/#GC_ %_XK>-S(F_6-9GBL=QW9^6")<00
MQ]$CB4=2Q/L.AZ!H_P 4?^#H3Q!>^-[>&^7X??LLPR^%;>\4-]FFN=5MA)<1
M ]"%EE0L/^>WTKYY^.7_  :X?L2:9^WY\%_"GPC_ &5_$TWP9U+0O$#_ !4O
ME\97TBV]XBP?V<#*\_FQ[B9N(^&Q\W05[]_P49_9L_;J_9;_ &^_ /\ P5$_
MX)R_ 2S^*36'PWF\!?$;X:S:T+.ZO]-$\<]O+!*P/S!HT!;#%3"GR,&; !L_
M&G1M,^&G_!R)\#?$?@^TAL;KXA_ OQ1I_BS[/&$-_':2)<0-)C[Y5T&">??M
M4?\ P;6?\FG_ !F_[.D\9?\ H5I6=_P3Y^$O_!03]KG_ (*/7W_!3K]OO]FB
MU^#FF^&OA[/X2^%_PYDUQ=0O+<7-RLES=7$JA0S%8]H.Q RR<(,9/SW^PK\=
M?^"OG_!,K0OB9\"O"W_!#SQE\3=+U[XS>(/%&G>*8?B1:Z2LL%Y+&$00FTN"
M1MA#;MXSOQM&.0#]J:*^>_\ @GS^U+^U5^U1\.=;\7?M7_L'ZM\ M8TW6Q::
M7X>UCQ;'K#ZE;>2C_:A)';P!!O9H]I4G*9SSBOH2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *CN/]1)_NG^525'<?ZB3_ '3_ "H _B_\$?\ (Y?$
M3_LI6K_^C%HH\$?\CE\1/^RE:O\ ^C%HH _8K_@R+_Y-.^-7_91+/_T@6OVZ
MK\1?^#(O_DT[XU?]E$L__2!:_;J@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYHUF1HI$5E92&5E
MR"/2I** /SA^(_\ P;C?!V+XI^(/B?\ L<_MN?';]G=?%FH27_B+0?A-XXFL
M-/N;ASEG$:,NT$@';D@8XP, ?07_  3H_P""4O[,?_!-72O$5]\(O[;\0>+O
M&5Q'-XP^('C#43?:OJS)DJKS-]U S,VT=6.6+$+CZ<HH ^&?VTO^"$7[/'[5
M'[0EQ^UU\*OC=\2/@;\5=0MU@UCQS\(_$DFFW6I(%5,S;",N8U"%@06 &<X%
M:7[!G_!#;]E3]B#XPWG[3^J^+?&'Q8^+E[&R2?$SXH:RVI:E$&38[1,_W'9<
MJ9,EMI*@@$@_:E% 'YZ_M6?\$$7_ &COVSO%7[;W@3_@H[\<OA/XJ\6:9:Z;
MJ"_#/7AIN+.!(U2W\V(K(\>8U;:S$;@#C@5J_LY?\$"?@'\,_C)X?_:#_:A_
M:1^+G[1?B[PC<>?X0OOC1XRGU6#1Y<AA)%!(Q7<K ,,Y 8!L9 (^]:* &31^
M;$T0;;N4C<.U>)?L ?L0>"?^"?O[/J? +P3XNU+Q!')X@U+6M2US5X8DN;Z\
MO;EYY7<1 +U;:..B@5[A10 4444 %%%% !1110 4444 %%%% !1110!\X_\
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M52H^8]J=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %1W'^HD_P!T_P JDJ.X_P!1)_NG^5 '\7_@C_D<OB)_V4K5
M_P#T8M%'@C_D<OB)_P!E*U?_ -&+10!^Q7_!D7_R:=\:O^RB6?\ Z0+7[=5^
M(O\ P9%_\FG?&K_LHEG_ .D"U^W5 !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX'_!O^U+BR74+G4=3U;7K[[3J&K:A<R&6XO+F7:HDFD<EF(51V   %>K444
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MPTT'XP_"_P 11ZMX;\4:1;ZIH.J0QNJW=G/&)(I5#@, R,&&0#@T =%1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<?ZB3_ '3_
M "J2H[C_ %$G^Z?Y4 ?Q?^"/^1R^(G_92M7_ /1BT4>"/^1R^(G_ &4K5_\
MT8M% '[%?\&1?_)IWQJ_[*)9_P#I M?MU7XB_P#!D7_R:=\:O^RB6?\ Z0+7
M[=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ&L4$T%S=3R<[(1.Z,1EW6%!D,Y8=5\,/^"R/_!0#X/_ /!2OX=_\$\/V]_
M7P+U*\^*VDI)H^K?!K4=0:3PS>,)A]GU&&[N)?-97C"LJF'C+*S@X !^JE%?
MG1^P%_P65^*WQ-^$W[4#?MV>$/"/A7QY^S'K6J)XBL?"UI=6]G/I]M%*T4X2
MYN)I#O:!\,' <,FT#//C$O\ P7]_;0\!_P#!.+X-_M+?&/X0_"O1OB!^T/\
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M^R'\:M%TWP7X!\4?'SX-ZG)I%NVAZPL?AWQ)*_G+:7L<Z.R^1(]O,=T;;'5
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M@DZ+#)+HWB29&FEU%KAHO,EB,<L$8B9BG[DG8"Q)^>OCU\#OBU\<O^"46C_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>>***  KNZ
MTW8*=10 W9W4T;.>M.HH 3:>[4GE^].HH ;Y?O2[?EVFEHH 0KQ@4,NZEHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "H[C_42?[I_E4E1W'^HD_W3_*@#^+_ ,$?\CE\1/\ LI6K_P#HQ:*/!'_(
MY?$3_LI6K_\ HQ:* /V*_P"#(O\ Y-.^-7_91+/_ -(%K]NJ_$7_ (,B_P#D
MT[XU?]E$L_\ T@6OVZH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_X3>G?_&* /[!J*_CY_XB:O\
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M-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A-Z=_\8H _L&HK^/G_B)J_P""U/\
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M?_&*/^(FK_@M3_T>-=?^$WIW_P 8H _L&HK^/G_B)J_X+4_]'C77_A-Z=_\
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M^"U/_1XUU_X3>G?_ !B@#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\
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M'C77_A-Z=_\ &* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\
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M\8H _L&HK^/G_B)J_P""U/\ T>-=?^$WIW_QBC_B)J_X+4_]'C77_A-Z=_\
M&* /[!J*_CY_XB:O^"U/_1XUU_X3>G?_ !BC_B)J_P""U/\ T>-=?^$WIW_Q
MB@#^P:BOX^?^(FK_ (+4_P#1XUU_X3>G?_&*/^(FK_@M3_T>-=?^$WIW_P 8
MH _L&HK^/G_B)J_X+4_]'C77_A-Z=_\ &*/^(FK_ (+4_P#1XUU_X3>G?_&*
M /[!J*_CY_XB:O\ @M3_ -'C77_A-Z=_\8H_XB:O^"U/_1XUU_X3>G?_ !B@
M#^P:BOX^?^(FK_@M3_T>-=?^$WIW_P 8H_XB:O\ @M3_ -'C77_A-Z=_\8H
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M^5?Q^_\ $35_P6I_Z/&NO_";T[_XQ2M_P<S_ /!:AUVM^V+<8;C_ )%K3O\
MXQ0!P'@C_D<OB)_V4K5__1BT5SW[-&N:EXE\+:UXCURX::]U#Q-<7-W-G;YD
-LD<3,V!QR2310!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img205580551_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img205580551_0.jpg
M_]C_X  02D9)1@ ! @$%H 6@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +7"T$# 2(  A$! Q$!_\0
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MOV4>H:-K>D745[IVH6DI91+;W$3,I*2*\,\3;9K>XCEM[B.*>*2->@K^1/\
M8H_;B\:?LF^)GT^ZBO/%?PB\17L4OBOP7]I"SZ?<,8H9/%'A-IV$%GK\%LBI
M<V<C0:?XAMH8;'49;:>#3=5TO^K?X=_$3P9\5_!F@_$#X?Z]9>)/"?B2R6]T
MO5+)CM=<F.>UNH) EQ8ZC8W"26FHZ==QPWMA>PS6EW#%/$Z+_GUXJ>$V=>&>
M9J-7GS#A[&U9+*<ZC3Y85&DY_4L="+E'#8^E"[Y&U3Q5.$J^&;4:U*A_NO\
M1G^E!PA](KAR4\*J.1<=Y/AJ<^*.$*E=U*E!.4:2S?)ZM10GF&1XFJXQ551>
M(RVO5A@LPBI5,)B<;VM%%%?DY_3X4444 %%%% !1110 4444 %%%% !1110
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MY9F&%J*KAL=E^.H4\5@\7AZBTG1Q&'JTZM.2^*$T] HHHKF/0"BBB@ HHHH
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MY+G3%^*7Q&\+>#]2UV.-I%=?#>B:QJ5MK7B6XW0S*MIH&GZC=N89@D+&*3:
M?2%%?S>_%?\ X.OO^"+GPSN;NRT3X\?$3XRWEEN6:+X4? _XC36SSH6#06FK
M_$+2/AYH=_T!6ZL=3N-/<,OEWC8?;X'_ ,1DG_!)#_H6OVP/_#-^!_\ Y\%
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M;F35O!^K75J/''@&[N&CTCQ/80[X_-B<I+_96OV4,TKZ5K5O$TD$NV"]AO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAMO$.BM9Z7XEMK50"?/UK1+C3;Z4-B-8O"SLI625A+_0Q7\?7_!.[7;SP_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDN3I'B#2RZQZ[X,\6Z?;W%K_ &WX-\6Z6;C1/$NBRS1K?:9=S"&:VNTMKN
M_P!V>BOB3_@G7^W-\+_^"CG['_P>_:U^%(_L_2OB+H;P^*O"$]Y#>:I\._B-
MH,S:3X[\ ZO)&(W>X\/Z_;W*:;?S6UD=?\.7&B>)[:S@L-;LP?MN@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M35DLKGP[\0X[+S((?&>EOX@,&CZ=XUT/1[4 _I"HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSRM+<ZEX]^$,M[\(/'FIW3.2_P!HU3Q?X%UK4I Y)S=AE9D97;].Z "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA:Z)\8?@QXBAE-P[(]QXH\%^,=-N8UM2HCA:*/PA:,UPCL]R)4CD55M(B_\
M<W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !1110!]<?L&_\GA?L_\ _8_6?_I%?5_9!7\;_P"P;_R>%^S_ /\
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MO]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?YX?_!\7_P E4_X)V_\
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M@<!2E9U*U3EISS#,:L?K68UX1J5G"C2PV'PY1117W!^-A1110 4444 %%%%
M!1110 4444 %%%% 'UQ^P;_R>%^S_P#]C]9_^D5]7]D%?QO_ +!O_)X7[/\
M_P!C]9_^D5]7]D%?P1]++_DL^&_^R8C_ .K7,3_;_P#9??\ )HO$#_LX]3_U
MF,@"BBBOY6/],0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#_%%_X+6?\ *6__ (*-_P#9X'QQ
M_P#4XU6OS!K]/O\ @M9_REO_ ."C?_9X'QQ_]3C5:_,&@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS%?P4H[QNKHS(Z,KHZ,5='4@JRL""K*0"K @@@$'-?T%?\$]/^"DD6NIX>^
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M7_NR;_W[BO[_ "@#^4'_ (@V_P#@DA_T,O[8'_AY/ __ ,Y^C_B#;_X)(?\
M0R_M@?\ AY/ _P#\Y^OZOJ* /Y0?^(-O_@DA_P!#+^V!_P"'D\#_ /SGZ/\
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M?K^KZB@#^4'_ (@V_P#@DA_T,O[8'_AY/ __ ,Y^C_B#;_X)(?\ 0R_M@?\
MAY/ _P#\Y^OZOJ* /Y0?^(-O_@DA_P!#+^V!_P"'D\#_ /SGZ/\ B#;_ ."2
M'_0R_M@?^'D\#_\ SGZ_J^HH _E!_P"(-O\ X)(?]#+^V!_X>3P/_P#.?H_X
M@V_^"2'_ $,O[8'_ (>3P/\ _.?K^KZB@#^4'_B#;_X)(?\ 0R_M@?\ AY/
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M#K^[S_@^+_Y*I_P3M_[)_P#M'?\ J1_""OX0Z "BBB@ HHHH **** /[_/\
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MB>,?"O@+PIIBA]2\3^-/$.D>%O#VGH0S!K[6M<O+'3;12J.P:>YC&$8YPIP
M=517XB?'_P#X.-/^"-7[.TE_8^(_VV?A_P#$37K+STBT+X"Z5XK^.9U"XMU!
M>UM/%'PUT/Q!\/X)&)"1S:IXPTVS>3<@NMR.%_'OXO?\'L'["GANXGM?@K^R
MQ^T[\5F@5%&H>-+GX;?"31KN8N?,-E-9>)OB;K1M4A*E9K_0-/N7N!+";)(4
MCNY@#^S^BO\ .?\ B'_P? _M!ZFTW_"I_P!@GX-^"E;;]G'Q#^,?C;XGM%B2
MU+^<WAOPE\(A<;HDO478MMLDN+60[UM)8KWY*\2_\'GW_!5?6;A&T7X5_L3>
M$+6&:\:.'2OA5\7=2N+FWG>,VL6HW/B+X^:O'+-91QE%GTZTTE)WGGDFMV7[
M/'; '^HK17^41-_P=Z_\%D))99$\8?L^6Z22.Z00_ K1VB@5V++#$T^L3SF.
M,$(AFFFE*J#)+(^7+4_X.\_^"R*NK-XS_9^D"LK&-_@3H@1P""48QZLCA6 V
ML4='P3M93@@ _P!7FBO\N+0/^#SK_@J]I%Q++J?PS_8F\4PRK&@MM9^$GQ:M
M$M]K[GDMI/#GQ]T*832)F,FZ>[A4898-P)/UC\/_ /@]]_:2TV>)OBI^PE\#
M_&=L)"9XOA_\5?'OPSGDB\Z-@D5QXCT+XLQPR?9Q+$97MIU,SQS^2$B:WE /
M]&RBOXI/@_\ \'MG[&?B![:'XZ_L??M(_"V6=K6*6X^&OB/X;?&?3;*28E+F
M:YF\0:G\%M2>QLV*.TMGI%W?3VXE>'36G2.UG_7OX"?\'+?_  1C^/SV]C8?
MM@Z#\*->GFCA;0OCWX1\:?"1+83$+#-<>,/$FAI\-A"S[UD:'QO,]H(S+?):
MPRV\LP!^\%%>?_#;XL_"OXR^&[?QE\(/B7\/_BMX0N]OV7Q5\-O&7ASQSX;N
M=Z"1/L^N>&-2U33)MZ$.OEW3;D(89!S7H% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17YJ
M?M&?\%C?^"77[)\E[:?'/]N/]G_PWK>F><-2\(>&?&*?%/Q]I[0*S.E]\/?A
M/;>./'%I(VQU@CN/#\<ES(K16ZRRJ4'XE_&O_@\N_P""77P_FO-.^%'P_P#V
MHOC[?0M,MEJ^A> ?"_P_\%W@B#B-WU/XB>-=%\9VJW#^68@WP\F=83*\ZPS1
MI;S '];]%?Y[_P 3/^#XGQ?<27%M\&_^">?AO1XDP+76/B9^T+JGB22YR+=F
M>X\-^%OA7X56R\MOM4 BC\5ZAYP-O=&: B2S/Q%XM_X/2_\ @J#K)FA\+?!'
M]B;P;:.UN\$Z_#OXS>(-:A\M!]HC>\U/X]+H\T-S)N8#_A'8YH8BL:3LZM,X
M!_I^T5_E):E_P=^?\%B[Z^N+NU\1?LY:-!,RM'IFF_ VTEL;0+&B%+>36/$F
MJZDRNRF5C=:A<N))'",L02-*/_$7C_P62_Z'7X ?^&)T+_Y9T ?ZO=%?Y;GA
MO_@\V_X*Q:)*KZK\//V+/&$7V>.!X=>^$?Q2L\NC1F2\23PK\=O#C+>2JCJP
M;S+%/.=DL05B\OZ[^'G_  >__M&Z9*C?%C]@_P""?C6 2$R1_#SXM>._AA*T
M6XD(DWB7P[\7420)A3*T$BELN(0#L !_HT45_&)\'/\ @]>_81\3M9VOQP_9
M=_:=^$=W=-Y<U[X+F^&_Q?\ #FG,2N);V^NO$WPR\0O:A-^Y].\):A="01(M
MDZ/)+#^T'[.?_!P?_P $>?VG9+*P\#_MO_"OP7XAO/)B;PS\=CKGP U&"_G5
M3%I<6I_%[2O"'A76M0D9XX8(_#/B+7(;JZD6SM)Y[LF$ '[-T5C^'_$.@>+-
M&T[Q'X6US1_$OA[5[=;O2=>\/ZG9:SHVJ6C,R+<Z=JFG3W-C>V[,CJLUM/+&
M65@&RI V* "BBB@ HHHH **** /\\/\ X/B_^2J?\$[?^R?_ +1W_J1_""OX
M0Z_N\_X/B_\ DJG_  3M_P"R?_M'?^I'\(*_A#H **** "BBB@ HHHH _O\
M/^#&/_G*+_W9-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL?Q!XAT#PGHVH^(_
M%.N:/X:\/:1;M=ZMKWB#4[+1M&TNT5E1KG4=4U&>VL;*W5G16FN9XHPS*"V6
M /Y*?'C_ (+\?\$>?V=)-2M/'O[>?P4UW5=,\V*?1?@[?:Y\?-1:_B4@Z6?^
M%*:+X]LK34!./L<\>IWMC#IUUOCU6>P$%R\(!^P=%?Q]?&#_ (/1?^";7@Y[
MFQ^$GP3_ &J_C/J$.#!J4WACX?\ PV\'W:F<QL(]4U_Q]J7BZ*00HUP%N/ 4
M4962VB\T2/<"T_.#XB?\'Q7C6YEEA^$W_!/#POHT">6(-1^(G[1.K>)I;CYH
MWE>71?#7PE\))9_)YT$<2:]??-Y=VTV"UD #_0DHK_,2\6_\'JG_  4RU7SX
M?"'[/_[$WA*UFM?*2>]\#_&WQ/K5K=>=*QNK6\E^/&DZ.5^SF"%;>\\/7BB5
M)YVD99XX;;PO6_\ @\&_X+":M<0S6&H_LS>&8XX?*>TT3X(2W%O</O=_M$S>
M)/&7B"Z6;:PBVP7,-OLC0^1YA>1P#_5AHK_*$_XB\?\ @LE_T.OP _\ #$Z%
M_P#+.NFT3_@\/_X*_:3;S0WY_9:\3223>:EWK?P3U2WN+=-B)]GA7PW\0/#]
MJT.Y3+NGMIKC?(X\_P L)&@!_JJT5_F<^$/^#V7_ (*#V4ZMX^_99_8U\2VP
MFE9H?"&E_&WP/.;<VS)!$MQK7Q@^(4:S1WA6>6<VKI-;!K1+>"5A>K]N?#3_
M (/BM(E,%K\8O^"=VI6052;G7?AI^T9:ZF9'V'"P>%/%/PBT@0KO RTGC.X)
M1S\@,0\X _OJHK^5/X,?\'B'_!(_XDSVEG\1(_VEOV>9I9E@O=1^)'P@M?%?
MA^TSY1:[BNO@KXK^*/B"[L4$C L?"]O?EH)PNG%?L[W'[-_L^_\ !6W_ ()F
M?M2S6-A\#/VXOV<O&&OZFR)IW@V^^(^B^"/B#?EPF/L?PZ\?R^%O'5RJM)''
M*\/AYTAFDCAE9)75" ?HC1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%0W%Q;V=O/=W<\-K:VL,MQ<W-Q*D%O;V\"-+-//
M-*RQPPPQJTDLLC*D:*SNP4$@ FHKY!\=?\%!_P!@?X774MC\3/VW_P!D'X=7
ML%TMC-9^.OVE?@QX1NH;UEN'6SEM_$'C33YH[IDM+IEMW02E;:X8)B&0KA>&
M/^"F/_!.#QMJ":3X-_X*!?L1^+=5DDMX4TSPQ^U;\"->U!Y;R=;:TB2STKQ[
M=W+275RZ6]N@C+3SLL40:1@I /MNBLO1=<T7Q)I=GKGAW6-+U_1=1C:;3]8T
M74+35=+OHED>%I;/4+&:>TN8UECDB9X)G421NA(96 U* "BBB@ HHHH ****
M "BBB@ HHHH **^3_P!I+]NW]C+]CVQ>]_:?_:@^!_P/E^QM?VNA_$#XB^&]
M&\7ZO:HGF%_#W@A[]_&/B60I\Z6_A_0M2N)%Y2)A7X(_'W_@\!_X)'_"62>R
M^&-[^T!^TWJ"R-!!<_"SX3S>$_#8E10SO>ZM\;]9^%FK1V8(>%+G2O#>M-+,
M$:*![.3[8H!_4]17^?C\4_\ @^(UB2:ZM/@E_P $]--LX(YF%EX@^*?[05UJ
M,UU;BXC*-=>$/"7PMTM+"9K1)@R1>.-12.XN(V#R16;+??!WB_\ X/2O^"H6
MM,\7A7X)_L4>"[/S()(I8_AW\9/$&LJ(XBL\$U[JOQX_LF6WN)F,H$?A^WN8
M52*);IL2O, ?Z?\ 17^4=??\'?/_  6-N[RYN8/%'[.VF0SS22Q:?9? O3Y+
M.S1V)6WMGU+7]0OWAB!VQM>7UU<%0#+/(V6-=/\ @[S_ ."R*NK-XS_9^D"L
MK&-_@3H@1P""48QZLCA6 VL4='P3M93@@ _U>:*_RZO#7_!Y]_P57T:X=M:^
M%?[$WB^UFFM&DAU7X5?%W3;BVMX'D-U%IUSX=^/FD1Q37L<@1I]1M-62!X()
M(;=5^T1W/U[\.?\ @^"^/&FR0?\ "W/V!OA'XSB&!<GX<_&CQE\,I&^6\#/
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MK/\ ](KZO[(*_C?_ &#?^3POV?\ _L?K/_TBOJ_L@K^"/I9?\EGPW_V3$?\
MU:YB?[?_ ++[_DT7B!_V<>I_ZS&0!1117\K'^F(4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MBB_\%K/^4M__  4;_P"SP/CC_P"IQJM?F#7Z??\ !:S_ )2W_P#!1O\ [/ ^
M./\ ZG&JU^8- !1110 4444 %%%% ']_G_!C'_SE%_[LF_\ ?N*_O\K^ /\
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M7U*XDN]1U75;RYU'4K^[F.Z6YO;Z[DFNKJXE;YI)IY9)'/+,36?110 4444
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MKG&+E#A[BAT5[7!U:GM*D,@XB5%*EALWH4H2]AB8QI8/.*%.6*PD:%:&,R_
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MT HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OGS]I/]I/X=?LO_  ZO/'OCV\\VXE\ZS\*>%+.:)=<\
M8:XL6^+2]+B?=Y5O%NCEU;5I8VL](LV$TPEN);.SN\']JG]J[X<_LH^ _P#A
M*?&,IU;Q%JQFM?!?@:PN8HM;\4ZC"$\YD+K*-.T73A+%+K&MSPR6]E')#;PQ
M7FIWFGZ?=_R6_'?X[_$/]HOXAZK\1_B/JIOM4OB;?3-,MS)%HOAG18I)'LM
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MU<=FF:9A6E7Q>,Q59WG4JU)=$E&G2IP4:5"C"G1HPIT:<(1****[3QPHHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_ !Q?^#D+_E-K^WO_ -E
M^'W_ *H_X7U_L=5_CB_\'(7_ "FU_;W_ .R@?#[_ -4?\+Z /Q!HHHH ****
M "BBB@ K_7Z_X-<?^4%'[#/_ '<S_P"MA_M!5_D"U_K]?\&N/_*"C]AG_NYG
M_P!;#_:"H _?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\=O\ @JK_
M ,%N_P!C#_@D_P"$#'\7/$C?$;X^ZYI,NH^ /V:/A[J.GW/Q%UY'C<:?K7B^
MXD-Q9?#'P+=786'_ (2SQ/";C4HH=2/@WP_XQO\ 2-0TV'\/?^"ZW_!TMX4_
M9@O/&7[)/_!.?5_#OQ$_:(TZ;4O#7Q+_ &AWAL/$GPV^"6J0-+8ZCX?\ V4P
MN=(^(WQ2TJY65-0U"^CO/ /@F_MTT^]M?&>M_P!L:+X:_P X;XB_$;Q_\7O'
M/BGXF_%3QIXH^(OQ$\;ZQ=^(/&'CCQIKFH^)/%7B;6[Y@]UJFMZYJUQ=:CJ-
MY,0JF:YN)&6-(XDVQ1HB@'ZF?\%/O^"W?[<O_!5'Q)>6OQG\=-X%^!-KJ0O/
M"7[-7PTNM0T;X6:,EK<K/IE]XGA:<ZE\2O%5FT4-P/$OC.>_%C?_ &F;PMI?
MA:QN3ID?X_T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?M1_P2I_X+M?MM?\ !*CQ%I^B?#KQ2WQ7_9LN]6-]XP_9D^(^H7=WX'NE
MNY0=3U7X?:L%N-8^%?BZ>-YYDU7PR6T#5-1-M=^,_"?BZ.RM+:'\5Z* /]KO
M_@F/_P %</V/O^"K'PL?QQ^SKXQ;3O'_ (<L;67XJ? 7QG)9:9\6/A?>SLD'
MG:KHT-Q-!X@\(WERZIH7CWPS/J7AG4_-33[JYTKQ-;:OX<TK]/:_P;/V?OVA
M?C5^RO\ %SP;\=OV>_B/XF^%/Q8\ ZDNI^&/&7A2^-G?VKE3%=Z?>P.LMAK6
M@ZO:-+IVO^'-:M+_ $'Q!I5Q=:5K.G7VG75Q;2?ZDO\ P0G_ .#BKX1?\%.]
M%T;]G_X^-X;^#7[<>BZ/&K^&UNHM-\#?M!1:=:7,^J>)OA M]<R3VGB2TLK*
M35O%7PQNKBYU/3[1KC6_"UUKWA^QUS_A& #^FZBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **P?%/BGPSX&\,^(/&GC3Q!HOA/PAX3T74_$GBGQ
M3XDU.RT7P_X<\/:+93:CK&N:YK&HS6^GZ7I.EZ?;W%[J&H7MQ!:V=K#+<7$L
M<4;,/\T'_@O5_P '.GCK]KZZ\9?LD_L ^)?$GPT_92_T[PU\0OC+8M?^&?B1
M^T3;"3[/J.G:)(C6NL^ _@WJ2)+;/I1-EXJ^(6BSR0>+X]&T#4]2\%3@'[?_
M /!:+_@ZQ^$?[)=SXJ_9P_X)\R>$_C_^T=I\EUHGB[XS731:]\"/@]J*&6WO
M++0Y;"[6/XN?$#2I$9)K/3[F+X?^';]X%U?6O%&I:?KG@NW_ ,XO]H#]HKXY
M?M5?%3Q+\;?VBOBCXP^,'Q4\77!GUSQEXUU674]1DB6262VTO3H,1:?H/A_3
M!-)!HOAK0;/3/#VAV96QT?3+&SCC@7QBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#L/ 'Q!\=_"GQIX;^(_P ,?&7BCX>_$#P=JD&M
M^%/&O@O7=3\,^*O#>KVV[R-2T37M'N;/4]-O(U9T$]I<Q2&-Y(F)CD=6_P!"
MO_@B7_P=BZ!\5;OPE^R__P %1M:\/^!OB#=?8= \#?M>);67AWP'XUOY9$M;
M+3/CEI6GV]KHGP\\07,KQHGQ%TBWTWX>78<MXGTWP0ME-KFL_P"=)10!_OY6
M]Q;WEO!=VD\-U:W4,5Q;7-O*D]O<6\Z++#/!-$S1S0S1LLD4L;,DB,KHQ4@F
M:O\ ,1_X-[O^#DGQ=^QEK7@K]C7]N7Q=JWC']CW4)K3PW\./BIK+WNM^+?V9
M)IY8[?2[&\NB;G4O$'P-@9A;76AE+O5?AW9F*]\)^9X>TZ3PI-_IM:'KFB^)
M]%T?Q)X;UC2_$/AWQ#I>GZYH&OZ'J%IJVBZYHNK6D-_I6L:/JMA-<6.IZ7J=
MC<07NGZA93SVEY:3PW-M-)#(CL ?YZ__  ?%_P#)5/\ @G;_ -D__:._]2/X
M05_"'7]WG_!\7_R53_@G;_V3_P#:._\ 4C^$%?PAT %%%% !1110 4444 ?W
M^?\ !C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110 44
M44 %%%% !1110 4444 %%%% !17,^-/&G@_X<>$O$GC[X@^*O#O@;P-X.T74
M?$GBWQCXNUK3O#OA?PQX>TBUDO=5US7]>U>XM-+TC2=-LX9;J^U"_NH+6U@C
M>6:5$4L/\Z'_ (+>_P#!UKXV^-TOB_\ 9<_X)C^(?$'PU^#3?;] \<?M56Z:
MAX:^*/Q0@+2VEW8?!^&>.SUOX6^![F(&1?&-PFG_ !-U])H186_@"TM+N+Q&
M ?TA?\%??^#DW]D3_@FC%XC^$7PTETO]I[]L"SCDL3\*/">MQCP/\,-3=65+
MCXU>.=/%W!HUY8D&>3X>: -0\<W3+;6VL0^#M.U2T\1)_FF?M_?\%0/VTO\
M@IC\1/\ A/OVKOB]JGBG3].O)KKP7\*_#_VCPW\'/AO',LL7D^!_A];7<^FV
M-Y]EE-E=^)]6EUKQMK-I'#%X@\3ZL8(F3X"N+BXN[B>[NYYKJZNII;BYN;B5
MYKBXN)G:2:>>:1FDEFFD9I)99&9Y'9G=BQ),- !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5_2S_P $F/\ @YK_ &T?^"=USX9^
M%7QDU'6/VLOV3=/^RZ6/AWXZUR27XF?#;1D/E+)\(OB5J0N]2M[/3(/)6S\
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M/.SLU=3IU:52,*V&Q-&=/$87$4Z6)PU6E7I4ZD?XE/CY^S]\2OV;O'U[\/\
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MT*PF$PN PN'P6!P]'"8/"TH4,-A<-3A1H4*-.*C3I4J5-1A3A"*2C&*22/\
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M\'"G_!P-XS_X*4^.M;_9E_9NUC6/!O["?@'Q(\:M ]SI>M_M,>)/#]^?L7Q
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MXW+,UR[$0Q.#QN&JWY:M&M3;B[24J=2#M4I583HU80JTYPB4445Q'KA1110
M4444 %%%% !1110 5XU\>/@/\._VB_AYJOPW^)&E"^TN^!N=,U.V$<6M>&=:
MBCD2R\0>'[UXY#9ZE9F1U^9)+6]M9+C3M1M[O3KNZM9?9:*Z\#CL9EF,PV89
M?B:V"QV"K4\1A<5AZDJ5>A7I24J=2G4BU*,HR2>FC5TTTVGYF=9+E/$>4YCD
M.?9=@\WR;-\'7P&9Y9CZ$,3@\;@\3!TZV'Q%&HG"I3J0;335T[2BU))K^,G]
MJO\ 90^(G[*/CYO"OBU#K'AO53<77@GQW96<EMH_BO3(6428B:6X&F:Y8"6*
M/6M"FNIY["62*:">^TR[T_4;SY=K^XOXO?!_X?\ QT\":S\.OB3H-OKOAS68
M2,,$CU'2;]$<6>M:'?E'ETO6=/=S):7L(/!DMKF.YLKBZM9_Y-?VOOV./B'^
MR9XR6PUM7\0?#[7KJZ'@CQ]:6[I9:I#&SR+I.L1 ,ND>)[6U"R7>FN[P74:R
M7>E7%Y:QSFW_ -$/!?QOP?'N'I9#G]2A@>,,/2LO@HX;/Z=*#<\5@H+EA3QL
M(1=3&8""2LI8G!Q^KJK1PG^"?TO/H;YMX(8[%<;<#T,9G/A3C\2Y2?[W%9AP
M/7Q%6,:66YQ5;G5Q&45*M2-'*L[JMRYG3R_-9K'/#8O-?CZBBBOZ%/X."BBB
M@ HHHH **** /9?@1\=_B'^SI\0]*^(_PXU4V.J6)%OJ>F7!DET7Q-HLLD;W
MN@:_9))&+S3;P1HWRO'=65U';ZCIUQ::A:6US%_6E^RM^U=\.?VKO ?_  E/
M@Z4Z3XBTDPVOC3P-J%S%+K?A;49@_DLY18AJ.BZB(I9='UN"&.WO8XYK>:*S
MU.SU#3[3^,BO3_@_\8_B'\"?'6E?$/X9^(+G0/$6ENJ2;&>33M8TUIH9KO0]
M>L Z1:IHNH&");NQF(RT<5S;R6][;VUU#^*^+W@[E?B3@'C,+['+N+,%1Y,O
MS1Q:I8NG!N2R_,U!.53#2;E[#$*,ZV"J2<Z:J4I5L/6_L#Z*OTLN)/H]YVLJ
MS+ZWG_AAG&+57/>'(SC/$Y7B*JA3GGW#CK3A3H9A",8?7,%*=/!YO0IJC7='
M%4\)CL+_ '$T5\@?LA_MC?#S]K+P8+_1)(M!^(6AV5LWCGP!<S[[[1YY"(&U
M/297"'6/#-W<C%IJ4*F2U:6"SU:&SO9(HYOK^O\ -W.LES7AW-,9DV=8*OE^
M98&JZ.)PM>/+.$K)QG&2;A5HU8.-2A7I2G1KTIPJTISISC)_]!?"'&'#7'O#
MF5<6\(9Q@\]X>SK#1Q67YE@:G/2JP;<:E*I!J-7#8O#58SP^,P>)A2Q6#Q-.
MKAL51I5Z52G$HHHKRSZ4**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "OS[_;C_;N\*?LI: /#V@QZ?XK^-'B"Q:;0/"TDY:P\.V4R
MO'#XH\7?9V$\5@LJDZ9HZ26]]KTT<B136=E%<ZA!R_[>'_!0'PW^S-I=[\/O
M <EGXC^.>K:<'MK0B&[T?X?6M[&IMM;\4)YA$VJRP2"[T+PV4=KE!#J6L"WT
MJ2RAUC^6_P 2^)?$'C+7]7\5>*M8U#Q!XCU^_N-3UG6M5N9+S4-1O[ER\US=
M7$K,[NQ.%&0D<:I%&J1HB+_4'@EX$5N*Y87BOB_#U</PS"4:V7Y;-3I8C/W'
M6-6HTXU*&4WM^\5JN.5XT'"@_;S_ ,W?IC?37PGAC3S'PR\*L=A\?XBU:=3"
MY[Q#1=+$X+@932C4PU!2C4P^-XH<')>PESX?)9.,\9&KC5]3I7_''CCQ9\2O
M%FN^.?'.NW_B3Q7XDOY-1UG6=1D$EQ=7$@5%5514AMK2VA2*UL;&UB@LM/LH
M+>RLK>"T@AA3E***_ONC1HX:C2P^'I4Z&'H4X4:%"C"-*C1HTHJ%.E2IP484
MZ=.$8PA"$5&,4HQ222/\.<7B\7F&+Q./Q^*Q&-QV-Q%;%XS&8NM4Q.*Q>*Q%
M25;$8G$XBM*=:OB*]6<ZM:M5G*I5J2E.<I2DVRBBBM3G"BBB@ HHHH ***_2
M_P#8-_X)^Z_^TUJ4'Q!\?B_\-?!#2+\(]RD<EOJOQ$O+.X"WFA>')BT;VFD0
M.DEMK?B9!(()@^DZ0LVIK?76A_/\3\49)P=DV*S[/\;#!9?A4DY-<];$5I)^
MRPF$HI\^(Q5=IJE2AT4JE24*-.I4A]UX<>&_&'BQQ;EG!/ V4U<WSS,YMJ"?
MLL)@<'3<?K69YIBY)TL#EN#C.,\1B:O65.A1A6Q5?#T*O-?L-?L'^*_VJ/$4
M?B7Q,FJ>%O@EHEWC6_$\<7V>^\4W4$A63PUX-EN89()[LNC1ZMK/E7-CH46Y
M9$N-1DMK&7^J/P-X&\)?#7PEH7@;P-H5CX;\*>&[&/3M&T;3HS';VMO&6=F9
MG9YKF[N9GENKZ^NI9KV_O9I[V]GGNIYIGT/#?AO0/!V@:1X6\+:18:!X<T"P
MMM+T;1M+MH[33]-T^TC$5O:VMO$ B1H@Y/+NY:21GD=F.W7^:7BCXJYWXF9M
M[;$N>!R+!U)?V1DD*CE2P\;./UK%R7+'$YA5@VJE9QY:,).AAXPIN;J?]#_T
M;/HR\'?1VX8^JY>J6=<:YMAZ:XJXQK8=0Q..FG"H\LRR$N:>7Y#AJT8RH82,
MW4Q56$<9CYU:ZHQPY1117Y8?TN%%%% !1110 4444 %%%% !7\CO_!3O_D^/
MXW_]TU_]5#X K^N*OY'?^"G?_)\?QO\ ^Z:_^JA\ 5_3GT4?^3B9S_V1>8_^
MKSAP_P Y?VG?_)A.$?\ L[V0?^L9Q^?!-%%%?Z"'^%(4444 %%%% 'UQ^P;_
M ,GA?L__ /8_6?\ Z17U?V05_&_^P;_R>%^S_P#]C]9_^D5]7]D%?P1]++_D
ML^&_^R8C_P"K7,3_ &__ &7W_)HO$#_LX]3_ -9C( HHHK^5C_3$**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH _P 47_@M9_REO_X*-_\ 9X'QQ_\ 4XU6OS!K]/O^"UG_ "EO
M_P""C?\ V>!\<?\ U.-5K\P: "BBB@ HHHH **** /[_ #_@QC_YRB_]V3?^
M_<5_?Y7\ ?\ P8Q_\Y1?^[)O_?N*_O\ * "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4,L)U+PKXNT2:\T36[+S(YA;70O+">SU2TL;ZV^7J* /]RO_ ()__MR?!O\
MX*+_ +*?PM_:M^"-\I\-^/\ 25B\1^%;B^M[W7_AI\0-,CAA\9?#7Q7Y"0^7
MKWA75)#!]H:VM8-=T>?2/%&E1R:'KNEW,_V;7^4)_P &O?\ P5GG_8"_;(L_
MV>/BQXC^Q?LJ_M>>(- \'>)I=2NTATCX8_&2XD31?AQ\4!->7,%AI&CZC<W4
M'@GXBWSO:P#P[?:1XEU2XEA\!V5I+_J]T %%%% !1110 4444 %%%% !117Q
M=_P4)_;=^%W_  3M_9$^,?[6?Q8E6XT7X:^'9&\-^%X[I+74_B#\0M7;^S/
MGP_T9V65UOO%'B*>SLKB\2"X31-(&J>(;V+^S=(O9$ /YVO^#J'_ (+0W/[%
MWP4'["_[./BZ33?VHOVBO"=Q-\0_%?A[4#!K7P/^!>KM<Z9=SVE[;-Y^C_$#
MXIB'4="\-3P21ZMX;\*V^O\ BJV?2-5O/!.K3?Y?M>\_M/\ [2?Q:_; ^/\
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MU*%N6*3F\#E&%G*HLMRFG5G2PT)SJUJF)QU?%8RN4445^<G[^%%%% !1110
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M]@3_ */B_8__ /$E_@O_ /-K1_P\*_8$_P"CXOV/_P#Q)?X+_P#S:U_ACT4
M?[G'_#PK]@3_ */B_8__ /$E_@O_ /-K1_P\*_8$_P"CXOV/_P#Q)?X+_P#S
M:U_ACT4 ?[G'_#PK]@3_ */B_8__ /$E_@O_ /-K7I'A+]J?]F+Q\UFO@7]H
MWX#^-&U".2:P7PE\7OA]XC:^BAD,4LMF-'\0WAN8XI5:.1X=ZI(I1B&!%?X/
M]% '^_Q17^&A^S7_ ,%#?VY?V/=5TW5/V:/VK?CE\(4TMH3!X>\,^/\ 7)/
MMTENRO#;:S\.M6N=2\!>(+&-E4KI^O>&]2L<CFW()K^UK_@DE_P>!'QGXI\*
M_ 7_ (*F:)X7\+2ZY<6FAZ!^UWX!TK^P/#4&J7,L,%FWQT^']J9=-\/:?>SR
M3+>_$7P"FG^'=$=K!=9^'^D:$FM>,-- /[U:*IZ=J.GZOI]CJVDWUGJFE:I9
MVVHZ9J>G7,%[I^HZ?>P)<V=]8WEL\MM=V=W;2QW%M<V\DD$\$B2Q.\;JQN4
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M!CPKI^Q?B>8K=4^V^./@[H=H%UR[G22\UOX4V'DR7F?AYX?TK4 #_-@HHHH
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ML['SO$8FG\.\7_P4*_X*3I&FN? K]G/7Y5NEEN=)\??%/1KGRUA6/]S>>&_
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M75)$\7_"A&,8BCN/A5XGGDT?3;1;B]N?^$!U+P#JVHW(U#6;F"#\):_UW/\
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MFU3Q'XK\4:I:Z+H.BV$<CQ1&ZU+4[RVM(6FEB@1Y0\\L42O(O^R[_P $9/\
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M2:6'_A(?B!XGU3Q5J\=N]PSS?98;[59X;59&+1VZ1)P% 'E5 !1110 4444
M%?I]_P $<OV"+[_@I'_P4,^ '[,UQ:7DGPZOO$#>/?CCJ-G*]L^D?!/P 8=<
M\=XO8F$UA>>)H$LO 6@W\22FT\3>+M$FDC\A973\P:_TA_\ @RU_8GMO G[-
M?Q^_;P\3Z3L\5?'KQH?@K\,+R[LPLUM\*/A9-;W_ (OU71[X@-)I_C/XFW\F
MB:K;KE%O_A'9.3N!"@']K^C:-I/AW1]*\/Z!IMCHVA:%IMCHVBZ/IEK#8Z;I
M.DZ9:Q66G:;IUE;I';V=C8V<$-K:6L$:0V]O%'%$BHBJ-*BB@ HHHH ****
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M_$[7%]X$\5W>V0P>%/%.M7$,37<%JR?J'10!_@/^(?#^N>$M?USPKXGTG4-
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M62*D7BVQTV2#X1?%/43;QM*[:]H&F3_#+Q'JEXT%G:7'AOX9Z?"9=0U^8O\
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MA=W5Y<O+<SRR/^Q= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6+RK,</.6'S+*,:H>ZL5E^,IU</.<4J>(IQIXNAS8;$49R****^8/T8****
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MA"BBB@ HHHH **** "GQQR32)%$CRRRNL<<<:L\DDCL%1$106=W8A55069B
M 2:GLK*\U*\M-.TZTNM0U#4+JWLK"PLK>6ZO+V\NI4@M;2TM8$DGN;JYGD2&
MWMX4>6:5TCC1G8 _T@?\$^?^"<=C\++?1/C7\=]'AO?BB[0:KX.\%WH2>R^'
MB%"UKJ>L09>WO?&C;UN((9!+!X6=(7BW:\AFTOX#Q$\1LA\.,EEFF;U/;8NN
MIT\JRBC4BL9F>)C&_)33O['#4FXRQ>,G&5+#PE%*-6O4H8>M^Y> O@#QO]('
MB^GPWPKA_JF5X1T:_$W%.,HU991P[ETYM.K7E#E^M9CB8QJ0RO*:52&(Q]:$
MG*>&P5#&X["<C_P3V_X)MKX0.E?'#]HKP];S^*2MOJ/@+X::O;Q74'A@.B3V
MOB7Q?8S+)#)XF7<LFDZ#<(R^&G5;[4HSXB%O;^'_ -O***_S-XVXWS[C[.Z^
M>9]B?:597IX3"4G*."R["IMPPF"HRE+V=*/Q3FW*K7J.5:O.=23D?]%/@[X-
M\$>!_!V#X-X(R_V&&I\M?-,UQ*I5,XX@S-P4:V:9QBZ=.G[?$3MR4:4(PPV"
MPZAA<'1HT*<8!1117R!^JA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_BB_\%K/^4M__
M  4;_P"SP/CC_P"IQJM?F#7Z??\ !:S_ )2W_P#!1O\ [/ ^./\ ZG&JU^8-
M !1110 4444 %%%% !16_H7A/Q3XH^U?\(UX:\0>(OL/D?;?["T;4=6^Q_:?
M.^S?:O[/MKC[/]H^SS^1YNSS?(F\O=Y3[>@_X51\4O\ HFOC_P#\(WQ%_P#*
MZ@#@**[_ /X51\4O^B:^/_\ PC?$7_RNH_X51\4O^B:^/_\ PC?$7_RNH X"
MBN__ .%4?%+_ *)KX_\ _"-\1?\ RNH_X51\4O\ HFOC_P#\(WQ%_P#*Z@#@
M**[_ /X51\4O^B:^/_\ PC?$7_RNH_X51\4O^B:^/_\ PC?$7_RNH X"BN__
M .%4?%+_ *)KX_\ _"-\1?\ RNH_X51\4O\ HFOC_P#\(WQ%_P#*Z@#@**[_
M /X51\4O^B:^/_\ PC?$7_RNH_X51\4O^B:^/_\ PC?$7_RNH X"BN__ .%4
M?%+_ *)KX_\ _"-\1?\ RNH_X51\4O\ HFOC_P#\(WQ%_P#*Z@#@**[_ /X5
M1\4O^B:^/_\ PC?$7_RNH_X51\4O^B:^/_\ PC?$7_RNH X"BN__ .%4?%+_
M *)KX_\ _"-\1?\ RNH_X51\4O\ HFOC_P#\(WQ%_P#*Z@#@**[_ /X51\4O
M^B:^/_\ PC?$7_RNH_X51\4O^B:^/_\ PC?$7_RNH X"BN__ .%4?%+_ *)K
MX_\ _"-\1?\ RNKLO"/[,7[2GQ N19^ _P!GKXX^-KLS?9Q:^$?A-X]\27)N
M/)>X\@0:-H%[*9O(CDG\K;O\E'EV[%9@ >'5-;V]Q=W$%I:0375U=316]M;6
M\3S7%Q<3.L<,$$,:M)+--(RQQ11JSR.RHBEB ?W0_9?_ .#;;_@L/^U%JVFV
M]C^R5XH^!'AF]DC2^\<_M07"?!'2=!CEVE;C4O"/B*";XMW<:ALR1^'?AOKM
MW%M82VR,,'^Z#_@C_P#\&P?[+?\ P3C\0^&_C[\=-?L_VK?VL-"DMM4\,^(]
M6\/C2?A#\'M82+>M]\-? ]_/J%SK?BS3;F206/Q(\9SRZA:R6NFZQX2\+> M
M8AN)[@ ] _X-G?\ @D]XB_X)I?L5ZAXO^-OAW^P/VJ/VJ=0T/Q_\4]"O(0FK
M?#;P3HEG>P_"WX3ZDS$M'KFAV.LZYXJ\8V_EVTNF^*O&&H>%KI;P>$[34+C^
MD*BB@ HHHH **** "BBB@ HHHH **** "BBB@ K_ !Q?^#D+_E-K^WO_ -E
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M@M+2":ZNKJ:*WMK:WB>:XN+B9UCA@@AC5I)9II&6.**-6>1V5$4L0#_N1?\
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M4C151%"@ 34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ!POGN$I2;<*-;B;+\WP.,]G?X547"V&E.*M%27.ES3DV4445_(9_JH%%%%
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MBBB@#^_S_@QC_P"<HO\ W9-_[]Q7]_E?P!_\&,?_ #E%_P"[)O\ W[BO[_*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O\ '%_X.0O^4VO[>_\ V4#X
M??\ JC_A?7^QU7^.+_P<A?\ *;7]O?\ [*!\/O\ U1_POH _$&BBB@ HHHH
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M /&:_B#HH _M\_XC>?VI_P#HQ_\ 9_\ _#A?$7_XS1_Q&\_M3_\ 1C_[/_\
MX<+XB_\ QFOX@Z* /[?/^(WG]J?_ *,?_9__ /#A?$7_ .,T?\1O/[4__1C_
M .S_ /\ APOB+_\ &:_B#HH _M\_XC>?VI_^C'_V?_\ PX7Q%_\ C-'_ !&\
M_M3_ /1C_P"S_P#^'"^(O_QFOX@Z* /[?/\ B-Y_:G_Z,?\ V?\ _P .%\1?
M_C-'_$;S^U/_ -&/_L__ /APOB+_ /&:_B#HH _M\_XC>?VI_P#HQ_\ 9_\
M_#A?$7_XS1_Q&\_M3_\ 1C_[/_\ X<+XB_\ QFOX@Z* /[?/^(WG]J?_ *,?
M_9__ /#A?$7_ .,T?\1O/[4__1C_ .S_ /\ APOB+_\ &:_B#HH _M\_XC>?
MVI_^C'_V?_\ PX7Q%_\ C-'_ !&\_M3_ /1C_P"S_P#^'"^(O_QFOX@Z* /[
M?/\ B-Y_:G_Z,?\ V?\ _P .%\1?_C-'_$;S^U/_ -&/_L__ /APOB+_ /&:
M_B#HH _M\_XC>?VI_P#HQ_\ 9_\ _#A?$7_XS1_Q&\_M3_\ 1C_[/_\ X<+X
MB_\ QFOX@Z* /[?/^(WG]J?_ *,?_9__ /#A?$7_ .,T?\1O/[4__1C_ .S_
M /\ APOB+_\ &:_B#HH _M\_XC>?VI_^C'_V?_\ PX7Q%_\ C->&_M._\'@_
M[2'[3O[-G[0?[-GB#]CGX&^&]"_:"^"/Q5^">L>(]+\<^/+W5/#NF_%3P+KO
M@:]U[3+.]A%G<ZEHUOKLFI6$%T1;R7=K"LI"%B/X]:* "BBB@ HHHH ****
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M\/%\5?\ !5#XF>-+F'-K\+OV//B;K5I<[HSY>O\ B7XD?!_P;96_E?:HI_\
M2-"UOQ/+YXM[NVB^R>3,L,US:2C_ %%Z "BBB@ HHHH **** "BBB@ HHHH
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M>O[V*_B_Z7O_ #;W_N[/_?9/]>/V57_-^/\ O%__ ,$0****_B\_UX"BBB@
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MVNY5:U2RO&G&G"!1117A'V@4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MBB_\%K/^4M__  4;_P"SP/CC_P"IQJM?F#7Z??\ !:S_ )2W_P#!1O\ [/ ^
M./\ ZG&JU^8- !1110 4444 %%%% ']_G_!C'_SE%_[LF_\ ?N*_O\K^ /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD10I]EN3XD^TV.Y#-]BEM_M,L]QYL\G^T17^.+_P<A?\IM?V]_\ LH'P^_\
M5'_"^@#\0:*** "BBB@ HHHH _JY_P"#-[Q(NA?\%<M>TMM0DLSXR_9$^,WA
MM+=(Y775FM?&/PE\8'3YFCBD2&.-/"CZH))W@B,NFQ1+*9Y88)O]3^O\H3_@
MT._Y3)^"?^R ?';_ -,6F5_J]T %%%% !1110 4444 ?XPO_  7W_P"4R7_!
M0G_LX#6/_3'H-?D#7Z_?\%]_^4R7_!0G_LX#6/\ TQZ#7Y T %%%% !1110
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M\=_M9^-S>WQNO#OPVT"XG3P/X"CNB\%C"V8VUO76B(AU/Q/J$0'VBY*M;Z;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5_CB_P#!R%_RFU_;W_[*!\/O_5'_  OK_8ZK_'%_X.0O
M^4VO[>__ &4#X??^J/\ A?0!^(-%%% !1110 4444 %?Z_7_  :X_P#*"C]A
MG_NYG_UL/]H*O\@6O]?K_@UQ_P"4%'[#/_=S/_K8?[05 '[_ %%%% !1110
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M:?[?_P#XAO\ M%?_ #N:/^'3O_!4W_I&G^W_ /\ B&_[17_SN: /@"BOO_\
MX=._\%3?^D:?[?\ _P"(;_M%?_.YH_X=._\ !4W_ *1I_M__ /B&_P"T5_\
M.YH ^ **^_\ _AT[_P %3?\ I&G^W_\ ^(;_ +17_P [FC_AT[_P5-_Z1I_M
M_P#_ (AO^T5_\[F@#X HK[__ .'3O_!4W_I&G^W_ /\ B&_[17_SN:/^'3O_
M  5-_P"D:?[?_P#XAO\ M%?_ #N: /@"BOO_ /X=._\ !4W_ *1I_M__ /B&
M_P"T5_\ .YH_X=._\%3?^D:?[?\ _P"(;_M%?_.YH ^ **^__P#AT[_P5-_Z
M1I_M_P#_ (AO^T5_\[FC_AT[_P %3?\ I&G^W_\ ^(;_ +17_P [F@#X HK[
M_P#^'3O_  5-_P"D:?[?_P#XAO\ M%?_ #N:/^'3O_!4W_I&G^W_ /\ B&_[
M17_SN: /@"BOO_\ X=._\%3?^D:?[?\ _P"(;_M%?_.YH_X=._\ !4W_ *1I
M_M__ /B&_P"T5_\ .YH ^ **^_\ _AT[_P %3?\ I&G^W_\ ^(;_ +17_P [
MFC_AT[_P5-_Z1I_M_P#_ (AO^T5_\[F@#X HK[__ .'3O_!4W_I&G^W_ /\
MB&_[17_SN:/^'3O_  5-_P"D:?[?_P#XAO\ M%?_ #N: /@"BOO_ /X=._\
M!4W_ *1I_M__ /B&_P"T5_\ .YH_X=._\%3?^D:?[?\ _P"(;_M%?_.YH ^
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MWP&T?4;NS#6UWXQ^+/C70/'.I?V-=RQ,IU+P[X=^$T4&KFUE6XL]/\;:?%<
M6^L()/SX_8X_X--/^"JO[1OBK1S\;O _AG]CKX63303:UXV^+'B7PWXE\8_V
M8607,?ACX4> M>UOQ%>Z]&CAH-.\;7OP\TN4++OUZ*2-89?]*C_@GO\ L#?
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M]D.Z\6P%T4-+-X"^,?PRTLP0SM.A$C0>/YYS;);S-/%;2W!E@2S99_\ 3 H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^
M$+_@^+_Y);_P3L_['_\ :/\ _4=^#U?YXE?Z'?\ P?%_\DM_X)V?]C_^T?\
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M43Q"]M=(U/X)_L[ZQ;7%Y"KF;R[S5KS74M+J5$286D]O$SFRE"?Y?%?Z,/\
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M **** /\87_@OO\ \IDO^"A/_9P&L?\ ICT&OR!K]?O^"^__ "F2_P""A/\
MV<!K'_ICT&OR!H **** "BBB@ HHHH _V>?^" __ "AL_P"">W_9 -(_]/NO
M5^O]?D!_P0'_ .4-G_!/;_L@&D?^GW7J_7^@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#_!&^+'_ "5+XE?]C_XR_P#4BU*N KO_ (L?
M\E2^)7_8_P#C+_U(M2K@* "BBB@ HHHH **** /[^**** /] "BBB@ HHHH
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M$'P[PN$RKQ2PE!U,;@H^QPF7\>4:$(J&&QU6<J=#!\0TZ4%2R_-ZKA2Q:5/
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MO!<2*RM';WGA&76[.X<'Y(9W8@@8/^YC0 4444 %%%% !1110 4444 %%%%
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MS!<QAW^SO9KJ?Q;UFSBF@C60W=I?PSR2""%(?[3: "BBB@ HHHH **** /\
M&%_X+[_\IDO^"A/_ &<!K'_ICT&OR!K]?O\ @OO_ ,IDO^"A/_9P&L?^F/0:
M_(&@ HHHH **** "BBB@#_9Y_P"" _\ RAL_X)[?]D TC_T^Z]7Z_P!?D!_P
M0'_Y0V?\$]O^R :1_P"GW7J_7^@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@#_%%_P""UG_*6_\ X*-_]G@?''_U.-5K\P:_3[_@M9_REO\
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MVT,\37GC+Q%>S-;.2;H _O+HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_LX#6/\ TQZ#7Y U^OW_  7W_P"4R7_!0G_LX#6/_3'H-?D#0 4444 %%%%
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MB2OW7Z-__)V<B_[ L\_]5&+/XL_:!_\ *+W&O_8WX-_]:K*C\4:***_TK/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_%%_X+6?\
M*6__ (*-_P#9X'QQ_P#4XU6OS!K]/O\ @M9_REO_ ."C?_9X'QQ_]3C5:_,&
M@ HHHH **** "BBB@#^_S_@QC_YRB_\ =DW_ +]Q7]_E?P!_\&,?_.47_NR;
M_P!^XK^_R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_'%_X.0O^4VO
M[>__ &4#X??^J/\ A?7^QU7^.+_P<A?\IM?V]_\ LH'P^_\ 5'_"^@#\0:**
M* "BBB@ HHHH *_U^O\ @UQ_Y04?L,_]W,_^MA_M!5_D"U_K]?\ !KC_ ,H*
M/V&?^[F?_6P_V@J /W^HHHH **** "BBB@ KC?B+X"\,_%7X?>._A?XUL%U7
MP;\2/!OB?P%XMTMQ&4U+PSXPT2^\/:]8,)8YHBMYI6HW=NPDBECQ(=\;KE3V
M5% '^#A^TA\$/%7[,_[07QN_9X\<131>+?@A\5O'OPKU]IK9K7[7J'@7Q/J?
MAR74K>)GD!L=5&GKJ>G3Q2SVUU87=M=6MQ<6TT4TGBU?U?\ _!W]^QD_[/G_
M  4LTW]H[0-.:V\"?MH?#G3/&TTT=N8+&W^+?PQM=+^'OQ'TNU5$\EFNM!M_
MASXTO[CS?/NM9\9ZM+-"FU9[C^4"@ HHHH **** "OZ)?^#8W_@H5;?L(_\
M!3+P)H/CC78]'^!_[6-G:_L]?$R:]DV:7HGB'7]4M[GX0^-KIWE@M[3^POB
M+'P]J6KWLHL=%\'^-/%^HW"$PQR1?SM4Y'>-U=&9'1E='1BKHZD%65@0592
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M^ M7\06-C;:;H'PSB64 _N;HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK\@:_7[_ (+[_P#*9+_@H3_V<!K'_ICT&OR!H **** "BBB@ HHHH _V>?\
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ME]3ELW0S+*JN,P&(BFG*CB*BBU)IK^[*BBBO\A#_ *K0HHHH *_G5_X+6_\
M)4?@G_V(/B#_ -2)*_HJK^=7_@M;_P E1^"?_8@^(/\ U(DK]U^C?_R=G(O^
MP+//_51BS^+/V@?_ "B]QK_V-^#?_6JRH_%&BBBO]*S_ )X@HHHH **** "O
M[V*_@GK^]BOXO^E[_P V]_[NS_WV3_7C]E5_S?C_ +Q?_P#!$"BBBOXO/]>
MHHHH *^9?VS_ /DTW]HC_LD?C;_TRW5?35?,O[9__)IO[1'_ &2/QM_Z9;JO
MH>$?^2KX8_[*')?_ %988^%\4?\ DV?B)_V0O%W_ *S^8'\8-%%%?Z_G_*2%
M%%% !1110 5_21_P1:_Y(/\ %3_LKDG_ *AOABOYMZ_I(_X(M?\ )!_BI_V5
MR3_U#?#%?@GTE/\ DU.:_P#8SR7_ -3Z9_<'[/+_ )2:X<_[)OB__P!4U8_9
M"BBBO\VC_H0"BBB@!KND:L[LJ(BL[N[!51%!+,S$@*J@$LQ(  ))Q7\8'[7G
MQVOOVB_C_P"/?B/)=3SZ#)J4N@>!K:9F*:?X'T.>>UT"&&(JGV<W\9GUV^@
M(75=7U!][F0NW]8_[4_B&\\*?LU?'OQ!I[/'J&F?"+X@RZ?-&_EO;7TGAC4K
M>SNE8 G-I<S17.!AF\K:K(6##^*&O[-^B9P]AIRXJXIK0C/%47A,CP,VDW0I
MU8RQN8-7O:5;EP$5)6:C3J1NXU)(_P C/VHO'>8T:?AEX;86M4HY;C(YMQCG
M-*,I*&-Q&&J4\HR*,[64H8-5,[J2IR<HRJ5\/4Y8SH0DRBBBO[3/\@@HHHH
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MS_@K'X@_8"_;6\-? #XA^([P_LH_M=^+- ^'_C72+RYDETCX>?%O7)K;P_\
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MQ_\ .47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110 4444
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M/;_L@&D?^GW7J_7^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#_!&^+'_)4OB5_V/_C+_P!2+4JX"N_^+'_)4OB5_P!C_P",O_4BU*N
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MZMMO5MO=G^Q<8QC%1BE&,4HQC%)1C%*R22T22T26B6B"BBBD,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _Q1
M?^"UG_*6_P#X*-_]G@?''_U.-5K\P:_3[_@M9_REO_X*-_\ 9X'QQ_\ 4XU6
MOS!H **** "BBB@ HHHH _O\_P"#&/\ YRB_]V3?^_<5_?Y7^9'_ ,&EO_!2
M+]B3_@GQ_P -^_\ #8WQ\\/_  /_ .%N?\,K?\*Y_MWP]XYU[_A)_P#A ?\
MAI#_ (2_[+_PAGA?Q+]D_L7_ (33PQY_]I?8O/\ [6A^Q_:?)NO(_L=_XB1/
M^")7_1^_@#_PWOQQ_P#G74 ?M_17X@?\1(G_  1*_P"C]_ '_AO?CC_\ZZC_
M (B1/^")7_1^_@#_ ,-[\<?_ )UU '[?T5^('_$2)_P1*_Z/W\ ?^&]^./\
M\ZZC_B)$_P"")7_1^_@#_P -[\<?_G74 ?M_17X@?\1(G_!$K_H_?P!_X;WX
MX_\ SKJ/^(D3_@B5_P!'[^ /_#>_''_YUU '[?T5^('_ !$B?\$2O^C]_ '_
M (;WXX__ #KJ/^(D3_@B5_T?OX _\-[\<?\ YUU '[?T5^('_$2)_P $2O\
MH_?P!_X;WXX__.NH_P"(D3_@B5_T?OX _P##>_''_P"==0!^W]%?B!_Q$B?\
M$2O^C]_ '_AO?CC_ /.NH_XB1/\ @B5_T?OX _\ #>_''_YUU '[?T5^('_$
M2)_P1*_Z/W\ ?^&]^./_ ,ZZC_B)$_X(E?\ 1^_@#_PWOQQ_^==0!^W]%?B!
M_P 1(G_!$K_H_?P!_P"&]^./_P ZZC_B)$_X(E?]'[^ /_#>_''_ .==0!^W
M]%?B!_Q$B?\ !$K_ */W\ ?^&]^./_SKJ/\ B)$_X(E?]'[^ /\ PWOQQ_\
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MP]H.F_VEXYGFK^HJFNB2(T<BJZ.K(Z.H9'1@5965@0RL"0RD$$$@C!H _P
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M(+]_".H!Y)K^\\'W44_@?Q+<M=>?9:%K>HMXKLP#_7KHKX._8(_X*6?L<?\
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M9X9[>>%TEAFB=XY8W5T9E8$@%BBBB@ HHHH **** "O\<7_@Y"_Y3:_M[_\
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M8^'=!L0MO#<3A;C4]1MHY'C@E:.-GD\M@I!\^K^V+_@S[_X)9ZC\7?COK?\
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M)[5M/^_/"'_!\C$52#Q[_P $VI%=8YVDU3PA^U4KK)+YH-K"F@ZS^S]&8(Q
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M^KZ)K>D:A%!>Z=J6G7L$UM=VES#'+#+&RLHQ0!RM%%% !1110 4444 %%%%
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MCDBMW^T&%[BX_%_]H_\ X.7_ /@LG^TC#J&EWG[6>K?!7PS?K.H\._LX>&M
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M%'] 4 %%%% !1110 4444 %%%% !1110!_C"_P#!??\ Y3)?\%"?^S@-8_\
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M04444 %%%% !7][%?P3U_>Q7\7_2]_YM[_W=G_OLG^O'[*K_ )OQ_P!XO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"%]?['5?XXO_!R%_RFU_;W_P"R@?#[_P!4?\+Z /Q!HHHH **** "BBB@
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M %%%% !1110 4444 %?SJ_\ !:W_ )*C\$_^Q!\0?^I$E?T55_.K_P %K?\
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M$OBU\.M0FF_X1GXB>#+FX,D=QI>KV\3V^IZ>EU=7?A?Q)9ZUX3UATUG1+^)
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MWA_5-?T*_DU7X3_"VX:Y1[._NO'?C#1HKO5]%E21;SP#X;\:&0QN+83?Z[M
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M_#6A6K/@;VM]+TRUB9L#<4)QS0!W5%%% !1110 4444 %%%% !1110 4444
M%%%% 'YE?\%-/^"3'[(7_!57X3GP!^T7X,6S\<Z!8WD?PK^._A&WL=/^+'PL
MU"YWRXT37)K:5=9\*WET5EU_P'X@2^\,:UA;P6EAX@L](U[2_P#+>_X*N_\
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MPWG6S#+*4;*./WGB<%"*CCO>JX=+&\U+&?ZJ_0T^F_/A[^RO"?QGS:53A_\
M<Y?PCQUF%64ZF1)*%'"9%Q'B)\TIY(DE2R_.*TG/)KPPV/G+*%#$Y3_2[156
MRO;+4[*TU'3KNUU#3]0M;>]L+^RN(KNRO;*[B2>UN[2Z@>2"YM;F"2.:WN(9
M'BFB=)(W9&#&U7\.M.+<9)QE%M2BTTTT[--/5-/1IZIG^S,)PJ1C.$HSA.,9
MPG"2E&<)).,HR3:E&2:<9)M---.P4444B@HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*_VN?^'*7_!(_P#Z1R_L@?\ AC_!/_RKH_X<I?\ !(__ *1R_L@?^&/\$_\
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M?^'*7_!(_P#Z1R_L@?\ AC_!/_RKH_X<I?\ !(__ *1R_L@?^&/\$_\ RKH
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MO@EXXEU&3Y7U?5[OX;W&@:+XRU)HB8#-X^T/Q9%Y?EGR/-M;.6W /\8BBO\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\B_MU?L6_!O\
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MPAX&\$:%J7B;Q7XEUBZW&#3M%T+2+:[U'4+ID225H[:WD,<$4L\FR&*21?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH YGQ3X*\&^.=.;2/&WA+PSXQTEUF1M+\4Z#I7B'3F2XC\J=6LM6M+NV*S
MQ$Q3*8B)(SL<,O%?)7BW_@F?_P $X_'TLEQXW_8#_8K\6W<LFH3-?>(OV6_@
MAK&H+<:LRR:G=Q:A?>!Y[V"\OI8XYKJ\@GCNIIXXIGE,L:.OVW10!^46N_\
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MB=EP9I"W:44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"SS_ -5&+/XL_:!_\HO<:_\ 8WX-_P#6JRH_%&BBBO\ 2L_YX@HHHH ****
M"O[V*_@GK^]BOXO^E[_S;W_N[/\ WV3_ %X_95?\WX_[Q?\ _!$"BBBOXO/]
M> HHHH *^9?VS_\ DTW]HC_LD?C;_P!,MU7TU7S+^V?_ ,FF_M$?]DC\;?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO3Q6"QN$KQ4Z5?#UZ4I0G"47T=XR4H349QE%%%%%<AZ@4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,OB]\'_A_
M\=/ FL_#KXDZ#;Z[X<UF$C#!(]1TF_1'%GK6AWY1Y=+UG3W<R6E["#P9+:YC
MN;*XNK6?TVBNC"8O%8#%8?&X+$5L)C,)6IXC#8K#U)T:]"O2DITZM*K!QG3J
M0DE*,HM--73.#-,KRW.\MQV3YQ@,)FF59GA:^!S'+L?AZ6*P6-P>)IRI8C#8
MK#5HSI5J%:G*4*E.I&491;31_'3^U]^QO\0OV2_&*6&M;O$/P^U^ZNO^$(\>
MV=O(EEJ<,3R2+I&M1;2FD>*+6T59KO33));W,6^[TNYO+>.Y^S?'M?W.?$OX
M9>!OC!X,UGX?_$;P[9>)_"FNPK'?:;>AU*RQ,)+:]LKJ%X[K3]1LI@L]EJ%E
M-!=VLRAXI5Y!_E'_ &TOV(O'/[)_BN6\B2]\3?"#7;]HO!WCH1(SP23"6>+P
MSXK6W58]/\1VD,4GE3B*#3O$%M"VH:6(I4U+2M)_T*\%?'+"\<4:/#G$M6C@
M^+J-/EHUGR4,+Q!3IK6KAHKEA2S*,5S8G!12C52EB<''V?ML/A?\'_I@?0QS
M+P:Q6+X_\/,-B\V\+,77Y\7A$ZV,S+@6O6DDL/F%1J=7$\/5:DE3R[.*DI5,
M-.4,OS6?M_JF.S/X;HHHK^CC_/X**** "BBB@ HHHH ]0^#WQD^(?P(\=:5\
M1/AGK]QH/B+3&$<FW,NG:QIKRQ2WFAZ[IY98=4T:_P#)C%U9S8*O'#=VLMM?
MVUK=P?UD_LA_MB_#O]K'P8NH:)+#H7Q#T2RMG\<_#^YG+7VC7$C&W.I:5+(L
M?]L>&KNX7-GJ5N&>U\ZWLM6BLKZ1(I?XYJ[[X8?$_P <_!SQOH?Q#^'6OW?A
MSQ5X?N?/L;^V*O'+$XV76GZA:2!K;4=+OX"UMJ&G7<<MK=V[M'+&?E*_CGBW
MX091XE9:ZU/V.7<48&C)99FW):-:*O*.7YIR1E.M@9R;]G42E7P-23K4%.$L
M1AL3_6?T7/I5\4_1XX@6$Q'UK/\ PVSC%TY<1\+.KS5,).3C">>\.>VJ0HX/
M.:--1]O0E*G@\YH4XX3&NE6IX',,O_N:HKX>_8L_;8\$_M8>#TAE>P\,_%S0
M+.+_ (3+P,;G;YX0)&_B;PJMQ(USJ'AN\E*^;'NGO?#]U*FFZH\J2:;J>K?<
M-?YM9]D.;<,9MC,DSS!5L!F6!JNG7P]9?.%6E-7A6P]:%JE"O2E*E6IRC.G*
M46F?]"7!'&_"WB-PQE/&/!N;X7.^'LZP\<1@L=A9;/:MA<51DHUL'CL)54J&
M-P6)A3Q.$Q$)T:].$XM!1117CGU84444 %%%% !7\ZO_  6M_P"2H_!/_L0?
M$'_J1)7]%5?SJ_\ !:W_ )*C\$_^Q!\0?^I$E?NOT;_^3LY%_P!@6>?^JC%G
M\6?M _\ E%[C7_L;\&_^M5E1^*-%%%?Z5G_/$%%%% !1110 5_>Q7\$]?WL5
M_%_TO?\ FWO_ '=G_OLG^O'[*K_F_'_>+_\ X(@4445_%Y_KP%%%% !7S+^V
M?_R:;^T1_P!DC\;?^F6ZKZ:KYE_;/_Y--_:(_P"R1^-O_3+=5]#PC_R5?#'_
M &4.2_\ JRPQ\+XH_P#)L_$3_LA>+O\ UG\P/XP:***_U_/^4D**** "BBB@
M K^DC_@BU_R0?XJ?]E<D_P#4-\,5_-O7])'_  1:_P"2#_%3_LKDG_J&^&*_
M!/I*?\FIS7_L9Y+_ .I],_N#]GE_RDUPY_V3?%__ *IJQ^R%%%%?YM'_ $(!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17%_$CQOI_PS^'?C
MWXD:M:7E_I7P_P#!?BGQOJ5CIP@.H7NG^%-#OM>O+2Q%S+!;&\N;:PDAMA<3
MPP>>Z>;+''N<?P.W'_!\?XB'BJ1[7_@G%HK^"5U+;%;7'[3U]'XJDTA6""62
M]C^!DND0ZE*@-SY"V$]K S"R^T7 3[?( ?Z"U%?G]_P38_X*2?L[?\%1_P!F
M[2_VCOV>+[5K2PBU:X\)_$#X?>*X[&U\<?##QW86EG>W_A;Q/::=>7]E*LME
M?V6JZ%K>GW4^FZ]HM[:WD#6]VM_ING_H#0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%?-_P"V%^T9I7[(7[*_[0?[46M^&=0\::5\ OA'XX^*U[X1
MTJ_MM*U#Q+%X,T&\UD:):ZI=P75MILFI/:I:'4);2\6R25KG['=F(6\O\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOIM]!,DUC?"WNXR6A"G_ !5* /[_ #_B.<_ZQ=?^;L__ )(]'_$<Y_UBZ_\
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MCC4&^)'P8O+"U<&73(OAUXR.K:)X;COH/]#O-5\$IX6\2BV$0L]<M);:TF@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0OB#X,\#^"(=,:1-2F\7^+/$>FZ#X:BT]X989DOI-:U"R2T:*:&1;@QE)8V
M< '^]O1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^8'_!:W_E$?\
M\%&O^S0/CA_ZA.J5_BC5_M<_\%K?^41__!1K_LT#XX?^H3JE?XHU '^AC_P8
M^_&O7=2^'?[?7[.NH7UU)X;\'>,O@E\9O">G,[R6=KK'Q$T;QWX*\?72*0$M
MIKNT^&?PZC.UF-VMJQ*1_92TO]X]?YX?_!CI_P E4_X*)?\ 9/\ ]G'_ -2/
MXOU_H>4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !6=K&CZ3X@TK4-#U[3+#6M%U:SG
MT_5-)U6SM]0TW4;&ZC:&YL[ZRNHY;:ZM;B)FCF@GC>*1&*NI!Q6C150G.G.,
MX2E"<)1G"<).,X3BTXRC)-.,HM)QDFFFDT[D5:5.O3J4:U.%:C6A.E5I581J
M4ZM.I%PJ4ZE.:<9PG%N,X23C*+:::;1_,%^W[_P3OUCX"7VK?%GX1V%WK/P3
MO+D7.IZ7&TU[JWPRN;R8K]EO"YDN;[P@T[I%I>MR-+<:=YL6F:X[2I:ZKJOY
M25_>=>V5EJ=E=Z=J-I:ZAI^H6MQ97]A>V\5W97ME=Q/!=6EW:SI)!<VMS!))
M#<6\T;Q31.\<B,C%3_-O_P %!?\ @G)=_".;4OC)\!]%O=0^%<@FO?%O@ZS%
MSJ%_\.61&FN=5L=[3W=YX*=4>6X>1YKCPT^[[0\FCLDVG?W3X'^/4,Y6$X/X
MVQ<:><)0P^3Y[7DH4\U44HT\%F5632AFCLHT,5*T,Q=J=5QQW++'?XL_3*^A
M%5X1>:>*_@[EDZW"CE6Q_%?!6"ISJ5^&7.4JF(S?A_#TX.57AR-W4QN6PO5R
M%7KX6-3)54IY/^/-%%%?UJ?Y<!1110 4444 %%%% &IHFMZQX:UC2_$/A[5+
M[1==T6^M=3TC5],NIK+4=-U&RF2>TO;*[@=)K>YMYD22*6-U='4$&OZS_P#@
MG_\ M>1_M4?"F0>))+:#XL?#\:?I'CVV@C2WBUB.YBF71_&5E;1*D$,&OI9W
M2ZC:6RI#8:U:7\<-M:Z=<:6DG\CE?;__  3P^,UY\&?VJOAM=F\DM_#OCW4X
M?AIXKM]X6WN=/\7W,%AI5Q<ER$BCTGQ/_8>KR7!^:*VLKF,,(YY0WXOXY>'V
M#XWX+S#$4\/#^W^'\+B,TR?%1BO;S6&INOB\M<DN:=''T*<X4Z3:C'&+#5FT
MH34OZ[^ACXZYKX-^+V0X&OCJRX&XYS+ <-\69;4J2^ITI9A7C@\KXAC3E+V=
M'%9+C:]*K7Q,82J5,IGF.$2<JU*5/^OFBBBO\QS_ *-0HHHH *_G5_X+6_\
M)4?@G_V(/B#_ -2)*_HJK^=7_@M;_P E1^"?_8@^(/\ U(DK]U^C?_R=G(O^
MP+//_51BS^+/V@?_ "B]QK_V-^#?_6JRH_%&BBBO]*S_ )X@HHHH **** "O
M[V*_@GK^]BOXO^E[_P V]_[NS_WV3_7C]E5_S?C_ +Q?_P#!$"BBBOXO/]>
MHHHH *^9?VS_ /DTW]HC_LD?C;_TRW5?35?,O[9__)IO[1'_ &2/QM_Z9;JO
MH>$?^2KX8_[*')?_ %988^%\4?\ DV?B)_V0O%W_ *S^8'\8-%%%?Z_G_*2%
M%%% !1110 5_21_P1:_Y(/\ %3_LKDG_ *AOABOYMZ_I(_X(M?\ )!_BI_V5
MR3_U#?#%?@GTE/\ DU.:_P#8SR7_ -3Z9_<'[/+_ )2:X<_[)OB__P!4U8_9
M"BBBO\VC_H0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /R _X+\?\H;/^"A/_ &0#5_\ T^Z#7^,-7^SS_P %^/\ E#9_P4)_
M[(!J_P#Z?=!K_&&H _LH_P"#-KX%?!'XZ?M,?MEZ3\;?@Y\*_C%I6A? OP'J
M.AZ9\5/A[X1^(6GZ-J%SX_FMKB^TJS\6Z1J]MIUY/; 6\US:1PSRP 1.[1C;
M7^@A_P .]?V!/^C'?V/_ /Q&CX+_ /S%5_"'_P &0W_)T_[<'_9O_P //_5B
MS5_H^4 ?'_\ P[U_8$_Z,=_8_P#_ !&CX+__ #%4?\.]?V!/^C'?V/\ _P 1
MH^"__P Q5?8%% 'Q_P#\.]?V!/\ HQW]C_\ \1H^"_\ \Q5'_#O7]@3_ *,=
M_8__ /$:/@O_ /,57V!10!^<WC3_ () ?\$J_B!'=IXF_P""='[%TLU^UY)>
MZEHO[.'PI\)ZW=37\3Q7-Q-K_A/PQHFMR73!VDBNFU W-M<8N[:6&Z59A^<W
MQQ_X-4O^",'QEMKLZ)^S_P"-/@+K=YYQD\1_ [XP>/-*N86E$FUK3PW\0M2^
M(_P^L_(>3S(8[;P9'%E(XY8Y8$$5?T944 ?YU_[9/_!E'\6O#%KK'BC]A/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M _\ ]0G2Z /T_HHHH **** "BBB@ KP_]I+]G'X-?M<? [XC_LY?M ^"M/\
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M *A.J5_BC4 ?W>?\&.G_ "53_@HE_P!D_P#V<?\ U(_B_7^AY7^>'_P8Z?\
M)5/^"B7_ &3_ /9Q_P#4C^+]?Z'E !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK_&&K_9Y_P""_'_*&S_@H3_V0#5__3[H-?XPU ']OG_!D-_R=/\ MP?]F_\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_
M'_P?.?\ .+K_ +O9_P#?1Z_O\K^ /_@^<_YQ=?\ =[/_ +Z/0!_ '7^US_P1
M2_Y1'_\ !.7_ +- ^!__ *A.EU_BC5_M<_\ !%+_ )1'_P#!.7_LT#X'_P#J
M$Z70!^G]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRYLMS#"4:BC4EDF28B,<P6865'&9GA\'A<*\32I9C]7[2BBBOX%/]PPHHHH
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M_P#M9?\ )K'[2_\ V;_\9?\ U77B.O\ "'K_ '>/VLO^36/VE_\ LW_XR_\
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M;S_L.N?M"?%6XT6U<,'5=-\/IXICT/2H5<>8EOIFG6ENDA:18@[,QS_V7O\
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MSQV]A$5$<>E>,_A!%X.T>#4%C186U7Q+X'\837"&2:]BNKZ0W@_KE_X)Z?\
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M=K:PWB)=PVMK9PVT5THN8XEF^>O*?^&L/VIO^CE?C_\ ^'D^(O\ \T=?UO\
MPO\ ^#)']LK6K"VN/C%^V+^S;\.[Z:%I9M.\ >&OB5\5S:.VYH;>6[US2_A+
M#),J^6MVUN)K>&8RI:SWT,<=Q/\ 15__ ,&-&M1Z6\VE_P#!372[S6A';E-/
MO_V/KO3=+:5I(A=(^L6_[3FJW:1PQ&=[>4:'(US)'%%)#:+,\T !_(E\-_\
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MA/\ R?U^W#_V=_\ M+?^KG\:U]__ /!M[_RFU_8(_P"R@?$'_P!4?\4* /\
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MH0SLSD?'[5D!9BQ"1Z!H$<:@DD[4151%Z*BJJ@  5\??\$]O^3^OV'O^SO\
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M@O2;W('V?7O';64/@SP_)\PR-<U[3P/7@T >K_$3_@K?_P %1?BK<M<>./\
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MBDHQ2222222"BBBD4%%%% !7\ZO_  6M_P"2H_!/_L0?$'_J1)7]%5?SJ_\
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MDCJBLP_QE?\ @NQ_P4(MO^"E'_!2+XU?'7PKJ=UJ/P:\)M8?!;X &X,RQO\
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M^*[7P;!X4\0(XFAU'PGK7B#1IHC'J3.GV7_P2>_X)E_%[_@JI^UQX0_9T^'
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MCP_\1?",<DTDTDO_  AWQ T;Q-X5:9IIO.?1VE$LBN';Z\H **** "O\P_\
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M\??$'4K&#RAX@^(WCF\23Q%XPUJ9S+*DFJ7KV.F+,UAH-AI.DQ6VGP?8M%%
M!7SG^U-^R5^SI^VK\(=?^!?[3_PG\)_%WX:^((Y&?1_$VGI+>Z'JAMI[6V\2
M^$-=@,.M^#O%FFQ7,XTOQ/X:U#3-;L!--'!>K#//%+]&44 ?+/[&W[&/[.W[
M WP$\+?LW?LP> ;7P!\,?"\U[J1M_M,^J:_XF\2ZL86UOQCXR\17K/J7B7Q5
MK36]M'>:I?R'R+"RTW1-+@T_0=(TG2['ZFHHH *_RA/^#O'_ )3)^-O^R ?
MG_TQ:G7^KW7^4)_P=X_\ID_&W_9 /@3_ .F+4Z /YP?A/_R5+X:_]C_X-_\
M4BTVO[8_^#LK_@M;JOCSQQX@_P""6O[,OB^:S^'G@&^MXOVO_&.@7S1MXX^(
M%E+'>VOP)M[RT8(_A7P!,EI?_$:))Y&U;Q\L7A&_@T]? >L6^O\ \->F:E?:
M-J6GZOIEPUIJ6E7UIJ6GW2*CO;7UC<1W5I<*DJ/$S0SQ1R*LB.C%0'1E)!]]
M_9^^ WQX_;F_:5\#? WX3:5K'Q.^/'Q]\>2V-@=1O+N[N]4UW6I[O6_$_C'Q
M=KDZW<]MH^CV2:QXP\;^*-0,R:7HNGZQKNH2-';3.0"/]EG]E']H/]M7XT^%
M?V?/V8_ACX@^*WQ5\7R.VG^']"C@BMM-TRVD@CU'Q+XHUS4)K30_"?A/1_M,
M#:QXG\1:AINB::)[=+F]2:YMHIO](O\ X)8_\&E_[(/[*FE^'/BC^W)'H?[8
MG[0:QZ?JC^#-3M+I?V;?AWJ:1)++IFF>#+U;>Y^+MQ;7#W%O=:[\3+8^&=5M
MEM)+/X9Z%>VSWUY^P_\ P2+_ ."2GP _X),_LXZ7\+OAQ8:?XI^,GBS3](U/
M]H'X[76GQQ^)?BAXT@M0;BVL995:[T'X;^';N:\M? ?@J&8VVDV$DNIZI)JG
MBS5_$.OZK^K] &3H.@:%X6T72_#?AC1=)\.>'=#L;;3-%T'0=.L](T71]-LX
MEAM-.TO2]/AM['3[&UA18K:TM((;>")5CBC50 -:BB@ HHHH _&S_@IE_P $
M*_V!O^"GOAO7+[XH_#+2_AG\?KBSN?\ A'/VF?A3I.F^'?BA8:JZ1&TE\:BT
MCM=*^+.AQR01P3:)X^AU.YM=/FU"+PKK7A34KYM7C_RP/^"H'_!+3]IG_@E-
M^T!<?!/X_:3;ZMX=UZ.]UGX0?&;PS:WW_"O?B_X0MIXXGU30;F\B672_$FBF
MYL[3QMX(U"1]8\*:G<VQ,NJ^'=6\->)M?_VTJ_-[_@JM_P $W?A/_P %1_V/
MOB#^S7\1;;3=,\5R6MQXH^"/Q*N;3S]1^%/Q>TNRN5\+^*K66**2[;1;QYI?
M#_C;2K<;M<\'ZKK%C ;?4CIU_8@'^*9X.\8>*OA[XM\,>/? OB'6/"/C7P5X
M@T?Q7X1\5>'K^XTK7O#?B7P_J%OJNAZ[HVIV<D5UI^J:5J5I;7UA>6\D<UM=
M0131NKH"/]D?_@AK_P %0M)_X*J_L*^"_C/K$FFV'QZ^'UTGPK_:2\-:=%#9
MVUG\3]#TVSN?^$NT?38RIM/"OQ)T2ZL/%^C111?8M)O[W7?"%M=7\WA2\NY/
M\<_XI?#/QO\ !?XE_$#X0?$S0+SPK\1?A;XT\3?#[QUX:U!56]T'Q;X/UF\T
M#Q#I-SL+1O)8:K875L98F>&41B6%WB=';]G/^"#O_!7R]_X)(_&_X_\ C+6M
M/OO%/PY^+_[.OQ T4^"5-\^CZG\<_ >@:QXO_9YO]8BT^5+JWL;_ ,9)?_#3
M4]8ABG;0?#_Q-UK6Y(O*TYI8@#^GS_@[%_X+:ZM\*M-U3_@E[^RSXSDTSQWX
MO\/V=W^UWX]\-W_E:EX3\$^([$7FD? ?3K^V876G:YXYT2YLO$/Q%FMI()8?
M FIZ+X7\ZZM_&/B:RL/\[*WM[B[N(+2T@FNKJZFBM[:VMXGFN+BXF=8X8((8
MU:26::1ECBBC5GD=E1%+$ ]S\5OBEX]^-_Q-\?\ QB^*7B34/&'Q'^*'C#Q#
MX\\<>*-5E,M_KOBCQ1JESK&LZC.W")]HOKN9HK>%4M[6'R[:VCBMXHXU_P!!
M[_@V _X-_P#P]\/?"'PZ_P""F'[9_@R'5_BIXJM;#QK^RA\(O$MH)]/^&?A:
M\C2[\-_'#Q?I%W;^5=?$;Q);-%KGPRT^<W%IX%\.W6E^,9%;QWJ>EIX! /A;
M_@CG_P &D7CGXZZ1X2_:+_X*9W/BSX-_#+4_L&O>%_V7-!D;0?C%XVTB1$O;
M2?XL:ZZ27/PDT/4T-ND_A#3K=OB?<6$]];ZC>_#'6;6UEF_OZ_9J_9'_ &8_
MV.? 5O\ #+]EWX%_#7X'>"H5MS=:7\/_  Q8:-=:Y=6L"6T6J^+->6.3Q#XR
MUYH(XXKCQ#XLU76==NU1/M6H3%01]%44 %%%% !7S#^U7^Q?^RQ^V_\ #B\^
M%/[5GP-\ _&KP9<PW$=G!XLTA6U[PU/=& SZEX)\9:=)8>,/ FM/]GA1M;\'
M:[HFJO"AMGNVMI)87^GJ* /\IC_@O!_P;@_$7_@F0FH?M)_LVZEXH^,_[%%]
MJ$46N7VM1VEW\1_V?-1U.^M;#2M)^(DVFP65MXE\%ZQ?WD-CX<^(FFZ5IZ6M
M])%X=\7Z;IVH2:)K?B[^6ZO]];Q?X1\+^/\ PIXE\"^-] TGQ7X-\9:#JWA?
MQ7X8UZQ@U/1/$/AS7K"?2]:T35].NDDMK[3=4TZZN+*]M)XWBGMYI(G4JQ%?
MXXO_  7;_P""85U_P2Q_;S\:?"#PS!J5Q\ OB38_\+;_ &<];OVGNY1\.M?U
M*^M;GP1J&IR^9]MU[X:^(+/4?"E[)-/)J6HZ-;^'/%&H16S>)8(J /U+_P"#
M4O\ X*]:G^R%^T[8?L*_&GQ1-_PS-^U;XJM--\!W&KWH32_A#^T3JJP:;X:U
M6T>8D6?AWXN/!IO@'Q+:H/(B\4/X&\0F73+"R\47&H_ZB-?X!]I=W5A=6U]8
MW-Q97ME<0W=G>6DTEM=6EU;2+-;W-M<0LDT%Q!,B2PS1.DD4B*Z,K*"/]JW_
M ((R_MNR?\%"/^";?[,?[2>LWUO>?$35O!9\#?&-8I%,T7Q=^&E[<>"?&]_=
M6XDF:P_X2R^T>/QWIUE++)+#H?BK2F>1]X<@'ZAT444 %%%?G)_P5Z^,GQ _
M9_\ ^"87[='Q?^%=U>:;\0_!G[.'Q'N?"FM:<]Q'J/AO5-4T>305\6:=-:@S
M6^H>$H=5F\2V-R,1VUUI4-Q.R01R.H!_ %_P<Z_\%Q?$_P"VE\;O%W[#7[./
MC*XT_P#8]^!OBRYT#QYJWAS42+3]H[XL>%K](M3U?5+VT81ZK\+_  !X@LI]
M/\!:5!/<:'XDUJPF^(]S)JRMX&;PU_(_17]SW_!KY_P;_P#A[XVV7A;_ (*4
M?ML>"X=:^%]GJRZE^RK\$_$MHLVE_$35-!U"YMY_C-\1=$O+<QW_ (%TC6+(
M0?#GPQ>;[7QKJ=E>^*-;LY/!UGX>C\9@'Q1_P1R_X-8_VA/V\]%\,?M"?M=Z
MQXF_99_99UR&TUGPKH\&E6R_'OXSZ!=QI-::MX2T;7K:YTSX<>#=3@D^U:7X
MX\:Z3JU]K5JMK>^'/ NL^'=8LO%4/^B!^Q7_ ,$R/V%?^">WAV+0OV3OV<_
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MWO+>>TNX(;JUNH9;>YMKB))[>XMYT:*:">&56CFAFC9HY8I%9)$9D=2I(/\
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M=/\ #EE&&MO@EXJOHE:VTU]!@3X97EZEC:ZGX<\*?;M8\:0_YNGQ<^$7Q-^
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M :Q_Z8]!KY _X)[?\G]?L/?]G?\ [-/_ *N?P50!_N<T444 %%%% !7\ ?\
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M5?[03:W\/?V=]*F-I<2>')[6SMCXV^,.H:=<[UNM)^&>FZKISZ?#);7=M?\
MCG7O!NFW]K+H]UJTMM_D$Z]KVM^*=<UKQ/XEU?4O$'B/Q'JVHZ]X@U[6;VXU
M+6-;UO5[R;4-5U?5=1O))KN_U+4K^XGO+Z]NI9;BZNII9YY'ED9B 9]Q<7%W
M<3W=W/-=75U-+<7-S<2O-<7%Q,[233SS2,TDLTTC-)++(S/([,[L6))_2C_@
MFA_P2=_; _X*I_%:7X>_LV>"XX/"/ARXL_\ A:'QO\9B_P!)^$GPML;L-) /
M$7B&VL;V;4?$FHPI(V@^"?#MIJOBG61'-?)I]MH-AK&MZ9ZY_P $8/\ @C_\
M7_\ @KM^TDWP]\/W>H> O@%\-?[(\0?M#_&E-/\ M47@_P .:A<SKIGA3PNM
MS&VGZE\3/'/V#4K7PGIMXS6EC::?K7BG4X+O3= GT^__ ->K]EG]EGX%_L7_
M  +\!_LX_LX^ ]+^'?PI^'>EKI^B:)IZF6[O[N4B75?$GB3590;[Q%XL\17Q
MEU3Q%XBU26?4=6U&>6>>7;Y<<8!^-_\ P31_X-K?^"=W_!/73- \5^(_ VF_
MM8?M&V"P7=]\:_CAX<TS5M)T;5XBDBS_  O^$]Y+K/@[P##:3QI<:9JUV?%7
MCZRG,I7QRUM)%9V_]"E%% !1110 4444 ?D%_P %&O\ @AQ_P3U_X*9:+J]Y
M\:?@_IO@GXT7D,C:7^T=\(;/2?!/QBLM0$92VF\1ZO;:=-I?Q)TV''E'1OB+
MI7B6WMK:2X.B2Z)J$J:E#_F2?\%<?^"'?[6O_!)'QK;W'Q&MH?BM^SGXKUJ;
M2?AI^TGX+TB^M/">LW;)<7-EX7\=Z---?W'PU^(4VGVTUZOAG4]2U/2]7AM=
M1F\(>)O%%OI&L3:?_LL5Y+\=O@3\(_VF?A'X\^!'QW\!Z#\2_A-\2]!N?#GC
M/P9XCMFN-.U73KADEBEBEB>&]TS5M,O8;;5=!U[2KFRUOP_K=E8:WHE_8:K8
M6=Y" ?X,]O<7%I<07=I/-:W5K-%<6US;RO#<6]Q"ZR0SP31LLD4T,BK)%+&R
MO&ZJZ,& (_TZ/^#83_@N_KO[<?A4_L+?M<^+/[7_ &K?A=X7DU3X5?$O7+Q!
MJ_[0GPQ\/VR)J5AK\TVUM6^+GP\L8X[O6M2$DNJ>._!PE\5ZA!<:WX9\::_J
MG\7_ /P7(_X) >._^"2'[5$G@RS?7/%G[,OQ9_M?Q1^S?\4-51)KO4]!L;BW
M77/A[XOO;6TLM//Q$^'DNH:=:ZXUI;6UMK>BZGX=\56EIIZZY/H^D_EM^SO\
M>OB5^RY\=/A/^T3\'M=F\.?$SX-^.O#_ (_\'ZI$\RPC5- OXKLZ=J<,$L#7
M^@ZW:K<:)XBTB606NM:#J&I:3>I+9WL\3@'^\G17SS^R5^T9X0_:[_9C^ O[
M3W@-5A\+?';X4^"OB9I^G?:X[Z?09_%&AVFH:KX6O[J%(XY-6\)ZQ+?^&M9"
MH@CU72KR(HA0J/H:@ K\9O\ @N)_P5E\*_\ !)3]CZ^^*=G;:+XG_:#^*%]?
M^ OV;OA[K1GET[6_&<5E'=:SXQ\26=G<6M_-X%^'&G75KK'B1;6YLWU+4K_P
MUX434=+N?%%KJ-K^S-?Y5W_!X-\8_'_CW_@K5=?#'Q&]];>"/@3\!OA5X<^'
M.F/)=KI=S!XXTRX^(WBOQ3:VLRI:G4M5U[Q$WAK4M1LQ(;JT\%:-8W$[2:2L
M%L ?S0?%_P"+_P 3OC]\3O&_QG^,_C?Q!\2/BG\2/$%[XH\;^-_%%ZU_K>OZ
MU?L#+<W,I"0P6\$*0V6FZ;90VNEZ/I=K9Z3I-G9:996EI#[_ /L.?L$?M2?\
M%%?C=I/P#_93^&FH>/?&%U&FH^(]9G<Z5X%^'/A@3+#=^,OB/XON(GTSPKX;
MLR3''+<&;5-;U V^@>%]*U[Q+J&F:->R?L"?L,?'#_@HS^U)\-_V5/@%I4=S
MXN\<WDMWKOB;48;H^%OAMX#TDQ3>+?B/XTO+6*1K'PWX:L94+*!]LUO6KO1O
M"NB17OB/7]'T^\_V.O\ @G1_P3G_ &<?^"8_[./AO]G;]G;PW';6UM':ZG\1
M/B)JEK:GQW\7_'9M4@U3QQXXU2! ]S>7+B2'1M&AD&C^%='%OH6A6UM86P$@
M!^(7_!,O_@T]_84_9!T[PW\0?VM+'3?VV/V@;>&UO[VU\<:5L_9T\(ZL8XY)
MK'PQ\)KP20>/8;.22XL9-:^++>(-/UN**UU:R\!^#K[-K%_4UH.@:%X6T72_
M#?AC1=)\.>'=#L;;3-%T'0=.L](T71]-LXEAM-.TO2]/AM['3[&UA18K:TM(
M(;>")5CBC50 -:B@ HHHH *CFABN(I8)XHYX)XWAFAF19(IHI%*212QN&22.
M1&*.CJ5=258$$BI** /YE?\ @JK_ ,&P'[#W[>FB>)OB%\ /#OAO]C[]J:Y^
MU:K9^-OA[H2Z?\)O'VL,LDQL?BE\+='^S:)!_:UT\KWOCGP-8Z)XNBO[M]:U
MU/&R6RZ'<_YA7[7W[('[0'["OQ\\;?LV?M+>!+[P%\3_  /=*)[64F[T/Q+H
M5V\IT3QIX+UQ$2S\3>#?$=O"]SHVMV)V.4N=/OH;#6=/U/3++_=?K\%/^#@7
M_@D/X6_X*F_L>ZY-X.T&SB_:Z^ >CZ_XU_9S\40K%;ZAXCGBM1?>)/@IK-RX
M$=UX?^)=OI\-KHQNY;=/#WCNV\-ZXM_::1_PDMEK !_D=_!WXP?$S]G_ .*7
M@+XU_!OQEK7P^^*/PR\3:9XO\$>,?#]R;75-#UW29Q-;7$1(>&ZM9U\RSU+3
M+V&YTS5],N;S2M4M+S3;RZM9O]F+_@CK_P %+O!G_!5+]B/P!^T=I$&FZ#\2
MM+FD^'?Q^\!:=+,T/@CXP^'+#3Y]>@T]+D?:/^$9\4Z?J.E>-?"+M->F#0?$
M%KH]YJ%UK6CZN(O\5R[M+JPNKFQOK:XLKVRN)K2\L[N&2VNK2ZMI&AN+:YMY
ME2:"X@F1XIH9422*1&1U5E(']4/_  :1?MZZE^S!_P %';?]FCQ)K,EO\(OV
MV=#/P]NK"XG*:=IGQH\(VNJ>(OA'XA1&W;;S5BWB?X;)! J?;KOQWI,UV[)I
M-MY8!_JGT444 %%%% 'Y@?\ !:W_ )1'_P#!1K_LT#XX?^H3JE?XHU?[7/\
MP6M_Y1'_ /!1K_LT#XX?^H3JE?XHU ']WG_!CI_R53_@HE_V3_\ 9Q_]2/XO
MU_H>5_GA_P#!CI_R53_@HE_V3_\ 9Q_]2/XOU_H>4 %%%% ',^-?&7A;X<^#
M?%OQ"\<:W8^&?!7@3PSKWC+QAXDU.1HM-\/^%O"^E7>M^(-;U&55=H['2M)L
M;N_NY%1V2WMY&"L0 ?\ &!_X+%?\%.?B+_P52_;/\=_'KQ!=ZMIGPFT"ZO\
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M;XO_ /5-6/V0HHHK_-H_Z$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA>']5M5S?^#O .G:-'/;7NH:!XE\3^-=%F\I@#]@O^#G3_@X2\'ZAX-\=_\
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M=QJ.C7'&F>/?%'CQH\I=#'^8]_P2@_9;M/VTO^"C_P"QQ^S3J]BNI^%_B/\
M&[PO)X]TYHUE&H?#'P3]I^(?Q1L@KY0-=?#SPGXF@2219(HG=99(9HT:)_\
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MXO\ P<A?\IM?V]_^R@?#[_U1_P +Z_$&OV^_X.0O^4VO[>__ &4#X??^J/\
MA?7X@T ?W.?\&5G[$EEXQ^,7[27[?/B_1OM-E\'-'L/@'\&[ZXC+VT?C_P ?
MV']O_%+6;%U93#K'ACP!'X7\/ N)(I=)^*FJ+L$J1R)_HN5^!/\ P;(_LYVW
M[.O_  1K_9866QCM/$OQSM_%_P"T9XMFCA$/]I7/Q1\174G@R^<%5DDD7X3Z
M/\.[!II&D,GV$-$PMO(C3]]J "BBB@ HHHH **** "O\H3_@[Q_Y3)^-O^R
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M<")#:VEO#!$BHB@=!10 4444 %%%% !1110 4444 ?A)_P '(W[(&F_M?_\
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MG_LX#6/_ $QZ#7R!_P $]O\ D_K]A[_L[_\ 9I_]7/X*H _W.:*** "BBB@
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M"NH0ZA)X3\4:3K$]AJ5O97^@_P!JKX:N+.!M% /[9T44 %?SX_\ !;O_ ((
M?!K_ (*_6OA#XE:;\0[CX"_M2_#;PW)X/\,?%"/PY%XM\*^,?!":C?:Y9^!?
MB1X:CO\ 1=5N;/3-9U+5;GPQXFT76[>^\+R>(-=ENM%\56MQ;Z7;_P!!U% '
M\\__  ;]_P#!$-O^"0/PE^+=[\6?$?P]^)?[4'QI\7-#XG\?_#S_ (2"Z\,:
M'\(_"TKIX \"^';SQ9H?A[6DFOKN?4_&7C>9-&TR"\UO4](T!VURS\"Z+X@U
M#^ABBB@ HHHH **** "BBB@ HHHH _Q^?^#E_P#9 TW]CW_@KK^T)I7AC2H]
M&\!?M V^A?M1^!M/AA%O;P6WQ;EU5?'B6D,:1VT.GQ_&/P[\2X=+MK-$M;'3
M(K.PC53:LH_%;X,_%/Q-\#?C!\*?C9X*N&M/&7P>^)7@7XI^$KI)I+=[;Q-\
M/O%&E^+=!N%GB_>PM#JND6DBS1_O(RH=/F45_;3_ ,'Q'P\L],^,/_!/7XL(
M(?M_C7X:_M!?#RY*LIN#9_##Q1\+O$EB)5%HC"$3?%W4# QO[E6=K@+:615I
MM0_A-H _WT/ _C#1/B%X+\(>/O#4TESX<\<>%] \8>'[B9%CEGT3Q-I-IK6E
M32QH\J1R2V%[ [HLDBJS%5=P QZBOSJ_X)#>++_QO_P2O_X)U>)-4W'4KK]B
M[]F^ROIGE\Z2\NM$^%'A?0IM1ED\N(>=J3Z:=0FC";89;EXE:14#M^BM !11
M10!^8'_!:W_E$?\ \%&O^S0/CA_ZA.J5_BC5_M<_\%K?^41__!1K_LT#XX?^
MH3JE?XHU ']WG_!CI_R53_@HE_V3_P#9Q_\ 4C^+]?Z'E?YX?_!CI_R53_@H
ME_V3_P#9Q_\ 4C^+]?Z'E !1110!_"M_P?#:SJ$'P3_X)^>'HI]NE:I\4_CO
MK-[;;%/FZAH7A+X=6.F3^81O7[/;>(]7CV*P5_M.YP3&A7_.PK_3=_X/2_@=
MJ/C?_@GM\ OCAI.GM>O\"OVE;+3?$,\=O$[:1X.^+7@O7]%N=3EN3;/<06K^
M-/#?@+2'C2ZM[>>ZU:R,\-S+#:-;?YD5 '^U'_P0X;1W_P""0?\ P3K.ABU%
MD/V5OA<L_P!C0)%_;":*B>(BZA5!NCX@74S?/C,E[]HD+,6+']5:_C._X,]O
M^"DG@OXN?LBZA_P3N\;^(]/T[XT_LR:IXL\4?"O1;^Z\O4?'?P'\<>)[SQ=J
M-SI+3DR:GJ'PY^('B?7M,UJTCD9M,\*Z_P""$LX396MX;+^S&@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_G5_P""UO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/H?_ ,O:U-'_ .#?#_@L[KEZMA9?\$_/C9!.T<DHDUB3P3X>L@L8!8-J6O\
MBW3-.60@_NX6NA+*<B)'(( !'XO_ .#@K_@LWXWM!9:S_P %!/CA90B-H@_A
M!O!WP^N]KRPRDF_\!>%?#5^9 \"!9C<F5(FFA1UAN)XY/SJ^+_[5'[3W[0C^
M9\?/VC_CS\<) T;A_B_\7_B%\2W#PE3"V[QIXBUIMT113&V<QE5*D%1C]>_"
M7_!L'_P7#\7/&T7[$UUX?LC=2VDVH>+?CI^S;X?2U>*W2X\V33;SXO\ ]OW%
MK()(X8KNPT>\MWN&>(29M[HP?<_PG_X,T/\ @J=XVFMIOB-X^_92^"^EEH_M
MT>N?$?QCXS\2PQN#O-CI7@3X=:UX?O9H2 'CN?&&F1-N!BN),-@ _DDJYIVG
M:AJ^H6.DZ38WFIZIJ=Y;:=INFZ=;37NH:AJ%[.EM9V-C9VR2W%W>7=Q+';VU
MM;QR33SR)%$CR.JG_1E_9K_X,E?V<O#,UAJO[6/[8?Q6^+<L;+<7/A+X+>#/
M#OP<T(2+TT^[\2>*;SXJZ[K%BS --<Z?I_@^^D1C%";1T%P_].7[&O\ P28_
MX)V_L!QVMU^RW^RQ\-? ?BVWM8[:3XG:K97GCWXM7($31W3'XF^/;SQ)XST^
M'47DDGO=+T75]+T-Y&2.#2X+:WM;>  _SP?^"6G_  :H_ML?MIWWAWXE_M6V
M.N?L8_LW7$EGJ$W_  F6C&']H+Q]I+O%.]MX)^&.JPI+X+M[ZT$L2>+?B=#I
M?V%KBQU31O!?C:P:>*/_ $E_V*/V%/V8/^">WP4TGX"_LK?#+2_AYX)LI$O]
M:O@QU+QAX[\1FWCM[KQ=X_\ %=TIU3Q3XDO(XEC-W>R"UTZT2'2=#LM*T6TL
MM-MOKRB@ HHHH **** /G_\ :R_Y-8_:7_[-_P#C+_ZKKQ'7^$/7^[Q^UE_R
M:Q^TO_V;_P#&7_U77B.O\(>@#^H7_@T'\#Z?XL_X+'>%=>O1']I^&/[/'QT\
M<:1O1G8:AJ&F:%\-I3"RR((I/[*^(6I@NZRJ8C+&(P\B2Q_ZN=?Y8G_!FW_R
MEP\1_P#9H'QE_P#4V^$%?ZG= !1110 4444 %%%% !1110 UT21&CD571U9'
M1U#(Z,"K*RL"&5@2&4@@@D$8-?X)7Q;\'#X>?%7XF_#\;0/ WQ!\9^#@$G>Y
M0#PSXCU+11MN9(XGN%_T+Y9WBC>48D:-"Q4?[V]?X0W[6'_)TW[2O_9?_C)_
MZL7Q'0!^S7_!JYKUWI'_  7(_9 T^W2-H?%.A_M):#?LYD#1VEO^S!\8O$Z/
M"$=%:0WWARSC(F62/RI)6""98I(_]=^O\@7_ (-<?^4Z_P"PS_W<S_ZQY^T%
M7^OU0 4444 %%%% !1110 45^;G[4'_!8#_@F3^QM<ZEI?[0W[:7P/\ !WBC
M1_,75/ 6A^)7^)7Q+TZ2,LOE:A\-?A?:>,O'=A)(Z/'"+[P_;K+(DBHQ\J0I
M^$OQS_X//?\ @FQX!EU/3?@K\(/VG/C]J=IO&GZPOAGPC\+/ 6JL&4(8]8\7
M>*KKQU9QNN]RUW\,4D0!!Y3,[B( _K]HK_.E^*__  >__'O5'NH_@;^P=\(?
M!"!IDLKKXK_%SQG\4W= 8%M[BZL/"'AKX.B-G"7,DUG#J4HC-Q!"E](+.2>^
M_/CX@_\ !X-_P6$\9F?_ (1S4?V9OA+YK;HQ\/O@A+J7V4>=;R[(/^%J^,OB
M864)#);9N3</Y-W<,6-PMI/; '^K#17^._XO_P"#E_\ X+>>-'N?[1_;J\3:
M3!<0WMJEMX0^$G[/O@M+6UOC)NBMKGPO\)M*U$36R2>79:E->S:O:A(Y(M0$
MZB:OGW6_^"Y'_!7SQ!=QWE__ ,%%/VJ()HK=+94T3XH:QX:M3&DDLH:2P\.-
MI5C+<%IG#W<MN]W)&L4+S-#! D8!_M145_A_7?\ P57_ ."H=_:W-A?_ /!2
M/]O>]L;VWFM+RSN_VPOVAKFUN[2YC:&XMKFWF^(CPSV\\+O%-#*CQRQNR.K*
MQ!X?_AX3^WU_T?#^U_\ ^)+?&?\ ^;6@#S_]K#_DZ;]I7_LO_P 9/_5B^(Z_
M;[_@U _Y3:_LX_\ 8@?M$?\ JCO'%?SG:CJ.H:OJ%]JVK7UYJ>J:G>7.HZEJ
M6HW,U[J&H:A>SO<WE]?7ER\MQ=WEW<2R7%S<W$DDT\\CRRN\CLQ_HQ_X-0/^
M4VO[./\ V('[1'_JCO'% '^MW1110 4444 ?XXO_  <A?\IM?V]_^R@?#[_U
M1_POK\0:_;[_ (.0O^4VO[>__90/A]_ZH_X7U^4G[.WAB+QM^T#\"_!DZR/!
MXN^,?PQ\,3)#;K>2O%K_ (VT32I%BM'5TNI&2[8);NC+.Q$3*P8@@'^X_P#L
MM_"J/X%?LR_LZ?!"&W6SB^#GP)^$7PJBM$\H):Q_#WX?^'O"*6ZB "'; ND"
M)?) BPH\L!,"O=J** "BBB@ HHHH **** "O\H3_ (.\?^4R?C;_ +(!\"?_
M $Q:G7^KW7^4)_P=X_\ *9/QM_V0#X$_^F+4Z /Y@J_W^*_P!Z_W^* "BBB@
M HHHH **** "BBB@#^7'_@[_ -*L-0_X([:]=WD'G7&A_M(? W5=*D\V:/[+
M?S3^)]$DGV12(D^[3-8U&V\JY6:$?:?.6,7$,$L7^4K7^KU_P=Y?\H;?&G_9
MP'P)_P#3YJM?Y0M '^GW_P &5/\ RBR^/G_9_P#\4_\ UG7]E6OZ_:_D"_X,
MJ?\ E%E\?/\ L_\ ^*?_ *SK^RK7]?M !1110 4444 %%%% !1110!_@I?&C
MPQ_PA7QB^+'@W[/9VG_")?$OQWX8^RZ=_P @^V_L'Q3JNE?9[']W%_H</V3R
M[;]U'^Y5/W:?='[E_P#!J_K5UI7_  7*_8ZL;>.W>'Q+H_[2>BWS3)(TD5K!
M^RW\9O$226A26-8[@WN@6<3/,D\9M9;E!$)GBGA_&C]K#_DZ;]I7_LO_ ,9/
M_5B^(Z_7_P#X-<?^4Z_[#/\ W<S_ .L>?M!4 ?Z_5%%% !1110 4444 %%%?
MFM^TS_P6)_X)A?L?S:GIWQ]_;9^!/A;Q)HK2QZMX%\.>*O\ A9_Q(TV>('-O
MJ/PW^%EKXT\<Z?,[ I$E]X?MQ(RN%)$<A4 _2FBOX_OCE_P>?_\ !-SP')>Z
M=\%?@Y^TY\>]3M]WV357\.>#_A7X&U#Y?D\K5_%/BJ_\;6^6X?[3\-H]BX9?
M,;*#\H/BK_P>_P#[0>JR3K\$/V#_ (-^!8AO6VE^*OQ:\;?%>1L*JQS3V_A'
MP[\&%3>P>5[:.Y?RU=8!=RF(W$P!_HP45_E.?$#_ (/!/^"PWC)[EO#FJ?LT
M?"99]OE1_#_X'MJ26>V>*8_9C\5/&'Q,D;?'&]JWVN2ZQ!/*R;;I8+F'X^\7
M_P#!RW_P6\\:B:/5/V[?%6F0S0W-LL7A#X3_ +/O@<P6]R[,4ANO"'PFT6_$
MT(.RVOY+N34H$5=EX&RQ /\ 8DHK_%9US_@N'_P5Z\0W)N[_ /X**_M66\IM
MUMBFA_%77O#%MY:F0AA9^&I=)LUN#YC;KM8!=L!&&F(BB">27?\ P57_ ."H
M=_:W-A?_ /!2/]O>]L;VWFM+RSN_VPOVAKFUN[2YC:&XMKFWF^(CPSV\\+O%
M-#*CQRQNR.K*Q! /]P&O\$;XL?\ )4OB5_V/_C+_ -2+4J^@/^'A/[?7_1\/
M[7__ (DM\9__ )M:^1KBXN+NXGN[N>:ZNKJ:6XN;FXE>:XN+B9VDFGGFD9I)
M9II&:2661F>1V9W8L22 ?T[_ /!H=_RF3\$_]D ^.W_IBTRO]7NO\H3_ (-#
MO^4R?@G_ +(!\=O_ $Q:97^KW0 4444 ?Y-7_!VO\<IOBY_P63^*/@Q;EKC2
M_P!G/X1?!;X,:84N!-:>9?>$Q\:-:\A%)2*:WUWXO:CI=\N/-%WILD4I_<HJ
M?S?>$/"VL>./%GA?P5X>@6ZU_P 8>(M%\+:':NQ1;G6/$&I6VDZ9 SA7*+->
MW<$;,$8J&)"MC!_1C_@M1XSF\>?\%;?^"CFN3O<2/8_MB?';P8K7,4$,@A^'
M'CW6/AY;HJ6\DL;6\=OX7BCM)683SVJPSW,<-S)+$F?_ ,$;?A]!\4/^"KG_
M  3Q\(74'VJRE_:\^!OB'4;4R0QI=:9X'\=Z/XXU*VF:?"M;W%AX=N(;F)"+
MB>!Y(;5EN9(6 !_LX?L_?!SPU^SO\!_@M\ O!J+'X3^"?PI^'WPG\-A8_*+Z
M+\/?"FD^%-.FD0L[>=<6NE13SN\DDLDTDDDLDDC,[>O444 %%%% !1110 44
M44 %%%% !1110 4444 %?QP?\'IGQXN/ W_!/S]G[X#:=/-;WGQZ_:1MM;UC
M87$-[X,^#G@W6M5U'3IMKJI9O&7C#X?ZE$)!(F=*<A!($DC_ +'Z_P ZO_@^
M$\<37_QS_8 ^&S2QFW\)_"?XY>.(H1=0/+'-\0?&'@'09Y7LU@6YMXYD^&5N
MD5U+<RP7;0S16\%O)97,ER ?PMU_K7?\&HO[-UE\!/\ @CO\'_%\MA':>*?V
MFO'GQ,^/?B:1HC]KDM[OQ"_PV\%1O.X\Q[.7P'\.?#FLV=NA%K!)K=Y+$GGW
M=W-/_DHU^O7PD_X+U?\ !7'X$?##P#\&/A)^VAXT\%?#'X7>$]$\#> O"6G^
M!O@]=67AWPKX<L(=,T;2+>ZU3X=7^IW4=E96\4(N=0OKR]G*F6ZN9YG>1@#_
M &?J*_QQ?^(D+_@MK_T?O\0/_#?? _\ ^=?1_P 1(7_!;7_H_?X@?^&^^!__
M ,Z^@#_8ZHK_ !Q?^(D+_@MK_P!'[_$#_P -]\#_ /YU]'_$2%_P6U_Z/W^(
M'_AOO@?_ /.OH _V.J*_QQ?^(D+_ (+:_P#1^_Q _P##?? __P"=?1_Q$A?\
M%M?^C]_B!_X;[X'_ /SKZ /]CJBO\<7_ (B0O^"VO_1^_P 0/_#?? __ .=?
M1_Q$A?\ !;7_ */W^('_ (;[X'__ #KZ /\ 8ZHK_'%_XB0O^"VO_1^_Q _\
M-]\#_P#YU]'_ !$A?\%M?^C]_B!_X;[X'_\ SKZ /]<#]JGX7P_&_P#9@_:/
M^"]S;->V_P 7O@+\8/A?/9I";A[N'Q_\/?$7A26V2W$<QG:=-6:)81%*92X0
M1ONVG_"!K]OO^(D+_@MK_P!'[_$#_P -]\#_ /YU]?B#0!_6K_P9H_$BY\(_
M\%5_'?@@RR-IWQ8_9(^*&@-:A28O[8\,>./A;XXTZ_<JN4DM=-\/Z_91%V$1
M75)E96E,#)_J1U_D5?\ !JIK=OI7_!</]DVPFBFDD\2^&OVC]$M'BV;+>X@_
M9M^*WB-I;C>ZMY+6OA^Y@7RQ(_VB:#*"/S'3_75H **** /\,;_@H3_R?U^W
M#_V=_P#M+?\ JY_&M??_ /P;>_\ *;7]@C_LH'Q!_P#5'_%"O@#_ (*$_P#)
M_7[</_9W_P"TM_ZN?QK7W_\ \&WO_*;7]@C_ +*!\0?_ %1_Q0H _P!CJBBB
M@ HHHH **** "BBB@ HHHH _QA?^"^__ "F2_P""A/\ V<!K'_ICT&OD#_@G
MM_R?U^P]_P!G?_LT_P#JY_!5?7__  7W_P"4R7_!0G_LX#6/_3'H-?('_!/;
M_D_K]A[_ +.__9I_]7/X*H _W.:*** "BBB@ K^ /_@^<_YQ=?\ =[/_ +Z/
M7]_E?P!_\'SG_.+K_N]G_P!]'H _@#K_ &N?^"*7_*(__@G+_P!F@? __P!0
MG2Z_Q1J_VN?^"*7_ "B/_P""<O\ V:!\#_\ U"=+H _3^BBB@ HHHH ****
M"OG_ /:R_P"36/VE_P#LW_XR_P#JNO$=?0%?/_[67_)K'[2__9O_ ,9?_5=>
M(Z /\(>OZ_?^#*G_ )2F_'S_ +, ^*?_ *T5^RK7\@5?U^_\&5/_ "E-^/G_
M &8!\4__ %HK]E6@#_3[HHHH *_A _X/?OCK/I_PO_80_9FL=09K;Q9X]^+'
MQU\3Z6DF$AG^'OA[P_X \"ZA<1=6:YC^)WQ%M[.0#Y!:WRG'F#/]W]?YC_\
MP>L^-I=6_P""D7[.?@*.[CN-/\&?L7^%=<>".Y:0V.N>-/C3\:HM1@GMLF.V
MN)='\+>&KLL )KBVN+5I,QQP&@#^.>O]>#_@UQ_9OM_V>/\ @C;^SIJ-QI2Z
M7XJ_:%U;Q]^T7XN/V=(9;]_&_B.?0? >H22 "2Y6[^$?@_X>3PRR\K'((H\P
MI&S?Y#]?[HG[ W@*T^%?["_[&/PSL8O)M?A_^RG^SUX-B0P2V[G_ (1OX2^$
MM(>2:&=Y+A+B:2T>:Y^T22W+3R2-<2R3M([ 'UI1110 4444 %%%% !1110
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M35DFO(?AO\7-+MQ#>^+/A[<7LUQ/I=U;747B3P!JU[<ZYX;EO=/O/$WA'Q:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y ?\ !?C_ )0V
M?\%"?^R :O\ ^GW0:_QAJ_V>?^"_'_*&S_@H3_V0#5__ $^Z#7^,-0!_;Y_P
M9#?\G3_MP?\ 9O\ \//_ %8LU?Z/E?YP?_!D-_R=/^W!_P!F_P#P\_\ 5BS5
M_H^4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S_P#M9?\ )K'[2_\
MV;_\9?\ U77B.O\ "'K_ '>/VLO^36/VE_\ LW_XR_\ JNO$=?X0] ']7O\
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MVG:I967BZP)B F^$G@.V2#Q1\2HY?-+6WB"(Z!\/)S9ZE9?\)XFL69TN4 _
MVNN\$> /'GQ-\0VOA'X;^"?%WQ!\5WZN]CX8\$>&]9\5^(;Q(RBR-:Z+H-E?
MZE<*C21J[0VSA2Z D%ES_JJ?L:?\&FG_  2M_9EM-+UCXO\ A3QA^V3\1[:.
M":[UWXVZS/I?P^@U**0/)+H/PC\$SZ-H!TN=$1'TGX@ZI\2B"9R+XI(D</\
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M_G05_J=T4 ?Y8G_$&W_P5P_Z&/\ 9 _\/+XV_P#G04?\0;?_  5P_P"AC_9
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M -K+_DUC]I?_ +-_^,O_ *KKQ'7T!7S_ /M9?\FL?M+_ /9O_P 9?_5=>(Z
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MIU_J]U_E"?\ !WC_ ,ID_&W_ &0#X$_^F+4Z /Y@J_W^*_P!Z_W^* "BBB@
MHHHH **** "BBB@#^8'_ (.\O^4-OC3_ +. ^!/_ *?-5K_*%K_5Z_X.\O\
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M6O7Z,2LS:GJVK>)?A=9(J*8K_P")]I?3SPV5A<E@#_5QHHHH **** "BBB@
MHHHH **** "BBOY3=6_X.[O^"<_@[]KWXC_LT?$+P7\9/#OP^\ _$SQ)\+T_
M:9T.RT#QM\-]3U#PMKTWAW4?%DWAW0]2_P"$VB\!SWUG?3Z;K6@:3XJU2^TU
M+/4(M!^SWA-N ?U945S?@WQCX4^(?A'PQX^\"^(M'\7>"?&OA_1_%?A'Q5X>
MO[?5=!\2>&O$&GV^JZ'KNC:G:22VNH:7JNFW=M?6%Y;R/#<VT\4L;LC@UTE
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M _\ RAL_X)[?]D TC_T^Z]7Z_P!?D!_P0'_Y0V?\$]O^R :1_P"GW7J_7^@
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M0=#LXD:*]O?B;KDOG"ZF:V_OLK_'9_X-K/B7J7PO_P""UG[$.H6,\D=IXO\
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M%*6)R?,,/C84Y2<8UX4IKVV&J22;C2Q5!U,/5<5S*G5DXV=F?%>(_ V5^)?
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M?]G?_LT_^KG\%5]__P#!R%_RFU_;W_[*!\/O_5'_  OKX _X)[?\G]?L/?\
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MOQ'80?$?Q);@7$-OH/A2VTG5%M3XOT>6?_5]H **** /\GK_ (.I?^";]_\
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M&)08M0T/6[..6671?%'AS48[K0_%'AZ^\O4M!UVPO]*U"&*ZM94 ![I1110
M4444 %%%% !7\@/_  =<_P#!8+3?V3_V<M0_8%^!OBSR_P!I;]IWPN]M\3=0
MT*^":A\(?V>M6>:RUT7L\)<V7BCXQ007W@[1[ @7EKX(E\7Z_(^E7,_A"\U'
M] ?^"W'_  7F^ 7_  2@^'6H^!_#UWHOQ9_;1\8Z#<'X<_!2PU*&:+P-'J>G
M7)T?XF_&5[9GE\/^#;.Y^SW6E>&W:V\3_$"3;9:%'9:*NL^*] _R8?C-\9?C
M#^U%\9O&WQH^,?B[Q%\5/C-\7?%4NO>*_$^JYO=<\2>(=3>&TM;:TLK*&."V
MM;:".RT7P]X>T:SM=+T72;/3=!T+3K+3+&RLH0#R*OK_ /X)[?\ )_7[#W_9
MW_[-/_JY_!5<[^V)^RA\3OV(_C[X@_9M^,UO#I_Q1\'>"?@KXJ\::)''+%-X
M6U?XQ?!'X=?&IO!>II*3_P 3[P3;_$.W\)>(V@>2SDU[1=2DL9IK)K>5^B_X
M)[?\G]?L/?\ 9W_[-/\ ZN?P50!_N<T444 %%%% !7\)'_!\3X9-U\)?^">/
MC'[%#(N@_$7]HCPR=0:1!<6I\6>&OA/J@LHHBX=X;\>"VGGD6-DC?3K=7=#+
M&LG]V]?RB_\ !XQ\$;OXE?\ !)O2_B;IUC)-<?LZ_M,?"KQ_K-_'YC"R\)>,
M].\6_!N]BG4.(5M[SQ=\1? V9WC:9+FWM889(X[FX64 _P L&O\ 9+_X-T?%
M]CXW_P""*G[ >LZ>BI!9?"[Q3X0D"RR3 WWP^^+/Q"\!:FY>2WM6#2:EX:NW
M>(1-' [-#%<7D4:7<_\ C:5_IQ_\&8?[4&E?$C_@G]\8_P!F"]U.-_&7[-'Q
MTU'7[+2C)B2'X7_&[3(O$/AZ[BC=MS[OB%X>^*:79@7R;=7T\R[);Q3* ?V*
MT444 %%%% !17/Q^+/"LWBB[\#P^)O#\OC6PT.S\3WWA"/6=.?Q19>&M1OKS
M3-/\0W?A];DZM;Z'?ZEI]_I]GJTUHEA=7UC>6D%P\]M-&G04 %?/_P"UE_R:
MQ^TO_P!F_P#QE_\ 5=>(Z^@*^?\ ]K+_ )-8_:7_ .S?_C+_ .JZ\1T ?X0]
M?U^_\&5/_*4WX^?]F ?%/_UHK]E6OY J_K]_X,J?^4IOQ\_[, ^*?_K17[*M
M '^GW1110 4444 ?Y/'_  =._P#!-2^_8C_X*#>(/CSX)T3[-^S]^VOJ'B+X
MN>%)K*V=-/\ "_Q;-Q:7/QK\$7#QPQVMM)=>)M6C^(>A01+#;KH?C5-'L4F/
MAK4)%_F:T[4=0TC4+'5M)OKS3-4TR\MM1TW4M.N9K+4-/U"RG2YL[ZQO+9XK
MBTO+2XBCN+:YMY(YH)XTEB=)$5A_MK_\%3_^"=7PO_X*A?L;_$C]EWXB&UT?
M6]2A7Q7\'_B%):FZO/A?\8- M;P>#_&-O&@,T^FLUY>>'O%NFP%)M8\&ZYX@
MTNVFM+VZM+^T_P 8G]H_]G;XN_LF?'+XE_LZ?'CPC?>!_BO\)_$UYX6\7>'[
MY6*I<P+'<6.JZ7=E$BU7P[XATJXL=?\ #.N6FZPUWP_J6FZO822V=[#(P!_K
M1?\ !OU_P5U\,?\ !4S]CK0E\8Z_8Q?M<_ 72="\#_M%^%II((-2\1W%O:"R
M\.?&S2+-''VCP[\3+>SENM6:V@MH=!\>6OB?0A96VDQ^'KS5OWIK_#*_81_;
ME^/W_!.S]I3P)^U!^SGXD_L7QKX/N'M=8T'4'O9?!_Q&\&:@\(\1?#SQ_I%G
M=V9UOPGXA@@B\^W\^&\TO5+72O$FA7FF>)-$T?5;'_7F_P""5G_!7/\ 9:_X
M*P_!2#XA?!37K?PW\4_#6GZ<GQF_9^\1:K8O\1/A;KL]O;"XF:U7[-/XH^']
M]?S26_A3XC:;I\&C:\L4EG>6^B>)K+6?#>D@'ZGT444 %%%% !1110 445\#
M?\%&/^"D7[,O_!,3]GS6OCY^TAXLALE:'4+'X;?#32;FSE^(GQB\96MO'+;^
M$/ 6B3S1R7<PDN+-M>UZX$6@>$M-NDU;Q#?V5JT(G /SH_X..O\ @JOI?_!-
M;]A?Q-X>\">(ULOVJOVGM)\1_"WX$66GW:Q:UX1T^[L8K'X@_&<A)H[BQA^'
MFAZM''X8OE2;?\1=9\'QM:76F0:T]I_D+U]S_P#!1?\ X* _'+_@I?\ M4^/
M?VI?CMJ&W5O$<BZ)X%\$65W+=>&_A/\ #'2KR^G\(_#7PIYD-J#I>@Q:A=W-
M_J1M+6[\3>)=2UWQ7JD(U;7;YFA_X)R_L+_%'_@HY^V#\'OV3_A7:W4=YX]U
MZ*Z\;^*X[5[C3_AO\+M$DBO?'_Q"UF38;>"U\/:&)AID%W) FN^)[S0/"UI*
MVJZ]I\,P!_J=?\&SVF?$'2_^")/[$$7Q&O;Z[U.Z\/?%34_#D>IF:2^L/A]J
M7QS^)EY\/[)[F>>=[FQ'A*72KK00ODPV'AVZTC28((X-.CW?N[7 _"KX9>#/
M@K\,/AS\'?ASI$/A_P"'_P *? OA/X<>!]"MP@AT?PCX)T&P\-^'=,CV)&A6
MRTC3;2WW+&@<QEMH)Q7?4 ?R5_\ !YMI>K:A_P $F_AY=Z==S6UGH?[:WPAU
M37H8EF*7^DS?"OX\Z+#:7!B^184US5]%OE:Y_<_:+*!5_P!(:"O\MNO]D?\
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MZU#4=0NKB^O[^^N);N]OKV[E>>ZO+RZG>2>YNKF>22:XN)I'EFE=Y)'9V9B
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MG_!7S]@__@IGX1TS5_V;/C1H;_$*73VO/$?P!\=7>G>$_CIX/EMX!/J,>H^
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MU>"4CBBC0,\DDCL$1$4L[$*H)(% '^YK1110 4444 %%%% !1110 5_E"?\
M!WC_ ,ID_&W_ &0#X$_^F+4Z_P!7NO\ *&_X.\T=?^"R/C-F5E$G[/WP)>,L
MI =!HFK1ED) #*'1T++D!T9<Y4@ '\P%?[_%?X!*(\CJB*SN[*B(BEG=V("J
MJ@$LS$@*H!))  S7^_M0 4444 %%%% !1110 4444 ?S _\ !WE_RAM\:?\
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M:7K&CWUUIFJ:;>V[AX+RPU"RE@N[.Z@<!X;BWFCEC<!D=2,U^RGP$_X.'_\
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M VD+<ZE;?#+X=O?PQ7;>%]%U"]U'6Y;72Y_&OB7Q;=Z)H=QI@!YO_P $&O\
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MUW0-3O=&UG3+M595N=.U33I[:^LKA5=E6:VGBD"LP#8)! /]^"BO\5?X4_\
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M>T&YCBOKCX>?$(:=;V]G;>./#]E++=0V6EV?BO2/%FBZ79Z-'_0)_P %O?\
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MI3?CY_V8!\4__6BOV5:_D"K^O_\ X,J$<_\ !4OX_.%8HO[ 7Q11G"G8KO\
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MGT>/6[C4M"TO2M$US7M)3P[J%U-;Z]&44 ?T_4444 %%%% !7P-^V[_P2_\
MV$_^"B>@1:/^UK^SOX)^).KV%BVG^'_B)!!<^%?BQX5MBSRQV_AWXF^%KC2/
M&5EIL=T_VQ_#\VK77AF]N41]3T6^0&,E% '\D/[4G_!D=X3O[N^UG]B_]L_6
MO#EL[2-9_#W]I3P9;>)HT:1MZK_PM3X:IX>N+:UM^88K>;X3ZK=/$4>;4GEB
M=KC\6?B;_P &A_\ P64\!2WD?A7P/\ OC6ELLS0S_#+X[^']*BU Q1W#HEF/
MC+IWPDG1KEH(H83?PV*+)>6YN&@B6[EM2B@#XR\;?\&['_!8WX=:K;Z)XR_8
M]_L?4[K3XM5@MO\ AH']EK4/,L)[F[M(I_.TKXW7UNNZXL;J/RGE69?*WM&$
M>-G]Q\$?\&K?_!;GQC+;&]_97\*^!]-O(;2YMM:\6?M&?LZW-A+;7D;2I-Y'
M@KXG^,=818X_+:5)-*28>=&(XY&681%% 'Z<_ 3_ (,F_P!LKQ1<V%U^TC^U
MC^SW\'M'EN$>[L/A;HWCOXU^*H+)2OF0S0:YIGP@\.6^H2E9$C-IXAUFS@C>
M&Y>6>3S;%/Z4/V+/^#53_@E-^R;=:/XI\=^ /$W[7WQ&TU;>?^W/VCM2L-;\
M"6VI(N+F72_@[X>T_0_ 5WILS?-!IWC^R^(4]G@-'J;R@3444 ?T?:-HVC^'
M=)TW0/#^E:;H6A:-8VNF:/HNC6-KIFDZ3IMC"EO9:=ING644%G8V-G;QQP6M
MI:PQ6]O"B111HBJHTJ** "OYI?\ @LI_P;4_L]?\%5?B3%^T7X/^*>H?LP?M
M,S:'9:%XQ\:Z;X(M?'_@KXLV6@V5MI_AF;Q[X0_X2/P??P^*-&TJSMO#=EXU
MT;Q#'=+X=AL+'6-$\1Q:%H<%D44 >0_\$8O^#9"W_P""5O[4D?[6?B_]KN;X
MW^,=.\"^,/ N@^"/#?P@3X>>&K.W\80VEI?ZMJ^NZGX_\::IK,T=G;$6FGV>
ME^'TM;EQ--?W\2FW/]7%%% !1110 4444 %%%% '(^._A_X#^*7A/6O 7Q-\
M$^$?B-X%\26OV'Q%X+\=^&]&\7^$]>LBZ2&SUKPYX@LM0T?5+4R1I)]GOK.>
M+>B/LW*"/YE_VPO^#1G_ ();_M&W.I>)/@Q9_$C]CGQM?2371/PAUU?$OPRN
M+Z<C?-?_  P^( UN.PLXP/\ 1](\ ^)_ .F0,25MBI*$HH _G;^.G_!E%^W/
MX1N+NX_9]_:B_9M^-FC6[.8(O'ECX^^"'BZ^CWLL7V?1+/2/BUX8CF9-CRQW
M?CRVBC)=([B<HIE_-SQI_P &KW_!;SPC-=_8_P!E'PSXTTRQAO+FXUSPM^T;
M^SA;Z<MM9[W>9;?QC\5/"6M,LL*-/"@TGSO+PLL<4Y\FBB@#P[P;_P &[O\
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MXXHI9K70/#6GZ;ID5Q.D$(N+E;;[1<&)&GDD90:** /2**** "BBB@ HHHH
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MXGAT^WUS7DLY;F[N=3O[72H+>PM&N;V\N7@M+='%I:^1;R7-Y+%)=S_45%%
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A>F:7I]L@"6]E8VL%M"GRQQJ.*Z"BB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>24
<FILENAME>eldn-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-20T15:30:42.0459+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.eledon.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:eldn="http://www.eledon.com/20241231" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" namespace="http://xbrl.sec.gov/stpr/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100040 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100050 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" id="DisclosureDescriptionOfBusiness1">
        <link:definition>995467 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995477 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" id="DisclosureShorttermInvestments">
        <link:definition>995487 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>995497 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1">
        <link:definition>995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>995517 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>995527 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>995537 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>995547 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" id="DisclosureSegmentReporting">
        <link:definition>995557 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>995567 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995577 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995587 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" id="DisclosureShorttermInvestmentsTables">
        <link:definition>995597 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>995607 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables">
        <link:definition>995617 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995627 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>995637 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>995647 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>995657 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" id="DisclosureSegmentReportingTables">
        <link:definition>995667 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" id="DisclosureDescriptionOfBusinessAdditionalInformationDetail">
        <link:definition>995677 - Disclosure - Description of Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>995687 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail">
        <link:definition>995697 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails">
        <link:definition>995707 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" id="DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
        <link:definition>995717 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" id="DisclosureShorttermInvestmentsAdditionalInformationDetail">
        <link:definition>995727 - Disclosure - Short-Term Investments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" id="DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
        <link:definition>995737 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2">
        <link:definition>995747 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" id="DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
        <link:definition>995757 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" id="DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails">
        <link:definition>995767 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995777 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>995787 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" id="DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail">
        <link:definition>995797 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" id="DisclosureGoodwillAdditionalInformationDetail">
        <link:definition>995807 - Disclosure - Goodwill - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>995817 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" id="DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail">
        <link:definition>995827 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" id="DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail">
        <link:definition>995837 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail">
        <link:definition>995847 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" id="Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail">
        <link:definition>995857 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" id="DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail">
        <link:definition>995867 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>995877 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" id="Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail">
        <link:definition>995887 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" id="Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>995897 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail">
        <link:definition>995907 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
        <link:definition>995917 - Disclosure - Stockholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" id="DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent">
        <link:definition>995927 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" id="Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail">
        <link:definition>995937 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" id="DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail">
        <link:definition>995947 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" id="DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail">
        <link:definition>995957 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" id="DisclosureStockbasedCompensationAdditionalInformationDetail">
        <link:definition>995967 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" id="DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail">
        <link:definition>995977 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" id="Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail">
        <link:definition>995987 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" id="DisclosureStockbasedCompensationSummaryOfRsuActivityDetail">
        <link:definition>995997 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" id="Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail">
        <link:definition>996007 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" id="DisclosureSegmentReportingScheduleOfSegmentReportingDetail">
        <link:definition>996017 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" id="DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
        <link:definition>996027 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="eldn-20241231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="eldn-20241231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="eldn-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" xlink:href="eldn-20241231.xsd#DisclosureDescriptionOfBusiness1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestments" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:href="eldn-20241231.xsd#DisclosureSegmentReporting" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="eldn-20241231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:href="eldn-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="eldn-20241231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:href="eldn-20241231.xsd#DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureGoodwillAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:href="eldn-20241231.xsd#DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:href="eldn-20241231.xsd#DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:href="eldn-20241231.xsd#DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:href="eldn-20241231.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:href="eldn-20241231.xsd#DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" xlink:href="eldn-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NoncashActivitiesAbstract" xlink:label="eldn_NoncashActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXConvertiblePreferredStockMember" xlink:label="eldn_SeriesXConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of available-for-sale short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award total number of shares authorized.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Total Number Of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New aggregate share limit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statutory federal income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X1 non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X1 Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Non-voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series X1 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of RSU Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign operating losses carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating business segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anelixis Therapeutics, LLC and Otic Pharma, Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights cancelled or exchanged.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Exchanged</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled/Exchanged</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities, in-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities In Process Research And Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquired IPR&amp;D</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounts payable, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts payable, accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable, accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards expiration description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock, Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Goodwill [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DescriptionOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fourteen employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">NOL True Up.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/label">N O L True Up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NOLTrueUp_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOL true-up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common and Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement .</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Basis of Presentation [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X Non-voting Convertible Preferred Stock Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidClinicalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty FourUnderwritten Offering, Net Of Issuance Costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X1 Exchange Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X1 Exchange Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesX1ExchangeAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Exchange Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increased number of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest or penalties recorded during the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants One Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights cancelled or expired.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercisable for exchange</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cancelled/Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled/Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting Agreement[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Agreement[Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net valuation allowance Increased (decreased)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Retained earnings / (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective federal and state income tax rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Federal And State Income Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Expenses, Offset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing expenses offset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ManufacturingExpensesOffset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing expenses offset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestone payments obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestone Payments Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RegulatoryMilestonePaymentsObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development and regulatory milestone payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash cash equivalents and restricted cash maturity period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Restricted Cash Maturity Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and restricted cash, maturity period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, number of shares reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, number of shares initially reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued in lieu of making a cash payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Securities Purchase Agreement Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, term of contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Cuts and Jobs Act of 2017 Change in Tax Rate Income Taxes Expense Benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant subject to specified beneficial ownership limitations percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options Outstanding and Other Equity Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with exercise of pre-funded warrants, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with exercise of pre-funded warrants, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X Non Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series X Non-Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X Non-Voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of warrant activity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Warrant Activity Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Warrants to Purchase Common Stock Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock warrants exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock warrants to purchase common stock shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Area of office space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area Of Office Space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AreaOfOfficeSpace_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of office space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Armistice Capital Master Fund Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Armistice Capital Master Fund Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Armistice Capital Master Fund Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Current income tax expense (benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-current operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TextBlockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Text Block [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Exercise, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and administrative expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fee due for milestones achieved.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fee Due For Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FeeDueForMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fee due for milestones achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement initial closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Initial Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Initial Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Likelihood of Unfavorable Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, likelihood of settlement, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from operating lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Corporations and Agencies Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agency Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual license maintenance fee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual License Maintenance Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnnualLicenseMaintenanceFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual License Maintenance Fee</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock and pre funded warrants net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock And Pre Funded Warrants Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock and pre-funded warrants, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-Term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rental expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected life assumption using simplified method, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Issuable Under Options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Provision for Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of available-for-sale short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Asset, In-Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research expenditures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accredited Investor.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accredited Investor [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccreditedInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accredited Investor [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants or rights assumed and replaced.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Assumed And Replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value, assumed and replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assumed and replaced</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Factors Used to Identify Entity's Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Losses before income taxes:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total financial assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Payments Under Noncancelable Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense, recognized over estimated weighted average period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Country [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement third closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Third Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Third Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected life of option (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets right-of-use asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Right Of Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Time-based and performance-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Time-based and Performance-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PreferredStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate net sales achievement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Net Sales Achievement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AggregateNetSalesAchievement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reaching of aggregate net sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">RSUs Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements Issued But Not Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock exchanged for X and X1 non-voting convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Exchanged For X And X One Non-voting Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock exchanged for X and X1 non-voting convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation permanent items.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Permanent Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds Includes Reversal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">September Two Thousand And Twenty Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">September Two Thousand And Twenty Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">September 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties associated with uncertain tax positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Expenses And Other Liabilities Table [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain on Available-for-Sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrealized gain on available-for-sale securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on available-for-sale securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accretion on Investment Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion on Investment Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion on investment discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccretionOnInvestmentDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion on investment discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Exercise, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease remaining term of contract.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Remaining Term Of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining term of office lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tegoprubart - Other Development Programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tegoprubart - other development programs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tegoprubart - other development programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement second closing.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Second Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement Second Closing [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leerink Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Leerink partners LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_LeerinkPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leerink Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Workers' Compensation Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X One Preferred Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X One Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXOnePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X1 Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Two Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Operating Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance as of December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance as of December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development tax credit carryforwards for federal and state</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Irvine, California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity distribution agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Distribution Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EquityDistributionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Distribution Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Effective Date of Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Business acquisition, date of acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MASSACHUSETTS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Burlington, Massachusetts [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets depreciation and amortization.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Depreciation And Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PerformanceBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax examination likelihood of favorable settlement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination Likelihood Of Favorable Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, likelihood of settlement, percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercise price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Category of Item Purchased [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Category of Item Purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforward expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards, not to expiration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Basis of presentation and principles of consolidation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Presentation And Principles Of Consolidation Policy [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of U.S. Federal Statutory Income Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Anelixis Therapeutics, Incorporation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Anelixis Therapeutics Incorporation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anelixis [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Anelixis [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2023-07 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid for amounts included in measurement of lease liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liability:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Percent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash activities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NoncashActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guarantor Obligations, Current Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indemnification obligations amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Issuable Under RSUs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants available for exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Shares of Common Stock Issuable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSU [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research and Development, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risks and uncertainties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks and Uncertainties [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Uncertainties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred income tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred income tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Guggenheim Securities LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guggenheim Securities LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_GuggenheimSecuritiesLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Guggenheim Securities LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManufacturingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs Vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of cumulative change in ownership.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Cumulative Change In Ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of cumulative change in ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common and preferred warrants outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common And Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common and Preferred Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty Common Warrants Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty Common Warrants Three Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2020 Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty long term incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Long Term Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2020 Long Term Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares weighted average grant date fair value of stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of pre-funded warrants exercised for common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Pre-funded Warrants Exercised for Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of pre-funded warrants exercised for common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">ROU assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Gross unrecognized tax benefits at the end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Gross unrecognized tax benefits at the beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Securities Purchase Agreement Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Vesting period of stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement, Net of Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of private placement, net of offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">State income taxes, net of Federal tax benefits.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State Income Taxes Net Of Federal Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Supplemental Cash Flow Information Related to Leases [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other supplemental cash flow information related to leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Supplemental Cash Flow Information Related to Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">January Two Thousand And Twenty One Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">January Two Thousand And Twenty One Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 2021 Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonStockWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Israel Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Israeli Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Net Of Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of net of offering costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds after deducting offering costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic weighted average shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average number of common shares, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions from tax positions taken in prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Otic Pharma, Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Otic Pharma Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Otic Pharma [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses, other assets, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Purchase Commitment, Category of Item Purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairments of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Time-based vesting requirements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Time-based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TimeBasedVestingRequirementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Time Based Vesting Requirements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Goodwill impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Impairments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Impairment Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation state tax rate differential.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation State Tax Rate Differential</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State rate differential</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions from tax positions taken in the current year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash investing and financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options assumed in period weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Assumed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant subject to specified beneficial ownership limitations permitted percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with exercise of pre-funded warrants, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses, other assets, accrued expenses and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in operating right-of-use lease asset and liability due to new lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease in Right-Of-Use Operating Lease Asset and Liability Due To New Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in operating right-of-use lease asset and liability due to new lease.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Settlement of Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Settlement of warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Settlement of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Aggregate Fair Values of Warrant Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">In-process research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research And Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_InProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited / Canceled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">California Franchise Tax Board [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ProceedsFromIssuanceOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Long-Term and Short-Term, Combined Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt, Long-Term and Short-Term, Combined Amount, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Warrant Liabilities and Fair Value of Financial Instruments Issued in Excess of Proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Securities Purchase Agreement Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Otic Pharma, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Otic Pharma Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OticPharmaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Otic Pharma, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of preferred stock, conversion blocker, percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Preferred Stock, Conversion Blocker, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock, conversion blocker, percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining milestone payments for first licensed product.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining Milestone Payments For First Licensed Product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining milestone payments for first licensed product</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Loss Before Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Significant Components Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fourteen stock incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen Stock Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Stock Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Five hundred million aggregate net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Five Hundred Million Aggregate Net Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of 500 Million Aggregate Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less current portion of operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares of common stock issued upon conversion of each share of preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares of common stock issued upon conversion of each share of preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Board of Directors Chairman [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Board of Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right number of warrants exercised.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Warrants Or Rights Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series X convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series X Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SeriesXConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series X Non-voting Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Biotechnology Value Fund LP, Biotechnology Value Fund II LP, Biotechnology Value Trading Fund OS LP, MSI BVF SPV LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Biotechnology Value Fund L P Biotechnology Value Fund I I L P Biotechnology Value Trading Fund O S L P M S I B V F S P V L L C [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BVF Exchanging Stockholders [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Personnel-Related Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Personnel-related expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Personnel-RelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Personnel-related</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , Shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Settlement Of Warrant Liability Into Common Stock Due To Exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Settlement of warrant liability into common stock due to exercise.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement of warrant liability into common stock due to exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Short-Term Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agency Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TableTextBlockSupplementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Table Text Block Supplement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warranty liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees, Commitments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of one-time milestone payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Asset Instruments Measured At Fair Value On A Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of operating lease asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Operating Lease Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AmortizationOfOperatingLeaseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of operating lease asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Present value of lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cormorant global healthcare master fund lp.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cormorant Global Healthcare Master Fund LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cormorant Global Healthcare Master Fund LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Short-term Investments Classified as Available-for-sale Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 6)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average number of common shares, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tegoprubart - Kidney Transplantation Programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tegoprubart kidney transplantation programs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tegoprubart - kidney transplantation programs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership interest percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One billion aggregate net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One Billion Aggregate Net Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_OneBillionAggregateNetSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of 1 Billion Aggregate Sales [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasuries [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with vesting of restricted stock units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ALS therapy development foundation, Inc. license agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A L S Therapy Development Foundation Inc License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ALS Therapy Development Foundation, Inc. License Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants Member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Underwritten Offering Pre-funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Range of exercise prices</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of milestones achieved.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_NumberOfMilestonesAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Milestones Achieved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Outstanding and Other Equity Awards [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on lease termination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Termination of Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EGenesisIncCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">eGenesis, Inc. Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_EGenesisIncCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">eGenesis, Inc. Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty Four Underwritten Offering, Net Of Issuance Costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PreFundedWarrantsMember" xlink:to="eldn_PreFundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCreditCarryforwardExpirationDescription" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="eldn_DescriptionOfBusinessTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_DescriptionOfBusinessLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NOLTrueUp" xlink:to="eldn_NOLTrueUp_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidClinicalExpense" xlink:to="eldn_PrepaidClinicalExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesX1ExchangeAgreementMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_UnderwritingAgreementMember" xlink:to="eldn_UnderwritingAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ConversionAgreementMember" xlink:to="eldn_ConversionAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ManufacturingExpensesOffset" xlink:to="eldn_ManufacturingExpensesOffset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RegulatoryMilestonePaymentsObligation" xlink:to="eldn_RegulatoryMilestonePaymentsObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCreditCarryforwardExpirationPeriod" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AreaOfOfficeSpace" xlink:to="eldn_AreaOfOfficeSpace_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ArmisticeCapitalMasterFundLtdMember" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_FeeDueForMilestonesAchieved" xlink:to="eldn_FeeDueForMilestonesAchieved_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnnualLicenseMaintenanceFee" xlink:to="eldn_AnnualLicenseMaintenanceFee_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccreditedInvestorMember" xlink:to="eldn_AccreditedInvestorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:to="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsRightOfUseAsset" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PreferredStockWarrantsMember" xlink:to="eldn_PreferredStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AggregateNetSalesAchievement" xlink:to="eldn_AggregateNetSalesAchievement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:to="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationPermanentItems" xlink:to="eldn_IncomeTaxReconciliationPermanentItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:to="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:to="eldn_UnrealizedGainOnAvailableForSaleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccretionOnInvestmentDiscounts" xlink:to="eldn_AccretionOnInvestmentDiscounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_LeerinkPartnersLlcMember" xlink:to="eldn_LeerinkPartnersLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXOnePreferredStockMember" xlink:to="eldn_SeriesXOnePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EquityDistributionAgreementMember" xlink:to="eldn_EquityDistributionAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MA" xlink:to="stpr_MA_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PerformanceBasedVestingRequirementsMember" xlink:to="eldn_PerformanceBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:to="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AnelixisTherapeuticsIncorporationMember" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202307Member" xlink:to="us-gaap_AccountingStandardsUpdate202307Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_NoncashActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:to="eldn_RisksAndUncertaintiesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_GuggenheimSecuritiesLlcMember" xlink:to="eldn_GuggenheimSecuritiesLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManufacturingCosts" xlink:to="us-gaap_ManufacturingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PercentageOfCumulativeChangeInOwnership" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonStockWarrantsMember" xlink:to="eldn_CommonStockWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OticPharmaLtdMember" xlink:to="eldn_OticPharmaLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TimeBasedVestingRequirementsMember" xlink:to="eldn_TimeBasedVestingRequirementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:to="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SettlementOfWarrantLiability" xlink:to="eldn_SettlementOfWarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_InProcessResearchAndDevelopment" xlink:to="eldn_InProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ProceedsFromIssuanceOffering" xlink:to="eldn_ProceedsFromIssuanceOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_DeferredTaxAssetsLeaseLiability" xlink:to="eldn_DeferredTaxAssetsLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OticPharmaIncMember" xlink:to="eldn_OticPharmaIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_FiveHundredMillionAggregateNetSalesMember" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SeriesXConvertiblePreferredStockMember" xlink:to="eldn_SeriesXConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Personnel-RelatedExpenses" xlink:to="eldn_Personnel-RelatedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:to="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_TableTextBlockSupplementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AmortizationOfOperatingLeaseAsset" xlink:to="eldn_AmortizationOfOperatingLeaseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_CommonWarrantsMember" xlink:to="eldn_CommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_OneBillionAggregateNetSalesMember" xlink:to="eldn_OneBillionAggregateNetSalesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_AccruedClinicalCurrent" xlink:to="eldn_AccruedClinicalCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ContingentLiability" xlink:to="eldn_ContingentLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_NumberOfMilestonesAchieved" xlink:to="eldn_NumberOfMilestonesAchieved_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_EGenesisIncCollaborationAgreementMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorOpinionTextBlock" order="88.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="89.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="eldn_InProcessResearchAndDevelopment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXConvertiblePreferredStockMember" xlink:label="eldn_SeriesXConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_19"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_20"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_19" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NoncashActivitiesAbstract" xlink:label="eldn_NoncashActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" xlink:label="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnrealizedGainOnAvailableForSaleSecurities" xlink:label="eldn_UnrealizedGainOnAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" xlink:label="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" xlink:label="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="eldn_NoncashActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_UnrealizedGainOnAvailableForSaleSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_AmortizationOfOperatingLeaseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_NoncashActivitiesAbstract" xlink:to="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_AccretionOnInvestmentDiscounts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" xlink:label="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RisksAndUncertaintiesPolicyTextBlock" xlink:label="eldn_RisksAndUncertaintiesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_RisksAndUncertaintiesPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TableTextBlockSupplementAbstract" xlink:label="us-gaap_TableTextBlockSupplementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlockSupplementAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:label="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" xlink:label="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" xlink:to="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="eldn_DescriptionOfBusinessTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="eldn_DescriptionOfBusinessLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="eldn_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ShortTermInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_SettlementOfWarrantLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="eldn_PrepaidClinicalExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidInsurance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="eldn_AccruedClinicalCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_GoodwillLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OtherCommitmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_OneBillionAggregateNetSalesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AreaOfOfficeSpace" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_FeeDueForMilestonesAchieved" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssued1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_NumberOfMilestonesAchieved" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RegulatoryMilestonePaymentsObligation" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AnnualLicenseMaintenanceFee" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AggregateNetSalesAchievement" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ManufacturingExpensesOffset" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ContingentLiability" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:label="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IsraelTaxAuthorityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_TaxCreditCarryforwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationPermanentItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_NOLTrueUp" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOnePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_LeerinkPartnersLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="eldn_AccreditedInvestorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ConversionAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_PreFundedWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_GuggenheimSecuritiesLlcMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EquityDistributionAgreementMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_UnderwritingAgreementMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOffering" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_6"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_CommonWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreFundedWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedVestingRequirementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_PerformanceBasedVestingRequirementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" xlink:label="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_FactorsUsedToIdentifyEntitysReportableSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ManufacturingCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Personnel-RelatedExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpenses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="eldn_InProcessResearchAndDevelopment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXConvertiblePreferredStockMember" xlink:label="eldn_SeriesXConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" xlink:label="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" xlink:label="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ScheduleOfWarrantActivityTableTextBlock" xlink:label="eldn_ScheduleOfWarrantActivityTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ScheduleOfWarrantActivityTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessLineItems" xlink:label="eldn_DescriptionOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DescriptionOfBusinessTable" xlink:label="eldn_DescriptionOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="eldn_DescriptionOfBusinessTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_DescriptionOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_DescriptionOfBusinessLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eldn_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaLtdMember" xlink:label="eldn_OticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OticPharmaIncMember" xlink:label="eldn_OticPharmaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" xlink:label="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" xlink:label="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" xlink:label="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" xlink:label="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="eldn_OticPharmaIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonAndPreferredWarrantsOutstandingMember" xlink:label="eldn_CommonAndPreferredWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="eldn_CommonAndPreferredWarrantsOutstandingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SettlementOfWarrantLiability" xlink:label="eldn_SettlementOfWarrantLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="eldn_SettlementOfWarrantLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnelixisTherapeuticsIncorporationMember" xlink:label="eldn_AnelixisTherapeuticsIncorporationMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_AnelixisTherapeuticsIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" xlink:label="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FiveHundredMillionAggregateNetSalesMember" xlink:label="eldn_FiveHundredMillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA" xlink:label="stpr_CA"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EGenesisIncCollaborationAgreementMember" xlink:label="eldn_EGenesisIncCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_OneBillionAggregateNetSalesMember" xlink:label="eldn_OneBillionAggregateNetSalesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MA" xlink:label="stpr_MA"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AreaOfOfficeSpace" xlink:label="eldn_AreaOfOfficeSpace"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LesseeOperatingLeaseRemainingTermOfContract" xlink:label="eldn_LesseeOperatingLeaseRemainingTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:label="us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_FeeDueForMilestonesAchieved" xlink:label="eldn_FeeDueForMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfMilestonesAchieved" xlink:label="eldn_NumberOfMilestonesAchieved"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RemainingMilestonePaymentsForFirstLicensedProduct" xlink:label="eldn_RemainingMilestonePaymentsForFirstLicensedProduct"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_RegulatoryMilestonePaymentsObligation" xlink:label="eldn_RegulatoryMilestonePaymentsObligation"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AnnualLicenseMaintenanceFee" xlink:label="eldn_AnnualLicenseMaintenanceFee"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AggregateNetSalesAchievement" xlink:label="eldn_AggregateNetSalesAchievement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ManufacturingExpensesOffset" xlink:label="eldn_ManufacturingExpensesOffset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ContingentLiability" xlink:label="eldn_ContingentLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_FiveHundredMillionAggregateNetSalesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EGenesisIncCollaborationAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="eldn_OneBillionAggregateNetSalesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AreaOfOfficeSpace" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_LesseeOperatingLeaseRemainingTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_DebtLongtermAndShorttermCombinedAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_FeeDueForMilestonesAchieved" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_StockIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_NumberOfMilestonesAchieved" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_RegulatoryMilestonePaymentsObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AnnualLicenseMaintenanceFee" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_AggregateNetSalesAchievement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ManufacturingExpensesOffset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="eldn_ContingentLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EffectiveFederalAndStateIncomeTaxRate" xlink:label="eldn_EffectiveFederalAndStateIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NetOperatingLossCarryforwardsExpirationPeriod" xlink:label="eldn_NetOperatingLossCarryforwardsExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationPeriod" xlink:label="eldn_TaxCreditCarryforwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TaxCreditCarryforwardExpirationDescription" xlink:label="eldn_TaxCreditCarryforwardExpirationDescription"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PercentageOfCumulativeChangeInOwnership" xlink:label="eldn_PercentageOfCumulativeChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" xlink:label="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IsraelTaxAuthorityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_EffectiveFederalAndStateIncomeTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_NetOperatingLossCarryforwardsExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_TaxCreditCarryforwardExpirationDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PercentageOfCumulativeChangeInOwnership" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1ExchangeAgreementMember" xlink:label="eldn_SeriesX1ExchangeAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXOnePreferredStockMember" xlink:label="eldn_SeriesXOnePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ArmisticeCapitalMasterFundLtdMember" xlink:label="eldn_ArmisticeCapitalMasterFundLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" xlink:label="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_LeerinkPartnersLlcMember" xlink:label="eldn_LeerinkPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccreditedInvestorMember" xlink:label="eldn_AccreditedInvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionAgreementMember" xlink:label="eldn_ConversionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesXNonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesXNonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CormorantGlobalHealthcareMasterFundLpMember" xlink:label="eldn_CormorantGlobalHealthcareMasterFundLpMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeriesX1NonVotingConvertiblePreferredStockMember" xlink:label="eldn_SeriesX1NonVotingConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_GuggenheimSecuritiesLlcMember" xlink:label="eldn_GuggenheimSecuritiesLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementInitialClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementInitialClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ConversionOfPreferredStockConversionBlockerPercent" xlink:label="eldn_ConversionOfPreferredStockConversionBlockerPercent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementSecondClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementSecondClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementThirdClosingMember" xlink:label="eldn_SecuritiesPurchaseAgreementThirdClosingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_EquityDistributionAgreementMember" xlink:label="eldn_EquityDistributionAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_UnderwritingAgreementMember" xlink:label="eldn_UnderwritingAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" xlink:label="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOffering" xlink:label="eldn_ProceedsFromIssuanceOffering"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" xlink:label="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" xlink:label="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SeriesX1ExchangeAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXOnePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="eldn_ArmisticeCapitalMasterFundLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eldn_LeerinkPartnersLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="eldn_AccreditedInvestorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_ConversionAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesXNonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_CormorantGlobalHealthcareMasterFundLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eldn_GuggenheimSecuritiesLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementInitialClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ConversionOfPreferredStockConversionBlockerPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementSecondClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementThirdClosingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_EquityDistributionAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_UnderwritingAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SecuritiesPurchaseAgreementMember" xlink:label="eldn_SecuritiesPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eldn_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonWarrantsMember" xlink:label="eldn_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreFundedWarrantsMember" xlink:label="eldn_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_CommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_CommonStockWarrantsMember" xlink:label="eldn_CommonStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" xlink:label="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" xlink:label="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" xlink:label="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eldn_CommonStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PreferredStockWarrantsMember" xlink:label="eldn_PreferredStockWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" xlink:label="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eldn_PreferredStockWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenStockIncentivePlanMember" xlink:label="eldn_TwoThousandFourteenStockIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandTwentyLongTermIncentivePlanMember" xlink:label="eldn_TwoThousandTwentyLongTermIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PerformanceBasedVestingRequirementsMember" xlink:label="eldn_PerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" xlink:label="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" xlink:label="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenStockIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandTwentyLongTermIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_PerformanceBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" xlink:label="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" xlink:to="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ManufacturingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_Personnel-RelatedExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="eldn_InProcessResearchAndDevelopment" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_InProcessResearchAndDevelopment" xlink:label="eldn_InProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="2" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AccretionOnInvestmentDiscounts" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AmortizationOfOperatingLeaseAsset" order="10" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="15" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="17" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" xlink:label="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:label="us-gaap_GainLossOnTerminationOfLease"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccretionOnInvestmentDiscounts" xlink:label="eldn_AccretionOnInvestmentDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AmortizationOfOperatingLeaseAsset" xlink:label="eldn_AmortizationOfOperatingLeaseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="eldn_PrepaidClinicalExpense" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="4" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_PrepaidClinicalExpense" xlink:label="eldn_PrepaidClinicalExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_WorkersCompensationLiabilityCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="eldn_AccruedClinicalCurrent" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="us-gaap_WorkersCompensationLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_AccruedClinicalCurrent" xlink:label="eldn_AccruedClinicalCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="2" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationPermanentItems" order="7" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_IncomeTaxReconciliationStateTaxRateDifferential" order="9" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eldn_NOLTrueUp" order="10" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="11" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="12" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_StateIncomeTaxesNetOfFederalTaxBenefits" xlink:label="eldn_StateIncomeTaxesNetOfFederalTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationPermanentItems" xlink:label="eldn_IncomeTaxReconciliationPermanentItems"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_IncomeTaxReconciliationStateTaxRateDifferential" xlink:label="eldn_IncomeTaxReconciliationStateTaxRateDifferential"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_NOLTrueUp" xlink:label="eldn_NOLTrueUp"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="-1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="eldn_DeferredTaxAssetsRightOfUseAsset" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="eldn_DeferredTaxAssetsDepreciationAndAmortization" order="5" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="eldn_DeferredTaxAssetsLeaseLiability" order="6" weight="1.00" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsRightOfUseAsset" xlink:label="eldn_DeferredTaxAssetsRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" xlink:label="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsDepreciationAndAmortization" xlink:label="eldn_DeferredTaxAssetsDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_DeferredTaxAssetsLeaseLiability" xlink:label="eldn_DeferredTaxAssetsLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Tegoprubart-KidneyTransplantationPrograms" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Tegoprubart-OtherDevelopmentPrograms" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ManufacturingCosts" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eldn_Personnel-RelatedExpenses" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ShareBasedCompensation" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-KidneyTransplantationPrograms" xlink:label="eldn_Tegoprubart-KidneyTransplantationPrograms"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" xlink:label="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Tegoprubart-OtherDevelopmentPrograms" xlink:label="eldn_Tegoprubart-OtherDevelopmentPrograms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="eldn-20241231.xsd#eldn_Personnel-RelatedExpenses" xlink:label="eldn_Personnel-RelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="eldn_PerformanceBasedVestingRequirementsMember" name="PerformanceBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" name="ALSTherapyDevelopmentFoundationIncLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" name="SettlementOfWarrantLiabilityIntoCommonStockDueToExercise" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_EGenesisIncCollaborationAgreementMember" name="EGenesisIncCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TaxCreditCarryforwardExpirationDescription" name="TaxCreditCarryforwardExpirationDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" name="TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" name="ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" name="JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_FiveHundredMillionAggregateNetSalesMember" name="FiveHundredMillionAggregateNetSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" name="ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" name="ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" name="BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_GuggenheimSecuritiesLlcMember" name="GuggenheimSecuritiesLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOfNetOfOfferingCosts" name="ProceedsFromIssuanceOfNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_EquityDistributionAgreementMember" name="EquityDistributionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_DescriptionOfBusinessTable" name="DescriptionOfBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" name="IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_AreaOfOfficeSpace" name="AreaOfOfficeSpace" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ProceedsFromIssuanceOffering" name="ProceedsFromIssuanceOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementSecondClosingMember" name="SecuritiesPurchaseAgreementSecondClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ScheduleOfWarrantActivityTableTextBlock" name="ScheduleOfWarrantActivityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_Tegoprubart-KidneyTransplantationPrograms" name="Tegoprubart-KidneyTransplantationPrograms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_RemainingMilestonePaymentsForFirstLicensedProduct" name="RemainingMilestonePaymentsForFirstLicensedProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_StateIncomeTaxesNetOfFederalTaxBenefits" name="StateIncomeTaxesNetOfFederalTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SettlementOfWarrantLiability" name="SettlementOfWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AggregateNetSalesAchievement" name="AggregateNetSalesAchievement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" name="IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ArmisticeCapitalMasterFundLtdMember" name="ArmisticeCapitalMasterFundLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TaxCreditCarryforwardExpirationPeriod" name="TaxCreditCarryforwardExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_DeferredTaxAssetsRightOfUseAsset" name="DeferredTaxAssetsRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_CormorantGlobalHealthcareMasterFundLpMember" name="CormorantGlobalHealthcareMasterFundLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_NetOperatingLossCarryforwardsExpirationPeriod" name="NetOperatingLossCarryforwardsExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SeriesXConvertiblePreferredStockMember" name="SeriesXConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_Tegoprubart-OtherDevelopmentPrograms" name="Tegoprubart-OtherDevelopmentPrograms" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember" name="AnelixisTherapeuticsLlcAndOticPharmaLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeriesXNonVotingConvertiblePreferredStockMember" name="SeriesXNonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" name="TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeriesXOnePreferredStockMember" name="SeriesXOnePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_UnderwritingAgreementMember" name="UnderwritingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_InProcessResearchAndDevelopment" name="InProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" name="IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_LeerinkPartnersLlcMember" name="LeerinkPartnersLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_RisksAndUncertaintiesPolicyTextBlock" name="RisksAndUncertaintiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod" name="CashCashEquivalentsAndRestrictedCashMaturityPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" name="ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_AccreditedInvestorMember" name="AccreditedInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PrepaidClinicalExpense" name="PrepaidClinicalExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IncomeTaxReconciliationPermanentItems" name="IncomeTaxReconciliationPermanentItems" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" name="TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_NOLTrueUp" name="NOLTrueUp" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_PreferredStockWarrantsMember" name="PreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ConversionOfPreferredStockConversionBlockerPercent" name="ConversionOfPreferredStockConversionBlockerPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" name="PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" name="IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_OticPharmaLtdMember" name="OticPharmaLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_FeeDueForMilestonesAchieved" name="FeeDueForMilestonesAchieved" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember" name="TwoThousandFourteenEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TwoThousandTwentyLongTermIncentivePlanMember" name="TwoThousandTwentyLongTermIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_CommonAndPreferredWarrantsOutstandingMember" name="CommonAndPreferredWarrantsOutstandingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" name="PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_OneBillionAggregateNetSalesMember" name="OneBillionAggregateNetSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_NumberOfMilestonesAchieved" name="NumberOfMilestonesAchieved" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember" name="TimeBasedAndPerformanceBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ConversionAgreementMember" name="ConversionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_DeferredTaxAssetsDepreciationAndAmortization" name="DeferredTaxAssetsDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" name="ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_AnnualLicenseMaintenanceFee" name="AnnualLicenseMaintenanceFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_AccretionOnInvestmentDiscounts" name="AccretionOnInvestmentDiscounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AmortizationOfOperatingLeaseAsset" name="AmortizationOfOperatingLeaseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_IncomeTaxReconciliationStateTaxRateDifferential" name="IncomeTaxReconciliationStateTaxRateDifferential" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" name="CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" name="ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_UnrealizedGainOnAvailableForSaleSecurities" name="UnrealizedGainOnAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" name="IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_SeriesX1NonVotingConvertiblePreferredStockMember" name="SeriesX1NonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_NumberOfPreFundedWarrantsExercisedForCommonStock" name="NumberOfPreFundedWarrantsExercisedForCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TwoThousandFourteenStockIncentivePlanMember" name="TwoThousandFourteenStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember" name="SeptemberTwoThousandAndTwentyCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AccruedClinicalCurrent" name="AccruedClinicalCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" name="IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment" name="DeferredTaxLiabilitiesInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ManufacturingExpensesOffset" name="ManufacturingExpensesOffset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_PercentageOfCumulativeChangeInOwnership" name="PercentageOfCumulativeChangeInOwnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement" name="IncomeTaxExaminationLikelihoodOfFavorableSettlement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="eldn_Personnel-RelatedExpenses" name="Personnel-RelatedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_SeriesX1ExchangeAgreementMember" name="SeriesX1ExchangeAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_RegulatoryMilestonePaymentsObligation" name="RegulatoryMilestonePaymentsObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" name="IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_OticPharmaIncMember" name="OticPharmaIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementThirdClosingMember" name="SecuritiesPurchaseAgreementThirdClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" name="IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" name="BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" name="IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_CommonWarrantsMember" name="CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TimeBasedVestingRequirementsMember" name="TimeBasedVestingRequirementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_EffectiveFederalAndStateIncomeTaxRate" name="EffectiveFederalAndStateIncomeTaxRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" name="TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" name="PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_SecuritiesPurchaseAgreementInitialClosingMember" name="SecuritiesPurchaseAgreementInitialClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" name="TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_AccountsPayableAccruedExpensesAndOtherLiabilities" name="AccountsPayableAccruedExpensesAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_CommonStockWarrantsMember" name="CommonStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" name="IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" name="IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eldn_AnelixisTherapeuticsIncorporationMember" name="AnelixisTherapeuticsIncorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" name="ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_ContingentLiability" name="ContingentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_DescriptionOfBusinessLineItems" name="DescriptionOfBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" name="IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_LesseeOperatingLeaseRemainingTermOfContract" name="LesseeOperatingLeaseRemainingTermOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eldn_NoncashActivitiesAbstract" name="NoncashActivitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" name="JanuaryTwoThousandAndTwentyCommonWarrantsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" name="IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" name="ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 17, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELDN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ELEDON PHARMACEUTICALS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001404281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1000967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">19800 MacArthur Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949) <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-8090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,881,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,885,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">173<span></span>
</td>
<td class="text">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Crowe LLP<span></span>
</td>
<td class="text">KMJ Corbin & Company LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, CA<span></span>
</td>
<td class="text">Glendora, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Issuer (the "Company") as of December 31, 2024, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statements of the Company as of December 31, 2023, were audited by other auditors whose report dated March 28, 2024, except for the effects of the Restatement disclosed in Note 13, as to which the date is August 19, 2024, expressed an unqualified opinion on those statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provided a reasonable basis for our opinion.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matter</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Classification and Valuation of Pre-Funded Warrants</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#8217;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#8217;s conclusions and inputs to its calculation of fair value.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consulting with specialists on the classification and valuation of the pre-funded warrants.</span></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#8217;s valuation.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#8220;Company&#8221;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year ended December 31, 2024, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,549<span></span>
</td>
<td class="nump">$ 4,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">5,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">143,730<span></span>
</td>
<td class="nump">56,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_InProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">32,386<span></span>
</td>
<td class="nump">32,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">177,405<span></span>
</td>
<td class="nump">89,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">5,833<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">5,430<span></span>
</td>
<td class="nump">2,545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,577<span></span>
</td>
<td class="nump">3,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">2,183<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liability</a></td>
<td class="nump">640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">44,865<span></span>
</td>
<td class="nump">76,211<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">59,265<span></span>
</td>
<td class="nump">81,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">473,640<span></span>
</td>
<td class="nump">326,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(355,586)<span></span>
</td>
<td class="num">(319,402)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">118,140<span></span>
</td>
<td class="nump">7,208<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">177,405<span></span>
</td>
<td class="nump">89,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_InProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_InProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 51,964<span></span>
</td>
<td class="nump">$ 30,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">18,613<span></span>
</td>
<td class="nump">12,688<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(35,753)<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Series X1 Non-voting Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Series X Non-Voting Convertible Preferred Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 84,183<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 287,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (202,865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,776,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,970<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">33,017<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">33,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares', window );">Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares', window );">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue', window );">Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in connection with vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(116,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2023</a></td>
<td class="nump">7,208<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">326,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,402)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,110,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">48,064<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">48,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares', window );">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,636,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue', window );">Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value</a></td>
<td class="nump">6,155<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">6,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue', window );">Issuance of common stock in connection with exercise of pre-funded warrants, Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares', window );">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,356,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue', window );">Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</a></td>
<td class="nump">$ 79,533<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">79,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock Option Exercise, Shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Option Exercise, Value</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(36,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 118,140<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 473,640<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="num">$ (355,586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,789,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with exercise of pre-funded warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with exercise of pre-funded warrants, value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccretionOnInvestmentDiscounts', window );">Accretion on investment discounts</a></td>
<td class="num">(2,799)<span></span>
</td>
<td class="num">(1,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(30,900)<span></span>
</td>
<td class="nump">76,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">7,751<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(47,271)<span></span>
</td>
<td class="num">(39,527)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of available-for-sale short-term investments</a></td>
<td class="num">(156,131)<span></span>
</td>
<td class="num">(78,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of available-for-sale short-term investments</a></td>
<td class="nump">85,817<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(70,314)<span></span>
</td>
<td class="num">(45,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Proceeds from issuances of common stock and pre-funded warrants, net</a></td>
<td class="nump">133,307<span></span>
</td>
<td class="nump">33,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">133,522<span></span>
</td>
<td class="nump">33,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">15,937<span></span>
</td>
<td class="num">(51,797)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">4,612<span></span>
</td>
<td class="nump">56,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">20,549<span></span>
</td>
<td class="nump">4,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NoncashActivitiesAbstract', window );"><strong>Non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock', window );">Common stock exchanged for X and X1 non-voting convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_UnrealizedGainOnAvailableForSaleSecurities', window );">Unrealized gain on available-for-sale securities</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease', window );">Increase in operating right-of-use lease asset and liability due to new lease</a></td>
<td class="nump">920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise', window );">Settlement of warrant liability into common stock due to exercise</a></td>
<td class="nump">$ 446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts payable, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccretionOnInvestmentDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion on Investment Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccretionOnInvestmentDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock exchanged for X and X1 non-voting convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating right-of-use lease asset and liability due to new lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NoncashActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NoncashActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and pre funded warrants net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of warrant liability into common stock due to exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_UnrealizedGainOnAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_UnrealizedGainOnAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479092/842-20-40-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strategy and Oversight</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#8217;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">materially affected</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in this Annual Report on Form 10-K, including the risk factor titled &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#8221;</span></p><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management processes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board addresses our cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.</span></p><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.</span></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. Description of Business</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#8220;CD40L&#8221;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#8220;ALS&#8221;). The Company&#8217;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#8220;Eledon,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;we,&#8221; or the &#8220;Company&#8221; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2020</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Eledon acquired Anelixis Therapeutics, Inc. (&#8220;Anelixis&#8221;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages all its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> include </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,443,755</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.3%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.34%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.040000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.73</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of common shares</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.76%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div></div><div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p></div><div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></span><span style=""></span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. Short-Term Investments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The objectives of the Company&#8217;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such investments may be required prior to maturity to implement management strategies, and therefore has classified all investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.294%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.14%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.14%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of the Company's available-for-sale securities have a stated maturity of less than one year.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. Fair Value Measurements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities are recorded at fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1&#8212;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2&#8212;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.</span></div></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,679</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,093</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,308</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,736</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"></td>
        <td style="width:6.879%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.199%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.439%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"></td>
        <td style="width:6.879%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.199%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.439%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.2%;box-sizing:content-box;"></td>
        <td style="width:6.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:28.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which expired and or settled as of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract', window );"><strong>Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock', window );">Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.709%;box-sizing:content-box;"></td>
        <td style="width:2.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.697%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.956%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,128</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">624</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">729</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,552</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.08%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,642</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,601</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,430</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for each of the years ended December 31, 2024 and 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 19, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,817</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Irvine Lease Agreement&#8221;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Irvine, California, that was set to expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 4, 2024, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36-month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating lease for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,138</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office space in Burlington, Massachusetts, that expires on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 21, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Burlington Lease Agreement&#8221;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and do not include options to extend the leases for additional periods.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#8217;s judgment.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.833%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">407</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.299999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.84%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.860000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.433%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.514%;box-sizing:content-box;"></td>
        <td style="width:2.941%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:24.544999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">391</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,087</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">954</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Grants and Licenses</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ALS Therapy Development Foundation, Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2015, Anelixis executed a License Agreement (the &#8220;Agreement&#8221;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#8220;ALS TDI&#8221;) for certain patents and &#8220;know-how&#8221; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million each. During 2018 and 2017, Anelixis issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million wort</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h of its common stock in lieu of making a cash payment. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> milestones achieved during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional milestone payments.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million beginning on the earlier of January 1, 2022, the Company&#8217;s first sublicense, or change in control, as defined in the Agreement. The Company has made a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million annual license maintenance fee in each year since 2022.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the first calendar year of reaching $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lonza Sales AG Inc. License Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2018, Anelixis executed a License Agreement (the &#8220;Lonza Agreement&#8221;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#8220;Lonza&#8221;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">eGenesis, Inc. Collaboration Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#8220;eGenesis Agreement&#8221;), under which eGenesis will gain access to tegoprubart for eGenesis&#8217; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company offset $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnifications</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts associated with such indemnifications have been recorded to date.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contingent liabilities requiring accrual at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,951</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,736</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,753</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.88%;box-sizing:content-box;"></td>
        <td style="width:3.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.64%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#8217;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.913%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.783000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.422%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,508</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">908</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,170</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,358</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,819</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,273</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,137</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,740</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,089</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,560</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,202</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">366</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">475</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,809</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,567</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,085</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,056</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,319</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,037</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,828</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,623</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,682</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,841</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,379</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,811</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,183</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,752</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:61.448%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,596</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,232</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The net valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2022 to December 31, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#8217;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, available to reduce future taxable income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also has state net operating loss carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if not utilized. The federal net operating losses incurred since 2018 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million do not expire. The state net operating losses begin to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2035</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal research and development tax credit carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. If not utilized, the carryforwards will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2036</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has state research and development credit carryforwards or approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which will begin expiring in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2030</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> if not utilized</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#8217;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% occurs within a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has not completed an IRC Section 382/383 analysis regarding the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limitation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#8217;s unrecognized tax benefits will not impact the Company&#8217;s effective tax rate.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#8217;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued interest and penalties associated with uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any interest or penalties in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. Stockholders&#8217; Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized shares of preferred stock with a par value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">515,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110,086</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and outstand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ing at December 31, 2024 and 2023, and </span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series X non-voting convertible preferred stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares designated; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,422</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding at December 31, 2024 and 2023.</span></div></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each share of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or X non-voting convertible preferred stock (the &#8220;Preferred Stock&#8221;) is convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.5556</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2022 Exchange Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 11, 2022, the Company entered into an exchange agreement (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange Agreement&#8221;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#8220;BVF Exchanging Stockholders&#8221;), pursuant to which the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchanging Stockholders exchanged (the &#8220;Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Exchange&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">550,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,899.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Ser</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ies X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2023 Private Placement&#8221;) (i) in an initial closing, (a) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share, or pre-funded warrants in lieu thereof (the &#8220;Pre-Funded Warrants&#8221;), and (b) common stock warrants exercisable into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#8220;Common Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;); (ii) in a second closing (the &#8220;Second Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,202,024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of common stock (or Pre-Funded Warrants); and (iii) in a third</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">closing </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Third Closing&#8221;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,252,530</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 28, 2023, the initial closing occurred, and the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,730,168</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,421,350</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">909,088</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs, in exchange for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,727,400</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#8220;2023 Registration Statement&#8221;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#8220;Subsequent Closing Warrants&#8221;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#8217;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.149%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:20.823999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:23.064999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.80</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Conversion Agreement of Non-Voting Convertible Preferred Stock</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,782</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,883.586</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">437,977</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;2024 Securities Purchase Agreement&#8221;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#8220;2024 Private Placement&#8221;) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,110,484</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares (the &#8220;2024 Shares&#8221;) of the Company&#8217;s common stock, at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants (the &#8220;2024 Pre-Funded Warrants&#8221;) at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.369</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per underlying share, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Private Placement resulted in gross proceeds to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting offering costs.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Equity Distribution Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#8220;Sales Agreement&#8221;) with Guggenheim Securities, LLC (&#8220;Guggenheim Securities&#8221;) to sell shares of the Company&#8217;s common stock, having aggregate sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, from time to time, through an &#8220;at the market&#8221; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;) in connection with the underwritten offering, issuance and sale by the Company (the &#8220;2024 Underwritten Offering&#8221;) of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,356,173</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.65</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and pre-funded warrants at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.649</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per pre-funded warrant, which are exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Offering Pre-Funded Warrants&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#8217; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#8217;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, or net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after deducting underwriting discounts and commissions and offering expenses. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (or, at the holder&#8217;s option upon issuance, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#8220;Exercising Stockholder&#8221;) exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">501,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">501,197</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">583,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">583,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">240,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">240,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the Exercising Stockholder in accordance with such exercise.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.5%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,788,032</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,564,302</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,778,451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,274,293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.492%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.297%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.837%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.2%;box-sizing:content-box;"></td>
        <td style="width:17.836%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">247,264</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,800</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">298,692</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.08</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">509,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,844,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock Warrants</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,789,301</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.52%;box-sizing:content-box;"></td>
        <td style="width:2.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:41.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Warrants were issued on September 14, 2020, with an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Plans</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months that vested stock options granted to Board members may be exercised upon termination. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#8217;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares so that the new aggregate share limit under the 2020 Plan is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,960,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,381,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options, with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,476,372</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the granted stock options subject to the Company&#8217;s customary time-based vesting schedule. The remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,905,485</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#8217; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,763,085</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stock options were issued.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2014 Stock Incentive Plan (the &#8220;2014 Plan&#8221;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved for issuance under the 2014 Plan as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,373,242</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,077</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.708%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.762%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.282%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.762%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.282%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,218,033</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,026,451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.10</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.07</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,381,853</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">235</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">622,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.30</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316,465</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,667,177</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.72%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.93</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.47%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.304%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.304%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over an estimated weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.4</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. Segment Reporting</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently operates and manages its business as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;CODM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;), is the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1691d7f7-1fe6-4184-b13f-c7d5693df0ef;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</span></span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b5c49917-80ca-456f-a3d2-e4aad4794ea8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">single</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment entity, </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span></span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.026%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.078000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.078000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,351</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,543</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,930</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. Subsequent Events</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has evaluated events subsequent to December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#8220;Otic&#8221;). Otic owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#8217;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#8217;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#8220;ROU&#8221;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments with original maturities of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months or less</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> when </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">government securities and U.S. government agency securities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RisksAndUncertaintiesPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, all of the Company&#8217;s long-lived assets were located in the United States. The Company&#8217;s products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#8217;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages all its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Reportable Segments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reportable Segments</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#8220;CODM&#8221;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#8217;s Chief Executive Officer and the Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Long-Lived Assets</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairments of long-lived assets have been identified during the years presented.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">In-Process Research and Development</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In-Process Research and Development</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts allocated to in-process research and development (&#8220;IPR&amp;D&#8221;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#8217;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;D was impaired for any of the periods presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#8217;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#8217;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> include </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,443,755</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> respectively, shares underlying pre-funded warrants to purchase common shares. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.3%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.34%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.040000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.73</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of common shares</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.76%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;) are measured and recognized based on the quoted market price of our common stock on the date of grant.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgment is required in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">second step is to measure the tax benefit as the largest amount that is </span></span><span style=""></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">more </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely of being realized upon settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 7. Income Taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Notes to Financial Statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Warrant Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liabilities</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for issued warrants either as a liability or equity in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 815-40 Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (&#8220;ASC 815-40&#8221;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements Issued But Not Adopted</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Adopted Accounting Pronouncements</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">early adoptions</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> permitted. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASU 2023-07, effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t impact the consolidated financial statements. See Note 10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the adoption of ASU 2023-07.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Issued But Not Adopted</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#8217;s present or future financial position, results of operations or cash flows.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation and principles of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share), these shares are deemed to be issued for purposes of basic earnings per share.</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.3%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.34%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.66%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:14.040000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.73</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of common shares</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,543,787</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,619,197</span></p></td>
          <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a summary as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.</span>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:57.76%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.72%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:17.4%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options outstanding and other equity awards</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,007,789</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,909,155</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common and preferred warrants outstanding</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,567,751</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,577,332</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,575,540</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,486,487</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Short-term Investments Classified as Available-for-sale Securities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of short-term investments, which were classified as available-for-sale securities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.294%;box-sizing:content-box;"></td>
        <td style="width:1.8%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.14%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.14%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.577%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,603</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Table Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Financial Asset Instruments Measured At Fair Value On A Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasuries</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,464</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,679</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119,629</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,093</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">138,308</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:33.387%;box-sizing:content-box;"></td>
        <td style="width:1.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.12%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.323%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,246</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,736</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company's warrant liabilities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(see </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Note 8. Stockholders' Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"></td>
        <td style="width:6.879%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.199%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.439%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.514%;box-sizing:content-box;"></td>
        <td style="width:6.879%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.199%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.758000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.439%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.498000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Aggregate Fair Values of Warrant Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.2%;box-sizing:content-box;"></td>
        <td style="width:6.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:28.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Settlement of warrant liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">446</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,865</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract', window );"><strong>Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.709%;box-sizing:content-box;"></td>
        <td style="width:2.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.697%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.32%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.956%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,128</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">624</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">185</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">729</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,552</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,027</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities consisted of the following as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.08%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:18.119999999999997%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,642</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,601</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,430</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses, other assets, accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued expenses and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Operating Lease Expense</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The total operating lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.833%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.203000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">407</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(a) </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Includes variable operating lease expenses, which are immaterial.</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of Other Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other supplemental cash flow information related to leases were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.299999999999999%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.84%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.860000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liability:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">378</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.433%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.46</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.49</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Payments Under Noncancelable Operating Leases</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.514%;box-sizing:content-box;"></td>
        <td style="width:2.941%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:24.544999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">391</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,087</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">954</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion of operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-current operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other supplemental cash flow information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Loss Before Income Taxes</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss before income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Losses before income taxes:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,951</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,736</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">198</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,753</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Provision for Income Taxes</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.88%;box-sizing:content-box;"></td>
        <td style="width:3.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.64%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.4%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.68%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred income tax provision</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of U.S. Federal Statutory Income Tax Rate</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.913%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.783000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.422%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Statutory federal income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,508</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal tax benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">908</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,170</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,358</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,819</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent items</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,273</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State rate differential</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">490</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NOL true-up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">566</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,137</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,740</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,089</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,560</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,202</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">366</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">475</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research expenditures</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,809</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,567</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,085</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,056</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,319</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">91</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,037</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,828</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired IPR&amp;D</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,623</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,682</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,841</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,769</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,379</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,811</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,183</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,752</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:61.448%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.277000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in the current year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,596</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">972</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions from tax positions taken in prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross unrecognized tax benefits at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,232</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,636</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.72%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.492%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.297%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.837%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.2%;box-sizing:content-box;"></td>
        <td style="width:17.836%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date Issued</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares of Common Stock Issuable</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Expiration Date</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.90</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">247,264</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,800</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 17, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 2020 common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">298,692</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.08</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 14, 2025</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement common warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,151,518</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 5, 2028</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 2021 pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">509,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2030</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,844,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Securities Purchase Agreement pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,989,516</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024 Underwritten Offering pre-funded warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,931,507</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfWarrantActivityTableTextBlock', window );">Schedule of Warrants to Purchase Common Stock Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the warrants to purchase common stock activity:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.5%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Warrant Activity</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,788,032</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,776,270</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,564,302</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,921,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,423,000</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#d2effa;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,778,451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,274,293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,052,744</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember', window );">Preferred Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ScheduleOfWarrantActivityTableTextBlock', window );">Schedule of Warrants to Purchase Common Stock Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants exercisable into Series X</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preferred Stock which are convertible into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,789,301</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.52%;box-sizing:content-box;"></td>
        <td style="width:2.44%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:41.04%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roll-Forward of Series X</span><span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Convertible Preferred Warrant Activity</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed and replaced</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled/Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,207.419</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and as of the issuance date:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.149%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:20.823999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.481%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:23.064999999999998%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">96.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share price</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.80</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ScheduleOfWarrantActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of warrant activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ScheduleOfWarrantActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:40.708%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.762%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.282%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.762%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.282%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,218,033</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,026,451</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.10</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">862,631</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.07</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,381,853</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">235</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">622,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.30</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316,465</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.29</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options vested and expected to vest as of<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,637,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.02</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options exercisable as of December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,667,177</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.37</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.8</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.72%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
        <td style="width:2.54%;box-sizing:content-box;"></td>
        <td style="width:26.1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.3</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90.5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected life of options (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Estimated dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Summary of RSU Activity</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the RSU activity, as follows:</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.72%;box-sizing:content-box;"></td>
        <td style="width:1.26%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.38%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.72%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares<br/>Issuable<br/>Under RSUs</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted<br/>Average<br/>Grant Date Fair Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(In years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of January 1, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited / Canceled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding as of December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.97</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards</a></td>
<td class="text"><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total compensation expense related to all of the Company&#8217;s stock-based awards for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 was comprised of the following (in thousands):</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.47%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.304%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.46%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:19.304%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation classified as:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,277</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,491</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,845</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,054</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant segment expenses, as provided to the CODM, are presented as the following:</span><p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.026%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.078000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.078000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - kidney transplantation programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,452</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tegoprubart - other development programs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,448</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,048</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,351</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,543</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,930</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,577</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,924</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">431</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment and net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,537</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business - Additional Information (Detail)<br></strong></div></th>
<th class="th"><div>Sep. 14, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember', window );">Anelixis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Date of acquisition</a></td>
<td class="text">Sep. 14,  2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DescriptionOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DescriptionOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 7<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod', window );">Cash, cash equivalents and restricted cash, maturity period</a></td>
<td class="text">three months or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating business segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairments of long-lived assets | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit', window );">Tax benefit | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement', window );">Income tax examination, likelihood of settlement, description</a></td>
<td class="text">The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement', window );">Income tax examination, likelihood of settlement, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">12,443,755<span></span>
</td>
<td class="nump">5,776,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member', window );">Accounting Standards Update 2023-07 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in Accounting Principle, Accounting Standards Update, Adoption Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption', window );">Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember', window );">Anelixis Therapeutics, LLC and Otic Pharma, Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=eldn_OticPharmaIncMember', window );">Otic Pharma, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership interest percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash cash equivalents and restricted cash maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax examination likelihood of favorable settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was early adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=eldn_OticPharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=eldn_OticPharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (0.75)<span></span>
</td>
<td class="num">$ (4.73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares, basic</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares, diluted</a></td>
<td class="nump">48,543,787<span></span>
</td>
<td class="nump">24,619,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">24,575,540<span></span>
</td>
<td class="nump">33,486,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock Options Outstanding and Other Equity Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">6,007,789<span></span>
</td>
<td class="nump">14,909,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember', window );">Common and Preferred Warrants Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">18,567,751<span></span>
</td>
<td class="nump">18,577,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=eldn_CommonAndPreferredWarrantsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 119,603<span></span>
</td>
<td class="nump">$ 46,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">119,603<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember', window );">U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">$ 46,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">$ 18,679<span></span>
</td>
<td class="nump">$ 4,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">138,308<span></span>
</td>
<td class="nump">50,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasuries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">119,629<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">137,093<span></span>
</td>
<td class="nump">46,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Treasuries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">17,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Government Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">$ 119,629<span></span>
</td>
<td class="nump">33,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 2 [Member] | U.S. Government Agency Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - Warrant Liabilities [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">$ (30,900)<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance as of December 31, 2023</a></td>
<td class="nump">76,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(30,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_SettlementOfWarrantLiability', window );">Settlement of warrant liability</a></td>
<td class="num">(446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance as of December 31, 2024</a></td>
<td class="nump">$ 44,865<span></span>
</td>
<td class="nump">$ 76,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_SettlementOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_SettlementOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal</a></td>
<td class="nump">$ 59.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PrepaidClinicalExpense', window );">Prepaid clinical</a></td>
<td class="nump">$ 1,915<span></span>
</td>
<td class="nump">$ 4,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 3,552<span></span>
</td>
<td class="nump">$ 5,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PrepaidClinicalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PrepaidClinicalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AccruedClinicalCurrent', window );">Accrued clinical</a></td>
<td class="nump">$ 3,642<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other liabilities</a></td>
<td class="nump">$ 5,430<span></span>
</td>
<td class="nump">$ 2,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AccruedClinicalCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AccruedClinicalCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 04, 2024 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 19, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Aug. 12, 2022</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Milestone</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Milestone</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,000<span></span>
</td>
<td class="nump">365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining term of office lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Indemnification obligations amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ContingentLiability', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_FeeDueForMilestonesAchieved', window );">Fee due for milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in lieu of making a cash payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NumberOfMilestonesAchieved', window );">Number of Milestones Achieved | Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RemainingMilestonePaymentsForFirstLicensedProduct', window );">Remaining milestone payments for first licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AnnualLicenseMaintenanceFee', window );">Annual License Maintenance Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 500 Million Aggregate Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AggregateNetSalesAchievement', window );">Reaching of aggregate net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Amount of one-time milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember', window );">ALS Therapy Development Foundation, Inc. License Agreement [Member] | Achievement of 1 Billion Aggregate Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AggregateNetSalesAchievement', window );">Reaching of aggregate net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Amount of one-time milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember', window );">eGenesis, Inc. Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ManufacturingExpensesOffset', window );">Manufacturing expenses offset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | ALS Therapy Development Foundation, Inc. License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_RegulatoryMilestonePaymentsObligation', window );">Development and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">Irvine, California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">38 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AreaOfOfficeSpace', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2027<span></span>
</td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">Burlington, Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_AreaOfOfficeSpace', window );">Area of office space | ft&#178;</a></td>
<td class="nump">6,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Nov. 21,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AggregateNetSalesAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net sales achievement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AggregateNetSalesAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AnnualLicenseMaintenanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual license maintenance fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AnnualLicenseMaintenanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_AreaOfOfficeSpace">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of office space.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_AreaOfOfficeSpace</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_FeeDueForMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fee due for milestones achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_FeeDueForMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_LesseeOperatingLeaseRemainingTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease remaining term of contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_LesseeOperatingLeaseRemainingTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ManufacturingExpensesOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Manufacturing expenses offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ManufacturingExpensesOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NumberOfMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of milestones achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NumberOfMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RegulatoryMilestonePaymentsObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory milestone payments obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RegulatoryMilestonePaymentsObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_RemainingMilestonePaymentsForFirstLicensedProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining milestone payments for first licensed product.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_RemainingMilestonePaymentsForFirstLicensedProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the entity has committed to make for future royalty guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477866/928-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyGuaranteesCommitmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_FiveHundredMillionAggregateNetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_FiveHundredMillionAggregateNetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_OneBillionAggregateNetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=eldn_OneBillionAggregateNetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_EGenesisIncCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Components of Operating Lease Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liability:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating lease</a></td>
<td class="nump">$ 378<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">9.46%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current portion of operating lease liabilities</a></td>
<td class="num">(314)<span></span>
</td>
<td class="num">$ (383)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Loss Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Losses before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (35,951)<span></span>
</td>
<td class="num">$ (116,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S.</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (35,753)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax provision</a></td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net valuation allowance Increased (decreased)</a></td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 5,560,000<span></span>
</td>
<td class="nump">3,202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards', window );">Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest or penalties recorded during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_PercentageOfCumulativeChangeInOwnership', window );">Percentage of cumulative change in ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 88,700,000<span></span>
</td>
<td class="nump">68,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod', window );">Net operating loss carryforward expiration period</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal net operating loss carryforwards, not to expiration</a></td>
<td class="nump">$ 87,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationPeriod', window );">Research and development tax credit carryforwards expiration period</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">$ 37,700,000<span></span>
</td>
<td class="nump">30,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards for federal and state</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationPeriod', window );">Research and development tax credit carryforwards expiration period</a></td>
<td class="text">2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_TaxCreditCarryforwardExpirationDescription', window );">Research and development tax credit carryforwards expiration description</a></td>
<td class="text">As of December 31, 2024 and 2023, the Company has state research and development credit carryforwards or approximately $2.6 million and $1.5 million, respectively, which will begin expiring in 2030 if not utilized<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember', window );">California [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod', window );">Net operating loss carryforward expiration period</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NetOperatingLossCarryforwardsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NetOperatingLossCarryforwardsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PercentageOfCumulativeChangeInOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cumulative change in ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PercentageOfCumulativeChangeInOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCreditCarryforwardExpirationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCreditCarryforwardExpirationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_TaxCreditCarryforwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_TaxCreditCarryforwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="num">$ (7,508)<span></span>
</td>
<td class="num">$ (24,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_StateIncomeTaxesNetOfFederalTaxBenefits', window );">State income taxes, net of federal tax benefits</a></td>
<td class="num">(908)<span></span>
</td>
<td class="num">(3,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="num">(2,358)<span></span>
</td>
<td class="num">(972)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="num">(7,273)<span></span>
</td>
<td class="nump">18,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_IncomeTaxReconciliationStateTaxRateDifferential', window );">State rate differential</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NOLTrueUp', window );">NOL true-up</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">15,137<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation permanent items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_IncomeTaxReconciliationStateTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation state tax rate differential.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_IncomeTaxReconciliationStateTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NOLTrueUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>NOL True Up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NOLTrueUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_StateIncomeTaxesNetOfFederalTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>State income taxes, net of Federal tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_StateIncomeTaxesNetOfFederalTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 22,740<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">5,560<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research expenditures</a></td>
<td class="nump">18,809<span></span>
</td>
<td class="nump">10,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">3,281<span></span>
</td>
<td class="nump">3,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">52,037<span></span>
</td>
<td class="nump">36,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxAssetsRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment', window );">Acquired IPR&amp;D</a></td>
<td class="num">(7,623)<span></span>
</td>
<td class="num">(7,682)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(7,841)<span></span>
</td>
<td class="num">(7,769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(46,379)<span></span>
</td>
<td class="num">(30,811)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (2,183)<span></span>
</td>
<td class="num">$ (1,752)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxAssetsRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxAssetsRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, in-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at the beginning of the year</a></td>
<td class="nump">$ 3,636<span></span>
</td>
<td class="nump">$ 2,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions from tax positions taken in the current year</a></td>
<td class="nump">2,596<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions from tax positions taken in prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits at the end of the year</a></td>
<td class="nump">$ 6,232<span></span>
</td>
<td class="nump">$ 3,636<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2024</div></th>
<th class="th"><div>Oct. 29, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 20, 2024</div></th>
<th class="th"><div>Jul. 08, 2024</div></th>
<th class="th"><div>May 06, 2024</div></th>
<th class="th"><div>May 16, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Jan. 11, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 09, 2024</div></th>
<th class="th"><div>May 07, 2024</div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
<th class="th"><div>Nov. 06, 2023</div></th>
<th class="th"><div>Nov. 02, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Jul. 10, 2023</div></th>
<th class="th"><div>Sep. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,789,275<span></span>
</td>
<td class="nump">24,213,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,307<span></span>
</td>
<td class="nump">$ 33,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember', window );">Armistice Capital Master Fund Ltd [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_NumberOfPreFundedWarrantsExercisedForCommonStock', window );">Number of pre-funded warrants exercised for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember', window );">Series X1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,789,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember', window );">Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="nump">4,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember', window );">Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="nump">110,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember', window );">Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOffering', window );">Proceeds from issuance offering</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="nump">$ 79,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,052,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares of common stock issued upon conversion of each share of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,356,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,931,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,052,744<span></span>
</td>
<td class="nump">21,564,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Stock Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,110,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Common warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Initial Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Second Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Second Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,202,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Third Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,727,400<span></span>
</td>
<td class="nump">1,727,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts', window );">Net proceeds after deducting offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Securities Purchase Agreement Third Closing [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,252,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Common Stock [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,730,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Securities Purchase Agreement [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,989,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement Warrants [Member] | Pre-Funded Warrants [Member] | Securities Purchase Agreement Initial Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,421,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember', window );">Preferred Stock Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants available for exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="nump">50,207.419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 14,  2025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Pre-Funded Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Common Stock Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ConversionOfPreferredStockConversionBlockerPercent', window );">Conversion of preferred stock, conversion blocker, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Pre-Funded Warrants [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Pre-Funded Warrants [Member] | Leerink Partners LLC [Member] | Underwriting Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage', window );">Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember', window );">BVF Exchanging Stockholders [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Series X1 Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,899.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember', window );">BVF Exchanging Stockholders [Member] | Common Stock [Member] | Series X1 Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Series X Non-Voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,883.586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Common Stock [Member] | Series X Non-Voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember', window );">Cormorant Global Healthcare Master Fund LP [Member] | Common Stock [Member] | Series X1 Non-voting Convertible Preferred Stock [Member] | Conversion Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember', window );">Guggenheim Securities LLC [Member] | Maximum [Member] | Equity Distribution Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant subject to specified beneficial ownership limitations percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant subject to specified beneficial ownership limitations permitted percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ConversionOfPreferredStockConversionBlockerPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of preferred stock, conversion blocker, percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ConversionOfPreferredStockConversionBlockerPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_NumberOfPreFundedWarrantsExercisedForCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pre-funded warrants exercised for common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_NumberOfPreFundedWarrantsExercisedForCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and pre funded warrants net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of private placement, net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ProceedsFromIssuanceOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ProceedsFromIssuanceOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=eldn_ArmisticeCapitalMasterFundLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesXNonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=eldn_SeriesX1NonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eldn_LeerinkPartnersLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=eldn_AccreditedInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=eldn_AccreditedInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementInitialClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementInitialClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementSecondClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementSecondClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementThirdClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementThirdClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SeriesX1ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SeriesX1ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_CormorantGlobalHealthcareMasterFundLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_ConversionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_ConversionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eldn_GuggenheimSecuritiesLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">101.30%<span></span>
</td>
<td class="nump">90.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">96.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eldn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail) - Common Stock Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">21,564,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">12,921,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="num">(1,423,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="num">(9,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">33,052,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">15,788,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="num">(9,581)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">15,778,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">5,776,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued', window );">Issued</a></td>
<td class="nump">12,921,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="num">(1,423,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">17,274,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail) - Common Stock Warrants [Member] - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">33,052,744<span></span>
</td>
<td class="nump">21,564,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">5,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">3,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">247,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">71,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Jul. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">September 2020 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">298,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 3.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Sep. 14,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2023 Securities Purchase Agreement Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">15,151,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">May  05,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">January 2021 Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">509,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">Dec. 31,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2023 Securities Purchase Agreement Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">3,844,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2024 Securities Purchase Agreement Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">7,989,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember', window );">2024 Underwritten Offering Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Shares of Common Stock Issuable</a></td>
<td class="nump">4,931,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eldn_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail) - Preferred Stock Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning Balance</a></td>
<td class="nump">50,207.419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced', window );">Assumed and replaced</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired', window );">Cancelled/Expired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance</a></td>
<td class="nump">50,207.419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights assumed and replaced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants or rights cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eldn_PreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2024</div></th>
<th class="th"><div>Jul. 10, 2024</div></th>
<th class="th"><div>Jun. 13, 2024</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">622,000<span></span>
</td>
<td class="nump">11,026,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Shares weighted average grant date fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation expense, recognized over estimated weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod', window );">Expected life assumption using simplified method, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">For stock options granted to the Company&#8217;s board of directors (the &#8220;Board&#8221;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of 12 to 18 months that vested stock options granted to Board members may be exercised upon termination. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Employee Stock Option [Member] | Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember', window );">Time Based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,476,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember', window );">Performance-based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="nump">5,763,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,763,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember', window );">Time-based and Performance-based Vesting Requirements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,381,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,905,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember', window );">2014 Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember', window );">2020 Long Term Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,373,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increased number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized', window );">New aggregate share limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember', window );">2014 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award total number of shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discloses use of the simplified method to calculate the expected term that stock option awards under the specified plan will exist before being exercised or terminated, the reason and justification for its use, and the periods for which the method was used if it was not used in all periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_TimeBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_PerformanceBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandFourteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandTwentyLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Issuable Under Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">15,381,853<span></span>
</td>
<td class="nump">5,218,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">622,000<span></span>
</td>
<td class="nump">11,026,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited / Canceled</a></td>
<td class="num">(316,465)<span></span>
</td>
<td class="num">(862,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">15,637,388<span></span>
</td>
<td class="nump">15,381,853<span></span>
</td>
<td class="nump">5,218,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest</a></td>
<td class="nump">15,637,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">8,667,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 8.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">2.22<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited / Canceled</a></td>
<td class="nump">7.29<span></span>
</td>
<td class="nump">8.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">4.02<span></span>
</td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 8.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest</a></td>
<td class="nump">4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (In years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, balance</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Outstanding</a></td>
<td class="nump">$ 20,628<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested and expected to vest</a></td>
<td class="nump">20,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 7,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">101.30%<span></span>
</td>
<td class="nump">90.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option (in years)</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Estimated dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of RSU Activity (Detail) - RSU [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares Issuable Under RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">1.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice', window );">RSUs Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.47<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 1.97<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 13,122<span></span>
</td>
<td class="nump">$ 6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">4,277<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,845<span></span>
</td>
<td class="nump">$ 5,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Reporting (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FactorsUsedToIdentifyEntitysReportableSegments', window );">Segment Reporting, Factors Used to Identify Entity's Reportable Segments</a></td>
<td class="text">The financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. Significant segment expenses, as provided to the CODM, are presented as the following:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FactorsUsedToIdentifyEntitysReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the factors used to identify reportable segments, including the basis of organization (for example, whether management has chosen to organize the enterprise around differences in products and services, geographic areas, regulatory environments, or a combination of factors and whether operating segments have been aggregated to reportable segments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FactorsUsedToIdentifyEntitysReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of significant segment expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">$ 18,613<span></span>
</td>
<td class="nump">$ 12,688<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">(36,184)<span></span>
</td>
<td class="num">(116,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Tegoprubart-KidneyTransplantationPrograms', window );">Tegoprubart - kidney transplantation programs</a></td>
<td class="nump">27,452<span></span>
</td>
<td class="nump">11,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Tegoprubart-OtherDevelopmentPrograms', window );">Tegoprubart - other development programs</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManufacturingCosts', window );">Manufacturing</a></td>
<td class="nump">12,448<span></span>
</td>
<td class="nump">8,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_Personnel-RelatedExpenses', window );">Personnel-related</a></td>
<td class="nump">10,706<span></span>
</td>
<td class="nump">8,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">13,122<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">6,543<span></span>
</td>
<td class="nump">4,930<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">70,577<span></span>
</td>
<td class="nump">43,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(70,577)<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds', window );">Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds</a></td>
<td class="nump">30,900<span></span>
</td>
<td class="num">(76,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (36,184)<span></span>
</td>
<td class="num">$ (116,537)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Personnel-RelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personnel-related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Personnel-RelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Tegoprubart-KidneyTransplantationPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tegoprubart kidney transplantation programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Tegoprubart-KidneyTransplantationPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eldn_Tegoprubart-OtherDevelopmentPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tegoprubart - other development programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eldn_Tegoprubart-OtherDevelopmentPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eldn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManufacturingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred in the production of goods for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManufacturingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  N(=%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  N(=%JE_GT<\    "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%*Q# 0AE]%<F\G3=%#Z/:B>%(07%"\A61V
M-]BD(1EI]^U-XVY7T0?PF)D_WWP#T^D@]1CQ*8X!(UE,5[,;?)(Z;-B!*$B
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MMK;+![=7]R9K6Z7VM;9+L, 16,O:WJ!F  .[O537_\06,;:2$/+W=&7,\=N
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MX/J<0S72'W" ZD7MG_\+4$L#!!0    (  N(=%J_8C;F,@8  /T<   8
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M;>V-9.OF==4-DY*5S>6*8+7MVD#]OF2J\]G>Z#=@W1O/^?]02P,$%     @
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M;"]W;W)K<VAE971S+W-H965T-2YX;6S-G&UOV[86Q[\*X3OL;D!=B]2CNR1
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M@9*1"I@DG"$!>>RL_.5Z8>)MP"\"K3P9(U/)GO-G,]EDL>,9(:"0*D/ ^G:
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MSK=#G#;^_0$3$OS^06MW#$*!Z44K?P%02P,$%     @ "XAT6CJ]<<40"P
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MB?2+_ E@@TN2XZ\15&[A9Y1]\DO9?4B^#X^4-3S!00_N857FJV0#18%:RHX
ML[_[@S>=$!&/="??72?7=5JN0SIQI((1>=:M4OE_0D""F =IZ59 E!FVN 8]
M.)K>]O!KM"RC+]H^V!4 4%<JX"T<N"NDXI=!/2FPOA^4I6(JP4<A8'^L."%*
M@JXK3QRF1@&U%[ NU7\4WD!].'GGW ?"#+CCW6(.I(^8553)%84.*V+K!?'9
M4'E4F2Y;N.60M9X6GBR$!VSXS7FA56&.3P/N HT?M*4AX.P>3G06Q>"\^(P2
M(YR,K([QMFFW,2/)%14.E>YP K2]*U<5079A]<!9 $V=5X,X62*N1D9&M ?*
M8+%F:/^,+*3)?.B3!Z=65G8\&EF<:;Q3R#XGYF3RQYMHA5BB1#@+8APG6 %M
M(1IZ0/L'#U1:EG3IUMQAY*.TC@9%0D"B+67M804G8#.T\(;L3*#"NYN-J-SC
M@W+/GBF9&<B*$L1E]UE9"53E*Y>+O'D7)241;FNPJ)*3JH>V;. [UH)]G<L]
M\5QX]V= ))V[<=1C1/+LQ5:)>YG#IJ8F)-EFTS8?#?]P_C!JD66+Y# ZZUVV
MTC&=8 %QRZBNS0V6T3?R *)FMYX#:'WD+"/QQT4JIWO$J=JS@!"Q5IU=\][$
M%Z\E5)$09(I*82)LN!AR$9:J\KJMC,"N1S=:./Y]TZC&O&Z'97)30([+SB.H
M-_3?O[X9#3W&>L^W!4C ME)#Y;C(@[GCKQ+/P'D52Y Q,@4&Z)?@F-#-0?AN
M3A422]1*O"FH0GW>W4;N"&\2G_E#L;T587/&D<+57!@Z4,#VRP/=X(6!P\26
MT0&9VI/ POG0(6#O@@^V& @E)XBKDJQ0&XFS7/1FH@-OYUOY#'Z)$]4RW(,E
MY :P51QP0ST1"*2G6D#:::#O18AEYP44GI""*5W6^KA%H5[X,2Z&?VA.IJ:)
MZWE#V<A*G8\M\5E]T,B9W4C F$M4+1:X&'#ZVP@T%>U(D@^3^R9-:O>0]"Y?
MU4W5+.W1&E2)J8-EK2!&_+; WJIF(QI-8E)Z(T"-LEMYST_V _-$ES62&L0@
MO06_F!!#>DLLXA%]P/6T?($*$,WMP<<,:8L83A@!U/=EV\AG\:!$>)7@(>BQ
M2(LA%P#-;<3QLE5%(--P%"'9H"[S?</Y)/F X91A#>=!JWF.8I:<XG SE_#9
MRQ,U4TUAO9P<Z;_#=\[R220#J1>63FU;H]%</WFT&S9@B1@6/ E!*YJ6 *V^
MG/K2H >"*^92M08>ZFR=%1(B91U=[UV*L@@HQ.E8<(L0/HTUL*^W[3U4* 5H
M5R40 0H9.#"Z472$U>25$K=TD/E<,3Z6G"@6AY%KAB6-?PGOA$*BWS(PB-#2
MAC6#ZO=#TU;%5%%@#Y,>86=-'RG/S$FCSS+Z/GW,^G3DNSH'6W!FW<5G(+X<
MQ26%)Y)5_2HX4Q )BG##_+%%-HO%#'Z+HXRT8(/&H.O-0%"!,YV=)'_WJ9;^
M,6D(=&2T&$2:;A2&4G %K)J15=M/B,/]4$'EQ*B#$3B+?O7' !YAQ**D*T5:
MUY#_ 1J<^SU"8#I 0P6X@@O9FB' *) /+Z3I&%&R+@#E'@@+RFJ8X8JQ& :N
MMIV@A6RG6?22T9O#T_@P*ZF=X3OH[^!#^+#F?10P:#B$X\3VF9>!\C)\4#O0
M^>19@W#.:WZ1K87[M!60YV:KD6 X:OQ VU_3RJ7F?7#VG3 $0@ O,E+F2;I!
MS= 3Y'O'Q$C"T L5-@=I(+']P5B$ATB<IEX7V(#E .0IV12/0J%?7,XHKA2*
M_/.:"5'/B',%1P^?N7,I[@@PRI?PF.A&2V8-F@SO2)(R\N.=6ZK?^K-R'#K2
M^:\T&)6L$(^V<( _\7U$#>! ^GQ.S;R6:X&B6#R;4Z?UL#M-5,4QA.:0U'L!
M&D6TBUN!@Z7C)Q"A^-_"E36K?8NP:!%1"C^NE&+8CU"!-CA#MS^__M%[0ZG*
MC8X#9(H;O 3T; @+\HL PZIY(/? 'L$G2@*"CMSY>$\\OJZS'*1LP;M)"=?S
MF=A=/T5)?O,13K+@\,^"P^T>TA+L"L>C$AZ;CV5ZH"(!AH]NCQV2=Z)M]5AD
M:6C<$F9XF ,F4N[.?A;')]N4FM4PPZT9RTT%=<3ZDF#7O0-\[\4Y<+^K?5<=
MHU,._>^3FQ_@I/Y U_@'<8UOU#5^UY)V -K$'HH@ <V;MA@C@1,<)"&^#%)A
M,%LD0^>=*UHR27&Q4).L'0 49-Z;?^<S*'S"+88JH9L>\L(XS(T%W^JXG\"/
MMD0*H?5WR$CKX#'1\93S7M.#BTHO.=@%ET1*#IH[8FK,E))9X-KTO_,/P&U;
MJAMA.$.]$0R".PR&.9CA55,=6"M;,]G-E<+V$/EC%;("ICKX$/A&H+/B7*+F
M%/9/L\.G[T1TG&!/I]&5:Z<F&$?/JJ^X<P<.DQG#*$G(2%:F,\!GPDI2_)IM
MCK-D]&-+4;20H\BSMI7<:TAI9JIU?8R;E)U[M8 XQ#I>GN )/X+FQ08NM48D
M$?;($@T5B&YE)^&PLWAU434/EINUY$S@EKHN5#S0JR8JT*N9[8/4@*]K'(ZD
MCS)541U-1/,Y$K<[U63OS$BYHC-7Q\?%)Y-B9)2O_'TH!!BX= B^?(S4T(_J
M9'YC0A.PU*<K@Z,V=..3.Q4'2G0^9=M)\E,3;;\[F#&.JAYEP;3AHF36=XR@
MMH[%H8V63ZDF;^O9.PVB8+0BV_PZ KH;JRQX["[4VL\L^CINU+V]>/ONE[]E
MZ\W7KT,(K<61VN(9B52R$7N!3G,FDZ2ZNX-G4>I"B@JM"YDC8:<843B5QA=Z
M!O6RI/TS%K&H7&F<Y)3?@)DYYM*P*-+AAH I9O+(_MP")TZP>[N0WT0/X@&&
MM%C(>4,"W]#2GDT.K++T5)Q&\,&M%(4T" OA%LO?$C2Y(MTET]<?Q)-P:TU%
MCYP0;DV1+[-RG\KDG+75UBW8OJ*J!+;7S1IN[AQ$+RPC<5\6&BUI L+C_>LH
M3/>3NIBF1TY)MK+5+(=WWP*EDFGD+W-"L"1BL[H>-,4_Q4?&;<R\+*B8^(*Y
MY85'0GCY$@Z,P]W'DK8QQF/X^%UOK@A %!XDP@P-\!!SR!QBYLV/X.%)^:.4
MHY'%J_*#J[8*8]Q,P-]I.8G?!+W@PX^"'\$M8V19:AG)4\ 14QJ@4YA(T@*-
M]Z3P*';"RF@6;'37D0<479_&&1VP ]N>1& C SJ_*C;ZY-U_:K.R5GV<:$XP
MU&&CHGY<XI'AIA#A&=W.6(PX9!^I(1'57@9',*(K$\F32E+,NXB&19-+V-8H
MWG]PS.C#!=.>@5""$M<GT_@)%H*IE'^,5F(O<72 [+C<YYT#'&KNK(<#XGU4
M%EY)YL)(]/;J2*Y6=?#(=J?2PIH4$^BCU_U)B1DUXX%>G?#82=8U2G\:T$SL
MV5$C]L8'H[\<17,_PN?[,7U'(Z51N>4<MC//W;'K@UTL92$0)WU<^)$EIS(/
MDTE_B\\(]E([%%>6SG$]4,<4/C4>4+,:TV:#@R4R/SB4APFN."V-+FUE_EHC
M)A,?XE@9_.0X/T9?VW9:3#UL[Q:P@J"1K-]_J,[%"2I+L+A2"%Z4'WF>3M(.
M_(=':Z2G(1;W)S%L%BWFQEQ;JS])C0=BX[]1SOD/P\:$.#;SBV1= G?ZAK E
M 4GNRHWH4>%HA\3I%4>KQB&S9B-Q<U;<2^PQSBZ;S9:M>R2 B7FFZJ12LVPH
ML6JD95$)!J-3:YV';;>3KWN4O1':^\K\CL!%*43#$^Q3T_$[86VH.8>$K[52
MA22#I#S&*L0.+Z+T>XT(N2^M.^Z>9DF*+WXKFIVQO_VI*_*0R('A3NTY;_$#
MG4\L9)F[D^3=]%RL(&^<*MS&:;^"M]]:!K%80>O ?M^AG^M>A0Q#J8F,[US=
M-E45&(0-Z1#)ADV$3#JII)W \'EZ"E&J<&PV.%S%LL8148WI+-V89V[JN&=#
MEPS"9"4CDTCU5E4RB<8;N)^#]6?MR-8N5DGZ294L_!3 R)H%LW$K77P$IOCJ
M,61]<!Z#7(NV/K1E#ZFC"8A+!5%1)_*<:RD-BW:*2="&$-W@N#];9D*>#SH+
MZU_T5&G:I>I7DEIG>&*RP+J[1M33E*/L:3&T@F;,?]"]]01%LQ+<#)T<C+IF
M.&.MCKJ='BL [/5N>4#Q4I+)\3N(-"2C$L32)GO9ZCPV[0LY%SG,2<[@0]T\
MU)Y#GK[,.W'E.E0MQS"S;L9NF*SX??!5^NDD46&V!'LL0!#*)\UN^Y)^J/"Q
M7UT&9F.C/S C\ [?WZV(0NP6S@% EBK8B('2%E/YG<%95N5#Y66RP$*A22(\
ME_4@!$&(S__&;:K,+U$O3-(>I"/?%;/,LM3U('1J72.LW$W:7HO=P"D5%62.
MUX=,)DCD7-0-5)25ICSC!H'7_%(\W6C;XWY]VN__=;<B_(\3/N'(PI)L)B91
MUG;,5C(UV@WM=J;U1<DI+F9@&&CA!C5_V;&ZWQ+HV(\3\+$XSB0O$8('I?12
M":7:E+RQC";;D-M2'3WY9:A]YY)U$^[%O%I)^!0;?$H#D8EZS*%5(2),/);C
M6YB[4)Y!\.*T5S"D[>CZS_S2IL_,6Z4276KCWB.3/YCE[+*UVSFHR ^/NTIV
M(6"<U)J=3DQ3O3PE7IX.*(M?4?-8"O/'FTV"_WAVGEY>7J375U?RVU5Z??TB
M/;\^3=(H=5TA*K0EQ9.H)*K"GF9T!5UTM/2UK)]H*NHG['_15IK=>=11.C2;
MM8!85[PVB?9]Y7;4_W-6@3ZR-4#FH9$<CX6U+LD8_34Y/3D]/1M_^B*UI;TR
MCNDA%<EHW5A/5!K 9N88(@DX^>R_V)4A]VL^$VZ3TY]]_I:F!5YG)IU.C*SA
M6BMQ:OP\J2SL?O'93UX*_II\GER\2,]>7B9?R(>SLQ?IU<5U$HT)#Q\24CYS
M>G)]98]?GEQ?X-G?G@I.ER_3*XK&R^OD_#)]<?9E>O;EM=T9(5CN:=P^2[RV
M=G\6,-(I8H3,\+Z.XG@J.+\B2 +-EHAC5LANMYD#\(@V3*Q?W#LF"TNK5<"=
M*8B('DDA4'%DM/]34@_+QEW,BXDZCP$LR6'Y \P D+Q(3T^O<29?)F>7Z9>G
M.).KJ\]NE7PKF2T<H]"1>?&T9SC3%WC^ZDS^O+Y.+R[./_NU8<\+#OGJ^@IG
M?II<7*27+U_@O^M$2)QI_N,V[A*?%FNLXM$=["175Y07&*)8VS8T<;^6I'@F
M;EE4-(E*#[_N90LGXJ0)K0-&\5658>&['(::2BRC!2HX8-T@X$QM=)QSLB[!
M,6[3)K,B],W%+:RA_"$1A5+/5>;;J$BB.V"STVS!ADRI4(]+BA$)'&GFTIY;
M)-O256"56+RQ;0E']@_7-C#M$B;,$3-9C$(\#$(L+K>N&XHG43/2L<6C#O<P
MVIH>,ZUB^Z:43)M"?'M8U$?V()TFJE6"RQ;$2X=(W":JY&T<Q%VG?LA"EH<J
MYXEZ:HO:SG:U/KDK*ZTSJ]P==MKB"H"6@>.G??8G[X.]B!0-EMOMMX(4C=/T
MGJ#$Y Z!6:^YPT\(!(XDE0M+SMJR4I&-#C J69=L=I,:E]6K)8LTV8$HF]6)
M,;K9.M=%17V6 8T3YAP&G&JQ1>(JNU['JU$A_O(![F#ID)W3$/?:32[O3$7O
MD&^DS-J&!%(>FQ^;;Y-M>03[K5QD^28KE<)P"#J-N"S9-LPB%\2D;P=175R^
M[)S3L-K:/8_@'X8N7,DADM+.:A^#:XE"+RUIJL6W<WJHFSS+",/'8(_G*+WY
M5&/R7OSM< OG[GTW=N>V+JH)"XR%0O6$^7\,C40*6F-3C\JWPD^N(M:3C($(
M% NG&.227[./V,;=(83<*1#')9O#H3$L>N<#O5*G[SE]RLX@-7?X?/2.H<FE
M=O=(Z90N@R0"QIK%DGU2O3CA!R:5RPV:QM=R 7/SY:KQ '&(CK@NHNE,036F
M#;7)C7ANU7 \9BC*W9G&C 2;!DI[J!C3@YLINS%!*L('EL/6%*4L.)MO9_'G
M2"(M&J#/I'T7 O-L%PP]4AJ3F/VKW5(+&TZ4AMU(WUL249]WQ5@K:!OKWNFT
M4=;-R".^',"?I8]=]M4L#<(Q7ML9UA+MW;N#<VG%#FR T:6L19>4TM%#-3A)
M?5$H7 QF?X+U*@B,_V8IG5#>/<QYDC:TAZ7Q4\ZG=R@?QMLSGRJ:9MHY9 0?
M6SFN&K?.9^ MUJ>G!+W=R;A9 YS/ 8>+YCRAN U:TG]>#V,<L2;*IUV^BXJE
M3RT79[)@N WD5:R#V<_4Y]N(WYD%D;&<3-Q)CBG$U1M@&2V]8#<3R 36#;S"
M67E?$<N0XJE;U R+=MO&1,MF6W_(!M3'BGX&WO'F/4U[>T^9<XQ'&-5Z-)!E
M639CDV].'4OC'HEPAWR2D-6@J^J:L/W#UM4G+/E=#+V^+"GV+@C0#CL^I2&/
M76*0>RIV84X[?WL[X7"\VU@<NA"+C,D2+0+S?^J,6(J&EF!L4M(<8*T*9I>X
MI,",^22242KW'W*[C^U5@L;LL+7@J+>9]0-O/51-5!TGP2K.EHVT(V*%DRX$
M),>7Q@]73B9:"X0U3W;TL,=DVK$;UE/B#ZC:6XH2VYQ_8;EH8*>O5%VBH#8^
MG\.=S3M9O4-^ 2>9WL%&I,)FPX)@Q_X/!D/#Y!:6.72F!,&F2)WJH[$E7/TX
MZN3MBO@QR0YLA>8^-+.N=YOIS1SMJI'O2_'Y/ )K*C>&NH469DF"9W;L.)6+
M*(H1\QU,MS?2H?.QB]L-'F].>01IN:T!1Q9?<F#O<C5XMH9"#.\K55):MMW+
M'6^VAEFHUK&AJH@988YJX(/'-,NR5NQQ)5II$Y#OX);-R"ZN^%H-VQ:3=D[)
M,RLH5@)&LJ\L+/]M55;38"U<ORY[@;G8@/"F! MJ(<T;3EQOC31J(B(MFP9T
M8WMY:*C2:7QU&7$,]50+5S%Z4<6FNG/(@]86_SQ<-3KN0>_7T4OK()M0%KF[
MUBTW[!;$Z?AU(VP(ING#$>8$0M()%8S M*- O(+1E8DB?8TQHPN^OEHG9[^D
M/RB7  BH@1@Z5UQ%ZG=JD*-K&-&%@)07HQ-Y\\[U3@ACZ,/?1#+'.^EWD:W_
MS=Z5\$,$#3%KPRLZY 0TLQQ2=-;Z(:ULD2\:DG\'WKH3O07HCDD'2:;=-H4$
M6Y,+FC=WMR$$?'EV-;L\A:V5M]M(9S99_G=7+#G3C+?QK3B--=^P&6K$VY\?
M:KFC#(*BN6W.\=TV[Z798/PEC2K>]HZ#[9A!"SJH)4ZYQ2N %+T- NJ"[551
M1QKD:!ZY[)*=R.VE+R%? 0NY7#JI(4K?PDDXG.TLKR#?FB"9U*7&^'C24&OF
ME^<F1R AK\CYY(TQ4F/>?V7,#55+WSCC$PI['8\C%>'FZ'2U'1?4$BVC"QKY
MUHP)PBVFT(C1NA5?X,;+_>++4-@8],IU\*;39MU 1M&((?#G%+TZR3AG4C;L
MG;;,*/TF36AP&^?M5K[>%AU!UIFD3V$R0)"/#J:,:L6BN8_6=MUWT^R$]1T?
M?O#0XGM[&=^U-#K->BFI,Y4[,84X*D^F]CYL_[10B7+#CX^N+T2/1)'6$3EA
M2BB7WO2BV7#=^'5A;5,W]%543.!S_<3K'W2Z]08Z9QOA[2#$O&IX^S%<_KZY
M>S6VKBNJ'7SL_49V-^+&^':8GYH367YV>IWZ2V%V3XQS?/YKLRGSY/SEZ1=?
M)6_C&RLX]/WK9,GK^$TNOS+.'73M\'HANZ'H_ N1V+>L#[G8)-AU,JWSM.-"
M_I*:X>+T!3UQ+XJ*C@V'?+JU3PE*L%6N%4&T7522,2?)NQW:[ ( $[N5.T"%
MW0*P9!IM'R1U:[7\\ JCR3L\^-ZTN_<CRZ.KH8R+I/<[NHP7OQHG9 UK=GPJ
ME_;GON5AI9_<:D2$7+Z3<KPT5K/Q$8MBJ 9H<P?K),Z-"GT(%<^N4LVAV(L'
MPFJ^[OZI)R^UI82)(;H\A4]Q,W_$KJN=<#?S.A7S;R1\/X1-#:J[I[WC*^*(
M='+I6PC<[BNI+'LBZ>.DC]]5\(1%[KR?<W9Z2-U2[:*/UO)>O+^49$RBE8D(
M'G'G.-XH/KR"4H&  %" H<"X"(: + %1L,R($E^F4__, .+Z\A! C".?  R\
MT;Y<TMO0C,@N%&21;7=3WV@4 G'Z==J)GD1J%L_<U+N><%F<[.YX7S]V,<SJ
M?J)?_YKP'Y-]-DF)@\7+(SXU;?&&2:!/+"Z'LO!IT2>FRG9LT>6C0G Y.[T(
M0A"<<'BOHQC?3AP>&SKSO>Z4!7_2W'(D&LGG=\.\5Y-S?CH3H=H9S9<[[J[]
M)K2\:W@29(HOPSBPY8F&2=Y@SH@P4<'PL*$O@Z,<'^*:O)_(WBMV4%Y]4F+L
MB??VR5YCB&F* -Q]I!+F_9G3*IF'-8['2T H[!^Q,9^:7HJG_SS>OTBM:C$%
M>PHSW:4_,Q5PZ\U4_,NCZ/]4#7!RZ-Y%]$KP"2'@.T&U83;76_\!13=3%#5U
M\&^3H89\'KUE B/>\$4+_"" BS TXYO4FC:WEJ?D!@/HKT",]=59$H7<0EI4
MDLP),23/0CLWG[U[<^L+EWJQW]YJ:>F28MKO(.^#D0)*-G;#>EX=KO1:45YN
M/VAM;/\M8&E\!R<*=7P$J?="#[WF]WGT>F9Y'P5?0BUORJM[?5-S^#:\Y_I&
M7^\\#M>79/^8D<N\L;7 HVRT>J:O0O0?@"+RLN=YT_?-6OY<N0PA!@?@]T4#
M[;8/7""\_?N[_P502P,$%     @ "XAT6L*U- +I!   ]@L  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&ULM5;;;ALW$'WW5PR4(FX!69==R;=( GQ)
MT@!-8<1V^E#T@=H=:1ESR0W)E:)^?6=(299L66X?^B)Q2<Z9,V>&0P[FQCZX
M M'#CU)I-VP4WE?G[;;+"BR%:YD*-:U,C"V%IT\[;;O*HLB#4:G:2:=SW"Z%
MU(W1(,S=V-' U%Y)C3<67%V6PBXN49GYL-%MK":^R&GA>:(]&E1BBK?H[ZL;
M2U_M-4HN2]1.&@T6)\/&1??\LL?[PX:O$N=N8PP<R=B8!_[XE \;'2:$"C//
M"(+^9GB%2C$0T?B^Q&RL7;+AYGB%_B'$3K&,A<,KH_Z0N2^&C=,&Y#@1M?)?
MS/Q77,;39[S,*!=^81[W]LEC5CMORJ4Q?9=2QW_Q8ZG#AL%IYP6#9&F0!-[1
M46!Y+;P8#:R9@^7=A,:#$&JP)G)2<U)NO:55279^=%L8ZX_NT);P2<_0>1+<
MNT';$S;O:&=+G,N(D[R TTW@L]&^</!>YYAO [2)U)I9LF)VF>Q%O,:L!6FW
M"4DGZ>W!2]>1I@$O?0%O([PF7./8@] YO/]>2[^ 6\QJ*[U$!W]>C)VW5"U_
M[5(A^NCM]L$GZ-Q5(L-A@XZ(0SO#QNCMF^YQY]V>"'KK"'K[T/]#KO;B[&;Y
MN_$(:0MV.X&[ L&,OV$X1 [,!#S-7)FR$GKQ]LUITCUYYT"N+: R2F8+$!;!
M&UCYH8'4F:R$:D+)/6<#Y="!DI2.G!-BD486HW-.E!,3G-;"YDLGF,.DUKE;
M,?;,6&XPS@QU#N>9ZGWKM@53,T.K S?WF&V&?KI,S4@3]<==K1#^DB84@L"5
M<$Y.)+&@"!QN>:9U,1-2B;'"(^J;1TXHW(!K\@X./,P3/U=GQ19"*18PQI4(
M.:MF+.M(;8A!%CR69:6"0#2KB7,,C4K7XS1ZT8$=M3E#67A"6RBUY7(N??$(
MGQ.((PH+$S L(I3Q>(N8,][ U*O:9H2,'!+%9X-^SJ'G8@@[199%X:2>AJ10
M8;!U3MU4"9V1#-R]2.0+$I<*I91U"11N+EUF:L:STK$QN5Z[D\2DI+S+OSD6
MG;?)@#Q99& 61U-!4' T(/>!GJ [(/]6+^N3]BPDJASJ@!W20=IQ$S_B T/E
MZ0N3 Y=%6%5R@JNZEYKVUHP32^.12F9BR>TM@, ^4.$J9N;17H2+BE6-*L3R
MC&$M5U:BN,UJ:&T=53YR%BM"9&E"NJ0%6I9ED'TBZ',F5(TMN-=TDZO ?$HW
M>'2H#"4PXI!ZJJ9^SLDD'G59JX!AN*Z $VNQX"N:CC:;!9W#O-&L,A>W-]E#
M852.UAT"QGY+$4@%*]]1Q(E1]$3@9+ \JV="@-AYPILP+R0=G#DE>JNR7SE^
MO(% Z7[!<DQ1K.Z8$#L-TO.#9VL'%^L,7W&&-W3[&'3;F/@MRO>!9?[*,A_L
MZ3\_0;=[UCSNI#3J]^GG9TC.X)?5?')V<&>\4"](\"_,GX:2_H^AI&DSZ3*5
M-#!) Y$X^<SP69.%+FT\.8&$8R#+^/E:^+WC9N^LP]$'E_W@<CEY02UN^Z(Z
M?*TT"D&%3+7G0Y6OVR&A*'3<M*F)4&7# H5MP:X[O;WQ%BO13L.+DV\C*OGX
M+%O/KA^U%_$M][@]OH@_"SOEA"B<D&FG==)O@(VOS/CA315>=F/CZ9T8A@4]
MS-'R!EJ?&+K4EQ_L8/W4'_T#4$L#!!0    (  N(=%I*[D]=N08  %\3   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;+U86W/;MA)^UZ_ J)TVGE%T
M(67Y$MLSL=O,Z4S3IG72/'3Z )$K$0U)* !H6>?7]UL0I"E9<NKI.7V1"'+W
MV\NW6"QYL=;FD\V(G+@O\M)>]C/G5N>CD4TR*J0=ZA65>++0II .2[,<V94A
MF7JE(A]%X_%L5$A5]J\N_+UWYNI"5RY7);TSPE9%(<WFFG*]ONQ/^LV-7]4R
M<WQC='6QDDNZ)?=A]<Y@-6I14E50:94NA:'%9?_UY/QZRO)>X#=%:]NY%AS)
M7.M/O/@AO>R/V2'**7&,(/%W1S>4YPP$-SX'S'YKDA6[UPWZ&Q\[8IE+2S<Z
M_ZA2EUWV3_LBI86L<O>K7O^'0CS'C)?HW/I?L:YEHVE?))5UN@C*\*!09?TO
M[T,>.@JGXP,*45"(O-^U(>_E=]+)JPNCU\*P--#XPH?JM>&<*IF46V?P5$'/
M7;V1RHC?9%Z1>$O25H:0<6<O1@[@+#)* M!U#10= )I$XJTN76;%]V5*Z3;
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M/#PY[@M3?\ZI%TZO_">4N79.%_XR(XDP60#/%QH9" LVT'Y3N_H+4$L#!!0
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M=T5O-VH'H/6%HJ/7#5R"_M_ ] ]02P,$%     @ "XAT6G;.21$\#P  TRH
M !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULO5IICQLW$OT^OX*8>!<V
MH-%(<_L$QN,X<> +L1-CL=@/5#<ET6XU%;)[9.77[ZLJL@\=$SM8+&!XI!99
MK+M>%?O)RODO86Y,I;XNBC(\/9Q7U?+1\7'(YF:AP] M38E?ILXO=(6O?G8<
MEM[HG#<MBN.3T>CB>*%M>?CL"3][[Y\]<755V-*\]RK4BX7VZ^>F<*NGA^/#
M].!7.YM7].#XV9.EGID/IOIM^=[CVW%#);<+4P;K2N7-].GA]?C1\S-:SPM^
MMV85.I\523)Q[@M]>94_/1P10Z8P6444-/[<FAM3%$0(;/P1:1XV1]+&[N=$
M_27+#EDF.I@;5WRR>35_>GAUJ'(SU751_>I6/YLHSSG1RUP1^'^UDK7G)X<J
MJT/E%G$S.%C84O[JKU$/G0U7HST;3N*&$^9;#F(N7^A*/WOBW4IY6@UJ](%%
MY=U@SI9DE ^5QZ\6^ZIG-VZQL!6T7 6ERUS=N+*RY<R4F37AR7&%(VCA<1;)
M/1=R)WO(C4_4&U"8!_5CF9N\3^ 8O#4,GB0&GY_<2?&%R8;J=#Q0)Z.3LSOH
MG38"GS*]T[\CL'IA0U:X4'NC_GT]"96'U_QGEQKDD+/=AU D/0I+G9FGAPB5
M8/RM.7SVSQ_&%Z/'=XAPUHAP=A?U[[?9W>3>NLJHBZ&Z6S/OEL9K^JY>&T1!
M4!_GAK8L=;E6A3QRTZG-C&+)50T'\.I6>^MJ_-1LE[5#]=%5ND!<EY4R7Y%C
M@E'(,4H7Q=9B94M5X;C,E<$5-M>5R56H\$>X==.T!0N8]PR,>3.GY'%K%"P:
MU$KCI^72NZ\6P6R*M;JG1L,S!%514'Z@PXW.YD2-#EL;[8,RY,8*3F@6$XB3
M')$/P8?3H7I7JNNEMX4:/Y3?!KP]J08,&@\2MJR<TNKTZFA! ;(I(Q]_/K@:
M7R(QU1K^-Z643))UE0I%O/*W,.! W>C"8E-I-1VH68O6DQ5*]4M=&G4Z8GXN
MU7WBYY\_7)V<C![+;K&ANIYYPRKD'\>/'^R4!F="\9_K4O+HRH)[HKB;5%]Z
MR(ZDQ?;2)3BT@47>+?SXX=\7GJP;L =*%CV0&K;-MM=<9CHU7" 4>5?R@6\1
MT9O,S4K[)XF8YY9T!+\NP<NO[WY3.H K\4D1M;!Z8@LL:]U:+UQ=LKCDD>>-
M1S*S'\RR$B'.OL6]+NYPKXO!^/3JKS3\O/9($+/*E0/U!MPC(FJ(4(5M+WOK
M;H6SD_$.3VL)[?<VRB&-4PBC0C_OTQ=//F.%;)YZIP'W,_%_,N*PER=S(P%!
MVZ8P%^**2PQ_ (+"&?$$:-J6&6S/--[5/ADJ9L2YAJ0:?!/P(NT183J]G^).
M8QHCUG.G2L=DBSJ'AI:2+CEB*N0Y%B.2YTS<*@+.9%V.I/UNPZVZFNGHA!RL
MJ]*JI4VI&?K/V ALJVVJ75+>< 4MA43Z?*N+FHTL&Y9Z+96 !%S#:DMM\[W<
MMB0=].H)MY$6:EI12MTJUK2+U[-P)!"!OUS52R<&WXRPGOSXEW\&>L,&4B7.
M:U@DS6:9KTV^P3QE6FR'NG-$ #M%H*>RBKRA)/_&$^+(PJ.L9R6VY6]#4BJR
MK<]]MP(':H6X0G"2,Q$#GHT&!H/):@K2B?/ +G0L3H?<&;Z;  WE[)*.C\3N
MVHM>8E0F"' =Z 1VY=+!&!5JNFS-S:3",\_>8BO2(TZ'/ZJISJ*6!PT;6.=
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M7#!=:22#B*IR2B7;>6I\%0=TX\NH'9@WKQOTO*GI[3,T!2229C.,H='@4+U
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M"_#[U+DJ?:$#FO=8G_T74$L#!!0    (  N(=%J9LEZD&@P  "XC   9
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M*6<;"K&&1VUW^ QMJH 8[D#0O_D5 C$#FA&L -F")7(M"XX3E0.K14F)(G&
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MP89RTOZ* ]]IQDR\SA$P@A3$?20V!5I,#L8K<?H-*(S?D669IW50A%VI2J\
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M*T0-4!<A4(P?P_#VTBB:MB7K8FFS262$/F6JT?88ZAA0#B??PR)-1J8',(;
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M>=_[GVI##-$8?T0GSBF4/&UJ2^(!E08;GIP+)]XS1 ;B32E^J9%FD]@W2_U
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MB@BI^2I$2G!4&\E,0)Z@7#R,TE'*Y !"/)VV-0Y_-G[4+W;1*47#3<3>>8P
M?X?)[2?%3E-]B!D!_H@CH@/5:8 -2<H?T).S6^^"W\-XNE]<-\7\[ *)::>D
M=8_.WNQGT*#[+Q)-F6VK);"6)K,H'@[%MV(VF%SA3X(E1USZ].RG4!B2)(K3
M230:)R(=)/'9C[XGQIM+\9+<7V!Y(6:3-)H,$_$(;.+I$?&'KAM29??%DC08
M#=($6Z^P3(?C5OHD3;GQ2 =I>O:JG6@NQ-@W)(_P9GA2J6$"Q2=C4$T'Z=47
M*#4BI29#JN(S5BI.L75,2L71))V=O0D!&2:R_?3C XJSI&?]A8S"E,:P.:73
M+)I,IE$";'XKQH/A5$P&Q'0:S:YF"'^,&Z736;@*0\/6SBGM!)OKQ0(A2L$R
M5]56J3*,H>&ZH9THZ"G#L]CY-!TN.<)$W[]R\S-^I[>EJ.Q>$'"!6LG\0%!X
MP4D#<<.Q(,M# <C'H3L])NI@TFD$^'C<M[?ZP#LT-/4]3P,P:GU(?!0]PI?O
M^^= *>-;$2-,D/B+=I!NZGXS-KHCKCK6AG;O.KTA7W-/Z7N&JI=][EU==2XQ
MGYS]FVSCV_<S-H>"$#$5T.LU]$#H7 LF<3(8BN_$50ST?G?VKKVQA&=Q?H [
M7UTB?$$T'$Q!\ZIWU=+Q^(5NTA,0?(7_DK-7[>UN>VO EYQ-&@+3_<K?#3:H
M:(QM[V$ZCGSH:KCI> ].W9T\=JX-E+#\^2>#JR$_H^4D%OU*<?("X&B=6)FM
M1\N[VP]M?>!BXTGOI_VOR_%(0I0ED74&HVF;5!N/-JF>[B3$;SZC731['OD]
M1S/K(8,OR?;-GOL59C1A@?#KM*?*H92_2951(Y"/<AJ^=<SO?^MX%3Y:O.?.
M]>CW#&YR?>KG0G]\_C_RM:/)E%^!/%+ <KX*8O9HNN#9Q=0.&]RC$Y%^>^K.
M*BN0)OP,) $XX!?;Z7L'7<YU)K'&:)2S*.5BA'GV*CG[294(P,)?I>5KS'#T
MG8P[TF;++)J-QN@XXO'HS+OSY W:7@J:]B1-L9A$8^R^/GZ:8?A&U>I<GOTE
M]\[!E:9\',HY]?GT*<2?T58*CO?I8-(D_,ZU^,&=?T<X?9CA3R]M;COU20'V
M(,@\" ;'/@1>=C[=KI5=\@=J@@+&&_\5MWW:?@._]I]^]^3^ _IK:9>HA*)0
M"VR-!]/QN;#^H[3_49D-?PC&Z(^IGY<K)=$*$ '>+XRIFA\DH/T_ U[\#U!+
M P04    "  +B'1:[%"22,H$   H"@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6R-5MMN&S<0?==7#)0@38"-M#==?!-@.[T!=6/$:8NBZ .U.RNQ
MYI);DBO9?]\9[NKBQC'R(BW)F<,SAS-#GF^-O7=K1 \/M=+N8KCVOCD=CUVQ
MQEJXD6E0TTIE;"T\#>UJ[!J+H@Q.M1JG<3P=UT+JX>(\S-W:Q;EIO9(:;RVX
MMJZ%?;Q"9;87PV2XF_@D5VO/$^/%>2-6>(?^M^;6TFB\1REEC=I)H\%B=3&\
M3$ZO<K8/!K]+W+JC;^!(EL;<\^#G\F(8,R%46'A&$/2WP6M4BH&(QK\]YG"_
M)3L>?^_0?PBQ4RQ+X?#:J#]DZ=<7P_D02JQ$J_PGL_T)^W@FC%<8Y<(O;#O;
M]&0(1>N\J7MG8E!+W?V+AUZ'(X=Y_!6'M'=( ^]NH\#R@_!B<6[-%BQ;$QI_
MA%"#-Y&3F@_ESEM:E>3G%W>X(HD]?,+&6"_UZGSL"987QT4/<=5!I%^!2%*X
M,=JO'7RO2RR? HR)SYY4NB-UE;Z(^ &+$61)!&F<YB_@9?L@LX"7?6N0\-?E
MTGE+*?'W<_%V:/GS:%PFIZX1!5X,J0X<V@T.%V]>)=/X[ 6N^9YK_A+ZMQW(
MRQ"_&H^0Q"/X,N[/:X1K4S="/U)V64NKZA&HQ*WPZ$#HDI)+4S4ZD-[!LG6$
M[6C!@=%(5<A 8JD07(<=@3=4!1NJ[@;\FG :2<XTV5BB47@@F;5KE- >2Z#N
M0:.P#VFW87(6_^DJ='3,[CL'Q5IBU7-C[B46,O2"6MRCA;>T&[QY-4_3^.SZ
MXX>;[CLY>Q>!=$RE!\ '+%HN?3!5)0OR[#:JI!:ZD$(1 T<U3!%6P>W H-_;
M,&.+O3)E8-\I00.*-#@1@Q'<L 5S91.AE"DZZK2#:6V!K"((* C1*%D*!J">
M0GQ1LZINC\6XPCG6GJ?,AI@H!8J59J('1+$14H4CX4W7E&WDND3G2;!&F4?V
M=WCL4%A#L%6K@^QN!)<T"732*_7<$1,W+_UC=.#6$2,HTB?<"[K XY!IY; =
M]\R2XWZJ[1,-G*<_WBL<PD%V2F&YTI*.C=+GP.>!KB3:/N*TI#3;R/+I043A
MN$)QAJP3G8B5(7I;"O-T\"<*V[6K ?<8;C39X.,^U78[G X^X\HTMET*Z^$]
MW,M2X^-12@>:S&%E1>W@-:2S*)^D])$DT4D>_\_?<(7LRB7$LG?-XBED43*?
M#BB)VHI:4VN92I)&>3Z'>13G\\$M6F>T1O7>H@K*)7$T(\]YE$V2P9TWQ?W[
M3O""E*88.H()(:<I3*-)/AG\B)J3J3NPDNX4R:TP5$@?=S#,((].,HK >#(V
M7V@#LSB:S&:09U$<QX-?0DY94Q]7S=N=T3OZ[ SAW>!C4$%JHH@1:'IY9-$)
M'T(TG>6#Z[70*Z1EJ(2TL!&JY=*%K;"6LT!)L91*>MGWJZ=6AZJ6FL)JNZ22
MSK6D"6'B0\$U19:D?(%8LO+1"?$BKM,H31(B>,LY%5H-97=/%+QX0!?"()/0
M;)+T;+!KL<R$(U$LPVLRRZ9TF#E9\B!)2-&,9'CN@A@?W=XUVE5XHW"!M-IW
M%_E^=O\,NNQN_X-Y]X:Z$9;:CZ,V49%K/)I-AF"[=TDW\*8);X&E\?2R")]K
M>LJA90-:KPPU[7[ &^P?AXO_ %!+ P04    "  +B'1:MQ<VJ*$"  #.!0
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M0>OD$/O+'N0PQ5=#"&DZ@O_K_E8AG)FZ$7H'E7" &Z%:05CP+@2X1P@9X(?
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M'/%B0@PC6K! R4<[-*\T,,-HPPO6NSC,)"\1;*TLMU RI7(^8Z,9:IS(:*S
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MZGFW@3S+.V;9<J[5GFAGC6ANXJ5Z;R3'I2O*D]5XRM'/+A\TU(R7Y.,+EMF
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MS+#JNNUP[<*JVG>5M;+8H_QTAW\*0#L#/-\H9?N%"S#\S5C^ %!+ P04
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M- 79]EW;%RU6MM=Y)[06E7U<,HK7'S,!QPLA].;%*.B[W^?_!5!+ P04
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MD6I&F^;!R+4;)^;2X'#BEBN<!D%9 7R_D-)T#]9!/U]._P-02P,$%     @
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M56+5<B0@O0*0GM7'O[-X!D+/66SG@IJRF&421TDL[+S6)?FQ*?LZ$'(#/6-
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;,U636_;.!#]*X06*+K
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M=M-XF(0H; _3'MSDMK%PXF#?M/#O9SLA"UH[\;"7V->^Y_B>DVLG.Z4?3 &
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MJH%V"79_K12^!.[B].]D^AM02P,$%     @ "XAT6NJ>N?]Z!0  ?R<  !D
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M.ZRZMZH*;:%5R=.Z$!K54_NZMZKL<K3JO0#J]_=TAQ9MT*S:RB5Q%:UB*8[
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M:HRV97,E-1TMROI47PN-=T3=S/ 6!VD"<#X50N\[YJ+H_A=$_P!02P,$%
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M#HY(7--VD7;B=!T*\8-V5-;#L*+&B\8?H/VYUNYEXB_H6GG^&U!+ P04
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M E;%:5AQ8V3F#I0>I#$R=9<QH[ TV@'P^UQ*\WQC)ZC.)"?_ 5!+ P04
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M^A)"-71Q@*%='*AFH)J):A:JV:CFH)J[UQH;F(='(U //:F/:@&JA:@6H9I
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M,!^E6^.6_SO4$2NG0\Q6YRZOG=+4P+]POOLQSW7R5OP__ ^I#!!Y;P=$&K5
M3:'MRE69(&)V02>5=$,&IR!N3JQC;!"[YP.51W+-'NDN[\?-E(UYKE/E: IM
M5YG*8KGDG<O&;=20-86V*U=EV]PC;=L196.&.IFX.;'BQW4=27OKB#)&OLQ.
M;@5X+$UD?LA6WLU/AV_(]20[1-V[/R;7X^RLU*Y@\B/G.\J782(@PH6"=%I7
MZ@W.\U/<_$*R5780.F=2LCC[&B#UD>L!ZOF",?ERH2<HS])'_P%02P,$%
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M"*5U,.L;(?3)L 3URQ;_ 5!+ P04    "  +B'1:"W7W=B,)  #M5P  &0
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MILM*E'D3+%N0IT7]ESXV'\16@#MX(<!K KQ] _PFP-\W8- $#'8#_!<"ADW
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MXFL<D9N!K#R<L"T93/[\ _KV7UU2]0D6]@16D]$M971-Z)/O&\&%S- X6UZ
M9[*,LTS>RB(D5T!$NG3,\3R-I^KQ=@(])X"!)Y-BNZM1NZ.'8& [C7ZA<8!G
MTO=*^IZ1OE[4S=65\_1:P_>1_ [9#9;M;A#:R'<]V*!I',B9-/V2IF^D^?65
ML"CFW43]%H-+SVX3-;[AU)3O":PFQJ@48V040WYI%R26LR[+]DQE>=*MRZBM
MBP-]U_<:PG3T"WSD.\T$,([J3,Y!R3DX?ID3?36M\:!CC?O.R F"!O>NCEW%
M(&QW;!:#&J]QR6MLYI77>[ E7$VH^F23U[5T8_)!4-W<Q6]\+#_CVT]-^I[
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M#U+KR006$GR$I825IX0'3.61CB)H390W=%IVPOBNDY7I":VN3.5*X?@T._%
MU.ZE6AXSF@F&(['!"?A!6 H^WV7@C6#&OW2*UZ<#G?6*%O:%5M_-J@PM.F!H
M:RYC?]4Y #/*U0<^2/5^6^?.F!DB*""@76  Y((Y?NO""H_%RJ'DL-I =<$J
MDXN,MN_<TG8 ]2C]>G6W?:'59:S<+3K@;H\K>P=0_$*V\7O*P&!?RLS,4"?+
M]Q'^&%7^&)DW;J?+)2-++ BXDY4PSG@<@9\XV72+V.NN;:]H85]H=1TK X[,
M!KS2,2YUW"H=+\!.9>P4-0?V=\VY[:/FWD=7-Z>Q^16:!WFN")7K1F;7?6Y)
M:^_:=BK0D[LNI/H(KXXJKXX.>/4CRY;?FO51,&XIT^MN<%]HN3+6SCEB2MA2
MG\=R$-%-)O+3LK(U/_.]A5>A/AIMM$_AU52?@%H53'Z0_ VSI5QQ("$+"6D/
M1W)J67XVFS\(NM:GE<]4")KJVQ7!<\)4!_G[@E+Q_J!>4)Z03_X'4$L#!!0
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M%;+!T,.Y;!J!*0/Y?DJIV$S4!_(VU/L'4$L#!!0    (  N(=%KUQ[7#1P,
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M%T SD!9@?I\)H3<W]@7MP>#T7U!+ P04    "  +B'1:P[*QQEX#  "0%@
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MX@CF #Q@2!29Y^#.\RA8/Z>"S?^@1W\!4$L#!!0    (  N(=%J7BKL<P
M !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6
MH@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.
MD4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,
M<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW'
M]I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ "XAT
M6KV41/@/!0  =BL   \   !X;"]W;W)K8F]O:RYX;6S%FEMOXC@4@/^*Q<MV
MI78AUYFI2J7>9A=I9HM*U=>524RQFMB,[=!V?OW:R; ]H7"T+Z<\09Q@OIS8
MY_,E9\_:/,VU?F(O=:7L>+!T;G4Z'-IB*6IN_] KH?R9A38U=_[0/ [MR@A>
MVJ40KJZ&\6B4#VLNU>#\;%/7U SA@7:B<%(K7Q@*'J1XMF_GPR%;2ROGLI+N
M=3QHOU=BP&JI9"U_BG(\& V87>KGO[21/[5RO)H51E?5>!!U)QZ$<;)X5SP+
MD/=\;ML2Q^=WW(.,!_G(5[B0QKKVBK9^[AG7PE_<'35.?Y65$^::._&GT<U*
MJL=0C;^+(;B--@Z;SRZ(I^;_A%$O%K(0U[IH:J%<%T<CJ@"H[%*N[( I7HOQ
M8',)XZID-\KY(+&)ZJKRUX8[]7\]*;N[=AX7Q-"<2G_"3,H6G [RRA_K2I;^
MWTMVR2NN"L':X%H &". \<$ V=&4 \@$@4P^$'(6(,(/+-,+=KL2!D"F"&1Z
M,,B9TP6 S!#([&"05]PN 62.0.:TD%/^RM:6385I?QY:Y+6T1:5M8P1 _(0@
M?J)%G"@K2V'8O>&E3X#LPABN'KM@ L+/".'GCR6<^L=>2&';=#F%?>8+ OF%
MN#F^SH6QHFA,R-YWTCZQ[USQ+I#'#.;P$9;$1[28U\(61JY">>@IEXV52ECX
MH"/4,<22F35US<UKFVGDHY+^9]Q[\:(H=..]"#$QTT3$JIDMM7$G]\+4WM-K
M8=UV;XDPQ43$COG*I6$/O&H$^RYXR#3O\#"Y1,1VF1JQXM(/=%Y\)5;88W;K
MEKY[7UCK57T,,3&]1.1^J6O9/=@VT7C?.)]]A JI!T)B>HF(_3)1A:X%N^<O
M?2;,)Q&Q4,(0X6FI*Y^R[6_LYD?C$R)DPTP2$:ND93NYY%:$!UJ'!OANB(U)
M)"*VR$P\MA.!.['R&<8W-SBTQKP1$WMCULRM^-$$MIOU5C:),6/$AS3&/S'$
M1.<FU,9 ,1.(B:DC)E;';K&Q(S]IKH3]'6)B"HF)%;+'<!M.B(DI)"96"&JZ
M?MO$)!(32P0U'3N"F)A78O*)RIOK=K9(3"SQ1XAE2WH[(3&[Q-1VV6._7Z!P
MA01S34+MFFT)[@ID@DDG(9;.GED4.V$792D=Q,2DDQQ4.BG$1)?$J*6#8F80
M$Y-.0BP='#.'F)AT$F+I[%'X">OX(28FG818.GLQVQX$9_H))IV$6#K[1AH^
MG+[V$F)B^DF(]8-@AJ<.,3$!)<0"0J/9&Q"EF(!28@'MQ]Q.[REFH9380OCP
M$LXI4LQ"*;&%<$QHH12S4$J^,X.-@D\@)KHU0[XW@V#VNQ!FH?20JV?]MHE9
M*#WDU*??-C$+I1\Y]=F8O!V)?--^V DQ,0NEY!LU^S"G1J^ATU/,0BFQA;8P
MNP&'5KSJ-MWA]B9FH8S80EN8=Z+0OEE6LINR:8B)62@CMM#V0P_#HJ82FV$R
MQ,0LE!%;"(UF+V]FF(4RZKG0KG6$MS8*,3$+9=1S(8#Y1OG?LX>8Z"L"U'.A
MW='<<$),S$(9]5P(P^RW3<Q"V0$V=MXPH=,SS$+9@?9X?G4CB(E9*#O48EPG
M3OC^"F:AG'HQ#L'TU4-,S$(Y]380%LU>%\HQ"^74*W)8-/N8F(5R:@N]6X'M
MB1UB8A;*J2V$8?:CB5DH;RTT;"^VYV>E6$@ERK_]7UA?7O"JF!H6/KKW3M(L
M;!$OFJJZ\F6WZIOFY>:UT<TKK^?_ E!+ P04    "  +B'1:M7%@?!8"  "J
M)@  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=D[;MM %(7AK0A<
M@$?W-;8#RU4:MX$W0,BC!RR)!(=![-U'D OI$"G2&#P5,21X^3?\0 R??I5#
M.^Z[4]WM^[KX.!Y.==7LQK'_D5)=[\JQK7==7T[G*YMN.+;C>3EL4]^NW]MM
M2;I<YC3<SFB>GVYG+EX_^_(_$[O-9K\N/[OU[V,YC?\8G/YTPWO=E3(VB]=V
MV)9QU:2/P_5T39>#W)TG-XN7MU4SO+Q)D^8.4@C2^8,,@FS^((<@GS\H("CF
M#\H0E.</NH>@^_F#'B#H8?Z@1PAZG#](EBCCDB!I@C6!UH)<"X'7@F +@=B"
M9 N!V8)H"X':@FP+@=N"< N!W()T"X'=@G@+@=Z*>BN!WHIZ*X'>.OG8)M!;
M46\ET%M1;R706U%O)=!;46\ET%M1;R706U%O)=!;46\ET-M0;R/0VU!O(]#;
M4&\CT-LFFR4$>AOJ;01Z&^IM!'H;ZFT$>AOJ;01Z&^IM!'H;ZFT$>COJ[01Z
M.^KM!'H[ZNT$>COJ[01Z^V2SFT!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U
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M4$L! A0#%     @ "XAT6J7^?1SP    *P(  !$              ( !PP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ "XAT6IE<G",0!@  G"<
M !,              ( !X@$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  +B'1:]!E3\><1  "T70  &               @($C"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ "XAT6K]B-N8R!@  _1P
M !@              ("!0!H  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+
M 0(4 Q0    (  N(=%J<ETT#;0,  $0/   8              " @:@@  !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  +B'1:[9M>T"@$
M  "C#0  &               @(%+)   >&PO=V]R:W-H965T<R]S:&5E=#0N
M>&UL4$L! A0#%     @ "XAT6GZ4/EFY"   (TH  !@              ("!
MJ2@  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (  N(=%K=
MQY6TU 8  &\=   8              " @9@Q  !X;"]W;W)K<VAE971S+W-H
M965T-BYX;6Q02P$"% ,4    "  +B'1:/K<A($X"  "E!0  &
M    @(&B.   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M"XAT6BQU:+Y# @  B@8  !@              ("!)CL  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    (  N(=%H\I3,X$0(  -T$   8
M          " @9\]  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  +B'1:.KUQQ1 +  #4-   &0              @('F/P  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  N(=%H+*]?=7P0  (P)
M   9              " @2U+  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ "XAT6L8C/#3\'@  "5P  !D              ("!PT\
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  +B'1:PK4T
M ND$  #V"P  &0              @('V;@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    (  N(=%I*[D]=N08  %\3   9
M  " @19T  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M"XAT6DCNW2T- P  &0@  !D              ("!!GL  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  +B'1:=LY)$3P/  #3*@  &0
M            @(%*?@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    (  N(=%J9LEZD&@P  "XC   9              " @;V-  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ "XAT6I?<87* $P
MJTP  !D              ("!#IH  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  +B'1:(?KKI\\+   E(   &0              @('%
MK0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (  N(=%KL
M4))(R@0  "@*   9              " @<NY  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ "XAT6K<7-JBA @  S@4  !D
M     ("!S+X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M"  +B'1:N$8MH^X?  !#8P  &0              @(&DP0  >&PO=V]R:W-H
M965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (  N(=%ICOF+?"00  !4)   9
M              " @<GA  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L!
M A0#%     @ "XAT6I CO ,! P  5P<  !D              ("!">8  'AL
M+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  +B'1:)9:P["<%
M  !%#P  &0              @(%!Z0  >&PO=V]R:W-H965T<R]S:&5E=#(U
M+GAM;%!+ 0(4 Q0    (  N(=%J0]1D.+P,  '((   9              "
M@9_N  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ "XAT
M6M4]434$!   )0H  !D              ("!!?(  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  +B'1:#5Q7:CT&  #T$   &0
M        @(% ]@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   (  N(=%I;\[H-VP8   D7   9              " @;3\  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ "XAT6HOO=DN4!0  :PX
M !D              ("!Q@,! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  +B'1:L5<F%J4#  !Q!P  &0              @(&1"0$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  N(=%I?N3%A
M#@(  .$$   9              " @6T- 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ "XAT6DD6GO#/!0  0QP  !D
M ("!L@\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  +
MB'1:&AZ@_SD#   #"0  &0              @(&X%0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  N(=%K*UDNH<0,  /4+   9
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M970S.2YX;6Q02P$"% ,4    "  +B'1:9_M1 7D#  !*#   &0
M    @('/*P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M  N(=%JNR<[8>P(  #8%   9              " @7\O 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ "XAT6NT#V::^ @  _0<  !D
M             ("!,3(! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  +B'1:YJ77",P"   C"   &0              @($F-0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  N(=%I)#DX]G0L
M *V3   9              " @2DX 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ "XAT6FP)9!YR @  Z 4  !D              ("!
M_4,! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  +B'1:
MR*4@Z P#  #6!P  &0              @(&F1@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    (  N(=%HXR&$P,@,    +   9
M      " @>E) 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ "XAT6E]PI>N5 @  \08  !D              ("!4DT! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  +B'1:X$"_KXH"  !'!P
M&0              @($>4 $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    (  N(=%K%SQ2AQ 4  )\<   9              " @=]2 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ "XAT6J++O,P(
M!   I0P  !D              ("!VE@! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  +B'1:RQU6W@0$   O#0  &0
M@($970$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (  N(
M=%H1";D=_P(  %$(   9              " @51A 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ "XAT6B=D#S":,0  H4P$ !D
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M=#4X+GAM;%!+ 0(4 Q0    (  N(=%H+=?=V(PD  .U7   9
M  " @6:H 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M"XAT6O@RXJ>D!0  +1\  !D              ("!P+$! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  +B'1:SL-W6#\#  "5"   &0
M            @(&;MP$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    (  N(=%H]>A__>0,  )(.   9              " @1&[ 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ "XAT6O7'M<-' P
M#PP  !D              ("!P;X! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  +B'1:5I+:9ZX#  #Z"   &0              @($_
MP@$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (  N(=%H.
M)O/L"04  "04   9              " @23& 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ "XAT6L.RL<9> P  D!8   T
M     ( !9,L! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  +B'1:EXJ[',
M   3 @  "P              @ 'MS@$ 7W)E;',O+G)E;'-02P$"% ,4
M"  +B'1:O91$^ \%  !V*P  #P              @ '6SP$ >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ "XAT6K5Q8'P6 @  JB8  !H
M ( !$M4! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M"XAT6M(T9!3L 0  !R8  !,              ( !8-<! %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     $D 20#V$P  ?=D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>206</ContextCount>
  <ElementCount>363</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995487 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995497 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995517 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995527 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995537 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995547 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995557 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995567 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995577 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995587 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995597 - Disclosure - Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables</Role>
      <ShortName>Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995607 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995647 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995667 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995677 - Disclosure - Description of Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995687 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995697 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995707 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995717 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail</Role>
      <ShortName>Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995727 - Disclosure - Short-Term Investments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail</Role>
      <ShortName>Short-Term Investments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995737 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995757 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995767 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995777 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995787 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995797 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail</Role>
      <ShortName>Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995817 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995827 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail</Role>
      <ShortName>Commitments and Contingencies - Components of Operating Lease Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995837 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995847 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995857 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Loss Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995867 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995877 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995887 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995897 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995907 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995917 - Disclosure - Stockholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995927 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent</Role>
      <ShortName>Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995937 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995947 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995957 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail</Role>
      <ShortName>Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995967 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995977 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995987 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995997 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of RSU Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail</Role>
      <ShortName>Segment Reporting - Schedule of Segment Reporting (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="eldn-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails</Role>
      <ShortName>Segment Reporting - Schedule of significant segment expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="eldn-20241231.htm">eldn-20241231.htm</File>
    <File>eldn-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img117130267_0.jpg</File>
    <File>img117130267_1.jpg</File>
    <File>img117130267_2.jpg</File>
    <File>img117130267_3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="595">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eldn-20241231.htm": {
   "nsprefix": "eldn",
   "nsuri": "http://www.eledon.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "eldn-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "eldn-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 288,
   "keyCustom": 75,
   "axisStandard": 26,
   "axisCustom": 0,
   "memberStandard": 30,
   "memberCustom": 45,
   "hidden": {
    "total": 11,
    "http://fasb.org/us-gaap/2024": 8,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 206,
   "entityCount": 1,
   "segmentCount": 81,
   "elementCount": 690,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 595,
    "http://xbrl.sec.gov/dei/2024": 43,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "longName": "100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
     "longName": "100040 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "longName": "100050 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:GainLossOnTerminationOfLease",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1",
     "longName": "995467 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995477 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments",
     "longName": "995487 - Disclosure - Short-Term Investments",
     "shortName": "Short-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements",
     "longName": "995497 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1",
     "longName": "995507 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "995517 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "longName": "995527 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity",
     "longName": "995537 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "longName": "995547 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting",
     "longName": "995557 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "longName": "995567 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995577 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995587 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables",
     "longName": "995597 - Disclosure - Short-Term Investments (Tables)",
     "shortName": "Short-Term Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "longName": "995607 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables",
     "longName": "995617 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables",
     "longName": "995627 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "longName": "995637 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
     "longName": "995647 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "longName": "995657 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables",
     "longName": "995667 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
     "longName": "995677 - Disclosure - Description of Business - Additional Information (Detail)",
     "shortName": "Description of Business - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83",
      "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83",
      "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "995687 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
     "longName": "995697 - Disclosure - Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R35": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
     "longName": "995707 - Disclosure - Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail",
     "longName": "995717 - Disclosure - Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)",
     "shortName": "Short-Term Investments - Summary of Short-term Investments Classified as Available-for-sale Securities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail",
     "longName": "995727 - Disclosure - Short-Term Investments - Additional Information (Detail)",
     "shortName": "Short-Term Investments - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
     "longName": "995737 - Disclosure - Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)",
     "shortName": "Fair Value Measurements - Schedule of Financial Asset Instruments Measured At Fair Value On A Recurring Basis (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
     "longName": "995757 - Disclosure - Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Summary of Warrant Liabilities Measured at Fair value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_66748007-3bbb-4063-96d0-b1f1e7fe5949",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_66748007-3bbb-4063-96d0-b1f1e7fe5949",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
     "longName": "995767 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)",
     "shortName": "Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6f5052df-2ced-4dca-8f26-17b0a53037c7",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "longName": "995777 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail",
     "longName": "995787 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Prepaid Expenses and Other Current Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "eldn:PrepaidClinicalExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "eldn:PrepaidClinicalExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail",
     "longName": "995797 - Disclosure - Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)",
     "shortName": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "eldn:AccruedClinicalCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "eldn:AccruedClinicalCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
       "div",
       "eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
     "longName": "995817 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail",
     "longName": "995827 - Disclosure - Commitments and Contingencies - Components of Operating Lease Expense (Detail)",
     "shortName": "Commitments and Contingencies - Components of Operating Lease Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail",
     "longName": "995837 - Disclosure - Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Other Supplemental Cash Flow Information Related to Leases (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
     "longName": "995847 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Payments Under Noncancelable Operating Leases (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail",
     "longName": "995857 - Disclosure - Income Taxes - Summary of Loss Before Income Taxes (Detail)",
     "shortName": "Income Taxes - Summary of Loss Before Income Taxes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
     "longName": "995867 - Disclosure - Income Taxes - Summary of Provision for Income Taxes (Detail)",
     "shortName": "Income Taxes - Summary of Provision for Income Taxes (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
     "longName": "995877 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail",
     "longName": "995887 - Disclosure - Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)",
     "shortName": "Income Taxes - Reconciliation of U.S. Federal Statutory Income Tax Rate (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail",
     "longName": "995897 - Disclosure - Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)",
     "shortName": "Income Taxes - Schedule of Significant Components Deferred Tax Assets and Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail",
     "longName": "995907 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_96c27b64-8362-4c1a-a77f-cd19f6405d90",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
     "longName": "995917 - Disclosure - Stockholders' Equity - Additional Information (Detail)",
     "shortName": "Stockholders' Equity - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
     "longName": "995927 - Disclosure - Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)",
     "shortName": "Stockholders Equity - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Common Warrants and Subsequent Closing Warrants Granted (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3363cfd2-6725-47cd-bf09-3c58731efbb2",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
     "longName": "995937 - Disclosure - Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Warrants to Purchase Common Stock Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_873fc4f3-2e27-45ab-b247-49134db6a39a",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_844f75c9-11bb-444d-8d75-a4c62096d783",
      "name": "eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
     "longName": "995947 - Disclosure - Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_1206a149-d99b-42c3-828f-7f43aedc8be0",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f0cc14de-6299-424c-a1bc-ca5ae324df9b",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
     "longName": "995957 - Disclosure - Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)",
     "shortName": "Stockholders' Equity - Schedule of Series X1 Convertible Preferred Stock Warrant Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_0cfe28eb-20ed-4453-b17c-b2da148bbb6b",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc",
      "name": "eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eldn:ScheduleOfWarrantActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
     "longName": "995967 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail",
     "longName": "995977 - Disclosure - Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)",
     "shortName": "Stock-Based Compensation - Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_96c27b64-8362-4c1a-a77f-cd19f6405d90",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
     "longName": "995987 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
     "longName": "995997 - Disclosure - Stock-Based Compensation - Summary of RSU Activity (Detail)",
     "shortName": "Stock-Based Compensation - Summary of RSU Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3959ebff-dd82-4919-8415-9cfb3aeb832a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail",
     "longName": "996007 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d74c7b95-2405-4e2a-92fa-de35246ee4c0",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail",
     "longName": "996017 - Disclosure - Segment Reporting - Schedule of Segment Reporting (Detail)",
     "shortName": "Segment Reporting - Schedule of Segment Reporting (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:FactorsUsedToIdentifyEntitysReportableSegments",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
     "longName": "996027 - Disclosure - Segment Reporting - Schedule of significant segment expenses (Details)",
     "shortName": "Segment Reporting - Schedule of significant segment expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_a83408d9-d439-46ef-8f80-2334a97de048",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c01ec1c7-4246-48a0-911e-d83e8235923b",
      "name": "eldn:Tegoprubart-KidneyTransplantationPrograms",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eldn-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "eldn_ALSTherapyDevelopmentFoundationIncLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ALSTherapyDevelopmentFoundationIncLicenseAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALS therapy development foundation, Inc. license agreement.",
        "label": "A L S Therapy Development Foundation Inc License Agreement [Member]",
        "terseLabel": "ALS Therapy Development Foundation, Inc. License Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202307Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202307Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update 2023-07 [Member]",
        "documentation": "Accounting Standards Update 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222"
     ]
    },
    "eldn_AccountsPayableAccruedExpensesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccountsPayableAccruedExpensesAndOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts payable, accrued expenses and other liabilities.",
        "label": "Accounts payable, accrued expenses and other liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r815"
     ]
    },
    "eldn_AccreditedInvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccreditedInvestorMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accredited Investor.",
        "label": "Accredited Investor [Member]",
        "terseLabel": "Accredited Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AccretionOnInvestmentDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccretionOnInvestmentDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion on Investment Discounts",
        "label": "Accretion on Investment Discounts",
        "negatedLabel": "Accretion on investment discounts",
        "terseLabel": "Accretion on investment discounts"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AccruedClinicalCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AccruedClinicalCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued clinical current.",
        "label": "Accrued Clinical Current",
        "terseLabel": "Accrued clinical"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Total accrued expenses and other liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "terseLabel": "Accumulated other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r66",
      "r128",
      "r626",
      "r647",
      "r651"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r18",
      "r469",
      "r472",
      "r539",
      "r642",
      "r643",
      "r965",
      "r966",
      "r967",
      "r973",
      "r974",
      "r975",
      "r976"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r973",
      "r974",
      "r975",
      "r976",
      "r1051",
      "r1107"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r158",
      "r159",
      "r160",
      "r161",
      "r172",
      "r221",
      "r222",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r294",
      "r295",
      "r298",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r511",
      "r512",
      "r521",
      "r522",
      "r523",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r579",
      "r580",
      "r581",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r351"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AggregateNetSalesAchievement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AggregateNetSalesAchievement",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net sales achievement.",
        "label": "Aggregate Net Sales Achievement",
        "terseLabel": "Reaching of aggregate net sales"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r858",
      "r869",
      "r879",
      "r912"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r872",
      "r882",
      "r915"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r907",
      "r916",
      "r920",
      "r928"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r392"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AmortizationOfOperatingLeaseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AmortizationOfOperatingLeaseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of operating lease asset.",
        "label": "Amortization Of Operating Lease Asset",
        "terseLabel": "Amortization of operating lease asset"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnelixisTherapeuticsIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnelixisTherapeuticsIncorporationMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anelixis Therapeutics, Incorporation.",
        "label": "Anelixis Therapeutics Incorporation [Member]",
        "terseLabel": "Anelixis [Member]",
        "verboseLabel": "Anelixis [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnelixisTherapeuticsLlcAndOticPharmaLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]",
        "label": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd [Member]",
        "terseLabel": "Anelixis Therapeutics, LLC and Otic Pharma, Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_AnnualLicenseMaintenanceFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AnnualLicenseMaintenanceFee",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual license maintenance fee.",
        "label": "Annual License Maintenance Fee",
        "terseLabel": "Annual License Maintenance Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "eldn_AreaOfOfficeSpace": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "AreaOfOfficeSpace",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of office space.",
        "label": "Area Of Office Space",
        "terseLabel": "Area of office space"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ArmisticeCapitalMasterFundLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ArmisticeCapitalMasterFundLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Armistice Capital Master Fund Ltd.",
        "label": "Armistice Capital Master Fund Ltd [Member]",
        "terseLabel": "Armistice Capital Master Fund Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r100",
      "r124",
      "r148",
      "r184",
      "r193",
      "r208",
      "r212",
      "r255",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r459",
      "r461",
      "r513",
      "r620",
      "r698",
      "r777",
      "r778",
      "r815",
      "r836",
      "r1010",
      "r1011",
      "r1067"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r130",
      "r148",
      "r255",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r459",
      "r461",
      "r513",
      "r815",
      "r1010",
      "r1011",
      "r1067"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value",
        "totalLabel": "Total financial assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r802"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Opinion",
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Losses",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r273",
      "r619"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Securities, Available-for-Sale, Total",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r273",
      "r489",
      "r614",
      "r802",
      "r807",
      "r988",
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "eldn_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation and principles of consolidation.",
        "label": "Basis Of Presentation And Principles Of Consolidation Policy [Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biotechnology Value Fund LP, Biotechnology Value Fund II LP, Biotechnology Value Trading Fund OS LP, MSI BVF SPV LLC.",
        "label": "Biotechnology Value Fund L P Biotechnology Value Fund I I L P Biotechnology Value Trading Fund O S L P M S I B V F S P V L L C [Member]",
        "terseLabel": "BVF Exchanging Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Board of Directors [Member]"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r449",
      "r796",
      "r797"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r449",
      "r796",
      "r797"
     ]
    },
    "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Effective Date of Acquisition",
        "terseLabel": "Date of acquisition",
        "verboseLabel": "Business acquisition, date of acquisition",
        "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r11"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusiness1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r75",
      "r76"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "Irvine, California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California [Member]",
        "documentation": "Designated tax department of the government of the state of California."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r122",
      "r762"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Total cash equivalents",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "eldn_CashCashEquivalentsAndRestrictedCashMaturityPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CashCashEquivalentsAndRestrictedCashMaturityPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash cash equivalents and restricted cash maturity period.",
        "label": "Cash Cash Equivalents And Restricted Cash Maturity Period",
        "terseLabel": "Cash, cash equivalents and restricted cash, maturity period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestmentsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, and Short-Term Investments [Text Block]",
        "terseLabel": "Short-Term Investments",
        "documentation": "The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r72",
      "r145"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r72"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in measurement of lease liabilities.",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liability:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was adopted."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r118",
      "r157",
      "r221",
      "r256",
      "r257",
      "r258",
      "r264",
      "r265",
      "r294",
      "r298",
      "r432",
      "r440",
      "r441",
      "r450",
      "r451",
      "r453",
      "r464",
      "r465",
      "r477",
      "r478",
      "r511",
      "r512",
      "r522",
      "r534",
      "r535",
      "r579",
      "r580",
      "r640",
      "r641"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r118",
      "r221",
      "r256",
      "r257",
      "r258",
      "r264",
      "r265",
      "r266",
      "r294",
      "r298",
      "r432",
      "r440",
      "r441",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r463",
      "r464",
      "r465",
      "r466",
      "r477",
      "r478",
      "r479",
      "r482",
      "r511",
      "r512",
      "r522",
      "r534",
      "r535",
      "r579",
      "r580",
      "r640",
      "r641",
      "r952"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was early adopted."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r157",
      "r221",
      "r256",
      "r259",
      "r266",
      "r294",
      "r298",
      "r433",
      "r442",
      "r452",
      "r454",
      "r466",
      "r479",
      "r482",
      "r511",
      "r512",
      "r581",
      "r640",
      "r641"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r171",
      "r261"
     ]
    },
    "eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "negatedLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "label": "Change in Fair Value of Warrant Liabilities and Fair Value of Financial Instruments Issued in Excess of Proceeds",
        "documentation": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds Includes Reversal",
        "documentation": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal.",
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes reversal"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r125",
      "r126",
      "r127",
      "r148",
      "r175",
      "r176",
      "r178",
      "r180",
      "r186",
      "r187",
      "r255",
      "r307",
      "r310",
      "r311",
      "r312",
      "r316",
      "r317",
      "r322",
      "r323",
      "r326",
      "r329",
      "r337",
      "r513",
      "r655",
      "r656",
      "r657",
      "r658",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r686",
      "r707",
      "r725",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r951",
      "r970",
      "r977"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r186",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r335",
      "r337",
      "r655",
      "r656",
      "r657",
      "r658",
      "r791",
      "r951",
      "r970"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price per share",
        "verboseLabel": "Warrants exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Common stock warrants exercisable",
        "terseLabel": "Common stock warrants to purchase common stock shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights assumed and replaced.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Assumed And Replaced",
        "terseLabel": "Estimated fair value, assumed and replaced",
        "verboseLabel": "Assumed and replaced"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExchanged",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights cancelled or exchanged.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Exchanged",
        "negatedLabel": "Cancelled/Exchanged"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights cancelled or expired.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Cancelled Or Expired",
        "terseLabel": "Warrants exercisable for exchange",
        "verboseLabel": "Cancelled/Expired",
        "negatedLabel": "Cancelled/Expired"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants exercised.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Exercised",
        "terseLabel": "Number of shares exercised",
        "negatedLabel": "Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right number of warrants or rights issued.",
        "label": "Class Of Warrant Or Right Number Of Warrants Or Rights Issued",
        "terseLabel": "Warrants issued",
        "verboseLabel": "Issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Warrants available for exercise",
        "verboseLabel": "Number of Shares of Common Stock Issuable",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage",
        "documentation": "Class of warrant subject to specified beneficial ownership limitations percentage.",
        "terseLabel": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage",
        "documentation": "Class of warrant subject to specified beneficial ownership limitations permitted percentage.",
        "terseLabel": "Class of Warrant Subject to Specified Beneficial Ownership Limitations Permitted Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 6)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r92",
      "r623",
      "r685"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r300",
      "r301",
      "r748",
      "r1007",
      "r1009"
     ]
    },
    "eldn_CommonAndPreferredWarrantsOutstandingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonAndPreferredWarrantsOutstandingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common and preferred warrants outstanding.",
        "label": "Common And Preferred Warrants Outstanding [Member]",
        "terseLabel": "Common and Preferred Warrants Outstanding [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, number of shares reserved for issuance",
        "verboseLabel": "Common stock, number of shares initially reserved for issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "eldn_CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock exchanged for X and X1 non-voting convertible preferred stock.",
        "label": "Common Stock Exchanged For X And X One Non-voting Convertible Preferred Stock",
        "terseLabel": "Common stock exchanged for X and X1 non-voting convertible preferred stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "verboseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r828",
      "r829",
      "r831",
      "r832",
      "r833",
      "r834",
      "r973",
      "r974",
      "r976",
      "r1051",
      "r1106",
      "r1107"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r686"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r686",
      "r704",
      "r1107",
      "r1108"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2024 and 2023; 59,789,275 and 24,213,130 shares issued and outstanding at December 31, 2024 and 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r625",
      "r815"
     ]
    },
    "eldn_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrants.",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common Stock Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Warrants [Member]",
        "documentation": "Common warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r104"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r153",
      "r184",
      "r194",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r777",
      "r778",
      "r1010",
      "r1011"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r153",
      "r184",
      "r194",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r777",
      "r778",
      "r1010",
      "r1011"
     ]
    },
    "eldn_ContingentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ContingentLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent liability.",
        "label": "Contingent Liability",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ConversionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ConversionAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion agreement.",
        "label": "Conversion Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ConversionOfPreferredStockConversionBlockerPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ConversionOfPreferredStockConversionBlockerPercent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of preferred stock, conversion blocker, percent.",
        "label": "Conversion of Preferred Stock, Conversion Blocker, Percent",
        "terseLabel": "Conversion of preferred stock, conversion blocker, percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of stock, shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of stock, shares issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Shares of common stock issued upon conversion of each share of preferred stock",
        "verboseLabel": "Shares of common stock issued upon conversion of each share of preferred stock",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r36",
      "r59",
      "r85",
      "r332"
     ]
    },
    "eldn_CormorantGlobalHealthcareMasterFundLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "CormorantGlobalHealthcareMasterFundLpMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cormorant global healthcare master fund lp.",
        "label": "Cormorant Global Healthcare Master Fund LP [Member]",
        "terseLabel": "Cormorant Global Healthcare Master Fund LP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r318",
      "r324",
      "r542",
      "r561",
      "r618",
      "r764",
      "r766"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r972",
      "r1050"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r972"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax expense (benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r972"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r972",
      "r1050"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r941"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r941"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r854",
      "r943"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r941"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r934"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r935"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r935"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r936"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r849",
      "r938"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r849",
      "r938"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853",
      "r942"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r851",
      "r940"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Debt outstanding",
        "totalLabel": "Debt, Long-Term and Short-Term, Combined Amount, Total",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Summary of Short-term Investments Classified as Available-for-sale Securities",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1049",
      "r1050"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1049"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax provision",
        "totalLabel": "Total deferred income tax provision",
        "negatedTotalLabel": "Total deferred income tax provision",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r107",
      "r972"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Gross, Total",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r91",
      "r421"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r401",
      "r621"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State",
        "negatedLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r1049",
      "r1050"
     ]
    },
    "eldn_DeferredTaxAssetsDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets depreciation and amortization.",
        "label": "Deferred Tax Assets Depreciation And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "terseLabel": "Research expenditures",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "eldn_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liability.",
        "label": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Foreign operating losses carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Federal net operating loss carryforwards, not to expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "eldn_DeferredTaxAssetsRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxAssetsRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets right-of-use asset.",
        "label": "Deferred Tax Assets Right Of Use Asset",
        "negatedLabel": "Right-of-use asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits",
        "verboseLabel": "Research and development tax credit carryforwards for federal and state",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves",
        "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Net, Total",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "eldn_DeferredTaxLiabilitiesInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DeferredTaxLiabilitiesInProcessResearchAndDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, in-process research and development.",
        "label": "Deferred Tax Liabilities In Process Research And Development",
        "negatedLabel": "Acquired IPR&amp;D"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_DescriptionOfBusinessLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DescriptionOfBusinessLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Line Items]",
        "terseLabel": "Description Of Business [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_DescriptionOfBusinessTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "DescriptionOfBusinessTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Table]",
        "terseLabel": "Description Of Business [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r353",
      "r384",
      "r385",
      "r387",
      "r799"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865",
      "r908"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865",
      "r908"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Domestic Tax Authority [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "eldn_EGenesisIncCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EGenesisIncCollaborationAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "eGenesis, Inc. Collaboration Agreement [Member]",
        "documentation": "eGenesis, Inc. Collaboration Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r173",
      "r175",
      "r178",
      "r179",
      "r180",
      "r183",
      "r447",
      "r457",
      "r486",
      "r487",
      "r616",
      "r634",
      "r768"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r175",
      "r178",
      "r179",
      "r180",
      "r183",
      "r447",
      "r457",
      "r486",
      "r487",
      "r616",
      "r634",
      "r768"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r182"
     ]
    },
    "eldn_EffectiveFederalAndStateIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EffectiveFederalAndStateIncomeTaxRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective federal and state income tax rate.",
        "label": "Effective Federal And State Income Tax Rate",
        "terseLabel": "Federal Income tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax rate",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r801"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense",
        "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized stock-based compensation expense, recognized over estimated weighted average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options Outstanding and Other Equity Awards [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r115",
      "r136",
      "r137",
      "r138",
      "r154",
      "r155",
      "r156",
      "r159",
      "r166",
      "r168",
      "r170",
      "r185",
      "r260",
      "r267",
      "r295",
      "r339",
      "r430",
      "r431",
      "r443",
      "r444",
      "r445",
      "r448",
      "r456",
      "r457",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r485",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r539",
      "r632",
      "r642",
      "r643",
      "r644",
      "r661",
      "r725"
     ]
    },
    "eldn_EquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "EquityDistributionAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity distribution agreement.",
        "label": "Equity Distribution Agreement [Member]",
        "terseLabel": "Equity Distribution Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r858",
      "r869",
      "r879",
      "r912"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r855",
      "r866",
      "r876",
      "r909"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "us-gaap_FactorsUsedToIdentifyEntitysReportableSegments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FactorsUsedToIdentifyEntitysReportableSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Factors Used to Identify Entity's Reportable Segments",
        "documentation": "Description of the factors used to identify reportable segments, including the basis of organization (for example, whether management has chosen to organize the enterprise around differences in products and services, geographic areas, regulatory environments, or a combination of factors and whether operating segments have been aggregated to reportable segments)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r775",
      "r783"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r503",
      "r802"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r503",
      "r802"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset Instruments Measured At Fair Value On A Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r502",
      "r503",
      "r505",
      "r548",
      "r549",
      "r550",
      "r789",
      "r790",
      "r793",
      "r794",
      "r795",
      "r802",
      "r807"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r493",
      "r802",
      "r1056",
      "r1059"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r500",
      "r501",
      "r502",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r613",
      "r802",
      "r808"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r341",
      "r346",
      "r490",
      "r503",
      "r548",
      "r793",
      "r794",
      "r795",
      "r802"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r341",
      "r346",
      "r490",
      "r491",
      "r503",
      "r549",
      "r789",
      "r790",
      "r793",
      "r794",
      "r795",
      "r802"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r490",
      "r491",
      "r492",
      "r493",
      "r503",
      "r550",
      "r789",
      "r790",
      "r793",
      "r794",
      "r795",
      "r802",
      "r807"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Aggregate Fair Values of Warrant Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r504"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Warrant Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r499",
      "r504"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r493",
      "r802",
      "r1056",
      "r1059"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Balance as of December 31, 2023",
        "periodEndLabel": "Balance as of December 31, 2024",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r504"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r502",
      "r503",
      "r505",
      "r548",
      "r549",
      "r550",
      "r789",
      "r790",
      "r793",
      "r794",
      "r795",
      "r802",
      "r807"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring Member",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1059"
     ]
    },
    "eldn_FeeDueForMilestonesAchieved": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "FeeDueForMilestonesAchieved",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee due for milestones achieved.",
        "label": "Fee Due For Milestones Achieved",
        "terseLabel": "Fee due for milestones achieved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r320",
      "r335",
      "r475",
      "r510",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r633",
      "r786",
      "r802",
      "r805",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r816",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1052",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "eldn_FiveHundredMillionAggregateNetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "FiveHundredMillionAggregateNetSalesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five hundred million aggregate net sales.",
        "label": "Five Hundred Million Aggregate Net Sales [Member]",
        "terseLabel": "Achievement of 500 Million Aggregate Sales [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Jurisdiction [Member]",
        "terseLabel": "Foreign Country [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on lease termination",
        "label": "Gain (Loss) on Termination of Lease",
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total",
        "verboseLabel": "General and administrative expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r709"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill impairment",
        "terseLabel": "Impairment charge",
        "negatedLabel": "Impairments",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r277",
      "r283",
      "r288",
      "r788",
      "r804"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r788"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Indemnification obligations amount",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "eldn_GuggenheimSecuritiesLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "GuggenheimSecuritiesLlcMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guggenheim Securities LLC [Member]",
        "label": "Guggenheim Securities LLC [Member]",
        "documentation": "Guggenheim Securities LLC."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r842",
      "r865"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairments of long-lived assets",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r33",
      "r79",
      "r803"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r80"
     ]
    },
    "eldn_InProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "InProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-process research and development.",
        "label": "In Process Research And Development",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "In-Process Research and Development",
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S.",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r403"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r96",
      "r99",
      "r617",
      "r630",
      "r770",
      "r777",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S.",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r403"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossBeforeIncomeTaxesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Losses before income taxes:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "terseLabel": "Income Statement Location",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r299",
      "r495",
      "r499",
      "r504",
      "r637",
      "r639",
      "r710",
      "r760",
      "r806",
      "r1078"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "terseLabel": "Income Statement Location",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r299",
      "r495",
      "r499",
      "r504",
      "r637",
      "r639",
      "r710",
      "r760",
      "r806",
      "r1078"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "terseLabel": "Income Tax Authority",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r404",
      "r405",
      "r414",
      "r426",
      "r801",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "terseLabel": "Income Tax Authority",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r404",
      "r405",
      "r414",
      "r426",
      "r801",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r396",
      "r404",
      "r410",
      "r411",
      "r412",
      "r418",
      "r425",
      "r435",
      "r437",
      "r438",
      "r439",
      "r660",
      "r801"
     ]
    },
    "eldn_IncomeTaxExaminationLikelihoodOfFavorableSettlement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxExaminationLikelihoodOfFavorableSettlement",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax examination likelihood of favorable settlement.",
        "label": "Income Tax Examination Likelihood Of Favorable Settlement",
        "terseLabel": "Income tax examination, likelihood of settlement, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Likelihood of Unfavorable Settlement",
        "terseLabel": "Income tax examination, likelihood of settlement, description",
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority."
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureIncomeTaxesSummaryOfProvisionForIncomeTaxesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit",
        "totalLabel": "Total provision for income taxes",
        "terseLabel": "Income taxes",
        "negatedTerseLabel": "Provision for income taxes",
        "negatedTotalLabel": "Total provision for income taxes",
        "verboseLabel": "Provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r111",
      "r169",
      "r170",
      "r184",
      "r195",
      "r212",
      "r402",
      "r404",
      "r436",
      "r635",
      "r801"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r398",
      "r399",
      "r418",
      "r419",
      "r424",
      "r428",
      "r654"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r801",
      "r1041"
     ]
    },
    "eldn_IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "label": "Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds",
        "documentation": "Income Tax reconciliation Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Statutory federal income tax rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r801"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r1041",
      "r1043"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r1041",
      "r1042"
     ]
    },
    "eldn_IncomeTaxReconciliationPermanentItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationPermanentItems",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation permanent items.",
        "label": "Income Tax Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IncomeTaxReconciliationStateTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncomeTaxReconciliationStateTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation state tax rate differential.",
        "label": "Income Tax Reconciliation State Tax Rate Differential",
        "terseLabel": "State rate differential"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCredits",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r409",
      "r1041"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r968"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "eldn_IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in operating right-of-use lease asset and liability due to new lease",
        "label": "Increase Decrease in Right-Of-Use Operating Lease Asset and Liability Due To New Lease",
        "documentation": "Increase (decrease) in operating right-of-use lease asset and liability due to new lease."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r907",
      "r916",
      "r920",
      "r928"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r932"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r932"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r932"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Investments, Fair Value Disclosure, Total",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Total short-term investments",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r1053",
      "r1054",
      "r1058"
     ]
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel Tax Authority [Member]",
        "terseLabel": "Israeli Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty Four Underwritten Offering, Net Of Issuance Costs, Shares",
        "documentation": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value",
        "label": "Issuance Of Common Stock And PreFunded Warrants In Connection With Two Thousand Twenty FourUnderwritten Offering, Net Of Issuance Costs, Value",
        "documentation": "Issuance of common stock and pre-funded warrants in connection with 2024 Underwritten Offering, net of issuance costs, value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock shares.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Shares",
        "terseLabel": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock value.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X1 Non-voting Convertible Preferred Stock Value",
        "terseLabel": "Issuance of common stock in connection with conversion of X1 non-voting convertible preferred stock, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with conversion of x non-voting convertible preferred stock shares.",
        "label": "Issuance Of Common Stock In Connection With Conversion Of X Non-voting Convertible Preferred Stock Shares",
        "terseLabel": "Issuance of common stock in connection with conversion of X non-voting convertible preferred stock, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with exercise of pre-funded warrants, shares.",
        "label": "Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Shares",
        "terseLabel": "Issuance of common stock in connection with exercise of pre-funded warrants, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock in connection with exercise of pre-funded warrants, value",
        "label": "Issuance of Common Stock in Connection With Exercise of Pre-funded Warrants, Value",
        "terseLabel": "Issuance of common stock in connection with exercise of pre-funded warrants, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Shares",
        "documentation": "Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, shares.",
        "label": "Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value",
        "documentation": "Issuance of common stock in connection with private investment in public equity transaction, net of issuance costs, value.",
        "label": "Issuance of Common Stock in Connection with Private Investment in Public Equity Transaction, Net of Issuance Costs, Value",
        "terseLabel": "Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , Shares.",
        "documentation": "Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , shares.",
        "verboseLabel": "Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Stock With The Completion Of The Second And Third Closing In Connection With Two Thousand Twenty Three Securities Purchase Agreement Net Of Issuance Costs , value",
        "documentation": "Issuance of common stock with the completion of the Second and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs , value.",
        "verboseLabel": "Issuance of common stock with the completion of the Second Closing and Third Closing in connection with 2023 Securities Purchase Agreement, net of issuance costs, Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants [Member]",
        "terseLabel": "January 2020 Common Warrants",
        "documentation": "January Two Thousand And Twenty Common Warrants Member."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsOneMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants One [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants One Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants Three [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants Three Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty Common Warrants Two [Member]",
        "documentation": "January Two Thousand And Twenty Common Warrants Two Member.",
        "terseLabel": "January 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Two Thousand And Twenty One Pre-funded Warrants [Member]",
        "documentation": "January Two Thousand And Twenty One Pre-funded Warrants Member.",
        "terseLabel": "January 2021 Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Operating Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_LeerinkPartnersLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "LeerinkPartnersLlcMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leerink Partners LLC [Member]",
        "documentation": "Leerink partners LLC.",
        "terseLabel": "Leerink Partners LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Payments Under Noncancelable Operating Leases",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "eldn_LesseeOperatingLeaseRemainingTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "LesseeOperatingLeaseRemainingTermOfContract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease remaining term of contract.",
        "label": "Lessee Operating Lease Remaining Term Of Contract",
        "terseLabel": "Remaining term of office lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r58",
      "r148",
      "r255",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r460",
      "r461",
      "r462",
      "r513",
      "r684",
      "r769",
      "r836",
      "r1010",
      "r1067",
      "r1068"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r93",
      "r628",
      "r815",
      "r971",
      "r1005",
      "r1060"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r121",
      "r148",
      "r255",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r460",
      "r461",
      "r462",
      "r513",
      "r815",
      "r1010",
      "r1067",
      "r1068"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r1053"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased",
        "documentation": "Information by category of items purchased under a long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased",
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "stpr_MA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "MA",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Burlington, Massachusetts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManufacturingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManufacturingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Costs",
        "terseLabel": "Manufacturing",
        "documentation": "The aggregate costs incurred in the production of goods for sale."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "eldn_ManufacturingExpensesOffset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ManufacturingExpensesOffset",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing Expenses, Offset",
        "documentation": "Manufacturing expenses offset.",
        "terseLabel": "Manufacturing expenses offset"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r348",
      "r393",
      "r493",
      "r577",
      "r636",
      "r638",
      "r652",
      "r676",
      "r677",
      "r732",
      "r734",
      "r736",
      "r737",
      "r739",
      "r758",
      "r759",
      "r785",
      "r791",
      "r798",
      "r807",
      "r808",
      "r812",
      "r813",
      "r825",
      "r1012",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r348",
      "r393",
      "r493",
      "r577",
      "r636",
      "r638",
      "r652",
      "r676",
      "r677",
      "r732",
      "r734",
      "r736",
      "r737",
      "r739",
      "r758",
      "r759",
      "r785",
      "r791",
      "r798",
      "r807",
      "r808",
      "r812",
      "r825",
      "r1012",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "eldn_NOLTrueUp": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NOLTrueUp",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOL True Up.",
        "label": "N O L True Up",
        "terseLabel": "NOL true-up"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "verboseLabel": "Cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss and comprehensive loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r74",
      "r97",
      "r119",
      "r131",
      "r133",
      "r138",
      "r148",
      "r158",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r169",
      "r170",
      "r177",
      "r255",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r447",
      "r457",
      "r487",
      "r513",
      "r631",
      "r706",
      "r723",
      "r724",
      "r835",
      "r1010"
     ]
    },
    "eldn_NetOperatingLossCarryforwardsExpirationPeriod": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NetOperatingLossCarryforwardsExpirationPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration period.",
        "label": "Net Operating Loss Carryforwards Expiration Period",
        "terseLabel": "Net operating loss carryforward expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements Issued But Not Adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r907",
      "r916"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "eldn_NoncashActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NoncashActivitiesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash activities.",
        "label": "Noncash Activities [Abstract]",
        "terseLabel": "Non-cash activities:"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_NumberOfMilestonesAchieved": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NumberOfMilestonesAchieved",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of milestones achieved.",
        "label": "Number Of Milestones Achieved",
        "terseLabel": "Number of Milestones Achieved"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating business segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r778",
      "r981"
     ]
    },
    "eldn_NumberOfPreFundedWarrantsExercisedForCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "NumberOfPreFundedWarrantsExercisedForCommonStock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pre-funded warrants exercised for common stock.",
        "label": "Number of Pre-funded Warrants Exercised for Common Stock",
        "terseLabel": "Number of pre-funded warrants exercised for common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r771",
      "r783",
      "r981"
     ]
    },
    "eldn_OneBillionAggregateNetSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OneBillionAggregateNetSalesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One billion aggregate net sales.",
        "label": "One Billion Aggregate Net Sales [Member]",
        "terseLabel": "Achievement of 1 Billion Aggregate Sales [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r770",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfOperatingLeaseExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r814"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Expense",
        "terseLabel": "Rental expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of lease liabilities",
        "terseLabel": "Lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability",
        "negatedLabel": "Less current portion of operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsUnderNoncancelableOperatingLeasesDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Non-current operating lease liability",
        "terseLabel": "Non-current operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating lease",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r530"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "ROU assets",
        "terseLabel": "Operating lease right-of-use asset, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of operating lease right-of-use asset",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r814"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfOtherSupplementalCashFlowInformationRelatedToLeasesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r814"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r777",
      "r778"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r815"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax, Total",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r14",
      "r132",
      "r134",
      "r139",
      "r166",
      "r514",
      "r515",
      "r520",
      "r615",
      "r632",
      "r965",
      "r966"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "verboseLabel": "Other income, net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Prepaid other",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r962",
      "r1006"
     ]
    },
    "eldn_OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Supplemental Cash Flow Information Related to Leases [Table Text Block]",
        "documentation": "Other supplemental cash flow information related to leases.",
        "terseLabel": "Schedule of Other Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_OticPharmaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OticPharmaIncMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Otic Pharma, Inc.",
        "label": "Otic Pharma Inc [Member]",
        "terseLabel": "Otic Pharma, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_OticPharmaLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "OticPharmaLtdMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Otic Pharma, Ltd.",
        "label": "Otic Pharma Ltd [Member]",
        "terseLabel": "Otic Pharma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r863",
      "r874",
      "r884",
      "r917"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r863",
      "r874",
      "r884",
      "r917"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchase of available-for-sale short-term investments",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r141",
      "r224"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "eldn_PercentageOfCumulativeChangeInOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PercentageOfCumulativeChangeInOwnership",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of cumulative change in ownership.",
        "label": "Percentage Of Cumulative Change In Ownership",
        "terseLabel": "Percentage of cumulative change in ownership"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PerformanceBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PerformanceBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance-based Vesting Requirements [Member]",
        "documentation": "Performance-based vesting requirements."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards.",
        "label": "Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards",
        "terseLabel": "Period for which cumulative change in ownership annual use net operating loss and research and development credit carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Personnel-RelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Personnel-RelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel-Related Expenses",
        "documentation": "Personnel-related expenses.",
        "terseLabel": "Personnel-related"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "eldn_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-Funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r322"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r686"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r322"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r686",
      "r704",
      "r1107",
      "r1108"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r624",
      "r815"
     ]
    },
    "eldn_PreferredStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PreferredStockWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock warrants.",
        "label": "Preferred Stock Warrants [Member]",
        "terseLabel": "Preferred Stock Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidClinicalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidClinicalExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid clinical expense.",
        "label": "Prepaid Clinical Expense",
        "terseLabel": "Prepaid clinical"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses, other assets, accrued expenses and other liabilities.",
        "label": "Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilities1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses, other assets, accrued expenses and other liabilities.",
        "label": "Prepaid Expenses Other Assets Accrued Expenses And Other Liabilities [Text Block]",
        "terseLabel": "Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r763",
      "r787",
      "r1006"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement Warrants [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "eldn_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock and pre funded warrants net.",
        "label": "Proceeds from Issuance of Common Stock And Pre Funded Warrants Net",
        "terseLabel": "Proceeds from issuances of common stock and pre-funded warrants, net",
        "verboseLabel": "Net proceeds after deducting offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ProceedsFromIssuanceOfNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfNetOfOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Of Net Of Offering Costs",
        "documentation": "Proceeds from issuance of net of offering costs.",
        "terseLabel": "Net proceeds after deducting offering costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "eldn_ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds after deducting offering costs",
        "label": "Proceeds from Issuance of Private Placement, Net of Offering Costs",
        "documentation": "Proceeds from issuance of private placement, net of offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Warrants",
        "verboseLabel": "Common warrants issued",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "eldn_ProceedsFromIssuanceOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ProceedsFromIssuanceOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Offering",
        "documentation": "Proceeds from issuance offering",
        "terseLabel": "Proceeds from issuance offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of available-for-sale short-term investments",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r989"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r12"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r340",
      "r348",
      "r379",
      "r380",
      "r381",
      "r393",
      "r493",
      "r551",
      "r560",
      "r577",
      "r636",
      "r638",
      "r652",
      "r676",
      "r677",
      "r732",
      "r734",
      "r736",
      "r737",
      "r739",
      "r758",
      "r759",
      "r785",
      "r791",
      "r798",
      "r807",
      "r808",
      "r812",
      "r813",
      "r825",
      "r829",
      "r1008",
      "r1012",
      "r1056",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r305",
      "r340",
      "r348",
      "r379",
      "r380",
      "r381",
      "r393",
      "r493",
      "r551",
      "r560",
      "r577",
      "r636",
      "r638",
      "r652",
      "r676",
      "r677",
      "r732",
      "r734",
      "r736",
      "r737",
      "r739",
      "r758",
      "r759",
      "r785",
      "r791",
      "r798",
      "r807",
      "r808",
      "r812",
      "r813",
      "r825",
      "r829",
      "r1008",
      "r1012",
      "r1056",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r855",
      "r866",
      "r876",
      "r909"
     ]
    },
    "eldn_RegulatoryMilestonePaymentsObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RegulatoryMilestonePaymentsObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestone payments obligation.",
        "label": "Regulatory Milestone Payments Obligation",
        "terseLabel": "Development and regulatory milestone payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r347",
      "r540",
      "r541",
      "r622",
      "r629",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r703",
      "r705",
      "r731"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r347",
      "r540",
      "r541",
      "r622",
      "r629",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r703",
      "r705",
      "r731",
      "r1066"
     ]
    },
    "eldn_RemainingMilestonePaymentsForFirstLicensedProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RemainingMilestonePaymentsForFirstLicensedProduct",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining milestone payments for first licensed product.",
        "label": "Remaining Milestone Payments For First Licensed Product",
        "terseLabel": "Remaining milestone payments for first licensed product"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r318",
      "r324",
      "r542",
      "r561",
      "r618",
      "r765",
      "r766"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r760",
      "r777",
      "r1075"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "Research and Development [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r856",
      "r867",
      "r877",
      "r910"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r868",
      "r878",
      "r911"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r864",
      "r875",
      "r885",
      "r918"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSU [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained earnings / (Accumulated Deficit)",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r87",
      "r627",
      "r646",
      "r651",
      "r659",
      "r687",
      "r815"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r154",
      "r155",
      "r156",
      "r159",
      "r166",
      "r168",
      "r170",
      "r260",
      "r267",
      "r295",
      "r430",
      "r431",
      "r443",
      "r444",
      "r445",
      "r448",
      "r456",
      "r457",
      "r467",
      "r470",
      "r471",
      "r474",
      "r485",
      "r522",
      "r524",
      "r642",
      "r644",
      "r661",
      "r1107"
     ]
    },
    "eldn_RisksAndUncertaintiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "RisksAndUncertaintiesPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and uncertainties.",
        "label": "Risks and Uncertainties [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyGuaranteesCommitmentsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyGuaranteesCommitmentsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Guarantees, Commitments, Amount",
        "terseLabel": "Amount of one-time milestone payment",
        "documentation": "The amount the entity has committed to make for future royalty guarantees."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Stock price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of accrued expenses and other liabilities.",
        "label": "Schedule Of Accrued Expenses And Other Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Expense Related to Stock-Based Awards",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Provision for Income Taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Significant Components Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of U.S. Federal Statutory Income Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r801",
      "r1041"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseRelatedToStockBasedAwardsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureGoodwillAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Table]",
        "terseLabel": "Schedule Of Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r788"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Summary of Loss Before Income Taxes",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options, Common Warrants and Subsequent Closing Warrants Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Assumptions Used in Black-Scholes Option Pricing Model to Determine the Fair Value of Stock Options Granted",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r82",
      "r84",
      "r86",
      "r87",
      "r125",
      "r126",
      "r127",
      "r186",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r335",
      "r337",
      "r655",
      "r656",
      "r657",
      "r658",
      "r791",
      "r951",
      "r970"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Summary of All Option Activity Under 2014 Plan, 2020 Plan and Inducement Grants",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Company's Outstanding Warrants to Purchase Shares of Common Stock",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r800"
     ]
    },
    "eldn_ScheduleOfWarrantActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ScheduleOfWarrantActivityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of warrant activity.",
        "label": "Schedule Of Warrant Activity Table [Text Block]",
        "terseLabel": "Schedule of Warrants to Purchase Common Stock Activity"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementInitialClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementInitialClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement initial closing.",
        "label": "Securities Purchase Agreement Initial Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Initial Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement .",
        "label": "Securities Purchase Agreement [Member]",
        "terseLabel": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementSecondClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementSecondClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement second closing.",
        "label": "Securities Purchase Agreement Second Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Second Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SecuritiesPurchaseAgreementThirdClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SecuritiesPurchaseAgreementThirdClosingMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities purchase agreement third closing.",
        "label": "Securities Purchase Agreement Third Closing [Member]",
        "terseLabel": "Securities Purchase Agreement Third Closing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r673",
      "r674",
      "r675",
      "r733",
      "r735",
      "r738",
      "r740",
      "r747",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r761",
      "r792",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r829",
      "r1013",
      "r1077",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r776",
      "r784"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentReportingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r773",
      "r781"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r196",
      "r197",
      "r198",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r220",
      "r771",
      "r774",
      "r775",
      "r777",
      "r779",
      "r782",
      "r783"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Reportable Segments",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r215",
      "r218",
      "r772",
      "r773",
      "r780"
     ]
    },
    "eldn_SeptemberTwoThousandAndTwentyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeptemberTwoThousandAndTwentyCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Two Thousand And Twenty Common Warrants [Member]",
        "documentation": "September Two Thousand And Twenty Common Warrants Member.",
        "terseLabel": "September 2020 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesX1ExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesX1ExchangeAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X1 Exchange Agreement.",
        "label": "Series X1 Exchange Agreement [Member]",
        "terseLabel": "Series X1 Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesX1NonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesX1NonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X1 non-voting convertible preferred stock.",
        "label": "Series X1 Non Voting Convertible Preferred Stock [Member]",
        "terseLabel": "Series X1 Non-voting Convertible Preferred Stock [Member]",
        "verboseLabel": "Series X1 Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X convertible preferred stock.",
        "label": "Series X Convertible Preferred Stock [Member]",
        "terseLabel": "Series X Non-voting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXNonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXNonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X non-voting convertible preferred stock.",
        "label": "Series X Non Voting Convertible Preferred Stock [Member]",
        "verboseLabel": "Series X Non-Voting Convertible Preferred Stock [Member]",
        "terseLabel": "Series X Non-Voting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SeriesXOnePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SeriesXOnePreferredStockMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series X One Preferred Stock.",
        "label": "Series X One Preferred Stock [Member]",
        "terseLabel": "Series X1 Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SettlementOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SettlementOfWarrantLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement of Warrant Liability",
        "documentation": "Settlement of warrant liability.",
        "negatedLabel": "Settlement of warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SettlementOfWarrantLiabilityIntoCommonStockDueToExercise": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SettlementOfWarrantLiabilityIntoCommonStockDueToExercise",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settlement Of Warrant Liability Into Common Stock Due To Exercise",
        "documentation": "Settlement of warrant liability into common stock due to exercise.",
        "terseLabel": "Settlement of warrant liability into common stock due to exercise"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vesting period of stock options granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period",
        "negatedLabel": "Forfeited / Canceled"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndCanceledInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, forfeited and canceled in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Canceled In Period Weighted Average Exercise Price",
        "terseLabel": "Forfeited / Canceled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, grants in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares Issuable Under RSUs",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, nonvested, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options, nonvested, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs Vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, vested in period, weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price",
        "terseLabel": "RSUs Vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Estimated dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method",
        "verboseLabel": "Expected life assumption using simplified method, description",
        "documentation": "Discloses use of the simplified method to calculate the expected term that stock option awards under the specified plan will exist before being exercised or terminated, the reason and justification for its use, and the periods for which the method was used if it was not used in all periods presented."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected stock price volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected stock price volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r352",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Increased number of shares",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options assumed in period weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period Weighted Average Exercise Price",
        "terseLabel": "Options Assumed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Options exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Options exercisable",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited / Canceled",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited / Canceled",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock options issued",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Stock options granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares weighted average grant date fair value of stock options granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "terseLabel": "Number of options outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares Issuable Under Options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance",
        "verboseLabel": "Range of exercise prices",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options vested and expected to vest",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Options vested and expected to vest",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options vested and expected to vest",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years)"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award total number of shares authorized.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Total Number Of Shares Authorized",
        "terseLabel": "New aggregate share limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRsuActivityDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r357",
      "r376",
      "r377",
      "r378",
      "r379",
      "r382",
      "r388",
      "r389",
      "r390",
      "r391"
     ]
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU Activity",
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfAssumptionsUsedInBlackScholesOptionPricingModelToDetermineFairValueOfStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life of option (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested and expected to vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short-Term Investments, Total",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "verboseLabel": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r963"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r146"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "eldn_StateIncomeTaxesNetOfFederalTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "StateIncomeTaxesNetOfFederalTaxBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfUSFederalStatutoryIncomeTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State income taxes, net of Federal tax benefits.",
        "label": "State Income Taxes Net Of Federal Tax Benefits",
        "terseLabel": "State income taxes, net of federal tax benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r125",
      "r126",
      "r127",
      "r148",
      "r175",
      "r176",
      "r178",
      "r180",
      "r186",
      "r187",
      "r255",
      "r307",
      "r310",
      "r311",
      "r312",
      "r316",
      "r317",
      "r322",
      "r323",
      "r326",
      "r329",
      "r337",
      "r513",
      "r655",
      "r656",
      "r657",
      "r658",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r686",
      "r707",
      "r725",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r951",
      "r970",
      "r977"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r63",
      "r64",
      "r115",
      "r136",
      "r137",
      "r138",
      "r154",
      "r155",
      "r156",
      "r159",
      "r166",
      "r168",
      "r170",
      "r185",
      "r260",
      "r267",
      "r295",
      "r339",
      "r430",
      "r431",
      "r443",
      "r444",
      "r445",
      "r448",
      "r456",
      "r457",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r485",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r524",
      "r539",
      "r632",
      "r642",
      "r643",
      "r644",
      "r661",
      "r725"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r219",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r673",
      "r674",
      "r675",
      "r733",
      "r735",
      "r738",
      "r740",
      "r747",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r761",
      "r792",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r829",
      "r1013",
      "r1077",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r185",
      "r524",
      "r578",
      "r653",
      "r672",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r686",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r705",
      "r708",
      "r709",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r725",
      "r830"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r185",
      "r223",
      "r524",
      "r578",
      "r653",
      "r672",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r686",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r705",
      "r708",
      "r709",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r725",
      "r830"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r870",
      "r880",
      "r913"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Stock Options Outstanding and Other Equity Awards [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued",
        "terseLabel": "Common stock issued in lieu of making a cash payment",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in connection with vesting of restricted stock units",
        "verboseLabel": "Number of shares vested",
        "totalLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAllOptionActivityUnder2014Plan2020PlanAndInducementGrantsDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Stock Option Exercise, Shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59",
      "r60",
      "r87",
      "r363"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock Option Exercise, Value",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r60",
      "r63",
      "r64",
      "r87"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning Balance",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r64",
      "r78",
      "r688",
      "r704",
      "r726",
      "r727",
      "r815",
      "r836",
      "r971",
      "r1005",
      "r1060",
      "r1107"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r147",
      "r321",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r336",
      "r339",
      "r476",
      "r728",
      "r730",
      "r746"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liabilities",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r729"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "terseLabel": "Ownership interest percentage",
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSeriesX1ConvertiblePreferredStockWarrantActivityDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfWarrantsToPurchaseCommonStockActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TableTextBlockSupplementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TableTextBlockSupplementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Table Text Block Supplement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "eldn_TaxCreditCarryforwardExpirationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationDescription",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration description.",
        "label": "Tax Credit Carryforward Expiration Description",
        "terseLabel": "Research and development tax credit carryforwards expiration description"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TaxCreditCarryforwardExpirationPeriod": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCreditCarryforwardExpirationPeriod",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration period.",
        "label": "Tax Credit Carryforward Expiration Period",
        "terseLabel": "Research and development tax credit carryforwards expiration period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardLineItems",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardTable",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]",
        "documentation": "Disclosure of information about tax credit carryforward available to reduce future taxable income. Includes, but is not limited to, description, amount, expiration date, limitation on use, and related deferred tax asset and valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "eldn_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax cuts and jobs act of 2017 change in tax rate income taxes expense benefit.",
        "label": "Tax Cuts and Jobs Act of 2017 Change in Tax Rate Income Taxes Expense Benefit",
        "terseLabel": "Tax benefit"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Tegoprubart-KidneyTransplantationPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Tegoprubart-KidneyTransplantationPrograms",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tegoprubart - Kidney Transplantation Programs",
        "documentation": "Tegoprubart kidney transplantation programs.",
        "terseLabel": "Tegoprubart - kidney transplantation programs"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_Tegoprubart-OtherDevelopmentPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "Tegoprubart-OtherDevelopmentPrograms",
     "crdr": "debit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSegmentReportingScheduleOfSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tegoprubart - Other Development Programs",
        "documentation": "Tegoprubart - other development programs.",
        "terseLabel": "Tegoprubart - other development programs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TextBlockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TimeBasedAndPerformanceBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TimeBasedAndPerformanceBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based and performance-based vesting requirements.",
        "label": "Time-based and Performance-based Vesting Requirements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TimeBasedVestingRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TimeBasedVestingRequirementsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time-based vesting requirements.",
        "label": "Time-based Vesting Requirements [Member]",
        "terseLabel": "Time Based Vesting Requirements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "auth_ref": [
      "r986",
      "r1065"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r320",
      "r335",
      "r475",
      "r510",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r633",
      "r802",
      "r805",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r816",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1052",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "eldn_TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Four Securities Purchase Agreement Pre-funded Warrants Member.",
        "terseLabel": "2024 Securities Purchase Agreement Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Four Underwritten Offering Pre-funded Warrants Member.",
        "terseLabel": "2024 Underwritten Offering Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Securities Purchase Agreement Common Warrants",
        "label": "Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants [Member]",
        "documentation": "Two Thousand And Twenty Three Securities Purchase Agreement Common Warrants Member."
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants [Member]",
        "documentation": "Two Thousand And Twenty Three Securities Purchase Agreement Pre-funded Warrants Member.",
        "terseLabel": "2023 Securities Purchase Agreement Pre-funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandFourteenEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandFourteenEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen employee stock purchase plan.",
        "label": "Two Thousand Fourteen Employee Stock Purchase Plan [Member]",
        "terseLabel": "2014 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandFourteenStockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandFourteenStockIncentivePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fourteen stock incentive plan.",
        "label": "Two Thousand Fourteen Stock Incentive Plan [Member]",
        "terseLabel": "2014 Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "eldn_TwoThousandTwentyLongTermIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "TwoThousandTwentyLongTermIncentivePlanMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty long term incentive plan.",
        "label": "Two Thousand Twenty Long Term Incentive Plan [Member]",
        "terseLabel": "2020 Plan [Member]",
        "verboseLabel": "2020 Long Term Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r158",
      "r159",
      "r160",
      "r161",
      "r172",
      "r221",
      "r222",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r294",
      "r295",
      "r298",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r511",
      "r512",
      "r521",
      "r522",
      "r523",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r579",
      "r580",
      "r581",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAssumptionsUsedInBlackscholesOptionPricingModelToDetermineTheFairValueOfCommonWarrantsAndSubsequent",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. Government Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r767",
      "r793",
      "r1076"
     ]
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsClassifiedAsAvailableforsaleSecuritiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Short-Term Debt Securities [Member]",
        "terseLabel": "U.S. Government Agency Securities [Member]",
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae)."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r832",
      "r833",
      "r834",
      "r1076"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. Government Agency Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetInstrumentsMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r767",
      "r793",
      "r795",
      "r802",
      "r1076"
     ]
    },
    "eldn_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting Agreement[Member]",
        "label": "Underwriting Agreement[Member]",
        "documentation": "Underwriting agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "eldn_UnrealizedGainOnAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.eledon.com/20241231",
     "localname": "UnrealizedGainOnAvailableForSaleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain on Available-for-Sale Securities",
        "documentation": "Unrealized gain on available-for-sale securities.",
        "terseLabel": "Unrealized gain on available-for-sale securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Gross unrecognized tax benefits at the end of the year",
        "periodStartLabel": "Gross unrecognized tax benefits at the beginning of the year",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r415",
      "r800"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties associated with uncertain tax positions",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r800"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest or penalties recorded during the year",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r800"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions from tax positions taken in the current year",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r417",
      "r800"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountsOfUnrecognizedTaxBenefitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions from tax positions taken in prior years",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r800"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r102",
      "r103",
      "r105",
      "r106"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Net valuation allowance Increased (decreased)",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfWarrantLiabilitiesDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfWarrantLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCommonShareEquivalentsWereExcludedBecauseTheInclusionIsAntidilutiveDetails",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liabilities [Member]",
        "verboseLabel": "Common and Preferred Warrants Outstanding [Member]",
        "label": "Warrants [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r828",
      "r831",
      "r832",
      "r833",
      "r834"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "verboseLabel": "Warranty liabilities",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosureStockholdersEquityScheduleOfCompanysOutstandingWarrantsToPurchaseSharesOfCommonStockDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "terseLabel": "Weighted-average common shares outstanding, diluted",
        "label": "Weighted-average number of common shares, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r180"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCommonShareEquivalentsIncludedFromComputationOfNetLossPerShareDetail",
      "http://www.eledon.com/20241231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "terseLabel": "Weighted-average common shares outstanding, basic",
        "verboseLabel": "Basic weighted average shares outstanding",
        "label": "Weighted-average number of common shares, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r180"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.eledon.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Accrued compensation and related expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-6"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "7",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-3"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477866/928-440-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000950170-25-042754-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-042754-xbrl.zip
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M0Q3I]Q'-(PCT;A6.0:V6'\LPM:,/:*-!VM]538GMOJU_JZOIR=NZ4P:3&-_
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ME7L#D-P!AI8R$!U43JST!:>F"$KWE@_78W<WE(ZY=^@.D5B$0"0X0,327!)
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MFI&'8 NN^GFZ^345D#?PA.WO\IKO*I<J)_1&V;X7'KT51UI@<&1!K?&4:,'
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ML(MI_3BOT-)$#9\S#DN;*@W@FU*2TQ!9SO,4>&]52X^.DET3<32NM7-&5&%
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M!Y.U9H[-+=C[Y;;/F:L/M07OJ\L>>SS;R-G% +,]F$GPS6 ZAQ#?8,(&$_;
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M+,.7I; 5-5L"F\^X/\VF=32;UC/'<"X5MLE"!,\1F-B=MH+WKBX_8FFS63D
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M!_(14T)GL!I?$\H;>'?@W77D'L_8;XE/9];C+#+?I9N<2]-U=HRQ:L!$=5P
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M6&OFX0E$)]F#6,RD>5I/VT0:YI=H%OR6EX4\*%V:(;/Q+;$1I#/6>__DG7.
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MOI1\JTM_6K#+ ZZ#:#G7@+N]X5_3)U?W9"D:_L=?Y# 3??RW1<GI*G3FDV'
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MI=];(=#'5=$%Y%QRY22A=O1+M\WY_-SFD.Q=\/N9+DU[8*%)[-0E-Q&00DH
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M<\B\V?5WM8F[:PXWD*<*"_*EGICX(^DMYOH;3%7<5IR\'BA#7UGO-5G,8SO
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MP5'"UQCS5.JDTV9F6E,TJ$LVI^,L_J[F8A7) +JE&K2-K0:*K^L8QX?9CO]
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M$"N[X<@MLH<#8! > <=,'\':Z>KDXS;"LS)^P7!P>19O@Y+S,NI]*[Q("L@
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M$+T_0]RT;^BF[-O&JF$:&1NTNF] @"]$@MI7T[PFO0$:N? 7^3SB16PVI[H
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M/!DUYF3U?QGA &[)#]0R!-<[JN(6-WU"!O"P(N-V_][5HS$+-OR[[1P"D#=
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M<=USZ3H9>;@>@^01X5:;E.S]*'SN0BW;DK.2A(#C.MI\GL)T9F:3Y[[E,J\
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MTANA[2!*;Z2 ?BVP&U2C\&!%I#O6@MFNBMM.D4X!]6!9S0@Y&1Z_V6XO^&:
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M&B-YCR0RCU:4=-8)8IDC'HT: EM5.H!/J4ZC?5/R-[>9X^:;VU\%#]<2*@K
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MLF$J4&!R^#G[ZC"-6CNS*2U<QU/H0U'T"@\7;^6@);>\[.: "DQKG!ZI+G0
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M+91.KPJ\Q.PJE6L0U+M-*>QF?=R?HKQ(=\N.:JO-"[O1(.%Y\C8X"$>[>)H
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M,&<F&8_+$35^7AXX9G#;/RNX63%SV114#6Y8UO^[[=DYQ+AE OP3E&M:U<D
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MXTKKQ;']II/NE"8>Z2%3FGR/JTLW6@_*YIO-][[-%R2>DEZ5'32;7#:Y^Y5
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M3"'O(S]]"?KV=']Q2_[S[8K5)G'_$U2K7;&:L[G6,7RO)87BO=<4?D-%L'\
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M&DR5"G&]6#V+>N>*H&4D>-T*FM:$"VZYXXY?]0V7R5. DG4\<N9F'H@&HED
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ME).2#JK5?SQZ>/%P19=M8(XQ,'++8Z%"I2FM\I(VD4O1%F6\(I X6* LY6+
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MAU+*><8^6.]I08I\W910SH?I!$*8/MD)5*8.!4&P,M*4-JM#11&F\#))V:D
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MP6H1*9&7)0.7M3DKU\)D>GKPH(60@N]D6.;:8([V3BG9PZOV!@S:&<CL3$9
MT1PKBDI$\@+Y%,%-76TKIQY]^K$^(P:9,5-C9.A8!!AP$1DXU7KSO:M%/;A:
MU(&K176UJ*X6U=6BWCKD8A2TRD\Q'&[!,VCT2!GEZ>'M1;6@AEOISK=D+D'-
MZKY)>JX@1!V#B(P)5%'$.=W0IM.N@ININYP:S":<9SC,")="$,I@%:R;']0
M)2-S<0HJV\H1K#]$PD.U6C'J*8@/5D1QJ'-[:I8$6A,(AT>></O%2L/K@$^[
M(9XC3Q=6X;"9#9/K# EF6-&F5_,G>/":+GFP&T\QTUOK_>-UT!,#Z3*;[ALR
M+]CNJL5A:VTW58F##*:,>QO3 LH,\WFE[<RL;637LR'.008OX*CC/*P6W'=9
M'W-#?9(,:X*)'(ESH<(YP"Q@F<I<KC3T;!J4$846:O-E*;4V6TO-&30 4)I7
MEA&JME.ED0D'H193DVFL69;K?EC;GJL1N\5!FF%X0(E(96Z4Z)X)GB9LQ 5]
MA>Z,G8JB9$M56".75'34);0VR3WE&\"&U<<I$N6LV],\8\(,)0$Z1ZAO;+Q5
M,W:0DB\POZT&\WU'9',9Y)K)..5?%8:0E>29!VH((2Z*IJ7"B0H5N^4B%TQ6
M8LNL@<UKS!JW!8Z:56%<+$5DMILD!8L,/1?!0H_QXC$R^G$M)22UAN^SE. "
MX5->S>,T4(%$GLVAZ)XG<&@7I%038 GIG) C<5I-U_M830UO8"NVE$$R4LW1
M"SV+$;8#L[^<.( 7P9K/8?-@&9'*X."&6P_Q93G1#7Q ELXUZ=T84D1;6ZD1
M.[#I(&+[QXAE6,[AVAE/+DU(<;(>8V%'4$VT5[1=-;%AXM=8*RD+@?0@)S7Z
M"*6ZR%DPSN*\*%F4?5,S;;#0@OU$Q)ED64*H)I<8T"$-0D(LLM71%?ZF+!B2
M^F3MS:3[9XS.V-":" F#%&S6U)*!0^>7)[^1.O-Q7 +5G/A*&MHS]FQ,]]I8
M!7ZY)' \JB:;<A&4^D[B39E;;B$,Q3RFFDGME:QE8H^=@_,VAUD2I58T!$^X
MG&>LP>EI>4G[RD\0%)QF/!(-S"!SZJAI[" 7E[F8#/6F  0B*)D!-2*6S;WZ
M>YG5V03)ES@ 59U9\R+))6_^]*_DEKKHB6*:J<?:JN6HZ-UID.= Z+7XI'6:
MEMW@%%I#H5&;%1K581Y/D9>9RDF^9K5]-B=TI;5)]J.=X;KZ\H9%9*HO9\T1
MI[Z%[61,'&DCR:=Q[)AQ,33&D\K>2/90(4AMY* V-$)UW7)4QJ*>3FY9AGYC
M3(E:EAI_9UF$[9^**^$_9+*:4UG9I1+%8+(MS=TJ"TK(#>V.D3T2YKJ]6Y/B
MW&1OH&OE;E'PUHJ6JEQ>LI+(I6UGC)]SL\-HE$7J&CTSO%N97HZ5FZQ<%Z@?
MI3J"S?N"/118L.1]P/2+\)Y317[OY9^?/W[Y0/_NO_R%\\5!'F=501[;G]W/
MW<:@//E,-<E/U4U8Y=%D;!0"T5_-A!P<K1-EX)T)&C4-;I8P$Y>,7%$9')IH
MPM4-$=?76:K$TJ\JY$ <K%QEH(Y*&1SD=YJU@5%DHX%,X<U9JN ?DF!9B(;:
M,M:(]59?/H/G%JF:"5G##58M>*X*5KIN34C]I],8MEG(0H@F,C+.>;F>&--E
MB+HA%U6NK)2C085<L8B=!98O+ %X;B@4'7=M&AAT*4$J>:@Z8H4;;VA+N$1/
MC:D/="3 M(X0!R$_G[[[3%9]L%QYKZV@R5D*+F!9E5*#,+8T&]-LB3)=T#0H
M7L':2XI-6+5;*'BLQBT*46H<GI:GTYJH3E]+E C4"<H-1 T%4[\H8<.5# "6
MRE9!@K:ZV3:[?H1J_17NH5*0=B\!.2;6#3J45EN7+\'<&I,L P]$P3=LRPA7
MF_"NR#'24YAXV=H#5@I<WYQD!6M7\3U,@*4N2)/.+&UO^B?4S49;UD)5JNFH
MIJVE(T V/UGYEXK-&Q%5E4;7^#8V$AD/M)6M2O+)S1(DDB[ZO"RB5EO0A)$L
M;9J0Y66T>3&X 1@?YAI<A@&ELNG:.EOJ=GBHYXP93U<&B*ANOE@>D\R\POJ=
M&&N(,=O.;8GAUTFTMJF2)Z0QG,"/!?BA6,:QJI&Q+A S5JUBV"LR_5KT-&+N
MTMRV.D7;)--Z1%4L. S"V'.9Q->OQZW:GR4K86S&;589E/-,NQS&BE^O89$<
M)W](+11 W273OHB:05/W2NJ1ZY8(=6&9)[09+8>IIV]KX2%[R:T)C[8TM2H6
MR$:I.4#V>(,:YJZ%WI]9%,'A(:Y1)&+!W&E%E?P7&W6/$3P-OY$$IO%A6M$H
MK65HNK.1=<VZ:F"*+=@HMG8P)5>-\3$;"Y<PJBC+!]O*.UQ=Q:'750Q=786K
MJW!U%6YPW@X;HEC[T%!AF2^,N,12#M"S*QIU.+(9,+_"S:NW"DR%*>;P&Y4<
MLF;!:#]7"MML?[2!R.M5L=SO:(P3/0-86RN9ZK.PP,A]RU=J3-^P0D T F]#
MMR2=F32'6RME55EM5F&4;(;A-QV!LZY7P8!9:_D"HUND"".@0M)M5IU)2:L(
MQK7)=*"BJJ#TD"[@D=S +>-E)AUK&A.82J_45Z$1CGH%>:RBDP+E=\'I3+V8
MG(;Q<8#OBDC(ANIC,^W ?(J-4T#NZ0P'*DJ <$'3IW5 4RY)%L50J@SCM!(%
M0H=KJ 6H*&!!ZIPX?B3' EJ#-*>!Q$O0 .9VQM;.3DC3]ARL8%D;9,)*SI=N
M;[V8954J1[GQ*6"EF<%]P?!Z?_*RN)*4+&>U$7=2/G/=P24OS :7L6?W2/F@
M)+3I5+Z"/KO>?V67@NJIVDOSM.^^,LM32\K2^@A.J_Z.O"8*&<HR!0M;DFH
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M%)(T@@E)%ZJ;Y4+(%!](?PU=*;4$FS^NT\WQX?V90$*SE KV*3,%J;[T$A&
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MCPG4A-95M/.@RH]/_&&OOQ&N?<>:^W$.8CI *CD@T)B]VMW]WC$;7N?_>HK
M.L[Z;9D$#%OW :2?+ #_ "+A(A:7;B3P5:DKWB^0H6]DJ-G9@-;N@'K.] ZI
M8#RJ_ +\572OX4/B9,7F14'C6XHLC"D>3G%+S-P%.9HI8$I$XD(DV9)#[WID
M-?TD!X=P=#2"]4A_&)QC<Z43 E<=UB=[JU];6^TH^YK-LNG2P'^S>7T#6D=C
M=IEGF._:3/=BAL.8, ] 'A.]+,)($BA# DOO>M>NK751+_9*_V\NI(,E+#H)
MK+XC.--&RP A\ZQ1G(7D\F+(]%BKG6M08VN-')5TO22ZZ^ ;BQ?3H!!8P+1&
MH>8;Y,OVAF2'W=%H<M(_Z8_&_=[1\&3R\\O++(^X$.W%-R&6L,RD6:!%>W3%
MIF#YS_%@<*3K?ZQB*GYOO]?[N?'4?>%;SI>E(F$>]*4-23V$01+D5-?,?BK^
M2LYN!X^>DLS(/NR/4IM!'@!O61R/3K!8+)-L)6!Y(CT/SMDXW<C-,]E37IAB
MJGK)H2-\1_AW0OA:]BL](?,3NHRJD(W-< ?&<0S-9OEYD,;_4</:@,95S?^K
M3Q\:PRB+F/PU3(CC!!S49*C58&6=$'8#XRRP$<!OTFS3?RQS\#X<%S@NN"<N
M:-I>\)@*9V)6E.G'>B0B2!+I58%1T:V)V!;R[/; PS H6G]'&"R#:9R08^+H
MWM']3NF>'0X*F)=%'%'$'^OV>$[P%H:*<:)MDXDQ>F9"]5W6#:*7GB-K1]:[
M)&NN@=-"G4HN&5#E)E:'&L7;^I!<G%?PAPS'#&L>H&G,UQ.WZ_DZC)ZOH>OY
M<CU?KN?KUCU?3I\[?7XWT;E@Q:$(:L7@  4JX1+'@G:6\'TK+XE#5-16X**[
M01.[](Z]M[];&;+3>H;,)7BNWJY&0O'J/&8CPLS!,%FIT!)C;G.<N)JX(C34
ML,)W^MZ,4O2R1X_MWL:R="Q9AN(VA:[E6[K>-I\(YG&F5[_,LYF@-BNXB[P^
MBGAO&5DD)O:0B6-E9LOVJ&4U!5J6?^(/ &,=IYH&WVEUB3A'$Q[K$<*Z!\J_
MZ"5PER%B*2X#ZLV!)9>R/U.6B^'0Q"3!=BVX$7Z&\RI7+R4"7;WH#.Z<IT!_
MYRO8?S#?$Y-OYA-0OH(]\U>M+"><#T2OA86H#A3S%+RTJ'+3$(J=8RY'?5U'
M"4]31NS#(,Z]BR"I:%]E(2DH!QU3HUVM7S7392X(VYE7LHI(HS2:MB;5H^@D
MXL/MO6G<+B0:*CP;[@<7.3M/8\73K:\O[;=O>CJ/$*<VC$L$)T(LGVI:B+\J
MDAPBCS/L;UV( !A5=51071J8']>^EKI/"M%\ +AB*'P\G@M.R*X,2D0)DUC*
M/VH\@_7,D@H%%1=DQ:KXEGJA?>\B0WD)[U[Y)-5@LTHO-UV"+*-P,2S.XG19
M:86T6&*2!_>U?D[X%_5-JR<BC+8C_T]G7\Y>G;[S3E^]^O#G^R]G[W_W/GYX
M=_;J[,UG[_3]:^_SV>_OS][")>^_>/_]Y^O?_WCS_@O_\N;SE[,_3K^\^>S$
M2;TV#.X(SC7B%/6+8F-W13:&['0-DA4864I[&S&BV<5J0^?+3 DCULBP!82R
M@KI)4PI0D-8VSS(M4ZILAX"H"%45=@%L%A9239QU_&_$Y650!7C6$K&I9"T:
M]J6&(6)[R0)5X?V9$BXTE; 6!CKM]/2C!B>@GC5^IYZ#RQ*G;;GPW7]5,0%D
MD?&S"+Z!\0;.X8+>@#OS[RHZ7T@ABI@*LCN6>MZP3!:KAQ;X%=3W7!0"-\&2
M:GX]/*KP%?&<D@SE&A<TT2Y0IH >P6:;+1MU5V\D$:A)]K1\$V'F(UY%>I[A
MSL(!Q@7C@; LX\;@#5_9]?[%9]ZX"'9R'B.8-@5^\7/ #B>#^EN*7<TEV&N1
M# 5?" W<>P'F>E9)(& TWPB.FW<2B4N S7;!T>(I[F@ MC_W$NONOS#.PVJ!
M?<NA @NVJ)7)#6U.^H4^ELQJ.$K\>G-\P32K^.!"T#W4N:BE]H9-U^O$7G=8
M7(0^2K!$>L;B$P3.XP\K8+-"A$DX9;M8+1#[Y*.8^AI53A01F0EQCXC2;#!_
M,%\LZ:!BT. ":P:,=GLB2N66%NYI&.9H$KEJS)ML6D%^I9(J9.,I<P\E*6$2
M;RG^A6SM);E*C*UHG!X1R//97*!I08[$A5Y+G(*Y=D&.+Q;5TXH0F5/5V\"K
ML<&JPL04*113$JH#"B200$R1" *W',\XGJVT8\S\;JDND:-@,>IO*N9!,F,A
MQQ^E.JH2_ *"/.!G6?<JB6^53'!D0_O[**X84TFNXQ*AW6TXQY60&.6X#7!)
MA"+!@*O#)8Q*+P\P8"G$Z-&D$1?!OT%T$U@G?8E>)J./YX5Z,BI"U-2PL"!G
M2:J7I;^)D(P#0B^RH.R+<"XBQ!_/<OX"=3:X%J!0G,60"K8J%J)\Z<VS2T21
M G,]6VB2\8+H@BP$%<PDC=10S/(K%#%992D:1G\:)/288BY@\TAIQEL:,<;F
M084E<YZV%E(Z+\/="A2"";!?%\1+L" K!M<AUQMM3_4Z5D3AH640(P>]<-6\
M+E^P&Y_L0]&&PB89G<-P&RA62X6:;'256(YD[Z%DQ59;:]3;+(IU952.)G=*
MD\JF;*'%6@U5>T'@EL50CD0=B?XXB5K5>:I5KE96[=>)%'6^/4L"0U6Z(G M
MX[:A?.!)3H:I1=%::B.;-932BJJY.#6?4.5;V/OD+D9^<M28.*5=8EF:7R4E
M!E8]LO9JO27X*(XA;UH/6W7L0QI72>.'<!#+RE1?X,QBBF_I1AAK1?*%*QD?
M0X%9I1@N5,Z>-TNR2W99T4D,</P8);S8[8+K.=Y7+W21I::*QFFXA!Q'UN:;
M%V;FE@E]JQ&!0JU$[K_>%YWV_ZC>S1$[\EWU5IB]CP0>C7(B<5TJ*47'6H48
MUIA5\. TSY)$O7,9@$Y0N*RT@ S]R37NHV.RO&KPDM'E5NXX@5FBTPEGR;%?
M%80A_!><]B$3=-F%GM5AX@^X@U-A._SMJ_1M[$GJ72*]QCXO%1[(K6>"E6%>
M3;68641?G9?2]<YJX0M8)85Y9%"*UZ*Q*+7[D=</6;[I@NI$9(S68BR.4$4H
MY^6[:)/P,73X<22S%/#J9-7U3I-R3K-0X+8HDZ"GB%;;8%?^,BO(:R*YM ;.
M$13RV^!W%?WQZ4%$2QJ;4_%^&:AY)&8OUJ,QGBJK5)B=<O^VO1W9C/AVC3L/
MI*79U8D?1IWXR-6)NSIQ5R>^T]D@C\1\YMQZ#?5&)V/++//F0#>D^N'?8#*2
M]880Y%@=&59)D&N;XDM&P?_Z>"PR&_$&I;"E22 3_9G$$HFSAD6^??;*)6FO
M@T_K_$99EE=6;:W+R=;'2JC))K)D[S]4,[U>BDQ9N@#' UHUR\%ED$=6*@L-
MPW,LN>M0+LSDIJR2.S?;M7$ ]=H^":(OBS+BVASOJE"IX-^2  [A<SC/* VX
ME%.>XY ZX[-()+Z\VB[Q,&"B$O"3H+?(/>6T: '[$\_ ]P,IHXI::IEH! !=
M625A[+3G<?&M,P/_G"H;K5?2R Y3W#5%QP#^O8I%$DF_Z1Q]PQ2?!0+R/R+/
M8'<(XW^:8:T/EW"E- 82]@C7@]O![V4G"1YHJBPWOMPJ+-)7QU+@RFD,C)^*
M15V,L1J!L :/A?Z6TD3)>59(L'*N[^0\,Y?&8]7.11 G>+.L$!,X\( >?4D#
MV4F$XSQVM2CS:%E\MH1G+X#L*H([U6MH?"[NP#JM-$IQ6>2*J!/@$*5S[8OK
M21CUNQ5455CJ2BEKDD/7^TV$ 8(LV,.0H@Q6CJJ.=%ZM=$O.9\#0SD6,DR=J
M]QF2+NWO2N)9C7H,O1?Q8IEP^<%"@+/,]0SU+R#!(ZM!%,"/*A6,T47UU$ZH
MT16Z\@D^$7W3"R1SK!/DG3+1$5-BT$)\8#EAE4>TD?2L3]<EE+Q9*UVW%Y:Z
MDE _;QFL\ CX=6KOY@%O.4<1T#)0AR!#!AAUI8HP?@H/AH(;*1XCR0PV#RA%
M$)W/JK+*1?TEEBZ 2V<BQDLH7H>[R#O!57!4_RG#3A&LB!:BPD#VO1BA"Q(T
MFTJQL>]E/^%AG:9B,+T2F+O4R-18)VOJ8S]]_E,//>/:&ZJG5]%/24Y1G2G^
MJK*28D-46Z^GAZV/E$EK1:G$Z,[XO3(S(#L?WIE"4V?WKFT/:SU9("YKY$"8
M@<B:TU0SFBR"-I)=KRNOX;'4=I\,!^,I!,KTB@/'T)JJI3+LH28ZI]$U0[&T
M!\IOZ%#XD36?_3+%5KD,<6,01.*ZHV;H8)HX6"+=H/PW8PUEG;$%^%[K?=%J
M )G/[))4A)]-Y\VK)"/E;(9YD84S(Z4.+]]O:&T)1NY9$-M:,Q\HT/8O5I^6
M'&4W]#[*V3@?]6P<) #=.N19Q%4CJ'IOUM5N1Z?F=MC4YBOK?67W;%E-5=8[
M+!4A/Z!606G/R[&[1ZAND\TU-#S!!M?]![7WM%=8RCPE3E"S>JW4IH3:(E,C
M,*Z8BWX=>]#PC$*49<)UM6"LQ4H]9FFBAXS6^ YX,HA3I^FN8HZSM/-1EF]O
M*L=_ ,W7&-$HTSC[HOY.59XP2;)0%0O$R,F\D1LCC\K:._OXZ7\'B^7+UU>-
MV0V\*4H.?"!8<U.06=P)EHM-@H:<"1YU@@!HW-!%2@5W)J'*A#@%YCVG*1BR
MH0:;NY):"ALT]!2>E:5VDMTJC;\.N)F2Q/C;):>[S05QH5XDE&MI.LFR,*QR
M65AO0U+A_-0+]!TS9>H&NC &N^:F98!JTV\N4S4,P8Y$:"=0(;G9"=JM!4:P
M46I2BCVH.?E3ZC7E7E:."<"VI]D"+!*-;*"K%'C.<:%VM>N]9@A$F1;GAPI[
M35><$GW*BE/\:&Y,A;72:57JY#\H-$[CIYRP1@L,17&<\]'EH%7@5;.<Y2JF
MM&?X-A3.6.X 9VM=+KZ#5_T(?<C')'O^A34^><$]B" :_H*#C^78;]VZEYD0
M$;(3F>,Q,0N10Q)_$Z0R@Y3(2X>TUMNDM:3"FQ-\(=V%I*\[]&1K)<UE-;U]
M=I5+?0T@Y>!!&##"6 N7.,"M?V%ME/H4_CHVJ<]F:N L_Q6?V/+9E#TRWRW?
MA8FD;;_YND\DMDPW+Q4?4*7Z\W2MS!672\&D[_%E1$_U=K6U0EY0EZ9>M9(%
M1BE0L,[P-3LE]HY9:YAE855P; K?]4VL9 ^]7PM]DWD;L(<$%BV&?RU;$Z10
M,$WB8EZKRJHOFPUDKJU3MB4<9<@A4; 9R\T4\)L=];#;H+&_B.?AM'\>T00P
MCYRAP[  6Q"&(7N,1/)6*@?7S!5FN8Y*@.+&(G*FYM4AL)!UT!E[6J>FLQQ,
MT!3^S4Z6"[74)H)'H@CS>*F<J5SMHO17:_WY]BXR)6.MV#+#AW')FW34ZC@#
MJJCC"I@!8!FP7) #<-1X2LZT-^CN>:#B<[58H**!;_ELY>9LR@,?.;3">_MP
MYOX^C 9[+*4YK@[Q(.L0QZX.T=4ANCK$G=8A'J#IN9VA^>;SG^^^?/8^O/4^
M?'SSZ?3+V8?W&W&I]LZ"? C(02K;B0L-Q>3]#R%+O*$.D+5P/9F)F"!QAGJC
M%"U+DHQP3TH2@3(Z6*BZ*/).V^UKA2^RHHT7UVR\]YQLOJPJX"_%+TWPB7V3
M>->9)3]HWO%FMW38DLZO&WOX,7AY)Z'J(+Y$MX9V>S^KZX&.DF!9B!<%XY3I
MYMJ<V)/N>X:OA_=K>^0B+F+.#;Y0]\N+X*JHWHDZZG>/>L<_VWI+?B<KKE\W
MW-?OC@>WN.L6M_2[O>-[>I7[I@/YIM[HOKYI/-K%-_WMUS)O<JVT+-$<F@;A
M-RPY3:..5"0S^G_MBL3J6&>G O_0PO!UV[;7!_N59M&'02*E*DO:-7<2#5WY
MIUQ:OW1WBSQND?G'=R3RVUW#S4+_MK9K&>U^YW:[4S=3CG>Q3T"E^,O?GQT]
MNXL]TYZ3"F<L2W8?/651[2T]WMJ^WNH8T"!F>_AOT_S7?]BFV2YI^(#/8^_E
MPQ5[RT*_-WQB,F1P)S+$4:3;N;W8.<>GCMH<G][)SCFW:>^/R(G2AQ.E!VRF
M[]9MPJBU\X\.4Q X_\@)B_L6%D,G+)RP<,+B4=#L;H7%3]X_@SS&1D0G,IS(
M<"+C4=#L;D7&STYD[%'XR,6,'OY<7,S(A=\?";6YG7-\ZOAT_ZG-[9SC4\>G
M^T]M;N<<GSH^W7]J>]0[=T79"34TK<<0PMFL-PMW'4. 7WY0'.RT'VNW8;0/
MW+5FS7UXL2<R]H&:W Y0R!H^WN4VTML?G9AU>^>8U3'K/A.<VSO'K(Y9#X3@
MW-XY9G7,>B $]\CW[N;Q!E6S</O0@@V60R]I_;H["D#8Z"CT,OOMO2M0>AXD
M/K'M9)U6-/);\,8V.__4)?1VNY=FA[EW=<J\037J?E#;?HCG.V7O<=\_.;I-
M#]%C(,=[YMI'185.##HQ^'C$X+#G#_N#)TJ.ARD&G>EW4'OG9-Z^R;Q!WS\:
M.YGG9)Z3>8[('K>HF_2?* 7>5NO^?+?E8BY\^U#AV]]Y_B./8XQP8%Q1,E+Z
M?@@;I]%VV?7J=-Z=;>4CU(K]8_^H?QM(&$?)^T[)5R,\[ <M.SGLJ-?)893#
M __H^-A1\B.DY-L@[3CCUY&J$[H[+WSP3P9C1\B/D)"=S'6D>B"D^L1D[FCB
MJ'@_ _5W6V<]N,] _>!Q!.J_9&60J)&E5O.W"],[K>FTYE/6FI.>/YXXS?D8
M*=F%Z1WU'B[U/C$Y/!KZ\!1'R8^0DIT<=M1[N-3[Q.3P8.+LX4=*R2YT[TCU
M0$CUB0G=>^\1/QPJ/O@:^UU&Z@\Q%/\N*PIOEF<+%8[/4A>&/R0-N"][M_?Z
M[:EHK^</$D/?%S*\K8+ZQ=&CDX-.#CXF.?@@,>Q](4,G!YT<='+P0.GN;N7@
M@\20]X4,#UP..B?XH/;.";T]$7J=)XOS>?#%U2Y"VYB15<Y%[L5IF"V$[Z7"
MH5$[S>0TT\%JIJ%_,GBJNLD1H8M%.+H[++J[VW(V_VCBA)\C0B?\'-T= MW=
M+?21/Q@_U73481*A\W$/:N\.D\@>H:2[=^R+?:' @R^/=1#4/T;YK^9!>BZ\
M./5F09Q[%T%2"2^;>9=!G@=IZ25Q,(V3N(QAQ0A37;]J%J=!&L9! @\HRKS"
MV8.%%Q=%)2)\IO@>BJ+ *Y=Y%@H1N5+=0]*3AU/FO_>:U#6K6-.\3ERG]J.D
M9->I[:CW<*GWB<GAYY,C?]"_[]D[AT/*AU.(YR2RD\A.(A^^1.[W)G[?2>1'
M2<H./,.1ZH&0ZE.3NB,G<?<T/>!JL^^:V D]8RIF62YDA;97!M\=D/5!J<%]
MV;N]5W)/184]'X[]R?B^AT7N"QD>3J!F7W;,"3TG] Y?Z/7[1_YXZ"IWG-1S
M4L])O2<B]8Y[_N38=:0<$A4Z47=0>W>81/8(1=W1R1.EP(,ORG91U_K!?,RS
MB[B(L]2;9;F+NQZJACJ<O,W>ZS"7?K10/UW^\?"#'*[TP]&LD[T')GO_]_\Z
M'O0'CI0?(RD[J>M(]4!(]8E)76?Q.HO7R=Y'1+-.]AZ,[.WT7>OUOL;=7;7S
M75/[>U%Z"58\(W))F"W@$7.1%O&%H#^[X/O!JL-!=X!R),JJ:2(>C2#YZ8$U
MXPUV]1'JQN?#([]_[[4U3X&N']HY:>RJ<T\<W3IYO/_R^&$*O)\"83N![ 3R
M(=*M$\@/7'L^O/<NPT,BZP,+A#HI[,CU<,GUB0G?>Z^&/R1*WDGD'OXW@(^E
M?^Z/Z#/OONIU/\#:6W[N\34KV%'<_P:?3T]^$9?PTO &&_))%"+(PSDE#5Z+
M"Y%D2\0U]]Y\7XJTJ-7LU_;*!H,?=X?#X<]7(,(?[?WV;;597^;"FV5)DEW"
MI1[QBU=4"U@]O*CP2OAY*?(XBSH9")X._]L+"72^0(3XW-[MR-IM(7>;6B;,
M<PIOB;? ^R/O.=Q?SK.J@'N+7U[<G(8?$\O*O>>UR*73H(*@*C,ES'%U^'CX
M&+R\DP2KK)*7\)OZ/9#B/ZOK@:R28%F(%X58!GE0"K4I+/#IOF?-+">VNM#,
M@-4+=7]+^I)?-YIT3R;XNN^X2[@T^9FP[=]?/OMUPVW#;N^H?_/;;G-+OSLZ
M&MS+J^[QHP;=T?&@9_[?_;SV7C_PI#?<P:NNR.H?7YG4;Q,./Y#IO[-F427)
M6J3E\1T)2V.![X-SMXMD_5WMU/T[P4"E^,O?GQT]NXL]^_%"JP>CQVTMJ$OF
M]FF61#<XAO\!(\=[ [9A]+=I_NL_7HM0+*8B]X9]?Y<T?!?(X$Y". F!$F)P
M)Q+"49O;N6UWSAE;>W]$3I0^G"AUQM:&8QCT!K>IXG-6E1,%3A0\.E%PFX(%
M)PJ<*'"BX'&) IYT[(3!/GAQSG5[^'-Q0MI%P1X)M;F=<WSJ^'3_J<WMG.-3
MQZ?[3VV/>N<<(/;# W-\$>?9,J^F05YZ'>];'*5BY95YD!;+)$C+H$2L[&6>
MG>?!PL%T'%+_R[[LW>%T&#Z5!I;!Q!^-!T^4'/>^U6J/J=")02<&'X\8[/?]
MD]%]8_#M"SD>IAATIM]![9V3>7LG\\;^N.],O_N,63@PT=W&++)R+O):PZH+
M5SB=]<0,HT>HJH:](T>"C@1=B,+1W0'0W=V*/K]_[(3?(1&A,_(.:N\.D\@>
MH:1[/O"/CY]J#/9.,8-=,<7#!R;^"-)J%H1EE<.E^R$SG&(ZJ+USBFE/%%-_
MX(]&QXX*'16Z (2CNP.@N[O%E_=[3O@=%!$Z.^^@]NXPB>P12KJ1/[KW.:R/
MB0A=/<3#AQT^BKS(TE0DG5PD02FB_9 63B4=U-XYE;0G*FGB#TY<B9XC0A=Y
M<'1W"'1WI\+/U2<?&A$Z,^^@]NXPB>P12KJ^/WFRE0\/$WEP!0]W3<.?RRS\
MUID&A4 @F07."2/$B/T0&DXS'=3>.<VT)YIIY \F$T>$C@A= ,+1W0'0W1V;
MY:.3OB/" R)"9^8=U-X=)I$]0DDW\">NR\R5/AQT .(#@3^(]7GP3A_MNSZZ
MY7B4 Q46.R7#'Y\T\UAT6O_X9'_(^.I1,XZ0#\KT<B+V25.F$[%:Q ['^T/&
M3L0ZDW4O"-')4R=/;UGQ=IL)R4Z<ND*10XK3?,G*(/%R48@@#^=>D$8UQ$X7
MP#EX;3CH#E"01%DU3<3>Z</#0:*^]:X^1M78]T^.'E8]-@[@42I(%])Q0M<)
M72=T%>ZR/[SW%APG=)W0=4+7"=VG*G0'??_HWD?R/3VAJT)!\+\!?"7]<XOO
M.(+_O!=GW[S]JM?]P$[4/IB6&:<17/MBW!T.AS\W5[&[/=B6>^YZ1SY=%X+R
MXC3,!74T_33H=R<>O##!(;BS+/?*N?!6<+\G8-<B[[4(Q6(J<F_8][U!;S#R
MJ0LJR.&W,KONZF'7^P)7J/=YET'A+?,8-A(^T8LJH9XQRY(DN\1/4R>Y#SOI
M-<@JBB^\, F*XN_/8 F+3A(794<D G>7EK$4N1XQ+JD%*>/%D$DOBG'D\.K%
M+!'?FX3W[ZHHX]E*O9VNZ11ED)<OB<0Z^,;B!3:B)3&NN4&,YAODR_:&.H?=
MT6ARTC_IC\;]WM'P9/*S'7;^)L02EIGHS8E3_+X.[=$5FX*<?SP8'&G6Q\-1
MTH?>V^_U?FX\=5]8%%:@>2*;>3_UQ]VQYL(X]6XTLMJW6.HR+N? YV PI$'B
MO?KT 7Z5B$G(:H;Q@[",+^(R)FG@957N?9SC:OI37_YKX/WVYO.7#_\B,:+^
ME($$Z23!5"3TEK3 A91Y'"0%28_VI1KQ#(<D_Z_C)\=/=\=/H.<L=AIT3S9S
MT^9A:C=@)&28L_/3]^I>4&)!2>H-M6,B\#)X,ZK EYZC?D?]]ZE-1MV13?X+
M&[(?Z+,HURD='Y;#-8V+L_P\2./_D!"'FY1]:-0(D']4A:2.X,U17IU[136%
M/4U#P?8G_DE>!=0>I^BVL<: *Y?+9.64@V./^S6VNL<V>RR;T)+&3Y(.BOT
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M+?' %5,JAJ"7;MG!;9]!'QL)8-$(K?(%<C\>;I;;ZWOA6JY<<?\N1%A)?8A
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M./SA=5AF_ANQZ65-$5$X$HT.\2@< =OE8?MWEC)1]OVEX3&50F*+WX:SFTD
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MUZH0.H45G-:Q5.4*4EYTPPC-Q/V_^GDBBE(_/(V[G?H(A8>3$OA %J%0O!]
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M@)R+<[E:+E10F-I*X -] JBD(I4@2P!]4$D!Q-DT<3XQ+Y5R!&. <[5VG%C
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M:Q]H;687[/>VB03)0H,X"3 4!0.2A9VP]H '\ ">1EOJK8,!KH KX K@ 3R
M!Y*%-H1_[:[9FKBXPN-54:7" IG"P+!Z>F^P%_1M?: ;&Y4I_(NF*8WSEJL2
M%*:I$OB@/ *HI"*5H$  ?:!  '$V39S/])Z84G8P:#%DH!3P41(?B P:1$6
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M72#.DM4"N!='+$,F[-<D^U "-; *^"B)#Q+V#:(BP  8  -@  R  3  !L
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M!V^0?P=[D'\';]3GS5<_3SR6$DM'$AYK;("!)'P3H 88  -@  R  3  !L
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M5B 59!#M7O,VB3[</S3!'#!G"17$Y&J2Y:0/&03F-0P_Y0(JZ@=1=C1N#C
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M<0F%!$"?-[J )J@#ZBQ;2,"T"S^KQ:B!5<!'27R@'V@0%0$&P  8  -@  R
M 3  !L  &  #8$ _T%S] /(.D _4=_:;NN$,K)XZ._L/BZWY,L'_C66Y% F<
MACZ+,S93#Q#O7OZBT@H<GIZ79PW<DX_LAD7)6/[LDS <5"@/:KJ!PYA%X5VX
MX'2"QZ($MSBO8-.5 G9UX"@1_UVU=N"?C38R8 Z4 J!/\^BSZ6H!8$Y;F',X
MN9ID.3&,=2H%0"*@L0MH(.??>.(!C*V#4=[_YR-^L9>&/W<R&F=:QM)PJ A:
M+W,#&GID+. !/( '\#03'I4F,H !,  &P&@4&*V>7R! V*P  4'I]D30UB)
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MF!$ !L  &  #8  ,@ $PV@(&TM8*+\MWE),  V  #( !,  &P  8  -@  R
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M@EWA9]-@ 7_ GX;!HK#["I( %L""*6F'@%+8&BN!#_;WPT4 &D"C,09+87S
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M?\"?AL'2N& A2 )8  NFI%8"I; U5@(?2!U;E$$#&  #8  ,@ $P  ;  !@
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M;2:*"9S[UVQ$9:Z>'%>9^],P_N[1;*89R!"0! G5@P7\ 7\:!HO";BI( E@
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M8>[])LQ"+XS"_'Z_NGY!_KQXG#UX7Y_;RCX6D]O>4]<L<4G_1]?\2$2@C%8
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MM10>^$WBV@^T2U@.@$^(8ZGV)M8B+<;PQO!>NP@3)&LGR1!2:O:B#S$"Q A
M%] %(:7VAI1^9V%^30Z[Y'>:?P]CA)4:-OB;Q+>C:QJFO!G5_I9?$YH&XA^5
M4"K#Z@#40H1)U3>Q7(1I(S,,AKB*Q%(!(A &A$'$2#TF(@0 NH NH LB1FHX
M]R^.&/V#W_OO811E28S]=8T<_DUB'/;0@4 MC@RUY$TL%QG:T$R"0:XBM52
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M:>R'-+KDUBIG(S$\5 7RY,O'XW^3BZ_DZ.N7\Z^G)Q\/+XX_DD\G7PZ_'%5
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MIU>,10&ZXBR*1)Z;X<])DM0PL)C%-[\Y57F[LU8:+@GESG@"7E_G$[^C:_W
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M.(WEV-JR\W9Y)W\H3GT.29H_OILM8B/_=(FF._^!C/SP<R=#L=W@,R.[DO>
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MM;U&@J]6''C_V*CLBY1_^UY.4X@AY#3K88N;:+L_L/XT)-I8)5$Q&XQ50>%
MX4#A>E0X;Z5V#)-2P>K+QHPJ*YQ6R&#G0E=!E392O=R#PA$SXOBNC<2 +;:O
M<##!UW\H_6&VL)/5WA GLTE&8=NEB-3+)OY[.5Y /1IX'>!U[+37\8T:?\RU
M"CGJI<[EJ)?DX-7A))%S22=N-:%^(].#Q]>8Z77'2!N: 21$CTC_BS)AR$),
M"^H"4 5UN;&[.!;,J%34)1C$)2'(22N0$<([)31.(6XBXMR:NJ@1Q1JT!29F
M=S&:G(RM&T_&BW+@3MGE!*++9ZC_=(\6/@FS93D^:6B$\M \U7_V[ K\@%5W
MQAF@5 3"6 XP*=>E*% A9SA%2EJ=L(R"V8WL'/KVBK;VIV%[@:=2H^R-#,LY
M&/9HKLR?OV5,"#YW#*X@/L]'?&(.$1(/ @5JRQ:1UB##N$6*68F=9B&QM>,(
M'Q*)/I'X:#/"<F K>H8]F#<9FN9_;6YC]^MP2']U;YKO_7NW>X0=H+EW-?=[
M3_ [#;ZBW(>PX=73;,8 QS$VUI>Z4#O]FJ]NIK-%_JK%K-!BEV_J%FJG\=1.
M_;B;;<XOG.8/MWNWS!;&GQH_L6U;*.=C1.=$45J1OSBWMUQPWMS_Z0XD_O("
ML9=I$K^@,)['CLU>9$,L3Z<OP[@]F]BO+\J[:RRT)S*=E!:=IXCPGBJO_'/9
M+L;IZT7KNL^B. TOSV9M5TC^8AXGMFS5FDGL2S%E,<\EGWVY)T-]%W[5=/X;
M])A%29M^&G&#?3-8SG\6;)U<9@7/C3N>3L;3_%P+.U^\L,O%[.7--W*WKUY>
M0;%+#=J4;?_"3C[;K^W+G_Y\ =JGD27;G,R+ _ ?V3OXK3S4 S'P>05YE_V+
MU6VR>S";VP[>RSRFYJ7YJTSQY2 ZMXF;9,=D.WWWH4AC,TO-P>JE]K(O[;7^
MO&").QV3,H*OT<+Z\-[L*'XN@G5EV6TV^G&\=1VS6X'?Z[>O7QV]:][_=?^7
MG_</7O_ZX?!@_^WQJ#E\=[#W&(K;^H,W3^AI7?1A%QSE1PAQVL;PVW6=_^U*
MW7^;G<5,*T/M\8.C=\=';P]?[7]X_:HY_I#_^?GUNP_'S=&;8??WT?O7O^Q_
M.,Q/W^R_>]4<'/W\_I?7?WW][OCP;Z^;MT?'Q\-^_![@.E!3_/%PVBQ.9LO6
M3D,[:N(7'\L,;3EFH)LWRZ/G_*\\LNR?H%N'*9^EN5U<?\N_+(^Y<B!OAC&E
M,>5RE/VJV?+\DM6=",9[^ \7U_MR$-=9&U^T\<QF(HT71EGE1+K/_71[ROO3
MN!UWF:2O+RX^?\=<]NIVDNT)^H?K/M!Y,U=.T)^_\3&R9Q[PH0=\A.\Q_C1W
MJKQ%O[/V0?_N0OJ[1LTCUD-L;+^%BR%^!XWHK8I#7W,CVUC!L"E+/?T<4D9I
M>>?__"1_VH3-'K_<KC<\/EC@[]4-_S?:>?,ZN_&K\XRN'U*T30Q7W!];PSU0
M^."[""C\(11.@<*W2>'E+#G@ZCJ)8,,5*T 6]6-VZV3!@"SZ=^S F^N_7\";
MZX^@ 6U@N4%8#L8IH W&Z;836-^IO]RNS_-,ZB\?YO ?=2LPRJ+,^.6L+-9H
M!T*Q%1>X/#'']EA?43W+@NU@L,)@'3+@GKGM8(O#_C>E^"6VT<[]2;>F+L1/
M<3([*^M38?.)BNI_AV*[>FI[!TRW3[%IA*72$FP0X1HCKK1"6EB-B M<4JZ\
M#_QVW:[5C&,=# J<E5VG8D(ZY4]3QK@U*D3,]?J>Q2MRV9^&5U?4\GH5;&VH
M:%>0D9&\[Z+=H8S )R8JH/E=!!G0?!TTSYPUU#J+C",:<<XBLIQ:Y&D@A%LM
MN$VW:=Z38(+D$6G,+>(QN?R9(%$(*5.^QM%ZU0?-,SQBI/>]Z(<R OM-24/T
MM:EQ^]]Q&N=VT@5?-N2KQNUBWM7>#H,J09AA+]$^-UV"S7_7-#TX6?Y'G-+\
M(P=>2%L6D @J,.XC44QM(G0[9Z8LZ?LW>&FSJD[T2!+6MZK#\(5MYD%I *J@
M-#<.-E.*1YU\#AS+SK+.1^2B\2@Z)UQ*S"JYIC0/B1Z?2&GH2&K8='[@$>;C
MY_>Z9I5-CJ;G-]EFR'E]+X/N9M?OCF_O)5%%1+K:I'ZVB951$(^"EP!>PC/W
M$F(B5EC+4!(LNPK1>^1TL,@)::ATDEM"-Q&/7J[5/'<+VDV=18-'0BGP"W9A
MP$($"E"M!*J@+=W\)<6,L%#.S62("^.0H8ZAX(2@WA(3_4;F+[>E+9R-LFU
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MZ)R*^L<S4@>7P>U1^L>[V?1O76![<!77OK\(:[N/WW]I^_VV920CI2GDH>Y
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MQDQ(PYWD:W4D3ZX%&ST\$82@XE$*0E"1Z>J$&"0_ (2]@Q!XKB+3U0DQX#D
M8>\@!)ZKR'1U0@QX#D#8.PB!YRHR79T0V]$$)K:"4.<=8M0JQ /QR#(?D*/"
M4A:Y3FXM@;F=0_\@@5G=*(7C_)Y)!5HYI.^.,K-O'-7'FU_S9?//\_$B?W%S
ME%*<YWM_XXB^/2A6 _\!_ >(DP"$$"<!S]4.,> Y &'O( 2>J\AT=4(,> Y
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M&G0G K='RT6[L--B_1ON0=N]>]TO.'SWYGL'_!(\PKKW32Y@\#[1X(6 =Z?
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M'24$*<X5XE)CY%CDB'L?E":".!+A/.^=&-Q/O]/"4"P&4@)2 E+R6"DQ2>!
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M@R=F$\%L*9%-K]M%IH=%V>AG-^:N'NBE9V,5?%^:"QSP:P[XRK6V%U-\=Y'
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M*<MW@N:3GYMPXB^M2_+=1'^_,%T:C?J!PI;'K-47MJSAVX<):6$?_-+W!_?
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M)IFK4<BVM_88D@2?F]_#S^)D)L\%!=F;6QD1'HF8B)0SDF@;"17&8:+$JL+
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MY]'\X[7SL8:00?N_@O:?OS8&[W+^(JZZ25!<SI/%O>'E9"SOP#AI+FE>14-
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M-@KC$YB?!5;WF[]-RJTAB2%0^Q(&M5C=D"XP?8>60"B@ *(P&B%'+57A,+S
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M1BTM:B>K7-W]HL-D4,^[5KM'K_X,O&P"2U]<M=[2H)>5T3CC^F_&$%Y7QDM
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M0ZU(IGE*4F5XDANJPW!MXNT>),&K=O?TDL%+!B\9O&3PDN&PK31C;;1*<TM
MX"C"&8](SJ4@(8WC)!0VYRHZI.S91RM-+WMVP X.TR5S*%#S0L@+H=,30IM%
MA,AT$D4\)%)&&>%@CQ I4DET*H#7JQA$R'JWY1V(B#WWK?0.JGV9(7Y&WG #
M3?+23-2=CS<=MQ@_O[F;?I#N(1V42JL\8S%)4IF"!I ;D.8F)Z%.N,XHF)!B
MS4BTB4C3-,J),CA/ST2"2,YSDF><<IFGBBL[D% 5!4T@38>@"7BZ?BVZOC_3
M;1B4[:63QV(OG1Z43B;)><HX)383!H?C1227F2 FD6D644MC'-F^=^GTJN$S
MYJ75.=&YEU8>BX\?B\],6ATJI&=8'%M#.<E4'!..P3W!N2(YQOFLC37E_)#R
M<"_3\;P\/-V@GQ>,7C!ZP7@Z@G'+C/.,FTPE(8F4U(1'3!,!+P.KCDE*D\3&
MN=F'V-KW>#SO7#RR0*2O>-L'T?]:3N4XJ*_*:DJ BUT'Q>36U%,,2OH8Y/&K
M!\,>MGE<Z49^E.Y#N@++6:; SB6*)9)P$<5$YJ$D,HY#GC#&I%U+2<H2Q=(\
MX41$"2-<4;@\32U1FF8VX6&LLW @ 4F>C'@6#D]G&#:1'Z$5X,>\>[3ULNFT
M9),1-%22I<1D(2;+I"F1&4@I+;C(6)Y$L4E>03:]:C@R]K+*RRHOJTX>;;VL
M.E99=:A@I)!9%$4@_E@N#>$A2,.<QI9D)HRS+$I#:L-#2L-]!".]-#RC<*07
MBQY_O5@\5K&X66B%6:H$XYQ0RD$ 91Q,.!T;$L8BCH3,K<KV(K3V'(KT;L6A
M!"/A,Q[[W[JS^,?LVE2%@K]U<3LD&;%X]WVO>PF(YGMU:RPF&BY\&U^ TOC5
MZA)ZVT\>6-&>(IV[!L>[\3@H;3"],L'[\AH6=/?G.I =5R! S:0&0N^5:P97
M\M8$$A:.RFP Q(X_W.%3QJ:NX5&P*WAE<&=D=>$!W0(Z6*)*(#K\J9C,9,L!
MD>R -O_JR&^))KN(4YPF3+*01%0I+((71%+X3P[V32;B4%JVYM63(N*AT!G1
M' OG$V.)L"(D+(JXS%)M0BY610*V279=DK\O:C4NZUEEZE_AD=^-2_7[F\
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M_(*=]RH S'>R+NK?)F5>F^H6J>/#Y&8&[X4%*+A+(J_Z%5;RW;A4O[\)#+#
M&WC+M)J9/E=8:H]X$4715_?T*4R>A%BBZX#X<M3:-5W]>F6 ]X_'Y6>X-'#,
M):AGU[!^>%$=3.'G]^4U+/3NSW7PN46R\>(\@@[+AK"9KVMC7FM!SZ33?Y13
M$XB+X-,4D/$*&(2IZC\'/_PQ*Z9W0P+E-\%U2VF!G 86*#&X15(,0+F10=71
M7I C\06R#DH;?&^4N<Y-%41T%+"0\4!.-'Z(@J^+">!2.:OAF_H;]_UGN GN
MAA? (VN@B\*""@#852#YUL&DG 8+F@[< TP B/F[F8X"@(2Z@G4 %&K,XX%%
M_61NS3B(NH6[+IV?B^E5>V=O#U>%J62EKNXNA@3RH,>P.W'?$F2SL'Y353F;
MEITVA(O#IX/\PLO)6-Z5L_:2YD4T!#7HJ^YZV.!8WM3F;6UN9"6GIF-7C<;D
M[GNS*7WFMJ@+1_AW;[MG;,F+:5[+THN8<GSO%X06KK'=+G#&+]^^^<L]]R87
M(LV>=RM]YFWT(HU%N/CGN<]YWFW1!<W.:L/L@B>ONU]X8W;( P;5YW0W_$#.
MG;@WY6X3DWUA'IZ?)3JT <"[@M:!Y_]2OI,!P"]/!C\88NXW.71-C=PW"A_Q
M21QRW+#GZ,,Z+L_1#SO1_8C9R'X9>F.84\_&CYLO[+C@TO..T\#=U^ =S/,.
MSSL.']3TS.,8F4?DF8=G'IYYG![ROD*-LF<=@W0][;6ULI^3^9)S_>=ZCHBO
MZS_"O.FAP.^X<J+/)=_Y<&4H0\'+HR@Q&0JP/!/T3- SP=/#2\\$/1/T3/"L
MF>"6SDR9357&(Y)0G1 >\Y!DAAJ2,*&IY<H:L=;(W:8VS1(E26RT(=S*G.2:
M4Q+%N=$J3C.6IJLE(KW*D#VVQN CD<1#*'\;"BEZON_YON?[GN^O\_TPIC:-
M#4F3C!*>"$:D8I3$"@2""8T1T5II8)*D7(1A2J(\SPD/DXADV$LIIY::U)HX
MXVL=^3S?/VJ^O[&D^0 %O0>L7_857K["Z]0W["N\3FK#OA[@J&+HOA[ 5W@-
M,[5FM<+KD!EZ]V>0#>$L?(V7Y^F>I_MLR4&S],/7>)TY(_><P7.& 7.&0U9P
M><[PVISAR.-IGC6<2WV69PV>-7C6,$#6<.CJJS-G#+[^RM=?^>PKGWWELZ^&
MF7WE2P]\"JIG@IX)>B;HF:!G@IX)>B9XKDQP<QY^9H5E4D@B9903GE-+<B8C
MHC@W7,7&9*E=FSPFJ>(FTB06TA+.!2629Q&Q+$U#P8PR(3U('GZ:C!BE/@_?
M\WW/]SW?]WS_'KY/0\ZLHI(8:SCP<)X109DBD0:.+\)8A]D:WX^B.(QMEI.4
MLI1PH23)F$A)S+,PX8F-$II[OC\(4CQT_=4K\>7]#X_</#X3O\6[BLE,MJB&
MWP.@W !%-99UC;AU:<AR8=:;I0F+_W$1A"]O2?2M'9LO1!>5<:B+-56SZ\FW
MNJAOQO+N+?ZZAFX7,> 6[J2-M807*7[S[UD]+>Q=MRMW+S$3_>U-61?NX949
MPZIO3;^28Q[A^O)(='U)A=W+XH2[/O0?R9"&N]%X"?T:=.N0ZVH>7VNA6TS&
MQ006-I556ZVW_ .<>_-U@XLNR"8M /^M''^6=W5;M?/75QL**X.K"MG]?TU+
M]2]<U Z"Q>XU( S*RA'CVQD0587;;V*T<RIJ89+C>,_]'-ZOKD:SM,'[YJM%
M1$WVSK-C$QM%$))PCR^LT_=NR?A5&?5#+.-%C'H#9)]PQHV>U.?IK:+$XC1A
MDH4DH@I'<U-!)(7_Y#*+,A&'TK+D7^S-MLFYCWOOVN1<*XRT40J:&1,1X:!Y
M$9&DFA@A0FMISDRXUA9EWY-S=ST:]XD2Y,AFX]Y4Y6VA#<X;K> G @KL9UEI
M9 XX9%1>7E;F4DZ7QHVVOVV:GJO@TLL29^UJ-ZMT/L2T'8*Z/#?U[<G5CR?1
M!7MN]3@7KUO,+"ZB9Z[UR*IKGY)"-2AQM$]_SLN!<MKE$KO->AQ"@MU^$QR[
M/*U.0M_M%2./ ^(GF-+X2'_FEOS%@WM[7W@BW\FQG"BS93[\TQ/_7^P=/B=Q
M]1*'Y\$1;Y]AAA=CT=F$$V28I%0DFL0LDX33.".YE91$-@/K,XVMRM;:N3TG
MG#"W5ULC]1H6]4\PAWZ;E'EMJELT6CXXBPALUW*B0& Z8[Y>-F7GLM0]:V!1
MB..CR,-*WLZT>8'DW6$EP6D7#;R_DI-+$Q23%;?%)I>%G.B5JVPQ 2E?R#$\
MH)Y6,Z3>.BCJ>F8T/M-\4:9V&L!-52IC]-,K$KS@]VQF5R#Q\AZ>_/5+@F,O
M25"0G)LP 3V"IY1P&0LBTCPE3$2A%"K+LC1>:Q!K0:-@VA*FC"9<@T8A+$L(
M3?-0QE$8I6K>&-R,]>1MP\X^3.9JQ4?;FML]?_B[B>[]_F/'PSXL6-@'Q\$^
M3'YP_.NC_;GE7H]7+&HX3/CT@(81A:,L#,]1PWBNSO_-X(Q\KVH\\N@^F>ET
M[!3\30K&L[Q@7C-X#?;PL O1ZPXO];QZ[>)EVH41,@TCE9 <E K";9233/"0
MV(@FD4EME$K]8NUBP<'6U(J[G76>3PZN#@R2W@>B,.S -W%T0NL5 P/<:P''
MH06P"X9L09<S3$(Y0KYP@.#!8R!X@BK!9H%MN651EJ8HL&/"P]R2+ I! LLL
M8SQB)DFS7<R+&7* 85=C9DZ3LO=:\K"Y#& X@F#_A1#/R_%,3BG%4[UR\ .^
M5>,9YI!B5FAE@$)KN!VN^-,FL^D)^WX%ABVR4,K04*(29+XY<&V19QE1+%+2
M1)A4K5Z2P?P:_ML/+?Q_:4&_E8\G2WP\?H"/Q]G%]C#Q$) ]@/O'[B@GFY&[
MKDL X;3+14;T_#0#^?C'#-UU[\=EC8G0[5'4P=>@O6L#!-!@^BMMU3WY;3$%
M9J*>L/E_E%,3B(O@T[14OU^58Y!U]9^#'_Z8]9R.0SBD;T8!O$Q= >.X*2J
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M]%T6?(D_G151=9;O*[!JR?JR!DNY$^]P)[+J @6-AD:#/O\UG[J,X:@JQ"%
MT+=!F_WGWR2E^'G'89T?F[WXT+CHCL0?R?/OCK,MNA#X$A[VQWS: <2G:G8:
M]>/V1ZWK3M"<,*SH^P AW.>JC5!XF*"HM'<ZV,M>*X]X7I9(84$0HXK+0HJ2
M%O:RC!"5YX+E H'G '(E,$7:4;# 25ERGWNLK=DS*)+RD8)B\(Y;N ?,L@X?
M]P>/GA#*3,&0\#A'8%YI)*6/UIJ0%%Q,<+LN+[W&S%,J&2*>@PY5E@)0,H'
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M:2Y?3SH(<T+\N)#EZO^ Q;\6*"Z.!5RT655W_0%_J[Y+AY8<8)/XL=#OL!K
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M8J:\[8.C7U+/HT_7HU98+FV.2$G!GR-8@V?'-2JX+IUQU$I/]NX-ONH1YU<
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M6>[+S/7A;3MR[BZ-H]OAK-I5"MI,7_04"YO\H.RZ;/K9:=58= YW780?AI*
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M_EM?17!]K?QE95S*!U?$25QW+:Y?21))&B.Q8-(8N]484C)#%=%(L% 6;91
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MU>;W,*A;,L&GCN=U/;'=:T"=U$T4QI,Y"%43IM]%#A=2U--$3VKSYWX6[WT
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M^KR@,3#3X0@FW2:8['AKT]<G:^N\K,]@)!=Q0TP\;S-E3&#F8'V$)KJK9_O
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M\7!I!@!#T?(=&0I=/W)_14*)U65.I$2F=*"BM<R1=LP@9H5V.F>.DXUJI-M
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M8%Y)1(T#+]+H7-D-&VQ7$]N_Z6RP$1)3&_+?1*@? --9<8:8$9QSZ@#A-@(
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M;A'+WV:^2N#NK$J_Q9_B$@S"%O6W8;8(9RS'H]^R76U00'=&V&\0-&_)MPT
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M7W6"WC118(^\Y#GC#K^9D%,N!@LCC+2,=%2G)RQYS0BX#"ZWWC,!KJ=SB*6
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M)JYV7?8JI_LV[RN?3F/X[L<O9Y-%;< <9"GVCA@6S\3O.#H[WA\2I#H@]W-
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M'%1S,3W4NM7$ORP#]8AN.<4V2>P$PM(FQ(/W2'LBD/-,R92XD:)3:,#81)'
M-%H1!;CRU"-#&4'426VMLBE@]>BY&"+&1)"Q(-7)?A826-7]X.A7TS'#T?LF
M11U%("CQH! 'O8T,)QJ!OD\IRDBX[&PT/9K>[TDZIC9+5DLQ;$OQ++3>%>F8
M*(A@E*#@4D['D+R12'N4G*6*^@0?I&,HJ"&E8_YJST>BY&%T[7\9<AYF9\,1
M&>7S$U ]AIIUZ9-RK9;\9=FAQ\RZ,(=C4@919L%0T0RKZT1"D9'@-2>.$GW9
MN%D9)!8F]\J0" 91):1#2DA0KXRDF, OCS_L")LQ(:HZTL]!_*JN'QS]:LIE
M.$H?2\LR(@+"2>6R,LX0E(:#*J>:*>Y-8.3!E/YCI%S8-<8"7CBN&.S55 S;
M5#P+M7=%SL41'PJF+O,*<<(\,AP3Q&)PR0D#_^_D7.ZBH8:4<_E3]$T'#",Y
M\\)P[8 9<N;E!ATP-1_33\5;K?S+LE&/Z)HKIA(W22,5)44\4(6LI0XI&24#
M$XBY[>1CM/".\J!1E $L)@:+:;'@*(5 ='*>LR< @6%CS?F8"%;=[.<@@%7;
M#XY^-2,S'+4O.2<46YN'@D"\(WQ H/434C82;Y4WSG;V)!U-[=>,3 ^EMYJ*
M 9J*JO:N(O$OW[VI'2%#R4OPFI<8I/JIMJYJZ@=R4 FXFI)*C1RE%G%M*-+"
M)L1"4#*D:"SK=&E[CU,RA*!$E4/<D(",M1%%'G (6AGI^>.#TXZ--F-!*NC@
MLQ# JNT'1[^:EQB.VG?!:9H41B[IA+@D!FF6+(J$"V>%EAC;!U/[-2_10^FM
MIF* IJ*JO4?+2]1^B8?,2_QM%N+B\V*R@@]'[U("+3_[4/,1/54[M[5Q#F0D
M+K:?G(BSU6@YGT[":,-#?:'P('3X'<GY#+7\8>>6\Z2BB@11XUG>V)G'R%&!
MB)?))QMT"JSCW+(4=7 !,2L5XM0ZY SVB$67A(Z..^,>/:?!QX:1L<"]V/WR
M%:YK;"-F58RK57EYD5/->PS'-"CKF1*Y'X,H, V",F28H4@FXY4(,075V2%S
M---0\QX]E-YJ*@9H*JK:J_T83V[I[_FF?K!3._-Q9)>C>1I=V@1$>7^DY 7K
MF?O%2/2$YB IS-=N&FNJX_ZICEL0]!FJ]BL:."Q5V.>-D99IQ%WB2'N<D -7
MUT::-/.=C26$8FD)-R@8X\"C]0QIJA-2B3,;@]<NXL??6,+&6-"QXKP/[NE7
M&:_F.ZIQ^1H%0>SSMP4B\@4ZM'VQWI6H_27JLY3[2L%[4' W/(7?+5C: Q (
M8?+I1L]--/S]!*'?YR:8=O-I^/[2ZKZVFN;0?*O7DQ6LPM^"K+\N8HJ+10RC
M]ZNY_]?HOP^4RH%L5]#L:ZOZYC"(A]$BQB@,PH*[W#.,<\^P1!9SJ1TA//".
MR\E((-8GBYCC GQ5EY")3""78F(R41:%W;B<<1IFK]_[TQC6TXL\Z1OP!3]-
M5N>_9\[X':[\PQ2>]IM17'I[!F>M%NNX*Q/EA4YF 8CT6IPPQOYP^87LL(M\
M&FZY!7/<B!7>E%S"YL7W846=O,9XM#J-BSCZ##_ZM-"#5+O%G1ZCKAUT$-YH
M9(+CB'M"D''.(<,LED8G$Y*[+'>!ZD X")I)1B%NG$7:48XDQ'I:YV9/\OBA
MGL!CBM4))^;*4*\7++%I.AK%IG*3-<]H,EO-1^]!'<)5_^\=EWO)\B_79^!5
M7CR#/%%'>PC2*XI>ME5P:W\Z @[*;%NHLB5Q_^41&P*.&9-(.<; IDF+K"4"
M19)P<(ISI3I3AN\DCQ>DV=*OD*_4 9<_+Y?K&/YV-I\U!RYAA?<?/#Q6VHS9
M5VJ%O>"GYM&RT6NGBBT+6[VR">*T42EDY$9">-11:A_ 3C=G@38;+=?NG]&O
M1L!P+LYBFO@)'##_/ ,ZGD[.1M/)1W#(\GG+;T]V/:K^^-[')FK'3=\XY<4G
MWZRG77Y>ZFN[7LTW&;.\PGP+>*!\.)K:\_FZ/:2Y&\$0P?QA<[S/)>VS97R]
MC&=V85=Q0Y@FV"GG?7.H;/5ILIRXR10\PM>;:UQ1CVIN*_B)H/FV7S+%\A+;
M1X97\.7[;[[[RJGTA/.[G4GN=AHG)_@A[WA-*5!_M0/Z$"/>N3P(@>R-P^#G
M%O%6HMPU@7H; EW?+7O@<0^05!^)HA<YQ*/D%VY$\M] 0:*?Y@MP:$,VEC=W
M7_.C(G:B!(7'OVW: \+N'%B?S9>3;$%?+^(43.FG^%CNZ]V(U?#GCM.UX[6V
M,=%HDXQX4-$>!N<^6E*P&JI!&ZIGSZO5<CV ,OY]OK+3JF6?5,L^4&?@#<MB
M<&Q/=.PCMO^QN[#\_8J,+\EHW:<SZ#FV]]R;>?K1(_$(.=\@@F4Q.22#\(CK
M&) AA"#N*";)6R,U[@R-]"E2'1VB& [G7##DB/+(T6 )U\XY^?A["V]0@ZD2
M]4"6\[Y8 D/4]4>5S3?+Y?HCA.,Y@[^(9U.X3*@6LUK,:C'[9S&%\28&9U#0
M-"$>!$6:2HRHTYQ%;!7#G2HIMUS0X"+"/%C$DZ?(NF01#81Y2I3SSN]U"QTT
ME[^LLTO=W6C9:H\\&ZC5';>UIFGR!2SY_\;%/#.0IH1^7ZWHPUK1VQC+*V/5
M&G]NW\AF,_*-[&:7H('&E.R="-HK%GXT@WHGGGQ!.N#!Y+>:X']X%9,,S"(5
M3$2<!(.T4 XQ+*WCP3@6.@V[#VN"M]KGJ2QO%<<:V/;0*K_-.>'I-(;O?OQR
M-EG4J+:_4>WU=:,!B__#L=>MRFW/VRQSR46,#*,D=<X+4XI,2!Z!'4J4.F-=
M[.#4/:Q9WJJ?=XM6_SR'R/A92VJO:[>]LC*]1F\9(D&?@=D^C"@R8'7P6(;[
M,.%>C.GVF!M&E4?19#.L)4<.8P$_'/P3DEG+.W,=\U!'92S"5N3Y"=XBC54
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MU;,G3M@; ?KK^']A1[II$J=]]&!6_2T]:KQ75(QTP.R=_MW"\]4)(*=AY*^
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MK<RF86&I=C8 R D'U'$#M,<!*&ND$-!:%=C!;!EY3@WI;)(Y?2OC>=XN<@C
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MG+[Y*E[XZZ],Y:Z_^8^OOSJ;?!I]\_]02P,$%     @ "XAT6ND<*.]$>P$
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MH5-;'-RPN11-Z= )BU2M &B,9;3NPTL7SK>WWO/C'_/RR]Q'^U1WNW8$,EU
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MF90N'WWOB4M\0A5ODPO1>KKU(&2X@#;)+9/6*7^*5FB*W2_@N=['7EGQJAX
M#B_DL+&\KFIM,F*'[GY$S$<1J0O1K!@\KSB'%@WHFZ;-[.CS@\,;T&%AN1>L
MRQ;$M2U3^D":,K!<=(YC[\<#: WQ[=U#K5F\?LYT1Y(5[XUYE5(DC+L>>*F
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M:0O&\.>I&S*7ZY(*8F4?6?,D\R9I+\3PY9^>O=7SZ6ZS\UFG09DSJ(JJ+H(
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M0[E1N*_( $ (0B&_<#@S)SOSJDO:QR:YPD:B?BVJA(B>HHOD@H)<SKM3[>"
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MS86- +#A.$^WW\&M*EP(H*B=T'48495\1^/SKW 7A9'K!4ZT9YY[>"S@$DZ
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M4%I 0+L*5U@%S&1@U5E:&Q:[I:&<QK!,&FDU)M]Y77=T'6(49DJM]*.R4]&
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MJV]BD?.5<(A$!RE*=8V?'V6,'_T<3\S4W7,8)?<TVERRNAC]+!6:XX[!.T:
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ME7D_Q3V;>Y5H'O!W&<1)Q 22F!66N7]V E$S\D<6FS!]0R:1WJ-1JI?S5[5
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MNJ-3Q;U7_>4=]+AQ;U)O$&\T;-%A39XYT.C8WK>]Q\_7EC1N'+89Y[,!AE]
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M>1UBZSRD9A(2Z_T\!'+3X"XLIE#(AR6KZ/+.O0>RK(CHOV) >H\B[\T/@OS
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MRE#3A$]J7VU>9DF'_99#LHG6#2HDLNSIS*VZ4V"<)*I0Y!GJ:1NQA@TX&0]
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M%+QRE!2/NA$6J;^\6[OQQIV'RT&. VS184U2Y.!Q-_( X^=+41HW#MO,,3[
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M9)R4R^@,G(TZ]_159&(N^! ?]!]F$4'06]8S)6+LS,%'-CM-,XXCR[>Y]['
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MTQ/P0!!ZY>>/MU'X8X1OV MTP8I35 C"H)F"EHH<&LK:-F#%,I>2-N#(UE$
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M&8@BGA_LT#::JQ[J\<X/U9E^Y@XDJ,^DTFR&)%TIO..D[]=^"(>HCR G64@
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M=17:D$-EIY^+5E8*^D:AX8OW9!NXR[Y6CVI[5NQ H8/CZ*$P7^I\@JIR5A#
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M2VD#&($#5:P@2Y^W49.U4:\$Z-B4%6SX#._XV TP@;JW@46(*G$,-N*G@UX
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M_*MVWQ1L.7'AM]YE5##IQ$7@@F.JX,G)2KXE?UC!CY,5?0NNN((;)ROU5OR
M!4=.5L+5.B +SIR\D-O XUGPRHC4RS&8RD!'(T,Q/0@#VT44)E'@>Y0;;H"
M40]K0M(<MLHX$-/*39XIZSBV&'-A)T&:B%]R7_8"(#72<U-.K<,=UVL*#N)R
MWV70#-A1 RBE*33Q8+E?3*,QE\M.-G1UNOL9R]8-LB<%J].0TJSN=*0%;I(L
M5E2F+D)HE^FH%NPZ: 2Q^R .%SH:!G%.8I\D/W^\C<(?(_0PNT!D\CA%?,X[
M<5#2_HL(DGR@W=J8C/$2WF&S/5%38;H]78M66M[4ZL(VS !L4+HHUE$ -W?"
M,/.;ST=]]<D(;$V2C404=VW=2:LJ.2'ON9CPB&O]D"S!"DT_6/F0GWWU#\I
ME?+3D[!8\70Z;B! GP^N^@95IR-L'<4I IM+V=%TA*B*CG-)#W!'VW]%:W).
MU]]R!RI-1HS @\]@XZ7[ZY;HJ#E4:SJY-5<%UTK?Y6*6+"::-'>Q>DH(?>HT
M6DOE.E->R5O7IXGG,1%?Z-&40H4WF_Z*/EAS2F$6,_,5Y3HZ0.DGO6S;H*XE
MBR\[E. (7G8YS*1ZT\V6Y_E,C78'*VH>7KA;/W4#:</KINIPQ8'OS'G(DPW?
MDX2X\1+U 5)V2]4=>:B*'5J<)MH;*]YW]>-5%)QLT'6)U37#KZTRY6FZV^P"
M5 O3<Q"]Z6.RAG/??R5,G,"D/333 ,@5^G.U52O3G;#Y17;X5%66M6&?'-X@
MTPWSGJ2N'Q+ORHTQG5@B+0V04OVEKV-W@XH3'Z>UY^BT,K;/GI&HP1;91Y?Z
MA5)7PR(U6&/UEQ6;4JE=[*B4G-C(6E&YW)2M;84,5R7S%C>KOD_[<R,S62%7
M5#.CU$DP36_%RA/HMK8NG03G#INA#N><.SU6-;(7:;*;5=A\$LQKQRZET>=$
M^*2R&U52IZN--:?%H0:6'B7?.&=/@EEJ#Z&JD'6JAU(3,;3YN<^9]O%=,ZVQ
M@*JV7([!(Y#CGB.[N-1<(FTMD+[OY=5.(#UDHCTUEK463 ^:A4^"@^UX5K4]
MGPB3&HNFTGUZ$JPY+&8=,/^?$)<:G.J-' PXRSZ]:Y:U5L\T\6 X-<ZUOA0;
MN$N,P4,+Q=B#GJ&%>U$A\PH^O=.HL6X"1!/?E9/8I/I[LYGCS DQJ<GQK[P@
M_S@H<R)8IS8QI]T%J7().C4VM;X-ZUV21F&?;5NPY?'>UO7I)'C8X(VD]J$Z
M">X,9%S,LU"]Z^.L'7^:>(Z-PC;;%EE3:]")K*(^>Z[6-TZDQ'C7BZD=OU0>
M;*.PZ3TML@:VQO]\UVMLH%M1XT$IP G'7W^V8K3<T1E8D]1?(JF<B=\ 6\P$
MLP/W%S$=GD?M2'<DIK!V&D(:5OX&)7)J4"+?L :^80V,<#PQB,W9+EW#W?AO
M4LXFWK#2-_R!0:>#)B5L,Q6\PCC3T)W[1\7TPS&8AVK9@)/04MQH4M,&LAH>
M4W4U["&C=GOK2MLS_,,;I;:*'8_.9E[!347YDW"D_A9_]2W>XUN\ATW,:G%V
M52_0D_!&_.:A_\T/V)[M)P2_D_!H:K[UFNZX]\VO;UZ88V^_4W1I:L*K1NJ#
MD_"=:,TOK5CUWMT".O&I=/^];[-V1QZI#JEAC=>V)QC)?H0+C@=IP%?J@".Y
M6*)SY7$9LYE3:$;= 2.2KO3T\*(\8NM02A)]^0G1Y501!GQ\&C+JZTP+10AO
MUDAPF:V7>EH.5)J,F,\DA $%P.*9M_%#']=)"GN\GII#M0:VAEW05(WS\-KU
M8RH;+5;<:;[HA"1]SU19\Q &QQ-+T3MP'EY]Q9B7Q8H&OQ"O;!DWTJ4]9TG3
M,V2Z(><N_==PS3-?T!V,++^ASLDJBDD68T^2JZ^P(N$*ARF)]U0"0(]WJ D7
M8$!W']S%)*F_ <;I<6(VPF#YC)[#)EYI43UUI2<;_BU)\VG1#+I89K*A"D=X
M\80[=Q-_J1FRNJPU0[_T@UVJM9CJ2D\'[TPP@HIXLU?8J"\\_?QB59'OZV:D
M71NVD<JGH*F]N&TK=CSP#LCSRECSJNQ\$A:K@V^'8B1/K91^$@QKL[8.O 1.
MPB;3:H$=?&Z<!,L:+#$S[YY!K3M_9=P.R0NJDFSB=ZLEJG@@C6($LRV0JL6Y
M-^J#["3P EHS6_%L&]0L5-R\CT=X8FK>B2<1!-F"/9JWZ4G8A7JP*7L'F[,+
M'0>C6KZX.?O^\HU]'5_QG(%_/5F[I#Y7RW'8(H\RL/8H<_QD#&0#01MV%%)$
MB0;AD,HZTZEEBZ.I#?]5E[4AB$49M:8O]RW2^F0CK57'?//0WYJZTY/V+8C<
M4%[W9@80BV))-;"EM:=F?9W3#0[7I0I.DAW"LRQ6TG4#7(O"D"R1CS_YZ?HN
M]E]A/>=I->;AW>XY\)?L+'F,W3!Q:6D*,2C:O(B2-&'+246YJ:YMSDA;OY0;
MUS^V1<&S&$RP)EC/UN24K9U_3>$I)IN=2@G\:[%J<%;UW/3=>IN<+PWDR2$9
MT[R[8^!,OR.A6V\F^(*C>UP3/+L#DM(!PC\?R#(*O5GH/:[]V+L(HH2:?(I$
M/;Y%C^MHEX 8]O@&Q]S^$;K'JKN8&CKO=O%R[29D]@(_XSG8^_:U8K#O?U;:
MK74;QCK%"7+UE<1+/R%HGR?7.]11"F3PGL?HX98MH[??X7BPX6FUJ,P;XQ*6
M9/AR!Z^AB&OY[T&ZB_UERH_LV9L;>W1]7D?QBOCIKKH$AFO7Q * S5N9D(,[
M^#K:Q4]0(WZ#+9P2. S@6@,*>Y_]9D;S#OC:;C,:&8R=&YA^7% 37"+.()WC
M=(>&;".:3L4 -->T,Z$F[E\[GE'U,=*HV.A</8,T08,C";S!L= ]@4=YXJ<@
M=<2O_I(P&N]!>GD):2NJ[62LVVECY@[FZ5 RI5'5;U$IH]IP?_GXUR/4Y/_R
MZ3M+'$*:!:378*@/ZG*_97=-ZL:I35XSC<SU!1\MM5'\)*(4:AT"-"@')P7\
M]PTR<0! P+;I-$X9$? ;P&2_RT_KZCAH+)"E=U_CX_R C\!)A$]]0Y8<_ZQ2
MRV"GQ27E>676C>0DX!>;'W[-/4S&8%Q@$<^^058: --]W]O.AG..:T/'B/F$
M^_XYLHOCC0\ZG=_4-^34T=VJOJ&M&O#0^@;5.KZWUVF$]';EL16N7Z,$$UMX
M[QWG)!6WT: 1R^]HCCJXL9D+87[?_"PNT(\G\I [;$+MYV$GV/E-R36A$Y^8
MA&\O\.D\_L0<O/=7^0 GB\8-3G#PE-^2/;P(!?M.^95HSB-1</N4WXOMW!4%
MQ]XW%E0SCJE1USX.^FJRTOYR^-"K>%)FW!GT!<0\&ZY"JY W._I^H.=F9H09
MP?=1Q25+X:XNW&1]'41OQY=Q)R9P%5T2]M]YF.&J\MOJ<!*>I@U,F5&A-$80
MR[=P)5_R)<DA.T%>IS?*+$E(JO,2[]C8E)[ON#;OXNC5AY5VOG]*$&0XFZ49
M/$5>&4)Q_4QW:.B;NW\K+*7L#&D.H52M8MM"8_;F 19:74.3$7WG[H6POP3!
M(2:S5]</T(?A.HH?W$!295^29QW%;5L9.%P1(9Z!X0<GZ$#AH;-)Y8J4JZ]+
M"K'N 3M^AH/UYT5(#MO75*/OW^AT:'=\J_,)R+=#Z'$T>7EK7/K),HB2':RE
M^MW6NUD[HO_PH0QC#4CA6'^,AKG[1NEJNF1RKA_BD!?A(XDW,,G,9G>#XHR&
M ;55;+MR%.NVVY53U]# IYU(]H!(_8V5R3!LU2'7N:V!:9HME]$.FH;K#>\R
M^&>\R^3C1 C(4HX,%3'M&YE.&)#XCK<V#.Z+F^+%O5^L]%>Z3BCHV-K D_@4
MPC,GP,S-> 8LPL9TM*T]?:I%>IK=(]#W8@4' 'VYS381B '_IN?=@=2A;9NQ
M8YVV0 8X7,^B)WYQ.L3YH(NE;E[?MLM.(6'T?L!;1Z3B[=?[\3@XZ$ME"=$S
MX,-B]0'&4%Q.[$P(O6Q97>[(8W1+WE0RV-"M#WW+2T=;EHY<'HGR5C]8R;8E
MJ) %>PN3TSXF\?_1VO$*]S (6+G;#7Z Y5/\02K)3)/5%;D,=AY-R,4>UO=N
M2JY6*U+[]#0XB,%1EM,TX&JX4KJW_3Q,(TG>IOM/W)*J[="YK>$E]IAY<(9Y
MG B^^:D(KA'/ZVH<YP(?8[U.J"<):+L\3<UYV?&@7JIM6/G;/(N2O_QY<$7H
MV.DE%6K2D;N<;+D((UV[).N':MEAQ&]ORRWE+^QD)!T4&\/>W*3=S:B'W6\&
M]9RPTONFQK998D]K)I\$-DMWVZK,WM;&RG>^MYL9/_,TS_T-DB>Q6(<R5&:,
MKYFBDV#HF(;.0M;W6KO@.S\,^ML4L_7:W99W$LNYFYS:U:)X$EA(PTBGXYPS
M)S$! TFZM0+=23!R($FWJR7^7?.XI;S;QO+_KOEF6@YK[Y!P$NSO)YFU<'XX
M"6X.K2W4^EN<!$C;8.K!QBX>H[ U@FFWB:T#B56U1\0IK\^68E4;[YQWO3Y;
M2E)#N@:=Q'(=6])JZKAT$LP>1JYJXS;UKL^&KG>7:9>L44!*;9F$E@=T=U^N
MDX!Z-7,<'_ ].PE.&STTQ@'1M31UARGE35-ON]/"+S:QG'_Y\SB Q58BMA@Y
MDD?W/#PM?.D6FZ"?_\1)0$J;.M /NHQ^X_: W&ZCEAX#EEO->..@4_FNOM@_
MXY"HJ6U_[R>_?G%#]X6>)P_ AY2\[.%@^!R]DAC/ACQWBG'\*1CD[U^BUS\L
M]QYSQ88_<@]L^,<O%5K.(S?V%JM+/X8G:10G"PJ@_[).'V%DYT$5Q*-K*X,X
MG'<E$%^/B.5*%O'#[GDI_@6"S#8*$Y]95'N0WK7]J9AR8 7?E#'HZAC0N*WI
MB:5B3Y*0!&8#]8L)!<3WX(N_VK/[G1:&/Q$%WX63MLU2&*:CZ=FDG$<-?D>O
MIBPEM9 !JP>=K)WIB<Q6XSR$,>) O>O +6<'[]C(5.3Q\< &FX>K")UE7\8^
MZH?NTLJ5T??$4[4T%:$('+I8Y8-L19N^\O3S1A.ZW+EQNK\*7]R7+OM9W<3T
MI-U%"07;3A9QMJ\2>2NU/[F:M#@5X?DT9 <$W"%<5/"7]-602Q,-:6_?J/WS
MWO5<:MSL="R %Z_O!L%^1NV"Q%O$]_#PAK?S<["_\7\EP?XQ*I>Z)R\^2E%A
MVGQ##-#/].L$=3]Q2O/\Y#_V7R?-FSW6==*2,4-U9I%\F$_L$&=,OPZFWTB'
M3L9[LHWB]#&B(N[PMVZU^6G5K#VU8ZA!'4'_]%[CTP?12FEY/I#&YQOS]>J?
M!KROTZV<*&L'4$"V6?1E?<])<7V LWMP'=,8<2W63L!@QWF3F?S&V>'/:FF&
M3I2]DYW7I[JR!SBT:Y2^8WB]6\M*TZM8HY,^*9X/L'S;:L+'<,JVEK]FUG0'
MG?Q)S8+155X]O@=UV+:6R::.[R&,#R<U,8.N_A;6C#$\M:UE\G&L_E.=G7%4
M*VW,,V-X?+]G=O<R^XSAY5UA]H0.WI?D_V?OS;8DMZVTT5<YR_>2+,FVK']U
M7^183G=F1JX<I.ZK6DP2$0$7@PQQR*K0TQ^ 4W# 2(($0/+"<E4%  (?-C;V
MC-B-X#'/0K],$8-!E/FCOC#N7B7F\[I\Z!@]A3YT!1[4HW?05AN\Q+ZV(8B]
M7SHQS'*6SAM <]0.&,B0) _N-M93-?K@-5V!2SWOA)^/]4MZ.#C1:;-]@;L@
M4]R"I(OO>LPG7P1S/WA'6["SC<=9%)<9'^':Z=TC,03-ZG N16#96:U-'!=S
M1YP9ITHGIW/51L[9E1C I-=?T#RSS7MM;A[O8/<9R8Q3+K_1G(Q[/H*+8 %5
M4OL#TLG1WRWD =66<8YZMYVV$UVA?MX([MEE]S'CE%*WHGX8.8M?Q+%[RE\=
M*FNZU]X:XE=[GU9KIK[DW7\!E'.J;ESEKY;WGQ/M5"L<V( :9"JIH?; A!+8
M9\Q/6LIX;FL\%-+-59CI-B"P3P-G+(3^D$Y;U)4:0Y]L+S)-KE@O-X@9LD*O
M36X(]9+0+8<15$5\;#OXU<2%CSFKA[9#39@4[P@SNYAQ8 4VIU7CB '"<@YC
M5D]U'_IHO7%NL[#K3.9SYAS#5B-]9N\.V(]A L2/H7A_,\XD>7,:!F]Q1!9V
M)CM52^TZE^?59*_N5:MX!CZ.;K\*XR3.JK.^XW66KZ)RSO' 0?6]>"TZ[\OZ
MO'G<8.BH9O (-832*!8Y%.T9<YH:DP&[/-(0!_L@U<0N]M*>/8=Q4)OK$P5:
M,Y(0 @1ZFG&T>9O4$ 1$\)CQP>Q$KKS'X(\4QP=_V.?S:L^>=SIIS?6=SM:,
MN&>2VMZ0D\C9D,9)I*]]2>=/)')LC2!3[,LB!"YF[W3#P(5''\18H MB- DO
M3\'"TSDQG5@#1]3&@?";9-N;.($')+.VJ_!2&FET$P0N0C?*Q6P8?[E"IQ\F
M^$]4GP"]A]9()FRK;SWKQ"0RN;Z*CPN&"WL7WA"84>+ ("F9$OM0"/4S1C3.
M)R:V#6)]]9G>#T<'1GF""[ILCF'L^)OM?1CL[N$'\'+_L=A*>PVET>=0I/L\
M(SZ,Y!9\5J[!!_##8YZ2@N=)=3Z(]-6V-/*L"N\_<V$B/;4MZ\:) G2 \*MV
MF;%$C"IYO?0Q%>)+4)LR8^(NNX[0P7GRG2!F[EJ?D?3[^@29"JVY02X3P8N
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M.L] JF9L PKR\/EV_=ZF\LA9&PLD.#$'+";'FS6&TIRQ\O()LZC%XD?Q\0E
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MF/_CPO-@OKR[ -'7(?N@C1Z-15B]LQU\;>X@S3M#:FK&N1ZFK)(QF$YGTGB
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MN]Y7X)6\<-,VK0X?6)^1XASZ?N4<8>+X>3F39W1BH@^ MC.Z31-T!G%Q-\S
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M%B;6UQ#E8ZI20,PK;-:Q&&INO[6<CYI=$!"E!,BV9?R?-V03U  1O2+'P-O
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ME,M3\:-@94/AD=0N6_J<$+S7C(;&$%D-SXY)DT-PQ*Z*2SR\@EUXC-)W!VW
M_T O *?7R GBH^\4?!-=2;O(Z<Q9LO.(L\X"BVI63-$)4_MI(YT')TBWB,&D
M428.Q%15C]!0,<!/2/@/@P#XWQ4Q1>5%2T*5WMB T)&Z<94;&M)H;*HSN9\;
MV0"I@4)#]';ZIYQ;G[% SIMTK:6^:6.6]HB$ZN:DV'3#Z:28L5SML2O[+JB]
M]?B[@_W;R3UTWO'[(S![A+SV^RT,G,"%CE^+)KV+XQ1'A=]\<T$<;[:(>;L
M>$3V-/8G-8>(O3K?BKVZ1!P J8_,X+!N:WW6;Y!PCU>SC5XE7T1]JROX5&UI
MM=:U32%]])HQ4#3!EL37?C!T;&*<*S8*%&$Z>./%EAD%G81^6J6!2&B)RV!N
MP^A/;B^6YG"0IDBZ!6 1$3*R^+',#<O(3>]#< R+R#+23GM2&<T2,T9:WVQ
MXUJ "O3^/O?8S)[X$4Q.!6+_4$IO8>+XL\*KKI 7B/VR(D9"C&-J*\#[YWI
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M-PRP)  "ETXHK!X&62^$K19&'$JB4:ZG+8^TH+-SC^@F/0<\XL5XR?_#.?7
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MC:=-@P?'HD!JQ8G:%P65Y,3[SF])!IR?\FF*7!Z\"@_',,@N0GK*.;N/OMH
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M%/<)+E9C%Y]?03-+[ZE*G[(4?OTE\W76"U1W&#5DUTP8(F'KX2SU<,M+'E@
M/\V(9WE>O+7(CWHO31CX;.\&C,E[)HRL'G$#1K(/6IZM.2+@A2W1FBBS9_2?
MSV*A9F5PV&M8FDOJH9E(;?[ 078@<:"O+62,&%/<V361QY?O]8=Z$>?%BMUB
M=##A^7=.K6CZ0_"TCHKC@YHQD/20(&([?0"+O,77QI;91]M2F'776DL@MQV%
M(H@EWFAD06IL%@>Q^35Z[HM3;4*GME?^!CVE)&V73FA-5=,NJW)+N\1$F4-.
MH.H>P^A<22:T @\G H CSK0;OBK"D#I76&5[#%[8>22=Z[G">3ZX?- F0FH&
MC!0LC#"D,2O,7UU7O,9R4&MC%,0$=V[ZX$P""N3?5R'+KB;C(.Q,X*M!FBLY
MKV]OF_CVMHX:S=.G60]EF*/G6Z^O]-KW4M=TCVM,[IF6O$RF?8IF^M($ NRC
MOS)IN4=^3(A(6JKE'O0QX:JIO)9[N\=$B:1(6^Z;G@RN2BNWQG,GYK3# K(3
MG.KU,+I^O**$8KW4RNK'&WDQJQ]O-#_>OYT@12+;Z]?P=1^F,:)Z=,^^?D5:
MXDG4Q2<[Q.K]6[U_J_=O=&(WU?LGS"XV ;EX1]]1S*(M?AU[<8+CCJ5K"U$+
M!5MX'D7;%HK73"/NFG!W;1N%AE%QVNKC**](=$RR@8?(*O*#*%X%Z;L9:(P$
M2]'%*1M[.BI$W/DI M^)AH/T',F /919I=+Q)UC[;9A&(RZ][_ 3K;QZJB<!
M05F>6,62I<9=8QD6&LL@K;^;#-$:YK"&.:QA#FN8PQKF8.DE4S/9F(S2&@&A
MA[/H>;MQRL($(YZMFBW-<I3DJ4G<_&9Y8,BH!%2W\5D>&M(#IQ[V0\L#0GJ
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MW!^)@<S9-)XX+K9QG%',6:ZP]4W2O*9_%T7$:N'-%!C,Y,7WD*/[0B/_*7.
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M2A^3&H6Y]=SZ)KV)UZAQ^1 C$,F:3.DGE$-!5ZHL1#@16:$VR9;N<H.5?U5
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M#%Q,Z@6VE\'._,T.8H/!G24DVNH_*!3=GXQN&Y5_MVC<<<F*<>-]D&C7.#<
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M=&U%=[!FOOBY_62P9K\S^A]02P,$%     @ "XAT6G;3R39X!@  5CL  !
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MD2D6BJPT*ZS%1[,2ZKNE9A'++V>\1(M$/3@.:*;+E2L23GF]*H/IE].CEHP
M[< B@ <NH^0K">!/_YYB$&XYJ&:B,*PEXI6P!>D<UN@!^E(^.+ERE(=K<T:W
MOE659<&[1)%EF9Y1_Q<!;0FG$00)6H&44+U\?JA/)MB)=*<Q+><&"O><AYJ6
M+)")F[[<CUW4.&&Q1THAC*Y[UW8F>B--P1S998?4J+IT1U$W)9Z[%68PBQZ@
M?8+\W"OTW-G9J_<PO3?7CEA+NMMUD%7JZ1^*VDQ2Q5Y6T 9BQ0^&S+5T=<M&
ME=KCE2L=7E"TE:^P#9%$"^+GWB(@?22F<9B*.;PQ!.L8T:9;-5"#ZJW]K%<
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MN6UI:&0>NT'%S.&-,T8F)P#YMC-VEA7';* LMFJ]\N*M5^BPCN"P4@1T2 4
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MC.. 0Z/![1-R,W<A$2[T#8W\*VY:3X=$P43\>?:9R\Y3\D!J3LRD_AB$]^<
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M1Z^^6PJ^^;&IM9#8H_D TPR SY-$Q;W!^<+=Q@.1\VH\H!T=R?&'S:@P%]K
M&^F@S*$'@0Y]9=19,9;7?I!MR91QDH!N4*/;T4K#Q?!'P&:3#O5 1*$/\["O
M:>EYO'3=2N.T8\4VTAQED:,-/]1/'._:=Z]!I$9X&\M#*@4"78#C(B"U\2NC
M^X$T[7OS95PG%8E:\=$JR1(%#P=BC)5%*N"QZ"O3MG]\(;Q>6(CX0)XBE>.
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M+OZ7TX(;E?[[>/VW_8KTWV*XXX$^5>(VFG^C%]1PSJ*<8 >C.>' :H!&YA3
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M.5X]!S.!0>/8R] F/A]=DR11TD%SV1!/33L6,;O;"9-+C(M/8RGA T.S5*J
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M    96QD;BUE>#$P7S@N:'1M[+UK5]M:EB[\N=Y?H5-=U0UC*"[NEU"GQG#
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ME]/+WWAL.<2__^_G?F\(4?!_7SJC+I]?!%OI^W;I:V3JI9KW.^]W>3["SU.
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MMM_9 ;=C=P?N<W1XO+]_M$:9>TZI6^.\!C5D4 Y-FS#RA1(E$=+19 :$RJ4
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M\':PRR 'DW Z%;@>?OR'WFQN#:=D[*E\'?0$A)*QWX.A5/)E97<AZZUC:K
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MP!^NX ??^P3Q?D!.9U+<W'KOTQ!^]+U(W$ @<YM$^"/:)]#HX'?""8=?4R8
MJP2;1-\#=FY,!56AG( -MB[CDXLDG<$7=$!A0'8?<6'\L<G)IK^D)D31"MGD
M,::!*A9=?W *)ACS',K#=VJS9#'38D[%C$E!!FL<4%/92"Q@ VJLHN6UX\:F
M2=3QY+ZBNY),'"/WP'/Z9;] )FZPA,&)EOKG<YYB65"1J7:E5&3(Q223-]*9
MX O[\@<(38)4[V:VR/#<XZ_O!8:]V8/;(O<"MA1=*"J;H1>2@/M" 1BEM7SZ
M,Q>L[D6 V]3QNO5O<,)[^L &JCA;;CF=C.])NY%?ATY=8_)O'>UMCK] ^!V)
MR8WT.7UU"*EH"*]:,6M1$R0X15F(:\:GY?72"5-"4Y?0P) 8Z6?@'< VQB)R
M !*\[VC"9S$H3Q^I@<#SX(<9)T4,SV@'YT9X,J(+(P'A]"^XC :G$:2S""6$
MZY#Q LUA.*-UA_&_BG0A<]49,A2EWB28@9=#O^/AZ-03"O_E]X87L-:O(GS?
MNRG@#?LJR,<KP66XHBL?$!0UG)40W6:JC4ZHRCL>HQR&=.]@E,APPZXFE_^F
MA7FDSJMRS(,QW0_7"+HIA5@DI:_JZJA\S%5W<VO7EB1J(:1$#0A,"E\QH<Y-
MFL FQ^(&K#>.'L1K(7O;M(@\N#C*7S%VLROX;':6Q.<MR[@   \ SX/QECI/
MU3>/MACVU)'HU5$)N-DBG-,Z[E-L'(Y5H(*E=U1F\IHD=J"":V*7MBK<C*KP
M<Z8\UE<51@1MFUIKCC>_V]"R[[6;_+8<!(GB8<".[]IG<-TGKLU0.7B:G&U3
M^KE(GTUV-.,Q897B^DG&SO>)I7-39O[F(?ESX [-PDFL$O64L0FRW,-80_Z,
MZ_"](B:CGR4)YKS0#PJYCF"7;/E!7]UA^[GZ_$>>M(;6 *4G[JGPM2+W*F"5
MAPS#-V_%8.(UR6G;S?,CNGF:Z74,>A?#UJUM@%O[O.[&^@3L??^?/<0V7@Q?
MG;U]M<[M;F/;=$HEU,2;!PL[(6#2B\ETBOAUS/P(S%!0&DD6A@.9C+T/":,B
MQN$4\??1H@)YY\R3NB8\VUV8%.C*SF1AD=*"^*G22&"5J*2<@YEG7><(6_YM
MQT.?8NG%")"3AB# \&?RR^UNB+H&:=,/T1[.!AW.9OK#71!%KAM4!%C+*9Q7
M2HF#C(I_XX=F"8]\#LW(9X9)!9,[G/'@JZ"2 6HR(*1C11'DG4@7GN81H*O9
MQX6CQD>$J+ZK1A("5'#YWLWL^UZ@LZL9?OM3$$9XY>YDD@KB)S2I4#SN1J>4
M(V>\"5\KD-^MUA?JH7(=""-R5$L(])BHAX6[B)N$$KQ.<$]*4F]AS8[CFJVW
M)?=H@I$[E2K4^(ZO8ESD,NL_@3.+%8I'M"O^JGS/K7)]B<JUF8@YZWA.9>V'
M&NN4"K55;$BZ0AY:0OJ";X#XT4!!>ZEL-UV2K).U*_HBZ5L7G>4HXJ"D>WWK
M(Z!VN*9+!3)'(\V"+\)R7O1'V29@<R:5Z7C "*Z)X'6JE*,T6&E/=+.AWA-2
MI_05UF5)]0&H %:,$9Z+:K3\- H_MN26=.VE7V^=KB;IA6:"=QYJWU:Y21.#
MU"4ER9\B.<X(;K^]\X9/$(-7)'Z#8XO[VR02LH!-QU*B4RD@<>Y^8ATW*P8:
M"1"X>&6]@%P[=FR<TH!R3!9P$?1VK!N TTG^"/- +ZM#N!",I2HPY%KX-ZD[
MZPEY9P6#4,JK+Q<V2LZKA!/PAF??^(";':\_K5^3%68:S0MQ-*).6+F#F'G3
M@N!9%BT7/V+5I=?JK_+<(W3OQPAA@,\Z:CS2 !)U8[C137ZK-;NY5JL[FZ0[
M]QNI.VMCJ(!H U1<1E3>62D^<B(Z"Z%RCRA[.!8S.-P$Y1\)$4.@Q&5*13V?
M"F)0&!M_A%IQ@II6'-_+T)E3JW""24KK4/-!BUMO<>MK.TTM;KTYZOLNS&"W
ML>GE[6TX 5E;CT)OHBJ'QYDC7%=,9"_X<NV-B&Y,W!=P.E-JVJ3X%E2P<OG
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M_%[ZZ.!WD@$L,[])E+B3%M;W:HOS;7'^U1?GV^1\.ZIUA>!1ZP;H[;D*DQ3
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M)5B&M\H9U/9 K.;>4I,8P6_?AU\%4I3(@(V5"'/@6+- %7+&'4MO[8D%CJ2
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MP)IJ2.K=0/=K"^9TMQU7)PG]""".5/7<LV,,&7GF^C[+'&7.!4G36KFY>Y=
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M+7$E:H"8TX!P.F0GP!2'$MRJE:!VIC<L+<,;94EX:"RV"X3CO-9*^CJI[?
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M8XJZ%4S _IRRYY8M7QU$ZS ]E!ACE6HT@V6=:!_^7>H2U&JH50!-4@!'C50
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M-!%3D<HYFH$.->6'S)TV5W9J^ ["I,0*2-T8<J%8 4KBD/J<<-:6&']AJTB
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M[(@+=NB4//U?)L19]MS5\V8GN'?@5UO;ZTMPEX_?_MY+/GX-M1\O:^A<K<I
M3#TI+6HJ0-:2C',3F J$4[WPOH0QMS'& >+=6>\QFB9CP!/6-L5=*%%C+F8L
M*/+;A#JR='L?JT1[H'1-'Q8/ $70&<\NI$5BRQ'.B)5#"NWE;A!!4B '9\/[
M3@/UFTTU:BWEKTETHF%\E:U9!/UW-#@^0:8!:/<X\7G.%/D6_$T]D$W*5/=
MF#,&%>M>&+Z2,.4/_AW,2$%(,JQG!E]]Q! Q,<VF 3AACUD>YDA (Y/"":/D
MX-^()O9U^1G'@!//C3%0-5N:..1=F<:PJ9HL5U81+JGA6/@*;(LDR@,#U;!
M!E*9!:M[YBX'4"(SVSJ19A9D?9M[^A[U3"X'FP:8665F^B S&#_X-/;X0\;!
MPJ5# @+ZI1OS^_2QO21$\8=S 9(.PAAG4Q0Z]?LL3\9??.\FG.;J$K["VDGX
M*/- P4UN4>Y('*0,<6NB%!UW*ZWAGU:-W63[D=](K5$*'0X?]4&N8P0K^K(E
M)-4-?!K]2\*;6H?.9PJCU.KIX-=HSVW$!XD$E6:P85+">D&'82LQ-K$4,=5J
MN,T4=U(U3MXC+B#G$?+J@9P/6-RQU>Y,9FO"/]"+;IV--E?P8G,%S:S#5",:
M<O1)/4D?@=4OMA+(*HUC+[62OT$8-P*..%Y 9:/"'&]#]@&Z^",*FV37/P4S
M8!,F5N$&=17B@K#=&OLFB4T4U3[^DH%6/)=#VATLZRS5(!7[8E:.W#K,!>>O
M^A@#AMG-PE]3+"Z?J;+F384JI\UDZ+,])MHBCD#*N6_GO?.M/GM)D,&NVPP[
M[N;10@5M\B/P%V.>^?WJCE=KC>3[37&*BDX4Q<7,4'WR-<)L-8RY9J@NQ#\)
M".&W7J<= =]$7=C,ML$2& -\5F+<U+TG 4]@)[<E@Q"&^$.)I-4^BM41.WQ<
M\2 L@T%R^P(?$YJZ;74TZUMNW-^R.TR,*GGYSUI/L5_V@$KAT$+Z8 RZ@>=%
MY.<-[.\M,V%ZP0BBP(YW#3Y;@CH],]I#>YZ5O@>]$+@\G6HD/;7P0K[;W"2W
MV7V:S-IV;,:6TT_LR[#;K_@[2G0H9$DH8M#[H_N8J:T?K8?]O X$5O;)<P=(
M(*%'*\AE\)/4'',G:E]^J[R:I+R:V0#:GU:SPLJRDP^F. VJ-01%?P7"SDGL
MB:603CE3S&?H#-VB+"%%H$=U+2M=H%,E69;MA7##9FEQ5JK Y,Z91]EJT:.;
M,"Z'HG3-LJ!]G1("O78 6PWO4)V'RSZ2TF'FZRJ2YLW4#V721@&%TR&LP?Q5
M/6R7C811D6GR)B7'D6@N$&F)[XXH+EJMT22ML=](K=&-%U8VUDD+&3IME57C
M(Q5\U8DUAR$<(Q^90,8#+F/'N@YDDTUV$I0)'>DH% 7QD*=,.%+*'-:D":7I
MQCPW+(3R4&4;7HWJ:DJ!MD9X*1"^YT.TX%2!K9/EF::V,Z;MC&D[8UK[M\S^
M'332_JWB2%3LE^6AN%7WL40Q::4-)<Y" \PKWG3KY#5)R \;*>2&"R_4$LZN
MD6)WK<Q4P914 @$11D[EX,C)['-Y<^QPFE;[J>K:A^N3VG7@)D(Q<6@I@UHB
MU!5Q5N!]3)1ETO"J=P.=4I&!'RLY6U3/AOAWP=0\VW_;WE%79:Y]V/R)E<PK
M;XT*"$VS&I&)X$;I1BI3]V OU@ /'FI0V>QXO4<_!-Z8]J:\$R:^I!%4J<C3
M)* A5-%"A;<K$P7$>-Q.%&R8=GK.OHX?68$TR ,J:V5$A:U:/7V;8@KCP6D1
M3U3_YU#'=H&19RXU*6;CH$X%FC)A3O._D)**4;<RUUW58"K?2T$J?!ZTA)Y9
MAG )S1QM>115U\'GSVJ*(,JOV6M!J ?\F4A836UA]69L</9NXE!Q,1++$%%E
MN4V%!I'[#4;FF#6?S],@S."GJ9!@F%H*17XY2M$CX&>3YM$EL5$R"L^"N#."
MWUA,5%0[4*J,])2;8Z,GU:^"FOMD K^ZC14B<F+3QD_%B?4&N#(@OLA=?$BJ
MRE/."-2$[P:?A5^YI$55MM)7TX_KR+/<S;>!9LLV?]-L/F9*<ECK7'&VR9D(
M#Q^-,OMOE9_2ZEQT99R>$P]JEJM$CI1%^#K7@C36#%%O*TCXKRS^/G[S!G'$
MD#"K6<&(5N 2RN%A,3DJCTO)&D_56JLF6:OC1EJK2DUUGH8)L0$0_R).#1@O
M;$"N.A]FGN5$I4D)GYJGJ/H4#;6/TQCB,+O% ^9;C-2D'' 4"N5:F0#=:DVP
M& 5QK8'"F)1IZJPAF.70UQJ :<@Z^U.ET<H?KRZABC^ER*%6%1)]0^42CRA9
MRUTM(0JML07+R^L6?6&@"0Q-?9A:PXT9J=3WY9T=:&9E4U2G2-M\VHCFTV;.
MYWIL\VFU)_K56<B?*Y@_SCPV=737CVD]S9K9>VH\[:9TH(X#1/E#S+Q00 V*
ME&2!MXKQ^,G=IR]&$53&@CH(MXG(8(D8VE?H9Y:V-#RBC_!PU6YN[W3VO[>9
M]^A%-_,V6R.HV/NE:P7\AU!Y CL5A'%\R0NO'X#.<]K"V,X6Z7D!^,?S)%<H
M\3!%![M(:<;26#@9*LPM53ORWF+6?186,T[[3<.4^K:8M-TW=/*^[-=SB?CQ
MMI:&@P"M2(D9OGR$JW/LU"/58L?4(ZGG/#$C[=1FGA ^#OX9Z)50(P263@1$
M4;'@Z0/@4,#+L\GEK&^9!>M=H%&5P2)-= A:F4^/2)LI,]I5:CL\2B[#;*6(
M;X(;X;Y-WWZ59"#&$=OH*D4M&90:$EO<G"2VNA&T-("?$"5C"E!5VX#L[:RY
MS"6/X[H*TB^PO;D(9N7)%8H$3XXM,*,_3=.HGF<IAPH2 )BI:/6T47RG%.<Y
M<SK5P -YA1.9U4-"6UNX]?9(0EY^02:NM[* +*";)WJ>$VTUGP3?7 B_+R<M
MF8]F<7+OS:771''^++G#&6+P;]#OM[P6F5>.X(<,>QC5I*@T50E2/;@KM^9*
M66\?;AP1]@<$(9F -9#7^!NJ@PF_Q!D2#$H4MS-5"^=:VF,IHN#>IP"\P+[)
M5-P4D2;OE^BA.SU;P$60W7":18*\K<%3\L&Q1Q(3S:@E%*TPW'5)?EKW/6E)
ME"\7114K!C)YK>:B>7=A$NED9VX/G/",@%9J_>ZN6O.Y<-)=H,4F%CD>>@^S
M#/BS'@O1OS@UHR!*:M67FT#_9&5C9(5?&3PMA'7X#[C0B<F]$]OE1-#D29D_
MPHINDJJ"A>*M5G]A5:L$TG>U0QS<E/6$);*U!H"*I\X1WV#E8)4':!09*B@X
M]3@$G4,+738]L9)CVER1XJN9ST)ZA=>,$8EY$.O 66LN:[;Z-9]X(LR9RULG
M^C7QJ$(;\KO0E*7F:#A).WF>"MG"O7+YM8LKJ4<ES<$,BTQ8WI;5)E\FK.!
ME&UY[DRR*M>%?75;%&8YR5ZW&G-6/[:89!\Q%T^><M59+4^T7]$FU@[*JI%<
M;/GH&H8"ZSX\D#!@,?W_V7O;YK:-+5WTKZ!J[LQ(58BV)<=V$I^Z58RL)#IC
M2[Z2G)R<;R )2HA!0!LO4KA__5VOW:L!4+(=22&]436S(TLDT&ATKUXOSWH>
M2?NEAE:5$-@SM#&7+AEZ6:$@D.OV[[2EA6X"OM"&GC.9H[N\OAUQH I#9<L\
M=_W8,B68':'%PI]CD9X:^UFRY;2MZ@X\G6P9IWEI:R<RE[&=NMBH_?$WU.$0
M\]A)&],ODZXT23CE<)&;I,(33E?I)OFV=_10C\C6$=FZ&<C6+\J;?/V1/@JO
M72?H\*VWOIT4(K?EH;N'KAN=F X%$/>C.>(R,<8[YS DJI76)<_7RSOBN0K_
M!&^8%.@:%RT,F$E[*N^XI.8AVO/W99D[SI)=[FX<N!D_*!Q%I6,SL3?I'C4[
M:V5I)>*4>,MBT&#@/\ 7=]T)OUY'<UU@:)Q1BE'5,P&/CD,=WX_A@S'#VD.^
M 'M75J*V%_F9^&E8S<\$H>9"_7#>*BE3@&I$#<D'HTNPO!\-5MWU6L[K6<K>
M 097N[$@3&KN%.MUTN1E>>VR+<F,(#%5F:#.<I7BJB><7UG,E>AH(&0EM;\8
M%E]:\$.IYY=G'R'4V)DBVU#;-#G)N[G3?H<$\4C(6'MZ.YM(^.$]K <N-N/%
M(#3SW-]#5$ :S="'T1:03.*UT$B58**NTF_ A8)(HC:1,=9>Y[!)=NI=\;2Y
M+NV4O=W3Z V2.?;YU4U%AP[/A_=A_/=N2<=OWO*4"%B'5D2*#YT;"*3UF?_A
M(SX&IKJ=L>;##M#2<R]W8 ?U@$UNCCFDPF6!N"9VQG)X!-C<L<V:75:I_'6>
M@J.BP0IZV%7&D?$,'&.T-+$J6E<M,Y/WV*T<&(V@H96D:WAKL_6R>\J#"FX+
MF->1=N>S<O.O]IZ]>OE(%'\O]IZ]>+E!!=!PPCXP"92A65.E"59LY0V&R[Y;
M!I252)QOP3DWQ1R-Z"R3T>Z?B#]\P?+<N^^AMW2)_I4Z_G<O]_^-Z_@O7SU[
M^=WS;Y\_.WCY_<N'JN/O9+O;6,2_,,>N)F2"/,R:E(L]0SB!-R^9J41.:4Q&
M<YY!LA6O'P&/,J[C1UC'V[^0??X9_23P8T5#"OU.&"G*2LWZ2WM<H-NR0+=S
MA;Y)X?JSS-2 .4=/OQ@7WY8LOINM7'O'6K"AQ R8QEEVG>0^="U1;JMJ$ 3
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MUR4AL+%YXBI-YFB2TUE+\)$ZR1FOZ](906]10.X[$[<YMY"8'@A]VM8(2G)
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M5[VS;5SQV[3BO]_*%0]>3T_ L.^R8(^91"^B3;70^$Z=+A>'96[;<%:#-LW
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M\L)@].O&L/[9/HOSDX<.WBKZM+H*4$P;Y:)A9)1[<1C.U1 .%5X/O)S=Z)W
MIH\[S#B^^K.V1_FSCMB#K_J #0Y!A;J@16P$_L<[UTBOV]<9DHK0*L1#;"T$
MV6)\-= A##Q3FC '@O2OAE2LGI[$=W7\0/;19\9K'Y@,?,]P>&/F-ZD<UPZ'
M+O.TSBHYW>6A?9_MCJ;()_B7:\>Q.G^]VX73("H;5F*M)'G)E-B9F7&]2NG^
M>#S4=EON[*-NHA>W(<:G=>-U8XAV#G:CI&76@0'&]MJ@[Y&#9N<YUCKJAMP5
MI J"$<'G5\A.)V8./F&".CL&.*;<,_+XP=$!#Z3*B-$/C;7Y.Y^JRL!.+6ZU
M,QEOJ!MF;OB%5E)JD1+5A%9:2IP$N!I@!!C]NK>*#@6*];@^ BV'Q&2HF1%(
MS@!G-@<)B%E-#^NV\*L&B7C@7>@1&#"/7,$L*3B]N^C[Q99_MHB(6K-_4G?"
MS7<[;S0QR &YHZ[J=<<.KK;UYED>M?;OI >9O6^YJA!A]P@V]46G6>0FTNZ]
M'VA]ZV&%QTW7XG^!=?<5UUMQ3Y,<3I7YBFZ4!@($N$^NDQ6; >UL#Q 77*/\
ML_FL 6#CACP4DDA757HC9"%(0<*K4Y@ZG(@5'V<Q[30,:^"TK*_Z9SA*&,+\
ME[=VP+J;R62Z;A?.+N4:)#7)G\H?!9:7WQ(YF0ZEXIEX0M8!>O[F-LU1PF3_
MP-5%PY6DT#SV#Y4^FII.B3':#!B>\MM=HZ7EGDY."AB)@Y4P)1;,9<ODG,(+
M'MY<@"4^S76+3/B"_T!A-3=8LZ/^VM(GJ_BBNTUE(!B%**#'(V!,1YJ=-69U
MXG_"Y^;2B\1]+8ZFU&TVO9P <,PW*E/M1;YNNXX_X9D>+.,URE8\!OO__G:B
MV]\=GQ\>O7T[.3DZ_7 >O3\[_?7X_/CTY'SLJ=B&-.OS)Z7T?KA5=_1_+LXF
MT2^3_SLY>X/K[L/YT:;5KS:\]'P'YZ[MJ&9N)O2RYH2WY!@1?57N>!6>/;@3
M'D%(V3U$+\[_YJPEIV@K]<GT0O!+7,?FRH)[Y6/1N9N5YNE,?X-SBOMW=K^2
ME*FG0"(0+$17?!W3X4 ]MXX E<8VF[77F4GLM@SV"K@/,?NH[7&8;+DI)7NF
MPWEM2X4+9K<+9CP+>5B3#AAU7BI.L;%T!R&+%CA=X*GDJSYOENNPB'VDX>;3
MH[A<LC:8>"&9HSRV]&S@XW;Z/!Q><F2)&RN+FWOD;:=DRN'IR<79Z=NW1V^B
M\P\_GE],3@X_23]E! &.(,#-  &.; E?:@D>C2WA^=:*^AS].4NO.;_VWM4M
M)F"W;C+J7MIY4[67WYS)+J[MGP88B B'G]PBT7O97 F]9K<;HU<S28M+))(1
MVFE_PW DGC 8G#/>(OCQELODY%LFQ<PY=@%=WIIK[D4]L@C\ZF5:H&B$M X,
M>XD\$M3<<\(-J@UD00B4MISFG*Y6\:+ _U_S:4UC80JX7CLG"-LGV:4L=-EC
MJ\Y'?QAZM^J&^S]^J#7W27J!GK#"3;F\I#6#QC\=E@2YQ?+V>3ME::::KASM
MA$N!;K3NT4J^T36R$_69P.SS?<:S[?47'ZK=PHLEJ:B/J6V.K[6-Q-1E*L\A
MOF;@\9</[2J]@W,M0B-#R4M7YO$[ L.NU;#\"B6UD;BGQ%H5MM=)?5)7^QWO
MZXZ=\[4Q^?R]7OJC'DS;*6;T!DT%^9#U.BV-;<V\_^U^T.-)[R9;*;T[9 (%
M:T/M>F #J>OW"@X?M**WI+0']VBQAM1B'YZE-<3T'0L"2(N<IWK[V;7/P64F
M+3@?%?4Y<VT3?*H\SV89)IZH-Q#O7 O!73VK,H;S82?B3"!"TCV:$O[BDM6E
M$FU[R0ECK@\D1;\/YV34HR/"EW/);7*)^))[4[]/%'T]W8O_K__8?_GL]5=2
MT/N*S<KTJS$KXEEYXT+-N3>BTG!9E;<H*D5(;=9MJ$K1ZHI#@U,G.?PO/'A3
M95,!;==-B92<<72%'BN%*Y9,5QMQ6Y5B'1K@@WMVXZYXK%TQ^XIVQ=OD5G<%
MQD$_I7/2;1S^,,0AT<[!?O1A[WSO$.F<]U^^>AU]]VP_2N'QTG_N[8;,935$
M]WE2,8J<S^,%WR >")#P )\3&I!B]CG\+]*RQJ;AG?92%51HQMVRX;MEOI6[
M95UZQ!\@ZT\9KE *!9WO\EN[ 773:+\-,>4MVT*=S=B 9)L*[L]T&5X)EO@\
M9("ZT9IRS0WA2^N'/NZKK=E7Z5;NJ\',G.\,4<DGW!":6VZZ:.D.[+]*"<0K
MZ4%*:@LZ@PEF\ CY%,=.G;C0MPL=.77P[M[3:S+T!J0AQR E[3F?2,<A_7--
MGG)$I&U'>7X[<9"_38Y_/3K[ZM++?[O]?\0,\]."'Q_N"/@IR7)J?RQ<&U-
M%>;)[HB7<@F/D#DG2IG"4#FAT'^$%^IP1: &J?;<7I6W$&]H_Q[R&A.+<$D
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M<'Q&SXS;(%<1<RD%Z:S1RW"DWSXFQ@\N86LV6#_P.\QK578:C[I[RD9-6&E
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M'*@6[4Z:42ERNO+@R$I3%XM,N92:*Z,E&4W+@D&N[A#893QE"G<KLIF#\2)
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M"9NNYJHJV\LK[FLD_2^4]6802L5X(+@>Q$(9@5ZXYFPA,)YG"Q>K+<M*VV=
MXG[+%H] I50S)X7Z6(P,7 LEQ<#:H('RPA!4KH>I4EIZ$1]W>O;+-"E,U^(Z
M 4P\!/MX4W=QSC*"#Y\U,,Z:4ZJ",: #A+ ZJ4",EM/LLF505H"!A;.BS&_8
M_U\D-TSWI;&:T)]+C2J)L+&U#X7MWMS3U$[JJ*U[%6\_^8UO%W(D!,+5QS.3
MMQ5V5];1;9KGV@U3P]PA FDO^HVNXF^!': M 9=8V-U>:YG4LQ:M!=UND2+&
M#?[!GQQ/A$T_$;93%.[L^.=?+LZQ[\$1I-][)#Q1>>[IS/I__<?^RV>O'Z0S
MZRN.P(9L?8<1AKLQP!3AX>'8WD3K!/QO[M1/7?.XY3QP3*_:PCZ_8?PG=3.6
MJI#"9*N>"$8!4=3 4&N$4:2W25X[;UN:.FK/A";\,7>05C*1([5O\"%##.-*
M=T//[M6.@V\.'XM8B,=F3N:+')BX14M\LT;V.*2-':("6C>AL4=\89^C2ZC!
M;45]27/#?;+NIWX9T<[ R^AR%G[QR^C.XF[L2[+!!].!FZ(G0^#&DAA)7<BX
M0Y$RMX5B'KM"=:M\%1D%%4'%,<)\!CL97GZ5T6<\TC*3R)\) W(ZZ>M=5P;&
MM[H&">A;?^;\[A.'O600(K$D6E+& '7/G5!X5=BL;35-Y_T[9'VPMXH%1#N<
M0S< 2@'[X+# (YX1VCXKY_ TNC1<N'L_8!"N[X0!BE('*90I\A)4*&!W+Z1)
MMM!1>D/> Z]YD^O.0T>1LSLH56'ZK*W>G7_I24@8B[D&Q:X2#B$#^YJXFDO2
M-*@4.8\4Z7$$WJ:K?H"?GGF:,=II?BIG;>6F+[9M HS-Q7:#<"BN=:$/3?T&
MC#EB6'NS$DZ#?TI:V?J:#=Z_Z()G!QD^94),F[2B?>FZFGS1>3/Z& 3YQ9UM
M]E"ZP I3;?24DFC=<O D']Z>\TQWCZ,RA"B/GO6F>];;*3UT?C&Y^' >G1V]
M!\=ZTR"J&RXQ=&8.P%#=E:JZ&3$'AOII8$[ 9J""&AG@K)IK>D'0J'@4,Q%$
M0EJL8#\^(K^5DUV-/1%@K1W!.2G.T:&%M4-5[4-\?4NGB65?-)U<3JZOU^-@
MGF2>]CVZF'34M**)[61%M/-*",S4177F4S3C#(C&]3(;(0)2?U6GUCN,(R1W
MA.2.D-PM@.1NN+'ND;4;< XU?@VS!"7<I<0B*@7W:%FPK+%HTGOLC"Y9-/!P
M4V*_1<>0#HHR:&"X4XEUQ+QN/#!O.S&O%ZJE(C%T#>&O*T<+:Q=R;D3$Q,&L
M'%20C["0GRTX*4*=T<Q53(>WSYK$D5-K44&!=5>D;1?<&W>0JG]+[L-?^?6(
M6=V6K;&=F-7?KIC)$TX(ZDJFA8[9L2!K7*=-N5C4G+9<,%.I98X3#INEYK@Z
M::789P0(>G)#CO@]V29-6PZG)\6'5\U/SP\:*&]371>+K?"SIR_%#I12I8)6
MFJ7%G?NU;;>_._WP6'MMMI5[[4(S^XY\ZJ?L3UB99ZE4LSFI'W#5&HY@[4CW
MA,[8"_4UBEI]K<MVOI7+=N+@F.S>UY:/P77>:2N=[3WNQAP;EW#;[-HN3KP/
MQSQ[>T@7 0>F=GH(TK)*Z<"CY'Y'*W"UMK+&XA\KGVZ+M1?2O7Z?P%LY;A&/
MH?&18)],T!/)AX63K*K2FW)&*\D547R5PE=,&&<T:QQUDUR'BA[D:%^7MUKK
MM&!CQU?B(;,.](.NNO<=N ###U&EB%DRQ3;DNV=! [F&\_4U*2AT5%DI7CV5
M(;F-=4:$J76$?2V=%C57B,9G6!G@KTM6WC$&(G1J*LRUVCO)B!:()MYY(5G*
MQ.O#7QO*)ZY(6DUS>R57K@[476%1I3#LA9^[O6CBL\'_70L,FE.T.&J1G_-.
MFCZ!FW->XG8N*?_*TQ-P6*GTP4 YS*1Z49W.D)G!%69Y6Y.D^[6;7([:(*8-
M"JQWQ6Z:L[ ^J='Z<_M/L-3=G G$",;#+DH(0[&L./=R[UEAY]'DL>'+LUUR
MT8DUC<@LD71L9W\7?E,T5_!QXTVX4/5: (:"%8#+S'?)SQ 07;;$](Z0_K/[
M['"'W>%GY-G'Q@$AYSH5(X")_&I.27?:EG9!&*(UG,^==->]-$Q#)1]QJ&O5
M!L=JX*97 [=3%_SBZ&1R<N$E?WXZAG\?'D_>1H>G)V^.+XY/3S:N(6BST\YZ
M+-_%V\\X:3)LW"UC96FL^]CG]K)=*C=I5Z5$2/I]!@$-9=6FDF>HL )%A@H&
MX(X1(<E4QGK]M\.<9/! ""3RB0I_XL2B&$Y^\ +!4*%?0$>%W@@L,/C.J?2<
M4!Y0[D$QH?281!_P?!IZ<O*S8\.+KU O.$?H3"@7B.*@DR$IBA:Q3PZH(JH]
M0Z7)I$\<AW)XS,=/AQ]KT\1AM=5/C#N_:SLS23NG1L\=/#7D9_-)?X:@3T(X
M1 <&'_ P0K$GPP]"YQRE<+HO6N*1V566+LQHRP4<W*G!J^^.I\NFGR[;*2DW
M><-'"!PG9T?OCMX<'Q&D^^WDY,W;T[,WKZ/S#V>_'O\Z>?O@Q!0P9R^^?_YO
MG.5_L7?PXMFKYP=PG^]>??_BQ7</NAB?DMW[X8[F3LQ)!IA@,.A9#"BK.4@L
MQFLE9<R1:S19*51QR?4 P22#Q>6C2;Y7*Z0RQ6-3(D"(5+"5*#C#/&"H).PJ
MG*AP7C8=Q9<@E*RPF3674]I'E1(NK6GBO$^LQT$3$3A<>^4T5J<+ J$>M!5G
MQ3HOQ,%![H@@-Y>:WG5SYS@X@A-:@UJ745!-M'5OCWP-&J(Z6\MTGC'9AFG#
MMO+PFD(9C,SI2>"//I8<K=-V6:>G9 U]#-9\[^5Y-ALE?Z>='9*VZUZL>Q\'
MU_,NM DU032!"B.8I[0A2^3O$;,*8=7+8=A_P\;Q8E>Z[79C1SI<W62R7RW&
MO(K2I,J10 ZKI(KZ'K!3@8D D[:\;BCDR):DV-@7HQ27'>$VZ*Z'";R,G'C?
MQN#]?K4(V*Y!/,LKCTKPCQOMP F!\ZG4 &)-9I)0X]0G=<VPZ51Z@[2KG(E,
M=_K]SYR8AV?S&KWW1_+>MU/-\;?)\:]'9^BP'YY^.+DX.CM\.SE^MWF"T)NM
M['ALL-4JA5&+45DNT=1Z60RR7NN3P!%N*TH.)(5WV=1A\A6-'N!;BTVW">6,
MG,_+5AO;XDD3"L8$C_(-IK3;O$9Z><*E@S=(0HEPKUNP;LC1C.2@XH?.TWI6
M9=?:M>2LI7^JUT;UY:J\98YGLI.!50_=<<K$DXE.C.2>4!P([L;-J_0VB5B4
M/SX3-*]#/61P5N8E7MN)JSC:&RSPPNGB=*,9I,\W1DF5=-Y)Q,#I5^;9G#A?
M@JR_R2;UWO28<=EPFWVPG9J!AZ<GYT<G%VN-]-C ,#8PC T,V\'J,Q@0$F)3
MFO5=6T) $\,QHHI/:4;I!L(\+FXSXZD-0WK'H^2E\#0C!A\ZY@LJ-C1#QQL6
M2RB],X4?$:0 EF%6I;A?]B+5=1@@LQD:I.U%R[P\EJ2KJ.E[>!),Y#5PV<QI
M#L&#M87!;^E3QHC)2%:*F952%]X9$X/T"#!F8@3HI**J=-'6X@S!%8+OKQU1
MIS E*<<41=QR3CDR*: *: =Q<.C/F<\L2H[A5R(B76.H6LD]Y,LB>TU(*/M)
M03HQTCGN^'X.]KPK7JC(X:F\=TFZ9BG3''E7-.R2')QW-V^]F8?770]-W6LS
M%9U52,F_E4L>ABJH5MDO<:12'?=;%U<(/<F*/]J"Z0D)6[;@4<.SD]C?*OJC
MG5^.8M#;X-AMIS+I+Z=OD1@O.H60?&1"^KN8D#8^U:#I3RD;Z7%1YO.:F*4I
M=IW-VNM,\@ !@SFA7X6JSE$2N10RH5$1'1)@#H=SIP21( X0H<#K7SD0OW0I
M"SA>TE4I3(,7:;6,![($BO>0J@\#/A3/-\4$!++5$@YO!_O7UGLMBM-TK"&$
M/25@9A]X23>8"7T[00[IF,8?8LW3BE">2+LP4ECX:S/\>>?Y,\&C,A6^4H\(
M3XUD,LCA8Y+Z6+,J,_+M@LF8IET]5P8"<\E,TT<TP)Q9?>!;^B?"L,PY#6ZQ
MNW2[*%GB\1_!^V''$05K&UJ93BC0%Q<^H8MCU\D(^C*<W%Q!1GFT2A-'D(+O
MWLL%]-Y/[)8ZOPA*G(7K:T<K'K# A$-RP6R,2,  MZ-O[G9R4>6G[);8<,WH
MJO!.NG1F46%RD%2HJU/@&C,)$[4@C5C#O$,RCCJ?%@]M1BJ[QJ7?.LNML\XZ
MZZC&3650KEA)92IK0C\YBNNKI%J2 XR_)D*(]$\P2!7)))!_J,VDW4K0'1>E
MW42KQD@"ZRI2WW1 :9<W.65#F3_#U:MQ6FA6]J*3$O'4ER[VT#X!BXM&J"][
MW"PS/[38>!52Z6S E'#M;*@&;4;7C!S*V^$@;F?Y^.3TY)OS#S^>G?X\^;=!
M[1X\/#3(!-G+MB$(J=+TPRDA=E\1LL)&>)7\*X&OLHW*:FKOE9(SHV.I6PA\
M(O)("$/*B$U63]/&L657KYX\@2*ECZW<,>VOQ%TV: 7='_.R1J]*B!F=*\$M
MR7.UM=Z^4O!>]Y[*72ONUE86FM! 0?E+4?Z%#R!/9,40@OZTX0>RRCR=>0BL
M-B6%IU=6!X^K0$R,5Y6725#Y,0_6-[#1.8Z0<B.5I7\F2F,'>;HNX71=#1*#
M^"]A@Q1W8176H:'1\Z78<Y)K*4-V_UH>J: ]VRMTB+SOA8Y%RT1QXGKI5,/,
M5XE^8"\Z2F97]JZR[.0@+[FG*^E(6Z][ .?D$HL=W=SK3; ?QA^M/+^#WC;S
M6:L9OLE<ZE_H<<%'<0DV?:]7_%S22T(.J?W.'_IDD7SQ/#$.G(DT$*WE%Y/,
M4KU+B;ZRN=(G%2I7?88!W00J7]I986K)FX1K>_;1DSKPT_5[X\F^Z2?[=FKU
M')W\>GQV>O+NZ.1B\C;Z9?)_)V=O/J7 -V(2-P63" MO.Q'3"BT<2+=/.);S
MMK+%\!7I>QM2>H _2V!(* QJI:ZDLS=(/+D&:?&4\-]@S6OJ/\8L.\Q,26AD
MXBV$WSA*U;77V+D54A?B2,8_<9]WK*3)6.:XY0"_3J_AY(GJ5=V@"^:^D60L
M10[WD,+4XAM4? O@'[MTK5_( 2S;.GK']%\[ C?."NXZAM@8D2.[L;;*FI2#
MG]*V[K' TLE$_3JPJT7]HFXQ,Y 2C\PUN1"+O,V0DU=]O852'M/KH/Q$ZKYF
MT)Y(NRVUD0)+'>2U8:K"\$*32 0ZJ,)8@VX)KKPNL; ;<5#/$O'C)+K)RCP$
M,3IQ1M@?WX[F;+O,V7;&R,,H8D=H4%JD'N7\A,E)1",Q6)@+"ZL0TI3+95LX
M:B8B%T!-&!=G79*<XU)@UF 39V3@:(M22R2KG@WI#F#'/C\46M#T$B[K-I%K
MG#PJ;K*JU!N<<3J=^PMWA@S0N,^V:Y\]I<?Z2/LL2"Y'.TUYR4<SY1PR.E&H
M'Q6V%R/,2OP1#J#91R8+1@9DF)."?IJ"6R%[I[SE7S45S",1)<,H88_A[Y8I
ML@FCWH3FF6/)/L="&2+W47H5$2CTM,N[8;9;4]J9W]W#&>MP1[Y1%,;09@R[
MP!@^835_8\,\ _NOEL8 A(APXL);EVC$^XUXOVW!^XV'S0,>-MC<.<UR, D_
M7&5S6&L/<_QLX['C_2LVK)R^]'9;=?VX>EA3SK,DQ?7KEM+>02WQ!^%%HJQB
MS3J(E>;6U3/L17Y8ZZ>2_6"<:BK>5-\F3B[^'2$DN )/>N">XHM,_9KP&PD^
MJ$*]ZOF0BKI ?E 'YA!)(V(\*ER/ S,9)1KJW<U TCM1!;6G9^IK)7EZB'F3
M>-Z/3;*WL<G=5@-$6&MG[#6Q2,E5LAL6=G3^O$<%PED]"ZE.[G@+,.P@OEWO
ME=_%53DJNW7V,Q)UX9M"6X85&D>KVWT-MA'5@)G## -B 8*>3;@8@P,D@^&H
MY+37MGL;9TN$]LPTA'I0BT]_(("#FN*ER(8+5=S!I,IJ2MSH2O=;9='?&[(S
M^/JXK:<LXVKQ*#^VF> 5*K]M''RF^R2VQZS2W556 H!P7)9&K<3 P.XV#Q-G
M$\2[S2XK87SMFB<W3IH&\7/E=P]63!E]AD<-4)]2</IA>8@'B#%ZZ*#,5TVU
MV"\YUDXK/,+PT G#G:+P@60E/8WE':T602\AEDV36SY^$'I'<9ZAZ9C)"8K2
M<'DV\QKQ/7/WW)&'NVW%#]MMK@\H0I +L:S5DU@B_57=H'>"$6;ECS'/SFDJ
MR%69H\)DNH:>8)U=OI<A8&T#O"NW4[E@(=IJV#[1-39?7=;K[RW1/JY%>4K!
MXH>U*(;.054VZ6 -]-%=F[.(F5LHZ#2%[__P^>ZA330<P*^>O;@/S;6!8*Z'
M[!9@B<XO5!*C!YNGLY)MT ]DN4@ G1J]'V?,7:=ODU305-)45C N7 $:2_F0
M0V6'?Z.8>E;B[235B5O!/^&Y?B\VO_PMJ9O@%^^4-A(N=YKE<H#@/CLLE_#
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MIV?O3\\F"@5X?W9\>A9-?CX[^L24Z%,?>)M-B';1YTP4WZ%6B4#5 *0N(]4
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MC-<8QFLF%KU"6$QD0*HX9H#G @2H_,G8'X/KF,]8$FJ]ECCU.6\I<@W$.O@
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M-K.I+)CFZ5GF+H+'%W9:T79OK<F*:2]B56R\<!7V@MF_F3"KJR2FYCT&M6V
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MN.6[?AB]@=NJ&4#3 8%1G5H#24(I0COS96:16/EL,_; KLWEZ87F<KPEH^S
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M74^1J1X)\G5G?SW.?C,Q6O;9KS7\9K,9!'4T489*)A'KKKU,-B6K"M50)9O
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M"I-DM2!7HE4U4XH>[7OE!):K%@#?-@9;DJ((0(VNSU'*P6LY&. 1@=M,X57
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MHOT-,ZSH =<BBP3P:SZ&(_(V$)/\XQ,'XRR/D/^Y()Q1)<<N8&>BP'C(N4"
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MJ7BZ-?G2H^%H=/$T4-V:NX^')]_L;NCYJR^^^]7PXO))R=[K;KX$E__$FQM
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ML8J(? U3ZL;ELD*JKD<\-IC5H1 ?"LI0EYE/_UO(Y2 ,8096(L;J9>.8:]"
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M ,VY4P6XZ$B]:,G=I_7U6U/.G^W1FGIK3:3B$JR1Z>9W*K#;)[IY4$)Z;4A
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MM@0+:>.:C V4'S8+&("XA<S1%'!_87U4!=LQV"1!Y)% H.<.F^+3L4(LGR=
MF])F!6TG29PJ*$2!$!&)$2ED06L!3;N#GV ;4JKU2P;O+7J^MU![O+> $680
MDD]U+GX%_;)Z7/9X^P#; ZKR[O<)N:?](L!DX5GTP"A3C2<!:'K2'X-Y?#"B
M9TNPWTCFN@"OD;=&7J]^#NY%''_8F!!UHH<32Q /HI<\N9),$FA:!A[$N!+<
MVH.+P'Q8/6\@9FHVA@\/G^I/1/!\Y%V!3_%,JBZ'[W0S%*) D 0/A<?7O9(!
M<=SJFA_%P/-!9JY,"T\91<.":S5T8(&_E1D8N3A ED4\,LDMWG\XH+$I3_FG
M*C@S430DWM6U%6;0! E(9V7!4<T1[9R@I_6G2]I&Y0R,*HO"UE5Z&C=*"V@$
MELH%^\2^^\1D?WWB_\(G53RMMYX5Y'>P-\1W[YM;S-H\"A5'\_K35TD_TKX6
M:=6G)D7B5#J8\22J-;5MH*$+(NM2XE;(=MQ@6#71=,J,3@D4J_"D*^%DW<8-
M?>VCCH(Y[?K-:3??7S<!9J<C1>O8+?3F#;X[(8T%NVH?Q#+W3]_7LCWFND/-
M;"FCJ+6TGPL9\SAL%$#7(C;JNB@OYH9/OLU[0V>$@?F&]B<+#5_*Z,]26_H1
MS<$XM5(_I4N',Q"M-\WTSKSU@@8W.H%%WK.O]WI:^\I>%(ITM"F"\;GT#M_O
M'=LBK_9\SWGG+<1-YWUZW3SID*<M'BM?]Z ;M#%Y").','D(PV-[B2MBT;)H
M6;0LVN]%M$P>PG.]'2%?,'D(.T,6+8N61<NB9=&R:/LC6B8/8?(0)@]A\A F
M#]EW=#V3A^SGO#)Y").','D(DX<P>0B3AWRS-)LZ;2:W)E)Q:<%2E$-+0\J*
M %E_9E(-E;A[^ATAT68JYY0NJ##_*K*^MB4!-"(=4T5XGW!E/(L'I7;3.&9Y
MZH$J3390_]*9Q.:39+_73&[&[#],U$8S1N 1 4,]@X15$P-_#=9#FM],M4K$
MVWL5E015J&S1V.U;;IO* AU,"WIF:I!8G1^+N9>N'/^!A2>)YZ9!@!!H SQ6
MF18A/5-;X8];H 4$OGEP1=W^-5MAOZUPASD(R,P>L:K-V,GS%N+MV-+S^G!-
MW[/-]=KF=I@PP=N<U!:V=56"_DT9:Z*WHPQ\57W]BT%J!/BC6@O<!JWR.<OK
M=FSRJ3T8<B#:<W,\VUUSO %SHI+CKJ$3J3$5L$,C)L.Q"@A9I'[4B.P5"2KH
MP?FA&)<.QN2<B.62$#=@JDKGE?:O #0"0$0*EX.M@GJW.":G8#MCI;*:9?*+
MUL\#?2@^M:X_+UH.A"F1]-BB;Q<&#V!@GQG99_JZ>Z'(P,]G,^XO736>()FO
M[_T?=?8W'0,DXQ0'QI^>Y,9ZSD6D#WEP6: $0D/*3.&-J3;<4 S>4Z>N,5X<
M)]9ZKRR^W3HQQ,$WVM"JJGRO3<9+4]^7IO/=79I6STA:"TMG41D(G03/\A!/
M"IH<&7R7(!>XM,&],Z3K1:<##S\*O! Z2PRX%F]:MKZG9>52_)+*Z ZYA&^]
MG8P5'M@\ #6",ZA,;O#@1\2T>LL4\(0\57 5T\KT'(H_WF,HO@&=:F/Q/8%$
M[X[B89UYBQ13#,7?Y/L-I#G7'2]G%0482*<%?G'BPY8 B*_&,KJH(JVW%1_A
M#=SM=^8R=8:1UHRT9J0U8XGZF83-HF71LFA9M-^+:!EIS7.]'2&_8J0U.T,6
M+8N61<NB9=&R:/LC6D9:,]*:D=:,M&:D];Y#$1EIO9_SRDAK1EHSTIJ1UHRT
M9J3U-\N0R0P.ZKF9TYBKBSG!^ ]5KZ7BG.JP2ILQ451:JT)9'LKJ#64N!E0(
MMRG"1P4NG*[2$GV1"UTE #]:Z +3D)W!HG>8F.Q@3M-.??)N4N) C,NB*F:N
ML"1AE>,/HA$'HY4L8=H#KK8Q%+ R1U-! H/0MDYV'.-H)*5K08-8C0M[T*J(
M.H9G'LVD3@])G&YJRC0.]:I]<J6.0Z)7&&25[^73LD..Y3)?S>SV/\2PSZMN
M?/!C5F+10Q+E5"**7F=SD\XQWSD4+NS4'\&IR2U,<0]3N;B>4\^32*/]32+]
M58$ZQ0(#"8]+:"64]LY2P%/]AIB.TF*]H. YP5GW.G6T5;*N-X(<( #E^>M6
M7:$G]EI3&+\>"EE4U5R]V\^[Z?L:5LRYP7*+F/$["Z6:J(ZM.,!"0.I>8D+]
M8!7L@WBA7&55S>M5CS[PTT]]<(@<S:JU @L(N0!UP5Q^S-NGW^&)3A5%JMSA
MQG/W=]GK+OP9V=BDG_0V3W/#9V>O+D>7H[/ST?'%Z>6K#7GA7[X*&N:)@GBA
M ;Y7D](#R\0O']\_HHCY.B4+"*O'=XBD9AO<)'Y31_6N&QN#36/],&V#^YA1
MW;BF*!WX"H<R36 !%>,*\^.Q<55QNI 1WYV!@:^"W2E^K6IXG^G02H O&0B?
MTP[^C(+C^B^L<S?H^*FFXAV%L EN*CR8CPJMK732Q_$PPF+YJ2U"%&3@"W%G
MJE62K;5Y 6'/J:(H AOC%M:U&L]JB3T/YZ6=1UU0#V+\KJB&K1W\L]WE/OG&
M53M[FF^DCNT0.O#K^,/_K4W V3['%P9I?B>^L)91=?(0S+>FGA*V3#':<L(G
MZSDJLH@L&SH'%9 6/0<UT*71&(AF2U^@X6?U8Y#LS2S1E"'V?I<)?'-5$79@
M%]8T[CJN"L\1"GE'H9W3Z'@Q.L,G11#<$>(H0*[Q$".&9X<*WG.X)=)S3<</
MD=78J]2SYBF\'^,]#0X4FVE:P-,:.L2 .4OPW(,\N6\'%@>9HCL=0&!*QQ?2
MHA--K)EU?&76.$C;\IN$VO:0TRB,CN"FY,N5+T?^A]0I.\B>.,B+/7*0E3W=
M.*<15!T*A;^-2W]@QWN9G=K+W.R1:GY.!WD;\_/'UHKH-Q&X)L*Z)9W)0GJ4
MREWUNH$V-["5*8FB (E]X(X6?'IE-P!7*9H#//P>PV9B0+[![R@P5P4V)E;-
M,)T+N57\^7FB8#&&%;6URTCE I?2PNJPD&,KU5.() 6O@F!#6EK!5U;T%ZU[
M['OX'.5+&+#JY9"=S].=#T31<^3::_D?V<05&-K#10T#T]K#$(BBI:NJN?MS
M CK0^/QM:PXM/*]12MP%"9[QSYPX'8BSWAV<B\=]'-,B,"T"TR(P\(_!*"Q:
M%BV+ED6[)U!YID7X?N;Z-=,BL#-DT;)H6;0L6A8MB[8_HF5:!*9%8%H$ID5@
M6H1]QPTS+<)^SBO3(C M M,B,"W"DVD1.'GE9TPB.7]2$8NA$/\P"S7'TF/X
M6YD6&LL%84I;;K(J"/:Y<:F6U9^8(X_ Q719I:!8-9,Z<TUJRN=R6CCS;3<R
MW][L4>;;?^B9+@).(Q/_4>DSI\$]7I$L4P\0;Y\HYC=X=L'#=74.']2)75/A
MT-CUEWH\MH?@*(7^J"J?BZE\M0LC#T9@' 7*B^EU5LVU0KH0*L)H55(ZI/%(
M$/9=P6] T3.L'A1@?GEI72D]B*7?<'H]' _/^PFI#]F0-"'=TJF[*.CY4/9/
MS*C0C:!]JJI9(#(+HLK);@H:5#KJH:3%:@U']#'>M7@P7,>5[)"X^^E Q .G
M40FY+O"W.S+NI>] &I!'8H#GU59^TFH-X7])M4L?K-5X>ZHFDKY ="OL3M"A
MP9P3U)_RZ#O&96Q'#ZAP<<VRHK*)G'@\#GG'V.34X<\UPSC5GN!47^W1MN0]
MOON"U?<VP,48SO^8I'Z_/8*GGH(CB<DGO3%97$;%BE'V0U"?$\WQ9Q[W@M,P
M1MDPRH91-IQ'^NT3<%BT+%H6+8OV>Q$MHVQXKK<CY$M&V; S9-&R:%FT+%H6
M+8NV/Z)EE,W70=G\]./8Q,N?_^6G'Z?%+/WY_P-02P,$%     @ "XAT6CJ$
M.<8G!   '!<   \   !E;&1N+65X,C-?,2YH=&WE6&UOVS80_IY?P;7H^B6R
M]1+'CN0%Z!RG,)8Z@9-B^TI))XNK1 HD'=O]]3U24N(T[KIN<1/  BQ3O..]
M/"2/O!OFNBQ.#\@P!YKB/QEJI@LX'?_E^$''&W;K3V3H-AS#6*1KHO2Z@-]>
M531-&9^'@VH5E53.&0_I0HM?6%D)J2G7T2LK-&6W7PUQM*A"M]-C//KL,)["
M*G2"J&3<R8'-<XVTOB%60C'-! \E%%2S6XABL7(4^VS4QD*F(!WL03W#JE61
M":X-"X2>6^G&L%IA9&D9+5FQ#F]8"8I,84EFHJ2\98R%UJ)$7@TK[=""S5&[
ML<DH,>-;/8DHA Q?N_:)ECG3X*B*)A!6$IREI%6M;EE[%(LBC39L\]"V?S+'
MTCZ!Y,95+CA8>)8LU7F8,>TD2 <+\7B5LYAI4D^9&7<Z[%;X0]PM_KN$)D$;
M0+Y8;$:7T^OQ](9<GI/)]&Q\-<87?L[&[R?7-^/9^(Q<??S]8C(B[T:CRX_3
MF\GT/3F?S#YLX+CG")*?",7?"Z59MOZO6#RUZW\"R4%"O";8I["/:$%T#H3Q
M1$B,<=3$)H)T"1DR\L20R SF3.F&>*VIAM*,G0K5(4$0.+[K'GG!8=,.W,!O
MVI[K]@9M^_CHKC_PC_RV/^@' [=I]WI>/R"4I_5G/SAQ78(ZSX4LR;4SL*3O
M6M,[&IRT$ON^VVNU]D_ZGG<O?>#[QYO2 R(R(A82?3?1GJ0H.24?J$QRXJ,\
MW_5[AZ2.VWS>(F> % 6KF3/&*4\8+7"B&[N4D3HN($5%5SF5)<[R0K.$%NJ0
M3'C2.22TJH!*(Q.QUCE3Y!WG"Q0RJPUI3?1<YX_O22.9D-:N-8HD@ =12LX@
M@3(&20+/>G'4:7? 2UB3+V [_CQG?WWM';O1\WN\QY/];*[OX-E?-+NJ2T92
M+(%<7%SM+PQ[O (NA#DGYU  'GTC-!%//L[H_@+R\*;R%0XF8TT*JI3)6.?@
M-*FFL0L%HP<;*>U& IL5L')2)B&Q22NZMBAYE#)5%70=&FK4)L M0C8'?ISX
M-F"U]MJQ#MY/?B C/K A3].X@-;4AVZ8Z3%4!XT3"VUS]ZB&"F^B'?=-U/"C
M'P6M%(0**HHW26BEHWC9RKYE"K/0@NEUV/+?L2%?>G=[L J"H(.WRC>;QC>N
MMOE\5Z<O8#0VY6-?EXB+$TN@GT+[=DS']K6[#8('11!3Y6B^"\C, G#M"K@%
M:6^JS>Y!WD=K9V.H;!9//?8;Y1#OB7:RL?/?7PH;^6]-T(DE>WNH*%>. LFR
M_W,5_,84[QS;+3CL$NOMU8%]1/L>B5WBO;74]YQPWT<@;)EPO=M2YX_M[>V'
M\M.C82J9]_7,_"X0-XXP7C".%FHJFV/L(0$/SKJ[/LQMR*89KJ:0%DNZ5C9*
M#[NFMGUZ,.S:JO@74$L#!!0    (  N(=%K.@I6NP ,  %P4   /    96QD
M;BUE>#(S7S(N:'1M[5AM;]LV$/Z\_HIK"A0M$-EZL6-'T@)TCA-X39S 2;%]
MI27*XDJ1 DG'5G_]CGI9G*%;@2)>,J3Z8%.\X]US#X\ONC@W!3]Y!7%.28K_
M$!MF.#V9_N[X0<^/^\TK*O1;C7@ITPJTJ3C]^: D:<K$*AR7VZ@@:L5$2-9&
MOF9%*94APD0'M=&4W?UMB&-D&;J](1/1%X>)E&Y#)X@*)IR<LE5N0J_G>B@L
MI6:&21$JRHEA=S1:RJVCV1?K=BE52I6#/>@G+CL7F13&JM#0<TO3 FL<1K4L
M(P7C57C+"JIA3C>PD 41G>)2&B,+U#5T:QS"V0J]6TS6B1W?^=GDS%!'ER2A
M8:FHLU&DC':<>^C\W_S5LL]4"1N+D(+6\6]8:O(P8\9)4$YK#M^^\8[<*.[;
M$2=QOWR"8!/)I0K?N/43_7>A3[<Y6S(#33K>$]#'G*IS:Y],)(B!JN^E8M-D
M\E+R=#_<3*[F-]/Y+5R=P6Q^.KV>X@^^+J;GLYO;Z6)Z"M>??KF83>##9'+U
M:7X[FY_#V6QQN</COAGD-/ON5-H[?_ _(>*QX_Z-0DX575: ?1K[P$@P.04F
M$JEPZR9VRP64*YJAHDBL"!9TQ;1IA3>&&%K8L7.I>Q $@>.[[L +#MMVX 9^
MV_9<=SCNVD>#O_H#?^!W_<$H&+MM>SCT1@$0D3:OH^#8=0%]GDE5P(TSKD7?
M1#,<C(\[BR/?'79>1\<CS[NW/O;]HUWK <@,Y%IA[/80@Q0MIW!)5)*#1>N[
M_@#>T6U"2P.95(!S=<?D6O,*4J83+C7JD_2/M386D;;DXB DAM1MG&<T9>FV
MIH%I^+!>H3)XQZUUBVTN4>:Y_SRH1>368X;O#Z$Y(<6JFTSKLYY@R5D31,8$
M$0DC'!.PY4O;:*><IDC =4Y4@=FW-BPA7!_"3"0]!%"6E"AK&'/ Y!:O$&LT
MLF@(ZJCS7.?CMZS5A%EP%9H$BN=^"J<TH<62*@B\)OY>MRR?PUIYZCWB"2\9
MSW]+=!\M^)]^3//SG>9'7,W[>%XHEWW=AX^7O\)$JB6>#&])44;X4I1$5'!Q
M<?U":7FIZ7#.\3C'J^,A3! <GO."D1=*Q<.KV8^3Y3F%^WA7AJ^&:RM="2=:
MVTK7BCIMB<KB08.(=:<4ME/XRCC=.BE3-*F+79BXZT)$^#E1<E*%5OJ@-L9$
M9#\O6%9U>&H=!U?@5RIF!VVUY+YFDJL.0\LN$YP)I,T09>H27O10@(:;[B8H
M1<EGAV2&JI#P#:ET7>>+^[8V>/(J[M=5Q3\!4$L#!!0    (  N(=%IC5$7!
MSP@  #M%   /    96QD;BUE>#,Q7S$N:'1M[5Q;<]NV$G[OK\!Q)AU[1I0E
MRXI;2LV,F[@=SYE>)LU#7R%R*>$8!%@ U*6__NP"I$7)LJ,D2FPY\HPMD5P
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M0Q9C#%L3KW1/$*=^G9>6@/TV1=#L).@UX?8VSZ;HYUD/J4\+O$NJD+U@4MR
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M9:Y6MW;6">3??G'WE1<;=S= I8=W83S\+HSE'L3D-F.K;*@VC_P645@U7WV
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MG\ .C^G5+V]_&![[E\;\'U!+ P04    "  +B'1:?3:P1<L%   P)   #P
M &5L9&XM97@S,E\Q+FAT;>U:;6_;-A#^WE_!N6B1 )9LV4G:2FX -W&V8&L2
MQ"[0?1IH\1QQH2B-I&.[OWY'2G(<QWE!ZVY.FR"(8_'(>^[NN2-Y4"<QJ=A_
M03H)4(:?I&.X$;#?^^RU6W[0:11?4:!12G2&&9L1;68"WM=RRAB7%^';?!JE
M5%UP&=*QR7[A:9XI0Z6):FY1QJ^J*5\\+AE,0Z\=I5QZ"?"+Q(1-_\TNEU&>
M:6YX)D,%@AI^!3B_T\#9;I6\6F.42>-I_@7"H)F;4K-GLCQL1FYL1%,N9N&
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MXSMDZ_]*!>PKP%9^  GD<'-) .NV<G%OY6(_YG1L([N'2X>CY7JNM?2C@]P
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M4%-245=3\U)S!RG\Q'\/2+G[_P^5\ 1I<#H5X,YQ5-\ =V^P[,4@L+>$.&=
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M6\;ZD*"(M;?=Q!7DY.3$OS^RVT2$0,$!(5+B)H$@&0!P='(6_XYJ< : R]X
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M71RV=HR$(XWJ6A+#QY3Y&O@C',47:\,B*OEF:Q_"#0& ](6#\KB3C0F$9=Q
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ME$+NR7$4M$$>):U[X(E4'A3ITD+<O3%5+H<([+K.P"*4VCZAHA%J#;>\/B'
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MC*ECC)\?&% :H+F!?5AZ4Z=C_2T1<)FL1>(5Z )FJ7"@ ,JX(BB*!S+0_)B
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M&3Z=G2J<TKPL;Q'_EGIW02.OGU%>/).KA225%G DN]:7R]A-X4^ @:PSJ_G
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MKWF?T%@Q92+1_T3\;%[*&$%*&P1(,O)CK;(P%95HEB8EH\:,/\-\T8&5%6M
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M_+(7R%G^=KTB%-=U>N]$=,F4<\ONH:U-3-IN8\=J[7C1?ZB<(_TVF*&DOF4
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M7J1+J*OO?'>WV>Y3/2P\OBSXQ_.!U]6%)[WW+=KL,^+;[5?OKPX0!%*"$,&
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M'.2^8#H!95@3<RK@EUL+_ 861^.8"X"5GO>964#,O61FJ"#TU$'@!J]R0 F
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M5/L^JX[V0+$H@DG/$5YTOT#_AAZ^,9.F.J@^HJ3Y#S_L8E#_[5^HG40]VY$
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MYQS:V@I1T<-A!O 6TN7F!\9!V\XRV25U\' QND;GU7B2-4;U7=J+3)+?H!?
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MP\<;5B=;".>4J2%!)$1DX])#J43%^_) 2EE*^QUP146(CL.\736=D\OLQ)S
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MOI/+D=:^-):R&=@7HFTHC+M-E[.,^,L5FY$3A ?9CY QI*FQ>^!0<JS?#<A
MV>OP#)I'J^B0L:=1_]1%H_-H:X79+%M:,$V";*7EEU?!<IHFVQEZ2GL2ZP*%
MTP/\0'"4WN!P%4QAK&H'65;6=(,],HSD"1S@!["9JH970,_*E% U%)X%@[?
MEI@>, .<Z>?-_,PL<3C&; 9ZVG8B#.%OO3.L%<CY;M!9_G0*'UK(K2[M ,GL
MVYFCX'@T+68M4XF,^#YEQL(3'/8P%X++6O&P0?6?S@\ZH#C "P$_R7+)7> F
M\9V2Y\P>84;F&F8P[Y_H/N %)\BW 1AD53ET FIH>\L@]-)T7(N'%AC.<BE@
MM)9+>L-4J1:7^#%GR>HSU$"3>$UT)K"%#_E6 ;YLBX,5<(<)+;9000N@N04J
MK+LYEYF'S5Q2-'.J85FQ$8#4K1DS %>Y?=0'Q@L1RS>4<8FK<JACW$(*FX]
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MB0W3/%!3PS3B>TJ9J94447G&$$YJV]&LN4/VW)*N+"+?B%HDO4NQ^.>)?*F
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MLQZK=2@G:V:I5FW'*M2R)REDJ8^X.^*P\(6 X3?*0[@)KDRV.SK%9@!^"]U
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M-N'"S$UMOT29<<)F._&Z\-)Z3ZFW[ROS?-D_+E&Z+XHVF_&JAR D6#L0)KU
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MH3V*?X2.G.^ KZBF[ :P1KPUO1F,E,Z.V@%^D)G\4J"+"D^G1? 3X$?S.5F
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MV%[P8O"_JI*2O$:WFB_E.XE_Z(:J2?S?K!!J3?DP[B3&K=08P22.+/RVN%!
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MRDR!KW"U1TQDIMGTH%8@NLTMT034NITO,8_1M9ML<62LW1IOPCK<C64:HI&
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M=2\VAE;>WI,NN&B%YY[R8M&/1>10IE(*"6.P4NP(L@(UC!4CA@B5\$%2%6R
M(H7VTV20/F9U6A]'GM;+77! O6'YR_9E*\^<_/>O_;<6[6QXN<JIZL66,,%=
M\U3.%4<T=<Z/0C@5P\;,IO 11Z&YL.G, N@46I ^B2U*G2 4ITR02I+'*<*D
M<5IIXABS+&&,M>! X]*?+T]]]=W0C6^7&U[\:B8#:YV+7NX*X3ZP2J#<=,_
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MN]C;@Z[)EZ8#4F>/1F(&1^)YS3VII>JV#+FD$5E?7(]OSM90.EA*=B]%D3.
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M]>% \E/7*,S]@$38[?#TE!LQL(1K28BX*^GHF,LP3-0E!"[R$AH?<1%+"+]
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M5XR2BE7#^++:(8RD?@ ETPT@E0W]F5I#/[S)T(YL,C0M(%#T'T.AFQD0NMN
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M!)<;<CR'%SQ;D#7?@';IYW<&OOIL_/3GG[4^^F&1&JS84@$V6>0!,U?F&YL
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MNI+912V0_*Q&1!E-CZO$:ZD*9"U'G:')KTM3E]<GJQ6Z1$VC+D716I]>-;]
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MB$T-0&:J#W(S/0A%OI0J+70@]K>J+ZBC\F^KHY(_3E=7PL(I<ECWAQ"V+V+
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M,7F2B+ L16Q0AC)1DIJ8*DS)RN EEV9QDNNSV<D7LKB)79G\^.X,W[CN]/&
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M<.LG@MNNR8#7G 4TO87 ,E\)'/O-P'+; W2B)E"8>D 4FP NV!(\8FP!D^P
M+MEH<"YR :<*##C6NH%#@SO8G_'X8=?A^<WN&O:K;3_VD^US[)C="/:5PRAV
MR/$-=@#]]I?^MX%P:!8P=!<"QVPE<.TV P>S!WR\-('JHP<DD0G@%5;@&6T'
M;LF.X)KE#,Z%KH N=P.G6G=P;/#XX7#6\[M]!_:;W0W<%]O'N ]VSW%O[%_A
M7CB^QCU%O\$]<G[[2X!'&MR1!I+&+&#J_ E\DY7@:[L)^"Z[@8W7!#I-#R@"
M4_ *L@*<TAX\$IT D^D"+@48<"YW_X&N\?SNV(#][G 6]\VA$__%_C;AD]T
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MU!(NNY_VZG;O(':ZWR.U>[P@G?5X2V[$OJ'4X=Y0JO%O*$<)_PX\D ;RNHG
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MD"=)O*0)P521*HK!CTUBLZ-SN3Y1E7Q:U&E?[^@KB"$^7?F<YQ,QS/$)_W?
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MP((/0BB"$.8F :&^\L )4X. 1!WPS3$$KPHS\%QC"8QN:Z /V(+KJ!VX;*6
M\RX'<#I$!:?3CD"[BCV@ >TE]@'[1OOFA+]R!=H;.CB]<%O:?];@8<0%?L;<
M$&3&]Y\W1)&N$A#A(P^A(6K B=<%=I81^):9 :O!"CP[;,"]WPX8PQ2@3SH
M?0<57 \X@LL)&KA<<@+GN]ASYT7G>><%_-<G%W!ZZX;_#0-<'KF#ZU* B=?
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M!]W]U$:&VZFM[O131]Q=3]]T=SWURMWEQ!=/Y^/ 7,K=%H0N#B!T9)R =NS
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MV"N$V$!"+!! ;B!*H($TP1Z4B&30))F#/LD$3+D,P(I+%^RXM<"16P-<N=7
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MF@$W9%HM@TRJ\.(J=\E/J7[R<PEA:J]B$G6>168;/0HK-7L07&=U+VBMS>V
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MR(9$L#4B =68!$YF7.!DS0-.SGS@["T M% 1H"9*@'VN--A6R(%UDP*0NY3
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MB:I )RH!DZ0 _B0Y""5)0SR7)&1RB4,9EQ@T<:^$==RB,,(M C/8P5\TX<]
MR7$\_^*_\_WN(N3Z""'[=PB1@8#G+D=&((ST0 )IXW5H@ I2 4V"(N@1Y/!:
M9,""( 6V!'&@$E;BM8@ BR@, <05$$D4@!3B,B@@\D,MB0_:2+S03^*!S;\
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MZK=,J%QN'5>YR2:V\J=),977)\56OK2)K?AJ'5=!K!#+\;Q- ;A6 ' 2W?=
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M?M0YS,>^3\&^3[@-H'\/0/TI@,H7  7"Q$QQS.1CGA3FR6.>"N9I8IX>9ID
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M0R?FUV[&-; +(.DG@- 3./YG >PN IC_"J![';"? /(/ 63^9('41RX(/@F
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MJ;@U?55Q:R3_X2368!>.P89I6(,VK$$GP,PN@&GHPB6ST+UFBT'F'&E(Z].
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M*NHS;SWUB;<5/O+VP9^\$_"6=Q5>\1[#<]Y;>,HCU!,)0CT>@T^H1^,@&JI
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M'[,?(\__Y@4#<\0P@X>?+<#/DP-XAS7YTP#@HR7 %]RL?@WZ^[L@97]_)V4
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MKN>U..Z1:'8\)]'H]$ABFM,'B08G(M'@3'CC^6B'KQ]7=$YO=!T_W.>C?^Y
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M7$IMQ2I*=7@WI3+\/TIEZ 6ELNP3364I^8=EK0#]F-N)N;6S /+GX#R8AW,
M?=QW*8#+,(#-*@ S]'*]]2*@M8$/FAMD07V#.JAMU ?5C>:@LM$6E#<Y@](F
M'U#<% 8*FQ)!?G,^R&VN YG-/2"]>1E(;=X&PLUG0;CI"0@W? #A>D)]9Z +
MYP'6NQG[7(HZFH%]CEX.$("Y;NCC=JBEYIO1@=&+U78 R.T2 :D]/!#ND0;!
M'A60W*N#F !_KS7P]SD!;Y\/$@[<?:D@OK\$./M;06S??!#=-P(B^WY";N+]
M'R"Z]R/R^2]F8[_;YN/S +-SL,\):P""-P!XC +8;\-\S-5%55?=!R![$$#R
M, 7BQT5!] 0/1$Y( >N$$C!/: 'CI!'03UH![:0CO@1Q0W(*7T*G<-&=P@5W
M&@M]"@-.X8>>0M\__3OR GGY%QW8]QJL>?Y*@*1UN [PKTT=^PX.YIIAK@[F
M*A\&D,9?E3@%('86@'&1AIL.=/Z?)0 N20%<5@#X10/@?^C\5R8"_#:V0<7-
MX35\"%_'!_#U6@0'^OH0P WLV W\L!LWD-__HO[[&1#6/&P[SL$]V/\# *:8
MJW4,0!%SA>< N!<!1'X!W/PC^.MPDPYPBPUPFX=2( "X(XL;4Q6 ^[H #\UQ
MH^P \!3;\13;\0P?@L]QP3_'HC_'8C_?@OR$'/V+$JQ]&HYWQ$X ;\QV.(+Y
M)S#_#(#\!:P]YG(PESZ6.W8&<P]YB#SZ^SSD"0LS."@H6),_A "OL"9O- '>
MFP!\P WS)]PD?8X&^((OGR_8CJ^XX+YBQ[]BT;]N^(MO9P[H_&((I08$]!!+
MQ GQ0Z*05"0/*4?JX2NTPF>8 9^@%SY /_P)@_ >EL$[6 EO81V\AJWP"O;"
M2S@!+^ :/(<G\ S_QE/\[2?(XQ\@0O1L271^+L+">[HV_JDY,AGQ0L*01"0;
MOD Q?(1J_+0FS)H.;V F9LW!K/GP!RS&K"',6HM9F_&S=V&YCL(#^ 5+]Q#N
MXF_<P=;_CI]T^P>(M!RV YU?0NI;.S@:0$2-@3 F85W<_SH/^@HQF)V&_<S'
MS'+L6QUFM6"?.C%K%B;,Q:Q!N ]+,6L59FW S]X!-^$07(<+.(7NPQ6LSO^P
M%Y=I!"Z-0?\7(B?$=J#S"R00::P)C@E/[Y_SH ^B/O"6%0XO68GPC)4%CYA%
M<)]9!7>9T^!W9AO<8G7!358O7&?-@ZNL17"%-0S_8ZV#2ZRM<)%U ,Z+G(.S
MHO?@-/L-G.00."Y.X-C?'/T;HL@#(H_.+\=%)+^="4EIP"=)$WC-MX5G/'=X
MR V">]P8N,U-A1O<7+C*+85?N35PF=L(/W.GPP7N3#C/[8.SW$$XPUL.IWAK
MX01O"QSG'8"CO'-PB'\?#DB^A;T" GN0W<@N :&^0U3%@"@Q@*B*(M@.90'\
MJ: (SV5TX+[4!+@EG *_";WADC ,S@OCX:Q4!IR2RH<34N5P3+H6CDHWPV'I
M#C@D/0L.RLR# S*+89_,2M@CNQ%VR^Z!G;*G8+O<[S J_XK:I$"H#8J$6O\W
MZ_Z&:& ^/EZ(-@T^:XG >W5Q>(KMN*V@!+_^'UMG 1[EM7[[]<U,7$A"! +Q
M$(6XN^O$72;NGA /Q""! ,$"P8([H;A;*5!::K0];<\Y]7]/J7NIR]PU2>#/
M/?<^?7Z=B>WU[G?O;^]W[7[?U-@!K\[SP8LFD7C.)!FW37-QT[0$-TQK<,VL
M&5?,.G'9K!<7S89PP6P-SIF-X:S9=N&T^7[AE/EQX83Y1>&XQ5UATN(]X;#E
MMZ*#EG^)]EMQCYIA[PSR!=2WXV7-)>Z!(Y<>.R6\:Z&!URWT<<_:&K<7N.&&
M33"NV,;AHFTZSMG*<,:V#*=LZW#"MD5XRK9+F+3M$X[9#@M';-<*AVW'10=M
M=XGVVQT1[;,[*]IC]XQHM]V;H@G[K\3;'7X7;W602[;,,#Z#0E]QF]L#=RZQ
MGL"K[@)>6J2,NPXZN+'(%)><%N*LLQ]..D?BN$L2CCIGX[!SH7#0N4+8[UPO
M['5>+-KCU"W:Y30@VNDT(MKAM$&\S6F[>*O3 <FX\TG)9N?KDC'G^Y(-+I\I
MK7/Y56G453[%FB>0+^)R1^UW_8!7N+S>#6"M[RW"57<MG/68BQ->MCCJ[8&#
MWB'8YQV'W=YIPDZO7&&'5[&PS:M*M,6S4;39LTV\R7.)>*/G<LEZSU').L]Q
MI5'//4JK/2>55WE>5E[I^8+*"J\'*D->/ZLL]Y:K+)MA<(:';ESJN:2^'DK]
M"'H^^O"+W').^ZOAF+\^#@988D^@"W8&^F-;8"3& Q.%30&9PL8 F6A]0*EH
MK7^->(U_LV25?Z=DI5^_T@J_E<I#?AN5E_E-J SX'5'M]SNOUNM_5VVI__^H
M]03\2.1JW0%RU2?YQIO;&?5?I/]^.A:X0$[P_=%0"?:'ZF)GF"FVACMB<[@W
M-H2'8FU8G+ F+%48"<T1K0@M% ^%5HB7A=1+!D):E?I#>I1[@Y>K+ E>J]H=
MO$VM,_B@>D?(&?6VD-L:K2'O:2P._5ZC)52N/H/:(SYG[M^,!)[E%G<ED5Z'
M'.;[?8QC1Y0VQJ.-L2'&%FMCW+$J)A KHJ.$Y=&)PF!4AJ@_*E_<&UDB61)9
M+>F.;%+JC.A4;H\84&V-6*W6$C&NWA2Q3Z,QXJ1F0\1-S?K(?VO517ZK61OY
MET9ME%R!^B,>L.2XS[X_DT3OKSA_(7OY?@>WNTUQFE@7;X354FNLD#ICN=0/
M ])PH3<^7NB)3Q5UQ66+.^(*)6VQ%4J+8^N5FV/;5!IC>U7K8U:JU<:,:=3$
M[-:LBGE*JS+VNE9%[!O:Y;%?:Y7'_:E9'B?7>)(/.0=>I/^_3NTS])Z',N@Y
M^7XS\[$V40TC2?H82C;'0/)"]"9[HR<Y1.A,CA':DI)$BQ,SQ,V)^9+&Q%*E
M^H0:Y=J$%I7JA![5RH0A]?*$#1IETIV:)0F36L4)5[6+$EXC7Y$_M(H2Y)I$
MXQ'O1M/[T_]?IOX)EE_[LA7G+ZPQ4X"15&4L2]-%7YH)>M+MT9GN@;;T0*$E
M+5)H2I.*ZE/31+6I.>+JU"))94JE<GE*HTII2J=J2<HR]:*4=1H%R3NT9,E'
MM?-2+I-79N6F?,'7W[7R4N2:,V@H>(LYOTW_?X'ZD_FL\UGVC/']ZG36N9EB
M]&;JH#O+&.U9-EB<[8JF+#_49X4)-5FQHJK,9%%%9I:X++- 4I)1KE244:]2
MD-&N*LL84,_+&-7(2=^NE9U^6#LSX]*LS(R7R.=\_YM69H9<*RM=KOF(US@.
M-]GOL]0_K#@#D@'K^'Z8^>AC+%VY6FC-,T)SGA4:\IQ0F^>-JKP0H3PO6BC-
M3105YV:("W/S);+<4J7\W%KEW)Q6U>R</O7,G-4:Z3E;M=*R#VFGYES03LEY
M859*SJ?:*=F_:J5FRQ5H/N)EYOP:M4X5 ON+Z3F+F .^'V#YU<5X%A=HHK'
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MRD:5(V03*N&RXRIALANJ8;*W5</ROU<)R_];)3Q/KOR(Z^SK21G7I$)@/>W
M,M+)K^L94SE?"_G]W")-9!7K(Z/$%*DE=D@I=452J2\22T,A+8U!?&F2$%N:
M*427%H@B2RM%$:7-XK#2I9*0DM5*P27;E8-*CBD'EEQ3"2AY2R6P^%OEP.*_
ME(.*Y(^YK#B/HP783E:3ON+I,Z!J4E@"Y+ L3Z]00TJE+A(KC2&MLD9\]2+$
M5GLAICH(4361B*R1(KPF70BKR1="JLM%0=6-HH#J'K%_]8C$MWJKDD_5$27O
MJBM*WM7_X.LW2MZ5?RKY5,@?<X[]/EP.;";#U.OF:R,I8RF>4T7O74/O6R=!
M;(,VHAL,$=EHCH@F>X0UN2&TR0\AS6$(;HY%8',* IIS!+_F$L&GN4[DU=0I
M\FP:%KLW;1:[-1V2N#9=DK@TO2IQ;?Q*XMKPA\2U7BYQK9M&<4_4WFI>#]0;
M(&U\7TN*:NDY&JC?3.]+FQ36IH'@=CT$=LQ'0,<"^'4N@F^G)WRZ N'=%0FO
MK@1X=F7 O:L KEU5@DM7J^#4M4RTJ&NCR+%SO\BA\SQY2>30\87(H?TWL4.;
M7.S0.LTQ]G-[/=>$.EZ/?&TB%=3.HW9R&Q#32>])V^K7JP2O/FUX]!O"?< <
M;@-V<!EP@?.@#YP&0[!H, 8+!Y/A.)@+A\$RV TVP6:P3U@PN$ZP'MPC6 V>
M$2P'[PF6 Y\*EGV_"):]<I'ETFD.4FN,+"/MI*Z%.:!V)K6E2X#P?L!_&?W_
M,+!H1!T.JW1AOWHN;%=;PF:U Q:L<87U&E]8K0F#Y6@<+$;383Y: +/16IB,
M=F'^Z"K,&YW W-$3F+/F#OD/YJ[Z"7-'Y,+<E=/LI U<T\[KD;3P?7D7KP-J
M)U,[:CD0, )XT"8N6@\L&!/!;+,F3,;U,'_<&/.V6,)XBP/F;G'#G*U^,-H:
M#L.M"3#8F@W]K668O74Q=+<NA\[6<7(4VEN?AO:6]S!K_ ?H;/X3.IOD4VQ>
MRG61FIVDMI?7 FUZ.OL<MPH(60=XC5%_"V"S'3#=20^\1PR]?9K0V:]'YF+6
M?@MH'[ GKM ZX ?- Y'0.) ,]0/Y4#M0 Y4#/5#>OQ:2_7LAVG\.XGTODD\@
MWOLC^6,*Q6?R] T"S>QS&>UY-ON<L(%S<)S^F[K.M*<V^ZA_D/KTQ[J3@.8)
M%:B<U(+XI!Y$)^=".,FB^"2+TE-NA(78*6ZZI[@!G.(%?DKQ84P4.<F.G#Q&
M:.A/T$"?^)(\G&(%<]W)/M?0#LO8YY2M]/_LKS]U70X!MOPS4UIUP]. SCE
M@_Y<Z;(8N*).Z/FOT/-?I2FXRCBNL3B]QN+T.N.XP<WP!C>!&[S0;W"0;[!S
M-^C[KY_EZW/D?;[_<HJ^C;P6-M/_L\\9_)58]C>0?74["=A1TY2:!I<![6N
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M$GOC>4DX[D@2\(PD$S>49+BF5(8K2K6XI-2,BTKM.*^T!&>5E^&,\@A.*6_
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M--G+(3S&Z7,>S_#?3_.O;C!CUZEPC4I/\K]G#V"F5)A?'6;-F)H+F#M7#G,
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MJ"KK9U2!0"EOV*ZRAGTJ:[Q$[L:;5-KX _!S\'?PE=P-"QY<4^?=CW02V-Q
MG@]FP#BO!_"EA_<[>-[2$*+&!HOJ&V)4VYBLFL8,537FJ[*I5!5-U2IO:E99
M<[?<S4,J;5ZLDI;5*FXY7D6MIZFP]2)P@URM#ZJ@]6<\O@N^5&'+@@>7P[>?
M%'Q'$^T EB.1IGD< 3U<;^>QF6OU+8&J:36KJM6NBK8$E;6ER]V6J]+V8I6T
M5ZJXO4%%'1TJ[!B0JV-*!9TKE=]YG/(Z]RJW\Z!RNJY7=M<#X*?*[ORK<CK_
MI=R.!0^,/PN?3OJ]K56:!\O .!@ ': )N51'6ES52=[?%:[2;JN*NV-5U),J
M5T^6"GI<RN\I4UYOK7)[6Y73VZ?LOG%E]<TILV^3,OKVR-EWOM+[KP7WR='_
MG!Q][RB][PLY>Q<\N+"-6(#G.+"JP]@#1!V 7CA;NB@_4JFJ1W+WH?\7A:A@
MP**\@2CE#"8J>S!=68.YRAPL4<90E9Q#34H?ZI9C:$1IPTN5.KQ>*<.[E#Q\
MCI*&KU+B\#U*&'X&O*W$H<^5-+B@9' .7+O@V@#FX)L  Z +WD9X:Y"N90/P
M#TFYH_[*'(N0<]PJQWBLTB92E3J1J90)EY(GRI0T6:?$R78E3 XH?G):<5-K
M%#-U@J*G]H,K%#5YI^R33X,_*VKB4T6/+WAP!ES;2?W7P#<#1D$?O.U(M/I!
MJ0+96CR&]II ?R.C4Y>$*'&I6?%+[8I;FJ#890[%+,M1]+(B12VKDGU9LVRS
MO6!<UMD5BIS=*LOL/IEG#X,C,BU[ OQ>YJ4?R3SSM2PS"]H+UV;C7C P9>P#
M MV4N1EY5@UW"?(H?S'\R).T62EAA9^B5H?)MB92UC71BER3),N\4^;Y/."6
M:;Y.$?,="I\?4MC\4H7,;U3P_,D*FK]0@6MNE/^:AQ2P^A<*7/VN E=]!K[6
M#LJY#KZE8 STCTIMX\3A%&VP1"I8AO9:#C]R,0%]'K5>BMP4K(@M)H5N67AS
MX<V>MK;9H9'!SI[^#@6&V12R)59!6U(4N"53 5M<\M_"L+N%[K6%ZMY"D;:L
M!DC[+4C;XZX!2,G-2+A-Y-2;/@9?:@NUOA),@V&^TH4WC4N\JT)%*Z3L-7B$
M)PDH]BC$M&6;%'%BH()V1LAO9R3A12JVB]1C5QKI!XIS-U//;H:\W83];JIX
M-X9V\\7=^\#WP)U\]FEIYQO@'PP37V@]?+-+O'>(]<](K7/>5:&2M43E1LG!
MUQ.VP[\#_I-0I2CVP--(C4\G#=U'.KJ/U/2,:.E,_#B+%.0LTH#]3(/[&>KV
M$W[[*=A^C.WGR_M1X6?=S&<?!:_RO;^#3[4:SADP3 MT&CN#UM$S*7,>8C4=
MW@2^:C]5,E.,T/V2/U5*.LV03UI^09AT$#\NM!I_#O/^6>P2_+@TSWN+L#$<
M'2;T#E,7AS!X"/5[Z&K>ISTNI3TN>1-\J.4TUP3UW4M]-VVF9U#F@EWPGP+_
M&2CRLR43G,$7P7LIH#I)^4E'P574Q]7(A&LBO#M5KK=+-\23)N''S?AA3)'&
M\K1Q;/HMU,4M)P.,W'Q$N@F)?Q,:YZ:W/3MS!JGOMA/H&92YT-B50WD3X+5=
M3-M?=LR*S(W@%H"(1T1X5TEH7MU%G=Q-G=Q+G=Q'FOX :?N##M_=.DQ##S$$
M/$Q#/[P54!</4Q</W\=UXN*AES5&R';OH0U.ETA E$V3)<%KYV.F&Z0 8T7F
M#M^*S-'5D8=]H%D15-Y5"^..G2>#I*>HDQ_3-L\B'7Z*'R^0IOV,J>A%XO-%
M&OOGNP&5^O.;P/?!DUI$.[?0QA7&G5&7,RI1WBC*:J)\ ??Y.!_U<3PM[XZ4
MY_7=G3I'5TF.GE[RBI_T*^+U=[2-(6>,DUO?)$;?9IKX"YWOG0V  O_U," ^
MW[G7MQLCR'='AL5S5\@"*IQY%E2C4-OT):KS,XWK8RU%K:[4ARB]]U%Z?T?Y
MOHOR_2L:[ATTWMOHOK?0FW]&Y[Z!\GR=QC+NP_@-CO^*JZ_J4[VBA?_<G6*<
M%/J"1XG[^58$_#R[,HP=*E^A^#Y7KCY1&9R-\'7K;QI".T[I313G&RC./VB]
M_@<_?H<?O\:/U_#C%?QX&5W[$KKT1;3C3U'ASZ&CGZ42?\(GGL;[I]#]3\)B
MX$?@B?^S*O*59U=&I-Y3/.7*@*](?Z(N_D>ME*,/WT>P/TWUSWIV9CSG.2'C
M..QOQ_YN[)^*W;,(CPL(D\-ZA$!^B+KX ?]_GQ+?C]7[4.%&[=_CP[W'^/"%
M9U>$/S5FHNZB*$\*9<F%RPU//1P=V%^DQS5*>$P3DK-87J4':9?O:S/VMWMV
M9MR#'W>AP>^D36ZG$]]&7=S".S?AX8VTSO6TZ/7'[,BXWN>#P6_<E?([3XB%
MZL>R4I9XRN&D#"XX*N%HPGX7MA?13<;HFM.ZE7:YA?BX66NQOUDWX,=U^'&-
M3J<ESF4(.41D7,N0<B>U8NQ9^06M]!ZJ_M^>W1@&C-]@-OC_*N_!.,]ZNIJ_
M'J N[B(N;E<R/-F4H02.:NPW8[\+^P.4<!3[4[J,.#V,'X?PXQ+\N!@_+M0>
M'20VSN?_<_GD.5@Y0(V=Y5G#>EMG$.%GR/M;T ;>]_$_19?ZOF_(N86XN(X^
M<C5]Y HYX,F#PPU'+7ZW8+D;^XN(OE$XIG0V?AS C_VTRYG$QS[MH"9.Y=\Y
MVHN')WOVK=Q+#3VM743S3J)N!SUN)_P&_A@N_81AY7X3W#Q>3=>^/-!8* ^'
MST9T)<"3 8\+CG(XZN!HA:,;C@%ZPR@<4Y1\&3RKX%B/W>-U(J^V4_)MU,Q6
MVL.XEV@SO6"3WZ^UR?\#;0SX"BQX\)*QZ&SS+H)?P>-%5N\?"<Z."-#^()/.
M\(O2:7[)VNN?I3T!1=H=4*F=@?7:$=BF$X*ZM3UH0-N"QK0U:%I;@F>U.7B-
M-@5OUH:0G5H?LD]K0R_4?-C56AUVIU:%/:Z5X:]I9<3[6F'Z"BQX\&.&U+L8
MWJ]FJKD0[.?U:4R!)^//'DNP]H1;M#,\5B=$I.GXB%QM,97H.%.5-ID:M='4
MK@WF7JTS#VJM>5SSYAFM-J_42LL&K;"<H#G+:9JU7*"ED5=IQGJ'EEA_J,76
M7VO:]A'X!BQX\$@2TYBQ,315.I#J70W9R;7M^+.5H7:K+4S'66W::$W0.JM3
M\[9\K;&YM<I6HY6V)JVP=6C.WJ=9^["6VJ<T8Y_5XJBUFHXZ7I/1)VLB^ER-
MQ5RNT9@C&HE]5,.QKV@X[@/P#5CPX'ZFE6N<I +@M S2&AZW,,1OQ)]U^#(?
M'Z@U,1:MC(W1\MA4S<9F:VELH6;BRK4XKD[3<2V:BN_21/PBC<>/:31^1B,)
MJS2<L%F#B;LUD'1 BY@$^Y)O46_RP^I-^85Z4MX#_P8+O%[0G9FD!,:.&-*P
MDW(H-X_K>;T&?U;@RQR^+$N.T)(DNZ:3$S69[-1X<I[&DDLTFE*EX90&#:6T
M:3"E5XM2A]6?.J6^M.7J2=N@;L<.=3G.5&?ZI6IWW@1^H#;GBVK+>!=\!19X
MC1*']Q+2C7WYTHE@$UC-ZSFNS^#+-+Y,IH=H/#U2(^FQ&DI/U4!ZEA8Y7>IW
MEJG76:,>9[.ZG9WJREBDCHQQM6<N4UOF.K5FG:#F['UJRKY8C3DW@N^K(><%
M->3^#7S)\P6NH<3AO(!4XY1"E#A8"Y:[X.?:%*GA&/4RG!VH@2RS^K.BU)N=
MJ.YLI[JR\]217:SV[$JUY=2K):=-S3E]:LH=56/>C!KRUJ@^_WC5Y9^FVH(+
M55-PO:I=]ZO*]3QXA^?_ @L>7 W?.:09)QFK0B74 5C*\RFNC>+'$#[V@Y[\
M"'7FV]2>'Z?6_#2UY&>I*=^EQH(R-134J+Z@676N;M6ZAE13.*WJHE6J*MJB
MRN)35%%\4.4EUZJLY#ZY2YX#?^'Y%V!!Y<4H\6)O&KS#C0($*\!B,,:U0=[K
MHUZZ\*>]*%0M118U%46KH2A9=45.U13GJ;JX6%7%E:HL:51%2:<J2@=47CJI
M,O<*N=V;55IVLDK*SE=Q^34J*K]7A>7/@+=X_KF*RQ8\. 37OC+CKBC: 7FR
M#$SR?!CTX4LG[[?RV.0.4KW;K)HRNZK+$E19YE!Y6;;*R@KE+B]7:7F=2BK:
M0+^**\=55#FGPJJ-<E6=I(*J<Y5??97RJN]6;O6/P9L\_TSY50L>7 S7*?!N
M)05>724M 6-@$:^[0"OO-?!86^FOJJH(E5=9Y:Z*56EUBHJK,U547:#"&K=<
M-34JJ&E1?FT/&%5>W3+EUJU73MTN9=>?K:SZ*Y59?Y<RZI\&?^+YI\JJ6_#@
M?.SOJ:8_((U6@"G2X&$>>T$[:  U7*NH0W?4A:JXWJ+"AFBY&A*5WY"NO(9<
MY386*Z>Q4MF-C<IJZE)FTY RFI?(V;Q6Z<TGRM&\7VDMEX,[E-KR)/BCTIH_
M =_*T;2@LVN\=XBM@V-9O7=5:!'H LV@ND$J)RTN0:X4M@0IO]6DG%:;LMOB
ME=F6JHRV+#G;7$IO+Y.CO4YI[>U*[1A02L>TDCM6*ZECNQ([SE1"YV7@B.([
MGU!<Q^N*[_BG$MJ_46+[@LZH]]XAM@:>);Y5H=XF[ZI0 [R5+>3\I,0NI$I.
MIY\RN\*5WATI1T^T4GN2E-+C5')/GI)Z2Y386ZV$WA;%]_8IKF]<L7TK%-.W
M5=%]IRNJ[U+9^VX%C\O6]SO9>S]25._7BNY9T"E-WCO$EL,UZ5L5Z@(MH!9N
M=P?E[T)[(ATSD"JIBX*5-&A6_)!-<4-QBAU*5<Q0EJ*'7(HBD.W##;(-=X$1
M68=G%3FR29:1O3(/7P1NDFGX8?!+F8?>!U_),KB@7?"LIXQ+P2A\?: =-'92
M!]U2,1(^KU_*'$1_#TN)HU+T1)ALDQ99IZ) @B*G'+(PH)FG2D"-3%-MBI@:
M4/C48H5.K57(U"X%3YVGH*EK%3CU@ (G7U#0Y#O@$P5/?*UM<*WRW1TV!+I!
M"V6NA=N]".V)/,H:07\C&1.GI)C%DG5IL$QS)H7/614V%Z/0N62%S&4H:*Y
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M4,DP<1/A53Q,EE@82-?!@M="WS6, F'X_ <6A\"&C:F[;F;WL*>$IEUOL-,
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M/LS(^<@?(#3TF,$>"?NPCT/@\;L.]#YH>:_P-N4=L,42L,7B?\4?AH!&@,9
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MF#4H8 XZ9H]<S" ,L @;,PD/LXD(C"+#K*(&L^@QNY1AAK&#9=R8:?R8;6K
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M;K!\MB)@V0 ,QQTA!ADYJ!>3FC2EP, #!B[EEJR8>D?"SK@G @9^4?:G?U?
M,.938+A?'WV@JV9 ;M ^4^&WKC.ZC<<<-G6\WR0C!77 H 8&)3#(@4$"#"(V
M[9Z 1?^8"QQ_5QW \%'#@(6?-40?Z*P9D!-TO@8,:TU.XW&'59W@-\I)M5I@
M4 &# ABD7/)-$8=RN[28>K>$1?N(S<S\^.\*8[C5&+7PD\:!!SJ"43E!UW2%
MS[;6Y# <=UHP!EF800D,,AZI0UQ"OEG*(=_F%5/N<-C4>T4P+OZN;M1&C.EJ
MBGKS3M. _>T8@_L5I=>ZSFPWG'"6J1,"!F#0 (.\E-@FX9,ZA"6D+CZ7=(L+
M'"S@*(!Q\7?57ALQNA,8NEH&[&^MC<JI=K^B<EO7FVV&DRZ3.C&@!P:5F-@D
M*R6VBOC$&P(>L;.DA-C%!@X&<.3!'/F[:@.&CN:H!1TM4?N::Z/R*EW354[+
MQC*K_I3+J$H,:(%!(28V2H2$UE(!H;V$3^@HYA$ZBX C'SBR.=3;?U>M=1&C
MVX&AO35J7V,PLL#GG*&V6S99RO2GW 9@4 .##!A$0D(+KQ3?QA'@VYG 40 <
M.= OF5S*S;^KEKK(46TM4?-;6Z/VUP<C&![G;(VM;(O%I#_CUJJ2*I5R8E B
M(30(1/@FKA#?P@*.0N#(XQ-N9/&('30>I?/OJKD^<F1+:]0;32V1AX*U$4RG
M8ZZNK&R;5:\[ZU&ID@)R8!!*\?4E$GPC6X1K9@AQ+7FE^-;L4D);AH#83N&3
M;_Q=-39$CFAJC5I0WQ)Y-% 3Q;':W]0;S3ML*MTYCUR=%) H"-5\&;ZV6(JK
M9TAP#7EB7%.V"-],%Q%:J$)B"ZF4W/IW5=\8.;R^-7)134OD"7?5(+ZI?(E1
M9=I=+M.=]X@U2;Y2%;Z2H\#5%,EQP3P9KBX;;$*7X!NHT#\D,:F1("8W_5W5
M-D:,JFF-7.)OB3QK\8\0J:TK3!+3OO)2_04W7YM44:+&^YDJ7&6^$E^=K<#7
MT.6$(!5$EA%K"3)2'4Y*^=NJ:HH8ZV^+7.9JB;RD\[T@$5E7F_GF ^5<PP4G
M1Y?D86OQ%04:O"]'C0_0581*JHI82582JXA*4A5>0:E.5U#_MGS-_2>ZVR-6
M65HC8V4-(XNXSO?5+/,A6Y'IHIUA2'0R]'AWKH[@I6L)%50-T4?6D'Q$#=F/
M5U/\.#75GZ:F_6VY6OM-L=V(6*_NBKK NSF4Q*A;R,JMV"'-L9_1YY3%6W.-
M.$>F@>BBZ4ENLH[D)NK('KR.XL'IJ)YT'<V;JLWXVWKD'CS\9_>(.;\X)FYY
M4/9R8JUTA3P@VFOTEEZP.04I+CN/7&%EDP-E1>0:4P&ESI!+;=1ET9JU&?16
M#36[74W.ZU 1BSJ5!$[77]4SAF<,SQB>,3QC^/\"PR",87:(P3(-8U"$&(3_
MQ5#9S5#?S="BI=/;--2L&RIR7B<P="F(G+^L1YY!PQ]Y1LS^V3D!&*8F!F7+
M%0'Q'F X#PS)KG*,@4.J,K-(M08&N4&73VG6YE+;U%D9-U3TS$XE-?>6@L*\
M+2$7W_RK^LD3/>R19_CLGUTO;'E@G0(,RQ0!R6Z#5W3.YBP%!C[99^&2JDW%
MI#H]D]2D+22WJO,I-U2YM"Y%-OV6C)Y[5TIGW2VE%=_ZJ\(8?O(.G_T(8[!-
M!H9WE0')+F X"PQ)KO)2LJ^,1ZHV<DCU.C:I1<,DMZL8E"Y% ?66+(]^5Y*;
M\[$PAWF/EUE\ZZ_JG][H8?_T#IO]DWL\,+R4&)0#@W2GP2L&!F&2RR8D^<OX
MI!I#":E!RR&UJMGD#@63<DM61+LK*<K\&(MA\ J9]XKSV+?_JG[T#ASVSPJ,
M8=R6!^63$FOD2X%A!S"< 89$ETU$\)M+24$#G]2H+2&UJ3CD+CGX9U@,1,C*
M_+BD*.L3#JOH(R:#??NOZON*@<-^K!@Z^Y^>L5L>V%],K%&\HPK(MAN\DM,V
MIRC!91/C_681*:@O)35I^*1V10FY2\*AW!864^_RV+1[;!;]8P8K[R-&,?O.
M7]5W&(-OZ*Q_>L=L?N"8" Q+E 'YAP:O%!@D<2Z;%.<W2TBU>A&I22D@M4MY
MI$XAEWR+#SYW,?C^#.#(8V?=R^4P[OQ5?>T;,/0'?\RL'[VC@6%"8HWR;65
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M1[\CS<G]6)C-O,>E<VZR,G@WF#1^V]/JC_(AT7^$&*:L_,DP^]0MQ5NYE27
M4'+&[!%<L3F%R>$XB" 4!VG4%I/:5"QRIYQ)O2,-Q4#R/B\I8-YCY13?9&25
MW"C,Y+<]K7Y_PF#%&&8!PR)@V*/S\4Z9/:67;4Y1HOL_XB!-FA)2NY)+N2DM
MIMT5LN@?E3"S/BEF%7W$*"R^E9]7TI&7RVM_6@'#P-_MHZ?^89V\\B?CS# #
M#QCX)\P>T46;4Q+OMDGP?K.85*L7DIK4 M(-60GYIA!\?AZ;>H_%ROBHD)WW
M40&;?3N7P>W(*>#=>%K]9A\<9K"]! PS3MU2+@2&W3I?Z3&31WS.YI3%NFVR
M=+]92J[5AF,0-\3=.1!L#OE.83'U;@X[^VX.AWD[B\WMS&*6W'A:80R_V4=-
M_=TVZ;V?3*^=NJ5:D%?)WZ7SBPZ;O++3-J?RJLNF2O%CN1@J$;%9(B"V"_C$
M#DX)L:N(2[J9RZ'<SN30;V=P\V_1>=S.#&[)C:?5KX[! W]UC)SR>SDPF*>?
MNJF:GU<IV*GS2_:;O*IC5I?NPO^,0;1RP>?'\@_R><3.++ )K81VDUR2?9/,
M*^H@\SDWGE:/'=$#'SM'3/G-/O&]G\I>/753,R^_2KA-%U#L,%88]I>5Z\^%
M8A!*&;%6+"$T\D3X9K80WUI8BF_+^5?\@=)!Y-,[\/R\&W@!H_UI]8LS>L O
MKN%3'CLFO/>39=JIF]HY^572=9I*_7J]Q[+#8M1=\*A",0A"4"#%UW,DN$:&
M&->4"RR90D++D_@#OI36EEZ:W996FO?4^M$]<, C]]#)O[C&K_C)-N54EWYF
M08UFJ:K*L5A39MYK4X/_+U.E!$0*0G6)'!=DRG!U^5)<?;8$WY A)C12H'^(
M,%;Q(FISFHC>G"K*>FI]Y8D:\$]OS.2?/&-6/'*\>*K+^$IAG?UE67GY<H/:
M=- NU5WVB-0I?C[X_FPEKKI0@:O)D>.#F3)\+4W6'7^0DNIQ4DI]FB2C(55"
M?VK=]45$?>\?_-(/OA'+?_2,.WG'.SS+XWY)J;&N-8N-1QT"_54W3YM:P0'?
MGZ'"!_* )4N)K\H NU 4Q!H2B" GU^#DE&":G!9,E6<\M;K\_2,?5@^<]$U5
MS+)O \-/-#9'DG3.66J19:NEQ'3"SC%<<[%U*1ZF%N_-U^ KLL'WIZL)?O#_
M V05,4!2D0($%;D2IZ*$_/A4Y=.K+= _HK,V<N)G#0.7=K1%[7>T1Y%%OGGB
MXK)=%J;I=#G#>-U1:$AQ%H#OGZ,C>#)!-"W12]&&8@ 51"VY@J"A5. T5%^Z
MAN9+^PMJKNK?KZ4A<GQ;:]1B;V?48<6=P3AV_5QFOF^+.,=Y7)-MNV+,+DNR
MYICP]DP#T9FA)[JH6!Z"GAS*0R#H*!Y\. _!DZ;+\*;^!=77].];WQ0Y+G C
M\EW-@^B#G,_'Q69WO4ZF-:_-IP3W%Y,#YTK)%;%2@CM1@7.EJ%,=:=H4.TZ7
M9,?K$\N)AH1RDC'>1C;&V2BF6"L-E&%^6E4'^_>M:HZ89+@;L8SWV_!=>=^]
M?(KV^<+K^+NKT],Z=M-26T[F)#9>+(RKN\:Z%HSG7*E)XEZJ3N%=K$KC7ZC$
M"<Y7$DK/!8BE9P-DX1D_573&3WMJ^>K[199U]IM:^FOTXD+TA?7TQ[-V$[]_
MYWCJP_47$S[;'7?MWM'4B[?/X,]U72*?[KQ..WDCGGZ\/3GS6%MJUM'6].PC
MK?B<PRW$G$,ME-R#S;2\@\T93RU4-RH"U;WT JJ>LPB5+=GYM>"#N$[6'D95
MP26MOR#)5,$@6#P,6KDK+\/AS,ITVS.RO.647)^-F.^WX@H#UC1FI265765)
MYE:7)0EJRA(E-<8$V5/I&<,SAF<,_UL91D:@^DG ,!L8%N_\JG1-7 =[=U%E
MP26=GY%@JBC"63Q,:KFK@.9TY&1XRC,S*VS4;+^5E%MIP1=4EZ47U9A3V4%S
M,K?6E%1::TB4U&D2I<&G$:K'&%Y\ =7,6H3*W][YE7!U? =[%S-0>%'O*XHU
M>9EI6!S$[F107?9\FM>63?=;,S(KR\@YU69"?M"$8]09TUCUQI22!D.RL$&=
M)*Y7)$EKGT:H?D0$:@ &[<Q%J.(M8%@5?Z-X)RO .*_W,:^%8S'%)"P.XBXO
MI%98<VF!LDQZM9F:56LDY=8;\(6-^C16DSZUI%F=4MHL3Q$UB%,D=4\CU( Q
M3 2&&<"P:.=7HO?CVS&&HK-Z'^N*V5N<9'5Q" Y',=E37D3Q6_*I5>9L6M"8
MD5EO(.<TZ0@%+5H<JU6;SFN3IPE:Q&FBQM(T2=W3"#4,[X\:@4$'#,J%.Q^*
M5B:T%^]@!YBG];[B2V8O)\'Z) YB8Y$#9864&E,NM<Z0F=&HHV:U:$CY[6H"
MJT.!*[DAQ@E:!3AA8PE.7/<T0HT8PP1@>"W,('XOH8VS@UW).JD/Q6)*XFPN
M7KK37D+V6HO)E>8B<M"83VG09=-:-!F9[2I*7J>2Q+XI)G([!01^&Y<@;"HF
MB.N?1JAQ&,8P/L2@>K.;87MQ)?NX'HM!>'G7;2Y^JK.<3ZZP<$E5)A:I3L\@
M-VGSJ&VJ+'JG(B/OMI3*OB,@<SNY9'X;FR1L8I+$]4^C$(/IA?&H?CK&L.NA
M>$68H?BHWE=RQN3E7PWGQ922?)8G^2!,<HNZD-*AR,NX)<W._:@TDW67F\'M
M8M'X;0RJL*F0(JY_&OV;X55@6+#KH61Y8AMW&Z>2<UCOXYTR>;$8A##152XD
M^/X5!^&0VI0LRDU94<8]+ ;"S6?=9>9PN@JS>.WY]-+FO Q1P],(-0T-,QB
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MO)'T>.&>M!]6'4O\>NNYZU_LNWKQTZ/Q9S\ZG7SJ[H6T$W>NXH_=BB4<O9E
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M'!X1&Y(8&Q&8EQ0<<"XU(/!&2F# K:3 @#L)@?[WX@)%/3&!HOM1@<*'XID
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M>2[6SX*IYL\2&2:]11Z&SYN9AGW]'D9WAUDF5X8X9JTOO<T;7G(QYP9Y,X&
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M#\*=^T#\OW.'O+V[X.R^G="X?R=<.S"3TO/H^IT($M&#(+X#".(%LQ$*+)#
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M;EM/&;/I<'UC_83:;SM"O8,=HW?BQ]Q:'$<9]4YCC&KG,;>SA#&W,L);^G2
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M')8&V^,R?YX/<M!; SC,9K!SV W6]$-@P3T&ID$GP2A6$0S254"O0 UTSVJ
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M2?Q*V2;Y+GO_K.%"V3F])2<7W,W77'\UTV1O:[+MB;HX9XVS8II140C+*B>
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MEY!",Q<GLNR"8WV=_*)"R%QQ')T5GN7A'GJ610]M8]'#7GHR0D8\W /'&,R
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MA /05<P;?20\,$3*%:-EG#!9SAZS%>RP6,D:JY4ML$G5%.>K&>. AB%NTS3
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MMD(8[2R"L;Y2&!VIB)&I&AA6J(O!U488,-,<?>=:H<]B&_0:X*+G.AYZ;G-
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MQKZ'B-)E8IP1"Q.MV9C(%\9$/PF,BY3#F%05C"S4_!96J?LEI-'P8U"[R?O
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M.3D8W)&#0>TY&# >1M ^I%!V 76=L?X_50;>-<K!HQ9E^*--A_%SFPW[=(M
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M]H8M_P59\I_(QQ_UT3TX=Q1@.N67'Z'\LP!Q=.V!UP'<_P3@4;[5F['O <3
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MLMD>15N&2GE;QLBR-_LKTS>'Z:9LBE,G;$K3Q&[,,XW:4&81OJ'!.F3];-O
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MU9H^+'O]A<63"%_&/@FX'P1\1N_Y7A0]5Z0"KX3IX6:8.:Y&#L:%J#'2Z:A
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MI3;UG&M-ZJNNU6G?.U>E"2<RJ#I-.) !Q/XQVJVG7\1Q'M+_/T/]\_2>QTN
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MKO=JH>^UDJP0:J_E_W"*<VX?+= FZJZ@YOPE0/-2H(Q6-9O:";1&H1N!R5N
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M#8'OF),?6)N?78#?1@#WN3AYP(71@U*:%UYP?[ F#QGD0P;RY[?DYT?4:'M
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M?PB>-( =/\*.I_#'TYZ68/C9,.DY['B> .1Y)OL7C$O2:> 7('B!2KSP O@
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M&+"1'L4?CQ&:7W:5'O=B$29<?#+*$JH]Q0+X5*?T-(W\]&Y @4]?!G_B_:^
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MU$KOQ[7"^]=:YO,/+?4U:XD!G^_Q+IRO$GX\P1+S Z;W\^'2">PYPOL'L>7
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M/*_BD0_U&)Y\%!8#QN_[/"C+;_U<S?_59)>:BN^<J),7[14,5RSUR,#V(KU
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M2ERNDN-*E!17JP2$27S\@&+CERLZ?JLBXX\J(OY6A<5?5FC\[\"7"HLS*]Q
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MK9-/W@%YY=THS[Q+\LC]I3QS/]7L'+.\LBTX!,=Z.$;AF&_- 56!$B/_ S)
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M-*/=3]/;YVE:>[2FMJ?*MCU?IG;^H!T!W[[(^,E?@&!L0_NW/45EB9I:OV(
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MLB4J,$\B( 1A@8TE-+"]! ?UE<"@L>(?-%]\@S:*3^ QL02^+=Z!/_!>$]\
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M1&R-(6Z-WN0W^$-#38K+S^.AGA50.PZY87SVQZV]J*\!N2Y%?Y#9P!K84!Z
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M#HD->4!*8-[U2_WY/4ST3:_"V %<I>2Z1U/"%4QW8K=+=V*+6Y^X 7-9.)&
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M-QQPRV8D\+K-0__?!4'_-@3LF0'T@W. ?7PQ\-56@D!_,T1;[P,>^@2P"1K
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M3(<3*XF@NL$;=+:Y@_%N%[#=[P!NAVW ZZ@E^!\W!\I)4V"<.@^\,X80IV(
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MZ6MM?Y-D;S48ZFPVR'4[/QCG;C"8AM4;+,;IWFS!Z=RZC=4=>.ZNUS_F-E[
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MUT@<\FU60('+6LAG*D%VD-;WM#CC+XE9UC.Q)4[3D77N[T.W>+X-VN;]BC?
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M>.?8'[AG.%]9)[CS]"-^X#[A#RX'_<%I(?]=@S]NO*BU/S]_P ?9^$P4:(M
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M0PG<=BJ#Z[ *4/9M!LH157 YJP8N-]3!^;$&.+_5^.X\J_G5>5[SLS-HSKB
M^K0+J$ZY@,I"_KL&RB82>&[Z]SX(5U,0_(U%P=]N"7#=I<"7@X]9Y!I@I2D
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M.Q=1L/46 ^M0";!,E@2+PF5@7KL<S-I6@MGVE6 Z* VF8ZO = ([M0I,+LF
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MN^VG#7.VWS?,VL*&&3M0_&0'"A_M8=U"P$J)^-][4FX;2$!7X@.&.C^P#(6
M9;,(O%S%@<Z6 H^PE>">+ .N^6N!4K4.7)H5P+ES/3CU;@#'X8W@N'_3O,-1
MY1\.YY6_DF^K?"8_W_R)/+WY _G;YO<.H/S6$93>.,+&UTZP_K7S_P)KO(;_
MWH-0( %K/0E\-_,#5T\0N):BX.LL#MY>RX 9) U><6N GB4_[U&Z_KM[O=)7
MMS;E.=>>S9\I VJS+J/JGYPG-#XZ3VI-._VA_<[IB<XKQRF=YTY?M9^Z@,83
M"J@^<@65AVZP:2%@MQY? ]S>#-QX'-S^ <I\$*0M"$&FHA!(%@=_CV7 ]9/Y
M[A,I]X65NGZ&4;#IHV>EZA2M2>,=M4/[K?L.W==NN_1?4O89/J<<,W[F<LGD
ML?,#T_LN[TS^<9TSO.T.NK>HH'73 S1NT$#U!OU_@:,"O@9KB,#&W1F &SQT
M(Q]$: A I)$(1-@L^1'FNNQ+,%OV(R]$_CTW0>FU3Y;:"U:)]E.O6OW']%:C
M!QY=9O>H?1;_N.^QO.UVR.J6VSGK&V[_V%QU>V-]B?K%_"(=C,][@?XY!NB<
M98+6&29H_@I<\./WDB$"5QK/__D9!+P?<:K\D* O]"/>4FPVUDEJ*HHA^RHL
M0/%I8)3* []4[7]\\PS^8I>;W& UF%]CM%M=\>JQN4@?LCM/WV=_EG;<X33M
MFL-)CV<.QSUG;(\RP>*(-Y@<9H/A(1_0G5@ N.%KX"U-@ #<FI%X+0FX_5/P
M?J1I"\ZFF2YZGV(O^3R1)O,PAK/^3GB8ZHW@!)TK 9E&%_R*S,]RJJPF?9IL
M3WAWD(^Q=CH>9HXX3S F7 XPSE'V,^Y3]C*GG,;8/VQ'.6 QR@63W7Y@B!G\
M"J@R!/#%\T-^]A9>2RK>CZR-I+D<#?ZI7$.1YSG6$@\RW%;=2O96O!H7I'8^
M,EIW,BS%^'APKL7A@%*;@_ZUY/W<5L<Q3K?+'I\!UV'V7O<A]@GJ /LFM<_G
MM5L?]ZM#'P]L^@+ 8F<@F&#&OP(ZGNN'YT?@YDW"_9LI2X!\!>*GHLU\KTIT
M!1\66XC=RG.6OIS)4#R3[*]Z/#Y<]U!T@LEX1(;E6&B!W4APA<-08(-S/Z_=
M=:?_#O?M?B,>V[B'Z5W<R_0.[C-:1\!GE\Y@L.\,!>N.4##?&@JFOP(O/)>'
MY_]\KS7UYST(:<*W8CG"^XJ-Q"=5&OQW*DT772UV7'DVCZYP+).C>C E1'<L
M(<9D)#;%:C JQZXWHL1Q>V@-I2NDQ7UK4+='6^ @O27@@%=3P#E&0\!#1F/(
M)[>F<'!LCL#/L)%@B5G\"IBXNX-P:\7AYLW$W5VX',U6R!!>U<H3[C>HD&[4
M&HF>K[!?<;S80_Y@'GOS:&:@[J[42).^Q$2KGOA,^ZZ8 J?VJ I*:T0CM3&\
M@U87VN=5$[J7615RBED1\@^K,F+:HSH*G&MBP+XZ%JPQRU^!-W[L(4L0)&(Y
MN/]+)=%TS0KTM$D6W6[=0+S<:" R66.[_%"Y^[JQ(M;F77D\G=ZL<./NM#C+
MK<EI=JV)N4Z-\:6N=;&UU*KH-GIYU Y&2>1N5E'$,>^"R#^]BZ+?TTOB?E!*
M$\ !LRE) .M?@0_>AW#<>RD_VWL)^E$ACMXV+$4/MBQ#-]H5B>=:]82/-5@O
MVU_M*C=<QE#I+?+3[LX+,6[/CK%LSDBVJT_-<JI.+G(M3ZRFEL2W>!;$;6/D
MQ@ZSLF,/LS-CK[&SX]]XYB9]<\U/ 4?,-B\%;'X%''P.(A<A2,/M7;@835<O
M1L];%J._.\70E4YYPN16':&)%BNIT7J7M0/5GLH]91RM]J(@H^;\2(NZG$3;
MRJP,Q]*, DIA6@4U+Z71,RNYBYF>-.B=FCC!3DZZS$Y)?L5(3_OJGID!3I@=
M9OLK\,-G(1HW9Z8HFBD1P=TIA/YJ$T$WMBU"YWO6$HYU:0GN;[>0W-7LM&9'
M/4VIH]I'LZ4\P+"N)-R\LC#.MB0_S;$@)Y>2DUU&S<BLIZ=D;&4DIO=[QZ4=
M8,>F76#'9;Q@)&;-N2?G@#-FC]G]"@+P.8@3QNTMA)Y6\*._F@31'QW"Z,H.
M$32Y<S5A8KNZP)XN,XF^=H?572T>&UL;O#7J:_P-*BM#S4K*8FSR2U(<LHJR
M7=(*2MR3\FKI<;EMC.B<7E9$]CYV>,XY=GCN4V94_F=J; &XQ!7@5R(%8/\K
M",)[D"B(9G%[_U--0M=;!-"E;D%TKD\('>M?A?;UJ?(/;3<1W]YE+].^U7U]
M0RM3O:J)JU=2'VR:5Q-EG5F51$ZMR'1.*"MTBRFIID44MWJ%%NU@!A6->0<6
MG<8>,T-*9JGA9> 240;DB%*P_Q6$XGU(X4-/BW%[UY'0Y79^=&8[[O]! 71P
MUPJT>TB%K[??2*QSIZUTTS97A>I.+]62=HYN7FN0<69SA&5*8[Q=?'VZ4U1M
MOFM8=24UJ*J9SJOL87 K]S YE:=8OI4/&/[5,]2 &G )J@%R4#78_PHBA-!\
M!D+WRA"ZUD1$YSKYT/%>W/_#N/]'I=# 'B52]XC^HM8AZQ6U?2[K2G?0E?-Z
MV%H973S#Y(XPL[CV6)O(+:GDD-9<YX#F<C=N4Z.'3],V.JMQMQ>S\807H_&>
MIW?31S>?9G#F-(,]MPGL?@4Q)/0Z%U\#W/\7MA!P>Y+0P0$BVC-*0 /C$JAG
M7)'8MD]'I'[40JILQ'%-_BZ/C1F#++6D/C_=F-X0X_ =T1;!/<DV_MNRR;[=
MI<ZLK@97K\XN=UKGL(='YW$/:N==*KWS(\6K"QR976#'[ 3;7T$B0@^*$+I:
MC]!D)P%-]!+0'MQ^_?L1ZCZR&+4=D2,T'-84+)\P%<\?)Z_*V.<FGSC&4(X>
MY6B$[0[2"QR)-.;N2C1G#V59,P:+[>D#]8[N YW.K@/#+BX#Q[%_7"@#TPYN
M _-VU'ZPQJQ^-8WWX3\5")UKQ?W_L[]Q^_7C]NHZ1$3-D\*H[K0,*I_<S)=_
MTFA1^@F;90G'**NCCG@JAASV4>8="M#@3$3HL XF&'H>R##Q&"\V=QVOLW+>
MWVGCN'^7'7G_<3OR^%U;A_W3UH[[P-)I'Y@Y[0737SW*1^AR'>Y_W-][>Q$:
M&,'S#_Q\#YR$*BX(HJ++4BCW\@9BVB5=H?B+EDLB+CBN"#KOL=KOG+<"^ZR_
M$N-,V&;:F3@-M],9VBZGB_0<)^L,[2<[C6TGATUL3I\PL3Y]W\1F\J.QS2DP
MM#T)^K8G_M>?Y0B=WH+0^':$!H?P_)_OP>/^+#_+AW*O":&4VV*X@^4(T7^I
M\X7^92+,NV4G[GO+;1GS3\8J^DWN6O>;(?*4F[$;G&ZD;R+?*%2QO5&G9G6S
M4]WRYHB&^9\G-<W_?*AA?F-:P_SZ#W7S/T#-_-K_NM" T*%NA';U([1M#YZ/
M^[-\$J&<RR24^)<0BGXB@<*>R!$"GJB2?)\8"#*?6(K2GS@M<7]"6^KRQ&>Y
MXY/ E?9/HF1LGR2OMGJ2M];B2=4ZLZ=M"B9/!Q2-GQU6-'IV0]'PZ3M%P\=?
M%0P?@>)"CG4@-+(3H1Y\#IOQ'I2=1"CK$D+QMX@H]*DP"G@OA3A3<@3FE J)
M-J7+[SIE)NCTP4[$_@-ED<T'+S&K#QQQ\^G@I:;3,5)&T^G+##X6+]?[V+!2
M]],V:>U/>Z2U9DZOTIQYM$KSTP=IS0_S&/R/4;P'._ Y;,'?!^7'\?P+",7^
MB5#@/81\9T00\[LD\OB^AD#YOI'H^$.#9/O#D-_RAX6 V3Q9T'C>5=@ O$3T
MP%=4&X(7:4+,8C7($-L,I4M4H$E\$VP75X*]$AOA+/908@-,8[/_HQ?O0>L8
MGH_/0-9YA&)N(!2 YS.>(T0%8>0"$L@>I G6($\P V6B$6Y^?3 D:8,YGP;8
M\:N""[\*T 24P%MP _ $%2!2:!VD"J^%8N$UT"BR&GI$9&&/B P<%UT%M[#[
M_Z,-GX'*PWC^63S_.D(\/)_^!"&G&83L@!]9@!@R!BFD#S($;5 @J,,FH@IH
M$)5 E[@>C$GR8$G"\4E:#132*J#SK01?OF40PB\)"?P2D,<O#C4"XK!58 GT
M"XC!/FSB?U1-()1]&L__ R%_/)_V%,]^C9#Y/$*&@) .OA;J>!TJ>!T;815!
M =81UL)Z@BPH$Z1!G; <=(A28$24  NB.-@1Q8!"7 2>1&'@D@0A@L0'*202
M%)&(4$LBP%:L^W^ GBH1#-6(8*9& @LMS( /S"P%P,19"(Q8(F 0L@CTDL1
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M:[WX492;U-^A;-D;@4&*5_QCE,]STM3/L/.T3WF7Z1UGUAD>86PQ/N2YS>P
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M.G_\+*#S^*6 SL-O_-H/4.!'(^-G<#7 G$T C>/7?YCR3P/$7*0._B\ CQL
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MGV<6VCYD$=*VR3*X[8A54-M=RY"V]Z;3VM PM WUPMI0=Z('.;0/=!8/C\^
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M'4#[+1<TOPB#VE<)4/ZF (K?U$'NNQ[(?#<#*;0#"9P"8N@+HA@&(I@$0EC
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ME/8;7U':;[BOM%LO*>W6D5Y):Y2S;//#U-])L[J!VBO[_LW*Y/<S!MN \!V
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M)!C53&$Y;'3Q]WAC_#AV'+ZTF(Z/S5SQCFD@7C.+Q5WS=+Q@7HC;%I6X:=&
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MC-LDB:,<9OUWLNX;:-%7K@?:-H[D8&A1DVD/P^F)O7<#SGN 6?L FP.ZF'C
M&!,.C,7XP2FP'G3 N,%Y&#OHBS&#$; :3(;%P7R8'ZR%V<%.F![<#).#1V!\
M\#J,!N_!>/_O,-XGP7BO)(RRE_I;6/>U&X .:M?1#A91,XUZ4?3C?H< 5]KV
M64?IP4_0@].?FIS6@=&0$;&":LB6V,%@R)7X07\H$GI#:= =*H7V4 NTAM9
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M?$Q^)Y(PC+>&YZASD74_$:UY#J@_GFM<+L&6LQRMC$T-?U_BK8<";S/D>D]
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M<?9>%>6<5F'.O2K(?5;YN>^!;WEM4D&.!0_B^SN->2#2SQM),_:0DF^"BZ_
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MVHUU*-S+AQ:E@$AL"^!['L 93%AB1^# Z1;#I1:3!"UBL%\48QED%M&Q+2*
M%W5:'KBT"$$+]R <OKO@&@V?K'48OCML,N/ ,OI&]*['U&7KB<4-]$N@$92
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MM]7I^ 4P_8!GT7LMFN$K#MX+;N3U7E*1K8&D'OAGN<M8+;1WUCP[+PW:!VO
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M 7^03?._@$ECFLBGT+\?G=L&H<5S+>M0YAIGPD+-6J D%=B2VP_WFH8/L">
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MC+D8XTP0X[FPB?H>COFU*M#1B&QC+\I49,] ]ASD+M![YF>CK(8S;[0^&^4
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M1P+R,ZG=0IIB);+KD=R"["[*,@7Y_91G-O*'J8&ER%]+1&Q'QR$=YNXAK#I
MH]E'1.PEFHP390P8ZR^,IRY_)LMRIM>LH6XTKZNR,:_!N -?7#2?@Q&)CB3D
M9U&R(KJK2N37(W\B\CN0/YENLP_Y \@>)C*78<%ZY.^B9H[2K5_@W54L>YG:
M^N=_K<%8(9-Y_N=5:[,SFOR]UF[H/+XX15P<I8W< .\_0)WLA??O4C;V%VD;
M];)%M41A,SK:T=&#CCYTS$;' HWP;YEY5\H!+<(7"RC5?&ITB)8RCVB?BVX#
M\X!QS-#/;2UG@%R>8#D:RNAZ;S0/"0[H=*,\?N@)TSK:R1IX_TKL6$&]+%<Y
MGJ_58MKM(NQ8@!W#U,L\XF,.=V>;5X;L(G*/:[IY!]&CZM4?B>8OS$^!FFK%
M<PPS#].]W\50<S/7X[P_B#T,(91S/%*<T>E!F0+0$TY9XBA+*F7(1D\A>LK1
M4X.>)O2T8\%D],Q ]A"O5J@;*5UXLM.\BN>JVJB/5J+?V'TWBB>]+(]#NV L
M>R05.DA:MA-[-F++2ORR1':4S05]7M1V(-(C*$\\>E+1DXV>0DI?3BNI05<S
M>CJQ9!JR9Q,MAH>,73O[B9ZSJB.R:XGX&OJ*&GJ[&EEV SX4R+##<'^6H?9(
MA&4/S";L64E:M B_S&48G#'. 9UNZ/-!5S!:(M&3@)XT6D<VN@K158ZN.G2U
MJ-:F6S4V,U0U9KXJQZQ6^=C=*AM[2B7C[E;QN%^H:/S?5&3[)3"9\3_HO<C0
M=I(T\ #8QNNUD92?+GX>_IGA06[G/%8==DYJ&>^NIO&^:I@0HKH)4:J=D*!J
MVS15V>:HTJY8Y7:5*K-K5(E]AXKM>U7H,%<%#B/*<]RI7,>3RG:\2UE./U.F
MTSO*=/X*F)0%[D;G>8:UHZ0;>U.-Y\#@ _C^ E+D ?PS#9]T4E]-KA-4X^2L
M2B</E3OYJ=0I5"5.T2IR3E2A<X8*G/.4YURJ7)=:Y;BT*LMEBC)=!I7NNEQI
MKMN5XG9"R6Z7E>3V<R6Z_TU)[E\#DY+!G>@_ Z\^3*JQ$ZZ_GNMRW@^1BDW'
MOAY2Y1;JJY8X*7.W5Z&;J_+=O)3K%J@<MW!EN<4JTSU9&>Y92G<O5)I[I5(\
MFI7LT:TDCUE*\%RB>,\MBO4ZJABO.Q3M_92BO/^J:)^O%>-C4HPWW!]]I^#W
M!TDSMI,*K^6ZA/=STJ]? R)50A\*?<<KV\M9&9[N2O?R5:I7L%*\HI3DE:!$
M[W0E>.<IWJ=,<3X-BO7M5(SO=$7Y+5*DWR:%DY2%^=^F4/\G%!+PED(#OE18
M@,F,6RGWB0+K7J 24LUBRQ+MV?#]J0SY[=A1CQU0.>6%V"C-WT%)?JY*\/-2
MO%^ 8OW"%.,?JVC_9$4%9"LRH$01@;4*#VQ76%"?0H/G*SAX@X*";U! R$7Y
MASPFO] _R3_T"P6$FA088C*?RWL4O7O+K>?!@@6D/+.*H";8T4**7D.,%!.O
MV:2'R6&VB@UV5G2PAR*#?14>' RB%!:2J-"0#(6$%BHXM%I!82T*")\F__ A
M^46LE4_$07E'W"JOR$?D&?E[KI_+.](D'W 674?0OQLNNY'4<P68S^N9W.OF
MLV9LK,)716GP'6(D(6:L(B,<%1;NII!P;P5%!"HP(EP!$7$*B$R3?V2>_*(J
MY!/=+._HR?**F2O/F-7RB-DO]]A;Y!;[D%QB?R>WN,]X;S+C-&6^ 5Z_TZ !
M#=9U*'#]Z=C2A1U-U$\E=55 C*13-W'435B\O0)C7>0?ZR&_6#_YQ(;*.RY:
M7GSH&9<CC_@RT"CWA&ZY)0S*)7$EV"OGI'-R2KHJQZ27N7[">[*V1,9QXVQ@
M=&Z'&JZ;:%F'8OR9N@^NWP%5:^#S"NS,I[Y2\4DT/@E.&R^?9"=Y);G),]E;
M'LE!<D^.E%MR@EQ3,N624BSGU#K0):>T67)(6R[[M%VR2S^M">E7P//@0]FF
M?2N[-)..4_[]I-U;X?9KX--+X/ESVFD3T))V[*K'+V7X))LX2<0G$?@D(-=&
M'EGV<LUTD4NFIYPS_4&8G++BY)B5+H?L0MEEU\@VNUWC<Z9K7,X2C<G99B$.
M.8S,.60).7"+G*]DDVVRG$MC[$<B[5[50YN BLPV]N)T6?;BU.*7(FQ)Q]98
M?!)"_?A G=R*;.58X"S[ G?9%?IJ0F&(QA?&:%QABL84YLFF".Y?9/P8HEX$
M>2[:#,BEBR BA?#NPK\#^&8AN52[Y=E$&^'S([VT"7XRB^L4WD_D?@5^R<5'
MR=1/)/430+UYX!?GJ@FRK732V$H&E4H&ETHZLDH:<"6!6TEG5TD%5E+ RJE@
MV/)@V4HR@@I(40792CE98SD99+E)!XS]2.A=/\.R#F48*C23:S?OZ[&E> K<
MD^_$XI<0ZLH;>UPHGGWS>(UI9D!K@G,W>4J-#"Z-#'B-=":-!&^CL; *@QN[
MP1P""T[1 />OA_O70X3JR-[JOC3/P^SM)Q;0NV:.91W*O"'BD6OK(&9S/Q=;
MDOA../;X420WZLH!F\9VD_QTP^DF,<AWX8LN?-&)+SKQ1:?1P=+A=M+@.C&\
M$T$=*RT;*]HA<6V0LE:X?RLVM)BT"]T;AZWK4*"DLT$WKQOFXP/NIV%/]%SJ
MP-B'@RA'?#1N)@G.3'CE#!*,Z?AB.K[H]_AQ34H?ONBC<^NC/OIP6A^%Z%T*
MR(RF0>JF0A*GO$DG^!\&))-Y+Y!Q)JUQ'LKP"%_CVK*<*EM&6P!Q?!:,79[0
M1">^.PYH%//' %O+FI1A[!C&CB$2H:$(R\+'(1K1/.IC'A4ZCT+-W4JC(U,<
MO$IAWV!@_MR\%L78"W3].I3.=?3-(!\D@5#N>:TA!L$XH.NQV@#^6(4_5F''
M*NQ816RL8L!?Q>"_BKA866[9 &A,N(T@<,51.D+:Y[*7I*7_-)^+LF$]MS=A
M'DVG9PMU@*E%-.64[<0 \ ;.8*RQ]F0'V"E+LKG+^OH'C /$QT[LV(4=NX(
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M(0Z2%L1.TI;82G4B-E(>Q$JJ%^D@'4 LI$.)N4PL:2^32MK)9A(3V5QB+%M
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M66,M4=+81Q0UKR*_(TJ:#409>8TC[SS2#/#95(1]B>Z-WZ-!V!,(RN9CC7:
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M'HX81!S1B1WA-(YP("<XMA-^T0G<WPG$V@G$T FDR1&$P1'!OR,B-@?HX-#
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M%X2YDY3Y)@IS'L8*O-B9?$/4_@G,X0.82S58TSL,$%7@,97HI*_ [%Z@HU2
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MCZ_4\U=4YW5X10&64P#C>Q3@& 70H%<Y*BF PBE:20H@?9@&F%*  S1@##]
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MI-;2@ 0*0,_^)(P"W*4!OA2@E@:XT+60IP!F]%JN'070HH.84 J@0 <QF11
M_#H%N$YK>9'6TIP"L-;%)U. 2S3@BYJ0F)@(+R04$I?38 $:ZBL?W[[&'+0O
MOEEV_TF++]Y:T[\T5=\]U]*3<QNF1_O::A!5@>N/AU.[:S1YPUCVX[+4YLL'
M+JPHYF&D5'-_DF5%Q>-$^#UN/O7\K"K_<Q;!6$5[O3<%.$@#K+]3=: !FM1N
MTL\T0(QF<W3W)R<I@!4-V$4!^M$ F@\FTX %%& 3#9A, 6[3 %80XT@!XFA
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M/S:JIZ4FO\_9\!= >Q,A(OP >F\2$O\)B@5L '^,0F^P)JS.VYX%B.$'!+,
M?OR &2P %6JQMHH0'7[ 374:(,T/J.W,*H(?T##\[P!L4U& 8ZR1\AT_H)HU
M7-.DE;6,6D0!+M-1*?W&JF$1I<4D&E SCL^G%,-H0,/+<<JZ%AV] H8F_)&U
MOUC@)2YE+__N=KC6]*]+=5\^5+]]4UGYIIK_YW?VKIJ9'!<Y9$!?[^X>KAUM
M+=L9\B] >!M3K^WH=?E9+*>G9E[V2Q32F5\)5F!.KP[$LHO@![#7."C !=9:
M#N%_6U3MP (\Y"\BA 6@UI.GL@#4ZL!6<1I +<26L/:*T"_%Z5>DK.6#)71$
M2+^0ND*/#ZQU\YD<?D!;&G";UH(&-!3QQC'YMA9N_4;-V"3@$/:IU'FK-Q\\
M6_J2%;ZTIO^P]/9QV;4+IPN/'-RS8^OFO+S-_&_^"F?$A?AT<;)J9]!6C2,C
MRKB%"A^@3(S5;RB'LF<#^#NO ")5S ?8S0;P!S&/62\XR7)^)?JR -2[8/9J
M#\5 UK$ ??D!YPUI@"ME:6\:8,H/8*^C<"C !M:K' IPV^=O  VSZ.5@&G I
MX&\ #9M^[OR7TK;WBQ&P&7U5IZY]PT:G+5AWX%(+]QM5MEYL]-^1*B\?WKY^
MU:*Y,Z8P)"@F.BHJFC^*B?"R-=20YYM<^;=0IK-Z'K6.PGX%0KT#J7-B 6SY
MM61MTZ#)/WU4C=4OBK3^!E#!)FN4J5AO66G 0N&_ 1RVH %4&/^2]1:%/K._
M2(,"'*, %^GQ(9L"-*QLMH3!:=\]BG5^X6V&MFR;=D[=@T:F+]MU6=#E*"_6
M;3O\Y^U7K0?E6A.3OG]Z7UGQY.&]VS>+;UPO+N-?\KJZ=D[JV)$1(0/Z^O3L
MZN;L:&O5@7\=I=A8D?42A+]\ >LH_("TOP/L9A$M*LHI9^\5H2Z[&,H"4!L@
M9[, U&;T7:R7J-2A_E+6"VGZP%P"#:!WBJ]O1P&HQ9Z&$GJ(L:, #<N;+W&J
MVO9CO41]E*!,B)""KI7GP#%SM_PIX!K)B_&CTQ>LW7WZ]COVL];4FOYWZ=NC
MXC]/'#FP>_N63;DYV5E9:]91MV5,C1S@W=75T=K<U$!;0UE>2I1^P\G>C4:]
MP+RLPP+,Y0/4L0Z2T*<X)K, % /9R@I!J)?%UUGCG"$_X%,T#9"E3)6I0B,H
MP"'69C(*\#R.'HPI0$-.\W"-8]6'==RE/(&KA;BZF4?P^*4'!=PJ=FQ@M_Z1
MXV>LWO5G2^>SBZ\\KF[A46MJ3?]PJJ^KK6.OBKT]O"5[>>:<&5,S4B8FC4M(
M'#\Q@_]E4*6_LW4[?2U5CHQ$4Y!/]4TV.Z Z3A;]_I(&_,D.0?@![^E#.ZR^
M.8>U)98"[&8M]U" 6ZR56-I6?[3A?RY"S_][>C5[JM%IR!2ZA.<IO-%65K]C
MO_C,?0)N7SXZL'VG7L&QDU?LOM+"#LY]:_>?+6OY\OG6U)K^M:GVW8O']^^4
MWBR^?OWZC9([CRJIN],/S4F?,#8V.C(B-&30P*"@0:'#J6._13:Z:AQIOO5:
M?D 5M7^:L+:S3Q6E =0>RWS6.Y!]_(!B^A@(R>('?$FE7F#0>^8:<OE7<\3,
MZ1N[+D7\6B>1M>B3M);^D-6G^=;<AW*&+D%)JP1=P7YZF(:9BT_8N/F;S[6P
M1W-+QO(M1_]R V?KNY'6]!^5RJ^>+3IV^.#^?7OV[CUP^,2%6W3LO"(V,G10
M8%]_G]X]>W3OZ=UG4!2U/6&SB;P$_QKE '[ 57K7/DU1/B;3"RGZE!(YMA1
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M8V6K>OF%9M:^KR7)L@1!X3@X'0%Q[QY\4;(,XF8]WQ/ZPR?YM?F:H_0B>LS
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MZ\L):OA%;<M^:H.:O/ZUU.-_:6*<W[?WIVGCMS51R&[? QLN@KJ@H3[-6YE
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M6"L7^+_@Y>[Z3G4HKDH4-Z<TS86J$P:\]V?ZIYOV6D3]UL>&YEHA8(7GSU.
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M:<6?N]VD9/')FJ:2?6"C]6H_'H'2>P%/ A@UHA_BX^>0[-PW?,<?:_^R\W-
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M_ZB\&V6*: 0PH\FPS=,GB=4NCO&_R&L/X1B.&MGL2W<FB2)?4@!)HK93.&$
M9R&DUEG'S?E5M^B661,G#/Q4)8<4/^,E1/YI(&M1-@FC$BX;*M;&353XWL2&
ML$K=6A$+6V#V#.WV [!-LNNS<*GW9R9@-YF'\&.DJRAUMZ=70]B/6LCEJM*W
MT,=O"1D [G "/UD^!5CYGXMXIC5)%BS.!PAQBDMFT4Y!Z_GN2>;MB@V+Q]-$
M[_&?2E_-U32H4^E@!16^ M^ +?E'R)*M^HQ/TZ#))74Q!VWLI::@>4=).L$I
MOR'5=QQG@H&1T#19:'@BZ:!Y$IE$E]R?.KQTG+(JF,&#"52SG#YG#G_"*$U-
M)#'UIGI<^EN$>_6$U9??-,79)TB /%;<OE8(;M;=0R0<2RJBF&9>8:-RFC@K
M.G_RZ'5;ND;&3O9@TC<]PT\!->*E:W?5XX[QWFCM^26O/FL"'<Z2:^RIIT"8
ME%'5$]M=IP"9!D?CZ.VA7/""]AFMC^\KHUHFME=/ ?(-NA;1.X_/=VHG,TSS
ME$9 -PB@;NZ@+0VD. A:<>\:OR:-1#DJH[Z^R\U:G!19*[ 1$5@;=.Z[844T
MERV2GWP\X-Y0WTG\\$HT9$"SJJ%9+?Y\H]?;'Q">Z@=9,X?<0S:N!2$2>>9O
MCV^$D9NJ7(:<X#YY0OH:\(=RM+?\X^A8%C;Z\.PSXI P [1)"BH<X-ZCR,H$
MX>HIAU=H$F99-O8\"^J@$ UU4LISA JFI^8T6?,E+.MS,2:MO@XU4O^6K'SJ
MH7/6CXR&'1-G+,-XQ7L%GI[!?CV?#,706A-PI@GQ!JE@:M!G+T?=J;E#9Z:"
MBDR6"]TLY'GZFOJZ6S#V*#$"\_T<)+!%&_,-H_GZ\S')FK)'G3PS,,K"MHEZ
MX[#**S.XS,7WT\O/8V7 U^;($SX;MMH!21[8(N3#X9"''D8>8ZMF.:-6H/>3
M+N;S\HG_A2;!6U$77.NS0.MCNDZ:T_\QC_$V"1Y@W\7.\SS#O"G=I./$AL8B
M@LH7AJK>W=R[VRPFA_2UD;!K3O%="!F&="X9/7L&;MI/X\XIW*7=T>WU.]_:
M[W QREGUO#:VHWB,7*QKC8J28$*(EI:EC:U@#:^BIU/\K#"1B:R+S8\QV/P5
MHXAU,C>8>X( 6H-F"+K;Q#4R$5G5-]BA;'?4WYP%%"OM['#\V7&E>\1[NJY?
M>>%MHR-;.OK:-P\EOZ!&]:7)QH4B-%#,I\<58_1 8I^@ $#8-3W#639HZ6/0
MFL'[JZ%[@3%)2T.VSKLHF8^1EJ7@3./AD\K@_'%FI;-*I09F;R!_,'>5SD6_
M7YR+(4D^TX@7-(PA>:<*'5Y]X&=9/C5H"_N)W\Y+$JS2T"J3,,/[S<G)9G%(
M5O'L0<R%*7,JWG->5>"J>;]'TP]I#&/' 0"(R)Z?H*BE&]P?9P:8&ESI0)SO
M(I^9XX^WW!&)%>Q. 68#PGLL;3Q*"_435X2[#5M:!O)BS  X1''=JH'03I_S
M:'OINR8&SB,W=:-?%_\"JV9,OOG(O#8=KI[NIXY"9P)J]_H4K!SJ$[QT%]6:
M[;':PW>V7*L6:RV3@$F6MK[7CR+'[)L5I[R7,JRPZJFP PWX'6>?CC+G5R<O
MC\#A6]]/ 6/4=:> ?N&>%R[ -3>9?L*C^'SAW<ND_U@86+U>WRH+-9:S_<^4
M80@(,;.7&7=,\#HY9@+^#COLW4_9>$1YM+X'=O8;VKHV7;B=.JZQ5D+0F/BK
MO^BH0G?7K\T]A.)0Y-60CZ0P,KT:*&0YO(4WR[X;.=;KW;YEHA IP2.<.N.K
M6=2%"=NL<5.0LC[VB-S8@>BH4<671!(D%J*E#?(FQ[R)A7V\'OX\!6CVY-LW
M>F2A&@4-\]N^A7V?GU.'LWH@WB.? <5<,].**A[8QP%S/+F1ZN=>P%JLGSE"
M B +,=KT4P'5ONUTJ9WD[\=X-QQ24.OI:-C,1,TVIYL?U'CW:R+6J\]-@RO8
MD30_D6\MPY1_6#@L]O-NN\F%UB>WWTA.3I<QAS1[ZVA'QS(-_X:#?&.BTJAR
M\E@CPKZJ'L;/&T@/P+]_#7+G^.>CI'A#X[.%!3ZCF&46.H6+8:E!JT_QE_ZW
M_,XW."1T]J(*;9O#NV"K,Z%.2"8%MD!DOGSTN&?_%G,X*0WO$F2A%&RI#EY9
MG3XW86+082">EJ9S38Q#&6#6Y^+VPH.D9=S>1FZR4[:NZH3U'\*!G\!R'[IZ
MQZ'Z9Z1_1?2$/GM8.GK.1M<VH^F3G:!1VEQTRG'UJD()'R_0T8WKR"CCB/_L
MAA;WZ;)N_=M4?L^!O19KD@_]N*Q[#PM'R"T#?)6&4K&7V32!\GNHC/1A6O4Q
MH+9;?X;__]A+5)LL4_WGKOB/+L S>PFY)3)@?N2V*OEHV/^/<[))/@8[FD3O
MF&8='?\YPPHGR7(#?&RXZ:<,\G7:R;AM%*'7EEKNEB2:DK ^JK<YV[1\0"G:
M%[.!#% _DY"DLIS6E69PP1I179K>GHGG\4?P,I!!/7=QW[A#Z%0B&*'GI961
M]_*W$P[O_O":0&68=?FD*UJ_+N^E/P"'4<6#MG7:DIK6\TP&FWP'9DYJ;D":
M3M3ALR)?H%D/?_G+>I._I&7)8@O.6F+^)M RG!XQ;_VA]Y5U?NM.O+CM)A06
MS??,.R4=^M,[ULQ6@C^H<4M0)OLA ,#<\ZJT-&GDPQF=\(W1JFR*N@900XW4
MP))/C0[]#M $9+UIW.$^/]Z"L8F _F2SZ,,].L=B)YWG-*6Q@3LY6:6FV^K7
MYQ$0QPYVZ",L7O+K[535R?KA>_RV_$@*[_5*/[*#;WS F,WD:KB^F)K"\(4)
MAY]*H/<90KR<;K+=4@7N_/-^&M4>RR15$\M07\XX9DO'MF8 <*VRX5WKMVFO
MX7HZR94_W8F7 W%LB)Z0((9J_&(57JCFH'9? %?:TG8[K2\\TC$XFMQVF,FA
M:(Z-HP\.B)8APC>NF:IVK!EP@$<:-L?-EDR4%R8G^.P[3+0;FM]WFWI/.,P6
M3'Y1I9:(,&"2+:?3[46C1+B#!W4=+XGLF>U"1N@5;'Q04^FJ4^+]1I8(![^'
MOW_B8&LV?J( " 9OH[2AK4^9:;.3VATZUC*%U[0F]C/@=3ZAX*YZAVA!M51!
M]AV'GEA37$G"0UV&+N#^49?%7*JU'51P<LN($%@Z-;+*->P3H#R.Q>FKYW@'
M[9/?,R2Z%L]T9KXSL/C!NG7TQ'O/M2\O(;&5I9=WH_ [T_6JF?O"')>*F@G7
MVK8D0U3[Z>_<C(;Q)NS7#I^<>4L/C '+O]0(_G-S1R@@=U,)G.H3VX$4R6/?
MV U*0!5&&WJMKXH;2B(55<C9%"D#R,*)R-@#<)76K#_"G<K<=#C+)^RGFYE8
M8MP$GFF;@LI9,@6H]$04><][@T,DPT_267D7+FG1WS<^/+8Y^S[DW,Y7H9>9
M<9AK8"6_4XB#*R5#Y!V[.F>P5=5GAD'Z&S^"09^CGN&(&#5^@F=M9-@.\.G7
M:Y35RB3O=I<Y[$=I&Z7&-VCJ3U(G?9[CJ,MGZP3&_G((6<YV8BH_VJ(MPOCM
MWH%4*SF^1_,H<;J= @(VW%(\'(LSNVF;.WQVXJ0 ^!8@"MV89#O416(I+IN^
M15L.0T_;6)+%G0Y[E@L,<2C?7+]F'9D#^[WFDE<OU==M O*YGP*2GI^H_3OW
M^ 4GKFP9;+D^DF?)G^/W(KZA4P1ZJY&/L(NZV7[M0^/-_4_F^</6P19[3I65
MD;9=ZWK".V+I1?;"ASJ\TTI[\O8<2X9Q_C+E[!_A90\K58$HGRK.6"9^%);6
MMFFU4K2?>-?G)."3O5"J)5Q;+?QBOZ^(87-$H):[5#O7R;YISBN7,EKV;%@,
M#"2O[]&1WRUZ-U-Z9OC1 P-=-P<<OS>4QH/0_8D[G[\7+K+*=6Y>Y;?RJ4CR
MP4SD98K6W6I\S$H[)89;MV)0RV?0A;*<&###)'\7B33:E7SKTQ4_(?31GIBS
M'=KDX6$?*9%WC'^0_G(:X^$LCI8,V?3@/C,84OITT+,ZKG50>7H CA"'G:J%
MM%W@94UZM"Q_XSNHRL_G/A+-C"F(;Q<PXY-2RO?3V,,N!3 ^1]S+Q-%9_EDC
M^D-)>+B8\%_S\P@[_<D89<_&<O[A;.AQ9](#FSO5%%.-DHS[1;Z;\;9WN#=/
M?,/ H51N9OO!_&2J1]5*O9S;#)^=SZ.H(JNHHJ+]A,F.L9TLH>Q0>VRUF$E#
M(4QW\R$^,ZS:)NKEB^JBPFHQ2 $YUY!BT@IX7VB!NG$9"^MH;]VH%?%*FQ+:
MJ#KJ3:MC(/S"+)L#X @VJJR;D;/O[.E;Y7-<?*HB#9 Q5B*2N_(DBW#HRK.R
MB0I^LO;V@@AZ ,G-V14:PW=1K5XJ?LH'/%>D*8/Q>UP/]RD8=M4S=TN]6&)%
M=Y*W-816)33XP7+=F8+:\S$GMR5;(KO:G9L_'_U19#L;=M?]!TJTR^\J$#8!
M'ZBO.R:HLX8(+*6C/PI/$HAZ^[&$RY ! &I:X]X-;T)D/ES@$V#-+5S\O'3_
MX:]B8'N_M4R,T,]KY:75ZJ'U25K"82?>[[ZJ89<<*LM*8)7J*=3QWOX!2GPF
M(.IKVK_3:TEBF)!&5)M;T1*IRWNWTPO^0@IY624V]= )=R$Y"6WR>?*' ,(O
M%_3$)6=KE0E=XG=Z$':;S":+$ !LV&\NV&@0Z1>Y;5@]:IV?3:$LM(Z12+,C
MQH/W388J+]4+7<^&A]\1@/MJ1KTM*M%>M/0M"J4!I9?-[ [IUO@K@AQF:,?S
MTJ5?3MF[8P$1O!P4M#]EV^V%5M9*0&5RM)9#<E53L=')/2E%XB.Z-=\#S&^1
M%#&XM;=]W? HK_ < V:=)[(!DE[SALL2A9O%JCX<JWGN]BGO;(:/ 1<^#IJD
ME#SPK$_;42KE5?ZN>%M=DXT-7\I+B2,DH%L-NYQ@MO1<ZZ"MBI>6:)6BB&W^
M1X %G5*MHX>-?5\NW#>_(YO>'X#?IAH&[62+X[@0&QJ4 >S\ZS/R:5\_[4T%
M]784W/=HK^;>MZ4U\/5-^&K3-KUX^Y"')PJ$GH5A-!R2AK4#%8W[*^<[HIH;
MWI&7?ZK\QZ$5)'0&GLW>8/>-3/XRE<:_BFS&A,<6NXW-Q1,#/_2$.+D\V/;.
M)KB_+#X 7XJ, ?\-VJ;0JUUB38*K<F1L8O,%&D!G#@S UHVA2A->K:T+$X!$
MB0PVIBK,D@X.6*ZEIE:27I%S2W4=3N16+\I+YK-)SBC(576N#29GOAK:H[.R
M-RFP]-;R\[05CL!7,BUIWO!OY&R3>09#Y.1_H,G7Y.7<XM S34]@2W#<EU?S
M'M)FDX2<27/R!T.L4[2JJG=[Y/[00="C5+LR-CHRA?.'Z;]^^K56P)8S; P
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M,H?^Z(FRUS]J)^J?"0P69;/SBU'68=_5UL/SN*(K!>/&6*KT1Z@_@RI,O$1
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M8)YYGB"B:S\_L=Q/E%I4[K"K%@UO'B4=';JFUOQU>/CG1L.H]YRZ.AEAIB*
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M^ /H&9D>HF[SW5.:4..:O_^/TP28\)^6F7]OW5G_<'YBQ>4U1IK"G]Y\=B_
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M![!_%I*-G$.FZ>E.T=4RI.2DL*2POR:?D)(^526'?3NROLF&G\/Y%W95^U^
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M[%UCV1?&97B&V.@H;WZ\K$JG[?8P-2/LS>%&6[H14[+&KV;AC%M-XEN47J9
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MIJ-X+%;<;_2FR1*(K".G2XXB1"HR+L82:93:V->:,^Q,OE<1;Y*E7"L#0KQ
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M""JYUG%C+CQL>1-*%U[^&D%#KTF9_IS$&=O(DMRTJ.LP$^M@%+$XS,PC4Y/
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ME2LL1.SG&"EU1Q4::)7?3 D+Z";KV>_61L<\ IR6R:*ZKM4*!JZ.FJLJ\:)
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MT>"V'N*%Z>#0*=2LIT6Q/E1]D>#E5(:!8NCB6C]OI[*&.U(% <MA(U7JP[M
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M=EF.\5CK8?]!BX WCL=H_'PB<XW!<X+S:IW@7O= )P:<>#ZU$=G@5<ST+D]
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M&)D*O5IP6M:T4/,-\)\B;12M09()X+"<C 1XF-&E#_TE&.BBAOX;,OPO!/R
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ME%&UUH-C%Y?J?7Y&IU#X%#>R7$)KMG \$"(I7>?%4^#/-NQOB+$X3#^CS"Y
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M'$7<\^-S@.Y]:XA)5OC/=)^4;9*/D.;@(:GVAA(R^5F-3HDPI;$IB;"'F;S
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M"+!?**=)ED?P3]@)-[C"0B$1+D,&+\^$$-8FR3CI&L_, =-LRZ=F5LWK  [
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M8LJOL1%NSL%8;UGM1&S4-!T85N'%T&8)8KA6GYV +U?1\":'JLWQ05J6F@)
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M#Z5E&+8R4SRB9E2:@(:#R^?:D@=V!@H$4!-^H$3I8OJ0<79VW@]R6HOJ=N
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M/%+'%+<"@4RD2+DL,F7"YI02H]8/C)EYBAV+%#G45IIR/I)9YN8VW,=?<*W
MD!9?= %P*U==L3@KSG9WGUQY8'J(+")F*IUH9FEX+-&P]03D1#>P+G(W(>==
MM47!_67T".#(_[NW)A:A>4F27G&U;037@AX!]DBG]#RT"^E8EF>;.CM*6:I6
MC$B5>;XPQH'>')_0W*^+;'YU$UM_%>PYFWC3&B:'$W%8L*WC"_??!!J%<3__
M0/3\L8QHQOLMSG9N103+0'EP)2VB":2GPO-[AMP/.\VV;'R$'V$;1-P5(T%,
ME^CV%4JRJ';%D;]4(JZ(LHIZ?" PL:4M="(_6 E?Z5Z=Y^$2A:=3#'\F.UPC
M)>/Q#K1O<R=ME-DX"[+!KV%H;!UUIL &< V?C P]>_Q&)]8]V-SKQ*PS[=HE
M_5<KY\W$A_L;CS]H+4N\NT?J8:@+6@EW-KMDZ"ZY&.$P%C-58_M;JA(3M8#=
MIOK:^XC2ESQR5Y;Q^L\C[J+>$M=<SCJ7W.B;F98&B71E7>(VXSJM,KQ-RR#*
MBNM)=U=>Q]?$NQ*-^_F:C:/F\OA6]?61G_L?-.]CK7"C(B7VPX7A2Y)\G[!P
MF]7?!-AJB+'._@O2S&LP.[S&0[X$CNH5U9W_M4*X^2R97E-(\EK(=&L@<ILF
M&T9S.R/%969&!DB9B&T'B'D$X5OL/\9?$U9^2BTQG*68D[#ELNZMXCWG7E3Q
M]P]'B!+D# B++(/6>W5/L#GQM%8_(71J/'8=TS$MW36$<'54%+Z^"?[MMD3V
M!TW58TD@M>4 5')D=K%D<_=X-!*IW+]>*7^P)R-H%J(OTJ\6+NE!>^65?<'?
M6/P'#65!GSQ('OP[82W88F5)Y1Z[42R'W7#/40*'QMN=*M*66#&4!'ZC.@[&
MF*WK=(C=T'5)<0#7>IJ@)Y?KO#DV<ELRAF*!.Q,^SH_]=*TY--@0,;N@W V>
M?U7X!\W"->HNX@-)YVM>XO$MRP:I ^ZI!U.\5>Z^=X7DAN"-2")_*F+NDM_G
M?]'V%E!Q;,_>* D$ET ('ER"NS,0W-V"!X>!P5V#N[N[!7>'X*XS!'=W=_LX
MYUSYW_O>^]Y];ZUOS>KIJM^NGMF]JW;UWMVUJU<V',.> E783XM&L7UU]:]L
M"Y'2J199+]B&6KSZODT78O:T=6-\[@XVW]"<EJ+<I*A-+%=;JB-AP9)60@M!
M?C$G2F2L#/'KS#D1L>):_2">*)+<KX]7GWA.,/,QS355(ZQC?"YRD45M)($[
MG1<K/456RC9SEP,<:J[2?.0JVT@8RW*1OL^"'OH*Y>UN<3%XSB])[<IO-XW?
MGRG-:L]K-DV,+$Q*$U0D^ZO>"E92!V6YN\9 Q;.MVH!6V<[MGD$X05$NO9:*
M-XBIK+Y8=CZ!+D%Y>S*?T*$P(P7C@O0[YN6S?U#Y(;W&,/IG#-[D(R)C-,JD
M\5@BW<)"+H0:Q0(D%CUT5%("$:Y@VX]_OX? [R06 S(FR)409]I=N$BF<(V2
MMZ9CGY@,.B_]K0&4DO/3O0_GT>/@V/Z]9A.F='5R6D_>["Q0< 2W[_[N0?>W
M5U(5T?\- WZ"RU&YP399'MB1&<[<[N6_ATGR%X.7M8XOU*;"$)UGO1!2I-#>
M"HF,'4<PBWYPB?O<+91N$RTCS8EJP*7616*N=9P_DU.0-49UT7=]SHS=1&%B
M:9_M < ,3$[@1/&C+W2:%JQX&6H)SAA5?WPZ?6[=,"=Y'%(BI%2DZ-$(4GXZ
M/?\8F<?6-LL\+C1 8AA=/?A]B\X.BQN)<%E_!TM2")K^JY^8&#X91>!4,2EX
MS9* '9\^]M-:4X18)NPG6I^G&^QFGPI_T\7"/!VX8M(3,Q2>2/1NK [H752K
MHOD]@<"Y^I*=\;U!_@>D;F+]FR%(MSJ=Q3Q)K2U_G_!<,>D[__Q8G2AABI1O
M"@;<;%^,TLE^9D,8/BD"90?82K9LX^CQ^#0Y7>TJ<'=%!8)]W&D0:#FJ%:62
MC^J=2:6TU:FV64TYSWF=/Z5Q4L4,A]9"!J]0&WNY$17,"2B&7D#O[IT.%P^P
M(DF%R6,J?&3(>S3?TPM]RA8@4CBX^X0 N]%&1B\<,FFQ A84)8NAZ>9L-G:T
MBI:U&&9,;./7/..Y#:8LV>!I<Q-X?SZWXUVXB>/\)3Q6CAMGY.KHQPH QW_4
MU;_@YB[=K63[ZP$!J;F4T!\/,3%V"/J!EMDLLL>Z6V8+]&E2DO\/GY 0#DB
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MCOCR'Q O9S>0NZ/T?O:07!*.4;E_%W-[;FR8;K:K^<,=HZ+KYL<RN2KUOO#
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MX=2!'JZ4EEXZXO"'F46I@,OT%LZZPG/)8[@Q E;3 SN;PHS(8Y2S,-!+PCU
MQ.WNQD(MP:J$^,DG62L5^A+O=K.J:/8]GGY]ZI)[8P=;O#F?,!FMFIV;G)N:
MYGN!R!3BNT6;Q*SWL05J#-Y%Z&V%]VI1*/QKDXLTO\0OI*U6VA4R)LU7)]V<
ML"]1V&#XZ@7>1DY,)LA/FU]Y*NGYY@6V\5S\A820 FF-))7NA-)9SZI^Q<0O
M/%)2"(SK#:A];]:]!K0ZA6_5\?DIFF&Z80BD;:PZ)\8!1-T7B%SY#6 ^C-FU
MM'_4&KN(='UX[KG&=_4<E9-7/L6S:9*)ZC AM/\97:-(<D)!4([" C^$BA&<
M2<::+(+GDH$(=S 4]'D+YZF#)$(D(0G&%,U_0D$71198U.*?2^NJ,S]F@SVP
M.7M8Y$9>6,0>/4G *D L7M0W'%GD-YHFMO0YFN&D!=Y6G=KA&K["FG4XQ)<5
M\K(ADM@4J;1(.A5>F+;(*,O;KR]:,DXOF812Y<O H4VJ419!07QEWHZQ,"U.
M<*WA9T;"\P$K+U8?B2U6!V9O@Z3270%(;!4#[6*/#-A)7HU_@D9@((D >[27
M#>^E2I^D_8*[@66,8\CIUP5:J-^=][!3_966J.II[^J8D<F G&)$!\!"&Y-D
M7/)3VN:/Z2T^VF"'TE/Q8/)RN=TZ]S+_D"2$*T(19]2/CD+LT)R\9@)#83]&
M?%VP?J?C)*-@"\$$80;5//+?/EDF?K*\7YZJG]$ZOO63B/<[<X14 C?<LO3F
M7,85MH4VI('NZDU355A^9.!_JP(+1$V-%^"H2C^;1SL:!Y_AL"S0C(,JVZ]>
MMU\-NL&<;@V$QW/$^[C]D3P&%0-!_FTN:M* \2-6\JR>T+/E[7(XTJAPNAVU
MYP4K(.'$P+5!RAF[\DOI&C)Q)* H& -0: E+!.$W]RO=>?$L*";USGDYN#E-
M;T;*<U5K!8:7<I)2$*$_#PF-P05O]5G^D10^Q:C#DU<ZDQ_]2(;W_BQ\$#^$
MN$22N&2?N)2%Y/);*2L1D\)]:-!H/+^1X8Z8?BN&)&D7):*2#,D&<U_QU=&D
MRDQ%UYS-HO^*>G3\S\?^_><(':-C]^2='V,E&A!V $>=51<[E6!%]B 0;>T*
MBRBC4QBYJG%&]LWS<=@KX _94]%U['2E;E$Q+_FT!M9H.V=B17XB]H))"?XQ
M^$3!)?(E51+U.[6@-;VP@A&7O!#>#1 @EM'R\1+!4P)ECBZB9%]!.#]'1W=K
ME^80O]+ZZZ"T9(WL-M$\3)[$@/UV%4XTY,]1-2:==*6V(0M;!!N"@-^LH/[]
MI'B!&LU5SOOR9.I!5@Y:T8*>&^G'#'6S8_LZ]3&M^AA#[;6Z/?C'0Q9)/2WJ
M?<Q+*2V*54;UI75J5DQ]GN0+"0J, 3K?:($7%P<"?I,,<7AR'#:<=9B5[&08
MWREZ,ZSYR"\?8*B.,DM*K)K;XLC(,>_[UQ\\DS2LGC6F3<MDT,2ME$ V8,71
M"COF$CRB+@K*O"C_H?2685CBS_57;KTKIBQ4?H]YZL!CBZ87D;$>Y[MA$[CO
M'*J5)AF%AA29MKBL$(,_0/UE-D2&\^A$L?Q4%YDH85M=27HA)"&PDH"XS!4K
M4Y;>*U3E9C'3G'H>?V#G-@5N(B"\W6Y;E)==UHA;WX*_)WSDJ XKQ[32F$.:
MINJ@=F]:$-].D1-3_YP5,WK2C6:!7\./GI<-SYFO/Y"-,,,_CADC4"8'"9'T
MXR%NH%H*@>:Z;9/\$"I/D>JM'/(N"7?X=KD6Y4Y *T95F1/&:!V,YQ"39CRC
M!9[Q'<0VC3!/]]R/5%$ *OY+L!FKFE^PK_J6] 7GN^9B3G:8G('=?JZ!CQ1F
M"&YQP$F\X+@P?2N-3\CL[\KB:+B-GO*.9H\ZAW6"Z=]EYGZH"X;3:D:2\$D4
M2B4P1\,,!])V/=&%\P8/?G,FBO_9LJN .91O@_I=1AP3ORBVZ@\]O7XZ=0_Z
MV=X>>BE...5\-7R9,QXOZ0A+&A?Y-:R>8_1&M$N_FQR"(GYR6)G&H-\WKV^M
M:*-&??F)88.X=W [F$-?>3_0HJHFJWP@QT>2V/YJ@XO"FXJ"_$F*1<0Q1:C(
M3;.ZO=,*)PW0)-$QB,VU/;;CA*W_'!T/1" $3G;E#Z(#L=R<];4&_4E."/K]
M=4:,A?AM=?=,;LBZ&J-W31'>T[]+^>@TSBOXU !-*K?18RF]U*A"N0TN^/ 5
MXAE\)="*<V+TK%#:9#"&=5>JU/O0F$.KNY3VF-C.)_LN'P_>+K@[-[_KMV!4
M8K9'/?1V\0?=V ^?R2FIF1?[;)LY2BI^F;1SW-/:?B@8SE )H7'IRIH7^>NA
M&U:&(%"01+SD3C)V0[S3A6!6AMJD\@-AT*T)P:Q^19!-F@LURHAH(984QEHS
MNMX Y<MVI?RGOY;@/8S:B:QKA/8',EQ\CQ^J&\&F9Z7K3K00$*R<!R69W^ "
M,3-XE3+$$7"DWC9RU[/HOS86<*]XSO-BT:#1S!<.=[P?CHG;I#V(H*Y4P]@-
M"<O.)#U\N1V?AH@>GZ#!:-KJY,G>H6-A.9TF,)=*TI'ZN]MF/5/BIU:D^IYC
M 2' >WD%W5^ ]Q+H!Y\..O50WJIL#:ZI)$O0=.0-'^DFOS'!7'*CJV:%5410
MP<B#IH?-T_$ 0#,GGO?V&O.3Z-,UD'8!J67;HSY^-T'EHM),;'!"LOU%Q/+(
M^TWW6R**L&"V>@Q1%M"CBSR8_!H/'4V9!8(=#?Z6!WEB<R-:[E2LR$A%PI43
MC]%H4LI+\%KKC2:=J_TJX0_Q(4,/W'.'^>8,%RWH$MX;8&B/@1JJB!8KA9"=
MJ(_3U@=[-@]$^5&!8PBO3\K/B_Y34EJ4\H7-EI&-%$N#K!*N DG<I&F/F?=!
MA2AI4Y+R1][7@3J%FU#"&>&%8G=5-&#.L0H@-^A?(;.<8\Q_AZ8$F2'<L-BX
M8H!??P-PN"+(X:VI=WMOUG,K\$<^!RC8;$4L/&+<C^[\!1*\Z#_<HY'/'G@A
M88'0')ZM9COJT??3*6:0YH)&Z,(E!'5'AAR0GAR7PE]-\YALT0SA_K'1G0C$
M<QI]28 KZCU@@Y<L7@R5)-@B)RB':V4^&76O)3P:>"/"_Y/((]P;:/D7XA^9
MEO^085(:M8^NVF)14$(1>!\E_-AI_VST8+%,D2IDPA6M)A=-*PXWEH@Z;[A3
M 5UG0]/5]X&_ !K@SGXJ\W<5DDE943@2)0<BO@WZ."N)&-Z+^8L?>/GI0O;^
MB>W&\D=KSX%=9@M*D\[/G7QR>-/<8]8A%7A]QUO*#[R14[]UV69:3,IP(9AM
M4;*_([KC5>CE)8G ))Y- 9/U43YZ5D$W&"!X'\%;Z!8A8GR6WM\D/_!FOZLM
M+S6>_!^#!Q B/V%,&\V\2XW[;>C_%T= R25CD[S.W/T7&X$VP+AE_?N; !E8
M>'9B\LZ1_XO,%9-HMH!(8-=[.1]^H]AUF"R&EQ:XL(C.+V_FRQ9K@A" <S-"
M.&^X2.=N'&59?9P(J!EH^/Y?(426-RA#J?%/\@CIS2'ALN%BF;LCM.4@KDNY
M*/M[?7@"""H0COV]1D'_/FF\X)ADY!L'G>HS_FV7V#Z:>Y!@"_4?X'= D,$>
M<MW9H-\K5%P7<S8+GNM'XA\C5:U_I2KIT'W/MRCP5ZU8^+R8>P-]1MXT]5^U
M^;?&_[M^_T/U;T4(T5*<&S%^%V?!_BY;@K.CMKB^].+P$!Q22'!7,@NX[M$1
M+P#+3['"IS'<+X)BFNTLRV\/4UN"X4*Y>#*<O&WF(#I;GZ)8@&%B35CAA\^]
MD\7\T[N;)*MT^K_LN=DR+[DH:824^?>WJ6S^:;D<:C*X[97UBV-P57!X/0*]
MM&)A3E#;#HODF2-ZRB;G,MX-40[ASSKF@T][FA_5 L60ATA$T(1@-:&OP6-B
M(LB!^8+&V8S$B^FD6II)O@9DZ9*V!)1(S4_(1)5$*5B!NFUNODQ2$/3[<S/X
M*])+\JS8SSD8]0C\Q%DDQ9)[")JW:-7Y0'OMR;8W$UMJ$GV:EE=]A?J<E4(K
MM+X.JYF8BO'FJTPD/SS]CC828)(2W&._D$3A"@X3(H5@A2(PDB?ZBY>0U]$+
M10F2=\;]9D$?2?2[9&684)(2$@3"M]5MD(GYYZ)^<(6&^-9#IDW<7(O;(+I
M1O:DE!NF"@,U;:JUAMUWQ2'3&F9(36)<#G@''H1&;BEN19!VB3K^=T4I,<ED
M!#SH7BK^,'YD"(QD\F@V@R0\_C$<\MS]7CP M!-M=K-F\RG- "K%;A$I,D5T
M/$D1-PY!A,G!*Q@Q!,U8B4$J!2\CR1EJ1GID7%?R>O+L0:Q"$3&CV,D0?BGY
M6.G@[<R0,]6G<J?#;%96&#=4,L(?;3Z9>0IY$""*&#O$-GF#?TS&HIAUM@%W
MC_S%&R&HV?37%\1P(VX:@@)4I2!JX?B<887MKW;QW%+_,\#/-KP[/C!D=VS5
MYZTWCDB>I6+*4X!2!5VA+V'<H %BV6%R/;#E@CCL!PB:T&K9;:UH$U7!N!&"
MA'[*'TK06)%K?U, 1M7][A=.R.OAMMC?C$5!M,1\2XSM ES[]^NR2##;,ODI
M7(S*WU-^_?>58T__?PBDY +HRSOR-Z/H7V+#HR Q#*DEVH_ QV-C,_,N% #C
M<;!9FLV]0LG\)S-5G6<H%AB!@O<FIX7H"8\FQ9X5@""2WY+Y 3O+Q(<PGYT,
MX8)0[-.>;D!NF#RC$.DD82CY?@XZ#B0<W<D,("0 %NOP!N5-OMS5G-(M"](%
MH1D E#X=?/RT)UI"7$=V)<"6 I2D1[I#!R(IX_D1"_&2&BYD+09?/:X?SA.*
M0VEBK"E+24RZO2?\.9 -0=]#OL;S!;PC_/GT"(][.)<(J5JRDXCY&APU<51#
M+_XN$IH E@O9!F>-^;?ASX'_SOI*1O]' 6P<8_M86S[,V <*V+]O^&;.[39P
M'__KG=]_N1=\BQ+-G2\XA*@W'R*7/9N]P?S/NY?(",2XPFUQ_G<LQJB9U!,=
M<2VXUC\83^+1/T,0VR1C# [-^9M.",/8.T(?XSNU+%6W:/M9!;UAS7-T0O\
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MZW,+.\1^5[VD4S>'4MZR9+E;@79.!'YXH0]<MF946ZRO:S8:>X4Z4$+Q!C<
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M5=L_@6+]*Y:W:Q63.\.+Z> *;6YNCG>;&W'<91YBZJSQ \ZYVE\O(MZZU*X
MTV#'[*3Y62H*+_MC%+CO"'0]+_TKA.LY*$*5ZW"K0*3FSOAKM%IM9+>\<T[9
M%ZX&A':-C496[D<!P:BU&\[^<%;\"B+RKH$A&Y\+;6*/)'@BBFZXH2J?"TMB
MCS1X(LI_F']*_F)L_AOSGV)_EWQA^,@O[1\5NTZV-2=QSX#Q8Z^J$::]*0B
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M,3Y6Z69^M0X]'1F?552&!6Q-BU%3Q13U'E.I.8CE]G!R.2SZ>Y Q;,--*^;
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M)U^)SEIEQ%...$$,;XV"3N;1EFN(6D4$G)0$G&*1_OJ.R]?>L9P+:B47<)+
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MA,&[]N/D\N=F_#8E^G;.;J$M4:)!JC[.S$U9?-4X_-Q0<=3Z(C5C+#UL5@O
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M/9FNX'$:V"?E!#Y:W4BM#IGK*#GGDWU<66%EN@D11)67#],'647+"?9#8[*
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M6K2DK3I51>R@5^9E2$3LPJ7CJX[ED,;"1HE: XO?HYOSBLNN[1*UZS?7*R+
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MA1J B2?T6?H7>Z)""?QK3-X_.6,+/Y%+F_!5'W+5LV !-9C+]N)[V:YNW)G
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MP&I*!^LJG+YH#(]J(R$PO9-+V$Q2*0WGX,SRJ^,M"?Y\]0FSKJRC#U&'])W
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M*E[7>@_TY!*2>G[) LL_L7#8/;E-"*6VW-6:I[M[N7:M/-?&H+!K7QCF+\*
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MI54##-JM#@^L[LAS)<ZSRA,ZJ^JQ PMLT!7L,NNKH^3QN,"2C!+9C".3#0T
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MEDN.X;D?KR+_'YY8)D 248<_P/S_XP.,^Y?K&ZY_L^DY^CT]F3L=;>)=0IM
M.&0#3F$Q+MM3WLC*C(=&R18C:OB>'@\5%?#VE!LCITJG[>7 RAA;1.,].1<-
MVZ]^D]ZJG_Y-5?5O%A*W&Y"S#NS:@%YQ:K(#/P*QC34'.L-2] $IVVP0P^L@
MLR/KKUX3\$Y</8AI#\8$C@5;:/16$@@QA3_'JG?WQNWJ=;RA\3=2L1 ?!-J<
M+B4&I.3+.17$O#L/" L89#Z# MJ%Z?S1DN7H1)O?-!D,-LHARBEF:9:*_+2
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M4[#,<[>4E2K9 ('4,?EL^ ,L%F>4!XZ@7=].T/4_Q(S)A.!DX.#XHP0](5%
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MO86. 3T*?(>J24U15)G$K]QJ3JWP_XY!VE3_\G(J#;Q_E2J4S$JD9DL4V-Q
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M' )9L)V,QCX ,7J,P,VMQFT-]*!YS8U1I#V0'9831>S]S'7REGE81D([D$!
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M'&=8=:ZB2<KSW26YEWM>\=LV(H>[%#Z;1.%"8RLYD0[3,:)N;LIRO^?43MK
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M!7$$XWWP#W6QB0Z'YNFH@W&G#)'8(PB03)AI)_[EAI0PD\#&(H\97#IO4LA
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M_.A/-5Q/T*S#@E"6]2!?HH5F8K]4%V!@?D@8?IZUW%3G"U4D(38(BSJ5:FK
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M=92V ?*QDM7L4>8+)![7*DU*U!_J'Y=L7530A^"+ G C6-;WN>L^4C)R+9:
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M_4UKZ6T]]2W9E=_\P3_OIJG/'%_U+(L'Y[+:-=Q1V[2_[NG'IXSZ^EM_U,F
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M$:M7?/)9LDM^1&!?\.3'3UGWT?E3AK11T6^Z#4V/1I\\6.$A:$B%X%)R$J)
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M'<NB_QWF#H%GQS'Y*-(@J>@G6%&\HT>['R75QGFUS*--M:<9I%8KUG63+7>
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M7T66+9D,AH$JII]'PS==)XF!2A:A&<2>GMU])MTV1T9CC7_!&OV!JTT%X.D
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M?;Y]IF:77^M<[IU\U(0=UO)Q&XI3Z"B](2JL9CF9(&7H* =ZDZ!,@*&[/7(
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MXEXW%]3PR/$ES<CG>V6BF][Y\: DIVO='SRPKC?JTC56[]BO<>[R=R>C4J\
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MZY^<PN'U]%<2/+\P4;9M,9)H*0G_NY"@[M+2 .6L'+@IW0*L8>RB/2QWS+0
M]II&=/O\$3IG)&S=%UMR^(,%RK(8;W_N<J.)3"YE!:'Z52"]KXJQ_N^V*I!=
MH+OY]XM>98[]E1%(-8KNN8E/'U)@_!^BH HK]O:L=3(CCW8Z4H'G:G!AN#!]
M9D9XE9JM<97QGX.W3],;8\T=:\Y8AHK"<,/EA?2ZNYI2XM43:SZLJH-70GO6
MV[7Q#>,2L0X3V_WKZRNC/0*_+IV\+XL-S1!T&BACEHM#;P8%)_4^N\BUQ@F*
MZC*$-L0GC@/VV(IY)^7$?-F?CNPRG41[WI,/;QT)S,6KLQ G0-CCXL"Z;^\!
MBM(=GXG\]2O*JKR[SIWTM0R-C-@K>= *@F\0J+WH9>U'++F/M(N+X@R^^*WE
MR2?XGZ^NC6 30.@;.61RQ16OU<'!.S#Q-S"V5X"6R(8I20/D2+SXDWU%PW0)
M!RGK;-P7I_.<ZG4WPA.D6167@HQE%6M\N].]6,STA;PKR\[ ]<I "6,CJ)H
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MCVO(8]QA3/"&C+@YKON6%13-)B;78U-P9ZC#W<5,!#_/4.=Z;'/F&*+@ZQ+
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MFA)Y)ZC+6Y50I:9;7"(=;PPY>URT9I>>A#[WH9WJ"ZWWR\:_"+A.MI09FIL
M4S2)G?X"FL;![1N_0MI@+'-;LS-_ >V/M8D$["?A)$6H?G3:;RGJXZ'JG @:
MM3KD 'S*,\M\&1HH2NU(K@N?Y.GW%X6CVQ]@GFR/,?+4W@NR+H?3_J;DM2>\
MRE , U<4UO7"G7[N8X5(:\EQMN=$U^>$N\_?C]3WE;P0)1"%+MB>!#8=B+(&
M2D^>5SK"-16*)L+'\^1,_LS[E^Z>/@+S8\@#FH52=T\G[(3J2_GCX&$J?/+
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MP8,8R.M;;G>9N8QAU5=2#D@0YRT7>>,SI0Y$.P<I*LQ9C0X'<!$RK3!!!13
M"]!'K?:A.DD<+PD)-TH,IP?WTH*:U.C;YYCNJ4[9E3W3V31IW)L ^L_UE=_4
M*(^O9#-<NH\-'=+[MQDGF8\JQ?$IV4A7#VN(BH_V;'AA1'=37F)Q)TITA&Z
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M;(&F02R;"1SSEO?BW]["%U;DX90[1QYW Z1Y4OG-[2W"\#(2G:_?*2NC^VY
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MDAJ5MA2)G>/A) !7FSA/4CCP/99)'F&AIZ_[ _-JG7!&P-3Q(_I6W.0<!.Y
M0[S^\W-\:\X[:-6J5OY^SO1W^4,/:IN8H7XK^L3IS3MX(PP%7'GM#G[Z Y!R
MWM:"],Q*S([9.V]Y' 5F?OK2.*3[]2A%7>0T[%>A7UFFRG(D"IR8%YH/GVL1
MO$J"N=4Z.0J9)-70(1 M+6RC<+L([_HK.I'[-4<BL3Y$;L*]ADN&,M<T;G95
MDM"EB)E,UL^N,8[PN2OQ('^B#JX8 &6D&BDJQ]!:##_.Z$1T.P[^DHPY$@-D
MUF:VH&\T4^,+*:VHBAW_8@ V!Q?TVX9L5< 8E@2[XBUPG<58NXDE'W\&'/N+
MS12WE8\>P+:2<,6I,WN7IG3\A:$_68^D4%OA]O-@5S4C70HRN?C.5&/*TK!7
M4/*>W- 'B'MNSW/G^@.X2\F."0*96JAGJH\,(_'^RHNA 'K:V*+?XL2$-_N.
M5+!=HF>?"BD[U689O1+5NMR*&4U1#^A6INF3%VN/KG0\S<>.PO8ZNPI6RDS<
M<K77K'OEDXH,.U[UWB_TA;UNMW*$0N;D5KW)J[X9U#Y)NR_.-V:PT&1'(.!,
M2N_#5-[P-C]<57I)LVM(6HOQI+WW_V[!=!6R4S(%=Y>I7ZTF&4&"\Q=P[O%T
M-6AU7SG,/^71KUSGG 4-XOXB+H[K='UPS^3Y<]!$"DW.I8MVPC[KAZ@E0F"@
M):X_-^..A;< 9OF9.)D+>P;/G9+PL\RL=Y;V=,\'F@;R*:$:IC;"(PLZ.2_X
MQO0^W/_ZV=\612CT C;.=Q_3*ON)75%KEHCN%SUZ*31].'Z\H>3*39./J#MC
M0&L<&F.HBD+WC2N'[!.NB4GOV01I#A/ZT&.4U4!W^V=L^Z4"0!AI?E3>P;34
M06YW[SW8HFOR=:L[4T7IY6"<K=DZ-4F.!-^/!'Z>8/J9<' .YM)@"O-SJ<;Q
MU-4\$04ARI%T4%*2F_I]&,II<NHU L70RQQ/D04?NE*GPE6^0^YJ$<!PA-^%
M.-;04 /<-6\MTBEW+'ODTH,$IF(4,# C&B_!69F^#!_1%@OT>EX5NB!2' 2+
M0MZ(A;ILI5&$6R'MOKZ/.%7M]4=IC)W'M<0N+2X=48O4GY-)X#@62M@?!TOH
M+UR7C&42:RV]JOUM/AD_!C)7L/F1^WAVN9O&3]Y:8H+Z^H.UP55\[3-E.59C
MMM*'X-0 FJY$T?R?Y(NM&.$;\=52!_'=%OB!# GDO48]#>01AR16UH0W]8X7
M3E5PYIU'W_X"_%(/W-P(4GK6Z('XV*C@%I_+VDY3+;C]URO'/(G]TJ[R!][K
M( +*&;!S_,A\,XBFFLNUA;1E&&[8G]O\7U7^PC-N-N=1BF&3&,"=P_M(,I04
M;-Z%\LA1 34V[DFQ*D E%<:_:V!!\ ?B[IY[) 5U2@&2O).Z'+$DG6,8F*J+
M!X@-@O[L/,^0\" 9HVH=2:0KB3)J+J*78B&('N]WS&_"4]X[TK"&9D\CWC10
M86&^@:V<1\"R6[IWIS5".NF5;YSHEZ+=E\[J<^EEV0I1%XM_U-!==BYH @A-
M^VK.V0_N/!XHCCLM_NAE?!@[H0B]-8Q8<J'Y"Q#Z'&@71"<]LWD)'A+>@+^?
M\!=$_?.,4AYWUV_B^]PUN'/+:'/E9HJ<VG81BY$DZ.L,*R-Y,$V96WY56W;F
M$U_OVO:KDSKC\T"W5Q5&5Y9)?:*+ZX;Y9 -'X;$:(U1W_H452XKN+V#-:B7H
MLG_7U?.=H=SL[&GT&ZW^1ZP80%"0Q).SVHBE.X@;7IJ=/D4Q.)M\%JZ\FKOC
M"7:OS2X0Y9Z =3C/%RGD5"[AN:*"!?1Q3.GO:^6 W561^)%H\)Y_">29Q I.
MY5*&FG[UUV;'JU.BR:DF\<('7 O?>NV#0LK1G46C2&C<16KG\F7F?AS.NE<[
M77+\:Q3;7"Z"5JQ<6T=(:<&(%S@<;+@  E,='^B[K/.RE3JMD_6O]4F66^B$
MN9Y;ED:%/%X.EIHO"VS,S\UT%V^PC=[!N2ZGP?G+S@I.Y7JQ$]\?M94"5J.C
M2<4;/KWAYBBB(2<!I?4H)K\8O RR#NM%YC<+V@!RG&N..3N[D'[%[MN;VIXL
M8=*J]-_AJXA6R,I W[J'M>%+H^Z, N7.9@76'WYQ_3,0(Y&S=)W5NI,:<HV;
MAQF.F6BUN1B#E4P<$T**W"]LCH=?VA(88Z+DK5,;>4FT>MIVK-ROZ7$:8[S*
MV-?V%]V?QS?]L,_^Y(D2.O( 38#LC=T;&TZVM=6G7BZ&-Z=?V%O83<W;8P48
M5.5TI\:,4[U!" D?$7)(^.HP>%L,O*&0#?=MQ,-XF<EZI*R%(C@SXNXKBN2V
MP?:/Z:VK\#K<8D*W!S89) 0YW(05V&B2G C=LQ2B" 3:)F>>#S,8K(;?PP$G
M0N+0*TS$GW6QK*O)[?LK<5\''/NM19"I'^JBGDD$E]R2*"4A!=L0Q1OEV/I3
ML %E)"^Q9N=C36 $423GOD?E&=%R<-X[K%\[_)++8+</]^G=S#M00^2CRP?)
M2)Q$SK\ TA(/T&8HL1K?S&Z"E.3I)?O!RZ0\=HT?R!]P\WY7"2#!G)B,"MHZ
M+]Q$LFBV#5#/GGJDKBO$DT+&2S)[>UKW<FI74:+N-!_,]X]2!XN]N2W/>6 M
M=5=<%N]TR&PV-S&_.](VX]B?],;0MNYU:;"E3>TA>%MA;@Y)3,^525<'(YS$
M]W<,N(+(2GT?<S8Z88)FWMKP>HD?O0#Z61O2>M"FI*'CJZ580Z=-?J2J+"SJ
MQ$7WA>$ [H VDY#+Q@4\?YV53(A,GXN7DEN &^T,QA*W0LKBFJ&!+8IP)/<;
MPE5WWO.1'9SMY\[$)X(R!RD2]LC*3C6DOLR&.NV0JUP_Y\\0B[[+#R#TY,E$
MY@UC5@\6W,76%,^Z2>LRBE0K'L-'UOF/+DT)RX^<O:@G\+DW>)%8OO3/J67F
M6)"1!4-[5K;T+Y(&CY90H9T8(T;G\Q_"/ZK6YX>##RNQ(WO*(S7W96ZM8-9/
M<51>3*M"S_D2Y6 ]%ND3- ]-C.R397_H%Q+^$#Q@)P_><@T2O5(D)36;]C]R
M3>A<AD,!K6[DHC+?:4*Y&YV/!V]>YZ#CXFC)C%25BPV_U[V^2&>4Y0UU8GOJ
M'DOB6+W6XY$G1 98/5#S&_EP6#S5BHI-\6/$D1!14')"0"_&FF9"C2!&ST%W
M+U^"IRP\M7@[X0]5[OW7I/*QQDU= VRFRUP[T8L$S/#!*%"&=)TN?V('EH:P
M.W4(NNL[XJ /O!W4&G7'"S4E-63+5[CLZ\^F18)D\FM&"NZ5\U[FPED%I!GX
M:=X:9XB/C/R(V5;\Z,0M .$_-Q\\'MMG7 *GUS.:W=P\AZQ:4C-/WLW<M86<
MK7A#+B7'?-$X-CP0<E;4&M)']3*85YL+*#EJU?M@V!!3$\7ER8D$6WXFB-&C
M8&]WDU_O3G>6W)2N0A%LFP#?=M;?W\.K#P;B0M]'=ANXXKV71B^);G;"+<I6
M,-SBU:/&G.CUU1S:"R)/?1H2[3:_7#_C]2$G^)T3OWIZ_FXU1%"BZU7'F/"[
M06=_SA;NZF9FH0INZG& H<*.!Y7=8^C^)U2.G?2(9MED%%O%8\U< YT7_\9N
M3;P?$Z<X =Q/"&:?0B.(,JG*Y Y?7_ZC/=[\LZGO_>>I9!A"X'_T45C:I4=7
MIR[G#SAEM!(3.XO_P?^W W,=*U&4@:C_6(A?WWU@E)1*FDI=I+W%"$G)D@$_
M_Q:XT&.>-[?3_.U1K\<>,/6POQ%/_4/!;\TB6VIBEZH^]%/(_E/-X?]/5?U.
M_FNJ3(0$5 GX6ZNV:(?D8,ENE?E; X-MU2Z78_[^?L7\\NAIB(9H1+4*GA3J
M B#J(Y>XNE]SX&.2??3_ 6E EK^^T2OF;BUC6K0$\K1 53GCJ/YL5AEVYC!O
MNVEI;-V4]8*#JB?G5EJ&'*IZ!BW[]]PXR;2^=HKVW9Q6UNTRD5J=)_A=5AYV
M&V7N<8][[V:61[BM8+9N!I3SF!YC3G9J%,77K.GOH'>:X[*2:[DH6(X@ #(*
M.84 X#@N(MP[M2-=[W: /?./-(IQ4<W)RFOA 5DD&EE-".8CV1ZQMDW2UNX;
MNU%SNN^R=3S/.AH>M&L;=41^>7X@L0,'8]C,EGW*LY";:V)TO<NN0GG Y?Q$
MX(.=B3B'=-KFDM[RWD66&:)BCQNAJK*PS!!S!&$[A=_7B@[YP1$ D!8]PC49
MN@X"4#.2,9$5=!IU*BQ>KR[C2>_1KB^V>(56Q=J%2K#)5E!+"+BE*C[-D ]Y
M[E]&7^K'NF?[)*@H"Q SZ<0W\Q62.3B4-0.;]LEWN7>'<TMMEVF2,7-G W]L
MFU@E:5%$C-"#)F:@JJUZP?U:[;M5M#W:D@>VDLD2B.D@H^H^<S-Q+DER>L6K
MGB;NW/KFV6ZU7&UW;#[V GS6(R[2,]5QX&H%=<6G>38)WMMPLI4FAEC-&5D-
M00<+O%OLTL/>HPJ&TO\ V<3::,ZC(@$U(%<A2I-*&\VO;=UNH8=TN&EEMX7*
MJSN3\U: 5U$4  IE2F6(>\-SN]O%>W%J+GT69#VA9A4+JKQ(X'A7G&8/JL]&
M2RW[89)&FB*Z6N$)SDI^,O+RE2"<U;#13()(9%*.C<&5A0J?#AN].Q1EMHOB
MTBT'F\X/2.7Y*>S-W6AO;A-GN)TN9;-96$+S("JNR5TE@#2M.;F'LP[IM<TE
MO>6\BRPS1,4>-T-596&8(.8(Q/N^[SR7-[<R-+-/,Q=Y'<U9F8YDD\2?>FX_
M1F_JQ[UI$I8C/J@G%#^Q%,3[)>,'N(E95KQI2JGRX>VF!5T8@@^YB.,%F)H
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MU =+W'X GX<5CL;51^4[GY,96UB/#VG\K'VEK9'P,X_SCC[;;X'^C<%?C4X
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M AM8X+.RB&2HJQ1H/ * 8,<,[7LP^;; ,/KDA?(3@Q[':16J<CR$ROX1YJ_
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MTN(SFJHM*!N0\E?-5A3%E'ZI;4;;LUG(#-D.VNUJ-6MC4BM,B:GAP'4Q:_\
M$;ZLT5KD0J=SAC%&( IK('*M*-T#\AJE6R/*/:#:N[ELTTN1=^$<:GYSL<@/
MA/  G$>Y[N%W'>11NU=?LHC_ ,FAY1^,V?*-/#'I&[3!&8=2-<Y'^BOX>'.<
M/:V+^A6I! 1#]HX_*<<*\PITDXTL=*]'X<58Y^ZW?T)/S<>/W5=QV6YDMIU^
M=&>(YF' CH(IA-N[Y(MM/D!=1@]DWTUS*GI%5^B,=E<+%=6<R@C@Z,#P((^
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MM6X8V;;O6!!Z3M%S.(66E5#ODA8?BZJ5IG3, FF+?:]FCCA@A51&BY(B**
M<@ % .088/3JFN399X8.-5 10Y@CIP9X&TSJP9:5'#P\^'L=JFCCW2VE-S;,
MXU%G5:-'7B W.O*!4$98N=BWF%H+VTE>*:)Z55E-",LO&,N;#]]>]VUF[5.V
M%9GTQ$4HFGCGJJ.>N8S44E79;:&"WBB)$5244O0 5&6HY<.'"H%,6^RW+0K
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MJ X3201IY"!YIY:>+'ZMVPN-I1PZF04D<TRU9\!7(<GQ^[".,%G8@  5))X
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M!F+=/]#.( !YH:*^TKJ8+&@#06L:9#3OP -14 59?I;!SCT'5SWENT7 ,<%
M>U"(W%@-:WAS3KGU7E@(9=SWC]BDHYAPKOU%1P3HF%J4F,S@>PTN:S',DZ!V
M*?\9+@QOOVF+;GM'KU*+#I1@TCO+5S3A5P51XD[8ZQ&_T::LGOI4Y5Y=+XNM
M+(?OCRZ.[&@[].2QH:B&7^89OQX<L_O<^M-QSQ_ 4V,'=1*/_3$#IK3YX0C1
M,S?Z:D3'?3#<GH'B]I(STI FUR5TR3TT85:[B@4R^\X[,!BWR5?4ZYV"LP)U
M3K*Z\>,2(?458"Y(AL'DIZO_PIXUQ_E@R2UF>*#5-,PS=QLJ6YT]GD3\&&2A
MF!<T? M:,8?V*RDQ$=$SLB58CY9<,>9U=/2$1K9HK4D)%TM)7#^.ECRGA\ +
MA>KOJ/ADNW+PP4F&0V&\6D,H\J="BS@[#Q:FG\.1C4QK\J-#R(MB1/?>O\,H
M7PHP5S+X/7Q"(?>*MU">&@*"_B!24/*#^))%87Z_BHE\LA6/4.,\\Y"E@7GN
MMYN83CJP)4%5R$^#"(,^,$VH\-NH^WA;96P*LA>A^;8LSSH+;"WH&G@LUUD#
M-#K@9 KV\S&-NR9YUF=IN4(/O>"4M)G9%/B._[D%K]95@=8E#R^6D9 $O6C*
M4$*Z&TS#!U]'@O:6&(;B1 M(SFUC-14V75=DM96S?FVXN,@; /4OP9#\8Y)#
MU/./R2#7^7:0OP<6]U.K/EQ_*Y+[#:B<X-X5@LS$)2)CIB94QAH%"L2/Y^_)
M6"JL^(C-HM,33OB7>);PGF<X/=F*-7BOQT$YC-3GVS&_V"_?7O^[']!%)+JC
M2Q>MW<]\MW;'PWZ/T*1V70DY=\!T(6/5=C^C^#AP$G;IQ 5[V<8U_I3,9 >[
M YRBUK+'N0/_M%UX^5[<=U>+5"\V?FI,\TJ0OQJGIE/ M%"A!;;6\@PP;ER(
MG+NG1CNK#FXDCMC)Z<<795*5<0/! MG5I]#1/'/YW_G5Z:%A&)W3<3P/N 0(
M&L+N9KPVG,Q'(_Z#QISO)"]OS3:',F/@F2]C],(9O.N[M$AL8L'H\BCIR((W
MX3V\P[Z.0W;-FX"VKY=XNHU4V'7UEW&"6$'O=>9CIAUG&.)K OTX^6ZY1]((
M:"->XBKN682YU3P[[H(Z& WNC RTO\T_Q $9*W"DXXS]:UKM3;9U>/8:_][L
MW\A]O[%HUEI4[F'</'5Y_LZ_7/++]"LF'5DH2&+(1$X5>:E]/C$M-' ,4WU'
M&C[-<PS 9<TED,":BG8-'N@]FP6QZDZRN(.'C*&RAORUJL89  E;&0<-9?;L
MP8'U\*24.I_+81Q0S=62\O?$-._OAA7JU9G$:"Z&/1F+B=KN/RDBHN*GRTEC
M)/X AE/C>MS*,1OUBRN.:3)^ B7<?Q(BALQ'#=_]@BA;AZ38?(]-BR31L[\E
MYUA#JQJ!LW>[L<C?9&^'VB?B:VI3B0F,KXP(N9&2?X-&8ZP*?5N)D_D3(=0#
M.[OC'GDJ=+O9^S+?D_E/SW8[YF_4_J@V_O(&> S;?M$\WA0XK_LT[\'FG^HV
MNSZ]3'U;412 0E598 \]'U^S&FH1'OO6HG7K-R;WCBZG@0"[<RK?KN*29&=-
M63;0(VA"AI<*&1WWDU/72L:.^U[>21KK9+QBZ-=37H1T HA:=\TEMP%N""UF
MA)D]ZB5HJ$?CI\X4BR5"8.+7.J R-N?YK@E1>HGIP'092 ENCIR+ N _:_B%
MS*46LE&-=X,E)R *L/Z*S-YF!,!;F"&,=4A3Y+58\$Z>S>/PXAK^Y#^Q0?G)
M.'WRF#(Y*D_LHO0;C#AL+5P?<P9K.@-^!X<#JZ>_NOX#1-4;;R.*G0F+59G_
M,'1P&HX$DL;95AWZ\\.2S%'5WPXEWJ4L/<#M8E"T[?V:R,>XQLG+O?6=_+8Q
MHJL] DWW1D+RQSWZT):5./:8S*3!/F,L?$29<CTV-.*XIH5BX.7U*'4BZHTK
M9,"C\&/3E9DTQKVF%LOK*Q%K7*N8=QG/J%K#"D>A21#_GX8'[MROTRIVL3P<
MR5-^4;YIWME=@O$&9[_9" ]#XRS^L'V+06'X<)&:I7OL1",\1I)!?A 0>#PV
MY0?]\GKH^&*X;_,&F!)X YRFBQVWGO%P5'OE* D=G!7][A![U_6-\;WOYK2(
MB+ZI)@Y'HCK0ADVEPZ31ISRQQ!I8&JMPE0S[J"7 $$)1$MPL8%%,*#;C_?-[
MWL=8.MV<I<%M"19<>R!Y1[D [P-(]=L^18_%&71GQ/]R0Z14Q*, [(4J'O&B
MAU# I;7[1=^K"ZDFC9?,1_X-("=@EA?J4?#D?]MY(5C#FJL%L6.[TE]OU^8I
M-%\?GURH5"N3ZQ.,[!YM787AR7C@C:QXSBMK$]"%<I2%#$3[8E^L&>D;":QA
MAK'J:Q*P6:40L02B)P#J)1[(3']_D21]NHH:71=()=5NQO,)#O9Y#!)*[M%;
M<?;K:QW&)3(MP:U.5H^&Q#.4B2%]=O;9CFZM\2Q8A^*_)D(LS1<J)%Y)A@RD
MUITX(T-]!K7JON5^WK50S"I"]W[9Q63D7R;^ T=,T1)%C U8?.0"00/+]W'S
MAT+ KNLYUW/^F.I6<0L'R)%-_(1#,*)K35E*6W;%/]PGR[]\A8GMJ:TDO^.A
M1_R2XYK%C8BUY1V6#ZLI(36W9+^/',)MD>V2]0XJX+>D3@SB&XD1BDJ,23^K
M5"4<4L&MI/V@%?D]+.:.VKN!II/4V/6ROZU]-N>9Y0??.U6D*I\"FS/;3,D3
M<A=3TI9O/?LDOKEESR0?:1+0M+_]@C)2JE+P#;>]IU:R\L&07=R9'VL9NPU)
MX_3M]7UH2^;S*.6'._I'W5) L=]M :YMK[7@YC? $5G G5*^VZ8OE.<04<$&
M33SVP_+M"9S>;Y!H'D-)=\RN_'$<1W, F2PSC.%4(^FQCUR/X#YUQ!C,L,U=
MRZ)-">(EMI4O8"@>B'_?K86%F5,0M#L0)9DA=@FMHV@9<GV-Y.0VZ"KJA;O-
M)Q(TO;!;HI^N"?[P!F I-@X8Q0C&_N0[\6!]0;"B/N1H=X+J:$(8[1G50C\/
M8?)IY/C);(XYUX*I'6MHX)[$@EJ+(R  W8(9F\X\)"N1!\/D,P!1J#^+^&;%
M#'<>X@.RE"@OJ@ED8[#7=\-4UDX162K'.K'RM1%D%W)7?A!-]GR<I\UV3^3(
MZ%5,?&_?"MQ4)'41RN[M'<YRJ.W:(.%PM"Y6(K#@^=6/9=]3$*O(6VTC?W:.
M6Y*GI[__B?!__EUG.#EAV"B^)CSIQL4#^SY1T2*,)9X_D^EL*"5,ITZJN,8&
M*FH*XS)TNF2N6O^,T5"#1N5 -G:&Y,IG50JDAHK[. LR/6B1/BE"9U$LZ1[7
M^254LRXK:X5V:.#ULP!"R1'M]0;)TYA)%>[0\S%9"6_/.LG9:VUTUW9"G,W-
M^GDR=_@P$;]EN0[-EOJUS.Q1[<.#H8?R+BVE@"9([K!KH$V@/S<+P/V8FMF4
MSJX:J[[K.7N<HO9\$/+?;@":.%GZ7/7?R25R(5U]R>"L4Z&U>OK(PC@\-"^S
M1%I+9&WAG$Z7WN4MCIU-KUT9[Z,-3*W?Y.X#F!$2OSY$D/<H9/?ZU^79.9ZG
MC+M9\#IXQ,H9[-G#V_*R+/%5H@3O.\#ZCJ[E''Q=&N7G4K$)0H[2,%EW48@2
MO<2N_VXH>9&JT6\D]("-3D 7I;12^NI(I,V,P.;W>NWW*]S1K'8,:7=.)><1
ML4KX)<F$/N$VJB06;GT7A)!;'!L^C1%VRTA)[))<P_VO.9W,T4X77E\=,FO+
M&N).LDX2<T246-ZATZ!KH- [&%]NKF\?=H0M.=)W+-F/U5>22!"Z@U4;#R!I
M-YO0[).RSNY;K_>:GR;>-UM7H)&2+KKM?WM]P+FSH=J/>X9A6&Q"65'-S9K8
MOLPTR8\:QR]](DW1B]8.U(LC^\M125.OO7G^'#TS4"&'=RUG^EDPGIYGT$B-
ML=11SS!KX1='KJ%W<9R<8=0U;L8AO+:=2MFL3<FF<6@UWM87<$BBA92]JT9F
MK3;Q63>4#@T8HBEVV,6')P2 ES"@T63-++H"+A([]!TIL']/8JCV*>@0Y,(?
MDT_HM )V&;M32GMMUNY*;1DHSBN4+"F0HP(+HG#G7 1K^WY[)+LE]1O+O'=T
M+BRS;67YV8@<VG33X7J])^1[B  SZHG 7(@\C*5UY=4?_M**D'NGFUJ HLHI
M<K[9G7WOF.W1U=0FE\80\>L[[6G)UPA,&$'8#E'K3.VFWY-1A*.A=DIK,TU?
MR6YV=91-GGY^5S=!\J0=.=<8Z6%J24VTEF94<,Z:KWH5&L@6L =N/R.5R!,*
MF?W)EVMS.9>%'<CM0F,_9"M**N8H/2-N6-R/C.&:,]O#/P@QRK'0CM&_2?YL
M9XQ65X6?@&V,2BW!W'^],\[(V:RL[@+A5K8ZTR. ^$7E\&^$U,BX+'!7"M7Q
MWHO(=S5I)8=A:D9Q/5#[-'2[GQOEMG8CUU-.'9-<Z\C-0]*_G:=7NO=%N\@]
MR4/4\](,X^%]Z]9>)J!/K2.S;X ,QS? $H??S(B<"<]V2WK\&T#(O? IJB/>
M6K;&DVBLQ$V!T_@-0%"?3.(;/-A38A,:^6U^E(!R!6@5VA$S%T9XZ;H# UNK
MPW^4XVQM67^&6#D&6"ZW*\^92"7+*HZJ*PK1%%Q.HOEMQ:9W/3NVQ-$J.+.S
MF<FZHBV0RJBKP/'M2X#? '\XWP#=7-=G1+K/.K=5EFV]4 GY4UF=6#7+,5L6
M $I<FF'6UL/GKRKOE_''G9E(8N7MU'VTKU!2WOGUNG#,62)A"_QBE/'>@FT:
MZ&OS9 *H0Q(1P:,^@H[)W63LN;=$,GL=[=#:HE0RPZ.Z"F+*!+!-BU?6R JX
MT4%IQ,%W3-,[FLTR6%-".\';*DWDA]LF1;+C>FG6O7OJV9?==AL-8FKN6.T$
MG \/,FEXNC(?4N*H8P8@<8\4S%[.!,/84A-HE+1I@K&Y[Y7MW*]EA8NSS]]Y
MIP8^Y#X\]SF?JA*A0DQ66>*2;+DI(9L5J4<-C6>U%F,H24*_6AE":C84:'DU
MP1R''>=8_(NP!27:K74B:PM-A?..Y-ANA[L0-),])M*M0SKWE*9JGD)K62O0
M?"@CC[V*&V1FB,>A?<VF+XUZHXB!&=];MM1\@2O;:8U6AN&W>]M"5Q(.B#"W
MG_8J0@=XJ@^"^J]9V7+6TAF $M7@A7&$:&F$WLD+DQLZ7<4R>R!J5>Q+TH0A
M[$*B/A<D;0W0]5G2%+1HHWU&:,HGPANU22WLVG1"JI8/BVGXSDZ/HP*?%R:D
M5*UG6Q894ES(,C%ACTK+)3F%&]OLNR4U2W]8+>U.(D-GNU:8D+J[S*) SGL$
M*??<>ZYF/Y*WF.F5L9X?O;:+A?I#R4>_-M)Q?;S2RUSF&BJ5)J+$Q"CQQ$=>
M)L>OX'<PO*IUJQ/POW1B7]^8=2SRLO?88K#-C5]@41@F0ZHH(>K>:!P6+L9<
M1UDJ$W2Z7==:<'1\'56OP!L;%!HG+^"%E^/$-%Z#/1_MNCEZHF:1.%G:9A!A
MJ4[E4FMC!I)8#;$Y_]BJ?0-P-YJ_'H>\@+XIO)YW_/USU1K0\^.>,_;F>4-\
M*<?Q93)*U@B571<F/U#4LR!20>=ZHC.9K3&R0E@3ZMA.DC:Q]S&7H^E.MSC7
M.!AGA_']@R; &GK8WA61)[V."OT3MRJZ!B.MG=B8A6)HV#)X)01B\6'/+0*8
MM898;"*?-[>4F+XP]%C-')E%DM9KLXR0*A#JYJ!6ULHX&%.>70@F;BD[678@
M4P_08E?Q,7\96RRMEKGI<(,=(O&S%U/A%,O%-C^GMM\Y1/=N.VXYUYP-7_Q:
MOE_!(5# :YQ#9T8?25G4IS#NM(I-LLOH[FEGFQHI279DIDL>SE%ZN8?NBZV/
MD.CIM&8*-KO&<LU5B")-A,R!O;JI/C+-1%UW>ZC[@;@^T"5G<P,5Q*[*.5O@
M9!R&X/=@K22A(\;"O>L9^N'HP2YMB9=E_JO5EOM!Q&>'* 4WSTGZ$XOM&^K]
M_9?+O#%_')9>B00IZOB77!/)(IA'6\)K "=FZ&\ C$W/69CN]E*=0,#?(>?7
M2C>8QGH_OQ(K"_6Q-1_"9+1*&A16R[[7KE9,BD1%)"AZ0%KRH)DBGD :>:#.
MG=_!/Q42GQV%3;DC,>3HEB_0<HD;WEYF+!?XK"0.2\__]]K21%>@=0^L&0^V
M!]XU.TE>VN^4^0ECN.%+T"\KB=%%JONT#_.@KN)3PT9J_N'%&]F1L"0T<GQG
MA- /^L%21R1C]7JZ[OS$V[[3S>^6!=\;FGOLG*"S28Y*_UH$BD%0R*6WQ(UX
M59,WJ!,%H)ZX][8R<H[T:(NR5GJJ>;H,50QK(@WL=!LTSY"&+?HL[]LLTL(L
M"=ZQT\_A[R[(/EU_]K(_GP)/,U'4X&D6"2L&EJLC5@-:B[%8):N4C.Q$<6R:
M%U;22SWLEHZ*,%M%U*_G96T2^,@^?\O#4<H*$]P4M&E/,\58TDXC%(Z3V9,_
M@M\/N)/CNU8CM_Z\]+,CU4J=]9['TD.+J[9:CQ8S"&IA+FOTVT7R-1&\50]#
MN5DA$M^H#Z@2@JT\/,>?AG=!K(_JS<'\G<>%-)*7HD#]IFU:0_J[#%W@M=0P
M_IV!Z/&W"7OL36[$ "DPQ83/?%-'O1#_T$7O&AK?S1I9-O4=T]G5[P@*.CPT
MFA:@$#F?YOFS5%<2B?)[ZF"A8)%O1A=M?DN->1.GN&",(<0%HIBHD%(G)?28
M?FK\,6ZQBRW]XI8-+YWN,/U40WZ%"N("/?J@&DN-6(=T<B.GY0H3S^<#G\H;
MBT02?JK=5$J@=+N^[,+&+ V$P"'3QDT&H20YFB(WKMC.$1,QSG0:?F4'TO*>
MO>0S5,VVY')1(E$NIA1%@;AMZXOZ^%/3F0*7N@I-HB+19&;+2@:>7VRV[48*
MQ*6![[HZBH?DP*ZEX8"%,CPK<P_K:2K$V:-W[ IWDK(,]9L]W,A-VVIATN$'
MI>\ZA(P-B59F*,(ZU+YD1&M?2QEN/7-3KB@3:97ACOB^R?48OIM3ZYN8;W@<
M(PG.)P;L>P&N?+D"SKF?R6[-[D*G&VD+BK7V1M:^2LXS+":&C&OG:08 00]N
M.F+Q#FUC=7^##E/A*R]#06)Q O4/Z:^0J[X W_"GYMCNGG6%YNXFHJ>3A+3W
M(!D?EKH2M^/IV#@,&?9?#W9>'Q#HE0):Z&XP*W>IP4(;>PE!]/M0Z"<<5A*=
MV2O<..H+2W"UDV^SXL*4G(%%G&ZL!4KBUZQX8>%+XEY8OH? &,F9)=<XV+>V
M5>BF922423C2PI2/G%O0QW?O]&;<C\4H)=;"%$(;8PF8/><_LG=(M060]5/'
MLEH#Q=<LA!JL^&B= X/%BRA'AO5_GG.@I*TK_Z_F G6YT)Y<Z4IU+&*\HB'-
MB N>5MO96[&2EO[@$(ER4%"T,JCPU&$7SXEIIZX !(QTTGB8NI;@F(U5*<;1
M889WS('OF81VE*AQF7<KCOS)/=.9%X$D;I33R$A+_86/U3%_+#@H82M)AQJI
M7[D6VIDGH7KIR,P\3E)<H 3U:\H E[H/?:V.O%*_:;@.K/A1)K@=>HQ>-J>8
MF<C70^WV=F-G+65^8KJE?P\85UB1W--%@)R/^OGN,QQT!_WH:"NM'92CC!@\
M&2^V,)YV&]UV#K@?^W$*?H!NOS1Q/N7XW3^\ ;Y$OY93^?6^ : T;X#*83*/
M7E]6[R2Z17OWHE#"DP+(#P^1LQ4%*T?/] I'.OWM%ODM;LV)O93$IG)2F_B^
MK?^^*04L[E^T_WBV_'PG]'Q^\;KV_D55[-GW#= F\P;0BA;[Y<5<ES?B5X:Q
M(NC*%K\.O)&UU='63*S3WC=^J1LUDRU]'RF"[1'<E!_$W0G;F:\]9TP42Y N
MWRW#Z6!3NHD@EM<[BGD9%L [Z5F/B@,;^S<$6D;QDA?S1L5]MIY]+CV^LR%Z
MV;OX]-X-:KQ16\6>)0LC+Q:53]PG**(T7,XT0VAW#J34<G9,?P/4@&"C7[KS
M'*LL5HU+>!0<@5]XX?II:8>1L<C<^'G2N]HUGV1*$J.S1:+4QQ&2D O')K2K
ML<$:B92C7IZ^2SAPO0:Y.,A$I]:%QR@RJ(?#5XY)0)5.4TD+VL+"LQQ@7.N^
M+%K)327U@2J;[UI#A](S6IIW9%V27E0#(EX-2PT+2TF,VF;=E9)MMLEPL%PP
MAC:E XIZW=.F5 *3M#TM PBM;@F,'B2V]W-+M1^[F:\F^C.B;0@D]F?O@U'=
MS&]?#[:$2"<.#SK2B*B/&*[(WXOF\'CVO/<HC[WV8.O71PMV,LWKXW11;>>R
MVNPTM#KZ#? I&"4(8X)830/P1FTW2(,T@?#180H5@!WD+K@Q[O]G&]4CZQL[
MGI5W4G>S8XOQ)QS9[*VH-C3-B#PR2%C9E7G(K<WW%F0UPAH1T0F#;3W)1.I7
M?0?5?D"=^"N!F$4^(D?D\K4V;;P=P7/:A9V#<J^QY9M'F@?@'5/!H58ZN=Q&
MW1N@)<0YA%5I6)K1\OOB*$VM?L5CJ33NT4)*^9]VU\[5@][4UF;1RQ C!"G+
M\!8)!5J>D^7]7###^.FRAD\7$"14'L?3=M\?I6V/H,5THR.I_FT_+1G[Q8*W
M]"\^^[";;@V=[B)Q\J@8_WXHM'M7M W:H4 2!5N_#6U/*@ACN5AD&CIJ1-13
M_:;<>PR;T-^\H%>22N/EA]K;'\28[(>GX*'/NQ:.D:ELZ>!F9WN76]5*_988
MUBOJB'9I3"SJ#)9)8R:83YU;TG</9@U=>[%<& )SW[O)7Z6W=B"J/Q:VG%*Z
M-LQ/K<UAWZ^I-=8N6BJV].$C@221')]EU24+22VJKB:!*AMO #TLQN*-RKAC
M%RO;25E7RT@58F027B[D5#BWI;B+-X"?6L3>?A\RCH*2@>,0I%K!,LDJML*G
MWS[JT)C1;\>Q;.LE0W'<1[S8+B$K"SKVFX3ZZH/\(>(BN=IFOMY[RLR.S0]1
M2JL#N!(Q']?1$(P2;%%/ZTE/2<&-,)&<*ZCAD&<MW<^/131S1U/# " C6=Y:
MD[.1X^%!O+TFF>^856++Q@<^'9 *@.YP:#7G O6BV8DI<>,>5$OV@9X.8^*]
M%KS0W*(U$^B?BX+YRFS66(Z_RSLSFLIYDJTX,IS3MJI.(==_^G'G]RLMVWB:
M=>NS"+&9RKM&PTEN+-IF)!-E^3*))%<HNV]WU^KV-.5N[<+R$7.F7A-8$S<2
MOBQUY K'^T&)HD_!J<AV&7;$I 3XCE>XJNW-'7!Z\8/'T,21(/0<MM1+LZZB
M$2QG1U241(N' ,\SJ0ZT[H/U[;9 V8K/L7I72F=VX*4.KI64.USJ56G:H<6V
M F1X6[%DC]>\EE8N/(A!,L:W4<>Z0F\ N(=U+4<'\GCZW#7-^8J$4]MM%?G?
M>!.+938Z3*RO'!<F6[,>WH5*"E@G/&*):1VU6TWO !167[IZ>"!'X^W3#DV.
MOF9A(M(^;+J5/%QFOG0@^- %GGTI-(0PL@ 8;->NPW#;<'#J/GF42X&6(E-W
M;B0LJEQ,>A>2V]*[NZYKU1A*0OJZP67^#O&=:4%(JFAL<Z\59J652Y-\=*+M
MK$[_"8O*1Q>HYTOW>=)Y.Y+2@(][6Q.R(==XEC!!G,<)X7[<T%+RX#//^J#8
M0&Z"8BLFOZ@2*4"ALM9[9?W<B-N$1^Y+/-,;("7YG.K/%/BK^I(YS1K*W/B/
M&*/5=+\>PGG-GDZX^$]]L9KOQ_!_SH:?0W5*$> [CZ?3Z/.=XA)3^2:!/K%W
MJL"1IW)*"S^M>.Z^RM&,;>W]*><J\)'@DM -V1B8W.T#2P Q.4F-F@VGX/2P
MLQ^^I^0 6U%1X*T>KDJSL@@_207?Z*G?,L-Y!+4P(>5G2^,99N(=X:MT1AQO
M.N8)&9<VYFD879UF4!JF$],0C>CP>1+IN+F(+,J!N(D_WA DMKOW7;WN$5%;
M0OQ(Q*GF5WG[ !0"L57'Y]>K]M5-_Y8>_XDC&'&^ IITZ2HII73\7X7F-\ 6
MT1M@<O25;NT-<($1<+C_!L#[\@9X"/UQ??4&B!0(>![<?O1^ PQGB[_L.O_M
M"=A3R7^];'\U%;]BF'T#>!N] 3BI_L3;O %ZV-\ Z?_O:SKWP>[.6U^:S@3F
M6]J:Z<;(C3>22A,2U5'Y]C/N:[\.L;*2'*)D9M0$X.=\EL4B/=P-]#[ ]$<2
MVT$6D;W1 KKG@XD)AQR;<Y:+_]"9G^NK?ZBZC<$!_2\V([.*][C_W3MQ)+HN
M3,DJ1)>[A(B/)6.!*5$)W\,B*WY9]_P&\#0)6-KWWNK>=;KG<9K]TK"NE!+$
M_JS874^X:%F ')LJ7TB\+N#@B>5FU=ZLII8-E5>L!-X:_LP,%V]L>$A[[!;1
MY]2P_CK'IAF"W_A+!Z3*X0F#?7+RPE H_!%,,%UZ=EI3@4(T=Z:-(W3 *]0*
M\X0Z<J<I+(BDH<H5CU8E 5,IU(MZ?%P)A4'/?5#_%T^BM6)]]KJB.-G4$D=6
MRA;NNRH/(HRD:@\?F;@ULA"O%B7^DA-CB*4=+=\1TP["8,&-NA/9%^B#-\TZ
MS*DTW2F1$_9=4YJ6Z)-4?;DF0DE%(:)+(7'C!=_FR^;];^BBG>$(#'9G2%>_
MEC2H:3]4HUVP@+IGCRCGOQ%@!!-XKN%2\X,J"&5 6,I*DR0HEJ-EZ'P*M-B\
MJI^#_MY!XA]8MT_C1%I?7O>?"F$-T.7@ZW5O8/3Z&R S=DVBNK_1F%/.AB7M
ME=WOJA5F<A[,FIO+^-.-_ K-8NY42XL6'E73PP7(,XM7-] .-32>Q> O/6\6
MUK$Q+)XG9ZU'D%:7P_[&XDQ6MTD15M?<;YUDPG\@&TM4XF\JEX\_OHZ889@M
MVH>WZ94L^[U@3^I@RB=<F'*E^PVPK;4GM-F7F_\TY?^T?B]KHK%A,DQ'=6W>
M*GXE.?S\O<\2%UC>7Z6V,U*I8C+N!3P;3O*+W T7A+NFQ)1I-QE4^4FJ7?GG
MTJ)-/;)0!6A#T3MQ*H.8&-\AKD?EXE\GMO-B[#?PU/$<<@=^0#G=A^$LC6Y0
M57]O;8^H;H?7S:BDR2.GKYUD3?MH-QHOAK3M-8EJC" _+2&&^7[SY$32M1:N
M/GH5E5?"30@U.-!W"*C@)<@O\T^=YFFE=WXUEN;B1=AP:O/B4X+Z*0IOT6K\
MU5SM[)198O_>:,(N-$>!]5>7$7+>/"KZ%=R_5V(1GDY(SJU([B*TXX)"&309
M[7_[:3E-8$5A_5,[+TVGX4*IA[;+(?%R=MR"7OZ"UJ-^?H_XFO->L&#J?DLF
MI40$B[SZDK ;)K&)8M?!0!-U'"V)R[W7^50\CXB^Y)/5ZJOMR&9[R,-*;^&E
M'!G.S4M_WA>^[];34<^QW,IL$[8L"-["8(J_H!8*D'"CJM-GT':?Z%[4D0-3
M01Z#DHYL4A-#H@0L.'5_>?19T.\-T/P/%1?_>,'ZXL>][^>78[RA#?:D7=B:
M'0$TF<[V>\Q:<61.*PY<K<-(48J@R>$%YKE;QY:\59;NH<488 S 1( 9", ,
M;T;QZ#ZV]HIM6OOD>5.2Q0&28*I0@F]BN30\,1,# S!Y';M5K_A'##4MVR-Q
M1 VL$^*KP%2_^8S8\]:BH?J?(*GZ40Z)8Z1;F?9%@< E0ONVQ\UPO2B72B\'
M?F6MHJS ?O4PPUPV7L,\%@-YOV?K3<>ZIAK/S=!!%RK1@^]7]5.[^1+YW?YU
M9Z7KM3"$4?8S6-G.R!+!)\4:RSCVVK%*#"D$T+9+!^8\=)9\BB@K0A;33A/)
M=1+H;#*^YOERRGH^LCJ OR'YI9'5'KE&=S<#LY-@#_J#XBCLU)?8$49CV?S)
MQT,Q2P8QGG2AY^OJND#=KW4GW855XTF^LB<F#<4N)#A?84NZE1P<CS4G9)V>
M.,XGK7]=,S?VV+E4&>JWP+G S2]&3O4-P^G,Z4&W[71]^$/K,%E^L\MX/H?!
M]0H68O8^DHLDLX-];#XOFT3( I:+E]B5J9JO^_:,L?R,Q+ZD5L(1PH<QT=J^
M-T"3TNKG]8XD$K[J$_/)T@&M?12\![<>:'G)^<\4'IE?R_.+Q2BF3;(U3/WD
M\7UQ!_O5YG9L!:]&"]R7O#[<K@7S,%(AO3\J6G_5749C>2 N Q*V^G<I^PMF
M[12=OX N*\DQ8P4(@<2.%;4&0827SU%;=HMZ@0-2FUEN#/K+([4S+NSG='2-
M!8AZO-.A(G4-\F/DX0D6BD>JTB4[3 364_N<H(SR+CT,8DHP H8=Y:>8EXD,
MEL=* B&6H@@WRMW6[>4H#DU!X"2C1A^RT(\UG#> 46L6[JX[-16NT*F7EB>_
M,*[][9_&D@<US_H'O4?N-\#W!^=GUK\9;X!!W_:7U%?E@%U1Z.O$&X"!R;>R
MZZJ0,N;?(1N["*2QY+EF/KQ+D.VEJ',BT)Y@=SHJ(.R\QZ_\NK'RN=U!0BCO
MYZ/^/YD[EG:9H*^ ,!8#M.KB?NH3NUC_8;ZDZYF8V:6P$LO8G1;^FORH#R?2
M:]MY_)#Y!B CJ^GV\JS-NF<ERP2Q+.@9#D,DD/XLFHW:H/'4W,KK*.%)6[;L
MQU8]]X"=R$RO"%@)[@<'?\NSV*(^\S#)X)#S+QV>3S']F%%Q!(+#A+%D$@!
M/DA3226CTZ\J2>QZL@36=.V8,=HXP<UR9Y-WHV =@C$B0):OL(5';YGK9S:/
M)USF-X (&7N"F+V)O-P"=] 5N=7Y+V[2F*;Z3IN8!LF9CJ095S0*0]>%C"0T
M)/2L/[T;E3LR7+\?M1]\,0;2+3PP4Y\XL.G: P1D+,7@F<,CKZU J"<H]PX^
M6ZM^9W/0RJ.SQ68?CSJV&KB;+(/X2P*FO_O!HY'\][2!4074[<$=2M4>/\D
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M"/.TJ\GBCM9<L0DW!8TE<20K[7;E[[*[K+'"=8>\VO6E9A3!8^6KRU%TFT#
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M-@6# QK3.P6R6'8RS8!_,(-1Y\S[QE_)-Y731<[A[AFE9^09T;1@Z4DQ%6F
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MCKIQ0J3I?BOIZ@M];;A/:W7C8ZP_'/0/44J^[8A@975G.L/B84^M):>+KCM
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M2==R34(T'!D8W9"+[&A&71C4G[WGH5Q<3V@1J-HER#0\"*Z<YB#TG4F(__>
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M<BPL%;;8+T9Z2;H9\S-E! 7.D?:>[Q(+GJMZ_43L686MQZ@ER3:ZI8C(N\E
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MD[7ZJ7(>3F;!^VN[/U\OF_7A%UWIJYDA5?"A[E" 4[="ZY>WXN:AJ\[*265
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ME(6M*;YM3^1=_];[#_#$_]G&M _[JXVBXXY,&HPVG NF75X3\)@-1<Y0&3M
MBD..[-6(^R8!6KJ.S#P!'0F8<K$+@C.Q_K-/$G_[M-GP<T3NO'0=FBEK-B@-
M_1R/PM^?HTIJ,BZDJYJD*$0_*K5;?J/Q;W;[T?Z$^CC*,\U;UF-)ZT8UJ[0N
M^>JR)J;7U/@0+*]\9DA[9.? ?_[UO2)<7@@+=YZH^HWS?@)/S_ /"@2.(<(
M<M5G&R#.B'.\,%3#(-9I=J5:<CI58PM$K@<=O64%W3FIM&D'S,#.MZK;M5X
M2W\%&BN&PN+-_G:.KJN<H<XT'WW-1&#7-CZ9N +(HG?]C\1"85;(NE"K9E_
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M[B#+=[Z,!!'-UNY"*J1^PTN /V%$.\$3Y!K^RFD%HZZZ%%\=.0VWWX/69YM
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MH8%XX'@1&P[I,9];?Y.\@4W[[$,S_2X/8PPB<8VN/S>M@?O_T_Y?$7FH,8E
MR2;!$QWV&/ N^83TP^XZCBJ GRG7*59(WI^I][?)]JB/S-;*^%UM;&[/]#,
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M1ZO+G6F+&DE3W^JK_]9]!]JO7Z+F$E^\']S[?X<FO5Q_('B;;:M=JRV"^]%
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M[KUNL8P[*+BXV8[CIYSQ@6V5SVF.57K/Z4]5OO#+[OY[YH"UGY)9MR-]YBK
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M\!5XV5D-S^OTSX'D/UT8]9!;3LT54FEIJPEPQE?.,?Z!G(Z>#MI-/'Z%<L#
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MGG)\/589/ALI<-E^XT03K40M(#9O" 3>V%TE/@/\&CF'?QQ3#F!:DRPQ',F
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M'>>&!!]YTX))J->,S[XP)6!\G/Q[J$ E1(_=KLH&3FE>.%@.JKP5I";N>LB
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M)!LD;#;.X N07C"IM]KVO2_'F;F(N_S7%5656NE2JQ2Z>+NIVO6Z?6_)F6>
M]UKVP-P[)WLBI\GV3K%,7Y1VFT VH\PC8 [O-FCC7;VAV>JZ%PE7VP-#F-J\
M2WN+D9&-^\373])#R-IO'!+.NLPF$<$^WH'?3=1:@5VPZYS.3(JR4L?^3[%"
MVKIAF%A*] GY2X=DK-NP4SQEN&I3TU!A-7(FS:[,32ZD 5W;!S%?FBWZ).C6
M+.^8B,QZ@,K[$-OBO)1H<D'INZ,X?U?]0 ]LQSZ@\TDZ)ROYTPA9P]>FQ2W
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M#]]F:2(*:0!@$4!%6JXXS\0GO5*0Y3B>B?S@.[V[FW@!MCBW20_^WN;45ND
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M+T;V67!P7A&3H$/@P_C[($FN=>D31F )/82#$A9_8,DI>?&Q\[GM/^)GY9]
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M6X"J 0YM# %@=-43CY W8_S(MTJ;E"X^$MR*$OK,)O_M'*,SJEJKK!KXV0K
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M!99XWJ[%M&C_*4Z#?U,9R' K3R!54'F@BOW3YM,(>W(!9_J RT_:-@LM4]/
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M2OL'GX8V_B-M_K])^_^30CY)>YU\:U,SFGOS>V2R7F7'/[8 38%$I]O6PO=
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M4L/46;# V#SB /+4!%A_JF_=/MW"K-8>L3[X]D5RLPY2S^P"R=4EMZX;#X<
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MR;Q6F6L%E<?0FA$QPT2IFR9Y!B(8XF,4 !&X,NCA9(3GES4A[,ET^F(J:)[
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MHRMV._\[]M06;YM23#38@-7:L3+$PKV7Z?N+KN?-)JE)HLV%3'R6F]3A!_#
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M>%Z.KH=WM*3V8ZHD2M#,H]&8EO:CT&E8VG3G[\9?&SO^.<UZ RQ>' F9RXT
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M9AD]3F:E@N.:DE!!RCC&(/[0EI.'G7R_FC-\F5CAI!$):V/40<-^"6GJ",3
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M^PGP6^X3MD&CVP*]@<D3CJX-7E:<U",T4K]CONC:D1&IE"IR(.+JYS_^-YD
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M) 8%]]+ZZL3/\UEQR;83G;ZY+U0@BA9]8,W %5FK&#!83 UWP/X&./S59?R
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MP,1@^??*"!X4.7#H=$HK*_X6&]ADQ5+^HQYVO)4C'V9%4)081,P91!RSE!C
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MQIG50/2$)2%Y%CO&2-]$WWF/QJL9GN7MG7I4G/T\2=FRK/9W>'P<]NV&0X*
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MRI;OX))X\^C@9'R>U^E9>]12LYR!T+7;JCS>.U^XXBE)*8B7[-\^I(?J'?3
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M"^K'SW\K0_\HD\OJ5+4V!RUJOP8,N@X:%?0)!MV+IN_YF/T"I 9[[7)IM-Q
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M*ZDL32ISGHU:5OD;'S=HMQDBW[#%0"[LB?4LFC8^P$U8M28))#RYQT8JE69
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MW+O,=J_-F8C87K>FJK4+@VH:?Y'T'51K)ZIGLJ:/6M=]LMYKM1U\QK2>.,-
M9@YZ4;;[_GHX8TC-+27B^EG/7N?B#R-.+VSB%^J<#*X4H2NITVT\+%T2S55
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M$N%.OIW$$RR!<%16(7F !.\A]TA,.".)\5]:L(J?@:WH4.S->76[/974OR,
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M4YM%6AR]?S?6(]JUE&A67V/?_V_)4QCSABD3T>+P\<WS%%-99R 6%YD7@)+
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MQOVUPSP"E?ZMGZ.^Z"G=;1EYLY9XPX;Y @?:P:D?OW)TLWN($J2,6R%N=O6
M%F26-Q [T@2?HW2=1#:45P&XO+GE8WTB<[$_(-//6\ >A&3)JCJWH17R$:E6
M8G"2?I;MK>D+6B]&!JYZ#%R]?$E=,Z>'N_"5"ZI$&Y6&C9:GU\G%U@09NI8;
MN$-<K[+=U0ZNKO=791V4O)9I!2$:YSR1VU-[\/E[\NI2A7=#1\MTLQ<]:,G5
MGNT%N%NQWP]:QEV\'R3O;!0],H_<#71% .$H97%BLZ2B!=A*&=3O\P0:XS.8
M@8Z)QDZ@>I89:EL7&-,SO8'(PGR/.X7>%8K;8S:3J-_K<QSJ7+<'OX8V+73*
M#C<[G;)KP&_[->)0\1+W=TEMYWX[D>8["BO(%KP .<6+G+VE8\.DY(7I>?%A
M&RB#+C8>I>QF51QZ9&5K96:E-JLU.M]9Y!PE>^+)-,_Z:IF>X_;$8_AVW-QM
MCJ)4.?1&WDJ0Z*KTS09"P4I6 ,P5+9N(<(M8XRPNT/-, >4'XGJ8TUOY>P<F
M6+BIK]S5C(Y3]42?CZ4U"Y;C;>89:TF8WMO5?95A 5HCF!,-]U\\/$V861>Z
M2ZA8)5@3N7:B0L?;>PNXJ,D08:L _P(W[06/\4WVVSMY.W!PN4[T*RG/:;3#
M)J;"+BA84LJ-T.:*TW@R:<W:[H^+]^K_ M:7&J;^0C!JKQXT8O$7@T<;K*B>
M%7*+=1:S)8Q;V=%[ND<RB\S'#<[WCO2XI6QNQ"S VOO>J3Q^SG9'&;;^5.E%
M8^?D:O>"&B.+EY9(55<GWTDOQJU2N?QGT:4[OV(&M4&F(C#7B&H>9 'J)/T>
MM=DMDC)R(#=/7LK&[I#<%./!?!Z2-0"PF7*=:/(.*-&T+J:<SC;Y:;WOZ&)[
M4=:A]G%3T[B]OMWP,B;'/DO2N09^\AP_3O"9#2/;P##31XX0<+I.,:9&SDCN
MXRZNWN+LR&-34S80VLVP4I2#,+RHU!]1:=@#8O0$ZD)2S[4[L'=7JJ]?$PUJ
M^CPLY0YJOB5]YK,GW$@)-L,F9$P,-VO)NJI?E"*R%Y^&&")#,6FTXS2/"OV\
M@5@N%_A*9>/I4#N?Y8/NR9L2">,:H4$!LX?9%'9VO)C SHJ:=NN6FHYU_DQ$
M*:')!]^3GL=1403(]?5\SR^?S'W6DHMD>>SO;E+9E3E@VSMI-P=T W)1CY'+
M)G,HN&RQLI(ZJ=JG#423_BUF*&[*O'L#T8)CG]:; [(P*Y=V+F/P,@LW@.RU
M\(A+K!=-WHL!I@39I?5BD[*G0=' H?)J[YFL>QU_\8]EWM7[R\Z@_.#*5=BG
MN&J\-?LD\G,V,B,F7J09-:6BE%/OCM:(?GW92\58C-T/LN@;(_F-EU[_33<\
M #W%E[2<_*UQ=^UR Q05[C7I6NNLS$CM.:M&6_Z@>I)VTC69INGXA=(OE2L1
MG?$&NFSC")#A*$PM)SBZ+5FK:IRWD"T!"4UU[NXSS^[<M;B!V!IGD_0O0KH]
M'Y.)E%WR\LFY]9*_X(/>8Q<5?V7=)\R^TO%[+:$)U[;9GWK&(>IF#&SW<6(E
M7R%%DM6!Y.6ID1)^;81><J.@0P43RXV\5H$)=8;L&,A%*8H]QL@G*[^;%W\L
MY4H">!L(UH_$$4*XY8Y[C[;*3_H2CE&N4/[!JD-;^+A<#K+CI,A5["Q =PW^
MX34Q_8BC1-E/,N^>Z#PN\,RJ7.C4'<?XRJ.1T T6?NS2TS&R8_T4,4"UZ7F1
M4V?CT*7Q"=_1E4LCL4O-./N;!3L#0S)3U4H/VB'QN\J3:AI?>_OM,G).T7).
MCCKI%E=K6ZIA,QKIZ775GOSY!&8^(U6-5%R06+^?E'8X&%=MP&L<IFNMA1D-
M.Q1750T5.(S<)59U?WYETIF!"UM-ORWMC2<T3 YUJ%&4_:4CA;B6V+)]EM=@
M"2"_A[(?AF:Y-53RD4\O:Y%[\A20V]M26TZNTD9*NIWJ3SSY\RT]?;B+<.Y/
M8/H9[P"UL92Q?"(V:GM>\CBU^</ZBC\JW;:T'NCNB4HO3NM^?HJ[:_KX8E]/
M",NN*YQ;=TS^4_,'\,Y25KW5!)IGWO#[B)[$#"ZR?R"4T Y<A3TO=&@U&Q>$
M2TKB(KL)&=3'\YEDFV#),_JG(%Y1KKHCU,:+4IPD]?-ETIM)4QU._.>7!L^I
MKX_X<19/3.\/0*<UVS\8,IO1)L%369C35=^;0L_,W?-&^%?-9)I#3<"X1@VF
M)O"#ZX-DFJKGMW?#=Q^T/FMAYWD_4C1ZJ.9-N\"2MT.N$$\L#"KXY!S^A=CU
M^F@^/2QSH-=D6NC5^*-Z+@\R7ETQGB-DH&2P^WQ(2&&B0+6HFS")MX8G$;-(
MW24.![_Z"@AP565SFDRSJL/:_RF6Z<4APV8Q)>?'X^IBO$8CHEI6K+NUYF_%
M+O'+%ZX=#1V?]IM^E]JPFDT%/>')JS%A+8U[K)8GLI3V<G[";B'[C7?J0@PW
M$+^\!@;Y0&%ENH(V.%1*>;NIVI^*[\!S]1QMH2I!O>,C_P(96::4_7[0XDLK
M$V[$3_W=GKHJH_M',4YV7QYF,I>SVZ;/,D87$AQB:*Y*#HZ%-*WZ%J-"UZ92
MRYPG3O0#);?(.3W4E<M]4Z^+QA=%EK>K9?O>K9=[%M-<U3^T)R]4TK:-^CIX
MSCO8+?MSQ&J#PD(!LI<Z7<2;Z,$GH1X3V!P%RJ1E&BLGBH]<7A<0N+@,<@2H
MB%<F&X"=&5ST=E)M]ZSN*$4/J0TE]&A=NU?N:X_Y1M@=J?1%:&T%'O/^-$0D
MH]D$R)BY@A*<ZNZT!!6IX%?A-<@:%+%131];1$>@4R]PVZ3:2[H_@?%=J&3*
M":B""P=,K9F1[+.+8C9ZN5E"X./3K?0JB!SE#FN^N^!U76VH84Q$A5^H9<KH
M= 7%R\5-I\0XN?J5A9'LL+L')J0?&>A<:N1DTQE <J')60GG"S1$AO8C5[.N
MOCY^TK8R..?1F)?'Z%B,XXQ[J4_UJ[=O[]2ZQEU7?I]SP;(QL[0RT^#!\^,#
MN/_'#6&4):#K^@;B_>:7#*=P*WN8C>;2.^)?&-W%@B_([\ISP-+;#<2W->N)
M0>;[J)P-Q%Z<Y/@YV#X*D3_#KPB#!TPWW%P&!TG>"M.#7($(1<9"%7. C-@>
M1&9T7.>=PBF1]/IFM8;(05SD;I\S(*>W[8W/4IF60*&PXL'B^!N.C\^LS79)
M08_+.U_?M_LSRG,FJ)KIN4C93/8KT^AN[A+OX,YFFL4;FE&]X7/E.SGY-PZM
M61[YZ_I% <GOP._EASWWI^H>OQ-YM.!&8R7M0$N8J7USR^,WXJ8'S*JH*3MA
M[<@&(HP)&:2E;B N#N[YO[M S]UG[J8H0BP^D(Y5@5-4JHI<)LYQ4@'E#FV0
MUN&6,+<2PLNA]ZQN=PJIAAP(:<7!;&;FFDG8N\LI4PT1:*<BYW&,D]'BS"NK
M!!'"/(LY=V\#H1N+GD(*KPJ\X.Q <?7%:AL(_F#7<V6>5W=>T@1*'7LB@#(@
MW0IMK9R"(F=\!?$LAEP8Y5 ^=Z#W64SETI>9 X6=<H#:TI^+UUK/+VK=5="_
M+7FFY5%NK9GZX]%BHJL#7MF69C#,?M6\[^3 5<O(8P]&LKFJF ,+KYR/NZPQ
M&SYX9B]QCR*5=R:&F1HK^)1>\.BVS9[?:<WQ4*FXX'/^[GT_G_L7:3+H^;.9
MDK>0ATA![ RA8:5;"<,#0VPCJ=Y !*WJDO6AI ?AU 85W$]6<:)_409G]X'Z
MV<WI+5&Y 2>&L89L,!\FJCWD@[3P&^0;904)W,3C?0MS2Y\*O^*?O3G<\<N!
MUB<C#X!:W%P!KHFQ#'!AN^;&5<L2$<BGH& >>B_0%4 Y)?:0W)-N)8EZB_53
M.ZQYC)LH1:R.^)B@[8]OC&S"+M.U.F7W=C M!P-,][$INT%Y?^*$#X8]\#RW
MH 8(]>NC 9<&O+-%"K:YQSH,!Y5U3$]H&#RR6A@EI:WI8(-\:&K4PP6[3'Q&
M[II^T$^MUE@R>'#DN]K^ELL'-4=3-7E7KK)?>:<[%[/8_-K@;X$7,*1VJ#@V
M4+.Y0C6=;GCJT."'V4P) PZ+B_0E#KG&@ SH;.94O[ 01+$&T^&5E"/C) ^^
MK283MF#U2?^0"-RB7MAWS$F^?"J3A:QYDN!##4Z^K!NI3^E0H7#5_L[G899?
MUAEOC-GSX=^?#S,ZJR75&+P6"3FWNK('G)'*P<YC6Q 4(SHR&R V&XW<[.MR
M2GA<<K?C%'BK[P6U6>7J7^+M#Z -!,\KA1P,4R"G#R=/MHG3(TI-DDFU;-W#
M0RL5J0E(>:C(9>QPI%DFH]2-GI.K6("*TL<K>'SA'?FVZ$[+*,D."PSUJ-;Z
MJ\K-_G4M_?>B9TBBV]M#N4ZN#Q6]7Q4D9GN<LT$G(-.K8;=HIF=HK1IP_R!>
MWBC7[VZ!8]O! 8QSZ4/ [)O7FCW(9S$UI5J;Q03,_07LQOT>!1TD+*^+0J$)
MWL<24=" 8)6GGLF<*U,CM*1E7UZU4A"=)Y6P. IZ O6L;RC91:WQOX:A:Q%>
MOPY?%)B67YW8;#YY.#9Z>UG: 4?H VS$Y 6,E7V\"(";>T]D)^W"R>$"%6+L
MAJT< 2X3*3XAR:['!3UCIM_P;$FHG'D7COUY&!V;J+O4=V):]6.&T$39Y:A3
MU -'H,[7>O_+*C^3 .0)TC].#D<K;'?3,WJY]\M.9#>J=WG5I=V55E6LJ(2X
M9MUU*Q@[:1O5:-%1'7@$K#,:HY_D-G@7J";55/EJGTW=?^3'2%'3U63CJE=#
MXY4'M]?=^SYD0RF@_)O:PECN$AF2?X)H-6&HQT4LQK2;\+6 VH-7(&)WC %$
M9IJN&E0G,B,?@33IH2,!4)[KB-6>FG!P-AS0(-OQ>O,<]+S ]^VF)=STY36G
MXSW7S,?;&6EB^V^PGQ[AMK&,D:DXT'EU6JMO#LGB3!T7IDJJF"&#&M"2\);D
MOE25V#JK#"IF$+D<W;:TSMUD?Q!6@J1X:MJU#80.&27D*",5K?=?N&#SL(M>
M<FDB=G5W6'LKX^C]HZ,-!4<*B",,S[I=V/UNE6,^=Z\,JIZL,7)^=$5\NQ3C
M7YL0VJN4[>'C5N:(S@8]HF,%L70WI$/!#2A.KGJ8[KM'QTQOY;Z'H=?\_4.?
MZ'$VKZ+OEEK>3N-%J+@$W/N8HN+RK^WP'^IO%.B ^V[?MKQE Q%R4W1Z ['X
M!AR[R@1=J=]_[5OY#C^M$[D#B]\$[^((__5;24M2NR\;B$8K8.U$2/WFA6 H
MD?;HYGU@(6RS_WDOL]>JEWC/%PYW,(49/ @9J_=QU,C;)&6=IT@C0@HD#T;U
M$N27<:&,),HN:(!+0"X5%_4@=Q.U2MFM&3R)Y>IRDEM#;-+Y"-,EYR?MON%G
M3%CRH;=$7B^86B1CJ9R=2'NS0R0&R.$TX)=O@NA?),7 I=,)_/ANW'2>T$M"
M%6-$%F])\?RB6RVG=?&*8DV!8FVYHVD>OP"J#GST,G)V;WNN8XFVO#'5=%]=
M.$5IM)FJV'GUDQ>[BWO0"BNOFMP]T6/TK0)-S*:G5,LX)P_'J7B:RKFXS1<=
M+K!P]FNDC.TJ]2I/*6;W6F1?TE;/*#_SIHK_,KELO[*',;O%J7]Q3,<W*3E*
M]_I9DU>X 7]5T>;5:C_!^'9#'".8OP7SX3WI"<F?L%GB9.D>!XNR8/#>0#QF
MI%,.0<\VK]FP"N2A%:$BOC.C1GR^4Q#YE/\<X.;=8I@-A/!2Z0^<N(Z#>Q8I
M/S][*O#_7(1.J\><_-"<[Q0#US%XGC!U9U4(&[%;X4#7 1P7)RG[C-U&>1-P
M=!PW]S<3?,+D'H'P^INBE&+4#*[WHE( L&X#P85A+B)4"Y73TI^([&[G;O8[
MEBI16^P>D@!OW"36MJ0*=<KAY+C:LQ=GE9)J<WLF6 FJ/O=KWL0>@?[YA>XJ
M^_1J2]*5E@*:I_K7S*D31K?ZG,,<"N45K)57@ATJB1,>2W.?;%4>3AC?(;%/
M3T?33L7B5#\QEN2%A9(LYJ4L_&04;WU9=8Z:PI%OWNP2)\L1Z9-_DK1)CY'Q
MPV;,72R!'<_T&2^C(X1'G5[EXC,[HG:DJ3UG0+BY>!8S ]C5DJ= _!I>]*=C
M7,B#A2%O(FYR.5*ZV:7K-.6UCW[/X)2OL!6J!9'", D5B  @ _.;Y&AP_@P$
MB$Y+AXG<5142KIN)B/-6&,SI/ SY<M%9:TQYDB-//_/A1,^-;8_#VY_/D")G
MG)KR'5)G^5Y/WEC%OWZ2IG!834^K:C3;@%<5R*MQ+C5P+C09(IV[7.OL4'!X
M;Y@'UV.\I'D_7=NA\CK*FBL^V\L%*=/W:00%GV<%%NZU!NXLHUK5I!P-F[':
M[ K/[$\U1W+F]64#S.9?,TMKC(5]4CE]/E(6]K5;K-!<]+2=5+;-?'FK"( (
MO(]59G7Q7)GE25P(=6J5K_\B/%%]^<:[PFJN+T>5>.T+B7]6$#R; ]!(K"ZL
MDL K;>VT[/XSCZ9M>.YW.$*XDLX$BOS)\I(6RDFRH>3V9E/PQW0V86JFVZ<H
M>1\4P5\Y+I7=JLZ61^Z^L$A5[-A7O_3%%UKMUMV1QRK[V1_'+G[(K&QN#TMY
M?*?K6_^=B5:OP_8A]6AY9$TWYNCYWE'GUE,*#FF'%.N5\DMU'&+H 9C.I[*N
M'SX4E+LX'[WK\\M5#+K.<<GM[I&1KI&P7)D]GDSLL3*C!SE^N*>NR542U^@J
MVC\EI>:R#L>=-A :=[W>H%K,TSL2>(P\V.^T4#-QVZQ0(G/RF7ROQPT"P@LX
M1.)]&X@4>6Y4VHWZK ?$&P?:,6G=>N&_2W<^+3MM>=K->^1A\RW>D@]S-,[Q
MKY[U+\JB6E@(\&$#E9?U@[Y<)#*4]C%!1W0*JOESB1;IV+I4SD2P)/P;0OY-
M=A8$IU;SJ>KVP?QG&XB?R/B\GA$B;@M%E63^PC)X 0KGR;]S8UG.,AE=<0?*
MD/G^(VA]05'D\2.%2)E=OJR$7Q9J"B+2RYUS=AHY5]*LG"Z<O?_@?8&1LZ'(
M)S_E[F]O*]A)_?QL]J!<H^YK!\KK.Z0;(W4!D35T#6ND\['B.TYC-943C^FR
M2X95W80!#]4UF96F.4822F$#$;XZ'?0"UU3_#)6!W4'"\>-[\I!DX[&YY^UC
M$<%@0!&OU&'$IOGQ^&IDE&F'#7W!<Z@^GPZ5^3ZKX(4;&V#6GMS#J-[N)-3_
MP 0%Y!@-N66'NZ5X]U9>#]$8S2QVRQH_;C_M\NESNPZ&V(X)&\K/ICE4+KPZ
M7V1V@*NOQCU8^6"ZX_<VS\2SF09UN[K_IRXS_1)8I<]14:WZ*SESJ&RF,G )
MN%7<QF;L)&\9?C".-1S\&RIZT>KS.8,8_6!)^G-SD@T8^9R7H]<;8#G&^#:X
M*QQ/#\5N>6.%KP\S+VQ8\+2,ZZVM(K9Z 5I>PO@-Q X6.6X$N(2>9$KE&*)?
MEGQL5M/-T+<*-Q RG8=(2=;#/3*>8^)37.0NLO=XG.24K<C_74[QDE?Q:=JR
MUJG9=UU!N@^%C!L;B. +=Z'[UG_Q'C^J;STNXU! /F<<:.A*NV _4B70:+>(
M5W]I>=4UK/9]$:;"^*2AC04SY.=^<.IAB*-,=JUGKI9[=%S8V /^X/:T[O'Z
MRJ=<%PNZ4TQ?X9><43]?5T*_S(O!28[P3TFE5%OZA@J+6?%)&%Q'N//+=7//
M".F ;L>9#80L\,?FXYWZ2:NQ'+4PX72?$)]EY5(>7F;PU6P#L15ZP!?ANMJC
MTEM^D?9_J7QLOQK[J5[B*-S\=3J8\H[0UEK"JXL7XB5E5DX"-Q9%OM-)OR?@
M<#X!Q/U!WDNL:WE>RH>NC?2BE,EN<W!DL8>:&T9C!QQ=P/&LVC!+X3W:8O&E
MZBKB>#N%%AR#$]+J*#VZ"$DQ+@0'F:ZO:(HL_4)O%"W?%)&D+\KV2O[&_O0.
MNJ2>=&8HL@67LH%HSF7P.;+$Z-/_= ;<5N5D?L-I05<U3&+K</;@:FXL1]:;
M. 1T&U\=^%X$4Z&9Y"$S= ,Q"4AEX8+=]AOD+](F3?2BFOI8Z!Q.DWI:YP&Q
MEV"^*^L=_L6L_GBGP2P)R37O4;!SP"F1]4U+'I$H?((@),_J.B]OS\+TI>K
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M:@6ZSPA1*P3(VUR[\Z60NCPFLIOB?D=*-1*$,/-5_$M2Q01?D+TW$!\=\J#
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MJ5P#:VB>WJ\9H/.F6L;R_N8W@4V.E)><9OUE":PMF- 6T2GRK["N""+\1$Z
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MW(E/WZI/1L#O/;:+Z@FG2RX<<-4]2_+7&2SUF;]--O\ZG6GXH:>D[?-#;^-
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M7*U\@<Y40,NO$$%M0P9498XJ'2F4!]F8E/&0FQB\!#KL$/[ $&*G6L+$OB=
MXT35;(4/-FGF5+HM\730D[3%+Y[6.-P[U9NYRR5G@N7/-%-@SM,,9UR=:Y1I
M3L.'^X\?3Z3-^SK-!WGJG?._=]G_P(%/W5$[LTVDJ@L=*7(/.X$1AWT#W@TE
MA?#7,G*K/][/6B"$GD5^/B+.SXG&A&](D[42U- !YLIFL=5HX4S^C>7%?T&;
MZ]\K2_XOU$5P)0+N4%#?<#$2H'.)@P@9'A3__M#,I$;V"\,;43Z:[1]"6&@&
M5'(,;$$GMYRW/%@?WR$?BTHM87HW# =BHR.VKN8V#T1OPDY(V__1@^Y;^F&C
M?9K2_OB,[RB[,YT1]#:%I1U HB5>8^DZY]8YTTV=.JMONU2N7OESH*W*WI?\
MV5\G1%'%4B=) 7KG=+Y.!>P2^9ABE4E ;7>+ZQ"I4Y]6V73!]KG?SC<"L5_>
M/"N&8A694TQ0QZ83DXEL<!A)Y62S0_B[!KFD?H0JQX;MT9'<+U3'?IT*)K&)
M-YLHV_L1VE/P7?,CE#T<.&/^XQO-9\#3G/OA"GBM0OU=-OV+&;&!BD>@H#IT
M<9CC\?W;O%NX#51!!?(\(<4\I-UL!3G^"US)#W=%4(JS"0*>',8@@XD9[GCY
M=,:H&I*#\]OE9= :%,6:1T,KJEB5',2X,>QBI+N]'.85]$<#3\5:>1_C^,&$
MNF=R@K(DSW/#IW2QGGI&=*LWK0W3&;GL!CM;C5(*7+;(?R;_M1GB/+6>8R@7
M@MJ=OP\CN^U4F7?_L-WIZ9SAAG>QQ%J\N(JURH@@FQ;$E^*/[V%N%.[$7N8:
M"T@4+?Q(B1%XBV<K'!9*@<_O8Q6X=P B73<2-D57DP>E)U&RH&3TD>(C=#\S
M<<0'M_.]8LJQN6_GA3(CU*=Z'P?./1LJ_-(UR,?P_/'=\*:FA1">)C]&4,M7
MY9EAT1TB2"UF,:R"KPUF\C1QJIQ#1&#75_;2@B;'D4DSK)K@[P =6-<O6W%P
MA40Z0;8K4@6F<&,USL'4;J"!*C=?$,M-W5)[?H$J3?@Q!OY(#9US6&?^8.FV
MB,[13I0R2L&Q^-KUH.%$NP-1C]J*Y'<U#6O;&984_687UO*W4V.!7Q,5K*:'
M*^/7B[?MW1^]OU'S&-+#-<2Q(9>$#--,NU_GIJY+>S#G%F\G&RI,(H3T)?FI
M"W*I8>CM?#=!-G6R&?E$@DYXNZN+C4/NND)(]IY9C&9G&G:,$]H=T Q)=B:&
M-9-.#23N/EHU1_F-(WA\(^XA-OI*VS':=0^?D0'5"U/N #/E\1?U@2-]R6@U
MBC1^$+Z1.EG7@ES(X:'X$$$2SI9W'/^.*66Y#]\WQ19!%N$LYI@U[S1@D'H]
MAC"%E TM@&4U/L#FV#5PPJU(<P6Q!IF5+R/*WV/S<*8Q<L6MD;O1O1X_'*:)
MI^H-:S3='T<GDE*?[K1^[KF59Y70T=_1Z?GL:'O W!#)3L=-Q^QA9[2<V?'Q
MU[S!5W4K93#7)^==]XNGYNCJ6C=P&OM(#WB2)7\Y8V)7KO903H(VR?:E2[0F
M,@A5L-@WOL0-$E3P+8 C#,M#H)A?;#[^_6;G<(P4J.P*?&K" ,DO1!# R0<^
MKMDU7M%8%>%>(MTPS%< GE[W.$WT&#8^@I9C,L-'N3MM8LJP1W'V#UOO=TJ_
M_<B_\>,]Q<N2J33_6?-H([W-'J^GE9RQYXU=O=.FN1>KM9IZKUWV6[JK&WJ/
M<P![WF_/_6+$<[BMEK6^JV?1B:*<@K9%33M]7>/<R*#@P9&>A>_;41C9R7A3
M0=[WKY-5 70V3H&]M -G*LCBV[*R4V(5DA NI?/K77^TVB,[T8KA?\/&=18&
MYUV/B6-%7HH\./?.*=UV]-<ZZNU.MG1#TZ'E+G6\[>@0^I]F]W]L6"20"_RU
M=':^VE]O]W@/V;ANMRQ%?:?'CN'<Q=#N)ITOMS'NBBV'DPR>D_6VZ,@,T >F
ML]2>N]-9L_Z#(PJM9;:VW,CRTG^IQ+@-"TK_$$'^7( +=_>+(!_YHQ.7KQ\7
M ^[?/:G\?34BR%]P@WZTTS^9ZC]CP-RDC<+X6@+H8B."Y'Q%8__+-%40_U\>
MSEZV!.JC%YB\$SA7,)LG@<;M!Z4Y96R+@@3D9 'A"53LH?+?[S#$9"'0$2R"
M&C:<V97.1FX"TZ;HX_)E\JGL)6CC]/UYO/)0R3NO@<SA9]0G348=SSG9_PS6
MM6:DJ]Y,<KF9P;GC^=*E>$K/2NLEGHMQ_5383VZ+L3CS=7-&241&[OX[)*O7
MQ>4J%EY60O&_'AJO+N">6UVW^M$F0JP88RE"U[>WBR L![@0U7M])F]U6XQ@
M0X XM J;1)!?_R5U\+]3QOI[76@2$3BQE.*W 701![2=()OR*]^)TQ4O5,9*
MT"T1'-695 1F:FG79\IV(#EY41/$3/DH&C3V[0*3UAS[K]P+(S]>/,\N$7(G
MM T>1R[V9PQ:9RZ3?]@E>S/$D.+5/EU)/;KT5G;M*K!<%+5;I0RV4F[[4O.(
MJ=R1!RL7/KS.T-A&ETRGL:?^Z'#T/&.U[82_GD6TDEVBY[!3SND6YRC;QIJ2
MY/?4ABZ^?(%0RI^SD8%6PL,J%YLYUO,LQYHI)"PT]HJE]%#K 5;C$$*^9,]0
MY,ISAR.=?EO[KV3O>!_:M'[0Y]U+C0K*FPCO,WTR"P5/8R[O_0"]00CKH290
M@>/5* A?2U!J8*G$CWDNKL,UV().&/$F10WG6=!.E/^"W^6'_ZMD>[]-FF'K
M858;P8&3P=Q^H37P ?U!Y@5V;ZL1,K7AKT>60^OEMZW@,WT_;)VN55R:\4.G
M,A\]^F!Y2FEJ42A"U6RT>.NSKO'.[0<*#I;45(RD7KAZ/1"1Y[U:[?R*(Z?#
MFO=GZ?0H.;O^YNV4PW4NS+U_GWT[+0Q>(8+42RQJLHF9!."4&&\9BE-U%K/Q
MG'D?@YAFB1!?5%0H86.K!<]:^,9>M7<VF1O/$<>92;:4)H,J9VO2E,37K7C)
M^A#'SJ*6'1O')/(M(BOG2W1+!AT;GSY#51(NH$'=K!L\,]PE +Y Y^WC*WT_
MQ#?,\ ]T[1)]*8$I2=F BP%K )=V9(-'JHE%!,UO&U!1S5Y2 Z79/N&96S(W
M+S&,*<U)!"GT>ZO+CSXS@=O'JQK6;OF\Q<O]:,-WN6?9_$[+L[2WKU2]373=
M&#82BP^/)9JO7KR+EQP^D[?G?9G-IJ$+-<)1O[76R-:HL0\(??/=%['=T:5V
M>9(!P["O->;&=9X+ 0^^S;[4ZGYZT,!=O-Q!I1'>MN*,A&ZXWL??Q>/2!0_%
M*%)ZJHO!3"B1_MY4RL'3\<HC'IU^<)!4C2U&^AN"6C%)QN1MV C?@BD4G9S<
M\BGY>CG.C*-?\_3>;E@!XYY\W="J.\<PQ<#8P= N[:O?P'/TV%=V2";!OR\!
MV6B,;(+RY5RX'H*GA&"4LK"7N<M2"1O(/0ZB>5[AR,:E5,M]?%N.=9Y:#K F
MW$G=/C'[E8E3?G.E^FXE=9CO/>JGG.-PLD:-9VMZ-3]FW.;KK1]-&)=;ZPWR
MMOIK% ^0$A+"7%S#AVEN>3I7]K7=;!\F:;O2',6T/*/*.?+E0":V*GI:NVWJ
MSJ>=9!<YE?Q'!USRO+,:S;$M=H_FN]:8/N6.!RK3$ZKM:CP'']ZV:WAH^SK!
MWQ'Y?$)AD!_%&11*HL6HMD7L+!_$B4='D"<V-%P%IS @@ISOP60*(6)D>PTD
M<(,YI<W@#=YI,)M!V/ZZGJ4+W^DS'T/DH+S#S5\7"7^M;5B^0M[QECF+#JT?
M*0S\ILZ+QFT&1X'7S!=^!\!^WB5AKPCRU+V\QJ$*&W&2$$]X:DWDN6$KVZ^:
MQUI5F<\#CTL))*P+?3VS8Z'2,;?E[42X-O:&^Z2L9O(/>IWO,SOL*8UK0TF1
M!=VY',]7]A6L!#=R)F.DPY$XXG8A1M'U\1!:__WN !X%<8:#;=E1B:B&PVKI
M9X'N^R7:_4^AT.,RD@*O_H_.Q>:2+R_[E#C?CE-?;1)N7>09X5\NXTS!'%X@
M+@KLXNV<$T'4+.%@!5P&WP-_0EX,XYWFFX+JDPXVG;!SW@;541SJU*&\JOE,
M=F_<"XKRLZ'-U 3<[D*]JY;&(PT6X3+>GL8OC3\$#+)0H#8YP=+<M+,!_, [
M@1]%/AE=Q'!TI_)&4QHC[1GP>OBB!,LPJQ 3K]]Z:-VB,3O9Y!Y2<J\[>ON*
MUOG5N#CX!NQ5,__:G%/]JV8-X(M! R_*]1]MN57=I@V^J@Z6?7TQKZWJ8J;.
M;7K3L60]UXM@+(6YYOK!"C9\)HSD00IQZ\DG[AW&%MZ-UMMT,,/7\-S0M/M.
MAH8WU>@2V:^@3C"-"OZ@$^ZFHM5.#5)L=NC[EYHC(__8'*'^77/DQ[4]_ =E
MT/\R7:/4R5S"<@[F[49AWT9NG @R7,JJFB9,EB.7;V6_^RKL\^&*@?/P[%3+
M>KU0LIBG@1_VVRC.42EXAIH)IVNAEW<4:]1.D15466[!)G=8ZG/0[=DI0E6@
M+ZE!1IUMFKS4&'F9 >.26<\M=*W[5WJT@EN'HBVLOXQW=X\H73 (2=/ZT&7R
M/[\A$(/_"+B2<(+Z="D# >?MQ_>KZ0(%:>)W^\91#(H\!Y5$D<+9CN(.L]';
M(ZA*N+"JT$+AC9I9/*QET*18UFO0H"9:5==M\/'C\]'2RG<,%C4+)T(_8GX+
MK$6_>TPX0ULFG+-&,#W+>WI77UKZ78B[[%49,?&:IU;='HBLG8)6!32+((V5
M!NCJX4_3Z\4FO3TO\3X5Y BT0U^WSK_@"Z/_Z OD_Q:^L*HNW/J-YV7#VXOO
M(0+NAC"LQU1! D6*CQVR_(6O#-^@,<QW8<G .RVU.$EY8EBT*]P=#<4=89.*
M^2'5L^L.O-Z'8;%^>8_L(P,O:;8TGO0](R0(!YB "^K=.VX[D%?Y!U+\P>/I
M[!A&WR_>?E8/B9O]T+,3<""_]*&/@UQ''K>91=TZ2X'WMUI=JWA_+&?6U'PU
MO_S0K0.W?0\LJH45HDQ_-"NT=E^Y9#95YY4P/]U8YYDV5'VLT<M?PP.Z4#NT
MOS\1UMMR*]TUSV%OV]SM)F*9\^-H/7GE#5)*F2HF4FYACGEF["G[G8M1<E';
MW4A[2=VVPQ]'##@)F+IU#[&GJ@GJ^=?*L3Y"R3P6<:R,6\NY>N]/K*E0TH&G
MC;5GVR13-O.OCIQ?R9;B^_:;D-/>8*OIEJ8#N WL.PL-R%28=>Z$2C(#9M"&
MB6#'R2 ^WYH[U.^CO)G<B@RAIJ$AWV^N2V8"1VM0W'K!(Z$B,WLLKH,).&5G
M,QL83 5J*%0:Q8$[-@ >'<0DM8.@]B1YMP^VIP/#OE<<PRXAL8@RLVH20-;]
M_G"A/N!0\CR:%><C,#S6LHPL0?VH#]]^+*%=H@!-KKS+"G4M1;A.I56Z2%6_
M9 //%O:V?;DRF!"U7*01LS18,1[^>;X\J]<_E>Q7X9-6X]B&T#!-(J%V?^[P
M/^"IXAJIYE"IMTV[UPO_Y<% V!BQF5B?S%>1F9*YS)T%R QB!N$)=>$W%GP3
M+@(LB)A$9R-W7X'^4:($4#O?"K?A3@XOM!Y@-^.<.--G(H2_I=-+E I[G#B;
MQCL>R/MI-P!OGK0D6R6Q=8M-NU:08TBN7"2&>U]09+E-.":";,!OP(_!-U C
M'&S8A@N5O"!L 3>9LZ48@$X5+.34@.[2A&VX X,4<ZPN8Y2Z#2?-\6D?]<XK
M2$58L:^\N3]\(?I=>M]&S_"6$F(%]IXST/61^,/MU^O'M<H.HPQ??0[JOJ+E
ME*L5$.I8;)-$ZCTZ7.G^H,R]L-*Y42KW7'.X\Z/&C-G!7!0Y>+A4,7!Y_%M\
M8OAPH#D8RR%M3JE4='>MM"O2<"PC.6;&1@=\(PV7-Y0Z/PCB1?,"<-@ABNKW
M,UM;HWG[\*/4INQV.*A%7%28HF819?C^/!,"K1Q\RFPT65OHGQ1!MMQ[WI<B
MU.-@%F7C9%^JCF89"VQ;-_\)0L+7:[C9#_SZ# H0ZR83396@RQP9U";>L#3'
MBVE]$[R+G(E^LL:7C^'" >@+HLI<R?9F0"*!RIHK40.O"VY%/L"9 ICD:#$K
MW$I(:O6X?#^4&<FQOE4S=T2O@M HJ.<=FPKZ\/XS]17SAYE*QL&%EMS9D;)[
M9]7=[)5UTEQKC>C=GC-_1*OJ'21)73GLCK9^_]BY:,Z==-@N^MS$X"LCJ5J2
MW6.7K#Q-E=UARZZ=M-; &YY+P55LW\-#Y%><5<RK^Z6*3I4.UKO9^:A%+X#:
MP93$FX#WQ)P4G *(W Q.Y()Y3&IT7SIQ"][($W<=B$E=:CT:WC1H3)0]K_D,
M-IJB[Y5)>2[WON]Z&"Y3CGYX?'&=PSL@?,7<WI4@@@1CLIFU!7RY/I;'0B3[
MN@^-(H-Z)T&#-V0O:@8"2+8'?2EC0GIT7\MH-!D"ZEH-( YC.)4LU>F:42[Q
M#X3V0P+MZ'[=J'(PI\,TDAS^E +C%_]HJFM#G +>9EC =,UHSGEF#X<BYMRT
M O;,+IL-T89S9Y=)9D.5BB\O.1[P6U$I,S2%;G.$[W2O[SX0K6[:ZX!\[$(^
M9A<>E8=PT*)5&MD.WHM@)I1?\%I^;3DE3G7!H)C:1_S/(R93A(,BB-CA0L"]
MZ(0)"TY6HF%2M-*5HZQ.C@,SN56"A90$J[OBK;1W<W?RCW.RXLG@G.)2S<*J
M[6\<*52U9]AZ4=-5=Q&D..]?:#$-)C*"GITZI"QM#T_*0YA(F<5>P%8=O)<(
MBZJ4.'SY<9A9IX%C]^)$]\PA3>@=-L<LP^W4=@U7QFAURL/2Q!I%[1&2SNW3
MV>K3:;F%:<^?/&G^UQI<_?_0X/+_K^R=_+OJ0E>AZU#\W7U"Q34N0M!&/;<$
M.A. .B2KB;\Y8C(;1%%9YP@T=3&JZ%J8V,VA)B$;Q,K$)#M!FO%="T;\6\\B
M4ZPQ(9L61ZC']W*?\D+&]?&H'_7PYCJW2QG1</^TCK-S ]S<B$O7+^T0?%)[
MI-M?8&)>6]#LOB./W*-[Z:6=?F5_8N6]L]5QN$/*"G;D^AI[XEP.\<O\0#&L
M;IID%[4VZUJ$N1#*+-2WW4=U1 9#00,T(_L/(G"*FDT '# PW!Y"AI\\2)QD
MII=L!-&<?4OL&/Z>&'$HX/0Y,;316/?*/VU8T> UMM/4=5EKCGME#3AJU_",
M8YJTY#R#'KZ"6C1;R>T?/#E'%;-V0W0:-9@Z5F+X=I!+%N0(OS_GZB@AF"!S
M1IJ99+D)[+IV?W8]^X:?A;.^=\^QYB&$"S#/[DMJ]17G:RB34DE@R9AZ <Y@
M :W)N_YM&/X@2G+64A5XFOGMR(^N[K7A2U\4:E1.A:QNJ<,^FZI^-E5\N/6,
MAP[#N1AQ(B2Y:G"M/#G/ !]VV/>UP_KN^NW[RO2,28)KB'WRGCI2GAK.TI+[
M'@"K_BY0K0#MBOM3*B?"EY?I^=T[FSYW\7?W"*7#.$;<=?#[LVVXP>(?]B^H
M=94+!&#QD>$"(:0OT;R84A;$E@FQSU0X@9*-B+5)$,)#(R>9DBANC4T[Y1=@
M] ;.J-0S I:QSDQ%LO1'C E;T*!+.](?#FI#^0>0"S-BVTN"&\3>%2*4#^&;
M)K_@8>*10+X(0A-[5X*14 X]QM<0KPT3N/U]HQ=-FDT%'<4XD3;$B^$BN7WQ
M7!'DK*" YT1MM.ROQ'7\J.4B43+TAEKD6,/<V=)X;L-\BSVLN=*[.!9[QXWD
M\XX7VVC1:'XY=\XMMZ),T:%;;3:#@SCJHBHH<U8<"[3(_5Q%WO+-W[I<DE5N
M5PSW7] >Y)IH;J45FW5N=[SH1&S%YQ#:=420R3H_:7%RO823$Y12-N.L!!FM
MACQ?$,Y-X4@D-Z)E/ZN9@'D/0 ]:9GEHK/Z76\CDZ*6M$=0M0IU9-8/!5:.K
M34;[_M37+UMVUWS2_%X#=4)0BYRL%4%JF8MPGBG?"=0$ZH5;*WE:^%=X).=+
MP8.WV,M3370>-6$7ELY:?%W,CI0]TS)TY00PLU F7D3OL%7](_:M;PPV)V<8
MVV[.K[ETKH2]03^O[^./-V$SEH7*I*S\0)TA]X/1I !-9R7*OB)-[[1*V.4\
M*>Q;_^D@Q\*H*T7[;KMDY,2,*PK5DZ0.XT)'L">=2,F)AZ?-8G,2=5Y?(FT=
M)<7G[S'-LVW4<+,S\$BX/]"T(CM)! _'MT]H 2$T26HD&=2869CAA0K?4"56
M,H]8B[-T*%,A K\%6$N[@*PS_*UMH%& M.78+'SE!,RT"[5+UL=5X]"M "%U
M)7++6@<FNN:S&@QH;,T?=R"R*OF[#;FK8/OWC5^"<KX-SY9_KOZ-L87CVLD!
MONIDWQ:L]_C)!N@&OB6PLI[8&<^*4.YYFN,V\GC7FOOP:DW(F>'*VS.NHZLU
M[NS7[ZS['?-8 LT;/YKBJC??8#UZOE//7<I3QZ1<J=U^_O4#[6./AN:.0^T>
M[[ER\4W1H_<75V:MJJW?/STQ%?7>]H[_5%*GC;)W1I#D,X&M2['78++&8;;.
M )WV>-_%]##[G>9/')K1=Y_^2[4@[N^+P4S.?Y<J]5/73UT_=?W4]=]5%WJA
M;1+];1="600)("=35_I#T!^3_XEV]/RUOY?+Q1:GT$>%=*[<YY&/PH%/7#=_
MEX)[/&3!O=O.32;%Y(BQ=\'X<E:%6AMTD8PYUJB&69A 1SA>^=:,I_;V],G%
M^?J--@ZOV;@ 7UG,/QJ9VQVJYOVD@:<UI _8ZBYFV)")JO2IMK9GRXAK;)]0
MW/R]]+!].=U-25KJ$S/GG!Y$)%IM%%]#HCW0)$P=O4D [O13OVTO!<7P?H_X
M M\.<Z BB+M"6L2 [G+.JE$?@>7,UQ=![D=/$OG[C#'"XV5".4,:<UW33U*,
MV@*MQ53+?$5':^/_7L%OZ5P^8+@XS)&>?)Q9*@;B%A0CO@FHP*% 4PK5RFNP
M7>R*O,IPH4HKB-D2S[YW/8;.Y;80:=D95^>K)\";2[2"D4'#Q,@@>]^#WQ1\
M&KS4^DX+PT20(&2J>!&CX(MH3C67!!I-8MXQN7$#J\RW@^S&;!HUW=3O .@/
MD$_U(ZP>.9"QS!.WIUXHQ$(7;I#GO$O^-HBS'%5>M/QUD*^)__7YP(?S)^I]
M;0)7O6RD^LQZZKQR+[^*WV"_N9MSY?(V1_/\/8GF>236YQ'2-DO?U J2.]E]
M]ZR)6Y/FDK6NR\?Z$KTDA[O^!U]^1!R]X]YUV4;"QX!^5H?%D=-^0TJML2NJ
M4\J7+R,=2]0>JBK6D)/[TFVS.B_&U04LC$"6O$GLF@?*",NJ<("$EQ=!^LT!
ME% 6)@;2OXTN1P'*[#Z^PCON EC&\[/G&0C?$W[!J_&/@!(\>YP5>#SL3[X7
M& :T=+DTU0WPK1Z9)B\V5&=*<)W 6Y:5_OZE[6$A^L*F1UU5?5&R%B]:KL:1
MD,[4R73"4^;B 9Y#&*$Q^P5A?,8%L,FV/"3L)"HETRUBIE#T9RM'T-)\U).1
M:#C,B_8RC!5I9 6TC@I5AG$[:WS::T)A"HDUC4BI.3_9IN%6S4ILY2G.]AKR
M4B'@=T2G?>K I5?+9\X_^3Q9>><L8%;DRGFF@UVS,XO-(P7L]PR_<+ X?'_!
MDVIW.[<]0V=VSZ@<+#%]\0E\+[_]L-^U&UE!>E<.+EQ 2B<D22N[&+IIIE8>
M>ZRLFO:P''8EPC6]VCI7 ^:<;?YP2A)/$3M9.>@C@IR8;T>"IT*9_&0;O@XZ
MD;KBV"HKYBB=F2+(7]'\,MQWJ-^+'RDQ^'X?(8CJ*#G .4< %C!9(DAC3 =J
M3).EFMAWDP*?O>J-3N$?N(]%.0(>J=,<AMJN)DY=9(0/!Q/?:H4S(<+0L])B
M]$OI-LEBTG?8A*R2^2IBBK1YNZ!&3'8P<GBZ*?/)6H9__XH(DN+=U>7@P\Z^
M^04'G60JC/%M!BP5S^"V#35\D#C]G".19-*W$XQS$+[B&*9'FNB*()OF\"K#
M^5UNSUK-TWS#6H*&DZAS\E?KBRK5\TYMBKK;*44QDG$:K5D-=Z:]88QVG.6X
MN:MVYYMN QJU1LIAT=JT!E*EQ]C+H2Q[ADKJQ[N4Z[!K";77# XE2<LZ^'\6
MA#^*<@,:]C][KZ^9ZE1]D_'(UWQ(I[O</$^+5NW:]L#M,.%WXC^X8/\_^BE>
M 3^(!ER(:MCG#")@!4UA/D$S"H#1=LR[:N[-P59#3LC1>S2A)$?F2Q.K= J:
M2%'DV-![/9PYADFK-<?I+<P$DUZ/3LKV41/X9N;GIO3J<;^VBFIS[]DU)_X,
M9XK[EWB5*O$C1, 9.J[,/2"(%[.+OK%*[HEZ06%2<9D7EC#E1DVXT!K%Z?ZT
M=#+9<P1GR^)!=_-_!7O)$>GW.S!QI.LY[135-RN9&VFFWNYE[","ZZ^N]7>C
M:(!C1$J&CCLCZ%NT854@YTY5<^)Y*\7IE>7WK[T<]RC^-4 ;(<'(L&9UF/%\
MN7REN^OMVUEO*8>[]P\4FROBN@Y6<>[B)23M#<J2:O0Z'P?E=9G1^S;K/&O9
M76Y[-J3OL <I.:?P8CFLIJ-GW?<?,G,VZ$J5)GPNQFJ*()*9XCKRM_EOR\T"
M*G*RS _^_4F8PE&TV/JAT"2AOJ"0&DD8P[@#,W\T]*6,,VE:5]!0OG-==B=\
M>RN"JH P_1/[E0[+IF?O^(!-C3:4#\.KY[2/NU<"7^P_+_+M)]_Y;K0;-;Z^
M\2@8R(8O[A1!)#8+NT60)P0Z =0B=D#?*7.]P&I V?T-189OG<-29=X4JH7Y
M:8L726C0_B<:2Z 7?LBZRS/G:U'S.6<Y,KE^ZK5@',<)=SQ(Q3M1F'J-4#G;
M%/-R,&%2KTM.IV$B\F_^<UTF)0Y)E6A5\;6'3KEM.[2G\(4;?;+Z3;5C&\(7
M&FB>%]JD/?X@;*SH;=^.@^_W:@UYV>P("+/72HI)(QW?F(P>>Z: WIE$TJ/E
M:RHG,YQ)R:1$\F*I7>:5LNWAETA7"'X_YJ#JX$8N#Q1!.$9":2@ G3R4-R5=
M+,WU!ZF\+: /-SV'M7DFL14:%1/(7E+ HCTX&C6]HYE[@2(U2X5#DESIL(4
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M)EE-\D[Y[!K\F013DXJ7E4]=2<'/7450$;!6[(RON$Q6QL(/J/C(6EQ0TKT
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M1)6$$$-;H=U_D5ZQ5-"Q]%W$0RSHLL3\HT%?.M)0\(RFTH+6(MAS2EW @QE
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MYB8>0;DN%@+3?4"3/-WE@'P,VVS?51?_*\!3",\9<WY@]Z &X5:?!'-\R.6
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M\Z6/CFMMM#K</S,)JP67K=J^V%^5>!&*?P$0RPI-O]65,8%2XJ>F]&B0WM&
M7SV-4SB;,,W$%40\XB?FEE@=\D],K84M(@I7D7JE]F 5.Y1E3'2"KKH\_'V9
M3]T)S;--?AQ'G20+RH6+M24Z(PD'-F&?0"/SPO[#O9'[K<*5S+(Y9ZHLW.@-
M[%&1<O#6 XGWW^E/5%L=S2=XUWG<>?P(UY,?4J^-[1<07AX./@\WO%V@WI33
M(P"UM:)= SE^_&E0[?]B[TVCFLK6=>%8-HB(D4XZ)38@ D)LZ VDU (4!*3O
M20DBG1@1T"@A*:5O4TI7(A 10@B-*!!0A$1(@!)4I!=0((E(+VLIX!+2?/&,
M.\Z^=U>=7>=^XX[O?F>?_6.-P6!EK3QSOO-]WN=9:V9.3SIEHV?!EG V_42)
MEE/I?8YV9H7EG0*--0K/?C1V8B_A%;..O*  [.->:T6,^+%6PJ"3H"*7E%2'
MC",KH92Y]XZE=J_'2;$))H^ 4CH7*V'/,\;OB^#B\,?" P.),11,%U;.MNPD
M)>1TT$KW5?0H<>4"T,$BQ_H:07-@WX3;/%B)OP#Y<. I*HJQ#%U\"" 1&[6O
M%"H^T1=UG=L; ";0.%[5,N[37SUO]GX<O+A4$7W]T^Z#*RMWT,/%PG#S_9"P
MKVU\%WKBP4B2H$K??E1VD4T$3F!&=X<BE)ND)M )A1LAG3(H\318V%#E@3\"
M:5T'5D:=2.VF$JU$":C6MFX@<,A<&X\%[<3Z-'>5F"3<4^!K9L4B[%Q%N(!6
M+,0OA;L0\OA]:^&$UYAU# V<"":4'%T[-HP/%^02+Y%C_=G$C>A@LWTLQ+J'
ME02X#<!C7QO3@HQXU=MG<NHS(;&C\37M%<)QB;R&1.X RBF*BLOD/ )OC :9
M<LF;)X)[BS>!5RI\PZNL(V?\)TV<:(FMQIQR@YS.*A5";Y5'7YM+IY:)2^2A
M@4$U!;6]F=1VI=G,*H>#ZEIO4HM<#70"P-)R)[;?T\?ZF2]YEG0KZX(#SJT.
MKW6N.+F 2M=2"C02JP2&;LG3F+J&^4DN.46EN@6QE4^$-+G(=!7YQA*5J=9=
M4MSJFP;$%!7]597$P:(!_#KJW)":3A^EIS]A8-^SWG,Q9J="'V\VJ=X+Z7+A
MR1AYYL_,'^88:I 3?'X =&M'U!J40U8<Z682?Y\K6J+)YSH@M$%(0/YVO0&/
MWY!9*O8)U0G9:MG%WC.K9X1J?>?H?9>J*J=JLO?Q$3U-/@"Y?1RPPT":B_/1
M@,7]&@'37)Y_69 O.S=!2=.!+T@#")X]JSO%=61\P0WTZA#*X^;%TJ.+U>!*
M!.J7F7+X'\&PPEQ.M7QPH<&M87IS>)-'H&'Q1$ ^>N?YQY%S+A7*G%J5ZU&G
MSSJ7.[987FZW+@U,S]_E'F,%/ZB=;F47DE^DG>VJ;=Z9?QAQ/"]<'G!HZ2^V
MSBI*Z0JYX,SQ&:!ZJ1H[MU@6NMV*XUD3,6RK'9.V+J6SEI>IISD:"R'V< $\
M%%,/G\\6(QB!5-D8.F)^YCYN9*WMVMCZ&H! !QLXI=G<>]T[9_+2"TDTW)$A
MUM>Q_;&N3T!?<D6(*2$WAO.V"N%6UX^MG*?69GS\J$2F0K5K%L)N,NP#\ ZS
MBW ,KPKI(M/(SJ16&;P'1)X@)Q[!/;25J6L;+ 9&<"SOGGL^,7OHS<I1%KUM
M?>Z&U:52CV68=;(BF/F0.1PH^6Z-NR'C5,\GP&!\1,4<FDY<&(GR<9RRKGG:
M;[!NHCJ!L7$0M3/7+8*E_KF-8WOATQ=/X)WNGM23@U@L/>RP;I34:,7=YCZ.
M?9O]+2:,&5)-\M47/&VRGR!OFD;O$L'.,=^NV0D*^*%@C4WH*T4NMD5L%'#K
MV8/D.G0+)K$QISGXNC\7N;T%M&^[$9B"B@+0)PM%L XU$VR2VC90%3K)WN%F
MZO**B8<"-Q>[1@:2V%U2W<H3T^U9C]UG;Q=G#M1+6N:_VW7@8W:%2RPE.7?@
MD8*.;QX-7?$-X.;[%ZA$<7(Y_JDK$0E'ZLH[)'^A: ^WZ?"\RYV<5FHZ:0[%
M!EY2"BD=O<4A&5F$VC7-2F'/>&UW(D&9!5+9"#7SK=,8"3T#Y;IH8JII=QM\
M0S!YZ]1 U7+%N/2[X,O0YZ_>L:V]LX=PJ;;]D<J5F2ZAO]&KS+_:X')6!W'[
MIII<UBQPT@1%W%'N% N9)+:ES+0F*1Y)!6?3*E0#QU,8YD%C4I /5X<H@RO!
M>7Y$;\); 6*13E /$NJ"Q2$R[V<(LH!/>G,C[EF;(8]U!)?ZX]W)Y@9A*-//
MQ[\5+?G]^<6&BV+*_-4+DEOY"=CT??+I5N AF4O<.<)(G,#<).Y"A:[]B"/;
M0_Z5>+=!@SA3JUL/H\@2P]"]YV/20WRGF% L9WS[PP:J>17E_5R*@0^25!7
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M0JS^$(R =&M$,)[^'ZZJNG%@_3ZAC$!"^$N>E5#J(A-ZA0!(T^BE#;UHP"M
M!&L/]4V!_?Y]PLMQL2G9+V[NK5&D\*@5?]\J7+!.G\3?,4P$\X8>_'($S4&\
M(4Y+EA GZKO$GJA'!-LL%,O!'VW%W;*Q'L._0)_^%Z#_OH ^(W8%YX655@/"
M8S[F[2/'NG=XC;[OP 9CM_AXU>F=493:&5+;:K]?Z^0>5':UU1_0>QNQD=^D
MOS^1?]PY*K9HS3?B8>?_ *7X?X41VO.C\M]!"?K#G3V7SF[ZN[[YNWX9;)9?
M=_L/??-W_6)0;?$O0/\KH!JYDSUVS>&2O?JULC,[KFQFUBZ@'N_SQ52<DGLQ
MLBM;QN/Y.Q=GV1._F,[^W0[TZ/]ZP_N_.Z#;/4MF.TXMOLPSS]UCBW%*EYI9
MR7 U_N3A:/!><B3IOO:!UC(EV):A/X ZTX,>F$6OJ P0EZKF0OZIN^B_(*"/
MR[H2)VV/G8WLJ2N)K&D\']57.9"=([FEYE&<0L#N[<<W;-]L0GT[;:KJX5$;
MU&ASU'.T]FCP8,#=M%,VAP^)]=:=TR]0>;T#Q ^*-.)0_)0P\X6C.[$C/5=P
MPXLXG75_"_&_#1?^UP146>!ULL??-#"W>":8Z5J;OA*\DLHPE/UD-;KY7?K-
MIW;.$^?#?<+^IYW4UHW_)=[E5"Y:%G>M974'C4M2#%U%QC<9%(V<+@OUW0NJ
M5?@_"/(TBS,^ZCN;QZ":/2131W[:_$7OTJ<]\4>,C%\Y[S'-3#<-SYHR$:OZ
MO9-BYV5Y.,WO7E;)B$.*;7VO]7P*/;B'ZD@/^95BF:7I6N59FVX:2>M+S9IU
MSL]+V[.9JO7]"MOZ.Q>)_[#+^M440;=X/O9^<*$.@$G61RA"&,]?W@>-J0.,
MQ]2YU4U5%VM>K/<.SFO/#+]&Q3RO91W<'^IUUU^V33V@H7A=\T\<TX@"TU^S
M3;,F#SA3C9_8R<6&9VDJ:QSH/&)KK;L_+[CD#<V%XIMMNJ3M5&5)-W8I]LSB
M.69[NNREVE%,?[VDH-4?ZQC'?1>P@[*C[\Q?T@(TM&(KH/"O@>/<Q86V"83B
MC+EL7QUQN'CEU\0)$>RF'M[H7*7'[(V&A/-0Z$2W$OUKZH7^Y06_01',1X6<
M5/VSHJE982Q5<$O'/>.W2[*AM&EA!Y,N06(&(5.8#48WFP)+<.@SO<0+F)$;
M7R>J?_F$.DR=<_7,J.*$8M=#7FP:D3M#QVP/=1T2[C9:??_./JK8,T@EO"YC
M[##EX OUSZL&5_(#%-(BTO4?*5W<@90)21[)0,^.NX7WC66NOE?#52=\9K9>
M7ZI-4PB\=3;;\LM6NV-2"<V&U5[(U>Y!Y^6O>QDTKSOVIT<,H=LK'?\P<$,Z
M8"#W6ISY%KP>E HF=GQ=+,4A.-A;* =P?5M#CV7M.R]<=*NI[J?F"C-*[6G%
MD47;[+07 1=J#N;FADE76KW,7L?_W&N._+ZG6U,H($T,Z9; [5NYT/!X$+6O
M%.\-(.==RG%67$(5F-E&AE_HU6?*C$*R:RLE?0SMF3%)H+L=JP1%T27KCIUB
M!BS*0E8L<UWF&[YR94A>6YPI-9V7MM_+2]%VT.40=$.O&:5K^J2<T5[@[>+R
M:LOVW(.5WV)6Z>71*#TU/5GVT(-RIZDFW\"3DBX.D8^-\SKCS_A8&UN;CU .
M:FAVH7[BO5)]&-AE'6_DI)A\)__RDQN?LEW@?<2_8O[JETA9\=]6JIRA!3JG
M>YC')<6BK#CDC5#'REXH=,UBFK =H+94IZ%51+"@9^B4PD-0 0AGF:L#%V@<
MY"\K"+F'EU#(B7$IW!'#(;HT\GG?3*-F,HI'Y"7K&H1M:\441W:/B& 37]G(
M[80.T\36\8RQ=?UXN35W1+(;9EMD*10(2K293K7K8-?C30;QYRJ"S97 G()J
MW#4+:!<7G9A>/#YK;M8KU(.L/ 8>!O885"></ E02;L+0Z4KSM\MV-Q+<Y+R
M>CO(0KF@+$P-*LY-VAF'0 T*GO&FOT8X7QZ8.F:TY3+%L<JC-5V;?BY]YY>#
MU=IU,]SIM1#C,H[VN5G7(BL9E3ML#I!BEQY2][%(^VTE:D\DU36*YDB1'*RP
MSA(^^JN,^V;#(C9TSQ=Q%Q'!B&U\-&@H_'H61+!WV7.0\?@ 399]JB%B(\H?
MM+>J'WA8+53%::XD]C=)!0-R[014>J3TC3'X9LB+:U==/39KNH->\G;FJVEI
M-C$0>[>,V/(3^KPMDOW57+49NONPPS\0E!WEZ"ZRIQEP?EBC@'R0H.$]NV/D
M"*3W=26O#HI SR\&5GM!MSXAI&9W7$/+[PU#MC&P<<O[@KDVT>EZ!XDU1WTO
MV<^_9)&'RYO(CNPOT9J:"DZYPYCAIY8.3@TZ69YV,\78A31JY@@Q).!=84_O
MU.J*:N9(^^%\6D2T5[2%LJ6=XD>'+"_78.:COY0?#'NH8XU Z,2LP_MPO\^X
MM(%2'PZ'8K;IDS;/,160*"T@DX=F=TORU7J;H@W>$:2?07V\Q83O2U!/V,?Z
ML\]ZV)?//.+;@XBX3_N!-2_<KVP&HKFVG]H+2BQTK1T1)S!Y ]Y[S 1$)%<Q
MQ15F4S!3AB )!7*8K>@TY@YS36CMN4IUPD&^OT2Z_F(L>:LY O>,^RHQO@J%
MI@4WF(X]JX)TSO3A3:[39AK127J1KT+/UO9-.736GK9,X^7P)K>>N!3'BV4;
M#UF3!E6+->P&'%E"P1,3PM17ID23T;U)AX*0*R\_0_VL9WZ[P2<!IM*#JS4N
M#V:_.!+=!6VEQ6N+[_&$F:6O_YBI5(%4G@0+3<+ 44:@%T<B+9*\"R?1EG-A
MT6JH+N<)Z>*OOZ^,9-RNG/&,VW%C**')X?ZLC/?TF!:0F*R_H-EF+@MNS"GF
MC,L%K=H]+1V?61'!-,:%X]_G.K/@D%<>M1TSHMB27H0[ME)$6@EX1&*)8\$X
MC+OTI84H9P#_P0LW>@JRX(:^J$81R+(H3!3E>-ELO0BVO0E!P=D\7Z6.UC&W
M> 1K<=VS0OJL]#K<*GSC#^[7+MT'U]CR).C<8P.=]N+RLC43)ZKUI?S^<9UT
M3."BYL8;.;'EPSD_Q)LJS/(.U0%O?WO:R^YO.T=[DZ]@Y.(<;YU]O[SUK'>G
M<PRUL?]]T77D4^9?#J<3#>(43""\P'+LDQF'^PF[H8K6/*RX$7@3@-KV:A]7
MH@5!0FQ#70.&SD)/(\X% T-.8 ,+B< ? <;91&G(J-UI]JQ>.BCA E0U_#)E
M$^,8"*I?GLY[F:,VS,..[)M@LDC)YMLA"QY1;:9P%RB"I?-E0#FN:W+QN&?(
MJ\ P0 3CV#(R(WB+RA"5?745+U0"D EU!Y:;313=048M9U37E_.I<LF$KM-\
MS/'6FT*OW_KRJ*A-AG(A)5F:\=7*3WJ*[!4\RAJ#Z3;2GAE[B^E%)ZI,>^DF
M[;:LHUTA)T><7AYRT:):ZUUN>Y,E7\'5/A?4D6>P$^NE8/E0Y4[SK)^6<[%4
M?]R#9JM_+-@GF7&(!NS\,["OK5 !<&-5)ZG,KRZR=:78OIJ0M_ (Y "F<B[=
M!%-9#)FU]1#9$](0)VB*+PP(C",8!.=)E])*9T<H4ZU5$6W 2)#B"F%O]M")
M)ZEG+W9+B2O&<?1Y<?G /6L=@XM[A(V4\^[B+<KA8EN8TOR :,"?EY,,1'.I
M*4U'U9[J%=_':T#@0[QA'T.2[SJ@]P 8;!+NHD/7>"*8[ ON9.^G[KCVNNV7
MG@:85 8X'NDZNKDS'1WJ>:3%SYGF*%A<U-:T ZAK*4+^'=*GD+FUIZ/&'[^=
MX=F%O_P\<X)N'V#IT,[)#QD0='^:>>$20K%?25'[X)6[.#VS]C8B!ON78O<;
M$L *MT24\'T )+MZ!Y3H4P^M0\02L4^) =BMX_S3@AQB\*N39T!J@@$\I9'$
MZDX4[L@8=49(ZT62TL;,?&17$?*O#"8'&N:7'X9X6I#;T8DJ^$P/CSF$]?>)
M [>R">V(]0;VR2K7V-4IJV.YP<#5%>E]7&9J'2*6O+,I&NCC="=]6GI+MT%N
M@OJX';^8JT#%G-Q$U'4B-N(<E@I)N(!A#6F+RV%N%F\JE[26FT-/]RV:A@#"
M")OM0*I>^R"[W3&N[&RK7X6=GGF+V3F+UN NN1-&5*T1%RW:E35K/+\?EZI1
MD>C></?G,D[ YM<&H-)+W<T&&CX5M"&GTO[+ Q\&W%M!BD/'72?:BQ7J/^:J
MET)S@9@; I&)IN2$.EVO-C4#T"H9Y32A9*[M@7/BP%O@&60UU+D2O%'SFNQ,
MH0G(C"-LYAM"\5Q,HIKBX&3SFE$BG9QDZI9PL,GB.G5NQ7-G8_QX0M/)3;E?
MJ.QN2,N*]5Z59S0OQ8''ZQ!!-X[5 @G)MKW*XP;>)"CP@Z![%QC2P"*+)!O"
M4"2U7"-N:]*H"*[F>C3%!%-8H)Q]?T9Q!?X@<#7WX2P##3#CEY[5@1?BL[?F
M&K"'^[I ?$UQ<M663-:@6"*TGJO@5FA':6R4['[+J3 ^H=MY)3;.*2?A2=JB
M%@LS<D')ZL!@ZYL"8[\#KZM,>(?=\1J*COD7IC:;OBW?$G''(6X_=7\Q;=7J
M+P?9YTO/Q&?6">[P#7A5_L]5.MJDUJ*KI?E6=9 9E[SS.-#%'2OZM]4DD(IV
M[D)EB+F2WM<D>0U8WTI W5IT[XU,MVHE[(5R2T,;W9*B=!#2LSF&-P3]IJ%+
M*N0%VIII,%'- #E\3RC+5 Q%J^KK6K5X7DOF(SC?7\RA(K 3BY![SJIN=ZP!
M=B?4T$+>MKRX$8=H'9DG[.Z3A2M!#>P;R+B%A[Z?7Z]YTI_UTMT/U@@[7RZ)
MI<\\H4Y-@_B8:\"RZ'-D(]_/G="CJ\^*8-*F=7VY3-4Y057VG BVQ8.0S8LG
M+OP6<_B(R\[+BU_SW.X4>[230!6*0QGCM-<,\B^EJ";4O6;!UX VBCLS#B%K
MP-RN]Q24<.Y?(OT Z3S';!.JX\]!F3S59KCU/6]PPY@2A %B6WU-H>2'P025
MWCW"-Z!Y0RGD-V4!#-#;4N<:$\B"8FHJ60J$\^535PX!5''5D\#;@HKM6G75
M6W&+7$RJ4 IWHY?'H;:Q>$3(NW!#JE=F&V+SL@B6((/;8I],@$/%_D:)R]*&
M0YROJ7R-(MPSCZ']/7QTT?1JQE,N&AZ\^J XYX)[DA,ML0L<F!G,C%?)NIP]
MVUK96_9.JU-^4OF%ML&]-*]@1UK4)^L!+_VN0WT5]C*_300Y%RF8OJE*9?46
M*)WN=2AP?UT28*<[]""K],XENGK![ D1[,)?/1' STV,CZ)7 D'F+7,=_LD:
MJ #+(6[#;WX2BDV_S'<%F.D,25PU1S_1JA[<6,S_"9!H1TOC%#L8V^D#2UY=
M,?:LKXV+"947^:>#->_>MZ=MN%PG5!".HFL3V\V<V"H2<2@?;C.2S5"%(B3:
MI9B2?'O(!*R82$R+PL0K*BKNP  UW\=7.AJ.6L?%(G#;1H0;^J(0.W"JUN".
M1,IL[JI>+@WC&:*RDAQ6IA7P-,W?T[$+?)RQJ\U/XZ!NE,JV\+C[%49V_?D\
MQ_P'U,Y)Y98*FN6'"%2]8['21V-E&]D2 ,Q ;IOT.>$4]UZ^W,CEA/.LI=W.
MSB-4_7F>.B/G+XUP-2>1+U^Q<@AJ*\<C^Q@(ONO@L@T\_4:^BD0K1C5D?)/0
M!#K)L6(C%;KO^^#2<*JMX\KX &#H1\BV''_B5B?+Z1$#BI9(AZ?7C<O-J'3?
M6I;>--JN8DXK\KPT1FPY3CP_"E<UNOF)L1>ZJ6Z?_(BOE-DQ T3S+HI@/^R%
M'IO-WS@%74<N:$BP[A(#?V_RVL'4AEP7+3.Y(6/NT(L+0-C\95RIY%+2<H[M
MO=8K%%3%D?A3Q_L+3'X.=\@/IG7>R[\_HV6YY7+^SCP'I[@'[[F]G2:#]J;A
M55M'#Q9HO7*,=^<!-53MC.UEM/:0BK32F?YXBPWO\C4E-;K4Q\5N_J\>OF"T
M^/8"!CH '3LF)O!?FJZ!FB[U WQ8H1PQ164H0:B(]_V^)UYU+ :X][XKF/.;
MT 3O!1$GD')\'0AA7K0SN.)5&!C:[BO]I ]U^%HI],PUI:-U]>'=2I]IOJ7@
M"?I"=3Q9?HEXB[ ?I";3[5,:Q7=;D."^SIX@)R(VF^OC_08^$11QF5Z@9F+D
M8E*UF$52.8L9NF$HF4VU'#._+F_08O(5(Y5S-68'5LYW9H=0$W@YTF2E_4IS
M_MV1=_ALSRM5-KD22;GTXLU]^>5]=*-NNT-5EE=HJNV'*^QL*<8-5U[5E#6F
M>!1B%"TK@P8=VSF9%,\(FIU\B*;#%9>L&9>XX,Z^K!GG%-O6TS%&?\WA/XT#
M9XG#LO D-Z+T.)?>AWF+MTV<J!+!,LY!8: ?;\*"U*Z\-.=SW'R'K["W7K@Q
M=P57!R7<\1V9OJ8F_00J0B3IXOV/0#OF[!/;;];)I*[9$,;)ZXB!<]A4H>(3
M,/YC$>C$"62U@8%)^@($YUK;>-+8!BB0!MVS&%ADJ%B BQTBV#;4ODJ<W$3I
M/>Y:@>FQ47O(DV$($;[Z*O^*2SG6Y;,M.N;G=T?P@Y00_7TYO&Q/(-W:(4=N
M>_Z,=>1,>8_OZT\D,T^'*,?+=B4*BP>H"D?S2PM4!B;O3IAE2W9F>U1>4"YS
M3=-VCE07\_HE:Q=UFF'I@,DSSR.A"XB_9/ ?!'GF1B$BF(((YC\^+(*MD,"5
M>](/FT&=E1#("7S6GH?^!67$30\9&W<#<UL%$AV$?7UX.8ZT29,7S]93"6N@
MVH61ABZU-=ER4Y>\=(\,TZL\G8W0<H17:, 5>TN(%MQC[, '">ZK?]]K4Q[O
M"[6 5ASDK29-"G^]H 3Y ,0FX]$\4A*(4VQAPO<BMAD4V'.QJ0;(1*%L[T*4
M%FI'7I9*=9MB/UZ".G/#*$-/EX%P[S_B_;J\K5')^BVYC+?G9O5. Y.A.VSG
M#+UPAWCC3J=;&5N>9?76.28:/.7A"J]G]^*0V+3B!'>^_)>MJ,<&>T[ I>W<
MC8U,!K+\)9_R'H%IJA_O13@PU:M6J_YR2(&D>/0EY,V&!F9=8BK>!NQ@W=!D
M86\2MD%'>43Y:7-]:!>8.4%,%\*#,/)-1\OG/#>,RQ@04Q5W('E5;MR3'JSP
M"?(6G!>G(Q;OQ'G!>,4Q\[<!T4G\X\6'21Z")H),*&,K)(*% 2P'T(X,5D\L
MSJ_QT*0=:"G&,?PV:!&08S=V)-29Z; =9@BZXF" SYZ/2S9Y\$BP4:C6(I8U
MICW4M*UAA"@N@E:G>Z,*_$_V-UG<EYH4D.Y^^2RP40QJ,J4YNGO;FCH')%$3
M:;:N!=:'5EPSM&.OW#F;%>)$LW/1<J8X7A/49G^FQ1 E7FDD1=(Z%.-IKDV7
M!P[+EUO':;G>JUCDA%*4?,.S3;-F+0L\HX)9"W\M%Q0$F>8ZN%1>QWSUFCX^
M'(S)2:7B:GG(>0$0RFU(T1<KE-%Q#^@JBXV1,=\)8=M6!W)B@VFSINV4T <C
MLYYM+U5\&$45(;EOW#LVN-U(7VY]$8%\8\#R30.6Y\[->C@7N5)4DH]13)TN
M%Y!=7BD&#H1<Y<SUL=\4)9>,4I**[9J--+HT[2KW.4H_).58SQ6_^4^\L:DQ
M_+_\#@EC^G>338;Z73XOWB1^. 5@!2D,-1&LSZ( =F.HE?A-3E'87IU$7'W4
MY.1[VQ<+D(4_M8E@CRNX"&$E4GZHY(]K6VN4X$2PYS=$L%34N8E=$NUC,H/\
M*& %(?T.M]9RPRI9/\RFK5"B <PN^%3,D>2?XW0=&Z:3I$]RJ]!V_<@F(SUZ
MX/F\R8+XA=>_#9T=>0TNTR$#*MYO$!W(''432@V+TT.X:<!<8XZXQ7P=H54-
MU<N7+%9V76,/,79"</"98ZS=%]V)QJ<--4C8/>=&>EU38UW?GJ:G]35-A0<6
M*$OHMY@5CJ "'8Q(8FX]/_#=G&V !/?-M^"/ PW)4=A=<X@:-S91)I@LQ[S0
M?*7C1Y(7,'8;//H<(X>/KH)(;2N-GTI R.03ZIA8:<U>-<WNQ"6Z]-21X!U2
MF!A#S81PYVF7]K.TTQ/3/Q]I<K%^DO*(HN76<?ZW@]QZM3Q(_OYCQP0U@P [
M=ZI2+VOMXLG([EQ6N*5LU/3$7%_YXR=IA-!XB@W<.NI!V<]'WUVPM9%Q6OC<
MGZ-B<%B6HG*[E6;W<-];3F\YX2D.P57\A: 9%,;%)HP9 T0V4NS6*Z:Q7,1Z
M<:4 +R0T#MXLLR^9&SD6,B*](+@UF[>?%AI1.KMZ_8GBC4M%6+."#X?>6:B'
MOG7[W+*&$(Z8ZPORB/[5OXA@F\RW!8M@DAK0XIHC89C8X)H^@9$1OE'39 "D
MYR)8XI@"Y -&M*D=@$B\\23/PNRH<Q7CH\&NIO7)E&F&:F^4&=)Q:+GJ4N]@
M)_2NQ-5H_!3T965:4,H/ RI65@39*"LN>=AP<24;T)P/Y9)'CG(2VZN'OWB!
M#4F,+;BNB::(]Y 3M],P%DY"\J\#BSR)FQ-WPHQ::>$\'\<6_FDN0A)BS+Z%
M;G3Z'/6:9P.73 N/-&L;:,4X*HW4:;E4.6HW/8JL1<QWWHTK.VXX[<BFM9>G
MKM13/$NT.K-5LO=UQ/&\-WKO4*L*B2(\=5IOV>RIK_7B389AO6>M]?7(4-L*
MMZJ$+(W3+Z)U!HKLHOP]Z:97A+$5+X4'^"&0$8"V:  UVZM3,5L9VW%7/W\8
M'@D5P>3QUSG8Q%7=@9'R9YZCLXR# Y'WE#^=./+XEM;(V<I*MPURX")?-EUX
MQ%8\VI8%=QXR],4E$DZO.K&V$@/MB9G08<*""[7Z?-'QUS 231)&MW2;HC53
MEA<(,?[<BX;I5_"!#Z=[9PIW#B#'CJ7O^ZG/_\M>[&VF/S9>[0=!-?,B$3I
M7MBS9H7S;\4HXAT JY7B0>9YQ,U".7 YGI2Z9!^+WFHN"SFQ3*O&BK[_\CTT
MYYJI:V(,>,P;Q(]\;."N"S,OCJ'-Y +N/AXCJ1^87X(_+&GY15!2VZQQ9VX_
M&:#%Q@6X*3JZ=^),]:>U:]*TM#HO55G330:T(S]F:?=?3FO6OCNX]Z&J.@YU
M\%QJMV.!-N[%D]Z6OHPMN)$!G49MITK.9FUGFN.'J!#GV*P9)Z=\HC]CE]A-
MA(+1+,,Q \@>A#\?ET>I1A_\U0-JX(RG1L)5H N?<(Y:&@FCOL!@$6W&J4L^
MHO6SE<)HHWK/49CZB>@\/C#$V$QX20;LN\@CY)4%("'S(=X(^$#>\ E_$L1R
MX"S6 XC(D4A&,A1'0@B[:\&Q7&#J])LJW3!SO5#7Z"9-S:2PY<T'HXZ%/OJZ
M&MQ?;;#+=^K+N*68)\L(_4PX'P%$K&0+BKQ6X(V"0H*VV$DQ[G%%L%CB1H(&
MKMA54,;X 7>2MXU:.LV0!0-3EJ4#VZZ-;8=N7I\06/F\&>)B$O F$]W;QF8>
M?)J)'*5Q^JJK=S?N1'L=C=(Y_]H%:%HJ.[LZ7LOBAOJ'G'6A_E*\N;-$Q[5D
M<:.+=8%VBK/JBDNX_+0,)JEL,J1@Y^SAHM0/%;[,?D&IIK351COFHX1SGE?2
M-"WC;6B-CNG6=4]#1T=Z6?T/F9<,L".*$SMNBI.8N++8 8]=1?)U%N5Q$<^%
M9L)!*'>BV4BXG:2"8\T3@63<23&A7QPL$E>)T#8U+>&;[Z\Z(GX<)+15A!(O
MU0I?UC6NG3DF(#!_18]T":\LBF#!/XK[)U($6]Q7/?<Y;5&=DGVN9G5IKK\<
M9,H'*K6=%,I>076\#Q]8^T:WOB%(.1O=>?QV(#T";^=_@K(ETE6*DZ6A92*"
MM=9?SXWN]$1&:%&=[.F>H4'L P]2OK%F3J0<N/_#/SC@W0CHP'<-K$QX1=YJ
MKLJW! SO<@K<O$2P^"JJV.($@ &%%3&4F!SL5AS9-1B5CO!X\Y /1A1[/F@8
M;7J\(9.6]'O/"\5)([YYQ/?-98O@$YI"61%LNPCV;<;MG=@T><*_&2$3Q-K5
M2Y\L.(Z*QKPR(T;B-G(ZUH-&B;]=[#/G5#;HO]3,^Y@5D-IVHJ2\T3FDQ3$V
MG*;0M6$DH\ >Q,ZT+?T"WF-5JT5L4_F^5%1LPF=M[Z.LWSJO7_#QC#OTALT%
M!JC)E<5.<$?O98K24T:H8=TI0;B87%\3^M%+>_@;Q/V#X2)$,#-M-.<+F0X7
M;":N0P.Y4*((UFW-W%=6/<+D;L6)V_R3G8TX'!7$S[QOZX7[YV:T1#"KU%1Q
M(ZB2(MC+Q#G2G[7204P^^8(RXO1)2/RI."8;+;SA\FV7!0+<A-(5P1YH:H@U
MA@OSVV4B^WV,!GH:#"<*Y3GH;[_^;V$L%N[NB&<N_?2!"6DWB&!Z<.A>=0E5
MH*:'%%^9KRF"'4$\1 /?ND<2A7'H7\B0#?^D"#9%L?K3N'R(DB>RE8 &85+^
M]Z557$6PR1813"YJ*4L$*VX3CV'(*4X$^WARN4.(,%D[*Q9*B8#<]PQ((O*7
MROX4-3_C 0F*5=LA@O7(W1'!)LK'^4_0W$N,.^0EW!.FF"4OD_F_$YZ('>L4
M.@2QNEWX Y&#!.$B6&$VXH^P,;?[Q=VZW;]U?'7O%0Q?01R;7 F^[5"ODY"D
MJ"B"<>S$<.["AQ 0?FI!?,4)Q'-[OH9PCPCVI;?X3S!7?#9-0?]=C,74G=RX
M:DWLX8I9B*_52ORR9Y7W)[%T)OX1,L'*P8I_G"1%G$Y^001<L$)O!&B$.6V_
MBO+&B%/'V%YX'NU-_&,@27^"M_KWV0,B6-)A#E8@8X(4;A&;G*[8?X[1YV+%
MWV&U4J!8@X'_P)?X4D)/Z<D5RI"2S-TSE"_<=8=#GJH-.04LV4GK^'7'-Y!?
MI/RS=L2_TO!?:?BOT?<_1E_M]XU<SQ.#1RT*_ 'D\ZMR[[U]&"+85OQQ]=,1
M>VX/7.6?]=[M=V)]SOJ*PQ^K_A7V?Y*P_RGI$)X+V\CUX[$B6"A\"[VYTQWG
MSZU/O%3%)4M8'$W2)!TCUC>9K-!*GS;V:J!0CC9F [%D/>[I31K8#X;/T(GC
MV_$8H*%M53.C2:KJ/41DCR&>97RQZ[_XX?S/G59WL>%*>_0N?G(Z]-ZS4T6+
M>\%UU^9O:H:K9H A\;;?H7RSK(DGH:;4&\.$<W$NV5JN:3Z/WL[:12EX:V 3
MKL3%T)6O#)1,=FF[$)V Z)GW//1ZL%3B*.^UYBO^"<Z63\9GONY]I1F?L[]0
MMH0[^=OYM[_U/ "^E6Y[33G@0EOV/F\"/(FW'W%B<T2P1D\=#O%M\<H0D+C@
M,;%$;XRV7<]E)B[L53L(W,T^ZQ/G8CFTM/'J> 3%F_GJH$VCEZ0[Z\#PX^[W
M"L+K4]\VA;&4ZX^J=Q^*NFR2LZF8ZAMO46SO&46S]54H<XUU.3!8.FE79:)E
M4=?]-?,FQ(OG6W'PU+0G1H:L*6]TP3E>4@OOT.>O#X0J;[U=E#T?RNV**Z><
M5(ZM5G)CN<7-]-\*=4PY4+US]?F#E .P_W'\D% A@NUNMA$V(=%+A=9W6$+4
M1>9<[_??AE"LRD6PWY&.(EBU5+= \TZ)V..05)&K2_7B\&O]N&/Z00KLP'_R
MT/G;9E]>!NF54;W,^:,!_-+[TGG@^/=%VOF*:Z?X")#9@DQR##V+.]F1L\/5
MLZH[$7F_+VK4J,\@_1BF#UGWK*M"U_JUSK-=F-./GJ5C(]?6M/B9&Q<*!BIK
MQ*/+ AO?YG?(O=+02-(3AW>5;=[IJM*LV>68L _N:! T2$76FD;M46Y9RG(R
M_K*3N?%> #1?<;2UIWWR:2%<(?>CTL&?Y*?] /<1.98?0)]8*MAIL86NY1S;
M>S8_UTF<.!>8PWV<J?DJX/L4H$WF2O7-Z/@EJ73';UB^ TUL^U9+*97CMF4A
M*AG4J." TN#6ZZ59NV-M>NNZ-C](.:R09Y)SVHR;HOWXMY>NYU+9O,?T6;_'
MOW4NAQM76@2;#%3[UKVWIH><7M1Z;<O(&U:O3.K\W/1,O>NRLKE#+&MRV-<M
MCC5QA+]M1QXEL?5GH*[8"IY8;&=J6:!]-FTO_:I;6/THGPC9TV9%L,=&"V%K
M5]%MV 3,KN7N!$3=US:BA/ -0H)Q@+]+0!8>);QI-."3 %8+0Q(4P6ZB?"AX
M&&#/'I?%2;!]E<#]<0$]7FVK:B0*KH$U9$.;'JEZ]?XAI=0]DOQH*!%_&K!B
MC=?#%XZ!T9Q%MCAV,R(8O7H!6XX/ I"L)^8JN,6.<25]=(+:?D $^P4O!<PN
M=A"WFBL%%1J"Q'B4165]0107(X_S_'K"UHUSE52VF:#!3%R65F6[WH#/3BK,
M#KX6-&N_*53-*3V2X!7?,1 ?'7W1W&V+_'3Y]FRM2C//<=<B)QE'K(RR2VQD
M\!NJEB,A9FOJ['+9:Z6'(;B#EH&I73-V\>^W6H::+NN@+$X-QK)[BY?SEH"E
MB4>?TU6276F^E?L\\%_7//C2F)' %3]H;<U<! LIC46W(^,8IE ,=>Y.)0G[
M8%:H#@A6R,4A0^$G[MB:Y=RKL FX'ATF>_=2V)Z\L2/5>Q]!1AS20C(8R$'/
M5W'0<8U?YQ/7SH80ZW-9R$2"/'2LE+^_QWP=WV&(L1U:Y)8F%TT72@.+*?J+
M(YDVP!*Z=C\)"&2KI.40D$-X'RXR[<;&[EMXM;R%0GJ 8LJ22P^2Z%/VT'N_
M_Q9C#,WOT>WV<T6I&:;91JZ1.P]OD:$XRN7+YP-O\\Y2MUH<*(\BUU"TE?*/
M.:T4&#?54RZZ#3WZ[>G/CYU:NM9Y/BC>,HN[YC! -3YQ)86:PG+./LTI?]%_
MOYEND<3R<ZMU%L'4"5(0?.46$=(:NP<&\H@W%^X/5C,GLM";4#*@1,?8.B Q
MI9(@>1RD$X/$0L[\ -C-JMX %?LT@1L<WP6!F)&0[4'7"@\PP*U"M3 =#(-^
M:V3UG>9S9BUU'@0_CK8A@#//?&PXQ+;Q]0A)PH"XWKJ;N;7[[F= UWFZ1X4*
MA&00P\+4&22RD"I0X?5Y_7'(LHZIZ!,ZHB[<,$#W>K^WK\U-)2&G$-&OI\ZH
MNRV"E:;H]"?*^VFU-V;(P1%AL=18ZVT.\<9]G5\N/CQ"E?:[DQ#F6![;Y%S6
MJM+NB.K,UTVD:<OF(&60Y](*];XX9,UV7J^WOV?<3XO:__Y,88&6LVM6L6?)
M4I8?08GPHG WB&"AAYU6+ 2)>.R:%-\"R@5')Z;2"+OPQB UD;$7OQMT):V9
MXO8)%=J?7JL*0= -D]?.A!*EFIP .4S?DLZN(T@$'ET+8),-$*DJ4^D&/HHL
MPQO[X[G^%>-!S-_&=PIW$=[XH@2)36X33'F^GE@FQV*$_:MP=EC(:^SPOHGN
MYW 5O*(@22@59&J_@%5DQT1T,.$'&>OXNZ 8('>EH"\0(,0&:(K+> -!4]@K
MKORHXURTH@VXGC6&:.CW&^*[<;KG]Z;,M(+8@<-1A^L^=_J.//2W,J1IIE1^
M !]5^59Y1DX:]Z\HJ2S*''B=KM379K<]WA2:77HZTYVI(&8]KY:^Y_VOM->V
MF(1Y/\C?L2.%U$^QD;;.]GP<1UO#QVQ,2*,-56O_YAE!<XP\I*]]Q0YQDZ '
M2B0SSY.^3W;S).S$VT.*8$7'T'B=&XFAB[\.(7F81/0F/A:4XI#9I'7X &@/
M9W$=BX/9B7?OT;?%<+ZVZE3'KD[=BGJ/[N@"^]AD>%V!9HN1BELRRK#QT\WK
M\K7AY!I=<BHZL%N.V&*&#JE6XAM"+3SF+<1V]$0ZL:9[_O68.F0!W.L0P7:B
M+(!8;F#<TOM]W,H<@CH4"B2R"+K0W>")[J3571\,J[B"8RV-RQED'EPJ:!69
M'+5K?Y?#FU=,,9.FBV _HX<#N? 4?!27N1VGV>Y:@W<>V#W(T(%L6A$[&6;\
M8Y ]&.B2T=IUNHD)50%.G*_L\:UX->AN>'70:EA&.G<*'+I)%VLM6WTO]SK2
MCO106TP-N?KBP8/Z%5*Z2)N:NK[(5X:](RR[ODK=HMI'CQ[5QNLN'*RLTNT]
M%NUEXX7CW1H9V<Q+V.Q_ZH&%A<NV!MF?A:73CBRW*C=5NP+4H(O\H4=9P9-U
ME[5^SM?Q>V]"ZUL1]EZ>S.+VEZ', N)8K[:I=,1$^>GX75[2^CG0]?J9X @N
M5='M: 4ILT/K34OYX\MET]'&]G=/.(17/M;W1<I\&Q?!-@Q!H>#ZEK%- HJY
M!NYKB]I>* "Q8+_FCP\4E.$W G/MX<>IN*E6M#1#?:90H@^O(9'!/WSI"WP]
MU,T^BW.=:A]3!PPFV8U?XZ/0\O8E4/TQN.+QAS-7T3F-0\^1Z4-H9;P7#7&+
MJ:"G7T&"C(D3Y/8UL56$W-3T<NW)$RNI@&F?+0-JWCBT<M3+!A@Z/<CUDF(B
M.O;A?%DN:9ZO*BRNWCHL.-+C;4S08)\#[V8</E?6Z1%OZEQ@'I*B']R3C0Y0
M.M9Y)3S>^'CGE2O9^27O[IEMM=_* 8U1#1(';8,Z]&B.Y;0NV\YFZT["H%.*
M0YP\U3'"(<[9/TJ)(G_[VWHN>?C.5QYU84@LG"6 1#9V/?0 ?HN(8/Y,ODG<
MY ^^GXJGHR$+ UW'12]H+H K9;\5ES$[N$ON+'@M]MS04CIN9*;Q]D"=U(M(
MG]/I:37#WN18AJJP$U,_M1"UIDMX;[X;XG',0I\CZCZ,US#%^G\B7UQ*(Q=W
MCH:8RX@-1C>+N:DN"742].?:9H]5A85BC>+%-0J1,E+PBI'+TWR:>68@$BL=
M?.W.*T2B;N1'^QE&2A^\#??NH$G0&]:75N6?@IS+* Z<,9>M!_?/E/;6G]NY
M0\7X]P53YVSU?B^&>X;L<VZYB6MUT@<:ZJ-[2N0[K<H3KZC)^0JGK[QHR+51
M3BG<XM5:Y>9"/5#\;1$*G2"K\0,ATIJD^QDRX$A4G47 \(&A8&B[N9+@OE!:
MV"V"U9!:NX<?3(E%,*L@L,4QR)"Y/1+S%LVI$;YQ,]?.;5/$;&LZ#(Q/D-K2
M UO-U7L"GX+,%'PXIT"*Y>GZ;)^YM"?> =K#ZQ[NXHS/ZS&!LV1):+V3@*H;
MV9T^_IBX$+YF,J>2."^N&T<GI,?(#\552'X_(+%@Q5U,W!X\IMI#V.D99,C0
MA$YRF'%,^F([=C/4U6ZT*DU*P!_FVJYGCVEEBRV2J3:5S9^E&.6>Q5UWR#8^
M=W[&9NNL-:ZS<)"!F'U<9.)8:%C,ZF<YMO .?-:R4IIS80]6ZT->M_MH@F(?
MOWV>!AJIMRJV.E)5<%OLLK?:#Q;NE:G:NM$@B9)<D=8RM'(G[E%(^D$#%<1+
M<IJY(M[G&>0!(C@&U2WHC&MJACWHB6;3:PN*X5AX"S*E%W=5''=L!C%4[#YW
M!F'D^"8\"G 3T$QMTL1R#F0\XZ:?;&6H#Q(Y&Q_C5#MDH*LV]W"378+[!B*8
M J&+"=A50]K(>2;H-D'J0']?+1Y+0E\D)A%DH/ABO I8WPRD<A59S(RQ_: B
M.UV*I_8,G-UUU DZS2EP:LE3>ZS;D8H_S.O>-4V6\0,1\1- 0WRDO=S<#5+\
MZUK!CVYM(R2^W/B*[0#*@FMV=9'S-<4REX?8*;:#G6!BZQPZG;BK;G%XKFW,
M),;*;K :9<6M'LZU@W)#UXY!&5_=AY8JX+*X> -R@F(]0QU$Z7)];HP[# 4^
MZ==8NHSWB,^VMCG<.NA^0SD!89".0NI:9X?7A7!F/5U"7%EK.]&?RBFVEG63
M*IUZ)8'6!N1[:9RMSEK]UR_II;+=NBHF92M2KU"M<S;1M9?NI:M$'C8?EPNI
MHRQHF.KS3/6L\VD#!1N_^1"ID!"93MC]"*HH$HXPI0E2H>A:S7ET&?_0O96-
MD&*5%1<Y4NL)$3E,A5FUPX#FPKHU1[P*Y,1%9""V+1>HLD<R<B<PDM,WJ!WC
MP\]:\N"_+$;Y6'[Q[5LB*T")[&N^ 6MJ?".H"[C&<>/+>+4A%,PW\?$ %[\1
MHJQ%XS \NT1XJWTJ6:8I &A=X[8QVPOD.&RAYAN4+@<MB^,NMJJ\'RRB>(W@
M[50,AFZ^)D>7SN61DL/TJZQ[5[#BG.;A/4S.41)6Q;*FO$BEL^#23_U7O#OV
M9<U8.-2%#K(N'*WR;+Z6G 7*!U\I.U>\4S_:O_60^V]^S#IM.XJRG;./-6K!
M)/"Z;[1*5("V<'G+_\/>FT8UM6U;HW$K(B!$0.HB6U&IB0H(8B!;45 0(S6"
MD UNI(B("&B$F*C498XBH A$10QU1"I%3" )<!01J1645%NI92V+N#35%^_[
M<\^]]^US6WOM>\5]Y\=J+4EKS#G'F&/TT?MB%HX-#S=&'[W]X%6F_M/34:C#
MU3FEGP\25H.I3 3@19XRD"J1:H@OT88H+Q$&SY*73X34 '+O+8MGP@T7.*N)
MYO,D R(22N.?3R?%.)\07NL WG%ZD.OQN,, HV#Y-,'K/C39W^G>JZK"-E['
M /X,6]L^-LU*B>R?<U@*!?+Z.:J,TS3(+)/&IZV''B+4%F4P^,^[BL+T  J[
M(/ZWB48[>$X@296^%C_$FK%Y! SE)AL8I"*TGMU>##2'9Z-;3J]L&?YJY/7K
MV,C(QR4W&:RN-7 7,@<7\>!-(6*A=;YA(J@,>E975(1_<=+!K(]O,9QWR.?V
M['6? JL]LTGC*1V-/CNJE"\&N>A6I;/?OZ8TCM=*BM;O0B@H'MG@J9#6_0$R
M=-;_Y-4Y/F:;.U*?$S;HEQ1=[59>'9Q,<D3'KZP6[YYL8[SI[R-N'R7%Q:_#
MUW>[[ *W?F-QIMR%6X"L;.(6/(O;5VM=F$.+)6I#68"@IU(;>L+':LOC9#".
M9QD/7]SEQ%CZ"OKRD@7XBRAG4$/$7,TF&I'9G"(Z"F*(W.=3^I=40;BP!J#V
M(0N<3*_(/50C@QG\#NDT+*)754%QHD/B(Y+R+XQ+# UKL0EHTH=M.9^)VLTK
M.,GJE:I/; 4#:'?QJ9Y0')><S=C0I<<=@B_\P#(-L!NA+(\6$/%U=5@@N)I+
M82%RP\P@+P'&"(H2G6<S5A-BSLMYV>EJ20M?U5:J3M+%XG''@(L3-*&S@?_H
MDCW#@47_=?S+BAR'U8,7?@1?I"TGO-GZ]6GCF'UQ@H*AEK[CJ0!5?LQP=4&U
M?M/1BMBC;!XX[ <47=^$5=)O:XZ)\$?YLIQBDZO2\.V+'K9$(UHA+40KO:_!
M/G@<L*=Z7KMG-E&IHUDZ-'5BDW[1G?QB?5W3KU&^2H8>-;Q]0:^YD\W82]@V
MQ24!^$TX."&#Q2.G#+@K3&2V$_P*RHM+?CW00U&CZXN]@--/ =]^;)LU9^DI
MV$?*9ZC/CM&-Q$=:@?-YXMU5G.CS9"[ZEQF"QZLNAQKHO@QV.-/2,B1>I8U>
M=?$KFCW-V$B<HK3!ER9!'"^JAS:UNH>H(+GALHHX43;+)FD0SD*;0#37F%H#
MM0AS(?_[A#T IINS!A_")Z>+=_,Y.6'FF3*8^Q@A5)"ZHAA31F4AX?T\VGIW
M&4RIKY'O',_JW,]H\_,MU1P_4ZV0=I].==7,Z/:<&A09NMB:,_]\5)Q]O'[1
M/^H*<Y_?P@&>P%/3J=BY?,XB*'8_/OA:;4"\@0_V."VC]Z2Z<+M'NZG"+?[G
M%U8/AFY*?*[O>/W\:JT'-BAY^RNJ0H"6I&D;[?, (.*2^U3W2)6JY?SN++!>
M!EM'WQH$3<L%;*1( Z+PL5<^ /!<:X(O\&T?T$]N>^K>.[,)G,Q"'/(*8:9@
MLNX\"EG1B)V25%*B[O4Z/A[[:#UR=&E(;R_HR2W-ZTIU6%I%E1-^5ZFV.!RD
M+1^HQ@5SEN)!G#"1#N6(U*'+;2LYMK%8'53H'<*9\:[5?%HF8PW=D'"H95+L
M!7H>'9=J2">#UY\K_<9RR^)]R.-K/03ZL]!WIBQ*-XX5>WQNO%(57$P(L]5#
M61^JNQ$\O@//:!19^2M_J?>EN96OZ#[?495WA?":$&;L<ZO<92-5W\_\5?_$
M'5]X6L_O,?S:T230+X8+Y"DNGWF4JU4S?B?LGL;U*O, YJ$IQ_QMVW9<R>)6
MEG$VH$]2%.568-!16#WI2TJK#GL%(1U#(QC1V'P$+)F4B5 0QX$./$H?344Z
M[F+X$,BZ\D5>>D. ESGUA!T0NEZ\:SPI1PP'M?L%_=ETPRD(U^V$R!2?B'%Y
MPFL,FY@38IOCE\9!'!>]W *$' 2',@E>M3$,%08W#]VBN"3B(W+3/":2D; 9
M0C" [J,8> G@:Z+I+K>.9+D_'6N(FQ@-: >@+OT7+MJE^\=.-V0TM'^#BY(/
M1 ;FX/Q8 C,K:S,4\UKF3FIK^>.%?G@6:U^CKEVQ;EW25G.?KK&ZB5L^!6;>
M59XIQVT]*DT5PX(Z6XY=#+320D>N^^1=LIF^+:G^R$?_#PL!^2;':NP]"NS-
MCK0N3M:+*7A/82ST6<[N7I?,2I460>-%J?(>_DI> -UVPL4PEK*:;D0PA12Y
MV#>N_0&=,AA[GFX93#@#?%L>KY$R.1N_(-?B5_NV3-R!?NXMV0SUUXG/O*)O
M"5F<4:3TI/6^"HYY>'%Z(V<#*5).[+A4Q#KQ!6"UH+_/FB2\#34+AO+1+2NY
M= V"-MC12U(E1 U+=XFW  Q6""*+N!.DI1%VU.$M><9/@%'VS(9'HZ@0T[[!
M0%Y_^N_ _2?W<72-4G] 0K\KY'1>#SQBDA<;\3YP^CU$BLIA^_='W'&3<\ 3
M]1%G@CJ+8SPRS-PJS/V[F6I:F[":3O:Q?4T[JP^&6_ NG'F[:;UA3.KZ?LWE
M[8]2' VW++(6+2I_R=0Q2*-Z-.#&R^L"_)K'MU$]\ 0KR]%JIR"+I-G\JKSO
M2*$"P,GN,A I27N)&T!B6B,^L+=22W)-!HM"J$)53.F6D956M#H^GAV,Z.&L
MG2^;2*-%EY5K=Y:0&Z-_%#>^I-3%I&2T/152+L8[5[_=\-9U"PY* ]QY@;WW
MH%1Y/M^&3M2(-T "*KY%^(<,=B6;D#KNLFMZD;'&Q6).B@ "<OC6YX45H&*F
M^&3ES@D4(HK+T,1K'FT!33.I#Z$L[C*);:RB,]57&BYA&%,3%>I)1_P"U^J@
M:S-K;_K]:-WV>;T?>$YX+;<J ']\<NW(MS]FO7P&%Y]9,L-&*O02/]4R+T)-
MQM0<:O'HCQ<\PPXES%I*2WY%K!]XP<W^D&C8;\'I\2YCZZD$83+.O>@F\XPT
M42YF,%F4UJ8BL%2JW".@9&)7=?D*]J#UH!:ITL5:/"[X,:1710@N]0/B61=M
M_6_Q.84N:_"6?'2&'.>Q>8B-1/7I>^=_V!2'\U;T.'A2;][]MZYWO&@A\P\<
MKBZBE:2_XLG"=I!4Z&($)4J5S4%:3^5FN6\N$M]1X%_)9$1;(&NH(%AA)9^X
M \]'J$$=\G+)@Z<3MT()0+T[M/?V5-#;^6#D%3N2HE@-DO>)6&@OBI:JMH/4
M')1)TXQ<L'I?#ZQRS5MX5:UKI:#C&+XI37BUAKO@F^E;^O[0!/&EO^F 8:?6
M_(A_^#Y[2__$*I][T>/5LQ&.3@4I(S6?E1<T>H?TEJJ]O'SK40+$K6?>82-V
MM9\'ME<:5P>ZX7-\JP[M:W,Z2W/K>$9Z@,P4'^!R7F.$ED!6WA<C')-N!="6
M2D6.4'ROL0ZXK?3B'2B/1=S\2JH&.1R>:#5*W3_&;1MKO8AS'VL\G23Q]1RS
M;EQI%2U>6+;A9O+U3+"-9G?I@5JA_&;'_,-WJZP.I(R_WSCMG5SG494;'U!4
M7)3R!A&8SNI7RF"%GS!UY#WX<@8LO^9S/7JTP'Y;2<XSMV5KS12%C=Y!1O^P
MF!5K _WO6R7[(9FVE"7:%XUM18LW=@A(+$9>I1H4VB"=1*@Q(N5,4OP+V$2I
MHA6*W8'I/NPO=&/Q;\!+6A/^6[?4!NC$NX@./9GHPE2WEYXX40<5?+762SZ$
MU'0=V_SP$#$(NB!/I%G)?=0)T3'B2QFL-:O_YP+C;L9:>^P;4:_^;/Y7"D+:
M)^=T&57B",GMMCAW9MEL1L2PBTDL?0M 2;-;7MW3F8;S60PS&5:=)4?1M\WN
M:QNS;FB: 4GGS&C$4HV3?B="?8."QFA7JDJ?=[)Z @NU"X^YF_D5[Q\MC[I2
MM<Y#ZVFCHW\BS6UC_1%?DG-@YMGG([<7+L;ZS9VH/[GC-FB+OQ"Q>#*YY;S_
M2$R-A^Z"_*\.C-0Z>>BFC-;O4[_/J&#+XWN7^# :)ET3M/!).H!0=T$17R):
MT<O>((9)5(+><)<#^2M+3T 3'F=YMP!7< (+N+.]$,>!TQ2^D4-8Z_"2V+(^
MQF7;,&%WK2</JSVG<$HSL.6Q?GH8","E2D] 5_<\8=4X?2L>(5PGJ:1"LR('
M:$B8)$]2\FNR,!6@9-J1E*?P?"8?L0$_W<LP2,9FS*R&>@0JC3Z?C-3< 3,R
M!E"].[^KH[%JP>E]06&]SG*HUG!(WN>Z+W4CM0%Y_A;C==5+)H.>TP+C\("*
MC=/4=9XZYN,^9XJC4SVN\P+LJ&8N*89&U\(7ANN/%"?->U<=Z)]^YM;QH,<=
M6>W3DNN_U9&WZ4A1?JQ;_CNG9 N?XN S9="L<!T4 G[F8I?J@2QN_+*Z#*9\
M)5Z'L!' I,GE<KPOA&R$AD*!#T]^[E)F7$'MX,I@*HM3[_H+44B>]9&A/J>:
MX96F-LDNEE?I_E8D3E)QT?%:-.][2S_G(7KY!. K+(8:11[$;OHN2$N(G#K4
M95LG?<5HD<&6;5 7J03TF!R/7#WCX?,4+1<#2,!K+^6C-^#WL%/HEWYO!D_F
M)/#B, <G/RYM'D?:;'E<TIN$'B^S?$DMCZ@5['C4AE'=>D-TH(#I=YN:QMY7
M'1UAN-7-ZU'-)/5(VVYF0KU'@XE3\N;A><Q6)D;A<D_G#;E:.)GJ<+F7^233
M >[D%Y69+PA6,M\=ON!W)T SO=:_VN=H[9%#%#)=3QXQB>) :+Z>.(;8R(AG
MY!JK@>A>^!1&F#2&CO32Z4&W?#$V'W71)/P"[:GS)-4M>./E,-H/-WXJP!K$
M$BV?M(,')O.ZO&['8%3'\\N.Z\>\LM>SJX\O(LB%W9KKDMNG(B!O8(B-EF,"
M]V]AFD @B[$!0DHUR%,AW:3FV?0N;Y$GX0B O1+5]GDYGH@0'X9<Z\060&DA
M@109:4BT!*NIN:A]4P%5YU/K(9Q76^>N19TO,0=2-C[JV'VWKJ_B,"H&\UID
MY<3R+42H+)E9V2/J7Y&M[:H.N.W,"!JG!B?X-V^H#TUU?5G/U+..C[2X#MHT
M.@1.\8VWW6MV9,1C%^V)+6''QX]7AWU*GWM>X+'A>@UOUB--&,73Z9/!H*UR
M:SDY). =]G48$D+'R&"J>T1_$)^C6QTN,=K:9##]O9*K7,9E$B#7:<R0:HBQ
M1(*O2'OX!>Y2]3QY ^Y6K?'+DFTK+UNDHQ-?R#OC6Z0?AP]<N"'FZ-WT87GW
M>MS*U(10U\?T9; 3 X#+9\R,G!@,G*D7QYX5Q2$QR&? L<CC7J>L8MWP#,'N
ML42,I&5[?VHM[;RD:F>OL\N+.T:WK^2:T;9__:>+0.6(!EDKBF^5LD@BZS*,
M]':E,^U#):.:_%_].KQ2A127O365%+:0)<Z'93 *;<I:!C,W+R.]V<0D_<@Y
M;G8W5WH%G?%77?[O>RS=#X[8>Z7Z/1A."E%Y&A@X;L-K'FU=U-WRN.OIDT<)
MAMI"8+_>GR7NO]?5.;^$;3G\7M?-M[QJW3X;W_*I_!.Z]]^;'VJMTKTW'7?O
M6MP3'8]BCW'SX:HCR3C_<G.?:@^-6I]&CVO>&4YG<L^6SVZK6G=@MX?7EELQ
M1E0F5DN\'\"R,<KX-)[73"-.L!@:-HQRZK3P=%Y>7OIT+X9J<+!%N)C*WZ^S
MZZSE =3AGF[83CG=02O;HQ&+:#6441W!YU7KRGKQ7OJP=108D%4=9B\II-2V
M+P_WGAG>%W#HUPU#R;%:(WT+QY:J*M];3WS #B$ATQ6QI@SF*:&T/D'DHC=:
MQ25C\LL:[PY$15I4#U)8HCW7U[R9TM#;,OF^X J'8T-\]CEX>OMF=W3M5^FY
MBYL([KR/#B^!F^?V7F9&F/^QL]&-JFG&:#BYLR@6?W@+?RRJV+OVPFAM@&UQ
MK'C\S,MB1?,($@=Y^_RPB(PRY"Z-H@7Y MON"/Q4I8Z>*^NQ'WELI_Z9H\6&
MDW95CAY)^%LZ>]TR""[Z22?2>\Z&MRCD].W;^(DO#\I95]'2OU\(<.>OUA1X
M+S ^J8PQ%IF?9;!#?]9:H05] ]*GUHPO'D<5.O_]U6/_[.F;<)K'"O4>2GT#
M!O_=L5JK3^9:=LMG GF9 8Q08/2M8E49++W?%U 46SEK3Q^2?^DXU"(=[ARA
M#S3$=-+?) UUS&.GRD[>D51(2AMC2%/G$%/!]LL2\K2U=/@#[8ARB3[=5LE=
M+_='H4;[M@RK (?7?FP)1M6G81-6ZVNLES_[8EA1,3;<JZ[X@G.Y_O4BE'A:
MO9 9>:$$:3G :/N,LL'FLR/?8";FWLM@4S<6=%.*S]P\/PFJER 4OK[='\.C
M=X3MK,H4TJ<:CF_:(OF4^[U*N%]2@>9=E_Z"M^5FB4U_K+!IT/Z7=3\/ %]L
M9[QY(H.UV>]I=%_2WY4GN5,O@_T^%X"(_I0D,16%^(AV?WXO"KD@/4[R'#\Q
MQSL#+46N5[,5N2NX:P:7:"*^IMS -(7S?+RK<G\T1ED\(L5[N5&;:TV=CK^]
M%G??S3/W1<(;M\#\ESL92ZA)K4O,"%NK6XMCMNBEAN38#;6Y XS6,\V9!D9?
MG48J$8MXO%NAR1M1<,+1:^X?2J^03F&F4@68/L14'H_6S7A#X>YJOBU]@= ]
M >UN@.KY0\LQH"*OB<9_&H91Q"?VX>KG*S<"I*5X,', ,WJ@-,=Z>?WY,.NR
MQ>6 476]G*M#=<07Z/;2+!='@@NTR$?F&AN/,*(X>G+.H^'RJWB'Y!YA#Q]I
M-%^V<IENM("&-VP&MZ[D+1$M9N;#U$:^4C)_9%VFV:WH'."_.[$7*(HIB:^=
MQJ4$E"?E-&T3#TK*I>O%>(@"KDB5OY\'=(1=$$5DCW\Y*7Q".0+TTK*D".D0
M8H.+P0R^D:X@WO5HI&NOH$*'3^O!&D("[X["8[\VTT?%6T'%'N$0];=K>T]W
MDBN2$X&/3Q*H'"+[C-@^C_7-6 >2P43V/P^1DFJ+@^6%F!%#T;-#:DA'-+%3
M<U1VYV0V.A:1,[,*R*P'!D*A7M&.Q>"^/(#!3VXJY?GR2(HQ#&6Q=6W(YN/1
M+AKC;16^*UAX9! 59:_+JQDDU3\;8WKN;"SHD9!69]%R: 55N77 >'1$W5@)
M0NW!T5HSP>+O<QY!^'$J1AT8YA^>5M*-P UHA6G(8$'E,0*3XN%N@<L=,LU5
MU75UB-(1QSI_X'IMOWH._ON(S\"< ->G>W.DXKC#5P> (BCM09.#MU7QXR]3
M=(G:XBA@YFH=/:->CI!H-D*)<&#8;O#T'L_0O5\NNOL#F;2&H&.QM>$7(U-^
M7!QD!^)B+N#.AF]XNV_E*M OO":I(.["A9D G!X*F:) M\'G]2S0^.]6\\B]
MZ-7X;\' 0^>W$\I2DY$NRZ:%R:G-;5^[A!Y3Y=IWFKAEKS7M3N>)Y\2G1NB6
MTM$ISO)7 >D-19@.)8N\Q>X3:&[YC!GDSA_2DK(9+4]7+KLHXH?8/M#T7A">
MWJ58(_Z#-+U:(!EB(Z=\6#P1M'((F$Q#F?.F9; '>,7>S_/ZL]DH=/V"L<9(
M,J::%$W.)3UT6#8%$EF4?WN++44@-J)C,:I$-K85D\&(BH*4:OICSHM,(1U_
M:'WG1I(J<<]\,"(_*0H*J<=7/0-FF2N9'!47$X@4./D%DU\RY35F;  T<M*2
M.;KX$R\I*N%%]^]D]SZ+V%+EXY%>95CRVD.7AKMU\72A,G6\OG.D0'EF:-W[
M?1F$ T[)"_L<#_TXRN_R+7!'N:C9I%^8[YW,KZ[@Z(6LG_M3!O-M)%._UJE7
MZP7>64[(U<W]LGT\]E7U[A.;1-9<^%2(\"Q$$V U"+OD//FG*6Q:-ETMSY?2
M*UT%*/9B?\'W]]&UT@Z,-WXQBHC7P >R.H5537,),4[+[^[GU3ZK?1U<G=F8
M'$\-U:5M*]1F0P=$^R$=?D!5,L^2DLUIZ>6P$^O%^Z7/ 0<FDIR"[GWG)F)B
MX5U!J*UUN,FCAWB47Q8G@NE9=9@3]PC[7S5V.=3.4^#B8^=0U@G\QI-<UPL)
MD K@$/:*:,XA]5C3]<0.DBI2E RFC>\7ID#%/+A&#'JU#!:)?MW26ZDMN<N(
MBE^+Q_1T4BZAHY%PXFC*OUTP=-HZ=I9KRC(*GF0[(-3H.Q?DC"Y9[;% !LLN
MZT^OEI/_RUVX)OO[E./GF;=RZ,K$Y\'PY<_5;V+/ER*:'<1:*L*!">FVD+F)
M8<Y"9^D2 Z0*"ML AC!SM%5BXZJQ<+[3[>8%'CI'.X"<'*>))3BU7ZV^<I#W
MM&6NGHEW% 7[@8[D>)]&0QOMBA3=7/L2FZZ66%U'S\6-VZ\6&YXS5<RD#NG;
M%B@%U*^;J'L@G6 XVR#[!M[XUV:R)&$5^E!7:+!NOG,*4G'?;GM"Y,$N9\(?
M52&K,OLCZLR<7B4+W/)GW8K8J2CTE^9& A'2Y#U%\MT>\Y$%6"4[54WNARKJ
M/$*GK0#'1Z>U-B)Y88WU!ZB8ZAB2AKW*\DD5S.H%IW)]>M$N2B3_0NN36Z_;
MO)P\HZL]IT_89%UVL24@H&KN!:(I80=$ R;Y#JQH=!M![K>P->!DAAC+Q9,>
MI%4D#H)165^]7/>21;KNF\;/+ZA(RDT2+_R9?HID1S>'O$$2KZ.' 6T;6K8$
MG62P;HY:$BT7T6[:"Y\F"9^ *[WD+)=-4!L0Q:7)N>J4+?.\IO0%W1YJXV*4
M" <AVPO5^$">'AWH8'G"<YR&"KOV\-#IE3:M0'].EV=-\/S5 U2O8C"*.;,;
M&I8K.,B,VAN?SMF0A)EZPIO-1WF*X#/25S[2 5)+Z"QKY<VHX!P9.,^G%_'1
M^26,=017Y#)2Y(;/$V2Q+4EIY^%5XN2\GO:R<VD->)+K"$HKH0E?RCY7!.VO
M 0JQ]E[N]M=\V?UPJ\#F6E\EY;\-SKW7FO-H,+>RBAUT>EQH--'O??W!"-.W
M0L'0?8+_OD\O8[??V>>^9UB8#0\*VYSPCT<K,8&.=\+LJ,?XU1ZJ/@,)%H6_
M=)W(S=QY;X=:4'P=1BC:*Z\*&6(-J$"$$:M+*J5K\1V\J'Z:FC@$,)5K$^U8
M^4/4%$?*Q5(2=A4.N[:4QU[F2MP/ P1CD^:GXZ@#)T#M$?$MRL;H\RG.U8VM
MLY[CF\8WETP/RV#1Z"FR=*-['_R-)L]=_"L'*":Q_,0AH"ES:%GNND,,.3?C
MK?FY#YK'R>ZZ*'DB*9;!U@F;93 E]RDY(*(?DEK0K80]0E*;A"':%V^RE$@\
M/2U.DER3NI!Z@AGA\1N)+V:LH600>72$\0=RBK(?/,]&9XS,=\YFCC(]+P)9
MWE ,\/)S;["FU[T0?%YW$19:.3Y&U'OKA>/'PX+P,MC!L>1W.AYM8'ON-[I\
M4 KVK9T EDSB4ABM'^1\S)1)>D,3-MYB(PS:EM%'QI*W0,G 2C]%29S*S:&;
M0<5)HI".4;$B]YW<48=<=D[\B3'9-_KU8!MN5*TXIA9[+,'3K,=UQS.@J)M_
M9L7@VHEZC$I^11"?>H/C5'W9QUMH[5>+A5_)4$Z:'RF(?U?K?;;>QW:I,*&P
M,K2<SRMD\@,4G0=J7'6N9)B';RIY]*=_HJ(.\M33<K.(A%%:0+7'Z)V4)JWK
MT:-G?F0)LR3U)-X^<;R$[")GG4P%N1NQ8GMR+UQ7O$ON9+)4@[*$A'XC\30!
M-:J O$Q;(D'NR63(@]&*;F$\_'DB71MJMQ"[9YEQ^O$GZ=\E@<NA(L]H[$,&
MLYZ4K5^:V88UQ)-[C9TAN6-YI$M)!:X>KZC@4"\E3Z[?Q7I<N&H81&/;3N%Q
M/2D*?1VU!U+Y9%WHROPIU&[>$Z,0GXZ'D_;124-PN:LJL'HN6\16DC;TZ2'(
MU(<X0-) :8I^BT:T8-F(/(8>?0_$X7)R6['9=!CDRVL\SX/GB VX*@A]:)&I
MXS2;\06K1=@+IKR-D6X (E_>HV^;M++#:."VOPZ9Z[3^6*_((,Z0-J*CL-F(
MAWUMB0)D1IB.I!4=.4W)"PYD8:8R7(R@(G^P@;&F2^5>K'X&C8W-.Q0.9+F"
MC(*O" V"XN2I+Q6NO97&0#I=#^Q/^]+2 -VW/N_^&.@JZ;C!LJA:[ZXZW'B)
M_;PZQ>-"N[Z-'VAOZFO?/WKG$$L].#UZ@OU[M'=0BG*3=M"-SK/5CF,T_:&[
MQYZFW"":-KIN9_95&K=D8G++,@Y;;<*8#=1%6-3=2+%_'Y:)0(0]84<861T_
MT^)O$J!!W3L<UB-'F4).Z\PML*B;I"Q%29^7H3/MX#E3I%P$"ZO#B&+DT9&2
M.U)#O'L84$).YJL\51%$KN22HGX>\^$''8-G?WERS%JLPM]$Q5-9TBW@KQCE
MH8M5BX&=7O1J823)!;'6/EY)C)0\1,NKW5HY6W0BG:;D(MKDGS@Y4O.))1DL
M!B%O*P@"(T5_$#0EM^0HL8?'R2'QUH'(-+KEV[?X%K8\?)Z-=(5NH_ X<#R&
MC=5$?H7G)R[H$RNMV_*P60 +)V)P&=EAJZ B:JQ3/XMFB$?W3QVYRE?%,5/:
M:[D,S6BZ^6@K8R-T=KD!Y<IK=/OF^I31_A!<FT9LC&R,GMS96S-_/G9B<N+5
M864UU#>;0K7[VDEF;L7*KYV2JW6'^X_6'_%A1\0@F\*;QQ.TMA??GWN^/7U'
M4*Y6[6A!BCWI@E.2:.?ZYT%30341.S0:PPIW5NL^]W^@FYML8KA+N^5'I>4J
M3U5/O7W&,SLK#O'.?)T;J[70JB5^U+(0;V>T]2\;"1A3:<+;<N*^6OJ2M*;+
M'R>R\0(BIMET!^BQR >_PG/NSVERL17OZH!R[JO"F715R36B@_L:)ZN3WPXQ
M2F0P]K SJP=W(7Y=R+/&AD"!XG*"R$V\#:0N90#!V#>CW,HGX*SP 8CIHZE-
M1U^5CA'WC-+5(7UX&@?>%I^K2D*S/TBNT0B1?'."*\]K,W]3)**G0LN.MN&9
M6EE\LK4=_1'%@O"KA")6 ENDRHER, M]#)8\!3O<BEA3I4L'%*Z(3235<EA>
MN:3]3:F6..A]Z,S4>VHW*9>CNDS V,5%K7OP"+1R:NN[3D[6OFE=?GZR-J%-
M% ^1>=BE]Z*3I![#9%(V0CV)EL50(1I# \(GPRO23813$/6"_?V;,0Y+9#Y)
M=:X(/\KO[Z5I8A>FVNOK8R=_G+S>N9+?Y5^#2Y%VU 3W)M9@%TKG9U.]NR-M
M7VR_H;P[A78,6$K4OWXA87ZRST6U)&Y-W>A@I$5=T^\\_^&J=.:TQ_8BJIQ%
MEX27NR)[!8LG;3(07Z^^;ZTWCUP^VD-J>O#<-,5^9[9;476I6_76X':DSA.:
M=VH %;.XHBB=(*G;P:=,N[$MILL' "R3H]@5#]8SP\Q!]VZ2'L$2>MPH/@MA
M0 -?*#4NH4Z\'XJYR,=HB TA+?Z0HO@H,)1ADM5?TGE !KL4+][*1\H3)"8T
MQL6Q"#N<C%0[\(&B+2>S]X+=F9SIQ&[.PU,D920!PRUP/0;MX*+S2,9+XDC5
M3 H0S^<L;XT#]V$ND=3:D*N]>'DY8M<$P30Y:]>&XXM'\;2#K:_Z"\5FC*BQ
ME:9)3-%/N8X17H:L11[$"=)#'3;R"D6]"P&Z<J.6='3Z.5,"8:WD-M$H-H#H
M#'D#_4Q]]YZ*5!9='W"$\GCU>1R%!1E,G1!ZOB96?W#HTA>&^G%\U3X@*PM)
MP-;-*]WO_[U#!MM-0$DR93"<##9M((1# L%33[G"A*^2_P <Q>HO(-I/$;7
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M7)0MI\E@BLK2(;1NEQ90SW?/_-CES,?%IS,_8M9"OGY0&C?TM%D;4A6?U9^
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M]SC$ 08.@=MRXKA^8W^";7VT.QRHDN,W^CN0E&+38II;W=66B89O*ZIM;YK
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M]O^IVO0_K]K^S[-H41@H7"V#72'$<%IZBSO8C-R) /V.OM2YD*62?2&AGEZ
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M1O$(8T"9?;%[AOX7%=LJDP8]^T*7]#F;#!?[PP2K8OV?KXD1]+2/??L6RCI
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MH$'.-6$PB[H-_O$Y^AP7DC 9"?_:^Y\W:<._G[/(OZ?L_\"4A?O<-I('8;3
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MXD**O!9J+(>@<K_,7._\"8(1UC>"'U-UL_ =_#:N!M'.A4R-;OS"+H6CB#O
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MI=B%NKK1[H?T7"5[(.4I<?&"TVNG[QOO^QDI#5TKRBAY,J8!JSX:AGB#__4
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MI!6O+@\^0KO^.-RF?*8*01/95<@@;]P#3Y<N9F4I4*9)CC_[-9\><7J!,ES
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MWQL9 Y2K5&U3.G\4,QUI\8572MHZI+>@GN93ZI5OLF/@*X,7WL=\]?(-;Z7
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ME/D<$'VPH3?@SUEKZ]$IX;8;?F^<PR)^"LVO&\?'486')E%O@KHGU+"KR2\
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M]9$OI3SS>$$D3%FJA;JSQ89P"$N"4"J#3(C:^+7D-^2]K?H*\%.P+]X$EPJ
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MGM+;)^IAWQCJD<F*MH*//'X&4T!R4?*^LWNT(/JQ[BD]:ER/4V$4EV=D_>@
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MUPKCB^=PC:@NFAIIYS#&'PKA+F9BM\T4J?5;(I/)6Z'WMGFY7+R,T!>VC@6
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M"+_2@3]A-> Y;E$E!'33C>!HO@_F$#>2T+F"SK*<R BPZ)OJ)_F4PA_Y[;?
MV.4$3-ARSCP?&NN8:)AJIR5-H#!KFO\@!O%2$F,654;#6@HBE6KN$9[K]Q/
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M#:Q>\L0P&]LCH\Q=3V]7!ULXZ&ZQWG/G%O9EA_F _AKT*+82*K/4 *&;,S2
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M@^_R()*)_9W-VU6(B7_@,!L$&<,? RAK#P04X@5C.?P^P7TS$>1ZJ9A=)26
M[FNHI_2WR% B66,?6 (X<SYW+:<7L;+,ZLS[8 W"?&"F'0$F=B)EZY9"6X;Y
MEU@[S6PTUOV OK2PIZ,<@)+>"JMVW*RPBVW7SGNT(&&H$"1G&I*2I15TNO91
M;F<PD)M9.^<(1R'DT@Z8C5H,>=HTZ:06J-[7'?H4<*@\?6,Q^K'/4Z^<@S$X
MW#-CY9T7M915[)-JE!Z]O]UJK^JA[1978GZ\NL=!WBFNAFC.@A*V\F/ &"XZ
MA=+BD('8CC^=RVXN$Y/[ P)QJD02=^-W#K<:7./0<T00&:$D893ULRDY&;FK
M76<!^3/?)*H.5X12 OW]ACA@*D^9[9W2."#'1P-Q9/)J+C)MAN>5R3520ZT:
M,\V%\I1LEBQ"F3 .DR&>'4@O"F,@)VAK R"2I],[7HB4CF-M%PX2FQRN\\T!
M(D>'\3J,\XPPT*X'&">UFZ'?"U]OT+)-/YBS[5,Y-=>\>PD6;VGPB,1IBLS<
M%=4KN6$<^M2&_DR/F?[9?1DUU\OU5QZM/E)X&KTG(_9<H7>=6^.L5711_LGC
MGC5N:?IUCKV'BB/A\'J/<(Y>-\ZMQ$KQ4&/]:MGQ9LV<8/^[T+0JOX12C515
M4YY4[337>=>41K;?;2>//SY;.!5U.TC[M6O0OH5L1N&/@'6;7E!0=WU)&<B<
M)O8NH+=$H@%7VB[A"Q$$&HM5Y&N A< ZA]JWG'$:[SI*,%SP:TD6;@/[.J=@
M(".N# <[,6ZZO-UW84H?N))YX/G#@(6"J1TMXRLNR%.C^P2)@C*$*FZ8X\"7
M[^-Z=T&EF/->E-VMT9MJ_&-@ EM@=F83\0 >R($E;=!(L1\T_!,?J&(PF=E!
M\^I'/R'UU=[M?)R9$&4LI\?>=,KXV!V]+?)M?X0[8[@"I=?CWAVL0-5_'%D
M^XF48O#B076VX+A9I*L)5<6UZ<0PU2DO8I@<I$9Z,%AUQZLJO<KK851*55K/
MDR[3/TH"7)&R;K&:Q15.!@M?*USE2AQ[%:I>5O@UA;C=%T&*Z>0Q@K1 '$2A
M*%"3UNTHE,2U<.D=4!GP&_M-&Z^\4Z@NH+3&;=KZ@I@N)G)Q@4.7P!1H6(&>
MT]@MN'6?YXW YYPRE'2DUV70;6V*A6[8;1C"<8"=!=%]Q$?D#A<D1[F;,H%:
MV\I;3T4<GD5+(WY!@U>&V72^7.9: :C,(:HWI[,W*0K'@*GAOD+6X[[?3?^\
MSRNH^R/"+R3M9C6N].6 YUA.OE1M802F9>4NF]IE3*)(+.'1P0"+\9FA&I:#
M)W*(Z<)?AHQ6KUW9M-,XRKO?/$XP'#654?,<65ZA[_##97HEH64CF1(I4:;(
M75.X!D\>++-RR+][2I>G45>]X1)[-F9>L6RO:42HL81]I=%PV=Z^^9&:P9YS
MF'.!\*@=P0O50YEU^G)54B,?_"ZEY$4XVPVDLOEVJKD]3LW^J\P5(*,N88:F
MZ)5ZX8!4FJ1'!T<GO4S_T"U&-4!URT:'>%UV]3S;MORYA@$#',E908@?"Z0Q
M=!EXXJ8'GC"(.,*/&#*C,<-ZQ7E[[RT]%(/:&B&"-)MGK2J KS$/YA$Z8R)(
MF#6+?"7S#WX V;9IG/8+.$I=^!:QX2+,#:;-;MB\])V<!&V 98[W4LUFJ/"-
M"*)!#$>)Z5\3NE/ZFK-0,DJ')-0,""?L%U2*("$&]%V$MW[&2T>B@CD4TD9?
M5KLR1ER X^9Z*]1+GW.-94 MOU$TB@=-G@%$$+)AK/5KA)&\+VE#ZEX5[V*P
M!7?OW%M/GF)T?OC90V]S=E7*?%+(-SP? 3?5>[KIZ2"Q/'JY2C$E)8%9?(,L
M,3,RD^PQ[QU[:.62:0V;=Z3T<*GYYM&6IDXGVAC5T]TC," R=DYW^&ZOZT6I
M4]G"6- ?D)C66:15\D_Q"I-C,Y>D%GK=_''C7&@/[ 9Q-V$?WEO,M_[$R[)O
MKV0?6.^C* F-<;0^I"S_V#U0IZLHQ@>'<1K#NR>4XU#.F[%6V])*U%>!)]_1
M0LEM[ \QOPF2"$H8J]%F:J4_WY5'ZD-FE\J_;?)WJ+_[&WB-1^52NE'I+&A9
MVM@)]JT=9D0)7+D=#Y4'],T,<"2YOP[JGQ!!KO+=P.!I2C8,RC\--'#L"^,?
M@M*]S/@U\\Q8Z4!B=Y ::O>L6\ Q&S$/;G*Q[6(V9]8$XF*"TK8/P=W9G^E6
MQIEX\X1JT+M[S*HEK:G$WZEMJ<[(R'33V5]:VC_10,T %V586[<OASDT-,0T
M2YL:&YM2/!&UM,3^+6//V=]R= ?/97MZ_/1QX'!) %V>5.?6KJ68U3O-4UP8
MO_N ZV#<Q;D$AMO?_VR5KXU\Z)'U-$]1%1=I0M6K;LA&!JF<UPNU"'"1PN&/
MRF_[O9?](!@ /$9J0BUJ#VK)6[JE[',MWK>J?SDS,[?.6S[(4TO"2:[F;(8N
MS7 UZ7_")4FS\)]XUNQE4JL-@OP0U\?8\*H*X] T!-5=FZ>3I!\@!KETN<!C
MG[H75>"3">P[AQ'A'^WWR@92^0?)*2+(RJE6 Q$D&8,5ZC\BJ('F7:JT- T1
MQ .@I:T:;)(5\;]^6\:NV!S\^@5KT#=U(,WXZ"?.F./]K^P<B_*II<>Z0V9=
M^M>GB%VM@(1@QY281W6%V8D@'_4AG2)(ZB! $68HIQ*!J"@1I$>LIJ7+V4B!
M@K&4"#+-G!1!,NJ60>]2B A2IB;^<_#D+)V?ZL W&( 0WV9/BR#\ [%HX?$_
M=L+ 0)BD"#);AO,60;:/L?B>,. 90EX$&3P.T(0R=72P>NK'@MAIZ(9L*TP$
M27F3*3:2Q]^@_@;U-ZB_0?W_$-1W+A=VHWT+WAFQ=9#O'P=,]K7#AOGGHJJG
MYH(.-+SEN]SW^WXEWHN.+65X-;<U9 ])/[\;?.GMLL_%L)1#CO>]7HL?D[BY
ME3AX2%! !YCX(R+()T+[;;&2@1TUQREW]D6\?PKTWKCR:-;^ @[!+4+_97I!
M!<J6KP&/_)U*F#O!NGI.3CG*ZAF,(;>"Q[>H3K6_5.C4ECS<:/C\34..'<"5
MXSVE[P2$$5EY^UQ]6ONT^Z/?W7&OK',5"R<9KYH4^4C9F)F,*QD.KU@ C7@&
MNW$ ]GA<J(9*(_('!D40J?6U[2+(O>!-(R*[$0P305X)KHD!2WWK@*UHX<0R
M4[)$603YQX._FLYS4/@X6ED _4;C6YVC?T\0H]^]^3M]]@8;RK=_C!6>183^
M*T.006_Z(W.!/'1"3-EDJ RD,&QACO+O/5PN.,\QWH!]1H.Q?<2O8EIWXUH'
M>N6W2R2AEJ^Y"&(".T+L:A-<I\_>)O2CP2B$B@CR#2D>A?5.39A.6FP20=*&
MV101Y,CJRL!?QA8J?OX=.6L/$(7R5L8BR+[3_[>IX8C=B&GC#4T+6Q%$MO:N
M"'*;?(?.#A)VL%9.(D-H_*.4G2+(=XIXE.5%,6'XC;'V8RU?!# @@MS9V C[
MR^#_TKR^%IE"TO=QH;H)B]^*Y, N*0MD]^X33W/,1>R4_^'>\R#6%HO#W9:_
M((+LNKTL#(+QH$^DA3=R=HL@W9@#8D]I?<+^U56S_S*V[_RG$@LYYJHI]K$P
M3DPK3\:+(,90D/1^F]A>#CN('+-<XC?9;^;_PE\K_\*OZ)/B4?\R/CL(MU68
M@I400=A'[HD@7Q5A"SJRQ+<BB)78'976(D@AB6_[1<SA[FFE('FJ+^C?;WR_
M^R^=AORK=VF5Q+^.#]#@/XD@Q\W%2@6X,TC\+D5>S;U!GR66$-G#ZB)(/T.X
M;_TGXJ!L%PS,/L_B=^-?_TN?P?[BV_%AY%_'_FN2;+SH1J\@W]"!N1P19(;]
M?WH&UHZ""9MB]UQP[6.3%NEK1RK]4@88V+0I!Z;=*+LP4@0Y<T$^P5[]HTP/
M_)$CY-P\_5_/.@P))..0-F)K[7B36;QSFMA7>('R:O#OHO!W4?A?5Q0N@E@[
M029<K=8/E]FE(2<HX1MP9&SN+)JQ9$#CCJL:]><7*WSKS&R,'9K:FD/=/(M4
MWN;OESO6D_CYWR:7AP=GYT:3Y5!=R:?5"(^L,K?\D_TJ5G'[]H^463@U9''W
M,_/.%T4T#ML_(6R;+M:^:E%K+''IH9H\J4;J'=X>1GJ<83;K5:%M%1<^2DW.
M=O*,>*UW_+ZVRG%')R/3.\E_97#E0F6'+N*&;I#BC],66D0017_6?Z*\!1U;
MM8?^12F3_T+TL/\BK/[B%L@9\2]G090(8B?=10>/-HL@G =_H9]>Z__6>*>V
M_]?&%'W5H1>9^H\^O#9O/95[.)*9]Z>:9[/:O8*9(DMEHY?/_O'RJNR?==A_
M/3ID;AHK(>Y%7PUGVZX1N2__ZM1?]R#_F9<CV;$_UJ?<2V6C^6K^1)YGVW^N
M6OWT/R[4_D;U-ZK_W5&]C$2K$!0=J:P^6#=4&G[+-U!3<[ZYIV1*4M'SUPNW
M7OVZ]:E%E6'[$;R>L_5OQ!L:2M[.X8IY\V,=-88G5$Y\Z/QYMT-=K!@J#0ZY
M"OZ?+/#_!O4WJ/_YH+R\JGAD=@!]HAU-;CTH]*J),+P;YQ_S>+_<ERN,2S4W
M<]^&/D?^!>0Q,&%ZZWC'U"X+2Q7@36;GJ@A"/MCXOVE%^AO5WZC^1O4WJK]1
M_8WJOP"JK_1__O_^NO%?7TJH3:._R\'51)"S-!)]93#L5XTF<=__K4<$J:_A
MP(2UQ@KC][WO\O^RX>+_N@_LI^_F(LBVVX+GPH-BQ-;T\]<,N)\[4;OP%CR'
M+.-V$]"<O<C$]AAI=6^PT@KM>$K7N39N:_/62$F0T6GUQZCF$V#IEM\K9C]S
M_^$/ALWNSQG[8;J$MVC SX:($D&2['$20BF]3=-9Y,XFV@VK\4P"C&_#$T%^
M;]\7(=09;S691M\POY<(2P]2>-( ?,[$JW"4<QU&S_C3)>>5_7KJ1UL-JL()
MOSP9SO)K-7%X1>P<I'S-)N\2028&\,8BR(@U)YN@)$9^N1W"/R9^'A[7SR5V
M84E^>.J:KJ =CV;3R1KR;[TX#L.$/7P\&%/3$\>]9N L$P[,O0WT!<ENMX;M
MF_VEKSET,<6>-9(3KK;O<8P4VP\(V_71LC>0H<#SN8IDWJY=/TR[6E?M6^"?
MWV^P(?3WG@H858*I&89JO BR"+"SIGK",G@M<M';7>Y$NYP\H-FRYB7_2[^N
MWRW7A[YW/M6_1I3=<5L/K'*6OYXC+7]EJ, 8ZC5682"<%[Y' V[+H)[W=>1%
M(@E67[BH!4BOQ8+#'/1>PJLI>7!^PZ'[B5F;09!YX;KP4&:/01C'QH&[W(65
MF)Q]%I5S/=@LAW+E_.B4[\.D#ZS"#%V;Y+5H 94^W510P&I$B2,5"YN07XL"
M=8!^-F7Q.0_+P3)8<KBM04.KFZ^Q7&2RUMM5E"2(ZE:-%T=')#*#60ZZNP$;
M8)<(XH6YIF9[I=#Q<9*Q8D2AO"WF@1!&[ S"JVVJ@<M"J5$ R1!!6N)[R#"^
MDH 2(D@FJ 7,MUN"$96LR':]9I[9PP:>&=^$>BR"BC<%&RZ/7<V>PV'5\;!+
MZ7NV+=<Z+*/>L0 76BH%<!!!9.A+6"!3*-FPZ8V/![_S%KA]B^4\AZX8W!%.
M2PK>G?K.KLQW=OV4W8/P\75Z [8S^Z#-L;C7\4Y-MZ:^=7LW!-K&- ^C7L4$
MV UFO#S\<J]Q@3?UEGOQPHS/7E>#O4_.F?7T'J[*F.D>J^I6B''R)<AT9054
M2$W$>;L:L'(][[$'4M[$!#@HAL;J?V[:)Z72;BV=VM&N]_+0K;P(MI:AF2K>
M&JU7<YOKL?#"7K[L]J#G?F:*>X69^UK8VA9!8[L>810)G"1O)S!ANQNAD'"6
M MYNFDA&:+>]Q:M4@)FNP$XQK9=NU^2?!L@D3M/0*ET1E]GM&)%0">HX47QR
ML H#9CVKO65&>1MXN4E_/X(KV"*4CM@,?D?LU*:'02=SNU@RR+ H9^YX+XOY
M97DMO@VXMIZ&V$=E['_+9'#W%H6\(5>V],H@NX\B-)_2 0G2=.&I47Q,?/E^
M[Z*J:T=_,FH<@QF(<\527*WJ8?7QB^(Z\O/-$1$DQ#@'H<,K3"*&TU.8T"6]
M:35TJAS>BC=548?CNO/HF:WQW"BI:SK^PWQK\R3^4>HI,%DG>54:IHXK9UA5
M%M:"_O[/Z(^3G2D.ST<(OF /0.\EJ(L@R7'$Z6($;&S<!SC:PH,*I13OB;]0
ME-+\U7^^*)3$;3->HQ1V3AD]RE";]*],VW0J1/%<TRV>#%>T/GI>_[RIP$*G
MN37W@K'D&>#I&$*EU%EU#]Q!XVU7B+2R?:TNYW+$Z0',RSWV3%P6K"%MBWN)
MCNG3B+X2U!V5LR!#)?/%X;F9A(_U>Q;-(9X]GV$>W:=+\(C8^KTVI"Q>D9,%
M'MM8=?OXH;H]]*OWO^\U'!@FIL, 3QIH1%_TAB6U'R9V_BJ"G"%.L+K0CQ>G
M$#_.?E["L!W2:XWY\1?@#IAJL^(BA0W8D@TO1^;HEY&Y;Y&RSAS8MN;K-:_#
ME%-#Q^'(*AS)>32JG2TN2REBLWLACO#UP&5@>>W'<:N)^"W#](CE20F.1.H*
M_89J*C7#G@IET$B(G:,:S'7GNSU*:\]$D.L?$]LPMLI6J9_*'X(+'01UP"Y[
MF63F@G8;VS_F;4?B2:_=$V3@B9OJA&%BPU%Q!F^+$#RD8Y"3&*'D)'<Y74/5
M"MG=YLT9R+E @('2W+2;,JN]%"K^$NC+DP@ ^^1PY]R E?8#0U^^\)6Y=&E<
M[SI[K(Q+VPV>ZT9' KUMTYLBR!.$E7 P2%8,.Y38&2/\13B&;KR23>O<-!9.
M4AJP27#E:4J.AM);,Y@"2.QB4E(;::E%5QY<?),<587&C*VYXX^VT,<;*3O]
MYX/V)=OQB"EQ"S9:IQMO>N%J\L[[//M^T6!K[DS"PP.^&G%WSH2'*!S9J^1<
MRGET.TO1\,"VX&@?YD1JP,4M<J],?/BJI<JR?@K 2H63QV>E^9P8RO1L*"[@
M2DS1C(5GZ<>$4*1L\7A_],34L=0>-J_)Y/9Z1M?T@YF51Q;?&0>[SI@\W%-K
MIC?:/>9YSDO>>98U42Z4ZMR\P(<+:A"*A#_1@!=R0IF!;"!ET",,?ER)./&-
M0^^R?AJ'36,.9-R*,D<] C2>1+5KXM&#JS:V'J/8,\/&9N2=^.-WO8$K31PT
MJ4##"+Q&!;&],* DXK _L=./'CY12YQNB3>:IB6=18$'FIONS;&V=($Q?<%P
M[^WE'.,LJY/+O/.P]&U-$VZ3[+4LGGGR9,>-AO?S%^;VQ_C9A?#02^F;D7AQ
M1B6U"=_3 1?Z!&U-MK"'HMBXG QKU+BY:<<_ W;C%3G$GW$QG>T2P)4Z=J"M
M3^%)<4N;= 76T\_E.@ZNO(Y:=6XC,J8T!FE\[T2 V]6N.,JW>PB6+*ZPH/5B
MEH/BJ_^X)QR52EP]*JB<#V9,A/C%UOOP2="\3[A:#4=_E5Q=3O!.M9K>.Q=]
M][K #^HW!;A*AOI><QJADFK<@N:+.??FCP: 9-,*KTIY8\Y.^^A\MLG3I9U*
ML3.I5?#(\H[O!9' J(F/D^FC)^,%H::SHVD'\BVF7!4^?:QZ)W 2D,65J7%#
M!%ER%%>F/D$-,>+C6X+2+*N)LD@!%CC(#'@8\&9LN'L9V/C*=02^-'"P:5.&
MR8QU#?W<GO1ILL(QZOO9JZFW0$[@:3.6#"Y;:[0VZJ%I)>('Y1!*RVY&X_S7
M7,1F],6[@O) X=H5'K5O&=0]4/<0M!>G*$+W;6M4U#27FX"W9<-VXF!VP&^Y
M^'#@)O#>ZDT#YT;M,JT5PS7R=FTQEGG=6U[!M(VQ%%M^%9#@*"]6B#'S!(7B
M*?R!A!CIY'90FI"+=E7"/UG-A2EGGQU]9O-QR@JX6,:&IM+E+M9I9L3?\GE8
MMW*_];E'8]IP=ZD$<.UFD3M70+"=)S:BNRB[^#B!.)^G)U'7IXS;QAJ7)?DA
M8$4<0.U1):5],;S MPMFLVY0Y D*.%O_MK<75VVL?8:CXFH"S7V>4IR?C)B6
MN/5*STX7++NVM_@:5:S, 7T['=33>D]U!6-";K_1?EUEI5AF];6C]OF^-SI9
M_1BW;#]/_=.,3WLLSAT"W*GZ3R)O8SQ<FENKBSU[W#O.'O+DW:ZVK(2F'<YX
MV2;)@.Y-?/4D>7^:])%ROUB,>RK>/C"[5%K>W+4VG%/%H3G>O_<?NS%#!IC6
M0NFZ:KPS'3N)7C,1W"% ^=L'A1IX!YY2'1<+ >_:CL&/83A$*.C@/HI7IV;*
M:*W5@R7$HR75"VO-!7Z4";[>$:.\QS<?1(0IUU\S$EN9(&@6ZO\XZH!^[IKQ
M6AK8+RZQI"D57L5R-UH==SS0F%V0S[%1ZUJH!,]R41E=N,563\Z RGS71LCS
M?TPY,2<G_WR9IH:YM,<\0_@2"=BC)HABVH'=_!7O#:IP!\@$ YYR3OM/((O]
MA1;".]<#@\9]4&+9W31J/3'N%T=/%BJ!<AOJI]#A1Z,E'\:I]:,>.\:H/#X"
M=V=\5Q'#.RP.L$9B)T*<2K1W2 ?09-,!3Q0+B#B>_CB'THV50['IH"=:#1XX
M,_ML=>S.@=Q$0?TT*DVH\U9M*0)KLFD5F1V__55 I^1YF:\^[UNV=:L$)::S
M6^^56C5#U1@CAP:T7YB 3AG9D98])R],;<$M3K4F5#M 7>NPM18N;O=&(IJ_
MM_=MO<-]$F_ZYZ'WJ&+/CE.]9W 9[=IA=[Z@,RL7!FFWACLZ0W=WG'^7\&2H
M5+-"'^GMN4]_=-DJ70<VFRB4(FUB**!8-"P&\VS7,H=J^=:UN'6G7(90 ?1F
M4Q1M'[R?#=(&29S79R=1PX9-UH$Z[H-FTFWF)X:\_7D7ZS$1=7/*\5;&::NZ
MAC1VVZT)])_$Z9L4L1SJIDP^GU[O:1+\T:K,1J6*((VLQ>^\FA[8#L(1O"E0
M>I-CM(7!&%<EC+]=5ON-YY .1]=&Q,L%3N(*NYZ5U"W?N/A90PL(HNM/^OJ^
M"),GB#MIIR\RDKCWQ_XV$21<!'EGO7;UQQELH/MQ08WI\O8()4J+^G(RW F+
MEYU&J4W-J=:.:4@V@,DA/&@W<@>VL43+ 9BB<+8^F-LH:&!?.^<^)-3QG6,&
M+GH_RY-]<7=S)]Y9T"2"G&>!AL 8$3OPNU!"<.<A<9HJ5!^-5<%; \OH03-Z
M6A&E6P39.A&1B_/O4?5]B]#'!Y7V=_NQTJ/"@$\5U/E2G=)0GD3/TSB[X<8/
M!J=:"H:OPO>E!JCYE6H6["++>S#.Q<Q[8#AS;F\BV(_,JH9]=LRX%T>[E7O_
M1'I5/U2U>'[49R@94W":;$,XW(,P*W.7\1:SM#G.)<MM?B!>W>^I]DE71-8\
MO"NA<1]\/V;HE8EET!:%#^%4)\_*0KJ*\[S8-.Y"Z<3-XX2W=, =J2+L1:OB
M)0%C!EJ21";8X$W 1"YT&TCLNVJ<^; U!!#3_X 1O$$ECN3+@W6SY,&+'&X0
M4)@:QS;*IZ0UIJ]FQRPNE=NT7AE7O= 2+#;YA'!0X\=)&PP?85>0/(@%@HFA
MS\E,B6[83ZB<5204M_:-$[?6 "PS2AVZ2<-\ARB>O"L0^6&N%-[<7I^T'3 :
MBF#Z,R>"U):.:=.)#.A.OP419 =<;Q,O_""4&NRMXORXUT$H+0,4<G+]G3A3
M_8% %@(!#K!M$CLWFLLQ$=$/YOP<TE?1&CC,B1'C9$-G&5[&F*7Q1[)&WZ8A
MWF"D5693W)!_;M?$%;]_SS\F*"?W&9/INYL2ASC?@L:%6GP'WOJ-E;JS/N^>
M3"1,MSEWU18:P]>5'QYX>O->ZE+='QNM:.E+(_JAN'<A[SP=SUMD/4Q3C+$8
M>@-,[-)"UMWNE2(LLE-SI)0+30,6F@L>G_Z^5UF19^.4$+2],B0CKH+"C@FP
MU_M*]=;LB=XN3WKT_<+G%\O'*_5]YK,="@+RY'(?9Q8NF//EQ'.,V_Q5. %K
M@64A0UC,K1WHGUOW_3C+E+N-TH64Q1\%EG,:;1+1O,]=V9CC(\:MUC4!8 LG
M+,OTM;T9&!/W$$P2Q)8<Z/HJ_5Q-Q=.KB\..6OJ/HPG?"=]2]OZ@_T>)CYK(
MC(%D)6+#KN<\^;7K8L_"$V%I_&MBD>+070H#M:>QF9=[.-E'NAM^7&6?<O13
MOS^8#M2X-1UQF(9JQR*;YJ)31G\1CJ,^#["WB2!BYA"&FLCL10*GEM/&+GT
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MV;C%HRUYWZ_58)E:BZ"Y]9LC.[^9]\<DC/@44W1>/ *K UJ?7'TR=_:(N>'
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M!KM[\O?0+Y*W\@041[26SHM]8J8CP6X*M=0K/@<%<$BMQ>P9Z PS8@YWC$^
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M%?'<N.>)C57OQV]UF=[CN_F"SW8))[Y]]PN0/D?Z 6B94I4X"*L;HR0;DS.
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M6<T87<5H27 <OVPC>DSB0/8!;22:"UTE.Y[R8W[ZO Y[1EZB@AN%[BV H%=
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MU(6)J06O[JFDB!O,SSX<V1#SF5.FV 'ZQD-PK* 78!*/V4V:; N 4FDX2["
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M"'8I!@6MJERX'ODEV0 ,2&6H1C/U.H. 0H3Z7*@Q&, *8J;;K[MF6*$-27#
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MERL^_,[-?4$[UKO&76]5IM=:G9:+>YKZI0BO<7_L2KD'5B.]P<#3IS0"SMB
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M5@^WF^6=Y0I-LPHC5H-71>9"4,>RM_1@;\MOT8Z'&SSS]IW-.<C5M+C'M]N
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M@7>+YIN0)R]WWJ$*<]^/&>)4F4GRFK"<]RX29JE*3IXZ_<,:P!?9J\3\=41
M7S2IXWWT'*GVCG+MMSQTQ-\["K>,+FBEJ=-?]$$JZ:M&4QGS[08&'$_LL%TP
MPELJ,>(Y/H!T!HCLO=\PPA5T 2WIY9?ML:XQ_\L7'NDQZUE08M*1Q7OR O04
M54N)T9Z$-RHQ^SR$!,04]E1BKF83_HB:VN>Q)=%V&C7^\%XP1OQ\#71$=K/$
MQ0HMG*JR ^,EMNA)E:[,B$54CZZHE#)1;41UTZ=N21_<3.IG>!PXNK<-&T5X
M&_%8!+YG7@8^VE-]5$87I?(^9U:BI@.@)YK.R*;#N\%B)6:[WJ=G:\]WWT=Y
M$AY^QO5/AO_/&%J[TL7ES!7/V0Y9$$&(W>2*'YL-7B3SRT-_(I<^.+I?%5VL
MSSZ^M_[PZFTG.^N7+UG0#:Q18LSU1A3)I^D?VXY4%KD6SZM"R>=/H;,6R%,X
MY0_$U_X[++F?;^8'RH$1Q''B=48C\X.=./H/O(_\>R07WV;O"ANE Z"(>=&L
MG_ZT-YGW!]H>?R0Y5[+Y_\R?1!4G._S*?\^RN#_8D<.-_#U#XS\9_K,S1.0#
MO"]>_[Y_]I;*ZU=L(^DW9S4$@3=6[HX:LS_U6GR[IQ#ST, [P2K?>M\?9[(<
MS4(Y*FKWAME*3%5TL.__P'G]KQ^Y_M48%C%5.O$#C M+BKJTM0G"^>0/2RU%
MQ$$'CK:QL3 OQ3BQ/EQB;'V[I< X/'#K["_A&[_-*0"B)TM.,2NCY G^A1'1
MK,G6I/:+S?[^/V[9*1\&JP/_T1#FBV6;-.AT%B1D1VV\KWNEBMP\V_3$B(-<
MGK== -N5F/Y+5K_I,3-3>?77CSS1=EO"Q_(#/_W;7S7O\(P]XH99^U\\]/+N
MQ/7S9NS"D=MU)5W#SI. W/ ^ZG-XY;/_O85=/K"<)Z[D;AAHHL.6%OD\4O1*
M^(.DMX,Q&B:;YUUN-[]S+ K0B/-,6N89O1S!]5%=P9*1 S 9PG9Q\1!#2,@T
M<X(HT,X"R_YYCE9(C^R9N6 X9$L?9U8EQ+YZ@7\"^RQ^#U_H%JV+G4L&5M.P
M5)*BA+859DH^*C%KN684"YFPF/\+4QI_.?;17AL[80!7_1_[I&8S]=MQ>)XX
ML>W9>B1<K)78F:#6>5SWX(A]70)1W5/R>6N3)_!4Y4'W1F8WRGIP\&:>H XG
MF7OI0,\"FFWYP*M$^5F8>0?F/0; V^WT)%! 5##G*F /Z;2Q[5H2;ETL=@WI
M$VT)="KY4DP=8M4"NI>=;W;^:&8];%/1?'^0V]+GLF+Q+[0!7'/$3.^B.W((
M7B(EC-(?X^['"["Y?QV-Q.E08\""+A0/%T!D>7*_RVZ)3807^(:GJO2R"#J(
MS6W$ :9+Z)I>":@-=(IWD\+N;)4_"F,%(KOO#\S,Q;5%/^P.W6'46'O2TG.)
M.VSYQ%,KGV4HJ7WQM_-CH]1SL$=FC8^NS[9G$=G\MS;\I@,VA^+,4\N,"MG4
M=4"N5,,O2C(EV%;7DY<:-G]GQ=%]NIYKF&_M+QA*M^=@#Y4;E1^_(M#,[OFI
MS"AN(-6RQU"CL;IO02";F-TM 7X8$_%%RY@KJ-_"#5"$[%2=U,M6 O"Q:?YX
MG=(NVM:<CB"7D/70\V:'Z$SN#O@"*!+03,&S.3$1B773>#MH+L/&Z/B^@_V-
MMP?G'Q&) UNI[B.H!@'$8]/I!BX79%AU) 1.E ')*B.W$T"[+GK#7&:[Y8UI
MILD<ZD"9_>B$ZE%MP9U9H$@X[@)Z=!)TJ,'XS> @=WDK&,%0N5)3_OW6EJSY
MN5631AZ9<Q]#EJ$:*\ "F:A3E(5K<.U.=S&&V#+]F:;;>Z#NO0H6?B7Z7(23
M*LJX%O"3B2XSS?[37#W*Y>G. *:1$A/1AC6F8 6M98RL6*8N; ;DA)B-H];U
M0Q,O7*+)41O+<S[7@0.H^L^+GO#9;OE/$$/ &V5*)F8F8R3$5Q[R?8I&0GCT
M*-K[Y<676HK+!0DS.60I*AA&-:;'UX/X2DX@0H"+V>\^3 WCMT)Z;U4%M@UW
M&XEQJ1*>[N)J/N3!/X5M>?(@@7LTHRZ_ZT5EUI7(X9+ &7NK [<^,&H\U9UZ
M=6HE-T%@5H<;[&]_8AA_*;=ZUXG)J))3?_?(>+9][3D#J_E[]64)V^B'.P=9
M1N=^]G=V:CV?;MC?^7,8)SWE:)E%2-6O\)LG[6&Y['E>#D]\B[<&6;(8@ARI
MAW- HOQ'.!&,%],1W0]=]$: P8N8)7<PESJ(,L=N?]F$)X^[M ^0MJ2X &)B
M5OEV,"+[HRE.\K9)>J3F7:MCU]OT#JJKU& >T'"3LETWC7^:4V(R@69&!S$C
MQ Y>(9Y>?'0!(([A5'ZOB[>$ 6&Y45/_5L1< J2*U-LU6=2_0!%"'([D7-YR
M2Q0YOLK(O:DB<#(@P;^80PHJ;ZH+'-U7=6?OKU,#;SA+*>;R'V"1$K-BZ1#7
M"0E2%+FX@6'RB\!+1K>HH:JJ6(C%476@@+QV/RE#CQH$DV6F)T<Z:7KP;H@@
M3<^Z!4<??;%EOHSP;2)1=SK:F4(/+.TDWO!B4^@'VSZ+Y%:*--YI;.IA=& $
MOW/DX[-EW4J,.CUB3H_&9X*'B)E&PX\JIYLO,I?&$E>K3,?4HFVFW.[^EJXG
MBO0!@"E@9;OKW4CG1U<6Y@N+.S)O%K@/Q@Y49&WEZG[-=M>S)BY)[3P!&@#D
M='[8I"\KIRX_[9B+:QEI1^<'WYZ8D![#W$.!V7/JWK%3SOF7HUWP=IE1 36'
M<NU6G<(97I4F%5D;%@]5^:CO6V)ED%W>GQ8IN13UE@*<N<QW6(4W<WH2PSYD
M/T3SDS-3Z.+*D*60.PO<-'T,7K/X'=4>#E@DPG>[.W@-$]T,''Q!<IJ@A5J0
M0\S[YJ/7('C/)$T^7;\]&*I\/"S211PK0\CC:@]@-ECP>._$H6U:,;'&/_?W
M/SA.1#7:0(;7 -<)_ANR7%'-H6FA3WFF5 !4DZ? D^%B)2:-)5$%#UV*KO1;
M0-O%1TI^M&-:IL<1VIK YF[D4ELCT@*33T]78E;'Y6$[]'\438^M+*[;DW@C
M"(V,^A*NETB]Z*CZG"R+%\K(=B9VSZ6(&G$S'!GS%5;.5-SBD8!T$0Z_F5*\
M%PX/3:J@U.(NT[:.$"*5F-P0&R"MET-A=-)UJ.'B!P/B&;.04LE5JC'8T!6$
MO.WF\P["*7([Q:VY+_(2].,D-_.T$%$VT,B:/;)(1KZ#+25T^*#+<B980K&5
M3G26)M$E[QL4+1;9/@+NE_:TE._<V]#GT"E.!:GUD$O>^6ZOAQMT1P*L)$%^
MYT2S3E'N7&NU-/:*:Y*'YSZ23OEM@Z\'X'&X7*^!CO/#>:3"4+<' CT?M;U7
M6&G'KC2<W<+VT$6?9:>^DVQ_T.ISR=^B=$U(T5$/W33^^9,[$-T#=QV>YU;[
M5#I/.E\]0'DR5+'JZ"<E1@B\8O)I2^%D670Z'<O50!(558@/R'IL1._LS=U.
MQ?31#*><X_F]FM-CU)+>U)O02C:T3\KBM]GJ4#A=K7JW61Q*P&/<JC?07/Z\
MC?'!GQ3(KC/:E3?*@-)6)>9R'F(&;6V2X+30Y_AE,&\Q=!JU@M??0OL:)D4-
M7== : .8P<?JO!:&BE\G=@6-=&.S@!747564@JYBWMAA2K3DS-WZ:B2XC$J0
M:K;-+8V2.W]?["4STK],CV*,VLK3%2S4FJ(K_QZ*F-TC <8*5.E\>?O16R\1
M>[@8].C ?PU?@*+%S(YH+:K10U7PWTQS^-)+S,(NISSI$8QM;:F$)QX[BE;'
MG3&:PND&38VOHJ0G;ZK\\+YA<3TZP-55W&J/671#PN%P*$!>,,B+5$F+%77H
MIB@Z2)P;DTGI,TG1(%N>##O<?$V). S.\]+;?18#T>?-3!WN5Y06MY$W;2"'
M0?60,72H^\#GO!OD S2#=\[1>7>_R4C!%G]O8^%_U^A(^C(M0),P>]"QL3NL
M]C"_QS2]*Y25P]^R99L?Z23*V27]M27(B11;,3]5>&6$9FXG72ZZ7Y6=R[HJ
MC916* JSY9=H2PNION><KIM9&1P\5A^WO;%&@J__ZL0'-W=*22$I:6^9_C*Y
MASB@:RZ#V1C/IZM1(V&_VN-3J!K45(6,?3]65%@=&21,0W/ND/#&D&U&TRS6
M[_(K[SZJAP18&SG6FT[UN!7"+Y@L>?MC]=%=%U;*X4U8V)K0,9VG*^WM7 &O
M6/2U?2SZ 5C7O@<DRYBSRRPNHP:V F(ZW@)LZ<Q"C2D9OKS^[BYS".@JUWTQ
M@?9 ]$R7/2!;4LR81;:+ZR[V^D#?)FRMNDVI= >5F!? /=O'P&KT.:\A(AW1
MDF%7PM:23[D.3!UX0FJ1C>B+<<9((%Q\DQ)_',Z0UGD*]4OBYCJ!//PN2(G)
M=XF75@^C%E!+3M70C#VP&F[U(ON^L+>Q\WS8<I1NR%UB.[L?8LH=%>V\[^FI
MA(:RYQ5AD$Q^3]'.U9G$-1:.=-JF)43PHY?#/E).-RXS9"U<RD:(X#A'.FV;
M9ROM7?FNI.A1C&360C+!%YF]0S<WMX)I;12.8"0# +!=RZR?6)^T2_\[^<2V
M:W>7:>Y;D_UT\PE%T?&L3JD$6#WM?K,RLW- T)=;DZ@?I%L25['WT4:K'0/;
MGETH<3I]+2CVPJJ0(PQA@$"R8PH6D:^%GGNYZX6@=L?M:0DXM-VARFC\U<OG
M:\<JMKB;-58&X3@CN):6Y+.\*((1[6GY*M@#8DL)F:AA%%,=.:+*5;C4D_ >
M,E@@^228R]TY_(EK"C/N4MA=3 .7]353(>L&MGSS:#!N.EJ=$M_)M6$<[(NK
M\W$#N2VLEPX]$/?+4N42J@GT+4X3B;H "F2\5$($(V^<@-/"8VE#-%MP0J @
MB(L9+L1J<@DG'=D@( Z@FT@\XW9-26]FPGM&'(NBV873HVG!FOSRKQ/K="0.
M5[>T>TIZR@*>X9>C0BX>S.CFP9L/%4AS/!6VXI%NXBA#O@U6 P52WP16AL4@
MXJ7$:%2*>5W8=.;J)B=D=Q6Y8'ILA:HJ? OYISGG7>QQ;QZ\:YL2Z9B0]JCJ
MM;#EV45>@\5L%F0A=U%<Y8FOXUT53'/0K!@,Z!(MB<5E\9I4TQ$FUE+U(5L^
M;I3>U:J6U4Z0VJ;1],"Y/*:LO 9:)BTJ$T=KOB1DM">!Q1+TV@U24&_FW#Q3
M__5.9OC.AL8=J$F9V_X 0>OA]/TF[ILNI4;YYJTZ>V2^?<!T[Y5I=P?HZI8+
M@11QE/NM&B=/S0"MX#7^#IO#?;9) _<,Q6XW&[[U@97!%VPM#/+N/-% D>QH
MUTIX46D9"E+^CMVY(7!A@&64'2/T%AZI</>=5I1".:A&,M@F,2M>W <_[Q5[
MS#I 9(DJF=5.<?7AUQ!;0DCE&I)H2T!>?JS!#3.55KP6*E5B<K@:,$/F"O#'
M"N77;L*]06# #RY[Q/2E(J G3@:L@^G?OFCW8[\S=2M&UN[KP)O#KRJI2^ X
MT%B>#5?(9HEB48>(T9H%%A6 B<0O"[VXZZBG>*6>_2[[I#;QW4PC%WU2"UZ?
M&^R$'+T161D$:08#2DP4[.D)G2JLI-Q<W(.4PI(ZQ$=10C\A@JT#.D1+$><7
M*LFU#8K()YPQ]=RGJ*2NAQK$X;T"(H;575IVFGH8=H,2!;.R68),/X-+H&X=
MIA(YE-U[08]TO#X\-B(<=^6"[CEWIK@:]4-Q[%YM!;2X 7W.-*9B%X^3E1@C
M%T_QPW9',78-O6.W$O,],:75(M.!/*L=G 8SP?GV(_'2N553-.V,8RE=.W4I
MEQS.N'*^'_SX:!-_]I>B)]V^B0^V^HM.NQ_Y*?0\<FCKN0J+_2>CQ!M=>L:[
MGQ1N*3I79(X]U-)<F>UIFL4.4-?;>VO]SX=\PZQT:WR86M<G'MSIUDQ-G:XZ
M*B')9";UU6_ NH!=J</&NMZ,>DYJ]++T*D]]BY#K;R?\'=Z8N#G[)FW"P9:?
M^$<; 4WJ(9P:(=)7<<WE#.3A!>^71(\-?<2E98B[.%*;:.$'9/>+N,QV!YQP
MDA"9$[U\FK<Z%%";Q-MQ85WRC1#@^.3"_1"LAFB,<OD8QY3>X8/J4RS\%-7K
M6[[T,)"P1G"PW Z*!+MGUT.Z':@1_)=Q+)SX_8)VGM07HJZ!*V5 N@L@HVM[
M5)+B/XT5L@0B=9C3A3=K!-^SDJ31ZN_&:"R)<:\N2D#<%3_0R7-92DQ#;_)'
M0B:SOJ63F8MK 5)0<XJ^+URV&(20%+5<8ZH7>+%)W+L$[2OBV@\1)'^-%1DB
M29 V"VRFF\%QL;/NQ)4M?.QHCJ!H?$6*$&\V;/L>\0B3\#0I[(\60N"^[:Q6
M#:V7"0;-+1NEXC^H\NLQU=SEW45[$P!D8[D: UVG72AEC HD(S\T6G.:>Z2!
M'^<TDMJ$)>O859?,'-O H6><4=KK2UK<4M>F7U[KG2]?6V%U1GJOB9-=I.,[
M3,Z(5:3:N;!7U=^]C3,.BC,! ^\D18Z4//9A#@UO.'K*J-!HD'3!^[E3:SO)
M8^I!ZT[^/H-:3\M.J_+Q2_[D+(H><<WE2HT#!C-;E^:^<P]<:$0;MMA?<'$+
M&K0>6 R0Q,^^$A.R@'5<,V03%_:"!B2G><9471E.55WVYM,VP^2.($(*UP6V
MZ-"J>$U:Z$ZY@[A"FD+<ZG93ND5ZNV<%Y;F(CS-N5P.9W8<IY"/N0]3MM\G^
M(V,.G&+T%= 4T,5)!AKC9[3 %DFQ #"B"/@B4]H.N-<=SK--TQ6_&J>POP4_
M\;&9SD,M/]@'<[)$.E3<IHSJ4=+P&-#I%>^WKL1%WT@M]?F/-RE=LJ./F!TA
MYEX1\B3X4?SB?GK'5FI2M 1GQP<:6!W,,7,^W3 N>E:)666!K!]3I5KN:NHF
MD)=V&O]XH7^*MAX='*':U;U4L/G-"6\*&2^Y0]5_'QW]^]BQ8V=HKT0:^*V4
M4IGMC![4(,D0'"=+QZ\M[J+2(58VNH%BQ\>OAR_=@ ?A8%7UNPQ=C^";1AK7
M0,0NIG:[<<VKR%:TI<KT;!=@,#I]LFOFV+LQ__O@\7UJ.1FL@H&G]W;D;O,1
M2'=<'_>K/EE_@$)R&B,[\\5AWG?8/K&U_H%4GBXNRE_=K].]2>_ E7?N9F\2
M'@X=;#$U[#5>Y6[L]'.8.U?_*TE6W0_5O[J$A%K%5KK?K#N0T_G6*2K1V>=L
MD9&OU6)0X_3#%B$=]%:I=S-#52BLE[*):4PS)!34%-MV6J(&U-.*:@0G86*F
M""MI)C#'8ZBQ#MO%GSC @Z]54<]#K S4:*I56,?I).A3;6$[F<K+HVSBVD;G
MLQJ5&"U*_MR!A6F91>[[CX0?F'JT]3 NJ-%Q@<#'F<"]?+/U]]#GPUNTQIGB
M9S['0+3I^U/YB_N';%:]& ."+]6'1(W<F_E@_J#Y"AMU#*8]8S;C^+Q1#_DC
M50*_1+&0TPJZ%SRZ>0:T/F<+/F$L%=D/^]U"S%6>P1GK[4Q0S&4UB?*<-]7+
MDNQD0B:#IAM9OAL"D .(.E@@];\F\PIV U]7%;6%WIZ*_Y1@.XW-Y*XA.6-G
M<NXB*T&:$K-F:LQV1E:#; !;K@ZW^I;(*UG4'<R.UDWR0=MG124+54]WMI4L
M^NQL/K/+T?'MYG%IY?:.-P:DJXZI=1DUN%G]_4[2R9-%%C9I+B:383%7!B?F
MG>=)OG=K)5/NV;GT\^#'B72V<^N;!T]E>D2#^BLQ:]\HRHSNY]Z+.\?1O/;\
M]@Z]<TY6]U/Q;1E5&K&F6]P(I]]8S!9MNK7=/JH/R2%F 4WQZ73QE02L*LT%
MJ(;D,G),9<%2%MH3LD91R7%9 VE*6#,1N,<</?A)M':4F:7J]-'J*%414$PU
MA)Q%?X%SV =Y6'NGC]@<(\><,]&(VVU71M:ABK7G/47_V*<T%>US!)H^=6,Q
M<(8XH)N>ZZQ];?$;VM]X)K% ,D[-Q0(,Z0V"]W"H>\'XS'E13G<01!#23:BF
M#X;FU9O:&-J1SA[)[]NCI0PC4L!%_5ZQ:*5G>!7E_J^"U[P3/-@".S,)7I"3
M%5>^@=F+AN@S9[59 M@K8?!S>$:4)]$IS!5-<YECN"Z"^J21VWB%= _DN+<O
M+K%NGW !R+YSJ$HM-Y:A"QSCLJ/-V&'LGFW9[Q;T.WC)O+6(BNL*,T43S96,
MZB^J\>DY])6\\&@-JBL$R$499WF2KT=0XU=43T97$>ZE?]"CWJQ8SDP$M/*O
M^*&Z=PMGBBKE[9..COSQ=X+IDS&?5S%7]P6Z\/1FUN'OKFR\]\"D54_OH,BB
M*H-_@M?PEG7<6S @]$_?I%=X2<(*LI>X7ZG78<M"[Z-?YU(N-M9?R]>?UNFI
M":ONUF<\97D-_/PA^\'UD-V+[MH&\0&Z/NI[*5%]L>NS6>YQ%O[W*XR"^N@=
MWW(U8:8J0)6W@60^?2U*H'#D+)"5B5Q2*3>"P,N\(\&C4QW1%>>0+ZK*@VSJ
M\0L0O9NIB3>%]3U!=TX2B^+C;V8%H<5)M7##X987""Y"2K[*\:JR!N#-(WQC
M47J=S)B>03<JE>Z@#10SZ]FT9[]&FJU,D1$0^[JT6^C7#^%(AUWH!C?0\D>:
M67 /=(!@9MO5 ';)'B=OM6DGVV:&YP@XG\EB[,LV^2.P^#'AY07QIR[Z99$)
M:DGK-</"2Q;W4.V_?/ /GQL=D-\ .1T,PUY(7ZK&>#]/U*2D=(V]_7'Q6ZH:
MF"'D9#B&+"\]# Y-I'1W>040[Q=W!GQRI.FW?X@.+0;$W3-VT#(!83GAM&T&
MTX0@OH;#4N/!8AECMB$4*A80&@@"(%?ECKJ)8D*JV=<P65RGZS5"4YL*.M4@
M9GXU">AQUY$2XL8SI*Z;@$Q<PWQC];@M#XZ7?=E#.\#9JSC[["7;53YYP6&1
M([XQ!?*SY1'%S@^N.S^K-W#:TSJ:KZV5Y&Y?[W.K.G2M]%'3EM<^G5T&D:PR
MR&__D?./ARNL7EK1AAW.WWEB?^]E<8$DIFDC:=?9G3'TD#+J1N>[7!O^^5C2
M+[^R4Z] A-H2)696)L9E,-7PEL@)6 2FR#-A#9%&^Y$*>-.$A-<9G>%\MD8V
MEUEN"UU^!R($<*YC-S.MW!HN $4R]RK9L[#C]\#Q7*8V?@,EW=2X<^E"3[<=
MQ=W5VN=!XPP7BPZW8CM%.:J\HZ[2RJDB WJ$**\$EWP#K@Q7W<"!)? L56+T
MJ3N23@X(XLN=P8AL=!7B!0O B9!^>X(NR2@^H]V#Y2'[CDJ4*(@^_?2FCYJ>
M-H!G>SN2 K7,V"R>HIZ PZ&944YWF=IC[BI%#?T4<>R"W$-10B!AQV1^*C^T
MGIY+,3.Y3CT'NB@Q318"1C9='SD.A@EXZ[8V&0<3+C<<I29!SZO$*OUVB&@L
M.H[@S>R'MMHK,1S>*?HH2X@#1]8!N#CLZ(!,K8.^ G&!]TAME\#1QQ5U2@Q9
ME$-OPLZND>)TX0_!_9PXQ>X.H_#BV<+%_8@>G 26]!X T;*=+?BF"S7PA!!O
MB3Y'G_=3'6Z_RZLE70^\TY)1<Z+>SSRGRD>G9KA&+UTH89FX K7A\_>N)L1.
MA2F:PIWA7+=5P95$N[Q=[H>K<CQ7!''-VS1+8DQ/G]6^?B^N1G+]G3=S^-[5
MVO,<S^FK"P9/O8(:?WWCGEN9(9! !@Y!M_TLNV+*CAE3INRWB?S0H66R50%X
MK>%8SIAG!W"?,#,J,<:NHU3*4^!1&Y&@&K5\]7-T^)G;L)J IM<*3X(B*?8Q
M1PW>) L</-O$S#3;#J67U5 N[ZF*Q!N#346%"DXM^=XY)0;TFLOGZ= C@=$/
M@5!W)U8GF.K1W\C)!?14LZI8EM>25M>N.AV=POT*6O.BW1"JG>:W4M<9[2RD
M2W^VF0_VG #EC!MP1,##OE]&VAUO3#IO8H=&Z-]5Y?7>63MPNANG-:_*&825
ML4H,0[22LP7QJT2"0=N4)L97<(#\\HNXSS9G.-1E,F+& D?(5$EG+:XVI;0C
MZD)4+26Q>WSMB.KR5?!=8=,9S<[Q=4/4/5KY]9)F5<WU4E/L(:2G?0*: "$S
MQ\RP ?:KH0TQ&R\^@@:^@]58E!1WR)ZNWCC-TZ+$\QD667%,C6-_A\T6I4"G
M)D.[)1?=0!2_>D1V1X<';;Y\+[.&O(8:%THOU82*L,-^1<%&$"5*S#I L0PC
M$>I.KL^L"+KR=<-F_U^NLYWA[)\>*_SSC [?K!T4^(644@H[?8_C9BU#WYCX
MN9RVZC8VT7*8/V8/PMEZ$8Y%AQ@NYGL."_KS"=-^T\.%$>Y%5@4*[,ULZPEL
ME<;FFS_\A\?ONP:X-__06_!NV3#WC[^F1XY"\_,S>&?H>DS(<3<CF-UI')8O
M]75[7G>Q6^/NVO"LL.2?ORG??]=ST?.($L-<%"$:JEHH_[#:^S(]^*BBJEJ)
MZ57,H2N(2DSW9K1_D#Z!?E)BEK*4&-F5)8LL-]HZ>A2)\$&)251BDGV4&.@)
MH;$)]UF)4>FJQS5*#/P&0YOL ]*88T$,1(D95V+$ODH,<IXQ:^.!TN?HH!4=
MW?477&ML@"1"7E2IQ! ^\6 ]@A)C4ODGHC\1_091Q^^7#P9(? #1=N^1EM.'
MWWN/V.G4*=YL?#[P?EN4Z'>X?R#$ON/P>_\M>H_?XKZ!?>UL#3;\%OV1W^%>
M]NE0-K+E=^A_CQNC&+C)T_P]>MR?B'Z+Z([JH3]F3Z./FPD+QZM'I(Z_?=8M
MM&_0CMDR'F'0.\9ZOO([0]'UI42SMS\0XC;_?SUL_Z2(SL82YQ,8BO0F0&&=
M,,;AUU=/+7/BM1M^<_WXH1U$;QJ-];#J7R9._>LBVO0?+XBB&9=Y'ODZA9ZP
M1YP2A__J(Z']!BDHTT#_TPUMC+Z/&$N<_W/\_B<B"B.;QG(65XW2+=F0_F]/
M>YMZ''9Z-B_I^-NSP8GEL>838D801C'X3QJ"_KL0/02^@O4[<-B9.%/;QS1M
MD',Y]AG0:327XW!F-Q]OUN_B&%9+80N-4L=X6>U>U6.1PQ?]/W&_AM:Q8V)J
MIEN?/3T_Y<RM<!EI37LF?,JQIEG_9\;VOG(E?(7EYOW")Y9-ADZBPB>.#3%O
MBZVCQMX/MVWD:Q\IS3TFOE5IL?:-GO6%S4]&#ARK?[O_UF>_N>__<R?Q/K)0
MST:?\.XK,9EX*R$T$J(H19>2Z<9U\UZZP2DR,PZ8*'E?!?F;D@4[G6G7)(]"
M;#,#N*:EPKZI<MQ ;)DML<]A^=#PW/[Z@=A%3_4Z<4-+/B'Q_S[0=:2 NJ,^
M?FR_VFJ^?8U5H87#@>M^E8=*"DBKL_>[KVGT[C.W\MU\)&ZC>Y[5H:;]?G<F
M?=(<_>]PK0I-O"_4V#;M"B&R_U-KWLDC_K,ZV)^(_IL0_;']_L/NW]XY8)*1
M3/_E.S!:D<TU4V(&W,HP=.7H_P)02P,$%     @ "XAT6CP1K^8[C $ F%H"
M !(   !I;6<Q,3<Q,S R-C=?,BYJ<&?LNW=44UW8+Q@$1+H@O06E*8CT7J+R
M @("(DU R*N(=!#I$!*5(AT! 44A(B B)2*]A@Z*$*FA0^B=A!(":3=^W]R9
M67?-G?;/S!_?7GFR%BL)9S_GV<^O[',.=9*Z"+AH:F1B!*"C#5,Z4P" .@,P
M -"?._?W11L,M!?C!49&!@9&%B:F\Q?86-C86%E86=DYN"^R<W!QL+)>Y+O(
M=8F'EY>7C9-?@(]'@)N'E^?O/Z&CI_V&@9&9D9&9AYV5G>?_\:"V [@N,#QB
M/D]/=P5PCHN.GHN.V@T  @!TC'3_,0#_RZ [1YOC>:8+S"RLM"_47@2<HZ.G
M/\= _W?6M$^C:)\#&+@8N2\KW3I_R>H1TY4 'N67Z047)&Y7=?#>'\9*JCQ^
M_HJ9A8]?0%!(2EKFZC59535U#4TM;8-_#(V,[YB86MO8VMD_<'!T?>+VU-W#
MTRLP*#@D-"P\(CHF-NYU?$)B1N;;K.R<=^]S/Q<6%7\I^5KZ[4=U36U=?4-C
M4V=7=T]O7__/7R.C8^,3Z,FI:<S2\LKJVOK&YA;NX/#H&']".#W[FQ<=@)[N
MOX__P[RX:'F=8V"@9V#ZFQ?=N="_7^!B8+RL=)[[EA73HX!+5Y1?7N"YG5Y0
MU<$LH7(?R_OX^3 +GZ0J1@KW-[7_R.S_7F*O_E]E]K\F]K_E-0U@HZ>C%8^>
M"P "D*T_)UX%_%?\5_Q7_%?\5_Q?!^(MR!LXD[B.=\<-Y6$V($#^>+N]?I>H
M@N-+?O8W!NH]$JI/(M9;H\#@K 6LK>6I_+P8%?!=E@K80"/LY0LMVB[?_MQ4
MK?MQI/6NON!09G63?@HY%[18@ >*MDET8=A=NZYAO,OZWTW>S5E;=<\*5_K8
M^\'DWAW=E63[R2S2H4?3X/[KX$AY:_.&2//;OYXTU.>KQ*4:BI=Q%IQ#^L/<
M4*EX4 U_IYY<M]6=I++NSVC;6NO?&K+Z?CIRS[9WNAK4IG(7)>)J366'ITY5
MDJ[]EDIHE1TZ<$2H40& (W^^[===8CP3M;$Q#_.T?WE7,?NVN><(Z\\N+FOV
M!H#A(.P)Z^XD%1#[R!\-/!#VIRB!PR'V5$"&TS*02.\"VWB-: >?>A+&5P5,
M!=X-CJ?L^JV%]RJW\=VS<?->J-^"W3Z3_AP<Q==)ZEL5+@M;/SC,:WZKKK(@
MB$BC CQ!A*OFZ';.I(B25TM85>UI!T.&5\?'!G0P9:E,8=TOO1JN"*^ST0[8
M@8P'^!C#1$ER)*50 :]283_1A ^4UG+D4:[VZH#B495 PNUO3=6DX:G<Q[(8
M['"IR=0<]"X90'X#\S:A KSNZ)I+S@ND=<$G=\^]%-UL/(2T4ZJ^*%4O5$3Q
M@_-A6!,% HZ03@4X7T>^'3\3?-@8>]6J^U>>VI.*4XDRA3)M@H?-U[TY*D#E
M!>$0=XO"2J)Q>8K$:(Y=E+3D6X>:^3LY08GO%FJK3JK_'"$2?&&+%:%H?B5#
M*H"E=RZTX2$5X%LO"#KN;"L@-X%6QMK$J0!T$?C,2A0J[PD_X*JE BK+2#V1
M6G8<<=+)Q78:H7M$B9[!JH9D-8_.M^6Y.\W59R),XD($XZ5]$L_$(0;6C>(.
M,]<7Z_CZ)3T"_VJW-E PQY,X \E,^V(>-8L,BI+#CN*KJ8#,3$(2%? H@0K(
M"W#3]'J0FY%B&Y2S%;)&R&WPLLJZYE 7Y4P%< :T40&?'_E3 =&]5, R#P&V
M6,EO9,M-4HIU1?VV=I1<GA1@# ?NE!+9C(EF!!9B=]JR-/:TKLT;5'WC SYE
MTM!WIF6L;WXS=7P[HH_$;7J@\W 3S"W>T(":;1EQE.S5L[,'%4?47EM5_;(Y
MZ(# B9EKOV]](/LFU)(D4T!2I16T. S8(]3")W;MCT++U6I-PS;NI+*@G[U@
M@**H%DODF?W4M%V9>^5F=E-J7C#O;NR8MRJ_HF90^H5^-XE7%Q =X"00,\D8
M:]^+;N/'Z<&G@H5]E'_D#0\*$G\8+727D&YU,-C/P;!FG,DGTS$NX@3?TH?A
M$Q/I,,_-?%?(\*N.I\D1R3\41=O\'=?Z5FL*C+<%HMK(.H5E"K^W+>K'<3KD
M:;S[ABV/%?A&U#W[W\B:M-WE1<0+[=C>:%^&_&NX)^+AN5'E+Z_4R[R1RF'R
M[,-^?:RLS!AAN:N!T_>/AI\C.2TUWWY%&4$/U-Q0_APN8"PH,?41V(F\6-.J
M8X-;3]SU>?2T;4+-NS9!R/ZT.->X_7K?6/Z75E(U'9MIL!?IZBEI5#&?MS<+
MF !_[ W&VJ+BZS5\INUC(5J/?$QF>$=0S]HC^+BE8;+CV#02[^N>$'1ZVJ4P
M!1-DK:Z.9Z")O_@)W4#TT?(VK=8OJ8#%3(I0FG&]/S^AR[9Q7%!%-4*[CTVI
M'BA;D[CZ8OTCVQG+0=KT:PHS2J%CG]Y+3 D;UQJ(\,P-W5?P47AD%< FV)'N
M'/:L<8"][&7F)+J8*<LVYT?B OI0M[%\^FU4>7%=*TAB7^$%N):)=C"/5F7/
M%I5(2>VL'W%-(PHV4K\!5  ?W>6<NE7)$(03HAT5C;Q4:QF-Y%8%\6TJOVT<
MW>.=U\VK_B<L0QV0''??>"72?E\_I<S)>UHOM<1-YH-[)$.H8MN%V=2"MXM'
MBXFXZNLL'8.:D.OX'[\C>SM*27<:#7GL4R-O&?+<H_N/4)MS-0K]]VNAU+M%
MNFV',_>$H!0_XS2+<1_$G/[!]*QD++3 I.2I7*%IXM4BQ?] >Y3E)5B'G3]$
M;TG/W@S(_N_'!W,#/E+:HS?(J?::!QPJR4O(V]N+(&Y8Q[5'.,[X8/-[)+,,
M^JA@>506.5[XZ8E\\NFRYI!*XO$SH$U+6_W!PI'NQZ[M[+1Q_4AH"1I)![V*
M[(7'M(GABG*?;RJ4_7,@K/9AB,LW/5,87PG=B^"H74 S854P7B0^@NVG,/E@
MB;(469EDEW<0N$90\NE48]5)U=A1Y4'+64O^B L*TUQ?L#&RC@_ PWFSR!&Q
M/%8.0K2WFXP\Z. 4,QT&J[&J=M[7"FDM2@P5(OD2(Z[I%BQJ1S>C-XRV/#6^
M?S +\;>RW:D5-K=04!_:$FZH3L'>$0T\YGW\!O41YKTPO02;"@I[UH6))QF3
M$>ONO]O4Y^T&V]+; IMGB@.H@!_HW>U HC'$0I\[I\/*X^KUXF:BHY?1(BG6
M:.Z+U'9S9:1]%A70X4C9[T(2(ZF Z> 5./8N\%3K*8TAU="'J6WYV1PQ/TZ<
M^^:KT2[K [:]Z-3'7Z]%UCMZ3I)]/R?*K7&6LI H.!2)5_FDHTT%K2I%"& <
MV:RO=F0>^M'_9'(UU/=O29:ED3>]L0;+,%(V2!@V^72?"C"JC9RR$,J6#K1U
MC92$4/P3*V)C1 4=3W;/X!Y40->L/W+CG1.M'7!(0H\)#?P8GS4J?X5CWIKQ
M!XK5F)"2S[6@\$_(+SZ3/^OS=2PSX9H]C,Q**]IZ59$UKH_H=4CCV_GO$$9H
MY&)&;K+ZAQK_^#ITCNZ:SIS\)Y>/D &)$SS"XMDOS\'1C&KPDFZ#I48IX_T;
MF]MXR_L$6]K!0%C.Y&,/U04>3XU\CHRG+/4_^JNG2S6)>P WT7"YE[.)1.F1
M/>'M!WZ^7\R2PM^8B%0IN@5+B+_2%$\])C#A^#'SK=B27NVT.%V3)Q-"M4D[
M&<K/R[7C[#9^&8LGD@5HF/H0\K0-9QFMAJ+;RCF/J6'/$8J\,_7(__+E0K&"
M!P$;(BRKOY6G;38C(?H+T+QA=,[38*_QLS8)6+/+;^*7Q&N5VT(JS0R&@M?[
M )S68,6H.UMR[)!@3%W#187XH$(M3:ZDR?I+FRE3%>^*398=)((SU 7MK-\8
M5WT9=4I0Q0,->>X+6-FHR4?>'7ZA'5?H^?A"/_'N-E ,J<0+ML1!H\O,5A]L
M1P2OM+!GGP3TSQXM"E7:>T_FNT4^1'].E#55;K%<J@!V.$H-52&\0IJ,<GPT
MS$+#KZ:JBJU0 ;)K%"[($^Q^[S[GO'<^?[9WGO3\@9E48R[HNFD_W?5/A_5K
MRYJ(GU3 3/62<0+)DG@KK/GVN%I9<X7PG3:/ZSZ"_7$,TZT7 ^"!@U%(*H"A
MXS[HZ10'!T=U8#050)?:^NLTH@O#&Z[S<V;4NK/@78N1TI_$&ENR7UKEU\^)
M6%20W#)HVIK"PAE,!)'LQW2%^5]B)D8F!-R(KEMQYV;^J*N'FR>[3[3]1O3!
M"%?W27GZK52 2PC\[*I]5=:?DOA*C*VS$RE-6*W;MNN>=='./L5] [@32[2S
M)%IMYDLU?^BR(CS;..BX>&??'/5AC4GKYS^]ZI''B +O0RJ PBQ%!5Q!=Z>=
MG551 7^D$65(#\0TZTURGBZ]0GQP)CZIT>2UY6BACTFPNC)/Q-6MP<G(-QP/
M?FNGWK"YVE>;\U-HL>K& TTTXL8)3-V5,@:JY7M)5"'<UB'VC]JB]X7]X)_+
MYYV&Z$[S4CFZK4@/5A993M5H>N9DK\,> V'K7J2KJ+.DW$3$4^0@5N@V)<*V
M-<X^OC)W^5[KF^_FW47,\.RK';I74@&4+VU'Y&C8XPL^\C6HA'S]&H?*8MO&
MX9KPG"OBX0YK3(3F;_EYEIKTL]E,S"^[#I?L55M=R.D88]&DOB4M152V?I+?
M/BFMBL(<MM!-!7!!Z-V7.'G#;"&BD6%WWVS&;:#$8U[6SKYU+CH(619WU<_"
M40'=((*LVOI+2#""$ X5Z0AK<MZ9>+RXS<CV0:1RM^U6;\"H=!L9$:,+H]6\
MX76?O@8:<ALJT?I^7,&M19T*F.P@M>XY^>WKN@OV/I/K[1@XOV6R9)MCB-@\
MRQ]2U^RQ8&79.VL%@?^<P?"^!)1,WT+,M'ORZHC]/Y$_GR9/%??E7WH2&XCT
M6M=$F1ZS'%I.S2QVDN@(]E\(2L&!%4E:3S-W4_Q7_.97<=6!KH)]CD=-A]O/
M(QTB%>+.(L12.#UW"G>A<G)GL;P&-NB:07;;6E&C44N[5?.Q;0&0>;?UT>#3
M+L>8P9(%)W W!UOVZ/5$$*_TC^K:P4J$ZY)E"@Q[OPP9 ^:%F"QN4( =WZ33
M@WQ[EKUZ)11^<82<RHA&F4>Q$N5(T!Q\.L%-(4EZ^-+-H#&I*N*5AQ]>W)95
MW^WAKZ2\VP6_A=?!2'G ;G\B,YQ,YWW$1&$.IP*DT8$T';F-(/,R1JEK,-W.
M9E%[)&PR@[2!M+$*NU2JVY3(]8#-M56V?UW]W/;OV9O/U;667)Z.@E9?MT(B
MPA^]N5')K9L&?I<(I_%N;1),O_-@'D]/!<C+%SOP'S(DAH0T5"(>C_-8W7ED
M>'_LN )DF#0XIE!1?H5"_CT@1/$QKC#\$I9Y9^*#7]ZW*7"=2I)WS!N:4BT:
MK:[M"8X4LK$RO/R?E/>?(08D.E)&+D%_0\^-M!ASO,B_[#UG$G3H=_)T5ES)
M1)K<(0S:PB6';H.O_H\\$.5)M*4,;A(MPH3-L,O;NYAAMZ^5!?C8&J(%R5 R
M4GW_+JQ\*'"F&%)/!7"D1E,28^"$*T!2N@N%?77^9Y3[$A50CS18KRI3QJ.V
M%CC)S6?OJ0#LB?#^F30?%4#0I=DG8Y)>+Y&2$(ND< I3 <GV \!:F1T*LAK6
M'4^2S<6@NQSZ0O&%WGB(WW7UW?DY]>/!(-@/F9W/\%KI@B5O=YQ*F#]1Z*HD
M6QW8\Q#2N2QP>$E@:G^BM3YZ( OHM[QW<I+&[JIRS0[/XG+B'TH1.+M$$5N.
MH@+^Z5R@ IAHYJE7;I=SJFOY.ER,PN.9KYQCXLR[+YD-JBJBA)FGVNO@*P.3
MC_YZ,\SP']CPO4Q:JQC0W)[<CN74\N((B8'@\(6@%NQ*6\Y2_WTY5_WG<L8&
MH.AVT.-0N=/=0ST2RV^]LC-TE__>_H&>;**<[$Q/KN@JK<=\C_/T(V>7=X;G
M)$S@)[<&PQ(TJO;JLM<J>&SX<R:F@\Y[-\=7/&(Z;_+Q2EKWB* >;S20)EU4
MRX3"TNZ$"RQ>6?C'1/_=G-.S0=%N;TF+'[VSKPW>0.,^F/O%Y$8J'?W'0K S
MW$\Z$E7?F9ZC$4Q%O^;!T^84(.541G7$_Y%Z]EHKK\BEGF 6<[8$50N-Z^G?
MW1YM7=B^3V,KP\?.80M=V<KAH=J4''^9$[>6%,L5QUSS'>F1V9G/WSS/:E,1
M_!]<P_TCQ>@6_&7[M3;[I2M&)B/_8^GQLL^M"$75Y/!;]_GZ"PP,J,38BJU@
M9?-SEIPE'CYUUK#],28(Q=8VF-PYVY7.RZN4*YL<J11>AG7G$&YA2[KSE=(L
MG:V.DOQK6-5S?G&3VEVA'-IG0GO>W4A?\*D:(AZ)YZ"IIP2G>XEY#XR<U)$J
M0@?/BK6,@^ KD-I"6,<#_V#?Q[W=))7Z^(<H$1TJH.[=[FR[NYBQGO>1*1(.
M9(+USWV&H8^ 9TK>9QP(=_7.X2[-R*O3)_LK8>_U9>NNF4]D[?K-1[U*E.,[
M[&T3&_VBY.P][5;S:;$(G5[(V5X;QJQ1=21?W%AK:#6JMJOBZ#P-+?2$-@SY
MEC@P4;3-70K*_)A+OEL9\L3QV'J334=-HU&M37%#(LN_\V\FP>]FVM8@N3>%
MEI4WFRJR/PV<Q%9TFAJC/55W=@.<77JS>.SC*=,N:FBH&&7011'=HO'5K-@+
M/^!3Y7(K!<?4F*@NCM=YF(P?=);U*U\V]YL&A^<Y)F9IV41*+LSZD\S)1;K,
MV!+GD1I15WL3B$'IG(&G;]%4FOIR4#*O0SLQ:>CY)'XP(@I*\^UC"#5$JCY[
M2UMC+AX?%3&XFA^J()GL;F&BFPENY=U<$[BZV'@E;V;V4'G'IZKEP.NGWKG$
MJPAQ/.W]TW_%_R20<LC%;_ #IQ8]*N!?FKH=1H"_J9W2[":C#0T[YC#[Q',(
M2DH$_@!V4KN!8M6F H*@7T\-[A(BR[W%&"8@SIXL@T6>_(I.+C_@^9?4]^7C
M*9NR1E$!VRX=Q$N4X0P:BU;Y!+.6\G<Z=O U?;S<]@^*65_O'KR_-A)-NL3?
MJ0U.@_#BW+N:QG_,;3J^M9M <VD$N[U]$L$U)M9-#P:20@BWOI'8" 7E!&/;
M^XXCYG@T0+2>;_?W<X5*8Z8_<:)E6ZWE2FJR&-D@4CE2&@+_41I;8B9HB5C[
M0!HF!N-,;> 8RZ2BE.C>,_EEN6O]XNV$*T@Z*F"U9!G\!535MRNB+TD9A*I@
MI1LCU\+2NIIXIZ??WYD+?"+^[[MC)6S)9$DKU!TV8-G;\".7N^M7Q;4C[V.=
MZ@A<=V_*@V#+(] G)",5T)]7 $/' ,_DO0\T*"Q:5( ,>,G_#/^#"ACQV#X>
M^#_?!#MX[G_2& $:%&L+IFP";4]5QFB,]A[.UR*([1WH*UM"7=K,%_-NE&=O
MVN(_)W'5ZL92XW9RVF_[62!V L0$VB@.HSD@^E&2-RZR?8&YQ1VG=F.A,U]@
M7/=VG9MAE^<$0C&^+F1OFD,E^M3>F@I@*\$E41)*$FCDYJ! !5QRJ913Z$)7
MR&:6/CUS%C.ZI-3]IU H:'/N1IW[1LEN+-$0HH3+V9E9CA(VP$V\_N95;S=<
MSA=2GWA@^L]P!@]'RSD8"RE_%+0BX4T%.-N?)NZ13(BZ$',L-"&TW!O*@#ZJ
MD!TVL P/?209\ \S@.^QHI8X5*WS?[=W%B%P74]734/H_IHY%> D!M6Y9,]K
M95$>[MQ"!5B?B8";]+,(GD0'*N#G3Y(AS7K2).40\CEZ+ZT8*@2=@!T\AW'!
M=I1 AXB\?F0*R'+L3)=(4#PF<R)ABS3_>G#K&$5DIQF*SX6(ZFVL4SM<#'H9
MHC3R9(0DM[1K?7MTY>T0'A_XUN@Y0#[M(=VI7645T8KDA*YPF2<N\<?+Q X7
M/B%Z?Y6-2+U066YA=;_5T^:^B<;:<TQ@[H,(KJ+%&;/^$QA!EC,U2($7XC5<
M,R>]IC/3*FQ.U#OZTR_*;93^SK#/R.HG<#?U] NL0_[HYQX5X"%_>T]5GK$R
M12L+^ZPY7TV$F F6V= 7G6CQK30H\>3CCQBJ")7FGI]6SW80@-_*"->+VCX^
MP0/).:OD/"CPH64%#XS?.U8:><% _L=5'7&F-F4SL?>ZS^@J/_J4+GX'V[?.
MV('+M+Y;E:;V13V>,)FCQ)]9T*#PM?X.#C[#BIDOP%GB W'9+XNZ_=1DZLW*
MPLX'RG5=^74Q,N^=V(K]DE]6Z7Q8H$/-F+RDM_/MWJ!\F3ZE_N0+FOHQ]D=*
M8&[H*!AK/J>PY%(5NN0/ '=@YI[O&>7N6[;,X;5F/V;?_O0N0>\FH^4GQ.=?
M56/8S>&*SQ$+)-2'P>^\2NQVA66.3J1D_Q@@EH8O'%OJ(=D@+E6=BBLDV:*F
M+^_:HIKS]X;)1\>=>_M@D[!0? )!#]?W3\.P#\2U&&Q0YF3F>R,O4*DN;\E-
M=LL*__U7)C@3SH5\XI\$8BV&[<+/@P=\6A545X@/F4J)P^LB]!T=B"O9@KY/
M/5:,$VTTW?Z]9;WA/99M&XO8_Y/5*HH^/M3]NC;9 FITT3BV@Z'[R?%@@@RH
M_35=3I>&#Z=XBN,*S5:FH8==Q/Z4D^0_>>;>R$_A@Y<X]KC[I:Y.N::<$[\>
M+@-X'JY&(!+5H+-B&H3+%0\>>$6D],6W"#VQ:1CU?Z*LRI7Q_$_CS_LJ>:T<
M2JG'1.8"[Q!]Z>'K:E'*&+^C;0+WVGS0IJ1?0=;K,2X7CD?&EVZ;V'W(V-B+
M.N\,9G6Y82/^^:P,9@^2!BT6Z%]'JZ9-P\#U51/!K#H!OE[_W'/6%I>^_!'P
M3&Z#)E*E7.J_;N<SX&9S4\CCQ"_%YPH?_A[A%;-:?/+1?@",M4*<:J==A*$K
M$)1$WJ,^$C>8\@\G$#9I0=.7AD+X*A.86\^I\9&NKAQL^H?+<[)ERS96KGM>
M%W?=16*<"V+P[5O%V"?.NI_ML[!IQ((C)1)"PQ,)]0HJ /R<"MAXVG@@^:$4
MIC"VB9HQS:)UKP&^"P]JSJ<"\.Z$R(! W1P-;L]$U/4AYW=[?B:ZN:1^<JWN
M(X0GO&8_37Y7K=5H>DZ!W\?*N?\KLMGBA0AG)_(NTI6FH/9?@_"LEF3FL@,T
M'D,%9'ZA^44RE):#J7)WOCH"=<CG,=T^#(6GYRP!I]U[<OLZTC@@.O5CB(KR
MZT\:X/<^SBIEG!EGO:?7<(XO8F_LT,7S\N^48IS!O50 $ (L\ Q%-X4WMMHU
MYO]R3S2LO^D"?A\.O/*=Y+V!)$@;MYLS+9U'+/D+AN7<K9V0#\I.'.J<V%.2
M]-:![%^V[I M  Q!<7C$L)X.1B,Z",9GO!0%ZM)VBVL58?>IGZ@;X,EW<I4[
M>,%YR_E!2V<V[U",1&73:74.4XYMS]?'LI;FJ@?&RVF[4L5AR$5T+_P2X:EY
MH&W<A/"7W '^D3<30Z'_W)+//'BCM<<.38)U:+?)#>(D%AE;4\AC.8Z(UWLN
MO0Y2/LU&T+"?DBO8R9^4W3 4B=<)PVU20O!?,GPK:48S*D^VV!HZ[@MB7!>^
M!J,L[%HB*<S%N$#*15"J/";IB^THR99S*EKG7ZGN1_D2!-) ZFKVEQ\/=AIM
MS.8=21-40%RQE3_=>VU?XH_1%3PI"&1?V_H4U=6DAB_[:I$]H7Y/K_M0J_/S
ME>S'T!="I*N$-%QUCY@N[B1>UX#<6.KXI3A*_O<SJ='/W<G=GP$<Y_GIL8C1
M-,(U_NY]PBV8>UF>T+S_#9K_KV?]]Y.(1@92MV3SQ;>H?*0.Z(E"C/LRJ _%
M[I&11LAQNJLFO&0OWL',1L.-EA $B>7'KVN]*<Q+7C 3H75>*<<6Q1HJX MJ
M'#[%BED]Z8*_@ K63(BMF8><T7T%UZXD'Y1GD#J$ R1Y;Y>EV:H1J #<I3X7
MR>@EIH3"M&ZAST:Y>;^^)?U4!&1]US^&'KQ\^;(=L4Y<LB2]!?/0O,_][;^[
MDM=SH1,5#@.A_F/A8WHI0HII9HA^,I3\9L>I%UFU$.L3K%.6,%1<XNPT^&Q4
M*8=3M>S-Z=!-71'<2_!;(/<-77\LNB]W/_;8/-(VD6C:G#%]4^&)^*ZNHM8*
MURO. MZS<2(+C>6^DD!4 ,(!>?39D8"FL.1@4W2U<,*&N-VW=^5)MYCK6L4!
MGY=X[Y5L#2]3",4OR@M2RDQVI2E'OWY[-"YZVJ7BS/8\H273R*J<'CY"+5$G
MS-ZNX7W)6,5E;=]MK0'!@E,-8(@S386<0_Q#*%EN!L6!.4@&2TFG#"%GSA]S
M1);7_M4W%-PR^Y=N'TQK7:PI*@D^)78#Q]DU4'=NP2Z-:-J?W2N3_-B0OFT#
M&]6"B#A:(,CFT$AY!Q0W+X8U+"?Z!0]4AP8ESI+S1?Y5//(4O ,Z^HUF?'CI
MC$;>&W,4I_S8Z\\I*#SY?CW*];#-/]Y%!0>.SRM$JSG4LIMN9,4)EYX_E83R
M&D5FOI##-V.@+[VQ9HLAF=YESIKFPF9$B\+09ST?&RR5W1^;: WM'9_^W1/:
M)QA3 :P:^)CO8WY,)#-=)2"^9NKAZS>*#ZR_: 4V;\0A'2&ABWD*2QHQ:I;L
MWB:JN78ES/6-=Z0\\MX<"^>DY^X,>1M,WWYM6$9IY1#)3B9_W&YU&@:?[4&U
M*"/@VI-DB@[A&Q7PM"RX.,Q<^DK?G=JLPEL"(+F?:2TKSP/_Y&O;"_L2M2$V
M8ZJ&$P58_O@OHT\L-9U9F4U_P)<V!Z%O/6!8B[08%WK<T_2EP,C2"S7-64U$
MZ>+@2XZ_?IE82:^LT$<G'Z9&HLO#D/AJ@L'B/V^\\O6&NZM>F;=^7/!\^Z_[
MGG$#VAC_UO/K:(=UTQ$5H/"[BZAL*_+-]=L4[;S"5Z J81)+:2GZ7(27"KIZ
ME5[:? 6>E]FY[_QJ?LWHHM*Q=^$1N!K\ ]U[2+Q)$AZ!V.LU.7H9YD^<76A;
M&GK-9M_ QO*=Z<M.R"#4"#JV<%%7 V>V7)+08H6Y4YQF/"9E<G&0_^V(IB$'
M,?+)J_#U1D0;35P%ZI"X<&P^W9^]S6LM;[W+5 NOU1SK[&TI]/0D'*G\DOV5
M+VLC(=<'-M?^R$_B1>R1=/YNL9!+7$S^;MS2@#S;GTCO#-/<IH',8@4L%+-
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ML0C+7-L*:Y1_"W9ATAJ/QIU/6Y97P)RD'%\+3F&RR?(M5]B75%![.]AY+7#
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MY"JQ9ENM;^UK<ESVD\^EQ&*6#Z8>E4:YYC6"K7> DPKX]#%]$$2UI0['!O?
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MZ^5!T\[3%A;?68]1!7Q6H*(WZ)#_#G>?4_,,?N&ECO8)ID3/X052\JXMJ%+
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MVJOR9@U/C@=4C'TON_"!]?#HT.U[S\YT/N!%\P+1I/CH;4A%J8? ^WT8!+:
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M5[9/ %1'0Z]9TP:QLJ])>OK<DF*Q@-!1AR8!L%J/\0@.-PU!,YRE!8"D@^0
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MX%]>=\Z&\C93%X.M64B]#>Q JFJ%5R5J5L,9A%85H'OWHOF+! #6!]M]]I0
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MC D%QYL$P.R^>:T U/3AA;!1Q!-PM4FK^7F(VG=F3/%]R'"HPS>&,&PF&B(
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M#(NA(E SHW0TEZT&44#6)P$P7$,F/1P0 .D2X,AY#&,AR7=KN,8,]:^^^ED
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M*Y&LE::\])'-,>GE-QK,9M%ZY4N\*180R%S4:-NIWY)3*Q]>M^E+C[)P.(<
MRXE4)"#X!ZUQ5>2R-C-JFR;:^L9M8S*W?7NR9%G5=K]%ID>"X/6$:NJLM@LX
M7P/2L*C@ZN]/]_CML[0FSW7PDW4^>=OLR\S9\^;1]UQ;5;+I%ZH "*EDJ&4)
M %@X#DU[BUL^#B*H\OTMFG:/9R  #DHAO1)G"DN U6*0'QRR%0-#!)X&B;@'
M/BT L#OK6/H($4-OP:-Y8<C@7ATT@+$3 #R176#U.6A=U\*"@5#3N;_ZL3KR
M2&7&/'^5+9'/1$&6+<]!39#TU$]QE0 @QJ!1\*&_*M0<:;EWX5%FW1W7S%%I
ME'/.^\7) X'+]FP(:@W"2O/PD-AK'JH]/SY>P>('GW3%J>?:*:/C2V]H8XW@
M!M2TR00X3G?GK^H<R'F:3D\)J4GQ)*4V\C[M_!2[.>5Q]<[&3:HI&JXSY4\P
MGGX&")DUP3O]V[.Z_6\RFV%".#B0@I:81:USZ74C5RA8L_J;QPXK%V'UQ-_D
M"+UW@)HN"X#J%E@343VE+E2VG "XAQ")+1J(F%($F8YPU*"U /A Y1G[MDQ4
M<J]!W$%2;;S["N]0&@*U09X];FKOW4X,?NK-#%A+WG&GV=])>"+NUR)K_KC;
MOWWTT1_S=R80?RN?]"_"=WZ=A_]*5 XIZ9< _UB(8?HW^FQ\6AA>]@CAXZ9T
M$7[@1>2/9V!)LX!-I'<C;#).YHR1V\H22B_6.2IN*U5+C %3 +\=_,^S*6_>
MV<9D,93ZZ7O#[Q_8[6&=]M-<C^A!!RL$5#[01/DXXG?73L)?7W^;(=$1G5?+
M21[900XL3&4GD(PE;#I0AO^5]C-%<\+07]$?RR6AK4AYJ18"@#0J .)MOB)"
M-0VI15[& #:D>(X08KC=SL7W,=4QM[#L:8/JSOQ+E)XAL1O5]$')VX,+V+O[
MN?-@;D-3S^:OY;T57$[X# IR1B%B<E8>RQU ?/5J908RVH,B$+"19;=,\!QY
MG-@O+67PEX](Q:JB(''$%[2G99M6"@!)GM9@28/;+C=KC8PTBD]HLML<,)==
M7+3EQ N9&R<C,)]F1RZHTU]..AT[8M!>S$/P-_-^P+]HYDWX.[;/"S9R0#"1
ME(Z>E9T0  L![K?1<TQ=.,0UDE\(#BVA$3D<I/GW9[>P#@N :%VD!V#7@2-7
MREUB>5%C8"B/T)&#G38YCMR#F$EP1%S4**;QP#_;1?U?LO)3T +M4H=T&"OK
MI!6E.K4*%&[:Y[O%WN[=]/:I;;E0[X]/R;>7#:R[#Y'2=/:J1!PK\?9Y=O[V
M4=![<_TX]@69<10;A)=B=D-Y@U-2(]:^PQ$J3+>O00WIA_)\U$OL ZP7+[(]
M^&A"73@%S3A#"O1N8:E%@(P5*%C/?FH"P9@E4HR625WF[9;*_K6,^T62$;V8
MFS<S79:ERZ]>O\1JQ6GQGA^F@PYFW&4\748D* 4Z$8(5-S)^Q&3:C7"&>[<J
ME>7=-[TOLS+T>,TEK<V1GMD1 YB[5Y&^!O9EV$ 86D7Z %;>>2M]I=S>PUO/
M>R@>3'JWX^3DAD7>ZQ-%2_^S(]%!T@?1OYGE:A5R\*,C3*(?.^8ES<JMN>A1
M]N3 _L5KOMB\/(44"6*^%P#9;KPTX8^&\CE8B4-"&]9WK]6CD"@$WCZ$N[Y&
MS<N6!?XSPAE_;HO6KE_K(Q+.3G7@1]7">3ZW+M(QN;TM&H<?-+J5/5)3<536
MI[3-VKR\6T_?OK54/\N?!3ZC7WFV361OY,6HU*;&=UFVW(G/TRT\[<L4_FH/
MI*Y0 N#RJ3G1;OHPYFU1L>'FJ!KM_'A\?>2 (\JW/#N3*@Y^*$M'"IY/Y"PG
M6<O %X8>I4-:TX8NJ8LO6=Y]E7:5' ?R'C)#)XIWXUS:8PTV%&%)'UQ_R$)^
MK',(\/0A;4.1(_(!RA>==D0L3^4(@!6\GN&%$$*EL(4* 4>U%R:%#O&-_A43
M)!KWH51ZDVMEN9SYI,@A?_SL%Q63KIV!:X.>\+:C]TTX98X9-V_3ONW?'&EP
M^$2&;,R&UX\Z]7K8SNF,^4F10:J4]^#A-G(A3TTW-&LR]:)\F_BA2-.OO(Q(
M!JF6B/+6,"68?]99&;_50.;%>:GP ?$;%D>^EZ?R,_0W9WH75OJ>>H<T0EJ+
M N<PLZ+DWEG%8[[-\4D]KU^XY)[N"SW]8+OVMOT5+2[L,Y<+WM!?=UK'F=NY
M@^:WT7:I-=WRJE8'Q*L.6#Y.^>$PMMO5SLQLW(N#6@E6'^"=$@")7RDP@%3U
M.E/>+JU:+&?U5W!@!<C4F2>P#$)Y;#N0BKCK%>B<"?3PQSZ8KP4A?*=G#]*D
ML8.P(Q$NO S.:H;"B ;[@%I"GE1@[NNA-#$7IW_1?/(P&V3V<JUHIN$_<!Z,
MJ?T4+3'EXK)WXD=R^%][-@Q.D^($@)NYDQO.F%8;LIZVM&=:V:B(79;1CW;$
ML)42UB$.9O_"RO3SPKX3=1W5'6E#T>/3B*.]MNFTOK5IR*?KD'?;XV^L$[:V
MMO:;_ F'$4\TAFD(_'>C]_\"6ZRL+)*"VTA#][0/VDST<&VH8P)@S7!^E^%:
MB')&.JXV<F+5$TWV#L/VP.TW0ZP^;!"K]?^Z03-2@G9OCP[[*YW4J\'*Y3\M
MM<LR0W QM(&I4:'*<<SOV/6AX7WXHJ'$K6OW]+Y'[;@];K2<:X[;#M5S=> .
M:0&@8+C*^[IWH3E3@=A3\%5!HFAFZ7+'XP?=-AT/<;A[;BX#FZM638TDRZ-=
MY(@$LK2G%G0HRY._-W\2==BSYT%C4(Z9IL2E%_7I.N/H)># :W")H5:IM8UM
MG_=.VRO=5W%&BX6OCRTFWR2E2\Z=BIE[E^HLV?FBQL:Z+<W[>W!U<E!KX!ZE
M +6D7^%.?W0\AG_,S27$'OVUV!A2"^IO=[W^*G.5G"'S))3AH^UT(C^0 $<>
MX2C]RBJ+$6KQW\ZHD#?\,K1> !@ML4'4+4&.P/E._9CYUSZG 58 /[2+<J,<
M*O\?]MX[K(ENZQL>1$6EB32E104%18A*LP!1$1$0(RH@($1!1$1 4*2%C(J
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ML6$E483JLP*;X7LDS^Y& [HF'Q,E"5W\'S4-?[7(C7XLNS71\>G06W9[]8T
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M3SAZDEQ U^%'@I@#G<JPB@DL["4L2<V#;$'\<ISESR[I\Z0$_U'=Y[ :)L#
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MSJ+Z=/)),]6$HNUX/9YH.UK[XXOO97P2IU7K6Y9T0P9V02K>NRW+256^Q[B
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MUH#E:F7;&-%]7E,N?9QU=>Q0&U_'IGSK_=$S2@+NXYG92=!&8L_27VH?P.T
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M1Y/)25?; H[P)_?V](UI^E^3TK8U:LXL%L"B^6;BA7_6^O:9/QVQ0/C3K@[
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M<!RTPC]:'^O"!03O#""9LTVD&7B:T\Z"%1>\ZR%L'I$%LQ/;##'>BGK+JN"
M=:AX#&,MW42<5OB+#YO^ZA,9YZ#Z&>$%+J  .8&]BAWJ_[AUIE"6/0M9@FIC
M1S-3EC/@7&K$[,7NY+S.)XM[4TP:/<-UR;6DZ#I#%;.82/(1CY/Z_EJVFEJ\
MUCP:)XN^91"L'XWL.S$>2@QP>3DYG3GSSE1??"2Q_8_>@_I/^;>28\LGJ&@P
M0I.N2OI^LK'NK',7/2:Y)ZP7;U5+C<U];>T=\NE[]K;9>B9:-''/6 B=]VM;
MV!AJ5OLP/*,<F?$ W1>N'K5=5P,LWX)3PAHQW@\(BX_UJ% #LR)RT\]C] 0K
M"X\<-91Y(R"Q0HV\;WN9!.<5R5'0CV[%B,6*]^L8F'S3$'$4'R&DY(4+=:C=
MB=/?S_S_V'OS>*C??G_\C2)EB4C6481"BE"V(=E2#:D(F3Y4MFS)EC$C0EE#
M*,HH(>MDEVTPHA*R[[LLV6;$>#,S[_F]N\_OOL]]SN.L]_=[?O?Y/<[YXWIX
MC[GFNJ[W=;V6Y_/:7D'R.V8$$@Y4D*6_7F("@WO;8#Z4L0_!C9R,1Q^ Y.A(
M,FP5R]8.@H;]).N2R)T][MG5_&\U9ME'6(3GBU5W_&C[L!T/UY8KR3+(7?YQ
MYCT^ETQ\Y*-ZO++*POE+W!K:\E[%U%)NJB\_8@(R'\F5T"<:BG%0'C?37SKS
MFF-*_8D[).I4O 2IKVO5*7<[\_'=MA?Z9C_+NI]_)#")K0[P26V-+$/S*A?E
M%U@YAX5?M;-]=T,BTTLB8CW':5RFBWZ^:/AROD-NGF=+QP^9?9O#E^4IQ*E*
M^@'D#'Y%<9H)\+LBA.AZ[_TUYM2YJ8R[4CC5Y<(OZ[W&>?M9 [B#+P-+<?P@
M$R#'M1#)J+B8G9LI$;48):4KIWL+-A6/12N<_.&+XID#?@1<5]BCL\'"X.@5
M2JG8\2D=O8D2+./<RGK9=)PZF[X[ $7RB.VOKERNS,#<H"C$VS1!HG$W>MNK
M6-B>^%UXSPF!MS+P>N@XQ>G.:#39HG-8QHV]QR;M8M</Y5']/Z2_58A<2JC0
M>W#1PZ-*G2_98>0#Q^K=^!ENCN8#92)VE3DN%I)M1LY^8@4Z;TP*']+/,=[!
MGBD-R8>[3>!U3E<E.T:MUEJ%_-0,#,T<-G4,=)5'C)6\U4RY&'U[OYY4M%A<
M5R<H2_Q$>(H\ .T-PD_G1)2_5OHD<KIIT"6U/%./D<NRZUVFY)V!W>B%0KH5
M@##K^J<ZQ!(SP[M]D, $1A'?+%7) Y#.&FX4T5&-/H3[7(Z#)B'[CX1P(F4K
M$'[T60<)VZ+FL(ZI3,"$X7,%@;#]I]G#_\#N!=O53/(22:1N-L6OFCNL_5N$
MDL*S8W=UYJJ/'Y^Z\F!L<GCC5+YATIVVZ\=-V]&_SB+!:Q*PBW[C>HD)-/AD
M0H)&H<0%ZQX<6=RUX&W%3CMN'A=XMOX-[-;QI^ <EMMB>/KQ. [<]_)LN/LT
MNF!(F=DXL:'H3 1YROO-C?IA_ZQ)&PS2YV ".@ZPDR"L_]MUQ!4,0'Y;'W;"
M>2$,3)-8T+/W<>0\+7$F<*X_#?[]TJ7$*<O09'4IDK6[+G)]M7S@S\8H["F!
MOK9F[\\E3@Q%T'?CXLF.I#,)O'&I"E[OC7NLCN?5 ;LF+<?[X'_';9_AEH)(
MBK\CT-,ZZG.>$F-,Z<A\Y!GRUL43QY2V8>F5%OC3EHRJO[>I_=_T_S=WM$N;
MV[\C'L;/S8A-*NXEX>X__9S!Z_BG4WW_W$$01B-_;[T/J76R3L^BV9HH9K_V
M\Q&BBK_X=?C1F/<ORK-3NHA\7 D'/76^:8(FM(+<L,I#5"!6Y)UIQ^D"O1AG
MQ1>]Y3(O%<I&A*2E!TYPFLW>WW^\E%_[U'@9[K;QNU#J+1 M5EQ[Y<0C)V'I
M*P4Y;6+[ P0;?J\NP96[N5(3&:_6-A#<+$I/RD:J-FU$KWN&_,B\?CU*-CK)
MM\7K%\MG]F"DILY!,(=*8A"5RJ-BV%JV1"Z'WEL2[&NR%5=!/?T\)7 ^ZV7Q
M%^# 9]E"?]F5.)H2&$JUI70DOO//_+3?/_]&WS*Q3.9CL+$OYH>GM?['6+W9
M1W;Q-&6H>T*":!_5[M"HAN1=);1D*G]]P.UM^O'&X5?1'M$R_6T BUCHHT4K
M7(42J7.8M\5B8>(@I+1P?VC,/RR]J?5B+&OB#=*>T???Y62.:KZ(F??2?"HV
M&XP-_SE\:?MWA)VLPM2R <?&_6T5$B;1)36XF9>=,V@E7.,!F:<Z&N"JFE0[
MCB<F5"+EU%P]E1%>+JXR/;!L,+DB:O8H7;!KEDS-O:-U1W@O>UC\([8UPVL1
MI:'H5#MM1IK.65RC%O8L3*E=)S7WM7N0J-T7^C7:7Y?:-BKF'Y0PF);;MG%7
MAK%([DPP[S 3$ +;SI'9'WD7^:=8EGXO<W6K]X'>*).X I^8?WP1K&R,B%$A
M26B0YV/L [20!.?J8<G=L7@_,9K>PN5NKV[B >@,MH\)E*FOM+^YX<\ZTG#?
M9K'=2Z!T<$'DWO;').\/GU=M7&;GA=F.\[HP^.'W]H):_? E^";&.1Q_@-*,
M![^)8$O&LZFP5\8Y7RMY="B[QU[$*@_..TFS+>7],P4X5?L'$S@"UT8+W8Z<
MJQ=A JUC:_#S@.F_Z+3JT8*P>+OHX.<"0=SVP3Z814C5OXV4_\G[G[[EYY]%
MEE6M2F]M9 (\R-G)TW$TKDKHL>N:!J@RU4I_Q0ZKU!_)3.![3- \^H_FB99,
M"-%+SR=-;-E:,C"X!/@]ZL\PK/[NUQ;];_K/#OK_Z7$QJ:">C:QW'M78YRP@
M!TT6]U7_P7]L_?QW8I4(KW4T9@+QT[P[-.2W@5+XL\.%6^GJCXOW[A[Z@K30
ME>@RT*=6(>?+<%N#F2N>N$XG)K!6K'O W(Q1Q+N]@F!0Y6BVB%_#2-JRV:[>
MJTC74"C0B D$1>H,<-"I<1!-@$55D'=XD@FDPW!IPCZN')9P[4PF4/\)N/2O
M%&T;2R"@.*++VHR+KM[X_#%>[Y!L^F9OT)_K8W4YCOC'4A!_J1%(C8SX2S%&
M_UAEL,S;-W]NH_F?*\S@?/\>^^<F_J5H-I46Q+HBF@E4(5\4N4X1Z$'COY]?
M/] Y\3&,KHXY>-7>S//0P\@Y2.R2F)]EVFM+.8U7?H243[*,0H-MW,NU/X:A
MCKQ:&+5NB/S+C=P);?R/-^=O>-./2)XE=<MQA;Z5V_AO%1$,Z]C0U*5_<^8'
M@ 4QBPF,G=Z18\?Z+T+23."QYG0*=6((ZGW ,)E;5W>;"-=R+ ]TI*O![?B>
MPP02X;]/"3<'D(Y,@ T,O5;5ZUYV1TB=N][BP'.NL0X.[ZNXJ9?U"#CS8>+:
M+\MQR_;[!8X*Q:??#5^'"KK E@/A52GR/H>#FYM./D];P]4KO9E#D(?C8-3[
M @;)\*LTPXG[/1/8.!9'YT;0+SW$T57483*PLTN= ;D@_[IPI?[[B&V*4AT3
M6#=ZPWC=@ML0YOV(6^=X@2.Y(!E[813.!O?9 :-_:'PVDGP:1U%=A G;MPE>
M)K"P?V)K&ZXH_"Z(8P*ZX4R V&[TCR7J_6^!_UO@_Q;XWZS F[^1<<E$"U:A
MI,OCM&P/=G#<UOO=M"Y"C/7DF:VB?$@X;8H),%A%(2:@BODX*7^F;"V6>O#9
MB<^2?;.1JK)GKMT%L-=&SH5;Q&59_MQ(]8IZ6#D_URDK%#V-23D0;C5ZT5$D
M\<*7$S^WMBRQT;3A2#E",-+M[W[0]G]2^B_9_^*4P3L?-XF*+?,()U;*I$TC
M]X\%11F54 QZ;&U7%*2N)QN,ZBYS"A,6[/KGY$><W"6?F>[Z+!TSD'E,>!=6
MD []IH_8 PL(#J+KI4!C\NR5QIR;+\JEN C$VXG\JP),P,_KC'@INA;)19Q]
MY6\#-?I.[!QS8LO^*V?+LN<SX5@?A'!9R;6M/?6N6#/Y.G<L)\'R;;"6'R2X
M^I$)Z, <.>CWS-*6+1/ ^\".?VGP?0:O.!,("RS"=5;#?OX!KJEN #D_AENK
MIAZ78VO%3=DMX7^M$K?&$&2"3^?V%IJV6A<9"5 F0,OJ>3J-P-@RHLN/>4-!
M Q"-8/_OUL5316YYXYJK]X>TKNTWY:@:P@QXC0G\I2R[T%S_^ZX3 H,N4<<5
MKB^%GSNKC6NI%OF;J_N;7LUU8M?/X:""E --^0(."OIS^<[I8L1^\?[^DS_8
M;10C-_'_TLSBC&7+U9S8G'"3^U_0G81MB2P%!=G'K_VJ<3\@1_6_;M?"7S7)
M9_FJ94F 8RQ,??_<-.1?6A4H*, R0_Q+T^+^L9,^&0#^:W_IALR_ZH&!8G-=
M"<U_HSHSCF?^CH9]+81 9\?[%99F14>EY[4V"+KD\9<%5J:G>M?"AD^* LO.
MU<@(F1Z,0:X+[W$M/[0/,.N=NN#T[RWT_:V)A?<"J ]CT77/9[A!=P\&=_[J
MK^[Z_60<_94T@BJ:Q@3T76@2"$A"GHZ<PUYK1;2V$9?FEPZL_0,U_?\\XN__
MY/1_F6+""1&&)L,V8%N+H0_5*A W1!@$\ X3D)YIFJ#NJV "7:;H2,2_DT-7
M7/5OW)9Z:/PDS%%=8)_>2/_DC>;&S:QNP8]+6?_RXCA:*1+.7HY _=*F(^E1
M+COPIPES PPO#>8KC1?+XX8L9R[6LY>2Q>.>W#+=H[1[>2>JH?FSJ'R9(2G:
MISU(;Q*!,4<G(,ET)!^N2[8;1BS>LDQ I'!MS^]CP],I9@849--<18DL]XG$
MO( 2N<WAA8RM-5U$GH"E,#ET&M9F2 -DNT1)"=WD71'GH2-.&)Z+C<WA%LW]
M<0.UR]+Q'UY,<'UB989VQP51W!E>>RS/RM]NI'FE<*S]'F5TK+PJREZ>=8]A
MA_?*3:-E"]I%.VP_@OT=I8X:RA%Q]^;E(*T;(Z-E/\^["H]5Y:W[I9\:#M9>
M_X<=K6TZ6M@>' _Q+A/@K<B=B=O?F//YZZ7ZUWS\=C?YAL]$R+Z?G>29"]:^
M'/F-W%+#&XE1SW)5H]2:N:@5WVQ)<+A?\.006RQXI&SA7[<&M>@61/D\";F'
M;D7N)%D491?.*/I2%&9ZRD8O4>TG/FFR/1:34*F)35KYVZ:X([(PAV%2NWW&
M&+FLK@Z%]VT%+*+Q%?62E61"RXW-P'<)IJ[:=LZWK<*M@E>ZZSLC[.?%+CK4
MQ&WC$[U&9RX4H:^X?[E:@S5I9K"]K96"1 \T3OR:RL=-A#&!Z?P!+?%IAGJK
MG41Y_X/<BQ5^P(PGZ1C';N-E/4):\ZU35E:Y_=G3M9W$1L<;OG?433GM5!(L
M2QX.CKR-E ^FAOR][]O[GY+^;\=Z^;T(^1O%[$8S@<3.7N124QL3T",,P_P#
MO7Y92Y$)W*KQ8 B4@V_@/';_),\(;_@M @F_+^0DKF2E"KGYQ8DMZV]THFRB
M_\K\4OV_;.!^4-#K:IF+D",Q O[>#8U>U_Q)5X%1;P.,>B='<8,\;=O:V#G+
M*3S]( >$8I^!&GS17Y9^\@*,PXR7R#MQH>E'&.DZ8BZIA";B'A>1I+E01^U/
M8_U//:1+C;N..=Z]+9T0(#WP#3;N:\%HMGIAND2/#YH'Q!F0XV)'S"-%-;7Y
MSZS$?.,2;5?6?;%;US:BE?M1NA?Z)'@ XAR@F8 3C:FR3TX?^L--R*(T<O4;
M?K\18O6FOFP;\<=DK*9E.CV0$:NC2M_=,TGA;49PVZ+><1Z4Z76H$7IVN)-3
M*I/_4377S*\,WN^=X!'?UP4V&"%*W]C7SZF*'14AG0';U@9AY[.,<N14?FKG
M+Z.&]:DOR9;+-9.&%*5HCT,!,3]N.%<,NN8/X3Z*))P1-Q4#--)U=6!BN:N7
M44B7I8Q,]?C+7B*/Q87X3.P=,>2)RDFD.KL]'9:-DO7:K@?O/;/BO_R3O@)W
M9@Y=OX;2N?*TR-EOX/YK>5*7S6(%>>:)I7UMEE&NH^SZ1@;O6P)QLNH^M[V>
M(_DUXL+8NM;.EQN?6WWX!#N"EE;P0TAJ-UEVQ2-CM'UJ(.W"P+*N^C W36GX
M\!5/Z2L\TM%,P/^!UGYN3-TD?D23*D_V:!)%17C=J.N,Z/]L?5/?>^JC>-%3
M,PD34>>C@[.)Z74:>T%YJBT8FH-18'S44GP/BII5H?>.@B^<D[M'LP=2+E?A
MO[(:N'L7][[ZE=1I#= 2H7TPAY:>G\(QPMR9P,8%RVQ<HQ@3F/W^ W;NL5M,
MP*#1#G9^NXE,(,&;3(2:*G$[1^6[D9-QGHJ=RWX^^U3RODR+SBJ*)MWB\HS=
M,XOPTA5D LX3H+QZB X'V *#7SO![UF4\?(<XS_JJF(7;(9(<I^=FM.L:HXU
M2'/Q&)H(SF!A!0R9VDY]>X)(SOG<\V1[ML<G3NU64-*T&>[4352DUE':?FPK
M[M#A 275?87ZGX9MSFJ(>7_)EU81Y)(X?SBDJE,4'Q(@QH4AT8*@$1PWSKF0
MX^)WNC!YLZPM1F?A<KI4;:S<B;VWPI^:*_NJZ6VGO5_411"P;(RWF,,4Y.1S
M)G" KN@[7!&V.WHK@21QT#]=KNT+6RY2(?10XYE9L<E0="B^@K#"F07U$"5\
MD.(+U3[4Q)R;UC8V6=D97V_KB_UQB/XNFE^EGVC !":C?J@2AT9:=Q0W3HTY
MQQ1]"'2VO&]<,F)8(L_6N/LJJ[;\5"=XC!!,/TN>H)8-E"'W+CS$13QP*E"X
M'4NZ6&EU^+J30/&>#,!D]CO'(G'Y&,T71%/CJRK P$Q_;ZON<EX>T/?8?$V]
M4[3RD^B3^VNL7B5,1L<&]RNM_#92YF3D\O8TC;#'2>3T^!F*>-2]^O43NPXF
M$\959 Z5QD[IL;TY.UWWBWH?1)!I#1*[R>,U4W'L3ND2_>7B[/V:=487BV/'
MIWW\,WVYCP2W*K#Y_&0A/,-*8[093W%W/*+[QZ4I/)D^/C/[1'-J$\\)*?_,
MGZ]2D'!Z<F__Y:F/$6>DS3@$,W"-GC^"+A\NI,L9/YB!BC<8M[_([<@W9T#V
MQ//U+'0,.64%0?[9VJ+#6T<S@$6\)GW8EG-Y#C@8?HTC7%BB>;^A'N'SQ,@(
M=0F\23,&94::(&[0EYIR?<#92^BITIO(<:?@CMF8_?S7'C6.DG(N[P[ZK;OG
M>F5P$6C^91.)\P\+R[YJ"[^1A"*)24"0,^TJ=AC'2[Q=I]Q>:Z[8\:8(_2:A
M[7S/<]7FSSS[$IJ/2TI&)WZ99$/S,0$2108:T(,95CIRN8X)P ;S'E[3HV1;
MTQL<^(H45K4A#L=1F4!U=_G(4%AVX318JRG,@QI:N3YK$W:1,0J@>A/1E1J5
MRSWDSNN@C0]YLU;XG=Y40"%W1EEDET#+J>"?@Z-B8B<QJY\YSF;PH*A7&*5:
MG#2;!<M*B4/J&KZE.;O5=TYD9*#<#STKVO.U6BQH:D-29(21171!L4%?(4X)
M24K02&U/HGALHG-X==TSGFL"SP#QP4FNS5G+".@KC#<O=O)";7B^0BWG''\F
M@.XK-[Z5,&[JQ76=.K!G9O=MU(NDCD, *8E#RWO[]WEI33 T8&9B1/.3B&].
MP)%%#3:;Q>M?68X<>NRT?A)]975^@FTX6"<Y#=KW]&1?KS[Y-4\*,27H]M.*
M^9(GOO,2FUM"R[DT!_  M9P\UK<6?B<%U7]OC]".X+:YMSNOT:$S_IVZI*K&
M1D(R_2S-"6H>%P/-.4A5]R0\N([F#!VMP),22B_O(6G6C[X\1/_TZ]4Z-T:<
M)@+NM$WYK;1.N1+V_+1D(PD]7%HT:[__Z';5AY??G*0MOC\SVPF18]L<H=8Q
M/M)/T230H/U LXYXWV;KP-NJY(,](I)2?(=([.,DPHM3<?IVERB6T-X)\GS#
M!#==LV!A6'NN9OKU_78/"]**LA%5P/X<(_O:J, S94%]L?V7Y6&B.EGU^\ G
MYC 3(%Q"P>RT@G +MD_&V(YTOAZDXY+'4\OA2^FYTW%\H[8ME2GFG-;#P\>L
M^?C9#]F6W6N._6CVT(P=W8 '%2H?U_I-I]T4:H4$$AOYQB\>CKA664N[5G"C
M@?W>6^7H="M68'9@ %>VMB+[!OJ&Y^R,W713^W6S1V1.]%K41?^MRK37!?OV
M[YD9J,/^IA^W==C\':8&8C'",VCNQ6>+!_R3-5^HGE&\YA V%]%V3$[WS-T;
MATZ)B4<^3$ -X3[<2T6OR--X0(W.:8DHA^DV-^T?'TZZ[E?\=C\HU=#8-IQ#
MX8!3IQTW@-6DBX!M.70U1O8#Q-,4JKI?M3N^2"W_Z#N%^L W=V]E%+>LO?!1
MI?70%+ ]UDHK-\C3'H<6K V@F#OBR\DR$^9RMQ4>F7@\BX]+)?(2[^+W+*1+
M,2HQ1Z?&+$U*>Q^(Q@G4%53?^7:<NFXP=V:/&=D2\%I!?Q=ZI"/F;SF%C1XV
M>JREG0TZFCI?;.F\4&[J'_7J3L5[-EDVO NPL/ W4%CY%JU+-'E_B^:'*W/9
MLK4E@;E<)0;[Z&E?ODCUR-2E1RZ1II>FI'^<<U>D:HWZVH1^RW@3_2X[.8_!
M&X5%T@6[=02=AR^UI'E[>VYYGW:7E0P&.@57T24Y](1]B!TPC0F<4VV%AF )
M82-/,(*04.C-B.5<V(6&M$+U,G]:9W=7KKMH:'(YZX;=91O&_-S9ZSSA'%%+
MWTEZAGO3GP:L2S0:"%B2\!]V8[5QC9>9@&LG8AC;W06*3G5&EW?R#BVHQ5O;
MZF>@VUBJZYZOW1J_L3LR/ 8XV\@=FTVTJI?R7[H,WIE4VN]?>MV^VCW*07$#
M_'E-H(+C8PM2A*["B-%2PM&LL.,:V)H"PX&3%?G(2%45&:M=,?1/UZ7ZOCF#
MWSD": !V&+&_3&D8K_\=*PU.-%=3HPJ%3Y]U4RT\YYI47NW+*CLD)5X@?>V<
M?U--D#RU@[@;.9F%W%,$L6$'K+.+;XW?Q#^Y@^9W7HW4C1G6GU,"N KR6MF*
MT=:,7 8>>\P&XPPJ3JZ)V!B7X%R=NRZIC:M]8Q^R%/\P%2[']OT]X3%R,@]9
M-M^,&RK5!WV\R+_0-_?>M)O>T>QWE3NAU2729(;=%#TT/G;JU< CC":#@',A
M#+=.S:5,H<,.=LK493=W3J.$3;G+2VIC5WZ01 7Y6A^WCHEVC$;S9" *GT<W
M7DW\SC4PQ;VV<H=F ;42A=YU8=RF"QW,>A6&).:-*.)=O8I%;V1#8INGK-@B
M8AXQ#+"OH6ZB8+V<?PWU*GDBA@DX+@76X/E=[]^XV2J8]4[]2M:[8A7CO1>R
ML!;E)BUZ BS3UI9T0?;YZ?D5]"0^7&=7%[(4<\JG("C*O,]'=<SG05YA4JQ.
M/'=;[RR>ZKJ\-BPRTER)9ZOUX@BM'V$"G%=3+RYEXQQ-?HP&93H/_:@P%-7F
M,<!IPM_X*#VQ]FL5%]EJ((^:4B2T#<9;Y-QFDBU\?KFSJNTVH8WR13*2P9L4
M]9F.,!HOQHCB]TG%YQW&M#N,3N4?7Z222\X],^Q"/H\J#O\E:][!$_BGRSHT
M,8HTU )>9).S7OG+C".9Y*Q<@"8_^XGR<C^AGCTJ;SRAIGYKII]HG+_.!"#.
MUS1GS"W&&ZS&3ZPX93XRT;IKJNM'M:E7CHU-O-P#EDH#D?1H_P[Y3=;@O2 -
MVKN/YCN"_0*)5'[?V./0JW/$]:3PO;<O_?3O\%Q@O#6GVX8(:CXSF?2F<N.T
MB!5&3]VQRM@1K*J0I<1M;__'3OW+$:MZH@5\CU[%56?L.,H$:TSLHA]GY.'<
M?7HQIAZYK@_'4Z0_I6Y=ZVW/BJJ2G0WCY P[>\B@B79-B?\3S0QJD#C2,]^K
M>M.;5)&B_(BM<+&V>^T&(*.L_'F08_49CTKL)JUR$K%[$<>#$7P#H@W*8SM-
MN]VDRBK#I?>ROGWTBD?YLLFF=&H#.$]&D=!E2J1+E@V0?.S=;E7NZ.[AI!M3
M#VY]I93*[[YE9"O!*;[ ]@WYQ\3P+Q2C2.>@6@%U,1O,O^!3WO\ [#"_+9^4
MC*0B=@4'[.+K4,;^OM:H!.,/QI-;J6%=&YU[P%_-6.&>=]^G7ZZ<?GW9U>GE
MMP363^;!LH#W"CH#79JS[$4>H%I_['/'<-YY/SSZ,]Z(>S8E91TUE\=O>?SR
M=[V[LUSKKK]XH7VPH,BJO,$-$GFAF(3@,W&[A["P5/%A%'/ 1-+#@>85M'ZO
ME/+P^,A2Z;V7>O+Q+_5^[J$?9Z-90?U,H&3@24;4IX?SD8JO1W"#F#O[;I(\
M3W*R_/BRJC,3(K_I!],S)B!C2<Z'&KMQB^?+/:B_0(M,NA4C"9*T_IG\5+4E
M,:NSP*I#=\)#N_:NV5?4Q;P2O%E+L"PC%NGJQD:M!&]7KSPVS?8/;TSF=C0:
MM1K^JG<XZ8EHYBU.BTV.>+LM=,0$V8B(L/-WH.8DZL9$#&KIO^O<M:"'U+)*
M5M;6.$EWI=I,YS2/<4S.DQ@>+3HRM3;:")-*YQ_VNHY2JRW!F[[WY,2_"+#\
M\J,+>%-)Z*&H*2/JW4</,EO'I8PJ>T(TUDKB,L>4YZ6 *=16'$VFW@(>"!.,
M#QA#T9_I?/I@[9#_6K.=;,_4=PG_%9^@RZXO$E ZAVOEBX')>+PW6F?4/_#3
M1"43B-,Y0;>G")0.@HXDC6N?II\#>\P%V[.>.QZ2YK%B K4//_P.OQ4B#Q/J
M%G\"].D+<N.M", P8V35:R\B2BT;Q_Q:4YL5?9/EBD=N& ZZID5H.D1+-!0+
M:P?+EF/52;2+T "RO#)R4[A6,!_,NUKI<7(1VG^WM*+,XG7>C;WSP5YU3\\0
M\F$\4HF5_U@&!I%'2/%5-C8K%^:HU[C#';A<\EN]:-/8JC\U0P.\W'.>\5RF
M;[KR:DU_>4VN8]I9YUV!]GK+[#V/5E$/@>U\JA2<[QE&GQSW*0T1CA=>6RV/
M.4%==@YA M<N5>[<['++.WJ?Y<'8>@6]9/YLPR<LT7(*-G-1I'Z(EU&JRFUT
MD0D8X<T_E/3B[8,/WJK9QWL%\Z%U-)61#6I/G\6@R6F-J:._]D7%Z!N5?4PV
MI[M_SW783M05#_I[WTWPWST)_D"*$5T0X1.E684%Z6<I M9N?8,R(Z@P$=?<
MAC-'C]@6"\^HVDQ&K#B0B=3PU.F!1NS1R"V+2I2RF_*<6F5-3-#%RRR?@(<,
M@2L''NGN,\ ,S1!!N8@&0D3Z"3PI-2ZJ?8Q1^F+U78^;='5(WZ-&?N/@O,G-
MN;JV!O1^S%F*?A,5>X1<5.Q:Y%3I6BU?<Y8M=Y/C>^SD+UUQ;L$?1#&<,R$"
M45H85MX:6VO$DZ(ZCFUW$'E9E,,6<N5H&]_G>4$\69]:!=K0SHUU.DQV\K?Z
MY.LATDXD^1VP&7OKN#O:G:6U.U@[\K]D8NY/$:I!\R+0;V8%'YL=(TK:^?'J
M>G]/9DS;Z0M^F3R9T?M=UPB@#"*VO/,)HH0C;(VN]]XT=WS$=LRJ5:M5:?;3
M8:O>=-"6BV;9@2?;$+;YZ\68P "=">R<J*N$.&&5D?DC@PD,7F$"L/2+ (LP
M$H*T*;(DCR%]VP',L2(TZ'<C?*==BMCC>/);7G=PP\GY79ZN<YV@M&PKZ@E.
M".-&$1EI&3_=3[?PN)-C;>)V,/_AKP*%[C/V;YXV2N[=0H/R2O27$4^(RX<=
MF$!F&.8-3&9UF$ \$YC&,T(5B!OWGK/L+*%#JU-6'"BI2L/#\[JH2(EC-P4Q
M[OU'FET2MH_P5BZO4^=%?>E5BY&,:<*\*-Q]B4,UL*T/F=CQRN!=F(ND=([L
MFU:K(R=2G2A;4?13OLD:U$1[V;*J!,$D<WJO[?-;5\FM[PGMO(]P9(O.N''5
MRGZZHIM+O0X841AP?5P\A/O$GLQ2Y-E4/[Z\M:852?6O)TUF)(.Q7\S13Q 2
MD!PT@BP-K\P"\:V0_,#I)^7'_&Q>G,C HY19\,?>QITZUM#1Q&Z(*L1&0"W(
M<M\:FCFV;7CBJ<0ARVGVR!0U]?U#!NMM]S^LA5R-GL704GXL5IT4,^,0ISV
M>8_),A.XPW!?:A@7^8ZPIDP,)3AH;WVY<[=$3JZ9K=HB=,NPJU6V/,B'3+Q9
M2X%=^%Y7C=""E)W8)%<_S2-A%M+Q\FK @C)*D+X,]:8?!7.G.Z/\'D:TF,JG
M\8J6%W">5O<]=G=Z?U7TME,&2RPX1[R"FWR%WD]T]N '2Q3EIXOBW]_ G*T@
M-U7$>7EGZKN*?B:X?]B=9*9REW\^X3X[#+ 6C@J");C)O GAVGV4'JL*"CN!
MIV9*6^E:7:6&ELB= I2&E'&\;.I^Y9A&Y89Y8+-H@.I/\5LIIJ"HC\C9'_-'
MP?QSY.2/#U(L+>R<1QZ\N/=!O.+<Y/$? L?QM:8\)C+!2%LG0J<2*$> '9X9
MR%>H3HH++^2D)+S]DNO28UB2%?+A:ZO(J_#G(9S2?^B)\?MOIUV-H&Z3!X)G
M07Q D7^1-M\M&N9#.1TE;<:87G%,^)K!%5_ZJ#\8Z?R>$/X[V!F:;"8?-_Q0
ME,#N/RRG6!N4H^M^975HE^=/,U:VDWI-QN^BWT^&QL?J>M %(JAS%*'E$><<
MT+1!C6=<OC>#=JVE6#LWF5N']4+1=\/^^"?:]P5X]#YG\'Y\3VA1E&_"D<UX
M1?R5E20&ER!Y-^7U09>3-MG% BHF?*+/LXHF1Z/WUP1PY*@NXLB7/6"KU8P0
MIUN7@#:4$VL0OVIOWTS/Y@WS(]45J:IWCQTVTVIHX$O\Q<IA_@G /L)V,8$R
M1 03N(L*JZP_0SE:]^/'XP-&]Y+[Y41,[F >VQD#G@':\I^(MWA'.)K1%:QT
MPWZ?F!.=YWM.YR]9G6[7Z4UQRGSPK/+E8=JR;ZRN^8+\#U@;)Z*P*N)H,S(3
MH 9-T(_I)A\(*J5I(*56B.H(IY&:LY#8S'"](^.I%HYFY*_&?9<W1.02E)EI
M.V$C?F=YXPGAVB%6(6^-U_ACV,=F'&MC@NM&*V,T+SV:-!W9O:*@F-D+'7'M
M_U&@*(.H+K_6$/@T>)XE5A#W)'3H$N;PY&M3*H6105>1;?;@=H6.N!V\M&X3
M%;B@(%7%^6I;;;:(\DRWZ55\K!,;-362WL!X!(_>NW1YBE"SC<?C">&7.7U%
M\VK6ON4*K,(S'VWC2D?? _S&DCHL8R3'LP@G:(!8!L739#&2U93P-W=WLM]H
M-;6:]CQ;$1*Z6/!5G!@&7+':X>(QSN!U)W3&@?+S+;QBF"-D#U(@?A=8>IU<
ML%6Y%3_ZY=U8+?L=JYGCAW*%@<2X0DP,>6LF926-=ALD7:DG\SXI?V#*=;IK
MT:(UQ[E_2+K@=O'>;T&'2O>?+5*ACH-=%$+S0_5PK"C&^[L.:3J.YR8J@+W
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MQ"!I,PXT30AJK^<#O6EJ_@ZHCV0('Y3K>I S('_LIDT!P4\ATVO4BM]P#_"
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M#>[.8\[7!W (NF. @LNO8?\'+VS?']UG>[Y ;Z55S'(A@BZ@!%TD3E<R0F!
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MYWC+@X6@'OQ_@(;^QQN?6SF7\@?NOP"N$SQFSU >QE_7BO/H&(;)(B^2!;E
MU=YW+,76!K5$X9SQ_:K*@:<=WR*4.8(NKYBUS1';W_/ 3&$!&P68P(B^-SH[
MOF269 OT3,M7P&YR^C"5B_%<P!<&9.Q@UE)AH\=F3? K-LC:R4>=$(QV^7)K
MG6)M@BGTI0\C,OXE!B[YW*3GS,>^?=\W2#L!-OO_ABG]?PNNF O$6L&>Z8 )
M ATR &;U7Q!^_LMI<09D!.H[MIBDOX:109Y]BF[1>E/S6#;6Y@#+?&OZ]-'T
M1N-@6%7 T_X'*\J2WXE;H%XP 4ZOM/M!3,NS>6@2UFYUFO#R*.C(],*&B!V
M3.<"(FEX+E 42T_<W CD0*W8QD>Y .>N4 =X[1>>N8E*.6L.?H*FS71Q@0U#
M+1DT\247H*R@6XNTN, ,Z7=#&M1C+I Q,O-"@F]]Y _<?S7<ZK(W%<3:,X?9
MBC)F:S+1_O2X=KE2)>T'G1KS[VSDG:=:OA]\D# WJ\8H:$@E%\^WDA;3P&*F
MBI2H$+<G\)9RF/V1TV>/7C;X8K*T#4#>0Y,R<]<IC%CZ7>C<_7^ZN/@#]X_
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M[3:+0PW]-4-*7-HPEU,&/ _V5<KN_!&I/^Y8RIM<L$8XISMBH4SM=FU=<7+
M@N9^,Z>:DT;L9+8=X(M4WRSDJ"/%-Y^&!,9A% -TJ1%C;145M.G4^7V[!;\[
MH,,/AXQW\A<V*[_2^P6KP5(MHUA&3!/+2EK'(Z4/O&66F.#E5Y\(9.&[V_D!
MF4W?X\<;@K(B:/!V*.D-D7[@,<DJR;]CXMA@AX/*K8/KT1WSH+:=Q:S3GU23
M\*07L,J")T'*\K9F!M0Y0=;+\RH?H,Q9S@4^[_:Z<.I]&K0Y'"RFA0Q]RIR_
MW*%5';@#[5WJ*US''B@]>G!KMNOWZ9J3\#E\-$8V)".#"P@VF%'*)$]?RBN5
MGYS(UW'Y+**DKUSW=E\=%Q"[W/Z:&7ZA\M'QUB"X^IFROI*]6U'5="A;3.ML
MCGW,I/; )^AUGC ,51 :/7XEWT%@XL+?TW5W2.>&#,*Z;OOJU6>)7?#Y=#Z6
M3X8<#9'^77R&5.1LT (3F5,28UY'\BZ=<>=&KO3P8=7:_I%HSS#9<Z3\;3,@
MV*F-0(83W;V,@AWMFNI,"IT;&:HNLS]>7==0GWG1V=>)SVNO.;]JGV,WM 8T
M3R&!HL$5JNW6;/G"UJO!KU2"W6?%.(S9'^DMM;U[OT=?)H5@"]'7%M=UB7>(
M#$TG+C!38:YDP3K-&<#L7@V\&V'?!(L5NBJ=5JX!(9;.$6+7,WW#IE]*L[XU
M&PDL'N3/(R//TUT8<9O)U401/Z($V^8JW7XJH1B1([U1*@7WOUULL[?EPT[@
ML!&U1[NYB&&FW(:G.< (YYWKY!<UA*M+S[1FV]?',/=Q+L[A:>>H^X0]&%K,
M._=?[=MQY<.Q2.,S::"?!_GK-HOQOF:JC%#FWDC*\!V_=Q\KVE^,%J$[QY<R
M)K04J O65)B^+TYVLWH5NQ7;AFB(+'3Q6Y-JV0#QX?)P5CF.-]/PDV(>:0&S
M-^T0>.JAUQ/,8D;09NI*5\DC.<5S"V-4B[O(B=0=6^^O0I^@WF[;^=2<S[R)
M_^7!W^^//,&$,R!>CCR*B(V4[&<?+Q['/2G]=74M*F\6(J_84GNV(#(,BUG%
MWR7*XN&@=)PZS_>$ SJ;)H5H:7C/H0:78#_- ^\_[+KP._ZV&LA0\Y?4Q!GJ
MC8%"G#Y,=4ZJ]\/2&XL_&^[J*@C(=U@U^J.;%4F^O, (%(6+XQ]'O4&DD".3
M09?\WQAMVE/,Y<&[\#Y:J5!^J(\9B,3+T[9E)FV7W%6/F9J063ON*(648"8^
M-QJ(Q_1=R1R28_GA!+A ;'G,\U&D&%VXCCIT WD52#F[%CWU%BHIN?:D-,'E
MLNNJYU9>X&C\G^ROA-S&RX B6C0L(WX3P]&VEY43N?\:\OCU1%B,Y^&S&36[
M$CG\,-2("9U_:BT1=PAA[T ;20DIB?*VQ-G==Q[7O+ A.F/E8+4O^@CG(-*9
MUAD#V0UW-\ /^XN;I]I')F&E+A[2=YC?$;PL90B(5"_SHC&\:2,C$>^M8=N6
MEQ^XBZ,UHJF7-&!)0#Z3TKMB)M)B-8S]A::=X@)Q-<;916[NB*)+_1HJ3E?[
MM%;#LS[NOL5W^A;NZ^I"[@N"3YY_.:9XS-+; R[7NJWAL*2RI<Q.8 8H%/J[
M@?WO"RM(LGBJ\],&YPMFE<#+<\<D5SL[\5MMZ&HD;#I;0["-4),9#%>"-O3G
MH]Z79B3A*]%W4*KL\S3'-F%/(A<(1-@\J5JL'+^1J'XKO!P2D#W[@(^>RQ:K
M).]/J&;I.C$/P[-3VY5$&^O>#NG^LG9ZIA1\5"PQ_VH%YN*^]^B4NB?83IXP
MQK8J"IAGAYJ $X=UB+,CE[XHF81?O7?GKL'VI68P-=*Q!OF[QVH44HM92['%
M2O.7(FS;'..DPPMXPA_C9T:P/!L[N4KD].+?K46CO=*E%CJ;ZVYDCA/U61-G
M&/;&"S/?,W''C/A5[S[@6ZHN+X/3A#@['Y7C\.H1[LETT,FD;[!Q0^OG3RYL
M>62ZQ<V:W?B[;.I+M(1N[^^VNOO[E9:TR2#QI*I&S?8=OL5AF;:29YYO$\"<
M,X-_XYAR>B#;-I^;:BNE4OS5J,G\ZSFU]Z#9P7Y<8/*NQ6<N<'@)DP"FG<F(
M1PNS_3W(]<EZO=*SA." MQ 5//P]]0SB\',/947T*6"%.&H[M3G20ASMG)J.
MQ][2TJ7NDW@H&JN8P! 8EVJ/:/R+3X0OK#ZYUM6Z8;=0_&J\T[MXM&5-6EHL
M7SWHU?Z'&'.^DNQ/R,M,[Q=(#V9D&<+ )6])6-4Q<7Y-ZZI!MOZ76/,;"MXR
MD+8^@>D21*X+;[(?,C<66>?;@A#2C(B^163U.]8UB_!RZ^(2SVF9Z?[@\26H
M.4IQ#"'4A%(:8*M.":7+M=I560B_Q'@$R[*CC;S,;+[GK0=H,57LFSXJ"TIP
M#J<+[#WON ?EHO::Z<'3'OU,*]IC\O9XBJ(8I:VLQ&=DW^PW-[\$Z]IHJR_U
MMQ56"D&JM*_4XOG?C;6V.= #V2H&:L6^,-&0LP<PX3?#CN__Z-.;(T/'3+SM
M+ $YKT*9ASK;A0V:T>^FDQI,1[0_81&O#F07__K8VI-?']WN^!H(QWHQUU@&
M"'%&%FU(#IH>4A2BX;E\8[$,\[FN"D55B,ON,5)4ZX)(\;B$,4J2K4MOSTWU
MC@ILW^@I&"L%M^52PW*>*R18*B^"SJ\["*2AAKD $.IOPI,:4V4BDY-G2Q$0
M(6%GA&2X\3LUP9,":\A!S!I\+F-TCCR2B#J W$'#INI.7"*X05F:X.K3 Z^D
MEE2N6+\+7KIGT1/D_C@4+KQ:.CRBK<)8WGO7^KG#Y]F3._:L;G7\6/"[AJ,K
M&SQ<_>38G'T=72MAA7KL4L[<R?[52PG=GV:W(IJ4QOL$MK$D)XH[,&.VE-KV
M1B/GP%UMU_I#6*L_31+=95XOZ+_!,'=C\? LI@NMI(6XW53V^E2@P*\C,QL:
MA?OWW+GU!;5<,?O%_AR\["]KG((>5Z''I$;1\*A 4D:R[@G:][ZQ_1V9;\9=
MT_,*?@C';P4$MT;SJ1ZVO 6C7<"*,\_;;-YG6[Z8&QBS*?$+E'"V?'Q$Y]--
MA=W]6-@#_BR3H,G&<$;,Y@.<$F>@)N=X^\:-HG-OC2J'==?3I'/&IX7V4 MN
MPGL@\KQ5,41)((3:&>X'AN1=Z#5EUX)])@_P0JCP1JRL STS9CC:5)61RKQ(
M3L:3<B%\\#F3Y :K*1,-@PMUM;F0&T$OA1(6LX_IK&"K.%O9;K2UML58=P5Z
M>D*)[X$G!QZ+3]A-'W3QOJ!T[6/P4O:>:4/LB8:*VJ$;/ZOJ8DU2G>ZUJQ]]
MY1FBO,W:=+>5W[IX&YAF&QA'P&&C@JZ&D@-%?N4N5=4Z:]Y_4Z4?6%!H=5>@
M5I=O&E9A^9[YE>6*ZL-+Z:X[4UI&/&><0R>_J+0>MCVTV!:%;SS'>RSM4!=8
M?,%!9C/-Q;G.Q5[,UUTYAS$P0)J_37UT;,$<M38AW.FU'?>-Z4UK;84*-,A?
MG0H4]'7@+5T6V01A=2ZB4JFT\_6!!CQE<?XBC<A('/$WM2@;@\UP5*OM#^DU
M[IPA3!SUX'.+7H_N5=R<X9_.8![LJ0VD>Y"GFT%QQA*O7\,KF7<U+G$($W%Z
M90U13O0UU#EJ[W4L7L-_>( @([[0%K,]"FA'>,^S6-)(H\W\U<B)8(N:QJ\-
M=HB71M7= =_')VX8?BX178J+*>"L+OZGS?C^M\9\2S!J/^L@<YF1-]0@J'6G
MP<F[T!EQZ[:6^S ';'PHX%;"H9T*)?X[6W?M6"^9[B6$\Q2_VU-4+\X43\_H
M*%-SHY7A<I5GY5SE3NRN;E.6M;QN[@CYNA'H6ML.3C2V;R<FUJW%A2Y"66#G
M:K@MMM+FQZ>WJX1OAJ8. IUXFATQD2>^I$F<N"ARAH+S+%%X54-T:E!W1YGH
M_LKQ-L^/$E*4\',1P^%L<5#;/03_)689S=LMQ\RD70Z<I%J7T.'--QWSJ:N0
ML^=(H\D1/49B"S8A MI,3"1HQ86 JM >OW:O2Q']<K_<#[!9?\ROFK>TF(&N
M,&@-)(#:I'#[AC465^PE7(ISZB;C0OPUW8*B%7DKP_Z],&CFP9=%_O3[E/ F
MWN;OO(WL#B]VD2LHWO9!Q/_*MIL#'@NT\MO4N,E2=+-%,*V(<6\3@SLRWG&^
M=</]^8;7BW#V$4'MZL=]_D?!3.$H41:$TX$107LKGN$"EVF;90O%9-L?8T'E
M<,?M/^?+@<,*FWTWC1U?(X\QPZ>(*3C1(5-M<MEA88\3_TIK+%:NSC0M[?CN
ML%VU'9Q:($,3:%'T[MA(J/#)VV4<.6X9]NZUS5+BE;3IG^HW 47X3PQ392TF
M%"J,Z@Y7VO/5PR? U*FDM^29,75SM*4$Y%&5N5I"@+'%\"3JW1<^(^$%JL.Z
MMC92UB&*QR_=5G\0UW3HKN-8RL::W:!_B#^$T-(Q:6*KYC-\\$K\L><^17SF
MBH $G]=?I*8=6B^S"!UDGZNL$_T=/9G\Z?/;CTW7V$LNC\SGLJY=1@TL(VIM
M\/VY+4J:M(5"1J[QKK5C3FD>&;K(DLSW1_-%M!=A)QV[N8 <_DI@/%&NP4,U
MM7S?$%N;_.A"\BI,9%+>1O,H\.4AJQ,(;@>0_[(SV7Q5QZDRL:21ED"1<8VU
M] 53Z]P.H7-*MI>/2:HS6?C(<+-[>16L4"?,'7 5<7Z:'GP^ZP2-DVWL0W@R
MD%9J^_[)E\@M*H$?1P;0/#@/4 *^$H>]7<9$=2R?I^\GS.>Z#"_837QSO?5F
M'N(0U*,V!-G'-J1-MV?L@#$]VB,NR/4D(Q\?J'GOFN$E4,G_43G37 8J@]/D
M+2F^N3&RHY90_<SWR*\!^\";!\[E[G)8A\OV?KF<F>;80JS$-J7#VS&TTYBD
MS*C8"\,-UVHWNM-+:)[ PATNT%2#^>)8^0M*LP7'U<B]>)!;BU(=T86K.NWI
MJS9S^O%N:\@V[<^L()B[[T9H^?WBL6^C+IUP[T"YUEVB!R^D2UPYR%\(. AT
M\XA/8*JQ8QMVU+OETO#:O2<NYK6<+T/JJ1GZ$Q05X:ZA+>_W<(%X!"[Y=B!]
MF;.S;//#%.OY4(,9C77<1S-0@^.#&_A(?R!B"-5]@J^#CW!4?N\#$ FD.?WN
M4S+<2*]7P,_Y_G8<3'A6V%>X^9/*.[ZT_'P>Z6* 8J"5([%0;RU!,(BI>HHE
MW)#Q<WS\R^3U]D$N@'("J?OP#_C\5;/XY<<,3D4UTY%U%;F#^:',.9'V/'Q+
MJT-#9K!B2<EU65S*%R)-'%:DUXT\S@R:PJ=PQ'$\;;"2Z@^W;'![-^;Z<JK@
M2_&;M_-6NGRY=#6R5H*I'NV^&_W2ZQ(GK801NYS &MD'[4=E>K;D3Z6& *'=
MJ##4%_1V/7P2F'::F*KO,-KE#TZJ%NIVL:H:Z[*22<_U6;PO>I9#C1*XSJ-0
M)4RSP"@_S4#VQ=<^EP;4*V8,\EH;"RP^_EX95/7J<.)37XY<?^G*D\,]BE"[
MRN0KM=6UYA5MT;\7IQ#T!$IZ@I=8R4A"O\N-+:S&WW6SMZAPTSE?Z[7E\OY4
MM66LPPX@%M[>H/;:!8GF49 7LW*,^'VS$$4:*+$]OJ,HH)G,LA6_L\L0JF-(
M824T>I -V.+!4] ,4]@K9M9GN_#FD8W'B[C4UKPX9XN;-ON3TW9Y?I^N-5/[
MQMF&ZBW8L9G/WLL%=BS&ACR]"E=>KS40JWT4%'I &^=H6L&+KMM3\EW042[
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M%(Q959U&6H[?Q[T8KT\M'HVN=QYH?<]0VJC^?JW<G'AVDY_-HS9 \TC2M[.
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M_J&=T>3679AZ?E[AFA^Q-1;C\+6HL+&A^GE--H_'VGHRP;7;(EW-8\?K4^Z
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MZ8.ZU@$;:OU*8@+'K*?C ?X.X3 %/"?1A!Z49P@E!??H[!O#"B#Y2K3S16E
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MY$\8PY0_Q7.OBC9<1HFMK!GYM[G\'8(C?\^Y$U7=(PB7\!Q@'"!)('B]AZ1
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MB*IN+72IV"%&,]5O-6K]J:[M?6>_1;,/2XSW!@U!Y,:%V._,I'#320M3 Y6
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MMMR#)U?%]*_I\/7HO,DEPW)M3:S*[ZU7K#<0=T/A?)DQH))%ME+G=#XD'H.
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M0TVWTSC_6FJNP=RT%2(7EN)Q.P%&,/V[_#*J"B/(^>JQC/I#;>DB[13R69W
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MG=VE6BT]&7?^G5ZWT<>*)E>;Z0CVM8E]MR_<11]"$..+E6;Q%])'^DKA!L=
M#.\F-8M:-19Q$>9(GLW(NO7+4$HC]LI?IYI\!C2L\-PPGJ$@\<(=P.-6?C-&
M)I#YN^7,NU?T.!FMG0:R5ZF%D8G+*.>".B/(@B*44N9;BP[_VTX3)[5B05><
MA@/7TJ_'REGWU_4QL[EPI[*4ON'!_OSC@A&6]HYQ%=^7)OZ(JI X*7Q+VP$J
MP_(_>2%0.EO3.GQ?(]NER$J;(YU^P"G&?=[+RT&FFQVIDN\ZZ$E^<^[5I W&
M"V"TL=;4HQ$K6PU#E2X5H."IF5 \N<$8BE!,$0NL.?;\^0KL#$<Z59X\<LH
MT?8!^-1+0@2H$\WKG<L(11Q'O6[A6JC;/LO^Y\*YX5"EOHF]>3O7(R(E[!W"
M?6OIH)]1?^5?6V]M"\&*"<6(SF1/[D)3"PC'+B1.3W]3]M8?"$J8&]%?9?/A
MBX^.4\*EF2^O-)@]6F*"6_5.?'V \0C!7/W1<BTGS5 6+X:[O;3,\XN>3DTM
MS>DU#VGWH-TYY:$(R\,2J4BG:0/L;ZZ0[NQ4JJBL"7+BFQ&#N0MIAL0C(Q@9
M];VAPVT-%1WKG7BI."GV2!)3@]F/J:3#&J+%Z!>"Q[3=!!\> 7+DBC>;6^MQ
MDRIE\^_Y?(5</ /B4ET43'*OJ<ZZ(XVZ@A6G24&YPC6SH+(?%XT00.E09::6
MS)G:^GI04%7Q@15V._#.];S=OTUY+KF@/COO2JE=>3!6PLH@("9L0\[@1$=C
M7V>;?%;&T\=2V1,RJ.A;'0?_?Z^7;<=M-&;3:9MA$W!U93&$;\7)[=JK?)AK
M5LQ#RWA.+%69=8<R;9W^-,RQE[%Z;1N>HOI<LL5@+JN#]PK*1OK_ Y3*%6=[
M3-WGAPE;2-804$I ).6N> F.0VN9C+@W&/]]NK$C[N0.KS^=U;Y45:S:6K$Z
MF['AI,>OH[Q^KB:ET36YSK5ETJA_U OJ?49P\$\:M?U,- H*,2L[N>MR"]Z0
MUC5V]_'N4T_5P^3?K:9O!\[0!TW>8C%6)AS7%)8RTF^#L^L)/WTIK8,]YFH+
MR235L9.J ?71GD$FGS1GKA,K:K9^DER9AD(^;\WT_7$MG1=0"?\@H1#Y?"]N
M&,>\B:IL!XRF6J.AG"&WSOH]V3XI3W^]*U ]?4+[:M"%Y*@\_:)J7C51%#&Z
MWB7<L#^*Z]3D00==R[ #3,:>I%>GK.1&5*O4#61<QMV&E)65PX(_/CUT=:5.
M;I7' /O;Z7\5XX[5\5N"[Z+6KI7:KQ[7U?DO541R%J+:B7^;^#0IJ"*A0H=7
M(Y/O%:D-4(N@64%#OB^Y#DV9@1O!B!>/]RVY9-;8UBZ6:WO>_/QR^))E_*@-
MYM[-?TQNHI:$_3""#)7A>P /@:H*GR>(XT^TT>K]A\6QVHZ!-J'SY%N IQ<"
M+#DJ7KP@Q@5@98D13(:IZP#NH. 9"3UX8-A:<!OV"^2B&^]IS-955@+0K8';
MY]U\Y*T/Q\^K4?>%!0FE/+CF#2PU.CN-HBK<0=BT&+$+D">*]5;O-0L\QR@N
M/!2CG,V229PQF"B/V]]-=+KG3[CD^=)K:G;Z=$U=DHO[@:\'*RBG)!47#1'G
MHQ2*D<*RL[$O%V!Y;*NRC. -WQ(*:AJ,2*J,GZ0BK-(I[H'OVB*;+,>-['//
M'8J<4:0<4B-]+I B(4KZ@@ $GI][E'KD"?_QQ_\H'>W?RSM%7B"QE$L7A;_Y
MAL0H:):#'[0\QNUHILI A<VLT\NHJTFN8K!7;Y5E7&-X1!Z8E_3IM)O[KB,Y
MDI,(5!_OQ"%.JI%,/X-;VMTQB%"2]79-%/@FSDS81@&=\<DX12P>/WB4C4E?
M1H5B!HWQLD23W(: AHN@\+/UQJP#UJR :-.6Q55]X\9</?/XSSOV?):8^$XT
MX8NAH2\UTT+LQ):_%=[X4,#1V8%\898)[\8RJNDZ%U'ZNAZ/A2T Z$(?F.4I
M,JW"./1$\^$=/:;DE*B0.:C2FUN3035]W=97D78@O'+OT&LX^]WAJ(5]66FK
M4$0NWYW4@57%LF]3M*+QT!:$Z-^;V-.1^+L4X9!5$F\%9ACCO:<4,=:O']FO
MF:..^%:E[;ZEP+T]PY?GX07WA6N%??15%S"#:+9$UC9X_PA.;G!Q*>)A\##?
M?XO"O,9C]OV6M\85UVTVO?X <Q'MM8[HAEB\ _%<#ST"/R#/4$M.H:TA5!Z+
MHY,I$A<\;>,UOQ"%VET;-22.SOOZ;%ZQ_[W*]^OBOW9K9##;6> 1UI E9V$J
MOIAH]!R2 XT<H2L<:AI6H9RH>G]LB9E6Z/ RR?&IT3/X9ZW2/&C=6A/1,?J)
MP."1$W$J) TB /D5P\&0+6?2[U*CM4YWUX)][U/*A4OK:B+';#]<CUFY[IPM
M-9_.?DJ?\T"\*8YO&6ZPC#JD]AV% 3L1>N8SNV2/:4##!]YC%UW]-XI.VP E
M8*5&H90<7YDPQ+/NP9[ 7Z4I)K><\W+0>X-N3:X/<ZUD^7S]MN]";>/,CK/\
M4?7*3SL E^"[Z$Q@Y#Z":S6L7QG8JQ@H.P>8*ZJL]Q&5W8; BB-^3BW>/V%Y
MY1&C_E]WK,/:.O1Y*=F%'U*E7TKPL/I2YPRFZT:!8/JB.4L3Z"]\ HSK5(EU
M")NQ57M;I_'\3;"IX'%$_>:ZM91U5HHE87/!+X;5K[TP=Q\WRM'=7'3"K_]K
M=50&^P+5C2K: C2#,I<*##0*W[4FTW\E;%TZ]9\O^Z]YQ[B772/7C"*9 @PO
M= ;V!(M,?PFT=*12I*T<GQ*Q@E)LD$45>BTT9-?YK3[1AED.8_4*M>X0 E8.
MV9EL/5!AWE9GUR&A@9\JYT[,"Z4JV>3^&MXQP0W2>L*365L(30U&> 65:W>L
M\W1UUZ_W59/V&2%]W;N;Y@_,V$I_ZAVS/["4S[L&D?FBP^!LZ.P2^CHL&]&*
ME?AI; QH/C++($N/FY/V<#V2?]5&5+>3^&XOLR8VAV>PMJU[X/8DG[&Q=RG'
M+)"0,,_CB18U2-WTU1>64:F8E\/5W$DVJWD9I6G'+G=O;/7>6^_],[G:\NJE
MZE<U1:B5X M[V:=E-9CF6@648/>_Y$6*SU?R!B%-Q!ZN"5X#9[\&L,D,UT%I
M;T$!:27DX% 3ATLI6&NVX%V2_GN+G!_\,&U$+TFE?S'.Z]ZGOK/6; G12:3U
M@GM !&M@2"B5.MH!Z6"FH_@'J*W.YG:@)CT--N>NGV@^V?,+^GH?$U@_^-'G
MW#F \&GBXO7OOF(+EUJ-9& 3 56HAMC@"7!V6B:F>,+-3I&28D33A)YL-FU'
M+Y3J?>7FQ7F<NV9L$_ZTG\' %& J)=Z212M!LEAVA;6,(-\*,_J*MA'&"LJV
M11N\,IU5\6G%IO[ZZLZP,VXG*<<WT[2,S4_(:W^+<)X2ZQ-V"HU$@2SD_N-T
M]@-1=.44O9_%ZZ)!,F -VSGK3OBHD2(4Y#I?;>CC_1JW>U\659UCZO;0_=AA
ML;4J+R6<1"=60DS^16$K'3S2'B>4=.#'"[LP8,VV:%<461G> J4^]GIJ7J/T
M_/VW+SZ^&GE!*MOMJJZ&ZUC(I(DXH7M6N+Y0RH1/"O9^< 7/'(TN']IGK^+3
MCM?>U__+H)NIZ,-[];*N5W3@"N(I^[KWY4<WY[^E*+4_<5#[EJ*UY3[YTEWC
M;'*DC98KN]Q$*)6/#-\': BA"PA!1N3@YA^O^'MA>1!-IEIAV'NQC#TA.9->
MKRJ.RW\]Q&V3KC,Y0#<YT)9[U;92?XP,::.GC_/]0EF*0F1.[,'B*2F\HAW0
M+=#!O3*OM<4]KU22^<NGYTS"R,WCMH$&"0>3U'LTLG.O(92OGE*)W&'E6/SU
MP".^,S3.&?)SVU$;_%/Y0+/G14LOU\]IQ?Q-=M8(6$CL(/6H/<O=/JENE#"L
M5=V38/1A>U&P]X[6RK..NV<D?WT3SQ54$[5'<**S!SLIE>@D.&SD#M:S^Q%D
MR=$K:#Q6Z91RVB#L<47>7[M(G3YG'_:KK0&SVAH-6_7@/"$ O-\8J_DE^\\'
M=9V_+..\-"4E0H(['551H[LY= S KLP6#LHCCV;0*S\"H.LBO%.Y&0L=BVWE
M24-TS FYJ3=\AUO78^:LVNOCISSN:V*%LGS-Z-F!CF64QC)J])C8TKO5JU<I
M(L/Q8A^ICTMJ+](D\[Y3&BN(A^7:EU&2!I 'YJ3A3VS^=S9Z,:C2*KH]MOD_
M)[8>^MRR48=&HX&A$?]7W,I1;'KY+XPT%/'QZZ1W,Z<F/VS-B==#P?JJ)W9K
M3GX'H)1TX9KN993#P B6OX! 1\N8^/3!?XPQT3*Q8*0R+%>"G8LG*2RCZ)<P
M< 3= K$DEBMD@!:).*=T'AE3A9TVND? ">6-LM22JD<H-3JL<9Z1SNL@Y\>D
MH]E,!3'^P'XBXDCDY "&&C#&MT)\-6D&"WV-Q4PA?' 57I2E*QQ@*7BPZ5-M
M?-<QTC:N2<@\;GMNR8,&.[P2:Z?P@KCX^859&\P!44;!.O7R2-HF 86T JKQ
MKN4JI]$D"0Y'>[;_:=K+*QYY[?7HYF64TJ6,2@V4Q=Y5A%E8H0$#;:D7G=DD
M"F+Z#A.T,,I @RUEG3EY)R_JT>+Z2*WC])@?BWYU9VA&:I=@35YL&*N2(D1:
MVO)8C *&^5,"'_F1F+$7"T-DWKRA3\O':+YY4W_2S53NN=3=<RA-%(?N-2FJ
MY-+#K,MG4*K7PYYA9EP'V,@1.[(I'"NP?</'SM;3K'\(^GG-_S.KN(YYK'O
MW76TZ>G3VL# +VOVVFHV.]FJJNP26RSE:@ME\@5Y)5#R4\(DSU/PB+:3*%W-
M51S]&J:E"H6-2H;O8F9_\G58I]WF%JMW\-F.NRC4$D8H^1X!IQS!32S[ULL]
M/QZ"WBR?OGHOSDMWKD=6O=\3TYG2TNE3##6[RRF2^J%9KML\V627KF746?+E
M@MGI*Z7"A@(@M02?JH9-:$V;K4H,V)"YJ])J74S#V;/Z'VM3PC_%=(3^_MM!
MS.J[.31-;BNLGBPZR1K*'=WKPU'. D[U5\N$^?:<H?7BOW-_IB@^VZY[?N[
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MK_&V)7W^+#YO1_,0[8[CH$_H6Z[X/R'&#U\2N%J-<S&$<L6FDG4D.:B>_<>
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MV[!+8YVY/#EB]=]<(UVH2/W--U(Q[* LR@KHH(7,(2UC9Y8P5IHY6!0!11H
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MO_W+D_\C__I7AX6ZRN#$%W3=[Z2TSPV7G.6U-^HQ:OGKA85F6WTWZK7H>(<
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MMC$#ZT !5_LFT% 1>2@&*@FC<1+ -4OW!_6Q!G%:HX??EE^\G!KSZXK6RJ6
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M^#L[)!0,,"3ATE+Z2?9P7?/0 >E#^BGL0E!A<&Y;3K2)HS"DX+8QDW31<.R
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M0>?(R2U,=;5<VMO]7ROJV20 ERLIGH54UL\C0@+A4-?3((BCP&TC2\$DGZ(
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M"6CC4T&K00JR><O14Y<M4VR*ZJH+['*;.8TW/0SCGQLL"4G<*5=P^P<=Z*8
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M2$>O'K ?L,+%/+%HL'[7L_#Q#MS*2X>? NYRA8@?_TX+ZF^/%O Z[.U*DM6
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M##<*3/ #>0HGS$[G^ZTR,)VFECTN1*:0CGD/8T1=,&A1&=\45%(([AIOPQI
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M>;/-XR06IH6^B*#(P2Z2;*L2.B57H/7&#9^%&Y9=&JD\SO/W-S10);QU-]?
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M_01E0AU@WJU<\X2S:OD['4> Y_)+0?&+ST8,*XTY*A-#N$I0D)+AKD&O_B9
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M(]N+ X!.2Q?@]^D;;]>?/SO>DZ+D N%A+"C!$P??>\S,3+VMJ?R2W7GX4>+
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MU[04^"GNY9[@@-0<1O:&N6?)&YIU6'IM%IS+_&HJO8T*GK#QZL%M(JG#TL$
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M_'I)W,D8.- ]?CI'2<Z_P63&7JSB0FFZU_Z/QS::=$N+I&?.1IGZ4=#\5"
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M_K;8([GN5WI6V..BD8WJI3H>(?3$V]ZVUCEI[N]>[HO>^\L*FKM>:O,.=I8
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MT)P==]WD?RBC. 77F'Q8J[X7D%-X8%ZU O%ME/+O)8A6??]_K'-Y#SG2/F6
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MD[WT]8HX4ZS?((W1?S^2F_HB+3"[Z^KI^_D1)E>.Z'D>0B#\R_^>@K[+,7:
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ML:GIPN563]U#CZN^[_!%$)7)/=7E&0I$L"\>FC/(9W(+@^0%#.-QG';M$_N
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M-#J&7XNI21>M4MZ)T)8NDOF"=E(7D-D60&5O%.G#PC:"I /R'@F]>FF6Q^:
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MC?UV PE#P7^[#%/^#9L1\BP%(F6) O&^G^% YFRI42!>J=*&'LC<_^K'_RF
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M9&XM,C R-#$R,S$N:'1M4$L! A0#%     @ "XAT6ND<*.]$>P$ >RD6 !$
M             ( !0Y0# &5L9&XM,C R-#$R,S$N>'-D4$L! A0#%     @
M"XAT6G]A'J>T"   EDT  !               ( !M@\% &5L9&XM97@Q,%\Q
M-"YH=&U02P$"% ,4    "  +B'1:7)![BW(&   Z.@  $
M@ &8& 4 96QD;BUE>#$P7S(U+FAT;5!+ 0(4 Q0    (  N(=%IVT\DV> 8
M %8[   0              "  3@?!0!E;&1N+65X,3!?,C8N:'1M4$L! A0#
M%     @ "XAT6M /V&3;/   QAX"  \              ( !WB4% &5L9&XM
M97@Q,%\W+FAT;5!+ 0(4 Q0    (  N(=%K*SWYI8R ! !O/"0 /
M      "  >9B!0!E;&1N+65X,3!?."YH=&U02P$"% ,4    "  +B'1:7"4!
MN>@E   [80( #P              @ %V@P8 96QD;BUE>#$Y7S$N:'1M4$L!
M A0#%     @ "XAT6CJ$.<8G!   '!<   \              ( !BZD& &5L
M9&XM97@R,U\Q+FAT;5!+ 0(4 Q0    (  N(=%K.@I6NP ,  %P4   /
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M,3$W,3,P,C8W7S(N:G!G4$L! A0#%     @ "XAT6B#BS8TZ=0$ ^],! !(
M             ( !5\T5 &EM9S$Q-S$S,#(V-U\S+FIP9U!+!08     $@ 2
+ %T$  #!0A<    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>eldn-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:eldn="http://www.eledon.com/20241231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="eldn-20241231.xsd" xlink:type="simple"/>
    <context id="C_8011d9d7-7503-40f9-9f2d-d6ad11ebdb59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="C_81754e8f-b125-4baa-9396-af3d23d394f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="C_824d879a-0a5b-49ca-807d-ab0c7354476a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_82eefdd4-1476-421e-8c82-01746b54038c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_830b14e6-5177-41fb-b6ce-4f9c69a9e2b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8362f16b-85c6-4b35-869d-da150d474503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_844f75c9-11bb-444d-8d75-a4c62096d783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8633a155-8473-424a-b31b-6ae76ea8dfef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_873fc4f3-2e27-45ab-b247-49134db6a39a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_87cefaba-5105-4ff2-a002-a1c4d73aeb66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8c38178a-6212-4724-822a-073a46d7cd51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_8ca31066-99f4-48c4-a2bf-5e1ade8e2d92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_923a3e58-9c3e-413a-b35a-231f00431e8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_96c27b64-8362-4c1a-a77f-cd19f6405d90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_993efb3c-896c-44af-92dc-051235d5309e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9a1c4e3d-58af-4481-a493-f277082ece01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9a80f4c6-f976-44ce-8ccc-11733f31a205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-21</instant>
        </period>
    </context>
    <context id="C_9d05956d-2390-4ca6-b6a3-2f100db0a54a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a3d4e2f7-7728-4ff5-b3c1-f6d4d89e0518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a6d60598-ba1e-477f-8dff-52c79620152c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyOnePre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a6f2684c-3401-4fe8-a32b-794554ab28db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-11</instant>
        </period>
    </context>
    <context id="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-19</startDate>
            <endDate>2024-04-19</endDate>
        </period>
    </context>
    <context id="C_a83408d9-d439-46ef-8f80-2334a97de048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_aa45efb2-8f97-4e4f-8227-a73968b58522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_aadaadaa-a7c0-44c6-8113-f3d665a31ddc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-13</startDate>
            <endDate>2024-06-13</endDate>
        </period>
    </context>
    <context id="C_ab227fe8-0ca1-4386-b398-a0fc655a8391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_abc1f2cd-e8e8-41c3-9872-62e589ee5c9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_acb31783-dc63-46da-a53e-d4cc59b2703b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-10</instant>
        </period>
    </context>
    <context id="C_af30e24c-32c0-41f6-be04-5126201680f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b03f2283-1f48-4ad2-8437-e177dcaf160b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-12</startDate>
            <endDate>2022-08-12</endDate>
        </period>
    </context>
    <context id="C_b0f8372f-04b0-40a7-b325-70e0c012674c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b3bf1192-2c65-401c-8714-cbce96407407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b4bf66a1-e90d-4ead-835b-58305a0590ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b84bbaad-df1d-4435-bcda-30c2fee202cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-14</startDate>
            <endDate>2020-09-14</endDate>
        </period>
    </context>
    <context id="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_baf27155-1f9e-4cf5-835b-da4532020138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_bea8a10c-6aaf-4cf5-a1ef-0c858fe3ff2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_bf411a33-997b-43c5-804f-81fcc2c67a2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_c01ec1c7-4246-48a0-911e-d83e8235923b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c0260335-e1df-4dc7-9951-e61eec7e4e07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_c13fc831-8ebf-4b35-97bb-3fd07acab079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c1814a1c-a776-4ae5-81fb-2c334235981f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-14</instant>
        </period>
    </context>
    <context id="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c200f68f-c405-4e48-bf2a-38f307006e4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourUnderwrittenOfferingPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c48e2f04-d819-41f4-9794-6444de71c031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2025-03-17</instant>
        </period>
    </context>
    <context id="C_c48f7041-bd5d-4520-badc-9c02123e560c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:GuggenheimSecuritiesLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-20</startDate>
            <endDate>2024-09-20</endDate>
        </period>
    </context>
    <context id="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c508875a-d414-4f73-bf48-c4925adce371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c53b5cf6-4630-40a4-9931-9f67538e192a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c59b7a41-84c2-4669-8972-016e60680975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_c655824d-1655-43e8-bda3-bfbadd4707f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c6c9bd31-68b2-4a71-971a-851b219ff30f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-07</instant>
        </period>
    </context>
    <context id="C_c7360e16-b2f5-4ebe-87d7-85ccacc39a7b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c763de0f-2331-4e42-9eed-6f3c61e5a6f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-04</instant>
        </period>
    </context>
    <context id="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-08</startDate>
            <endDate>2024-07-08</endDate>
        </period>
    </context>
    <context id="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c88b7102-5db9-49c6-a914-b6a1c69ddd87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ca588c4b-fe6a-413d-9b1b-50b767ebb7e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cb145333-a71b-4f8a-9efc-683fbaf92968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyFourSecuritiesPurchaseAgreementPre-FundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cd66f0aa-05ca-4940-a515-241bc4f1483a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">eldn:CommonAndPreferredWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ce203d5d-8a57-4364-b573-86117fd33f97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cef653d0-53e3-464e-a7ff-1a07fbe50a84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d174fc95-378b-4f2e-a041-e159aefc096b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d212cec7-7f13-4076-ad8f-1298f4fbccfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d28d1435-9f97-49ba-8b24-67f48845ba10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d2bff3d0-c82e-407b-9765-471560864917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d74c7b95-2405-4e2a-92fa-de35246ee4c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d928ea5e-1b31-4b26-9a65-5053f8c68714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d98efdad-c5fb-4fe9-bf2b-dae2dda62705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_da023f2b-8828-431e-a5c6-01ba27160e08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_da93e26a-a221-416f-aa1d-44b6fa0cbbfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dd3aadef-8b9e-4abb-a618-63b7b63a02d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_df73341b-d5e3-4456-832d-4dec35538295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_df992d11-47da-4652-9a72-20ae69c98503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e03375d3-d9dd-4d85-99e4-7301552a0c4f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-06</instant>
        </period>
    </context>
    <context id="C_e092348f-329a-4fe9-9031-99230e36eb27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e2da67cb-75fc-4021-ac60-f7e057d84c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e3be1d1a-7a2e-46c0-af2c-74af00b30e00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">eldn:OticPharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e8e45f71-13aa-4500-9629-91aae4aff6f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_e9b52517-cc36-438f-9a32-3591a45bba9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-08</instant>
        </period>
    </context>
    <context id="C_e9c43112-a3f3-45ba-bd41-44cbb2d1fbf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ec3b3914-3993-491b-8996-5d595c2548d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ed194ea2-3267-4246-aebb-e5dd647171a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_edc2adbf-8141-490c-92ff-6e31ec443f9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ef1d6638-1928-4543-b113-5a669804d921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ef59653d-33ae-47a7-ad08-ba5af6c5f5ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementSecondClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_f0a737c0-ea83-4888-a416-315bbec6d943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f2abefcd-f6bf-453b-a559-74741ea3100a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-04</startDate>
            <endDate>2024-09-04</endDate>
        </period>
    </context>
    <context id="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="C_f5f8bce9-24d2-424b-9d3f-cb4374e792c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:AnelixisTherapeuticsLlcAndOticPharmaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f7f796ca-5ede-4fab-bd41-35bedc579277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f913f031-70f5-4d82-9777-c7eada81288b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f95c9f8c-c83b-4faa-a94a-8bc7cdd24a68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="C_fa324109-4c1e-442a-b30b-a82030888207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fa5ed16e-e45b-4b1c-88b4-26d3ddd75f76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fcd27fad-ba34-47a9-a7a2-6c51de3732d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:PerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <context id="C_fda21e42-08d9-4af5-8424-38a2c795691f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fe31b2b8-289c-4f2d-9530-6c3e7c7a5ee4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fe6f7e17-f28c-49da-acb4-0df89a0d0e69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ffbc6245-1de4-432c-97ca-016d4dec5720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ffcde828-6f01-4bd7-af9e-2cd1f5dee182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:TwoThousandAndTwentyThreeSecuritiesPurchaseAgreementCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_00e18809-6dee-4971-b3b0-b854a750129c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_027f47be-a809-4a42-bc04-44816aea7e4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-10</startDate>
            <endDate>2024-07-10</endDate>
        </period>
    </context>
    <context id="C_043095c1-b1ac-48c7-a4f2-27e2c8f8cc98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_087efa66-298a-4ae4-8500-8f2f2044cb36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_099f74fb-7263-4363-8e20-38ff695e2998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_09b59681-3f5b-4085-9903-94d6298ba631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-30</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <context id="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:SeptemberTwoThousandAndTwentyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0c7e74c0-0fff-4859-bb0f-e4991cbcdf79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:BiotechnologyValueFundLPBiotechnologyValueFundIILPBiotechnologyValueTradingFundOSLPMSIBVFSPVLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SeriesX1ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-11</startDate>
            <endDate>2022-01-11</endDate>
        </period>
    </context>
    <context id="C_0cfe28eb-20ed-4453-b17c-b2da148bbb6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1011d176-24c6-4711-ab33-00f6e6c3a295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_1206a149-d99b-42c3-828f-7f43aedc8be0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_13bc12ba-1049-47bb-868c-4b5d72553817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="C_18c0a78a-1e2f-466e-b8fc-e87b9eed2108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-06</instant>
        </period>
    </context>
    <context id="C_1987a0f3-1c0e-49ee-81ad-cc7a111a2cf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1a557357-a976-4702-be2e-81994f5f0bdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1bdd8687-8b04-4339-9c36-3704d34477a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1d2b5181-f6f0-4b8c-83a1-6db86dab8d21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1d975291-218c-42ec-9222-8136c8da23ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_1e0927e2-efa8-48c2-8418-566f24cf7f14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-29</startDate>
            <endDate>2024-10-29</endDate>
        </period>
    </context>
    <context id="C_1e34edcb-7733-41f4-96c4-4098b67eb851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_223d8e7d-db53-4014-ad03-258351d47431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_263741cf-175e-4ce0-9e5d-54eeafb843a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_2708372d-5984-4b8b-8394-2e808b98a215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:FiveHundredMillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2dca0082-86a4-43f6-957f-6b699928251b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_31bf3867-db9f-4f90-8142-37e4eadc782b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_31ca3166-3194-499d-a328-f836589f3df6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_31d1acfa-3b45-4abf-9e35-bfef36f23e5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_33505f9b-7127-48ca-9287-5490646f361b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3363cfd2-6725-47cd-bf09-3c58731efbb2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_33a03f84-df70-43cd-9c50-4ba91ddfe366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementInitialClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_37560e31-d09e-45ce-aca9-615ecf64f681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_3959ebff-dd82-4919-8415-9cfb3aeb832a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_396c0ec5-b10d-49bf-a96a-9db1863a6f32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3f46a1a6-a8f6-442b-b1ff-f3c98cff71b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_412645b3-9ae1-4e3c-b5b6-869162daa220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_43aca5e8-7607-40e9-b22d-49e309162053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_48114a84-98ab-4aa1-b043-13f209b76a80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:PreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4adef842-ba46-4a9a-9d41-be6305e99c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesX1NonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4f4b59d8-1b4f-410c-855d-a6241a17fff1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_50ee3b39-8b65-4a18-aa5f-b1aa2197b68e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">eldn:OneBillionAggregateNetSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_515ae42a-7ff1-4e13-959f-75425bb4a13f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_53f04ea6-32a3-4a74-9360-047d032d09a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_57da919f-7744-4288-b384-8049ba29e1b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-19</instant>
        </period>
    </context>
    <context id="C_58527e40-73be-44c7-ac20-a9366f484716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eldn:CormorantGlobalHealthcareMasterFundLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <context id="C_5a950f73-2372-4ecd-bd27-5625ddd12c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_601e9cd6-2771-40cc-9def-1378742631ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_62fc708e-94d9-4e0c-835b-84f88b33655c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:ALSTherapyDevelopmentFoundationIncLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_63ba02b2-0219-4203-aeec-903a75c59cda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">eldn:TimeBasedAndPerformanceBasedVestingRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="C_65c0870e-3c32-4ada-9d89-29c1727f64b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_66748007-3bbb-4063-96d0-b1f1e7fe5949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_66849e82-39b6-4778-bd00-50de1525fd28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eldn:TwoThousandTwentyLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6907689f-f9ed-4e1e-951a-30df656bbdd0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-29</instant>
        </period>
    </context>
    <context id="C_6c87749c-011d-4371-ab13-14962a69c063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">eldn:SeriesXNonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6daf1c28-0057-48b3-9e51-5792ff52bc2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6f5052df-2ced-4dca-8f26-17b0a53037c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eldn:JanuaryTwoThousandAndTwentyCommonWarrantsThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_74107382-fd40-42f9-90be-490979e94f04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementThirdClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="C_752ba685-b573-457c-ab6b-760279f576b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-06</instant>
        </period>
    </context>
    <context id="C_7539102a-4a3f-4b85-9f9a-eff15ced7207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="C_75635e8c-9491-4ef8-9631-b061f8135c6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="C_785be526-652e-459b-b095-3ed96eaf857d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7972f6f5-bbc6-4b58-ae0c-1d51da007c0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:EGenesisIncCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_79cc014d-d674-4ff4-b42a-bb3cc0e63e25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">eldn:ArmisticeCapitalMasterFundLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-09</instant>
        </period>
    </context>
    <context id="C_79dfe68d-c36f-4af9-8f4e-5e28df0b6596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7b2f7f52-abb1-46cd-b411-b13302614ae5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eldn:LeerinkPartnersLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eldn:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-29</instant>
        </period>
    </context>
    <context id="C_7cdba64b-c16d-4e4d-afdf-1f90b0947296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7d93a268-3600-4a83-af6b-4e24c9653c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7f974fdd-1b57-4a34-a7de-915221b5d0fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">eldn:AccreditedInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eldn:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_7f980e84-3bfd-4c6a-9f98-ef8ea64fd7f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001404281</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Segment">
        <measure>eldn:Segment</measure>
    </unit>
    <unit id="U_Milestone">
        <measure>eldn:Milestone</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_90bfbf48-ef71-4575-8a52-7482cf0e07e9">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_f400e978-1c14-4570-b233-ea68b2a2c832">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_0b8e0ea0-01c7-495c-8425-f3986990b5f6">0001404281</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      id="F_29380120-6261-4933-adfd-72f6c322e830"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      id="F_21dc383f-2aac-43ed-b5d6-870ed73f88bc"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      id="F_bbd260aa-271e-433c-b079-94771270927e"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      id="F_afd1d160-84ed-4383-a341-993295a87c54"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      id="F_90a1a123-deec-4dcc-8f08-aa722dd895ed"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      id="F_4e19efd9-6caf-49ac-88e0-63ff7273d146"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_1691d7f7-1fe6-4184-b13f-c7d5693df0ef">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_b5c49917-80ca-456f-a3d2-e4aad4794ea8"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <dei:DocumentType
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b758d615-6a4b-413c-8810-40b625f09f23">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_844cdbbf-29e2-4ab2-afc5-85d36b0016c5">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_878961e8-ed55-4d4c-9149-51f785a87de7">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_31cb0102-80de-4089-8899-3dae83ca82e2">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_09823324-2be2-4028-9ee5-1bd5a5ea5848">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_43949aa9-93eb-420c-954d-3eb68d6955a6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_0e07de50-88c9-40cf-b984-d20875ed3bd6">001-36620</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_2b1e8a1e-744f-41b6-94bf-ac2c6c4b8ba6">ELEDON PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_5888b583-f17e-4958-ac18-266b30e07baf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_afca5089-789f-4ca7-81b0-0ae6d620d380">20-1000967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_9fa3aff2-7c5e-4041-8ee4-ae667c9d7425">19800 MacArthur Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_06c4bd9c-9839-471a-a0d3-9ae614b6dce6">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_6dbf08b8-3b36-4ccc-9ab0-7ac424dd591a">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_7973b07b-2578-41eb-82d5-f5476fa8b8a4">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_2688aafc-f561-44e6-b4f5-4139b2476182">92612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_c17c5ad7-7bd2-49b8-9ccc-510f6522c339">(949) </dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_98b53bc5-a1c1-47bd-aa50-e1c233365fe4">238-8090</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_4568df1d-7827-460d-83f0-e2692220a7cc">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_3cb7bf37-e9a7-4db2-9472-c2f134d6f73a">ELDN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_590ea3dc-e24d-4ae9-94ac-69c485b32c26">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_9bff12d6-9942-431f-b13a-f2cc225a799c">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_bac9b3bf-82d3-4bab-8f86-847f91453401">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_c65ecd1d-8e59-49ae-8bd5-a95a36a853a9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_d4e1e418-d8b1-4441-94b0-19fb2362dea8">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_02ad8210-d698-4566-aa6f-c08cc89b16e9">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_d3eefb67-b060-406e-b3ef-f5921ca550fc">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_52286fa8-20f2-47cd-9868-8091a42cf005">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_6ad7b993-5037-4598-901f-9882eda8143f">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_aec8e73e-50be-408c-97f2-2e19f2c6c89d">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_20ed1262-1c3d-40c4-a529-98a99e0fd914">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_37560e31-d09e-45ce-aca9-615ecf64f681"
      decimals="0"
      id="F_837365be-ffd7-4315-87c0-fbf8b66df64c"
      unitRef="U_USD">64885717</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_c48e2f04-d819-41f4-9794-6444de71c031"
      decimals="INF"
      id="F_f7123269-7c5e-4574-89bf-e3c6abf2b6f2"
      unitRef="U_shares">59881775</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_fed6b0b2-0d97-4a7b-bd21-3f6a48bc16f6">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s definitive proxy statement for its 2025 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#x2019;s fiscal year ended December 31, 2024, are incorporated by reference into Items 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K.&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_dbe0f1d7-8006-4430-b22a-85d97b1fdaa2">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybersecurity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Strategy and Oversight&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and data related to our clinical studies and employees, or our information systems and the data contained therein.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We retain a Chief Information Consultant to collaborate with the company, including the Chief Financial Officer, and Executive Leadership Team, to help identify, assess and manage the company&#x2019;s cybersecurity threats and risks. This group identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example, automated tools, subscribing to reports and services that identify cybersecurity threats, analyzing reports of threats and actors, and evaluating threats reported to us. We also use a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;third-party&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; security management vendor to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our information systems, including, for example, incident detection and response policy, route risk assessments, data encryption, network security controls, data segregation, access controls, physical security, asset management, tracking and disposal, systems monitoring, penetration testing, and cybersecurity insurance. As part of our information security program, we provide mandatory periodic training for all employees on how to identify potential cybersecurity risks and protect our resources and information. This training is supplemented by firmwide testing initiatives, including periodic phishing tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our assessment and management of material risks from cybersecurity threats are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management processes.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; For example, the Chief Information Consultant works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. In addition, our &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, we do not believe that known risks from cybersecurity threats, including as a result of any previous cybersecurity incidents that we are aware of, have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;materially affected&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. However, we can give no assurance that we have detected or protected against all such cybersecurity incidents or threats. For a description of the risks from cybersecurity threats that may materially affect us and how they may do so, see our risk factors under Part I. Item 1A. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk Factors&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in this Annual Report on Form 10-K, including the risk factor titled &#x201c;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We depend on our information systems and those of our third-party collaborators, service providers, contractors or consultants&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which may fail or suffer cybersecurity incidents that could result in a material disruption of our development programs or loss of data and have a material adverse effect on our reputation, business, financial condition or results of operations.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_a7c6e283-dd80-48fa-800e-5f997cdd00ac">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_766dced8-d879-4338-b7d2-f0bb0ce54a5f">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our assessment and management of material risks from cybersecurity threats are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management processes.&lt;/span&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_24bf4382-f565-4126-9903-1eeeea8ca8e3">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_5f57f5f0-5390-4461-bb07-1ebbab6eea99">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer evaluates material risks from cybersecurity threats and, as appropriate, reports to the Audit Committee of the Board of Directors, which evaluates our overall enterprise risk.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_d10d074d-a44c-4ec9-b8d7-89d4ef754fbd">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_14ca2c56-ddca-43b0-9b5a-0532c480f0a8">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b215318b-5d1d-4274-bc98-57a0d35a5cf6">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board addresses our cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our cybersecurity risk assessment and management processes are implemented and maintained by our Chief Financial Officer who oversees the work performed by our Chief Information Consultant.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b29b80ca-2e5c-4e2e-bc9a-7f07e81b4cc6">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is responsible for overseeing our cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_aeb0a1d4-79bc-4cdc-ae00-06b1c2c35715">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_3a65dbb4-0121-42f4-9cf7-26dd225024c3">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Financial Officer is responsible for hiring appropriate consultants, helping to integrate cybersecurity risk considerations into our overall risk management strategy and communicating key priorities to relevant personnel. Our Chief Financial Officer, with support from our Chief Information Consultant, is responsible for approving budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_88393aa2-522f-4edd-ba6f-f45254d89e7c">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_12286c5f-2a13-469e-8159-a75ff7e95ad7">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Audit Committee receives periodic reports from our Chief Financial Officer concerning our significant cybersecurity threats and risks and the processes we have implemented to address them. The Audit Committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Financial Officer&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; also promptly informs and updates the Board about any information security incidents that may pose significant risk to our Company.&lt;/span&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b25cf37f-aa12-40c9-92cb-264e561dc8a7">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_cbee25b9-e38a-4f5a-993d-7feda161c30a">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Chief Financial Officer has over 20 years of operations and leadership experience, including experience in information technology strategy and execution. The Chief Information Consultant has over 20 years of experience managing and securing technology infrastructure.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2"
      id="F_69325e08-09a3-4d04-aa22-0a650cb33876">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2"
      id="F_90a256f5-23b2-46d3-b08c-dfd26e1346ad">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2"
      id="F_260cc79a-09c7-4d66-9d97-433150b5311d">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_ceff0a3a-8e61-4bd1-a4d7-894b317f1cd2"
      id="F_a435edc9-b801-4dd3-9360-b70a5da939b9">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_daa34ba1-0008-444f-829e-feeb2de68ccb">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_889967a0-6c36-4c56-9e1e-a197f5ee416a">173</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      id="F_14de40d7-1938-4eff-a08a-b92b1e02222d">170</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b04b43bb-624d-45c1-8ddc-086927084c2f">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheets of Issuer (the "Company") as of December 31, 2024, the related consolidated statements of operations and comprehensive loss, stockholders&#x2019; equity, and cash flows, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The financial statements of the Company as of December 31, 2023, were audited by other auditors whose report dated March 28, 2024, except for the effects of the Restatement disclosed in Note 13, as to which the date is August 19, 2024, expressed an unqualified opinion on those statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basis for Opinion&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provided a reasonable basis for our opinion.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Critical Audit Matter&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.  The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#ff0000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Classification and Valuation of Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As described in Note 2, Summary of Significant Accounting Policies, and Note 8, Stockholder&#x2019;s Equity, to the consolidated financial statements, the Company accounts for issued pre-funded warrants either as a liability or equity in accordance with ASC 815-40, Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period with any change in the fair value of the warrants recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. The Common Warrants and the Subsequent Closing Warrants (as defined in Note 8) issued in the 2023 Private Placement are liability classified and recorded at fair value using the Black-Scholes option-pricing model at issuance, with any subsequent changes in fair value recognized in the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;consolidated statements of operations. Determining the proper classification of pre-funded warrants as either a derivative liability or as equity instruments requires significant management judgment in assessing the specific terms and conditions. The valuation of the derivative liability for liability classified pre-funded warrants also requires management judgment in determining the fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The classification and valuation of warrants was determined to be a critical audit matter because of the complexity and significant judgment involved in determining the accounting for the pre-funded warrants and the significant audit effort, including the use of specialists, in assessing management&#x2019;s conclusions and inputs to its calculation of fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our audit procedures to evaluate the classification and fair market value of the pre-funded warrants included:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Obtaining and inspecting the securities purchase agreements to evaluate the contractual terms of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Evaluating management's technical accounting analysis on the classification of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consulting with specialists on the classification and valuation of the pre-funded warrants.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Developing an independent expectation of the valuation of the liability-classified warrants to compare to management&#x2019;s valuation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Consolidated Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheet of Eledon Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) as of December 31, 2023, the related consolidated statements of operations and comprehensive loss, stockholders&#x2019; equity and cash flows for the year then ended, and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_28520a39-8788-437c-b1ae-b14fe3cfba1a">Crowe LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_a55db684-b4af-481e-8a94-46db01e3aff1">Los Angeles, CA</dei:AuditorLocation>
    <dei:AuditorName
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      id="F_0edadf2d-2db6-4c77-bc03-a9af2679b09f">KMJ Corbin &amp; Company LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      id="F_697e6cf4-d1f6-48f6-8954-be5addea7c38">Glendora, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_154c8dd3-0a66-486d-a16d-4b36d0fe275b"
      unitRef="U_USD">20549000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_b5deff3b-5937-4607-9f18-44be237718e2"
      unitRef="U_USD">4612000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_e6047fe1-b87d-4a48-b626-37696c9b0903"
      unitRef="U_USD">119629000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_9694d387-e637-4c3f-adf4-1f88065b7752"
      unitRef="U_USD">46490000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_b70df460-7d8c-467d-b2f1-3ea6356c1e3e"
      unitRef="U_USD">3552000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_1798751a-6477-4ec0-9404-ed378a894c41"
      unitRef="U_USD">5027000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_7528eba7-5c84-48db-98f9-afbe561ab048"
      unitRef="U_USD">143730000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_cc015ba8-b813-4101-ab27-2523a74bb309"
      unitRef="U_USD">56129000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_3cebd40c-d03a-47d1-b84a-1e4d95ad319d"
      unitRef="U_USD">926000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_ae7392c5-3f39-4008-8d91-61da926d2618"
      unitRef="U_USD">365000</us-gaap:OperatingLeaseRightOfUseAsset>
    <eldn:InProcessResearchAndDevelopment
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_0d9edda3-3b8f-45bd-b465-7a8521f41c26"
      unitRef="U_USD">32386000</eldn:InProcessResearchAndDevelopment>
    <eldn:InProcessResearchAndDevelopment
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_586eeb6a-9f6c-48d3-90a2-b22ea0d90ee5"
      unitRef="U_USD">32386000</eldn:InProcessResearchAndDevelopment>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_96a10153-a8bc-46fd-8b5c-7cf1bdbed480"
      unitRef="U_USD">363000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_2090195b-c2fe-4631-88a0-a8e3891de4ff"
      unitRef="U_USD">186000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_90763d21-7f0f-42e3-b003-d2023044b8ca"
      unitRef="U_USD">177405000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_73c4a8d9-197e-473c-ba48-646088fa00d0"
      unitRef="U_USD">89066000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_b550d8ef-20af-46db-bc41-ccb94009db3e"
      unitRef="U_USD">5833000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_53a1dc3d-0b79-4bf2-b624-57681090b51b"
      unitRef="U_USD">967000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_bc5813c1-b058-4d74-b527-0d3b85ca60a9"
      unitRef="U_USD">314000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_94eb5e78-7266-46cc-bade-f7be895ebacd"
      unitRef="U_USD">383000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_49f57a20-9a67-49da-ac2f-f634d0538019"
      unitRef="U_USD">5430000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_484c1aef-a08c-4155-9896-34adddc11ac1"
      unitRef="U_USD">2545000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_95a10388-d581-442c-a2b3-bf27507a70c0"
      unitRef="U_USD">11577000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_409f5235-4c87-405f-bd92-0dc3c782bce5"
      unitRef="U_USD">3895000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_a97379dc-a58a-4a3b-814e-02a4374804b5"
      unitRef="U_USD">2183000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_ff70dda6-eb14-4f1c-990f-7dd11db399fc"
      unitRef="U_USD">1752000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_2c47cf38-43b3-4bbe-81e4-1e3a61123670"
      unitRef="U_USD">640000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_604606a3-5880-4855-8a2b-9028f6e5f673"
      unitRef="U_USD">44865000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_00c3769a-f868-4e85-a958-681783a1510f"
      unitRef="U_USD">76211000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_dae289a3-406d-426e-b658-cf7d9a4758db"
      unitRef="U_USD">59265000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_d38e0f47-a515-4056-9e6a-b2df991f8e78"
      unitRef="U_USD">81858000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_c57e90cc-c0ba-40dc-8d93-bf49743a1b4c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_c76834f9-0a37-4ee0-b0f8-f24d5dab40aa"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_35e5b2be-3111-4f86-b24f-421775bdc8ad"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_60ab34e2-69a2-4a74-aef5-c78b42acb1da"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_9a8fcba6-e3e9-4e4d-8b1e-e1cbdee25553"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_fc532e85-e5a1-40f9-9700-7b021eaf687d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_818e278b-2d4f-49b5-9f9e-7676de57a234"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_d2b20abf-ce00-4c98-a5b5-6063f97b5e65"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_3f654b9f-a7e9-4aac-b6c3-98b75de1f063"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_f2bb22a9-c874-40f3-9a28-61daecdc0e61"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_8b7c5870-4b4d-4f8a-871e-932ec880ab62"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_b4bb4e27-124c-40a6-8777-735105ef9e1c"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_12e11e93-9be7-42cb-846b-d7e3c837e7ac"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_07a19863-24bb-412b-9f1d-5846a974c4fc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_ba9e49e5-a932-434e-9826-7b5d096f73d0"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_b7570845-3032-471d-b73b-a87a383b00b9"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_d20e2fda-0c66-45d7-acc5-6e588771c0fd"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_af1e18c2-280b-444e-9f38-ab1d6133fadd"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_3e662158-9d9b-4abb-b910-ea3113f21606"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_ec72e695-e012-44a6-83ed-43eacc651c08"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_44a7f1c4-e07e-423c-acb2-ae1a8b9a4f69"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_da7b5fb1-7497-4dc5-a8b8-51bace5995ea"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_c90b6dbf-1b5a-4b93-8ca3-1c8df88eeeb0"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_8988b060-fcf6-4dc9-a501-fea4cb919bdb"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_12b91b5f-341e-4d8f-b52c-682214a61b22"
      unitRef="U_shares">59789275</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_9370fb9e-05b2-4089-ac6a-eefdc75bb3f8"
      unitRef="U_shares">59789275</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_50086be2-219a-410b-90df-8d10215e764f"
      unitRef="U_shares">24213130</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_99646a80-00c7-42dd-8771-fb9e1b97ebff"
      unitRef="U_shares">24213130</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_cc908b77-b7d6-4e74-aa90-90338143c08a"
      unitRef="U_USD">60000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_391bfc28-8665-4aae-aa55-eed46efecbb7"
      unitRef="U_USD">24000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_f7ad639e-4eaf-4395-b8dd-0c2a11b13486"
      unitRef="U_USD">473640000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_eaf5221a-b3bd-4666-b39d-e0b2575c03f1"
      unitRef="U_USD">326586000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_e822680e-f6af-4833-bbc0-06ecde34d5e1"
      unitRef="U_USD">26000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_31f1f298-d477-4718-a677-f18186971068"
      unitRef="U_USD">-355586000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_ca68b301-4b9c-4347-a687-90bbd086befa"
      unitRef="U_USD">-319402000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_10487d98-2bb7-41ca-b0f6-bbf8f4a812c1"
      unitRef="U_USD">118140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_a05397f8-2bd9-4611-b6a5-955cb7580fde"
      unitRef="U_USD">7208000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_225d133a-b248-4ea7-b942-76a8f06e53a9"
      unitRef="U_USD">177405000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_ef0ff4d5-d2aa-41a9-934a-73a60b83df3c"
      unitRef="U_USD">89066000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_2a26a109-1480-4787-85a8-1bd46247ccd4"
      unitRef="U_USD">51964000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_3ba92aba-9b18-443e-a42a-c2d114a854af"
      unitRef="U_USD">30312000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_3db63db6-4226-497d-8a3d-5d7d34ce1737"
      unitRef="U_USD">18613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_c774e8fc-4448-4bce-be9c-ebb5bff3a767"
      unitRef="U_USD">12688000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_ef1a5aa3-f53c-4ecc-b8da-b56926b64a12"
      unitRef="U_USD">70577000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_3b20313d-bbf3-459b-92b3-db552ca19ecf"
      unitRef="U_USD">43000000</us-gaap:OperatingExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_663eeb34-eb74-4b4d-a08a-179fb67a5187"
      unitRef="U_USD">3924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_63fefb5f-5ebf-44e9-a09b-ab4a0819087b"
      unitRef="U_USD">2674000</us-gaap:OtherNonoperatingIncomeExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_af783ee2-35ce-4d6c-974b-cc7993d52ab0"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_d13b46e3-80ee-4a3d-98a9-1d84c2ef0f42"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_8cfa75de-0cf0-475c-b426-e7e967099a79"
      unitRef="U_USD">-35753000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_315dc9cc-929c-4039-ad45-a230246baead"
      unitRef="U_USD">-116537000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_edd1cb63-55f5-44ee-9e01-ed5f6a2313b3"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_5f8f18cb-cd88-4e7c-8d19-1aac10d4948c"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_ba08427f-2436-497a-849e-0e60999e8a29"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_84e48dcd-189e-4df7-abd7-158e57838d20"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_5882da48-43b7-4369-b784-837ad627eb4d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_33b656b1-9139-4d06-b1fc-0c6f8ad2a105"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_dfa67eee-90e8-4b1d-8b60-aff6c65d9e6e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="0"
      id="F_d6866c3e-d880-4491-95ca-bd4edb79f95b"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="0"
      id="F_d30ebfc7-c8b2-455a-8662-e0651775745f"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="0"
      id="F_ca9827e0-f7ad-4efa-b1d6-f9dbaa28babc"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="0"
      id="F_be1cc26c-0b2a-4399-b6cc-1539357d5720"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_da93e26a-a221-416f-aa1d-44b6fa0cbbfe"
      decimals="INF"
      id="F_36e2d3a2-0a8d-47f4-b8ae-2cd7ee0b89f7"
      unitRef="U_shares">117970</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_4f4b59d8-1b4f-410c-855d-a6241a17fff1"
      decimals="INF"
      id="F_ba1f2766-123c-42f9-82a1-801ee90b8f97"
      unitRef="U_shares">6204</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45"
      decimals="INF"
      id="F_f0625e46-0036-492e-8bb3-b3fccca1d91e"
      unitRef="U_shares">13776788</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c4b4aeec-6ba8-41a5-a3aa-5c10bab25f45"
      decimals="-3"
      id="F_79c5df39-eb9e-4f0b-93e7-dc0c3f40dcda"
      unitRef="U_USD">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6907689f-f9ed-4e1e-951a-30df656bbdd0"
      decimals="-3"
      id="F_7a4c0bbe-5e0b-4271-aea6-6ed533dcf052"
      unitRef="U_USD">287034000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cb145333-a71b-4f8a-9efc-683fbaf92968"
      decimals="-3"
      id="F_2a99c07a-72e8-4327-b67a-7aecb48cabdf"
      unitRef="U_USD">-202865000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"
      decimals="-3"
      id="F_4087bb25-175e-4769-9bb2-e2610c8f9bee"
      unitRef="U_USD">84183000</us-gaap:StockholdersEquity>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="INF"
      id="F_574b3e0e-9529-49d1-bebf-d7e237596ee4"
      unitRef="U_shares">8730168</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="-3"
      id="F_932350e1-556f-4baa-872d-81b9edf6a506"
      unitRef="U_USD">9000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1"
      decimals="-3"
      id="F_bcccc4b0-9a4a-438f-9e6b-148747ecbcdb"
      unitRef="U_USD">33008000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_f9267dd6-5279-4242-8cf3-dc3f0ff9489c"
      unitRef="U_USD">33017000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares
      contextRef="C_ca588c4b-fe6a-413d-9b1b-50b767ebb7e8"
      decimals="INF"
      id="F_b1584e4d-555c-4caf-8f6b-2232d5f1c3c0"
      unitRef="U_shares">-1782</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="INF"
      id="F_54190f9c-ef18-42d0-83de-54080e313cb3"
      unitRef="U_shares">99000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfXNonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares
      contextRef="C_263741cf-175e-4ce0-9e5d-54eeafb843a3"
      decimals="INF"
      id="F_1e5331f8-98f5-4f41-8654-52071809a427"
      unitRef="U_shares">-7884</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="INF"
      id="F_bf2a181d-9baf-497a-87e9-46ba4a821eba"
      unitRef="U_shares">437977</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockShares>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue
      contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1"
      decimals="-3"
      id="F_2a2ef3ec-a32c-458c-b9bd-876c31e143a5"
      unitRef="U_USD">-1000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_c33bfbc0-42a3-4bc7-afd8-91ee81aca1ce"
      unitRef="U_USD">-1000</eldn:IssuanceOfCommonStockInConnectionWithConversionOfX1NonVotingConvertiblePreferredStockValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="INF"
      id="F_9d4296a2-1888-4b90-bb98-a88312612a92"
      unitRef="U_shares">1154197</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="-3"
      id="F_458903d6-0103-438f-8716-20868df4cb5b"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_70e23ca4-d718-40f1-a73a-85f71f9f6f95"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="C_c98ed5a3-bc88-4da2-97ec-97bd10d7cb7d"
      decimals="INF"
      id="F_a923ae29-fb47-4d5b-9159-2bc6fe7ea0d3"
      unitRef="U_shares">15000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_6813c221-7692-42b9-a4bf-24cdbb27f5e1"
      decimals="-3"
      id="F_3c8a46e9-6164-4035-96c3-6af0f80a4718"
      unitRef="U_USD">6545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_351991a9-bb51-4ed5-8478-e7269bebd64e"
      unitRef="U_USD">6545000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_48114a84-98ab-4aa1-b043-13f209b76a80"
      decimals="-3"
      id="F_52181fa8-5604-459a-94f9-0272d44e1f32"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_80c96a05-3fc9-4669-b249-f58846ac6eb7"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_5db84a56-b122-4dc0-9efb-70ed7fa61ec8"
      unitRef="U_shares">110086</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_b4af9692-0c87-4e80-b91a-f9d9c1461065"
      unitRef="U_shares">4422</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92"
      decimals="INF"
      id="F_f6a25f7d-14f0-4247-b3e5-f5336b5d023a"
      unitRef="U_shares">24213130</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_9d75e978-ec70-4e92-b32d-5a9fe9832c92"
      decimals="-3"
      id="F_59d0d670-49e7-4db9-b828-2076f73bb220"
      unitRef="U_USD">24000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e9c43112-a3f3-45ba-bd41-44cbb2d1fbf3"
      decimals="-3"
      id="F_0d5b72bd-6f29-488c-b5c5-b57de3e4efdb"
      unitRef="U_USD">326586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_31ca3166-3194-499d-a328-f836589f3df6"
      decimals="-3"
      id="F_41559d21-f34d-448e-b32c-a9d79f65ba8b"
      unitRef="U_USD">-319402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_ec831e9b-aa06-401d-90ae-996405c5a522"
      unitRef="U_USD">7208000</us-gaap:StockholdersEquity>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="INF"
      id="F_930a00fc-fe7c-49f9-9870-f5907132570d"
      unitRef="U_shares">13110484</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="-3"
      id="F_b4bf39eb-1675-4868-8877-8c9edfd911c6"
      unitRef="U_USD">13000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27"
      decimals="-3"
      id="F_73c550aa-5538-41c7-8550-9c1457b40de6"
      unitRef="U_USD">48051000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_63da2dfe-ce88-46c9-bb8c-9d8ac34cb2f2"
      unitRef="U_USD">48064000</eldn:IssuanceOfCommonStockInConnectionWithPrivateInvestmentInPublicEquityTransactionNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="INF"
      id="F_e8d537fb-ac7b-466d-a9c3-4bf1e2f27da9"
      unitRef="U_shares">2636488</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="-3"
      id="F_33e35406-7cc9-4736-8c05-56670e152ca6"
      unitRef="U_USD">3000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27"
      decimals="-3"
      id="F_2fa3f064-3981-4f2c-b3a5-b000fd7327cb"
      unitRef="U_USD">6152000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_f9b7bb35-9d94-4e9a-b664-85f4a6f6dd7c"
      unitRef="U_USD">6155000</eldn:IssuanceOfCommonStockWithTheCompletionOfTheSecondAndThirdClosingInConnectionWithTwoThousandTwentyThreeSecuritiesPurchaseAgreementNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="INF"
      id="F_b8f2c687-0cc0-444c-b099-9e402d91f7f8"
      unitRef="U_shares">1423000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsShares>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="-3"
      id="F_7f39a5c1-b15c-43a4-ac4c-c8035694b64b"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_0a512bcb-32a7-4d1c-a3cd-b25a23e48fbb"
      unitRef="U_USD">1000</eldn:IssuanceOfCommonStockInConnectionWithExerciseOfPreFundedWarrantsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="INF"
      id="F_e16477be-3265-4cfa-b2a1-77cc724b6a4f"
      unitRef="U_shares">18356173</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsShares>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="-3"
      id="F_6a43ef75-02cb-454a-8f64-f4aaf55eb531"
      unitRef="U_USD">18000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27"
      decimals="-3"
      id="F_55354fcc-e867-45e9-9c28-6c56d93f4f92"
      unitRef="U_USD">79515000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_0c5d2594-18c1-4c7e-9d29-f033e2406b71"
      unitRef="U_USD">79533000</eldn:IssuanceOfCommonStockAndPreFundedWarrantsInConnectionWithTwoThousandTwentyFourUnderwrittenOfferingNetOfIssuanceCostsValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="INF"
      id="F_3100aabe-8098-4802-b03f-8dc97aee7c5f"
      unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_7d93a268-3600-4a83-af6b-4e24c9653c56"
      decimals="-3"
      id="F_e84eee93-cd36-450a-9fbb-f1a7c03f6e41"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27"
      decimals="-3"
      id="F_3ff8fee2-d20a-4d33-a101-c4af70474245"
      unitRef="U_USD">214000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_804a0b2b-5d56-452f-bdb7-600bd9376d03"
      unitRef="U_USD">215000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e092348f-329a-4fe9-9031-99230e36eb27"
      decimals="-3"
      id="F_7e436c0b-aa16-4f7a-bf9f-5975880ad213"
      unitRef="U_USD">13122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_aeaa05c2-0485-4dc4-8335-81ad1a8e4a0d"
      unitRef="U_USD">13122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_fa5ed16e-e45b-4b1c-88b4-26d3ddd75f76"
      decimals="-3"
      id="F_f2cc33ed-69c9-436d-971d-3f78b0b34c2d"
      unitRef="U_USD">26000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_303f5e42-b588-437f-9392-a660ee192d43"
      unitRef="U_USD">26000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_7cdba64b-c16d-4e4d-afdf-1f90b0947296"
      decimals="-3"
      id="F_76f62d98-f08d-491d-945d-4a4cdf5c2bce"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_c3cd0d9a-fd5b-462d-b587-78caf922d367"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_56273f71-1b02-446d-b6e6-18ca25d7ad11"
      unitRef="U_shares">110086</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_4c31df40-0db6-46b6-9697-95dc157fc63a"
      unitRef="U_shares">4422</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079"
      decimals="INF"
      id="F_b2b9443c-0bfc-418c-acc1-9ed0ff1c6fb8"
      unitRef="U_shares">59789275</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079"
      decimals="-3"
      id="F_18adc8d8-8fdb-4e28-b4f9-0223576e7aa9"
      unitRef="U_USD">60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f913f031-70f5-4d82-9777-c7eada81288b"
      decimals="-3"
      id="F_08817c67-9eaa-4867-a537-d03bfaf833c5"
      unitRef="U_USD">473640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c88b7102-5db9-49c6-a914-b6a1c69ddd87"
      decimals="-3"
      id="F_276270a5-c2c4-4a02-9a52-31e7c184fb87"
      unitRef="U_USD">26000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fda21e42-08d9-4af5-8424-38a2c795691f"
      decimals="-3"
      id="F_03d0b6d9-8252-4c0f-a64c-341a48920cab"
      unitRef="U_USD">-355586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_be04ec56-2a6c-47b4-a53e-ffdbc7842ded"
      unitRef="U_USD">118140000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_c492b211-7447-4680-b3e4-4ccd78151b1e"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_9f50d237-a33f-4ec3-934b-5c44770d6773"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_fcc64686-8dac-4297-b3eb-b4c87e97d853"
      unitRef="U_USD">10000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_d2caa125-5c75-4544-99a2-bcc81ac4bfa1"
      unitRef="U_USD">359000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_c5d68cef-d6c7-46a7-acaf-d58519b1deea"
      unitRef="U_USD">374000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <eldn:AccretionOnInvestmentDiscounts
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_2f9b39a8-0ccc-410c-9131-efcc07a363ba"
      unitRef="U_USD">-2799000</eldn:AccretionOnInvestmentDiscounts>
    <eldn:AccretionOnInvestmentDiscounts
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_5874c709-102d-48a1-b08d-a8c71c8c5d12"
      unitRef="U_USD">-1203000</eldn:AccretionOnInvestmentDiscounts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_e58b22b3-d8fc-42cd-b990-559500ae0e10"
      unitRef="U_USD">13122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_ff52e49d-8da2-4fec-9bbf-140cc831727f"
      unitRef="U_USD">6545000</us-gaap:AllocatedShareBasedCompensationExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_883482ee-06d5-4d83-8da4-ba922f0a3a2e"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_d06be886-2802-45b3-8cbe-0a5051b0cd18"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_df848f4c-2734-4a4f-808a-adfe2d147ebc"
      unitRef="U_USD">431000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_13f130c4-f200-463d-848b-110f02003911"
      unitRef="U_USD">-1298000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_2fc31fa1-94f4-4532-a33c-70c4e2586550"
      unitRef="U_USD">1954000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <eldn:AccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_41e7624e-77f2-4d5c-8e15-bcde4bb9a14f"
      unitRef="U_USD">7751000</eldn:AccountsPayableAccruedExpensesAndOtherLiabilities>
    <eldn:AccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_79f37428-a5ee-4b14-b594-49b41f9aeff3"
      unitRef="U_USD">-2600000</eldn:AccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_931c0133-d525-4e04-9a61-f2904a4046aa"
      unitRef="U_USD">-339000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_e5d5df28-c1f8-4675-9a8a-90ddbf7efd19"
      unitRef="U_USD">-363000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_b28c613b-4c43-4785-b476-b8946e576d0a"
      unitRef="U_USD">-47271000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_a3be732e-64d2-47ca-9e8b-cf7016ff7233"
      unitRef="U_USD">-39527000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_582978f0-ae5e-4c70-8f31-6a86a9f37186"
      unitRef="U_USD">156131000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_064d9c5f-60a0-47e9-ab12-4350d6a13915"
      unitRef="U_USD">78287000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_612b4d75-6e4d-406b-903b-47abf9f12826"
      unitRef="U_USD">85817000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_5276ef9f-69c9-49db-ab45-141594fd8341"
      unitRef="U_USD">33000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_17775a76-4e3b-4663-b323-4e63ffd61a9d"
      unitRef="U_USD">-70314000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_ceb2213c-e20d-4411-8e5a-9efed337e2ac"
      unitRef="U_USD">-45287000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_60df9323-ec16-4df4-b1fb-0abac6d8ee39"
      unitRef="U_USD">133307000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_3f817092-1183-4356-9826-ff20a0a7be36"
      unitRef="U_USD">33017000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_88001ec5-729f-4877-92be-3210f4f06655"
      unitRef="U_USD">215000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_383f72b9-bde4-447c-8477-fda9c231e679"
      unitRef="U_USD">133522000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_ba46a8d0-a03a-41e2-af37-8c112fc1c10f"
      unitRef="U_USD">33017000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_7ccf3229-9aa1-45ce-8555-429853daeba3"
      unitRef="U_USD">15937000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_369e8d65-dac3-46c8-89b8-c9a29ea4073f"
      unitRef="U_USD">-51797000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_8085c339-6233-4b35-b35c-01027f0a297a"
      unitRef="U_USD">4612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"
      decimals="-3"
      id="F_df53ce2c-5528-4afb-9000-6e21b1f8e734"
      unitRef="U_USD">56409000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_c915788d-aa58-4aef-8785-c53a2028094a"
      unitRef="U_USD">20549000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_7c2251eb-12ec-4c23-91bd-81b9b6d10d9a"
      unitRef="U_USD">4612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_e46b7268-170d-4802-8c58-7c38f8330305"
      unitRef="U_USD">1000</eldn:CommonStockExchangedForXAndXOneNonVotingConvertiblePreferredStock>
    <eldn:UnrealizedGainOnAvailableForSaleSecurities
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_afcd9c17-75fd-473e-8e44-3f4e4052ff17"
      unitRef="U_USD">26000</eldn:UnrealizedGainOnAvailableForSaleSecurities>
    <eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_2ef989d8-9c99-4f1c-80ac-8a6af8576dbc"
      unitRef="U_USD">920000</eldn:IncreaseDecreaseInRight-Of-UseOperatingLeaseAssetAndLiabilityDueToNewLease>
    <eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_c34996e9-c11b-43a5-9422-8c4a694785e4"
      unitRef="U_USD">446000</eldn:SettlementOfWarrantLiabilityIntoCommonStockDueToExercise>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_b0773ac5-3198-437e-a803-b5d0e84a6560">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 1. Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (&#x201c;CD40L&#x201d;) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (&#x201c;ALS&#x201d;). The Company&#x2019;s lead compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that we believe has broad therapeutic potential. Unless otherwise indicated, references to the terms &#x201c;Eledon,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; &#x201c;we,&#x201d; or the &#x201c;Company&#x201d; refer to Eledon Pharmaceuticals, Inc. and its wholly owned subsidiaries, on a consolidated basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 14, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, Eledon acquired Anelixis Therapeutics, Inc. (&#x201c;Anelixis&#x201d;), a privately held clinical stage biotechnology company developing a next generation anti-CD40L antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases. The Company maintains its corporate headquarters in Irvine, California and has research and development facilities in Burlington, Massachusetts.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1
      contextRef="C_b97a5d68-c14f-45fe-92aa-99ea9cbd0b83"
      id="F_e57692ae-8ce5-4668-bb15-ccadc815409c">2020-09-14</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_00b664c1-b3fa-402c-916f-58548a4f88c4">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#x201c;Otic&#x201d;). Otic owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#x2019;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#x2019;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#x201c;ROU&#x201d;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments with original maturities of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months or less&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; when &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;government securities and U.S. government agency securities. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all of the Company&#x2019;s long-lived assets were located in the United States. The Company&#x2019;s products will require approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#x2019;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages all its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reportable Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#x2019;s Chief Executive Officer and the Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of long-lived assets have been identified during the years presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;In-Process Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts allocated to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#x2019;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;amp;D was impaired for any of the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#x2019;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#x2019;s prior period accrued estimates for clinical trial activities through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#x2019;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; include &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,443,755&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; respectively, shares underlying pre-funded warrants to purchase common shares. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.040000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average number of common shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;second step is to measure the tax benefit as the largest amount that is &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;more &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely of being realized upon settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the Notes to Financial Statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for issued warrants either as a liability or equity in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 815-40 Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (&#x201c;ASC 815-40&#x201d;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;early adoptions&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; permitted. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ASU 2023-07, effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t impact the consolidated financial statements. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the adoption of ASU 2023-07.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Issued But Not Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#x2019;s present or future financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_af8df058-23f6-4dd2-b85e-ce86c6d9a59e">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements are prepared in accordance with GAAP. Eledon, a Delaware corporation, owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in Anelixis Therapeutics, LLC, a Delaware limited liability company, and Otic Pharma, Ltd., a private limited company organized under the laws of the State of Israel (&#x201c;Otic&#x201d;). Otic owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the issued and outstanding common stock or other ownership interest in its U.S. subsidiary, Otic Pharma, Inc. The functional currency of the Company&#x2019;s foreign subsidiary is the U.S. Dollar; however, certain expenses, assets and liabilities are transacted at the local currency. These transactions are translated from the local currency into U.S. Dollars at exchange rates during or at the end of the reporting period. The activities of the Company&#x2019;s foreign subsidiary are not significant to the consolidated financial statements. All significant intercompany accounts and transactions among the entities have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</eldn:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="C_f5f8bce9-24d2-424b-9d3f-cb4374e792c5"
      decimals="INF"
      id="F_17b00d5f-348c-4036-bc3f-77f06078c384"
      unitRef="U_pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="C_e3be1d1a-7a2e-46c0-af2c-74af00b30e00"
      decimals="INF"
      id="F_27e80b6a-b4f6-4d86-81c2-4f49a1415fb0"
      unitRef="U_pure">1</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:UseOfEstimates
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_3bc08921-21d1-4f8a-8c74-07bde34edc19">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to stock-based compensation expense, warrant liabilities, the fair value of right-of-use (&#x201c;ROU&#x201d;) assets and liabilities, accruals for liabilities, impairment of long-lived assets, and other matters that affect the consolidated financial statements and related disclosures. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_6ac3104b-81b8-4403-b4dc-d7ca519a18d3">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consists of cash, cash equivalents and short-term investments. The Company maintains deposits in federally insured institutions in excess of federally insured limits and invests in short-term investments with the primary objective of seeking to preserve principal, achieve liquidity requirements and safeguard invested funds. We believe that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held and the nature, including the credit ratings, of our cash equivalents and short-term investments, but we have not eliminated all credit risk.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_00eccfe4-7325-490b-9792-c7f1995214de">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments with original maturities of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months or less&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; when &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;purchased to be cash equivalents. Cash and cash equivalents include cash in readily available checking accounts, money market funds,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;government securities and U.S. government agency securities. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents are valued at cost, which approximates their fair value due to the short-term maturities of these investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_18adf21c-a3ca-4520-9b4a-719acaed6c49">three months or less</eldn:CashCashEquivalentsAndRestrictedCashMaturityPeriod>
    <eldn:RisksAndUncertaintiesPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_144e18b1-caaf-4e31-99b6-0b495155d40d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, all of the Company&#x2019;s long-lived assets were located in the United States. The Company&#x2019;s products will require approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that its products will receive any of these required approvals. The denial or delay of such approvals may impact the Company&#x2019;s business in the future. In addition, after the approval by the FDA, there is still an ongoing risk of adverse events that did not appear during the product approval process.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks common to companies in the pharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of its stock price and the need to obtain additional financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's facilities and equipment, including those of the Company's suppliers and vendors, may be affected by natural or man-made disasters. The Company's administrative office is based in Irvine, California and the Company manages all its research and development activities through third parties that are located throughout the world. The Company has taken precautions to safeguard its facilities, equipment and systems, including insurance, health and safety protocols, and off-site storage of computer data. However, the Company's facilities and systems, as well as those of its third-party suppliers and vendors, may be vulnerable to earthquakes, fire, storm, public health or similar emergencies, power loss, telecommunications failures, physical and software break-ins, software viruses and similar events which could cause substantial delays in its operations, damage or destroy its equipment or inventory, and cause the Company to incur additional expenses and delay research and development activities. In addition, the insurance coverage the Company maintains may not be adequate to cover its losses in any circumstance and may not continue to be available to use on acceptable terms, or at all.&lt;/span&gt;&lt;/p&gt;</eldn:RisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_2d22359f-9a0e-4322-8d39-d14a3ff95bb0">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reportable Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments under GAAP are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources and in assessing performance. The CODM is the Company&#x2019;s Chief Executive Officer and the Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; business segment, which is the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_7f1e6a98-d2e7-4bdb-ae34-8d984b552151"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_58cbad51-7fc5-4b37-99f0-3b73b90a4304">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Additions, major renewals and improvements are capitalized and repair and maintenance costs are charged to expense as incurred. Leasehold improvements are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected cash flows. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairments of long-lived assets have been identified during the years presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_cdc89edb-4cd6-45c2-b3cc-a0125d10cf0d"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="INF"
      id="F_5226ffae-25fa-449d-a9d9-8374752eb624"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_950c0214-9c61-4f17-81e4-d616a696712b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;In-Process Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts allocated to in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in connection with a business combination are recorded at fair value and are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development efforts. If and when development is complete, which generally occurs when regulatory approval to market a product is obtained, the associated assets are deemed finite-lived and amortized over a period that best reflects the economic benefits provided by these assets. During the period the assets are considered indefinite-lived, they will not be amortized but will be tested annually for impairment or more frequently if indicators of impairment exist.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;amp;D is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative assessment. If, after assessing qualitative factors, the Company determines it is not more likely than not that the fair value is less than its carrying amount, then a quantitative assessment is unnecessary. If the quantitative assessment is deemed necessary, the excess of the carrying value over fair value will be recorded as an impairment. The qualitative assessment focuses on the key inputs, assumptions and rationale utilized in the establishment of the carrying value and related changes since the last quantitative assessment. Based on the results of the Company&#x2019;s annual qualitative assessment, the Company concluded that it is not more likely than not that IPR&amp;amp;D was impaired for any of the periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_18c55de5-2252-4c5a-a97b-e2b29a4ef7f1">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under contracts with third parties may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company contracts with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to its vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions. The Company&#x2019;s accrual for clinical trials is based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. These contracts may be terminated by the Company upon written notice and the Company is generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances the Company may be further responsible for termination fees and penalties. The Company estimates its research and development expenses and the related accrual as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#x2019;s prior period accrued estimates for clinical trial activities through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_f055d2db-8f31-41d1-8e52-570ca880565b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share calculation, incentive stock options, restricted stock units and warrants are considered to be potentially dilutive securities and are excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share was the same for the periods presented due to the Company&#x2019;s net loss position. Basic weighted average shares outstanding for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; include &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,443,755&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; respectively, shares underlying pre-funded warrants to purchase common shares. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.040000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average number of common shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The computation of diluted earnings per share excludes incentive stock options, restricted stock units, and warrants that are anti-dilutive. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_223d8e7d-db53-4014-ad03-258351d47431"
      decimals="0"
      id="F_2ebb8152-bfa3-4385-8742-6df38c0506c8"
      unitRef="U_shares">12443755</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c655824d-1655-43e8-bda3-bfbadd4707f7"
      decimals="0"
      id="F_ed480e45-a60b-472b-ad70-dd15d9d3a849"
      unitRef="U_shares">5776270</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_c6039368-bb8c-4da4-a7a9-dfc5e0f22ede">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share), these shares are deemed to be issued for purposes of basic earnings per share.&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:14.040000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average number of common shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,543,787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,619,197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_5a950f73-2372-4ecd-bd27-5625ddd12c79"
      decimals="3"
      id="F_2d8e0af8-5863-4575-8fde-d7835dd1536f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:NetIncomeLoss
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_06c43a25-8ae3-491a-bd74-f2cd26fe163d"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_b0e7fe1a-786d-4ed4-aa47-ba91b20cb202"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_36f8e6ce-a0f6-4496-9bc5-5d14a8b0899e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_a57d5bfe-418f-4ee3-b443-400165a70451"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_74d8758f-7578-4af1-ae68-9a338db488aa"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_fa810fe6-0c8b-42fd-8dc4-eac030b1847d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="0"
      id="F_e514815d-8645-47cd-b42b-6b31fc91d2e6"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="0"
      id="F_cd67de88-d3ab-4b35-a205-bd8b69b7b630"
      unitRef="U_shares">48543787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="0"
      id="F_7cd50913-3e43-4346-846c-54e38307eb1f"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="0"
      id="F_25c45b5f-28aa-4a7e-9ea5-23dffc2ebab0"
      unitRef="U_shares">24619197</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_43d89146-0091-43f1-b6cb-69ad3a5a0c1e">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a summary as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.&lt;/span&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:57.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:17.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options outstanding and other equity awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,007,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,909,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common and preferred warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,567,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,577,332&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,575,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,486,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_79dfe68d-c36f-4af9-8f4e-5e28df0b6596"
      decimals="0"
      id="F_814545f8-15d3-4fa6-8382-e19bc2a4dddb"
      unitRef="U_shares">6007789</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ce203d5d-8a57-4364-b573-86117fd33f97"
      decimals="0"
      id="F_74088672-6995-412c-9b9e-d40c9fad8435"
      unitRef="U_shares">14909155</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8011d9d7-7503-40f9-9f2d-d6ad11ebdb59"
      decimals="0"
      id="F_f4b9f624-58b6-46fb-b0fc-8d42a4fe627b"
      unitRef="U_shares">18567751</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_cd66f0aa-05ca-4940-a515-241bc4f1483a"
      decimals="0"
      id="F_cb00ab6e-d969-45d4-98ab-78116622c913"
      unitRef="U_shares">18577332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="0"
      id="F_df4dc8d6-1c85-4fb6-8cd7-e9f0bc9ed7d6"
      unitRef="U_shares">24575540</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="0"
      id="F_cf8cebad-dddf-4eb5-865e-991f22441dee"
      unitRef="U_shares">33486487</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_fcf5d144-1fc8-4a41-be46-76e4789f4c97">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_a371b26a-dc84-4d11-bae5-32fdc960d29c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. We assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting. We have provided a valuation allowance on our deferred tax assets as of December 31, 2024 and 2023 because we believe it is more likely than not that a majority of our deferred tax assets will not be realized as of this date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates the accounting for uncertainty in income tax recognized in its consolidated financial statements and determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its consolidated financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tax benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued any liabilities for any such uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. The Company is subject to U.S. federal and state tax authority examinations for all the years since inception due to net operating loss and tax credit carryforwards. The net operating losses and tax credits are subject to adjustment until the statute closes on the year the attributes are ultimately utilized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or processes, if any. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;second step is to measure the tax benefit as the largest amount that is &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;more &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely of being realized upon settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known. For additional information, see&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the Notes to Financial Statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_577725e9-389f-464e-92d2-e810af93f6cc"
      unitRef="U_USD">0</eldn:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxesExpenseBenefit>
    <us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_2f789d96-b7a3-4a0f-b646-a424f8cd9ef8">The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement>
    <eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_1a3ab8a1-e05f-44d3-8891-f6d16c7da1ef"
      unitRef="U_pure">0.50</eldn:IncomeTaxExaminationLikelihoodOfFavorableSettlement>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_4aef25bc-08b3-408e-99ea-148d84c62685">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for issued warrants either as a liability or equity in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 815-40 Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (&#x201c;ASC 815-40&#x201d;). Under ASC 815-40, contracts that may require settlement for cash are liabilities, regardless of the probability of the occurrence of the triggering event. Liability-classified warrants are measured at fair value on the issuance date and at the end of each reporting period. Any change in the fair value of the warrants after the issuance date is recorded in the consolidated statements of operations and comprehensive loss as a gain or loss. If warrants do not require liability classification under ASC 815-40, in order to conclude warrants should be classified as equity, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP standard. Equity-classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_ca8204a5-05ca-4124-8aad-3481f2955106">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;early adoptions&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; permitted. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ASU 2023-07, effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in these consolidated financial statements. ASU 2023-07 only impacted the disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t impact the consolidated financial statements. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the adoption of ASU 2023-07.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Issued But Not Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as information on income taxes paid. ASU No. 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires new financial statement disclosures in tabular format, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update do not change or remove current expense disclosure requirements. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on its financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company&#x2019;s present or future financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption
      contextRef="C_c508875a-d414-4f73-bf48-c4925adce371"
      id="F_1089dda6-986a-4c9e-b2e6-0bf12df3653b">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_c508875a-d414-4f73-bf48-c4925adce371"
      id="F_41b6d511-7ada-455c-97fd-8fdde15a98cb">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_c508875a-d414-4f73-bf48-c4925adce371"
      id="F_5ebd17fd-5c64-4d5e-9757-1544241f9bb8">2024-12-31</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_c508875a-d414-4f73-bf48-c4925adce371"
      id="F_af5de421-a188-4a70-91e8-c2d38cb1bec1">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_f7cf4405-a48b-4e8f-b5c2-ce0b59383727">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 3. Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The objectives of the Company&#x2019;s investment policy are to preserve principal, meet the Company's liquidity requirements and safeguard invested funds. Short-term investments consist of U.S. government securities and U.S. government agency securities. The Company has classified these investments as available-for-sale securities, as the sale of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;such investments may be required prior to maturity to implement management strategies, and therefore has classified all investments with maturity dates beyond three months at the date of purchase as current assets in the accompanying consolidated balance sheets. Any premium or discount arising at purchase is amortized and/or accreted to interest income as an adjustment to yield using the straight-line method over the life of the instrument. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. Investments are reported at their estimated fair value. Unrealized gains and losses are included in accumulated other comprehensive loss as a component of stockholders' equity until realized.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of short-term investments, which were classified as available-for-sale securities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.294%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All of the Company's available-for-sale securities have a stated maturity of less than one year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_865de5dd-04f0-4d90-a74d-741f989814af">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is a summary of short-term investments, which were classified as available-for-sale securities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.294%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.577%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b"
      decimals="-3"
      id="F_dc3e1d3c-7132-4804-b982-4e903144ba31"
      unitRef="U_USD">119603000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b"
      decimals="-3"
      id="F_5a588e54-3a02-4fab-86e3-94225d523ca9"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b"
      decimals="-3"
      id="F_b1f903de-d18b-4c5f-9e5e-cb6454ae388d"
      unitRef="U_USD">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_31bf3867-db9f-4f90-8142-37e4eadc782b"
      decimals="-3"
      id="F_15310c3f-2a3e-4219-8c4a-51fdd2992660"
      unitRef="U_USD">119629000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_0ffc19de-f1c3-4418-ab28-04944bc1455e"
      unitRef="U_USD">119603000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_4532b33e-1a2f-4e2c-82ba-3b2e7ab48108"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_3797753f-0ca3-41d4-b83c-be24c6449fe9"
      unitRef="U_USD">29000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_b2feade9-94b7-4d0e-8fdc-ce48a6d0146a"
      unitRef="U_USD">119629000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e"
      decimals="-3"
      id="F_d956e13b-65d7-436e-898d-2e28eba3764f"
      unitRef="U_USD">33213000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e"
      decimals="-3"
      id="F_f132dd67-465b-40dc-9d47-7ce46be1d001"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e"
      decimals="-3"
      id="F_5dedc7bf-d47c-4243-b4a8-0155608fb4c3"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8bbab5ba-b875-4f02-82f3-4fc95d453a9e"
      decimals="-3"
      id="F_89d63340-aa39-4e1d-a87a-d78453c55de9"
      unitRef="U_USD">33213000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf"
      decimals="-3"
      id="F_fcdcb925-67a7-4ebe-82eb-0d64d91ded83"
      unitRef="U_USD">13277000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf"
      decimals="-3"
      id="F_e6b47241-f98e-4e23-ba98-e6a7931f152b"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf"
      decimals="-3"
      id="F_e255fe14-9c55-47bf-844c-bc7bfff5d144"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_f687773b-cec3-4e38-a44b-b9414ab7c4cf"
      decimals="-3"
      id="F_494e9c60-3cad-432d-8000-f92a1166f5be"
      unitRef="U_USD">13277000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_2b29ce25-c26a-4835-ab0a-a55046222af9"
      unitRef="U_USD">46490000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_e810ca27-e907-4e77-a96a-d84892b635e6"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_8a93336a-2bae-4077-b15f-9e05993701f0"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_097c8244-1142-4947-ad5e-058538abfc90"
      unitRef="U_USD">46490000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_25762a20-31cc-4e18-a118-ba939850af26">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 4. Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities are recorded at fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company classifies fair value measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1&#x2014;Quoted market prices (unadjusted) in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2&#x2014;Observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. These fair values are obtained from independent pricing services which utilize Level 1 and Level 2 inputs.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's warrant liabilities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(see &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:28.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Settlement of warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds includes the reversal of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in warrant liabilities associated with the Subsequent Closing Warrants (as defined in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), which expired and or settled as of year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_2350326a-5ff2-4284-934b-2990dacef67a">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's financial asset instruments measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands). Included within cash and cash equivalents on the consolidated balance sheets, but excluded from the fair value hierarchy table, are cash deposits held at financial institutions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;138,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:33.387%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.12%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.323%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_396c0ec5-b10d-49bf-a96a-9db1863a6f32"
      decimals="-3"
      id="F_6ab42da7-b740-4cec-ba54-d2616f886fd6"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_3f46a1a6-a8f6-442b-b1ff-f3c98cff71b3"
      decimals="-3"
      id="F_09ee8c71-834a-42e6-86a3-3b897db46aa7"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_d212cec7-7f13-4076-ad8f-1298f4fbccfe"
      decimals="-3"
      id="F_0567f32e-5628-404e-9fde-bbd8d1b7c7da"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_e2da67cb-75fc-4021-ac60-f7e057d84c73"
      decimals="-3"
      id="F_9feba799-93ec-450e-a619-b47aa17be134"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18"
      decimals="-3"
      id="F_9b6336fe-3a79-4703-b162-e491aa6801ad"
      unitRef="U_USD">1215000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720"
      decimals="-3"
      id="F_e2776221-6597-492a-ba88-609201246873"
      unitRef="U_USD">17464000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1"
      decimals="-3"
      id="F_eb53d8cb-656e-455c-a554-697b6e20102c"
      unitRef="U_USD">18679000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_2dca0082-86a4-43f6-957f-6b699928251b"
      decimals="-3"
      id="F_a9b29f25-3eb9-4f46-9e58-db1d9cf41040"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_7f980e84-3bfd-4c6a-9f98-ef8ea64fd7f8"
      decimals="-3"
      id="F_b357317e-8c8f-4140-b5b8-2fc7dbf8914e"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720"
      decimals="-3"
      id="F_7ff62d21-0faf-421c-8c17-d366e341573b"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1"
      decimals="-3"
      id="F_ab505f81-362a-49dc-b79e-2837e3e85126"
      unitRef="U_USD">119629000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_12fb32d5-6ab1-4086-8a4d-41d6ae5f1b18"
      decimals="-3"
      id="F_bb4198b8-5d4c-40fc-a06a-94310f1b6f47"
      unitRef="U_USD">1215000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ffbc6245-1de4-432c-97ca-016d4dec5720"
      decimals="-3"
      id="F_1183625f-022f-4f26-a2d5-0ecc4f605d4f"
      unitRef="U_USD">137093000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c1c1dd57-6090-4d40-a0bc-80e5cf1a55c1"
      decimals="-3"
      id="F_72bda83e-c276-4320-aea7-2b654aa542f4"
      unitRef="U_USD">138308000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_ef1d6638-1928-4543-b113-5a669804d921"
      decimals="-3"
      id="F_3480e123-601f-4a1e-b969-51bb3245a199"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_8633a155-8473-424a-b31b-6ae76ea8dfef"
      decimals="-3"
      id="F_89659273-e8fe-4d92-9e7e-fffe8927625c"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719"
      decimals="-3"
      id="F_28f89ee2-6530-4c40-9341-3e74a40e58c5"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d"
      decimals="-3"
      id="F_58744214-0f28-4992-ba27-b313b386629c"
      unitRef="U_USD">4246000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_785be526-652e-459b-b095-3ed96eaf857d"
      decimals="-3"
      id="F_e2734495-a007-4557-b22b-0afc3c23af94"
      unitRef="U_USD">33213000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_6daf1c28-0057-48b3-9e51-5792ff52bc2b"
      decimals="-3"
      id="F_557688a3-7895-499b-81c0-9f4f788a3f00"
      unitRef="U_USD">33213000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_baf27155-1f9e-4cf5-835b-da4532020138"
      decimals="-3"
      id="F_c6650aba-eea3-4699-86fa-ebfe8819ef64"
      unitRef="U_USD">13277000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_8ca31066-99f4-48c4-a2bf-5e1ade8e2d92"
      decimals="-3"
      id="F_1c484a62-545f-49fd-a4fa-3c28bfe5536e"
      unitRef="U_USD">13277000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_65c0870e-3c32-4ada-9d89-29c1727f64b8"
      decimals="-3"
      id="F_838d4099-c5cb-47fb-9786-c0e12eb391be"
      unitRef="U_USD">46490000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d"
      decimals="-3"
      id="F_eb8514b4-38b4-4b85-9f20-1d0ef95b7932"
      unitRef="U_USD">46490000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8f3f58dd-c3f2-44d5-869f-0f38da5ac719"
      decimals="-3"
      id="F_53e06f98-ca9a-47c5-bceb-383bc2577757"
      unitRef="U_USD">4246000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_65c0870e-3c32-4ada-9d89-29c1727f64b8"
      decimals="-3"
      id="F_c879fcdf-86d0-440a-b925-947e5effef88"
      unitRef="U_USD">46490000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_923a3e58-9c3e-413a-b35a-231f00431e8d"
      decimals="-3"
      id="F_88be9288-496c-4ea3-bdf5-516eac86bb34"
      unitRef="U_USD">50736000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_c44c5d17-a677-47ba-9d73-bdac84233f87">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company's warrant liabilities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(see &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) measured at fair value on a recurring basis as of December 31, 2024 and 2023 (in thousands) and was based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.879%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.199%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.758000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.439%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.498000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_f7f796ca-5ede-4fab-bd41-35bedc579277"
      decimals="-3"
      id="F_59f7c943-61d6-4540-9e1e-628d1f4cfe8e"
      unitRef="U_USD">44865000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_66748007-3bbb-4063-96d0-b1f1e7fe5949"
      decimals="-3"
      id="F_5051f75e-7691-4682-ac21-5c9f7e0ee837"
      unitRef="U_USD">44865000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_9a1c4e3d-58af-4481-a493-f277082ece01"
      decimals="-3"
      id="F_9f8f2a8a-aa3b-4b1f-b2a3-c44e4c5ee97f"
      unitRef="U_USD">76211000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_33505f9b-7127-48ca-9287-5490646f361b"
      decimals="-3"
      id="F_1042fc1a-efe4-4449-812c-3de97805d09f"
      unitRef="U_USD">76211000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_f8eaf374-4283-4335-867d-e880ff1b2e0e">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table provides a roll-forward of the aggregate fair value of the warrant liabilities categorized with Level 3 inputs (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:6.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:28.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Settlement of warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_33505f9b-7127-48ca-9287-5490646f361b"
      decimals="-3"
      id="F_a067186d-529a-4159-bfa1-3f933475fc97"
      unitRef="U_USD">76211000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_6f5052df-2ced-4dca-8f26-17b0a53037c7"
      decimals="-3"
      id="F_1a44e069-b471-4a58-87b7-2830a8c99975"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:SettlementOfWarrantLiability
      contextRef="C_6f5052df-2ced-4dca-8f26-17b0a53037c7"
      decimals="-3"
      id="F_e8a703c6-b87b-4f3b-9840-f3163e7f37ad"
      unitRef="U_USD">446000</eldn:SettlementOfWarrantLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_66748007-3bbb-4063-96d0-b1f1e7fe5949"
      decimals="-3"
      id="F_f4f23977-b875-40bf-930a-8a992432e679"
      unitRef="U_USD">44865000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-5"
      id="F_890aa0e1-c6bb-4b75-8b99-c23cae3762ac"
      unitRef="U_USD">59100000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceedsIncludesReversal>
    <eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_cac27d44-06e0-4808-bb95-fa5cabfb0d11">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 5. Prepaid Expenses, Other Assets, Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.709%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.697%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.956%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other liabilities consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</eldn:PrepaidExpensesOtherAssetsAccruedExpensesAndOtherLiabilitiesTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_05617d63-31ed-4ae5-b8ec-bb4a8ba1bf6b">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.709%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.697%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.956%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <eldn:PrepaidClinicalExpense
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_051595e1-7429-4ed8-9ab4-c8bcb7688184"
      unitRef="U_USD">1915000</eldn:PrepaidClinicalExpense>
    <eldn:PrepaidClinicalExpense
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_05981656-4c01-4830-94a0-bcbef7902746"
      unitRef="U_USD">4128000</eldn:PrepaidClinicalExpense>
    <us-gaap:PrepaidInsurance
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_aebb2675-5194-4542-97d1-38880009755b"
      unitRef="U_USD">693000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_17ce243a-afa5-445f-8936-f01372f1a8ae"
      unitRef="U_USD">624000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_c897b715-ddb8-4e6c-8d61-2313c3e0e830"
      unitRef="U_USD">215000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_a36617d0-a0e7-4c95-9f75-5827b981487e"
      unitRef="U_USD">185000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_2c565b41-325e-4c36-b650-a674dbd47865"
      unitRef="U_USD">729000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_81bba03f-f843-4056-ac2e-7a692cf1b531"
      unitRef="U_USD">90000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_4c8b395c-acf9-4cb8-b65e-ee2b0dbfc1b8"
      unitRef="U_USD">3552000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_b329d368-e3a0-4d2b-8091-ffd7c76f502e"
      unitRef="U_USD">5027000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_6ea07de1-d36c-4523-be0b-c25fe1a50566">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other liabilities consisted of the following as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:18.119999999999997%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued clinical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</eldn:ScheduleOfAccruedExpensesAndOtherLiabilitiesTableTextBlock>
    <eldn:AccruedClinicalCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_a72ad3fc-9bb4-42e7-adf4-84bc5696b9a8"
      unitRef="U_USD">3642000</eldn:AccruedClinicalCurrent>
    <eldn:AccruedClinicalCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_0edb6d59-8266-4eae-a730-9a4a34dbd6ff"
      unitRef="U_USD">451000</eldn:AccruedClinicalCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_04efb182-982d-486e-a6ce-71393456e9dc"
      unitRef="U_USD">1601000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_0920d3ba-1961-4ff6-a26d-93dd2e0d35e2"
      unitRef="U_USD">2003000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_22a47f25-5121-491b-afa7-7664ae5de54e"
      unitRef="U_USD">140000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_619231ef-1968-45f1-b3c1-20cf42d53932"
      unitRef="U_USD">47000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_0436ff38-b299-4882-86aa-8426f76fcc70"
      unitRef="U_USD">47000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_a02d825d-8acf-4139-88c8-a0d75359856c"
      unitRef="U_USD">44000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_22d81313-71fb-45e0-830e-f3403d0bd194"
      unitRef="U_USD">5430000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_3e51edaa-01aa-4813-8a3b-164ea7dfd36f"
      unitRef="U_USD">2545000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_7a379e00-4e30-4103-80fa-c6080c25d95c">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 6. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases office space under various operating leases. Total rent expense for all operating leases in the consolidated statements of operations and comprehensive loss was approximately&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for each of the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 19, 2024, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;38-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,817&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Irvine, California, that expires on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Irvine Lease Agreement&#x201d;). On April 19, 2024, in conjunction with the Irvine Lease Agreement, the Company terminated an existing operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Irvine, California, that was set to expire on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On April 19, 2024, the effective date of the Irvine Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 4, 2024, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;36-month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating lease for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,138&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office space in Burlington, Massachusetts, that expires on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 21, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Burlington Lease Agreement&#x201d;). The existing lease expired on November 20, 2024. On November 21, 2024, the effective date of the Burlington Lease Agreement, the Company recognized additional net ROU assets and lease liabilities in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company determines if a contract contains a lease at inception. Our office leases have a remaining term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and do not include options to extend the leases for additional periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent our right to use an underlying asset and are based upon the operating lease liabilities as adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, we estimate incremental secured borrowing rates corresponding to the maturities of the leases. As we have &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding debt nor committed credit facilities, secured or otherwise, we estimate this rate based on prevailing financial market conditions, comparable company and credit analysis, and management&#x2019;s judgment.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our leases contain rent escalations over the lease term. We recognize expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce our right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;While we do not currently have any lease agreement with lease and non-lease components, we elected to account for lease and non-lease components as separate components.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have elected the short-term lease recognition exemption for all applicable classes of underlying assets. Short-term disclosures include only those leases with a term greater than one month and 12 months or less, and expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less, that do not include an option to purchase the underlying asset that we are reasonably certain to exercise, are not recorded on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.833%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Includes variable operating lease expenses, which are immaterial.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other supplemental cash flow information related to leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.299999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.860000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liability:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.433%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.941%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:24.544999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Grants and Licenses&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ALS Therapy Development Foundation, Inc. License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2015, Anelixis executed a License Agreement (the &#x201c;Agreement&#x201d;), which is an exclusive patent rights agreement with ALS Therapy Development Foundation, Inc. (&#x201c;ALS TDI&#x201d;) for certain patents and &#x201c;know-how&#x201d; of ALS TDI. This agreement continues until the licensee terminates the agreement with ninety days written notice. The Agreement requires license fees payable to ALS TDI, subject to the achievement of certain milestones and other conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The first and second milestones of the Agreement are the dosing of the first subjects in a first toxicity study in non-human primates and the dosing of the first patient in a Phase I Clinical Trial, respectively. Both of these milestones were achieved as of December 31, 2018 and 2017. The fee due for the achievement of these milestones was&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million each. During 2018 and 2017, Anelixis issued $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million wort&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;h of its common stock in lieu of making a cash payment. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; milestones achieved during &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 or 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Agreement was amended and restated in February 2020, and a first amendment to the restated license agreement was executed in September 2020. As amended in September 2020, the remaining milestone payments for a first licensed product total&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In the event that the Company develops a second licensed product, the Company is obligated to pay up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional milestone payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition to the milestone payments, the Company is required to pay ALS TDI an amended annual license maintenance fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million beginning on the earlier of January 1, 2022, the Company&#x2019;s first sublicense, or change in control, as defined in the Agreement. The Company has made a&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million annual license maintenance fee in each year since 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Furthermore, the Company is required to pay ALS TDI fees based on reaching certain levels of annual net sales of any product produced with t&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;he patent rights. A royalty in the low single digits will be due on aggregate net sales. Upon the first calendar year of reaching $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in aggregate net sales, the Company will be required to pay ALS TDI a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Upon the first calendar year of reaching $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion in aggregate net sales, the Company is obligated to pay ALS TDI a one-time milestone payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Lonza Sales AG Inc. License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2018, Anelixis executed a License Agreement (the &#x201c;Lonza Agreement&#x201d;), which is a manufacturing know-how rights agreement with Lonza Sales AG Inc. (&#x201c;Lonza&#x201d;) for the use of certain processes and know-how related to the manufacture of tegoprubart. The Lonza Agreement continues until the later of the last Valid Claim (as defined therein) or ten years from the First Commercial Sale of tegoprubart, as defined and subject to the conditions therein. A royalty in the low single digits will be due on aggregate net sales of tegoprubart that is manufactured by Lonza or any other third-party or licensee.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;eGenesis, Inc. Collaboration Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2022, and subsequently amended in January 2023, Eledon executed a non-exclusive collaborative research agreement with eGenesis, Inc. (the &#x201c;eGenesis Agreement&#x201d;), under which eGenesis will gain access to tegoprubart for eGenesis&#x2019; ongoing preclinical research and development xenotransplant studies of human-compatible organs and cells for the treatment of organ failure. eGenesis will pay Eledon for supplies of tegoprubart based on the number of study days per animal needed for the eGenesis preclinical xenotransplant studies to offset manufacturing expenses. As of year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company offset $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of manufacturing expenses. The eGenesis agreement continues until September 2025, unless terminated earlier by either party.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Matters&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company and its subsidiaries are not a party to or the subject of any claim or lawsuit that individually or in the aggregate is anticipated to have a material effect on the Company&#x2019;s results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnifications&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnification. The Company&#x2019;s exposure under these agreements is unknown because it involves future claims that may be made against the Company but have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future because of these indemnification obligations. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amounts associated with such indemnifications have been recorded to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; contingent liabilities requiring accrual at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-5"
      id="F_5cb385cc-1c91-4b9f-aa61-9f6133e31346"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-5"
      id="F_3ae2a208-5caa-4820-b98a-7b025afe17c6"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_57da919f-7744-4288-b384-8049ba29e1b4"
      id="F_29436473-cf60-4f49-8d11-8ef81142a06f">P38M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <eldn:AreaOfOfficeSpace
      contextRef="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92"
      decimals="INF"
      id="F_8a670456-5da8-43b7-9a5c-c7a14f90c70e"
      unitRef="U_sqft">5817</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_a7fcf891-841c-4ea3-b769-68dc3fb92d92"
      id="F_1f0da4b7-55e6-4261-adc2-f62e2d8f513b">2027-06-30</us-gaap:LeaseExpirationDate1>
    <eldn:AreaOfOfficeSpace
      contextRef="C_1a557357-a976-4702-be2e-81994f5f0bdc"
      decimals="INF"
      id="F_abfeb4d6-fbaf-4599-a071-32a48687926d"
      unitRef="U_sqft">5197</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_b03f2283-1f48-4ad2-8437-e177dcaf160b"
      id="F_f1123c63-7f05-49bb-88f3-cf67823857b0">2024-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_57da919f-7744-4288-b384-8049ba29e1b4"
      decimals="-5"
      id="F_275e8f28-bc7c-4c6c-ae77-9e268b53ec7c"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_c763de0f-2331-4e42-9eed-6f3c61e5a6f3"
      id="F_73af81a2-bece-41b7-9c48-bb36447f68e0">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <eldn:AreaOfOfficeSpace
      contextRef="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8"
      decimals="INF"
      id="F_e82cfa47-1b7d-46fe-864a-a94976a6ad46"
      unitRef="U_sqft">6138</eldn:AreaOfOfficeSpace>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_f2eb0599-7d50-454a-a9c3-3733546ffdc8"
      id="F_ef98869d-1e9f-4971-acad-f1bbd933e147">2027-11-21</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_9a80f4c6-f976-44ce-8ccc-11733f31a205"
      decimals="-5"
      id="F_4e89b4c1-c877-494b-813c-d198b36fdd1b"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_9a80f4c6-f976-44ce-8ccc-11733f31a205"
      decimals="-5"
      id="F_1e9dc572-3f01-41ab-90f7-688b9f4f3bb0"
      unitRef="U_USD">500000</us-gaap:OperatingLeaseLiability>
    <eldn:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_8855c84d-1b91-4958-8a31-bc692e481671">P3Y</eldn:LesseeOperatingLeaseRemainingTermOfContract>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_4d94416b-907d-4e33-adf4-ff04a1fd30b4"
      unitRef="U_USD">0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_bbc95bed-837f-4c68-9fb6-65a5d1f2a71d">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The total operating lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.833%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.203000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(a) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Includes variable operating lease expenses, which are immaterial.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_8eae38f1-529b-4066-8516-2c8b0b1a1fb8"
      unitRef="U_USD">407000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_fde50c73-6624-4dea-ab16-7e09d3112d67"
      unitRef="U_USD">400000</us-gaap:OperatingLeaseCost>
    <eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_729896f0-eed6-40fa-a86c-33c5ab953100">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other supplemental cash flow information related to leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.299999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.860000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liability:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;378&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.433%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</eldn:OtherSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_9fd90eda-2e1c-415e-9d14-31de7fa0408a"
      unitRef="U_USD">378000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_7972339e-c083-4a1e-9c51-6b8e109a08e2"
      unitRef="U_USD">378000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      id="F_0d203df1-26b9-4259-8907-3c98ed69443d">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      id="F_40e79c76-f18d-48aa-ab7c-8e973502c923">P1Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="4"
      id="F_2d7d48d5-192a-410b-924b-64b9ece2d8f1"
      unitRef="U_pure">0.0946</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="4"
      id="F_f6368990-226a-4a05-b7b6-043f3b5e6a3d"
      unitRef="U_pure">0.0249</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_0ced6984-b015-456a-ad59-e39d0a338047">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, future minimum payments under non-cancelable operating leases, were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.514%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.941%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:24.544999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;954&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion of operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_db02a04e-3862-4f04-947f-9814ab3bc8cd"
      unitRef="U_USD">391000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_df09174d-1107-4365-98c9-fb4cb07eceb6"
      unitRef="U_USD">403000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_a4dc325f-b937-4bcd-9fd5-fa8e3cc3c4c2"
      unitRef="U_USD">293000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_351a7de3-c262-4d05-9226-a77805ac4e86"
      unitRef="U_USD">1087000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_f2517901-9e3b-4463-83ca-d7a6cf65eaad"
      unitRef="U_USD">133000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_01544ed5-96c5-4d55-9e57-b059abd25580"
      unitRef="U_USD">954000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_93fa6f4f-bb40-42d8-a70f-d60919cb6cf9"
      unitRef="U_USD">314000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_70222624-cf1c-4a36-83e7-c10e059fec7e"
      unitRef="U_USD">640000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <eldn:FeeDueForMilestonesAchieved
      contextRef="C_abc1f2cd-e8e8-41c3-9872-62e589ee5c9d"
      decimals="-5"
      id="F_e0a5fa9e-0319-466b-8cfb-f5e64109266f"
      unitRef="U_USD">1000000</eldn:FeeDueForMilestonesAchieved>
    <eldn:FeeDueForMilestonesAchieved
      contextRef="C_62fc708e-94d9-4e0c-835b-84f88b33655c"
      decimals="-5"
      id="F_96ece248-4dec-4a88-b50e-003230427a80"
      unitRef="U_USD">1000000</eldn:FeeDueForMilestonesAchieved>
    <us-gaap:StockIssued1
      contextRef="C_043095c1-b1ac-48c7-a4f2-27e2c8f8cc98"
      decimals="-5"
      id="F_cde95983-5391-446b-a8e4-76ba91ca6f4a"
      unitRef="U_USD">1000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_f95c9f8c-c83b-4faa-a94a-8bc7cdd24a68"
      decimals="-5"
      id="F_0079c0e3-31d4-482a-acb9-a5b60ccb63a8"
      unitRef="U_USD">1000000</us-gaap:StockIssued1>
    <eldn:NumberOfMilestonesAchieved
      contextRef="C_33a03f84-df70-43cd-9c50-4ba91ddfe366"
      decimals="INF"
      id="F_eb0a7a16-0723-4785-8b09-1043605850f4"
      unitRef="U_Milestone">0</eldn:NumberOfMilestonesAchieved>
    <eldn:NumberOfMilestonesAchieved
      contextRef="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7"
      decimals="INF"
      id="F_70a1e74f-7297-4241-af0d-21d60d94d4a4"
      unitRef="U_Milestone">0</eldn:NumberOfMilestonesAchieved>
    <eldn:RemainingMilestonePaymentsForFirstLicensedProduct
      contextRef="C_1d2b5181-f6f0-4b8c-83a1-6db86dab8d21"
      decimals="-5"
      id="F_46241bd3-1a84-4a11-b4bd-6a75f3509774"
      unitRef="U_USD">6000000</eldn:RemainingMilestonePaymentsForFirstLicensedProduct>
    <eldn:RegulatoryMilestonePaymentsObligation
      contextRef="C_ffcde828-6f01-4bd7-af9e-2cd1f5dee182"
      decimals="INF"
      id="F_4ef77699-bd0c-429e-b5d2-8e8d540854d3"
      unitRef="U_USD">2500000</eldn:RegulatoryMilestonePaymentsObligation>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_00e18809-6dee-4971-b3b0-b854a750129c"
      decimals="-5"
      id="F_b5af7f3c-35d3-4b64-9749-a6428aa43da9"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_33a03f84-df70-43cd-9c50-4ba91ddfe366"
      decimals="-5"
      id="F_39fd93e3-95c6-48a3-a72b-71a5e5508248"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_c7ce4246-78e5-4fec-bc98-53d3293e0ef7"
      decimals="-5"
      id="F_60fecc2d-9fde-439d-a5cc-792b4cc3ac70"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AnnualLicenseMaintenanceFee
      contextRef="C_a6f2684c-3401-4fe8-a32b-794554ab28db"
      decimals="-5"
      id="F_2b9e8a9c-f9dc-4b72-ba3b-512d65ca18d1"
      unitRef="U_USD">100000</eldn:AnnualLicenseMaintenanceFee>
    <eldn:AggregateNetSalesAchievement
      contextRef="C_8362f16b-85c6-4b35-869d-da150d474503"
      decimals="-5"
      id="F_cdc78e42-d3fa-458c-b2df-6dc2dfca2058"
      unitRef="U_USD">500000000</eldn:AggregateNetSalesAchievement>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="C_2708372d-5984-4b8b-8394-2e808b98a215"
      decimals="-5"
      id="F_0ba50141-04fa-4c16-a691-670afefe1aea"
      unitRef="U_USD">15000000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <eldn:AggregateNetSalesAchievement
      contextRef="C_aa45efb2-8f97-4e4f-8227-a73968b58522"
      decimals="-8"
      id="F_156d5f21-b2fe-4204-8f0c-1f818a88d5c2"
      unitRef="U_USD">1000000000</eldn:AggregateNetSalesAchievement>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="C_50ee3b39-8b65-4a18-aa5f-b1aa2197b68e"
      decimals="-5"
      id="F_3092b0bd-6af7-4c11-bde9-156341749cf2"
      unitRef="U_USD">30000000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <eldn:ManufacturingExpensesOffset
      contextRef="C_7972f6f5-bbc6-4b58-ae0c-1d51da007c0c"
      decimals="-5"
      id="F_7fab2746-b0d6-44b8-94e6-7a3a9893879b"
      unitRef="U_USD">100000</eldn:ManufacturingExpensesOffset>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_716cfe97-bac4-4f18-bafd-ef80eebc8816"
      unitRef="U_USD">0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <eldn:ContingentLiability
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_5e4f7fda-41a3-4414-a441-446854c41d44"
      unitRef="U_USD">0</eldn:ContingentLiability>
    <eldn:ContingentLiability
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_e3e9b68b-5816-4cf7-9dfd-03f0b27e42c3"
      unitRef="U_USD">0</eldn:ContingentLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_84d6029e-af7b-4e7b-b51c-7c8191720521">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 7. Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loss before income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses before income taxes:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgment is required in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Based on its review, the Company concluded that it was more likely than not that they would not realize the benefit of a portion of its deferred tax assets in the future. This conclusion was based on historical and projected operating performance, as well as the Company&#x2019;s expectation that its operations will not generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets within the statutory carryover periods. Therefore, the Company has a valuation allowance on its deferred tax assets as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.913%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.783000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.422%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal tax benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,819&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;NOL true-up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,137&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,623&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,183&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.448%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in the current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The deferred income tax assets have been offset by a valuation allowance, as realization is dependent on future earnings, if any, the timing and amount of which are uncertain. The net valuatio&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023 to December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The net valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2022 to December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s accounting for deferred taxes involves the evaluation of a number of factors concerning the realizability of its net deferred tax assets. The Company primarily considered such factors as its history of operating losses, the nature of the Company&#x2019;s deferred tax assets, and the timing, likelihood, and amount, if any, of future taxable income during the periods in which those temporary differences and carryforwards become deductible. At present, the Company does not believe that it is more likely than not that the deferred tax assets will be realized; accordingly, a valuation allowance has been established.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, available to reduce future taxable income. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company also has state net operating loss carryforwards of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Both the federal and state net operating loss carryforwards incurred before 2018 begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2035&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;if not utilized. The federal net operating losses incurred since 2018 of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million do not expire. The state net operating losses begin to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2035&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal research and development tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. If not utilized, the carryforwards will begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2036&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has state research and development credit carryforwards or approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, which will begin expiring in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; if not utilized&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company&#x2019;s net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% occurs within a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has not completed an IRC Section 382/383 analysis regarding the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;limitation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of net operating loss and research and development credit carryforwards. Due to the existence of the valuation allowance, future changes in the Company&#x2019;s unrecognized tax benefits will not impact the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s ability to use its remaining net operating loss and tax credit carryforwards may be further limited if the Company experiences a Section 382 ownership change in connection with future changes in our stock ownership.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the United States, the Company files income tax returns in the U.S. Federal jurisdiction, California and Massachusetts. The Company&#x2019;s tax years for 2018 and forward are subject to examination by the Federal and California tax authorities due to the carryforward of unutilized net operating losses and research and development credits.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s policy is to recognize interest expense and penalties related to income tax matters as a component of income tax expense. There was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrued interest and penalties associated with uncertain tax positions as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recorded any interest or penalties in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 or 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_e8882c78-b3c1-4c1b-9579-462a39c34f7c">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loss before income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Losses before income taxes:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_daa49bce-fe77-44ce-b19e-baa5c4b5892f"
      unitRef="U_USD">-35951000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_fee65c4b-b7e3-43ff-b534-b8746e171f5f"
      unitRef="U_USD">-116736000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_60ea9b9a-1a22-42d8-a27a-32c039aa17d6"
      unitRef="U_USD">198000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_883c2a1b-73da-4ca7-9967-09dd866a7673"
      unitRef="U_USD">199000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_9c49264e-5012-42be-922e-c1008bb55954"
      unitRef="U_USD">-35753000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_c3b9c605-b235-4f5e-9924-47409f760d02"
      unitRef="U_USD">-116537000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_898f9f4b-ae22-42b5-8cb8-78e53fba81a4">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.4%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_e250f017-9355-4b89-ad64-4d1f1622a2e5"
      unitRef="U_USD">431000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_b553f2b4-6aae-4df4-9663-b4d905851e31"
      unitRef="U_USD">431000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_59496318-0906-4ab4-bf3b-e7dfdac5e0eb"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_509c9b13-5ba7-40ad-9214-cabc4bac4c87">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.913%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.783000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.422%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Statutory federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal tax benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,819&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;NOL true-up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;566&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,137&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_33ab3111-1291-4a9f-98f7-68b1f020f180"
      unitRef="U_USD">-7508000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_4801a004-a85e-45a5-96bf-1414b3a6dce8"
      unitRef="U_USD">-24473000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <eldn:StateIncomeTaxesNetOfFederalTaxBenefits
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_30737076-959c-422c-89ca-8936cef7c4a2"
      unitRef="U_USD">-908000</eldn:StateIncomeTaxesNetOfFederalTaxBenefits>
    <eldn:StateIncomeTaxesNetOfFederalTaxBenefits
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_faf3f220-6b79-4c02-82e8-fa9fed21bdeb"
      unitRef="U_USD">-3170000</eldn:StateIncomeTaxesNetOfFederalTaxBenefits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_448a211b-e8f4-4e84-ad98-248705709c06"
      unitRef="U_USD">2358000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_a6875fed-995a-4ce0-92a9-e8f6ee5081ee"
      unitRef="U_USD">972000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_d7938f1d-efbf-4e83-9cf5-47003616a3b4"
      unitRef="U_USD">2819000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_68525e68-1aaa-4567-8123-207c21f2aabd"
      unitRef="U_USD">728000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <eldn:IncomeTaxReconciliationPermanentItems
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_e50fa2dd-08f2-4927-8131-3daa6de6bccd"
      unitRef="U_USD">12000</eldn:IncomeTaxReconciliationPermanentItems>
    <eldn:IncomeTaxReconciliationPermanentItems
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_e328ca7a-c545-4f2c-8c8a-e2e0fcb8d62f"
      unitRef="U_USD">9000</eldn:IncomeTaxReconciliationPermanentItems>
    <eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_663a9b9d-5d8b-4dad-b8bc-4952955de176"
      unitRef="U_USD">-7273000</eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_491fad97-06ad-4e43-a707-882d454e48fa"
      unitRef="U_USD">18078000</eldn:IncomeTaxReconciliationChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:IncomeTaxReconciliationStateTaxRateDifferential
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_8d632007-66e0-4ef0-a863-e0c663a49a2d"
      unitRef="U_USD">490000</eldn:IncomeTaxReconciliationStateTaxRateDifferential>
    <eldn:IncomeTaxReconciliationStateTaxRateDifferential
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_f1539e6c-b437-4e0d-aa91-e254362fec68"
      unitRef="U_USD">32000</eldn:IncomeTaxReconciliationStateTaxRateDifferential>
    <eldn:NOLTrueUp
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_35a370db-b6c1-413d-8eef-716eca9a0d6c"
      unitRef="U_USD">-4000</eldn:NOLTrueUp>
    <eldn:NOLTrueUp
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_855905f8-00bb-4d09-a316-338392fc0bfe"
      unitRef="U_USD">2000</eldn:NOLTrueUp>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_8f370dca-68a2-4f3c-87d7-a5f4f68378dd"
      unitRef="U_USD">24000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_10562ae1-7994-42c8-8dd3-c23ae1e5ddd6"
      unitRef="U_USD">566000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_064b6ab0-038e-4c4f-a426-db0c37c46fc5"
      unitRef="U_USD">15137000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_3722742c-f775-443d-8244-e88eb96ef6ed"
      unitRef="U_USD">9200000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_3cb93228-cbcb-4a6b-8c78-fd0d2de63a9c"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_5fa77c16-d23a-4446-98cf-b1951588987a"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_1db02667-958a-4acd-b3b2-7fe1f8d85d06">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,085&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,056&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired IPR&amp;amp;D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,623&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,183&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_dd630ffd-c020-49ff-b137-42786180e95c"
      unitRef="U_USD">22740000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_2efc52a5-68ab-4dd1-9c3c-8976d6da862e"
      unitRef="U_USD">18089000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_b69b5cf0-dea6-439b-b1b4-a41e393b2d3b"
      unitRef="U_USD">5560000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_cdef6281-4654-49c3-a40d-250875c09764"
      unitRef="U_USD">3202000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_6b90eff8-8850-4500-b3ef-04418b3a4b4d"
      unitRef="U_USD">366000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_005d778d-97a3-4175-b90b-0670b48fd9d2"
      unitRef="U_USD">475000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_02197b3d-e6a7-425e-918d-47f4177f9b0f"
      unitRef="U_USD">18809000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_740f4b66-a1cd-45cd-98d8-464db1a38da7"
      unitRef="U_USD">10567000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_b581dbde-fc6c-4570-8654-7699186f892f"
      unitRef="U_USD">3281000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_9c2fe4e6-141b-4485-bac1-5bf86b3efd77"
      unitRef="U_USD">3085000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <eldn:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_1a4fc12b-af85-472c-a9c9-210c07e4c0c5"
      unitRef="U_USD">1056000</eldn:DeferredTaxAssetsDepreciationAndAmortization>
    <eldn:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_7f0b6abb-2538-4df6-932b-2bd11d5546af"
      unitRef="U_USD">1319000</eldn:DeferredTaxAssetsDepreciationAndAmortization>
    <eldn:DeferredTaxAssetsLeaseLiability
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_2d448236-e2fb-4bbd-91e5-278db94d6fe8"
      unitRef="U_USD">225000</eldn:DeferredTaxAssetsLeaseLiability>
    <eldn:DeferredTaxAssetsLeaseLiability
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_5cc60977-2708-4bcc-af4e-6f8ce800b22d"
      unitRef="U_USD">91000</eldn:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_de806cd7-e04d-47c5-950e-157727f55aa8"
      unitRef="U_USD">52037000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_e9d0ffa8-1d57-4566-a879-4e1a671e046e"
      unitRef="U_USD">36828000</us-gaap:DeferredTaxAssetsGross>
    <eldn:DeferredTaxAssetsRightOfUseAsset
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_7d6ce4e0-fc0c-4483-abdd-9fbf2e55f76b"
      unitRef="U_USD">218000</eldn:DeferredTaxAssetsRightOfUseAsset>
    <eldn:DeferredTaxAssetsRightOfUseAsset
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_1ebe792f-7bcd-4aea-a0b7-cf1b9602a989"
      unitRef="U_USD">87000</eldn:DeferredTaxAssetsRightOfUseAsset>
    <eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_5fddcbcf-3e81-4121-8079-398eba202602"
      unitRef="U_USD">7623000</eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment>
    <eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_37acb95d-c207-41d8-87a6-9e086554b89d"
      unitRef="U_USD">7682000</eldn:DeferredTaxLiabilitiesInProcessResearchAndDevelopment>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_34b184a7-5a15-4c18-8158-2a786df182ae"
      unitRef="U_USD">7841000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_8ff95c19-4139-4d0d-b652-b4e129bc04d5"
      unitRef="U_USD">7769000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_75847908-f3a7-489b-b796-3fc1255f8404"
      unitRef="U_USD">46379000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_53254db0-fbdc-424c-a15f-882359281c72"
      unitRef="U_USD">30811000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_dd900805-6022-46b3-9aaf-460e139b37c6"
      unitRef="U_USD">2183000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_0ff26a82-e271-4e4d-9708-b704672cdf21"
      unitRef="U_USD">1752000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_455df9c3-1153-4202-a4f9-d3fb9d859935">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:61.448%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.277000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in the current year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions from tax positions taken in prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross unrecognized tax benefits at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_b1d838db-8414-4527-80cc-642de2c7ee13"
      unitRef="U_USD">3636000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"
      decimals="-3"
      id="F_f6d6f894-3abc-4c5b-bebc-f0a63d7fd08f"
      unitRef="U_USD">2664000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_188f75c9-debb-4ff6-8da0-21f027bbd149"
      unitRef="U_USD">2596000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_9c67c031-d69a-4ad8-a1ca-2b11261da141"
      unitRef="U_USD">972000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_0bd46f61-1182-48df-8a69-ee1f2709efd0"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_c2466ab5-5e7d-4b4e-8a5e-8cf5372fb8f5"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_9b51f58e-6520-42e7-a64b-f5ec99d0bf3b"
      unitRef="U_USD">6232000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_0d47c734-c3ce-408d-b8b0-3fbc2dcc8ccf"
      unitRef="U_USD">3636000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-5"
      id="F_c29ffdb5-4502-48ab-b840-4f9c08a51dd2"
      unitRef="U_USD">15600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-5"
      id="F_259e1540-48d2-46bf-8c70-0d747f877b31"
      unitRef="U_USD">9100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1"
      decimals="-5"
      id="F_19075218-683b-4dd1-adbc-b7eff0e20dc4"
      unitRef="U_USD">88700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f"
      decimals="-5"
      id="F_857ed8cc-cdc4-4ffe-b884-388eba7f09fc"
      unitRef="U_USD">68900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_b3bf1192-2c65-401c-8714-cbce96407407"
      decimals="-5"
      id="F_22fc95b5-828b-4a10-b57c-84824ae09e0c"
      unitRef="U_USD">37700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_993efb3c-896c-44af-92dc-051235d5309e"
      decimals="-5"
      id="F_3f42899a-9acb-4a76-bbfb-3bd22c5c28ef"
      unitRef="U_USD">30100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <eldn:NetOperatingLossCarryforwardsExpirationPeriod
      contextRef="C_1bdd8687-8b04-4339-9c36-3704d34477a6"
      id="F_1cb67e64-3021-4f7a-8a80-5d912eb64c3e">2035</eldn:NetOperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1"
      decimals="-5"
      id="F_fdacc0f3-5a56-4ca1-aca7-fe3b603e3c7f"
      unitRef="U_USD">87900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <eldn:NetOperatingLossCarryforwardsExpirationPeriod
      contextRef="C_b4bf66a1-e90d-4ead-835b-58305a0590ab"
      id="F_84e7037a-dd92-47b8-8a75-8817921e6f56">2035</eldn:NetOperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_af30e24c-32c0-41f6-be04-5126201680f1"
      decimals="-5"
      id="F_e1675e7d-ab8d-4f8d-8893-c57934da7b8c"
      unitRef="U_USD">8000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_6e2dfc71-8610-4d58-a3c6-ff458ffa252f"
      decimals="-5"
      id="F_7c7914bf-faac-48e8-804f-7138813ad942"
      unitRef="U_USD">4000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <eldn:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_1bdd8687-8b04-4339-9c36-3704d34477a6"
      id="F_b5b799f2-4777-4111-8a20-a213100cc752">2036</eldn:TaxCreditCarryforwardExpirationPeriod>
    <eldn:TaxCreditCarryforwardExpirationDescription
      contextRef="C_4adef842-ba46-4a9a-9d41-be6305e99c40"
      id="F_1291e88a-75a6-4e87-bef1-4d88f3c14e8d">As of December 31, 2024 and 2023, the Company has state research and development credit carryforwards or approximately $2.6 million and $1.5 million, respectively, which will begin expiring in 2030 if not utilized</eldn:TaxCreditCarryforwardExpirationDescription>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b3bf1192-2c65-401c-8714-cbce96407407"
      decimals="-5"
      id="F_8bc22050-4d1a-44b8-9af1-008257833da0"
      unitRef="U_USD">2600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_993efb3c-896c-44af-92dc-051235d5309e"
      decimals="-5"
      id="F_6a1d20ba-5c42-420d-b1f3-0bf08f3de538"
      unitRef="U_USD">1500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <eldn:TaxCreditCarryforwardExpirationPeriod
      contextRef="C_4adef842-ba46-4a9a-9d41-be6305e99c40"
      id="F_84085083-9484-4a7a-93b3-7b77aa230d3b">2030</eldn:TaxCreditCarryforwardExpirationPeriod>
    <eldn:PercentageOfCumulativeChangeInOwnership
      contextRef="C_f2abefcd-f6bf-453b-a559-74741ea3100a"
      decimals="INF"
      id="F_20e1efaf-cc30-4ac3-ba25-d377ff410ad9"
      unitRef="U_pure">0.50</eldn:PercentageOfCumulativeChangeInOwnership>
    <eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_28a84bfe-6a5b-4ff8-9180-67eb1f1b4e58">P3Y</eldn:PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_787bab87-892c-44fc-a721-52d4e6267ea5"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_c4c11b79-3270-4ca1-8813-036a05d548b4"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_85edca3a-976b-4d61-9aff-484a252f7211"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="INF"
      id="F_15c95ee7-0184-4d79-a9db-86562730eeda"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_8db95188-c9e2-4b85-be3c-3d7beb53e416">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 8. Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; authorized shares of preferred stock with a par value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; non-voting convertible preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;515,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares designated; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110,086&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued and outstand&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ing at December 31, 2024 and 2023, and &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Series X non-voting convertible preferred stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares designated; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,422&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding at December 31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each share of the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; or X non-voting convertible preferred stock (the &#x201c;Preferred Stock&#x201d;) is convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.5556&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock, at the option of the holder at any time, subject to certain limitations, including, that the holder will be prohibited from converting the Preferred Stock into common stock if, as a result of such conversion, the holder, together with its affiliates, would beneficially own a number of shares of common stock above a conversion blocker, which is initially set at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total common stock then issued and outstanding immediately following the conversion of such shares of Series X Preferred Stock or Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock, respectively. The holder of the Preferred Stock is entitled to receive dividends on shares of the Preferred Stock equal (on an as-if-converted-to-common-stock basis and without regard to any beneficial ownership limitations) to and in the same form as dividends actually paid on shares of the common stock. No other dividends will be paid on shares of the Preferred Stock. In the event of any liquidation, dissolution or winding up, the holder of the Preferred Stock will be entitled to receive out of the assets, whether capital or surplus, the same amount that a holder of common stock would receive if the Preferred Stock were fully converted to common stock, which amounts shall be paid pari passu with all holders of common stock. Shares of the Preferred Stock will generally have no voting rights, except as required by law and except that the consent of a majority of the holders of either series of outstanding Preferred Stock will be required to amend the terms of such series.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2022 Exchange Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 11, 2022, the Company entered into an exchange agreement (the &#x201c;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchange Agreement&#x201d;) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., MSI BVF SPV, L.L.C. (collectively, the &#x201c;BVF Exchanging Stockholders&#x201d;), pursuant to which the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchanging Stockholders exchanged (the &#x201c;Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Exchange&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;550,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,899.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Ser&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ies X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 28, 2023, the Company entered into a Securities Purchase Agreement (the &#x201c;2023 Securities Purchase Agreement&#x201d;) with certain investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#x201c;2023 Private Placement&#x201d;) (i) in an initial closing, (a) an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the &#x201c;Shares&#x201d;) of the Company&#x2019;s common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value per share, or pre-funded warrants in lieu thereof (the &#x201c;Pre-Funded Warrants&#x201d;), and (b) common stock warrants exercisable into an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants in lieu thereof) (the &#x201c;Common Warrants&#x201d; and, together with the Pre-Funded Warrants, the &#x201c;Warrants&#x201d;); (ii) in a second closing (the &#x201c;Second Closing&#x201d;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,202,024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of common stock (or Pre-Funded Warrants); and (iii) in a third&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;closing &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the &#x201c;Third Closing&#x201d;), upon the satisfaction or waiver of specified conditions set forth in the 2023 Securities Purchase Agreement, an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,252,530&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants), in each case subject to customary adjustments as provided in the 2023 Securities Purchase Agreement, Pre-Funded Warrant or Common Warrant, as applicable. Each Common Warrant has an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and expires five years after issuance. The Pre-Funded Warrants are exercisable immediately and until exercised in full, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Pre-Funded Warrants and Common Warrants are subject to specified beneficial ownership limitations, which are generally set at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% unless otherwise permitted. The Shares, the Warrants, and the shares of common stock issuable upon the exercise of the Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 28, 2023, the initial closing occurred, and the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,730,168&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock and Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,421,350&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 8, 2024, the Second Closing occurred, and the Company received gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;909,088&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 30, 2024, and October 1, 2024, the Third Closing occurred, and the Company received gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs, in exchange for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,727,400&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2023 Private Placement, the Company filed on May 18, 2023, a registration statement on Form S-3 (the &#x201c;2023 Registration Statement&#x201d;) with the SEC to register for resale the Shares and the shares of common stock issuable upon the exercise of the Warrants. The 2023 Registration Statement became effective on June 2, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, the Company concluded that the Common Warrants, and the potential issuance of Pre-Funded Warrants in lieu of additional shares of common stock in the Second Closing and Third Closing (the &#x201c;Subsequent Closing Warrants&#x201d;) do not meet the conditions to be classified as equity instruments under ASC 815-40 and must instead be recorded as liabilities on the Company&#x2019;s consolidated balance sheets at their fair value and remeasured at fair value for each subsequent reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The valuation of the Common Warrants and the Subsequent Closing Warrants is adjusted to fair value (Level 3) at each balance sheet date until the Common Warrants and the Subsequent Closing Warrants are settled or expired.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, and as of the issuance date:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.149%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:20.823999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:23.064999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Conversion Agreement of Non-Voting Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;O&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n May 16, 2023, Cormorant Global Healthcare Master Fund LP provided notice to convert (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,782&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series X Non-Voting Convertible Preferred Stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X Non-Voting Convertible Preferred Stock, and (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,883.586&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;437,977&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock in accordance with the Certificate of Designation of Preferences, Rights and Limitations of the Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Non-Voting Convertible Preferred Stock. The conversion was completed on May 23, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 6, 2024, the Company entered into a Securities Purchase Agreement (the &#x201c;2024 Securities Purchase Agreement&#x201d;) with certain institutional and accredited investors, pursuant to which the Company agreed to issue and sell to the investors in a private placement (the &#x201c;2024 Private Placement&#x201d;) an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,110,484&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares (the &#x201c;2024 Shares&#x201d;) of the Company&#x2019;s common stock, at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.37&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and pre-funded warrants (the &#x201c;2024 Pre-Funded Warrants&#x201d;) at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.369&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per underlying share, which are exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The 2024 Pre-Funded Warrants were issued in lieu of shares of common stock and are exercisable immediately and until exercised in full. The 2024 Pre-Funded Warrants are subject to specified beneficial ownership limitations (equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% as determined by holder of each such warrant) of the total common stock then issued and outstanding immediately following the exercise of such warrants, and provided that any beneficial ownership limitation may not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% unless otherwise permitted. The 2024 Shares, the 2024 Pre-Funded Warrants, and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants, have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Pre-Funded Warrants were classified as a component of permanent stockholders&#x2019; equity within additional paid-in-capital. The 2024 Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#x2019;s common stock and meet the equity classification criteria. In addition, the 2024 Pre-Funded Warrants do not provide any guarantee of value or return.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Private Placement resulted in gross proceeds to the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting offering costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2024 Private Placement, the Company filed on May 24, 2024, a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC to register for resale the 2024 Shares and the shares of common stock issuable upon the exercise of the 2024 Pre-Funded Warrants. The 2024 Registration Statement became effective on June 5, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Equity Distribution Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 20, 2024, the Company entered into an Open Market Sale Agreement (the &#x201c;Sales Agreement&#x201d;) with Guggenheim Securities, LLC (&#x201c;Guggenheim Securities&#x201d;) to sell shares of the Company&#x2019;s common stock, having aggregate sales proceeds of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, from time to time, through an &#x201c;at the market&#x201d; equity offering program under which Guggenheim Securities will act as sales agent. In connection with the Sales Agreement, the Company filed on September 20, 2024 a registration statement on Form S-3 containing a prospectus and prospectus supplement (the &#x201c;Shelf Registration Statement&#x201d;) with the SEC. The Shelf Registration Statement became effective on October 2, 2024. As of the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;year ended December 31, 2024, the Company has not sold any shares under the Sales Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 29, 2024, the Company entered into an underwriting agreement with Leerink Partners, LLC, as representative of the several underwriters named therein (the &#x201c;Underwriters&#x201d;) in connection with the underwritten offering, issuance and sale by the Company (the &#x201c;2024 Underwritten Offering&#x201d;) of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,356,173&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock, at an offering price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.65&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and pre-funded warrants at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.649&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per pre-funded warrant, which are exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (the &#x201c;Offering Pre-Funded Warrants&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Offering Pre-Funded Warrants were classified as a component of permanent stockholders&#x2019; equity within additional paid-in-capital. The Offering Pre-Funded Warrants are equity classified because they are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of common shares upon exercise, are indexed to the Company&#x2019;s common stock and meet the equity classification criteria. In addition, the Offering Pre-Funded Warrants do not provide any guarantee of value or return.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Underwritten Offering closed on October 30, 2024 and resulted in gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, or net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;after deducting underwriting discounts and commissions and offering expenses. The&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Underwritten Offering was made pursuant to the Shelf Registration Statement and a prospectus supplement relating to the 2024 Underwritten Offering dated October 29, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A holder of the Offering Pre-Funded Warrants (together with its affiliates) may not exercise any portion of an Offering Pre-Funded Warrant to the extent that the that, after giving effect to such exercise, the holder (together with the holder&#x2019;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#x2019;s affiliates) would beneficially own in excess of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (or, at the holder&#x2019;s option upon issuance, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%) of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of such Offering Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Exercise of Pre-Funded Warrants from 2023 Securities Purchase Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2023, Armistice Capital Master Fund Ltd. (the &#x201c;Exercising Stockholder&#x201d;) exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;501,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 14, 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;501,197&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 2, 2023, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On November 6, 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; On January 30, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On January 30, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 7, 2024, the Exercising Stockholder exercised Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;583,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On May 9, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;583,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 11, 2024, the Exercising Stockholder exercised their remaining Pre-Funded Warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;240,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, which were issued in conjunction with the 2023 Securities Purchase Agreement. On July 11, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;240,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the Exercising Stockholder in accordance with such exercise.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants were exercisable into common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the warrants to purchase common stock activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,788,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,564,302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,778,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,274,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.492%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.297%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.837%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.836%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Shares of Common Stock Issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;247,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;298,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;May 5, 2028&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2021 pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;509,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,844,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants exercisable into Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Stock which are convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,789,301&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:54.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:41.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Series X&lt;/span&gt;&lt;span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Convertible Preferred Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed and replaced&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Warrants were issued on September 14, 2020, with an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and an expiration date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_f5bfe926-1d03-4379-bed8-885da804be07"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_6fa3de91-268e-4f6a-8aae-ec665208cf01"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_6deffbff-e8a4-4283-b1a0-66f17d7635ed"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_4dd1e6a2-7166-48bc-9cea-4c21d07afea5"
      unitRef="U_shares">515000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_035c4dd8-9b02-4714-964e-6d05d92b66e7"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_3ae25ed7-6d6f-46f2-8ad9-393677af7849"
      decimals="INF"
      id="F_79d0e5e8-497b-42f7-9dc8-b893d889eaee"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_a27122ba-bb3e-4612-9ccb-932f627a6426"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_4bf8a1ef-4a20-4972-8cfe-7e942db9e0af"
      decimals="INF"
      id="F_4d690588-823a-48b8-a2a3-e7145594ff77"
      unitRef="U_shares">110086</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_d2ac5c3c-fa63-400e-b31e-02ca8c95ef31"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_a8b42c0e-266d-4c8a-b4cb-a0f7efac839e"
      unitRef="U_shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_2564a1b1-0145-4b84-9dc0-2864d33a7b0a"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b0f8372f-04b0-40a7-b325-70e0c012674c"
      decimals="INF"
      id="F_6c2f0516-27bf-47a6-a1e8-2ce1d0cb5ad7"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_c0c7802d-a727-4e72-9a43-3c74442ec5cd"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_6c87749c-011d-4371-ab13-14962a69c063"
      decimals="INF"
      id="F_e272d8ba-9c13-4488-821b-e6c17f5d517b"
      unitRef="U_shares">4422</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_fe6f7e17-f28c-49da-acb4-0df89a0d0e69"
      decimals="INF"
      id="F_fb7e22c3-6db4-46f0-b762-a221d17270fc"
      unitRef="U_shares">55.5556</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_1e34edcb-7733-41f4-96c4-4098b67eb851"
      decimals="INF"
      id="F_662762ca-396e-4afb-9e9e-62b13e98e2f0"
      unitRef="U_shares">55.5556</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_830b14e6-5177-41fb-b6ce-4f9c69a9e2b7"
      decimals="4"
      id="F_0849a1ae-465f-48f6-89e3-cba82394c26a"
      unitRef="U_pure">0.0999</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_cef653d0-53e3-464e-a7ff-1a07fbe50a84"
      decimals="4"
      id="F_fd25b47c-94df-4544-bdea-c3fbff929968"
      unitRef="U_pure">0.0999</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_c7360e16-b2f5-4ebe-87d7-85ccacc39a7b"
      decimals="3"
      id="F_312525dd-6c09-40bf-9d79-3c68f7026f4d"
      unitRef="U_pure">0.099</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <eldn:ConversionOfPreferredStockConversionBlockerPercent
      contextRef="C_da023f2b-8828-431e-a5c6-01ba27160e08"
      decimals="3"
      id="F_2caf43a3-2cdd-46ae-a509-8c5daae152bf"
      unitRef="U_pure">0.099</eldn:ConversionOfPreferredStockConversionBlockerPercent>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_81754e8f-b125-4baa-9396-af3d23d394f2"
      decimals="INF"
      id="F_8e80927f-7295-4a8f-ae90-a182b03ef46a"
      unitRef="U_shares">550000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_0c7e74c0-0fff-4859-bb0f-e4991cbcdf79"
      decimals="INF"
      id="F_b713c0e3-2224-4a1c-8241-5c127c623584"
      unitRef="U_shares">9899.99</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36"
      decimals="INF"
      id="F_8c4b5c0e-e484-4a75-bb59-7ba4458fbc1d"
      unitRef="U_shares">15151518</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36"
      decimals="INF"
      id="F_47c93518-0222-4d26-b6f8-e6769b65de17"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_087efa66-298a-4ae4-8500-8f2f2044cb36"
      decimals="INF"
      id="F_e19deb7e-8777-48b4-9582-df62d4bd603d"
      unitRef="U_shares">15151518</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_ef59653d-33ae-47a7-ad08-ba5af6c5f5ff"
      decimals="INF"
      id="F_178efd26-d12a-4b64-ab01-d6106ded0134"
      unitRef="U_shares">20202024</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_f0a737c0-ea83-4888-a416-315bbec6d943"
      decimals="INF"
      id="F_eb6176d5-bb3b-490b-b5de-4961c4624f9d"
      unitRef="U_shares">25252530</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_601e9cd6-2771-40cc-9def-1378742631ad"
      decimals="2"
      id="F_2a5a7b6b-350b-4d2d-86e4-91301e7b0cee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7f974fdd-1b57-4a34-a7de-915221b5d0fa"
      decimals="3"
      id="F_459d0b7e-0169-46d6-85d5-35c5d5d14bf1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_9d05956d-2390-4ca6-b6a3-2f100db0a54a"
      decimals="4"
      id="F_097a7a9d-e609-4e57-a786-400f9c7b5a7f"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_ed194ea2-3267-4246-aebb-e5dd647171a5"
      decimals="4"
      id="F_492769d9-36f9-45b8-a675-5a5f2b846cbc"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_8c38178a-6212-4724-822a-073a46d7cd51"
      decimals="4"
      id="F_cc936737-1cb6-4e61-8201-c77722262ca5"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_7539102a-4a3f-4b85-9f9a-eff15ced7207"
      decimals="4"
      id="F_4102c1e2-8f7b-4295-9379-6149e2e8e120"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c"
      decimals="-5"
      id="F_e11cef9b-3fee-4a94-954e-91fe527f45da"
      unitRef="U_USD">35000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet
      contextRef="C_34e6d3ff-3e21-4345-bea0-0cd545bade2c"
      decimals="-5"
      id="F_9c41c3f3-9e26-4ff7-b656-473da3b46b38"
      unitRef="U_USD">33000000</eldn:ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsNet>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e8e45f71-13aa-4500-9629-91aae4aff6f7"
      decimals="0"
      id="F_8ef8461f-755b-4b44-af97-f44e9fec0eb0"
      unitRef="U_shares">8730168</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_bf411a33-997b-43c5-804f-81fcc2c67a2b"
      decimals="0"
      id="F_0d795e0c-7a71-4984-a7fa-9cd7bd739eef"
      unitRef="U_shares">6421350</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a"
      decimals="-5"
      id="F_fcd546cb-9a01-4e14-8027-1086afa57ac5"
      unitRef="U_USD">2100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_c7fe3d2a-d3ef-4b31-984e-844c12a69b6a"
      decimals="-5"
      id="F_d2ab88ac-95e8-4de6-86d5-4b3b068cf601"
      unitRef="U_USD">2000000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e9b52517-cc36-438f-9a32-3591a45bba9f"
      decimals="0"
      id="F_a9560d7a-9267-4487-a24d-4a5c90815a71"
      unitRef="U_shares">909088</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51"
      decimals="-5"
      id="F_b1292e09-3319-484d-9787-648b302fa831"
      unitRef="U_USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24"
      decimals="-5"
      id="F_a1dac2a7-7a5a-4018-9a3d-51389ca043ba"
      unitRef="U_USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_be97fff7-52fa-4a2c-a911-aa4eaa6d6d51"
      decimals="-5"
      id="F_7d056d1e-04a8-4c73-b14b-6a2af24ea9cf"
      unitRef="U_USD">3800000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_f3be3f9d-af80-4de0-ae49-c0f07ae9fa24"
      decimals="-5"
      id="F_3d97f050-e0b4-43db-bc35-1845ce71bf7f"
      unitRef="U_USD">3800000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_c200f68f-c405-4e48-bf2a-38f307006e4c"
      decimals="0"
      id="F_f369e936-b686-41cf-92b0-abd79ca1a46c"
      unitRef="U_shares">1727400</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_74107382-fd40-42f9-90be-490979e94f04"
      decimals="0"
      id="F_5bbb475f-2ec3-4fc6-8e21-546bfc1a79db"
      unitRef="U_shares">1727400</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2"
      id="F_1e845a8e-61f1-4816-8b60-56681b0089a2">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the assumptions used in the Black-Scholes option pricing model to determine the fair value of Common Warrants and Subsequent Closing Warrants granted as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, and as of the issuance date:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.149%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:20.823999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.481%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:23.064999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;96.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Share price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2"
      decimals="3"
      id="F_ad7b62e5-5bc2-4b70-b563-0beb5a02a18c"
      unitRef="U_pure">0.964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8"
      decimals="3"
      id="F_bf188f1c-cfa1-4934-af7e-9119e9ae021a"
      unitRef="U_pure">0.891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8"
      decimals="3"
      id="F_94633025-aa18-4123-b13b-52ec3226436c"
      unitRef="U_pure">0.943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2"
      decimals="3"
      id="F_b67b9a33-df86-4d1d-90ba-fcd1031d9c03"
      unitRef="U_pure">0.044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8"
      decimals="3"
      id="F_860afa12-820d-436c-8ff2-b9e0c42d17ac"
      unitRef="U_pure">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_bf231dfe-e30e-4f7c-8776-e3e1e4dd46e8"
      decimals="3"
      id="F_684e023f-3e1a-4eb3-9265-9bc6d3dc50bc"
      unitRef="U_pure">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_3363cfd2-6725-47cd-bf09-3c58731efbb2"
      id="F_7a2dab66-9820-4944-a4ad-bfa7021a56dc">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_87cefaba-5105-4ff2-a002-a1c4d73aeb66"
      id="F_abc75288-dc74-4f09-b4eb-19f04167ffa4">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_515ae42a-7ff1-4e13-959f-75425bb4a13f"
      id="F_2fb89093-a985-4b96-bdfa-bb33421e024a">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="C_c53b5cf6-4630-40a4-9931-9f67538e192a"
      decimals="INF"
      id="F_4c0c36b7-a4a9-4c98-9490-7984bce1988b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.14</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_bea8a10c-6aaf-4cf5-a1ef-0c858fe3ff2c"
      decimals="INF"
      id="F_a071e7f1-7029-461e-a41d-4d4771755796"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.8</us-gaap:SharePrice>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_df992d11-47da-4652-9a72-20ae69c98503"
      decimals="INF"
      id="F_8a51577b-4df4-4910-8a6e-a12ee632a463"
      unitRef="U_shares">1782</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_58527e40-73be-44c7-ac20-a9366f484716"
      decimals="INF"
      id="F_1b7f359b-5ac8-47be-9d55-a181ec47d881"
      unitRef="U_shares">99000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_c59b7a41-84c2-4669-8972-016e60680975"
      decimals="INF"
      id="F_41be5b79-8014-478c-aec2-8f4f0bbf570a"
      unitRef="U_shares">7883.586</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_c0260335-e1df-4dc7-9951-e61eec7e4e07"
      decimals="INF"
      id="F_2e25a523-4f13-4ba4-94d2-9f54fb7a7365"
      unitRef="U_shares">437977</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b"
      decimals="0"
      id="F_e94255c3-2aba-4ccd-b0f5-8896aa2a7d6f"
      unitRef="U_shares">13110484</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_18c0a78a-1e2f-466e-b8fc-e87b9eed2108"
      decimals="2"
      id="F_6508f6ef-44fe-41bb-8c04-550649da8711"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.37</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_752ba685-b573-457c-ab6b-760279f576b4"
      decimals="3"
      id="F_5edda2ad-4686-4a21-acc9-0db065f37fc2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.369</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_752ba685-b573-457c-ab6b-760279f576b4"
      decimals="0"
      id="F_5e7ffc2b-7c31-413c-bb27-663b8d5d2ac3"
      unitRef="U_shares">7989516</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_752ba685-b573-457c-ab6b-760279f576b4"
      decimals="3"
      id="F_6ac16374-73ba-478f-b32c-fd5ab7bf61af"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_d98efdad-c5fb-4fe9-bf2b-dae2dda62705"
      decimals="4"
      id="F_cc063103-85f2-4101-861e-7e39fecb813a"
      unitRef="U_pure">0.0499</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_1011d176-24c6-4711-ab33-00f6e6c3a295"
      decimals="4"
      id="F_05d4590b-cff7-4d3a-b95d-20e7b384ddc6"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage
      contextRef="C_1011d176-24c6-4711-ab33-00f6e6c3a295"
      decimals="4"
      id="F_ce5f47f8-b674-4f4d-ae54-9d70b7d0bb49"
      unitRef="U_pure">0.1999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPermittedPercentage>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b"
      decimals="-5"
      id="F_232c180c-5d85-4400-a079-9c9c28d5b36d"
      unitRef="U_USD">50000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
      contextRef="C_12c09e4d-13a3-4a3a-a44b-447d30c0621b"
      decimals="-5"
      id="F_f39d1117-f11c-42c3-b70e-6c7c9583825e"
      unitRef="U_USD">48100000</eldn:ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_c48f7041-bd5d-4520-badc-9c02123e560c"
      decimals="-5"
      id="F_6c94920b-1deb-4cca-9a47-f6ccbf83459c"
      unitRef="U_USD">75000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_1e0927e2-efa8-48c2-8418-566f24cf7f14"
      decimals="0"
      id="F_cac02d53-25fe-4e26-a5e1-1ffb30652f61"
      unitRef="U_shares">18356173</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383"
      decimals="2"
      id="F_3c201899-6563-49aa-bd21-f19b2ed7a9be"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.65</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7b2f7f52-abb1-46cd-b411-b13302614ae5"
      decimals="3"
      id="F_d5f8e7a7-20fd-4225-93c4-e60c66917f5c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.649</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383"
      decimals="0"
      id="F_41b3e9f8-a9f1-448c-8e1c-d08d8b6664b1"
      unitRef="U_shares">4931507</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_6a2ad2d2-dd43-4a9c-b2b2-827997361383"
      decimals="3"
      id="F_5fb81863-b87b-4d22-a607-35bde99a34fc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eldn:ProceedsFromIssuanceOffering
      contextRef="C_09b59681-3f5b-4085-9903-94d6298ba631"
      decimals="-6"
      id="F_c4b29d13-5945-403a-b325-b2a19ba62a96"
      unitRef="U_USD">85000000</eldn:ProceedsFromIssuanceOffering>
    <eldn:ProceedsFromIssuanceOfNetOfOfferingCosts
      contextRef="C_09b59681-3f5b-4085-9903-94d6298ba631"
      decimals="-5"
      id="F_cf6c7425-fcac-4d4b-8ac8-87ce838bd7c8"
      unitRef="U_USD">79500000</eldn:ProceedsFromIssuanceOfNetOfOfferingCosts>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_1d975291-218c-42ec-9222-8136c8da23ab"
      decimals="4"
      id="F_036549ce-ec18-480f-a321-210041910d6a"
      unitRef="U_pure">0.0499</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage
      contextRef="C_099f74fb-7263-4363-8e20-38ff695e2998"
      decimals="4"
      id="F_b66da4ed-015c-41a4-bdd2-3acba275ba65"
      unitRef="U_pure">0.0999</eldn:ClassOfWarrantSubjectToSpecifiedBeneficialOwnershipLimitationsPercentage>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_acb31783-dc63-46da-a53e-d4cc59b2703b"
      decimals="INF"
      id="F_6a84fc22-66ef-4b13-8d33-d4b5bc165fba"
      unitRef="U_shares">501197</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_acb31783-dc63-46da-a53e-d4cc59b2703b"
      decimals="3"
      id="F_a5ae940d-7945-4a1a-8d17-8c82d6ab88e3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_75635e8c-9491-4ef8-9631-b061f8135c6f"
      decimals="INF"
      id="F_c9c6b09a-79c4-40af-ad4e-a2ac7eddf0f2"
      unitRef="U_shares">501197</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0"
      decimals="INF"
      id="F_e9c35f04-bec6-4e25-903e-f2cdd9d40e52"
      unitRef="U_shares">653000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_813f12a7-c080-4b15-b17a-483f3a2ed0c0"
      decimals="3"
      id="F_acad543b-f8fd-490e-b307-560babd6e81a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e03375d3-d9dd-4d85-99e4-7301552a0c4f"
      decimals="INF"
      id="F_a4577b8c-ceaa-4284-992e-43e0a64e651c"
      unitRef="U_shares">653000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40"
      decimals="INF"
      id="F_7ded25f0-0429-416f-b7c3-ccebd2301a32"
      unitRef="U_shares">600000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40"
      decimals="3"
      id="F_e45572ad-7fb3-42c4-84da-9f7699ba273b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_bab7a219-fdf7-4cd8-8c25-6e3059775e40"
      decimals="INF"
      id="F_8a85850a-db9c-49a5-b4df-b500d1e4c7eb"
      unitRef="U_shares">600000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_c6c9bd31-68b2-4a71-971a-851b219ff30f"
      decimals="INF"
      id="F_a37b2424-9c8a-49d9-bba5-ee55a4b91944"
      unitRef="U_shares">583000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c6c9bd31-68b2-4a71-971a-851b219ff30f"
      decimals="3"
      id="F_0a925e7f-529b-4495-b41d-b3254fa33de5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_79cc014d-d674-4ff4-b42a-bb3cc0e63e25"
      decimals="INF"
      id="F_e561baaf-6e9c-4bf4-bbb0-0cbe9ac6d0be"
      unitRef="U_shares">583000</us-gaap:CommonStockSharesIssued>
    <eldn:NumberOfPreFundedWarrantsExercisedForCommonStock
      contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb"
      decimals="INF"
      id="F_a081e345-44b0-4060-8c63-978518d3aea8"
      unitRef="U_shares">240000</eldn:NumberOfPreFundedWarrantsExercisedForCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb"
      decimals="3"
      id="F_b252a8b3-8ec7-4259-954c-1f4be74179f6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a6f66374-7e3a-4ed7-b99f-e60ab16ba1fb"
      decimals="INF"
      id="F_32553b2f-8cdd-4f5c-b308-b0aea77b3647"
      unitRef="U_shares">240000</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_c13fc831-8ebf-4b35-97bb-3fd07acab079"
      decimals="INF"
      id="F_53b9e50c-c64c-490c-9d9b-49059596a317"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ScheduleOfWarrantActivityTableTextBlock
      contextRef="C_fa324109-4c1e-442a-b30b-a82030888207"
      id="F_aa1ef5e1-9e7b-4fe9-b764-78fd26ff7267">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the warrants to purchase common stock activity:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,788,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,776,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,564,302&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,921,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,423,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#d2effa;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,778,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,274,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</eldn:ScheduleOfWarrantActivityTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_fe31b2b8-289c-4f2d-9530-6c3e7c7a5ee4"
      decimals="INF"
      id="F_4988d877-691e-421d-bee9-0245ddfe94dc"
      unitRef="U_shares">15788032</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_a3d4e2f7-7728-4ff5-b3c1-f6d4d89e0518"
      decimals="INF"
      id="F_e1b6c300-3ec2-4019-9f52-2495075aa46a"
      unitRef="U_shares">5776270</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_873fc4f3-2e27-45ab-b247-49134db6a39a"
      decimals="INF"
      id="F_0cd3c8e2-0559-49ce-aab3-40e7e327dfdb"
      unitRef="U_shares">21564302</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8"
      decimals="INF"
      id="F_c2872f2a-de5f-4d61-9c04-57848d971948"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90"
      decimals="INF"
      id="F_2dab23e9-ee5b-40f7-9785-939cef757a34"
      unitRef="U_shares">12921023</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
      contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783"
      decimals="INF"
      id="F_428316b6-b6b8-4ada-9042-e6ba18a6e249"
      unitRef="U_shares">12921023</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8"
      decimals="INF"
      id="F_292b4ad7-60f7-4c36-94e4-d252d2ec7d57"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90"
      decimals="INF"
      id="F_db5fc122-f899-4b9a-a5ce-f58d8e47c948"
      unitRef="U_shares">1423000</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783"
      decimals="INF"
      id="F_cfecb677-c1e8-4908-b345-a6932ddde932"
      unitRef="U_shares">1423000</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_53f04ea6-32a3-4a74-9360-047d032d09a8"
      decimals="INF"
      id="F_5501ac4d-708b-4cb6-a575-9d33af921c44"
      unitRef="U_shares">9581</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_830a51b3-c8ce-46c7-8e0b-1c5b25864b90"
      decimals="INF"
      id="F_5c8ed1da-4c9d-4078-97b7-1870f8d629ee"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_844f75c9-11bb-444d-8d75-a4c62096d783"
      decimals="INF"
      id="F_dc07d464-898e-4e26-ace2-a6843492f6d8"
      unitRef="U_shares">9581</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_43aca5e8-7607-40e9-b22d-49e309162053"
      decimals="INF"
      id="F_8d70e18d-1037-4165-a929-ddafd4e01774"
      unitRef="U_shares">15778451</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_ec3b3914-3993-491b-8996-5d595c2548d5"
      decimals="INF"
      id="F_1b710f85-2a78-4bb1-84eb-c34f8b293ba0"
      unitRef="U_shares">17274293</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_1206a149-d99b-42c3-828f-7f43aedc8be0"
      decimals="INF"
      id="F_c679d456-7089-4671-a5e7-fe141a00d589"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_67544a77-b799-4b60-aaa7-f51bb55df6bc">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the Company's outstanding warrants to purchase shares of common stock consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.492%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.297%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.837%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.836%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Date Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Shares of Common Stock Issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Expiration Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;247,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 2020 common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;298,692&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.08&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;September 14, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement common warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,151,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;May 5, 2028&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;January 2021 pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;509,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2023 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,844,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Securities Purchase Agreement pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,989,516&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2024 Underwritten Offering pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,931,507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,052,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b"
      decimals="INF"
      id="F_b016f18f-86bb-4070-8c63-10daccc1e552"
      unitRef="U_shares">5586</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b"
      decimals="2"
      id="F_94d3c3e7-f643-49b6-800d-6aaa1bc91fe9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.9</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_f0cc14de-6299-424c-a1bc-ca5ae324df9b"
      id="F_24e2ce92-975d-4f1a-96aa-2aa00ef4e616">2025-07-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6"
      decimals="INF"
      id="F_f8aa5cde-c1db-47ee-b117-569973fc9a89"
      unitRef="U_shares">3591</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6"
      decimals="2"
      id="F_fff8730f-0bcb-4f6d-972b-84fe4c6eb670"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.9</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_bb56bc52-e0ee-4a60-9c4f-be42f85257d6"
      id="F_cf1d216d-e16d-484d-96f3-f83e79a09cc6">2025-07-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220"
      decimals="INF"
      id="F_e396f41e-bfee-44ad-9e38-a7ca357b09d9"
      unitRef="U_shares">247264</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220"
      decimals="2"
      id="F_59dd9aca-36cd-42f5-8f71-fe0da8ef9dab"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_412645b3-9ae1-4e3c-b5b6-869162daa220"
      id="F_8a92c7d7-04fa-433f-bf65-96c777cefb56">2025-07-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8"
      decimals="INF"
      id="F_5cce845c-3ab6-4a52-b93d-fd3b8c74e800"
      unitRef="U_shares">71800</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8"
      decimals="2"
      id="F_fbb89847-cde3-4fa5-94e2-214e61213a30"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_72412f37-0c9a-4990-b1d5-72866c2fa1a8"
      id="F_41026326-014f-4e23-ba0e-1ebfd2bc149d">2025-07-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f"
      decimals="INF"
      id="F_b7d01e32-4b92-4438-baa1-d7839c8540d2"
      unitRef="U_shares">298692</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f"
      decimals="2"
      id="F_b7034e32-a84c-4693-b26d-d02ec24357f7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_0b43429b-77cd-4eef-91f2-e9da25dc9c1f"
      id="F_01d47d21-08d0-47a9-84f8-49796b2fcbe5">2025-09-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07"
      decimals="INF"
      id="F_20af60b5-06af-4dcc-8c15-bc376ff4965d"
      unitRef="U_shares">15151518</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07"
      decimals="2"
      id="F_9fe8e5d1-f4d7-48aa-9418-965ffe6e1469"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_009e5ff8-a5e5-462c-9231-2b68aa7afd07"
      id="F_0e515321-dbf0-4713-9a8c-fba272cf713f">2028-05-05</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c"
      decimals="INF"
      id="F_23b0ef79-23a5-42ee-bb5f-e31dc841b218"
      unitRef="U_shares">509117</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c"
      decimals="3"
      id="F_06a3645b-0f78-4900-9c94-4728374c9d31"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_a6d60598-ba1e-477f-8dff-52c79620152c"
      id="F_0b1cd16d-43c7-413c-9401-3edbfb59fb5f">2030-12-31</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8"
      decimals="INF"
      id="F_737f49f8-7e62-4d27-aa2b-76e6394004a8"
      unitRef="U_shares">3844153</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_85cb24d8-e6dd-40c7-a054-fdd18fbc43a8"
      decimals="3"
      id="F_644120aa-e0e7-45cd-a2bf-7ae1ca7c9ba7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4"
      decimals="INF"
      id="F_1b246268-b22a-4892-85af-3dd76dfe9a39"
      unitRef="U_shares">7989516</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_cc0ff911-f27b-491d-9aae-e4d0dd8796c4"
      decimals="3"
      id="F_bdb82f70-bf8f-4619-83fa-e145ba58600a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b"
      decimals="INF"
      id="F_44f7e7e1-29c3-4715-9625-1c6fcfad8fd3"
      unitRef="U_shares">4931507</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c3fe8dbd-3a67-42ab-b90c-3ebf58eb4b9b"
      decimals="3"
      id="F_7ac375aa-e173-4523-9392-6f9c75defd71"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_1206a149-d99b-42c3-828f-7f43aedc8be0"
      decimals="INF"
      id="F_1a270c1e-4a38-4bf4-8c0f-b7acae2f83c8"
      unitRef="U_shares">33052744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ScheduleOfWarrantActivityTableTextBlock
      contextRef="C_31d1acfa-3b45-4abf-9e35-bfef36f23e5a"
      id="F_985eee59-054b-4890-85a6-a0468b114d48">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants exercisable into Series X&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Preferred Stock which are convertible into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,789,301&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (after rounding for fractional shares and subject to beneficial ownership limitations).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:54.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:41.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Roll-Forward of Series X&lt;/span&gt;&lt;span style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Convertible Preferred Warrant Activity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed and replaced&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#d2effa;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled/Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,207.419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</eldn:ScheduleOfWarrantActivityTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_d28d1435-9f97-49ba-8b24-67f48845ba10"
      decimals="INF"
      id="F_4d8d5c98-9db4-4c11-9bbb-93a0698f9dfb"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_d28d1435-9f97-49ba-8b24-67f48845ba10"
      decimals="INF"
      id="F_091add36-7b33-4a6a-aa15-e1f0db744772"
      unitRef="U_shares">2789301</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0cfe28eb-20ed-4453-b17c-b2da148bbb6b"
      decimals="INF"
      id="F_d5da3efb-6d5c-48ed-9111-4b201fca9680"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced
      contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc"
      decimals="INF"
      id="F_59c9edb9-d82f-4d52-8260-2b843e0a7302"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsAssumedAndReplaced>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
      contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc"
      decimals="INF"
      id="F_c7ef6d3a-7d9e-41d9-857b-306ab4d9b3d8"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised>
    <eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired
      contextRef="C_4a452dbe-04da-4fc2-abfa-2d13c217bcbc"
      decimals="INF"
      id="F_4645ee30-f68d-4422-9dfc-f0ff22b9abe3"
      unitRef="U_shares">0</eldn:ClassOfWarrantOrRightNumberOfWarrantsOrRightsCancelledOrExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_824d879a-0a5b-49ca-807d-ab0c7354476a"
      decimals="INF"
      id="F_c049327c-e9da-4864-b005-b0bbbb563aa4"
      unitRef="U_shares">50207.419</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c1814a1c-a776-4ae5-81fb-2c334235981f"
      decimals="2"
      id="F_d6d629de-5265-4848-97d1-9088ede1d0be"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_c1814a1c-a776-4ae5-81fb-2c334235981f"
      id="F_64cf8b12-3ea9-42a8-b8b7-4c8201fbe14e">2025-09-14</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_c7dd20ff-b759-4e65-a802-4be23331b886">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 9. Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Option Plans&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes compensation expense for all stock-based awards based on the grant-date estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options is determined using the Black-Scholes option pricing model, using assumptions which are subjective and require significant judgment and estimation by management. The risk-free rate assumption was based on observed yields from governmental zero-coupon bonds with an equivalent term. The expected volatility assumption was based on historical volatilities of a group of comparable industry companies whose share prices are publicly available. The peer group was developed based on companies in the pharmaceutical industry. The expected term of stock options represents the weighted-average period that the stock options are expected to be outstanding. Because the Company does not have historical exercise behavior, the Company determined the expected life assumption using the simplified method for stock options granted to employees, which is an average of the options ordinary vesting period and the contractual term. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For stock options granted to the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months that vested stock options granted to Board members may be exercised upon termination. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The expected dividend assumption was based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not expect to pay dividends at any time in the foreseeable future. The Company recognizes forfeitures on an actual basis and as such did not estimate forfeitures to calculate stock-based compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;) are measured and recognized based on the quoted market price of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 10, 2024, the Company held its Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d;). At the Annual Meeting, the Company&#x2019;s stockholders approved an amendment to the Company's 2020 Long Term Incentive Plan (the &#x201c;2020 Plan&#x201d;). The 2020 Plan, as amended, (i) reflects an increase in the limit on the aggregate number of shares of the Company&#x2019;s common stock that may be delivered pursuant to all awards granted under the 2020 Incentive Plan by an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares so that the new aggregate share limit under the 2020 Plan is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,960,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, and (ii) extends the date through which the Company may grant new awards under the 2020 Plan from November 15, 2030 to April 28, 2034.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 1, 2023, the Company issued stock option awards to its employees with both time-based and performance-based vesting requirements, totaling &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,381,857&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options, with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,476,372&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of the granted stock options subject to the Company&#x2019;s customary time-based vesting schedule. The remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,905,485&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options granted are subject to both customary time-based vesting requirements and performance-based vesting requirements that are based on the same clinical development milestones applicable to the Second Closing and Third Closing of the 2023 Private Placement as specified in the 2023 Securities Purchase Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the Company amended the performance-based vesting requirements with its named executive officers and other employees that upon the Second Closing and Third Closing, a full or prorated amount of each closing installment shall vest based on the percentage of funding received relative to the total funding opportunity represented by the investors&#x2019; Second Closing and Third Closing subscription amounts. On June 13, 2024 and November 20, 2024, the performance-based vesting requirement based on the milestones applicable to the Second Closing and Third Closing were satisfied and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,763,085&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; stock options were issued.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2014 Stock Incentive Plan (the &#x201c;2014 Plan&#x201d;) was closed to new grants following the approval of the 2020 Plan, and therefore, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares reserved for issuance under the 2014 Plan as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The number of shares reserved for issuance under the 2020 Plan and Employee Stock Purchase Plan was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,373,242&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,077&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, respectively, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.708%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,218,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,026,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,381,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;622,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316,465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested and expected to vest as of&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,667,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that had exercise prices that were lower than the fair value per share of the common stock on the date of exercise. The aggregate intrinsic value of options exercised during the year ended December 31, 2024 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Estimated dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The per share weighted average grant date fair value of stock options granted during the years ended December 31, 2024 and 2023 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the RSU activity, as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total compensation expense related to all of the Company&#x2019;s stock-based awards for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 was comprised of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.47%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested equity awards wa&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is expected to be recognized over an estimated weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod
      contextRef="C_82eefdd4-1476-421e-8c82-01746b54038c"
      id="F_7a223f2e-089b-4ecf-bd93-509b42718a96">For stock options granted to the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;), the Company determined the expected life assumption using the simplified method as the starting point with an average period of 12 months added to take into account the extended range of time of 12 to 18 months that vested stock options granted to Board members may be exercised upon termination. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_b84bbaad-df1d-4435-bcda-30c2fee202cc"
      id="F_2906465f-ec94-4df9-bfa4-f6588d4272c6">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_df73341b-d5e3-4456-832d-4dec35538295"
      id="F_4b215707-cdbb-46c7-9ec2-8d75e7416e00">P18M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_027f47be-a809-4a42-bc04-44816aea7e4b"
      decimals="INF"
      id="F_dee157d6-8243-49c9-9e60-ccbcf8c8b499"
      unitRef="U_shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized
      contextRef="C_027f47be-a809-4a42-bc04-44816aea7e4b"
      decimals="INF"
      id="F_b8fc7203-a16a-4f41-9107-d80385ceb962"
      unitRef="U_shares">17960000</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardTotalNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_63ba02b2-0219-4203-aeec-903a75c59cda"
      decimals="INF"
      id="F_d194fac2-f416-4c8c-9b2d-fdfca73a96d4"
      unitRef="U_shares">7381857</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_13bc12ba-1049-47bb-868c-4b5d72553817"
      decimals="INF"
      id="F_380f1ade-5457-4809-881f-3c6f9f054579"
      unitRef="U_shares">1476372</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_63ba02b2-0219-4203-aeec-903a75c59cda"
      decimals="INF"
      id="F_250feb90-7ea7-43fc-96c5-49021f55762f"
      unitRef="U_shares">5905485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_aadaadaa-a7c0-44c6-8113-f3d665a31ddc"
      decimals="INF"
      id="F_b99f732f-daf1-4ca3-b6b0-e69d1a5272b6"
      unitRef="U_shares">5763085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_fcd27fad-ba34-47a9-a7a2-6c51de3732d8"
      decimals="INF"
      id="F_656fc5f0-7b6e-443b-afcf-19a6826553ae"
      unitRef="U_shares">5763085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_ab227fe8-0ca1-4386-b398-a0fc655a8391"
      decimals="INF"
      id="F_333b3f7e-421a-4303-803e-b27f05953eea"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_66849e82-39b6-4778-bd00-50de1525fd28"
      decimals="INF"
      id="F_ddb592e9-0b58-487e-9bf9-161df93b4f5f"
      unitRef="U_shares">6373242</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1987a0f3-1c0e-49ee-81ad-cc7a111a2cf3"
      decimals="INF"
      id="F_eee6dd80-01d7-4de4-9340-77de19a1b24c"
      unitRef="U_shares">24077</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_8cd4a99f-cfb2-426b-bdab-6b39fccbf6d4">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes all option activity under the 2014 Plan, 2020 Plan and inducement grants:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:40.708%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.762%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.282%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,218,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,026,451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;862,631&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.07&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,381,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;622,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316,465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options vested and expected to vest as of&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,637,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options exercisable as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,667,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"
      decimals="INF"
      id="F_f756a6e0-138f-4a3f-a94d-86492ae901b9"
      unitRef="U_shares">5218033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_c88b1e4f-79ed-4924-88ef-5812caf2ee8e"
      decimals="2"
      id="F_1feaeb40-f933-4b48-9a05-5f41d35e447a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_d2bff3d0-c82e-407b-9765-471560864917"
      id="F_a864bba7-7a44-41b6-95cb-e624c8677ba2">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="INF"
      id="F_6cd3a210-ea00-44a7-aa48-7ac83b999513"
      unitRef="U_shares">11026451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_711b7440-08ad-475e-b0b8-ceee99bb404d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.1</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="INF"
      id="F_7aba8457-2399-44c2-9253-2de3f91eb719"
      unitRef="U_shares">862631</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_2e16568b-8008-4db5-9749-26ea2ca97018"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="INF"
      id="F_62d4c45c-280d-48e9-ad94-bfc20336c885"
      unitRef="U_shares">15381853</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="2"
      id="F_aee7fb2e-f501-48ed-b609-b942e082b4c2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      id="F_dc1b3b4a-0d05-4260-8a32-c7ab27664b2a">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_96c27b64-8362-4c1a-a77f-cd19f6405d90"
      decimals="-3"
      id="F_943df1b0-785f-4e42-b266-caf24a848887"
      unitRef="U_USD">235000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_cd406300-f935-4b81-8cdf-6e3dacee8ba5"
      unitRef="U_shares">622000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_2339c15a-0ce7-4974-a4bc-411aad48bf41"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_ed40850a-930b-40d3-8c92-2b8336b6be67"
      unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_3258fdcb-3281-4114-bc55-17f12ec3f433"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.3</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_9791cf65-7a97-4cf2-9f29-869019ee0b45"
      unitRef="U_shares">316465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_828f4fe5-ea89-41e7-ad93-574f271bebae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_11ab38d6-25d5-4e0f-8ba0-807e263c46d4"
      unitRef="U_shares">15637388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="2"
      id="F_e32cdc1d-cbba-4127-bd89-7991de1678a2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_ce475f1c-ced8-4bf3-9c98-d790da084d6c">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_cd2e02e6-c59d-436f-8587-c522b521a0cc"
      unitRef="U_USD">20628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_91b529a6-b33e-4c8c-9b7d-e73fee35d622"
      unitRef="U_shares">15637388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="2"
      id="F_54408ab6-d6b3-4011-886a-61d083fcce84"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_a3204eb6-1cff-4141-9885-4df4db99c106">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_bd174181-ffbc-4c5d-9a8d-a29c50310ea7"
      unitRef="U_USD">20628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="INF"
      id="F_dfc90392-905b-4ae4-96e3-062eea2bc970"
      unitRef="U_shares">8667177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="2"
      id="F_ca86967e-55c5-48be-9252-7ad2b0b288b0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_179a7bfb-273e-4a12-8efd-4ed96821c15a">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-3"
      id="F_8b438599-94f6-4c07-bb89-78eecb185957"
      unitRef="U_USD">7898000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-5"
      id="F_71c9e5db-22a7-4135-b4bb-9f2959bfada4"
      unitRef="U_USD">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_773ba3f7-e30b-4441-a186-75e5ab1bfa87">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:26.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected life of options (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Estimated dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="3"
      id="F_652e6395-cfcc-4701-bf11-8c97ddd19e28"
      unitRef="U_pure">1.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="3"
      id="F_2102d6a1-dca3-4cd6-b770-11b9d6743e92"
      unitRef="U_pure">0.905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="3"
      id="F_76f119e4-5c97-4c1e-b9b2-f669f59101a8"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="3"
      id="F_38b082f3-5bb0-4096-a0a4-c45e4fbf2962"
      unitRef="U_pure">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_cc92c6ef-029c-4c07-b971-11555e849742">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      id="F_24f73755-1234-4cd3-b6a4-a42af67ad47c">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_18a2fbd8-49b4-401e-b254-36ec23b2fa82"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_53a09bc1-ccef-4344-ab98-05e002697c01"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="2"
      id="F_7433610c-012a-483c-945a-a6a78c0bd0eb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="2"
      id="F_c31b9c7f-318e-453c-b470-664d44d971e0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_ede7bb7b-5d2e-493a-a200-fd53dca1031d">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the RSU activity, as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Shares&lt;br/&gt;Issuable&lt;br/&gt;Under RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited / Canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9"
      decimals="INF"
      id="F_5d3334d6-689b-46bb-a884-b131466cd28b"
      unitRef="U_shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_3d9bafe1-f606-41e1-9ad4-67db90a701e9"
      decimals="2"
      id="F_509d9280-483f-4dd5-a131-958ffa4b311f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.47</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca"
      decimals="INF"
      id="F_32319448-3885-4beb-936b-920c9be98fd2"
      unitRef="U_shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
      contextRef="C_e00d07c9-72b1-4c6d-b5b4-6aeb58d3e4ca"
      decimals="2"
      id="F_f3b7bba3-cc13-4d51-8bd9-d139ae08c864"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.47</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5"
      decimals="INF"
      id="F_4dbc667b-1fcd-4f90-b505-a39f163a7314"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_27c4adcf-0636-4d6b-ae2f-9cb8770cc9f5"
      decimals="0"
      id="F_0dce3385-27e3-409d-8062-c367594d9c8a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_3959ebff-dd82-4919-8415-9cfb3aeb832a"
      decimals="INF"
      id="F_5781a6c0-fcf1-4df0-ab0c-0715cc1f5fb3"
      unitRef="U_shares">46000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_3959ebff-dd82-4919-8415-9cfb3aeb832a"
      decimals="2"
      id="F_96293874-4932-4ca7-a282-75dddd7f26de"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.97</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_d174fc95-378b-4f2e-a041-e159aefc096b"
      decimals="INF"
      id="F_731b0edf-a420-4a79-9a35-b3280492b8c0"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
      contextRef="C_d174fc95-378b-4f2e-a041-e159aefc096b"
      decimals="0"
      id="F_2c444f35-8636-4df2-87b8-ae8ca8ee6f88"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0"
      decimals="INF"
      id="F_d4e5a72e-ec4a-4338-87de-7166b3eef6bf"
      unitRef="U_shares">46000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice
      contextRef="C_31caa76d-4ca0-47ee-bf30-ca5a26a567b0"
      decimals="2"
      id="F_7bc3bf18-c390-4587-8c9f-be1fcd3ee808"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.97</eldn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_88e913ca-d27a-4cea-bb87-e78f9be6cb6b">&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total compensation expense related to all of the Company&#x2019;s stock-based awards for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 was comprised of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.47%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:19.304%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,491&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d74c7b95-2405-4e2a-92fa-de35246ee4c0"
      decimals="-3"
      id="F_86d95724-1e9b-4f10-9307-5744ecf90a10"
      unitRef="U_USD">4277000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_edc2adbf-8141-490c-92ff-6e31ec443f9f"
      decimals="-3"
      id="F_4384f9a2-820a-4b98-865b-ed8f3d993789"
      unitRef="U_USD">1491000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_dd3aadef-8b9e-4abb-a618-63b7b63a02d8"
      decimals="-3"
      id="F_14642334-1033-4234-9104-0458515f1481"
      unitRef="U_USD">8845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d928ea5e-1b31-4b26-9a65-5053f8c68714"
      decimals="-3"
      id="F_96d48547-7814-4790-987b-f84a04a5b2ca"
      unitRef="U_USD">5054000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="-3"
      id="F_eb879ef3-d26d-487f-88c8-368982819449"
      unitRef="U_USD">13122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c1d9d64e-804a-4efb-a4d6-ddf6ef80eac7"
      decimals="-3"
      id="F_52433577-c3ef-4135-8c5c-75cd8caebb65"
      unitRef="U_USD">6545000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_8d3127d0-ad4d-498f-92ca-4bdbe97aa98c"
      decimals="-5"
      id="F_6f2ca0c7-6472-4fab-8a68-f2b5be4128ab"
      unitRef="U_USD">17600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_7522680b-bc8f-4e01-a38a-ae0373a97af5">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_9783de3b-75fc-4212-b881-8a501bc4490b">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company currently operates and manages its business as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment, to develop therapies to protect transplanted organs and prevent rejection. The Company's chief operating decision maker (the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201c;CODM&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;), is the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1691d7f7-1fe6-4184-b13f-c7d5693df0ef;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b5c49917-80ca-456f-a3d2-e4aad4794ea8;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;single&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment entity, &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant segment expenses, as provided to the CODM, are presented as the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.026%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - kidney transplantation programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - other development programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment and net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      decimals="INF"
      id="F_4dc6a6fe-b68e-4936-9ce1-b68474e230bd"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:FactorsUsedToIdentifyEntitysReportableSegments
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_32d34539-39ff-4469-9b94-7b02d17f280d">The financial results of the Company's operations are managed and reported to the CODM. Managing and allocating resources on a consolidated basis enables the CODM to assess the overall level of resources available and how to best deploy these resources across functions.</us-gaap:FactorsUsedToIdentifyEntitysReportableSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_a2e16cd9-2df9-49fe-ba8e-c93aa0a451e2">the CODM assesses performance and allocates resources based on the Company's consolidated statements of operations. Significant segment expenses, as provided to the CODM, are presented as the following:</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_3785f9a2-f040-4ff8-bb69-8b3c63890d71">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant segment expenses, as provided to the CODM, are presented as the following:&lt;/span&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.026%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.078000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - kidney transplantation programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tegoprubart - other development programs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,930&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;431&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment and net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <eldn:Tegoprubart-KidneyTransplantationPrograms
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_0e25599a-9ab5-49ec-ae23-4426ff4df650"
      unitRef="U_USD">27452000</eldn:Tegoprubart-KidneyTransplantationPrograms>
    <eldn:Tegoprubart-KidneyTransplantationPrograms
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_35616a99-61c7-49f9-a96f-010ad5307ec0"
      unitRef="U_USD">11940000</eldn:Tegoprubart-KidneyTransplantationPrograms>
    <eldn:Tegoprubart-OtherDevelopmentPrograms
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_8b594d10-d7f4-429e-9612-4591047b9582"
      unitRef="U_USD">306000</eldn:Tegoprubart-OtherDevelopmentPrograms>
    <eldn:Tegoprubart-OtherDevelopmentPrograms
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_129eaded-1c66-4afa-b5ec-c5cd59523d5c"
      unitRef="U_USD">3186000</eldn:Tegoprubart-OtherDevelopmentPrograms>
    <us-gaap:ManufacturingCosts
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_3610ada5-d637-45a7-bdfe-cf0aeb53b2ec"
      unitRef="U_USD">12448000</us-gaap:ManufacturingCosts>
    <us-gaap:ManufacturingCosts
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_a09f9553-a4c1-4fab-9168-74b02deb831a"
      unitRef="U_USD">8048000</us-gaap:ManufacturingCosts>
    <eldn:Personnel-RelatedExpenses
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_eacdfb3d-5d71-464b-9028-b6f575845c2c"
      unitRef="U_USD">10706000</eldn:Personnel-RelatedExpenses>
    <eldn:Personnel-RelatedExpenses
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_afae4fc8-5a3d-46bd-87be-b63d52a16716"
      unitRef="U_USD">8351000</eldn:Personnel-RelatedExpenses>
    <us-gaap:ShareBasedCompensation
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_5d606a45-688b-488b-8c28-2993ac12678e"
      unitRef="U_USD">13122000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_3fcb1f31-208a-4a85-bc95-8349a1b26230"
      unitRef="U_USD">6545000</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_839f39e2-dfd2-44b0-b681-baa253543e2c"
      unitRef="U_USD">6543000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_fc134c8b-f67c-46d7-9115-e82f9852e206"
      unitRef="U_USD">4930000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_31188c78-a33e-470d-b526-449b7698f124"
      unitRef="U_USD">70577000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_b9a39848-14bc-474e-a4d6-30991cb7a6c1"
      unitRef="U_USD">43000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_892338ad-0455-4dd3-8c96-b63edfadf69e"
      unitRef="U_USD">-70577000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_8a3000bf-4d0f-4b1c-b81d-5c90d45af9ae"
      unitRef="U_USD">-43000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_f3625d07-2536-4324-8141-29013a810dbe"
      unitRef="U_USD">3924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_361e9246-a0ac-45ac-82bf-f81e0d967161"
      unitRef="U_USD">2674000</us-gaap:OtherNonoperatingIncomeExpense>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_2570a038-3cf1-4805-81fa-24aa3296b83b"
      unitRef="U_USD">-30900000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_03e42872-32fb-4fe0-8244-7a87d42da45f"
      unitRef="U_USD">76211000</eldn:ChangeInFairValueOfWarrantLiabilitiesAndFairValueOfFinancialInstrumentsIssuedInExcessOfProceeds>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_225f1487-04e6-459c-ae92-10018fee512f"
      unitRef="U_USD">431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_c01ec1c7-4246-48a0-911e-d83e8235923b"
      decimals="-3"
      id="F_e31e035f-c466-4141-b23c-4e644e1dd8b1"
      unitRef="U_USD">-36184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c21c7ff8-2b4c-4d84-9fd5-808225a5e583"
      decimals="-3"
      id="F_d8715801-40be-4027-97c6-9430b21079a8"
      unitRef="U_USD">-116537000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_a83408d9-d439-46ef-8f80-2334a97de048"
      id="F_f11f3f7e-0aca-4a61-aeb8-93e7b76acfe8">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 11. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has evaluated events subsequent to December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through the filing date of this Annual Report on Form 10-K. Any material subsequent events that occurred during this time have been properly recognized or disclosed in the consolidated financial statements and accompanying notes.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
